AWAKE,CROATIA
174,177,ADVERSE,BACKGROUND,CHILD,CONCLUSION,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
WHILE
BASAL,DUE,INSULIN,MRI,TOLERANCE
ANALYSING,STRUCTURAL
169,COPYRIGHT,NEURONS,SCIENCE,SOMATIC
100,177,215,2MM,CONCLUSION,DISTANCES,DTA,ECLIPSE,LABEL,METHODS,NOVALISTX,PTW,RESULTS,SEVEN29,SSD,SURFACE,TPS,TREATMENT
003,276,284,469,704,853,898,BMI,CONCLUSION,DFS,LABEL,METHODS,OBESE,OBESITY,OBJECTIVE,PURPOSE,RESULTS,THERE
EVALUATION,MAXIMAL,METASTASES
AFTER,CHOROID,DYSPHONIA
CROATIA,DEPARTMENT,ENT,GENERAL,METASTATIC,RENAL,SURGERY,ZADAR
113,146,354,AMONG,BASED,BESIDES,DFS,FIRST,III,NANTONG,NUCLEAR
BACKGROUND,EARLY,GAMMA,HUNGARY,LABEL,METHODS,OBJECTIVE,PATIENT,PERSISTING,PURPOSE,RESULTS,SELECTION
ARGUMENTS,DESPITE,HOWEVER,HUNGARY,WHILE
177,AIM,ATTENTION,CONCLUSION,EMOTIONAL,ERROR,LABEL,METHODS,NETWORK,OBJECTIVE,QOL,RESULTS
BASED,DETECTING,HEMIFIELD
CHEST
AUXILIARY,CONCLUSION,JANUARY,LABEL,METHODS,NATAL,NORTE,OBJECTIVE,OCTOBER,RESULTS,RIO,THERE
ALONG,EEG
288,MRI,THEREFORE
000MG,178,BASED,FDG,FOLLOWING,HOWEVER,MALIGNANT,PET,SINCE
CENTRAL,EMERGENCY,MAY,MEDLINE,SCHOLAR,TREATMENT
OTHERWISE,TARGETABLE
PHYLLODES,RENAL,SURGERY,TREATMENT
837,FACTORS,ONTARIO,WHETHER
BACKGROUND,CYTOLOGIC,CYTOPLASMS,DEPENDING,MEDULLARY,MEN
002,151,169,COPYRIGHT,COX,DELAY,INC,LABEL,LOCAL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SRS
169,ANATOMICAL,COPYRIGHT,DTI,FIFTY,FRACTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
019,024,048,169,AGE,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SEVENTY,SIX,SIXTEEN,THESE,THREE
011,028,032,033,102,108,109,118,138,169,170,172,201,260,303,ACT,BETWEEN,CONTINUED,COPYRIGHT,CSI,EBT,FVC,INC,IQR,LABEL,MARCH,METHODS,OBJECTIVE,PFT,PULMONARY,PURPOSE,RESULTS,THERE,THESE,TLC
216,270,282,284,350,566,604,ALK,AMONG,IHC,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VENTANA
177,ACADEMY,CHINESE,COLLEGE,CONCLUSION,DEC,FEDERATION,GYNECOLOGY,IB1,IB2,IIA,JAN,JUL,LABEL,MEDICAL,METHODS,NECUC,OBJECTIVE,OBSTETRICS,PATHOLOGIC,PFS,RECURRENT,RESULTS,TEN,UNION
000,114,398,456,580,649,933,974,APRIL,CIS,COCHRAN,ECM,GALBR,HOWEVER,III,ORS,POTENTIAL,SIX,SMD,STUDIES
ETHER,FDA
946,BRAIN,CD3,CD4,CD5,CD8,DESPITE,FURTHER,GADOLINIUM,HOWEVER,IIE,ISH,TAI,TCR,TIA
CD151,CONCLUSION,DETECTING,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
001,002,009,078,169,CHO,CONCLUSION,GLX,GUA,HOWEVER,LABEL,LIPID,METABOLITE,METHODS,MRS,OBJECTIVE,PURPOSE,RESULTS,ROC,THRESHOLD,WHITNEY
169,BASED,CCM,GRE,IMAGING,ITALIAN,LITERATURE,MRI,RESONANCE,SWI,THREE
169,BACKGROUND,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,ROI,SIX,SMA
169
169,LITERATURE
HODGKIN,PNETS,SECONDARY,THESE
169,CD133,CONVERSELY,COPYRIGHT,HIPPO,HOWEVER,INC,MYC,NANOG,PDZ,PUBLISHED,TAZ,THESE,YAP,YES
145,169,CD133,CONVERSELY,CR208,GBM,GSC,IE1,IES,OVERALL,SIMILARLY,TOWNE,UL123
PALLIATIVE,THERE
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,VARYING
AFTER,MRI,THREE
946,AXIN2,CD133,NANOG,THESE,USING,WNT
AGE,PAS,PILOCYTIC,SEVEN,TEN,V600E
CARLO,CHANGES,HOWEVER,MONTE,MRI,NON
177,DIFFERENT,FDG,PANCREATIC,PET,THEREFORE
MALDI,MSI,PCA,PRL,SVM,TSH
APT,FURTHER,NUCLEIC,SELEX,USING
160,163,169,CONCERN,COPYRIGHT,EZZAT,INC,PATHOLOGY,PUBLISHED,SOCIETY
CERTAIN,HOWEVER,RADIATION,SOCIETY
EASTERN,FIFTY,GRADE,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,SEVENTEEN,SHORT,THESE,THREE
169,COPYRIGHT,INC,PCM,PGT,THESE
009,015,045,169,183,920,AROMATASE,BACKGROUND,COPYRIGHT,COUNCIL,EARLY,FUNDING,GROUP,INTENTION,LABEL,LTD,MEDICAL,METHODS,PRIMARY,PUBLISHED,RESULTS,RRS,THERE,TRIALISTS
002,004,169,183,206,766,767,AMONG,BACKGROUND,COPYRIGHT,COUNCIL,EARLY,FUNDING,GROUP,INTENTION,LABEL,LTD,MEDICAL,METHODS,OVERALL,PRIMARY,PUBLISHED,RESULTS,RRS,TRIALISTS
169,COPYRIGHT,LTD,PCI,SMALL
169,ADRIAMYCIN,ADX,ATP,CALCEIN,CASPASE,COPYRIGHT,DESPITE,GBM,INCREASING,IRELAND,LTD,MOLECULAR,TAKEN,THREE,TMZ,USING
BLOOD,ICH,VTE
169,CNS,COPYRIGHT,DIFFUSE,DIPGS,HOWEVER,INC,MUTATIONS,THESE
BLASTIC,BPDCN,CD4,ELDERLY
113,AIM,INSTITUTE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,ROMANIA
001,006,008,013,029,039,046,150,400,750,ADC,ADCHIGH,CONCLUSION,DIXON,DWI,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PERFUSION,RESULTS,THERE,THESE
AIM,ANXIETY,CONCLUSION,DEPRESSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PROVIDING,RESULTS,SCALE,SHORT
MRI
169,945,946,955,COPYRIGHT,IFN,III,INC,SNP,VIRAL
946,ALZHEIMER,APP,ELISA,IMAGING,LY2811376,PS1
000,250,AFTER,CAP,FEC,LAP,TZB,WHILE,WHOLE
CLINICIANS,PCI,TKI
DYSPHAGIA,PALATAL,REGAINING,THEREFORE
100,BECAUSE,CNS,CSF,THESE,USING
160,169,652,ADVERSE,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS
160,APRIL,EVALUATION,GBM,GROUP,HDACI,INC,INSTITUTE,LABEL,MATERIALS,METHODS,MORBIDITY,OBJECTIVE,PFS,PROGRAM,PUBLISHED,PURPOSE,RADIATION,RESULTS,RPA,SCORING,THERAPY,TMZ,TREATMENT,VPA,YOUNGER
137,160,169,177,AMONG,ASSESSMENT,BATTERY,COPYRIGHT,EVENT,HIT,HOWEVER,INC,KAUFMAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PIQ,PNET4,PSI,PURPOSE,RAVEN,RESULTS,THEREFORE,USING,VIQ,WMI
169,17Q,281,286,ATLAS,COPYRIGHT,GBM,GROUP,INC,NF1,R132H
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PARTNER,PUBLISHED,RESULTS,SOCIETY,THERE,URBAN
169,AKT,BAX,BCL,CASPASE,COPYRIGHT,GBM,HOWEVER,INHIBITION,IRELAND,LTD,NVP,THESE,TMZ
AMONG,CONCLUSION,FDG,FURTHER,LABEL,MRI,PET,RELATED,UNLABELLED
135,169,COPYRIGHT,LABEL,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
169,739,765,954,APAF1,COPYRIGHT,ECTOPIC,KAISO,POK,PREVIOUSLY,THESE,WHILE
FIRST,THEREFORE
169,CNS,COPYRIGHT,DELTA,HOWEVER,INC,NOTCH,THESE,VEGFR
CNS,REPORTS
BACKGROUND,BRAIN,EXCLUSION,LABEL,MATERIALS,METHODS,MRI,OTHER,RESULTS
169,183,ACADEMY,ALZHEIMER,EIGHT,LABEL,METHODS,NEUROLOGY,OBJECTIVE,RESULTS
BACKGROUND,BLOOD,DIFFUSE,DOL,LABEL,METHODS,METICULOUS,SIGNS
AFTER,ALZHEIMER,HOWEVER,TBI,TRAUMATIC
169,19Q,COPYRIGHT,INC,NEWLY
169,956,AFTER,BACKGROUND,BRITISH,IMAGING,JOURNAL,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,THESE,TRIAL,UNIVERSITY
AKT,COA,GBM,GLUCOSE,REMARKABLY,THESE
239,ALCOHOL,DROSOPHILA,RAS
032,150,169,300,ADULT,AMONG,CONCLUSION,INADEQUATE,LABEL,METHODS,MOLECULAR,OBJECTIVE,P53,PFS,PTCH1,PURPOSE,RESULTS,SHH,SMO,SOCIETY,THREE,VISMODEGIB,WHOLE
SOL,SUBSEQUENT,WEGENER
CRUDE,DCM,FUNGI,HOWEVER,MTT,PISOLITHUS,RKO
169,ASD,CCCTC,COPYRIGHT,EPIGENETIC,GIVEN,INC,NOTABLY,PUBLISHED,SOCIETY,THESE,USING
774,CPEB4,HOWEVER,IHC,PCR,WESTERN
FURTHER,LSD,MYC,OLIG2,POU,SRY
FURTHER,GBM,III,PET,PHASE,TMZ
124,177,GAMMA,KNIFE,PERFEXION
BASED,ENGLISH,EXTRACTION,ICU,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,SOURCES,SYNTHESIS
COH,FSH,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,GBM,INC,ISSUE,MYC,SPECIAL,TARGETING
169,CNS,COPYRIGHT,LTD,NEURO
12A,956,ABC,ABCB1,ABCC1,ABCG2,ATP,GOVERNMENT,HOWEVER,IMAGING,KO143,THESE
008,144,177,213,AMONG,BACKGROUND,CONTEXT,CUSHING,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,UFC
169,177,945,AUTHORS,CONCLUSION,COPYRIGHT,DISEASE,FASTING,GERIATRICS,IFG,JOURNAL,LABEL,METHODS,NFG,OBJECTIVE,OBJECTIVES,ORS,POPULATION,RESULTS,SETTING,SOCIETY,WORLD
GRADE
HYPERHAES,WHILE
1990S,ALA,ALASENS,BACKGROUND,BASED,DEPARTMENT,HOWEVER,INSTITUTE,LABEL,METABOLIC,METHODS,NEUROLOGY,RESULTS
DESPITE
169,204,COPYRIGHT,FINALLY,IMR32,LAN,SNP,THEREFORE,UTR
169,ALK,COPYRIGHT,FINALLY,INC,THESE
169,COPYRIGHT,GBM,INC,MICRORNAS,PDCD4,PROGRAMMED
169,231,233,COPYRIGHT,PUBLISHED,SAS,THESE
174,177,2012A,956,CARLO,CONCLUSION,CTV,GBM,KNOWLEDGE,LABEL,MATHWORKS,MEP,METHODS,MONTE,OBJECTIVE,RESULTS,SFS

BCL,EMA,MIB,NAB2EX6,SFT,STAT6,STAT6EX16,THEIR,THESE,USING
174,AFTER,BRAINPATH,GERMANY,SEVERAL,STORZ,TUTTLINGEN,VITOM
174,ADVERSE,AES,APRIL,BACKGROUND,CONCLUSION,CTCAE,GLIADEL,HOWEVER,JANUARY,JAPAN,LABEL,METHODS,RESULTS,SEPTEMBER,SEVERAL,THEIR,THERE
102,160,215,224,300,354,GENOMIC,GIVEN,HOWEVER,MENDELIAN,SIMILAR,SINCE
005,169,215,BED,COPYRIGHT,GBM,INC,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THESE
ANAPLASTIC,BACKGROUND,CONCLUSION,IMAGING,LABEL,METHODS,VIDEO
CONCLUSION,EXCELLENT,FORTY,GTN,IRB,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SIX,STATISTICS
10877,967,BACKGROUND,III,LABEL,METHODS,RESULTS,THERE,THEREFORE,TTFIELD,USING
004,100,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THREE
144,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS
001,005,009,023,028,169,309,540,580,AIM,ANTICANCER,BACKGROUND,CDKN2,CGG,CGT,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,REGARDING,RESULTS,THESE,USING
169,BRAIN,DDX23,GUARANTORS,HOWEVER,PRESS,PUBLISHED,TAKEN,UNIVERSITY
GIVEN,THERE,TRM
169,231,233,ALK,COPYRIGHT,HOWEVER,HSP,INHIBITORS,INTERGROUP,NON,NSCLC,PFS,PROTEIN,PUBLI,PUBLISHED,SAS,SHOCK,SMALL,STRATEGIES,THESE
169,946,C2C12,COPYRIGHT,FMK,GFP,GFP11,GPA,IBS008738,INC,MOUSE,MYOGENESIS,RAC,VAD
174,BETWEEN,COHORTS,CONCLUSION,DLT,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PHASE,PURPOSE,RESULTS
947,BECAUSE,DIPG1,DIPGS,JHH,JQ1,NOTCH,SHORT,TREATMENT
140,169,BECAUSE,CONCLUSION,FMISO,IMAGING,INC,LABEL,MEIER,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,TBMAX,UNLABELLED
BET,CONTAINING,CONVERSELY,GBM,HELICOS,HOWEVER,HOX,MULTIFORME,SMALL,TREATMENT
005,702,852,864,893,AUC,CONCLUSION,DSC,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROC,VARIATION
169,CSC,GBM,LABORATORY,PRESS,PUBLISHED,TISSUES
002,169,COPYRIGHT,DWI,GTV,HCV,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PDV,PFS,PRE,PURPOSE,RADIATION,RESULTS
102,169,177,945,CONCLUSION,HISTOLOGIC,INCREASED,INDUCTION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RELAPSE,RESULTS,SIXTY,SOCIETY

ALZHEIMER,CONCLUSION,LABEL,PEARSON,RESULTS,UNLABELLED
AFTER,AUTOPSY,BECAUSE,GBM
177,956,963,GBQ,PET,SMALL,THESE,TREATMENT
018,15Q21,169,215,746,AFRICAN,AMERICANS,BACKGROUND,CDC5L,COMPASS,CONSORTIUM,ELTD1,HDAC9,HEART,IL1RN,INC,LABEL,METAL,METASTROKE,METHODS,NOMINAL,OBJECTIVE,PITX2,POPULATION,PTPRG,PURPOSE,RESULTS,STUDIES,USING,WDFY4,ZFHX3
169,384,BMI,HIT,LABEL,METHODS,NAFLD,OBJECTIVE,RESULTS,SOCIETY
001,DISCOVERY,OBJECTIVE
001,005,4TH,CNS,DFS,THEREFORE
10878,BACKGROUND,CARCINOMA,CONCLUSION,CONSORTIUM,EASTERN,FINAL,GROUP,LABEL,METASTATIC,METHODS,OBJECTIVE,PFS,RENAL,RESULTS
169,BIOLOGY,CONVERSELY,DEPLETION,FINALLY,FOXM1,HOWEVER,INC,MOLECULAR,SOCIETY,THESE
DESPITE,FGFR1,FIBROBLAST,K656E,ONCOGENIC,PAS,THESE,THREE
945,956,GBM,HIF,HYPOXIA,ORTHOTOPIC
001,010,031,AGE,CONCLUSION,INS,KNOWLEDGE,LABEL,METHODS,NAA,OBJECTIVE,POINT,RESULTS
ACCORDING,CONCLUSION,ETV,LABEL,METHODS,OBJECTIVE,PEB,RESULTS,SIXTY
101,102,104,124,169,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SELECTION,THERE
5XFAD,945,946,947,ALZHEIMER,AMYLOID,APP,CONVERSELY,PEROXISOME,PPARA,SDS,SEQUENTIAL,THEREFORE,THESE
947,C53,NUCLEOLAR,THESE
ANOTHER,CAROTID,CONCLUSION,ICA,LABEL,METHODS,NPC,OBJECTIVE,PURPOSE
AFTER,ATTENUATED,CHEST,CONCLUSION,DEPENDING,FLAIR,FLUID,INVERSION,LABEL,METHODS,MRI,OBJECTIVE,PATHOLOGY,PLE,PURPOSE,RECOVER,SIX
ANATOMICAL,MRI,PNC,RESULTS,WHILE
160,ATTENUATED,CSH,EMT,ESRP1,FURTHER,IGF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
GRADE,MELATONIN,MULTIFORME,OCTREOTIDE,RETINOIDS,VIT,VITAMIN
131,169,500MG,BACKGROUND,BETWEEN,COPYRIGHT,DOVITINIB,JANUARY,LABEL,LTD,METHODS,OCTOBER,PFS,RESULTS,SECONDARY,THERE,VEGFR
169,BRAIN,CHC22,CONGENITAL,E330K,GUARANTORS,PRESS,PUBLISHED,SIMILARLY,THESE,UNIVERSITY
169,COPYRIGHT,INC,PAPILLARY,SEVENTEEN
169,COPYRIGHT,EPIGENETIC,LTD
169,ASSESSMENT,BRAIN,CNS,COPYRIGHT,LTD,METASTASES,NEURO
DESPITE,FINALLY,N10
169,ANALYZING,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FIRST,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SRT,TCP
577,783,BACKGROUND,CONTEXT,DUTCH,HORMONE,HOWEVER,LABEL,MEASURE,METHODS,NFPAS,OBJECTIVE,OUTCOME,PRIOR,RESULTS,SETTING,TREATMENT
125,150,BACKGROUND,BBT,IMAGING,INCLUSION,IRINOTECAN,LABEL,LGG,MANAGEMENT,METHODS,PROCEDURE,RESULTS,SEVEN,SIXTEEN,THREE,TREATMENT
169,CONTINUING,HOWEVER,PRESS,PUBLISHED,UNIVERSITY,V600E
169,BIOLOGY,FINALLY,INC,MOLECULAR,SOCIETY
169,AUTHORS,BACKGROUND,BLOOD,BTS,CNS,CONCLUSION,INC,LABEL,METHODS,PEDIATRIC,RESULTS,SURVIVORS,THESE,WILEY
169,COPYRIGHT,IL8,IRELAND,LTD,MARIMASTAT,MMP,MMP14,MT1
100,457,551,553,ACCORDING,BASED,BESIDES,MMP
160,293,757,CNS,COMPETING,CONCLUSION,COX,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE
100,169,945,BACKGROUND,BESIDES,CNP,COPYRIGHT,GFP,GIC,HOWEVER,IRELAND,LABEL,LTD,METHODS,NG2,PCR,PDGFR,PRIMARY,RED,RESULTS,RFP,SU3,U87
169,509,555,ABSTRACTS,CIS,EFFECTS,HEMATOLOGY,MEDLINE,REVIEWS,SCALE,SOCIETY,STUDIES,TEN,THERAPY,WORKING
000,169,700,956,ALZHEIMER,COPYRIGHT,INC,PARKINSON,PRINCETON,SLC11A2,TFR
169,COPYRIGHT,IMAGING,INC
CNS,COMPARISON
169,945,DCA,MRS,NHA,NOTABLY,PDH,REDUCED,TAKEN,U87,USING
141,BACKGROUND,BELOB,CEC,CONCLUSION,LABEL,METHODS,RESULTS
001,169,349,AUC,BACKGROUND,BASAL,BOX,CONCLUSION,DIAGNOSIS,FOXC1,GEM,IHC,LABEL,METHODS,PAM50,PCR,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,ALTOGETHER,AUTOPHAGY,CERTAIN,COPYRIGHT,HCC,HEP3B,HEPG2,INC,PEPCK
APOPTOSIS,CREATED,REDUCED
CONCLUSION,LABEL,LATER,METHODS,MRI,OBJECTIVE,PURPOSE,THERE
90O,OAR,PHILIPS,PINNACLE3,PTV50,PTV66,TPS,TREATMENT
174,CONCLUSION,FFF,KNOWLEDGE,LABEL,MEDICAL,METHODS,MUS,OAR,OBJECTIVE,PHANTOM,PTV,RESULTS,SYSTEMS
KREITER
147,APHDS,BACKGROUND,BRAIN,CDI,CONTEXT,IDIOPATHIC,LABEL,LANGERHANS,METHODS,OBJECTIVE,OUTCOME,PEDIATRIC,PROVIDERS,RESULTS,SEATTLE,SETTING,THESE
946,BECAUSE,CERTAIN,CLR01,LYS,THEREFORE
10P12,10Q21,13Q12,215,542,620,771,788,CHINESE,HAN,PITUITARY,SNP
169,COPYRIGHT,DESPITE,EXPRESSION,FEDERATION,INHIBITION,MG132,PUBLISHED,SEVERAL,SOCIETIES,THEREFORE
001,006,033,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RCC,RENAL,RESULTS,SRS
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MENINGIOMA,METHODS,OBJECTIVE,PATIENT,RESULTS
001,149,169,261,287,AIM,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,END,HODGKIN,INSTITUTE,JANUARY,LABEL,MCL,METHODS,NHL,NON,OBJECTIVE,RESULTS,SIR,SPM,THERE
143,145,169,174,AIM,ANTICANCER,ANTISENSE,BACKGROUND,CONCLUSION,COPYRIGHT,GBM,IM3,INSTITUTE,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,RESULTS,RHO,U87
001,003,006,160,169,183,500,956,ACUTE,ASL,BRAIN,COPYRIGHT,FIFTY,HGG,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TLC,TMZ,V25GY
0MM,169,5MM,BACKGROUND,CONCLUSION,COPYRIGHT,DSC,EIGHT,ICD,IRELAND,LABEL,LTD,MATERIALS,METHODS,NPC,OAR,OBJECTIVE,PCM,PURPOSE,RESULTS,TMJ
002,ASSESSMENT,BACKGROUND,BIOMARKERS,CONCLUSION,DISCUSSION,III,LABEL,METHODS,PFS,R132H,RESULTS,THESE,TMZ
001,AMERICANS,ETHNICITY,ITALY,THROUGH
336,945,BACKGROUND,COX,ELISA,HOWEVER,LABEL,MEIER,METHODS,PBMCS,PCR,PFS,RESULTS,STRATIFIED
SELLA,SEVERAL
100,YEARS
ENGLISH,HOWEVER,INDEX,SURVIVORS,UTILITIES
001,016,109,127,169,1P19Q,CCND1,CIC,DUSP4,HOWEVER,HS683,IDH,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,VARIOUS,WTS
ACCORDING,III,KARNOFSKY
007,009,018,021,022,029,033,036,037,042,169,245,489,PBT,PRESS,PUBLISHED,RTEL1,STRATIFIED,THEREFORE,UNIVERSITY
001,100,169,AVAGLIO,C30,CONCLUSION,HRQOL,III,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RAW,RESULTS,SOCIETY,TABLE,TMZ,TREATMENT
000,100,169,235,305,350,439,450,519,520,550,607,764,787,966,AVASTIN,CONCLUSION,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,QALYS,RESULTS,SOCIETY,VALUE
100,192,201,434,458,723,893,BMI,HOWEVER
BACKGROUND,BRAIN,CONCLUSION,EOC,LABEL,METHODS,MRI,OUTLINE,PROGNOSIS
CRT,DMEAN,FFF,FLATTENING,MUS,NSCLC,OCTOBER,THERE
ULTRASOUND,WHILE
BRAIN,MRI,NMO,THESE
100,BESIDES,ELOVL,HAPLOTYPE,IMPORTANCE,L168F,LABEL,METHODS,OBJECTIVE,RELEVANCE,RESULTS,SCA,SCA34,SETTING,USING,W246G
BMJ,GROUP,LABEL,LIMITED,MENINGITIS,METHODS,MINIRIN,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,THERE,TOTAL
169,AIF,APOPTOSIS,COPYRIGHT,DEPLETION,INC,THESE
160,169,947,COPYRIGHT,INC,PEROXISOME,PUBLISHED,RE1,REST4,RESULTS
169,MANAGEMENT,OAB,SINCE,SMALL,THESE,TRAUMATIC,URINARY,WHITE,WMD
169,ABCA1,ATP,AUTHORS,COPYRIGHT,GBM,GLYBURIDE,INC,INHIBITION,MEMBERS,PUBLISHED,S1P,SILENCING,SPT,SUBUNIT,U87MG
157,169,276,2DG,CNS,COPYRIGHT,MALDI,PROTEOMICS,TOF
169,ACIDS,NOTABLY,NUCLEIC,PRESS,PUBLISHED,THESE,UNIVERSITY,WHEREAS
002,169,2CM,5CM,600MU,8CM,BACKGROUND,CONCLUSION,COPYRIGHT,GAMMA,IRELAND,KNIFE,KRUSKAL,LABEL,LINAC,LTD,MATERIALS,METHODS,OBJECTIVE,PADDICK,PURPOSE,RESULTS,SIMILAR,SRS
169,200,946,956,BACKGROUND,CATENIN,COPYRIGHT,EASTERN,GBM,INC,LABEL,MATERIALS,METHODS,MTS,RESULTS,TREATMENT,U87,WNT
169,760,BIOLOGY,FINALLY,GBM,HIPPO,INC,MOLECULAR,S760A,S760E,SER,SIMILAR,SOCIETY,UTILIZING,YAP
100,169,BACKGROUND,BASEL,BRAIN,CONCLUSION,III,INTRADURAL,LABEL,METHODS,THESE,UNDER
AFTER,MCG,MRI,MULTIFOCAL,PET,THROUGH
CHANGES,GROWING,IDO
BBB,CNS,GBM
169,ADVANTAGES,ALK,COPYRIGHT,LTD,NSCLC,TKI
BACKGROUND,CONCLUSION,GCT,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY
001,169,552,AFTER,CONCLUSION,COX,GPA,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,SEVERAL,SOCIETY
001,104,153,169,189,293,HEMATOLOGY,LOG,OVERALL,SOCIETY,THERE
SEX,THESE
GBM,GSC,HOWEVER
156,217,OVERALL
132,169,946,COPYRIGHT,HOWEVER,INC,MIR,SMAD7,TAKEN,TGF,THESE,UTR
169,946,COPYRIGHT,INC,KNOCKDOWN,LDH,U87,WNT,XBP1S
001,004,011,028,169,188,911,933,ASSESSMENT,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PREDICTION,PRESS,PROGNOSTIC,PUBLISHED,RESULTS,SIXTY,UNIVERSITY
169,231,233,COPYRIGHT,ENDOCRINE,GONADAL,PUBLISHED,SAS
100,AFTERWARD,AUTHORS,CONTINUOUS,GROSS,IOM,LABEL,MEP,METHODS,OBJECTIVE,RESECTION,RESULTS,TRANSIENT
118,1ST,435,AMONG,BRAIN,CALCULATED,CASES,COX,CUMULATIVE,EXCLUDING,GAMMA,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,UNIVARIATE
002,265,FSE,LABEL,METHODS,OBJECTIVE,READERS,RESULTS,THREE,WIS
FEW,MONRO,SIMILARLY,TSC
100,177,946,CD133,FCM,III,LABEL,METHODS,NG2,OBJECTIVE,PRIMARY,RESULTS,SHG139S
001,002,010,016,027,103,169,BACKGROUND,COX,HOWEVER,KARNOFSKY,LABEL,LEV,METHODS,PFS,RESULTS,SOCIETY
PET
169,CD4,COPYRIGHT,INC,THESE,USING
169,183,228,456,508,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATHOLOGY,RESULTS,SOCIETY
169,CAPON,COPYRIGHT,EXF,GTPASES,PDZ,PSD95,TAT
003,009,169,177,611,947,BACKGROUND,FIBRINOGEN,GBM,GL261,LABEL,MDSCS,METHODS,NOD,NSG,PEARSON,PRESS,PROTEIN,PUBLISHED,RESULTS,TREGS,UNIVERSITY
AFTER,BALANCING,FOLLOWING,HBA1C,HBALC,LABEL,MAY,METHODS,MRI,UNLABELLED
010,169,BACKGROUND,BDIXS,BMD,DECREASED,ENDOCRINE,INC,LABEL,METHODS,PROCEDURES,RESULTS,THERE,WILEY
150,169,178,610,AUC,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,MONDAYS,OBJECTIVE,PURPOSE,RESULTS,TUESDAY
169,BTG,ID3,INC,NOTABLY,PC3,SVZ,TIS21,TOB,WILEY
169,500,CNS,COPYRIGHT,EPENDYMAL,INC,REGARDING,WORLD
169,CHOROID,COPYRIGHT,CPC,INC,TAF12,USING
169,COPYRIGHT,HOWEVER,INC,MBM,METASTATIC
ALZHEIMER,ARG,ASP,H3O,HV1,THEIR
000,102,151,169,500,750,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FORTY,FURTHER,INSTITUTE,LABEL,METHODS,NEITHER,OBJECTIVE,OVERALL,RESULTS,SRS,SRT
056,169,177,ANTICANCER,BACKGROUND,CHOROID,CONCLUSION,COPYRIGHT,CPC,INSTITUTE,LABEL,LFS,MATERIALS,MEIER,METHODS,OVERALL,RESULTS
001,021,023,045,049,093,110,169,354,AIM,AMONG,ANTICANCER,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,CYCLE,DESPITE,GRADE,IMPACTS,INSTITUTE,LABEL,METHODS,OBJECTIVE,PCV,PFS,RESULTS
169,854,ANTICANCER,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,GEC,GIVEN,INSTITUTE,LABEL,MATERIALS,METHODS,PATHWAY,RESULTS
030,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EMT,EPITHELIAL,FRESH,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PITUITARY,RESULTS,THERE,THESE,TWIST
AFTER,CNS,CRANIOTOMY,III,RESTAGING
144,169,177,178,215,334,544,595,694,ADC,BACKGROUND,BOARD,CONCLUSION,DIFFUSION,DWI,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMITIVE,RESULTS,SEVERAL
169,231,233,COPYRIGHT,EARLY,FINALLY,HYPOSIALIA,ONCOLOGIC,PUBLISHED,SAS,TASTE,THESE
120,135,GLASGOW
AKT,EVALUATION,INDUCTION,KANK3,SULF2,THESE
215,365,809,ABCA1,ACOT4,AFRICAN,AMERICANS,BLOOD,DISCOVERY,ESP,EXOME,HEART,IMPORTANCE,INSTITUTE,JANUARY,LABEL,METHODS,NHLBI,OBJECTIVE,PDE4DIP,PROJECT,RELEVANCE,RESULTS,SEQUENCING,SETTING,THESE,ZFHX3
169,AML,BACKGROUND,COA,COPYRIGHT,EARLY,GENERAL,LABEL,MAJOR,METHODS,NADPH,R132H,SCOPE,SINCE,WHILE
CELLS,HTRA1,HYPOXIA,IGF,IGF2BP3,INS,LABEL,METHODS,OBJECTIVE,RESULTS,U87,U87GLIOMA
160,169,172,307,508,ACIDS,AMONG,BASED,ENRICHMENT,FOLDING,NOTABLY,NUCLEIC,OVERLAP,PRESS,PUBLISHED,QDH,UNIVERSITY
169,946,AUTHORS,BMP,COPYRIGHT,INVERSELY,MEMBERS,PUBLISHED,TGF,THESE
169,COLLEGE,COPYRIGHT,LTD,MRI,PUBLISHED,ROYAL
BRITISH,CERTAIN,DIFFUSION,DIG,DIT,GBM,METHODS,MRI,RESULTS
169,COPYRIGHT,EXPRESSION,PRIMARY,SCIENCE,THESE,TISSUES,VARIATION
ALK
169,COPYRIGHT,INC,PERFUSION
BRAIN,HOWEVER,THERAPIES
ALA,BACKGROUND,CONCLUSION,HOWEVER,IMPORTANCE,LABEL,METHODS,MRI
169,950,COPYRIGHT,FURTHER,NGL,PAR,PDZ,PKC,THESE
169,558,CNS,CONCLUSION,DESPITE,DUE,FULLY,GERMANY,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,OVERALL,RESULTS,SCHLESWIG,SOCIETY,THESE,THYROID
145,431,473,BACKGROUND,CONTEXT,INCREASED,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SMR,SWEDISH,THERE,WOMEN
215,BACKGROUND,DISCUSSION,INCIDENTAL,LABEL,METHODS,SINCE
DESPITE,THESE
169,384,ARF,AUC,BACKGROUND,COPYRIGHT,DVT,INC,INPATIENT,LABEL,METHODS,NIS,OVERALL,PREDICTIVE,REGULATORY,RESULTS
169,ACBD3,ADP,AUTHORS,COA,ERK,GOLGI,LIMITED,NAD,PARP1,PRESS,TAKEN
169,947,AUTHORS,ERK,HDAC3,HDACS,HISTONE,HOWEVER,LTD,MMP,NOTABLY,PTY,PUBLISHING,SCIENCE,TAKEN,U87MG,WILEY
169,945,AKT,BIOLOGY,GD2,GD3,HOWEVER,INC,MOLECULAR,PDGFR,SOCIETY,SRC,THERE,YES
120,169,DMB,HDC,INC,INFANTS,MOLECULAR,PTCH1,UTR,WES,WHILE,WHOLE,WILEY
DIFFUSE,GSK
AMONGST,ASO,THESE
001,008,010,169,475,ADVERSE,APRIL,CAS,CEA,COPYRIGHT,END,INC,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,SURGERY,VULNERABLE
128,BACKGROUND,COLLEGE,CURRICULAR,INC,LABEL,MATERIALS,METHODS,PUBLISHED,RESULTS
001,005,017,164,169,284,BACKGROUND,CONCLUSION,COPYRIGHT,EOR,GTR,INC,IOMRI,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PERMANENT,RESULTS,YET
001,169,COPYRIGHT,CTV,FIFTEEN,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PGI,PTV,PURPOSE,RESULTS,RGI,TCP
169,BASED,COPYRIGHT,INC,VARIOUSLY
169,COPYRIGHT,FURTHER,HEPG2,INC,PERIFOSINE,USING
BLOOD,CHOROID,CPC,GREAT,ICE,METHODS,RESULTS,SPECIAL,TEN,THEREFORE,TORONTO
169,292,839,BACKGROUND,BLOOD,COX,ELISA,HEART,HOWEVER,IMUBIND,INC,ITALY,LABEL,LABORATORY,METHODS,MILAN,NUTRITION,OBJECTIVE,PURPOSE,RESULTS,USING
001,01206,03128,131,150,181,200,2GY,AFTER,AMONG,BACKGROUND,CHT,COX,DFS,GBM,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RTH,SURGERY
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS

169,BACKGROUND,BLOOD,DOSES,INC,LABEL,METHODS,RESULTS,SEGAS,THROUGH,TOTAL,TREATMENT,TSC,WILEY
1451A,160,556,700,BACKGROUND,COATS,H484P,INDIA,LABEL,METHODS,NOTCH,TEK,UTR,WES
252,CONCLUSION,DOSIMETRIC,HOWEVER,HWB,KNOWLEDGE,LABEL,LWB,MALIGNANT,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,EXPRESSION,IMI,STG
169,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RCC,RESULTS
169,19P13,BAH,CUSHING,GENOMIC,LABEL,METHODS,MOLECULAR,OBJECTIVE,RESULTS,SOCIETY
169,BRAIN,MRI,NPV,PPV
169,THERE
169,AFTER,HIV,MRI,NON,PCNSL,RITUXIMAB
002,082,100,169,177,BEV,CBF,EVALUATION,FIFTY,GBM,LABEL,MCA,UNLABELLED
169,911,AUC,BACKGROUND,CONTEXT,GRADE,III,LABEL,MACHINE,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC,THREE
ACROMEGALY,EXCESSIVE,IGF,STUDIES,THERE
169,BACKGROUND,COX,FINLAND,FINNISH,HEART,HISTORICAL,INC,LABEL,MEIER,METHODS,OBJECTIVE,POSTSTROKE,PURPOSE,RESULTS,STATISTICS,YOUNG
169,954,COPYRIGHT,IRELAND,LTD,MMP
001,10Q,169,19Q,210,26882,26951,426,636,CONCLUSION,EORTC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,VALIDATION
104,169,212,249,459,920,AMONG,ASSESSMENT,CONCLUSION,EVALUATION,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PEDIQUEST,PRO,PURPOSE,QUALITY,RESULTS,SCALE,SOCIETY,STRATEGIES,SYMPTOM,TECHNOLOGY,THOUSANDS
169,COPYRIGHT,INC,RCC,RENAL
169,ACADEMY,CONCLUSION,DISTANT,FOUNDATION,HNSCC,INTERGROUP,LABEL,METHODS,MULTI,OBJECTIVE,OPSCC,RESULTS,SETTING,SURGERY,THESE
169,231,233,AUTHORS,COPYRIGHT,PRINCIPAL,PUBLISHED,SAS,TREATMENT,USA
110,120,230,BLOOD,CONCLUSION,HCG,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PITUITARY,RESULTS
160,169,211,ASN,AUTHORS,GOLGI,LIMITED,PRESS,WHEREAS
128,FURTHER,MICRORNAS
LMX1A,LMX1B,NOTABLY,PARKINSON
169,APC,COPYRIGHT,ENDOGENOUS,INC,LTD,THESE
169,COPYRIGHT,GBM,INC,MUTATIONS,NGS,OVERALL,USING
10A,10B,169,BASED,BRAIN,GUARANTORS,PRESS,PUBLISHED,THESE,TNF,TRAIL,UNIVERSITY,USING
AFTER,BECAUSE,CPP,CURRENTLY,GRADE,MRI,TEN
100,248,611,ASA,AWAKE,BASED,CALIFORNIA,CLASS,FIFTY,FRANCISCO,KARNOFSKY,KPS,LABEL,LARYNGEAL,MAPPING,METHODS,OBJECTIVE,OPERATIONS,RESULTS,SAN,SIXTY,SOCIETY,UNIVERSITY,WASHINGTON
598,ADVERSE,ANY,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONFERENCE,CONTROLLED,DUE,FACTORS,FIFTEEN,FURTHER,HOWEVER,INDEX,ISSUE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OPIOIDS,RESULTS,SCIENCE,SELECTION,SEPTEMBER,WEB
GTN,PLACENTAL,PRIMARY,PSTTS
BACKGROUND,LABEL,METHODS,MRI,STAGING,ULTRASOUND
169,AKT,ECTOPIC,RAS
169,BRITAIN,COPYRIGHT,EMT,FINALLY,GREAT,IRELAND,LTD,NSCLC,PUBLISHED,SOCIETY,WILEY
169,APMIS,FINALLY,HOWEVER,LTD,NUCLEAR,PUBLISHED,UCN,WILEY
169,COPYRIGHT,HLA,THESE
001,169,177,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MONITORING,OBJECTIVE,PHMEP,RESULTS
10878,138,148,169,BACKGROUND,BELOB,C30,COPYRIGHT,EORTC,HRQOL,LABEL,LTD,METHODS,QLQ,RESULTS,TREATMENT
001,002,006,007,018,019,169,177,301,AED,FACTORS,LABEL,METHODS,NPA,OBJECTIVE,REDUCTION,RESULTS,START,TIMETOSTOP,TTS
CTX,THESE
001,004,007,016,027,169,198,AFTER,CONCLUSION,LABEL,METHODS,NEUROTOXIC,OBJECTIVE,PRIOR,PURPOSE,RESULTS,SOCIETY,TREATMENT
CONVERSELY,MULTIPLEX,V600E
169,945,AKT,C9ORF10,FAK,FAM120A,FINALLY,IL13R,SRC,TRAIL
SPHERICAL
DESPITE
GSC,HOWEVER,REGARDLESS
RADIATION

AFTER,CENTRAL,CNS,FURTHER,NERVOUS
GLIOMAS
945,CCL19,CCL21,IFN,IL4
169,304,488,ALLOGENEIC,DISEASE,GVT,INC,MAC,MRD,WILEY
169,213,313,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,PARTNER,PUBLISHED,SOCIETY,URBAN,USUALLY
169,ACR,ACRYLAMIDE,CERTAIN,COPYRIGHT,LTD,WILEY
BASED,MEDULLARY,MRI
100,DCS,LABEL,METHODS,MRI,NPV,OBJECTIVE,RESULTS,THEREFORE,YET
001,012,024,053,125,261,300,352,446,613,876,900,905,913,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE
003,169,177,180,271,451,ACADEMY,CLINICIANS,CONCLUSION,FOUNDATION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SITES,SURGERY,THERE
169,COPYRIGHT,DETECTION,INHERITING,LTD,LYNCH,MMR,THEREFORE
001,004,033,038,125,169,183,259,ASCL1,BACKGROUND,C17,COPYRIGHT,COX,DORON,DUCKMAN,EXPRESSION,FUNDING,INTEGRATED,LABEL,LTD,METHODS,NETWORK,NOTCH,RESULTS,SMARCB1,TAL
169,174,BRAIN,GUARANTORS,HOWEVER,MRI,PRESS,PUBLISHED,SEVERAL,THEREFORE,UNIVERSITY
169,231,233,AFTER,COPYRIGHT,PEDIATRIC,PUBLISHED,SAS
2008B,945,CNS,CONVERSELY,ERG,ETS,GBM,HBS,SMA
ALZHEIMER,BACKGROUND,CONCLUSION,CSF,LABEL,NFT,P301L,RESULTS,TAU,THERE,TOTAL,USING
100,139,24H,BIOCHIP,CD133,CLUSTER,GLIAL,GSC,ISOCITRATE,LABEL,METHODS,MICRO,MIRNA,NG2,NUCLCAR,OBJECTIVE,PRIMARY,RESULTS,SHG,SHG139S,VEGFR
169,BASED,COPYRIGHT,EBOLA,GPC,IMPORTANCE,LABEL,LASSA,MARBURG,OBJECTIVE,SOCIETY,UNLABELLED,VESICULAR,VSV
169,946,AKT,EGF,FINALLY,NOTABLY,PARK2,WNT
000,AFTER,HOWEVER,MRI,THESE
804,AUTHORS,BACKGROUND,CBT,CENTRAL,COLLECTION,CONTROLLED,DATABASES,DUE,FIRST,GRADE,HOWEVER,IBD,ISSUE,LABEL,MEDLINE,METHODS,MST,OBJECTIVE,OBJECTIVES,PST,RESULTS,SECONDARY,SELECTION,SMD,TBI,THERE
102,169,385,396,BACKGROUND,BARTHEL,CHINA,EIGHT,HEART,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRC,TRIAL,URL
169,COPYRIGHT,DIAGNOSIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,PATHOLOGY,RESULTS,RMS,SOCIETY
BMJ,BRITAIN,COX,CVD,FURTHER,GREAT,GROUP,IHD,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR
000,100,107,169,260,ACT,AMENDMENT,BACKGROUND,BLACK,BRAIN,DIAGNOSTIC,END,GREATER,LABEL,LAW,METHODS,PREDICTORS,PROGRAM,REGISTRIES,RESULTS,SOCIETY
169,ASSESSMENT,BACKGROUND,COPYRIGHT,ETV,INC,LABEL,METHODS,PRACTICAL,RESULTS
AUGER,INSERTION,LOW,PEPTIDE
169,176,177,231,233,CONCLUSION,COPYRIGHT,CURRENTLY,GUSTAVE,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SAS,SERVICE,THESE
169,BACKGROUND,CENTRAL,CONCLUSION,COPYRIGHT,INC,KARNOFSKY,LABEL,METHODS,MRI,OBJECTIVE,OPTIMAL,RESULTS,SCORE,SEVEN,SRS
CAVERNOUS,SURGERY
CHADC,DERMOID,EPIDERMOID,MRI,TYPICAL
CNS,CURRENT,ULTRASMALL
945,946,AFTER,BACKGROUND,CHORIONIC,CONTEXT,GSU,HCG,LABEL,METHODS,OBJECTIVE,P453T,PITUITARY,RESISTANCE,RESULTS,RTH,THYROID,TSH,TSHOMAS
169,231,233,COPYRIGHT,PUBLISHED,SAS
P53
HOPES,MEDLINE,PROGNOSIS,RADIATION

169,667,BOARD,COPYRIGHT,HMH,HOUSTON,INC,JANUARY,LABEL,MEDICAL,METHODIST,METHODS,MRA,MRI,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,TEN
001,169,311,ALLERGY,BACKGROUND,COLLEGE,CONCLUSION,COPYRIGHT,CURRENT,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THESE
169,CBA,COPYRIGHT,USING
169,BCL,BIRC3,GBM,MNGCS,PRESS,PUBLISHED,SASPS,TAKEN,THEREFORE,THESE,UNIVERSITY,Y15
169,ANTICANCER,COPYRIGHT,ENGLISH,FDG,HISTOLOGIC,INSTITUTE,QUADRUPLE,SUBSEQUENT,SUV
169,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,GROSS,INC,LABEL,METHODS,MRI,OTA,PRIMARY,RESULTS,WORLD
169,915,972,APRIL,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FACTORS,IQR,IRELAND,JANUARY,LABEL,LTD,METHODS,NHS,OVERALL,PUBLISHED,RESULTS
AKT,GII,HIF,LOW,P53
BRAIN,MRI,THERE
100,CHOROID,CPP,CSF,METHODS,MRI,RESULTS,STANLEY,THERE,UNIVERSITY
169,AUTHORS,COPYRIGHT,HOWEVER,INC,NOTABLY,PUBLISHED,SOMATIC,THESE
143,AIM,BACKGROUND,DISTANT,LABEL,METHODS,NODAL,OBJECTIVE,PET,RESULTS,SIXTY,TOMOGRAPHY,VALUE
177,CRANIAL,DAILY,IQR,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SCALE,SIXTY,THERE
LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,THESE
169,231,233,COPYRIGHT,DESPITE,PUBLISHED,SAS,THROUGH
100,169,177,BACKGROUND,CONCLUSION,INC,INITIAL,LABEL,METHODS,OPG,OPTIC,OUTCOME,PROCEDURE,RESULTS,SUFFICIENT,VOLUMETRIC,WHILE,WILEY
169,COPYRIGHT,FINNISH,INC,NF2,SHH,SMARCB1,SMARCE1,SNF,SWI
169,BEHAVIORAL,COPYRIGHT,DESPITE,INC,RESULTS,SEVERAL
CRL4B,CUL4B,HOWEVER,KNOCKDOWN,LABEL,MATERIALS,METHODS,MMP,OBJECTIVE,RESULTS,THEREFORE,U87,WHILE
GBM
SHMT2
169,18F,CHOLINE,FEC,FLUROETHYL,INC,MRI,NGGCT,PET,WILEY
169,DESPITE,END,FIFTY,INC,LABEL,METHODS,NON,OBJECTIVE,RESULTS,SURVIVORS,WILEY
1P19Q,AFTER,ANAPLASIA,IDH,III,LOWER,MOLECULAR,THESE,WORLD
CD124,GBM,MDSCS,MYELOID,THESE
141,608,945,946,94E,ANXA1,GBM,INGENUITY,ITGA5,LN229,OVERALL,PATHWAY,U87MG
CERTAIN,MONOCYTES
MALIGNANT,THESE
145,171,AFTER,ANXIETY,BACKGROUND,CONCLUSION,DEPRESSION,EPWORTH,INDEX,LABEL,METHODS,PITTSBURGH,QUALITY,RESULTS,SCALE,SLEEP,SLEEPINESS
BECAUSE,CD95L,STUDIES,U87,USING
002,004,007,008,011,028,045,169,177,AMSTERDAM,ANT,BACKGROUND,CONCLUSION,CSF,DISEASE,DTI,ICARS,INC,LABEL,METHODS,PROCEDURES,RESULTS,SCALE,TASKS,TESLA,TREATMENT,WILEY
DESPITE,EXTENSIVE,GRADE,III,MUTATIONS
AMONG,APRIL,BECAUSE,DNT,JANUARY,RESECTION
BNP,CARDIOLOGY
169,945,CHB,CHRONIC,COPYRIGHT,FINALLY,FURTHER,HBV,HCC,INC,STUDIES,UNIVERSAL
169,799,ASIAN,BACKGROUND,C228T,C250T,CHINESE,COPYRIGHT,FUNCTIONAL,LABEL,LARGE,LTD,METHODS,RESULTS,SEVERAL,THESE
169,AKT,BRCA1,COPYRIGHT,ERCC1,HOWEVER,INC,SRC,STAT3,THEREFORE
169,177,2MM,3MM,7MM,AFTER,CARLO,CONCLUSION,COPYRIGHT,DUE,FLUKA,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MONTE,OBJECTIVE,OVERALL,PET,PTV,PURPOSE,RESULTS
100,177,CIVIL,CONCLUSION,DEPARTMENT,DOW,INTRA,KARACHI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,UNIVERSITY
160,169,COPYRIGHT,HOWEVER,III,LOCALLY,METASTATIC,PUBLISHED,SAS
169,COPYRIGHT,INC,PRIMARY,PUBLISHED,SOCIETY
001,007,169,AFTER,AHR,COMPARISON,COPYRIGHT,COX,HRT,INC,KARNOFSKY,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS,SRT,TMZ
001,002,006,019,024,169,515,COPYRIGHT,DFS,INC,THESE
169,215,AC133,CD133,CD3,CD8,CSC,GBM,SCS
169,AUTHORS,BACKGROUND,COPYRIGHT,EVALUATION,GENERALLY,III,LABEL,LTD,METHODS,PFS,PUBLISHED,RESULTS,SEVERAL,SOLID,TESTING,TUMOURS
001,014,025,039,044,061,100,177,DESPITE,END,ENDONASAL,LABEL,MEIER,METHODS,OBJECTIVE,PITUITARY,PREDICTORS,QOL,RESULTS,SEM,SINONASAL,SURGERY
032,144,289,CSF,ELDERLY,ENDOSCOPIC,FIFTY,FORTALEZA,GENERAL,LABEL,MAY,METHODS,OBJECTIVE,PAS,RESULTS,SOCIETY
100,FALSE,GTR,HOWEVER,LABEL,MARGINS,METHODS,MRI,OBJECTIVE,RESULTS,SEVERAL,U87
169,BACKGROUND,COPYRIGHT,GIVEN,HOWEVER,INC,LABEL,METHODS,OWING,PUBLISHED,RADIATION,RESULTS
169,182,945,BBB,BCL2L12,BTB,GBM,GIC,HIF2A,KOURI,LABORATORY,MET,PRESS,PUBLISHED,REPRESSION
169,ALZHEIMER,APP,DR6,LABORATORY,PRESS,PUBLISHED
169,244,BRAIN,DEPRESSION,INCREASED,INVENTORY,LABEL,METHODS,OBJECTIVE,RESULTS
RADIATION,THEREFORE
HOWEVER,JANUARY,OCTOBER
DECREASED,GLASGOW,INCREASED,SCALE,VEP
026,100,116,139,169,374,704,ASSESSMENT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSI,SIXTY,THESE
169,BIOLOGY,EGF,GBM,GENOMIC,INC,MOLECULAR,SOCIETY,THESE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,OVERALL,SUBSEQUENT
169,231,233,COPYRIGHT,PREVENTION,PUBLISHED,SAS,USING
177,BACKGROUND,BLACK,CHARLOTTE,CHBAH,CHRIS,CMJAH,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOTHO
CAVERNOUS,MEDULLARY,MRI
101,160,169,COPYRIGHT,GBM,III,INC,LABEL,MATERIALS,MEIER,METHODS,MGD,MTD,OBJECTIVE,PFS,PHASE,PUBLISHED,PURPOSE,RESULTS,TMZ,TREATMENT
2TV,DYNAMIC,LOGAN,MA1,PET,THESE
169,946,ATLAS,FOXM1,FURTHER,GBM,GSC,PDGFA,STAT3
AVERAGE,BACKGROUND,CONCLUSION,GALEN,LABEL,METHODS,OBJECTIVE,RESULTS
169,484,BIOLOGY,CHROMATIN,FOS,HOWEVER,INC,KV1,MOLECULAR,NUCLEAR,SELECTIVE,SNU,SOCIETY,SP1,THESE,WESTERN
169,946,APC,CBC,MYC,PRESS,PUBLISHED,SNF,SWI,UNIVERSITY
240,344,QDS,THREE,USING
169,16P13,BRAIN,CLEC16A,GUARANTORS,HOWEVER,KNOCKDOWN,PRESS,PUBLISHED,THESE,TREATMENT,UNIVERSITY
102,177,AGA,ASPARTATE,CHOLINE,CONCLUSION,DEPARTMENT,JANUARY,KARACHI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREDICTED,RADIOLOGY,RESULTS,THERE,UNIVERSITY,WHITNEY
169,BACKGROUND,CTCAE,DISTANT,INC,LABEL,MEIER,METHODS,RADIATION,RESULTS,TIMES,TOXICITIES,WILEY
001,169,ATROPHY,BRAIN,DIFFERENT,FRIEDREICH,FUNCTIONAL,GUARANTORS,PRESS,PUBLISHED,THERE,UNIVERSITY,WHEREAS
169,AMONG,COPYRIGHT,FEMALES,INC
169,ALTERATION,BECAUSE,FORMATION,GTP,SOCIETY,WHILE
021,029,169,18K322A,AGE,COPYRIGHT,GD2,INC,LABEL,MANAGEMENT,METHODS,MYDRIASIS,OBJECTIVE,PEDIATRIC,PUBLISHED,PURPOSE,RESULTS,STRABISMUS,THESE
ADDITIONAL,BACKGROUND,BMJ,CUSHING,ECG,FINALLY,GROUP,HOWEVER,HRQOL,LABEL,LIMITED,METHODS,PRIMARY,PUBLISHED,PUBLISHING,SECONDARY
169,340,CONFIRMING,COPYRIGHT,FURTHER,INC
169,AAS,COPYRIGHT,CRE,INC,LOX,MCRS1,RAS,THESE,WHEREAS
AFTER,BROCA,DIFFUSION,DTI,FAT,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
106,182,186,335,517,CONSORTIUM,FACTORS,GAMMA,KARNOFSKY,KNIFE,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,SIX,SRS,VHL
CSF,EBX,ETV,FOLLOWING,GRADE,JANUARY,LABEL,LESIONS,METHODS,OBJECTIVE,RESULTS,SINCE,SIX,THESE
BETWEEN,ESTIMATED,EWING,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,RFS,THERE,THESE,TOKYO,UNIVERSITY

CSF,METHODS,RESULTS,THERE,USING
CMN,CONGENITAL,MEK,THESE,WNT
169,COLORECTAL,COPYRIGHT,CRNDE,EXPRESSED,HOWEVER,IRELAND,LTD,NEOPLASIA,PUBLISHED,RAPAMYCIN
ACROMEGALY,DESPITE,GAMMA,KNIFE,LAR,LEKSELL
100,945,AFTER,OVERALL,RCC
177,267,271,ALZHEIMER,ASSOC,BACKGROUND,BEHAVIORAL,CSF,DIS,JAKOB,LABEL,METHODS,OBJECTIVE,PCNSL,RESULTS,RPD,THERE,WHITE
197,AKT,AXL,CDH10,CLDN2,COMPOUNDS,COUMARINS,DDIT4,ESRRG,EVALUATION,PAGE4,PCR,SLCO2A1,TSPAN14,TXNIP
TBARS
LABEL,METHODS,OBJECTIVE,ODD,ODE,OPTIC,PURPOSE,REPORTS
RESPONSES,RESULTS
102,169,225,720,956,CONTROL,HYPOCCS,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SOCIETY,STUDIES,THERE,USING
169,600,ATIII,BACKGROUND,CNS,CSF,III,INC,INHIBITOR,LABEL,METHODS,RESULTS,THROMBOSIS,WILEY
169,DESPITE,EPIDERMAL,HOWEVER,USING
169,CDC20,INC,SIXTY,WEBGESTALT,WILEY
946,CHEST,HCG,HISTOLOGY,PATIENT,THERE
169,HOWEVER,SOCIETY
169,945,946,947,BIOLOGY,CONSISTENT,ERR,EXPRESSION,INC,MCF,MOLECULAR,SOCIETY,THESE,USING
002,004,300,AIM,CONCLUSION,FIFTY,III,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
BACKGROUND,CONCLUSION,LABEL,METHODS
BACKGROUND,IIA,IIB,ITALY,LABEL,METHODS,POPULATION,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
169,EVS,GBM,GSC,PROTEOMIC
001,169,1ST,230,3RD,6TH,745,9TH,ANXIETY,COPYRIGHT,DEPRESSION,DEPRESSIVE,DIMENSION,DISCUSSION,HOWEVER,HUNDRED,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE
120,CEA,COMPARABLE,FINAL,LDH,PREVIOUSLY
945,EXPRESSION,GBM,GLS,THESE
169,200,946,CD4,COPYRIGHT,ENV,HIV,INC,MACROPHAGE,THESE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,MRI,PRIMARY,THEREFORE
001,004,012,134,160,169,AGE,AMONG,BACKGROUND,COPYRIGHT,COX,INC,INSTITUTES,JANUARY,LABEL,MEIER,METHODS,NIH,RESULTS,SURGERY,TREATMENT
169,AFTER,BBB,CNS,COPYRIGHT,HOWEVER,THERE
169,AKT,COPYRIGHT,DESPITE,GBM,IRELAND,LTD,THEREFORE,WNT
169,321,351,672,ALZHEIMER,CHINESE,COPYRIGHT,CYP,FURTHER,HAN,INCREASING,IRELAND,LTD,MALDI,TOF
001,003,011,036,037,048,AFFILIATED,BETWEEN,DEPARTMENT,PROVINCIAL,THERE,UNIVERSITY
001,007,018,025,177,329,PRL
BMJ,DOPPLER,GROUP,HODGKIN,LTD,PUBLISHING,SCROTAL,SPERM,TESTICULAR
008,021,187,BMS,BRAIN,EIGHT,ESTIMATED,MPNST,SEVEN,STS,THERE,UNIVERSITY
169,19Q,CIC,COPYRIGHT,ERK,FUBP1,FURTHER,H3F3A,HOWEVER,III,INC,NOTABLY,OVERALL,PCR,PEDIATRIC,THESE,TKD
007,AMONG,BRAIN,DISCHARGE,HOWEVER,KARNOFSKY,KPS,METHODS,RESULTS,SCALE,SIXTY,TEXAS,THERE,UNIVERSITY
169,945,BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,PRL,RESULTS,SOCIETY
169,177,247,757,DEPARTMENT,DEPRESSION,DRESDEN,ENDOCRINE,GENERAL,INDEX,INSTITUTE,INVENTORY,LABEL,MAX,METHODS,OBJECTIVE,OBJECTIVES,OUTPATIENT,PITTSBURGH,PSYCHIATRY,PSYCHOLOGY,QOL,QUALITY,RESULTS,SCREENING,SETTING,SEVERAL,SLEEP,SOCIETY,TECHNICAL,THESE,UNIVERSITY,VAS
169,ALZHEIMER,COPYRIGHT,INCREASING,LTD,MISFOLDED,MODULATION
169,BACKGROUND,CCM,DELTA,HBEGF,HEART,INC,LABEL,METHODS,NG2,NOTCH,OBJECTIVE,PDGFRB2,PERICYTES,PURPOSE,RESULTS,S1P,TGFB1,TRANSGENIC
215,AFTER,FIFTEEN,GIANT,LIMITED
169,AML,INC,LOH,WILEY,WILMS
119,169,AMONG,BACKGROUND,BECAUSE,CONCLUSION,INC,LABEL,METHODS,OVERALL,PARTIAL,PROCEDURE,RESULTS,SCALE,SEVEN,THERE,THREE,WILEY
CUSHING,FOLLOWING
100,APC,CRC,FBXW7,SMAD4,SOMATIC,SYNE1
8G7G3,SPT24,TTF
169,COPYRIGHT,INC
169,CNS,COPYRIGHT,IMAGING,INC,MRI,TODAY
MEIER,THESE
160,169,224,BAK,COPYRIGHT,COX,HOWEVER,INC,MEIER,MIR,MTT,PCR
169,531,AFRICAN,AMERICANS,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THESE
001,005,006,050,072,169,180,206,304,310,403,416,446,550,710,738,804,883,965,AII,BACKGROUND,COPYRIGHT,COX,INC,ISOCITRATE,LABEL,METHODS,PATIENT,PFS,RADIOLOGY,RESULTS,THESE,WORLD
345,954,DESPITE,MAP,NOD,RIPK2
67KDA,CURRENT,DUSPS,HOWEVER,KIT,LABEL,MAPKS,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,THEREFORE,WESTERN
177,3DCRT,CONCLUSION,CTV,DMEAN,DVH,GROSS,GTV,LABEL,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS
CALCIUM,CD318,CDCP1,CUB,FUNCTIONAL,ORAI1,STIM1,STOCS,THESE,TRASK
001,11C,18F,COL,CONCLUSION,FDG,GBM,III,LABEL,MALIGNANT,MET,METHODS,OBJECTIVE,PET,RESULTS
500,946,EIGHT,H1299,ITGB3BP,SHC,SRPK1,USING
001,10B,COX,FINALLY,MEIER,PCR,PFS,TAKEN
169,767,867,CHANGES,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,SIXTEEN,THERE
169,ABCG1,AUTHORS,CD133,COPYRIGHT,GSC,INC,LEVERAGING,LGG,NF1,PUBLISHED,USING
109,151,169,414,470,ANNOTATION,BENJAMINI,CONCLUSION,COPYRIGHT,DFLAT,FUNCTIONAL,INC,IPA,LABEL,METHODS,OBJECTIVE,OMICS,OUTPUTS,RESULTS,T21,TRISOMY,TUFTS,USING
160,SEVEN,WILMS
169,945,946,COPYRIGHT,INC,NOTUM,ORGANIZER,THESE,WNT,XENOPUS
106,169,ABOUT,AIM,BRAIN,CNS,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNLABELLED
109,116,169,BECAUSE,BROADENING,CARLO,COPYRIGHT,DESPITE,INC,LABEL,MATERIALS,METHODS,MEV,MONTE,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,LTD
169,ALZHEIMER,COPYRIGHT,FINALLY,ISSUE,NEUROLOGY,NGS,SPECIAL
169,COPYRIGHT,INC,THESE
169,BACKGROUND,COEXISTING,CONCLUSION,COPYRIGHT,DIFFUSION,DTI,INC,LABEL,METHODS,RESULTS,THREE
CENTRAL,MRI,SOUTH,TRANS,UNIVERSITY,XIANGYA
169,ATAXIN1,ATXN1,COPYRIGHT,INC,SEEKING,THESE
185,BECAUSE,BRAIN,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,TREATMENT
169,HEART,INC,UNTIL
169,392,946,BIOLOGY,ERK,INC,MH2,MOLECULAR,R175H,SER,SILENCING,SMAD2,SMAD3,SMAD4,SOCIETY,TGF
154,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,ENGLAND,FIFTY,LABEL,LTD,MATERIALS,MAY,METHODS,MRI,NETWORK,OBJECTIVE,PUBLISHED,RESPONSES,RESULTS,ROYAL,THERE
169,CNS,IOC,SOCIETY
169,AWARENESS,COPYRIGHT,FACTORS,INC,LABEL,METHODS,OBJECTIVE,PREVIOUSLY,RESULTS,SCALP,SPREADING
169,COPYRIGHT,LTD,THERE
100,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,WITHOUT
FIRSTLY,MRI
640,AFTER,BRAIN,FRIEDREICH,MRI,POLG1,TOTAL,WESTERN
013,018,027,063,160,177,215,BACKGROUND,DOSIMETRY,FFF,FLATTENING,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS,THEREFORE,THREE,U87
ENDONASAL,TSS
AFTER,DCS,WHILE
000,036,058,100,154,289,295,347,433,531,533,543,587,600,624,741,CRS,ESTIMATES,HODGKIN,ITALIAN,ITALY,LABEL,MATERIALS,MEN,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PREVALENCE,REGISTRIES,RESULTS,VALIDATED
LYG
AKT,AMONG,COMPARING,EXPRESSION,GBM,HOWEVER,KARNOFSKY,MICRORNAS,PCR,SCALE,TGF,THREE
BBB,HOWEVER,PARKINSON,THESE
ANCHORAGE,H2009,SIMILAR
003,008,013,035,113,150,169,ADVERSE,BMS,CONCLUSION,CONCURRENT,COPYRIGHT,COX,FIFTEEN,GRADE,INC,IPI,IPILIMUMAB,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRS
602,MIA,MMP,PAPILLARY,PTC,SIMILARLY,SV1,THYROID
169,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DETECTION,GPA,INC,LABEL,LTS,METHODS,PRESENTING,PROGNOSTIC,QOL,RESULTS,RPA,SRS
169,945,946,CONCLUSION,COPYRIGHT,CSC,DCC,DLQ,FITTING,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLQ,SMALLER
108,169,370,495,BASED,COPYRIGHT,DIR,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
169,359,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SASKATOON,SEVENTY
043,169,364,389,AUTHORS,COPYRIGHT,HRS,INC,IPD,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RPA,SRS,THREE
ADDITIONAL,AIM,ASIAN,BACKGROUND,BURKITT,CASES,CD3,CONCLUSION,DLBCL,EXCLUSION,GCB,HODGKIN,INCLUSION,INDIA,LABEL,MATERIALS,METHODS,MIB,NON,OBJECTIVE,PCNSL,PRIMARY,RESULTS,SOUTH,THERE
MONRO
001,015,049,120,130,177,225,ANOVA,BACKGROUND,CONCLUSION,COX,FRONTAL,GROUP,HOWEVER,LABEL,MATERIALS,MBT,MEIER,METHODS,OVERALL,RESULTS
001,002,130,169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GBM,INSTITUTE,LABEL,METHODS,PFS,RESULTS,TREATMENT
169,ANTICANCER,COPYRIGHT,GBM,INSTITUTE,LN229,P53,THERE,U87,WHILE
169,ANTICANCER,COPYRIGHT,GBM,HOWEVER,III,INSTITUTE,PFS,PHASE
169,945,946,947,BIOLOGY,HOWEVER,INC,LYSOSOMES,MOLECULAR,SOCIETY
HOWEVER,KNOCKDOWN,NF2,YES
000,150,800,900,CORRECTED,COSTS,GAMMA,HODGKIN,LABEL,METHODS,OBJECTIVE,PER,RESULTS,ZEALAND
100,169,170,AFTER,BACKGROUND,COPYRIGHT,CRUDE,GTR,INC,LABEL,LIMITED,METHODS,OVERALL,PAPILLARY,RESULTS,WORLD
009,100,169,ADC,ASSIGNMENT,BSC,CONCLUSION,CONTINUOUS,COPYRIGHT,CST,DTI,FAS,FIBER,FRACTIONAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WHITE
160,169,COPYRIGHT,EMF,INC,NUMBERS,PREVIOUSLY,SAR,SINCE
160,169,BIOLOGY,COPYRIGHT,INC,PERIOSTIN,POSTN
001,169,847,903,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,FET,III,IRELAND,JANUARY,KARNOFSKY,LABEL,LTD,MAY,METHODS,MRI,PET,REGARDING,RESULTS,ROC,SCALE,VOI
GADOLINIUM,HOWEVER,INITIALLY,THEREAFTER
RESECTION
AFTER,CONTROL,HOWEVER,METASTATIC
169,405,624,COPYRIGHT,INC,INDIVIDUAL
160,169,19Q13,C19MC,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
169,894,BACKGROUND,COPYRIGHT,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,RESULTS,THERE
108,194,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WORLD
300,CPS,DCS,ERS,ERT,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PTI,REPETITIVE,RESULTS,YET
177,AFTER,AUGMENTED,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
122,CNS,CONVERSELY,GRADE,III,LABEL,LARGE,METHODS,MRI,MRS,OBJECTIVE,RESULTS,USING
169,AMONGST,AUTHORS,COPYRIGHT,GBM,III,INC,MMP,OLIG2,ONCOSTATIN,OSM,PCR,PUBLISHED,REMBRANDT,STAT3,YKL,YKL40
169,BACKGROUND,COPYRIGHT,CROWN,INC,LABEL,METHODS,OIT,PATHOLOGIC,PUBLISHED,THESE
BESIDES,HDACI,HDACS
177,956,AFTER,METHODS,RESULTS,THERE
132,169,CONCLUSION,FDG,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
AFTER,HB1,LUNGS
BRAIN,EVENTUALLY,HOWEVER,MRI
CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,UNLABELLED
735,BACKGROUND,CHILDHOOD,LABEL,METHODS,RAS,RASOPATHY,RESULTS,SIR,SOMATIC,THESE
001,008,252,291,CLEVELAND,DETAILS,DISTANT,HOWEVER,HPV,III,IMPORTANCE,IMPORTANT,IVB,JANUARY,LABEL,METHODS,OBJECTIVE,OPSCC,RELEVANCE,RESULTS,SECONDARY,SETTING
001,169,954,BACKGROUND,BONFERRONI,COX,GBM,HOWEVER,LABEL,MEIER,METHODS,PFS,PRESS,PUBLISHED,RESULTS,STUDENT,SURGICALLY,UNIVERSITY
FOURIER,MALIGNANT
AKT,GBM,GIVEN,HGG,NTV,PDGFB
001,169,APHASIA,BACKGROUND,COX,HEART,INC,INSTITUTES,LABEL,METHODS,OBJECTIVE,PNEUMONIA,PURPOSE,RECURRENCE,RECURRENT,RESULTS,SCALE,TIA
169,DEPLETION,LABORATORY,PRESS,PUBLISHED,THESE,UNKEMPT
169,ALLEN,ATLAS,BRAIN,CNS,COPYRIGHT,GERMINOMAS,HOWEVER,INC,KIT,THEREFORE
03012,169,945,ABCB1,ABCG2,AUTHORS,BIP,DECREASED,ERBB1,FGF,GBM,GRP78,HSP70,HSP90,HSPA5,INC,INHIBITION,JOURNAL,OSU,PHYSIOLOGY,PUBLISHED,SILDENAFIL,TREATMENT,WILEY
169,BRITISH,JOURNAL,PRESS,PUBLISHED,TULVING,UNIVERSITY
169,BACKGROUND,CLINICALLY,LABEL,MEDICAL,METHODS,RESULTS,SOCIETY,USING
139,FACTORS,IBS,IMPORTANCE,IRRITABLE,LABEL,MANAGEMENT,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,REVIEWS,SYSTEMATIC,VARIOUS
645,749,AMONG,BACKGROUND,CRUDE,DIAGNOSIS,HODGKIN,LABEL,METHODS,RESULTS,SIMILARLY
022,030,100,146,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PERMANENT,PGR,PRECENTRAL,RESULTS,WHILE
001,002,015,030,037,078,113,119,162,260,BACKGROUND,CONCLUSION,COX,EASTERN,FACTORS,GROUP,INCOMPLETE,LABEL,METHODS,OBJECTIVE,PROPENSITY,RESULTS,SEVENTY,SRS,THERE
SBP,THERE
169,231,233,COPYRIGHT,III,LARGE,PUBLISHED,SAS,WESTERN
136,169,200,APRIL,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OUTPATIENT,RESULTS,VARIOUS
144,169,320,COPYRIGHT,HOWEVER,INC,INITIAL,KNOSP,LABEL,METHODS,OBJECTIVE,RESULTS
192,NSCLC,PRS,TREATMENTS
AFTER,APRIL,BECAUSE,CRANIOTOMY,CRT,ESOPHAGEAL,IVA,JANUARY,MARCH,MAY,TXT
HMB45,MALIGNANT,MELAN,PARTIAL
50S,60S,CRANIAL,EXTENSIVE,MRI,WHOLE
AFTER,BRAIN,PGR,THERE
STAGEIV,T4BN1M1
APRIL,DEPARTMENT,KRUKENBERG,LEUCOVORIN,MARCH,SEPTEMBER,STAGEIV,SURGERY
DEPARTMENT,HOWEVER,LOX,REMOVAL,SURGERY,THEREFORE,TREATMENT,XELOX
000,GENERAL,THEREFORE,TROUSSEAU
BACKGROUND,CONCLUSION,LABEL,METHODS,OUTLINE,TREATMENT
AMP,BRAIN,BTICS,CAMK2,DOWNSTREAM,GLUT3,TARGETING
110,147,169,530,764,COPYRIGHT,FIRST,GOLDENGATE,HNSCC,SNP,UTR
169,368,452,ASA,CESSATION,COPYRIGHT,FLORIDA,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,UNIVERSITY
169,ANY,HOWEVER,LESIONS
ABDOMINAL,BRAIN,FINALLY,FSH,MRI,PROLACTIN
169,ABCG2,BIOMARKERS,CD271,COPYRIGHT,IRELAND,JARID1B,LTD,MMP,RESISTANT,V600E
169,ALC,BACKGROUND,CONCLUSION,DESPITE,EMBRYOLOGY,ENGLISH,EXPRESSION,FLC,LABEL,METHODS,OCTOBER,PRESS,PUBLISHED,RESULTS,SCHOLAR,SCIENCE,SOCIETY,STUDIES,THERE,UNIVERSITY,WEB,WHETHER
169,ABL,ATP,COPYRIGHT,DDX3X,G302V,G325E,LTD,MUTANTS,NMR,PUBLISHED,TAKEN,THESE
169,946,ALZHEIMER,BIOLOGY,CLASSICAL,IGG,INC,MOLECULAR,SOCIETY
169,ALCOHOL,COPYRIGHT,DISORDERS,EFFECTIVE,FOCUS,HARMFUL,IRELAND,LTD,PUBLISHED
001,003,028,063,169,200,252,452,CAUCASIANS,CHINESE,COX,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,POTENTIAL,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
148,160,177,407,CD1,ECF,THEREFORE,THESE
100,AFTER,BACKGROUND,CONTEXT,LABEL,METHODS,MIB,OBJECTIVE,RESULTS
130,AFTER,BECAUSE,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,130,131,135,319,AFTER,FURTHER,LABEL,LOWER,METHODS,OBJECTIVE,OUTCOME,PEDIATRIC,RAPID,RESULTS,THESE
CENTRAL,CHESTER,ECD,ERDHEIM,LANGERHANS,MENINGEAL
AFTER,DOPPLER,ICA,ICG,LABEL,METHODS,OBJECTIVE,RESULTS
CSF,EEA,GROSS,HOWEVER,LABEL,LEAKAGE,METHODS,OBJECTIVE,RESULTS,TVC
181,AED,FLAIR,HOWEVER,LABEL,LGG,METHODS,MRI,OBJECTIVE,RESULTS,THERE,THESE,TOTAL
169,CONCLUSION,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PARAMETRIC,PET,PK11195,RESULTS,SOCIETY,UNLABELLED
169,AKT,BRAIN,GUARANTORS,IIA,PRESS,PUBLISHED,SEQUENCING,UNIVERSITY,WHILE
110,BACKGROUND,CONCLUSION,FIFTEEN,LABEL,METHODS,MIB,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SELECTION,SMALL,THERE,THREE
916,ARA,DHA,EPA,HEK293T,THREE
ALONG,THESE
143,175,427,700,AUDIT,AUSTRALIAN,CONCLUSION,DONATELIFE,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,POTENTIAL,RESULTS,SETTING,SEVENTY,SIX,TEN,THESE
001,191,954,ABORIGINAL,AFTER,CONCLUSION,CROSS,LABEL,MEASURE,METHODS,NSW,OBJECTIVE,OUTCOME,OVERALL,RESULTS,RRR,SETTING,SOUTH,WALES
001,003,034,169,320,410,ACADEMY,CLASS,CNS,CONCLUSION,HDMTX,III,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PCNSL,PFS,RESULTS
160,956,ABCB1,BBB,FDG,PET
001,120,125,169,190,ACADEMY,CHART,CROSS,FOUNDATION,LABEL,METHODS,NASOSEPTAL,OBJECTIVE,OBJECTIVES,PEDIATRIC,RESULTS,SETTING,SURGERY
000,20000,ALA,BACKGROUND,CONCLUSION,EXTENSIVE,LABEL,METHODS,NOVEL,OBJECTIVE,PORTUGUESE,RESULTS,SERVICE,TRANSITION,UTILITY
ANOTHER,APPARENTLY,BRAIN,DM1,FURTHER,GPA
169,GBM,HOWEVER,III,SOCIETY,THESE,TREATMENT
169,AKT,GBM,GSC

BECAUSE,EVERY
BMJ,GROUP,IDC,LIMITED,METASTATIC,OESTROGEN,PUBLISHED,PUBLISHING
510,CD150,CNS,CYT,GOLGI,HOWEVER,SIMILARLY
179,BACKGROUND,CONCLUSION,DOPPLER,IAS,JANUARY,LABEL,METHODS,OBJECTIVE,RECORDS,RESULTS,SCD
160,169,AMONG,AUTHORS,COPYRIGHT,EGF,INC,P14,PP2,PRIMARY,PUBLISHED,RMS,S1386,S1416,SIGNALS,SILENCING,SRC,THESE,Y1764,Y1798
188,215,217,484,727,901,CACNA1A,JAPAN,LOXL1,SNP,XFS
009,017,055,169,177,AGGRESSIVE,BACKGROUND,CENTRAL,FOLLOWING,GROUP,INC,LABEL,METHODS,NPSPNET,PFS,PNETS,PROCEDURE,RESULTS,THERE,WILEY
003,BACKGROUND,BEV,CBDCA,FORTY,GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SECONDARY,THESE
IRINOTECAN
SRS
ACVR1,OTHERWISE,PEDIATRIC,SURGERY,THESE
169,946,COPYRIGHT,SMAD2,TGF
169,ANATOMICAL,COPYRIGHT,IMAGING,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESONANCE,RESULTS,TOMOGRAPHY
169,ATTENTION,COPYRIGHT,FIFTEEN,GKS,HOWEVER,INC,INITIAL,LABEL,METHODS,NFPAS,OBJECTIVE,RESULTS
169,177,BACKGROUND,CONCLUSION,COPYRIGHT,EOR,INC,LABEL,METHODS,MRI,PFS,RESULTS,SIX,TEN,THERE
NAC,ROS,TEA,U87
169,ALS,COPYRIGHT,SCIENCE,SEVERAL,THESE
AFTER,CRANIAL,GCA,MRI,THREE
150,177,574,DAI,GIVEN,GLASGOW,LABEL,LEVEL,MEDICAL,METHODS,MRI,OBJECTIVE,RADIOLOGY,RESULTS,SCALE,SCORE,STATA,THI,TRAUMATIC
AMONG,CRT,GIVEN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,TEN,THREE
11Q23,169,BCP,HOWEVER,MLL,MOLECULAR,OVERALL
111,169,177,296,AROMATASE,CONCLUSION,IMAGING,INC,LABEL,LIVER,MBQ,MEN,METHODS,MOLECULAR,NUCLEAR,ORGAN,PET,RESULTS,SOCIETY,SUV,UNLABELLED,YOUNG

169,BRAINSTEM,CEREBELLAR,COPYRIGHT,EOR,FORTY,INC,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
CNS,CSF,ELISA,III,SERUM
19Q13,C19MC,EMBRYONAL,HISTOLOGY
HOWEVER
169,HEMATOLOGY,HOWEVER,RBC,SOCIETY
169,CAR,COPYRIGHT,III,SCIENCE
169,ACADEMY,BRAIN,HOWEVER,MRI,NEUROLOGY,NMO,NMOSD,SINCE,THEREFORE
168,ADDITIONAL,BACKGROUND,CONCLUSION,CONTEXT,IGF,LABEL,METHODS,PAS,PHEOS,PRL,RESULTS,SDH,USING
169,16P11,CNV,COPYRIGHT,INC,RECURRENT
140,154,207,347,609,611,618,620,C611Y,C618R,C618S,C620F,C620G,C620R,IRANIAN,MEDULLARY,MEN2A,MEN2B,MTC,PCR,REARRANGED,RET,THYROID
CHINA,CONCLUSION,JANUARY,LABEL,MATERIALS,MEDICAL,METHODS,MRI,OBJECTIVE,PROVINCIAL,RESULTS,THESE,WHILE
130,246,AMONG,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,XELOX
BRAIN,FEW,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THERE,THREE
177,BACKGROUND,BENIN,CONCLUSION,CONTEXT,LABEL,METHODS,OPTIC,RESULTS,THEIR,THERE,UNIVERSITY
001,102,169,400,946,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PITUITARY,PTCH1,RESULTS,SHH,SMO,SOCIETY,SONIC,WNT
111,CONSORTIUM,NIH,ROADMAP
174,INVOS,SINCE
THEREFORE
174,BMI,CAREFULLY,CONTINUOUS,MRI,NEITHER,RAE,SAS,UNDER
945,946,956,BBB,CD49B,EXPRESSION,PCR,TRANSWELL,USING
169,BIOLOGY,BRAIN,CLAUDIN,INC,KNOCKDOWN,MOLECULAR,SOCIETY
BRAIN
117,169,865,BACKGROUND,CALIFORNIA,COLLEGE,COPYRIGHT,COX,FRANCISCO,HCC,INC,LABEL,METHODS,MILAN,OVERALL,PUBLISHED,RESULTS,SAN,UNIVERSITY
169,1AR,945,ATP,COPYRIGHT,PANNEXIN1,PANX1,SCIENCE,USING
215,HISTOLOGIC,MRI,NEUROLOGIC,NHP,THESE,THREE
BACKGROUND,BECAUSE,GROWING,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,USING
GIOVANI,GROUP,HIGHLIGHTS,MEMBERS,WORKING,YOUNG
003,018,11C,165,BACKGROUND,BETWEEN,DESPITE,DIFFERENT,HUMANITAS,LABEL,MAY,MET,METHODS,OBJECTIVE,PET,RESULTS,THERE
169,BIOLOGY,EG5,ENDOGENOUS,GFP,INC,MOLECULAR,SOCIETY,THR,USING,XENOPUS
169,CA1,GRANULE,USING
DESPITE,HISTOLOGY,POSTNATAL,WORLD
SEVERAL,THESE
100,105,CST,DTI,FAT,HOWEVER,IMAGING,KARNOFSKY,KPS,LOW,MRI,RMT,ROI,SCALE
160,BACKGROUND,BRAIN,CONCLUSION,FUNCTIONAL,IMAGING,LABEL,LIS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
150,26S,300,3T3,945,949,956,CONCLUSION,LABEL,MALDI,MATERIALS,METHODS,NIH,NOC,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,TOF
110,173,CONCLUSION,FURTHER,GROSS,GTR,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TOTAL
BACKGROUND,CCNB3,CIC,FOXO4,GENERALLY,LABEL,METHODS,NEWER,RESISTANCE,THEIR
DLBCL,FDG,HOWEVER,PET,THEREFORE
200,250,400,956,PHENYTOIN,SINCE,THREE
169,ANOTHER,AUTHORS,COPYRIGHT,HOWEVER,INDUCTION,LAMP1,LAMP2,LAMP3,PARKINSON,PREVENTION,PUBLISHED,UPR
169,603,946,CONVERSELY,COPYRIGHT,GLIOMAS,IRELAND,LTD,MICRORNAS,MIR,PEARSON,WNT
169,ALZHEIMER,BRAIN,CHARCOT,COPYRIGHT,ISSUE,MARIE,PARKINSON,PIP,SPECIAL,TOOTH
001,129,169,COPYRIGHT,GROUP,INC,LABEL,LGG,MATERIALS,METHODS,MST,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THREE,TMZ
169,COPYRIGHT,FAK,INC,MEANWHILE,THEREFORE,THESE,TMZ,TSPN8,U87MG
229,ECTOPIC,FINALLY,INTERFERON,TAKEN
947,ACADEMY,BRAIN
138,168,215,LABEL,METHODS,OBJECTIVE,RESULTS
104,234,303,776,BUR,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
002,004,007,010,017,020,027,028,041,045,048,094,158,165,170,177,288,367,789,872,909,922,972,LABEL,METHODS,MRI,OBJECTIVE,RCC,RECURRENCE,RESULTS,SIXTEEN
CURRENTLY,FINALLY,HIF,ONGOING
169,BACKGROUND,BASED,DESPITE,DISCUSSION,EUSTACHIAN,HOWEVER,LABEL,METHODS,RADIOLOGIC,SUBSEQUENT
169,BASEL,COGNITION,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THESE,USING,WOMEN
169,946,947,CD8,COPYRIGHT,IFN,INC,MICRORNAS,TGF,TH1
140,169,180,740,ACUTE,BACKGROUND,BLOOD,HEART,HEMORRHAGE,INC,INTENSIVE,INTERACT2,IVH,LABEL,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS,SCALE,TRIAL,URL
18F,AMONG,BESIDES,FDG,PET
THROUGH
947,948,HOWEVER
169,946,CEDIRANIB,COPYRIGHT,CXCR4,DESPITE,GBM,HGF,IRELAND,LTD,MET,TGF,VANDETANIB,VEGFR
ALGORITHM,COMPLEX,RESULTS
300
476
AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TOXICITIES
99MTC,AHX,BRAIN,GLU,LYS,MDP,PET
201,273,355,781,810,817,831,FDG,FIFTY,III,PET,SPECT,SUVRMAX,THEIR,TURMEAN
001,177,ELF,HOWEVER,MFS,ROBOTIC,WHITNEY
500,COX,DDD,HOWEVER,INSURANCE,LOE
4TH,ENGLISH,IEAES,THEREAFTER
AFTER,CD117,MRI
CD271,FURTHER,HOWEVER,METASTASES,PRIMARY
ASSESSMENT,HOWEVER,MIB,PIS,THEREFORE
001,012,021,022,026,032,143,960,GST,MNSOD,PRIMARY,ROS,TXNIP,UNIVARIATE
945,BCL,HRK
001,014,027,037,196,19Q,1P19Q,CLINICALLY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
000,001,026,100,102,19Q,AFFILIATED,CHROMOSOME,CONCLUSION,COX,FIRST,LABEL,LOH,MEDICAL,MEIER,METHODS,OBJECTIVE,RESULTS,SOX17,UNIVERSITY
584,COMPELLING,LUCIFERASE,MICRORNAS,PTTG1IP,THESE,U87
TERATOMAS
160,215,224,339,BMI,METABOCHIP,OBESITY,PATHWAY
160,215,224,459,BMI,PATHWAY
CENTRAL,CNS,EIGHT,GTR,KARNOFSKY,KPS,SIX,STR,VPS
155,FURTHER,HMG,PEARSON,SILENCING,TAKEN,UTR,WNT
233,2CM,JAPAN,MRI,SCALE,WORLD
CONSORTIUM,HOWEVER,JAPAN,MAGIC,MOLECULAR,SHH,THESE,WNT
CA2,ELEVATION,MICROGLIAL,THERE
HOWEVER
177,AGA,BACKGROUND,CONCLUSION,DECREASING,DEPARTMENT,KARACHI,LABEL,METHODS,MRI,RESULTS,SECTION,THERE,UNIVERSITY
169,873,BIOLOGY,GBM,IGF2BP1,INC,MOLECULAR,SOCIETY,THESE
169,BIOLOGISTS,COMPANY,CRH,LTD,PUBLISHED,THESE
BMJ,BRAIN,GRADE,GROUP,HOWEVER,LTD,MRI,PUBLISHING
169,BRAIN,COPYRIGHT,INC,THERE
239,BBB,DESPITE,FINALLY,HSA,LOCAL,THESE,VARIOUS
BESIDES,SEGAS,THYROID,TSC,TTF
169,BBB,BRAIN,CNS,HOWEVER,SOCIETY
169,250,635,BACKGROUND,CAUSE,COX,DIETARY,HEART,INC,INPATIENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SWEDISH,THESE,TRIAL,URL
CNS,HOWEVER,IGG,NMO
19Q,272,945,ACCORDING,IDH,III,MOLECULAR,REMARKABLY,WORLD
169,AIM,ANTICANCER,CNS,CONCLUSION,COPYRIGHT,CSF,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,PPS,RESULTS,T790M,TKI
001,125,169,182,198,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DFS,INSTITUTE,LABEL,METHODS,OBJECTIVE,RAS,RESULTS,SERUM,SMS
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,EASTERN,GROUP,HOWEVER,INSTITUTE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PITUITARY,RESULTS
169,18F,215,803,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FLT,III,INSTITUTE,LABEL,LSO,MBQ,METHODS,OBJECTIVE,PET,PRE,RESULTS,SAMPLES
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,INSTITUTE,LABEL,METHODS,MRI,PREVIOUSLY,STATE,TOTAL
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EDU,EMT,HOWEVER,INSTITUTE,LABEL,MATERIALS,METASTATIC,METHODS,MTT,RESULTS
169,ANTICANCER,COPYRIGHT,CURRENT,GRADE,INSTITUTE,THERE
001,024,169,177,886,CGH,CONCLUSION,EXOME,HGG,LABEL,METHODS,OBJECTIVE,PLGGS,PURPOSE,RESULTS,SOCIETY,V600E
001,004,169,BRAIN,CONCLUSION,HRQOL,LABEL,LGG,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SHORT,SOCIETY,TREATMENT
169,COPYRIGHT,MELATONIN,MRI,PARTNER,PUBLISHED,SCN,SIX,SOCIETY,URBAN
001,166,169,177,258,268,424,579,CONCLUSION,COPYRIGHT,LABEL,METHODS,NEUTROPHIL,PARTNER,PUBLISHED,RESULTS,ROC,SOCIETY,UNLABELLED,URBAN
169,291,335,CONCLUSION,COPYRIGHT,GRADE,LABEL,MEIER,METHODS,OBJECTIVE,PARTNER,PFS,PUBLISHED,RESULTS,SOCIETY,URBAN
169,231,233,COPYRIGHT,PUBLISHED,SAS
BMJ,EDH,GROUP,LTD,MULTIFOCAL,PUBLISHING
BMJ,GROUP,LTD,MRI,PUBLISHING
169,COPYRIGHT,FURTHER,LTD,WHILE
169,BRAIN,GUARANTORS,HAYLING,LESIONS,OVERALL,PRESS,PUBLISHED,THERE,UNIVERSITY
215,238,ACYP2,THESE
19Q,ADULT,FGFR1,LGG,LOW,PEDIATRIC,THESE
256,AFTER,BACKGROUND,CURRENT,HOWEVER,LABEL,METHODS,NODAL,OBJECTIVE,OUTCOME,PATIENT,RESULTS
HOWEVER,SMALL,THESE
421,466,894,ART,BACKGROUND,CONCLUSION,CONTEXT,ELDERLY,GBM,KARNOFSKY,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,RECIPIENTS,RESULTS,SCORE,SRT
181,321,401,479,583,BACKGROUND,DESPITE,FORTY,FURTHER,GBM,HOWEVER,JANUARY,LABEL,LMS,METHODS,MTX,PREDICTION,PROXIMITY,RESULTS,TREATMENT,YOUNGER
169,183,300,340,341,517,559,ARG145GLN,BACKGROUND,CIS,COPYRIGHT,CULTURE,DISEASE,DISORDERS,EDUCATION,FOUNDATION,FUNDING,FURTHER,JAPAN,LABEL,LTD,METHODS,PARKINSON,PROMOTION,RELATED,RESULTS,SCIENCE,SCIENTIFIC,SOCIETY,TECHNOLOGY,THREE,TOKYO,UNIVERSITY,WELFARE
169,AUHCR,BACKGROUND,CHOROID,CONCLUSION,CPC,CURRENTLY,INC,LABEL,METHODS,PROCEDURE,RESULTS,SEVEN,START,TEN,THREE,WILEY
169,231,233,COPYRIGHT,PUBLISHED,SAS,THESE
169,231,233,COPYRIGHT,HOWEVER,PUBLISHED,SAS,WHOLE
BMJ,FAILING,GROUP,LTD,PUBLISHING
169,BRAIN,COPYRIGHT,INC,SIXTY,THESE
ANOVA,BACKGROUND,BMJ,BRONCHIAL,GROUP,HEALTHCARE,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,SAMPLES
000,100,169,743,AGE,AUTHORS,COPYRIGHT,ENGLAND,EPISODE,GBM,HOWEVER,INCIDENCE,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERVICE,STATISTICS,THERE
169,BRAIN,COPYRIGHT,INHERITED,ISSUE,SPECIAL,THEIR,THESE
GLI,PATCHED,SEVERAL,SMO
169,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,MICRORNAS,THBS1,THESE,USING
047,115,169,992,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,LOCAL,METHODS,NSCLC,RESULTS,SRS
001,003,023,111,386,AGGREGATE,GAMMA,KNIFE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS,THEREFORE
001,026,643,AVM,BROCA,HOWEVER,METHODS,MRI,RESULTS,RIGHT
001,356,CALIFORNIA,DATABASES,FLORIDA,HEALTHCARE,ICD,IMPORTANT,INPATIENT,LABEL,METHODS,OBJECTIVE,QUALITY,RESULTS,STATE,THESE
001,002,137,GRADE,GTR,METHODS,MRI,RESULTS
177,LABEL,METHODS,OBJECTIVE,RESULTS
BECAUSE,KNOWN,MRI,SRS
169,BIOLOGICAL,COPYRIGHT,D10,EFFICIENCY,IRELAND,LTD,SF2
169,231,233,ALK,COPYRIGHT,PUBLISHED,SAS,SEVERAL
160,169,231,233,COPYRIGHT,CTLA4,MEK,MELANOMAS,PD1,PUBLISHED,RAF,SAS,STUDIES,UNTIL
001,160,169,979,AGE,COPYRIGHT,INC,INDEX,JANUARY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SIMPSON,VARIABLES
100,875,879,886,CHINA,EPIDERMAL,FURTHER,JANUARY,LDA,NSCLC,PRIMARY,SOUTHWEST,SVM,USING
102,106,127,135,169,AFTER,COPYRIGHT,HOWEVER,STG,SUBSEQUENT,THERE,THESE
BACKGROUND,CMF,EARLY,EVD,KEY,LABEL,METHODS
169,AUTHORS,HOWEVER
HOWEVER,LABEL,METHODS,MRE,OBJECTIVE,PURPOSE,REASONABLE,RESULTS
CARLO,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,SPATIAL
215,256,448,992,998,CURRENT,IMAGE,LABEL,METHODS,MRI,NKS,OBJECTIVE,PURPOSE,RESULTS
ASIDE,BACKGROUND,BEHAVIORAL,CAUCASIAN,CONCLUSION,LABEL,METHODS,SINCE,THREE
BECAUSE,COMBINING,HOWEVER
000,003,021,103,105,163,169,177,BMI,CRP,INITIAL,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PFS,RESULTS,SOCIETY,USING
003,008,169,BACKGROUND,GAMITRINIB,GBM,LABEL,MECHANISMS,METHODS,NOVEL,PI3KI,PRESS,PUBLISHED,RESULTS,SER,SER31,SMALL,THR,UNIVERSITY
002,028,169,361,929,945,BACKGROUND,COX,FIFTEEN,HEART,HOWEVER,INC,LABEL,METHODS,MODEL,OBJECTIVE,PREMATURE,PURPOSE,RESULTS,SEVERAL,WILLEBRAND
169,BRAIN,COPYRIGHT,PUBLISHED,SAS
169,COPYRIGHT,FLAIR,MRI,PET,PUBLISHED,SAS
169,FERTILITY,OVARIAN,SOCIETY,STUDIES
169,288,BACKGROUND,BIALLELIC,BRAIN,COLORECTAL,CONCLUSION,EAN,HEREDITARY,LABEL,LYNCH,METHODS,MMR,OBJECTIVE,PRIMARY,PURPOSE,R132H,RESULTS
MRI,NEOPLASTIC,PROGNOSIS
ALZHEIMER,AMONG,BIO,POC,SENSORS
1GENE,AFTER,FIFTEEN,ICE,INI,LABEL,MAXIMAL,MEDICAL,MEIER,METHODS,MIB,MRI,OBJECTIVE,OVERALL,PRESENTING,RESULTS,THERE,UNIVARIATE,VAC,YOUNG
100,ANOTHER,CONTEXT,LABEL,LAPTS,LOCALLY,METHODS,MSH,OBJECTIVE,OUTCOME,PARTIAL,PRL,RESULTS,SETTING,THREE,TMZ
169,DESPITE,MSC,PRESS,THEIR
003,169,215,232,259,328,378,591,945,COMPARING,HOWEVER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,S100B,THEREFORE,UNIVERSITY
169,177,742,BACKGROUND,CIS,CONCLUSION,COX,HOWEVER,HRS,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,SOCIETY
169,ARGONAUTE,BIOLOGY,FINALLY,GDF15,INC,MOLECULAR,SF3B2,SOCIETY
169,180,956,ACCORDING,DOPAC,DOPAL,DOPET,ENDOGENOUS,MECHANISMS,NAD,PARKINSON,SOCIETY,VESICULAR
169,177,COPYRIGHT,DCA,HOWEVER,INC,PUBLISHED,SRS,SRT,V12GY
CHRONIC,NMDAR,REMOVAL
AKT,BACKGROUND,CNS,ERK,HOWEVER,LABEL,MEK,METHODS,RAF,RAS,RESULTS,U0126,USING,VZS,ZEBRAFISH
000,001,003,027,169,187,285,328,344,441,526,680,775,876,APRIL,CHB,CONCLUSION,CUMULATIVE,EARLY,HCC,LABEL,LIVER,SCC,UNLABELLED
169,AKT,CHM,COPYRIGHT,FURTHER,GBM,GBM8401,IGF,IRELAND,LTD,PDGFR
000,250,600,603,948,SEQUENTIAL
169,BACKGROUND,COSTING,LABEL,METHODS,RESULTS,SOCIETY,TOOLS
160,169,510,900,CHINA,COPYRIGHT,ELISA,GENOMIC,HOWEVER,IGG,IRELAND,LTD,PCR,PREVALENCE,THREE,TOXOPLASMA
169,AUTHORS,FURTHER,G3H,GFP,HGF,HOWEVER,LTD,MET,PTY,PUBLISHING,SCIENCE,SMALL,THEREFORE,THESE,WILEY
160,169,AUTHORS,BECAUSE,COPYRIGHT,HOWEVER,INC,PUBLISHED
DUE
CHORDOMAS,ISC,MRI
122,AIM,AMONG,AMS,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THEIR,THERE,TOTAL
AIM,CONCLUSION,DEPARTMENT,KAYSERI,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
158,956,AFTER,BACKGROUND,DDP,EXPRESSION,LABEL,MACC1,MATERIALS,METHODS,MTT,PCR,RESULTS,SILENCING,THERE,WESTERN
000,100,109,112,138,150,684,999,BACKGROUND,FAO,HOUSEHOLD,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SHATT,THESE
128GY,13PTS,169,176,182GY,18PTS,43PTS,48PTS,51GYE,52PTS,618ML,ACC,AUTHORS,BACKGROUND,BED,C12,CONCLUSION,COPYRIGHT,CTC,DESPITE,III,IRELAND,LABEL,LTD,METHODS,NCI,OBJECTIVE,PTS,PUBLISHED,RESULTS,TREATMENT
000,169,250,ABCG2,ALA,ATP,HOWEVER,INC,PDD,PDT,PRIMARY
169,ABC,ATP,CNS,INC,TARGETING,THESE
169,ABC,ABCB1,ABCG2,ATP,INC,THESE
169,231,233,ANTICANCER,BRAIN,COPYRIGHT,CURRENTLY,DIFFERENT,PUBLISHED,SAS,SUPPORTIVE,THESE
169,COPYRIGHT,FINALLY,GIVEN,HOWEVER,III,PUBLISHED,SAS,SELECTION
169,1MM,COPYRIGHT,MRI,PUBLISHED,SAS
946,948,GSK
510,CORRECT,CSS,CUSHING,HOWEVER,METHODS,MRI,RESULTS
169,ASTROCYTES,BRITAIN,COPYRIGHT,GREAT,HOWEVER,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
BACKGROUND,CONCLUSION,LABEL,LFS,METHODS,THEIR
FARLAND,FOX,GLIOMAS,GUPTA,HIGHLIGHTS,JANDA,KVALE,LANTZ,LEE,MEHDORN,SARIN,THESE,WHILE
001,122,131,BRAIN,COX,EFFECTS,LOCAL,MEIER,SRS
007,111,169,19Q,AFTER,ANAPLASTIC,AOA,CODELETED,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCV,PFS,PURPOSE,RESULTS,TMZ
169,7TM,FASEB,LY2940680,MRT,SMO,SMOOTHENED,USING
169,231,233,ASSESSMENT,COPYRIGHT,PROGNOSTIC,PUBLISHED,SAS,THESE
169,231,233,COPYRIGHT,PUBLISHED,SAS,SEVERAL,THESE
METASTATIC,SEVERAL
CUSHING,DUE,THESE
FORTY,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS,TRANSIENT
18F,BACKGROUND,BESIDES,FDG,LABEL,METHODS,PET,RESULTS,SPM,UNIVERSITY,ZHENGZHOU
AMONG,HENCE,HOWEVER,JXG,LANGERHANS,LCH
169,AIF,COPYRIGHT,ENDOSOMAL,FOLLOWING,LRP,PAI,REVERSIBLE,SOCIETY
169,ECM,GBM,ORTHOTOPIC,RHO,TIC,TRANSWELL,VIRTUALLY
DIAGNOSING
001,CHINESE,MEDICAL,OLFACTORY,OUTCOME,SHORT,SINONASAL
185,BRAIN,PET

PCNSL,PRIMARY
169,ATM,BIOLOGY,BRAT1,FOLLOWING,HOWEVER,INC,MOLECULAR,NEDD4,SOCIETY,THESE,UNDER,WITHOUT
600,800,BRAIN,CO2,DESPITE,EARTH,HYPOTHESIS
451,BVS,EFFECTIVE
ELISA,III,MALIGNANT,SERUM,THERE,YKL,YKL40
007,BACKGROUND,BIO,KNS42,LABEL,METHODS,PAEDIATRIC,RESULTS,SF188,THEIR
BRAIN,HISTOLOGY,NSCLC
169,340,AMONG,GIC,TAKEN
120,169,APRIL,FORTY,LABEL,METHODS,MRI,NFPAS,OBJECTIVE,RESULTS,SIXTY,SOCIETY
BURKITT,CONCLUSION,CONTEXT,EBV,EPSTEIN,FURTHER,HODGKIN,LABEL,METHODS,OBJECTIVE,PCR,PREVALENCE,RESULTS,SETTING
GBM,MULTIFORME,THEREFORE
169,29A,29S,COPYRIGHT,EXOGENOUS,IRELAND,LTD,THESE,U87MG
ABDOMINAL,BRAIN,DIAGNOSTIC,HOWEVER,PANCREATIC
400,DILATED,EARLY,NF1,OPG,THERE
001,109,166,169,253,275,888,ALK,AMONG,CONCLUSION,CRIZOTINIB,DCR,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PROFILE,PURPOSE,RESULTS,SOCIETY,TTP
145,157,ALTOGETHER,AML,BACKGROUND,FORTY,LABEL,LEUKAEMIA,METHODS,OBJECTIVE,RESULTS
110,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THEIR,THERE,TOTAL
169,231BR,BECAUSE,COPYRIGHT,HEPARANASE,HIGHEST,HOWEVER,INC,LAPATINIB,MDA,NEOPLASIA,PRESS,PUBLISHED,THESE
169,BMAL1,CLOCK,COPYRIGHT,HCC,HOWEVER,INC,NEOPLASIA,PRESS,PUBLISHED,STRIKINGLY,TAKEN
177,CONCLUSION,KIM1P,LABEL,LUXOL,METHODS,OBJECTIVE,RESULTS,TDL
CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,RESULTS
177,181,697,729,AFTER,AG490,AKT,ANOVA,BAD,CYTOCHROME,GBM,JAK,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL,STAT3,STAT3SIRNA,THERE,U87,WESTERN
HOWEVER,MARCH,NOVEL,SIX
AWAKE,BACKGROUND,COGNITIVE,COMPARISON,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,WORLD
122,THESE
THESE
160,BACKGROUND,HOWEVER,LABEL,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,RESULTS,THERE
169,AMONG,BESIDES,CHICAGO,COPYRIGHT,DESPITE,ENDOCRINE,SAS,SOCIETY
177,CONCLUSION,FORTY,HOWEVER,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
169,COPYRIGHT,FINALLY,HENCE,HOWEVER,HTATIP2,INC,PCR,SP1,TAKEN,U87
IP6K2,IP6KS,IP7
12MOPFS,142,149,169,400MG,CONCLUSION,COPYRIGHT,EGF,III,LABEL,LTD,MACDONALD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
100,107,169,188,286,ACCORDING,ALA,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,RESECTION,RESULTS
012,078,122,135,172,177,237,313,338,392,404,450,476,528,541,621,633,667,740,842,899,900,903,945,AES,APRIL,BACKGROUND,GLM,HOWEVER,ICD,LABEL,MARKETSCAN,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENTS
177,197,ASSESSMENT,BRM,CNS,GPA,INTRABEAM,KARNOFSKY,LABEL,LOCAL,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SCALE,SIX,SURGERY
643,COLLEGE,CORNELL,CPS,CSF,GROSS,LABEL,MEDICAL,METHODS,OBJECTIVE,PARASELLAR,PATIENT,RCC,RESULTS,THERE,THESE,WEILL,WESTERN
031,169,276,314,361,466,857,915,HOWEVER,III,JANUARY,MSI,MSS,STAGE
169,CONCLUSION,COPYRIGHT,CTA,DSA,ELABORATE,GTR,III,IMAGING,LABEL,METHODS,MRA,MRI,MRV,OBJECTIVE,RESULTS,SIMPSON,SIX,STR,TMS
001,002,007,008,170,196,343,665,HOWEVER,III
107,18S,28S,395,ADD,AMONG,ANNEXIN,APC,APOPTOSIS,CPG,DENATURING,HOXC8,MDK,MECP2,SAOS2,THERE
169,AKT,BACKGROUND,BASEL,BAY36,CONCLUSION,INHIBITION,LABEL,LDH,METHODS,RESULTS,THESE,TUNEL,U87
BASED,BEX,BRAIN,DUE,EXPRESSED,HOWEVER,THESE
002,003,016,046,108,ADC,CONCLUSION,ETP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
CESSATION
160,ALTERED,EARLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURFACE
169,ACADEMY,BIOLOGICAL,BTV,CONCLUSION,ENDPOINTS,FET,GBM,INCREASING,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PET,PROGNOSTIC,RCX,RESULTS,SEVENTY,TAC,TMZ
169,945,947,954,ACIDS,KNOCKDOWN,NUCLEIC,PDH,PRESS,PUBLISHED,SP1,TCA,UNIVERSITY,ZBTB2
160,169,231,233,AMONG,COPYRIGHT,CSC,PUBLISHED,SAS
DIFFUSION,DTI,DWI,DYNAMIC,HENCE,HOWEVER,IMAGING,MRI,RESONANCE
169,COPYRIGHT,RAMAN,SCIENCE,SERRS
CCS,CHILDHOOD,COX,CRT,FIFTEEN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNS,SURVIVORS,TEN,TRANSITION,TURIN
118,129,AMONG,BACKGROUND,DWI,LABEL,METHODS,MRI,MRS,PWI,RESULTS
177,BACKGROUND,BOOST,CONCLUSION,DIFFERENT,FET,GTV,IMAGE,LABEL,LESIONS,METHODS,MRI,PET,RESULTS,SKULL,TOTALLY,WHILE
CNS,DIFFUSION,MRI,PCNSL,PRE
BACKGROUND,GBM,KIT,LABEL,RB1,RESULTS
MRI
160,450,BACKGROUND,CBV,DSC,DYNAMIC,LABEL,METHODS,MRI,PFS,RESULTS,VOXEL
FDG,PET
177LU,AFTER,DOTA0
BACKGROUND,GCS,LABEL,METHODS,REDUCED,SMART
CD4,CSF,HIV,IMAGING,LABEL,LUSCHKA,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,TEN
THESE,USING
169,BACKGROUND,CHEMISTRY,CSF,DETECTING,LABEL,METHODS,PCR,RESULTS
169,BACKGROUND,CHEMISTRY,CONTENT,LABEL,NEUROMEDIN,NMU,SUMMARY
000,009,018,028,ADVERSE,COX,GEFITINIB,III,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS
003,013,016,029,KARNOFSKY,KFS,PFS,SEVERAL
945,ACCORDING,CRP,ELISA,GLUCOSE,ICU,JILIN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SERUM,THERE,TNF,UNIVERSITY
001,003,005,006,BACKGROUND,COX,FOXC2,HOWEVER,INCREASING,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,PCR,RESULTS
169,177,208,976,CCL22,CD4,CLUSTER,COX,DEFECTS,GBM,IDH,IGE,PATIENT,RATIO,SEM
000,163,177,689,99MTC,BACKGROUND,DYNAMIC,LABEL,METHODS,PET,RESULTS,ROI
ACT,AFFORDABLE,BACKGROUND,BECAUSE,CENTERS,CONCLUSION,HAC,HEALTHCARE,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,PATIENT,PROTECTION,PSI,QUALITY,RESULTS
BECAUSE,DIC,LABORATORY
143,INHIBITION,PET
001,169,1ST,232,2ND,330,BACKGROUND,COPYRIGHT,CROWN,DESPITE,FURTHER,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,REASONS,RESULTS,STAGE
946,AKT,DUE,PAM,SHH,THERE,WNT
000,169,483,600,661,AAV,ATP,CKB,COLORECTAL,COPYRIGHT,INC,THESE
BRAIN,CNS,CPP,HISTOLOGIC,HOWEVER
169,COPYRIGHT,IRELAND,LTD,MULTIMODAL,SHH,WNT
169,COPYRIGHT,DMF,EFFECTIVE,HOWEVER,LTD
BACKGROUND,CURRENT,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
034,146,19Q,EOR,GIVEN,JANUARY,LGG,MEDICAL,METHODS,MIB,PFS,RESULTS,THERE,TOKYO,UNIVERSITY,WOMEN
THEREFORE,WORLD
176,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,DIFFERENT,LABEL,METHODS,OBJECTIVE,RESULTS,SIGMOID
104,AVERAGE,BACKGROUND,BSCMS,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE
100,800,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NASHVILLE,NORTH,NOVEL,OBJECTIVE,RESULTS,ROBOT,TENNESSEE
BACKGROUND,CONCLUSION,INCREASING,LABEL,METHODS,METRICS,NEUROTOUCH,OBJECTIVE,OPERATING,REGARDLESS,RESULTS,SIX,ULTRASONIC,VALIDATED
001,212,BACKGROUND,CLEVELAND,COMPETING,CONCLUSION,LABEL,LRT,METHODS,OBJECTIVE,RESULTS,SURGERY
169,CHARING,CNS,CONCLUSION,COPYRIGHT,CROSS,EMA,GTN,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
169,AFTER,BACKGROUND,CATHETERS,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,TEXAS,THESE,UNIVERSITY
169,DIPGS,HISTOLOGIC,INC,THEREFORE,WILEY
169,ATLAS,FURTHER,GBM,IDH,PDGXS,SOCIETY,Y1068
CRICK,NUCLEIC,SINCE
130,169,AUTHORS,BACKGROUND,BLOOD,BRIEF,INC,LABEL,METHODS,MRI,PEDIATRIC,PROCEDURE,PUBLISHED,RESULTS,SMALLER,THERE,WILEY
ALZHEIMER
GCM
042,169,BACKGROUND,BRAIN,COPYRIGHT,GRONINGEN,IMAGING,IRELAND,LABEL,LTD,MEDICAL,METHODS,MRI,NFA,OBJECTIVE,PURPOSE,RESONANCE,RESULTS,UNIVERSITY
AKT,CD133,GDC,THESE
001,107,COX,ESPECIALLY,FINALLY,HOWEVER,KARNOFSKY,KPS,MEIER,PCR,PFS
169,COPYRIGHT,LTD
169,AUTHORS,COPYRIGHT,GROUP,IAA,IRELAND,LTD,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,CRANIAL,HOWEVER,INC,SEVERAL
169,ALZHEIMER,CONSISTENT,COPYRIGHT,CYS,GIVEN,NOTABLY,PUBLISHED,SINCE,SOH,STRUCTURAL
169,945,947,AGE,AMP,ATP,BCL,COPYRIGHT,COX,METFORMIN,NRF,THESE,WHILE
169,BIOLOGY,GBM,GLI,MTP53,SHH,SMO,SMOOTHENED,SOCIETY,U87MG,WTP53,ZERUMBONE
16P11,BACKGROUND,BMJ,CGH,GROUP,LABEL,LIMITED,METHODS,PCR,PRRT2,PUBLISHED,PUBLISHING,RESULTS,THESE
122,160,233,BACKGROUND,CONTEXT,ENDOCRINE,ENDOCRINES,LABEL,METHODS,NET,NEURO,OBJECTIVE,OVERALL,RESULTS,SURGERY,TUMEURS,VARIOUS
001,133,173,297,ADVERSE,AFTER,BETWEEN,CLASSES,COX,FIFTY,GAMMA,GBM,III,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,USING,VARIABLES
177,CED,CLEARPOINT,CONVECTIVE,INC,MRI,PARKINSON,PEARSON,PLACEMENT,THERE,THREE
111,137,215,480,CSF,EPIDERMOID,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OPTIMAL,RESULTS,SCALE,SURGERY,THERE,TOTAL
169,ALT,ATR,COPYRIGHT,INHIBITION,RPA,SCIENCE,TERRA
177,585,847,945,946,CONCLUSION,CTCAE,D98,DMEAN,LABEL,LTC,MATERIALS,METASTASES,METHODS,MRI,NCI,OBJECTIVE,PFS,PURPOSE,RESULTS,SIB,SIP
169,COPYRIGHT,HOWEVER,INC
239,514,521,AES,BASEL,CONCLUSION,EAP,EASTERN,EVALUATION,GROUP,ITALIAN,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RCC,RESULTS,SOLID
169,945,COPYRIGHT,EMT,FURTHER,GBM,GLUT1,IRELAND,LTD,SHRNA,SNB75,U87,YKL40
CNS,EWING,GROSS,PERIPHERAL,PNETS
947,ASSESSMENT,CONCLUSION,KARNOVSKY,LABEL,METHODS,OBJECTIVE,RESULTS
001,007,103,114,DCS,LABEL,METHODS,MRI,OBJECTIVE,OR2,RESULTS,THERE,THREE
CNS,CORONAL,DIFFUSION,FLAIR,IIC,ISSUE,ITSSS,LABEL,MELANOTIC,METASTASIS,METHODICAL,METHODS,MRI,OBJECTIVE,PRACTICAL,STAGE
OVERALL,VHL,VON
114,159,BMJ,BRAIN,COMMONEST,EPSCC,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,SETTING
100,177,ABABA,ACCEPTABLE,ADDIS,AFRICAN,BACKGROUND,CHI,CHRISTIAN,CONCLUSION,CUSHING,EARLY,ENDONASAL,HARDY,LABEL,MEDICAL,METHODS,MRI,MYUNGSUNG,OBJECTIVE,RESULTS,SEPTEMBER,THREE
STEROID,THESE
183,AUSTRALIA,CONFORMITY,D50,D95,D98,GAMMA,GROSS,GTV,INDEX,ISODOSE,KNIFE,LABEL,LEKSELL,MARCH,MAXIMUM,MEETING,METHODS,NCI,OBJECTIVE,PADDICK,PCI,PIV,POINT,RATIO,RESULTS,SEPTEMBER,SEVERAL,SOCIETY,TAE,THESE,TOLERANCE,TOTAL,TREATED,TTV,TVPIV,V10
169,180,BACKGROUND,COX,EXPRESSION,LABEL,MEIER,METHODS,MOLONEY,P16,RESULTS,SOCIETY,THEREFORE
100,113,169,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS,USING
048,169,177,AUTHORS,CH3,CSI,LACTATE,LTD,METHODS,NMR,WILEY
HOWEVER,IDEALLY
III,PHASE
ASSESSMENT,BASIQ,BRAIN,CONCLUSION,FORTY,FUNCTIONAL,GENERAL,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SYMPTOM
350,CNS,ITALY,NEURO,OCTOBER,TURIN
001,108,164,177,AFTER,AVERAGE,BNP,CARDIAC,CRP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TIC
APLP2,CCI,CONTAINING,FINALLY,FLICE,KNOCKDOWN,LETM1,PROTEIN,RBM,RBM10,SF1,SFS,TBI
169,CDKN2AB,COPYRIGHT,INC,MOLECULAR
169,BACKGROUND,LABEL,METHODS,QOL,RESULTS,SOCIETY,THERE,WORLD
AWAKE,BACKGROUND,BASED,CONCLUSION,DES,HOWEVER,LABEL,METHODS,MIXED,PRE,QMT,QUICK,RESULTS
001,024,026,110,115,169,277,316,461,718,AAS,AOA,AOS,COPYRIGHT,COX,DUE,END,GBM,IDENTICAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,675,BACKGROUND,BNP,LABEL,METHODS,RESULTS,SINCE
122,432,861,BACKGROUND,BETWEEN,CONCLUSION,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,187,BIOLOGY,GCS,INC,INHIBITING,MOLECULAR,RB1,SCF,SINCE,SOCIETY,THESE,THR
004,006,169,AGHDA,CONCLUSION,GHD,GHR,LABEL,METABOLIC,METHODS,OBJECTIVE,PREVALENCE,QOL,RESULTS,SHORT,SOCIETY,TBI
169,363,AES,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS,THERE,TKI,UPFRONT
000,180,240,956,BISPHENOL,BPA,BPS,HOWEVER,STRIKINGLY
ETC,FINALLY,HGG,IMPAIRMENT,KREBS,RAS,THEREFORE
169,543,967,HYPOTHESIS,INC,INPATIENT,LABEL,LEVEL,METHODS,NATIONWIDE,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RATES,RESULTS,SOCIETY,SOUTH,THERE
169,ACIDS,AML,NUCLEIC,PRESS,PUBLISHED,SPARROW,UNIVERSITY
229,248,477,AIM,ASSESSMENT,INSTITUTE,JANUARY,LABEL,LOCAL,METHODS,OBJECTIVE,RADIOLOGY,RESULTS,SERVICE
DESPITE,III,INITIAL,PHASE,THERE
GBM,HIF
CSC,GBM,STRATEGIES,THESE
169,A20,A925L,ALK,AUTHORS,LTD,PTY,PUBLISHING,SCIENCE,WILEY
GBM,HOWEVER,IHC,MUTATED,RESULTS,V600E,VE1
169,945,AAD,ALDH7A1,ATP,COPYRIGHT,GBM,GSC,HNPCS,INHIBITION,LTD,METABOLITE,NMR,WILEY
BACKGROUND,CONTEXT,LABEL,OBJECTIVE,SECONDARY
945,946,DISRUPTING,GBM,GSC,POSTN,RGD,SILENCING,TAM
177,980,METHODS,MRGLITT,MRI,PAA,PVA,RESULTS,TDE,THERAPY,THERMAL,THROUGH,USING,VISUALASE,VOLUMETRIC
169,APB,COPYRIGHT,INC,INHIBITION,MMG,ORAI1,STIM1,THEREFORE,U87
169,CNS,COPYRIGHT,EXCEPTIONS,HOWEVER,LTD,NEOPLASMS
713,BACKGROUND,CONTROLLED,CURRENT,KNOWLEDGE,LABEL,LIBRARY,METHODS,MST,NSCLC,RESULTS,SBM,SRS,STATA,THERE,WEB
160,HCC,HCV,THEREFORE
152,169,COPYRIGHT,FINALLY,FURTHER,GBM,GREAT,IRELAND,LTD,TAKEN
169,COPYRIGHT,IRELAND,LTD,MAP,MARK4,PTB
169,215,AIM,CALCIFYING,CONCLUSION,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SUBSEQUENT
169,946,BACKGROUND,CONCLUSION,COPYRIGHT,DAS,ELISA,FOLLOWING,GH3,HCS,IRELAND,LABEL,LTD,METHODS,PCR,PRL,RESULTS,SMAD3,TGF,WESTERN
001,002,233,AGE,CCI,INFLUENCE,KARNOFSKY,KPS,LABEL,MAIER,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
100,169,BACKGROUND,CONCLUSION,COPYRIGHT,ENDOSCOPIC,ETV,EVT,FURTHER,LABEL,MATERIALS,METHODS,RESULTS,SUCCESS,THREE
169,177,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,CSF,FRAME,LABEL,METHODS,NEUROLOGIC,REGARDING,RESULTS,THERE,UNIVERSITY
169,APART,BACKGROUND,BLOOD,COPYRIGHT,LABEL,METHODS,OCTOBER,RESULTS,RFT,SURGERY,THERE
169,8MM,CONCLUSION,COPYRIGHT,FINALLY,LABEL,METHODS,MTL,MTR,OBJECTIVE,RESULTS,SYLVIAN,THERE,THREE
169,COPYRIGHT,DESMOID,DTS,THEREFORE
BMJ,GROUP,INDIA,LTD,PUBLISHING
049,BASED,CONCLUSION,IGF,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SRS,SRT
009,169,183,229,APRIL,ASSESSMENT,BACKGROUND,BASED,BETWEEN,COPYRIGHT,EVALUATION,FUNDING,GRADE,GRADING,GROUP,INADEQUATE,JANUARY,LABEL,LTD,METHODS,NEUPSIG,NNT,RESULTS,SPECIAL,STUDIES,THESE,TOPICAL,TRIAL,USING
169,COPYRIGHT,INC,TYPICAL
153,GROUP,HMGA2
947,INHIBITING,NOTCH,PAS,PILOCYTIC,THESE
14Q21,16P13,ADDITIONAL,ARL4A,BESIDES,CHOROID,GENOMIC,LAMB1,MOLECULAR,RSPH9,TARGETS,THESE,TRPM3,VEGFA
ACCEPTANCE,BRAIN,EXCEPTION,FEW,III,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,SETTING,SEVENTY,TRAUMATIC,TREATMENT
350,456,806,AFTER,BACKGROUND,CONTEXT,CVE,DUTCH,FURTHER,HORMONE,HOWEVER,IRR,LABEL,METHODS,NFPAS,OBJECTIVE,OUTCOME,RESULTS,SETTING,SIXTY,TREATMENT
001,002,255,279,534,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PHYSICIANS,QUESTIONS,RESULTS,THESE
100,GBM,MRI,THESE,TOMOGRAPHY
169,CHEMOBRAIN,COPYRIGHT,HOWEVER,LTD,THERE,THESE
169,COPYRIGHT,DOSIMETRIC,MRI,PUBLISHED,SAS
169,961,CIRCADIAN,CLOCK,HESCS,PER
ACT,AFFORDABLE,DIFFERING,EMERGENCY,INC,PATIENT,PHYSICIANS,PROTECTION,PUBLISHED,RENAL,STATEMENT,THERE
169,CA2,COPYRIGHT,RETICULON,RTN,SEVERAL,THESE
001,020,160,GBM,GRADE,III,IPS,PFS,THERAPY,UNIVARIATE,WORLD
005,160,III,ION,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,OLIVARY,PCF,PURPOSE,RESULTS
169,FDG,HOWEVER,IMAGING,INC,MOLECULAR,NUCLEAR,PET,SOCIETY,SUCCESSFUL,THESE
169,946,ALZHEIMER,CONCLUSION,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,PITTSBURGH,RESULTS,SOCIETY,THK5117,UNLABELLED,USING
945,HIF,HOWEVER,SIAH1,THESE
BACKGROUND,CNS,CONCLUSION,HODGKIN,LABEL,METHODS,MRI,NON,PET,TREATMENT
ELECTRICAL,EPT,MRI,TESLA,USING

AFTER,AFTERWARDS,FIRSTLY,MRI
215,INTENSE,SKULL
002,012,016,022,099,169,255,316,539,596,693,983,BASED,COPYRIGHT,EASTERN,GROUP,HOWEVER,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS,SEVENTEEN
169,AMONG,FOLLOWING,HDC,HEMATOLOGY,KARNOFSKY,MPV,PCNSL,PFS,PRIMARY,SOCIETY,THERE,THOSE
641,AFTER,AGE,DETECTION,III,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
19Q,EXPRESSION,IIAND,III,LABEL,LOH,METHODS,OBJECTIVE,R132H,RESULTS,WHILE
HISTOLOGIC,LABEL,METHODS,OBJECTIVE,REGARDING,RESULTS,RETICULIN,SIX
CONCLUSION,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIXTEEN,SURGERY
AFTERWARDS,BACKGROUND,BSR,EIGHT,GERMANY,LABEL,METHODS,MRI,RESULTS,SINCE
AIM,BACKGROUND,CONCLUSION,COUNSELING,ECG,LABEL,LIMITATION,METHODS,OBJECTIVE,RESULTS,SCALE,TSC,USG
ANXIETY,AREAS,BACKGROUND,COVERED,GREAT,HOWEVER,LABEL,METHODS,OPINION,THERE,THESE

001,013,043,152,240,ACADEMY,AMONG,CHINESE,DEPENDING,INSTITUTE,JANUARY,LABEL,LUMINAL,MEDICAL,METHODS,OBJECTIVE,RESULTS
100,LABEL,LAR,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
810,CNR,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OFF,PURPOSE,RESULTS,RTP
AFTER,LATER,POSTERIOR,WHILE
169,COPYRIGHT,CPP,GBM,HOWEVER,INC,INK4A,THESE,U87MG
239,FURTHER,GBM,GENOMIC,HOWEVER,INDIVIDUAL
169,BORCK,III,LABORATORY,POL,PRESS,PUBLISHED,TAKEN,TBP,WHOLE
AFTER,CELSIUS,UNDER
169,BBB,COPYRIGHT,NPS,U87MG
169,187,374,CONCLUSION,LABEL,METHODS,MULTIMODAL,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THESE,WML
1970S,ANOTHER,DROSOPHILA,FDA,HOWEVER,PTCH1,SINCE,VISMODEGIB
169,181,BACKGROUND,COPYRIGHT,DON,ESI,GRAPE,INITIAL,LABEL,LTD,MALDI,METHODS,RATIONALE,RESULTS,SAMPLES,THEREFORE,WILEY
006,009,014,100,AFTER,BACKGROUND,GRADE,IMAGING,LABEL,LGG,METHODS,MRI,RESULTS,ROC
124,169,946,AUTHORS,CNS,COPYRIGHT,GPCRS,INC,PDZ,PUBLISHED,SIMILAR,WNT,WNT7A,WNT7B
169,CSI,INC,WILEY
001,169,BACKGROUND,COX,EMORY,GBM,HEALTHCARE,LABEL,MEIER,METHODS,PFS,RESULTS,SOCIETY,UNIVARIATE
103,120,157,169,277,380,BACKGROUND,END,LABEL,METHODS,PIC,RESULTS,SOCIETY
169,BRITAIN,COPYRIGHT,FUNCTIONAL,GREAT,HOWEVER,IRELAND,LTD,NR2E1,OVERCOMING,PUBLISHED,RAS,SIRT1,SOCIETY,TLX,WILEY
11C,BACKGROUND,CONCLUSION,GERSTMANN,LABEL,METHODS,MRI,PET
AFTER,BASED,EMERGENCY,HOWEVER
120,169,215,BACKGROUND,BASED,DL1,DL2,DLT,INC,LABEL,METHODS,MTD,PROCEDURE,RESULTS,TOXICITIES,WILEY
169,AUTHORS,COPYRIGHT,CVA,DESPITE,FLUENCY,HGT,HOWEVER,LGT,LTD,OVERALL,PUBLISHED,RAVEN,TRAIL,TYPICALLY
025,113,306,358,5TH,807,BACKGROUND,CNS,LABEL,MATERIALS,METHODS,OVERALL,RESULTS
176,186,1ST,221,319,424,5X109,BACKGROUND,BETWEEN,FEC,JANUARY,LABEL,MATERIALS,MBC,MEDICAL,MEIER,METHODS,NAUROIS,RESULTS,TRD,UNIVERSITY
456,528,569,612,647,685,713,715,729,734,752,761,776,792,812,BACKGROUND,CIS,FURTHER,HOWEVER,LABEL,MATERIALS,METHODS,ORS,RESULTS,RTEL1,SNP
TTP,U87MG,UROKINASE
160,169,ABSENCE,APMIS,FORTY,HARDY,LTD,PITUITARY,PUBLISHED,SPARC,WILEY
ALECTINIB,ALK,CRIZOTINIB,CSF,FURTHER,MET
CD3,CD4,CD8,FOXP3,GBM,HOWEVER,SCANSCOPE,THESE,TREGS
169,215,2YL,BAX,BCL,COPYRIGHT,H2O,HOWEVER,INC,MTT,SGC7901,WESTERN
APC,IDH1R132H,MHC,PLA
177,AFTER,BETWEEN,CNS,CSI,HIT,LABEL,METHODS,OBJECTIVE,PRIMITIVE,RESULTS,SEPTEMBER
GIVEN,MRI,RCC,TESTING
169,BACKGROUND,COPYRIGHT,GBM,GENERAL,LABEL,METHODS,PKC,RESULTS,THEREFORE,THESE,TMX,TMZ
169,945,954,COPYRIGHT,EGR,INC,LUCIFERASE,SMALL,TNF
CURRENTLY,GBM,GREAT
AFTER,MEMRI,MRI,PET,THERE,THESE
BMJ,BRAIN,COUNTRIES,CURRENT,FIFTY,GROUP,HWL,LABEL,LIMITED,METHODS,MRI,OBJECTIVE,PICTORIAL,PUBLISHED,PUBLISHING,RESULTS
MBP,PTM,SRM,USING
19Q,DISCOVERY,END,GRADE,III,INSTITUTE,LGG,LOW,RESULTS,WORLD
177,AFTER,CLASS,ENGEL,EXCLUDING,GGS,GIVEN,INCOMPLETE,LESIONS,METHODS,MRI,OVERALL,REGARDING,REMNANT,RESULTS,SIXTY,USING
ACCORDING,AFTER,FIFTY,FINALLY,FLAIR,GRADE,HOWEVER,III,LGG,METHODS,MRI,PET,RESULTS,SURGERY
EOR,GREATER,IMAGING,MRI,PROXIMITY,THEREFORE,THROUGH
A10,AS2,BCL,PHASE
ATLAS,GBM,HOWEVER,PATIENT,THESE
HDC,SAUDI
121,21MBS,34A,601,ATRTS,BACKGROUND,BASED,BRAIN,CHAIN,CNS,FIRST,LABEL,MBS,METHODS,OVERALL,POLYMERASE,RABDOID,REFERENCE,RESULTS,RTS
AKT,ATP,G161V,K179M,MET
001
000,001,006,011,025,026,028,COX,EPCAM,MEIER,NFPAS,PAS,PITUITARY,TROP2
001,016,019,031,047,162,EXPRESSION,PIPOX,SARCOSINE,SARDH
169,250,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,LAPATINIB,MBC,METHODS,ORR,PFS,PLD,RESULTS,SECONDARY
002,004,059,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,INSTITUTE,LABEL,METHODS,OBJECTIVE,REGARDING,RESULTS,SEVEN
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CXCR7,GBM,INSTITUTE,KNOCKDOWN,LABEL,MATERIALS,METHODS,RESULTS,SIMILARLY
169,235,COLLEGE,COPYRIGHT,COX,ELDERLY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,UNIVARIATE
AGILENT,BACKGROUND,HISEQ2000,LABEL,MALIGNANT,METHODS,MN1,NF2,NIMBLEGEN,RESULTS,SURESELECT
CONCLUSION,ESPECIALLY,ITEMS,LABEL,LATENCY,METHODS,NEITHER,OBJECTIVE,OVERALL,PREFERRED,REPORTING,RESULTS,SYSTEMATIC
01640,CPP,DESPITE,ICP,RUSSIAN
AMONG,BMX,EFFICIENCY,GBM,GSC,STAT3,THESE,WHILE
177,500,517,760,778,ALA,BACKGROUND,CLR1501,CLR1502,CONCLUSION,EXCITATION,HARVESTED,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS
001,100,BACKGROUND,CONCLUSION,COX,DBF,FORTY,LABEL,MEIER,METHODS,OBJECTIVE,PRIMARY,RESULTS
125,181,652,AQUATIC,CYTOTOXIC,GH4C1,GLYCOLIPID,MCF,N2A
169,ACADEMY,AFTER,BECAUSE,COPYRIGHT,PEDIATRICS
169,946,ALZHEIMER,BIOLOGY,CONGO,HEPARAN,HEPARANASE,HSPGS,INC,MOLECULAR,SOCIETY,SWE,SWEDISH,THEREFORE,THIOFLAVIN
CEREBELLAR,CMS,PFS
INFECTION
504,ACT,CLEAR,EDUCATION,MEDICAL,PHYSICIANS,PLANS
EARLY,MANAGEMENT
DIAGNOSING,EARLY,LANGERHANS
169,181,BCBMS,BRAIN,CNS,COPYRIGHT,CSF,LAPATINIB,NEITHER,SOCIETY,THESE
313,AIF,ALA,BACKGROUND,HOWEVER,LABEL,METHODS,RESECTION,RESULTS,SEVEN,SIX,THEREFORE
169,COPYRIGHT,DIFFERENT,INC
BACKGROUND,CAUTION,GRADE,LABEL,METHODS
AUTHORS,THERE
176,186,250,ADVERSE,AUTOLOGOUS,HCT,IMPORTANCE,INSTITUTE,LABEL,METHODS,OBJECTIVE,OVERALL,RELAPSING,RELEVANCE,REMITTING,RESULTS,SCLEROSIS,SETTING,TOXIC,TREATMENT
03012,169,AUTHORS,CMV,EBOLA,GRP58,GRP78,GRP94,HEPATITIS,HSP27,HSP40,HSP60,HSP70,HSP90,INC,INFLUENZA,JOURNAL,LAMP1,LASSA,MARBURG,MEASLES,MUMPS,NTCP1,OSU,PHYSIOLOGY,PRE,PUBLISHED,REC,RSV,RUBELLA,SIMILAR,WILEY
001,13N,177,18F,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,214,229,BACKGROUND,CNS,CSF,FCI,HOWEVER,INC,LABEL,METHODS,PROCEDURE,RESULTS,STOCKHOLM,THERAPY,TREATMENT,UME,WILEY
AKT,CPT,DII,HB1,NDEPT,OVERALL
954,DICER,ERK,GENERALLY,HIV,TAR,THESE,UTR
MALIGNANT,OCCASIONAL,RIGHT,THESE
122,134,ABOUT,CONCLUSION,EDEMA,GAMMA,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN
169,AUTHORS,COPYRIGHT,INC,MMERVK10C,PUBLISHED,THESE
BRAIN,CENTRAL,CHILDHOOD,CNS,DIAGNOSED,FOUNDATION,NERVOUS,OVERALL,PRIMARY,STAND
169,COPYRIGHT,ECM,GBM,HOWEVER,LTD,MINIMIZING
108,10877,169,9AM,COPYRIGHT,HDL,INC,VITAL,WBC
107,169,1CM,3MONTHS,4GY,5MM,COPYRIGHT,CTV,DESPITE,GTV,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PFS,PTV,PURPOSE,RESULTS
169,BECAUSE,BIOLOGY,COPYRIGHT,FEDERATION,INC,MERCIER,PUBLISHED,RESOUND,ULTRASOUND,USING,WORLD
169,BACKGROUND,CONCLUSION,COPYRIGHT,DECISIONS,DISCUSSION,FERRAND,GLIOMAS,LABEL,METHODS,OPTIC,RESULTS,SAS,THROUGH,TREATMENT,UNIVERSITY
002,057,100,169,177,960,CONCLUSION,COPYRIGHT,GAMMA,GKSRS,INC,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PADDICK,PCI,PURPOSE,RESULTS
169,CACL2,COPYRIGHT,EAG,LTD,MUTATIONS,SIMILARLY,THESE,TRUNCATED,VOLTAGE
169,COPYRIGHT,GBM,HIPPO,HOWEVER,INC,MIR,PUBLISHED,TAZ,UTR
169,954,AKT,ATM,AUTOPHAGY,COPYRIGHT,HOWEVER,IRELAND,LTD,OVERALL,STAT3,WHILE
169,945,946,COMBINING,COPYRIGHT,LTD
FMISO,GBM,PET,USING
169,600,CNNM2,COPYRIGHT,MAGNESIUM,MAGT1,SOCIETY,TRPM6
001,100,177,2GY,314,946,947,LITHIUM,SF2,SHH,SINCE,WNT
BACKGROUND,CLINICALLY,CON,DEP,FSH,HOWEVER,LABEL,METHODS,NFPAS,PDQUEST,RESULTS,THESE,THOSE
METASTATIC,SURGERY
126,149,163,169,233,AMONG,CNS,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POTENTIAL,PUBLISHED,PURPOSE,RESULTS,VII
198,BACKGROUND,BESTA,BRIEF,CARLO,CONCLUSION,EUROHIS,FINALLY,INSTITUTE,KPS,LABEL,METHODS,QOL,RESULTS
169,AKT,BIOLOGY,BTICS,CONVERSELY,EGF,ERK,FGF,FURTHER,HOWEVER,INC,MOLECULAR,NGF,NT3,PREVIOUSLY,SOCIETY,TRK
169,174,215,223,348,660,COX,FDR,GBM,INC,LIMITED,THESE,USING,WILEY
FOURIER,PROTEIN,SEP
946,ALZHEIMER,C1Q,LATER,TGF,TNF,WHILE,WNT
001,002,003,007,043,122,160,1P19Q,AOA,HOWEVER,IDH,MRI,WHILE
144,401,416,BOOLEAN,EXPRESSION,GEO,KOHONEN,OMNIBUS
ACCORDING,AIM,BACKGROUND,BASAL,BCC,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
102,154,160,171,183,263,362,500,AIM,ASSESSMENT,BMI,LABEL,METHODS,OBJECTIVE,RESULTS,SDS,TEN,THERE
453,AIM,BRAZILIAN,C677T,CONCLUSION,EMBRYONIC,GENOMIC,LABEL,MATERIALS,METHODS,MTHFR,OBJECTIVE,RESULTS,RFC,SAMPLES
002,005,210,233,396,BACKGROUND,EDITORS,FURTHER,HCC,LABEL,METHODS,RESULTS,STAT3,SUMMARY,SYSTEMATIC,TYPICALLY,USING
33342,BT325,FURTHER,HOECHST,TAMOXIFEN,U87
183,AIM,BACKGROUND,CONCLUSION,DTI,GEORG,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,STUTTGART,THREE
946,BACKGROUND,GSK,LABEL,METHODS,PACLITAXEL,RESULTS
BACKGROUND,DESPITE,DLT,GBM,INTRAGO,KARNOFSKY,LABEL,METHODS,MTD,SECONDARY,THEREFORE,TRIAL
BMJ,CNS,EPSTEIN,EXTENSIVE,GROUP,HISTOLOGY,LTD,LYG,PUBLISHING
ACUTE,GBM,HBSAG,HBV,HEPATITIS,LABEL,METHODS,OBJECTIVE,SINCE,THESE,TMZ
169,393,ASPIRATOR,COPYRIGHT,DOPPLER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,ULTRASONIC
NETWORK
160,GBM
945,946,ERS,SRC,STEROID,THESE,WHILE
169,CNS,FINALLY,GNA11,PRIMARY,SOCIETY,UNTIL
100,169,956,COPYRIGHT,CPG,ECS,GPR55,INC,OPE,PLD,TAKEN,TRPV1
169,AUTHORS,COPYRIGHT,GBM,INC,NOD,PUBLISHED,SNP,WHOLE
169,ABROGATION,AUTHORS,COPYRIGHT,INC,MYC,P53,PUBLISHED,TRP53
947,BECAUSE,GSH
169,COPYRIGHT,CST,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,ROI,SEEDING,SIMILARLY,WBF,WHOLE
000,001,002,115,168,177,202,ABOUT,AIP,BACKGROUND,BASAL,CONCLUSION,FACTORS,LABEL,METHODS,OBJECTIVE,PITUITARY,PRL,RESULTS
169,BACKGROUND,BASEL,EGGER,LABEL,METHODS,PERTINENT,RESULTS
594,CSF,EWING,OVERALL,VEC
1270C,1306C,169,266,AMSTERDAM,APC,HNPCC,LEU424VAL,LYNCH,MMR,MUTYH,POLD1,POLD2,POLD3,POLD4,POLE2,POLE3,POLE4,PRO436SER,SCREENING,THEREFORE
169,CNS,COPYRIGHT,HOWEVER,IRELAND,LTD,PUBLISHED
001,018,117,162,270,432,571,GROUP,HOWEVER,JAPAN,TREATMENT
945,954,BACKGROUND,CXC,CXCR4,LABEL,METHODS,P65,PCR,RESULTS,TARGETING,TNF,TRANSWELL,WESTERN
169,COPYRIGHT,DIEGO,INC,LABEL,METHODS,MRI,OBJECTIVE,PITUITARY,RESULTS,SAN,THREE
169,EXPRESSION,IGSF1,N604T,PATHOGENIC,SOCIETY,VARIATIONS
169,CD133,COPYRIGHT,HSC71,HSPA8,INHIBITION,IRELAND,LTD,NANOG,OCT
169,ACADEMY,CLASS,EXPRESSION,KARNOFSKY,LABEL,LAR,METHODS,NEUROLOGY,OBJECTIVE,OCTREOTIDE,PFS,RESULTS,THERE,TREATMENT,WORLD
ADAM9,FISETIN,GBM8401,PCR,U0126,WESTERN
945,946,EMT,FAK,HIF,HOWEVER,INVERSE,KNOCKDOWN,L1CAM,SRC,TWIST,WESTERN
AFTER,BACKGROUND,CAUCASIAN,CLUSTER,CONCLUSION,FURTHER,LABEL,METHODS,SECONDARY
009,169,223,2AR,947,AD169,APC,CD4,CD8,CELLS,CHINESE,CHO,COPYRIGHT,EPI,HOWEVER,IFN,INC,PBMCS,SAL,SIMILARLY,THESE
LEUCINE,LRR,LRRC4,NGL
100,ALDH3A2,C20ORF121,CD133,DTL,KIF5C,LOC203547,LOC642489,LOC650152,LOC653308,RPS6KA2,THESE
169,250,COPYRIGHT,DES,DULIP,DUTCH,INC,LINGUISTIC
177,CSI,KNOPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPACE,THERE
100,956,ACTIVATION,ADP,BRAIN,CELLS,DB029,DHA,GAS,LABEL,METHODS,MHBT161,OBJECTIVE,RESULTS,SIMILAR,TAKEN,U87,USING,WESTERN,WST
177,CASPASE,CCK,WESTERN
CUTIS
045,130,143,CSF,GROUP,LABEL,METHODS,OBJECTIVE,PREDICTION,RESULTS,SHH,WHILE,WNT
160,169,ACSS2,COA,COPYRIGHT,INC,NMR,PREVIOUSLY
100,174,400,MAY,MEETING,SCIENTIFIC,SOCIETY,SRS,USA
169,3K27M,COPYRIGHT,SCIENCE
169,177,CONCLUSION,EXPERIENCE,FET,IMAGING,INC,LABEL,MAXIMUM,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTY,SOCIETY,TBR,UNLABELLED
CD133,CELLS,CSC,FINALLY,NANOG,PITX2,PROP1
GBM43,NSC
169,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,PUBLISHED,RESULTS,TESLA,THERE
035,169,189,222,311,350,577,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LGG,METHODS,PUBLISHED,RESULTS,SEIZURE
CSF,MONRO,SGCTS,SURGERY,TSC
154,169,292,BRACKMANN,CONCLUSION,COPYRIGHT,HOUSE,LABEL,METHODS,OBJECTIVE,RESULTS,VSS
169,COPYRIGHT,CSF,ELISA,ERBB4,FINALLY,HOWEVER,IRELAND,LTD,PARKINSON,THESE,USING
00005,00081,004,172,INC,LABEL,MEIER,METHODS,OBJECTIVE,PEARSON,PUBLISHED,RADIATION,RESULTS,RIMGS,STUDENT,THERE
169,CBD,COPYRIGHT,FURTHER,LTD,SCI
169,ADS,ALT,AST,CAR,COPYRIGHT,ENDOCYTIC,LTD,ONCOLYTIC,PPCBA,RDB,TAKEN,THESE,U87
CONVERSELY,DESPITE,NOTCH,PRRX1
169,GBM,TPC,VX680
PITUITARY
BACKGROUND,LABEL,PATHWAY,PID,PUBLISHED,RESULTS,SEQ,THESE
548,BACKGROUND,EDITING,HTS,LABEL,RESULTS,SMALL,THROUGH
042,ACUTE,AFTER,BACKGROUND,BNP,CONCLUSION,ECG,INCREASES,LABEL,METHODS,RESULTS,THESE,TNI
169,CDKN2,LTD,NCM,PATHOLOGY,PTY,PUBLISHING,ROBIN,SOCIETY,VIRCHOW,WILEY
231,BRAIN,INDIA,NORTH,PMBTS
169,ACTIVITIES,COPYRIGHT,SOCIETY,UDP,UGT
001,101,116,175,513,673,742,DRUGS,LOW,PERIOSTIN,PFS,THERE
BACKGROUND,HODGKIN,HOWEVER,JANUARY,LABEL,METHODS,REPORTS,RESULTS,THESE
AUSTRIA,BRAIN,CONSORTIUM,KNOWLEDGE,MEETING,NEURO,ROCHESTER,SEPTEMBER,SEVERAL,SOCIETIES,USA
APART,CB1,CB2,CBD,CBN,DRUGS,SUBSTANCES,THC

208,398,491,MRI,PEARSON,SPOILED
GREATER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
SEVERAL,THESE
185,HOWEVER,METABOLIC,MRI,PET,ROUTINE,THESE
100,181,AIM,BACKGROUND,CUSHING,EXCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTIVE,SST,THERE
CUSHING,EARLY,KNOWLEDGE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
INCREASING,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SONIC,SUMMARY
530,650,PARKINSON,SPR,UBIQUITIN,UCH
169,CNR,INC,LABEL,METHODS,MULTI,OBJECTIVE,PURPOSE,RESULTS,SATURATION,WILEY
108,118,169,EXPRESSION,GIVEN,MATCHED,SOCIETY,SSA,SSTR2,SSTR3,SSTR5,SSTRS
945,AE1,AE3,CLINICALLY,EMA,HBS,METASTATIC,STROMAL
174,BACKGROUND,CEPHEID,CONCLUSION,HUICHOL,LABEL,METHODS,MEXICAN,MTB,NEELSEN,RIF,SUNNYVALE,USA,XPERT,ZIEHL
HOWEVER,III,JAGGED1,TAKEN
169,COPYRIGHT,INC,MCC,MCPYV,PYV,SEVERAL
169,252,946,CBP,COPYRIGHT,HDAC1,POK,POKEMON,POZ,PUBLISHED,SMAD2,SMAD4,SMADS,TAKEN,TGF
027,100,177,386,BACKGROUND,CONCLUSION,CROSS,ENDOSCOPIC,FORTY,HOWEVER,LABEL,MARCH,METHODS,NSRFS,OLFACTION,RAISING,RESULTS,SIT,SMELL,THERE,VAS
CPS,TYPICAL,WOMEN
178,179,185,BAT,BMI,CONCLUSION,FDG,FT4,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SERUM,SINCE,THYROXINE,TREATMENT
26S,945,948,III,PKC,RU486,S400A,SILENCING,THESE,TPA,TREATMENT
EUSTACHIAN,HYPOTHESIS,ITF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATHOLOGY,RESULTS,THREE
169,946,CONCLUSION,COPYRIGHT,INC,INFANTILE,LABEL,NADOLOL,OBJECTIVE,PURPOSE,SOCIETY,SUMMARY
003,BASED,CHINESE,COX,HOWEVER,LGG,MEIER,THEREFORE,VLGR1
169,945,COLLAGENS,COPYRIGHT,IRELAND,LTD
169,945,CHINESE,COPYRIGHT,GIVEN,HIF,HOWEVER,IRELAND,LTD
AMONG,APRIL,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,VHE
CNS,HOWEVER,NOTABLY,SCLIP,STAT3,TAKEN
001,169,571,574,809,AFTER,HOWEVER,IRR,PERINATAL,THERE,THESE
169,ALTERED,CLINICALLY,FBP,SILENCING
983,BACKGROUND,CONCLUSION,III,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
FACTORS,HOWEVER
1P19Q,GLIOMAS,PCV,UNTIL,WORLD
550,666,APRIL,CONCLUSION,COUNCIL,LABEL,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
114,BACKGROUND,BETWEEN,CONCLUSION,CSF,ETV,GAMMA,HOWEVER,KNIFE,LABEL,MAY,METHODS,OCTOBER,RESULTS,TEN,TRANSIENT
946,EMT,FOXM1,GBM,IMPROVING,WNT
169,947,954,APRIL,COPYRIGHT,HOWEVER,IGG,INC
169,BMT,COPYRIGHT,CUNNINGHAM,DIAGNOSIS,MRI,NETWORK,PCR,PML
169,COPYRIGHT,SCIENCE,THESE
169,AFTER,BACKGROUND,CHART,CNS,INC,LABEL,MEIER,METASTASES,METHODS,PROCEDURE,RESULTS,WILEY
169,AKT,BECAUSE,BERBERINE,ERK,GBM,MEK,MKK,RAF,U87
169,946,CHANGES,INHIBITION,JUN,THESE,TRANSWELL
169,DESPITE,PRESS,PUBLISHED,RECURRENT,THEREFORE,UNIVERSITY
AKT,EPIDERMAL,ERK,FINALLY,HOWEVER,IFI27,IFIT1,REGULAR,SHC,TRAIL
ASIDE,HOWEVER,SURGERY,WHEREAS
101,BACKGROUND,BMI,CONCLUSION,DISORDERS,ESI,HIT,IEG,INVENTORY,LABEL,METHODS,RESULTS
946,ACP,SEVERAL,WNT
200,AST,DLT,EGF,GBM,KPS,MTD,SIROLIMUS,TARGETING,TEN,VANDETANIB
107,169,AIM,ANTICANCER,BACKGROUND,CENTRAL,CNS,COPYRIGHT,CSF,DISCUSSION,INSTITUTE,LABEL,METHODS,MRI,NERVOUS,OBJECTIVE,RESULTS,SIXTY,TRB,TRILATERAL
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS
030,043,100,169,AIM,ANTICANCER,BASED,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,KPS,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DNETS,INSTITUTE,LABEL,MATERIALS,METHODS,NG2,OBJECTIVE,PAEDIATRIC,RESULTS,WHILE
169,ANTICANCER,BRAIN,COPYRIGHT,INSTITUTE,PALLIATIVE,RADIATION
CNS,COGNITIVE,DIAGNOSIS,HOWEVER,PRE,SIGNS,SIXTY,VITAL
ALZHEIMER,CA1,HOWEVER,RAS,THESE
EARLY,EWING,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ADMET,BBB,CNS,EIGHT,THESE
AAV,AAVRH,AVASTIN,CONCURRENT,ELISA,FOLLOWING,GBM,LOCALIZED,NOD,PCR,STUDIES,THESE,U87MG
ADULT,GBM,HOWEVER,THEIR,THESE
945,AKT,BESIDES,CELLS,FOS,GBM,HIF,JUN,MMP,PCR,TIMPS
AKT,CYR61,FURTHER,GBM,TAKEN
104,220,ATLAS,CHINESE,HSPA6,HSPB1,MMP,MMP19,PEARSON,RAB34
EPSTEIN,JAPAN,OVERALL,PCNSL,PRIMARY,THESE,UNIVERSITY
169,CEREBELLAR,COPYRIGHT,DIAGNOSIS,LHERMITTE,SAS,V600E
169,CONVERSELY,COPYRIGHT,FINALLY,HOWEVER,IRELAND,LTD,LYS,OTU,OTUD5,PDCD5,PROGRAMMED
169,COPYRIGHT,LTD,VON
169,297,CCI,COPYRIGHT,INC,INDEX,PUBLISHED,SCALE
169,COA,COPYRIGHT,ERK,FPP,GBM,GTPASES,HMG,LOV,LTD,MEK,POH,RAF,RAS,RHO,U87,WHILE
169,AUTHORS,BRM,COPYRIGHT,CRB,DROSOPHILA,HIPPO,INC,PUBLISHED,SCALLOPED,SNF,SWI,YAP,YES,YKI
169,COPYRIGHT,INC,LABEL,OBJECTIVE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS
169,BACKGROUND,BESIDES,CONCERNING,COPYRIGHT,INC,LABEL,METHODS,PITUITARY
169,CONCLUSION,COPYRIGHT,DIFFERENT,ENDONASAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,ALTERNATE,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PRE,RESULTS
102,169,BACKGROUND,CLEFT,COPYRIGHT,CYSTS,INC,LABEL,METHODS,RESULTS,THERE
169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
001,008,BACKGROUND,CONCLUSION,EASTERN,GROUP,LABEL,METHODS,RESULTS,SINCE,TEN,TREATMENT
CD2N2,CH2N2,DAG,PC3,PTDINSP,TMS,USING
157,177,200,500,AUTOMATED,CNS,EYELINK,III,LABEL,METHODS,OBJECTIVE,RESULTS,SPATIAL,THERE,THESE,THREE
AFTER,BACKGROUND,FURTHER,HOWEVER,LABEL,METHODS,RESULTS
AIP,BACKGROUND,CONTEXT,KNOWN,LABEL,LOH,MAX,METHODS,MUTATIONS,OBJECTIVE,OUTCOME,PGL,PITUITARY,RESULTS,RET,SETTING,TMEM127,VHL
PITUITARY
2ND,BAF47,BECAUSE,RTPS1,RTPS2,SMARCA4,SMARCB1,SNF,SWI
518,ATLAS,FINALLY,GBM,NOTCH,PCR,TAKEN

156,169,AKT,BINDING,BIOLOGY,EBP50,EZRIN,INC,INCREASED,MOLECULAR,PDZ,SOCIETY,THR
BRAIN,MANAGEMENT,NEWER
BRAIN,HEADSMART,STUDIES
169,394,441,477,786,918,AMONG,BACKGROUND,CASES,CRC,LABEL,METHODS,RAS,RESULTS,SOCIETY
169,COPYRIGHT,INC
169,946,COPYRIGHT,FURTHER,HOWEVER,INC,PREVIOUSLY,TAKEN
050,144,224,368,ARCHIVE,ATLAS,CONCLUSION,GBM,HIPAA,IMAGING,INGENUITY,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,PATHWAY,PURPOSE,RESULTS,VOLUMES
160,169,183,BASED,BECAUSE,GEORG,STUTTGART,THEREFORE
CUSHING,MRI
000,150,956,ANNEXIN,APOPTOSIS,CMC,FLUOS,OVERALL,PI3,TESTS,U87MG
169,382,953,AUSTRALIAN,HODGKIN,LABEL,METHODS,OBJECTIVE,READERS,RESULTS
719,BACKGROUND,CONCLUSION,FDG,LABEL,METHODS,MRI,PCNSL,PET,RESULTS,SUV,TEN
169,COM,COPYRIGHT,LTD,UCM
028,035,107,225,954,BVZ,ELISA,GBM,PFS,SNP,THROMBO,VEGFA
178,552,586,BETWEEN,DSC,FOLLOWING,GAMMA,GKS,HOWEVER,INITIAL,MARCH,MRI
CHINESE,EMERGENCY
181,183,AWAKE,LABEL,MAP,METHODS,OBJECTIVE,RESULTS,THERE
ADRENAL,AIM,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE
127,169,BACKGROUND,CNS,CSF,GREATER,LABEL,METHODS,OVERALL,PEDIATRIC,PERTINENT,RESULTS,SOCIETY
101,134,169,794,851,COX,DISCUSSION,LABEL,MACHINE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SVM
169,BECAUSE,COPYRIGHT,ENDOSCOPIC,FORTY,HISTOLOGIC,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS
CUSHING,EGF
002,100,169,ACCORDING,COPYRIGHT,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,NCA,NEOPLASTIC,OBJECTIVE,RESULTS,SCHOLAR,SCIENCE,WEB
AUTOPHAGY,CNS,RAF,THESE,V600E

174,DCVAX,DENDRITIC,GBM,III,INC,NORTHWEST,RESULTS
2DG,945,AUTOPHAGY,CATHEPSIN,LC3,LYSOSOMAL,SLS,T98,U87,ULK
DESPITE,HDAC6,INSTEAD,NOVEL,THESE
INITIAL,SBT,SECONDARY
160,169,5MC,AML,AUTHORS,COPYRIGHT,INC,PUBLISHED,SOMATIC,THESE,WT1
169,852,ABS,BUTADIENE,CONCLUSION,COPYRIGHT,DEVELOP,DUE,LABEL,MATERIALS,METHODS,MHZ,MRI,OBJECTIVE,RESULTS,STYRENE,TESLA
169,246,264,D617EFS,E450X,GLIOMAS,PRESS,PUBLISHED,THESE,UNIVERSITY,USING,VALIDATION
169,946,BBB,BIOLOGICAL,COPYRIGHT,DUE,INC,NIEMANN,PUBLISHED
IMS,MALDI,TOF
169,CEREBELLAR,COPYRIGHT,PARTNER,PUBLISHED,SOCIETY,URBAN
169,AMONG,CONCLUSION,COPYRIGHT,GRADE,HOMONYMOUS,III,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,PARTNER,PUBLISHED,RESULTS,SIMPSON,SOCIETY,THERE,URBAN
AKT,BRAIN,HOWEVER,OTHER,RAF,RASSF,RASSF1A,V600E
BACKGROUND,BESIDES,GBM,LABEL,METHODS,MRI,RESULTS,WORLD
DYADS,SURVIVORS,THESE
169,231,397,944,COLLEGE,COPYRIGHT,LTD,ONTARIO,OVERALL,PALLIATIVE,PRT,PUBLISHED,ROYAL
CASES,GBM
210,ABERRANTLY,BACKGROUND,LABEL,MECHANISM,METHODS,MTT,PCR,RESULTS,SIN3A,TARGETSCAN,WESTERN
169,946,AKT,ANNEXIN,BCL,CHINESE,COPYRIGHT,EGF,ERK,GLIOMAS,LTD,MMP,QUERCETIN,RAS,SHG44,THEREFORE,U87,WOUND
ANNEXIN,CURRENT,DEPLETION,MTT,NDC80,PCR,U87
AFTER,BACKGROUND,BECAUSE,BRAIN,CONCLUSION,CTA,HOWEVER,LABEL,LERICHE,METHODS,MRI,THERE
143,CHINA,CHINESE,DTRAM,FIFTY,MINOR,SSM
ACTIVATION,BACKGROUND,BAX,BID,INDIVIDUAL,LABEL,METHODS,MMP,RESULTS,THESE,U87MG
001,009,015,027,033,048,131,146,291,386,588,910,BACKGROUND,BESIDES,EUD,GENERAL,KRUSKAL,LABEL,METHODS,PEARSON,PTV,RADIATION,RESULTS,UNIVERSITY
AETIOLOGY,BMJ,CALCIFYING,GROUP,LTD,MRI,PUBLISHING
001,004,177,180,CRH,CUSHING,FDG,IMAGING,MAXIMUM,METHODS,MRI,PET,RESULTS,SUV,TEN,THREE,WHILE
DSRCT,EARLY,EWING,EWS,OTHER,REVERSE,WILMS,WT1
100,177,BENEFIT,BETWEEN,GBI,GLASGOW,INVENTORY,JANUARY,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,SHORT,THEIR,VSS
945,946,CONCLUSION,ECS,FORTY,III,LABEL,METHODS,MVS,OBJECTIVE,OBJECTIVES,RESULTS,SMA
169,COPYRIGHT,GBM,IMAGING,INC
169,COPYRIGHT,INC
169,COPYRIGHT,GBM,IMAGING,INC,MRI,SEVERAL
160,169,BECAUSE,COPYRIGHT,DESPITE,DIAGNOSED,INC
169,COPYRIGHT,EPIGENETIC,INC,PUBLISHED,SCIENTISTS
ACTIVATOR,GBM,STAT3,THESE,TRANSDUCER
044,049,100,169,19Q,ABSENCE,AMP,COPYRIGHT,III,INC,THESE,WESTERN
231,BACKGROUND,CK5,LABEL,LUMINAL,MCF,MDA,METASTATIC,METHODS,RESULTS,SIMILAR,THEIR,WHILE
169,BACKGROUND,COPYRIGHT,HPT,IMAGING,INC,LABEL,METHODS,NSHPT,PTX,RESULTS,SIX,TOTAL
001,002,003,007,009,473,AKT,BACKGROUND,EXPRESSION,HOWEVER,LABEL,MBS,METHODS,MIB,RESULTS,SER
160,169,183,ADMISSION,DEPARTMENT,DIAGNOSIS,GEORG,HENCE,HGH,HISTORY,LABEL,METHODS,MRI,PSYCHIATRY,RESISTANCE,SERUM,STUTTGART,THYROID,TREATMENT,TRH,TSH
169,AIM,APA,APN,B1LYP,B3LYP,COPYRIGHT,DVIOH,III,INC,NMR,RAS,SOGGA11,THEREFORE
141,ABCG2,CPT,MBL,MDR
ABI,AIM,BENEFIT,BETWEEN,CONCLUSION,LABEL,LIP,MANCHESTER,MARCH,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SEVENTY,USING
DIFFUSE,JMJD3
109,ALTOGETHER,CONVERSELY,EB1,END,GBM,U87,VINCA,VINFLUNINE
100,169,AFFYMETRIX,FURTHER,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SHROOM2,SPHK1,THESE,THREE
001,085,169,327,389,AMONG,CUMULATIVE,END,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,USING,VALIDATED
001,012,028,039,040,041,054,066,AGE,BACKGROUND,EASTERN,FIFTY,GROUP,HOWEVER,LABEL,METHODS,RESULTS
121,177,BACKGROUND,DEPARTMENT,EARLY,INCOMPLETE,LABEL,MARCH,METHODS,RADIATION,RESULTS
PRL
176,HOWEVER,HTP,LABEL,METHODS,MRI,MRIDB,MSD,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SAR,T1W,T2W,THREE
001,100,ACHIEVING,BRAIN,LABEL,METHODS,MEV,OBJECTIVE,PLANS,PURPOSE,RESULTS,SECONDARY,SFO
198,ALEMS,ALTERATION,DMS,THESE
BRAIN,FEW
BTB,ECS,KNOCKDOWN,MMP,PD98059,PP2,ROBO4,ROUNDABOUT,SHORT,SLIT2,SRC
AMONG,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TOTAL
169,ACCORDING,BACKGROUND,DCI,DELAYED,HEART,IMAGING,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRATEGIES,TREAT
C1Q,C5B,DEPOSITION,ELISA,GBM,MBL,MULTIFORME,SERUM,THEREFORE
ADVANCE,HELPING,THERE,WHILE
GBM,THERE,TMZ,TREATMENT

DESPITE
CURRENT,DESPITE,TREATMENT
19Q,26951,ANAPLASTIC,CODEL,CPG,EORTC,IDH,PCV
19Q,ADDITIONAL,EOR,LOW,LOWER,NOVEL,PCV,QOL,TMZ
000,CLEAR,CURRENT,GBM,THESE

19Q,CIC,FUBP1,HOWEVER,IDH,LOW,MAP,PROGNOSTIC,THESE
GLIOMAS
169,COPYRIGHT,DYNAMIC,INC,KMT1E,KMT2A,NRF,THREE
169,BASED,BRATS,COPYRIGHT,LTD,MRI,THEREFORE
169,CNS,COPYRIGHT,EARLY,GRAND,HIV,HOWEVER,LTD,ROUND
001,002,004,016,029,040,121,C30,CNS,EORTC,HRQOL,LGG,QLQ,QOL,QUALITY,RADIATION,TREATMENT,USING
EOR,GBM,INDIVIDUAL,MRI
169,AUTHORS,COPYRIGHT,FRAGILE,FXS,INC,MMP,MUTATIONS,PUBLISHED,THESE,USING
001,ILSSS,KEY,LABEL,LOW,METHODS,NPV,OBJECTIVE,OBJECTIVES,PPV,RESULTS,SWI
METASTATIC,PITUITARY,PROGNOSIS
13RA2,169,945,946,956,CMV,COPYRIGHT,EPHA2,FOXP3,HIF,PDGFR,STAT3,WP744
169,954,BECAUSE,COPYRIGHT,EXTRACTED,INC,SGP40,SGP65,THESE,TREATMENT
BACKGROUND,BRAIN,EEG,LABEL,METHODS,MRI,RESULTS
128,160,169,COPYRIGHT,FINALLY,FIRST,HNSCC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROBO1,SLIT2
CASES,CSF,GROSS,GROUP,GTR,HENCE,IMAGING,LABEL,LESSONS,METHODS,OBJECTIVE,RESULTS,THERE
7TH,BASED,MODEL,RESILIENCY
160,169,954,AUTHORS,COPYRIGHT,DIFFERENT,DISRUPTION,GSC,INC,NSTCS,PUBLISHED
113,169,AGE,AMONG,AUTHORS,CONCLUSION,COPYRIGHT,III,INC,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OGM,PUBLISHED,RESULTS,RETRACTION,SIMPSON,WORLD
169,600,APOA1,APOA4,APOA5,APOC3,AZA,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,TC7
169,177,342,422,764,COPYRIGHT,GFS,INC,IPL,IPS,RBS,SCC,THESE
130,169,177,215,916,ANAWETV,COPYRIGHT,GIBBS,HOWEVER,INC,MRI,SNR,TSC
169,COPYRIGHT,SHC
169,AUTHORS,COPYRIGHT,LTD,MICRORNAS,PRODUCTION,SINCE,THESE,TOXOPLASMA
001,006,031,073,124,169,327,456,535,591,783,830,COPYRIGHT,GROSS,KPS,LABEL,METHODS,NON,OBJECTIVE,RESULTS
169,COPYRIGHT,DTT,FUNCTIONAL,GROSS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,SMALL,THERE
169,CASES,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,POSTNATAL,RESULTS,STUDIED,TOP,VAGINAL
169,COPYRIGHT,HOWEVER,IRELAND,LTD,REDUCED,THESE
100,169,CONCLUSION,COPYRIGHT,DEFERRING,LABEL,METHODS,OBJECTIVE,PCNSL,RESULTS,RFS,TOXICITIES
169,ACCORDING,AFTER,CONCLUSION,COPYRIGHT,DSA,FIFTEEN,GAMMA,KNIFE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,REVIEWING,TEN,THREE
169,COPYRIGHT,CYTOKINES,LTD
169,ALK,COPYRIGHT,III,INC
169,AUTHORS,HENCE,KDR,KNOCKDOWN,LTD,MALIGNANT,NOVEL,PTY,PUBLISHING,SCIENCE,SUNITINIB,WILEY
169,945,946,99M,COPYRIGHT,CURRENTLY,EC145,FOLIC,LTD,PHASE,THEREFORE,VINCA
169,231,233,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,WCC
169,COPYRIGHT,INC,METASTASES,REGIONS
169,177,334,604,946,956,BESIDES,COPYRIGHT,HENCE,SAS,THESE,U87MG
169,AKT,APOPTOSIS,BACKGROUND,BAX,BCL,CASPASE,CHINESE,COPYRIGHT,DECREASED,ERK,HDW,INDUCTION,IRELAND,LABEL,LTD,MATERIALS,METHODS,MMP,MTT,PROTEIN,RELEVANCE,RESULTS,RUBIACEAE,THESE,U87,WESTERN,WILLD
100,169,BACKGROUND,BRAIN,COPYRIGHT,DERIVED,EMT,INCREASING,LABEL,LTD,METHODS,PCR,RESULTS,TARGETING,THESE,WESTERN,WHILE
169,COPYRIGHT,HNSCC,LTD,NGF,PERINEURAL,THESE,TRK
001,169,AUTHORS,COPYRIGHT,GVP,INC,MSS,MVP,PFS,PUBLISHED,THERE,VCS,VGS,VMS
169,COPYRIGHT,FDG,INC,PET,STRUCTURAL
169,325,339,ADDITIONAL,AIM,CONCLUSION,COPYRIGHT,COX,GBM,HRS,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WHILE
AML,BRCA2,FANCA,FANCONI,FANCQ,LTD,MDS,PUBLISHED,WILMS
011,06YEARS,169,177,29YEARS,CONCLUSION,COPYRIGHT,GBM,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,TURKISH
169,AMONG,CENTRAL,COPYRIGHT,FALLS,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OLDER,OTHER,RESULTS,REVIEWS,SEVERAL,SYSTEMATIC
102,169,195,956,ADDITIONAL,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TBI
169,945,946,ALLYL,ATE,BROMINATED,COPYRIGHT,HOWEVER,LAT,LTD,PSA,THESE,THREE,WESTERN
169,177,BBB,COPYRIGHT,DGL,LIM,LIMK2,LNP,LTD,MECHANISM,MTT,NPS,PEG,PLASMID,SUCCESSFUL
169,ASPSCR1,COPYRIGHT,INC,THESE
002,169,183,292,AMONG,CLINICO,COPYRIGHT,GPA,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,WHILE
001,005,014,126,169,193,339,ACCORDING,BETWEEN,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PCI,RESULTS
169,COPYRIGHT,FINALLY,MDSCS,THEREFORE
121,169,COPYRIGHT,LEUCINE,PCR,WESTERN
169,611,BRAIN,CONCLUSION,FACBC,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTEEN,SOCIETY,UNLABELLED
123,150,169,714,AMONG,BECAUSE,CONCLUSION,DPA,GBM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIX,SOCIETY,SPECT,UNLABELLED,VOLUMES
169,BACKGROUND,LABEL,METHODS,MMP,MT1,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,USING
169,FVB,SFK,SRC
169,18A,BTB,COPYRIGHT,FINALLY,HRP,INC,MEANWHILE,RUNX1,TAKEN,U87MG
169,447,455,AUC,BIOMEDICAL,CHINESE,CHO,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MAY,METHODS,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS,SEN,SPE,STUDIES
070,169,279,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SIR,USING
169,231,233,COPYRIGHT,HODGKIN,PRIMARY,PUBLISHED,SAS
100,120,169,BECAUSE,COMMISSION,COPYRIGHT,ESTIMATED,HOWEVER,PROTECTION,PUBLISHED,SAS
007,100,169,670,946,BACKGROUND,COPYRIGHT,DISCUSSION,INC,LABEL,METHODS,RESULTS,SALMONELLA
169,COPYRIGHT,WHILE
169,COPYRIGHT,FUS,FUSED,PARKINSON,SARCOMA
169,AIM,AKT,COPYRIGHT,ERK,LABEL,LTD,MEK,METABOLIC,METHODS,OBJECTIVE,RAF,RESULTS
001,017,036,100,124,169,310,809,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RESULTS,T790M,THERE,TKI
169,231,233,COPYRIGHT,DRESS,PUBLISHED,SAS
10H10,859,GBM,RAS,REDUCED,SINCE
169,COPYRIGHT,EPIGENETIC,HOWEVER,INC,KDM5B,MEIER
131,265,396,AMONG,CONCLUSION,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
169,392,860,CENTRAL,CHILDHOOD,COX,DESPITE,FINNISH,HRS,OUTCOME,POPULATION
10YEARS,169,17YEARS,1990S,32WEEKS,BPD,COPYRIGHT,DEX,EARLIER,GCS,HPA,INC,TRIER,UNTREATED
169,COPYRIGHT,CURRENT,DESPITE,LTD,MOLECULAR,MRI,PET
169,231,233,AFTER,COPYRIGHT,PUBLISHED,SAS,VERTEBRAL
005,111,150,169,177,320,CLINICALLY,COPYRIGHT,CROWN,DCE,FUNCTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PARAMETRIC,PUBLISHED,RESULTS,ROI,TDA
AFTER,DELAYED,FLAIR,FURTHER,MRI,RADIATION,SRS,WMC
169,AGGRESSIVE,COPYRIGHT,SINCE,THESE,USING,WHILE
169,CNS,COPYRIGHT,DMD,HOWEVER,INC,STUDIES
169,ALTOGETHER,ATP,COPYRIGHT,CXCL8,LPS,MCP,MRS2578,U87MG
169,945,AM281,CB1,CB2,COPYRIGHT,ELISA,INC,KEY,LABEL,METHODS,OBJECTIVE,PRO,RESULTS,TNF
300,600,BBB,BLOOD,GENERALLY,NO3,PACLITAXEL,SLN
169,COPYRIGHT,GROWING,PCR,PUBLISHED
169,946,COPYRIGHT,FURTHER,GBM,HOWEVER,IRELAND,LTD,PUBLISHED,REPRESSION,STAT3,TAKEN
169,180,210,916,BECAUSE,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,PDCD5
ANP,BRAIN,CPP,NOW,PTX,THEREFORE
169,COPYRIGHT,INC
022,023,111,160,169,AFTER,AMONG,BACKGROUND,BMS,CLINICIANS,CONCLUSION,COPYRIGHT,COX,CRC,INC,INCREASED,JANUARY,JAPAN,KINKI,LABEL,LOG,MATERIALS,METHODS,MST,RESULTS,THERE,UNIVERSITY
169,177,COPYRIGHT,DUE,FIRST,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PHANTOM,PURPOSE,REGARDING,RESULTS
169,ADULT,ASSESSMENT,BETWEEN,BRAIN,COPYRIGHT,FIFTY,FUNCTIONAL,GTV,HOWEVER,INC,INDIVIDUAL,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PARTS,PTV,PURPOSE,RESULTS,SECONDARY,SRS,STATE,THERAPY,THREE,TRAIL
116,127,169,COPYRIGHT,GBM,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RADIATION,RESULTS,TMZ
169,BASED,BRAIN,COPYRIGHT,INC,PITUITARY,PUBLISHED,SOCIETY,SUBSEQUENT
169,COPYRIGHT,DTI,INC,MAXIMIZING
169,CLINICALLY,COPYRIGHT,FUNCTIONAL,INC
169,COPYRIGHT,FUNCTIONAL,INC
169,BECAUSE,COPYRIGHT,EWING,GD2,INC
008,010,160,169,ACADEMY,BACKGROUND,COPYRIGHT,DIVERSE,III,INC,LABEL,MEDLINE,METHODS,MKP,MUP,OBJECTIVE,PUBLISHED,RESULTS
169,BACKGROUND,COPYRIGHT,ENGLISH,FEMALES,INC,LABEL,METHODS,PROGNOSIS,PUBLISHED,RESULTS,SCHOLAR
100,169,COPYRIGHT,PAPILLARY,PARTNER,PUBLISHED,SOCIETY,URBAN
160,169,215,217,COPYRIGHT,EXTENSIVE,FURTHER,GWASS,INC,PUBLISHED,REGULATORY,SOCIETY
169,COPYRIGHT,CURRENT,FINALLY,INC
ACVR1,IDH,TREATMENT,V600E
DIFFUSE,DIPGS
000,DSC,DYNAMIC,MRI,USA
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,RESULTS
169,219,332,946,ALZHEIMER,ATP,AUTHORS,CHAPERONES,COPYRIGHT,FUNCTIONAL,HUNTINGTIN,HUNTINGTON,INC,PARKINSON,PUBLISHED,THESE
169,AKT,AUTHORS,COPYRIGHT,INC,PUBLISHED,THESE
231,524,CA2,CCB,ERK,HOWEVER,KCL,MDA,NIFEDIPINE,SILENCING
160,269,352,353,AMONG,BASED,CENTRAL,HOWEVER,PERSISTENT,THESE,TOPLI,VOJVODINA
000,001,025,ASA,BACKGROUND,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SPECIAL
110,123,160,169,215,309,322,ADC,ASSESSMENT,AUR,BRAIN,CONSORTIUM,COPYRIGHT,ICE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PEDIATRIC,PUBLISHED,RATIONALE,RESULTS
169,946,CBS,COPYRIGHT,GAPDH,H2S,INC,INDUCTION,PSD95
169,COPYRIGHT,INC
BACKGROUND,BETWEEN,DISCUSSION,GIVEN,LABEL,METHODS,RESULTS
100,COLLEGE,FURTHER,GAMMA,GKS,KNIFE,LABEL,METHODS,OBJECTIVE,OCTOBER,RATES,RESULTS,UNIVERSITY
168,AMONG,BEIJING,GAMMA,GKS,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TIANTAN
011,137,162,ACCEPTABLE,AFTER,AMONG,GAMMA,GENERAL,GKS,HOWEVER,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SUCCESSFUL,THERE
100,GAMMAPLAN,HOWEVER,LABEL,LEKSELL,METHODS,OBJECTIVE,RESULTS,TCP,TREATMENT
141,BRAIN,CHILD,CLASS,GAMMA,GKS,GROUP,HCC,KARNOFSKY,KNIFE,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,SCALE,SIXTY,THERAPY,UNIVARIATE
100,BECAUSE,GAMMA,GKS,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PER,RESULTS,SUBSEQUENT
009,110,289,AVERAGE,CRITICS,DESPITE,KARNOFSKY,KPS,LABEL,MAY,MEIER,METHODS,MVA,OBJECTIVE,OVERALL,RESULTS,SALVAGE,SCALE,SRS,TREATMENT
008,012,024,CLASS,COX,DISTANT,FOLLOWING,GAMMA,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SALVAGE,SRS,WHILE
003,006,110,625,817,ACCORDING,ACTUARIAL,COX,FACTORS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OPTIMAL,PENDING,RESULTS,SCALE,SHERBROOKE,SRS,UNIVARIATE
215,CNS,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,WHOLE
176,227,270,403,AFTER,AGAIN,AVERAGE,BETWEEN,BRAIN,CGI,DIGITAL,FINALLY,GAMMA,GAMMAPLAN,GKP,IMAGING,KNIFE,LABEL,LIPPITZ,METHODS,METRICS,MRI,OBJECTIVE,PADDICK,PERFEXION,PHILIPS,RESULTS,SEVEN,THESE,VELOCITYAI
001,157,241,449,701,924,AUDITED,FOLLOWING,GAMMA,INSTITUTE,JAMES,KNIFE,LABEL,METHODS,OBJECTIVE,PADDICK,PCI,PEI,RESULTS,THROUGH,WHITNEY
134,176,178,204,219,268,302,305,318,355,382,749,792,825,ACCORDING,BASIC,BRAIN,HOWEVER,LABEL,LORENZONI,METASTASES,METHODS,MRI,NPS,OBJECTIVE,RESULTS,SCORE,SRS,SUBGROUPS
DISEASE,END,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SRS,TEXAS,UNIVERSITY
073,112,133,138,181,319,360,425,469,541,554,560,607,649,720,732,739,771,870,974,990,994,BECAUSE,COMPETING,GAMMA,GAMMAHOUSE,GROUP,KARNOFSKY,KATSUTA,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,THESE,ULTIMATELY
169,COPYRIGHT,CURRENTLY,LTD,THERE,THEREFORE
950,965,AKRIB10,B10,BRAIN,BRSK2,CERTAIN,CYTOSCAPE,EWSR1,EXPRESSION,GSE9508,MCODE,OMNIBUS,SMO
ANNEXIN,DHF,HOWEVER,MTS,SP1,TAKEN
100,215,303,623,798,902,926,942,ADC,ANOVA,AUC,DWI,FORTY,PARAMETERS,ROC
PREVIOUSLY,RIGHT
ECC,UNDER
GIVEN,RECURRENCE
122,197,714,BARTHEL,CONTROL,END,EOL,GBM,INDEX,KARNOFSKY,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,PARTICULAR,RESULTS,SCALE,STATE
101,150,AFTER,AFTERWARD,COX,GROUP,GTR,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,PFS,PROLONGED,RESULTS,SCALE,STUPP,TMZ,VOLUMETRIC
EARLY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SUBSEQUENT,THEREFORE
LABEL,METHODS,OBJECTIVE,RESULTS,S1013,THESE
500,956,ALA,CONTINUOUS,CST,LABEL,MEP,METHODS,MOTOR,MRI,OBJECTIVE,RESECTION,RESULTS
LABEL,METHODS,OBJECTIVE,RAS,RECURRENCE,RECURRENT,RESULTS,THERE
FURTHER,GBM,KTS,WILMS,WT1
DIFFUSE,MUTATIONS
THERE
BECAUSE,HENCE,HGF,MET
AMONG
945,946,DTX,GLYCINE,PEG,PLA,RGD,RGDYK,U87MG
CHEMOKINES,ENDOTHELIN
AMONG,BASED,BVZ,COMPARISON,HGG,IMAGING,MRI,THERE
5TH,7TH,8TH,AFTER,MRI,REVIEWING,REZ,SURGERY
169,BIOLOGY,GBM,RESISTANCE,SOCIETY
169,ABL,AES,LABEL,NOTCH,RAC,RHO,THESE,TYR,UNLABELLED
129,750,BMJ,DRUGS,GROUP,HODGKIN,LTD,PATHOLOGY,PUBLISHING,THERE
001,160,AMONG,CONCLUSION,DSS,FDG,III,INITIAL,LABEL,METHODS,MORTALITY,NAC,OBJECTIVE,PET,PURPOSE,RESULTS
169,COPYRIGHT,DISCUSSION,INC
169,AFTER,CENTRAL,COPYRIGHT,HOWEVER,INC
169,COPYRIGHT,INC,THESE
169,CNS,COPYRIGHT,INC,OTHER
169,CENTRAL,CNS,COPYRIGHT,INC,OPTIMAL
169,COPYRIGHT,INC,TREATMENT
160,169,AFTER,COPYRIGHT,GAMMA,HOWEVER,INC,KNIFE,MRI
169,COPYRIGHT,INC,SRS
169,CENTRAL,COPYRIGHT,DUE,INC,SRS
169,COPYRIGHT,INC,MONRO,SVZ,THESE
169,CENTRAL,COPYRIGHT,INC,SEVERAL
169,CENTRAL,COPYRIGHT,INC,INITIAL,MONRO,MRI
169,BECAUSE,CENTRAL,CNS,COPYRIGHT,INC,OPTIMAL,RADIOLOGIC,TYPICAL
169,COPYRIGHT,INC
169,BCL2L11,BH3,BIM,GBM,MEK,TKI
DESPITE,SIMILAR
BBB,CNS,FTM,HOWEVER,LUC,NPS,THESE,TMZ,TWI,ZOL
169,183,AFTER,BACKGROUND,BFM,CASES,GEORG,HODGKIN,LABEL,LYNCH,METHODS,NHL,PATIENT,RESULTS,STUTTGART,TREATMENT,WHOLE
108,169,183,BACKGROUND,BMI,CHILDHOOD,CONCLUSION,GEORG,HIT,LABEL,METHODS,RESULTS,SDS,STUTTGART,TREATMENT
169,BIOLOGISTS,COMPANY,CURRENT,GBM,GEM,GRADE,HOWEVER,LTD,ORTHOTOPIC,PRIMARY,PUBLISHED,THESE
AKT,GBM,RH2
169,260,340,440,946,AKT,BACKGROUND,CNS,CONCLUSION,INHIBITION,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY
172,177,945,CCG,CENTRAL,GROUP,HGG,HISTOLOGY,HOWEVER,LGG,MIB,PFS,UNIVARIATE
BROAD,HOWEVER,PEPTIDE
CAJAL,NUCLEAR
176,947,CONCLUSION,DOSES,KNOWN,LABEL,METHODS,OAR,OBJECTIVE,PREVIOUSLY,PTV,PURPOSE,RESULTS
ALTOGETHER,AMONG,GBM,IRS,TARGETING
A2BAR,AKT,CSC,ERK,GBM,NOTABLY,TAKEN,THERAPIES,TMZ
160,169,ALIKE,BIOLOGY,BRAIN,CHROMATIN,COMMONS,EXPRESSION,HOWEVER,LICENSE,LUO,MDK,MIDKINE,MOLECULAR,NEOPLASIA,REPOSITORY,SHARE,SOCIETY,SP1,XIA
169,COPYRIGHT,GALANIN,OTHER,PKA,SOCIETY,THESE
ALZHEIMER,BACKGROUND,C26,CONCLUSION,FATTY,LABEL,METHODS,OBJECTIVE,RBC,RESULTS,SEVERAL,STATE
BMJ,CRANIOTOMY,GROUP,HBL,LTD,OWING,PUBLISHING,VHL,WHILE
100,129,141,150,152,155,167,19Q,405,AMONG,BASED,DIFFUSE,FOLLOWING,FURTHER,H3F3A,HAARLEM,IDH,III,ISN,MOLECULAR,NOA,R132H
102,424,495,978,BACKGROUND,CONCLUSION,CONTEXT,LABEL,METHODS,OBJECTIVE,RESULTS,SOURCES,UNIVERSITY
009,436,THEREFORE
AC133,CAR,CD133,CSC,GBM,HOWEVER,SCS,THEREFORE
DROSOPHILA,INDUCTION,LGL,LLGL1
AFTER,BECAUSE
017,027,035,106,123,128,312,316,919,BETWEEN,BRAIN,CONCLUSION,DFS,IIB,LABEL,LOCAL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE
002,111,BACKGROUND,EFFECTS,EOC,III,LABEL,METHODS,OVCAR,RESULTS,THESE,UNIVERSITY
169,300,946,ADVERSE,ANTITUMOR,BNP,DOPPLER,FHD,LABEL,LY2157299,MACDONALD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,SMALL,TGF,THEREFORE
004,005,013,169,ADVERSE,FORTY,IHC,IL4,IL6,IL8,INK4A,LABEL,METHODS,MUTATIONS,OBJECTIVE,PFS,PURPOSE,RESULTS,SCCHN,SCREENING,TEN,THOSE,TNF
169,286,945,947,COHORTS,CONCLUSION,ELISPOT,EPHA2,GAA,HLA,IFN,IL13R,ISA,LABEL,LGG,METHODS,MONTANIDE,OBJECTIVE,PFS,PURPOSE,RES,RESULTS,SYNTHETIC,THESE,WT1
169,1970S,1980S,INC,MUTATIONS,PALLISTER,PHS,WILEY
T12,TREATMENT
001,006,DENSELY,IGF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
945,BECAUSE,HIF,LABEL,MET,METHODS,MIB,OBJECTIVE,OSMOTIC,RESULTS,U87,USING
GRADE,STR,USING
THERMOPSIS,THESE
DVP
FOXP2,MENDELIAN,MUTATIONS,SEVERAL
BMJ,GROUP,HIV,LTD,PUBLISHING,SYPHILITIC
003,169,946,ADULT,BACKGROUND,EARLY,LABEL,METHODS,RESULTS,SIXTY,SOCIETY
CHALLENGES,CPG,EPIGENETIC,GBM,HTB,K27,KIF23,LOX,PBK,THERE
EMBRYONAL,HOWEVER
ALA,DELAYED,FCM,HOWEVER,PREVIOUSLY,ROS,THESE
HISTOLOGY,MALIGNANT,MRI,PET
180,511,FIRST,GFP,HGG,HOWEVER,RRV,RVV
CREKA,NPS,TAXOL,THESE,U87
169,EFFECTIVE,INC,THESE,WILEY
001,160,ATP,CO1,CO3,COX,OXYPHIL,PCR
BID,DR5,FEW,HOWEVER,REDUCTION,SP1
AIM,BACKGROUND,LABEL,METHODS,MONRO,RESULTS,THREE,TREATMENT,TSC
669,807,946,BACKGROUND,BASED,COMPARISON,GESTALT,HAN,LABEL,METHODS,RAS,RESULTS,TGF,WEB
EPH,THEIR
169,GROWING,INC,MINIMAL,PD0332991,WILEY
LIMITED,MICROBEAM,MRT
005,BLACK,CNR,CONCLUSION,DIAGNOSTIC,FOM,FPS,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,VISIBLE
BTSCS,MOLECULAR,NSC
020,121,215,606,858,921,ADC,CONCLUSION,DIFFUSION,DWI,LABEL,METHODS,MINIMUM,OBJECTIVE,PURPOSE,RESULTS
160,THESE
169,BIOLOGY,HOMOZYGOUS,SOCIETY
BACKGROUND,CONCLUSION,CYBERKNIFE,GENERATING,LABEL,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS,SRS
EARLY,PRT,RADIATION
BECAUSE,EMBRYONAL
001,035,160,176,177,210,215,AUTOMATED,DISCUSSION,FOV,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,TESLA,TOF,VOI
947,ACMSD,GBM,IDO,IFN,KAT,KMO,KYN,NAD,PIC,TDO,THESE,TRP
CONVERSELY,FUNCTIONAL,MRI
AMONG,GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,THERE,UNIVERSITY,USING
004,005,008,019,026,102,135,CNS,COX,EFFECTS,HOWEVER,LABEL,METHODS,MORTALITY,OBJECTIVE,PATIENT,RESULTS,SURGERIES,THERE,THESE
120,132,AFTER,GRADE,III,METHODS,RESULTS,SINCE,THEREFORE
GLYCOLYTIC,LIN28,ODC,PET,POLYAMINES,SMS
105,116,296,584,767,CLASSICAL,HOWEVER,MICRORNAS,PRONEURAL,SECONDARY,TAKEN
100A6,169,AHNAK,CNS,COMBINING,ELISA,ESI,FGR,MGS,QUITE,RAS,SEVERAL,TOF,VCH,WILEY,WNT
DENDRIMERS,THESE
169,INC,SEVERAL,SPECIAL,WILEY
065,096,145,177,215,223,271,703,835,ADC,ASSESSMENT,EVALUATION,NGGCT,TEN,THERE
001,003,037,057,110,132,169,ANY,CENTRAL,CNS,COPYRIGHT,COX,FACTORS,FIFTEEN,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,SRS
169,COPYRIGHT,GBM,GYE,HOWEVER,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SIX,SOCIETY,TREATMENT
169,ACTUARIAL,ACUTE,ADVERSE,COPYRIGHT,DEFINITIVE,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SEPTEMBER,SIX,SMALL,SOCIETY,THREE
IDENTIFIED,III,ROC
APART,INCREASING
370,624,BETWEEN,CENTRAL,THERE,TPN,TREATMENTS
EGF,HOWEVER,RAF,RAS,ROCK2,S15,T45,THESE,V600E
ACC,BACKGROUND,CONCLUSION,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS
003,ADVERSE,CNS,IMPORTANCE,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,RELEVANCE,RESULTS,SETTING,THERAPY
BARIATRIC,DIETING,EXCESSIVE,OBESITY
EQUALLY,GALEN,TAKEN
GLIOMAS,HOWEVER,TLR
100,400,ABL,AES,AFTER,ARM,BOSUTINIB,HOWEVER,PFS,SEVEN,SRC,THEREFORE
000,001,008,014,177,ATHYMIC,BLOOD,BUN,CISPLATIN,DECREASING,DELAYED,MED,NAC,PHASE,THESE
AGGRESSIVE,BACKGROUND,BRAIN,CASES,FINAL,FURTHER,HOWEVER,LABEL,METHODS,T1B,TNM
ATLAS,EPH,THESE
169,177,AMONG,BASED,CUSHING,PCR,SOCIETY
CURRENT,OUTCOME,YET
ABC,ALZHEIMER,AMONG,CAM,ECM,NCAM1,PARKINSON,PERIOSTAT,THERE,TIMPS
MRI
169,BACKGROUND,COMMITTEE,CONCLUSION,END,FT4,JOINT,LABEL,METHODS,PRESS,RESULTS,SERUM,TSH
BASED,FINALLY,OVERALL,SINCE
ACRYLAMIDE,GATEKEEPER,H1975,L858R,MICHAEL,NSCLC,SW620,T790M,THESE
AVERAGE,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PRE,PURPOSE,RESULTS
BACKGROUND,DIFFERENT,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,RESONANCE,RESULTS,VALIDATION
112,116,125,135,180,AES,BASED,CONCLUSION,FAILURE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPN,SRS
CLINICALLY,GROUP,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RADIATION,RESULTS,SPARING,THERAPY
DTI,MRI,NEC,USING
BASED,CNS,DLT,GRADE,THERAPY,TID,TLAST
000,APRIL,FDA,III,PRIOR,THERAPY,THERE,THESE,TTF
AUTHORS,DESPITE
III,MRI
100,177,179,ERT,GBM,MRI
11C,177,CONCLUSION,ENTRY,MET,METABOLIC,PET,RESULTS
INSTITUTE,MRI,NEOPLASMS,RESULTS,THERE,TOTAL,TRANSIENT,UNDERWENT
169,HISTOLOGIC,SEZ,THROUGH
MICRORNAS,THESE

MOLECULAR,NSCLC
GBM,INTERTUMOR,INTRATUMOR
DUE,HOWEVER,THESE,UTILIZING
SUPPORTIVE
HOWEVER,K63,PARKINSON,UBC13,UBIQUITIN,UCH,UEV1A
AFTER,CED,CURRENT,GBM,HOWEVER,MRI,PET
002,023,029,035,044,177,718,855,COMPARING,FGFR4,MIB,NCA,P27,SGA,TORONTO,TVDTS,WESTERN
115,169,215,CONCLUSION,LABEL,METHODS,OBJECTIVE,PTCH1,PURPOSE,RESULTS,SOCIETY
169,ANATOMICAL,DES,MEYER,ORS,SIX,SOCIETY
945,CSNK1,EPH,EPHA7,FINALLY,HOWEVER,MYC,PCTAIRE,PCTK1
GSKJ4,H3K27,JMJD3,K27,PEDIATRIC
025,196,BRAIN,EVALUATION,HES,MIB,MMP,PAI
BASED,CENTRAL,CONTROLLED,DIFFERENT,HOWEVER,MEDLINE,PROGNOSTIC
CURRENTLY,INTRINSIC,MDR,MRP,THESE,TMZ,U87,USING
200,HOWEVER,THORACO
174,ALTOGETHER,BECAUSE,GBM,PRESTWICK,SCREENING,U87
004,341,48H,747,EARLY,FINALLY,HOWEVER,MCA,MEDLINE,SCIENCE,WEB
169,BACKGROUND,DIAGNOSTIC,INC,LABEL,METHODS,PARENTS,PROCEDURE,RESULTS,SCREENING,WILEY
100,169,835,AMONG,FREQUENCY,INC,INTERPHONE,MHZ,RADIO,SAR,TALAIRACH,THEIR,THEREFORE,WILEY
169,17P,22Q,CNV,MELANOMAS,MELANOTIC,SOCIETY

160,946,LHX,PCR,POTENTIAL,QRT,WNT
TEN,TOXIC
169,2HG,DROSOPHILA,EXPRESSION,HEMATOLOGY,IDH,R132H,R140Q,R163Q,R195H,SOCIETY,THESE,UAS
BMJ,BRAIN,GROUP,LTD,MRI,PUBLISHING,SINKING
169,CCR,DEVELOPING,EFFORTS,FOCUS,GROUP,HGG,SHH,SIMILAR,SMO,THESE,WNT
169,GLIOMAS
169,DESPITE,HOWEVER,III,PREDICTIVE,ULTIMATELY
169,ADDITIONAL,CCR,FOCUS,IDH,WHILE
169,ANOTHER,CCR,FINALLY,FOCUS,THERE
169,35INT,ABELSEN,ABL,ANTICANCER,BCR,CNS,COPYRIGHT,INSTITUTE
GBM,GSC,HGG,HOWEVER,MES,METABOLIC,SIMILAR
003,514,AFRICAN,AFTER,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,OBJECTIVE,RESULTS,THESE,WORSE
100,450,CSF,FIFTY,GIVEN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
CLASS,ENGEL,GRADE,GROSS,LABEL,METHODS,OBJECTIVE,OPERATIONS,PMT,RESULTS,THESE
215,ASSESSING,C57BL,INTRANASAL,MOTOR,PCR
176,BACKGROUND,INCREASING,LABEL,METHODS
141,222,CSF,FIFTY,FOXL1,POU,SP1,THESE
001,078,161,594,CTX,FURTHER,GCT,IPFSG,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SALVAGE
HOWEVER,PROGNOSIS
100,BID,FOUNDATION,GNF,INSTITUTE,IRINO,LABEL,METHODS,NBS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,TMZ,TRK
FASLG,MECHANISM,MTT,PCR,TARGETSCAN
169,COPYRIGHT,GBM,HOT,LTD,MRS,PRESS,WILEY
AFTER,DKK,EMD121974,PCR,REDUCED,THESE
169,AIM,ANOTHER,CONCLUSION,FOUNDATION,HOWEVER,LABEL,LTD,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,WILEY
142,169,211,255,334,363,365,588,775,AFTER,ALDRYCH,AML,APRIL,BACKGROUND,BETWEEN,CGD,CONCLUSION,HLH,INC,INFANTS,LABEL,MARCH,METHODS,NBL,PROCEDURE,RESULTS,SAA,SEVENTEEN,THEIR,TORONTO,WILEY,WISCOTT
035,103,AMONG,BACKGROUND,LABEL,METHODS,RESULTS
CONCLUSION,CSI,LABEL,METHODS,MRS,OBJECTIVE,OVERALL,RESULTS,STRATIFIED
169,3415482,ALZHEIMER,COPYRIGHT,PARKINSON,THESE
169,COPYRIGHT,CUTANEOUS,FIRST,MODULATION,SOCIETY
002,GROSS,GTR,LABEL,MEIER,METHODS,OBJECTIVE,PFE,PFS,PURPOSE,RESULTS,STE,XRT
ALA,BACKGROUND,FOLLOWING,GROUP,LABEL,METHODS,MRI,RESULTS
001,EXPRESSION,III,PCR,SIMILARLY,STUDIES,THESE,TRX,TRXR1,TUNEL,WORLD
001,005,007,023,026,027,036,133,189,19Q,354,381,AMONG,AOA,PCV,TMZ
AQP,CONCLUSION,DUE,HMG,III,KOLMOGOROV,LABEL,LMG,METHODS,MMP,OBJECTIVE,RESULTS,SMIRNOV,THERE
19Q,3RD,5TH,ACCORDING,DIFFUSE,LGG,LOH,LOW,THESE
FLAIR,MRI
ODN,PHASE,SIMILARLY,THESE
ALZHEIMER,BACH1,BVR,SINCE
169,EFFECTIVE,FORETINIB,MECHANISMS,MET,SHH,TAKEN
177,1ST,2ND,322,3RD,DESPITE,III,MRI,PFS,SIXTY,VEGFR
BMJ,ENDOSCOPIC,FURTHER,GROUP,LTD,MRI,PUBLISHING,PUTTING

169,177,328,578,819,944,BACKGROUND,FURTHER,HEART,INC,KIM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING,WMH
AMONG
CURRENT,HAT,HDACS,HISTONE,PEDIATRIC,SEVERAL
169,946,ANXIETY,DEPRESSION,FATIGUE,FRACTAL,HOWEVER,HURST,INC,SLEEP,STRESSFUL,WILEY,WORRY
215,875,BONFERRONI,CHINESE,FURTHER,HAN,HGG,LGG,NMI,TAKEN
169,AUTHORS,INC,INSTEAD,SOCIETY,THEREFORE,WILEY
082,165,490,517,543,557,819,851,924,AFTER,AMONG,COSTS,EXPOSURES,IMPORTANCE,IQR,LABEL,MATCHED,METHODS,OBJECTIVE,RELEVANCE,RESULTS,SETTING,TOTAL
CNS,NK1,NOVEL,SUBSTANCE
131,ASTROCYTIC,BACKGROUND,CONCLUSION,HOWEVER,III,LABEL,MATERIALS,METHODS,RESULTS,SANTA
006,028,042,045,046,049,CNS,COX,DEPARTMENT,EVN,MIB,SIMILAR,TOTAL,WORLD
GBM,HOWEVER,METASTASIS,MTSS1,THESE
169,433,COC,CONTINUITY,HRS,INC,INSURANCE,LABEL,LOWER,METHODS,OBJECTIVE,OUTCOME,PURPOSE,RESULTS,SIMILAR
CNS,GBM,MRI
250,600,ALZHEIMER,LASER,LCM,USING
AMONG,DESPITE,FINALLY,GBM,GSC,OLIG2
ERK,LTP,MEK,RAS,THESE
CONCLUSION,LABEL,MATERIALS,METHODS,PURPOSE,RESULTS,UNLABELLED
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,POPULATION,RESULTS,SWEDISH,THREE,WAITING
169,INC,PEDIATRIC,WILEY
169,INC,PCR,WILEY
000,169,181,200,316,400,431,AMONG,CCNB1,CDC20,MRT,PLK,PTTG1,TRIB3
001,216,801,CURRENT,GRADE,PARAMETERS,THESE
169,CONCLUSION,KNOWN,LABEL,LTD,MEK,METHODS,OBJECTIVE,SUMMARY,V600E,V600M,V600R,WILEY
BECAUSE,TREATMENT
169,BACKGROUND,BRCA2,CONCLUSION,FANCONI,FEW,INC,LABEL,METHODS,PHENOTYPIC,PROCEDURES,RESULTS,SEVEN,SOLID,WILEY
AUSTRALIAN,RESOURCES,TOOLS
945,946,BACKGROUND,CRENOLANIB,CSC,GBM,INSTEAD,LABEL,METHODS,MTS,MULTIFORME,NOTCH,OVERALL,PCR,PDGFR,RESULTS,WESTERN
EMT,JAGGED1,KNOCKDOWN,MSI,MUSASHI,USING
214,301,381,437,659,ABO,CSF,ENDOSCOPIC,ETV,ITH,LABEL,METHODS,OBJECTIVE,PEDIATRIC,REESH,RESULTS,SEVEN,SIX,THERE,UNIVERSITY,UTH
149,BETWEEN,EOR,GRADE,JANUARY,LABEL,METHODS,OBJECTIVE,PCMIS,RESULTS,THERE
100,LABEL,MEDTECH,METHODS,OBJECTIVE,RESULTS,ROBOTIC,SIX
417,ALZHEIMER,BBB,DCE,DYNAMIC,FURTHER,MRI,THERE,TOFTS,TRANS
EFFECTIVE,FOLLOWING,GBM,MTD,U87
000,169,BACKGROUND,BRAIN,CNS,CONCLUSION,LABEL,METHODS,PFS,PRESS,RESULTS
001,009,169,624,BACKGROUND,DURAL,HEART,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PARESIS,PURPOSE,RESULTS,SCALE,SINUS,THREE,THROMBOSIS
045,215,738,815,AGILENT,CONCLUSION,GBM,LABEL,METHODS,MICROARRAY,OBJECTIVE,OBJECTIVES,PATHWAY,POTENTIAL,RESULTS,VOLCANO
036,169,245,271,298,307,407,453,507,672,699,870,897,BACKGROUND,COLORECTAL,DESPITE,INCIDENCE,INPATIENT,LABEL,METHODS,NATIONWIDE,RESULTS,SOCIETY
001,159,169,177,206,244,AGE,ASSESSMENT,BACKGROUND,BASEL,CURIE,GUSTAVE,LABEL,METHODS,PERSISTENT,RESULTS,SIADH,WED
169,945,AKT,HOWEVER,MIG,TAKEN,TRANSGENIC
ATS,BACKGROUND,BETWEEN,LABEL,METHODS,RESULTS,THREE,TREATMENT
169,AKT,APLYSIN,BIOLOGY,HOWEVER,INCREASING,SOCIETY,WESTERN
169,BECAUSE,SMO,SMOOTHENED
169,5ENVE,BRAIN,FINALLY,TREATMENT
000,077,100,160,2HG,489,BACKGROUND,DISCUSSION,GLIOMAS,HENCE,IDH,III,LABEL,MEIER,MRS,RESULTS,SCREENING,WHITNEY,WORLD
GAMMA,GKS,KNIFE,LEKSELL,METASTASES,PITTSBURGH,STOCKHOLM,THERE
100,GAMMA,KNIFE,PITTSBURGH,STOCKHOLM,SWEDISH
224,CARCINOMAS,CONCLUSION,DEPARTMENT,FIRST,ITALY,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OBJECTIVES,PLASTIC,RESULTS,SETTING,SURGERY,SUSPICION,UNIVERSIT,VON
DIAGNOSIS,HIV,PML,SEROTONIN
106,110,151,156,201,250,307,BACKGROUND,CONTEXT,CPS,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SIR,SMR,SWEDISH,THERE
000,001,ARG,ARG194TRP,ARG280HIS,ARG399GLN,BACKGROUND,CHINESE,GLN,HOWEVER,LABEL,METHODS,RESULTS,STATA,THREE,XRCC1
020,030,040,BACKGROUND,GBM,LABEL,METHODS,RESULTS,TMZ,U87MG
100,EGFR2,INHIBITING,PRL,WESTERN
208,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SIGNS,VOLUMETRIC
393,ASR,BACKGROUND,CHI,CNS,CRUDE,INCIDENCE,LABEL,MATERIALS,MEIER,METHODS,RESULTS,STATISTIC,TUNISIA
200,AMONG,GBM,GSC,LABEL,MET,METHODS,MIGRATION,NPMIR,OBJECTIVE,PCR,RESULTS
GLI,SUPPRESSOR,WHILE
FIRST,MRI
46H,70S,BRAIN,FOLFIRINOX
AKT,CCK,CONSISTENT,EDU,FINALLY,HIPPO,HOWEVER,MAMMALIAN,MEANWHILE,TAKEN,THEREFORE
100,129,160,BACKGROUND,CNS,GTR,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SHORT,SIXTY,STR,THEREFORE
MRI,WHILE
BECAUSE,CXC,CXCR4,HOWEVER
CONCLUSION,CRH,CUSHING,IPS,LABEL,METHODS,OBJECTIVE,RESULTS
CAREFUL,CONCLUSION,CUSHING,LABEL,METHODS,OBJECTIVE,OPHTHALMIC,PATHOLOGIC,PURPOSE,RESULTS
HDL,HOWEVER,THEREFORE,THESE
001,120,466,MEIER,NSCLC,ROC,THESE
947,TMZ,WHILE

177,CHINESE,ENDOSCOPIC,ETV,GENERAL,LABEL,LIBERATION,METHODS,OBJECTIVE,PFS,RESULTS,SEPTEMBER
HOWEVER,PCR,VEGFR
CSF,MNI,MRI,SEVERAL
001,177,DCE,DSC,MRI,SEVEN
865,872,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
176,CARLO,D95,DVH,HOWEVER,LABEL,METHODS,MONTE,MRI,OBJECTIVE,PURPOSE,RESULTS,SITES,V20
T2TMETS
169,945,GBM,HOWEVER,LABEL,LIVIN,METHODS,OBJECTIVE,PURPOSE,RESULTS,TAT,THESE,WESTERN
001,002,007,100,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THESE,TOTAL
051,169,445,AIM,ANTICANCER,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EASTERN,GROUP,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,OLDER,PRT,RESULTS,SHORT,UNI
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HPCCC,INSTITUTE,LABEL,MATERIALS,METHODS,MTT,MUTELLINA,OSTHOLE,RESULTS,TE671
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HPV,INSTITUTE,LABEL,MATERIALS,METHODS,MMP,OBJECTIVE,PCR,RESULTS,TARGETING
169,ADR,ECTOPIC,HOWEVER,MEMBERS
169,LABEL,SUMMARY
169,BA6,BROCA,INC,MNS,WILEY
000,001,003,005,009,012,013,018,026,030,148,177,201,206,230,288,360,406,417,458,563,733,800,861,911,BASED,BETWEEN,CSF,GTR,HGG,OSS,PEDIATRIC,PFS
006,22981,232,26981,EORTC,GBM,PFS,PPS,TMZ
947,ANOTHER,ELISPOT,GBM,OTHER,SIX,THERE,TMZ

BACKGROUND,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,SWI,THERE
229,BACKGROUND,GIVEN,HOWEVER,III,LABEL,METHODS,RESULTS,SCALE,SFG,VCI,WHOLE
ASPECTS,BRAIN,GUIDELINE,PATIENT,PEDIATRIC
240,ADULT,BRAIN,GUIDELINE,PATIENT
CHORDOMAS
DESPITE,HOWEVER,LABEL,OBJECTIVE,OTHER,POC,POPULATION,PURPOSE,RESULTS,SINCE,STILL,SUMMARY
169,CD4,CD8,CSF,GBM,SINCE,THESE,WHILE
177,253,300,353,356,606,INPATIENT,LABEL,LOS,METHODS,NATIONWIDE,NIS,OBJECTIVE,RESULTS,TREATMENT
169,LTD,PUBLISHED,THESE,WILEY
INCIDENTAL,SVZ
MEG,MRI,SEVERAL
EARLY,III,ONGOING,PHASE
DIFFUSE
AREAS,BEV,CONCLUSION,DIFFUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,RESTRICTED,RESULTS,SMALL
ADULT,ANTICANCER,ASSOCIATE,BRAIN,CME,COLLEGE,DEPARTMENT,DESJARDINS,FOLLOWING,FRCPC,JOURNAL,MOLECULAR,NEURO,NEUROLOGY,OPTIONS,PHYSICIANS,PRESTON,PRINCIPAL,PROFESSOR,REVIEWS,ROYAL,SHERBROOKE,THERAPY,TISCH,UNIVERSITE
169,THESE
946
177,ACUTE,AFTER,CNS,DBF,FIFTEEN,GROSS,JANUARY,MAY,PBS,PEDSQOL,PFS,QOL,RBE,SIX
WHOLE
169,AGGRESSIVE,INC,SCIENTISTS
00001,BACKGROUND,CENTRAL,ENGLISH,JADAD,LABEL,MARCH,MEDLINE,METHODS,PCI,RANDOMIZED,RESULTS,SCIENCE,SMALL,THREE,WEB
169,CANCERS,CENTRAL,COPYRIGHT,GUIDELINES,MRI,NERVOUS,NETWORK
169,CANCERS,CENTRAL,COPYRIGHT,GUIDELINES,NERVOUS,NETWORK,SRS,THESE
000,040,120,141,304,655,884,BEIJING,FORTY,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,THREE,TIANTAN,UNIVARIATE
CARMINE,FDA,FRAMELESS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,WHITE
AFFYMETRIX,ARRAY,CANDIDATE,CDH19,CURRENT,GBM,GSC,LABEL,METHODS,NSC,OBJECTIVE,RESULTS,U87,WESTERN
ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,RESULTS
000,110,1980S,1990S,2000S,374,ADDITIONAL,EVERY,EXTENSIVE,MAJOR,REFINED
002,029,181,207,B10,BASED,BETULINIC,HOWEVER,INCUBATION,LN229,NVX
156,606,801,843,AMONG,GBM,HGG,INNOVATIVE,LFQ,PCR,THEREFORE
169,946,ABCB5,ABCG2,BACKGROUND,CD133,CONCLUSION,CSC,GBM8401,GLI,LABEL,METHODS,NANOG,NOTCH,OCT,RESULTS,SOX,TREATMENT
169,BASEL,BMI,HOWEVER,LABEL,METHODS,OBJECTIVE,PEDIATRIC,RESULTS,SDS
GBM,SALL4
050,109,205,961,CET,DCE,FURTHER,GIVEN,MRI,PFS,PRE,THEREBY,VWR
000,001,003,006,014,024,168,999,ADULT,BRAIN,EPENDYMOMA,ESTIMATED,REPORTS,SPINE
DEP,DIX,DVL,EGL,PDZ,THEREFORE,THESE,WNT
19Q,GLIOMAS,THEIR,THESE,WHEREAS
BSO,CISPLATIN,HOWEVER,MALIGNANT,REMARKABLY,TMZ
947,EGABA,HOWEVER,SRC,TRK,USING
100,169,215,BACKGROUND,BETWEEN,BMS,CONCLUSION,GOV,LABEL,MEDICAL,METHODS,MRI,ORR,PFS,PRESS,PUBLISHED,RESULTS,SECONDARY,SOCIETY,TMZ,TREATMENT,UNIVERSITY
002,169,III,NEURO,PCV,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,946,BIOLOGY,BRUCE,EBP,ERBB3,FURTHER,MOLECULAR,MYD88,NRDP1,THESE,TMZ,UBIQUITIN,UNION
100,945,946,947,WNT
169,COPYRIGHT,WHILE,WINSTON
169,7TH,8TH,9TH,CSF,INC,WILEY
FORTY
015,020,022,028,169,CDR,DTC,HERC5,NSCLC,PCR,QRT,SEVEN,STAGE
DESPITE,ECM,GBM,MSC
INHIBITION,JNK,JUN,NH2
169,ATM,ATR,CONSISTENT,GBM,INITIAL,MMR,TMZ
203,300,CNTN2,DIFFUSE,EXPRESSION,GBM,GSE9385,OMNIBUS,PPI
FSE,HOUNSFIELD,HOWEVER,MRI,OTHER
BACKGROUND,CONCLUSION,CONTEXT,LABEL,METHODS,PITUITARY,THERE
160,CYTOTOXIC,DAU,DU145,III,THESE
001,007,ADC,ADC10,CEL,COX,GBM,HAZARDS,PFS,PHASE,T2L
001,014,021,032,160,III,MTD,MTT,PCR,POZ,THESE,TRANSWELL
946,AKT,HOWEVER,LIQ,THESE,TMZ
177,EFFICIENT,PET,RCY,TRK
000,BECAUSE,EVS
ANIMALS,ANOVA,LABEL,METABOLITE,METHODS,MRI,MRS,NAA,NEOPLASTIC,OBJECTIVE,PROCEDURES,RELEVANCE,RESULTS
CNS,DOX,EFFORTS,METASTASES,THESE,TMZ
001,113,169,945,CONCLUSION,CONFORMAL,DELAYED,HOPKINS,INTENSITY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,REVISED,SOCIETY
001,055,069,174,177,186,417,821,99M,COX,GBM,SPECT,TECHNETIUM
079,169,177,263,331,495,808,946,EFFECTIVE,TGF,TREATMENT,USING
169,300,34A,ACTIVATION,MIR,ND2,SHH,SIRT1,SMOA1,STRATEGIES,THESE
SHH,WNT
169,ACADEMY,BIOLOGICAL,BIOLOGY,CHINESE,EDITORIAL,HOWEVER,INSTITUTE,INSTITUTES,PRESS,PUBLISHED,SILENCING,U87MG,UNIVERSITY
160,EMA,IDH,OLIG2,R132H
945,AKT,HIF,HOWEVER,OCT
169,247,458,AMONG,ANY,CBT,CIS,COMPELLING,HOWEVER,ORS,OVERALL,STATE,USING,VITAMIN,WASHINGTON
845,DASATINIB,EGF,ERLOTINIB,GBM,GEFITINIB,SRC,THESE,TYR
945,950,954,BACKGROUND,BCSFB,CSF,CXCL1,ELISA,ENRICHMENT,EXPRESSION,IL6,IL8,LABEL,METHODS,NEISSERIA,PCR,RESULTS,SET,USING
169,GBM,MOLECULAR,PRESS
032,100,105,169,533,599,BACKGROUND,GBM,GMB,INC,LABEL,METHODS,PXA,RESULTS,SEGAS,THR599DUP,V600E,WILEY
000,001,033,077,946,AFFILIATED,COX,EVALUATION,FIRST,LABEL,MEDICAL,MEIEN,METHODS,OBJECTIVE,RESULTS,SOX17,UNIVARIATE,UNIVERSITY
001,005,946,ADHEREN,CLAUDIN,CLDN1,CLDN5,HENCE,PCR,T98,U87MG,USING,WESTERN,WORLD
BOX,EMR,PANDORA
ALZHEIMER,GROWING,HENCE,PARKINSON
GUT,WHILE
CONCLUSION,CSF,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,OVERALL,RESULTS,ROUTINE,SIRIRAJ,THREE
169,945,947,ALTOGETHER,GPR55,HOWEVER,IFN,IMMUNOLOGY,LPS,SOCIETY,THESE,TNF
002,007,009,109,125,169,CYBERKNIFE,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,SRS,SRT,UNIVERSITY
003,024,120,19Q,PCV,PFS
002,163,758,GBM,HOWEVER,KARNOFSKY,KPS,LOW,OVERALL,PRE,SCALE
AKT,CASPASE,DEPLETING,GBM,GSC,GSK3B,INCREASING,MALIGNANT,PI3KINASE
BASED,MTA,SIMILAR
169,AKT,BIOLOGY,EMBRYONIC,FOXO3,HOWEVER,INC,MNSOD,MOLECULAR,SOCIETY
169,ADAM9,FIRST,HYPOXIA,KNOCKDOWN,OVERALL,RAV,THEREFORE
BACKGROUND,BRAIN,CNS,DESPITE,ENGLISH,EXPERIENCE,FOLLOWING,LABEL,METHODS,OBJECTIVE,UNASSIGNED
BRIEF,EXECUTIVE,GROUP,OVERALL,PARENTS,RATINGS
ASSESSMENT,GROUP,HOWEVER,III,NEURO,PHASE,RADIATION,SUCCESSFUL,THERAPY,TREATMENT
362,CENTERS,LABEL,METHODS,OBJECTIVE,REASONS,RESULTS,SIX
CSF,MONRO,THESE
169,EPIDERMAL,EXTENSIVE,GBM,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY,WHILE
169,III,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,EPIDERMAL,HOWEVER,NEURO,NOVEL,PRESS,PUBLISHED,SOCIETY,TARGETING,UNIVERSITY
169,CGH,DIAGNOSTIC,EGFRVII,EPIDERMAL,GBM,GENOMIC,NANOSTRING,NEURO,PCR,PRESS,PUBLISHED,SCNAS,SOCIETY,SOMATIC,UNIVERSITY
PCR,TOTAL
169,FAR,GBM,LGG,PRESS
178,956,BRAIN,DELAYED,FIFTY,INFANTS,LABEL,LEUCOVORIN,METHODS,MRI,MTX,OBJECTIVE,POPULATION,PURPOSE,RESULTS
GBM,HOWEVER,INK4A,TARGETING,WHETHER
001,002,003,015,018,063,AMONG,BACKGROUND,CONCLUSION,COX,DCD,HOWEVER,LABEL,MEIER,METHODS,NETWORK,ORGAN,PRIMARY,PSC,RESULTS,SHARING
002,008,011,054,081,126,215,ASIAN,CPG,EGGER,GASTRIC,HARDY,HOWEVER,HWE,KNOWLEDGE,LIBRARY,SCHOLAR,THERE,WEB
BECAUSE,IMAGING
169,232,786,FETAL,HOWEVER,INC,PROGRAM,SERVICE,STILLBIRTH,THERE,WILEY,WISCONSIN
001,177,313,BACKGROUND,BASED,COX,IRANIAN,JANUARY,KURDISTAN,LABEL,MARCH,MATERIALS,MEIER,METHODS,RESULTS
152,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,RESULTS,RRS,SYSTEMATIC
945,APOPTOSIS,HIF,HOWEVER,PROMOTION,RESULTS,THEREFORE
950,CHINA,CXCR4,MICROARRAY,MMP,PKC,U87MG
33258,BCL,HOECHST,LC3,LN229,MTT,OLANZAPINE,T98,THESE
169,177,946,CFU,COPYRIGHT,FDG,FDS,KLEBSIELLA,PET,SCIENCE
001,009,019,215,600,740,ADC,BACKGROUND,LABEL,METHODS,MRI,RESULTS
ANNEXIN,MTT,NOTCH,P21
048,169,400,CD95L,COX,LABEL,LOWER,METHODS,OBJECTIVE,PATIENT,PFS,PURPOSE,RESULTS
001,177,966,CONCLUSION,HOWEVER,LABEL,MECHANICAL,METHODS,OBJECTIVE,RESULTS,UNRELATED
947,BRCA1,BRCA2,BRCC3,HOMOLOGOUS,HOWEVER,RAD51,TMZ
130,ACCORDING,BACKGROUND,LABEL,METHODS,RESULTS,THERE
000,005,HOWEVER,STAT3,THEREFORE
169,CPC,CPP,CPT,DISCUSSION,EFS,LABEL,METHODS,MOLECULAR,OBJECTIVE,PURPOSE,RESULTS,SOMATIC
169,17Q24,945,BIALLELIC,CNC,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,PRKAR1A,REDUCED,RESULTS,S251LFSX16,SOCIETY
001,067,169,262,685,851,APRIL,AUTHORS,BACKGROUND,BLACKWELL,HEART,HOWEVER,ICH,INC,LABEL,MAY,METHODS,PUBLISHED,RESULTS,SAH,SCALE,THESE,WILEY
169,ONCOLYTIC,THESE,USING,WHILE
DIFFUSION
201,BRAIN,HOWEVER,MRI,WHOLE
000,183,432,ANNOTATION,FFAR2,GENOMES,GENOTYPING,HNRNPA0,HOXB2,HUMANEXOME,MEDICAL,NCAM2,PHENOTYPE,POPULATION,RESULTS,SINCE,SMPD2,USING,VARIANT
000,001,005,169,197,273,439,500,689,CNS,GENERAL,RRS,THERE
DETECTION,MNO,MRI,NPS
HAYASHI,HOWEVER
18F,AMINO,BRAIN,FDG,HOWEVER,LABEL,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUMMARY
004,034,177,CONCLUSION,DYNAMIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
128,136,252,946,AII,AIIIS,EMT,III,MALIGNANT,NBT,STUDIES,TGF,TGFB1I1
BRATS,PERFORMING

169,945,946,AMP,ATP,COPYRIGHT,SOCIETY
009,024,110,116,187,579,787,AGE,AMONG,CHINA,CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,REGRESSION,RESULTS,SEPTEMBER
001,003,160,177,AUC,CONCLUSION,EVALUATION,FET,III,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,TAC,TBR,TIS
169,372,BRAIN,BRESLOW,CLARK,COX,HOWEVER,LEVEL,RECURRENCE,SEVENTY,STAGE,THESE
1397G,3209C,37G,FOCUSED,G466V,MET,P53
THERE
ACVR1,BRAINSTEM,BSG,DIFFUSE,ECTOPIC,INCREASING,INTRINSIC,PONTINE
BACKGROUND,CONCLUSION,FSH,HOWEVER,KARYOTYPE,LABEL,METHODS,POF,PREMATURE
002,012,CTV,GTV,OAR
001,007,177,792,822,ANOVA,AUC,CBV,CLINICALLY,DSC,LABEL,MATERIALS,MATHEMATIC,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC
144,AGE,AGING,BACKGROUND,BRAINCLOUD,EARLY,EXPRESSION,GAP43,HYPOTHESIS,IL1R1,KNOWING,LABEL,METHODS,NFKB1,NGF,OBJECTIVE,PDGFA,PLA2G4A,PTGS2,RESULTS,SYN,TRAF6
EARLY,HMB45
DESPITE,ECTOPIC,FINALLY,INK4A,NOTABLY,NR2E1,NSC,OVERALL,TLX

177,APRIL,BEIJING,CALORIC,CONCLUSION,LABEL,METHODS,OBJECTIVE,PUHUA,RESULTS,TIANTAN,WHILE
AREAS,BACKGROUND,COVERED,CURRENTLY,DCS,DENDRITIC,GBM,LABEL,METHODS,OPINION,SUCCESSFUL,TARGETING
BMJ,DIAGNOSIS,GBM,GROUP,HOWEVER,LTD,PUBLISHING
DIFFUSE,GBM,HSPGS,SULF1,SULF2
300,AMONG,FUNCTIONAL,PRIDE,PXD001398,SUCCESS
BACKGROUND,CONCLUSION,DIFFUSION,FOLLOWING,LABEL,METHODS,RESULTS,VOXEL
100,1ST,2ND,AMONG,ANOTHER,BARTHEL,FORTY,GROSS,INDEX,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIX,THREE
100,105,121,124,249,257,260,282,302,381,CSF,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,UNIVERSITY
ANALYZING,CNS,DERMOID,MRI
002,005,007,020,033,100,926,999,DUE,EMF,GROUP,MAY
169,956,BRAIN,CONCLUSION,IMAGING,INC,LABEL,MBQ,METHODS,MOLECULAR,NUCLEAR,PARKINSON,PERIPHERAL,PET,RADIATION,RESULTS,SOCIETY,UNLABELLED
BMJ,GROUP,INTERVIEW,INTERVIEWS,LABEL,LIMITED,METHODS,OBJECTIVE,PROPOSALS,PUBLISHED,PUBLISHING,RESULTS
132,172,945,ANOTHER,H09,IDH,MSMAB,MUTATIONS,R132G,R132H,R132L,R132S,R172G,R172M,R172S,THESE
HOWEVER,PERMANENT
001,169,COX,GBM,MICRORNAS,PRESS,PUBLISHED,SCORE,UNIVERSITY
CONFIRMING,FOLLOWING,GBM,THESE
CHICAGO,ENDOCRINE,JANUARY,MEETING,PITUITARY,SOCIETY
MALIGNANT,NEUROG2,SOX11,TAKEN,THESE
10001,333,CHD,INITIATIVE,MEDICAL,PUBLISHERS,SEVENTH,USA,WOMEN
BRATS,LOW,MRI,POTENTIAL
COLIAGE,COLLAGE,GABOR,LOCAL,MRI,WHILE
BACKGROUND,C139R,D144E,FUNCTIONAL,HBSAG,HBV,L192F,LABEL,M125I,METHODS,MHR,MUTATIONS,OBJECTIVE,RESULTS,T123S,V177A,W196L,WHEREAS,Y225DEL
169,BRAIN,MOLECULAR,NOVEL,PRESS,PUBLISHED,REASONS,UNIVERSITY,WHOLE
169,CNS,COPYRIGHT,DEPLETION,INC
169,ACADEMY,CSF,IGG,KV4,LABEL,METHODS,NEUROLOGIC,NEUROLOGY,OBJECTIVE,RESULTS,SIXTY,SPECIMENS,SYMPTOM
169,CHANGES,GBM,INSTEAD,MRI,OVERALL,TMZ
169,C57BL,CRANIAL,III,MRI,PYP,RADIATION,SOD,THESE
169,232,BLACH,CD152,CD279,CD4,CD8,EUR,IMMUNOL,IMMUNOLOGY,JOURNAL,VCH,WILEY
187,955,AFTER,AMONG,CENTRAL,CNS,CSF,DIAGNOSIS,IGG,MRI,VTD
BACKGROUND,HENCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
146,169,BACKGROUND,EAN,ISOCITRATE,LABEL,LOW,MEIER,METHODS,MUTATIONS,OBJECTIVE,PURPOSE,RESULTS,VOXEL
GRN,IMPORTANCE,LABEL,METHODS,MUTATIONS,OBJECTIVE,RELEVANCE,WML
169,AKT,AZD8055,BTICS,CONCLUSION,GBM,LABEL,MEIER,OBJECTIVE,PURPOSE,RESULTS,THESE,TMZ,WESTERN
169,INC,MOLECULAR,MRI,PDT,PLASMONICS,PTT,RAMAN,SEVERAL,TPL,WILEY
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OTHER,PITUITARY,RESULTS
169,ALZHEIMER,AMERICANS,BASED,CHALLENGES,COPYRIGHT,ISSUE,SEVERAL,SPECIAL,THERE,WHILE
001,160,177,215,517,ALT,DUE,SOMATIC,THESE
001,169,961,CONCLUSION,FDG,IMAGING,INC,LABEL,METABOLIC,METHODS,MOLECULAR,NUCLEAR,PET,PREDEFINED,RESULTS,SOCIETY,UNLABELLED
945,946,DHT,FINALLY,GBM,HOWEVER,SMAD3,TAKEN,TGF,U87
ATTENTION,BACKGROUND,III,LABEL,METHODS,RESULTS,THESE
001,014,169,BMS,CD3,CD8,DENSITY,FORTY,FOXP3,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TIL,V600E,WILEY
151,1P19Q,235,491,807,BACKGROUND,CIC,ETS,IDH,LABEL,METHODS,PCR,RESULTS,SNP,TCF,TERTP
160,169,BOC,COPYRIGHT,INC,MILLE
215,FONTANA,HMB,MALIGNANT,PATHOLOGIC,STOMACH
105,177,AIM,ASSESSMENT,AVERAGE,GRADE,III,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,WORLD
011,021,324,634,828,LABEL,MATERIALS,METHODS,OBJECTIVE,RECURSIVE,RESULTS,SALVAGE,THERE
150,BOARD,BRAIN,EVALUATION,HENCE,IDV,IMAGING,LABEL,LATERAL,MATERIALS,METHODS,OBI,OBJECTIVE,OPI,PURPOSE,RESULTS,SIMILARLY,THERE
AMONG,III,LABEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
AGE,BENEFIT,CURRENT,HOWEVER,LABEL,OBJECTIVE,PCNSL,PURPOSE,RESULTS,STILL,SUMMARY
001,169,226,BACKGROUND,GLI,LABEL,MEIER,METHODS,PEARSON,PRESS,PUBLISHED,RESULTS,SHH,SMOOTHENED,SONIC,UNIVERSITY,WHILE
169,900,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,ACCELERATE,ASSESSMENT,BRAIN,COALITION,FOUNDATION,INSTITUTE,JANUARY,MUSELLA,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,ASSESSMENT,CURRENTLY,FINALLY,FLAIR,MRI,NEURO,PET,PRESS,PUBLISHED,SOCIETY,UNIVERSITY,WHICH
169,ASSESSMENT,BRAIN,ENDPOINTS,JANUARY,NEURO,PARTICULAR,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,MRI,NEURO,PET,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,AKT,APPROACHES,BLI,GBM,IHC,NT113,RESULTS,THESE,WESTERN
169,EMT,GBM,GTP,NANOG,RAD,RAS,STAT3,THESE
169,ATP,COPYRIGHT,INC,RTS,SMARCB1,SNF,SWI
160,169,AUTHORS,GBM,PUBLISHED
946,ASTROCYTES,BACKGROUND,BBB,BMVEC,CONCLUSION,FPN,LABEL,RESULTS,SC144,TAKEN
26951,288,C30,CONCLUSION,COX,EORTC,EVERY,HRQOL,LABEL,METHODS,OBJECTIVE,PCV,PURPOSE,QLQ,RESULTS,THEREFORE,TREATMENT
169,BECAUSE,COPYRIGHT,GYRBE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SEVENTEEN,THEREFORE
160,169,215,647,ALEXA,AUTHORS,IGG,LTD,PTY,PUBLISHING,SCIENCE,SPR,THEREFORE,WILEY
169,946,COPYRIGHT,EXPRESSION,INC,PATHOLOGY,PUBLISHED,SIGNALING,SOCIETY
100,EMA
BACKGROUND,CCRCC,HIF,HIG,LABEL,METHODS,RESULTS,VHL
ADC,BACKGROUND,LABEL,MALIGNANT,METHODS,MRI,RESULTS
HCC,HOWEVER,SYK
001,150,169,COPYRIGHT,CPS,INC,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,REDUCED,RESULTS,THERE,THINNED
11C,11CMETPET,169,BTV,COPYRIGHT,FLAIR,HGG,IRELAND,LABEL,LTD,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SIXTY,T1MRI
100,AGE,BACKGROUND,CEREBELLUM,CONCLUSION,GLIAL,HBS,LABEL,MATERIALS,METHODS,NSE,NUCLEAR,RESULTS,VHL
BBB,DOX,HOWEVER,METASTATIC,THESE,TREATMENT
312,ACTIVATION,BACKGROUND,EFFECTS,EFFICIENT,KNS60,LABEL,METHODS,MO59J,MO59K,MST,ONS76,RESULTS,TELOMERASE,THEREFORE
169,AFRICAN,BBB,CNS,HAT,INC,THERE,THOSE
169,BBB,INC,PCNSL
954,ABCG2,ATP,BRAIN,CERTAINLY,CNS,HOWEVER,INC,PUBLISHED,TARGETING,THERE
PRIMARY
18F,AXILLAR,BACKGROUND,CONCLUSION,FDG,LABEL,METHODS,PET,SCHWANNOMA
169,APP,AUTHORS,COPYRIGHT,DU145,INC,PCA,PUBLISHED,TARGETING
100,169,53BP1,947,ACETYLATED,ADDITIONAL,ATM,BCL,CHEK2,COPYRIGHT,HDACI,INCUBATION,IRELAND,LTD,MS275,PPV,RTX,SCRIPTAID,VPA
120,169,33342,CA4,COMBRETUM,COPYRIGHT,HOECHST,IRELAND,LTD
132,15A,169,COPYRIGHT,EMT,EPITHELIAL,FINALLY,HOWEVER,IRELAND,LTD,MIR,TRANSITION
001,008,118,169,226,294,654,APRIL,BNP,FOLLOWING,HOWEVER,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
015,016,046,049,050,084,177,BACKGROUND,BRAIN,GCS,GLASGOW,KARNOFSKY,LABEL,METHODS,RESULTS,SCALE
945,AGE,ALZHEIMER,FINALLY,HIF,YET
169,211,252,331,AMONG,COPYRIGHT,COX,GPA,GROUP,INC,LABEL,MATERIALS,METHODS,MST,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SRS,THERAPY,TREATMENT
138,169,967,ACT,AMONG,APT,BACKGROUND,BETWEEN,COPYRIGHT,FIFTEEN,INC,JANUARY,LABEL,MDCTA,METHODS,PFO,PUBLISHED,RESULTS,TROUSSEAU
001,002,003,015,024,169,BACKGROUND,COPYRIGHT,CROSS,GENERAL,HRQOL,IRELAND,LABEL,LTD,METHODS,MGH,PACKARD,PRT,QUALITY,RELATED,RESULTS,TCS,XRT
003,022,044,048,469,ATLAS,ENGEL,EXPRESSION,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,PURPOSE,RAD50,RESULTS,RINT1
BACKGROUND,HOWEVER,HRA,LABEL,METHODS,PCR,RESULTS,THESE
169,947,ATM,ATR,BRCA1,CLONOGENIC,COPYRIGHT,CURRENT,F02,GM05849,IRELAND,LTD,PHOSPHO,STALLED,UCN,USING
110,228,528,ATLAS,BACKGROUND,BRAIN,CCK,CHINESE,COX,GBM,LABEL,MEIER,METHODS,MOLECULAR,NEOPLASIA,PROTEIN,REMBRANDT,REPOSITORY,RESULTS,SIMILAR,TCTN1
052,607,664,CD133,MMSCS,NPSCS,OTHER,PANTHER,SCS,TSC,U87
169,176,180,COPYRIGHT,CSF,DSC,LTD,MRI,WILEY
169,946,948,ALZHEIMER,COPYRIGHT,DELETIONS,EBP,INC,KLHL9
GROUP,KCNA1,SAMPLES,SFRP1,SHH,THESE,WNT
946,956,AKT,AS2O3,AS4O6,ATO,FURTHER,GSK,LABEL,LN428,LOCAL,METHODS,MMP,MT1,OBJECTIVE,RESULTS,SUBSEQUENT,TAO,THESE,U87MG,WESTERN
110,169,270,290,BACKGROUND,BECAUSE,BETWEEN,LABEL,METASTATIC,METHODS,RESULTS,SOCIETY,STUDIES
169,5A1,6A1,COPYRIGHT,GLC,IRELAND,LTD,OATP4A1,OATP5A1,OATP6A1,OATPS,SCLCS,TREATMENT,WESTERN
511,EFFICIENT,RRV,THESE,U87,U87MG
160,ADH,III,SERUM
169,183,BACKGROUND,BOARD,COMMISSION,COPYRIGHT,COUNCIL,DISEASE,EDUCATION,ENGLAND,FRAMEWORK,FUNDING,IRELAND,ITALY,LABEL,LTD,MEDICAL,METHODS,MOTOR,NEURONE,PROGRAMME,RESULTS,SEVENTH,UNIVERSITY,WALES,ZONMW
945,CNS,SIX
MICRORNAS,NOVA1,SIMILAR,THESE,UTR
AQP,AQUAPORINS,CO2,FURTHER,NH3
BACKGROUND,LABEL,METHODS,RESULTS
AREAS,BACKGROUND,COVERED,ISOFORM,LABEL,METHODS,OPINION,PHASE,PLACENTAL,THESE
107,AGE,CHOROID,COX,CPC,CPP,DESPITE,DUE,END,GROSS,GTR,ICD,INSTITUTE,MEIER,PROGRAM,RESULTS,SIXTY
ABC,ABCG2,BMJ,GLI,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVENTY,SHH,SONIC,WESTERN
GCT

AGAINST,BACKGROUND,BRAIN,FCD,LABEL
160,BACKGROUND,CONCLUSION,CSF,LABEL,MANAGEMENT,METHODS,OPERATIVE,PEDIATRIC,RESULTS,SOCIETY

ALZHEIMER,CHALLENGES,DUE,PARKINSON
130,140,143,945,AFTER,BACKGROUND,BRIEN,EMERGENCE,FAILURE,FIFTY,FLEMING,HOWEVER,LABEL,METHODS,RESULTS,SBP
169,APT,BASED,COPYRIGHT,FITTING,GIVEN,INCREASED,LORENTZIAN,LTD,MRI,MRS,NOE,OVERHAUSER,WILEY
OTHER,THOSE
324,658,756,ASD,THESE,TRUNCATING
169,945,AKT,DSB,FAK,HIF,INC,INHIBITION,M059J,M059K,SRC,THESE,WILEY
053,098,916,ANOVA,GBM,IRANIAN,LIVAC,PCR,THERE,THESE
001,003,100,169,AFTER,CONCLUSION,COPYRIGHT,LABEL,LEADERSHIP,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SEVERAL,SOCIETY,USING
028,127,176,428,632,ALCOHOL,BMJ,CARTA,CONSORTIUM,CURRENT,GROUP,LABEL,LIMITED,MENDELIAN,METHODS,OBJECTIVE,OBJECTIVES,ORS,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,THERE,TOBACCO
169,945,946,947,948,CD3,CD4,CD5,CD7,CD8,CENTRAL,CNS,DESPITE,LTD,PET,PRIMARY,PUBLISHED,TCR,WILEY
BACKGROUND,CONCLUSION,DESPITE,GBM,LABEL,METHODS,OAR,PLANS,RESULTS
169,EPIGENETIC,GBM,INC,NOTCH,THERE,THESE,WILEY,WNT
BASED,DESPITE
001,028,149,160,169,717,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,INC,KARNOFSKY,KPS,LABEL,METHODS,NEITHER,RESULTS,TREATMENT
ALK,CNS,CTLA4,FGFR1,MEDICAL,METASTASES,NETWORK,RAS,SOCIETY
169,INC,MOLECULAR,WHILE
169,ACUTE,BACKGROUND,COPYRIGHT,GYE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,T4A,T4B
169,315,CONCLUSION,COPYRIGHT,FEDERATION,GYNECOLOGY,III,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OBSTETRICS,PRIMARY,PUBLISHED,RESULTS,SMALL,THERE,THREE,VAGINAL
143,169,956,BIOLOGICAL,COPYRIGHT,CRK,FDR,GBM,HOWEVER,LABEL,LLL12,PARK7,PGAM1,RESULTS,STAT3,THROUGH,TPI,U87,UNASSIGNED,UNLABELLED
FINALLY
HOWEVER
100,BALANCE,BASIQ,BRAIN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SYMPTOM,THERE
127,240,CONCLUSION,LABEL,METHODS,OBJECTIVE,PJP,RESULTS,THERE
250,300,CONCLUSION,FIFTEEN,LABEL,METHODS,OBJECTIVE,PFS,RESULTS
946,EMT,HOWEVER,INCREASED,INHIBITION,MICRORNAS,SMAD7,TAKEN,TGF
169,AED,COPYRIGHT,FIFTY,HOWEVER,LOW,SURGERY
181,CD133,CD177,ISOLATING,NANOG,OVCA429,PROM1,SKOV3,SURVIVING,THEREFORE
160,ORTHOTOPIC
169,AUTHORS,CCND2,CHTOP,COPYRIGHT,INC,PRMT1,PUBLISHED,THESE
169,ENZYMES,FORMATION,HEPARAN,HSPGS,THERE,THESE
EFNB2,JAGGED1
HOWEVER,MRI,TREPONEMAL
357,433,CD133,CONCLUSION,CSC,DENMARK,EQUALLY,GBM,GLIOMAS,HGG,HOWEVER,III,JANUARY,LABEL,LGG,MUSASHI,OLDER,THERAPY,UNLABELLED
100,169,ACCORDING,BEL,BRAIN,COMPONENT,COPYRIGHT,EMOTIONAL,HGG,LTD,PCA,PRINCIPAL,THEREFORE
169,COPYRIGHT,FURTHER,LTD,PEDIATRIC,THREE
000,253,288,423,500,697,700,946,USING,WNT
177,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
345,ADC,DIFFUSION,LABEL,METHODS,MRI,OBJECTIVE,PCA,PRINCIPAL,PURPOSE,RESULTS,THESE
CANNY,HAUSDORFF,ITK,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
CARLO,DIC,DMC_LOG,DMC_TPS,LABEL,LINAC,MCLOGQA,METHODS,MLC,MONTE,OBJECTIVE,PURPOSE,RESULTS,WHILE
169,C17,COPYRIGHT,DISP3,FEDERATION,FINALLY,PUBLISHED,SOCIETIES
160,BRAIN,LABEL,METHODS,MRI,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,THERE
100,169,COPYRIGHT,DORFMAN,EXTRANODAL,LTD,RESECTION,ROSAI
169,954,983,AMONG,CLDN9,COPYRIGHT,CURRENTLY,INC,PITUITARY,THESE,WESTERN
169,174,300,578,COPYRIGHT,CPG,FEWER,HOWEVER,KIT,SIMILAR,TISSUES,TSM
BACKGROUND,BMJ,COMMITTEES,DENMARK,ETHICAL,GLIOMAS,GROUP,IDENTIFIER,LABEL,LIMITED,METHODS,PROJECT,PROTECTION,PUBLISHED,PUBLISHING,RCT,SCIENTIFIC,TRIAL
100,1799T,600,AMSTERDAM,BACKGROUND,BMJ,CRC,FINDINGSS,GROUP,GUIDELINES,INITIAL,LABEL,LIMITED,LYNCH,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,SCREENING,SELECTION,UNASSIGNED,VAL600GLU
ACCORDING,DESPITE,LABEL,LOW,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,YET
177,313,ADVERSE,BACKGROUND,BRAINSTEM,CGE,CONCLUSION,LABEL,METHODS,NCI,RESULTS,UNIVARIATE
AFTER,DIAGNOSES,EEG,ENGEL,FDG,III,LABEL,METHODS,MRI,OBJECTIVE,OLE,PET,PURPOSE,RESULTS
039,100,CUMULATIVE,FDG,FUNCTIONAL,IMAGING,LABEL,MATERIALS,METHODS,MRI,NAA,OBJECTIVE,PET,PURPOSE,RESULTS,RPI
169,721,945,COPYRIGHT,DEX,GCS,LPS,LTD,MDD,PHA,TNF
169,BRCA1,GBM,GFP,KNOCKDOWN,REMBRANDT,SPERMIDINE
169,338,369,407,627,711,851,862,AVM,BACKGROUND,BASEL,DESPITE,FLORIDA,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,UNIVERSITY,WITHOUT
169,AUTOIMMUNE,CD8,CPG,DESPITE
19Q,19Q13,1P19Q,2HG,ATP,CAPICUA,CIC,EXPRESSION,HOG,LYASE,NON,ODG,R132H,R172K,R201W,REPRESSOR
20A,HYPOXIA,LNA,MALIGNANT,NKG2D,TARGETING,THREE
001,155,288,406,ARF,ATLAS,CHINESE,CPG,FINALLY,GEFITINIB,H3K9ME3,INDUCTION,INK4A,METHYLATOR,PHENOTYPE,R132H,RAS,RASG12V,REMBRANDT,THESE,USING
MRS
18F,BRAIN,FDG,MRI,PET,TCC
AFTER,MRI,PET
100,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,OBJECTIVE,REGARDLESS,RESULTS,RFS,SEVENTY,WHOLE
169,946,ADC,AIM,ANTICANCER,CAS,CONCLUSION,COPYRIGHT,FIFTY,INCREASED,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC
001,002,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FREEDOM,GROUP,INSTITUTE,LABEL,LDH,METHODS,OBJECTIVE,RESULTS,SCORING,SIX,SUM,TEN,THREE
006,008,036,044,169,177,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PITUITARY,RESULTS
169,AIM,ANTICANCER,BACKGROUND,CELLS,CONCLUSION,COPYRIGHT,GBM,GMB,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PAT,RESULTS
169,BACKGROUND,BMS,BRAIN,CONCLUSION,CTCAE,DL0,DL1,DL2,DL3,DLS,GRADE,IDENTIFIER,LABEL,MEDICAL,METHODS,NCI,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,TRIALSGOV,UNASSIGNED,UNIVERSITY
BRAIN,CNS,IPILIMUMAB,RATES,THERE,TREATMENT,WHOLE,WORLD
160,946,ADULT,CD133,EXOGENOUS,FAS,GAMMA,GSC,IL6,IL8,MEDIA,NPC,NSC,TGF,TRAIL,U87MG,USING,WHILE
NMDAR
140,945,956,ACTIVITIES,DIFFERENT,MUTATIONS,R132C,R132H,SEVERAL
AMONG,BMP,COCULTURED,ELISA,THEREFORE

169,ALTERED,BECAUSE,BIOLOGY,DEFECTIVE,MOLECULAR,SLC26,UNION,ZIP
HOWEVER,OVERALL
141,200
169,657,760,BACKGROUND,CBV,CONCLUSION,FOUNDATION,HOWEVER,LABEL,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
120,177,203,349,CHOROID,CPC,CPP,CSS,END,GTR,HISTOLOGY,OLDER,PATIENT,RESULTS
ENDONASAL
CSF,EEA,ENDOSCOPIC,HOWEVER,PREVENTIVE,THERE
LABEL,METHODS,OBJECTIVE,OTHER,RESULTS,THERE
029,047,CONVERSELY,III,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VARIOUS,WATER,WBT
BMI,CSF,DESPITE,METHODS,QUALITY,RESULTS,SIGNS
ENDOSCOPIC,HOWEVER,THREE,YET
947,CMV,LDH,OVERALL,RING1,SEL,SYTXV
169,ACADEMY,BIOLOGY,CHINA,CHINESE,COPYRIGHT,EXCITINGLY,INSTITUTE,LTD,PUBLISHED,SIMILARLY,SOCIETY,WHILE
CNS,DLBCL,MRI,PRIMARY,THERE,UNTIL
946
PITUITARY,SINCE
AIM,AKT,CONCLUSION,HSP,HSP27,HSP40,HSP60,HSP70,HSPSS,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,THERE
243,850,AIM,CONCLUSION,IGF,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,PITUITARY,RESULTS
ASPSCR1,METASTATIC
001,006,037,119,177,185,235,261,295,412,539,836,861,ADC,BACKGROUND,CONCLUSION,DWI,ENTROPY,FORTY,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,TEXTURE
417,BASED,IHC
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,STILL,SUNITINIB,TREATMENT
169,COPYRIGHT,EXPRESSION,FMR,HSC70,INC,TAKEN
ABCB1,MLN8237,VX680
LABEL,LANGERHANS,MOLECULAR,OBJECTIVE,PURPOSE,RAF,RESULTS,SUMMARY,V600E
EMA,EPITHELIAL,INI,MRI,PXA,SMA,SMARCB1,V600E
169,BRAIN,CLINICIANS,NEURO,PRESS,PUBLISHED,SOCIETY,SRS,UNIVERSITY
169,COPYRIGHT,FINALLY,SAS,THEIR
HOWEVER,MTT,PCR,RHO,ROCK1,TRANSWELL,WESTERN
160,300,405,854,967,EGGER,JANUARY,OPN,SIXTEEN
169,BACKGROUND,COPYRIGHT,INC,LABEL,LOWERED,METHODS,OTHER,RESULTS,SIXTY,WHOLE,YOUNG
AFTER
CONCLUSION,CSF,DISCUSSION,DUE,DWI,GROSS,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,SINCE
0CM,2CM,ADDITIONAL,APRIL,HOWEVER,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,TOTAL
013,PROTRACTED,TORONTO
029,ANXIETY,BACKGROUND,CONCLUSION,DEPRESSION,FORTY,HOWEVER,LABEL,MAY,METHODS,NETWORK,RESULTS,SCALE,USING
GIVEN,PROVIDING
DESPITE,MRI
CURRENTLY,GBM,UTILIZING
169,FAK,FEDERATION,HOWEVER,LTD,SEVERAL,SOCIETIES,WILEY
169,192,277,443,BIVARIATE,CALIFORNIA,FLORIDA,HYPOTHESIS,INC,INSURANCE,LABEL,LEVEL,MAJOR,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SOCIETY,THERE
169,AFTER,BACKGROUND,BBB,BICNU,CED,COMPARISON,CONCLUSION,CONVECTION,COPYRIGHT,DISSOLVING,E98FM,LABEL,METHODS,RESULTS,SINCE,THESE
169,BOC,CONVERSELY,COPYRIGHT,GCP,INC,PTCH1,SHH,SONIC
169,900,GSM,INC,LATIN,LHS,MANNEQUIN,MHZ,SAM,SAR,SAR10,WILEY
169,177,INC,TRANSIENT,UNDERGOING,WILEY
120,169,215,AAT,AMINO,BACKGROUND,COPYRIGHT,DU145,INC,LABEL,MB468,MDA,METHODS,PET,RESULTS,SIMILAR,SKOV3,THESE,U87
169,SOCIETY
ATLAS,BACKGROUND,CA9,CONCLUSION,COX,LABEL,MEIER,METHODS,MYC,PROTEIN,RESULTS
169,AGE,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,STUDIES,TURKU,UNIVERSITY,WILEY
169,BIOLOGY,BMI,FEDERATION,REDUCTION,THESE
169,APOPTOSIS,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,LABEL,METHODS,PDT,RESULTS,THESE,WHILE,WST
954,GBM,JAK,SINCE,STAT3
169,22Q,AMONG,CNS,COPYRIGHT,DESPITE,INC,INTENSIVE,MRT,RTPS1,SMARCB1
169,COPYRIGHT,FINALLY,PC4,THESE
BACKGROUND,CAT,CONCLUSION,FOXO3,KNOCKDOWN,LABEL,METHODS,PPARG,RED,RESULTS,ROS
118,155,19Q,1P19Q,200,250,574,641,738,917,EOR,GIIGS,HOWEVER,THERE
169,945,946,COPYRIGHT,CRYAB,GBM,HSPB5,INC,TNF
263,CENTRAL,CHINESE,CONCLUSION,DESPITE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,XIANGYANG
177,ABDURAHMAN,BETWEEN,CONCLUSION,COX,EDUCATION,JANUARY,LABEL,LOG,LOW,METHODS,OBJECTIVE,PFS,PROLONGED,PURPOSE,RADIATION,RESULTS,UNIVARIATE,YURTSALAN
001,016,150,178,200MG,2GY,CONCLUSION,GBM,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMZ
EGF,ERBB1,FTS,NUCLEOLIN,PREVIOUSLY,RAS,SALIRASIB,THESE,U87
169,3MONTHS,6MONTHS,ABSTRACTS,AUTHORS,CAB,CONSORT,COPYRIGHT,DIFFERENT,ITEMS,KNOWLEDGE,LIBRARY,MEDLINE,PREFERRED,PUBLISHED,REPORTING,REVIEWS,ROUTINE,SYSTEMATIC,THERE,WEB
001,039,169,215,550,COPYRIGHT,FERRATA,FOUNDATION,HODGKIN,THESE
169,201,231,COPYRIGHT,DIAGNOSIS,IMAGING,MRI,NON,PUBLISHED,SAS
ANATOMICAL,EXTENSIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,HCC,LTD
BASED,BIOMARKERS,CRC,USING
169,BETWEEN,COPYRIGHT,GROSS,HUASHAN,IGF,JANUARY,MRI,PRL,SCATTERED,THESE
171,CONCLUSION,GBM,LABEL,METHODS,OBJECTIVE,RESULTS,SCHOLAR
100,114,DELAYED,DENSELY,HOWEVER,LOCAL,PEG,PEGYLATED,PTX
215,363,451,659,666,FLAIR,GRE,III,INCIDENTAL,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE,TSE
009,591,AMONG,ANALYZING,LABEL,METHODS,OBJECTIVE,OVERALL,POPULATION,RESULTS,RRS
001,006,1306C,1575G,LABEL,METHODS,MMP,OBJECTIVE,RESULTS,THERE,TIMP2,TIMPS
100,974,AUC,CNS,CSF,FDG,PET,ROC,THESE
AFFYMETRIX,EFNA1,EFNA3,EFNA4,EFNB1,EPH,EPHA2,EPHA8,EPHB4,FUNCTIONAL,SHH,THESE,YET
622,FUNCTIONAL,KNOCKDOWN,MALIGNANT,MICRORNAS,TARGETING
AFTER,BMJ,GROUP,LTD,PUBLISHING,WOMEN
BMJ,GROUP,LTD,PUBLISHING,SUBSEQUENT
001,128,169,945,946,ACTUARIAL,ADULT,AGE,BIOLOGICAL,CONCLUSION,COPYRIGHT,GBM,GTR,INC,KARNOFSKY,LABEL,MATERIALS,METHODS,NTR,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,TMZ,YOUNGER
160,187,AGE,PGR,SIMILARLY,TNM
108,MUTATIONS,ONCOPANEL,R132H
945,GLUTAMATE,MOLECULAR,THREE,UNDER
APOPTOSIS,AREAS,BACKGROUND,CASPASE,COVERED,HOWEVER,LABEL,METHODS,OPINION,SINCE,THEREFORE,VARIETY
109,113,148,174,AKT,AMONG,BACKGROUND,EPHA3,HGG,HOWEVER,LABEL,MAPPING,METHODS,OTHER,RESULTS,RPS6KC1,SOMATIC
100,945,956,ANNEXIN,BACKGROUND,BCL,CA2,CONCLUSION,FINALLY,GBM,LABEL,LN229,METHODS,OUABAIN,RESULTS,TMZ,VAD,WESTERN
AMONG,BACKGROUND,CONCLUSION,GAMMA,GROSSLY,KNIFE,KNOSP,LABEL,MEIER,METHODS,OBJECTIVE,RATES,RECURRENT,RESULTS,SEVERAL,THERE

AUTOPHAGY,CER,COMBINING,GBM,REMARKABLY,SKI,SPH,TMZ
169,AFTER,BASED,COPYRIGHT,FINALLY,GTR,LABEL,MARCH,METHODS,MRI,OBJECTIVE,OCTOBER,RESULTS
BECAUSE,BESIDES,BRAIN,DIRICHLET,HOWEVER,MDP,MRF
DURAL,ESOPHAGEAL,THERE
175,189,776,856,AFTER,IGF,PRL,SERUM
100,AMONG,BETWEEN,CONCLUSION,GLASGOW,KARNOFSKY,LABEL,LSO,METHODS,OBJECTIVE,RESULTS,THEIR,THERE
001,137,RESULTS,SURVIVORS,THESE
000,100,BECAUSE,INHIBITION,METHODS,REGARDING,THERE
PRE
BARTHEL,BLOCK,BOX,FORTY,FURTHER,INDEX,LABEL,METHODS,MEYER,OBJECTIVE,RESULTS,VIRTUAL
BACKGROUND,CONCLUSION,CONTEXT,ICD,LABEL,METHODS
169,GBM,SOCIETY,THESE
MIB,MITOSES,PAPILLARY,WORLD
CENTRAL,CEREBELLAR,NERVOUS
292,338,AFTER,BACKGROUND,CLUSTER,CONTEXT,CROSS,IGF,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,THESE
CSB,FINALLY
167,ANXIETY,FCS,HOWEVER,IL1,IL1R2,LABEL,METHODS,NFKB2,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,USING,VARIATIONS
178,HOWEVER,MHA
169,239,DROSOPHILA,HOWEVER,INC,NOTCH,PRONEURAL
ALA,BACKGROUND,GERMANY,GLIOLAN,III,LABEL,METHODS,MRI,PNETS,RECURSIVE,RESULTS,RPA,THESE,WEDEL
CPU,DEFORMABLE,PATCH,RATIO,TRE
001,100,129,169,214,BACKGROUND,BASEL,BROCA,DCS,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS
ABOUT,HOWEVER,OVERALL
169,BACKGROUND,BASEL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,BACKGROUND,BASEL,GAMMA,KNIFE,LABEL,LEKSELL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,TEN,USING
100,120,395,541,573,BACKGROUND,CNS,CONCLUSION,FIRST,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SIXTY,TKI
ACF,MRI,PXA,THERE
945,GBM,IL13R

BOLUS,HOWEVER,MRI,PERFUSION
177,DBS,DISEASE,III,MER,MRI,PARKINSON,SCALE,STN,THEIR,THERE,UNIFIED
ABCA2,ABCA3,ABCB4,ABCC1,ABCC3,ABCC5,ABCG1,ABCG2,AHR,ATP,CRT,HOWEVER,LS180,MVP,SLC29A1,SLC29A2,THESE
169,DESPITE,HARNESSING,HOWEVER,NEURO,NEWER,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,174,200NM,COPYRIGHT,INC,LTD,MATERIALIA,PUBLISHED,THESE
192,ACCORDING,ALB,AMONG,CARDIAC,CONCLUSION,CYTOPENIAS,GLO,HLH,INCIDENCES,LABEL,METHODS,OBJECTIVE,PERSISTENT,PLT,RESULTS,WBC
520,609,BACKGROUND,DCS,GIVEN,LABEL,METHODS,RESTING,RESULTS
AV100,BACKGROUND,GAMMA,KNIFE,LABEL,LEKSELL,MATERIALS,METHODS,PERFEXION,RESULTS,THESE
143,BACKGROUND,CSF,FAVORABLE,FINALLY,GROSS,LABEL,METHODS,PERMANENT,RADICAL,RESULTS,SIXTY
ADM,HOWEVER,OSM,THESE
169,COMBINING,COPYRIGHT,FUNCTIONAL,INC
169,ACIDS,MIZ,NUCLEIC,POK,PRESS,PUBLISHED,SHORT,UNIVERSITY,ZNF509L
169,COPYRIGHT,HODGKIN,SAS,THERE,TREATMENT
BACKGROUND,LABEL,METHODS,PEG,RESULTS
169,BACKGROUND,COPYRIGHT,GYE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,180,808,AFFAIRS,CENTRAL,COLLEGE,CONCLUSION,DEPARTMENT,IIB,LABEL,METHODS,NETWORK,OBJECTIVE,OPTIMIZING,OVERUSE,PET,PURPOSE,RADIOLOGY,RECEIPT,RESULTS,SOCIETY
169,945,COPYRIGHT,HBMEC,LTD,MIP
118,473,AKT,ANNEXIN,GBM,MMP
169,945,946,ALZHEIMER,CNS,COPYRIGHT,ERS,INC,PARKINSON,SCI
001,002,008,093,111,165,169,24H,731,761,CONCLUSION,COPYRIGHT,GLASGOW,ICP,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,THERE
10Q,10Q25,126,184,19Q,BACKGROUND,CNA,LABEL,RESULTS,SEVENTY
001,346,368,ARG194TRP,ARG280HIS,ARG399GLN,CHINESE,GENOTYPES,XRCC1
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NEN,PNS,SPECIAL
IMPORTANCE,JANUARY,LABEL,MARCH,MEANINGFUL,METHODS,OBJECTIVE,RELEVANCE,RESULTS,THERAPIES
169,945,946,CONVERSELY,FINALLY,GBM,HIF,III,SEVERAL,THESE,TUBB3,UTR
AMP,LIVER,SIK
BACKGROUND,BURKITT,LABEL,METHODS,UNDER
169,CHRONIC,COPYRIGHT,HOWEVER,INC,THESE,TRANSCRIPT
00001,ADEQUATELY,AFTER,APRIL,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,GBM,GLIOMAS,GRADE,HGG,HOWEVER,ISSUE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PFS,RANDOMISED,RESULTS,SELECTION,SEVERAL,SIMILAR,TREATMENT,WORLD
001,104,169,312,315,375,997,CENTRAL,CRC,JANUARY,RECORDS,SEPTEMBER,SIR,SMR,SOUTH,USA,VITAL
946,954,AKT,CNS,EMT,EPITHELIAL,FAK,HOWEVER,PREVIOUSLY,THEREFORE,U87
169,COPYRIGHT,MRI,SINCE,SUBSEQUENT
AKT,HOWEVER,MICROARRAY,NOTABLY,THEREFORE,USING
FINALLY,SHH,SONIC,THEREFORE,THESE,TREATMENT
945,946,CD133,CD49F,CK2,GBM,INHIBITION,INITIAL,NANOG,U87
GATHERING,TAILORING
169,CLEAR,COPYRIGHT,LTD,RIGHT
169,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,PRIOR,PUBLISHED,RESULTS,SAS
169,COPYRIGHT,DESPITE,ISSUE,OXYGENATED,SPECIAL,THERE,THESE
001,002,120,160,177,BACKGROUND,CONCLUSION,EASTERN,GROUP,III,LABEL,METHODS,RESULTS,SCORING,SIX,THREE,WBI
169,COPYRIGHT,GBM,INC,LABEL,SGT,THESE,TMZ,U87,UNASSIGNED,UNLABELLED,USING
BMJ,GROUP,LTD,PUBLISHING
470,570,DMN,FRESH,FURTHER,HOWEVER,RESULTING,RESULTS,STAINED
037,043,155,169,BACKGROUND,IDENTIFIER,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,TREATMENT,UNASSIGNED,UNIVERSITY
117,132,136,138,169,COPYRIGHT,DIVERSE,HOUSTON,INFECTIONS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,TEXAS,THESE,UNIVERSITY
169,5MM,646,BASED,CONCLUSION,COPYRIGHT,IRELAND,KINGDOM,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THOSE
003,013,017,039,126,924,BACKGROUND,CONCLUSION,COX,HOWEVER,III,LABEL,LVI,MEIER,METHODS,PCI,RESULTS,TNM
AFTER,BACKGROUND,EVERY,LABEL,METHODS,REMOVAL,RESULTS
009,HOWEVER,IHC,LABEL,METHODS,OBJECTIVE,RESULTS
GLIOMAS,PDZ,PROTEIN,PTPRZ
INFLUENCE,LNCAP
AVASTIN,CXCR4,EPITOPE,GBM,MIMETIC,PEM,POL5551,PROTEIN,PVN,THESE,TIC
169,3MM,AGE,COPYRIGHT,FOLLOWING,GKS,JANUARY,LABEL,METHODS,NEUROLOGIC,OBJECTIVE,RESULTS,SEPTEMBER
CENTRAL,CNS,REPORTING
BEIJING,DEPARTMENT,OLFACTORY,TIANTAN
02402,07850,106,935,BACKGROUND,EPITHELIAL,EXPRESSION,GDS1815,GDS1962,GEO,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,OMNIBUS,RESULTS
100,ACROMEGALY,CAVERNOUS,GRADE,KNOSP,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SIXTEEN,TOTAL,TSH
140,BMS,CFL,GBM,LIM,LIMK1,LIMK2,MALIGNANT,USING
946,ABC,ABCG2,AMONG,ATP,FDA,SINCE
GLY63,LYS68,THR58,THR71
ARL,BBB,CONCLUSION,LABEL,METHODS,OBJECTIVE,OWING,PURPOSE,RESULTS,TFR,THERE,TRANSWELL
001,009,012,113,132,160,177,448,543,857,936,KPS,MEIER,PCR
169,IMPAIRMENT,MYOMETRIAL,PRESS,PUBLISHED,THESE,UNIVERSITY
029,3RD,429,AUTHORS,BACKGROUND,BASED,CENTRAL,COLLECTION,CONTROLLED,FISCHER,HOWEVER,INSTITUTE,ISSUE,LABEL,MARCH,MAY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PAEDIATRIC,RADICAL,RANDOMISED,RCT,RESULTS,SELECTION,SINCE,SOCIETY,THERE,TRIAL
3X4X4,ACCORDING,AWARENESS,CHONDROMA,CONCLUSION,LABEL,METHODS,OUTLINE,UNASSIGNED
ACS,FINALLY,GBM,KARABEBER,RAMAN
AKT,DIAGNOSIS,KIT,LABEL,MALIGNANT,OBJECTIVE,PURPOSE,RAS,RESULTS,SUMMARY,THEIR
180,250,BAYES,COMPONENT,PRINCIPAL
BRAIN,INO
113,ADH,PEG,THERE,WHILE
169,CONSISTENT,DROSOPHILA,GBM,HOWEVER,JUN,PRESS,STUDIES,THESE,WNT
181,BMJ,BROMIDE,CHOKEBERRY,DRAQ7,EXTENDING,GROUP,LABEL,LIMITED,METHODS,MTT,OBJECTIVE,PANCREATIC,PUBLISHED,PUBLISHING,RESULTS,TUNEL
106,123,182,215,416,947,AGE,KCNK9,MKRN3,PATHWAY,STUDIES,WDR25
CONCLUSION,FET,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
006,027,132,160,309,355,356,372,394,427,428,437,469,513,524,526,537,562,640,698,743,804,892,ASIAN,BASED,CAUCASIAN,CHI,CIS,EGGER,EPIGENETIC,GBM,HOWEVER,PFS
REGUCALCIN
DIFFUSE,DIPGS,HGG,THESE
125,169,EGF,INJECTION,L1CAM,MAB,RESULTS,RET,SIMILAR
021,045,102,151,169,183,GEORG,MRI,PRL,STUTTGART,WHETHER
945,ALPHA,DESPITE,GAUCHER,HOWEVER,PARKINSON,SYN,SYNUCLEIN
007,033,100,AMONG,BACKGROUND,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
007,012,015,016,028,069,865,971,980,BACKGROUND,EDMONDSON,EVALUATION,HCC,HOWEVER,INCREASED,LABEL,METHODS,OBJECTIVE,OVERALL,PDI,PROTEIN,RESULTS,SOLID,STEINER,TTP,UNIVARIATE
026,046,169,HGG,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,RESULTS,SEVEN
CNS,MALIGNANT,ROS,SINCE,THEREBY
100,CD133,CURRENT,HOWEVER,PCR
BECAUSE,FINALLY,LABEL,OPINION,RADIATION,STATEMENT,UNASSIGNED
169,AUTHORS,BRAIN,DESPITE,INC,MAPPING,PUBLISHED,THERE,THESE,WILEY
169,GBM,HOWEVER,LDA,MET,PHA665752,SU11274,THREE,VCH,WILEY
336,407,575,715,918,ARG194TRP,ASIAN,GLIOMAS,HOWEVER,XRCC1
100,117,119,137,146,165,802,BACKGROUND,BETWEEN,DIFFUSE,DLBCL,GIL,HNL,HODGKIN,III,IPI,LABEL,MARCH,MATERIALS,METHODS,NHL,OCTOBER,RESULTS
110,BRAIN,CELLS,CHEMOKINE,CXCR4,CXCR7,EXPRESSION,HOWEVER,MCP,PCR,SDF
001,282,292,419,474,694,BACKGROUND,CAUCASIANS,CHINA,KNOWLEDGE,LABEL,MATERIALS,MAY,METHODS,RESULTS,RTEL1,STATA,WANFANG,WEIPU
160,BACKGROUND,CIS,CRT,LABEL,METHODS,MONITOR,MUS,OAR,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
169,BASEL,BRAIN,FINALLY,KEY
128,276,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE
169,232,234,BASEL,CHARCOT,CUSHING,DURET,HENRI,HORSLEY,USING,VULPIAN
5XFAD,ALZHEIMER,ASIDE,FMEC1,PRESENTLY
002,169,778,CHANGES,DUTCH,GHD,HBA1C,HORMONE,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,SOCIETY,TREATMENT
156,169,207,BMI,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SIADH,SIXTY,SOCIETY,TSS
001,003,028,032,CHINA,CHINESE,CUSHING,CUSHINGQOL,HAN,PROVINCIAL,RESULTS,THEREFORE
178,200,800,ADC,ANOTHER,ASSET,AXIAL,DIT,DTI,EPI,FDA,FOV,IMAGING,JANUARY,MARCH,MRI,ROI,SIMILAR,THERE,WMT
CONCLUSION,CPA,EXCLUDING,IAC,LABEL,METHODS,MRI,OBJECTIVE,OPTIMAL,OUTCOME,RESULTS,SETTING,THERE
001,039,107,ADDISON,BACKGROUND,BELIEFS,CONCLUSION,CONTEXT,CUSHING,ILLNESS,LABEL,MEDICINES,METHODS,OBJECTIVE,PERCEPTION,RESULTS,REVISED,THESE
AMONG,CONCLUSION,DDS,IDL,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,SRS,USING
11C,18F,BECAUSE,DESPITE,FDG,MALIGNANT,MRI,PET
EXAMINING,FURTHER,GLUD1,GLUD2,R132H,SOMATIC,STRIKINGLY,THESE,USING
169,COPYRIGHT,IRELAND,LTD,NAVIGATED
RAG,THESE
169,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,INTENSIVE,LABEL,METHODS,MRI,RESULTS,ROYAL,TREATMENT,ZEALAND
169,219,BISEQ,CPG,DNMT1,FUNCTIONAL,LABEL,METHODS,MUT,OBJECTIVE,PURPOSE,RESULTS
000,001,002,007,039,169,174,295,832,ABI,AFFYMETRIX,AGILENT,ARRAY,AUTHORS,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,INTEGRATED,IRELAND,LABEL,LOWER,LTD,MAPPING,MATERIALS,METHODS,NORTH,NSCLC,PUBLISHED,RESULTS,ROC,SNP,STY,UNIVERSITY
HOWEVER
000,080,084,133,167,201,235,277,311,320,386,515,672,BLOOD,COX,DEPRESSION,HOWEVER,STUDENT
GBM,GEP
001,005,008,102,169,231,376,607,CONCLUSION,COPYRIGHT,GBM,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SVZ,VENTRICLE
169,COPYRIGHT,INC,STAT3
001,11B,169,AFFYMETRIX,BACKGROUND,CONCLUSION,COPYRIGHT,CXCL1,FORTY,IGFBP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SAG,SENESCENCE,SIX,THERE,TNFSF
007,169,2003_VS,2005_VS,2006_VS,2012_VS,428,64_VS,BESIDES,COX,EINDHOVEN,HRMALE_VS,HROTHER_VS,NSCLC,_2001,_2010,_FEMALE
169,CLEARLY,COPYRIGHT,INC
169,COPYRIGHT,GBM,INC,ONGOING,ULTIMATELY
169,COPYRIGHT,INC,RESULTS
169,COPYRIGHT,CURRENT,INC,NPC,SVZ
METRICS
169,COPYRIGHT,DESPITE,DIPGS,GIVEN,HGG,INC,RAS,THERE,THESE
3RD,400,AREAS,CARDIAC,DIGITAL,EYEBROW,HANDS,IMPORTANT,INVISIBLE,LIP,ORGAN,OUTSIDE,UPPER,VITAMIN
169,ALZHEIMER,COPYRIGHT,GIVEN,LTD,PARKINSON
BIMODAL,DEPARTMENT,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RADIATION,RESULTS,ROCHESTER,SEPTEMBER
152,169,252,COPYRIGHT,GBM,IRELAND,LTD,MEANWHILE,RESTORING,TAKEN
169,201,231,COPYRIGHT,PUBLISHED,SAS
100NM,12H,169,200NG,20MIN,24H,57KDA,90KDA,COPYRIGHT,III,LTD,PCR,RU486,STAT6,THERE,WESTERN
169,AKT,COPYRIGHT,FURTHER,GOLGI,HOWEVER,IRELAND,LTD,PROTEIN,TAKEN
177,198,215,480,565,CNS,IRANIAN,JCV,PCR,WBC
169,COPYRIGHT,IRELAND,LTD
001,BRAIN,EMT,FURTHER,H1915,HOWEVER,METASTASIS,NSCLC,PCR,THEREFORE
004,155,297,526,CNS,III,IOL,PCNSL,PFS,SG1
001,005,169,193,197,247,249,708,ACADEMY,CLASS,DBS,DISEASE,FORTY,LABEL,METHODS,MOTOR,NEUROLOGY,NMS,OBJECTIVE,PARKINSON,RESULTS,SCALE,SECONDARY,STN,THERE,UNIFIED
177,384,AMONG,FIRST,GROUP,HOWEVER,NON,NSCLC
169,CLT,COPYRIGHT,COX,FACTORS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PROPENSITY,PURPOSE,RESULTS,ULTIMATELY
104,169,200,AMONG,CONCLUSION,COPYRIGHT,CUSHING,EIGHT,INC,INCREASED,LABEL,MATERIALS,METHODS,NFA,OBJECTIVE,PFS,PURPOSE,RESULTS,SCA,SEPTEMBER,SRS
JOURNAL
FINALLY,MKI,PAZOPANIB,REGARDLESS,SORAFENIB,STAT3,THEREFORE
CPEB1,HOWEVER,NOTCH,RIBONOMICS,SIRT1,THESE
DESPITE,MALIGNANT,MPNST,THESE
001,104,109,171,177,210,467,875,918,989,DESPITE,LABEL,MEP,METHODS,OBJECTIVE,PERMANENT,RESULTS,SEP
001,409,947,BACKGROUND,CD3,CD4,CD8,DCS,HGG,IFN,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,PFS,RESULTS
169,COPYRIGHT,INC,MUTATIONS
001,003,050,105,126,149,169,176,281,286,287,291,BACKGROUND,CEA,COG,COGNITIVE,CRC,DEFICIT,FATIGUE,GDS,III,LABEL,MEDICAL,METHODS,PRESS,PRIMARY,PUBLISHED,QOL,RESULTS,SOCIETY,TEN,TRIAL,UNIVERSITY,USING,WOMEN
169,ALONGSIDE,CNS,OBESITY,REGARDLESS,SOCIETY,THYROID,WHETHER,WHILE
241,AFRICAN,BACKGROUND,BRAIN,CHILDHOOD,COMPLEX,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SOUTH,STATE,THERE,TYGERBERG,WESTERN,WHILE
039,042,169,ADDITIONAL,BPC,COPYRIGHT,GBM,III,INC,ITT,KARNOFSKY,MEIER,NOVOTTF,THERAPY
120,169,COMPLIANCE,COPYRIGHT,FDA,GBM,III,INC,NOVOTTF,PUBLISHED,RECURRENT,SEVEN,THERAPY
169,457,ADVERSE,COPYRIGHT,DATASET,FIRST,GBM,III,INC,KARNOFSKY,KPS,MEIER,NOVOTTF,OCTOBER,OVERALL,PATIENT,PRIDE,PUBLISHED,RECURRENT,RESULTS,THERAPY
005,GBM,GSC,THESE,U87
169,BACKGROUND,INC,INCREASING,LABEL,LGG,MARCH,MAXIMUM,METHODS,NEURO,PITTSBURGH,PRE,PROCEDURE,PROGRAM,RESULTS,WILEY
HOWEVER,IRE,NDRG1,REMARKABLY,THEREFORE
138,ACCORDING,ANNEXIN,FCL,FICUS,GBM,INDUCTION,THEREFORE,TMZ,TUNEL,WST
177,435,585,633,638,HOWEVER,INTENSITY,LABEL,MATERIALS,METHODS,MFO,OBJECTIVE,PURPOSE,RESULTS,SFO,SIMILAR,THERE
169,494,AMONG,BACKGROUND,CNS,CONCLUSION,CONVERSELY,CSF,DESPITE,INC,LABEL,MEDICAL,METHODS,PROCEDURE,RESULTS,ROUTINE,TORONTO,WHILE,WILEY
001,012,100,BACKGROUND,CARCINOID,EVERY,LABEL,METHODS,RESULTS
169,BRAIN,DESPITE,INC,PEDIATRIC,WILEY
100,290,956,GBM,SNB75,THESE
ANGIO,FAILURE,HOWEVER,MRI,PERSISTENT,PITUITARY,PTA,THEREFORE
LABORATORY,MEDICAL,PATIENT,PITUITARY,THESE,THREE,WORLD
AKT,CUSP9
029,112,128,CHINESE,FURTHER,GBM,HOWEVER,PFS,THESE
ADDISON,CONCLUSION,CONTEXT,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,SCN,SLEEP,VFD
ANOTHER,FINALLY,III,INTRIGUING,LABEL,MRI,OBJECTIVE,PEPTIDE,PURPOSE,RESULTS,SUMMARY
GBM,LAMP1,LMP,RED,TMZ
DESPITE,KINOMIC
CONVERSELY,MPP,PARK7,PARKINSON,TAKEN,WHILE
IMPRINTING,RAD51,SOMATIC
169,946,ADULT,ATL,BECAUSE,BRAIN,COPYRIGHT,EXPRESSION,FINALLY,GSK,HBZ,HOWEVER,IMPORTANCE,INFECTION,LABEL,OBJECTIVE,PBMCS,SOCIETY,THESE,UNLABELLED
169,293,ANNEXIN,CH2,CH3,CL2,HEK,NMR,NO2,OTF,SNU,VCH,VIS,WILEY
009,019,020,022,037,108,197,779,AMONG,NSCLC
FURTHER,HISTOLOGY,MENDELIAN,SEVERAL,THESE
188RE,99MTC,BASIC,CUBAN,FORTY,INFOMED,OBJECTIVE,OBTAINING,RESULTS,STUDIES
BECAUSE,ICA,RADIATION,SPECIAL
1ST,947,949,CD2,CD3,CNS,EPSTEIN,NKTCL,PRIMARY
100,100MM,102,104,106,109,111,120,140,160,177,271,BASED,GAMMA,GAMMAPLAN,KNIFE,LIGHTSPEED,PERFEXION,TMR,VCT
2MM,3MM,AGILITY,DYK,MLC,RAYSTATION,TPS,TREATMENT,VAN
287,4GY,CRT,CSI,CURRENTLY,DVH,HOWEVER,OPTIMAL,OVERALL,USING
947,GAMMA,PIERMATTEI,SOLID,USING,WATER
055,BEAMNRC,CARLO,DOSXYZNRC,FIRST,GAFCHROMIC,MEV,MONTE,RW3
740,788,863,869,884,888,912,958,971,ATLAS,FINAL,THESE,VALIDATION
253,320,355,425,BIRTH,BLOOMBERG,BMI,COPENHAGEN,GOVERNMENT,GREATER,HOPKINS,JOHNS,PRESS,PUBLISHED,RECORDS,THESE,UNIVERSITY
ALECTINIB,ALK,CH5424802,H2228,LABEL,METHODS,NCI,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
02425,03386,121,159,282,397,ADC,C10,C90,HISTOGRAM,IDH
RIGID,THERE
121,169,500,817,827,AMIGO,IMAGE,OPERATING,SOCIETY
DNETS
100,219,AIM,ENGEL,JADAD,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,REVIEWS,SCALE,SCHOLAR,SCIENCE,SMALL,SYSTEMATIC,WEB
128,350,ASHKENAZI,EASTERN,GLACIAL,KYR,MAXIMUM,MODELLING,SNP
EPIGENETIC,HDACS,HISTONE
33A,GBM,GIC,NOTCH,PDE8A,PKA,THESE,UVRAG
006,007,018,020,046,100,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,FREEDOM,INSTITUTE,KARNOFSKY,KPS,LABEL,LDH,METHODS,OBJECTIVE,RESULTS,SCORE,SRS,VARIABLES
169,1P19Q,231,233,ANAPLASTIC,COPYRIGHT,GLIOMAS,INTENSITY,PUBLISHED,SAS,STUPP,THEIR,THERE
191,CULLIN1,EXPRESSION,MMP
160,181,945,CONVERSELY,FOLLOWING,HIF,HOWEVER,MVD,SHG44,THESE
100,BETWEEN,LFS,PENETRANCE,TRP53
169,CONVERSELY,COPYRIGHT,CXCR1,CXCR2,FINALLY,GSC,HOWEVER,INC,NTS,NTSR1,SR48692,STAT3,TAKEN
100,160,203,290,DETECTION,GBM,H3F3A,PEDIATRIC,THEREFORE,THESE
100,143,160,297,3K27M,HGA,STUDIES,THERE,THESE
169,DROSOPHILA,IGF,INSULIN,LOCAL,LTD,WILEY
124,FOLLOWING,GBM,HSV,INSTEAD,ONCOLYTIC,THESE,UTR
005,215,221,242,256,AAO,AGE,AGGREGATE,ALZHEIMER,BECAUSE,CONSORTIUM,CR1,DISEASE,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,SETTING,WHILE
160,216,CEREBELLAR,EIGHT,GBM,HOWEVER,KARNOFSKY,KPS
AFTER,AWAKE,FIRST
100,154,AFTER,ANESTHESIA,AWS,ECG,FOLLOWING,FURTHER,INTLOCK,ITL,JAPAN,LEKSELL,MACINTOSH,SEVERAL,TOKYO
1970S,BMJ,GROUP,HOWEVER,JAKOB,LTD,OTHER,PCNSL,PUBLISHING
100,TUJ
ABCB1,ABCB4,MDR
128,172,204,AEG,ASTROCYTE,LOW,M059K,MALIGNANT,PCR,U87,WESTERN
188,27A,MCPH1,USING,UTR
AKT,CSF,HOWEVER,THESE
HOWEVER,WHOLE
169,221,AGE,COPYRIGHT,END,FORTY,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PALLIATIVE,POISSON,PURPOSE,RATES,RECEIPT,RESULTS
169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBS,PUBLISHED,PURPOSE,RESULTS,TEN
169,201,231,COPYRIGHT,EARLY,MRI,PUBLISHED,SAS,TODAY
DESPITE,FOLLOWING,LABEL,MRI,OPINION,PRECISION,REGARDLESS,STATEMENT,UNASSIGNED
AFTER,HOWEVER,OTHER,SCIENTIFIC,STAGE,THERAPY
169,AFTER,COPYRIGHT,GRAVE,IRELAND,LTD,THYROID,TSH
002,004,010,037,102,128,129,165,177,CONCLUSION,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,TESLA
006,136,169,186,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CPE,INC,LABEL,MATERIALS,MEIER,METHODS,RESULTS,SRS
100,169,177,COPYRIGHT,CSI,EXCLUSIVE,FIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,V95
001,004,140,144,165,169,ACTUARIAL,COPYRIGHT,CUSHING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS,THERE
169,DESPITE,EXPRESSION,MUTATIONS
051,169,177,AFTER,CNR,COPYRIGHT,CTV,CURRENTLY,FLAIR,GTV,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,SNR,SOCIETY,THESE
001,169,190,389,HOPKINS,INC,MEDLINE,PROGNOSIS,PUBLISHED,SRS,THREE
001,003,008,132,169,BACKGROUND,BECAUSE,CONCLUSION,LABEL,MEDICAL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,SOCIETY,TRIAL,UNIVERSITY
ALTOGETHER,MNK
160,177,3GY,9GY,AAA,BACKGROUND,CONCERNING,CTV,D99,DVH,LABEL,METHODS,PTV,RESULTS,SABRT
GBM,HOWEVER,ROMO1,ROS,THEREFORE
003,007,009,160,212,225,250,336,413,431,685,784,812,848,977,987,997,ADULT,GBM
169,ALDH1,CD133,COPYRIGHT,CSC,FINALLY,GBM,INC,NOTCH,STAT3,THESE,TRANSIENT,TRMP7,TRPM7
169,471,BRZEG,COPYRIGHT,JADWIGA,LABEL,LESIONS,RESULTS,SIGNS,SILESIA,THOSE
169,BIOMARKERS,CHILDHOOD,EPIDEMIOL
128,CERTV,EOR,EVALUATION,FLAIR,GBM,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,RTV,SCALE
163,CSF,HOPKINS,JOHNS,LABEL,METHODS,OBJECTIVE,PEG,RESULTS,THERE
10Q,19Q,19Q13,ERCC1,EXOME,FURTHER,IDH,OTHER,RAS,WORLD
169,233,946,ALZHEIMER,HOWEVER,OGA,OGT,TAU,THEREFORE
169,AFTER,ANTICANCER,BACKGROUND,COPYRIGHT,DISCUSSION,INSTITUTE,LABEL,METHODS,PML,WHILE
001,045,141,160,AFTER,DBC,FREEDOM,HOWEVER,LMD,LOCAL,MEIER,SRS
054,104,111,160,170,185,946,CALIFORNIA,CNS,ELEVATION,FRANCISCO,IQR,PFS,SAN,THREE,UNIVERSITY,WBI,WVI,XRT
142,169,18F,234,78GBQ,956,963,COPYRIGHT,ICR,LTD,PET,SEVERAL,SPRAGUE,THESE,VACHT
169,CAD,COPYRIGHT,IGS,SEVERAL,SOLUTIONS,THESE
013,023,037,057,169,177,945,AMT,CONCLUSION,COX,III,IMAGING,INC,INCREASED,LABEL,LOW,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,SUV,THESE,UNLABELLED,WOMEN,WORLD
236,HSP75,HSP90,KARNOFSKY,KPS,THESE,TRAP1,WORLD
ADC,ADCMEAN,EIGHT,LABEL,MAXIMUM,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN,THERE
150,154,177,BACKGROUND,CONCLUSION,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,SCREW,SOLID,SUMMARY,THERE
BRAIN,COGNITIVE,IMPORTANT,LABEL,NETWORK,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,WIDESPREAD
GBM,WHILE
BECAUSE,CURRENT,EGF,GBM,III,PHASE
963,CARLO,EUD,LABEL,METHODS,MONTE,NTCPS,OAR,OBJECTIVE,PURPOSE,RESULTS,TCP,THESE
945,946,CURRENTLY,INTENSITY,LABEL,METHODS,NTCPS,OBJECTIVE,PURPOSE,RBE,RESULTS,THESE,UNDER
CTV,ECLIPSE,GIVEN,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYSTEMS,THREE
169,19Q13,CNS,EMBRYONAL,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
169,DESPITE,GBM,HOWEVER,PRESS,TRAIL
CCM,CHINESE,PCR
169,GSH,HMOX1,INDUCTION,INHIBITORS,LABEL,ROS,TSC,UNLABELLED,USING
CD133,CNS,CONVERSELY,EXPRESSION,GBM,LINEAGE,NG2,OLIG1,OLIG2,PDX,PROM1,R132H,SGZ,SVZ,THESE,USING
127,169,AIM,AIP,LABEL,LEUKOCYTE,METABOLISM,METHODS,NM_003977,OBJECTIVE,OCDEM,RESULTS,SOCIETY,THESE,THOSE,UNIVERSITY
169,DIFFUSION,GBM,IDH,MRI,NEWER,PATIENT,PHYSICS
AFTER,CENTRAL,CNS,CONCLUSION,DORFMAN,LABEL,LIBRARY,METHODS,OBJECTIVE,RDD,RESECTION,RESULTS,ROSAI
PET,PROLINE,TOMOGRAPHY,TRANS
DESPITE,MULTIPOINT
001,004,027,044,100,160,644,807,COX,KARNOFSKY,MRI,PET,PFS
BKGRMAX,CONCLUSION,DEFINITIVE,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SEVERAL,SUVLMAX
BLOOD,BTB,ECS,HOWEVER,KRUPPEL,MICRORNAS
169,231,233,COPYRIGHT,PUBLISHED,SAS,THEIR
160,ACVR1,CPG,FGFR1,H3F3A,MEANWHILE,MYB,MYBL1,NTRK1,NTRK2,NTRK3,PFA,PFB,TKD
956,CD206,MEIER,MRI,OVERALL,PFS
IMAGING,U87
169,VCH,WILEY
004,ASIDE,CNS,CURRENTLY,DISEASE,NOTCH,NSC,PARKINSON,REGIONALLY,SVZ,THESE,WHOLE
001,005,160,745,804,848,912,GLIOMAS,SEVEN,THESE
160,945,AMP,HOWEVER,RAS,RCC
100,160,AFTER,EARLY,FAVOURABLE,HDC,HIT97,III,MRI,PFS,PNETS,RESPONDERS,THERE,TREATMENT
CBDCA,CTS,FURTHER,HOWEVER,INITIAL,MRI,THEREFORE
100,BACKGROUND,CONCLUSION,LABEL,METHODS,RATES,RESULTS
169,CBF,CBV,COPYRIGHT,DCE,DSC,EPI,FOURIER,INC,MRI,PERFUSION,SENSE,VOXEL
169,177,19Q,2HG,COPYRIGHT,HOWEVER,III,LABEL,METHODS,MRI,MRS,OBJECTIVE,OBJECTIVES,PCR,PET,RESULTS,SEVERAL
BMJ,CROHN,DETECTION,EBV,EPSTEIN,GROUP,LTD,MRI,PCR,PUBLISHING,THERE
160,948,ACCORDING,ALTOGETHER,III,SVZ,THEREFORE,WORLD
CONTROLLED,DOX,FINALLY,FIRST,GIANS,NIR,RAMAN,THIRD,USING
243,246,ASTROCYTES,CAJAL,RAM
003,169,177,BACKGROUND,COPYRIGHT,DTI,IRELAND,LABEL,LTD,METHODS,MRI,RESULTS
BAX,BCL,EXPRESSION,GAL,GH3,INHIBITION,MTT,WESTERN
286,316,3RD,4TH,6TH,CHO,HOWEVER,MRS,NAA
CHEMOKINES,EGF,GSC,HOWEVER,HYPOXIA,NSC,TAKEN
160,169,235,238,500,BORON,CAPTURE,CELLS,CONTROL,COPYRIGHT,INT,LTD,NEUTRON,NON,NSCLC,PUBLISHED,SINCE,SMALL,TCP,THERAPY,TREATMENT
CHINA,CNS,DUE,HIV,TOXOPLASMA
169,BED,BRAIN,COPYRIGHT,LTD,PUBLISHED,SRS,THERE,WBI,YET
BTSCS,HOWEVER,THERE
GBM,GMB,GSC,MULTIFORME,TARGETING,THESE
947,ANTIGEN,APM,CD8,CTL,FINALLY,HLA,IFN
CD8,COMPARISON,GBM,HLA

000,105,946,HUVEC,IFN,INTERFERON,MTT,PCR,THREE,TK2,U87
PITUITARY
169,5MC,AUTHORS,BEADCHIPS,COPYRIGHT,HOWEVER,INC,PUBLISHED,SUPPORTED
169,AFTER,GROSS,INC,WILEY
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESOLUTION,RESULTS,THREE
169,COPYRIGHT,INC,LC3,LRRK2,MUTATIONS,PARKINSON
013,100,114,177,BACKGROUND,GTR,LABEL,METHODS,MRI,NFA,RESULTS,SEVENTY
169,BRAIN,COPYRIGHT,HOWEVER,INC,PUBLISHED
AMONG,GBM,STUDIES,THESE
169,COPYRIGHT,DESPITE,GBM,THESE
174,AIM,LABEL,METHODS,OBJECTIVE,RESULTS
108,169,ADVERSE,BACKGROUND,BRITISH,ECG,EEG,ELECTRICAL,EXCLUSION,IRE,JOURNAL,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,UNIVERSITY,VAS
945,BORON
169,326,BACKGROUND,FEW,LABEL,METHODS,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SMO,SOCIETY,UNIVERSITY,WESTERN
ANOTHER,AVAGLIO,FURTHER,HOWEVER,III,LABEL,MEANWHILE,OPINION,PFS,PHASE,REGARDLESS,STATEMENT,UNASSIGNED
GUIDELINES,LABEL,OPINION,STATEMENT,SYMPTOM,THERE,THESE,UNASSIGNED
169,COPYRIGHT,INC
LOCAL,MRI,YOUNGER
BTICS,ESPECIALLY
169,BECAUSE,COPYRIGHT,HRQOL,INC,QOL,SEVERAL
169,COPYRIGHT,HGG,INC,TREATMENT
169,COPYRIGHT,DESPITE,INC,MALIGNANT,PARTICULAR,PUBLISHED
169,COPYRIGHT,CURRENTLY,INC,RADIATION
169,APPROACHES,COPYRIGHT,INC,INCREASED,NOVEL,THESE
000,100,169,6TH,8TH,CAUCASIANS,COPYRIGHT,GLIOMAS,INC,KNOWN,PUBLISHED
169,19Q,26951,COPYRIGHT,EORTC,GROUP,IDH,III,INC,RADIATION,THERAPY,THERE,TREATMENT
169,COPYRIGHT,INC,LOW,PFS,WHILE
169,AVAILABLE,COPYRIGHT,DAS,DIFFUSE,GBM,INC,WORLD
169,BBB,COPYRIGHT,DESPITE,GBM,INC,WHILE
169,INC,SEQ
169,700,AHNAK,COPYRIGHT,INC,SEVERAL,VARIOUS
169,COPYRIGHT,INC,PUBLISHED
109,AFTER,PET,SUCCESSFUL,THESE
177,BACKGROUND,BLOOD,DIAGNOSIS,DISORDERS,HASSENFELD,LABEL,LANGONE,MEDICAL,METHODS,NYU,TREATMENT
169,946,COPYRIGHT,PLASMIN,TGF,TREGS
169,945,946,947,COPYRIGHT,GBM,GSARC,LTD,PUBLISHED,RAR,SLGCS,T1338,T1389

106,117,235,260,ADOLESCENT,DEPARTMENT,EARLY,GRADE,GUSTAVE,JANUARY,PEDIATRIC,PHASE,UNION
005,133,194,282,ADVERSE,BACKGROUND,CONCLUSION,III,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PRS,RESULTS,VERSION
ACCORDING,JADAD,OXMAN,QUALITY,REPORTING,SIX,THEREFORE
026,105,215,301,392,608,891,913,923,ALLERGY,CIS,EOSINOPHIL,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,ORS,PENST,RESULTS,THERE,THESE
002,137,LABEL,METHODS,OBJECTIVE,RESULTS,SMA
035,036,100,147,33T,405,969,BLOOD,CNS,ELISA,PCR,S503P,SIMILARLY,SNP,THESE
AFTER,GROUP,LI4,LR3,PATIENT,SJ5,VAS
702,CARLO,END,III,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,ROC,SIMILAR,THERE
169,ESRP1,ESRP2,HOWEVER,LTD,MBM,OVERALL,PRM,PTBP1,PUBLISHED,STAGE,U2AF2,WILEY
946,947,EMT,MET,NSCLC,SIGNALING,TGF,THESE
DESPITE,MALIGNANT,METFORMIN,THEREFORE
169,GLUCOSE,HOWEVER,III,IRS,SOCIETY,TAKEN,WHILE
169,947,ACCORDING,COPYRIGHT,MRI,PARTNER,PUBLISHED,SOCIETY,URBAN
160,595,ESTIMATED,GIVEN,HOWEVER,LMD,THERE,THEREFORE
001,002,003,023,041,CONCLUSION,DSA,FLAIR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
002,005,025,050,CMJ,CONCLUSION,GRADE,KAPPA,LABEL,MAG,MATERIALS,METHODS,OBJECTIVE,PHA,RESULTS,RSR,SWI
CONCLUSION,DELAYED,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNR,SRT

120,956,ACCORDING,BACKGROUND,EVALUATION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMPSON
002,017,11556218G,11556218TG,216,275,4072111,4778889,CHINESE,CONCLUSION,GENOTYPES,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,POTENTIAL,RESULTS,SIMILARLY,THESE
BACKGROUND,CENTRAL,CONTEXT,ENGLISH,FGA,FSH,GIVEN,LABEL,METHODS,RESULTS,SYNTHESIS,SYSTEMATIC,THEIR,THERE
169,BRAIN,CHANTILLY,COMMITTEE,GIVEN,GROUP,MALIGNANCY,NEURO,PRESS,PUBLISHED,SEPTEMBER,SOCIETY,THERAPIES,UDVAR,UNIVERSITY,WORKING
169,INHIBITION,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,946,ALK,ATLAS,BACKGROUND,EXOGENOUS,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SMAD1,SMAD2,SMAD3,SMAD5,SOCIETY,TGF,THERE,UNIVERSITY
136,169,AKT,LABEL,MBM,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,169,896,931,AUTHORS,COHORTS,COX,EIGHT,LABEL,LTD,MEIER,OVERALL,RESULTS,SEPTEMBER,SRS,UNLABELLED,WILEY
169,945,AMP,BIOLOGY,INC,KNOCKDOWN,MOLECULAR,RAS,REGULATION,SOCIETY,THEREFORE,WARBURG
122,177,ECD,EIGHT,EQUIVALENT,MEG
169,AMONG,BACKGROUND,BRAZILIAN,DISCUSSION,HODGKIN,INC,LABEL,METHODS,MOR,RESULTS,WILEY
CURRENT,DDP,ENDOXAN,GBM,III,TEMODAL
169,BCC,DIS3L,PTCH1,ZFX
169,LTD,PUBLISHED,WILEY
004,CHINESE,CONCLUSION,EARLY,IIA,IIB,III,MEDICAL,METHODS,PATIENT,PROGNOSTIC,PURPOSE,RESULTS,THEIR,THREE
169,946,BACKGROUND,F2R,GROUP,HGF,LABEL,LECT1,MET,METHODS,PAR,RESULTS,SHH,SOCIETY,THESE,THROMBOSIS,TRIGGERING,USING,WNT
146,169,183,272,273,545,926,945,946,BACKGROUND,COPYRIGHT,DARMSTADT,FUNDING,GERMANY,GROUP,LABEL,LTD,MAY,MERCK,METHODS,OCT,OVERALL,RADIATION,RESULTS,THERAPY
100,169,183,228,247,337,429,444,538,545,553,956,966,ASSESSMENT,BACKGROUND,BETWEEN,CONSENTING,CONTROLLED,COPYRIGHT,FUNDING,GLEASON,INSTITUTE,JAN,LABEL,LTD,METHODS,OCT,PROGRAMME,PROTECT,PSA,PUBLISHED,RANDOMISED,RESULTS,T1C,TECHNOLOGY,TREATMENT,TRIAL
GBM
BACKGROUND,LABEL,METHODS,RESULTS
BACKGROUND,BTSCS,FINALLY,H3K4ME3,H3K9ME3,HOWEVER,LABEL,MEDIP,OVERALL,RESULTS,THERE,THESE,USING
GBM,OVERALL,STAT3
BACKGROUND,CNS,CONCLUSION,DELAY,FUNDING,INITIAL,LABEL,METHODS,RESECTION,RESULTS,SIX,TRIAL
1950S,1960S,1970S,956,AIR,CARLO,ESTIMATES,HOWEVER,MBQ,MONTE,TYPICAL
BACKGROUND,BFT,BRIEF,DAILY,DEPRESSION,HOWEVER,JOB,LABEL,METHODS,MRI,RESULTS,SCALE,STUDIES
001,672,ADDITIONAL,AGE,BACKGROUND,HOUSTON,HTR2A,HTR3B,KCNC1,LABEL,LINC00518,METHODS,MEXICAN,MINOR,NPY,OPRM1,RESULTS,SENSATION,SIX,TEXAS,THESE
ERP
160,177,FALSE,FINAL,FORTY,LABEL,METHODS,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,STUDENT,SUV
169,AGE,BETWEEN,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEX
CNS,CURRENT,LEBER,PARKINSON,PROMISING
169,COPYRIGHT,GBM,GLIOMAS,GPCRS,LTD,NEWLY,PUBLISHED,VEGFR
168,AFTER,CALIFORNIA,FCS,GMM,IL1R2,KNOWLEDGE,LABEL,METHODS,NFKB2,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,VARIABLES
GDP,GTP,HOWEVER,MUTATIONS,RAF,RAS,SRC,THESE,Y32
946,ALONG,EMT,EPITHELIAL,FINALLY,FOS,FRA,NSCLC,PBX,PRE,PREP1,PREVIOUSLY,SMAD3,TGF,THESE
003,169,524,CONCLUSION,LABEL,LUMINAL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
134,169,177,7MM,AFTER,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METHODS,RECURRENCE,RESULTS,THERE,THREE
000,100,169,AGE,APC,AUTHORS,BACKGROUND,BRAIN,CENTRAL,HODGKIN,INC,LABEL,METHODS,RESULTS,SOCIETY,STATISTICS,WILEY
123,169,430,BACKGROUND,GENOMIC,HOWEVER,LABEL,METHODS,NEURO,NOTABLY,PCR,PRESS,PUBLISHED,RESULTS,SOCIETY,UKF,UNIVERSITY,WESTERN
169,ALTOGETHER,BACKGROUND,EXPRESSION,GBM,INHIBITION,LABEL,METHODS,NEURO,NOTABLY,PRESS,PUBLISHED,RESULTS,SOCIETY,THEREFORE,UNIVERSITY
EARLY,ENGLISH,FURTHER,IDH,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS
107,115,AIP,LABEL,MALIGNANCY,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,ORGAN,RESULTS
005,118,169,BACKGROUND,LABEL,MEIER,METHODS,MUT,RESULTS,RFS,SOCIETY
BACKGROUND,BASED,GIVEN,LABEL,MEDLINE,METHODS,RESULTS,REVIEWS,THERE,TRM
ASPIRATION,HOWEVER,SEVEN,SUBSEQUENT,THESE
ASL,BLAND,CBF,CBV,DSC,GRADE,MEIER,MRI,NORMALIZED,ROC,SEVERAL,SIXTY,THERE,TTR,YET
003,037,160,793,845,AFRICAN,AFTER,BLACK,CARIBBEAN,COX,ENGLAND,EPISODE,ETHNICITY,KINGDOM,OTHER,PAKISTANI,RECEIPT,SOUTH,STATISTICS,STUDIES,THESE,WHITE
048,169,198,923,AMONG,BRITISH,CHINESE,CONCLUSION,COPYRIGHT,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QOL,RESULTS,THERE,THESE,UNIVARIATE
126,169,217,300,600,900,947,ALECTINIB,ALK,BACKGROUND,CNS,COPYRIGHT,EVALUATION,FUNDING,HOWEVER,IQR,LABEL,LTD,METHODS,MRI,NSCLC,RESULTS,ROCHE,SOLID,THREE
177,945,946,EXTREMELY,FUS,GDGEAYK,HOWEVER,MBS,PET,THESE,U87MG,WESTERN
BACKGROUND,DUE,HODGKIN,INSTITUTE,LABEL,METHODS,NHL,NUCLEAR,RESULTS
177,ACCORDING,CONCLUSION,LABEL,METHODS,MRI,MST,MULTIMODAL,OBJECTIVE,RESULTS,SEPTEMBER,WHOLE
009,019,025,029,165,189,262,393,447,464,514,579,586,645,651,704,743,801,873,898,948,953,965,ADDITIONAL,AFTER,BACKGROUND,CCCCC,CONCLUSION,HAPLOTYPES,HAPLOVIEW,HOWEVER,LABEL,METHODS,OCCURRENCE,RESULTS,SEVEN,UNIVARIATE,UTR
AFTER,BACKGROUND,DESPITE,END,JOINPOINT,LABEL,MEIER,METHODS,RESULTS
103,125,160,201,BETWEEN,CALCULATED,GBM,KARNOFSKY,LOW,PFS,PROCEDURE,SBT,TREATMENT
032,160,178,DISEASE,EOL,HGG,OVERALL,QOC,SOMNOLENCE
790,BRAIN,DIFFUSE,III,NORTHEAST
013,017,021,026,031,160,ARCHIVE,AUTOMATIC,COX,FLAIR,GBM,IMAGING,MRI,UNIVARIATE
169,201,231,BRAIN,COPYRIGHT,PRIMARY,PUBLISHED,SAS,THEIR
945,ELEVATION,SHH,SONIC
001,007,020,046,103,151,167,172,191,645,945,946,CHI,EXPRESSION,FURTHER,HIF,INTEGRINS,NSCLC,WHITNEY
005,006,022,10Q,169,299,395,ACADEMY,GBM,IDH,LABEL,METHODS,NEUROLOGY,OBJECTIVE,RESULTS,TAKEN,TERTP
169,945,947,BRAIN,COPYRIGHT,FINALLY,HIF,INC,PKC,PLC,TAKEN,THEREFORE
169,COPYRIGHT,INC,PTENMUT,SNB19,U87
169,818,902,BACKGROUND,CRS,HODGKIN,ITALIAN,LABEL,MEDICAL,METHODS,OVERALL,PERSONS,PRESS,PUBLISHED,RESULTS,SOCIETY,THEREFORE,UNIVERSITY
001,002,010,011,012,015,023,042,111,116,117,120,137,147,150,164,169,190,AGE,COGNITIVE,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,SPARING,THERE
AKT,CCL27,CCR10,CLINICALLY,GBM
098,160,741,ACS,AGE,COLLEGE,DVT,NSQIP,PRE,PROJECT,QUALITY,TOTAL,UNIVARIATE,UTI,VTE
FLAIR,GBM
AFTER,CRANIAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RIGHT
AMONG,ENDOSCOPIC,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
120,215,ACCORDING,GRADE,III,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
001,008,013,024,040,132,214,296,427,438,513,665,854,CDK,COX,DEPARTMENT,JANUARY,LABEL,MEDICAL,MEIER,METHODS,MIB,OBJECTIVE,RESULTS,SAMSUNG,THESE,UNIVERSITY
169,AMONG,COX,GIVEN,HEART,HOWEVER,INC,LABEL,OBJECTIVE,PMCA4,RCAN1,RESULTS,USING
ESC,INHIBITION,KNOWLEDGE,NANOG,SMARCA4,SNF,SWI
274,ATLAS,FINALLY,GBM,THESE
CNS,THREE
CRE,CURRENT,GEM,NSC,ORTHOTOPIC
HUC,HUD,MVNTS,NODULES,OLIG2,R132H,V600E
108,945,947,AKT,BP1,HBL,HISTO,JAK,NOTCH,STAT3,THESE,TREATMENT
BMJ,CNS,DIAGNOSIS,GROUP,HODGKIN,IVL,LTD,PUBLISHING,THERE
000,001,100,169,697,913,934,942,970,987,ADMISSIONS,ARS,BACKGROUND,CONCLUSION,INCIDENCES,INPATIENT,LABEL,LLC,METHODS,NATIONWIDE,PITUITARY,RESULTS
122,MVS,ONCOLYTIC,PRECISE
161,EARLY,PRL,SURGERY,THESE,USING
EPH,EXPRESSION,GBM
AFTER,CHEMOID,CSLCS,FOLLOWING,III,MRI,PATIENT
BCBMS
945,946,GSK,HOWEVER,PRIMARY,TGF,TNF,TRPV4
169,BRITAIN,COPYRIGHT,GREAT,IRELAND,LTD,NF2,PUBLISHED,SMARCE1,SOCIETY,TESTING,THREE,WILEY
19Q,HOWEVER,IDH,IDH1R132H,THESE
HENCE,HOWEVER,PET,SPECT
169,FINALLY,FOCUS,FOXA2,HCC,HEPG2,MMP,PRESS,PUBLISHED,UNIVERSITY
CD3,ENG,EPHA2,HOWEVER,WHILE
160,CNS,CSF,MTX,PRIMARY,PROGNOSIS
000,004,006,025,042,137,154,177,BETWEEN,EXCESSIVE,FORTY,IDENTIFIER,MRI
952,BACKGROUND,GLIOMAS,HOWEVER,LABEL,METHODS,RESULTS,SIMILAR,USING
C19MC,DNMTS,MALIGNANT,THESE,TTYH1,UNTIL
BACKGROUND,BMI,CONCLUSION,HOWEVER,LABEL,METHODS,NON,PAEDIATRIC,RESULTS,SEVEN,WHITNEY
ALREADY,DUTCH,VIRUSES
ACCORDING,RESONANCE,THESE,VEDIC
148,389,730,810,BACKGROUND,CONCLUSION,EXCLUSION,FOLLOWING,GRADE,ITEMS,LABEL,LOCAL,MARCH,MEDLINE,METHODS,OVERALL,PREFERRED,RCC,REPORTING,RESULTS,REVIEWS,SYSTEMATIC,THERE,TREATMENT
001,004,039,068,127,130,140,194,207,334,BNIP3,CONCLUSION,DFS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORTER,THERE,TUMORAL
002,11C,CONCLUSION,FIFTY,KARNOFSKY,LABEL,MET,METHODS,MRI,OBJECTIVE,PET,RESULTS,SEX,SRS,YET
CYBERKNIFE,MRI,PET
AGE,ALCOHOL,HOWEVER,INCREASED,TAKEN,TREATMENT
169,BACKGROUND,CNS,CONCLUSION,LABEL,METHODS,NEURO,PATIENT,PRESS,PUBLISHED,RESULTS,SMO,SOCIETY,THERE,THESE,UNIVERSITY
120,169,BACKGROUND,COPYRIGHT,DISEASE,INC,LABEL,METHODS,OBESITY,PARKINSON,RESULTS,SECONDARY
AREAS,ASSESSMENT,BACKGROUND,COVERED,CURRENTLY,III,LABEL,MALIGNANT,METHODS,MGS,OPINION,PHASE,SCREENING,WHOLE
FINALLY
001,011,150,169,BACKGROUND,CHD,CHEMISTRY,CVD,FINALLY,LABEL,METHODS,RESULTS
169,FIBULIN,INHIBITION,NOTCH,TAKEN,TARGETING,TIMP3
19Q,CLASS,CLEARLY,HOWEVER,LABEL,LGG,LOW,MAXIMAL,OPINION,PCV,RADIATION,STATEMENT,SURGERY,THESE,TYPICALLY,UNASSIGNED
001,025,111,169,BACKGROUND,GBM,IGFBP,LABEL,METHODS,RESULTS,RHO,SOCIETY,THEIR,THERE,YKL
169,INC,UDS,WILEY
169,CTC,GBM,LABEL,PDX,UNLABELLED
031,033,142,193,403,556,611,654,666,945,946,BBB,DFS,EXPRESSION,REDUCED,SIMILARLY
388,435,AUC,DOR,HOWEVER,MEDLINE,NSC,SEVERAL,SINOMED
150,160,200,DIFFUSE,FIFTEEN,GRADE,HOWEVER,KPS,MRI,PFS,TEN,TMZ
103,177,AFTER,BACKGROUND,BASEL,BETWEEN,GKR,GROUP,HOWEVER,INSERTION,LABEL,MARCH,METHODS,OBJECTIVE,PFS,RADIATION,RESULTS,THERAPY,THERE
160,FATIGUE,PRE
169,BACKGROUND,CONCLUSION,HOWEVER,KARNOFSKY,LABEL,MARCH,MAY,METHODS,PCNSL,RESULTS,TSUKUBA,UNIVERSITY
DESPITE,PTPRD
CONCLUSION,DEPARTMENT,GBM,LABEL,MEDICAL,METHODS,OBJECTIVE,RADIATION,RADIOLOGY,RESULTS,SURGERY,THERE,TMZ
177,BACKGROUND,CHANGES,CONTEXT,ENDOCRINE,FORTY,IGF,LABEL,METHODS,OBJECTIVE,OUTCOME,REMISSION,RESULTS,SETTING,TOTAL
100,945,ACROMEGALY,ACROS,AKT,APOPTOSIS,ARF,CCAAT,DERIVED,DISRUPTION,GLIAL,NFPAS,PCR,PITUITARY,POUF1,PRL,RET,USING
183,BACKGROUND,BETWEEN,BRAIN,DESPITE,GEORG,HISTOLOGY,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,STUTTGART
215,BIPOLAR,FIRST,ITIH1,ITIH3,ITIH4,PATHWAY,PBMR1,STAB1,THESE,THIRD
BECAUSE,EVS,THESE
ALZHEIMER,PARK2,PARKINSON,THEIR
954,APOPTOSIS,BAX,BCL,CAERS,CFEZO,GBM,THEREFORE,THESE
HOWEVER,SIMILAR,SRS,THEREFORE
GBM,LDH,MYELOID,NATURAL,NKG2D
169,ACVR1,FOP,WHOLE
001,007,012,112,169,218,64257,BLOOD,III,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
169,CNS,CONVERSELY,EVS,PUBLISHED,ROYAL,SOCIETY
169,HOWEVER,PUBLISHED,ROYAL,SOCIETY,THESE
150,169,PUBLISHED,ROYAL,SOCIETY,THESE
001,169,272,BAO,CLINICALLY,EXOGENOUS,EXPRESSION,FGFR3,GENOMIC,III,LABORATORY,MET,PRESS,PTPRZ,PUBLISHED,RB1,SIXTY,STUDIES,TACC3,U87MG
169,MBM,MOLECULAR
001,002,010,129,433,915,CIS,RRS,THERE
CONVERSELY,GBM,HOWEVER,RSI,SIX,THESE
002,160,AMONG,APOPTOSIS,ATLAS,GBM,PAR,SAC,SELECTIVE
110,120,169,682,832,937,967,CIT,CONCLUSION,DAT,ICC,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTEEN,SOCIETY,UNLABELLED,UTE,VOXELWISE
HOWEVER,INDUCTION,MCNPS
CURRENTLY
169,FK1,FK506,INC,KNOCKDOWN,SIMILARLY,TDO,TRYPTOPHAN,WILEY
BRCA1,ERBB2,OVARIAN,TAKEN,THESE
BRAIN,NPY,THEREFORE,THESE,Y2R,Y5R
956,AFTER,BLOOD,MRI,THYROID,TSH,TSHOMAS
100,169,ALERTED,BACKGROUND,CHILDHOOD,CONCLUSION,ENDOCRINE,FIRSTLY,INC,LABEL,METHODS,PROCEDURES,RESULTS,THEREFORE,WILEY
000,040,169,177,372,508,937,960,AUC,CONCLUSION,COPYRIGHT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SYSTEMATIC,WEB
169,AUSTRALIA,AUSTRALIAN,METASTASES
169,24H,APE,COPYRIGHT,DSPES,GBM,GNR,HOWEVER,INC,LUC,LUCANTHONE,MCF,PEG,TEM
169,AMONG,BACKGROUND,CNS,EOL,INC,LABEL,METHODS,PALLIATIVE,PROCEDURE,RESULTS,WILEY
141,169,183,376,410,521,ASSESSMENT,BACKGROUND,BETWEEN,COPYRIGHT,COUNCIL,EDINBURGH,FUNDING,FURTHER,IQR,JAN,LABEL,LTD,MEDICAL,METHODS,OVARIAN,PUBLISHED,RESULTS,SOUTH,WALLACE
163,169,COPYRIGHT,THEREFORE,USING
169,CHLORELLA,COPYRIGHT,CURRENT,HEPG2,MCF,VCH,WILEY
DIC,TROUSSEAU
AFTER,BRAIN
169,431,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LIVER,LTD,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SWEDISH,WOMEN
GIVEN,GKR,HOWEVER,MPM,THREE
017,AVP,HOWEVER,SEPTEMBER,SINCE,TSS,UNDER
000,160,574,THERE
160,DESPITE,EIGHT
231BR,BACKGROUND,BRAIN,CONCLUSION,DESPITE,LABEL,MDA,METHODS,RESULTS,SINCE,SSRIS
177,179,BACKGROUND,BBB,CTX,F98,HEK293T,LABEL,METHODS,PEGYLATED,PLS,RESULTS,USING
169,COPYRIGHT,EXTENSIVE,INC,MICRORNAS,PUBLISHED
169,BIOLOGICAL,CARLO,CONCLUSION,COPYRIGHT,CSI,ECLIPSE,EFFECTS,GIRLS,IONIZATION,IRELAND,LABEL,LTD,MEDICAL,METHODS,MONTE,OBJECTIVE,PASSIVELY,PURPOSE,RADIATION,RBE,RESULTS,RLARS,RRR,STRAY,SYSTEMS,TPS,VII
CD133,GBM,GSC,TAKEN,WNT
169,177,ADULT,AMONG,CONCLUSION,GHD,INCREASING,LABEL,METABOLIC,METHODS,OBJECTIVE,QOL,QUALITY,RESULTS,SOCIETY
001,003,004,005,026,043,100,AMONG,LABEL,MAXIMUM,METHODS,OBJECTIVE,RADICAL,RESULTS,UNIVARIATE
004,013,018,100,215,992,CCGCC,CHINESE,FURTHER,HAN,HARDY,HOWEVER,LABEL,METHODS,OBJECTIVE,RBBP6,RESULTS,TEN,THEREFORE,THESE
109,111,177,ADDITIONAL,AFTER,BETWEEN,CLASS,GTR,LABEL,MAESTRO,METHODS,MRI,NFA,OBJECTIVE,RESULTS,SEPTEMBER,SIEMENS,SURGERY
116,AGGRESSIVE,CLASS,CONCLUSION,FOLLOWING,LABEL,LEADERSHIP,METHODS,OBJECTIVE,PROSOCIAL,RESULTS,REVISED,SENSITIVE,THESE
BRAIN,FIFTY,HOWEVER,LABEL,MEIER,METASTASIS,METHODS,OBJECTIVE,RESULTS,TEXAS,THOSE,UNIVERSITY,UNTREATED
002,012,013,016,035,055,059,064,100,169,174,183,226,ABOUT,ABSENCE,APRIL,BACKGROUND,COPYRIGHT,COX,FUNDING,JAN,LABEL,LTD,MEDLINE,MEIER,METHODS,NON,RB1,RESULTS
169,183,947,EXPRESSION,GEORG,MUTATIONS,PCR,PRECEDING,STUTTGART
BACKGROUND,CONCLUSION,EXECUTIVE,LABEL,METHODS,PROCEDURE,RESULTS,SURVIVORS,THOSE
160,169,BECAUSE,CARDIAC,COPYRIGHT,INC,PUBLISHED
001,009,169,BRAIN,GUARANTORS,PRESS,PUBLISHED,SURVIVORS,THERE,THESE,UNIVERSITY
169,176,ALA,CONCLUSION,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,THESE,UNLABELLED,WESTERN
001,004,086,169,177,BACKGROUND,CONCLUSION,FET,HGG,HOWEVER,IMAGING,INC,LABEL,MET,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,SUV,TBR,THESE,UNLABELLED,WHEREAS
169,COPYRIGHT,DCE,LOGAN,LTD,MAGNEVIST,MODEL,MRI,REGIONS,ROI,THESE,USING,WILEY
169,176,COPYRIGHT,HOWEVER,LTD,MRS,PRESS,PRF,WATER,WILEY
BACKGROUND,CASES,LABEL,METHODS,MEXICAN
PRO,PROLINE,PROTEIN,SER,THR
139,18A,18B,195,19A,20B,EIGHT,H19,HIPK3,HOWEVER,LINC00152,RB1,RP4,RUNX1,TARBASE,THESE,VEGFA
169,BASSETT,COPYRIGHT,PHENOTYPES,THESE
100,103,113,365,AMONG,BACKGROUND,LABEL,METHODS,MULTIMODAL,RECURRENCE,RESULTS
100,160,AED,BACKGROUND,BESIDES,DISCUSSION,FIRST,LABEL,METHODS
169,BAX,BCL,FURTHER,GDC,NOTABLY,THEREFORE,THESE
BMJ,CNS,DM1,GROUP,LTD,MARCH,MAY,MRI,PUBLISHING,SEPTEMBER,WBI
BMJ,CD163,CNS,DORFMAN,GROUP,HODGKIN,LTD,PRIMARY,PUBLISHING,ROSAI
11C,160,BACKGROUND,GBM,GRADE,GTV,KARNOFSKY,LABEL,MET,METHODS,MRI,PET,RESULTS,TREATMENT
169,3410924,COPYRIGHT,CRE,FINALLY,GLIOMAS,INFECTING,PRONEURAL,REMARKABLY,RIBOTAG
169,954,BIOLOGY,EGR,HDAC1,HUR,INC,INSTEAD,MOLECULAR,SOCIETY
169,COPYRIGHT,OBJECTIVE,SCIENCE,SPECIES
188,196,BRAIN,CCM,CONCLUSION,GENET,KRIT1,LABEL,MED,METHODS,OBJECTIVE,PURPOSE,RESULTS,RHO,THESE
001,845,COX,DELTA,HOWEVER,MEIER,NOTCH,TTP,UNIVARIATE
19Q
946,CHINA,INHIBITION,LC3,THEREFORE
AKT,BCL,BESIDES,ERK,MA1,PNMA1,PNS,SUBSEQUENT,TAKEN
239,CD133,CSC,HOWEVER,PFS
AFTER,PRIMARY
001,008,JANUARY,MAY,MEDICAL,NSCLC,PERCENTAGE
1425EPN,160,177,ALT,BXD,IMETELSTAT,PEDIATRIC,TELOMERASE,THESE,TIC
169,COPYRIGHT,ENGLISH,INC,PUBLISHED
CUSHING,DIAGNOSIS,ENDOCRINE,FAILURE,OTHER,PRIMARY
AFP,CNS,CSF,CYSTS,EMBRYONAL,GERMINOMAS,MRI,PNETS,TERATOMAS
HOWEVER,LARGE,SRS,THEREFORE,WHILE
011,177,179,ADC,BACKGROUND,CHO,FORTY,GROUP,HOWEVER,LABEL,MALIGNANT,METHODS,MRI,NAA,RESULTS
BACKGROUND,BRAIN,CONCLUSION,CONTEXT,HENCE,IHC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
007,BASED,CVS,DELTA24,GSC,INJECTION,ONCOLYTIC,RGD

222,BRAIN,EMA,GTN,OVERALL
169,945,954,COPYRIGHT,GRADE,SCIENCE,TARGETING,TNF
100,140,169,384,COPYRIGHT,FRACTURES,INC,INCREASED,LABEL,METASTASES,METHODS,OBJECTIVE,PHYSICIANS,RESULTS
169,COPYRIGHT,DEPENDING,GELFOAM,INC
169,AGENT,COPYRIGHT,DC101,GBM,INC,NEOPLASIA,PRESS,PUBLISHED,THESE
001,169,557,961,ALA,BACKGROUND,COPYRIGHT,DIFFERENT,ESPECIALLY,FGS,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMPSON
169,COPYRIGHT,GBM,GCIMP,INC,NF1,PDGFA,THESE
169,COPYRIGHT,GENOMIC,INC,OZAWA
169,178,180,193,266,278,ACCORDING,CUSHING,DESPITE,LABEL,METHODS,MIDAS,MODIFIABLE,OBJECTIVE,QOL,RESULTS,SOCIETY
290DUPA,GOLTZ,LATER,NBCCS,PTCH1
160,AKT,CURRENTLY,ERK,GBM,IGF,THEREFORE
504,945,946,AKT,CD133,HOWEVER,HSP90,IPI,THESE
031,045,048,160,164,237,ASSESSMENT,BRAIN,CHRONIC,COX,FACIT,FATIGUE,FUNCTIONAL,GENERAL,HGG,III,ILLNESS,KPS,QOL,QUALITY,SEVENTY,THERAPY,USING
006,945,CD163,MBS,MOLECULAR,NKT,OUTCOME,SHH
004,BECAUSE,CENTRAL,CNS,DFS,DISEASE,FURTHER,LOCAL,MEIER,PNETS
105,169,BBB,COPYRIGHT,DCE,DYNAMIC,EKT,ETK,IAUGC,IAUGC80,IAUGC90,INC,MRI,TOFTS,WHILE
GBM,MULTI
400,ADP,AMONG,LAMIN,OBVIOUS,PAH,ZEBRAFISH
150,250,ERLOTINIB,GEFITINIB,JAPAN,NSCLC,PHASE,SIMILAR,TKI
DLBCL,FABP7,HODGKIN,HOWEVER,LTR,TAKEN,TES,THESE
ATLAS,COMPARING,GBM,NOTABLY,THESE
169,ADVERSE,ANY,BACKGROUND,CONCLUSION,CTCAE,INSTITUTE,LABEL,MEDICAL,MEIER,METHODS,NCI,NSCLC,OVERALL,PERCIST,PET,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,SOLID,UNIVERSITY
160,169,CONCERNING,COPYRIGHT,ECLIPSE,GTV,LABEL,LTD,MATERIALS,METHODS,MUS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,V10
AKT,SEVERAL
169,LEKSELL,LITERATURE,SOCIETY,SRS
169,946,A315E,ALS,EFFECTS,NMR,NUCLEAR,OVERHAUSER,PRESS,PUBLISHED,SEQUENTIAL,TDP,UNIVERSITY
169,COPYRIGHT,INC,PALINOPSIA
003,526,961,BARRINGTON,BRAIN,GERMANY,LABEL,LOWER,METHODS,MRI,OBJECTIVE,PMC,RESULTS,THERE,URODYNAMIC
AFTER,BACKGROUND,LABEL,METHODS
160,APRIL,BACKGROUND,BENEFIT,CONCLUSION,HGG,HIT,HOWEVER,III,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RADIATION,REFERENCE,RESULTS,TEMPORARY
153,170,BACKGROUND,BECAUSE,FATIGUE,LABEL,METHODS,PROCEDURE,RESULTS,SLEEP
001,002,003,005,008,009,124,160,177,COX,KARNOFSKY,KPS,MEIER,PCR,PFS

169,MRI,SOCIETY
3RD,4TH,APART,BMD
THEREFORE,TREATMENT,TSS
100,169,177,BREATHING,CO2,EPR,HYPOXIA,MRI,TREATMENT
18F,BAT,LABEL,OBJECTIVE,PET,PURPOSE,RESULTS,SUMMARY
177,CONCLUSION,KNOWLEDGE,LABEL,METHODS,MOSFETS,OBJECTIVE,RESULTS,TEN
169,BRAIN,FHL,GLY132ARG,INC,LABORATORY,WILEY
160,BAX,BCL,NRP,PAS,TSS,VEGFR
001,169,804,AMONG,ASSESSMENT,BASIC,BRAIN,COPYRIGHT,GPA,HOWEVER,INC,INDEX,LABEL,METASTASES,METHODS,MST,OBJECTIVE,OBJECTIVES,PROGNOSTIC,RECURSIVE,RESULTS,RPA,SCORE,SIR,SRS,THERE
169,945,COPYRIGHT,GIVEN,IRELAND,LTD,MEC,NOTABLY,PHD,TAKEN
160,169,COPYRIGHT,CSC,GBM,GROWING,HOWEVER,LTD
100,109,160,CTE,HOWEVER,MAY,SCT,VOD
169,230,AFTER,COPYRIGHT,DESPITE,DUE,FIFTEEN,GTR,MRI
169,7CM,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,GAMMA,JANUARY,KNIFE,KPS,LABEL,LILLE,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRS,TEN,UNIVERSITY
012,133,864,BRAIN,HOWEVER,OVERALL
100,120,169,BACKGROUND,COPYRIGHT,ECS,HGA,INC,LABEL,METHODS,RESULTS
169,COPYRIGHT,GIVEN,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
009,100,169,215,945,946,ADC,ATLAS,DYNAMIC,FDG,FLAIR,FORTY,HFSRT,IDH,LABEL,METHODS,MRI,NANOSTRING,OBJECTIVE,ORR,PET,PFS,PRIMARY,PURPOSE,QUALITY,RESULTS
169,COPYRIGHT,INC,THROUGH,UNTIL
BRAIN,HOWEVER,OVERALL,THESE
001,027,034,129,135,291,CHOROID,COX,CPC,CURRENTLY,MEIER
117,160,256,466,APRIL,GROUP,JAPAN,LUMINAL,OVERALL,UNIVARIATE
169,693,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEVERAL,SLE,THESE
CYSTS,THESE
169,A2317,ALISERTIB,THESE
215,GROSS,PISKA,TEN,THERE
169,956,BAPTA,BHQ,CONVERSELY,COPYRIGHT,DBTRG,GF109203X,INHIBITION,IRELAND,LTD,PKC,PLC,PMA,ROS
ACADEMY,BRACKMANN,CHS,CPA,EIGHT,HOUSE,IAC,LABEL,MEASURE,METHODS,NEITHER,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SURGERY,TEN,THREE
AFTER,AWAKE,BETWEEN,EOR,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THERE
140,956,AMONG,GBM,GMB,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SCALE,TAQ
169,COPYRIGHT,INC,TARGETING,TLX,ZHU
CSF,DISRUPTION,LABEL,METHODS,MONRO,OBJECTIVE,RESULTS,THERE,WHICH
AFTER,BACKGROUND,CONCLUSION,FUNDING,LABEL,METHODS,OVERALL,PATIENT,PFS,RESULTS,THESE,TMZ,TRIAL
164,179,2DG,800,BACKGROUND,CNS,CONCLUSION,LABEL,MATERIALS,METHODS,PCA,PROTEOMICS,RESULTS
AFTER,BACKGROUND,BRISTOL,CANCERS,CHI,CONCLUSION,EFFORTS,INDIA,KASHMIR,LABEL,MATERIALS,METHODS,PACKAGE,PEARSON,PRESENT,RESULTS,UNIVERSITY
169,185,186,BECAUSE,CHO,COPYRIGHT,FLAIR,FURTHER,GBM,INC,LABEL,LNR,MATERIALS,METHODS,MRI,NAA,OBJECTIVE,PRE,PURPOSE,RESULTS,ROC
169,ANGIOGENIC,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUNITINIB,WORLD
169,GBM,MUTAGEN,PRESS,PUBLISHED,SOCIETY,UNIVERSITY,WHOLE
BACKGROUND,CONCLUSION,CSF,LABEL,MENINGEAL,METHODS,USING
ELCWP,PCI
ELCWP,THESE
ELCWP,THESE,WHICH
ELCWP,III,NSCLC,PCI
169,177,204,COPYRIGHT,GROUP,III,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,RPA,SARCOMA,SCALE,SIXTEEN,THERAPY
001,169,177,248,956,COPYRIGHT,DSC,HIGUCHI,HOWEVER,MAT,PVA,SEM,SLN,TWEEN,XRD
THERE
422,696,AMONG,BACKGROUND,CHINA,CONCLUSION,III,LABEL,METHODS,NOTABLY,RESULTS
169,BRAIN,CONVERGENT,CRUCIALLY,DESPITE,GUARANTORS,HOWEVER,PRESS,PUBLISHED,UNIVERSITY
024,751,ACCORDING,COX,GRADE,III,MEIER,NHA,ONCOLOGIST,TAKEN,U87,VECHT,WESTERN
231,BEH,BRAIN,OPT,TREATMENT
FINALLY,PARTICULAR,QUESTIONS,THREE
001,011,210,AGE,BALANCING,FATIGUE,INSTITUTE,LEUKOPENIA,LOW,PRIOR
032,109,282,L858R,NSCLC,SRS,TKI
EVALUATED,GBM,MEIER,MRI,NEITHER,PFS
CONCLUSION,HOWEVER,LABEL,METHODS,MRI,MRS,NAA,OBJECTIVE,PAS,PILOCYTIC,PURPOSE,RESULTS
FINALLY,KNOWN,MRI
19Q,IDH,III,PHASE,THESE
1B1,AGITATION,BACKGROUND,CO2,CONCLUSION,DISCUSSION,EXTUBATION,FACTORS,LABEL,METHODS,THESE
CURRENT
006,007,491,BACKGROUND,DIAGNOSIS,LABEL,LOW,METHODS,MIDLINE,RESULTS
946,ALZHEIMER,LTP,STZ
169,BACKGROUND,CNSCS,CONCLUSION,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RAS,RESULTS,SIRT1,SOCIETY,THESE,U87,UNIVERSITY
AMS,SINCE,THERE
ECC
177,956,AMD3100,AMD3465,CXCR4,GBQ,PET,PLERIXAFOR,SUV,THESE
BACKGROUND,FOLLOWING,KNOCKDOWN,LABEL,METHODS,RESULTS,THESE,U87
946,BACKGROUND,ERK,EXOGENOUS,HOWEVER,IGFBP,INSULIN,LABEL,METHODS,MTT,PD98059,RESULTS,SU3,U87,USING,WESTERN
945,946,BNOTA,FDG,HGG,III,LGG,MRI,PET,PRGD2,THEREFORE
390,860,ACC,ADRENAL,BACKGROUND,CONCLUSION,JANUARY,LABEL,MEIER,METASTASES,METASTATIC,METHODS,NETWORK,OPERATIVE,RESULTS,SEX
BACKGROUND,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPARING,THESE
169,BACKGROUND,CSF,LABEL,METHODS,RESULTS,SOCIETY
008,023,100,174,BASED,CONCLUSION,LABEL,METHODS,NOVALIS,NSA,OBJECTIVE,PITUITARY,PTV,PURPOSE,RESULTS,SRS,SRT
169,ADULT,AFTER,ALREADY,ATM,CED,CONSISTENT,GIC,HEALTHY,KU60019,PEDIATRIC
ALCOHOL,DISEASE,LARGE,OFTEN,OTHER,THESE
AMONG,CHARACTER,EFFECTS
169,AUR,COPYRIGHT,DIFFUSION,ICE,INC,INSTITUTE,LABEL,MATERIALS,METHODS,MRI,MTT,NEURO,OBJECTIVE,OBJECTIVES,PERFUSION,PUBLISHED,RATIONALE,REGIONS,REPOSITORY,RESULTS,SCANS,SWEDISH,UNIVERSITY,VARIATION,WASHINGTON
169,CONCLUSION,HISTOLOGY,INC,LABEL,METHODS,OBJECTIVE,RESULTS,WILEY
165,945,CNS,HSC,IDUAC,IDUAE,MPS,THESE
169,215,CONCERNING,COPYRIGHT,DCE,DSC,III,LTD,MRI,PARAMETRIC,PRESUMABLY,THERE,WILEY
169,253,277,288,BRIGHAM,COPYRIGHT,EXCLUDING,FRAME,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SERIOUS,VARIABLES,WOMEN,YOUNG
169,945,946,COPYRIGHT,GAMMA,INC,KNIFE,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS
946,FURTHER,GBM,HENCE,HOWEVER,HUR,III,MK2,TAKEN
112,169,342,963,BIOLOGICAL,BRAIN,COPYRIGHT,CSC,GBM,HOWEVER,LABEL,MOLECULAR,NEOPLASIA,PRIMARY,REPOSITORY,THESE,TOF,UNASSIGNED,UNLABELLED
CENTRAL,HOWEVER,MRI,SHIMANE
DRG,IGG,MRI,PET,SERUM,T11
001,169,AIM,ASL,CBF,CONCLUSION,COPYRIGHT,DSC,HOWEVER,IRELAND,LABEL,LTD,METHODS,MRI,MULTIPHASE,OBJECTIVE,PURPOSE,RESULTS,ROC,THEIR,THERE,WHITNEY
ASIAN,END,INCREASED,INSTITUTE,ISLANDERS,JAPAN,PACIFIC,PROGRAM,RESULTS,SINGAPORE
CATHEPSIN,JAM,METASTASIS,WHILE
MIXED,MUCORALES
215,279,919,ADC,ATC,BACKGROUND,DIFFUSION,DWI,LABEL,METASTASES,METHODS,MRI,PATIENT,RESULTS,THERE
215,260,HOWEVER,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAYTRIX,RESULTS,SINCE,USING
916,963,HOWEVER,LABEL,METHODS,OBJECTIVE,PDE,PURPOSE,RESULTS,SYSTEMATIC,VARIOUS
00025,001,014,015,708,CM1,CM2,DELAYED,EVERY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,USING,WHILE
001,169,993,APRIL,COPYRIGHT,FORTY,GROSS,HOWEVER,LABEL,MAXIMUM,METHODS,OBJECTIVE,REMOVAL,RESULTS,SEPTEMBER
169,COPYRIGHT,DISRUPTION,EVS,INC,ONCOGENIC,RAT,THESE
169,AUTOPHAGY,BECN1,BIOLOGY,III,INC,MOLECULAR,NRBF2,RPE,SOCIETY,THEREFORE,THESE,VPS15,VPS34
160,169,BECAUSE,BETWEEN,COPYRIGHT,GIVEN,INC,IRELAND
169,ATRTS,COPYRIGHT,HOX,HOXD8,INC,PEDIATRIC,RESULTS,SMARCB1,THESE

BACKGROUND,CONCLUSION,GBM,LABEL,METHODS,RESULTS,SEVERAL
169,446,946,BACKGROUND,CONCLUSION,CONVERSELY,GBM,HOWEVER,LABEL,METHODS,NEURO,POMGNT1,PRESS,PUBLISHED,RESULTS,SOCIETY,SUBSEQUENT,THESE,UNIVERSITY
169,AMD3100,ANOTHER,BACKGROUND,CONCLUSION,CXCR4,GBM,GSC,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,SVZ,TAKEN,U87MG,UNIVERSITY
177,19Q,CIC,DIAGNOSIS,FUBP1,HOWEVER,IDH,OLIG2,THERE,THESE
141,239,260,AED,AMONG,CURRENT,IBM,PBT
000,100,169,228,246,592,AGE,CONCLUSION,CUSHING,LABEL,METHODS,NON,OBJECTIVE,PAS,PITUITARY,RESULTS,SIR,SOCIETY,SPR,SWEDISH,TSH
169,260,ALZHEIMER,BACKGROUND,BRAIN,COPYRIGHT,COVARIATES,DIETARY,FREQUENCY,INC,INSTITUTE,JOURNAL,LABEL,METHODS,MRI,OBJECTIVE,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,VOLUMETRIC
001,009,044,169,228,335,401,700,BETWEEN,CEREBELLAR,COPYRIGHT,COX,GAMMA,INC,KNIFE,LABEL,LOCAL,MATERIALS,MAY,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SRS,THERE,THESE
945,CXCR4,CXCR7,HBMEC,HOWEVER,KNOCKDOWN,TARGETING,TNF,WESTERN
169,183,201,384,AMONG,CONCLUSION,COPYRIGHT,HOWEVER,ICC,IHC,INC,LABEL,METHODS,OBJECTIVE,RESULTS,S1PR1,S1PR2,S1PR3,S1PR4,S1PR5,S1PRS,STUDENT,TMA
169,COPYRIGHT,CROWN,III,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,WORLD
113,144,158,200,241,327,485,956,967,AMONG,BRAIN,CD4,HIV,MRI,PML
ATLAS,GBM,HOWEVER,NEAREST,NETWORK,NTP,PHARMDB,PREDICTION,SUBTYPE,TREATMENT
DNP53,EGF,GBM,MES,NF1,WHILE
000,005,110,500,BACKGROUND,EEG,LABEL,METHODS,OVERALL,RAY,RESULTS,STIMULI
BECAUSE,IBS,III,IRRITABLE,TREATMENT
169,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
150,169,AUDIT,BACKGROUND,BRITISH,DEVIATIONS,FINALLY,FIRST,JOURNAL,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SUPPORT,THESE,UNIVERSITY
115,AGAIN,GADOLINIUM,MRI
JAPAN,PCNSL,PRIMARY,THESE
FDG,HODGKIN,IL2,MRI,NON,PET
ASIAN,EARLY,IVL,WESTERN
HEMORRHAGE,HOWEVER
CNS,FDG,IVL,MALIGNANT,PCNSL,PET,THEREFORE
169,ADC,COPYRIGHT,INC,MENINGIOMA,MINIMUM
10877,147,169,2MM,423,443,6MM,ACTUARIAL,BACKGROUND,BETWEEN,COPYRIGHT,DBR,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,PATIENT,PUBLISHED,RESULTS,RPA,SALVAGE,THESE
METASTATIC,THESE
398,501,514,CURRENT,DANDY,NOVEL
CNS,GSC,HGG
100,169,956,CONCLUSION,HEP3B,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PC3,RESULTS,STIRT,SUCCESSFUL,USNEA,WILEY

228,252,GERMANY,HEMATOLOGY,ONKOLOGIE,PEDIATRIC,SOCIETY
001,004,007,008,027,037,100,105,116,19Q,237,C228T,C250T,CONSISTENT,HOWEVER,IDH,III,ISOCITRATE,MEIER,MUTATIONS,PFS,RECURRENT,SIMILARLY
LABEL,METHODS,OBJECTIVE,PFS,RESULTS,THERE
037,076,337,467,840,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,RFS,THERE,UNIVERSITY
HOWEVER,NOW,THERE
169,PRESS,PUBLISHED,SURVIVORS,UNIVERSITY
141,169,COPYRIGHT,GBM,RELEASE,SCIENCE
169,252,COPYRIGHT,SCIENCE
003,036,169,177,BACKGROUND,COMPARING,LABEL,METHODS,OVERALL,RESULTS,SIMILAR,SOCIETY,THERE
945,CCRCC,FSH,METASTASES
169,497,COPYRIGHT,ECTOPIC,FEDERATION,PDCD4,PUBLISHED,SOCIETIES,THESE,TMZ
169,946,954,AMONG,COPYRIGHT,HOWEVER,IRELAND,LN229,LTD,RANKL,TGF,THESE,U87MG
169,181,3T3,COPYRIGHT,DOX,HOWEVER,IRELAND,LTD,MDR,NIH,OND,PLC,PRF,PSI,U87MG
011,015,025,BACKGROUND,CHILE,DUE,FURTHER,INC,INSTITUTE,LABEL,METHODS,MRN,NCI,PATIENT,PINDA,PROGNOSTIC,PROGRAM,RESULTS,UNIVARIATE
655,BACKGROUND,CLINICIANS,CNS,INCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SCIENCE,SEVEN,SURGERY,WEB
169,COPYRIGHT,LTD
001,183,275,ABCB1,ABCC2,ABCG2,BMS,HOWEVER,LLCPK,MDR1A,PGP,PPI,PROTEIN,RESISTANCE,RESULTS
169,2HG,APRIL,ENGLISH,IDH,III,INC,ISOCITRATE,JANUARY,REFERENCES,SCIENCE,WEB,WILEY
169,COPYRIGHT,MULTI,NOVEL,PUBLISHED,WHILE
946,AKT,CD133,CSC,ERK,GBM,NOTCH,PCR,SMAD4,TGF,THESE,WESTERN,WNT
169,239,BTICS,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESISTANCE,RESULTS,THESE
486,BACKGROUND,LABEL,METHODS,RESULTS,THESE
485,BACKGROUND,CASES,CHILDHOOD,CONTEXT,CPS,FINALLY,LABEL,METHODS
EDITORIAL,WARBURG
ACCORDING,BACKGROUND,BIOMEDICAL,BOOLEAN,BRAIN,CACHE,CATALOGUE,COMPUTING,DATASET,DNF,DYNAMIC,E5XXX,E7XXX,EFFICIENT,EGI,FIRST,HOWEVER,HPC,INTEL,INTERFACE,ITALIAN,LABEL,MESSAGE,MODEL,MPI,MPJ,MUTATIONS,OVERALL,PASSING,PRIMATE,RAM,RESULTS,SAPIENS,SITES,SOMATIC,VIRTUAL

ALZHEIMER,DIFFERENT,DISEASE,PARKINSON,SEVERAL
CAHAN,DESPITE,GBM,GKS,RADIATION,SEVEN,WHEREAS
3RD,SURGERY,THIRD
AFTER,BACKGROUND,CONCLUSION,CONVERSELY,GBM,GROSS,INTENSITY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE,TREATMENT,WORLD
FEDERATION,NEURO,SOCIETY,WORLD
001,APRIL,BACKGROUND,BRAIN,FIFTY,GIVEN,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
007,124,BACKGROUND,CRANIAL,FIFTY,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL
BACKGROUND,BRAIN,D33,D95,D98,D99,INTENSITY,LABEL,METHODS,OBJECTIVE,RESULTS,TEN,THREE,V95
954,BBB,CNS,LIEBESKIND,QUINONE,SROGL
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,INSTITUTE,LABEL,METHODS,SIMPLEX,TEN,VIRUS
001,100,169,5X4,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,WBI
169,ANTICANCER,ASSESSMENT,COPYRIGHT,FUNCTIONAL,INSTITUTE,KARNOFSKY,METRONOMIC,THERAPY,THERE
169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TOXICITIES
12P,169,ABCG2,ANTICANCER,APC,ASSOCIATED,ATP,BACKGROUND,BAX,BINDING,BRCA1,CONCLUSION,COPYRIGHT,EPITHELIAL,INSTITUTE,LABEL,MATERIALS,METHODS,MOLECULAR,NME,OCCURRENCE,P53,PROTEIN,RAD51,RB1,RESULTS,SUB,TESTICULAR,WHITE
169,239,945,946,BIOLOGY,DMBT1,INC,MKN74,MOLECULAR,NEUAC,SOCIETY,THESE,TRA
100,EORTC,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,THESE
BACKGROUND,HOWEVER,LABEL,MALIGNANT,METHODS,SUGGESTED
007,049,160,AIM,CGH,CIC,ETV,HIF,MAP,PCR,V600E,V600K,V6OOE,WESTERN
CSF
BECAUSE,DESPITE,HOWEVER,RADICAL,TMJ
183,AGE,BACKGROUND,CONCLUSION,COX,DUE,FURTHER,GCA,GEORG,LABEL,METHODS,RESULTS,STUTTGART,TREATMENT
00001,004,718,CIS,CONCLUSION,HOWEVER,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,ORS,PCI,PURPOSE,REMAN,RESULTS
001,177,193,231,305,BACKGROUND,CONCLUSION,CST,DIFFUSION,JANUARY,LABEL,METHODS,NAVIGATED,OBJECTIVE,OCTOBER,RESULTS,THESE
ADHSV,BECAUSE,GCV,MALIGNANT,MGS,SIMILARLY
169,HOWEVER,IMPAIRMENT,INCREASING,SOCIETY,THERE
CONCLUSION,GERIATRIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THERE
023,032,061,065,137,169,203,BRAIN,BSG,CONCLUSION,CONSORTIUM,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PEDIATRIC,PET,PFS,RESULTS,SOCIETY,UNLABELLED
ALTOGETHER,NAB,RSV,THESE
181,SHG,SMALL,THEREFORE,THESE
956,BACKGROUND,ECTOPIC,FT3,FT4,LABEL,METHODS,MRI,RTH,THYROID,TRH,TSH,USING
125,BACKGROUND,BRAIN,CLINICALLY,CONCLUSION,EOC,III,LABEL,LABORATORY,METHODS,MRI,PET,SEVERAL
PITUITARY
100,169,ADVERSE,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,THESE,TMZ
160,BACKGROUND,BRAIN,CHS,GROSS,HENCE,LABEL,METHODS,MORTALITY
169,COPYRIGHT,CPA,GL261,HOWEVER,INCREASING,IRELAND,LTD,METRONOMIC,NATURAL
169,COPYRIGHT,CYTOTOXIC,GBM,GLUCOSE,IRELAND,LTD,METABOLIC,PUBLISHED,THERAPIES,THESE
105,169,176,233,945,946,ASTERACEAE,BACKGROUND,BEH,CHINA,COMPOUNDS,COPYRIGHT,ETHANOLIC,HSS,INDIA,IRELAND,JAPAN,LABEL,LTD,MATERIALS,METHODS,RELEVANCE,RESULTS,SAUSSUREA,THEIR
160,ADC,BRAINSTEM,DAI,GCS,GGM,GLASGOW,HOWEVER,LOBAR,MRI,OUTCOME,PTA,SCALE,TBI,THERE
169,BRITISH,CENTRAL,CONCLUSION,CONTROLLED,COPYRIGHT,FURTHER,GBM,HOWEVER,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVERAL,SUB,VPA
169,ALDRICH,COPYRIGHT,DIAMOND,FANCONI,GLANZMANN,GRAFT,HEALTHCARE,HLA,LTD,PGD,PUBLISHED,SINCE,WISKOTT
169,219,241,288,306,312,628,798,850,CENTRAL,CNS,COSTS,EASTERN,EVERY,HODGKIN,PREMATURE,STOMACH,THESE,WESTERN,YEARS
169,ALK,ANAPLASTIC,CENTRAL,COPYRIGHT,HOWEVER,PUBLISHED,SPECIALIST
160,169,947,ATM,COPYRIGHT,DDR,HENCE,PIGCT,PUBLISHED,SUBSETS,TGCTS
945,CURRENTLY,EASTERN,GROUP,IFN,III,PHASE,RCC,SUNITINIB,TYPICAL
169,975,COPYRIGHT,CURRENTLY,GBM,LTD,MET,MRI,WILEY
001,169,CHO,COPYRIGHT,CTV46,CTV60,GBM,GROSS,INC,LABEL,MATERIALS,METHODS,MTV,NAA,OBJECTIVE,PURPOSE,RESULTS,THESE,VOLUMETRIC
100,169,173,177,956,CELECOXIB,CNS,COPYRIGHT,COX,CXB,MP2,MPS,NPS,SKN,THESE,TREATMENT
007,135,169,298,COPYRIGHT,COX,FORTY,GAMMA,HOWEVER,KARNOFSKY,KNIFE,KPS,LTD,MBT,MEIER,OVERALL,STOCKHOLM
169,AFTER,COPYRIGHT,LTD,THERE,THEREAFTER
000,001,032,053,060,089,169,209,372,470,553,593,838,COPYRIGHT,EGGER,FURTHER,HOWEVER,KNOWLEDGE,LTD,SYSTEMATIC,TEN,WEB
001,057,152,169,COLLEGE,CONCURRENT,COPYRIGHT,FINALLY,LTD,PROGRAM,QUALITY
169,COPYRIGHT,LTD,OTHER,OVERALL,PILOCYTIC
001,008,027,160,169,200,AUTHORS,CADM1,CDH13,CMI,DAPK1,ESPECIALLY,HENCE,HPV,LTD,OPSCC,SCC,SILENCING,THESE,TIMP3,USING,WILEY
169,COPYRIGHT,EIGHT,GRADE,LABEL,LTD,MBC,METHODS,OBJECTIVE,RESULTS
041,219,264,650,EIGHT,ELISA,HEPATOCYTE,HGF,KPS,OVERALL,VERSION
DETECTION,THERE
17P,233,243,ARRAY,BLUEGNOME,BRACHMANN,CAMBRIDGE,CGH,DISCUSSION,FURTHER,GTG,HIMFG,KARYOTYPES,LABEL,LABORATORY,LANGE,METHODS,MYBBP1A,OBJECTIVE,PELP1,PURPOSE,RESULTS,SINCE,SPNS2
169,AUTHORS,MUTATIONS,NSUN2,PUBLISHED
160,528,940,AGAINST,ITALIAN,ITALY,LABEL,OBJECTIVE,RESULTS,UNLABELLED
BACKGROUND,LABEL,METHODS,PLACEMENT,RESULTS
105,114,171,82Q,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,TRANSGENIC,USING
IGCTS,ONGOING,THESE
047,094,104,128,888,AMONG,BRAIN,FINANCIAL,GIVEN,GRADE,GTR,LABEL,LOW,MEIER,METHODS,MRI,OBJECTIVE,PEDIATRIC,PROGRAM,RECURRENCE,RESULTS,THESE,UNDER
169,AFTER,COPYRIGHT,EPILEPTIC,HHS,INC,RESECTIVE,THESE,TRANSIENT
750,AKT,TNF,TRAF6
001,026,COX,LABEL,LARGE,MAXIMAL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,147,152,165,242,268,330,429,438,495,573,616,738,830,921,AMONG,BECAUSE,CLASS,GROUP,HOWEVER,IIA,IIB,IIC,III,INCIDENCES,LABEL,MEIER,METHODS,MST,OBJECTIVE,RESULTS,RPA,SRS,ULTIMATELY
006,035,APRIL,BACKGROUND,CONCLUSION,LABEL,METHODS,MPS,NSCLC,RESULTS
SRY
169,946,FAK,LN229,MMP,SOCIETY
169,INC,MENINGIOMA,UNDER,WILEY
169,ABL,ADAM9,CDCP1,SRC
169,COPYRIGHT,INC,PREVALENCE
169,177,ANGIOGENIC,ARG,ASP,BASAL,CONCLUSION,GLY,IMAGING,INC,INCREASED,LABEL,METHODS,MMD,MOLECULAR,NUCLEAR,PET,RESULTS,RGD,SOCIETY,SPECT,UNLABELLED
169,177,1ST,227,246,2ND,335,3RD,4TH,862,AMONG,BACKGROUND,BASEL,CIS,CONCLUSION,COX,HOWEVER,HRS,INCIDENCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOAST
174,BRAIN,CONCLUSION,EXCEL,INC,INTEGRA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADIONICS,RESULTS,SIX,ULTRASONIC,WST
945,ALTERED,ASMEL,B16,CD11B,COMBINING,EPITOPE,HIF,LIBRARY,MYC,PREVIOUSLY,RAS,SOX,TYRP1,VSV
169,BIOLOGY,DESPITE,GBM,IGF,INC,KNOCKDOWN,MOLECULAR,SOCIETY
ACUTE,SEVENTY,SRS,SRT
006,215,268,722,ALS,PRIOR
CNS,PEDIATRIC
GDP,LMD,NPD,SHH,SONIC,THESE,TRANSPOSON
169,215,929,ADC,BACKGROUND,FLAIR,LABEL,METHODS,MRI,NEURO,PRESS,PUBLISHED,REGIONS,RESULTS,SOCIETY,UNIVERSITY
169,IMAGING,LTD,THERE,WILEY
14857,14913,AFTERWARDS,AMONG,BRAIN,CIS,FURTHER,ITALY,LABEL,METHODS,MONITORING,OBJECTIVE,OBJECTIVES,OCCAM,ORS,RESULTS,TERNI,THEREFORE
CUTANEOUS,DIAGNOSTIC,HOWEVER,PHYSICIANS
CONVERSELY,EXTENSIVE,SEVERAL
169,COPYRIGHT,DYSKINESIA,INC,PARKINSON,SORTING,SPECIAL,WISCONSIN
CBT,CIS,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,RRS
001,006,151,153,304,345,9TH,AIS,AMONG,BACKGROUND,CONCLUSION,DRG,FOLLOWING,HOWEVER,III,LABEL,LEVEL,METHODS,RESULTS,REV,SCALE,SCORE,TBI,THERE,TRAUMATIC,VTE
100,140,215,220,225,300,639,AMONG,BACKGROUND,FIFTEEN,FURTHER,IDENTIFIER,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OCTOBER,RELEVANCE,RESULTS,SETTING,THERE,TRIAL
169,COPYRIGHT,FICKIAN,INC,NUMERICAL
169,263,AMONG,BACKGROUND,BMS,CONCLUSION,GAMMA,HOWEVER,KNIFE,LABEL,MEDICAL,METHODS,MRI,NEITHER,PRESS,PUBLISHED,RESULTS,SOCIETY,SRS,UNIVERSITY
169,CURRENTLY,ENGLISH,EXTRACTION,LABEL,LIMITED,MAY,MEDLINE,MEK,METHODS,OBJECTIVE,RESULTS,SELECTION,SYNTHESIS,THERAPY
BMSCS,EPCAM,OPN,TAKEN
138MG,140,251MG,947,AKT,ARG,B1R,B2R,BRADYKININ,ERK,GLIOMAS,HOE,MTT,NOTEWORTHY,SSR240612,TAKEN
204,EZRIN,FINALLY,THESE,UTR
002,013,015,021,104,AMSTERDAM,BACKGROUND,BESIDES,BMJ,FOCAL,GROUP,HAGUE,LABEL,LGG,LIMITED,MCH,METHODS,MRI,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEIZURE,TMZ
500,INTRABEAM,NBS,PRS,THERE,ZEISS
031,AFTER,ICU,LABEL,MATERIALS,MENINGITIS,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PURPOSE,RESULTS,SOMATIC,THERE,UNLABELLED
CONCLUSION,LABEL,OBJECTIVE
CYTOTOXIN,EMT,GSK,SNAIL,THESE
HOWEVER,THEIR
BRAIN,PCI
ASIAN,EGF,NSCLC
DESPITE,HOWEVER,SRS,TREATMENT
AGE,HOWEVER,MRI
WHILE
CNS,CURRENT,DUE
130,4TH,900,FEDERATION,FRANCISCO,MEETING,NEURO,SAN,USA,WORLD
CNS,CSF,HODGKIN,HOWEVER,MULTIMODAL,PRIMARY,SECONDARY
DISCUSSED,NON,NSCLC

OBTAINING,SCREENING,THESE,WHILE
946,ITALIAN,THERE
1990S,252,GERMANY,IMMUNOLOGY,LABORATORY,PROFESSOR,SINCE,UNIVERSITY
AFTER,ASSISTANT,DEPARTMENT,EMORY,GREGORY,HOPKINS,JOHNS,KEN,KINZLER,MEDICAL,NOW,PHD,PROFESSOR,PROGRAM,RIGGINS,SCIENTIST,SHERMAN,THANKARAJ,UNIVERSITY,USA,VOGELSTEIN
AFTER,PATIENT,VARIABLES
MRI,WITHOUT
BRAIN,DEPARTMENT,GERMANY,GROUP,HEIDELBERG,III,NEILL,NEURO,PHASE,PROFESSOR,SOCIETY,TREATMENT,UNIVERSITY,WORKING
HEADSMART
GIVEN,GTV,THERE,USA
AIM,CONCLUSION,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVEN,SIX

HDAC1,HDACI,HDACS,HISTONE,SINCE
1P19Q,26951,CIC,CLEARLY,CPG,EORTC,FUBP1,IDH,MOLECULAR
BECAUSE,SEVERAL,THESE
945,946,ATP,CNS,ELISA,LABEL,LPS,METHODS,NLRP3,OBJECTIVE,PCR,PLASMID,RESULTS,STAT3,WHILE
ATLAS,BOOLEAN,GBM
050,169,BACKGROUND,CONCLUSION,DCA,EFFICACIES,F98,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THEIR,TMZ,U87,UNIVERSITY,XRT
001,008,169,172,ALK,BACKGROUND,LABEL,METHODS,NEURO,NSCLC,OVERALL,PRESS,PUBLISHED,RECEIPT,RESULTS,SOCIETY,SUBSEQUENT,UNIVERSITY
169,946,956,CGP,GIC,HOWEVER,RESULTS
000,100,169,BRAIN,CENTRAL,GBM,HOWEVER,INCIDENCE
BMJ,GROUP,HOWEVER,INDONESIA,INFANTILE,LTD,PUBLISHING
169,181,BPR,BRAIN,COPYRIGHT,HOWEVER,MDR1A,SOCIETY,THEREFORE,WEB
BACKGROUND,FINALLY,HOWEVER,LABEL,MICROARRAY,RESULTS
169,ACTIVATION,AKT,PITUITARY,SOCIETY,WHILE
100,169,49503,945,946,AGS,BACKGROUND,CELLS,CHRONIC,ELISA,HP60190,INDUCTION,LABEL,LTD,MATERIALS,METHODS,MKN28,PCR,RESULTS,WILEY
177,BEIJING,CAPITAL,CONCLUSION,LABEL,MAY,MEDICAL,METHODS,OBJECTIVE,RECORDS,RESULTS,SEPTEMBER,TIANTAN,UNIVERSITY,VARIOUS
001,002,004,009,021,091,358,474,568,589,AFTER,AIM,CONCLUSION,EVERY,LABEL,METASTATIC,METHODS,OBJECTIVE,PFS,RESULTS
001,009,017,024,082,106,169,353,546,742,994,COPYRIGHT,ENDPOINTS,INC,LABEL,MATERIALS,METHODS,NEITHER,OBJECTIVE,PBT,PURPOSE,RESULTS
000,169,815,858,ACADEMY,CONCLUSION,CTS,FOUNDATION,IRR,JANUARY,LABEL,LIBRARY,METHODS,OBJECTIVE,RESULTS,SOURCES,SURGERY,THERE
160,169,COPYRIGHT,HOWEVER,INC,RTS
169,AKT,AUTHORS,EGF,EPIDERMAL,LTD,WHILE,WILEY
169,947,BREGS,CD3,CD4,HEMATOLOGY,HOWEVER,IGM,SOCIETY,THESE
946,MBP,THEREFORE,THESE
BRAIN,SAPOSIN,TAKEN,THESE,THIRD
169,CES,COPYRIGHT,CRANIAL,EPENDYMONA,HOWEVER,MRI,THERE,TOTAL
124,TIKI2,WNT
DECREASED,REGUCALCIN
945,950,AMONG,GLIOMAS,HOWEVER,HUNTINGTIN,MYC,PCA,PLS,PROTEIN
ATTENTION,MRI
AIM,AVF,AVM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PATHOLOGIC,RESULTS,SQUID,TECHNICAL,THERE
HOWEVER
OVARIAN
945,ALY,CBP80,IFN,ISG15,REF,RSK,TAKEN
169,ACADEMY,AUTOPSY,BEHAVIORAL,COPYRIGHT,OFTEN,PEDIATRICS,ROHHADNET
AUC,CONCLUSION,DXR,HOWEVER,LABEL,METHODS,NPL,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SINCE,U87
001,GBM8401,HOWEVER,HS683,KNOCKDOWN,METASTASIS,MTA,MTT,THESE
AXIAL,B13,BRUNNER,FLAIR,GERMANY,MRI,SIEMENS,TESLA,VOLUMES,WMH
100,123,AMONG,ANATOMICAL,BETWEEN,CONCLUSION,DTI,FURTHER,HOWEVER,LABEL,MATERIALS,MAY,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
001,003,071,177,223,396,CHILD,CONCLUSION,ENDOSCOPIC,HCC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,404,CONCLUSION,FLAIR,GRE,HOWEVER,LABEL,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL,SNR
160,231,BRBP1,CY5,M13,TAMRA
169,176,BASED,CHENG,COPYRIGHT,DIRECTIONS,EAP,FINALLY,FURTHER,HOWEVER,SHORE
169,AUTHORS,COPYRIGHT,EPI,HOWEVER,IMAGING,MRI,NEUROLOGY,PUBLISHED
ABC,AFTER,CHASE,ECM,ONCOLYTIC
181,APLYSIN,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMZ
AMONG,FURTHER,HOWEVER,LFS,NLS,PLS,PUFAS,TLS
169,COPYRIGHT,DESPITE,GBM,LTD
169,DESPITE,PUBLISHED,ROYAL,SOCIETY
169,DEFECTS,PUBLISHED,ROYAL,SOCIETY
169,CPG,FRIZZLED4,GSC,ODN,RES,STAT3,THROUGH
ACVR1,ALT,DIFFUSE,DIPGS,FIFTY,FURTHER,III,MRI,THESE
169,190,269,490,COPYRIGHT,EDUCATION,FIRST,INC,ITALIAN,LABEL,MATERIALS,METHODS,MSKCC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
BBB,CENTRAL,CNS,NERVOUS,OTHER
240,AVAGLIO,ENGLAND,GOG,JOURNAL,PFS,THESE
BASAL,BCC
AREAS,BACKGROUND,COVERED,GLIOMAS,LABEL,METHODS,OPINION

169,BRAIN,CLDN1,TAKEN
001,100,169,COPYRIGHT,EARLY,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE,VOLUMETRIC
169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
BACKGROUND,CNS,DIAGNOSIS,EWING,EWS,FINAL,LABEL,MEDICATION,METHODS,OBJECTIVE,PATIENT,PRIMITIVE,PROCEDURE,SPECIALTY
BRAIN,MRI
300,618,ADVERSE,ALT,AMONG,AST,CTCAE,KOREA,THERE
169,BECAUSE,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PARENTS,RESULTS,WILEY
001,011,028,169,853,967,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,ENHANCING,INC,LABEL,MEIER,METHODS,PMGCT,PMNSGCT,PRIMARY,RESULTS
169,973,996,COM,COMPARING,CONCLUSION,COPYRIGHT,COX,FURTHER,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TAIWANESE
AFTER,APART,AUTHORS,BACKGROUND,CUTANEOUS,FINAL,KEY,LABEL,METASTASES,METASTATIC,PATIENT,UNLABELLED,WORDS
001,169,177,946,BACKGROUND,COPYRIGHT,DVL,HOWEVER,INC,IRS,LABEL,MATERIALS,METHODS,RESULTS,WESTERN,WNT
518,CCND1,NF2,THESE
132,142,ARG,CD4,III,MHC,PEPTIDE,R132H,TH1
GFI1B,GROUP,SOMATIC
169,218,COPYRIGHT,GBM,IRELAND,LTD,MICRORNAS
169,EGF,GSC,INC,S1P,THESE,USING,WILEY
169,CNI,COPYRIGHT,FURTHER,HGG,LGG,LTD,WILEY
CNS,GAD,MRI,PET,PUBLISHED,VARIOUS,WHILE
005,169,ADC,COPYRIGHT,LTD,ROC,ROI,WILEY
169,AUC,COPYRIGHT,DSS,FIRST,III,INTERPRET,LTD,MRS,NETWORK,PATTERN,RESONANCE,SINCE,SUPPORT,TES,TUMOURS,USING,WILEY,WORLD
375,AFTER,BACKGROUND,CISPLATIN,CSF,DOSES,GRADE,GROUP,HEARING,LABEL,MEIER,METHODS,OVERALL,PEDIATRIC,POG,RESULTS,SEVEN
169,945,GABAA,GLUR1,LTD,LTP,SOCIETY,THESE
169,7Q33Q34,DNT,FAM131B,NF1,SNP,SOCIETY
169,183,945,946,DEPARTMENT,IST,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,RESULTS,RTH,TRH,TSH,TSHOMAS,WILEY
132,160,169,175,218,ALZHEIMER,ANGELES,AUTHORS,CALIFORNIA,CLINICALLY,CNS,CONCLUSION,COPYRIGHT,GERIATRICS,JOURNAL,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCHWANNOMA,SETTING,SOCIETY
BBB,CNS,EPR,POLYMERIC,THESE
LRP,NRP,REGARDING,THESE,U87
169,CK7,HOWEVER,MALIGNANT,PREVIOUSLY,SOCIETY
106,169,177,90MIN,AMD3465,BASED,COPYRIGHT,CXCR4,INC,PET,PREVIOUSLY,SEVERAL,U87
001,207,ADVANCE,AUSTRIA,BRITISH,DUTCH,DYING,EOL,EXPLORING,FIFTY,HGG,QOC,THERE,THREE
169,COPYRIGHT,CTC,EARLY,SEVERAL,SOLID
169,BCL,CENTRAL,COPYRIGHT,FINALLY,GBM,III,IRELAND,LTD,NERVOUS,OVERALL,PRIMARY
012,169,548,ACCORDING,ASSESSMENT,BACKGROUND,BASED,LABEL,METHODS,NEURO,PRESS,PSP,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,946,CIT,CONVERSELY,HOWEVER,NATURAL,RES
169,177,COPYRIGHT,SEVERAL,SOCIETY,THESE
AFTER,BACKGROUND,BASED,FURTHER,HOWEVER,LABEL,METHODS,REGARDING,RESULTS,SYSTEMATIC
PEDIATRIC,STUDIES
004,005,007,008,023,738,817,947,AMONG,MARCH,SIMILAR,STI,THESE
19Q,TOOLS
19Q,TOOLS
169,CALIFORNIA,COPYRIGHT,FRANCISCO,GBM,GCG,GIANT,HOWEVER,LTD,OVERALL,PFS,SAN,THESE,UNIVERSITY
001,003,009,169,183,2MONTHS,COPYRIGHT,COX,GTR,LTD,MEIER,PFS,PRESENTING
169,330,COPYRIGHT,GAMMA,KARNOFSKY,KNIFE,KPS,LTD,MEIER,SELECTION,STOCKHOLM
169,COPYRIGHT,GDT,IGT,INC,SEVERAL,TAM,THESE
169,46187,945,BIM,COPYRIGHT,GDP,GTP,LTD
169,CEREBELLAR,COPYRIGHT,GBM,INC,RAS,THERE
006,169,231,AKT,BRSK1,COPYRIGHT,INC,JUN,LABEL,MDA,MEIER,METHODS,OBJECTIVE,RESULTS,TREATMENT,WESTERN,WHILE
954,DESPITE,EVALUATION,FIFTY,ICC,INTRACLASS,KAPPA,LABEL,MACDONALD,METHODS,OBJECTIVE,RESULTS,SOLID,THERE
11C,FURTHER,LABEL,MET,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEVERAL,SUVMEAN
CNS,INVENTORY,SITUATION,VOCATIONAL
169,HOWEVER,METASTASIS
110,144,148,153,169,ADULT,AFTER,BACKGROUND,BELOB,BETWEEN,COPYRIGHT,DEC,DESPITE,EASTERN,FUNDING,GROUP,HOWEVER,KWF,LABEL,LTD,METHODS,NEDERLAND,NEDERLANDS,NOV,NTR1929,RESULTS,ROCHE,TREATMENT,TRIAL
100,169,COPYRIGHT,GYRBE,INC,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SCALE,SIXTEEN
945,954,GROWING,MYD88,TNF
100,145,149,233,294,BRAIN,DESPITE,LABEL,MENINGIOMA,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,COPYRIGHT,HOWEVER,IMPORTANT,JANUARY,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PRO,RESULTS,STUDIES
169,215,AUTOPSY,COPYRIGHT,MRI
169,BAX,BCL,BID,COPYRIGHT,GBM,INC,ROS,THEREFORE,TRAIL
001,107,160,169,195,203,673,AMONG,BACKGROUND,CNS,COPYRIGHT,IBC,III,INC,LABEL,METHODS,NETWORK,OVERALL,RESULTS
169,174,ALTOGETHER,ARENICOLA,COPYRIGHT,FUNCTIONAL,HBS,NATURAL,THEIR
COATS,CRMCC,LABRUNE
HOWEVER,SRS
169,358,696,AMONG,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
BECAUSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,WHOLE
ICP,MEDLINE,THREE
001,002,006,122,169,COPYRIGHT,EXPRESSION,III,INC,KARNOFSKY,LOW,MEIER,PUBLISHED
THEREFORE
CONCLUSION,GRADE,III,INSTITUTE,LABEL,MAXIMAL,METHODS,RADICAL,RESULTS,UNLABELLED
ALA,ALASENS,APART,BIOSPEK,DETECTABLE,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SSC,UNLABELLED
001,002,025,107,131,140,146,239,BACKGROUND,BMI,CONCLUSION,CURRENTLY,LABEL,METHODS,OBJECTIVE,PRL,RESULTS,WILLEBRAND
300,DSB,END,GFP,HOMOLOGOUS,JOINING,NON,R26NHEJ,SINCE,USING
ADH,ALZHEIMER,DDIT4,GAPDH,HBA,HBB,MME,PCR,SNX27,SORL1,THERE,THESE,WBC
169,ALZHEIMER,COPYRIGHT,INC
AMONG,AREAS,BACKGROUND,CNS,COVERED,CURRENT,LABEL,METHODS,NOVEL,OPINION,PROLONGED,TEN,TREATMENT
024,IAA,RESULTS
CNS,CRANIAL,ELONGATED,SFT
AMONGST,MOLECULAR,TANYCYTIC
BRAIN,MRI
002,005,006,022,040,705,727,797,830,BESIDES,COX,GBM,MEIER,PFS,STAT3,UNIVARIATE
750,ASL,DISCOVERY,DSC,HOWEVER,MAXIMAL,MRI,ROI
100MG,150,169,BACKGROUND,COX,FIFTEEN,FOLLOWING,GRADE,HRS,KPS,LABEL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,UNIVERSITY
BASED,GBM
169,410,BACKGROUND,HOWEVER,LABEL,LGG,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
PCNSL,PRIMARY
100,289,832,AFTER,COX,HEMOSIL,ITALY,NUTRITION,USING
169,BBB,BIOLOGY,ECM,ECS,GOVERNMENT,SOCIETY,THERE,USING
169,COPYRIGHT,FDG,INC,PET,SEVERAL
048,169,AUTHORS,BACKGROUND,BLACKWELL,DENMARK,HEART,INC,LABEL,LIFESTYLE,METHODS,POISSON,PUBLISHED,RESULTS,WILEY
169,COPYRIGHT,EFFORTS,INC,PET,REVIEWING,SEVERAL
CURRENT,EXPRESSION,GROUP,HOWEVER,KMD6A,MBS,SHH,WNT,ZMYM3
169,COPYRIGHT,DIFFERENT,INC,METABOLIC
100,956,BRAIN,C57BL,FORTY,MALDI,MSI,NOD,SEVERAL
14Q13,215,BACKGROUND,CONTEXT,DHX35,DIRC3,DTC,FOXE1,FURTHER,GWASS,ITALIAN,LABEL,METHODS,OBJECTIVE,RESULTS,SPANISH,SPATA13
177,AGE,BACKGROUND,CONCLUSION,CONTEXT,CUMULATIVE,DEPRESSION,DTC,GERIATRIC,HOWEVER,ILLNESS,LABEL,MAJOR,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCALE,SETTING,SEVERAL,STATE,TRAIL,TSH
BACKGROUND,CONCLUSION,CONTEXT,HEMORRHAGE,LABEL,RESULTS
ALTERED,CURRENT,DESPITE,HOWEVER,LABEL,MRI,OBJECTIVE,PARALLELS,PURPOSE,RESULTS,SUMMARY
DESPITE,INITIALLY,THESE
100,AC2,CRL2397,GL261
956,AKT,ERK,FURTHER,GI50S,HOWEVER,RAS,ROS,RPTEC,SF295,STELLETTIN
115,169,19Q,ALGORITHMS,BACKGROUND,COX,CPG,HM450,IDH,LABEL,MEIER,METHODS,MOLECULAR,NEURO,NOA,PCR,PRESS,PUBLISHED,RESULTS,SOCIETY,STP27,UNIVERSITY,WORLD
169,AFTER,CONTINUED,DDLPS,NVP,THESE
169,COLLEGE,COPYRIGHT,HNC,LTD,NCF,PUBLISHED,RADICAL,ROYAL
ABC,ABCA1,ATP,GBM,HYPOTHESIS,ICS,LABEL,UNLABELLED
169,COPYRIGHT,DESPITE,INC,MOSBY
136,160,546,KEY,LABEL,MET,METHODS,MRI,MRS,MYO,OBJECTIVE,OBJECTIVES,PCNSL,RESULTS,THESE,WHITNEY
148,169,CGH,CLUSTER,CONVERSELY,COPYRIGHT,INC,RFS,TAKEN,USING
945,946,947,BIG,COMPLEX,GOLGI,POTASSIUM,PUBLISHED,THESE
169,BRAIN,CHARACTER,EKMAN,GUARANTORS,HOWEVER,INVENTORY,PRESS,PUBLISHED,SCALE,TASKS,THESE,TORONTO,UNIVERSITY
GBM,THESE
ABC,ABCB1,ABCG2,CNS,DESIGNING,PROTEIN,RESISTANCE
000,036,041,215,248,BASED,BETWEEN,CLPTM1L,GOVERNMENT,PRESS,PUBLISHED,UNIVERSITY
169,ANTECEDENT,COPYRIGHT,EBV,EPSTEIN,HIV,LTD,PTSMT,SMT,THERE,THREE
160,ALM,ALTOGETHER,ICA,MRI,THREE,USING
024,025,031,154,161,197,725,BACKGROUND,D2R,FSH,LABEL,METHODS,PAS,PRL,RESULTS,TMZ
000,BRAIN,CNS,HENRY,SECTION,SINCE
031,042,157,191,508,ANN,ARTIFICIAL,ATLAS,COX,NBN,PROTEIN
DESPITE,EFFECTIVE,HOWEVER,HSP90,IGF,ONGOING,SRC,THESE,TOR
OPTICAL,USING
CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
AIM,BRAIN,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PNS,RESULTS,THERE,THREE
001,004,169,BACKGROUND,BRAIN,CLEAR,CONCLUSION,COPYRIGHT,COX,INC,KETTERING,LABEL,MEIER,METHODS,MSKCC,NEUROLOGIC,RCC,RESULTS,SLOAN
169,COPYRIGHT,FLAIR,METASTASES,PUBLISHED,SAS
121,EXPRESSION,HOWEVER,NUCLEAR,THESE,WESTERN
115,144,150,169,945,956,AFTER,COMPARING,COPYRIGHT,CRGDK,DOX,LTD,NRP,PAMAM,PEG,PEGYLATED,RGD,RGDYC
169,COPYRIGHT,HOWEVER,INC
160,169,COLLEGE,CONCLUSION,COPYRIGHT,GEE,LABEL,LOWER,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,OPTIMAL,PUBLISHED,PURPOSE,RESULTS,ROC,ROYAL,SEVENTY,TUMOURS,UNI
001,002,003,082,114,479,522,945,968,969,995,ALS,COX,IMPORTANCE,INSTITUTES,INTAKES,LABEL,METHODS,NUTRITION,OBJECTIVE,PREVENTION,PUFAS,RELEVANCE,RESULTS,RRS,SETTING
169,BLADDER,BOWEL,BRAIN,BRAINSTEM,CARLO,CLINICIANS,COPYRIGHT,D50,ESOPHAGUS,EYE,FEMORAL,HEADS,HEART,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,MONTE,OBI,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SCANS,THYROID,TRACHEA
BACKGROUND,CAUCASIAN,CROHN,DIAGNOSTIC,EPSTEIN,LABEL,LYG,METHODS,PULMONARY,THIOPURINE
169,COPYRIGHT,CSF,ESI,MES,PCI
BACKGROUND,BAX,BCL,ERK,LABEL,MALIGNANT,MCL,MEK,METHODS,MTT,RESULTS,U87,WESTERN
LOH,PINBS,RNASE,TESTING
525,BETWEEN,CCI,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,PRT,PURPOSE,RESULTS,UNI,YOUNGER
160,CSF,TREATMENT
AFTER,IMAGING
100,2DE,AMONG,COF1_HUMAN,ENOA_HUMAN,KPYM_HUMAN,PCNA_HUMAN,SEVERAL,TCTP_HUMAN,THESE,TP53_HUMAN
190,197,527,AUTHORS,BACKGROUND,BRAIN,CENTRAL,COLLECTION,CONTROLLED,GLASGOW,HOWEVER,ICU,ISSUE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,PRIMARY,RCT,RESULTS,REVIEWS,SCALE,SECONDARY,SELECTION,SYSTEMATIC,THREE
EIGHT,HOWEVER
169,22Q11,COPYRIGHT,FINALLY,INC,MALIGNANT,MRT,SMARCB1
128,149,GBM,RAP1B,STUDIES,TMZ
160,169,AFTER,BACKGROUND,CHRONIC,COPYRIGHT,INC,INTERVIEW,LABEL,METHODS,OBJECTIVE,RESULTS,STI,THREE
BRAIN,FUNCTIONAL,HOWEVER,III,LHERMITTE,MRI,PPI
03012,109,160,273,680,901,946,AKT,FINALLY,FXG,HOWEVER,MYC,OSU,SINCE,THESE
BACKGROUND,CARLO,CONCLUSION,CSI,IMPORTANT,LABEL,LAR,METHODS,MONTE,OED,REGARDLESS,RESULTS,SECONDARY,TREATMENT,VARIATIONS,VII
FOXM1,TFS
042,110,169,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,RESULTS,STILL,THEREFORE
160,946,FINALLY,FIRST,FOLLOWING,III,NUCLEAR,THESE
150,169,COPYRIGHT,CSF,INC,MULTIPLEX,PBL,PCR,RTS,SEVEN,SMARCB1
ADP,FC101,ROS,TAKEN,USING
INCREASED
MRI,TYPICAL
HOWEVER,LOCAL,SRS
008,014,028,037,041,043,199,FEW,PRL
169,COPYRIGHT,DIFFUSION,DTI,EARLY
169,COPYRIGHT,HCC,LIVER,PUBLISHED,RAPID,WES
IMAGE,PUBLISHED
043,169,ACADEMY,CORRECTION,DISPLAY,LABEL,METHODS,MRI,NEUROLOGY,OBJECTIVE,OUTCOME,RESULTS,SECONDARY,SEIZURE,TLE,VFD
215,890,981,988,ANY,COPYRIGHT,FORTY,GCL,INC,IPL,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS
BIOLOGICAL,INSTITUTE,REFLECTING,SOCIETY
169,BACKGROUND,CONCLUSION,ELONGATION,GTP,LABEL,METHODS,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SEREX,SOCIETY,THESE,U87MG,UNIVERSITY,WESTERN
169,181,BACKGROUND,LABEL,MEASURABLE,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SERUM,SOCIETY,TRIAL,UNIVERSITY
001,101,ASSESSMENT,BRAIN,CENTRAL,CONTROLLED,EORTC,FUNCTIONAL,ITEMS,LABEL,MEDLINE,METHODS,OBJECTIVE,PURPOSE,QLQ,QOL,QUALITY,RESULTS,THERAPY,THESE,TREATMENT
CANCEROUS,CIP2A,INHIBITOR,MYC
127,150,CAVERNOUS,GRADE,KNOSP,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
BRAINSTEM,HOWEVER,THEREFORE
BECAUSE,CNS,DIAGNOSIS,MRI,MTX,SUBSEQUENT,THREE
AES,AREAS,BACKGROUND,COMBINING,COVERED,DABRAFENIB,III,LABEL,MEK,METHODS,OPINION,PHASE,TOXICITIES,V600E
177,300,BACKGROUND,CONTEXT,CUSHING,ENDOGENOUS,FORTY,LABEL,LTE,METHODS,MRI,OBJECTIVE,OUTCOME,PITUITARY,RESULTS,SEISMIC,SETTING,TREATMENT
AIM,BACKGROUND,CONCLUSION,HGG,LABEL,LGG,METHODS,OBJECTIVE,RESULTS
BAX,BCL,DESPITE,DOX,LINDL,MMP,PRANGOS,ROS
001,169,672,AFRICAN,AMERICANS,AMONG,BACKGROUND,BMI,CAUCASIAN,CAUCASIANS,LABEL,METHODS,NMR,RESULTS,RHO
169,ATTENTIVE,DVC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVENTY
169,945,BASAL,BIOLOGY,CONTINUED,DECREASED,ERBB2,EXPRESSION,GABRP,HCC1187,HCC70,INC,KRT14,KRT17,KRT6B,MOLECULAR,SILENCING,SOCIETY
169,COPYRIGHT,DOSIMETRIC,DSC,DSCABAS,DSCMANUAL,ESTIMATION,IRELAND,LABEL,LEVEL,LTD,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIMILARITY,TRUTH
001,002,169,177,AFTER,BT474,CONCLUSION,DU145,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,PIVALIC,REGARDING,RESULTS,SOCIETY,U87,UNLABELLED
EEG,HOWEVER,IMAGING
169,187,ACCORDING,COPYRIGHT,KPS,PATIENT,RPA
001,004,005,008,013,018,021,169,AGGRESSIVE,CONCLUSION,COPYRIGHT,EXCELLENT,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SURGICALLY,THREE
169,COPYRIGHT,INITIALLY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THREE
10MIN,169,BROCA,CONCLUSION,COPYRIGHT,FUNCTIONAL,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESECTION,RESULTS
001,162,BACKGROUND,CONCLUSION,ECLIPSE,HOWEVER,LABEL,METHODS,MUS,PLANS,RESULTS,THESE,TPS
00001,001,002,004,008,100,125,267,AHR,CAR,CYP,CYP1A,CYPIA,DESPITE,GLYCINE,HENCE,LABEL,MATERIALS,MDR1A,MDR1B,MDR2B,METHODS,MOREOVE,OBJECTIVE,PCR,PXR,RESULTS,SOYBEAN
169,AKT,ATT,COPYRIGHT,CUSHING,IRELAND,LTD,OCTREOTIDE,SSTR1,SSTR2,SSTR5
ADC,DIFFUSION,DWI,III,LABEL,METHODS,OBJECTIVE,RESONANCE,RESULTS
CHRONIC,THERE,WHILE
ALZHEIMER,FINALLY,FULLY,HOWEVER,MRI,PET,POTENTIAL,PROMISING,SINCE,WHILE
THERE
130,220,5MM,BACKGROUND,CARCINOMA,CONCLUSION,HEM,LABEL,LOCAL,METHODS,RCC,RENAL,RESULTS,SINCE,THERE
ATLAS,BIO,BIODP,DISCOVERY,GBM,HOWEVER,THESE,VALIDATION
169,FINALLY,LABEL,MALIGNANT,MRT,PROTEOMIC,SMARCB1,SNF,SWI,THEREFORE,THESE,UNLABELLED,WESTERN
144,169,2CL,947,BRAIN,COPYRIGHT,EXCITATORY,GABAERGIC,HOWEVER,ICTAL,INTERICTAL,NKCC1,SCIENCE
AFTER,HOWEVER,THERE,TREATMENT
169,COPYRIGHT,EBR,HOWEVER,THEREFORE
115,160,19Q,228,CPG,EPIGENOME,GBM,IDH,NOA,NOTABLY,WHETHER
AGS,AMONG,BAD,BASED,BAX,BCL2L11,CASP7,CIDEA,CIDEB,HOWEVER,PCR,TNFRSF10B,TNFRSF11B,TRAF2,TRAF3,UNCOVERING
HOWEVER,SOMATIC
169,BACKGROUND,CALCULATED,DOTATOC,FIFTEEN,HOWEVER,LABEL,LATER,METHODS,MRI,NEURO,OVERALL,PET,PRESS,PUBLISHED,RESULTS,RUV,SINCE,SOCIETY,UNIVERSITY
169,231,AKT,BACKGROUND,BRAIN,GAP,LABEL,MDA,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
945,ALPHA,BRAIN,FURTHER,GALSA,NSCLC
AFTER,CRANIAL,ICA
000,AFTER,HOWEVER,III,PAPILLARY,WORLD
BASED,LABORATORY
HODGKIN,MOLECULAR,MRT
COX,DTI,FLAIR,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,TREATMENT
CNS,DLBCL,EMERGENCY
9GY,AFTER,CNS,GADOLINIUM,HOWEVER,ICE,MRI

CBS,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE
001,130,169,BACKGROUND,EPWORTH,FATIGUE,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SCALE,SLEEPINESS,SOCIETY,UNIVERSITY
MALIGNANT,MEANWHILE,THERE
AREAS,BACKGROUND,COVERED,CURRENTLY,LABEL,METHODS,NPS,OPINION,WHILE
009,016,022,034,121,308,324,BACKGROUND,DIAGNOSIS,GPA,KARNOFSKY,KPS,LABEL,METHODS,OVERALL,RADES,RADIATION,RESULTS,SIX,SRS
BECAUSE,DEVELOPING,DRUGS,FBS0701,FEW,PARKINSON,PHLEBOTOMY,THEIR,WHILE
MULTIFORME
464,ADDISON
DNETS,ENGLISH,HOWEVER,MALIGNANT,THERE
AGGREGATE
AKT,CHROMOSOME,CNS,G251D,MIP,PAPILLARY,THESE,WORLD
169,189,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SOCIETY,ZIV
169,DUE,SOCIETY
ACCORDING,BASED,IRONICALLY,NATURAL,THEREFORE
001,003,011,018,022,030,034,043,168,169,COPYRIGHT,COX,GRADE,KARNOFSKY,KPS,LTD,MEIER,PCR,PTN,WORLD
CEA,CRC,ESTIMATING,HEART,HOWEVER,HRV,PSA,THESE
160,BRCA1,BRCA2,CBR,GRADE,INTRINSIC,TREATMENT,TTP
001,FIFTY,FORTY,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAPID,RESULTS,VANCOUVER,VARIABLES
169,201,231,COPYRIGHT,DETECTING,MRI,PUBLISHED,SAS,VARIOUS
945,946,ALA,ARG,ASP,ATWLPPR,FAL,GLY,LABEL,LEU,METHODS,NEUROPILIN,NRP,OBJECTIVE,PRO,PROCEDURES,PURPOSE,RESULTS,RGD,RGDYK,THR,TRP,U87MG
169,2DG,BTICS,GBM,GLYCOLYTIC,HOWEVER,LABEL,SIMILAR,UNLABELLED
945,946,BACKGROUND,CONCLUSION,CONVERSELY,DHT,DPN,IGF,INCREASED,LABEL,MED,METHODS,NSE,PPT,RESULTS
ESC,FANCA,FANCONI,HOWEVER,THESE
005,104,AES,APRIL,AUSTRALIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,OVERALL,PFS,RESULTS,SETTING,SEX
BACKGROUND,DESPITE,HODGKIN,HOWEVER,LABEL,METHODS,MONITORING,NHL,OBJECTIVE,OBJECTIVES,RESULTS,SAB
CEREBELLAR,DOTANOC,MRI,PET,VHL
BACKGROUND,III,LABEL,METHODS,RESECTION,RESULTS,SIMPSON
ACC,ADENOID,CUTANEOUS
169,BRAIN,COPYRIGHT,IRELAND,LMC,LTD,MRI,NSCLC,TKI
160,169,AKT,ATP,COA,COPYRIGHT,HISTONE,INC
169,AMONG,ANATOMICAL,CNN,COPYRIGHT,DTI,IMAGING,LTD,PRE,VII
169,BECAUSE,COPYRIGHT,HOWEVER,INC,THESE
001,006,HOWEVER,KPS,NOTABLY,WORLD
CNS,FDA,INTENSIVE,UNTIL
AMONG,LABEL,LIM,METHODS,OBJECTIVE,PCBP2,PTBP1,RESULTS,UTR,WESTERN
160,CURRENT,DESPITE,GBM
BACKGROUND,FARMERS,FURTHER,ITALY,LABEL,LITERATURE,MATERIALS,METHODS,RESULTS
169,COPYRIGHT,INC,OCN
100,169,177,COPYRIGHT,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIDCA,MUS,OBJECTIVE,PADDICK,PCI,PLANS,PURPOSE,RADIATION,RCI,RESULTS,SIDCA,THERAPY
DISCERNING,MRI,SEVERAL
169,23B,27B,AMONG,CONCLUSION,COPYRIGHT,COX,FSCOX,FSCOX_SVM,IFS,LABEL,METHODS,OBJECTIVE,RESULTS,SIMILARLY,SVM,THEREFORE,THESE
117,169,ADDITIONAL,ALA541THR,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,ENDOCRINE,FUNCTIONAL,LABEL,LCT,LCT10,METHODS,NEOPLASIA,OBJECTIVE,RESULTS,SAS,TAKEN,THEIR
160,DGP,IGA,IGG,JAPAN,STEROID,USA
169,COPYRIGHT,III,INC,MIXED,WORLD
169,1P19Q,587,ANAPLASTIC,BACKGROUND,HOWEVER,III,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RECURSIVE,RESULTS,SOCIETY,THESE,UNIVERSITY,VALIDATION,VARIABLES
169,ABSENCE,BACKGROUND,CPG,GBM,H3F3A,IDH,LABEL,METHODS,NEURO,PEDIATRIC,PRESS,PUBLISHED,RESULTS,ROS,SOCIETY,UNIVERSITY
INITIALLY,MRI,PRE,SRT,TEN,THERE
169,AFTER,COPYRIGHT,INC
169,945,946,ADR,ALZHEIMER,APOA1,AWARD,BBB,BECAUSE,BIOLOGY,CNS,CONTINUED,COPYRIGHT,DISCOVERY,DOX,INC,LABORATORY,RADICAL,ROS,SOCIETY,THESE,TNF
BASED,MEDULLA,RESECTION,TERATOMAS,TOTAL
AFTER,DTH,FRT,GBM,IIA,JAPAN,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PFS,PHASE,RESULTS,SCALE,TMZ
CSF,FORTY,GRADE,JANUARY,KNOSP,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
100,177,181,ACADEMY,ACCORDING,ANS,CLASS,CNAPS,COMMITTEE,FOUNDATION,HEARING,LABEL,MANAGEMENT,METHODS,MRI,OBJECTIVE,RESULTS,SURGERY,TOTAL
RADIATION
169,945,BIOLOGISTS,COMPANY,CYS,GL261,GLYRS,LTD,NLS,PUBLISHED
169,COGNITIVE,COPYRIGHT,GUIDELINES,NETWORK
169,BER,GBM,MMR,THESE,WESTERN
169,945,946,ANGPTL4,CBS,EPAS1,LABEL,MOLECULAR,THESE,UNLABELLED
133,147,169,240,263,735,AMONG,AUTOPSY,BACKGROUND,COX,HEART,INC,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,231,946,COPYRIGHT,EMT,FEDERATION,MCF,MDA,PUBLISHED,SNAIL,SOCIETIES,STUDIES,TAKEN,TGF,ZEB
169,COPYRIGHT,CSF,EPIDERMAL,INC,L858R,MOLECULAR,PATHOLOGY,PCR,PUBLISHED,SOCIETY,THESE
169,1980S,BASEL,CURRENT,MRI
603,CANDIDATE,THESE,TMZ,UTR
169,COPYRIGHT,INC
169,231,AMP,ATP,BIOLOGY,INC,MDA,MOLECULAR,OVERALL,PREVIOUSLY,RAPID,SOCIETY,WARBURG
169,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PMS,RESULTS,YOUNGER
LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
001,002,004,037,115,169,179,488,514,799,ACCORDING,AFTER,BACKGROUND,BELONGING,CNS,COPYRIGHT,COX,LABEL,LTD,LUM,LUMINAL,METHODS,OVERALL,RESULTS
014,018,025,160,MTT,P21,U87MG
100,BACKGROUND,LABEL,METHODS,RESULTS,THREE,WHILE
200,600,800,AVS,GRADE,HCQ,LC3,MTD,POPULATION,SIXTEEN,THEREFORE,THESE,TMZ
100,132,177,182,AFTER,BACKGROUND,EIGHT,GNTNI,HENCE,HOWEVER,IPD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCIENCE,WEB
695,946,ALZHEIMER,APP,N2A,THESE
BACKGROUND,CONCLUSION,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SAMII,TRIGEMINAL
AGE,CAREFUL,CURRENTLY,III,JANUARY,KARNOFSKY,MEDLINE,OPTIMAL,WORLD
002,007,010,011,014,177,BACKGROUND,CONCLUSION,CONSORTIUM,CPA,DEPENDING,DIZZINESS,GAMMA,KNIFE,LABEL,METHODS,NORTH,OBJECTIVE,RESECTION,RESULTS
177,956,ACCORDING,BACKGROUND,CONCLUSION,FACBC,HOWEVER,LABEL,METHODS,MRI,PDT,PET,PROCEDURE,PSA,RESULTS,THERE
107,945,947,CD4,FURTHER,HLA,LABEL,MEL,MELAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,VKH
100,169,ACADEMY,ACE,ACT,ASSESSMENT,COGNITIVE,COMPETENCE,DECISIONS,INCAPACITY,IQR,LABEL,MACARTHUR,METHODS,NEUROLOGY,OBJECTIVE,RESULTS,TREATMENT,WORLD
169,COPYRIGHT,COX,CYP4A,HET0016,PROLONGED,SOCIETY
120,215,BRAIN,CLINICALLY,DWI,GIVEN,GLASGOW,HOWEVER,MCA,NIH,SCALE,THESE
BASED,BRAIN,DWI
161,BETWEEN,GBM,GENOMIC,MAY,THERE
BBB,BLOOD,ESPECIALLY,EVANS,GL261,HS683,MRI,THESE
169,945,946,947,B16,BL6,CD4,CD8,COPYRIGHT,DCS,DESPITE,HPV,IFN,INC,MYD88,TH1,THEREFORE,TNF
169,AUTHORS,BRAIN,HAARLEM,ISN,LTD,MAJOR,PATHOLOGY,PRIOR,SALIENT,SOCIETY,WILEY,WORLD
169,COPYRIGHT,DARBY,DEPENDING,FINALLY,INSTEAD,MADIN,SOCIETY,THEREFORE
000,001,13N,177,18F,312,866,918,961,964,BACKGROUND,BASED,CONCLUSION,FDG,FIFTY,LABEL,METHODS,NH3,OVERALL,PET,RESULTS,THERE,THESE
AAM,APPEARANCE,ASM,AUTOMATIC,DDD,FIRST,HOWEVER,LABEL,METHODS,MODEL,OBJECTIVE,PURPOSE,RATIO,RESULTS,SHAPE,THESE,THIRD
ANCOR,DSC,ELASTIC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THESE,WHILE
ARA,BBB,BECAUSE,CENTRAL,CNS,SEARCHING
945,APL,PAR,PML
CD133,CSC,FORSKOLIN,GBM,HOWEVER,NOD,PDE4D,PKA
BRAIN,DESPITE
000,001,188,773,919,942,978,992,995,999,CONCLUSION,DSC,III,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,PWI,RESULTS,ROC,SWI,WORLD
AMONG,PET
AFTER,CHANGES,CHO,CONCLUSION,COX,IMAGING,INC,LABEL,MACDONALD,MATERIALS,METHODS,NAA,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE
1P19Q,LGO,LOW,R132H,WORLD
ALA,CSI,FINALLY,HOWEVER,MRI,PRECISE,THESE
169,AFTER,COPYRIGHT,HOWEVER,IMAGING,INTRADURAL,LTD,MPNST
946,AKT,BCL,CCND1,EMT,TGF,THESE,TMZ,U87
III,MEDICAL,THERE
THESE,U87,WESTERN
169,CHEST,COPYRIGHT,HEMOPTYSIS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,PURPOSE,RESULTS,SIR
169,173,403,AFTER,COPYRIGHT,SCIENCE
000,800,BRC,CAB,THEREFORE
BACKGROUND,CENTRAL,EXPERIENCE,LABEL,METHODS,NERVOUS,TUMOURS,WORLD
169,ACC,COA,CPT1C,FATTY,R132H,SOCIETY,THEREFORE,U87MG
169,ADS,ARDISIA,COPYRIGHT,HOWEVER,INC,KEY,LABEL,LC3,METHODS,MTT,OBJECTIVE,RESULTS,TEM,THESE,WESTERN
ACP,AFTER,ANACNPS,GLIOMAS,MMP
CANDIDATE,CHANGES,CPG,LABEL,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,SUMMARY
160,956,III,RU486
169,215,ALK,ANAPLASTIC,ANTICANCER,CAUCASIAN,CNS,COPYRIGHT,INSTITUTE,KIRSTEN,NSCLC,THESE
169,946,AKT,ANTICANCER,COPYRIGHT,DISKS,DUE,EARLY,INSTITUTE,INT,LARGE,MAGI1,OCCLUDINS,PATHWAY,PDZ,PSD,THERE
169,AFTER,AIM,ANTICANCER,APOPTOTIC,CONCLUSION,COPYRIGHT,END,GBM,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TUNEL
AKT,FINALLY,HYPOXIA,KNOCKDOWN,NTRK2,THESE
150,AMIGO,IMAGE,IMAGING,MAPPING,MRI,OPERATING,TECHNICAL
169,AUTHORS,COPYRIGHT,INC,METTL14,MONITORING,PUBLISHED
108,133,143,200,APRIL,AUSTRALIA,AUSTRALIAN,BACKGROUND,BASIC,BMS,BRAIN,COMMITTEE,DESPITE,FUNDING,GROUP,HOWEVER,LABEL,MANAGEMENT,METHODS,MONITORING,RESULTS,SEPTEMBER,SITES,THESE,TRIAL,ZEALAND
169,AMONG,COPYRIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PARTNER,PUBLISHED,RESULTS,SOCIETY,THERE,URBAN
ROBO1,TAKEN,UBIQUITIN,USP33
169,AFTER,COPYRIGHT,FURTHER,HOWEVER,INC,PARKINSON,USING
143,AKT,ERK,FINALLY,RAS,TAKEN,TMZ
100,119,160,956,BACKGROUND,CONCLUSION,GAMMA,GRADE,GTT,HOWEVER,III,LABEL,METHODS,MTS,PIPER,RESULTS,WHILE
120,169,ASD,BAREL,DMR,FIFTEEN,HOWEVER,INC,KCNK9,PEG13,SEQUENCING,SEVERAL,TRAPPC9,WILEY
001,169,509,592,935,COPYRIGHT,COX,GBM,GSM,LTD,MEIER,SIMILARLY,USA,USING
160,169,BACKGROUND,COPYRIGHT,GROUP,INC,INTERGROUP,LABEL,METHODS,PUBLISHED,RESULTS,S0220,SOCIETY,SOUTHWEST,TRIAL
001,015,047,074,114,161,884,BACKGROUND,DFS,LABEL,METHODS,RECURRENCE,RESULTS,THERE
594,609,945,946,BACKGROUND,BRAIN,BSSP4,EBP,ERK,HCC,HEPG2,HOWEVER,LABEL,METHODS,RESULTS,TRS,WESTERN
ECTHYMA
AWS
GRADENIGO,MRI,THROUGH
001,008,024,036,049,068,079,107,142,152,184,219,453,709,764,COX,EXPRESSION,GLYCINE,LABEL,MDA,METHODS,OBJECTIVE,PHGDH,PURPOSE,RESULTS,SHMT1,TMA
BACKGROUND,CONCLUSION,INFORMA,LABEL,MALIGNANT,METHODS,MTS,OBJECTIVE,RESULTS,USING
125,AUGER,FURTHER,SONIC,TARGETING,THESE
BACKGROUND,CONCLUSION,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,SELLA
THREE
BECAUSE,EXCESSIVE
HBALC,HISTOLOGY,MRI,SERUM,THYROID,TPO,TSH
169,AMONG,COPYRIGHT,GDEPT,MSC,SAS
169,CD133,GIC,MARKERS,SOCIETY,SOX,SRY,THESE
100,150,169,200,AUSTRALIAN,BACKGROUND,CENTRAL,COLLEGE,CONCLUSION,GBM,LABEL,METHODS,RESULTS,ROYAL,SEVENTEEN,TMZ,ZEALAND
169,ACADEMY,NEUROLOGY,NF1
003,169,CONCLUSION,COPYRIGHT,COX,FURTHER,HOWEVER,LABEL,LOG,MEIER,METHODS,OBJECTIVE,PFS,RCC,RESULTS,SAS
001,169,724,AUTHORS,CBP,CSC,FOLLOWING,ICG,LTD,PRI,PTY,PUBLISHING,SCIENCE,SSC,THROUGHOUT,WILEY
049,147,169,BACKGROUND,BETWEEN,COPYRIGHT,EOR,GBM,GROSS,GTR,HOWEVER,KARNOFSKY,LABEL,LIKELIHOOD,MARCH,METHODS,MRI,NTR,RESULTS,SAS,SCALE,THERE
169,CSF,HOWEVER
AMP,TAKEN,TREATMENT
AES,BECAUSE,CLINICIANS,ICH,STATINS
169,INC,KROEMER,THERE
001,009,027,032,046,169,AGGRESSIVE,ATT,CAREFUL,CONCLUSION,COPYRIGHT,COX,III,IRELAND,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OPTIMAL,RECEIPT,RESULTS,SBO,SIXTY
142,169,303,BACKGROUND,C57BL,GL261,LABEL,METHODS,NTV,PRESS,PUBLISHED,RESULTS,STUDENT,THESE,UNIVERSITY
160,169,174,APT,COPYRIGHT,EDB,FOLLOWING,LTD,PEG,PLA,PTX,TAXOL,THESE,U87MG
166,648,BACKGROUND,CONCLUSION,LABEL,METHODS,ORS,RESULTS,THERE,VANCOUVER
000,001,085,100,169,BACKGROUND,CNS,COPYRIGHT,CRUDE,DUTCH,FOLLOWING,INCIDENCE,LABEL,LTD,METHODS,MUNICIPAL,RECORDS,RESULTS,TUMOURS
183,ALA,BACKGROUND,EIGHT,GEORG,GROSS,HOWEVER,LABEL,METHODS,NAVIGABLE,RESULTS,STUTTGART,THESE
183,BACKGROUND,BECAUSE,CONCLUSION,GEORG,LABEL,METHODS,PATIENT,RESULTS,SECONDARY,STUTTGART,WORLD
BACKGROUND,DEPARTMENT,FSH,ISOTOPE,LABEL,METHODS,THERAPY
811,946,ARF,INCREASED,INK4A,PREMATURE,TAKEN,TNM,XENOGRAFT
COLLEGE,MRI,RADIOLOGY,THERE
169,COPYRIGHT,PUBLISHED
ALTAS,COX,EMT,EXPRESSION,GBM,GENESET,GEO,HOWEVER,KARNOFSKY,KPS,OMNIBUS,SIMILARLY,THESE
TAKEN
169,COPYRIGHT,HOWEVER,INC,NEOPLASIA,PARP1,PARPI,PRESS,PUBLISHED
160,946,CD133,GBM,GSC,IIA,IL6,MTT,RESULTS,STAT3,TAKEN,TANSHINONE
165,169,BRAIN,BROCA,GUARANTORS,HOWEVER,INSTITUTE,PRESS,PUBLISHED,TASKS,THESE,UNIVERSITY
HOWEVER
100,AFTER,CNS,CONCLUSION,FTD,LABEL,METHODS,OBJECTIVE,PCNSL,PURPOSE,RESULTS,SCNSL
169,177,215,524,627,AB4,AFTER,CNS,COPYRIGHT,GROSS,HIT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
ACUTE,CURRENT,DELAYED,HOWEVER,HT3,NG108,NK1,RESULTS,SINCE
001,004,177,217,BDCA2,CD123,CD4,THESE
169,COPYRIGHT,MCA,SOCIETY,THESE
946,FRK,FYN,HOWEVER,MEANWHILE,SRC,U87
1980S,DLBCL,PCNSL,PRIMARY
ASSESSMENT,CHILDHOOD,CSF,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SCALE,SETTING,SYMPTOM,VARIABLES
CAREGIVERS,CONTENT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONTARIO,PURPOSE,QOL,RESULTS,SETTING,SURVIVORS
BACKGROUND,EMG,ICA,LABEL,METHODS,RESULTS,THERE,THESE
CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,STS,THEREFORE
160,FIBROBLAST,III,LOWER,MIB,PCR,THESE,USING,YKG
169,APC,BACKGROUND,CDH13,DELETIONS,LABEL,MBM,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,UNRAVELING
CLONOGENIC,MALIGNANT
DESPITE,THERE
THERE
056,115,177,284,710,FLC,IGG,IGM,ISS,LDH,PTH,SERUM
115,CTV,LABEL,LAO,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RAO,RESULTS,SIV,THESE
LIPOMATOUS,SYLVIAN,THEIR

945,954,EDU,GBM,JNK,LN229,NAC,ROS,THESE,U87
ELISA,PCR
LENTIVIRAL,MTT,THESE
BACKGROUND,EMT,KNOCKDOWN,KNS42,LABEL,METHODS,RESULTS,SNAIL,THEREFORE,U87
100,169,COGNITIVE,COPYRIGHT,CRT,MEG,OVERALL,THERE

ACD,ANY,DROSOPHILA,NEUROBLAST
BACKGROUND,CONCLUSION,LABEL,METHODS,PALLIATIVE,RESULTS,SINCE
169,511,945,946,COPYRIGHT,GAG,HOWEVER,IFN,IMPORTANCE,INHIBITION,LABEL,MLV,MOLONEY,OBJECTIVE,RRV,SOCIETY,THESE,UNLABELLED
169,CD4,COPYRIGHT,DCS,FIB,HIV,IMPORTANCE,LABEL,MECHANISMS,OBJECTIVE,SEM,SOCIETY,UNLABELLED
001,123,AKT,ANNEXIN,CONCLUSION,DCFDA,LABEL,MDA,MET,METHODS,MTT,OBJECTIVE,PURPOSE,RAF,RAS,RESULTS,ROS,SORAF,TMZ
177,CONCLUSION,CONTOURING,LABEL,METHODS,NPC,OBJECTIVE,PRECISE,PURPOSE,RESULTS
100,MTD,WBR
169,E47,FINALLY,HELIX,HLH,IMPORTANT,OLIG2,PRESS,THEIR,WHILE
BACKGROUND,CD11B,DC101,GR1,LABEL,METHODS,METRONOMIC,RESULTS
160,231,CNS,MDA,METASTATIC,PTX,TREATMENT,USING
169,AUSTRALIAN,COLLEGE,IMAGING,KNOWLEDGE,ROYAL,ZEALAND
AFTER,BACKGROUND,CONCLUSION,CURRENTLY,JANUARY,KSA,LABEL,METHODS,OBJECTIVE,RAJAVITHI,RESULTS,SEPTEMBER
169,946,FEDERATION,GBM,LTD,NOTCH,SMADS,SOCIETIES,WILEY,WNT,WORLD
100,181,200
110,140,172,173,177,956,ANOVA,BACKGROUND,CISPLATIN,CONCLUSION,LABEL,METHODS,NON,NPS,OBJECTIVE,OBJECTIVES,RESULTS,U87
160,169,231,BACKGROUND,BESAN,CONCLUSION,DEPARTMENT,DIAGNOSIS,DISCUSSION,LABEL,METHODS,PHACE,REPORTS,SIX,SOCIETY,THESE
160,ABCB1,ABCG2,ADP,BACKGROUND,KO143,LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,RUCAPARIB,TRANSPORT
ADAMTS1,BINDING,CODED,EXPRESSION,FINALLY,IGF1R,IGFII,INSULIN,ISOTOPE,LABEL,NOTABLY,PROTEIN,USING
169,ARG,ASP,ATLAS,FINALLY,GBM,GLY,LABEL,RGD,THESE,UNLABELLED
GLIOMAS,IDH,III,IMPORTANT,SEVERAL
BRAIN,HENRY,JOINT,SECTION
169,GIC,HOWEVER,ID4,JAGGED1,NOS,NOTCH
000,169,240,CMV
11A,11J,11K,169,COPYRIGHT,CRT,CUSO4,HUISGEN,LDH,LTD,TNF,TRAIL
108,160,337,AFTER,BACKGROUND,BLOOD,BRAIN,CONCLUSION,DOTATOC,ITALIAN,LABEL,METHODS,PANCREATIC,THERE,UPPER
169,177,213,461,844,BECAUSE,GAMMA,GAMMAPLAN,JAPAN,KNIFE,LEKSELL,LGP,PRESS,PUBLISHED,RADIATION,SKULL,SOCIETY,UNIVERSITY
169,ATOH1,COPYRIGHT,HENCE,HUWE1,INC,SHH,SIGNALING,SONIC
100,169,COPYRIGHT,INC,IPS,MFG
306,950,BACKGROUND,CBT,CIS,FEW,LABEL,METHODS,ORS,PARENTS,RESULTS
128,ATLAS,BACKGROUND,CCK,CHINESE,HOWEVER,LABEL,METHODS,PCR,PEARSON,RESULTS,SNAI1,SNAIL,SP1,U87
HDX,NCI,PARKINSON,ROS,THESE,UBIQUITIN,UCH
CURRENT,DESPITE,FINALLY,FIRST,GBM,MAJOR,THIRD
020,022,025,169,1P19Q,ANAPLASTIC,BACKGROUND,CD133,DIAGNOSIS,HOWEVER,IDH,III,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
010,169,BACKGROUND,CONCLUSION,CURRENTLY,FORTY,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY,WHILE
BMJ,CAROTID,GROUP,LTD,PUBLISHING,RADIATION
BMJ,GROUP,LTD,MRI,PUBLISHING,SUBSEQUENT
104,ARTIFACTS,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
CONCLUSION,DYNAMIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
AD5,CMV,ECS,HOWEVER,MBP,ROBO4,USING,WHILE
000,139,169,600,BACKGROUND,CALIFORNIA,FARMERS,INC,LABEL,METHODS,NHW,RESULTS,STAGE,THESE,UFW,WILEY,WORKERS
160,215,945,PROFILE,TNF,TREATMENT
124,945,ADAPTATION,HOWEVER,SERP1,TEAD1
10877,169,ASIAN,COPYRIGHT,DEPARTMENT,DFS,ICGCT,LTD,PATIENT,PRIMARY,RADIOLOGY,SECRETING,SINGAPORE,SOUTH,TREATMENT,WESTERN
169,COPYRIGHT,INC,SURGERY,THESE
001,004,005,008,147,AGE,BACKGROUND,BRAIN,COX,EXTENSIVE,JANUARY,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OVERALL,PROGNOSTIC,RESULTS,SRS,THESE
147,216,CDK,LYS,SUMO1,SUMOYLATED,THROUGHOUT
169,5GY,945,BECAUSE,COPYRIGHT,FGF,HIF,LTD,RESISTANCE,SF763,SF767,SSR128129E,SSR12819E,THESE,U87
169,COPYRIGHT,IGFBP,LTD,THERE,THESE
169,BRAIN,COPYRIGHT,DESPITE,FEDERATION,FURTHER,PUBLISHED,SOCIETIES
000,100,298,SCD,SEVERAL,USING
100,169,956,BIOIMAGING,COPYRIGHT,HYPER,ICP,MAJOR,MEANWHILE,MSI,SEVERAL
100,19Q,200,239,354,447,CPG,III,PCV,TMZ,WORLD
100,169,5MM,BACKGROUND,BLI,COMBINING,COMPARISON,CONCLUSION,COPYRIGHT,GBM,IMMEDIATE,LABEL,LOCAL,MEIER,METHODS,RESULTS,U87MG
549,BLK,CNS,CURRENTLY,DISCOVERY,DU145,HDF,HSP70,IHC,LNCAP,NG108,PC3,SHOCK,TDF,THESE,USING,WESTERN
AMONG,ESI,MALDI
169,946,CLINICALLY,DESPITE,ECG,HEART,INC,MRI,QTC,RVH
562,EVALUATING,FOV,MRI,TOTALLY
MRI
000,169,176,945,BRAIN,GLYCINE,GUARANTORS,PRESS,PUBLISHED,SERUM,SEVEN,TEN,THREE,UNIVERSITY
169,ASYMMETRIC,CHROMOSOME,HSSAS,MUTATIONS,PAKISTANI,PRESS,PUBLISHED,UNIVERSITY
177,215,ADC,ADCG1,ADCG2,ADCG3,CONCLUSION,CSF,FORTY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
169,DUE,HOWEVER,NEURO,NOVEL,PRESS,PUBLISHED,SHH,SMO,SOCIETY,UNIVERSITY
169,377,64257,BACKGROUND,CONCLUSION,FINALLY,GBM,INCREASING,LABEL,METHODS,MIR,MIRNA,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SILENCING,SOCIETY,SP1,SUBSEQUENT,THESE,UNIVERSITY,WESTERN
169,209,CALIFORNIA,COPYRIGHT,FRANCISCO,GRADE,LTD,PATIENT,PFS,PRIMARY,PUBLISHED,PXA,SAN,UNIVERSITY,WORLD
160,169,340,ACUTE,ADVERSE,ALLEGHENY,BETWEEN,CONTURA,COPYRIGHT,FURTHER,GENERAL,HARVARD,HODGKIN,HOLOGIC,IDC,INC,LABEL,MAMMOSITE,MARCH,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PUBLISHED,PURPOSE,RESULTS,SCALE,SCORE,SIXTEEN,SOCIETY,TEMPE
FUNCTIONAL,TREATMENT
100,19Q,19Q13,954,CONCLUSION,FINALLY,IMMUNOFISH,LABEL,METHODS,MIB,OBJECTIVE,RESULTS,VALIDATION
018,053,086,091,756,ADC,CHI,DCE,DTI,HOWEVER,KEP,LABEL,METHODS,MRI,OBJECTIVE,REGIONS,RESULTS,WHITNEY
169,FDG,FET,IMAGING,INC,MOLECULAR,NUCLEAR,PET,SOCIETY
001,008,231,4T1,BACKGROUND,BARD1,EXPRESSION,LABEL,MDA,METHODS,PRESS,PUBLISHED,RAD51,RESULTS,THEIR,UNIVERSITY
946,CURRENT,GBM,GENOMIC,THESE,U87,WESTERN,WNT
001,006,104,169,BACKGROUND,BMD,BMI,CONTEXT,COPYRIGHT,CROSS,HOWEVER,INC,IRANIAN,LABEL,METHODS,NEITHER,OBJECTIVE,OUTCOME,PATIENT,PREVIOUSLY,PURPOSE,RESULTS,SCI,SETTING,TOTAL,UNTIL
001,169,CONCLUSION,COX,LABEL,METHODS,MRS,OBJECTIVE,PURPOSE,RESULTS,WHERE
169,VCH,WILEY
169,DESPITE,DIFFUSE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMIZING,RESULTS,WILEY
179,184,BACKGROUND,CONCLUSION,GROSS,LABEL,METHODS,RESULTS,THERE,THREE,TSA
169,177,947,956,AMP,APN,ENZYMATIC,GTP,HYDROLYSIS,N2A,NEURO,NPP,SOCIETY
FIFTY,III,KARNOFSKY,MACDONALD,PRIMARY,THERE
043,HDR,SIXTY
CNS,FINALLY,MRI,SIMILARLY
EFFECTIVE,III,MO28347,PHASE,SOC
000,14284,200,20202,486,BACKGROUND,BLADDER,BRAIN,CANCERS,CONTEXT,EASTERN,ESOPHAGUS,LABEL,METHODS,OBJECTIVE,ORGAN,OROPHARYNX,OVARY,RAJASTHAN,RESULTS,THERE,WESTERN
100,125,13R,169,945,CED,CONCLUSION,GLIOMAS,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,RESULTS,SOCIETY,SPECT,THESE,UNLABELLED
11P15,169,CD133,DROSOPHILA,GBM,MECHANISMS,MUSASHI,MYC,NANOG,NOTCH,TRIM3
GLIOMAS,MALIGNANT

169,946,INCREASED,LOF,PDGFS,SOCIETY,UNTIL
169,183,ATTACHMENT,BECAUSE,COPYRIGHT,EBV,EPSTEIN,IGG,INC,PUBLISHED,VCA
100,300,BROCA,DCS,HOWEVER,INC,LABEL,METHODS,NPV,OBJECTIVE,ONSET,PPV,PUBLISHED,REPETITIVE,RESULTS,ROC,THESE,TMS
ANNEXIN,CASPASE,CD133,CELECOXIB,COX,CSC,DNS,DPS,FINALLY,INCUBATION,JAK,JANUS,MICROARRAY,STAT3,TUNEL,WESTERN
169,AFTER,AGILITY,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,SYNERGY,UNIVERSITY
150,161,169,949,ACADEMY,ADDITIONAL,LABEL,METHODS,MRI,NEUROLOGY,OBJECTIVE,RATINGS,RESULTS,THERE
CURRENTLY,DIFFERENT
PRIMARY,YST
AIM,ALK,ANAPLASTIC,BACKGROUND,CD3,CNS,CONCLUSION,DEPARTMENT,FURTHER,IMFTS,LABEL,MATERIALS,METHODS,MIB,OBJECTIVE,RESULTS,SMA
ASTROCYTIC,BBB,MALIGNANT,THESE
BRAIN,CTV,DEVICES,INCREASES,JAPAN,MEDICAL,MRI,TAKEN
130,150,169,AFTER,BACKGROUND,BASED,BASEL,CONCLUSION,FIFTEEN,GBM,LABEL,METHODS,MRI,NOA,RESULTS
103,160,BACKGROUND,CAROTID,DISCUSSION,LABEL,METHODS,SUCCESSFUL,THESE
AFTER,OVERALL,POI,PREMATURE,THERE,WHERE
4TH,511,ASIDE,AVAGLIO,EMPLOYING,FEDERATION,FRANCISCO,MEETING,NEURO,PDL,REACT,SAN,SEVERAL,SOCIETY,USA,WORLD
100,181,200,500,AFTER,BCL,DIFFERENT,WESTERN
106,ANXIETY,DEPRESSION,EVALUATION,FIM,FUNCTIONAL,INTENTION,LABEL,MEASURE,METHODS,OBJECTIVE,PERCEIVED,PROBLEM,PROFILE,RESULTS,SCALE
166,169,CNS,COPYRIGHT,DDI,HOWEVER,I1T,I1U,LEWIS,PUBLISHED,SOCIETY
169,24H,CBP,COPYRIGHT,GCPII,GLUTAMATE,INC,MG132,SIMILARLY,TAKEN,TREATMENT,U87MG,VPA
169,BASED,CONCLUSION,COPYRIGHT,INC,INQUIRIES,JANUARY,LABEL,OBJECTIVE,PURPOSE,RESPONSES,SOCIETY,SUMMARY
113,CGH,CNS,III,SEVENTEEN,STRUCTURAL,TREATMENT,UNIVERSITY
000,169,244,756,COSTS,HEALTHCARE,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PROJECT,QALYS,RESULTS,SOCIETY
139,159,177,409,AVR,BACKGROUND,BNP,CARDIAC,CONCLUSION,CPB,FIFTY,HOWEVER,LABEL,METHODS,PWV,RESULTS,THESE
106,22891,26891,BACKGROUND,BRAIN,CONCLUSION,COX,DISCUSSION,EORTC,HES,LABEL,METHODS,RESULTS,THEREFORE
286,ECM,NH2,PROGNOSCAN,SPARC
ART,CD8,EPSTEIN,HIV
001,137,244,DISCUSSION,EARLY,GCC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCT,RESULTS,VFD
018,169,246,COMPARING,DESPITE,GENERAL,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCH,SETTING
015,035,CONCLUSION,EMA,EMACO,FIFTEEN,GTN,LABEL,MAC,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTEEN
AMONG,BACKGROUND,DESPITE,FIFTEEN,FORTY,HGG,III,LABEL,METHODS,RESULTS,SIX
169,COPYRIGHT,GBM,GLIOMAS,LTD,MICRORNAS
237,AIEOP,BACKGROUND,CLEAR,EFS,INTENSIVE,LABEL,METHODS,NOVEL,RELAPSE,RESULTS,SINCE,THIRT
169,ATTACHMENT,COPYRIGHT,GTR,HENCE,INC,LABEL,METHODS,OBJECTIVE,RESULTS,STR,THIRD
017,169,274,AGE,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RECURRENCE,RESULTS,TOTAL,USING
001,120,BACKGROUND,CONCLUSION,FFF,FLATTENING,LABEL,METHODS,RESULTS,STD
120,141,215,ACROMEGALY,BACKGROUND,EIGHT,IGF,INJECTION,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,SRIFS,TREATMENT
169,COPYRIGHT,HOWEVER,IRELAND,LTD,THESE
101,CONCLUSION,LABEL,METHODS,MUTATIONS,OBJECTIVE,PCR,RESULTS,THESE,TMZ
ALZHEIMER,BRAAK,BRCA1,CDR,CERAD,HOWEVER,III,SEVERAL,TMA,TUNEL
001,054,177,630,ADOLESCENT,CHILDHOOD,QOL
000,945,LBD,LBP,NR2E1,NRS,NSC,NUCLEAR,PRESENTLY,RESULTS,SMALL,TLX,USING,WHILE
128,160,176,215,504,956,ALZHEIMER,BACKGROUND,BILLERICA,BROOK,DIEGO,DISCUSSION,FOLLOWING,FOV,HOWEVER,IMAGING,LABEL,MANGANESE,MEMRI,METHODS,MNCL2,MODEL,MRI,ONL,P301L,PARAVISION,PRISM,REGIONS,RESONANCE,RESULTING,RESULTS,ROI,SAN,STONY,UNASSIGNED,USING
169,404,761,822,939,AUSTRALIA,BACKGROUND,CASES,ELF,ESTIMATES,FEW,GERMANY,HOWEVER,KINGDOM,LABEL,METHODS,PLINEAR,RESULTS,THERE,ZEALAND
103159646,240,6CONHOH,840,956,CH2,FIRST,H1299,HDAC4,HDAC8,HDACI,HISTONE,N25,PCR,PDB,RNHCO,THESE,U87
111,BACKGROUND,GBM,KAYSERI,LABEL,MATERIALS,METHODS,PFS,RESULTS
169,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,LABEL,METHODS,RESULTS,ROYAL,ZEALAND
COGNITIVE,III
169,237,CLR,DCS,HOWEVER,MOG,THESE,VALLEJO
007,021,037,169,363,415,COPYRIGHT,EXPRESSION,HMGA2,III,INC,WESTERN,WORLD
AFTER,BACKGROUND,CAUCASIAN,LABEL,METHODS,PANTOEA
956,ABOVE,BACKGROUND,CONCLUSION,FDP,LABEL,METHODS,RESULTS
ACP,APC,BACKGROUND,CTSL1,CXCR4,FN1,FXYD5,ITGB3,LABEL,METHODS,NR4A3,OBJECTIVE,PLAUR,RESULTS,THESE,TIMP2,TIMP4,VEGFA
007,009,169,945,CAUCASIAN,FURTHER,LTD,MINOR,P3A,P3B,SOCIETY,WILEY
001,ALTERED,LOH,NUCLEAR,PCR,PROTEIN,WNT
169,AIM,CHINA,COLLEGE,COPYRIGHT,DWI,JANUARY,KNOWLEDGE,LABEL,LTD,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,USING
160,169,ACR,COLLEGE,COPYRIGHT,IMAGING,INC,MRI,PUBLISHED,RADIOLOGY
661,INSTITUTE,SCALP,TREATMENT
001,002,007,100,112,133,151,AFTER,AMS,BACKGROUND,BRAIN,CONCLUSION,COX,GTR,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
001,003,016,020,028,049,055,112,118,127,173,361,834,AFTER,CHINA,CHT,CMB,DMB,EFS,ESTIMATED,NON,SHH,UNIVARIATE,WNT
169,250,577,651,700,740,967,AGE,AUTHORS,CENTRAL,CNS,COX,HODGKIN,IVL,LDH,LTD,RITUXIMAB,WHITNEY,WILEY
041,054,160,318,411,551,556,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DUE,ITT,JANUARY,LABEL,MEDLINE,METHODS,NOW,OBJECTIVE,OBJECTIVES,PCNSL,PFS,PRIOR,RCT,RESULTS,SELECTION,TREATMENT,WBR,WHERE
169,210,945,CASPASE,COPYRIGHT,GIVEN,HIF,INC,KNOCKDOWN,MNT,MYC,ROS,THESE
114,169,AFTER,CONCLUSION,COPYRIGHT,III,INC,LABEL,METHODS,OBJECTIVE,RESULTS,WORLD
C228T,C250T,HOWEVER,PCR,SNP,SOMATIC,T349C,THERE
001,041,042,169,18F,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FIFTY,FLT,HOWEVER,INC,KARNOFSKY,KPS,LABEL,MEIER,METHODS,MRI,PET,RESULTS,UNIVARIATE,VOL
005,017,033,040,050,10878,169,AOA,COPYRIGHT,III,INCREASED,ISOCITRATE,KPNA2,LTD,LTS,PFS,R132H,WORLD

160,1772C,1790G,387,437,945,CHINESE,HIF,III
169,AET,COPYRIGHT,INHIBITION,LTD,MDR,MULTIDRUG
116,169,231,251,ADR5000,BACKGROUND,CEM,CONCLUSION,COPYRIGHT,HCT,IRELAND,ISOLATION,LABEL,LTD,MATERIALS,MDA,MESUA,METHODS,NELUMBO,RELEVANCE,RESULTS,XTT
169,201,201TI,201TL,COPYRIGHT,EMPIRIC,IRELAND,JAPAN,LTD,PCR,SPECT
169,AKT,EGF,HOWEVER,LIPID,RES,YET
123,169,177,CHANGES,COPYRIGHT,IMZ,IOMAZENIL,PUBLISHED,SPECT,STATE,TEN
160,250,BACKGROUND,BETWEEN,CONCLUSION,GBM,JANUARY,LABEL,METHODS,RESULTS,TREATMENT
003,169,375,ACADEMY,CLASS,CNS,HOPKINS,III,JOHNS,LABEL,METHODS,MTX,NEUROLOGY,OBJECTIVE,PCNSL,RESULTS
005,169,ACADEMY,BEV,HISTOLOGIC,HOWEVER,LABEL,METHODS,MRI,NEUROLOGY,NOTABLY,OBJECTIVE,OBJECTIVES,RESULTS
124,128,169,218,4MRES,ADENOVIRAL,ADENOVIRUS,COPYRIGHT,E1A,HOWEVER,INC
169,AUTHORS,COPYRIGHT,ENV,HIV,INC,PUBLISHED,SIV,SIVMAC251,THESE
DESPITE,IMAGING,MRI,PET
ALGORITHM,APPLIED,ASSESSMENT,AUSTRALIA,AUSTRALIAN,BACKGROUND,CATCH,CHALICE,CHILDHOOD,CTS,DISCUSSION,EMERGENCY,FAILURE,IMPORTANT,LABEL,MAY,METHODS,NETWORK,OUTCOME,PAEDIATRIC,PEDIATRIC,PREDICT,PREDICTION,PREDICTOR,THREE,TOMOGRAPHY,TRIAL,USA,ZEALAND
200,AFTER,BACKGROUND,LABEL,MALIGNANT,METHODS,PCR,RESULTS,THESE,WESTERN
CNS,LABEL,LIMITED,METHODS,OBJECTIVE,OVERALL,PATHOLOGY,RESULTS,SITES
ENGLISH,MPNST,PRIMARY,T12,THESE
102,116,118,145,195,231,472,489,MALIGNANT,MANAGEMENT,USA
120,181,18F,344,946,CONSISTENT,DEOXY,F98,FISCHER,GCV,MRI,PET,RAT
000,100,APC,ASSOCIATED,BRAIN,C75,CENTRAL,CNS,DIAGNOSTIC,EDITION,HISPANICS,ICD,INDIANS,ISLANDERS,JOINPOINT,LABEL,METHODS,NATIVES,OBJECTIVE,PACIFIC,PITUITARY,THESE,THIRD,USING
040,055,100,648,900,ACGME,COUNCIL,DUE,EDUCATION,INPATIENT,LABEL,MEDICAL,METHODS,NATIONWIDE,OBJECTIVE,PATIENT,RESULTS
169,430,COPYRIGHT,FINALLY,SCIENCE
169,215,60S,COPYRIGHT,DCE,INC,MPE,MRI,RESULTS,TOI,USING
100,110,169,232,COPYRIGHT,INC,LYNCH,MMR,THERE,V600E
109,119,169,273,356,629,BACKGROUND,BASEL,BMT,DISTANT,DMS,EAC,FOLLOWING,LABEL,METHODS,RESULTS,TMT
AKT,HOWEVER,LGG,LOW,NEWER
169,ADC,CNR,CONCLUSION,DWI,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNR,WILEY
AMONG,BETWEEN,GUIDE,HENCE,LABEL,METHODS,MRS,OBJECTIVE,RESULTS,TECHNICAL,THEIR,VARIO
169,CHOROID,CPP,GROSS,LTD,TRANEXAMIC,TXA,WILEY
115,169,250,BACKGROUND,EXPANDING,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,BIOLOGY,ECTOPIC,GBM,INC,MOLECULAR,MOUSE,RAS,SOCIETY
001,169,177,183,AGHDA,BACKGROUND,BDI,CONCLUSION,EDE,EPQ,EPWORTH,EUROQOL,FEV,FKB,HOWEVER,LABEL,LTD,METHODS,NORMATIVE,OBESITY,QOL,RESULTS,SCALE,SLEEPINESS,TPQ,WILEY
100,116,160,201,2B3,ALS,ANIMALS,BACKGROUND,CNS,HALLMARKS,LABEL,MRI,PEGYLATED,RESULTS,THESE,TREATMENT,WEIGHTS


KARNOFSKY,SURGERY
ACHIEVING,BRAIN,EXTENDING,INAUGURAL,MRI
169,3DCRT,ANTICANCER,COPYRIGHT,INSTITUTE,LOCAL,MAJOR,RPA,SIXTY
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,D54,GBM,HYPEROXIA,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS,U87,UPR
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,R132H,RESULTS,SENESCENCE
169,ANTICANCER,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,CYFRA,EVALUATION,HOWEVER,INSTITUTE,LABEL,METHODS,RESULTS,TPA,UNIVARIATE,VARIOUS
008,15YEARS,169,BACKGROUND,CHILD,COPYRIGHT,EARLY,LABEL,LTD,METHODS,RESULTS,YOUTH
BRAIN,EFFECTIVE,METASTATIC,STUDIES
TESLA
AFTER,METASTATIC
000MG,100MG,1CM,215,4GY,5MG,AFTER,CEREBELLAR
107,215,405,513,636
BMJ,CNS,GROUP,LTD,METASTASIS,PUBLISHING,TCC,TREATMENT
946,AMONG,CD7,COMPARISON,EMI,EXPRESSION,LUC,THESE
169,CENTURY,DIFFUSION,DTI,GENERAL,IMAGE,INC,MRI,WILEY
C70,PETERSBURG
018,047,123,142,147,177,18F,204,AFTER,BRAIN,CPT,FET,GBM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV
CONCLUSION,III,LABEL,METHODS,OBJECTIVE,RESULTS
19Q,BACKGROUND,BESIDES,CONCLUSION,LABEL,LOW,METHODS,RESULTS,SNP,THEIR,UPD,USING
169,BAT,GLP,READERS,VMH
008,160,AGGREGATE,AIS,CBF,CBV,CONVERSELY,DECREASED,DIASCHISIS,DTI,EIGHT,INITIAL,MRI,SEVEN
BACKGROUND,BRAIN,CONCLUSION,CRANIAL,DESPITE,LABEL,METHODS,SIX,WIDESPREAD
001,1ST,2ND,BACKGROUND,GAMMA,KARNOFSKY,KNIFE,KPS,LABEL,LARGE,METHODS,OVERALL,RESULTS,SRS
003,004,442,ACC,CONTROL,GLUTAMATE,TESLA,THESE,UHR
136,160,169,AAV,COPYRIGHT,EVS,FINALLY,LTD,USING
188,578,610,AMONG,FIRSTLY,LOW,MARKERS,NFPAS,NON,OWING,PCR,SURGERY,THESE,WESTERN
169,956,AMONG,COPYRIGHT,DOCKING,LTD,THESE
177,956
169,COPYRIGHT,CSF,INC,LABEL,METHODS,NSF,OBJECTIVE,OCTOBER,RESULTS
100,109,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PITUITARY,RESULTS,THERE
BACKGROUND,CHINESE,LABEL,METHODS,RESULTS,TRC,TRIAL,VAS
ASSRS,HOWEVER,PHYSICIANS,SPL
AIM,BACKGROUND,LABEL,METHODS,RESULTS,THERE,TSC
AFTERWARDS,BETWEEN,SOMETIMES,THOSE
AGT,CENUS,ESI,HOWEVER,SF767,THESE
DUE,REVERSIBLE
169,ADULT,BIOMARKERS,CHRONIC,COPYRIGHT,DEFAULT,DMN,GIVEN,INC
024,35U,6MV,CA125,COX,CSS,MEIER,SIXTY
169,177,5MM,COPYRIGHT,CSI,INC,MEDICAL,OAR,PUBLISHED
169,177,AUSTRALIAN,BACKGROUND,COLLEGE,GROUP,LABEL,LINAC,METHODS,MUS,OAR,RADIATION,RESULTS,ROYAL,THERAPY,THERE,ZEALAND
169,ADJUSTMENT,ANXIETY,CONCLUSION,COPYRIGHT,DEPRESSION,INC,LABEL,MAC,MET,METHODS,OBJECTIVE,RESULTS,SCALE,VAL
160,169,COPYRIGHT,EXTENSIVE,IGM,INC,INITIAL,MRI,SIX,WESTERN
8G7G3,CLONE,CONCLUSION,FOCAL,HOWEVER,III,LABEL,METHODS,OBJECTIVE,RESULTS,SPT24,TTF
003,010,012,023,118,236,APRIL,BACKGROUND,CGE,CSI,DIARRHOEA,HOWEVER,LABEL,METHODS,RESULTS,THERE
177,BACKGROUND,BLS,BURKITT,CONCLUSION,EBNA1,EBV,EPSTEIN,JID,LABEL,METHODS,MUTUI,PCR,PLAC1,RESULTS
003,160,687,793,BACKGROUND,BRESLOW,COMMITTEE,CONCLUSION,COX,HNM,JOINT,LABEL,MEIER,METHODS,PRIMARY,RESULTS,TLM
169,BACKGROUND,BRIEF,CONTROL,CRAVING,CUE,DEPENDENCE,EFA,ENGLISH,INVENTORY,LABEL,METHODS,MOTIVES,OVERALL,PRESS,PUBLISHED,RESULTS,SMOKING,SOCIETY,SPANISH,TOBACCO,TOLERANCE,UNIVERSITY,WISCONSIN,WISDM
ALKYLATOR,EPIGENETIC,NOTABLY,WHETHER
153,279,HBD,JAPAN
1DS,ALZHEIMER,JAPAN,KOREA,SINCE,USA
112,150,181,211,EXCESSIVE,HV1,VSD
380,678,ASM,CROHN,FINALLY,IGA,THESE
169,AKT,BCL,BECLIN1,CNS,ERBB1,ERBB2,EXPRESSION,FDA,GFP,INC,KNOCK,LAMP2,LC3,LC3II,SIMILAR,TREATMENT,WILEY
169,ACADEMY,ADDITIONAL,AUTOPHAGY,BACKGROUND,COPYRIGHT,HSP27,HSP72,INSTITUTE,LABEL,METHODS,PARTNER,PUBLISHED,RESULTS,THEREFORE,THESE,URBAN,WESTERN
10878,169,2ND,AML,APE,BACKGROUND,BETWEEN,CISPLATIN,CONCLUSION,COPYRIGHT,EMA,FEDERATION,GTN,GUSTAVE,IGR,LABEL,LTD,METHODS,OBSTETRICS,RESULTS,THERE
169,176,5MM,7MM,ANY,COPYRIGHT,INC,MEDICAL,NOVALIS,PRESAGE,PREVENTING,PUBLISHED,SRT
169,CLINICIANS,COPYRIGHT,FURTHER,INC
169,APC,COPYRIGHT,INC,SENESCENCE,USING
BACKGROUND,GBM,KU0063794,LABEL,METHODS,PI3,RESULTS,SINCE,THESE,TMZ,TUMOURS,WESTERN
169,COPYRIGHT,LTD,STUDIES,WHILE
169,946,DEPLETION,GSC,INC,L1CAM,TARGETING,THESE,WILEY
169,INC,MET,TAKEN,TARGETING,WILEY
146,AMONG,DIAGNOSTIC,EBV,EPSTEIN,HHV,HODGKIN,PCR,PRIMARILY
135,169,888,ABT,ADP,BACKGROUND,LABEL,METHODS,MTD,NEURO,PAR,PBMCS,PRESS,PUBLISHED,RESULTS,RP2DS,SOCIETY,TMZ,UNIVERSITY,VELIPARIB
07728,134,169,177,BACKGROUND,BETWEEN,COMMISSION,CONCLUSION,CRT,DISRUPTED,HGG,JANUARY,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RADIATION,RESULTS,SOCIETY,UNITS,UNIVERSITY
145,169,201,224,237,241,588,COPYRIGHT,LABEL,METHODS,NEUROCIRUG,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THESE
169,AGE,COPYRIGHT,LTD,THERE
169,600,AUTHORS,COPYRIGHT,GUIDELINES,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,TGN,THERE,TRIGEMINAL
AKT,CSF,ERK,MO3,SINCE,USING
169,AKT,COPYRIGHT,ISSUE,LTD,NON,REDUCED,REVOLUTION,THESE
BACKGROUND,CONCLUSION,IGCTS,LABEL,METHODS,MRI,PRIMARY,SEVEN
BLAKE,BPC,CSF,HOWEVER,THEREFORE

BMJ,CMV,GROUP,LIMITED,PUBLISHED,PUBLISHING,SINCE,VILHELM
COX,EPCAM,EPITHELIAL,HOWEVER,III,MEIER,MODEL,MVD,WESTERN
ADULT,ALABAMA,BACKGROUND,BIRMINGHAM,BRAIN,CONSORTIUM,GBM,LABEL,METHODS,RESULTS,SIXTY,UNIVERSITY
169,9FY,CLONE,COPYRIGHT,EPR3864,ERG,EWING,EWSR1,FLI,MRT,SEVERAL,SIMILARLY
053,169,181,COPYRIGHT,COX,FATAL,INC,IRR,NO2,PRESENT,THERE
160,169,293,ARG247GLN,ARG51,COPYRIGHT,ERK,GLU49,INC,INDUCED,MAB21L2,PUBLISHED,SOCIETY,THREE
PAI
CLINICALLY,HPC
ENHANCING,FIFTY,GADOLINIUM,LABEL,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS,THERE,THESE,VEGFR
169,CHRONIC,COPYRIGHT,LTD
BLACK,DALDI,DESORPTION,DYE,HENCE,HOWEVER,IMAGING,IONIZATION,LASER,LIPID,MALDI,OIL,RED,SUDAN
DTI,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
FUNCTIONAL,NOTABLY
AUTOPHAGY,HOWEVER
100,169,177,52466,945,ACADEMY,BACKGROUND,COPYRIGHT,INSTITUTE,KYNURENIC,LABEL,METHODS,MK801,MTT,PARTNER,PUBLISHED,RESULTS,URBAN,WOUND
169,316,AGE,BACKGROUND,COX,GERMANY,LABEL,METHODS,MRI,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY,VALIDATION
169,BACKGROUND,BRAIN,IPILIMUMAB,LABEL,METHODS,MRI,THERAPY
POSTNATAL
169,2HG,AGAINST,INC,INCREASED,IQR,LABEL,LOW,METHODS,OBJECTIVE,R132H,RESULTS,TAE,WILEY,WORLD
26951,26981,368,573,C30,COMPARISON,DESPITE,EORTC,HRQOL,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QUITE,RESULTS,THREE,TREATMENT
100,200,400,956,AIM,CONCLUSION,HSP27,LABEL,METHODS,MTT,OBJECTIVE,QUERCETIN,RESULTS,TMZ,U87,WESTERN
053,EARLY,HNC,HPV,IMPORTANCE,LABEL,METHODS,OBJECTIVE,REGARDING,RELEVANCE,RESULTS,SETTING,SMOKING,STRATEGIES,SUBJECTIVE
169,AGAINST,INC,LABEL,METHODS,NEUROLOGIC,OBJECTIVE,RESULTS,THESE,WASHINGTON,WILEY
215,AMONG,SIMPSON
215,ARTIFICIAL,SKULL
133,179,266,AVP,BACKGROUND,CONCLUSION,IQR,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SRS
AFTERWARDS,BACKGROUND,CONCLUSION,DISCUSSION,LABEL,MCC,METHODS,TTF
EXPECTING,THESE
040,082,ARL5B,CONSORTIUM,GENOMES,KYOTO,MOLECULAR,SEVERAL,SIGNATURES,THESE
MCC
106,CD133,THESE
451,HOWEVER,THOSE
100,169,AED,BRAIN,BTE,PRESS,RANDOMIZED,RECURRENCE,VPA
945,GFP,HIF,HOWEVER,HYPOXIA,INHIBITION,MDIVI,MTT,NOTABLY,THEREFORE
BMJ,GROUP,LTD,PUBLISHING
160,169,445,AMONG,ERG,EWING,EWSR1,FEV,LABEL,LTD,METHODS,OBJECTIVE,PCR,PRIMARY,RESULTS,SKY,TEN,TUMOURS,WILEY
169,945,946,ASCL1,EGF,EXPRESSION,GBM,ICAM1,IL8,ITGA9,NG2,OLIG2,PDGFR,PRESS,REMARKABLY,SMA,SNAI2,THESE,VCAM1
235,ACCORDING,BACKGROUND,BASED,CNS,LABEL,METHODS,PREDICTIVE,RESULTS,STUDIES,WORLD
RBM47,THROUGH,WNT
SIX
169,AUTHORS,BCA,CURRENT,FIRST,GST,LTD,MRI,SDG,VOGIM,WILEY
186,268,628,ALZHEIMER,AUSTRALIA,AUSTRALIAN,BACKGROUND,DISABILITY,LABEL,METHODS,PARKINSON,RESULTS,STATISTICS,THESE
293,726,AUSTRALIAN,B12,CBT,CHILDHOOD,CONTROL,DIETARY,ORS,THESE
183,BACKGROUND,ENDOSCOPIC,ENDOSCOPY,GEORG,JANUARY,KARNOFSKY,LABEL,METHODS,OPENING,RESULTS,SIX,STUTTGART
MRI,NUCLEAR,PET,SPECT
CONCLUSION,INTRA,LABEL,METHODS,OBJECTIVE,RESULTS,TUMOURS
123,ABOUT,EWING,PAX
016,063,475,784,CDC,CENTERS,CONTROL,DIAGNOSTIC,DISEASE,LEPTOSPIRA,PCR,POLYMERASE,PREVENTION
ABC,ABCB1,MCD,THESE
GBM,INITIALLY
SIRTUIN
ADMET,ALZHEIMER,DESPITE,FRD,FRIEDREICH,PARKINSON
DESPITE,NFL,NRF,PCR,TBS
CONCLUSION,HOWEVER,LABEL,OBJECTIVE,PET,SIMILAR,SSTRS
14Q32,ABOUT,AKT,ASIAN,CBL,IGCTS,JAPAN,KIT,NOVEL,OWING,RAS,WESTERN
132,ARG132HIS,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,R132H,RESULTS,THESE,U87
BMJ,GROUP,HOWEVER,LTD,MRI,PUBLISHING,PULMONARY
169,COPYRIGHT,INC,MEDICAL,PUBLISHED
150,200,BACKGROUND,BMS,BRAIN,CONCLUSION,GRADE,IMBRT,LABEL,METHODS,NSCLC,RESULTS,THREE,TMZ
1319C,BACKGROUND,CONCLUSION,FINDING,GENBANK,GENOMIC,ITALIAN,LABEL,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,PORTUGUESE,RESULTS,SER440TYR,SNP,THESE,WHILE
001,100,104,124,5MC,BACKGROUND,CONVERSELY,DIFFUSE,EPIGENETIC,GBM,H3F3A,H3K9ME3,LABEL,LOW,RESULTS
COMBINING,FDOPA,HOWEVER,KINETIC,MRI,PET
169,280,AMONG,EASTERN,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,TKI,UNIVERSITY
600,GBM,PXA,THESE,V600E,WORLD
BACKGROUND,CD133,COA,GBM,HGF,LABEL,MET,METHODS,MUSASHI,RESULTS,SOX,TARGETING,VL3
BACKGROUND,BECAUSE,CD103,CD8,FINALLY,LABEL,METHODS,MHC,MODULATION,RESULTS,RTE,TAKEN
BACKGROUND,CONCLUSION,LABEL,METHODS,TREATMENT
027,COMBS,CONCLUSION,HEIDELBERG,III,KPS,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PRS,PURPOSE,RESULTS,SEVENTY
030,215,338,581,817,ADC,CSF,DWI,GBM,MRI,PATHOLOGY,PNETS,REDUCED,RESULTS,THESE
CNS,MAHALEY,SECTION,SURGERY
FAK,HOWEVER,MMP,TAKEN,VEGF165
169,COPYRIGHT,HOWEVER,PSS
DED,FDM,M14,NOTABLY
116,118,APRIL,CANAVAN,MRS,SEPTEMBER
100,150,6MM,963,974,DISTANCES,DOF,DOSIMETRIC,PTV,THREE,V18GY,V20GY,WITHOUT
177,AMONG,GUIDE,OBI,OGP,PENTA,RANDO,SRS,THREE,TRILOGY
DROSOPHILA,SMARCB1,SNF,SWI,THESE
100,169,200,945,946,947,ATP,BIOLOGY,CARNOSINE,HEK293T,INC,MOLECULAR,SOCIETY,USING,WESTERN
169,ACR,ALBERTA,BACKGROUND,BESIDES,BMS,CONCLUSION,KCR,LABEL,LOW,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
001,100,120,169,529,801,956,AFTER,AMB,BRITISH,CNS,CONCURRENT,CSF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
000,001,003,027,046,055,169,831,BACKGROUND,CNS,COPYRIGHT,INSTITUTE,LABEL,METHODS,NHI,OSA,RESULTS
CIS,HRT,LABEL,METHODS,OBJECTIVE,OCP,ORS,PURPOSE,RESULTS
169,COPYRIGHT,FEW,SOCIETY
169,COPYRIGHT,FFF,FLATTENING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY
006,169,DVH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,TEN
176,LOCAL,NUCLEAR,PCGEL
001,104,239,ARCHIVE,ATLAS,BACKGROUND,BROAD,CLASS,CONCLUSION,GBM,IMAGING,INSTITUTE,LABEL,METHODS,MRI,MYC,RESULTS,SELECTION
120,482,AUSTRALIA,CASES,PALLIATIVE
158,169,CAMBRIDGE,COLLEGE,DECISIONS,FIMDT,LIVERPOOL,PATHWAY,PEG,PHYSICIANS,ROYAL,THERE
169,DESPITE,DROSOPHILA,INC
169,DIFFUSE,DIPGS,INC,NOVEL,OVERALL
169,GLIOMAS,INC,OPC
100,146,147,171,AMONG,ANALYTICAL,ASSAY,BACKGROUND,CURRENT,IDH,IHC,LABEL,MUTATIONS,PCR,R132C,R132H,R172K,REFRACTORY,RESULTS,SEQUENCING
13R,169,945,BSG,CAREFUL,CNS,CONCLUSION,DIFFUSE,EPHA2,GAA,HGG,HLA,ISA,LABEL,METHODS,MONTANIDE,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SOCIETY,TREATMENT
001,008,160,169,708,BACKGROUND,BIOLOGY,CAUCASIANS,CHINA,CHINESE,COPYRIGHT,INC,JANUARY,KNOWLEDGE,LABEL,MATERIALS,MEDICAL,METHODS,OVERALL,RESULTS,SCIENTIFIC,TAKEN,TECHNICAL
169,COPYRIGHT,DUE,IRELAND,LTD,NSCLC,SOMATIC,V600E
189,BACKGROUND,BNP,DOPPLER,HBA1C,IVS,LABEL,METHODS,RESULTS,T2D
BACKGROUND,CONCLUSION,FORTY,HOWEVER,LABEL,METHODS,OVERALL,PAC,PANCREATIC,RESULTS
737,ABCB1,ABT,BACKGROUND,BAD,BASED,BH3,INHIBITION,LABEL,RECURRENCE,RESULTS,TMZ,WESTERN
169,COPYRIGHT,CURRENT,FINALLY,LTD,THEIR
GAMMA,KARNOFSKY,KNIFE,KPS,LOCAL
005,GENOMES,GWASS,HOWEVER,KYOTO,SNP,THEREFORE
AFTER,BACKGROUND,COX,KARNOFSKY,KPS,LABEL,LINAC,LOCAL,MEIER,METHODS,MULTI,PROGNOSTIC,RESULTS,SRS
BACKGROUND,CARDIAC,CAUCASIAN,LABEL,METHODS,MYXOMAS,PRKAR1A,RIGHT,SERTOLI,SINCE
169,954,CONCLUSION,DCE,DSC,HISTOGRAM,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC
001,006,127,165,217,255,337,340,BACKGROUND,DMD,LABEL,MDS,METHODS,RESULTS
1990S,25OHD,500,BACKGROUND,CONTEXT,DBS,DRIED,LABEL,MEASURE,MEASURING,MELBOURNE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SIXTY,THERE
122,130,231,234,235,281,282,327,340,341,342,351,354,721,BACKGROUND,CONCERNING,COX,III,KARNOFSKY,KPS,LABEL,METHODS,MRI,PET,RADIATION,RESULTS,RPA,SRS,UNIVARIATE
124,221,335,375,BACKGROUND,CHANGES,EXPRESSION,HAND1,HUD,INCREASED,LABEL,METHODS,PCR,RESULTS
6MM,BACKGROUND,CHINESE,CONCLUSION,CRANIOTOMY,CUSHING,LABEL,METHODS,PRE,THERE
BACKGROUND,LABEL,METHODS,PITUITARY,TREATMENT
104,177,BACKGROUND,CSM,FFF,GAMMAKNIFE,INDEX,LABEL,METHODS,PADDICK,PCI,PGI,RESULTS,SECONDARY,SRS,TREATMENT
160,205,BACKGROUND,CONCLUSION,DIAGNOSIS,EIGHT,JANUARY,LABEL,METHODS,PARKINSON,PHILIPS,RESULTS,S12,SONOS,TSC,TYPICALLY,WHITE
BACKGROUND,BRAIN,HOWEVER,INDEX,LABEL,METASTASES,METHODS,NSCLC,PRIOR,RESULTS,SCORE,SIB,SIR,SIX,THREE,TKI,WHOLE
220,600,BACKGROUND,BEIJING,BRAIN,CAPITAL,DISCUSSION,LABEL,MEDICAL,METHODS,SECONDARY,TIANTAN,TRIAL,UNIVERSITY
001,003,027,BACKGROUND,DEPARTMENT,INSTITUTE,LABEL,METHODS,REGARDLESS,RESULTS,SRS,THERE
BASED,FDA,GBM,NOVOTTF,SIX,THERAPY,TMZ
160,AGE,BACKGROUND,JANEIRO,JOINPOINT,LABEL,METHODS,POISSON,REGRESSION,RESULTS,RIO,SERRANA
200,322,BACKGROUND,CONCLUSION,CONTROL,LABEL,METHODS,RESULTS,SDH
LABEL,METHODS,OBJECTIVE,PRIMARY,PROCEDURE,RESULTS,THESE
946,ALZHEIMER,CNS,DKK,GSK,HOWEVER,INCREASING,WNT
169,COLLEGE,COPYRIGHT,LTD,PUBLISHED,ROYAL
160,169,5FC,5MC,AUTHORS,COPYRIGHT,DESPITE,INC,PUBLISHED,TDG,TET
008,169,367,562,860,CD3,CD8,COPYRIGHT,NSCLC,PBMCS,PRIMARY,TKI
BRAIN,MALIGNANT
CNS,DESPITE
BECAUSE,SCHMAHMANN,SHERMAN,THEREAFTER
001,194,AFTER,BACKGROUND,LABEL,METHODS,RESULTS

19Q,GLIOMAS,IDH,PROFILING,TREATMENT
169,BACKGROUND,BRAIN,CNS,CONCLUSION,COPYRIGHT,CSF,EPSTEIN,HODGKIN,LABEL,METHODS,MOLECULAR,PET,PRIMARY,RESULTS,TCL,TEXAS,UNIVERSITY,WHOLE
BSG,GLIOMAS,H3F3A,PPM1D,THESE
160,AE1,AFTER,BASED,HISTOLOGY,INI
169,COPYRIGHT,LTD,MEANWHILE
946,BMJ,GROUP,LABORATORY,LTD,MRI,PUBLISHING
001,004,BACKGROUND,CHANGES,COGNITIVE,HGG,LABEL,METHODS,PRIOR,RESULTS,SURGERY
CNS,METASTASIS,MOLECULAR
005,048,803,AIF,BRAINSTAT,CBF,CBV,COMPARING,CONCLUSION,DSC,GVF,HEALTHCARE,LABEL,LEAKAGE,MATERIALS,METHODS,MILWAUKEE,MRI,MTT,NORDICICE,OBJECTIVE,PERFUSION,PURPOSE,RESULTS,THERE,WIS
DIFFUSION,DWI,LABEL,METHODS,MRI,OBJECTIVE,PAPILLARY,PGNTS,RESULTS,SIX
160,215,AFTER,CNS,FURTHER,PCR,SPRAGUE,THEREFORE,TUNEL
954,967,BRMS1,FAK,HOWEVER,MMP,SRC,TAKEN,USING
AFTER,CYBERKNIFE,EIGHT,FLAIR,KARNOFSKY,KPS,MRI,RADIATION,RECURRENT,SEVEN
169,AUTHORS,COPYRIGHT,PUBLISHED
169,946,AMONG,COPYRIGHT,INC,SYK,TGF
169,BACKGROUND,HGG,LABEL,METHODS,NEURO,PRDX4,PRESS,PUBLISHED,RESULTS,ROS,SOCIETY,THEREFORE,UNIVERSITY
CONCLUSION,DESPITE,EPIDERMAL,EXPRESSION,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SV1,SV2
945,946,ELISA,GBM,IGF,SERUM,TGF,THESE,TNF
001,169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,COPYRIGHT,FORTY,III,INC,LABEL,LATERAL,METHODS,OBJECTIVE,RESULTS,THREE,TOTAL
177,FLA,LABEL,METHODS,MONITORING,OBJECTIVE,OBJECTIVES,RESULTS,TLA
289,315,375,408,418,AMONG,JANUARY,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS
001,005,008,015,025,029,033,042,136,COX,EXOGENOUS,IGFBP,IHC,INSULIN,LABEL,MEIER,METHODS,OBJECTIVE,PCR,RESULTS,SINCE,U87MG
AMONG,GAMMA,HOWEVER,KNIFE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE
AFTER,MRI,YAWNING
001,169,328,342,CHINESE,COPYRIGHT,GBM,HAN,STAT5,THESE
BACKGROUND,CARCINOIDS,CONTEXT,LABEL,OBJECTIVE,RESULTS,VHL
174,232,233,234,BECQUEREL,CARLO,EPR,GAMMA,GAMMAPLAN,HENRI,KNIFE,LABEL,LEKSELL,LGK,LKG,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,THERE,TPS
CNS,VON
ASTROCYTIC,BMP,GIC,GIVEN
002,021,054,BACKGROUND,CENTRAL,HOWEVER,LABEL,METHODS,PCR,RESULTS,THERE
001,002,BACKGROUND,EIGHT,FTM,FURTHER,LABEL,METHODS,MGS,PFS,RESPONSES,RESULTS,TREATMENT
BACKGROUND,EIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
BMJ,DIAGNOSIS,GROUP,HGG,HSE,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PROGNOSIS,PUBLISHED,PUBLISHING,RESULTS
169,946,AMONG,CBL,PRESS,PTPRU,PUBLISHED,SHORT,TAKEN,UNIVERSITY
169,945,BCAT1,FOLLOWING,MUTATIONS
AMA,ASD
169,BACKGROUND,COMPARISON,COPYRIGHT,LABEL,METHODS,NAVIGATED,RESULTS,THESE,VORONOI
KITAMBI,VACQUINOL
GBM,GDSCS,PCR,SINCE,THEREFORE,TREATMENT,TSA,VPA
169,COPYRIGHT,HOWEVER,INC,MRI,THERE,THESE
19Q,ADC,LOWER,P53,UNIVARIATE,USING,WORLD
100,MALIGNANT,STUDIES,SYSTEMATIC,THERE
DIAGNOSIS,EFFECTIVE,EPLEY,EXCLUSION,MRI
120,169,173,174,180,240,322,471,AMONG,CHINA,CHINESE,COPYRIGHT,FIFTEEN,GLIADEL,LABEL,MALIGNANT,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SUBGALEAL,UNTIL
FDG,MRI,PET,PITUITARY
18F,FDG,LATER,MRI,PET
AIM,DIFFERENT,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PHE,RESULTS
ENGINEERED
169,BIOLOGY,MICRORNAS,SOCIETY
001,961,BMS,CURVE,DNP,FURTHER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THESE
140,423,AGDEX,LUC,MBS,MYC,PTCH1,SHH,SMO,TRE,TRP53,USING,WNT
169,HOWEVER,NUTRITION,REGULAR,SOCIETY,THERE
DISTANT,NON,NSCLC
001,100,269,500,BACKGROUND,BECAUSE,CIS,CONCLUSION,ECLIPSE,GAMMA,GROUP,KNIFE,LABEL,METHODS,OBJECTIVE,OTHER,PADDICK,RADIATION,RESULTS,THERAPY,THESE,V12,V18,VOLUMETRIC
BACKGROUND,CONCLUSION,DTI,ELECTRODES,IOM,LABEL,METHODS,OBJECTIVE,RESULTS,STAINLESS,SURGERY,TOOLS
009,015,019,029,BACKGROUND,CGGAG,CHINESE,CIS,EXCEL,GBM,HAN,LABEL,MATERIALS,METHODS,MICROSOFT,ORS,RESULTS,SNP,STATS
001,015,022,048,054,057,092,122,194,246,290,323,381,423,566,657,782,821,934,BACKGROUND,CCND1,CIS,G870A,HOWEVER,LABEL,MATERIALS,METHODS,ORS,RESULTS,THEREFORE
206,AGE,BACKGROUND,BRAIN,FORTY,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THESE,WHOLE
GBM,JUN,LABEL,MATERIALS,METHODS,OBJECTIVE,OCT,RESULTS
169,231,BRITAIN,COPYRIGHT,CXCR4,ERBB2,FOLLOWING,FOXP3,GREAT,IRELAND,LTD,MCF,MDA,MYC,PUBLISHED,RESULTS,SOCIETY,THESE,WILEY
294,FOURIER,HOWEVER
HOWEVER,INHIBITION,LENTIVIRUS,PCR
ALZHEIMER,THESE
HEMOLYTIC
BACKGROUND,CD105,CONCLUSION,DSRED,GBM,GFP,LABEL,MATERIALS,METHODS,PROBE,RESULTS
106,K129R,MUTATIONS,R132H,SIXTY
169,CONCLUSION,LABEL,MAPPING,METHODS,OBJECTIVE,PARAMETRIC,PURPOSE,RESULTS,SIXTEEN,SOCIETY,THESE,VOXEL
169,AMONGST,ASSESSMENT,BASED,CONCLUSION,CSF,LABEL,METHODS,NEURO,OBJECTIVE,OTHERWISE,PRESS,PUBLISHED,PURPOSE,RCT,RESULTS,SOCIETY,THERE,UNIVERSITY
043,169,186,COOPERATE,COPYRIGHT,COX,DEFINITIVE,EASTERN,GROUP,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,USING
100,172,181,250,500,98G,BRAIN,ECM,HOWEVER,MMP,PMA,PROTEASES,THESE,TIMPS
BACKGROUND,CONCLUSION,CUSHING,FPA,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,SRS,WHOLE
ACUTE,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
172,AKT,EGF,HOWEVER,TAKEN
HENCE,MRI,THEREFORE
ACCORDING,AIM,CLASS,COMPARING,ENGEL,LABEL,METHODS,OBJECTIVE,RESULTS
177,BACKGROUND,CHOROID,CSF,LABEL,METHODS,PATIENT,RESULTS
ANXIETY,BEHAVIOUR,CLINICALLY,CONCLUSION,DEPRESSION,FRONTAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SUPPORT,SYSTEMS
945,946,ACTIVATION,HGF,INDIVIDUAL,IPT,MET,PSI,THESE,USING
124,ANXA7,PTBP1
005,102,128,166,ABSENCE,APRIL,CONCLUSION,CRP,KARACHI,LABEL,MAY,MEDICAL,METHODS,OBJECTIVE,PRE,RESULTS,SERUM,WHITNEY
GLIOMAS
169,COPYRIGHT,HOWEVER,ISI,ITI,LTD,SMT,THEIR
122,946,HNF,HOWEVER,MALIGNANT,TAKEN,WNT
129,CONCLUSION,CSF,LABEL,METHODS,RESULTS,UNLABELLED
CONCLUSION,LABEL,STUDIES
177,519,GEP,HBL,HODGKIN,IL2RG,MCL,NHL,NOD,OVERALL,PRKDC,REC,SZJ
169,487,59YRS,BACKGROUND,BRAIN,BRESLOW,INC,LABEL,METHODS,RESULTS,STAGE,THERE,WILEY,YOUNGER
169,CNS,COPYRIGHT,LTD,SHH,SONIC,STUDIES
177,3DGCS,3DGLS,3DGRS,BACKGROUND,CUMULATIVE,CURRENT,LABEL,METHODS,PERCENTAGE,RESULTS,SPECKLE,TNT

001,103,169,344,705,BRITISH,CONCLUSION,COPYRIGHT,ICU,INFECTIONS,LABEL,LTD,METHODS,OBJECTIVE,OR2,PUBLISHED,PURPOSE,RESULTS,SWEDISH
169,CANCERS,COPYRIGHT,GBM,LTD,MET,RAS,SHH
001,073,074,122,177,543,813,874,AFTER,GLASCOW,JANUARY,RCE,SCALE,THERE
169,BASEL,CONCLUSION,EXOPHYTIC,GROSS,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,RECURRENCE,REGULAR,RESULTS,SWALLOWING,THERE
124,169,AKT,APOPTOSIS,BACKGROUND,EXPRESSION,KIT,LABEL,MEANWHILE,METHODS,MIR,NEURO,PCR,PRESS,PUBLISHED,RAF,RAS,RESULTS,SOCIETY,TAKEN,UNIVERSITY
169,AG490,AKT,BACKGROUND,CONCLUSION,FAK,GBM,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,STAT3,TAKEN,TARGETING,THROUGH,U87MG,UNIVERSITY,WESTERN
169,BBB,BRAIN,COPYRIGHT,CURRENTLY,IRELAND,LTD,NSCLC,TKI,WOULD
169,DESPITE,ECS,GALECTINS,GIVEN,PRESS,PUBLISHED,UNIVERSITY
956,ALZHEIMER,CNS,GROWING,MPS,OVERALL
100,169,878,891,918,934,941,947,962,967,978,986,995,998,ATLAS,AUC,BACKGROUND,III,LABEL,METHODS,NEURO,PRESS,PUBLISHED,R132H,RESULTS,SEVERAL,SOCIETY,UNIVERSITY,WORLD
169,ARF,BACKGROUND,HOWEVER,INK4A,LABEL,MALIGNANT,METHODS,NEURO,PRESS,PUBLISHED,RAS,RESULTS,SOCIETY,THESE,UNIVERSITY,V12
585,685,BRAIN,MRI,THESE
170,ANAPLASTIC,DBD,GRADE,KARNOFSKY,PCV,PFS,PSF,RESULTS,THREE,TMZ
001,023,028,947,EVIDENCES,HOWEVER,IFN,THESE
169,945,BCL,BECAUSE,COPYRIGHT,EFFECTIVE,GLIOMAS,HIF,LTD
CSF,PITUITARY
ASTROCYTIC,BASED,BRAFV600E,HGG,IDH,NF1,TEXAS,THREE,UNIVERSITY
108,169,BACKGROUND,CONCLUSION,COPYRIGHT,HGG,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS
946,GSK,MTT,PCR,WNT
002,008,045,255,498,804,CHICAGO,ELLIPSE,III,INC,LEF,PROTEIN,SINCE,TCF,USA
FURTHER,GROWING
ALTERED,ALZHEIMER,CURRENTLY,FTD,PARKINSON
551,842,BRAIN,DYSPLASIA,EVERY,FOCAL,HOWEVER,LEATS,RELAPSE,THESE,WORLD
DEPARTMENT,JANUARY,MEDICAL,MUJIB,NEURO,UNIVERSITY
115,320,340,576,626,752,GBM,MICRORNAS,THESE
ALTOGETHER,ERK
BASED,BMICS,BMS,BRAIN,BTICS,DESPITE,SIMILAR,THESE,TIC
169,AMIDE,COPYRIGHT,INC,MTC,OFF,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,I113T,IDH,LABEL,METHODS,MIB,MOLECULAR,V600E
150,177,319,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SRS,THERE,THESE
FINALLY,REGARDING,THERE,TREATMENT
ALZHEIMER,DISEASE,III,MALIGNANT,REMAINING,SEVERAL
169,BRAIN,COPYRIGHT,HIV,INC,OPHTHALMIC
169,194,BACKGROUND,BLADDER,CIS,CONCLUSION,COPYRIGHT,COX,HAMPSHIRE,INC,JANUARY,LABEL,METHODS,ORS,PATHOLOGY,RESULTS,SIMILARLY,SOCIETY,STATE,TNM,UROLOGICAL,WORLD
169,COLLEGE,COPYRIGHT,LTD,PUBLISHED,ROYAL
169,181,COPYRIGHT,EEG,FCD,FEDERATION,IRELAND,LABEL,LTD,MEG,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMALL
169,COPYRIGHT,INC,OLDER,STUDIES
169,ADC,BACKGROUND,COPYRIGHT,GBM,GDE,LABEL,METHODS,MRI,R132H,RESULTS,SAS,THESE
169,2MM,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,CUSHING,IMPORTANCE,LABEL,METHODS,REGARDLESS,SAS,SIX,SKULL
169,AFTER,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,METHODS,SAS,WHILE
169,COPYRIGHT,GBM,LTD,METABOLIC
169,945,946,954,AEG,ASTROCYTE,ASTROCYTES,BIOLOGY,CNS,HIV,HOWEVER,INC,MOLECULAR,SIMILAR,SOCIETY,TAT,THEREFORE,TNF
BACKGROUND,COGNITIVE,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,VOXEL
001,017,028,ACADEMY,AMONG,BACKGROUND,CHINESE,DEC,GEFITINIB,INSTITUTE,JAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PFS,RESULTS,UNKNOWN
001,160,162,BACKGROUND,LABEL,METHODS,NEUROLOGIC,OTHER,RESULTS,USING
AVAILABLE,DAILY,EEG,FOCAL,FOLLOWING,MRI,SURGERY,THESE
11C,18F,FDG,GLIOMAS,MRI,PET,THESE
BACKGROUND,CEDIRANIB,CONCLUSION,LABEL,METHODS,MRI,REVERSIBLE
169,CYTOTOXIC,IL2
169,HOWEVER,MRI
043,183,ALA,DISCUSSION,HDR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,SEVERAL
169,215,218,865,BLADDER,CBE,HOWEVER,PRESS,PUBLISHED,SALL1,SUBSEQUENT,UNIVERSITY,WNT9B
HOWEVER
BACKGROUND,CONCLUSION,HHV,LABEL,METHODS
SUCCESSFUL
HOWEVER,INCREASED,THEREFORE
BESIDES,CHANGES,FIRST,MELATONIN,MT1,MT2,MT3,SPECIES,THREE
117,169,230,263,419,ACADEMY,AMONG,COX,DESPITE,LABEL,MEIER,METHODS,NEUROLOGY,OBJECTIVE,RESULTS,TIA
STUDIES
169,18F,COPYRIGHT,FDG,LTD,PET,WILEY
CONCLUSION,LABEL,METHODS,OBJECTIVE,RBF,RESULTS,SVM
003,100,169,99M,ADC,BACKGROUND,COPYRIGHT,DTI,DYNAMIC,INC,LABEL,METHODS,MRI,RESULTS,SPECT,TREATMENT
177,4TH,BTS,CAREGIVER,CNS,CRT,DIGIT,EDITION,EXECUTIVE,FIFTY,INVENTORY,MRI,ORDERED,SOS,SURVIVORS,TOTAL,VOLUMES,WORKING
INTRATUMOR
ATLAS,EVALUATION,FINALLY,PCR
197,DESPITE,GLUT1,STRUCTURAL,STRUCTURE
DESPITE,EPIGENETIC,FOCAL,GROUP,LARGE,SHH,WNT
001,007,019,028,100,107,149,169,177,185,198,200,BACKGROUND,ISOCITRATE,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
000,100,169,AGE,BACKGROUND,BRAIN,CENTRAL,CIS,CNS,CONCLUSION,INCIDENCE,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,USING
119,150,157,169,182,335,481,663,BACKGROUND,FORTY,LABEL,METHODS,MRI,NEURO,PRESS,PRS,PUBLISHED,RESULTS,SDS,SOCIETY,THERE,TREATMENT,UNIVERSITY,W18
001,004,006,009,100,101,152,177,197,268,298,BACKGROUND,BMJ,FACTORS,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,SEVERAL
CHOROIDAL,EARLY,OVERALL
169,BACKGROUND,FIFTEEN,FURTHER,INCLUSION,JANUARY,LABEL,METHODS,RESULTS,SOCIETY
HOWEVER,MRI
BAYES,FUNCTIONAL,SNP
169,ANXIETY,CES,CHECKLIST,CHRONIC,CIS,COPYRIGHT,DEPRESSION,EARTHQUAKE,GREAT,INDIVIDUAL,INVENTORY,IRELAND,JAPAN,LTD,SCALE,STATE,STUDIES,TRAIT,YOUNG
169,239,AIM,BRITISH,CONCLUSION,LABEL,OBJECTIVE,QTC,RESULTS,SOCIETY,SOD,THERE
169,248,COPYRIGHT,DLPFC,DMN,EAS,INC,PREVIOUSLY,PUBLISHED,STS,THESE
BACKGROUND,BRAIN,CURRENT,LABEL,MICHAEL,OBJECTIVE,PREDICTIVE,PURPOSE,QOL,ROBBINS
005,012,026,029,14Q21,404,820,CHINESE,HOWEVER,LTL,SIMILARLY,THEREFORE
GIVEN
948,GBM,HOWEVER,INK4A,PTPRD,STAT3
GENOMIC,GLIOMAS,MENDELIAN
169,COPYRIGHT,MRI
AIM,CONCLUSION,JACKSON,LABEL,METHODS,MICHAEL,OBJECTIVE,RESULTS
END,LDM,MEANWHILE,MEIER,P53,TDT,TMZ,U87,WESTERN
169,COPYRIGHT,LTD,MRI
100,CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,THERE,TOTAL,UNIVERSITY
000,003,103,110,115,125,150,151,177,AMONGST,LABEL,LARGE,MEIER,METHODS,OBJECTIVE,RESULTS
BASED,DONOR
074,144,ALTOGETHER,CONCLUSION,DECREASING,FERTILITY,FSH,IQR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIGNS
013,BXPC3,FINALLY,HENCE,HOWEVER,OVERALL,PANCREATIC,USING,USP9X
176,916,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,006,007,014,019,021,025,036,044,045,049,178,253,328,329,332,354,516,690,740,750,766,CAUCASIANS,CCND1,CIS,G870A,ORA,ORS,OVERALL,SCIENCE,WANFANG,WEB
160,220,CONTROL,FURTHER,HENCE,HOWEVER,NTR,NTRK1,NTRK2,NTRK3,NTRKS,PCR,REVERSE,THERE
BRAFV600E,MALIGNANT,MICROARRAY,PCA,TREATMENT
160,450,C19MC,CNS,ETANTRS,IHC,LIN28,NOTABLY,PNETS,STRIKINGLY
III,LYMPHOCYTE,MENDELIAN,PITUITARY,RNASE,SEVEN,SINCE
FSH,HOWEVER,PITUITARY,PRL,TSH
160,175,ADJUSTING,BRCA1,III,SITES,WOMEN
007,160,250,281,481,540,824,COMPARISON,SIX,SNP
001,169,967,BACKGROUND,BRESLOW,DESPITE,GBM,GEHAN,LABEL,METHODS,MSC,PRESS,PUBLISHED,RESULTS,TRAIL,UNIVERSITY,USING
AMERICA,DESPITE,NORTH
169,888,947,956,ABT,ADP,EFFECTIVE,GBM,GBM12,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMZ,U251TMZ,VELIPARIB
ENZYMATIC,EPIGENETIC,FURTHER,VORINOSTAT,WHILE
GBM,INCREASING
100,AAS,ADULT,GBM,MET
169,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATHOLOGY,RESULTS,SOCIETY,V600E,VE1
105,169,237,241,COPYRIGHT,EVN,GIVEN,NEUROCIRUG,PUBLISHED,THROUGH
169,GIVEN,HODGKIN,LTD,PCNSL,PFS,UNTIL,WILEY
169,AUTHORS,EPIDERMAL,LTD,PTY,PUBLISHING,SCIENCE,THESE,THROUGH,WILEY
169,AFTER,COPYRIGHT,INC,MOSBY
169,ABABA,ADDIS,AMHARIC,ANBESSA,COPYRIGHT,ENGLISH,INC,INTERVIEWS,LABEL,LOCAL,METHODS,OBJECTIVE,OROMO,RESULTS,TIKUR
AREAS,BACKGROUND,BBB,COVERED,GBM,HOWEVER,LABEL,MALIGNANT,METHODS,OPINION
169,AFTER,BTSCS,COPYRIGHT,CSC,GFP,INC,LINEAGE,TLX,USING
169,945,946,AHR,EXPRESSION,HIF,HPASMCS,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,ROYAL,SOCIETY,TGF
103,CLASSIFIED,FTF,LABEL,MEDICAL,METHODS,MRI,NIIGATA,RESULTS,UNIVERSITY,UNLABELLED
169,COPYRIGHT,IRELAND,LTD,PRESENTED,STAGE
001,006,108,907,916,CSF,LABEL,LOS,METHODS,MORBIDITY,RESULTS,THESE,UNLABELLED,WHILE
FIFTEEN,GBM
169,669,ANN,BACKGROUND,CARTESIAN,CONCLUSION,COPYRIGHT,GAMMA,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RMS,SRS,WHILE
HOWEVER,HSP70,PCR,PRODUCTION,THESE,THREE
CD133,EPIGENETIC,G9A,H3K9ME2,HISTONE,SINCE,THEREFORE
GAPDH,HSP70,PRODUCTION,SIMILAR
CADM1,PCR,SPARC,TNFAIP3
CONCLUSION,HOWEVER,IVL,LABEL,METHODS,OBJECTIVE,PURPOSE
105,HOWEVER,MTT,SMALL,TG905,U87
ADAMTS9,AS2,DNMT1,GROWING,PCR
018,19Q,931,AOA,AUTHORS,BACKGROUND,BASED,CENTRAL,COLLECTION,CONTROLLED,EARLY,EORTC,GROUP,HOWEVER,IDH,ISSUE,LABEL,MARCH,MEDLINE,METHODS,NOA,OBJECTIVE,OBJECTIVES,PCV,RADIATION,RESULTS,SELECTION,THERAPY,THREE,TREATMENT
158,169,172,BACKGROUND,LABEL,METHODS,MRI,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,955,ARRAY,CONCURRENT,COPYRIGHT,INC,MALIGNANT,MPNST,PATHOLOGY,PNSTS,PUBLISHED,REDUCED,SCHWANN,SOCIETY,TMA,TRANSGENIC,TRP53
FINALLY,GIC,PHAGE,RHO,THESE
160,169,CCL21,CD8,COPYRIGHT,CXCR3,ECM,INC,MRI,PLASMODIUM,STUDIES

DROSOPHILA,GFP,HOWEVER,IFP
154,169,221,222,EMBRYONAL,PRESS,PUBLISHED,UNIVERSITY
133,139,272,ASR,CHILDHOOD,HOWEVER,INCIDENCE,JAMAICA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
169,945,BIOLOGY,CAS,JOURNAL,MOLECULAR,PKC,PRESS,PUBLISHED,ROR,UNIVERSITY,WNT
000,100,123,357,7TH,APC,BRAIN,CHINESE,CONCLUSION,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE
001,007,100,169,BACKGROUND,JOURNAL,LABEL,MATERIALS,METHODS,MIDLINE,NANOSTRING,OBJECTIVE,PURPOSE,RESULTS
169,DISRUPTING,ECTOPIC,GSC,MYC,PRESS,THESE,ZFX
MRI,TOTAL
AFTER,AIM,CONCLUSION,INITIAL,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
140,AIM,CHINESE,CONCLUSION,LABEL,MASEP,METHODS,MRI,OBJECTIVE,RESULTS,USING

ASIAN,BASED,BIOLOGY,CHINESE,CHROMOSOME,CONSORTIUM,DISEASE,FOLLOWING,HKUPP,HPP,INDIA,INITIATIVE,INSTITUTE,MAHIDOL,PROJECT,PROTEOMICS,SINGAPORE,SIRIRAJ,UNIVERSITY,URINE
119,129,134,140,169,916,945,BECAUSE,BIOLOGY,CUMULATIVE,INC,LYS,MOLECULAR,NEDD4,PARKINSON,PR1,PR2,SOCIETY,SYNUCLEIN
AUHCR,DIFFUSION,INDIVIDUAL,MRI,REDUCED,YOUNG
001,027,109,OCTOBER,OVERALL,THOSE,TMZ
BACKGROUND,CONCLUSION,CUSHING,ENDOSCOPIC,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS
011,023,322,EOC,EPITHELIAL,INCREASING,MCPH1,MUTATIONS,PREVIOUSLY,REDUCED,RESULTS
138,141,181,DALTONICS,HOWEVER,MALDI,MICROFLEX,SAMPLES,SPECTRA,TOF

ANAPLASTIC,CNS,EPENDYMOMA,THESE
102,169,197,BACKGROUND,CHEMISTRY,FIFTEEN,FOXE3,LABEL,MALDI,METHODS,RESULTS,TOF,USING,VALIDATION
100,177,954,BACKGROUND,DISCREPANT,FLAIR,GADOLINIUM,GRE,LABEL,METHODS,MRI,RESULTS,SEVENTY
025,100,AFTER,BACKGROUND,CCM,DESPITE,ENGEL,FORTY,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,SEIZURE,THESE
DAS,MEDICAL,WHILE
001,100,169,181,603,DHA,FATTY,FFA,INC,MNI,NBUDS,OVERALL,U87MG,WILEY
946,AKT,EMT,EPITHELIAL,GBM,GBM8401,IGF,OSTHOLE,PCR,SNAIL,THESE,TWIST
EAR,LAR,PBS,PPT
170,265,369,749,AMONG,APRIL,BACKGROUND,CSC,DIAGNOSIS,ICH,JAPAN,LABEL,MARCH,METHODS,MORTALITY,PROCEDURE,RESULTS,SAH
001,073,079,082,091,120,147,450,662,725,782,975,COX,FLAIR,GBM,LOG,MEIER,MRI,PFS,VOLUMETRIC
169,ACCESSIBLE,ARCHIVE,ATLAS,CONCLUSION,COX,GBM,IMAGING,LABEL,MATERIALS,METHODS,MODULES,OBJECTIVE,PURPOSE,REGIONS,REMBRANDT,RESULTS,THREE
004,011,181,500,ALA,BECAUSE,BONFERRONI,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHITNEY
BMJ,GROUP,LTD,PUBLISHING,TYPICALLY
006,169,ALTERED,BMI,CONCLUSION,LABEL,METHODS,NFMAS,OBJECTIVE,RESULTS,SCN,SDS,SIMILAR,SOCIETY
945,BACKGROUND,CONCLUSION,EIGHT,GENOMES,KYOTO,LABEL,MATERIALS,METHODS,MICROARRAY,PHASE,PRIMARY,RESULTS,SECONDARY,TARGETING
SINCE
APL,ATO,HOWEVER,NOTABLY
11C,18F,AMT,FDG,FDOPA,FET,FIRST,MET,PET
177,956,ACCU2,TPM
11C,169,18F,COLLEGE,COPYRIGHT,CURRENT,GTV,ISOTROPIC,LTD,MRI,NOVEL,PUBLISHED,ROYAL,WORLD
169,BBB,DOX,INC,RESULTS,SLN,WILEY
169,INC,WILEY
005,480,BACKGROUND,CONCLUSION,CTV,DEFINITION,DIFFUSION,DTI,EXTENDING,LABEL,MATERIALS,METHODS,MRI,PTV,RESULTS,THESE
ANN,ARBOR,BACKGROUND,CAUCASIAN,CONCLUSION,DIAGNOSTIC,EPSTEIN,FURTHER,HODGKIN,IEA,LABEL,METHODS
169,AUTOPHAGY,CNS,LABEL,RAF,THESE,UNLABELLED,V600E
100,177,BACKGROUND,DESPITE,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,REZ,TOTAL,WHILE
5438A,BACKGROUND,CONCLUSION,CONTEXT,CUSHING,GENOMIC,LABEL,METHODS,OBJECTIVE,PCR,PITUITARY,RESULTS,WES
CALIFORNIA,FRANCISCO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAN,SCO,UNIVERSITY
232,CYBERKNIFE,UNIVERSITY
DESPITE
229,ANCHORAGE,GBM,S100P,SILENCING,SIMILAR
100,160,694,699,GBM,HGF,HOWEVER,IHC,RAPID,STAT5,THESE,TYR,U87
AGGRESSIVE,HOWEVER,PITUITARY,TUMOURS
000,100,124,145,160,169,188,206,ASR,AUTHORS,DESPITE,LTD,NCR,POPULATION,RATES,SIMILARLY,STATE,SUDAN,WILEY,WORLD
169,INC,TREATMENT,V600E,WILEY
AFTER,HOWEVER
CBF,SMOKING,THESE,USING
00001,380,468,848,AMONG,CONCLUSION,FIXED,JANUARY,LABEL,METHODS,OBJECTIVE,RANDOMIZED,RESULTS
169,ACADEMY,ATP7B,THERE
169,BMDCS,GBM,HOWEVER
001,177,183,AIM,AXIAL,BACKGROUND,DBS,DISABILITY,III,LABEL,METHODS,MOTOR,OBJECTIVE,PARKINSON,PORTUGUESE,RESULTS,SCALE,STN,TEN,THERE,UPDRS
005,106,120,169,183,BACKGROUND,DESPITE,EVENT,GEORG,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSIS,RADICAL,RESULTS,STUTTGART
001,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,III,INC,JANUARY,LABEL,MARCH,METHODS,RCC,RESULTS,TKI
ALK,RESISTANT,THESE,USING
375,ALBUMIN,ANIMALS,BBB,BRAIN,CURRENTLY,EMEND,NK1,NON,TREATMENT
002,006,016,615,AIM,ANY,COMPARING,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
160,945,946,CCRCC,CLEAR,CXCR4,DESPITE,FINALLY,HIF,HOWEVER,IL6,MIG,MMP,RCC,RENAL,TAM,TGF,TH1,THESE,TKI,TNF,VHL
DIMINISHED,FURTHER,MALIGNANT,WHEREAS
PARKINSON
AUGMENTING,CONCLUSION,GL261,LABEL,METHODS,OBJECTIVE,P38,RESULTS,TUNEL,WESTERN

161,GBM,HOWEVER

947,CD8,CTL,CXCR3,DCS,GLY4SER,IFN,INTERFERON,TREATMENT,U87
194,253,360,892,896,BMJ,CERENAT,CIS,GROUP,HOWEVER,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,ORS,PUBLISHED,PUBLISHING,RESULTS,RISKS,THESE,UNLABELLED
CD133,CNS,HOWEVER,PCR,PRIMARY,THESE
011,016,075,100,101,169,177,415,606,954,967,COHEN,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SNR,SSD,WHITNEY
378,AKT,EXPRESSION,FN1,III,NETWORK,OMNIBUS,PLS,PRION
BECAUSE,CCA,DECREASED,EMT,IRREGULAR,OVARIAN,SHC,THESE,TOKAI,UNIVERSITY,WHILE
169,34S,BESIDES,BIOLOGY,CAS,JOURNAL,MICRORNAS,MOLECULAR,PRESS,PUBLISHED,SEVERAL,UNIVERSITY
002,009,169,183,751,956,AFTER,AIM,APPRAISAL,BACKGROUND,BASED,CHILD,COPYRIGHT,IGF,LABEL,LIBRARY,LITERATURE,METHODS,NEUROLOGY,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SEVERAL,SHORT,SOCIETY,SSA,SYNTHESIS
169,945,CHEK2,COPYRIGHT,INC,RAD53,THESE
169,60S,ANATOMICAL,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MGM,PHA,RESULTS,THEREFORE

133,BBB,CB1,CB2,FIRST,GPR18,GPR55,JWH
034,169,3MM,COPYRIGHT,LEKSELL,LTD,THERE,WOMEN
169,945,946,954,AT1,BBB,CHRONIC,COPYRIGHT,INC,RAS
169,3709C,6232G,ARG1237,COPYRIGHT,DOCK7,EPILEPTIC,EXOME,GABAERGIC,GLU2078,INC,PUBLISHED,RAC,SNP,SOCIETY,THESE
314,967,ADC,CONCLUSION,LABEL,MATERIALS,METHODS,MINIMUM,OBJECTIVE,PARAMETERS,PCNSL,PURPOSE,RESULTS
AFTER,ENROLLMENT,GBM,RESULTS
169,839,945,946,954,956,AML,COPYRIGHT,HOWEVER,IKK,LTD,OVERALL,SPC,TNF
169,174,BACKGROUND,CONCLUSION,COPYRIGHT,FAK,FGFR1,GBM,IRELAND,KINOMIC,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PAMSTATION,PDX,PKC,PURPOSE,RAF,RESULTS,TMZ,VEGFR
1P19Q,ATLAS,CPG,ORTHOGONAL
BESIDES,TERATOMAS
100,BACKGROUND,CONCLUSION,KPS,LABEL,METHODS,RESULTS
169,REMARKABLY,TAKEN,VSV
169,BLOCKADES,FINALLY,NOTABLY,UNC5B
19Q,26951,ADDITIONAL,ANAPLASTIC,AOA,EORTC,HOWEVER,III,PCV,REGARDLESS,THESE
169,956,COPYRIGHT,EPI,LTD,NGO,THESE,U87,USING
GBM,KNOCKDOWN,RBM14,TARGETING,THESE
BBB,GBM,HOWEVER,THESE,TMZ
MRI
737,ABT,APOPTOSIS,BAK,BAX,BCL,GBM,MCL,TMZ,USING
169,174,176,177,AFTER,AUTHORS,CLEVELAND,CONTROLLED,DTA,HGG,LTD,MAY,NEUROBLATE,PATIENT,PFS,TDT,UNIVERSITY,VOLUMETRIC,WASHINGTON,WILEY
177,183,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART,SURGERY
743,ALK,ARG248GLN,BACKGROUND,CCDS11118,CONCLUSION,LABEL,METHODS,PATHOGENIC,RESULTS,SDH
035,169,259,BRITISH,CONCLUSION,CONTINUOUS,COPYRIGHT,EEG,ICD,LABEL,LTD,METHODS,MOUNT,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SINAI,SINCE,TREATMENT
DESPITE,FINALLY,GBM,GSC,HOWEVER,RPPMS,TAKEN,THERE,TMZ,UCN
ADP,ALLYLAMINO,CELASTROL,HSP72,HSP90,MICHAEL,ROS
ATM,ATP,CHAETOCIN,HIPPO,HOWEVER,INCREASED,JNK,OXIDATIVE,ROS,YES
169,946,BACKGROUND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TAKEN,THEREFORE,VHL,WILEY,WNT
HOWEVER
ALZHEIMER,BBB,CNS,HIV,HOWEVER,PROTEIN
001,003,169,177,BACKGROUND,CONCLUSION,COPYRIGHT,FLAIR,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,MRS,RESULTS,TREATMENT
590,614,BACKGROUND,BRAIN,CONCLUSION,LABEL,MARCH,METHODS,RCC,RESULTS,TEN
169,945,BIOLOGY,CYTOSOLIC,INC,METABOLIC,MOLECULAR,NADC3,SLC13,SLC13A3,SOCIETY
NEURONS,RESULTS,SOM,WISCONSIN
178,179,185,BASED,BRAIN,CHARLES,IMP,MRI,SPECT,THESE
BACKGROUND,CONCLUSION,ENDOSCOPIC,GBM,LABEL,METHODS,MRI
ADA,ADENOSINE,BRAIN,CSF
2ND,8TH,ALK,CAUCASIAN,CD163,CNS,DIAGNOSIS,IMAGING
AFTER,BECAUSE
BORON
166,183,CNS,IHC,MIB,RAPID
246,AFTER,HODGKIN,INCREASED,LABEL,LIMITED,METHODS,OBJECTIVE,RESULTS
APC,HOWEVER,LESIONS,VII
000,146,150,273,332,386,442,474,489,614,749,840,900,934,986,AED,CBZ,COMPARING,HLA,JOHNSON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAP,RESULTS,SEPTEMBER,SJS,STEVENS,TEN,USING
BRAIN,FREQUENCY,PMC,PSD,SMA,THESE
DESPITE,FGFR1,K656E,N546K,NOTABLY,PAS,RGNTS,ROSETTE,THESE,WHETHER
100,19Q,1P19Q,HISTOLOGIC,III,R132H,SEQUENTIAL,STUDIES,THERE
363,582,AMONG,ANNEXIN,BIM,CASPASE,CD133,GBM,PCR,SINCE,USING,UTR
400,650,950,CCD,DUE,LIGHT,NIR,OPTICAL
000,100,194,255,317,340,911,AMONG,BACKGROUND,BRAIN,CANCERS,CENTRAL,DESPITE,END,LABEL,MANAGEMENT,MATERIALS,METHODS,PREVIOUSLY,RESULTS
002,005,034,ADC,COX,FLAIR,HISTOGRAMS,MRI,OVERALL,PFS,WHILE
169,AUTOPHAGY,BIOLOGY,FEDERATION,GBM,MG132,PROTEASOME,U87MG,UBA
177,215,ACTIVATION,BBB,GTPASES,LEWIS,MNSOD,RHO,THERE
961,AUTOMATIC,BACKGROUND,BRAIN,COMPARISON,IMAGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
103,12Q13,136,171,202,ALZHEIMER,ATLAS,CHR,CHROMOSOME,CSF,DAVID,ENSEMBL,FUNCTIONAL,GAD,GPMDB,HPA,HPP,MACHINE,PARKINSON,PROJECT,PROTEIN,SRM,USING
GBM,III,THERE
BACKGROUND,COMPARISON,CONCLUSION,DESPITE,IGS,LABEL,RESULTS,YET
100,ALA,BACKGROUND,DEPARTMENT,GTR,HGG,III,LABEL,METHODS,OVERALL,RECURRENT,RESULTS
169,236,945,BRAIN,COPYRIGHT,FURTHER,GBM,INGENUITY,IPA,PATHWAY,SDS,SHORT,SOCIETY,SP1,STAT3
169,200,400,ACTIVATION,BACKGROUND,CLOSE,ENROLLMENT,ERK,KEY,LABEL,MEK,METHODS,MRI,NEURO,NF1,PDGFR,PRESS,PUBLISHED,RAF,RAS,RESULTS,SOCIETY,SORAFENIB,UNIVERSITY,VEGFR
154,169,AKT,CNV,HOTSPOT,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE
AVAGLIO,AVASTIN,BASEL,CHICAGO,DESPITE,GBM,HOWEVER,LTD,ROCHE
106,120,144,169,945,946,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,RESULTS,STATE,THESE,YKL
005,112,133,298,BEV,PFS,THERE,THESE
079,945,967,ASSESSMENT,DISABILITY,GENERAL,INDEX,INTERVIEW,ITALIAN,KARNOFSKY,KPS,PEARSON,QUALITY,RMSEA,SHORT,WORLD
DIGITAL
ANN,FOUNDATION,GENERAL,HARRY,MARSDEN,NHS,TRUST
169,AST,BBB,COPYRIGHT,CY3,INC,NMR,PEG,TGN
CRC,K252A,THESE,TRK
169,AFTER,CTL,ONCOVIR,PAMPS,SEQUENTIAL,TH1,THESE
BSC,DIFFUSION,DTI,PATZOLD,PRE,TRACT
169,FDA,GAUSSIA,LAN,NSC,PRESS,TRAIL
001,002,003,100,194,333,360,BNP,CHF,CONCLUSION,COX,HOWEVER,JANUARY,LABEL,METHODS,PATIENT,RESULTS,UNLABELLED,USING
FINALLY
001,103,EMT,EPITHELIAL,HOWEVER,SNAIL
036,BLOOD,CBV,DSC,DYNAMIC,III,IMAGING,INSTEAD,MAXIMAL,PERFUSION,PWI,ROI,TUMORAL
BRAIN,CHEST,METASTATIC,MRI,SUBSEQUENT
169,CLINICIANS,LABEL,LOCAL,METHODS,MRI,OBJECTIVE,OTHER,PANEL,PURPOSE,RESULTS,SOCIETY,TREATMENTS
169,DENOSUMAB,NONOPIOIDS,NSAID,SOCIETY,SYSTEMATIC,THERE
ALA,GBM,MRI

BACKGROUND,BETWEEN,CIS,HODGKIN,HRS,ITALIAN,LABEL,METHODS,PWA,RESULTS
122,208,AFTER,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPA
169,COPYRIGHT,III,THESE
BLOOD,MRI
AMONG,COMPARISON,GBM,T98,THESE,U87MG,WESTERN
169,ABR,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,FORTY,GAPDH,INC,LABEL,LC3,MDA,METHODS,RESULTS,SERUM,THREE

105,124,177,240,262,268,273,276,290,313,326,327,335,537,570,608,615,617,645,669,686,735,947,FE2O3,HOWEVER,LABEL,METHODS,MRI,NPS,OBJECTIVE,RESULTS,STERILE,T2W
AMONG,BET,JQ1,MYC,TARGETING
133,169,403,428,CMV,EXPRESSION,GBM
169,CD8,EADPTGHSY,ESO,REMARKABLE,TEN
169,CSC,FOLLOWING,FOXM1,JUN,MECHANISM
001,169,235,372,679,CNS,COPYRIGHT,LTD,SHORT
116,156,169,570,COPYRIGHT,III,INC,NOVOTTF,THERAPY,THESE,TREATMENT
160,169,BBB,COPYRIGHT,DCE,LTD,MRI,PUBLISHED,THESE
ABCG2,ATM,BRCA1,CD133,CURRENT,GBM,RAD51,THESE,TMZ,XRCC1
169,BED,COLLEGE,COPYRIGHT,FURTHER,LTD,PUBLISHED,ROYAL
200,947,956,AIM,CONCLUSION,HSP27,LABEL,METHODS,OBJECTIVE,RESULTS,TRANS,U87,WESTERN
000,CCND1,CCNE1,CDK,COORDINATE,PARK2
159,19Q,BACKGROUND,III,LABEL,LOH,METHODS,MOLECULAR,OVERALL,PCR,RESULTS,TRANSIENT,TREATMENT
169,237,241,COPYRIGHT,NEUROCIRUG,PUBLISHED,SPAIN
169,946,ANIMALS,BACKGROUND,BASSO,BEATTIE,BRESNAHAN,CELLS,CONTEXT,CONVERSELY,COPYRIGHT,ECM,FUNCTIONAL,GREATER,HOWEVER,III,INC,KEULS,LABEL,MAP,METHODS,NBR,NGF,OBJECTIVE,PRESENT,PURPOSE,RESULTS,SCI,SNK,STUDENT,THESE
MEYER,RES,THESE,WESTERN
001,003,004,025,038,COX,PFS,PWI,SIXTY
CURRENTLY,THESE
FRK,FURTHER,FYN,HOWEVER,SRC,TAKEN
002,AED,GIVEN,HOWEVER,JOHNSON,PHENYTOIN,SERIOUS,SJS,STEVENS,TEN,THERE,WHILE
GGS,POSTERIOR,V600E
DIFFUSE,THESE
169,AUTHORS,COPYRIGHT,FURTHER,LTD,PUBLISHED,THESE
169,AKT,ATG2B,COPYRIGHT,EXCESSIVE,FOXO1,FURTHER,GBM,GSC,INC,THESE
100,169,AFTER,APART,CARDIOLOGY,DESPITE,FINALLY,PUBLISHED,SOCIETY
107,169,174,177,231,233,CONCLUSION,COPYRIGHT,CRT,EPIGRAY,ESTRO,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SOCIETY
127,184,AFTER,GROUP,HIT2000,MOLECULAR,MYC,PCR,SHH,WNT

000,002,004,DOPPLER,LABEL,METHODS,OBJECTIVE,RESULTS
ACROMEGALY,AFTER
11Q13,AIP,BIALLELIC,LOH,MULTIPLEX,Q315X
143,160,239,CNS,NSCLC,PCR,T790M,THERE,TKI
BACKGROUND,DUE,LABEL,METHODS
FOCP1,FOLLOWING,FOXP1,MTT,WESTERN
156,169,AUSTRALIA,CONCLUSION,COPYRIGHT,GAD,HOWEVER,LABEL,LTD,MDD,METHODS,OBJECTIVE,PCA,RESULTS,THESE,WILEY
EVENT,FIRST,THESE
100,11C,BEV,CHO,FLAIR,KARNOFSKY,MET,MRI,MRS,PET,THESE
177,181,200,C75,CERULENIN,FATTY,INHIBITION,LN229,NUCLEAR,TREATMENT,WESTERN
100,ABOUT,AED,AIM,HOWEVER,QOL
133,591,FACTORS,KPS,LOCAL,OVARIAN
169,BTICS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,THEREFORE
170,CBP,HISTONE
1089C,949,ASN363LYS,CRC,NM_006231,SOMATIC
169,COPYRIGHT,DSRED,GFP,NG2,SOCIETY,THEIR,USING
169,BMP,CSC,LABORATORY,PRESS,PUBLISHED,TARGETING,YAN
118,228,ALZHEIMER,CHO,DLB,MCI,MRS,MTA,NAA,VSRAD
946,AAO,ALZHEIMER,NIA,ORDERED,OSA,USING
945,CTL,D13,FURTHER,IL13R,INSTEAD,TNF,WHILE
169,1P19Q,CHO,COPYRIGHT,MRI,MRS,NAA,SOCIETY,THESE
AREAS,BACKGROUND,CNS,COVERED,DESPITE,FOLLOWING,HOWEVER,LABEL,METHODS,OPINION
150,200,400,AIC,BACKGROUND,BID,LABEL,METHODS,MTD,RESULTS,SORAFENIB,TMZ
021,034,177,454,497,871,876,903,945,967,FORTY,III,KRUSKAL,LABEL,MARCH,METHODS,NEMENYI,OBJECTIVE,PEARSON,RESULTS,THEREFORE,THESE,WESTERN
169,946,COPYRIGHT,HOWEVER,INC,TAKEN,WNT
169,224,6GY,ATLAS,COPYRIGHT,EXOGENOUS,FURTHER,GBM,INC,MIR,U87
001,002,004,029,041,215,268,277,307,331,445,578,830,958,CMS,HOWEVER,LABEL,METHODS,OVERALL,PREDICTORS,RESULTS,UNLABELLED
103,224,246,AMONG,BOLOGNA,CSF,DESPITE,ITALY,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STUDI,UNIVERSIT,WORSENING
001,002,005,025,027,487,CSF,ENDOSCOPIC,GROSS,JANUARY,KNOSP,LABEL,METHODS,MRI,OVERALL,RESULTS,SEVENTY,SIX,UNLABELLED,WHILE
100,130,131,AFTER,CSF,DISTANT,FFP,HISTOLOGY,HOWEVER,LABEL,LOCAL,METHODS,OBJECTIVE,PERMANENT,RESULTS,SECONDARY,SRS,THERE,THESE
108,150,BSG,CNS,HGG,KARNOFSKY,LGG,MARQUEZ,PRIMARY,SIXTEEN,TREATMENT
BASED,HOWEVER,LABEL,MEASURING,METHODS,OBJECTIVE,PET,PSF,PURPOSE,RESOLUTION,RESULTS,TOMOGRAPH
LABEL,METHODS,MRI,OBJECTIVE,OPTIC,PURPOSE,RESULTS
EQA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBA
787,819,COMPARING,CTS,HOUNSFIELD,INCREASING,LABEL,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,RESULTS,RMS
174,BOT,DESPITE,HT1,HT2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSS
RAMAN
AFTER,AWS,INTLOCK,UNDER
CARLO,FURTHER,GRAPH,MONTE,THEREFORE
003,284,285,546,630,731,945,946,PCR,PI3KS
139,169,477,COX,HEMATOLOGY,MINNESOTA,OLMSTED,RECURRENCE,SOCIETY,VTE
160,169,183,ESPECIALLY,GEORG,IPILIMUMAB,IRAES,STUTTGART
CHINESE,ERCC1,ERCC2
945,CONCLUSION,FMISO,HIF,HOWEVER,HYPOXIA,III,IRS,LABEL,MEIER,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUVTUMOUR,THERE
100,BACKGROUND,CONCLUSION,EARLY,IGF,LABEL,METHODS,OPTIMAL,REMISSION,RESULTS,ROC
005,215,FDR,KNOSP,PAS,PATHWAY,PITUITARY
001,BACKGROUND,CYP,CYP3A,LABEL,METHODS,PACLITAXEL,RESULTS
CPA,PRESENTING,SPS,SPV,THEREFORE
BECAUSE,CSF,ELISA,FURTHER,GAL,GBM,GLIOMAS,HSPA5,INGENUITY,IPA,PANTHER,PATHWAY,PROTEIN,THEREFORE,THROUGH
002,008,248,EARLY
169,PRESS,PUBLISHED,PULMONARY,SURGERY,UNIVERSITY
169,AUTHORS,COPYRIGHT,LTD,PUBLISHED
169,AFM,COPYRIGHT,ELISA,INC,LABEL,THROUGH,UNASSIGNED,UNLABELLED
169,221,AKT,FURTHER,MICRORNAS,PI3,SOCIETY,UTR
169,AMONG,BFABP,COX,SOCIETY
169,CARCINOMA,CNS,MENINGEAL,POSTMORTEM,SOCIETY,THESE
BACKGROUND,FORMULATE,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
160,176,177,THESE
169,AHR,AMONG,BACKGROUND,DIAGNOSES,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
AGGRESSIVE,CSF
001,272,544,AIM,BACKGROUND,CONCLUSION,ELDERLY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,TOTAL
200,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
ALA,BACKGROUND,CNS,LABEL,METHODS,PORPHYRIN,RESULTS,SIXTY,U87,UW228
403,GBM,MRI,OVERALL,VOLUMETRIC
007,083,177,III,JANUARY
107,124,131,167,169,COMMISSION,GBQ,IEC,MBQ,PET,PHANTOM,RIT
169,AES,FURTHER,IPILIMUMAB,PALLIATION,RESULTS
CD11B,DIFFUSE,HOWEVER
ASSESSMENT,BCBMS,ERBB2,EXPRESSION,HOWEVER,SIMILAR,TAKEN
BACKGROUND,BITHALAMIC,CONCLUSION,IMAGE,IMAGING,LABEL,LOCALIZED,METHODS,MRI,NGGCT,RESULTS,THICK
130,131,135,143,AFTER,AMONG,CONCLUSION,FURTHER,HUNDRED,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SEVENTY,THOSE,THREE,YOUNG
GPA,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
145,ABCG2,ATP,DESPITE,FURTHER,HOWEVER,KNOCKDOWN
103,ABDOMINAL,CHEST,DLP,LAR,ROUTINE,RUSSIAN
BACKGROUND,GBM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPECIMENS,THESE
BRAIN,LABEL,METHODS,MRI,OBJECTIVE,TREATMENT
APA,BA6,DESPITE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SURVIVORS,THESE
169,19P,22Q,AMONG,CHROMOSOME,NF2,ORBITAL,SNP,SOCIETY,SPH,WORLD
ADENOVIRAL,ADS,AREAS,BACKGROUND,COVERED,FINALLY,GBM,III,LABEL,METHODS,OPINION,PHASE

CNS,FEDERAL,NORTH,PETERSBURG,POPULATION,REGISTRIES
169,DESPITE,EARLY,LOCATED,REALIZING,THESE
169,181,200,ADAMS,INC,NOTABLY,PREVIOUSLY,PTP,WILEY
169,BACKGROUND,CLINICIANS,HODGKIN,LABEL,METHODS,PML,PRESENTING,PRIOR,RESULTS,SOCIETY
101,127,TIOSENS
125,140,AFTER,BETWEEN,DUE,IBT,MARCH,OCTOBER,PRIOR,TEMPORARY
HOWEVER,MEDICINES,SEGAS,SURGERY,THESE,TSC
CNS,CSF,HOWEVER,NOTABLY,PRIMARY,PROTEOMIC
172,AKT,EGF,FOXO1,TAKEN
088,126,247,275,304,469,576,824,COX,GREEK,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
APRIL,CNS,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,ADDITIONAL,BACKGROUND,INCREASING,LABEL,METHODS,RESULTS,SAMPLES,SIX
EIGHT,GROSS,LABEL,METHODS,MRI,OBJECTIVE,PRE,RESULTS
DIFFUSE,FURTHER,GNT,H09,IDH,OLIG2
BECAUSE,CHEMOBRAIN,III,INITIAL,PCV,WORLD
BRAIN,UPPER
FLAIR,FOLFOX6,MEDICAL,SEPTEMBER
169,948,BIM,CONVERSELY,ERK,FGFR1,PKC
169,AKT,COPYRIGHT,ERK,IGF1R,INSULIN,IRELAND,LTD,MTT,NVP
169,CLEFT,COPYRIGHT,OROFACIAL,SAS
017,160,169,215,446,ASD,AUTHORS,CNV,CONSISTENT,COPYRIGHT,HDAC4,HDAC9,INC,PATHOGENIC,PUBLISHED,SETD5
12Q14,169,AFTER,BACKGROUND,CHROMOSOME,COPYRIGHT,GENOMIC,INC,LABEL,METHODS,R248Q,RESULTS,THEREFORE,THESE,WORLD
169,COLLEGE,COPYRIGHT,FINALLY,LIPOPHILIC,LOW,LTD,MEDICAL,PCV,PUBLISHED,ROYAL
100,10Q,169,CHEK2,CHROMOSOME,COPYRIGHT,DELETIONS,DNT,FAM131B,GAINS,INC,MBS,MYB,NF1,NF2,QKI,RB1,SNP,THR599DUP,V600E
169,332,945,AUTOIMMUNE,BULLOUS,COPYRIGHT,DERMATITIS,IGA,INC,PEMPHIGUS
160,169,224,COPYRIGHT,INC,SUV
169,COPYRIGHT,CPG,LTD,MECP2,SINCE
156,357,ALCOHOLICS,ANONYMOUS,BEHAVIORAL,COMBINE,COMBINING,FEWER,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,TREATMENT
CCF,CONCLUSION,HNM,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SRT
AREAS,BACKGROUND,COVERED,LABEL,MALIGNANT,METHODS,MRI,OPINION
DUE,GBM,WHILE
946,BTICS,CURRENT,PBAES,USING
136,ANXIETY,COGNITIVE,CONCLUSION,COUNTRY,CROSS,DEPRESSION,FORTY,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SCALE,SCREENING,UNIVERSITY,UTRECHT
580,728,CAUCASIAN,CHINA,CHINESE,CIS,CONCLUSION,ERCC1,ERCC2,KNOWLEDGE,LABEL,LYS751GLN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,ORS,OVERALL,POTENTIAL,RESULTS,STATA,VIP,WANFANG
CGG,CPG,EXPANSION,FRA2A,FRAXA,FRAXE,HOWEVER
169,362,398,BCAR1,BIOLOGISTS,COMPANY,CORRECTED,EXPRESSION,KNOCKDOWN,LTD,MECHANISMS,PHE,PUBLISHED,THESE,TYR
BACKGROUND,CMS,CNS,CONCLUSION,FAVORABLE,HOWEVER,LABEL,METHODS,OBJECTIVE,PONTINE,RESULTS,SCALE,THREE,VII,XII
1LI,BFH,MIB,MRI,PRIMARY,SUBSEQUENT
CONCLUSION,DIAGNOSTIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROTEOMICS,RESULTS,SPOTS
APRIL,ARC,AVOIDANCE,BACKGROUND,BETWEEN,BRAIN,CONCLUSION,CONFORMAL,DCA,DYNAMIC,GTV,HGG,LABEL,MATERIALS,METHODS,PTV,RAPID,RESULTS,SRS
105,242,BACKGROUND,LABEL,MATERIALS,METHODS,MTS,PATIENT,RESULTS
177,ANOTHER,BACKGROUND,CONCLUSION,DAT,EIGHT,ISOCENTRIC,LABEL,MATERIALS,METHODS,REFERRING,RESULTS,THESE
177,AIM,AMONG,CONCLUSION,DCA,FUSED,IMRS_80,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PADDICK,PRIMARY,RESULTS,SCF,SCHWANNOMA,VESTIBULAR
160,946,GENZYME,HOWEVER,IFN,III,MRI,PHASE,USA
177,AGE,BACKGROUND,DESPITE,GBM,LABEL,MANAGEMENT,RESULTS
003,168,352,BACKGROUND,COX,LABEL,MEDICAL,MEIER,METHODS,RESULTS,YOUNG
169,237,954,AHF,ARGENTINA,ARGENTINE,CD8,COPYRIGHT,HOWEVER,IMPORTANCE,JUN,PREVIOUSLY,RIG,SOCIETY,SUCCESSFUL,THESE

001,002,107,144,ADC,DWI,SRS
ACUTELY,AED,EEG,EPILEPTIC,NON,TREATMENT
BBB,CNS,FORMATION,NVU
FURTHER,HOWEVER,OLI
229,946,AKT,ELEVATING,NAG,NSAID,SMAD2,SMAD3,TGF,U87
169,AATXS,B20,BACKGROUND,DCE,LABEL,METHODS,MRI,NEURO,NOD,PRESS,PUBLISHED,RESULTS,SOCIETY,T1W,UNIVERSITY,VALIDATION
169,COPYRIGHT,LTD,NSCLC,PROGNOSTIC
FDA


169,200,239,BC200,BRAIN,DIVERSE,FAB,HOWEVER,LABORATORY,PRESS,PUBLISHED,SELEX,SOCIETY,THEREFORE,VARIOUS
100,128,BETWEEN,DISTANT,GTV,LOCAL,SRS,SRT
001,CONCLUSION,GBM,LABEL,LTS,METHODS,MRI,OBJECTIVE,PFS,RESULTS,STS,SVZ,SZV,THESE
CYS,DIAGNOSIS,EG2,EGF,GBM,IMAGING,MRI,QD800,U87MG
169,263,473,ABT,ANNEXIN,BAD,BCL,ECTOPIC,GBM,GDC,LABEL,MCL,NAVITOCLAX,THEREFORE,UNLABELLED
001,008,105,169,AUTHORS,DELAYED,IMMEDIATE,INDEX,LTD,REVISED,SCALE,WILEY,WMS
169,BRITAIN,COPYRIGHT,EMPLOYING,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,THESE,WILEY
174,BCC,EMA,FDA,GDC,JANUARY,MEDICINES,SMO,VISMODEGIB
CURRENT,DABRAFENIB,METASTATIC,V600E
160,AFTER,MTT,SCN5A,THESE
412,560,ENGLISH,FURTHER,MGS
532,BASED,CHINESE,GBM,HGG,HOWEVER,HSV,LIBRARY,MST,SCIENCE,THREE,WEB
AKT,ENDOTHELIN,ETA,ETB,GBM,JUN,MAP,MMP,PI3,THESE
160,KARNOFSKY,LABEL,LEVEL,METHODS,OBJECTIVE,POPULATION,THESE,UNASSIGNED
232,AFTER,AICARDI,ATL,BACKGROUND,GOUTI,LABEL,METHODS,RESULTS,THEREAFTER
BACKGROUND,BASED,BRAIN,CONCLUSION,GBM,HOWEVER,LABEL,METHODS,NOTCH,NSC,RESULTS
031,10P12,295,606,646,FUNCTIONAL,SIMILAR
GSC,MRI,VAE,VIRUSES
CONVERSELY,GBM,III,INTERPLAY,LGS,TAKEN,TMZ,WHEREAS
941,AMONG,BACKGROUND,CLASSICAL,LABEL,METHODS,MOLECULAR,PRONEURAL,REMBRANDT,RESULTS
169,945,946,COPYRIGHT,HOWEVER,IRELAND,LTD,POA,TRANSGENIC
169,BRAIN,CHARCOT,DYNC1H1,EGF,ERK,F580Y,FOS,GUARANTORS,LOA,MARIE,MUTATIONS,PRESS,PUBLISHED,THESE,TOOTH,UNIVERSITY
169,185,956,COPYRIGHT,GLN,GLU,GLUTAMATE,GLUTAMINE,INC,NMR,POTENTIAL
169,BLADE,COPYRIGHT,DWI,EPI,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PHANTOM,PURPOSE,RESULTS,SNR
169,317,COPYRIGHT,FOLLOWING,GBM,GDC,GNE,GS2,MALDI,SOCIETY,THESE,U87
101,327,428,646,BACKGROUND,DESPITE,DETAILS,DUTCH,III,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,REASONS,RECURSIVE,RESULTS,RPA,THEREFORE
AHEAD,CURRENTLY,GROWING
001,169,COMMITTEE,CONCLUSION,COX,DSC,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,STRUCTURAL,SVM,WILEY
169,BIOLOGY,HOWEVER,INC,MOLECULAR,SOCIETY,USING
169,COPYRIGHT,HOWEVER,INC,WILEY
BACKGROUND,DISCUSSION,LABEL,MEDICAL,METHODS,PROGNOSTIC
AKT,INJECTIONS,R132H,RAS,RTK
169,172,190,FIFTEEN,GRADE,MPP,PARTIAL,PERCIST,PFS,SUCCINATE,THERE,TMZ
169,MMP,USING
592,BESIDES,JANUARY,MAXIMUM,METICULOUS
TRUTH
100,2RA,945,946,947,ART,BIOPLEX,CROSS,CSF,HIV,IFN,LABEL,MACHINE,METHODS,OBJECTIVE,RESULTS,THESE,UNTARGETED
251,615,AMONG,BACKGROUND,CENTRAL,CNS,GCT,GERMANY,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR,THERE,USA,WESTERN,WHILE
CONCLUSION,CSF,DIAGNOSIS,EVOLUTION,IAM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RAPID,RESULTS,SETTING,TREATMENT,VESTIBULAR
003,005,013,169,ACADEMY,BACKGROUND,BECAUSE,CONCLUSION,CONTEXT,COPYRIGHT,HOSPICE,INC,LABEL,LATER,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,INC,KARNOFSKY,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PURPOSE,QALMS,RESULTS,SRS,THESE,TREATMENT
AKT,ATO,BLOOD,CD133,FOXO3,GSC,METFORMIN,STAT3
215,ADC,AFTER,DIAGNOSTIC,IMAGING
ENGLISH
DIFFUSE,REMOVAL


AVAILABLE,IMAGING

ACC,ADENOID
160,169,ALK,ANAPLASTIC,APMIS,CRIZOTINIB,JUN,KRUSKAL,LTD,NPM,NSCLC,PDGFR,PUBLISHED,THESE,WILEY
169,CVD,DUE,GHD,HOWEVER,LARGE,LTD,WILEY
169,AFTER,AMONG,FIFTEEN,HOWEVER,IRD,NOTABLY,PCNSL,SOCIETY

COMPLEX
ASYMMETRY,CENTRAL,ICU,INSTITUTE,LABEL,N20,RESULTS,SCIENTIFIC,THERE,UNLABELLED
CEA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,UNIVARIATE
001,COX,MARCH,OCTOBER,SEVERAL,TMZ
000,100,DUTCH,PEDIATRIC
160,ASSESSMENT
HOWEVER,MET,TRAIL,USING
BIOETHICS,INQUIRY,NARRATIVE
BRAIN,GOD,PARENTS,PBT,WORLD
SEVERAL,THESE,TREATMENT

ASSOCIATE,BARRAZA,BIOETHICS,BRAIN,CHRISTY,CREIGHTON,INQUIRY,KATIE,MICHAEL,NARRATIVE,NETWORK,NIB,OTHER,PEDIATRIC,PROFESSOR,PROJECT,STERN,STORIES,UNIVERSITY
CENPE,DEFECTS,FIRSTLY,MITOTIC,MPD,THESE
176,APPROACHES,ERBB2,FINALLY,FRESHLY,HTS
160,491,ARF,ATLAS,BCL,GBM,HOWEVER,INK4A,MIR,SMALL,THEREFORE
C620Y,C624F,C628Y,C636Y,EGF,FOLLOWING,THESE
169,COPYRIGHT,DIFFUSE
129,160,945,ECS,GBM,HIF,PFN,THESE,TYR,VHL
169,BECAUSE,COPYRIGHT,DESPITE,IMAGING,MRI,PET
169,COPYRIGHT,LTD,TAE
169,285,AFRICAN,COLLEGE,COPYRIGHT,EIGHT,FIFTEEN,LABEL,LOCALLY,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
130,169,ANY,BACKGROUND,CNS,CNV,CONCLUSION,COPYRIGHT,CTC,DOSIMETRIC,HNC,IRELAND,LABEL,LTD,METHODS,RESULTS
169,COPYRIGHT,INC
169,AUTOTAXIN,COPYRIGHT,GBM,LPL,LTD,THESE
160,169,2N0,BACKGROUND,COPYRIGHT,INC,LABEL,METASTATIC,METHODS,PUBLISHED,RESULTS,SOCIETY
169,BRAIN,COPYRIGHT,GENERAL,INDIA,MRI,SAS,TYPICALLY
EVS,HOWEVER,THERE,THESE
AUTOIMMUNE,CONCLUSION,EEG,EIGHT,HASHIMOTO,LABEL,MARCH,MAY,METHODS,MRI,OBJECTIVE,RESULTS,SIX,THEIR,THERE
BECAUSE,LABEL,METHODS,OBJECTIVE,PCR,RAPID,RESULTS,THESE
BACKGROUND,LABEL,METHODS,NAVIGATED,NBS,OBJECTIVE,RESULTS
032,FDG,LABEL,METHODS,OBJECTIVE,PCNSL,PET,RESULTS,ROC
945,946,CHRONIC,HOWEVER,THESE
160,169,ALIKE,BIOLOGY,CED,CHC,COMMONS,HOWEVER,LICENSE,SHARE,SILENCING,SOCIETY,TAKEN
169,945,947,CAPSAICIN,PRESS,PUBLISHED,TAKEN,TRPV1,UNIVERSITY
300MG,400MG,AFTER,CAP,CYP,HOWEVER,PHT,VAP,VPA
200ML,AUC,CREATININE,CSF,HOWEVER,TOTAL
CD4,CD8,PROGRAMMED,VISTA
169,ARX,CGE,COPYRIGHT,CXCR7,FINALLY,GABAERGIC,INC,LIM,MGE,THESE,USING
100,BACKGROUND,CONCLUSION,DOTATOC,LABEL,MCC,METHODS,NOTABLY,PET,RESULTS
CNS,MRI
DEPARTMENT,INFECTIOUS
149,177,489,529,556,621,BACKGROUND,DIFFERENT,HOWEVER,LABEL,LIS,MEANWHILE,METHODS,OBJECTIVE,RESULTS
169,AUTHORS,LTD,SOLBERG,WILEY
169,946,AKT,BIOLOGY,FUKUSHIMA,HOWEVER,MOLECULAR,SILENCING,SIP,TAKEN,UNION
CONCLUSION,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RECURRENT,SINCE,TECHNIQUE,TUMOURS,USING
143,FIRSTLY,IHC,LASS2,PCR,PEARSON,SIMPSON
239,ACCRUAL,GBM,GROUP,PFS,TREATMENT,VERUBULIN
160,GIVEN,III,LABEL,LEVEL,OBJECTIVE,POPULATION,TREATMENT,UNASSIGNED
III,LABEL,LEVEL,METHODS,OBJECTIVE,POPULATION,UNASSIGNED
BACKGROUND,CIS,EGF,EPIDERMAL,EXTENSIVE,GLIOMAS,GRADE,HOWEVER,III,LABEL,METHODS,ORS,OVERALL,RESULTS,SNP
DUE,GBM,GSC,PREVIOUSLY

FRONTAL,GRADE,HPF,MRI,PXA
131,300,ATA,BECAUSE,CHERNOBYL,CURRENT,IDD,THERE,THYROID
100,ABDOMINAL,BACKGROUND,DERMOSCOPY,HEREDITARY,LABEL,METHODS
100,174,600,AFTER,CARMUSTINE,EISAI,GLIADEL,INC,MGS,THERE,THESE,USA,WAFER,WHOLE
BRAINSTEM,MRI
001,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PEDIATRIC,RADIATION,RESULTS,THERE
BECAUSE
PFO
WOMEN
169,GROSS,HENCE,PAPILLARY,PET,PGNTS,SOCIETY
GBM,MALIGNANT,THESE
002,007,018,120,215,667,722,866,873,AMONG,BACKGROUND,CHINESE,FIFTEEN,HEART,LABEL,METHODS,NEUROLOGIC,RESULTS,SBP,WBC
001,169,518,573,ADHERENCE,AUDIT,CONCLUSION,COPYRIGHT,FLORIDA,III,INITIATIVE,LABEL,MEDICAL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SIXTEEN,SOCIETY,THERE,WHETHER
ACCORDING,BMJ,CMMRD,GROUP,HOWEVER,LIMITED,LYNCH,MMR,PUBLISHED,PUBLISHING,TUMOURS
169,ANT,BACKGROUND,COMPLAINTS,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THESE,WILEY
160,55933,947,ATM,AUTOPHAGY,HOWEVER,TMZ,U87MG
335,HOWEVER,MMP,U87
BASED,COMPONENTS,MEIER,MEMBERS,NEITHER,NVP,RAPAMYCIN,UW228
008,022,100,160,177,18F,ADC,AIM,CONCLUSION,FET,LABEL,METHODS,MRI,MRS,OBJECTIVE,PET,RESULTS
169,231,BECAUSE,GGA,JAPAN,LPA,MDA,REMARKABLY,RHO,ROCK1,THESE,TUNEL
112,159,AGE,CHILDHOOD,CONCLUSION,INDIA,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PROGRAMME,RESULTS,SECONDARY
160,166,177,178,182,201,218,226,BRM,IRB,MRI,ROUTINE
009,028,BECAUSE,BSG,CNS,DIAGNOSES,DIFFUSE,ENDOPHYTIC,III,LOW,MRI,PFS
023,174,BECAUSE,ESOPHAGEAL,FIFTEEN,GAMMA,KPS,SRS
954,AML,BAALC,DISRUPTION,HOWEVER,INCREASED,OLDER,RUNX1,SIMILAR,SP1
001,227,533,547,864,BACKGROUND,BCL,BIM,COX,JANUARY,LABEL,METHODS,PFS,POLYMERASE,RESULTS,THERE
169,COPYRIGHT,LTD
BACKGROUND,BRAIN,COLORECTAL,CONCLUSION,CRC,DUE,LABEL,METHODS
169,DNT,RGNTS,SOCIETY
ANY,ART,HIV,RIT
416,BASED,CHINA,GOVERNMENT,HCC,III,LIVER,MILAN,ORTHOTOPIC,THEIR,TRANSPLANT
EHASA,MRI
100,956,EGF,III,U87EGFR,U87PTEN,USING
231,947,IFN,MDA,TAXOL
AVAGLIO,III,SINCE
III,LABEL,LEVEL,METHODS,OBJECTIVE,POPULATION,THESE
946,ALZHEIMER,BECAUSE,IGVL5D3
169,AKT,BIOLOGY,DESPITE,INC,MMP,MOLECULAR,MT1,NOTABLY,SOCIETY,SP1,TAKEN
169,CD133,COPYRIGHT,FINALLY,HOWEVER,IRELAND,LTD,THESE
169,BACKGROUND,CNS,CONCLUSION,HISTOLOGY,LABEL,METHODS
001,002,169,220,BACKGROUND,BASEL,CONCLUSION,COX,GAL,LABEL,METHODS,MMQ,RESULTS
ADP,BBM,BBMD3,BERBAMINE,CD133,DESPITE,FOS,GBM,INDUCTION,JNK,JUN,TARGETING,THESE,TREATMENT
FOLLOWING
169,BACKGROUND,CARDIAC,COPYRIGHT,INC,LABEL,METHODS,MYXOMAS,PATIENT,RESULTS
169,COPYRIGHT,INC,OCD
169,480,COPYRIGHT,DESPITE,FACTORS,GBM,KPS,LABEL,METHODS,OBJECTIVE,RESULTS
000,001,067,151,169,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,SHUNT
AFFILIATED,AFTER,CAPITAL,CONCLUSION,FRIENDSHIP,JANUARY,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,RESULTS,SEPTEMBER,SHUNT,UNIVERSITY
169,231,233,COMBINING,COPYRIGHT,PUBLISHED,SAS,TREATMENT,WHOLE
169,AGAIN,COPYRIGHT,ERBITUX,HOWEVER,INC,TAKEN,THESE,TREATMENT
APLASIA,FGF,FGF10,FGFR2,THESE
AUSTRIA,CNS,FMIONPS,HOWEVER,NPS,OXIDE,SCI,SINCE,THESE,WBH
000,DUE,MEANWHILE,NPS,SUCCESSFUL
FINALLY
109,169,490,789,APRIL,INTENSITY,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
100,169,279,BIRMINGHAM,BRAIN,COPYRIGHT,DTREG,IMAGE,LDA,LOOCV,LTD,MAZDA,MRI,PCA,PCS,PNN,TEXTURE,WILEY
169,239,GLIOMAS,VCH,WILEY
TUMOURS,WORLD
210,BACKGROUND,III,LABEL,METHODS,MIR,PCR,RESULTS
169,945,ESI,LTQ,THESE,TOP,VCH,WILEY
103,169,2DE,AMONG,NFPAS,PDQUEST,RXR,THOSE,VCH,WILEY
IMAGING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,THROUGHOUT,UVEAL
MRI,PITUITARY
CNS,MRI,PCNSL
100,169,BACKGROUND,COMPLEX,ERA,EVEROLIMUS,EXAMINING,EXIST,GREATER,LABEL,METHODS,MRI,PHASE,PRESS,PUBLISHED,RESULTS,SCLEROSIS,TSC,UNIVERSITY,WEEKS
169,BACKGROUND,BROWSER,CHG,CHH,CONTACT,EPIGENOME,LABEL,METHODS,PRESS,PUBLISHED,SUMMARY,UNIVERSITY,WASHU
200,300,400,PERFORM,SEVENTEEN,THERE,VORINOSTAT
117,256,GBM,PROTEIN
III,LABEL,LEVEL,METHODS,OBJECTIVE,POPULATION,THESE,UNASSIGNED
CONSISTENT,GSC,THESE,TOWARDS
CURRENTLY,EMERGENCY,MRI,PITUITARY,SEVERAL
GAMES,THESE,TPJ
169,ABCB1,ABCG2,AFTER,BRAIN,CES,CES1C,CYP3A,EVEROLIMUS,FOLLOWING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,705,727,945,946,CK2,COPYRIGHT,HOWEVER,INC,PUBLISHED,RAT,S727A,SER,SOCS3,STAT3,TYR
169,COPYRIGHT,CSC,EMPLOYING,GBM,INC,WNT
169,COPYRIGHT,ELECTRONIC,GIVEN,LABEL,MEDLINE,METHODS,REVIEWS,SEPTEMBER,SLEEP,SYSTEMATIC,UNLABELLED
169,CERTAIN,COPYRIGHT,GBM,INC,OLIG2,PAPERCLIP,SALL2,TFS,THESE,TPC
169,1MG,2MG,7MG,AVERAGE,CONCLUSION,COPYRIGHT,EARLY,FINALLY,FSH,HDL,IGF,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
044,142,169,216,COPYRIGHT,GIVEN,HOWEVER,HPC,III,LTD,MEIER,METASTASES,OPTIMAL,PRIMARY,THERE,WORLD
169,ALBERTA,BACKGROUND,BRITISH,BRUNSWICK,COPYRIGHT,GHD,LABEL,LONGWOODS,METHODS,ONTARIO,PBT,PUBLISHING,RESULTS,THERE,YOUNG
169,CNS,COPYRIGHT,DANIO,FINALLY,LTD,OUTLINING
160,169,177,916,COPYRIGHT,FINALLY,GAMMA,GTV,INC,KNIFE,LABEL,MATERIALS,METHODS,MILLIMETER,OBJECTIVE,PERFEXION,PURPOSE,RESULTS
103,169,CNS,CONCLUSION,COPYRIGHT,COX,CSI,DFS,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS,SCT,TBI,THOSE
189,BACKGROUND,CAUCASIAN,CNS,CONCLUSION,LABEL,METHODS,MOLECULAR,V600E,WHILE
169,COPYRIGHT,INC,KITAMBI
000,001,002,004,008,129,169,346,491,726,968,AGE,CA125,CEA,COPYRIGHT,COX,III,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,NSE,OBJECTIVE,PURPOSE,RESULTS
18F,FDG,MALIGNANT,PET
128,DISCUSSION,ENGLISH,LABEL,METHODS,NOTCH,OBJECTIVE
142,166,177,311,576,703,CUSHING,DESPITE,INDIVIDUAL,LABEL,METHODS,OCTOBER,RESULTS,UNLABELLED
AGGRESSIVE,CPA,RCC
AFTER,CNS,DATABASES,FURTHER,MEDLINE,MRI,PROGNOSIS,SCIENCE,WEB
BIOMEDICAL,GBM,NMF,NMR

146,169,BACKGROUND,CONSORTIUM,LABEL,LARGE,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
023,024,157,169,191,19Q,203,AOS,BACKGROUND,BASED,HPF,IDH,LABEL,METHODS,MVP,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,BACKGROUND,END,LABEL,MEASURING,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
169,945,GBM,III,IL13R,NEURO,PRESS,PUBLISHED,SELECTIVE,SOCIETY,UNIVERSITY
DEVELOPING,MICRORNAS
120,125,150,169,200,APRIL,BACKGROUND,BEV,EUDRACT,FLEMING,IRI,JANUARY,LABEL,MEDICAL,METHODS,NEO,PFS,PRESS,PROGNOSIS,PUBLISHED,RESULTS,SOCIETY,TMZ,TRIAL,UNIVERSITY
169,CONCLUSION,EPI,FAT,IDEAL,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THESE,WILEY,WITHOUT
DIFFERENT,ESPECIALLY,GBM,HENCE,HOWEVER,PRIMARY
013,022,100,BACKGROUND,COMPLETION,INITIAL,JANUARY,KARNOFSKY,LABEL,METHODS,MTX,OVERALL,PCNSL,RESULTS,THEIR,WHILE
169,902,AIM,COX,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,PHYSICIANS,PRESS,PUBLISHED,RESULTS,UNIVERSITY
181,EEG,GLASGOW,ROUTINE,SCALE,SERUM,VALPROATE
BRAIN,DIAGNOSIS,HODGKIN,MRI
001,105,124,22Q,799,III,PCR,THEREFORE,TIMP3
270,AREAS,CAR,GBM,HOWEVER,THEREFORE,USING
ASD,HOWEVER,INCREASED,ISOFORM,NETWORK,SPLICEFORM
003,006,010,100,BACKGROUND,CONCLUSION,LABEL,METHODS,MUTATIONS,RESULTS,SOCIETY,THESE,WORSE
111IN,177,AFTER,AMONG,BACKGROUND,FSH,LABEL,LITERATURE,METHODS,MRI,SIX,SSR,THERAPY
014,487,527,BACKGROUND,ENDOSCOPIC,JANUARY,LABEL,LIBRARY,MAY,MEDLINE,METHODS,RESULTS,SCIENCE,STUDIES,THERE,WEB
169,945,COPYRIGHT,LTD,VEGFR
169,201,COPYRIGHT,ERK,INC,KEY,LABEL,MEK,METHODS,OBJECTIVE,PCR,RAF,RESULTS,UAI,V600E
126,AMONG,BACKGROUND,DEPRESSION,DISCUSSION,LABEL,METHODS,NTR3223,PRIMARY,SCALE,SECONDARY,STUDIES,THEIR,THEREFORE,TRIAL
INC,MRI,PUBLISHED,SCO,SPINDLE,WORLD
AREAS,BACKGROUND,COVERED,DESPITE,LABEL,MEK,METHODS,OPINION,SELECTIVE,VARIOUS
003,339,627,664,CENTRAL,COMMUNITY,CONCLUSION,COX,DISORDERS,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS,SPAIN,STATE
001,002,007,008,032,045,AFTER,CD133,COX,ESA,HOWEVER,KARNOFSKY,KPS,PCR,PERIOSTIN,WESTERN
003,165,200,AFP,BACKGROUND,BRAIN,CONCLUSION,GROUP,HISTOLOGY,LABEL,METHODS,PROGNOSTIC,REGARDLESS,RESULTS,SPANISH
011,033,044,532,583,ADC,BIS,CONCLUSION,DWI,GBM,HIPAA,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,OBJECTIVES,PCNSL,PET,RESULTS,SUV
ABCD1,AMN,AMONG,BRAIN,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,MUTATIONAL,NERVE,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THESE
006,007,017,018,032,AMYLASE,CONCLUSION,ENDOSCOPIC,HISTOLOGIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,005,COX,EIGHT,KPS,MAY,OCTOBER,OVERALL
006,124,128,221,407,469,DUE,FINALLY,GIV,HENCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
A10,ANP,AS2,BACKGROUND,BRAINSTEM,BSG,CONCLUSION,GRADE,LABEL,MATERIALS,METHODS,RESPONDING,RESULTS,SEVENTEEN,SIX
945,946,948,AKT,CONSISTENT,INHIBITION,THESE
CARDIAC,FLUID,IMAGING,MALIGNANT
MAXIMAL,MRI
LUNGS,METASTASES,PATIENT,UTERINE
169,ACTIVATION,ALZHEIMER,CANDIDA,COPYRIGHT,LTD,THESE
AMERICA,BRAIN,CENTRAL,METASTATIC,SOUTH
169,COPYRIGHT,FIELD,STATE
975,DBTRG,ELONGATED
100,169,946,CD133,CLAUDIN,CONSISTENT,MIB,SOCIETY,THESE,THREE,WHOLE
CHF,CONGESTIVE,EMERGENCY,RESULTS
III,LABEL,LEVEL,METHODS,OBJECTIVE,POPULATION,THESE,UNASSIGNED,WHICH
169,AIM,COPYRIGHT,CXCR4,GIVEN,INC,THERE,WILEY
001,141,306,HOWEVER,RADIATION,REGARDING,SCALE,THERE,THREE
252,BACKGROUND,CONCLUSION,CTV,DEGRO,DISCUSSION,DISTANT,ESPECIALLY,GROUP,GTV,LABEL,PTV,RADIATION,RESULTS,SOCIETY,SRS,WORKING
169,909,AKT,CIC,CONCLUSION,GLIOMAS,IDH,ISOCITRATE,LABEL,MET,METHODS,MYC,OBJECTIVE,PURPOSE,RES,RESULTS
ASSESSMENT,BACKGROUND,BRAIN,COGNITIVE,DISTURBED,HCS,HOWEVER,LABEL,LGG,PRINCIPAL,RESULTS
660,GENOMIC,MGA
FURTHER,HENCE,HOWEVER,LOW,SLC7A11,VEGFA
019,177,HOWEVER,PFS,RADIATION
ALZHEIMER,BRAIN,HUNTINGTON,NTRK2,PARKINSON,PCR,THESE
ANOTHER,APABS,BACKGROUND,CLINICALLY,FINALLY,LABEL,METHODS,RESULTS
CHESTER,ECD,ERDHEIM,LANGERHANS
169,BAYES,CAR,CARLO,HOWEVER,LAPLACE,MONTE,PQL,SPAIN,THESE
ANTIBODIES,BACKGROUND,BRAIN,LABEL,METHODS
169,AUTHORS,COGNITIVE,CURRENT,FOUNDATION,LTD,PUBLISHED,WILEY
103,107,110,146,169,373,519,599,762,AMONG,COPYRIGHT,MONITORING,RECIPIENTS,SCIENTIFIC,SOCIETY,THERE,TRANSPLANT
123,18K322A,945,946,ADVERSE,CONCLUSION,GD2,HOWEVER,K322A,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIX
H3K27AC,H3K4ME1,LSH
177,732,783,827,ENDOCRINE,MEDICAL,MRI,PRL,SIX,THEREFORE,THESE
000,001,003,160,945,AML,ASSESSMENT,CHANGES,ERYTHROID,FUNCTIONAL,MDS,QOL,RBC,RESPONSIVE,RHO,SEVEN,SIXTEEN,THERAPY
001,009,115,216,317,MUC15,PCR,WESTERN
169,SILYLATION,SITPPC4,SITPPS4,TPP,VCH,WILEY
INCREASING,IRT,ZIP,ZNT,ZRT
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,PET,RESULTS
010,078,080,092,099,118,177,239,249,263,283,585,602,675,720,938,COMMISSION,DCA,GROUP,PADDICK,PLANS,RADIATION,THERAPY,UNITS
177,GAMMA,GAMMAPLAN,HENCE,KNIFE,LEKSELL,LGK,LGP,PERFEXION,PFX,VER
177,BEV,DLG,GAFCHROMIC,MLC,PARTIAL,TPS
176,177,313,438,546,933,OVERALL,PTV,ROTATIONAL
000,633,ASXL1,ASXL2,H3F3A,KDM6A,SETD2,SMARCA4,SMC1A,STUDIES,ZMYM3
ATLAS,SCORE
CNS,RAF,RECORDS,SIMILARLY
000,009,019,100,112,448,560,BACKGROUND,BETWEEN,FURTHER,HOWEVER,INSURANCE,LABEL,METHODS,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,THREE
133,200,CPG,GBM,H3K4ME3,HISTONE,MEDIP,MRE,OVERALL,RECURRENT,RECURRING
BACKGROUND,BRAIN,CONCLUSION,CXORF66,LABEL,MATERIALS,METHODS,ORF,RESULTS
169,231,468,COPYRIGHT,HOWEVER,INC,MDA,NEOPLASIA,NOTABLY,OPN,PRESS,SEVERAL,USING
169,ATG,COPYRIGHT,RAN,THESE
169,946,ADP,ALZHEIMER,ANT,APOPTOSIS,COPYRIGHT,GSH,NH2HTAU,PPADS,ROS,SOD
112,155,169,215,263,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,EARLY,ELISA,KAROLINSKA,LABEL,LIMITATION,METHODS,MMP,RESULTS,SERUM,THERE,TOOLS
169,231,233,CENTRAL,COPYRIGHT,MRI,PUBLISHED,SAS,TYPICAL
FINALLY,GROUP,MBS,MYC,NOTCH
AFTER,BACKGROUND,FINAL,HOWEVER,LABEL,METHODS,SUBSEQUENT,THERE
169,GBS,GCSCS,JOURNAL,SCS,THROUGH
001,160,418,ADDITIONAL,CPS,LABEL,METHODS,OBJECTIVE,RESULTS
169,CONCLUSION,FNS,III,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OPERATIVE,RESULTS
250,BCL,BCL2L13,CERS2,CERS6,GBM,THERAPY
169,COPYRIGHT,INC,MOLECULAR,SEVEN,WILEY
BACKGROUND,CONCURRENT,LABEL,METHODS,RESULTS,WHILE
ANOTHER,DIFFUSION,MRI
966,ACTIVATION,BTB,CAV,U87
001,357,AMERICANS,BIOMEDICAL,CBM,CHINESE,COLLEGE,ETHNICITY,ISSUE,ITALY,LIBRARY,SCIENCE,SIX,STATA,STATION,TEXAS,USA,VERSION,WEB
000,200,BRAIN,CHEST,EMERGENCY,MRA,WHILE
CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PITUITARY,PURPOSE,RESULTS,WHILE
218,ADAM9,BECAUSE,LUCIFERASE,MIR,SLIT2
100,ACVR1,DIFFUSE,DIPGS,HOWEVER,ID1,ID2,MUTATIONS
946,ACVR1,ARG206HIS,ARG258GLY,BMP,DIFFUSE,DIPGS,FOP,GLY328GLU,GLY328TRP,GLY328VAL,GLY356ASP,STRIKINGLY,TGF,THESE
127,ACVR1,DIPGS,HGG,MUTATIONS,NBS,NTRK1,NTRK2,NTRK3,PEDIATRIC,RAS,STRUCTURAL
ACVR1,BMP,FGFR1,PEDIATRIC,SMAD1,SMAD5,SMAD8
169,GWASS,PRESS,PUBLISHED,QTL,SNP,UNIVERSITY
155,160,178,CARLO,FINALLY,FIRST,MCNPX,MEV,MONTE
169,360,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,T12
106,20A,CD133,CSC,GSC,HOWEVER,KNOCKDOWN,MICRORNAS,NORDY,U87,UTR
26A,E2F,HOWEVER,KAP,ROCK2
169,ACADEMY,AMONG,ASSESSMENT,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,HOSPICE,INC,INVENTORY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PEDIATRIC,PUBLISHED,QUALITY,RESULTS,SCALE,SYMPTOM,THEIR
001,019,105,10878,169,177,945,BACKGROUND,BNP,CONCLUSION,COPYRIGHT,CRP,CRT,HOWEVER,INC,LABEL,LARGE,METHODS,OBJECTIVE,PRE,RESULTS,STUDIES,TNF
000,151,169,ALIGNED,BURKITT,COPYRIGHT,EBV,EPSTEIN,EXTRACTED,GBM,HGG,HPV,INC,ISH,NGS,OVERALL,SEQUENCING,VIRAL
169,COPYRIGHT,INC
169,COPYRIGHT,INC
169,BRAIN,COLLEGE,COPYRIGHT,LTD,PUBLISHED,ROYAL
169,189,COLLEGE,CONCLUSION,COPYRIGHT,GPA,KARNOFSKY,LABEL,LDH,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,THESE,UNI
177,CSF,CURRENT,EXCLUSION,ICP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THESE
169,III,SIX,SOCIETY,WORLD
169,191,BACKGROUND,CONCLUSION,COPYRIGHT,DEPRESSION,DEPRESSIVE,DIFFERENT,GOTLAND,HOWEVER,LABEL,LTD,MAJOR,MDD,METHODS,PATIENT,RESULTS,SCALE,THEREFORE,WILEY
169,964,BACKGROUND,CNS,COCKPIT,COX,CUMULATIVE,FURTHER,INC,LABEL,METHODS,MORTALITY,RESULTS,VITAL,WILEY
247,507,695,CURRENT,HOWEVER,INCREASING,ORS,RESULTS
183,GEORG,MRI,STUTTGART
013,015,020,104,178,179,185,559,945,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TCP
001,031,100,120,129,150,254,494,BACKGROUND,COMPARING,IMAGING,ISR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RIS,TRIAL
693,ACCORDING,DESPITE,MVD,SMA
100,AGE,FORTY,HOWEVER,KARNOFSKY,KPS,MRI,NSCLC,PROGNOSIS,RPA,SRS,TCR
100,169,BECAUSE,COPYRIGHT,FAP,PEDIATRIC,POFLS,POSTERIOR,STRABISMUS
169,945,946,COPYRIGHT,INC,PRESENTLY,STUDIES
160,169,196,APMIS,CAUSE,FALCINE,HOWEVER,LTD,NORWEGIAN,PUBLISHED,WILEY,WORLD
005,250,680,FURTHER,HOWEVER,LABEL,LOGICAL,METHODS,OVERALL,RESULTS,UNLABELLED,WHILE
AMONG,COMPELLING,CONTROL,CONVERSELY,HUR,SEVERAL,TTP
001,010,015,016,021,024,027,091,101,107,177,202,CONCLUSION,LABEL,LEAVE,MATERIALS,METHODS,OBJECTIVE,PCNSL,PURPOSE,RESULTS,SIXTY,THERE
ALK,ANAPLASTIC,CNS,HODGKIN
100,257,4A4,700,BIOSYSTEMS,CALBIOCHEM,DIAGNOSTIC,EMD,IDC,THERE
399,945,946,957,AKT,EGFL7,FAK,FORTY,III,MICROARRAY,RAS,THREE
EWING,THERE,TYPICALLY
ALTERED,THERE
005,137,177,344,ELISA,SERUM,TNC
CTX,GBM,LABEL,METHODS,MRI,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,TMZ,WHILE
BACKGROUND,BRAIN,CONCLUSION,CORRECTION,DOPPLER,DTI,LABEL,METHODS,MRA,RESULTS
150,177,PFS
954,C18H19N3S,CPA,GBM,ML116,STAT1,STAT3,STAT5,WHEREAS
160,APC,LABEL,METHODS,NOTCH,OBJECTIVE,PTCH1,PTCH2,PURPOSE,RESULTS,WNT
BMJ,CLINICALLY,GBM,GROUP,HOTSPOT,LABEL,LIMITED,METHODS,OBJECTIVE,PANEL,PUBLISHED,PUBLISHING,RESULTS,SOMATIC,UNLABELLED
642,ASIAN,BACKGROUND,BASED,CONCLUSION,GIVEN,LABEL,MATERIALS,METHODS,RESULTS,SINGAPORE
C3D,C4D,C57BL,IPILIMUMAB,NOTABLY,PITUITARY,SJL
169,BINDING,BMVEC,COPYRIGHT,DTX,LTD,U87
286,287,500,700,716,ACCORDING,BASEL,CONVENTION,EARTH,NETWORK,THESE
BBB,BRAIN,CNS,FDG,FINALLY,PET,THERAPY,USING,USUALLY
HOWEVER,PRL,PROLACTIN
119,146,177,BBB,INSTEAD,LDL,MEANWHILE,NEITHER
169,HOWEVER,IMAGING,LABEL,METHODS,MODERATELY,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS
169,BETWEEN,CARLO,EXCELLENT,IDENTICAL,LABEL,METHODS,MONTE,OBJECTIVE,PHYSICISTS,PTV,PURPOSE,RESULTS
BACKGROUND,CNS,CONCLUSION,GRADE,LABEL,METHODS,PRE,RESULTS,SIX
19Q,26951,EORTC,III,THEIR,THERE
026,036,043,160,BACKGROUND,DCI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,TRIAL,URL
169,NUCLEIC,THOSE,VCH,WILEY
008,036,169,ADVERSE,ANGIOCOMB,BACKGROUND,DESPITE,DIPGS,EIGHT,FORTY,GLIOMAS,INC,LABEL,LOG,METHODS,OVERALL,PROCEDURE,RESULTS,WILEY
169,947,CD3,CD4,CD8,CHAPERONE,CONTINUOUS,ELISPOT,HSP70,IFN
HOWEVER,UNTIL
169,229,AKT,GBM,INC,LOCUS,PHYSIOL,RAPAMYCIN,TAKEN,TMZ,WILEY
002,004,009,053,10A,10B,137,145,153,455,CPG,CSC,FURTHER,GBM,LOW,PCR,SMAD2,TMZ,USING
216,CONCLUSION,CPA,LABEL,METHODS,OBJECTIVE,OUTCOME,RADIOLOGIC,RESULTS,SETTING,THERE
AAA,BACKGROUND,COGNITIVE,CONCLUSION,FLUENCY,LABEL,METHODS,OBJECTIVE,RAS,REGENSBURG,RESULTS,SAS,THEREFORE
AFTER,AIM,CONCLUSION,INCLUDING,LABEL,METHODS,OBJECTIVE,RESULTS,UNDER
169,AFTER,COPYRIGHT,DIFFUSION,DTI,FBT,IRELAND,LGN,LTD,MRI,ORS,PRE,VFD
131,169,823,BACKGROUND,CONCLUSION,COPYRIGHT,IHC,INDIA,LABEL,METHODS,MIB,PCR,RESULTS
169,COPYRIGHT,GBM,INC,LRRFIP1,THESE
001,055,169,COPYRIGHT,MRI,OLIG2,TAS
DEFINITIVE,HEADSMART

001,169,FDOPA,HOWEVER,LABEL,METHODS,MRI,MTV,OBJECTIVE,PET,PFS,PURPOSE,RESPONDERS,RESULTS,SUV
164,169,CNS,NMOSD
177,956,AFTER,CMRO2,CONCLUSION,CSF,HOWEVER,LABEL,LARGE,MATERIALS,METHODS,MRI,OBJECTIVE,PVC,RESULTS
169,BACKGROUND,BSA,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PDT,RESULTS,TUNEL
174,AQUAMANTYS,BACKGROUND,EFFECTIVE,LABEL,MEDTRONIC,METHODS,PORTSMOUTH,RESULTS,SEVERAL,USA
DAV,OTA
HOWEVER,THESE
MRI,PET
169,ALZHEIMER,ANALYTICAL,AUTHORS,COPYRIGHT,HENCE,PUBLISHED
169,237,241,BACKGROUND,CCM,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,MWODA,NEUROCIRUG,PUBLISHED
028,169,AFTER,COPYRIGHT,DUE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PIT,PURPOSE,RESULTS,THESE
101,117,169,183,227,355,358,370,BACKGROUND,BETWEEN,COPYRIGHT,FINGOLIMOD,FUNDING,LABEL,LTD,MARCH,METHODS,MRI,NOV,RESULTS,SECONDARY,USA,USING
000,169,COPYRIGHT,INC,MBS,MOUSE,MYC
AKT,BACKGROUND,CONTEXT,ERK,HOWEVER,LABEL,MEK,METHODS,NOTABLY,OBJECTIVE,OBJECTIVES,PCR,RAF,RAS,RESULTS,SETTING
JAMES
COMPULSIVE,CUSHING
100,CONCLUSION,DOSAGES,FENGCHI,KARNOFSKY,LABEL,METHODS,MIDAZOLAM,OBJECTIVE,RESULTS,SHUAIGU,ZULINQI
CONCLUSION,ETA,GBM,LABEL,METHODS,NORMALIZED,OBJECTIVE,OBJECTIVES,PET,RESULTS
BACKGROUND,CONCLUSION,IFG,LABEL,METHODS,MFG,RESULTS,SOV,THESE
ATM,MRI,WHILE
124,161,167,170,344,AFFILIATED,ANHUI,APRIL,DEPARTMENT,FIRST,JANUARY,MEDICAL,MMPMN,MPMNS,SMPMN,THERE,UNIVERSITY
CUSHING,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,QOL,RESULTS
183,ENDOSCOPIC,GEORG,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,SETTING,STUTTGART,THREE
169,BMI,CONCLUSION,CROSS,EPWORTH,FATIGUE,INDEX,INVENTORY,LABEL,LOW,METHODS,OBJECTIVE,PITTSBURGH,QUALITY,RESULTS,SCALE,SHORT,SLEEP,SLEEPINESS,SOCIETY,THREE
001,018,100,LABEL,METHODS,OBJECTIVE,PURPOSE,RENAL,RESULTS,ROACH,THERE,TSC
001,025,038,074,114,745,CNS,HET,LABEL,METHODS,NCI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SIR
BACKGROUND,BETWEEN,CALCIFIED,CNS,CPT,LABEL,METHODS,RESULTS,SEPTEMBER,THEIR
001,004,011,023,035,148,246,277,APRIL,BETWEEN,HOWEVER,JANUARY,MUTATED,STUDIED
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,MULTIMODAL
GSC,HOWEVER,OVERALL,RAPIDLY,USING,WHILE
945,STAT3,STRUCTURAL
LYG,MRI,MTX
001,LABEL,METHODS,OBJECTIVE,PEARSON,RESECTION,RESULTS,SRS,THERE,VASOGENIC
169,COPYRIGHT,ENGLISH,FEW,INC,KNOWLEDGE,SEVERAL,THERE
ANXIETY,EMF,THERE
169,23B,CCNA2,COPYRIGHT,FINALLY,HMGA2,IRELAND,LTD,PAS,THESE
169,ALONG,COPYRIGHT,GEOMETRIC,LTD,MERGE,MRI,SPLIT
169,AFTER,BACKGROUND,CENTRAL,CNS,CONCLUSION,COPYRIGHT,HGB,LABEL,MCCORMICK,MEIER,METHODS,PREFERRED,RESULTS,SAS,SCALE,VHL
169,945,946,ASTROCYTIC,COPYRIGHT,ERS,LTD,SRC,THESE
169,177,BIOLOGY,COPYRIGHT,FEDERATION,INC,PUBLISHED,ULTRASOUND,WORLD
169,BACKGROUND,COPYRIGHT,DVT,FIFTY,IVC,LABEL,LTD,METHODS,OBJECTIVE,PERMANENT,PUBLISHED,PURPOSE,RESULTS,TEN,UNDERLYING
169,ASSESSMENT,COPYRIGHT,DYSARTHRIA,LTD,MOTOR,PUBLISHED
004,110,169,222,COPYRIGHT,DESPITE,EXCLUSION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RADIATION,RESULTS,SRS,THERE
169,AUTHORS,COPYRIGHT,INC,LOCAL,PUBLISHED
169,2MONTHS,9MONTHS,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,FIFTY,JANUARY,LABEL,METHODS,MRI,OPTIC,RADIATION,RESULTS,SAS,SEVEN
160,AFTER,BACKGROUND,BECAUSE,CHINESE,DUE,LABEL,METHODS
001,102,EXCLUSION,FUNCTIONAL,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL
ACCORDING
ANOTHER,AVOIDANCE,BETWEEN,CSF,EES,FOLLOWING,GRADE,GROSS,HEUBNER,LABEL,MEDICAL,METHODS,OBJECTIVE,PITTSBURGH,RESULTS,SEVENTY,SIMPSON,THEIR,UNIVERSITY
LABEL,METHODS,OBJECTIVE,PREVIOUSLY,RESULTS,SYNTHETIC,THESE
CLINICIANS,CNS,HBS,VHL,VON
2GY,BACKGROUND,DESPITE,FURTHER,GBM,HMGB1,HOWEVER,HSP70,LABEL,METHODS,REFLECTING,RESULTS,SINCE,TMZ,U87MG,VPA,WHILE
239,BASED,THREE
AFTER,FURTHER,SELYE,THESE
169,185,CHO,COPYRIGHT,GLIOMAS,HOWEVER,LTD,MRS,NAA,PCA,RADIATION,SUC,WILEY
EPIDERMAL,HOWEVER
169,945,CXCR4,HIF,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,THESE,TNF,UNIVERSITY,USING
169,INCREASING,SEVERAL,SINCE,SOCIETY,SURGERY
MRI,THOSE
005,141,167,169,BACKGROUND,INHIBITING,LABEL,METHODS,NEURO,NTV,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,USING
001,003,100,169,215,801,877,ADC,BACKGROUND,DIAGNOSIS,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
APRIL,BASED,HOWEVER,USING

HOWEVER,NSCLC,T790M,TKI
ATLAS,EGF,GBM,JNK,MULTIFORME,PCR,SIMILAR,THESE,TMZ
169,177,956,ALZHEIMER,BENZYLOXY,CONTROLLED,COPYRIGHT,EEL,SAS
169,22Q,ADDITIONAL,COPYRIGHT,KINGDOM,NEOPLASIA,NF2,SAS
169,BACKGROUND,COPYRIGHT,III,INC,LABEL,METHODS,PET,RESULTS,SEVEN
177,AMONG,HUASHAN,LABEL,METHODS,OBJECTIVE,PITUITARY,RELAPSE,RESULTS,TSH
001,006,055,169,240,50YEARS,7MONTHS,ADULT,AGE,COPYRIGHT,END,HGBSA,III,LTD,OVERALL,RESULTS
100,177,946,PBAES,THESE
BBB,CNS,DUE,LRP,PEG,U87,VARIOUS
HOWEVER,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,REFERRALS,RESULTS,SIXTY,THERE,THESE
169,50S,CK5,CLARA,HOWEVER,SOCIETY,THEIR,TTF
169,CD133,COL,ECM,GBM,NON,SCM,SFM,SOCIETY,THERE,THESE,U87MG
DEPARTMENT,DISCHARGED,NEUROLOGY,SEVERAL
GASTRIC,WHILE
765,945,946,947,CB1,HOWEVER,OTHER,SR141716A,THESE
ANDTBACKA,CSF,FDA,GLYBERA,HERTTUALA,HSV,III,MOL,ONCOL,ONCOVEX,PHASE,VEC,VIRUS,YLA
HOWEVER,SINCE
MALIGNANT,STRATEGIES
ATLAS,CPG,GBM
946,ALZHEIMER,CHROMATIN,FINALLY,HOWEVER,SPR,WNT
001,003,169,177,876,AMT,BACKGROUND,CONCLUSION,COX,III,INCREASED,LABEL,METHODS,MRI,NEURO,OPTIMAL,PET,PRESS,PREVIOUSLY,PUBLISHED,RESULTS,SOCIETY,SUVMEAN,UNIVERSITY,WORLD
001,100,150,169,239,AMONG,BACKGROUND,HGG,III,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SIXTY,SOCIETY,THERE,UNIVERSITY
BECAUSE,NOTCH,REDUCED
AREAS,BACKGROUND,COVERED,HSP,HSPPC,III,LABEL,METHODS,OPINION,PHASE
119,159,172,177,290,332,509,558,628,873,945,959,BACKGROUND,CNS,CONCLUSION,COSTS,IRELAND,LABEL,METHODS,PREMATURE,RESULTS,TOTAL,VALUATION,YPPLL
004,008,009,044,COX,LOG,PFS,SIXTY,SVZ
169,BACKGROUND,GAMEC,LABEL,MEIER,METHODS,RESULTS,SOCIETY

AFTER,DESPITE,GIVEN,SUBSEQUENT
200,BACKGROUND,BOM,BRM,FINALLY,L9981,LABEL,LNM,LUC,LUM,METHODS,RESULTS,UNDER
AGS,AKT,CELASTROL,CHINESE,S6K,TAKEN,YCC
169,COPYRIGHT,INC
101,169,177,AUTHORS,COPYRIGHT,IMMEDIATE,LTD,PUBLISHED,SR101,THESE
3T3,947,AMONG,FOLLOWING,MEYER,OTHER,PANAX,PCR,PPD,PPT,REVERSE,THEREFORE
CSF
002,169,178,COPYRIGHT,CSI,FORTY,GLU,LTD,THERE,THESE,WILEY
FINALLY,LGG,LOW,TREATMENT
969,GBM,HOWEVER,KNOCKDOWN,PRMT5,PROTEIN,THESE
001,059,100,134,ADDITIONAL,BACKGROUND,CONCLUSION,FREEDOM,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPA,SCALE,SRS,THREE
HOWEVER
945,AIP,BASED,MEF
169,BEHAVIORAL,COPYRIGHT,DUE,INC,TEN
138,356,AMONG,DENSITY,GPCRS,LOW,RESULTS,SEVENTEEN,THEIR,THESE
163,FDG,MRI,PET,PIB,THESE
169,ATLAS,BACKGROUND,BRAIN,GBM,HOWEVER,IDH,KETTERING,LABEL,LTS,METHODS,MOLECULAR,MSKCC,NCI,NEOPLASIA,NEURO,PRESS,PUBLISHED,REMBRANDT,REPOSITORY,RESULTS,SIMILARLY,SLOAN,SOCIETY,THESE,UNIVERSITY,WHILE
THERE,THESE,WHOLE
001,637,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,IMAGING,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,THESE
INCREASES
BACKGROUND,BRAIN,CHOROID,CONCLUSION,LABEL,LOW,METHODS,RESULTS,SURGERIES,THESE
169,COPYRIGHT,GIVEN,LTD,MRS,PUBLISHED
169,947,COPYRIGHT,EARLY,GABAB,HOWEVER,KOREA
169,AAC,AMBLYOPIA,COPYRIGHT,FCD,NSC
BACKGROUND,COMBINING,FURTHER,LABEL,METHODS,RESULTS,TAKEN,THESE
169,177,COPYRIGHT,CSI,HIT,HOWEVER,INC,LABEL,MATERIALS,METASTASES,METASTATIC,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,REZ,SEVENTEEN
123,169,BETWEEN,BRITISH,COPYRIGHT,CVE,DISEASE,DSS,EIGHT,ICB,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,STR,TEN,THERE
107,169,ACTUARIAL,BETWEEN,COPYRIGHT,CTV,EIGHT,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SIX,THESE
000,001,005,017,810,AFTER,AGE,BACKGROUND,COX,HOWEVER,HRS,INSURANCE,JANUARY,LABEL,MEIER,METHODS,OVARIAN,RESULTS
169,COMPLEX,COPYRIGHT,USING
685,808,852,937,AUC,CONCLUSION,DFA,KENDALL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,THREE
001,160,169,183,COX,DISCUSSION,HRS,INSURANCE,JANUARY,KNOWN,LABEL,LTD,METHODS,NHI,OBJECTIVE,PRIOR,RESULTS,TZD,USING,WILEY
363,817,ASSESSMENT,CONCLUSION,DIAGNOSTIC,FNA,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,QUALITY,RESULTS,STUDIES
CONCLUSION,HOUNSFIELD,LABEL,OBJECTIVE,PHASE
DVH,EUD,INTENSITY,LABEL,LOCAL,METHODS,MODULATED,OBJECTIVE,PURPOSE,RADIATION,RESULTS,TCP,THERAPY,THERE,THESE
177,2ND,ASSESSMENT,CNS,EDITION,EXECUTIVE,PARENTS
ASIAN,C677T,CENTRAL,CIS,EASTERN,FINALLY,HOWEVER,LABEL,MEDLINE,METHODS,MTHFR,OBJECTIVE,ORS,OVERALL,RESULTS,SEVERAL,WESTERN
COUPLED,EPIDERMAL,ERK,FDA,GEMMS,GNAI2,PROTEIN,RAS,SUPPORTING,TREATMENT
945,AKT,GBM,PDGFR,SRC,TAKEN
NOTABLY
169,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,MDV,METHODS,MVD,RESULTS,TNA,TVCSA
169,ALTOGETHER,COPYRIGHT,DESPITE,GBM,GSC,LTD
169,902,COPYRIGHT,DESPITE,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THYROID,TSH
169,COPYRIGHT,DESPITE,MMP,MMP14,THESE
169,CHANGES,COPYRIGHT,DED,FAS,INC,PEA,REGULATION,THESE,THROUGH
169,AFTER,AVERAGE,CONCLUSION,COPYRIGHT,GTR,INC,LABEL,METHODS,OBJECTIVE,OVERALL,RATES,RESULTS,USING
169,ATM,CK2,COPYRIGHT,INC,IP6K2,IP6KS,IP7,PIKKS,THESE,TTT
169,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,NEUROLOGY,OBJECTIVE,PAEDIATRIC,PUBLISHED,RESULTS,SOCIETY
169,237,241,2CM,COPYRIGHT,LABEL,MATERIALS,METHODS,NEUROCIRUG,OBJECTIVE,PUBLISHED,RESULTS,SEVEN,UNIVERSITY
169,CHOROID,COPYRIGHT,GAMMA,HURTHLE,KNIFE,LTD,STOCKHOLM
001,103,169,206,ASSESSMENT,BITEMPORAL,COPYRIGHT,LTD,WHILE
00001,00006,00009,169,183,700,AFTER,BACKGROUND,BRITISH,COPYRIGHT,COUNCIL,FOUNDATION,FUNDING,HEART,HOWEVER,JAN,LABEL,LTD,MEDICAL,METHODS,PUBLISHED,RESULTS
000,169,230,APART,AVERAGE,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,ENT,EVOLUTION,INITIAL,LABEL,METHODS,NANCY,NASAL,PATHOLOGY,PUBLISHED,RESULTS,SAS,SIX,THERE,UNIVERSITY
169,COPYRIGHT,HOWEVER,MRI,SAS,TRANS
169,ATP,BASED,COPYRIGHT,GBM,GCS,INC,MAP,SYNTHETIC,THESE,VACQUINOL,VACQUINOLS
110,117,128,BACKGROUND,CONFORMITY,HODGKIN,INDIVIDUAL,LABEL,METHODS,NHL,NON,PTV,RESULTS,THREE,TOTAL
HOWEVER,MRI,THESE
CNS
AREAS,AVAILABLE,BACKGROUND,COVERED,EARLY,FURTHER,GLIOMAS,HGG,III,LABEL,METHODS,OPINION,PFS,PHASE
INITIAL,SELEX,STIP1,THESE

CENTRAL,MRI,THESE,UPPER
004,CONCLUSION,IAS,LABEL,MAXIMUM,METHODS,PEDIATRIC,PET,RESULTS,UNLABELLED
001,177,BACKGROUND,CONCLUSION,DCE,LABEL,METHODS,MRI,RESULTS,SEVENTEEN,SRS
118,956,BASED,BBB,DOX,GBM,MTX,NOTEWORTHY,OVERALL
CURRENT,DESPITE
BAX,BCL,CCND1,CYTOTOXIC,EXPRESSION,HEPG2,PCR,URGCP,VPA
9V8,A35,A64,D62,DOCKING,F25,F32,F36,G19,G65,GLIDE,GTP,HOWEVER,K20,LIGPLOT,NCI,P34,RAB3A,S16,S17,S22,S31,S38,SCORE,T21,T33,T39,V18,V37
009,012,019,031,120,121,158,660,867,COX,GBM,HOWEVER,KARNOFSKY,KPS,MEIER,PFS,STAT3,THERE,UNIVARIATE

ERBB3,HSP70,UPS
HOWEVER,THERE,TLC
001,061,243,259,AES,AIM,BACKGROUND,DCR,EFFECTIVE,FURTHER,HCC,HOWEVER,JANUARY,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,OCTOBER,RESULTS,TTP
BCL,BECLIN1,EXPRESSION,KNOCKDOWN,TREATMENT
160,169,BBB,COPYRIGHT,LTD,PTX,RGD
133,160,169,COPYRIGHT,FUNCTIONAL,INC,MBS,PTCH1,SHH,SMO,SMOOTHENED
169,CARLO,CHAIN,COPYRIGHT,DIRICHLET,HRF,INC,METROPOLIS,MONTE,MRF
169,COPYRIGHT,INC,THERE
169,946,COPYRIGHT,HOWEVER,INC,PANCREATIC,SNS,THESE
807,ASCL2,BACKGROUND,HCK,HOXA5,III,INCREASING,LABEL,MALIGNANT,METHODS,PXA,RESULTS,TES,THESE,USING
946,954,AKT,BACKGROUND,CATENIN,CONCLUSION,CONVERSELY,EMT,KNOCKDOWN,LABEL,METHODS,MTT,RESULTS,SNAIL,TRANSWELL,U87,WESTERN
BECAUSE,MANAGEMENT,SEVERAL
11A,160,169,290,450,948,AKAP450,ALIKE,BIOLOGY,CK1,CLS,COMMONS,GOLGI,GREER,INHIBITION,LICENSE,MOUSE,RAS,SHARE,SOCIETY
169,ADIPOR1,ADIPOR2,AKT,GBM,INC,THESE,U87,WILEY
169,2G7,ANOTHER,BACKGROUND,CONCLUSION,GCPII,GLUTAMATE,INC,LABEL,METHODS,RESULTS,USING,WILEY
GRADE,III,LITERATURE
001,189,AFTER,AGE,AVAILABLE,KARNOFSKY,KPS,THEREFORE
117,169,310,620,888,ABCB1,ABCG2,ABT,ARF,BBB,ELACRIDAR,INK4A,LABEL,METHODS,OBJECTIVE,PURPOSE,RAS,RESULTS,THEREFORE,TMZ
086,169,514,CD4,CD8,CONCLUSION,LABEL,MDA,METASTASIS,METHODS,MHC,OBJECTIVE,PURPOSE,RESULTS
104,HOWEVER,MRI,NUCLEAR,THEREFORE,UNIVARIATE
169,CUSHING,HOWEVER,OTHER,PRL,SOCIETY,SRL,SST,SST14,SST28,SSTR1,SSTR2,SSTR5,TSH
112,169,304,484,BACKGROUND,COPYRIGHT,INNSBRUCK,IRELAND,LABEL,LDH,LTD,METHODS,OVERALL,PARAMETERS,RCT,RESULTS,UNIVERSITY
AFTER,AUTOPSY,CANDIDA,ESPECIALLY,STAGE
CNS,HODGKIN,MULTIMODAL,OWING,PCNSL,PRIMARY
BACKGROUND,BECAUSE,CURRENT,LABEL,METHODS,ONCOLYTIC,RESULTS,THESE
084,COMBINING,CONCLUSION,COX,FORTY,GBM,HIPAA,KARNOFSKY,KPS,LABEL,MATERIALS,MEIER,METHODS,MOLECULAR,NER,OBJECTIVE,PFS,PURPOSE,RESULTS,WORSENING
GLIOMAS,GSC,PGI,TREATMENT,USING
006,114,160,169,183,AMONG,CALCULATED,DHT,ELDERLY,FURTHER,ISCHAEMIC,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TOTAL,WILEY
101,ASSESSMENT,BACKGROUND,CONCLUSION,GIVEN,GPA,GROUP,III,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,RADIATION,RECURSIVE,RESULTS,RPA,THERAPY,THESE
007,066,106,122,BACKGROUND,INVENTORY,LABEL,METHODS,MLR,OBJECTIVE,RESULTS,SMALL,SYMPTOM,THESE
PCI
047,155,AED,BACKGROUND,BESIDES,EOL,HGG,LABEL,METHODS,PHYSICIANS,RESULTS,SEVENTY
AUSTRALIAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PMG,RESULTS
169,945,946,BIOLOGY,CONSISTENT,DESPITE,GBM,INC,MOLECULAR,SOCIETY,SRC,THESE
169,945,946,BBB,BRAIN,DESPITE,DIGITAL,DROPLET,EXPRESSION,MET,PCR,SIMON,THESE,USING,WESTERN
160,DESPITE,HOWEVER,III
FINALLY,HOWEVER,THEREFORE
16S,454,CANDIDA,EMPLOYING,FANCONI,HOWEVER,MYCOPLASMA,NEISSERIA,PCR,ROCHE,THESE
GEFITINIB,NSCLC,PULMONARY
177,231,945,956,GELATIN,HOWEVER,MCF,MDA,NOS,NOSCAPINE
169,EVALUATION,GBM,GLIOMAS,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,COPYRIGHT,DROSOPHILA,HIPPO,INC,KIBRA
160,BACKGROUND,GBM,HERVS,HOWEVER,LABEL,NP9,PRIMARY,RESULTS,THEREFORE,THESE,U87,WHILE
EARLY,GBM
169,183,BRAIN,MBC,METASTATIC,OVERALL
011,135,172,255,802,BACKGROUND,COX,EASTERN,EVE,EVEROLIMUS,FORTY,GROUP,IRB,LABEL,MATERIALS,METHODS,OCTOBER,OLDER,PFS,RESULTS,THERE,TKI,TRIAL,VEGFR
100,ACT,BRAIN,CONCLUSION,IMAGING,INSURANCE,KNOWLEDGE,LABEL,METASTASES,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS
AVASCULAR,AVN,CUSHING
NOVALIS,PALLIATIVE,RESULTS,SRT
100,145,III,THESE
11P15,BWS,MRI,THEREAFTER,WIEDEMANN
160,177,ACUTE,ANALOGOUS,BACKGROUND,BETWEEN,CONCLUSION,CONCURRENT,CSI,HGG,HIT,HOWEVER,LABEL,MARCH,METHODS,OUTCOME,RESULTS
181,310,MRI,ULTRASOUND
53BP1,947,ANALYZING,BETWEEN,DSB,FANCONI,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
DNMT1,HOWEVER,SEVERAL,UHRF1
HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,UHF
150,178,200,215,500,600,AFTER,BACKGROUND,FIFTY,GROSS,KPS,LABEL,METHODS,RESULTS,TMZ,TREATMENT
139,680,956,ATLAS,BACKGROUND,CED,CONVECTION,GOVERNMENT,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,TOP2B,UNIVERSITY
169,AUTOIMMUNE,NEURO,PRESS,PUBLISHED,SOCIETY,THESE,UNIVERSITY
169,25YEARS,31YEARS,33WEEKS,36WEEKS,40WEEKS,41YEARS,ADHERENCE,BACKGROUND,CIP,CONCLUSION,COPYRIGHT,EIGHT,LABEL,LTD,METHODS,PREGNANCY,RESULTS
169,COPYRIGHT,SAS
049,169,AGE,BACKGROUND,BMRCC,COPYRIGHT,KPS,LABEL,MEIER,METHODS,OTHER,RCC,RESULTS,SAS,SRS,THREE,UNIVARIATE
101,122,409,946,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NFPAS,PCR,RESULTS,SMAD2,SMAD3,SMAD4,SMAD7,TGF,WESTERN
015,017,169,194,CAUCASIAN,COPYRIGHT,DESPITE,FURTHER,REFLECTING,THESE,YET
169,2KG,CONGENITAL,COPYRIGHT,DIAGNOSIS,FURTHER,HOWEVER,PRIOR,RMS,THERE,THEREAFTER
048,136,169,177,331,359,467,AGE,BMI,CONCLUSION,COPYRIGHT,DVT,EBL,HEMOSTATIC,III,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE
169,AUTHORS,BASED,BETWEEN,COPYRIGHT,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,RPA,SURGICALLY,THERAPY
005,044,169,BACKGROUND,COPYRIGHT,ENDOSCOPIC,LABEL,METHODS,MRI,RESULTS,WHILE
169,AFTER,CONCLUSION,COPYRIGHT,ENGEL,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,SEIZURE,THERE
946,AKT,FAK,FAS,HOWEVER,THESE
175,250,500,956,CST,LABEL,MEP,METHODS,MONOPOLAR,OBJECTIVE,RESECTION,RESULTS
100,101,144,153,177,CLASS,CNS,EASTERN,FORTY,GROUP,HIV,LABEL,MATILDE,METHODS,OBJECTIVE,OVERALL,PCNSL,RESULTS,STATE
CNS,FOLLOWING,HODGKIN,MATILDE,ONGOING,PCNSL,PRIMARY,UNTIL
169,231,BR3,BRAIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
100,12P40,160,200,945,946,BRAIN,CSF,DIALYSATE,IFN,INITIAL,MCP,SEVENTEEN,THESE
CHRONIC,KYNURENINE,QUINOLINIC
142,215,ALTOGETHER,AMONG,BROOKHAVEN,FINALLY,FIRST,LABORATORY,MRI,RADIATION,USA
435,455,ATTENTION,CIS,DSB,EIGHT,HRR,MARCH,ORS,OVERALL,T241M,XRCC3
152,157,160,185,234,313,622,818,881,896,AMONG,BACKGROUND,COX,EASTERN,GROUP,LABEL,METHODS,RESULTS
CONCLUSION,DESPITE,GROWING,GTS,INSTEAD,LABEL,METHODS,MIB,OBJECTIVE,PURPOSE
009,016,019,048,CHINESE,EDNRA,EDNRB,HAN,SNP
CERTAIN,ECS,THESE
945,AKT,CONVERSELY,CXCR4,GROUP,MICROARRAY,THESE
169,BESIDES,COPYRIGHT,CURRENTLY,IRELAND,LTD
169,BRAIN,CNS,COPYRIGHT,ERP,FUNCTIONAL,HOWEVER,LTD,STRUCTURAL
169,22RV1,945,946,CONVERSELY,COPYRIGHT,HOWEVER,RESULTS,TRAMP
169,ASL,CBF,COPYRIGHT,HOWEVER,IMAGING,INC,JOURNAL,MRI,RESONANCE,TAN,VALIDATION
169,AKT,BAX,BCL,COPYRIGHT,HBMEC,IRELAND,JNK,LTD,MGO,PUBLISHED,THESE
169,BRAIN,COPYRIGHT,CSC,DROSOPHILA,EARMUFF,ERM,LTD,SNF,STUDIES,SWI
169,5FU,BACKGROUND,BRAIN,CNS,COPYRIGHT,DESPITE,GIVEN,INC,LABEL,METHODS,MRI,VASOGENIC
169,946,COPYRIGHT,IFN,IRELAND,ISG54,ISG56,JAPAN,LTD,RIG,SOCIETY,THESE,TLR
012,028,034,040,049,169,171,ACADEMY,ASSESSMENT,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,DISABILITY,GLASGOW,HOSPICE,INC,INSTRUMENT,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PAL,PALLIATIVE,PUBLISHED,QOL,QUALITY,RESULTS,SCALE,SEDENTARY,SYMPTOM
169,ARID1,AUTHORS,BECAUSE,COPYRIGHT,DROSOPHILA,INC,MEMBERS,OSA,PAPERCLIP,PUBLISHED,SNF,SWI
15YEARS,169,1ST,215,5MG,8TH,BACKGROUND,BETWEEN,CNS,CONCLUSION,COPYRIGHT,EFS,GRADE,IRELAND,LABEL,LTD,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,VCR
160,169,COLLEGE,COPYRIGHT,DESPITE,EDINBURGH,FDG,FET,IMAGING,IRELAND,LTD,MET,MRI,PET,PUBLISHED,ROYAL
001,169,195,445,640,APRIL,BACKGROUND,CARCINOMA,CONCLUSION,COPYRIGHT,GROUP,IASLC,IRELAND,LABEL,LTD,M1A,M1B,METHODS,NON,NSCLC,PNEUMOLOGY,RESULTS,SOCIETY,SPANISH,SURGERY,TNM
169,742,845,BACKGROUND,CHO,CONCERNING,CONCLUSION,COPYRIGHT,FET,IRELAND,LABEL,LTD,METHODS,MIB,MRI,MULTIMODAL,NAA,PET,PRIOR,PWI,RESULTS
125,160,169,180,200,AFTER,AUTHORS,DLBCL,FOUNDATION,HODGKIN,JOURNAL,LTD,MOLECULAR,PATIENT,PCNSL,SBT,THREE,WILEY
169,BASED,CAPN4,CONCLUSION,FOLLOWING,GBM,LABEL,LTD,METHODS,OBJECTIVE,PFS,RESULTS,THROUGH,WILEY
001,500,956,CONTINUOUS,CST,LABEL,METHODS,MOTOR,OBJECTIVE,RESULTS,THERE
107,FORTY,ICM,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THOSE,UPDATED
BACKGROUND,CANCERS,CONCLUSION,DUE,ENGLISH,EPSCC,ESPCC,HOWEVER,LABEL,METHODS,OCTOBER,PCI,RESULTS,SCC,SCOPE,SMALL,SOCIETY,THEREFORE

AKT,CTP,ERPC3,MAP,NOVEL,OTHER,THESE
167,169,HOWEVER,LABEL,METHODS,OBJECTIVE,PEDIATRIC,POSTERIOR,PRESS,PSYCHOLOGY,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY,YOUNGER
169,468,BACKGROUND,GBM,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,TMZ,UNIVERSITY
005,AREAS,BACKGROUND,CBV,CONCLUSION,DSC,LABEL,METHODS,MRI,OCE,RESULTS,ROI
ADDITIONAL,CPG,NB9,NR4A3,SINCE,THESE
951,THESE
AQP
AAV,DECORIN,GBM,MALDI,PROTEOMICS,THESE,TOF,U87MG
169,CMT,CONFORMAL,ENDORECTAL,GERIATRIC,INTENSITY,LEVEL,MEDICAL,NSCLC,PATIENT,PRESS,PUBLISHED,SHORT,SHORTER,SOCIETY,UNIVERSITY,WHERE
001,100,ATTENTION,BACKGROUND,CONCLUSION,FIFTEEN,FIFTY,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS
309,725_736DEL,NEITHER,SDH
ADP,BACKGROUND,BRCA1,DEFICIENT,EVALUATION,LABEL,METHODS,RESULTS,THERE
AKT,APOPTOSIS,COCL2,LABEL,MESSENGER,METHODS,MYRICETIN,OBJECTIVE,PURPOSE,RESULTS,RPE,SECRETION,VEGETABLE
018,035,177,184,192,A0201,BINDING,CANDIDATE,CONCLUSION,CTL,EXPRESSION,GBM,HLA,HSP47,III,KLPEVTKDV,LABEL,LLLLSAFCL,MEIER,METHODS,OBJECTIVE,PEPTIDE,PROGRAM,RESULTS,SEVEN,WESTERN
BBB,HOWEVER,POH,THERE,TMZ
100,150,169,CUR,DOX,PAA,PVA,RG2,VCH,WILEY
000,002,169,AGE,CNS,FINLAND,FINNISH,HODGKIN,POPULATION
215,BLOOD,III,MRI
001,004,006,021,023,336,AFFILIATED,BETWEEN,CAREFUL,CHINA,CONCLUSION,HOWEVER,JINAN,LABEL,METHODS,OBJECTIVE,PROVINCIAL,RECURRENCE,RESULTS,UNIVERSITY
100,400,DIAGNOSTIC,LABORATORY,OPTICAL,SVM,VALIDATION
001,022,131,155,COX,III,KARNOFSKY,MEIER,PCR,PFS,THESE
183,BACKGROUND,CONCERNING,CONCLUSION,FURTHER,GEORG,GTR,LABEL,MATERIALS,METHODS,MRI,NAVIGATED,OVERALL,RESULTS,STUTTGART,THERE
CONCLUSION,IMAGING,LABEL,LESIONS,METHODS,MRI,OBJECTIVE,OUTCOME,PATIENT,RESULTS
101,116,159,169,ADVERSE,BACKGROUND,CARDIOLOGY,COLLEGE,COPYRIGHT,EARLY,FOUNDATION,GRADING,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTHER,PUBLISHED,RESULTS

100,AFTER,MALIGNANT,MPNST,PRIMARY
000001812,101,169,183,208,455,531,BACKGROUND,BRAIN,COPYRIGHT,DEC,FEB,FOUNDATION,FUNDING,JAPAN,KARNOFSKY,LABEL,LTD,MARCH,MEDICAL,METHODS,NETWORK,OVERALL,RESULTS,TRIAL,UNIVERSITY
169,177,AGREEMENT,COMPARISON,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,STOCKHOLM,VOLUMEVIEW
ELECTRODES,FINALLY,FOLLOWING
BACKGROUND,DISCUSSION,LABEL,METHODS,TREATMENT
DISCUSSION,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
140,DESPITE,EVALUATION,PAR
169,BACKGROUND,FUNCTIONAL,HOWEVER,INC,LABEL,METHODS,PROCEDURE,RESULTS,THESE,WILEY
NANOSIZED
DESPITE,FINALLY,GBM,THESE
CONVERSELY,PCR,TSA
CONCLUSION,III,LABEL,METHODS,OBJECTIVE,OCTREOTIDE,PFS,PURPOSE,RESULTS,RPR,SPECT
PLASMONICS
925,999,CCM,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,QSM,RESULTS
SINCE,THEREFORE
025,ADCY2,BIPOLAR,LARGE,MIR2113
BESIDES,CPT1A,CPT1B,CPT1C,ZFP57
AVERAGE,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PRE,RESULTS,THERE
HOWEVER
001,100,177,ACCORDING,BACKGROUND,CONCLUSION,CST,DTI,LABEL,METHODS,OBJECTIVE,RESULTS
133,310,569,882,BACKGROUND,CENTERS,CONCLUSION,HAC,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,RESULTS
001,004,10994,118,147,169,221,222,230,496,BACKGROUND,BIG,EFS,EORTC,III,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,SUFFICIENT,TRIAL,UNASSIGNED,UNIVERSITY
AE1,AE3,BCL,CENTRAL,HISTOLOGIC,HPC,STAT6
160,AIM,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROS,U87
963
169,7TH,COMMITTEE,III,JOINT,RADIOLOGIC,TNM
169,DORFMAN,EPSTEIN,KNOWLEDGE,MENINGIOMA,ROSAI
422,506,AUTHORS,PAS,PITUITARY,SEOUL,UNIVERSITY
APT,GBM,GIVEN,TMZ
169,BACKGROUND,BLOOD,CONCLUSION,INC,LABEL,METHODS,PARENTS,PEDIATR,RESULTS,TREATMENT,WILEY
126,169,BACKGROUND,GROUP,HOWEVER,INC,IQR,LABEL,METHODS,PROCEDURE,RESULTS,SHH,STRIKINGLY,WILEY,WNT,YOUNGER
115,169,171,177,ANGELES,BACKGROUND,CONCLUSION,FIFTEEN,INC,JANUARY,LABEL,LOS,METHODS,PROLONGED,RECURRENCE,RESULTS,UNIVERSITY,WILEY
000,169,AUTHORS,BIOESSAYS,CONSORTIUM,EWING,GENOMES,INC,PROJECT,THREE,WHILE,WILEY
169,AFTER,CCEPS,COPYRIGHT,DESPITE,INC,UNDER,WILEY
169,BACKGROUND,FIFTEEN,HOWEVER,III,LABEL,METHODS,NEURO,PREGNANCY,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
169,CSC,HOWEVER
169,GENOMIC,HOWEVER
169,946,ADULT,AUTHORS,DIETARY,INC,PUBLISHED,WARBURG,WILEY
AIM,ANNEXIN,APOPTOSIS,CONCLUSION,HOWEVER,HUMORAL,LABEL,MENIGIOMA,METHODS,OBJECTIVE,PERIPHERAL,RESULTS,TH2,TNF
AIM,CONCLUSION,ITALY,LABEL,METHODS,MITOSIS,NORWEGIAN,OBJECTIVE,PERIPHERAL,PREDICTION,RESULTS,STUDIES
100,150,CNS,HOWEVER,LIN28
ALZHEIMER,HOWEVER,RESULTS
169,CNS,COX,CSF,CSFTC,CTC
200,BMJ,BRBNS,FOLLOWING,GROUP,LIMITED,PUBLISHED,PUBLISHING,THERE
169,AFTER,AVM,COPYRIGHT,DESPITE,GAMMA,GKS,IMAGING,KNIFE,LTD,MRI,SEVENTY,STOCKHOLM
10MIN,169,239,24H,30MIN,AKT,CELLS,COPYRIGHT,DPCPX,INC,OGD,PRIMARY,SMALL,THESE,THOSE,WESTERN
169,ACCORDING,COPYRIGHT,HOWEVER,INITIALLY,LTD,POSTERIOR,PUBLISHED
169,177,300,CONCLUSION,COPYRIGHT,DCS,DESCRIBED,FEDERATION,IRELAND,LABEL,LLR,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SLR,TEN
001,011,169,COPYRIGHT,IRELAND,LTD,MRI,PCNSL,POTENTIAL,SWI,THESE,USING
169,BACKGROUND,COPYRIGHT,HELICAL,HOWEVER,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS
169,COPYRIGHT,DIAGNOSIS,MRI,SAS
059,111,160,169,ALTERATION,AUTHORS,CACNA1C,COPYRIGHT,HOWEVER,INC,PUBLISHED,RBFOX,USING
3DCRT,7GY,AVM,BACKGROUND,CONFORMAL,DESPITE,LABEL,METHODS,PTV,RESULTS,SRS
001,BACKGROUND,LABEL,LOWER,METHODS,RESULTS,WHILE,WOMEN
001,002,005,015,131,160,169,184,945,CD105,EXPRESSION,GBM,HIF,HYPOXIA,SOCIETY,THERE
169,NF2,SOCIETY
169,HOWEVER,SOCIETY
001,1ST,752,CBM,CONCLUSION,EBSCO,FIFTEEN,LABEL,LIBRARY,METHODS,OBJECTIVE,PAS,RESULTS,SCHOLAR,SCIENCE,SEPTEMBER,STATA,WEB
CONDITIONS,FEDERAL,ICD,PROGRAM,RELATED,SEPTEMBER,THROUGH,TRADE,WORLD,WTC
025,169,967,APRIL,AUTHORS,BZM,COX,END,EVALUATION,JANUARY,LTD,MARCH,OCTOBER,RESULTS,TMZ,WILEY
181,AFTER,ASA,BACKGROUND,BASAL,BIS,BISPECTRAL,BMI,DESFLURANE,INDEX,INDUCTION,LABEL,LIDOCAINE,METHODS,RESULTS,THERE,VRS
HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
BECAUSE,LABEL,METHODS,MSC,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SCORE,THESE
XENON
001,100,BACKGROUND,CONCLUSION,LABEL,METHODS,NPC,RESULTS,THESE,VBM,YET
APC,DUSP4,HOWEVER,MOUSE,OPC,RNF43,SP5,THESE,WNT
145,995,ADDITIONAL,ATP,DUTCH,HDL,HOWEVER,III,LABEL,LIFELINES,METHODS,OBJECTIVE,RESULTS,SMR
ALA,ASP,CCAR1,DDX31,DDX3X,GLU
CD133,GSC,TAKEN,TMZ
CEREBELLAR
485,INVENTORY,MEDLINE,OTHER,PEDIATRIC,QUALITY,USING
000,001,503,836,945,946,BACKGROUND,CA9,CONCLUSION,HIF,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE,THEREFORE
078,AIM,BACKGROUND,GBM,GRADE,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,SFS
100,19P13,19Q,19Q13,1P19Q,AMONGST,GBM,GRADE,III,JANUARY,LABEL,MARCH,MIXED,OBJECTIVE,POLYSOMIES,RESULTS,VYSIS,WORLD
CENTRAL,CONCLUSION,DEPARTMENT,DETECTION,FT3,FT4,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SEPTEMBER,SOUTH,THERE,TOTALLY,TSH,UNIVERSITY,XIANGYA
100,3CI,ABI,ABILITY,CONCLUSION,CPA,GRADE,IAM,LABEL,MEASURE,METHODS,MRI,NF2,OBJECTIVE,OUTCOME,RESULTS,SETTING,T1W,THERE,VIEWS
352,646,BACKGROUND,DENMARK,LABEL,METHODS,RESULTS,SIMILAR,THERE
022,041,BACKGROUND,CETRORELIX,CONCLUSION,DCE,EFFECTIVE,FORTY,GOSERELIN,LABEL,METHODS,MRI,OBJECTIVE,REDUCED,RESULTS,THERE,TRIAL
169,CALCIUM,COPYRIGHT,FURTHER,HOWEVER,INC,IP3,PLASMODIUM,THESE
169,COPYRIGHT,FINALLY,HOWEVER,III,INC,NAD,PCBP2,SIRT6
000,169,BAYES,COPYRIGHT,LTD,SVM
101,169,279,321,532,954,COPYRIGHT,FOLLOWING,FUNCTIONAL,GBM,INC,SNP,THESE
169,954,COPYRIGHT,FEDERATION,PUBLISHED,RAS,RASSF,SOCIETIES
303,351,442,829,BMJ,BRAIN,GROUP,INSTITUTE,LABEL,LIMITED,METHODS,MOLECULAR,NEOPLASIA,OBJECTIVE,PUBLISHED,PUBLISHING,REMBRANDT,REPOSITORY,RESULTS,WT1
160,169,945,947,ALTOGETHER,CBP,COPYRIGHT,HIF,INC,THESE
13R,169,945,COPYRIGHT,GOLGI,TUNEL,U87
177,ADV,BACKGROUND,BASED,CONCLUSION,DEVIATIONS,DUE,DVH,GAMMA,LABEL,METHODS,NPC,OAR,PDV,PTV,PTVNX,RESULTS
014,052,066,169,COPYRIGHT,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,NASRS,OBJECTIVE,PURPOSE,RESULTS,SIX,SRS,THERE,ULTIMATELY,WHOLE
244,ASTROCYTIC,BACKGROUND,DESPITE,GBM,LABEL,MATERIALS,METHODS,RECORDS,RESULTS,SIX
000,BACKGROUND,EGGER,LABEL,METHODS,NSCLC,PCI,RESULTS,SIX
LYSIS,MRI
DESPITE,GLIOMAS
150,344,CELLS,FISCHER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,XRT
100,506,586,AMONG,CAL,CALIFORNIA,CNS,DISCHARGE,ICD,LABEL,METHODS,OBJECTIVE,RESULTS,STATEWIDE,USING
BRAIN,DIFFUSION
134,194,226,246,284,311,357,362,AMONG,CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SAKARYA,THERE
CSF,CURRENT,MONRO,SEGAS,THESE,TSC,UNTIL,WITHOUT
169,COPYRIGHT,HOWEVER,VALIDATION,VCH,WILEY
002,019,038,042,254,582,DWI,FORTY,GBM,MRI,PFS
001,005,128,164,BETWEEN,FOLLOWING,LOCAL,MAY,MEIER,PTV
126,CONCLUSION,FDOPA,FLT,KINETIC,LABEL,METHODS,MLR,OBJECTIVE,PET,PURPOSE,RESULTS,TREATMENT
127,FINALLY,GBM,MICRORNAS,SEPT7

CONCLUSION,GKS,LABEL,METHODS,OBJECTIVE,PRT,RESULTS,SEVENTEEN,SIXTEEN
100,DUE,FURTHER,GADOLINIUM,LANGERHANS,LCH,MIB,MRI
169,AUTHORS,BRITAIN,CD133,CSC,GBM,GREAT,GSC,IRELAND,JOURNAL,KNOCKDOWN,LTD,OLIG2,PATHOLOGY,SHH,SMO,SOCIETY,TAKEN,WILEY
AD5,HENCE,THESE

HOWEVER,SURGERY
946,GLIOMAS,THERE
AMONG,NGS,PET,REFINEMENT,SVS,UNC5D
946,NGF,THESE,TRK,WHILE
AKT,ATK,EPIDERMAL,ERK,MEK,RAF,UTR
188RE,EPIDERMAL,GBM,III,SELEX,U19,U31,U87,U87MG
169,CLINICIANS,INC,WILEY
156,ALT,BACKGROUND,BECAUSE,LABEL,METHODS,NDTMM,PCR,RESULTS,SEVENTY
FGFR2,GAP43,GBM,GSC,NTRK2,NTRK3,THESE
169,PRESS,PUBLISHED,SFTPS,SURGERY,UNIVERSITY
156,209,237,446,ADDITIONAL,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
INSTITUTES
000,001,002,003,006,011,027,295,HIF,HSP27,HYPOXIA,III,ISOCITRATE,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,THERE
946,QDS
10001,333,CNS,FURTHER,HOWEVER,MEDICAL,NOVEL,PUBLISHERS,SEVENTH,USA,VTE

169,FOXR2,GLI,GNP,MUTATIONS,NOTABLY,SHH,SONIC,TGIF2,THESE,TRP53
FAK,FOCAL,GBM,HOWEVER,MMP,OSTHOLE,RESULTS
AFTER,BECAUSE,CNS,MRI,MTX,PRIMARY
ETV,FURTHER,JANUARY,MARCH,THERE,THESE,USING,VPS
BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
945,CEM,CNS,HBMEC,MIP,PCR,SUP
001,169,BACKGROUND,DNT,LABEL,MET,METHODS,MRI,NEURO,PATHOLOGY,PET,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
HOWEVER
ACPPS,ALA,DISCUSSION,HOWEVER,ICG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTHER,RESULTS,SEVERAL
133,AFTER,ATR,CD133,FOURIER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS

169,AUTHORS,GLIOMAS,III,LTD,NMR,THESE,WILEY,WORLD
169,342,BACKGROUND,BEV,COX,HOWEVER,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SALVAGE,SOCIETY,THERE,UNIVERSITY
EARLY,POSTERIOR
GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,THREE
396,AMERICA,AWAKE,BACKGROUND,ENGLISH,HOWEVER,LABEL,METHODS,NORTH,RESULTS,THEREFORE
11Q13,29A,FINALLY,HOWEVER,HSP47,PCR,TAKEN,THEREFORE
221,MICRORNAS,PNA,THESE,TIMP3,WESTERN
PERFORMING,PORTR
BACKGROUND,CIS,LABEL,METHODS,POISSON,RESULTS,RRS,SEVERAL
BACKGROUND,CONCLUSION,FSL,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY
100,177,193,203,955,CONCLUSION,LABEL,MATERIALS,METHODS,NIC,NORMALIZED,OBJECTIVE,RESULTS
001,013,464,753,BIOMEDICAL,CBM,CHINESE,CONCLUSION,CRUDE,HOWEVER,ISSUE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PITUITARY,RESULTS,SCIENCE,SMD,STATA,WEB
169,AUC,AUR,COPYRIGHT,DESPITE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,POWER,RATIONALE,RESULTS,THESE
003,169,229,643,786,AIM,AUC,COLLEGE,CONCLUSION,COPYRIGHT,DCE,DSC,HOWEVER,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROC,ROYAL
169,COPYRIGHT,LTD,PANCREATIC,THESE
181,220,CELLS,CONCLUSION,LABEL,LOADING,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,HUS,SOCIETY
CURRENT,DUE
ACCORDING,BACKGROUND,CCC,CONFERENCE,CONSENSUS,DIAGNOSIS,DUE,GIVEN,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,ONTARIO,QALYS,RESULTS,SOL,STRUCTURAL,STUDIES,TRANSITION,TREATMENT
AGE,BASED,CONCURRENT,GBM,GIVEN,INSTITUTE,KARNOFSKY,KPS,NOA,TMZ,TREATMENT
107,141,187,195,378,409,411,432,494,497,622,647,655,663,ATLAS,BEADCHIPS,EXPRESSION,MEIER,MICRORNAS,PACLITAXEL,PCR,SEVENTEEN,TAKEN,TAXOL,THESE
945,HIF,HYPOXIA,MDR,MTL,PCR,PGP,THESE,TLE
19Q,LGG,THEREFORE,USING
001,009,183,BACKGROUND,CLOSE,CONCLUSION,DFS,DISTANT,GEORG,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,STUTTGART
110,AFFECTIVE,FUNCTIONAL,HOWEVER,INDEX,KNOWING,QOL
946,954,AKT,AML,BAALC,BASED,E26,ERG,ILK,SP1,SPARC
132,945,AML,BASED,DON,ISOCITRATE,MUTATIONS,NADPH,R132H,TOFMS,U87
169,COPYRIGHT,LOW
32DCL,AATK1,APOPTOSIS,HOWEVER,SRC
BASED,DEFECTS,THESE,TRPC6
BACKGROUND,CONCLUSION,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
BACKGROUND,BASED,CONCLUSION,FLEMING,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,SEVERAL
125,CTS,MAY,THEIR,THREE
025,032,048,049,169,ALK,ANAPLASTIC,COPYRIGHT,LTD,SEVENTEEN,THYROID
144,162,BACKGROUND,CLONOGENIC,LABEL,MEK,METHODS,RAF,RAS,RESULTS,THESE
B16,C57BL,CHANGES,CHP,CSP,EHRLICH,F10,SWISS
448,466,CSF,DISCUSSION,HOWEVER,METHODS,OBJECTIVES,RESULTS,SSI,STUDIES
160,169,AGAINST,EEG,FCD,FOCAL,IIB,INC,MEG,MRI,PET,POWERPOINT,SHEARWAVE,SUPPORTING,SWE,WILEY
BORMANN,ENDOSCOPIC,LMC
164,507,AGE,AMONG,BACKGROUND,BRAIN,COX,LABEL,METHODS,RESULTS
140,162,486,5HM,AMONG,APPROACHES,BASED,BRAIN,CHIPS,CPG,FEW,GBM,LINE1,PATHWAY,RESERVE,THERE,UNIVERSITY,WESTERN
001,215,BACKGROUND,COX,LABEL,LDH,MEK,METHODS,RESULTS
169,CSF,DIAGNOSING,INC,MGG,RTS,THESE,THREE,WILEY
169,COPYRIGHT,HEALTHY,IFG,INC,OLDER,THESE,WILEY
169,HERVS,INC,LINES,SINES,TES,THERE,WILEY
007,169,16D,16Q23,215,622,67048,798,824,ADDITIONAL,CHINESE,CIS,CNV,GLIOMAS,HOWEVER,ORS,PCR
169,BRAIN,COPYRIGHT,DIFFUSE,INC,INSTITUTE,MOLECULAR,NEOPLASIA,REMBRANDT,SUBJECTING,THESE,WILEY
160,663,ASTRO,AUTHORS,BACKGROUND,CENTRAL,CHI,COLLECTION,CONTROLLED,LABEL,MAY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PFS,RANDOMISED,RESULTS,SECONDARY,SELECTION,SEPTEMBER,SRS,THERE
AGGRESSIVE,EARLIER,EARLY,MANAGEMENT,PITUITARY
100,GRADE,MTX,PCNSL,PFS,SALVAGE,THERE,TOXICITIES
945,ALTOGETHER,GBM,HOWEVER,THEREFORE,THESE,VDR,VITAMIN
PRL
EWING,LANGERHANS,LCH,LESIONS,MRI
BACKGROUND,CONCLUSION,ENHANCING,FIFTEEN,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SIXTEEN
BACKGROUND,CONCLUSION,DESPITE,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,WHEREAS
169,239,DABRAFENIB,FDA,III,PFS,RAF,TOXICITIES,TRAMETINIB,V600E,V600K
169,ACTFP,COPYRIGHT,FIRST,GNP,MMP,MT1
000,169,215,485,6MONTHS,COPYRIGHT,CPG,INC,LOWER,PBMCS,PERSISTING,PRIOR,PUBLISHED,REDUCED,SIX,STAGE
169,COPYRIGHT,INC,RAMAN
169,COPYRIGHT,GBM,HOWEVER,IRELAND,LTD,THESE
169,COPYRIGHT,HCS,HOWEVER,LTD,PFF,PPC
160,169,ABDOMINAL,COPYRIGHT,INC,PUBLISHED,TROUSSEAU
169,946,COPYRIGHT,HOXB9,INC
169,946,COPYRIGHT,DESPITE,DUE,GBM,REGULATORY,TFG,TREGS,WHILE
001,004,006,105,130,169,BACKGROUND,CONCLUSION,COPYRIGHT,ELDERLY,GBM,HOWEVER,LABEL,METHODS,RESULTS,SAS,YOUNGER
018,048,109,169,177,200,231,233,5CM,ASA,COPYRIGHT,EXCLUSION,FIFTY,FURTHER,III,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SAS,THERE,THESE
169,967,COPYRIGHT,LTD,THEREFORE,THESE
169,BRAIN,COPYRIGHT,INC,L1CAM,PLASMIN
160,169,946,COPYRIGHT,INC,LXR,MOLECULAR,RAF
100,169,177,COPYRIGHT,GGO,INC,LABEL,LOCAL,MAJOR,MATERIALS,MAY,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SIR
916,968,SAR,STRUCTURE
AMONG,OGT
NANOSCALE,NPS
001,002,005,111,114,129,159,212,225,264,689,819,865,886,CENTRAL,CNS,INCREASED,LABEL,METHODS,OBJECTIVE,RESULTS,VHL,WHILE
ALZHEIMER,ANATOMICAL
BBB,CNS,CURRENT,FUS,MALIGNANT,MBS
006,013,015,018,023,066,THESE
169,HISTOLOGY,INC,PILOMYXOID,PMA,ROSENTHAL,SLENDER,WILEY
001,177,CONCLUSION,FET,FIFTY,HISTOGRAM,LABEL,METHODS,PET,PWI,RESULTS,TAKEN,TBR,UNLABELLED
ACCORDING,DES,HOWEVER
956,BESIDES,BLOOD,HOWEVER,STA,THESE,TTS
102,169,BACKGROUND,BASEL,FOLLOWING,GTR,HOWEVER,INITIAL,LABEL,METHODS,POPULATION,RESPONSES,RESULTS,STR,THERE,XRT
002,008,401,AGE,BACKGROUND,BLOOM,CONCLUSION,ELDERLY,LABEL,METHODS,RESULTS,RICHARDSON,THESE
DUE,TREATMENT
151,153,199,230,BACKGROUND,CONCLUSION,GPA,HIF,LABEL,LOW,METHODS,MVD,NSCLC,RESULTS
558,945,946,947,956,CUE,GBM,MPM,MTT,RESULTS
DEFECTIVE,SNAIL
169,239,376,ASSESSMENT,CHEMO,CHINA,CHINESE,CLOUD,CONCLUSION,COPYRIGHT,FUNCTIONAL,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,QOL,REGRESSION,RELATIVELY,RESULTS,THERAPY
169,MICROARRAY,MICRORNAS,ONS,PCR,SOCIETY,THESE
IMAGE,MRI,PET,SIMULATION
ABOUT,PRIMARY
APRIL,CPA,DEBULKING,IAC,LABEL,LIPOMAS,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OTOLOGICO,RESULTS
169,177,485,AUTHORS,BPC,III,LTD,MACDONALD,NOVOTTF,PEARSON,PFS,PHYSICIAN,SIMON,WILEY
146,160,ADC,AWARENESS,FDG,PET,THESE
956,ANATOMIST,BRAIN,CCM,IMAGEVIS3D,THEIR,THESE
160,FURTHER,MEIER,UBIQUITIN,USP22,WESTERN
181,CDC42,GBM,RAP1B,TMZ
13RA2,A12,BRAIN,CASC5,DDX43,GBM,IHC,INSTITUTE,MOLECULAR,NEOPLASIA,PCR,REMBRANDT,REPOSITORY,TDRD1,THEREFORE
CURRENT,DESPITE,DUE,UTILISING
945,947,HCS,HOWEVER,HSC,IFN,MDA,RIG,TREATMENT
145,160,HOWEVER,MALIGNANT,RHO,ROCK1,THEREFORE,U87

DIFFUSION,DTT,MRI,TEN,TESLA,THESE
103,126,215,939,965,ADC,CAD,DWI,INTER,ROC
259,355,614,ATLAS,BACKGROUND,LABEL,METHODS,NOTABLY,NSCLC,PCR,RESULTS
BISPECIFIC,CD4,FOXP3,GBM,HOWEVER,MHC,NOTABLY,TCR
PET,THESE
BACKGROUND,CONCLUSION,IIB,JANUARY,LABEL,MAY,METHODS,NSCLC,RESULTS,SURGERY,THEIR
ANAPLASTIC,THESE
183,3DR,BACKGROUND,BET,BRAIN,DIGITAL,EXTRACTION,GEORG,IMAGING,LABEL,METHODS,RESULTS,ROI,STUTTGART,USING
183,ALM,BACKGROUND,GEORG,LABEL,MRI,OBJECTIVE,RESULTS,STUTTGART
ADHERENCE,BRAIN,CONCLUSION,DEX,HT3,LABEL,LOW,MEC,METHODS,NETWORK,OBJECTIVE,PAL,PRESTON,PRIMARY,PURPOSE,QOL,RAS,RESULTS,SECONDARY,THERE,TISCH,UNIVERSITY
1930S,1940S,1950S,1960S,1970S,1980S,1990S,CEREBELLAR,DISCUSSION,FOCUS,INCLUSION,LABEL,METHODS,MRI,OBJECTIVE,OPERATIVE,PREMATURE,PURPOSE,QOL,RESULTS,THOSE
000,100,418,BACKGROUND,INSURANCE,LABEL,METHODS,NHI,NHIRD,RESULTS
METASTATIC,RESPONSES,SURGERY
169,947,COPYRIGHT,DESPITE,E2F,HEXOKINASE,HK2,IRELAND,LTD,SIMILARLY,THESE
177,946,956,AKT,CONSISTENT,ERK,PDGFR,RAF,U87
FINALLY
001,011,015,023,256,351,CONCLUSION,IMAGE,INTRA,LABEL,MARCH,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RESULTS,THERE
151,589,864,BACKGROUND,BMI,CSF,EIGHT,EMA,EMACO,FURTHER,GTN,III,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,PATIENT,PRESENTING,RESULTS,TREATMENT,VAC
903,AIM,HOWEVER,LABEL,LIBRARY,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RANDOMIZED,RESULTS,REVMAN5,SRS
500,AFRICAN,AGE,CONCLUSION,END,GRADING,III,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PURPOSE,RESULTS,ROC,SIMILAR,UNKNOWN
398,571,874,BACKGROUND,BRAIN,DEPARTMENT,DIFFERENT,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,STATISTICS,THERE,WELFARE
GRADUALLY,LABEL,METHODS,MSC,NOW,OBJECTIVE,PERICYTES,PSC,PURPOSE,RESULTS
ACROMEGALY,CONSENSUS,GROUP,MARCH
DIAGNOSIS,MRI,THESE
026,BACKGROUND,CONCLUSION,FIFTEEN,FIFTY,GIVEN,LABEL,MANAGEMENT,METHODS,NF1,OCTOBER,OPTIC,PILOCYTIC,RESULTS
CONCURRENT,MRI,NAF,PET,WHILE
18F,FDG,MRI,PCT,PET,SPECT
177,215,ADC,CONCLUSION,DIFFUSION,FET,LABEL,LGG,LOW,METHODS,PET,RESULTS,THERE,UNLABELLED
100,132,169,AIM,AML,APL,BACKGROUND,CONCLUSION,COPYRIGHT,ITD,LABEL,METHODS,OBJECTIVE,PCR,PRODUCTION,RESULTS,SOMATIC,THERE
169,COPYRIGHT,CRNGR,FOLLOWING,LTD,THESE
169,AFTER,BACKGROUND,BRASILEIRA,CONCLUSION,CONTINUOUS,COPYRIGHT,EDITORA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,SOCIEDADE
169,200MG,956,AFTER,BRASILEIRA,COPYRIGHT,EDITORA,MACINTOSH,PUBLISHED,SOCIEDADE,WHILE
ADVERSE,BACKGROUND,BETWEEN,CONCLUSION,CSI,LABEL,METHODS,NCI,ONGOING,RESULTS,SINCE,SIXTEEN,THREE
PRIMARY,SELECTION
124,819,BRAIN,DECREASED,INCREASED,KILLING,THESE
BACKGROUND,BASED,LABEL,PCA,RESULTS,USING,WHILE
ACCORDING,CSF,FRANKEL,RUSSIAN,SINCE,TEMPORARY,THERE
AIM,ANNETTE,BILATERAL,BROCA,EXITE,GRADE,III,LABEL,METHODS,OBJECTIVE,PAPER,RESULTS,SIGNA,SIGNS
MRI
CPA,FURTHER,METRONOMIC,NOTABLY
BMJ,GROUP,LESIONS,LIMITED,MRI,PUBLISHED,PUBLISHING
048,056,123,183,339,368,575,651,673,934,AGT,CHINESE,CNC,HAN,HAPLOTYPE,HAPLOTYPES,HOWEVER,LRRC4,NCA,PITUITARY
001,ACCORDING,COX,CRK,III,NHA,U87,WESTERN
AIM,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
BACKGROUND,CONCLUSION,DETAILS,FORTY,LABEL,METHODS,OBJECTIVE,PAEDIATRIC,PARENTS,PURPOSE,RESULTS,SURVIVORS
051,BOARD,BRAIN,CENTRAL,ENGLAND,GENERATING,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS,THERE,WALES
169,BACKGROUND,BATTERY,CHAMPOD,CONCLUSION,COPYRIGHT,CROWN,EVALUATION,LABEL,LTD,METHODS,MUSIC,PUBLISHED,RESULTS,STG
169,177,263,867,947,AFTER,COPYRIGHT,ELISA,IFN,INC,MALIGNANT,MSS,NATURAL,NKA,THEREFORE
169,AKT,BINDING,COPYRIGHT,CXCR4,CXCR7,FINALLY,FOXM1,GBM,HOWEVER,INC
169,AMONG,COPYRIGHT,FAS,THERE
003,040,071,115,144,169,2MM,5MM,COPYRIGHT,GIVEN,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,RESULTS,WBRTMEL
169,177,6MONTHS,8MONTHS,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SEVENTY,THESE
169,1970S,BECAUSE,COPYRIGHT,INC,LGG,LOW,NCF,OPTIMAL,QOL,SINCE,USING
001,169,902,BEGINNING,CONCLUSION,CONTROL,COPYRIGHT,HOWEVER,INC,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
169,COPYRIGHT,INC
169,945,947,ATP,COPYRIGHT,ECS,FOXO1,IMPLANTED,LTD,PKA,PKACA,REG,TAKEN
169,BRCA1,COPYRIGHT,GIVEN,MCPH1
169,AIF,COMPARING,COMPARISON,COPYRIGHT,DCE,DYNAMIC,FIRST,IMAGING,INC,INTRA,MRI,MULTI,PCA,RESONANCE,ROI,THESE
160,169,CHEST,COPYRIGHT,FURTHER,INC,PUBLISHED,THREE,TROUSSEAU
110,160,169,BACKGROUND,COPYRIGHT,HIROSHIMA,HOWEVER,INC,JANUARY,JAPAN,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,THEREFORE
169,COPYRIGHT,FURTHER,IRELAND,LTD,MRI,NASAL,PAI
160,169,256,ADOLESCENT,ATHLETE,COPYRIGHT,III,INC,JANUARY,LABEL,METHODS,OBJECTIVE,PLANNED,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STRUCTURAL,TPB,WRITTEN
19Q,IDH,MUTATIONS
001,166,169,177,200,266,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,CREB1,ESPECIALLY,HOWEVER,III,KARNOFSKY,KPS,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,THESE
798,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,NPS,NSC,OBJECTIVE,RESULTS,THESE
CSF,EXECUTIVE,FURTHER,HVA,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,SOFIA,THERE,VMA
BACKGROUND,CONCLUSION,LABEL,METHODS,PDGFR,SORAFENIB,TARGETING
IGF
19Q13
CHOROID,CPP
000,DOPPLER,ENDOSCOPIC,EXTREMELY,ICA,MARCH,THREE
188,210,312,ACTUARIAL,CENTERS,EASTERN,FAVORABLE,GAMMA,KARNOFSKY,KNIFE,MRI,NEUROLOGIC,NOW,PETERSBURG,QUALITY,TREATMENTS
110,177,304,414,AFTER,BACKGROUND,CHI,FACTORS,III,LABEL,METHODS,RESULTS
001,020,169,197,216,343,396,464,549,609,748,819,953,967,BACKGROUND,BETWEEN,CONCLUSION,COX,DBF,GAMMA,HISTOLOGY,JANUARY,KNIFE,LABEL,MATERIALS,MEIER,METHODS,MRI,NEURO,PRESS,PUBLISHED,RESULTS,RPA,SOCIETY,SRS,UNIVERSITY
169,223,AKT,AXL,BACKGROUND,FINALLY,HIPPO,HOWEVER,LABEL,LARGE,MAP,METHODS,NEURO,NF2,PDGFR,PRESS,PUBLISHED,RESULTS,RTK,SOCIETY,UNIVERSITY,YAP,YES
CSF,FDG,IMAGING,MRI,PET
112,169,ADC,BACKGROUND,DTI,FRACTIONAL,III,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,R132H,RESULTS,WORLD
169,BASEL
954,GBM,THESE
FINALLY,RAN,THESE
BACKGROUND,DESPITE,LABEL,METHODS
181,454,537,947,MICROBEAM,MRT,U87
160,946,CNS,GCT,HCG,LABEL,MRI,PEI,UNLABELLED
BOARD,CARLO,GPU,IMAGING,MONTE,OBI,RADIATION
AKT,HOWEVER,MB231,MCL,MDA,ROS,TRAIL
BASED,BRAIN,CRC,LYNCH,PARIS,THEREFORE,THESE
036,160,169,946,AFTER,BACKGROUND,BXPC3,CONCLUSION,COPYRIGHT,EPC,IAP,LABEL,METHODS,NOTCH,PANCREATIC,PUBLISHED,RESULTS,TREATMENT,WESTERN
CRX,OTX
CHANG,CNS,SMARCB1
000,100,17P,17Q,NF1,PHEOS
BACKGROUND,BRAIN,CONCLUSION,HYALINIZED,LABEL,METHODS,MUTIPLE,RESECTION
ERG,GOLDENHAR,HOWEVER,L198P,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS,VHL
128,BRAIN,MICRORNAS
2CL,ANOVA,BACKGROUND,BMT,BONFERRONI,CONCLUSION,EXPRESSION,HOWEVER,LABEL,METHODS,NKCC1,RESULTS,RVI,SMALL,TMZ
100,104,ADULT,BACKGROUND,BETWEEN,CONCLUSION,GRADING,III,KPS,LABEL,LOW,METHODS,RESULTS
026,169,CYBERKNIFE,HOWEVER,JAPAN,KNIFE,PRESS,PUBLISHED,RADIATION,SOCIETY,SRS,SRT,THERE,UNIVERSITY
GATA5,THBS1,WT1
BACKGROUND,LABEL,METHODS,MIB,PAPILLARY,PGNTS,RESULTS,SEVENTY
001,005,234,301,BACKGROUND,CONCLUSION,ELDERLY,ESPECIALLY,FORTY,GBM,JANUARY,LABEL,METHODS,PFS,RESULTS,THEREFORE,TMZ,UNTIL
206,640,FINALLY
CPG,CURRENT,H3K27,WHOLE
11Q13,954,MEMBERS
945,954,BCL10,GBM,IAP,INHIBITOR,PROTEIN,REGULATION,SIMILARLY,TAKEN,THESE,TNF
946,BCL,GBM,HOWEVER,MMP,MUSASHI,NANOG,PCR,SP1,THEREFORE,THESE,WESTERN
CURRENT,METASTATIC

016,087,113,177,AGE,BMI,COMPONENT,FURTHER,GHD,HOWEVER,INDEX,MCS,NFL,PITUITARY,QOL,SCORE,SHORT,TBI,USING
177,BINDING,FAM,GBM,HOWEVER,LN319,MET,THI,WHILE
001,049,150,200,458,463,AFTER,BACKGROUND,LABEL,METHODS,OVERALL,RESULTS,ROCHE
637,978,BACKGROUND,CONCURRENT,FIRST,INSTITUTE,LABEL,METHODS,RESULTS,THERE,TREATMENT,WHETHER

324,AFTER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SSA,SURGERY,TSH,TSHOMAS
FAS,HOWEVER,SLF,STRESSFUL,WMI
INHIBITION,PITUITARY
169,FINALLY,FORMULA,PRESS,PUBLISHED,RGCCA,SGCCA,THEREFORE,UNIVERSITY
160,CNS,FIFTEEN,FRAMELESS,FRS,RECURRENT
LACTOTROPH,PRE,PROLACTIN,STUDIES
HOWEVER,SYLVIAN,THESE
131,177,496,CNS,JANUARY,LABEL,METHODS,MTX,OBJECTIVE,OCTOBER,PREVENTIVE,PURPOSE,RESULTS,THERE,WHILE
ALZHEIMER,WNT
422,428,4HC,709,EFS,LCL
288,BACKGROUND,CSGALNACT2,DHX57,H3F3A,HGG,KCND2,KIDINS220,LABEL,NF1,PAEDIATRIC,PTPRE,RB1,RESULTS,RET,THESE,TMEM178
169,BARRINGTON,BRAIN,CONCLUSION,COPYRIGHT,DESPITE,GERMANY,INC,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,URODYNAMIC
BACKGROUND,CONCLUSION,DESPITE,EARLY,LABEL,MALIGNANT,METHODS,PRIMARY,RESULTS
169,COPYRIGHT,FEDERATION,GAP,PUBLISHED,SOCIETIES
169,174,945,956,AFTER,COPYRIGHT,DOXIL,HOWEVER,MRI,SATURATION,TNF
177,CONCLUSION,CURRENT,DTI,FRACTIONAL,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
AKT,JUN,PDE,THEOBROMA,THESE,U87
1960S,1980S,300,INUIT,OTHER,PET,STOCK,THROUGH,USA
000,100,169,956,BASED,BECAUSE,ENDOCRINE,GIANT,PRL,SOCIETY,THESE
001,100,132,177,302,BACKGROUND,BASED,III,LABEL,METHODS,OVERALL,RESULTS,RFS,SNP,THESE
ENGLISH,PARTIAL,T11
BACTERIAL,FEW
DIFFERENT
183,BRAIN,DIAGNOSING,GEORG,STUTTGART,THEREFORE
160,AVERAGE,COX,FORTY,GBM,KPS,MEIER,MSM,SINCE,THERE
BRAIN,CENTRAL,INOVA,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,WORKING
487,945,CA2,DAG,IL3,IP3,MYB,PKC,PLC,PROGNOSCAN
205,356,CARMUSTINE,III,IOD,JAPAN,RECURRENT
169,COPYRIGHT,FINALLY,HOWEVER,IGG,VEGFR
169,COPYRIGHT,ENDOSCOPY,GERMANY,LTD,OPERATING,STORZ,SURGEON,THREE,TOTAL,TUTTLINGEN,USING,VITOM
169,BACKGROUND,CONTEXT,COPYRIGHT,DENOSUMAB,GCT,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RANKL,RESULTS,THERE
CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
177,AFTER,MRI,PEG,PITUITARY,PRL,THEREFORE
177,360,956,EDL,GBM,MULTIFORME,SAR,T98,THI,U87
005,125,252,885,ATT20,BRAZILIAN,CIS,GH3,HOWEVER,MEN,PITUITARY,V109G
169,191,COPYRIGHT,DEPRESSION,EQUATIONS,IBI,ILLNESS,INDEX,INDICES,INDIVIDUAL,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,RESPONSES,RESULTS,THESE,WILEY
022,023,040,967,BESIDES,CHEK2,CHINESE,ERCC1,GBM,GSTP1,HAN,MASSARRAY,SINCE,THESE,USING
202,588,AED,BETWEEN,EXCLUSION,FORTY,THESE
146,855,AES,EAP,IPILIMUMAB,ITALY,PROGRAM
000,100,160,177,579,ANY,EFS,FURTHER,INITIAL,THESE
FURTHER,INITIAL,MRI,SUBSEQUENT
169,CY5,HFN,VCH,WILEY
FURTHER,HOWEVER,TNBCS,USING
INS,LOH,STRIKINGLY,THESE
142,145,ANNEXIN,CONVERSELY,FLUOS,NANOG,NATURAL,OCT4A,OCT4B,SOX,SRY,SUBG1,U87MG
AMONG,CD133,ENPP1,GSC,KNOCKDOWN
AVAILABLE,PCL,U87MG
174,960,CAREFUL,CLINICALLY,ERK,GTP,THERE,V600E
FURTHER,HOWEVER,RCC,THESE,UMRC6,VHL
140,169,COPYRIGHT,INC,SAR,SINCE,SNR
169,COPYRIGHT,GROSS,INC,LABEL,METHODS,OBJECTIVE,RESULTS
160,169,177,946,BACKGROUND,CNS,CNSGCTS,CONCLUSION,COPYRIGHT,HCG,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TAIWANESE,THERE,THREE
001,169,3N0M0,954,AST,BACKGROUND,CASES,CONCLUSION,COPYRIGHT,CROWN,LABEL,LTD,METHODS,OVERALL,PUBLISHED,RESULTS
001,169,498,BACKGROUND,CALIFORNIA,COPYRIGHT,DIEGO,GAMMA,KARNOFSKY,KATSUTA,KNIFE,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SAN,SDGKC,SRS,UNIVERSITY
169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,PROMINENT,RESULTS,THERE
010,020,169,177,189,1ST,201,321,528,645,674,COPYRIGHT,INCIDENCE,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SRE
132,169,176,317,872,946,CONCLUSION,COPYRIGHT,INC,LABEL,LOW,METHODS,OBJECTIVE,RECURRENT,RESULTS,SOCIETY
132,945,BACKGROUND,CONCLUSION,IDH,LABEL,LN229,MIGRATION,R132C,R132G,R132H,R132L,R132S,RESULTS,THESE
117,169,404,473,527,CHI,COPYRIGHT,HOWEVER,INFECTION,LABEL,METHODS,OBJECTIVE,RESULTS
100,BACKGROUND,LABEL,MOLECULAR,POSTERIOR,RESULTS,V600E
169,ANXIETY,ASSESSMENT,CONCLUSION,COPYRIGHT,CROWN,DEPRESSION,FUNCTIONAL,GNF,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERAPY
000,100,980,AMONG,ASR,BACKGROUND,BRAIN,CENTRAL,GEORGIA,HOWEVER,LABEL,MARCH,METHODS,NON,RESULTS
BACKGROUND,COPYRIGHT,DISPERSIVE,DYSPHAGIC,EDICIONES,HNC,LABEL,METHODS,OBJECTIVE,PEG,PUBLISHED,RESULTS,SERUM,TEAMS,THERE,WAVELENGTH
CYR61,HOWEVER,NDRG2,SEVERAL,TAKEN,USING
11E,15E,191,69E,71E,79E,COX,INFLUENCE,LONELINESS,MEIER
DIFFUSION,DTI,GMT,HOD,MRI,ROI
CSF,KNOSP,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,STEINER
MRGLITT
CSC,DESPITE,GBM
THESE
GLASGOW,JANUARY,MONRO,OCTOBER,OUTCOME,RESECTION,SCALE,THERE
130,149,155,166,170,177,199,211,214,218,245,265,269,280,318,343,349,372,480,593,AFTER,BRAIN,CRC,ELDERLY,GBM,KARNOFSKY
001,009,013,033,047,236,778,960,971,END,OPTIMAL,RESULTS,THERE
124,131,169,181,8H9,BACKGROUND,CED,CONCLUSION,CSF,FIFTEEN,LABEL,METHODS,NEURO,PET,PRESS,PUBLISHED,REASONS,RESULTS,SIX,SOCIETY,UNIVERSITY
946,CASPASE,GIC,IFN,LTL
177,428,478,557,577,954,BACKGROUND,INITIATIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,REFINED,RESULTS,THERE,WHEREAS,WHI,WOMEN
CONNECTIVE,FORTY,HEREDITARY,SMAD4,THREE
CURRENT,DESPITE,GBM,NSC
169,BLOOD,CTC,THESE
AIP,HOWEVER,PITUITARY,POPULATION,PRKAR1A
169,COLLEGE,COPYRIGHT,HOWEVER,LTD,PUBLISHED,ROYAL,THERE
169,2OHOA,AKT,BRAIN,COPYRIGHT,DAG,DUE,EMA,FAS,FINALLY,ISSUE,MEDICINES,MOLECULAR,NACHOLEATE,NEOPLASIA,PATHOLOGY,PHYSIOLOGY,PKC,PUBLISHED,RAS,RELEVANCE,REMBRANDT,REPOSITORY,SPECIAL,STRUCTURE,THERAPY
169,177,215,ADC,CONCLUSION,COPYRIGHT,DWI,HPC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SAS
BACKGROUND,IB4,JNJ,LABEL,METHODS,NEITHER,PAW,RESULTS,SAP,SCC,SELECTIVE,TRPV1
AFTER,BACKGROUND,CELSIUS,COREL,DESPITE,EXPANSIVE,GERMANY,GLASGOW,GOS,III,LABEL,LABORATORY,MATERIALS,METHODS,MINOR,MRI,OBJECTIVE,OUTCOME,SCALE,THERE,UNIVERSITY
102,ANNOTATION,BACKGROUND,GENOMIC,LABEL,RESULTS,SIMILARLY,UTR
AKT,ANNEXIN,BASED,BCL,CSC,ERK,GLIOMAS,GRP,KNOCK,MUSASHI,PAR,SECRETORY,TAM,UCN
105,177,241,AFTER,AMONGST,BACKGROUND,CHINESE,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
COMMUNITY,DISEASE,EXTRACTION,GBM,SINCE
FURTHER,HEPG2,HOWEVER,INDIVIDUAL,L02,SWNHS
169,239,256,663,AKT,ATLAS,CCND1,CONCLUSION,COX,IHC,LABEL,MEIER,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SPECIMENS,WESTERN
001,169,ASSESSMENT,BACKGROUND,CRT,DIAGNOSIS,DYNAMIC,FIFTY,FREQUENCY,GBM,LABEL,METHODS,MRI,NEURO,OVERALL,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
001,002,008,015,017,094,169,949,ALZHEIMER,AUTHORS,CHILD,GIVEN,GLASGOW,GOS,HAPLOGROUP,INC,LABEL,METHODS,NEUROLOGY,OBJECTIVE,OUTCOME,RESULTS,SCORE,SOCIETY,TBI,THERE,THESE,TRAUMATIC,WILEY
BACKGROUND,DISCUSSION,LABEL,METHODS,MRI,SECUENCIAL,THERE
ATLAS,THESE,WHILE
160,196,6TH,BASED,DESPITE,DROWSINESS,HGG,SYMPTOM,THERE
001,215,239,295,ADC,AVAILABLE,LOW,MRI,SEVENTEEN,THERE,WHILE
200,CD133,GBM,THESE
109,119,CARLO,CSI,GENERAL,INC,LABEL,MATERIALS,METHODS,MGH,MONTE,OBJECTIVE,PUBLISHED,PURPOSE,RBE,RELAPSE,RESULTS
AKT,ATP,BCL,IF1,METABOLIC,OVERALL,ROS
169,ELISA,GBM,PCR,SOCIETY,WESTERN
PHASE,SURVAXM,THERE
945,946,AFTER,DUE,GBM,IL13R,IRNPS,RGD,THROUGH
BACKGROUND,BASED,GBM,HOWEVER,LABEL,METHODS,PREVIOUSLY,RESULTS
FURTHER,PEI,U87MG
CD105,CD11B
THESE
945,947,AKT,BTICS,CONVERSELY,FURTHER,HOWEVER,ICD,MALIGNANT,NGF,PREVIOUSLY,THESE,TRK
001,100,160,BLOOD,HOWEVER,KAPPA,MORTALITY,MRI,OVERALL,PCR
19Q,IDH,III,NCI,REMBRANDT,THESE
110,163,169,COPYRIGHT,FIFTY,INC,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,RESULTS,SEX,SHEBA
BURKITT

CTV,HGG,HOWEVER,MET,MRI,PET,RTP,T1W,T2W,WHILE
BACKGROUND,DOCK7,GBM,GEF,GTPASES,GUANINE,HGF,LABEL,MET,METHODS,RESULTS,RHO,TARGETING
169,CONVERSELY,COPYRIGHT,DSB,ECTOPIC,GBM,INC,RAD18,TLS
000,743,BBB,BTB,CAS,GADOMER,MAGNEVIST,STUDIES
KEY
169,PLATE
127,946,FINALLY,GBM,MICRORNAS,PCR,RGM,SFRP1,SKI,TGF,ZWINT

100,177,AFP,CLASS,GAMMA,GKS,HCC,KPS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RPA,THERE
153,181,229,ADP,ANTAGONISM,APOPTOSIS,DOXAZOSIN,KCNH2,LNT,U87MG
177,LABEL,METHODS,OBJECTIVE,RESULTS,STATE,THERE,VOXEL
100,169,177,BACKGROUND,HOWEVER,LABEL,METHODS,MRI,NAVIGATED,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,YET
ANKYRIN,HACE1,HOMOLOGOUS,HUNTINGTIN,HUNTINGTON,OXIDATIVE,SIMILAR,STRIKINGLY,THEREFORE,THESE
112,3DCRT,AFTER,AIM,CONCLUSION,COX,LABEL,LOG,MATERIALS,MEIER,METHODS,OBJECTIVE,POTENTIAL,RESULTS
FINALLY,FURTHER
113,169,CONCLUSION,CSF,CSR,LABEL,LOWER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THESE
006,156,19Q,210,245,291,CONCLUSION,CRT,GROUP,HOWEVER,IDH,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,USING
000,109,721,AFT,CONCLUSION,EOR,KARNOFSKY,LABEL,METHODS,NONLINEAR,OBJECTIVE,PURPOSE,RESULTS,SUBSEQUENT
001,169,297,AUDIT,AUTHORS,DIAGNOSIS,ENGLISH,INC,IQR,PRIMARY,PUBLISHED,ROUTINELY,THESE,USING,WILEY
100,108,160,CAVERNOUS,HOWEVER,RADIATION,THREE
M23
080,215,421,458,860,COMPARING,CONSORTIUM,CONTROL,EUROPEANS,FAM124B,INDIVIDUAL,JAPAN,NEITHER,SEVENTY,SPATA13,TRUST
BESIDES,BIOLOGICAL,CELLS,DSC,FIRST,IDE,MTT,NLC,SLN,THESE,U87MG
021,024,169,381,ALK,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
169,BF1,COPYRIGHT,FINALLY,FOLLOWING,H3ACK18,HAT,LTD
945,946,BACKGROUND,BRAIN,HOWEVER,LABEL,METHODS,PDGFR,PDGFS,RESULTS,SEVEN,THESE,TREATMENTS
AKT,HOWEVER,MICRORNAS,MMQ,TAKEN,THEREFORE,USING,UTR
CONCLUSION,COX,DELAYED,FACTORS,JANUARY,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OCTOBER,RESULTS,SEVENTY
AMONG,MOLECULAR,MRI,NEWER,PET,RADIATION,USING
021,024,130,136,270,BACKGROUND,BOHEMIA,FACULTY,GBM,IDH,LABEL,LOW,METHODS,PCR,PFS,R132H,RESULTS,SUMMARY
CNS,PEDIATRIC,SEVERAL
GBM,TECHNIQUES,WHILE
CNS,HOWEVER,THEREFORE,WORLD
BBB,CURRENT,HOWEVER,THEREFORE,THESE
169,INC,SEVERAL,WHY,WILEY
AVAGLIO,FDA,MALIGNANT,THEREFORE
040,042,169,AUTHORS,CASES,COX,GAMMA,III,INCREASED,KNIFE,LOCAL,LTD,PROGNOSTIC,SRS,WILEY
GBM,IFT88,NOTABLY,THESE,USING,WHILE
026,APOPTOSIS,AUTOPHAGY,COX,ELISA,KRISHAN,LOW,MEIER,PTPN6,WESTERN
169,BACKGROUND,BASED,DISCUSSION,KARNOFSKY,KFS,LABEL,METHODS,MGMTMET,MGMTUNMET,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
039,160,177,ADC,AGE,BACKGROUND,HOWEVER,LABEL,METHODS,PPT,PPTID,RESULTS,SEX,SUV
001,ASSESSMENT,BASIQ,BRAIN,C15,C30,EORTC,FATIGUE,FUNCTIONAL,GENERAL,INCREASED,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PAL,PURPOSE,QLQ,QOL,QUALITY,RESULTS,SPITZER,SYMPTOM,THERAPY,THERE,TREATMENT,WHOLE
231,ALBUMIN,BBB,CAROTID,EVANS,MDA
ADAR2,ADARS,ADENOSINE,AFTER,ASV,BACKGROUND,BT325,LABEL,METHODS,PCR,RESULTS,THERE
603,624,CONCLUSION,CUMULATIVE,EAR,GTR,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SIR,STR
CAM,CAR,CD171,CE7,OVERALL

IMPORTANT,ONCOCYTIC,THEIR
169,COPYRIGHT,INC
003,006,010,033,085,114,169,177,178,193,292,930,934,959,962,985,998,ADULT,CONCLUSION,COPYRIGHT,EOR,GBM,INC,LABEL,METHODS,OBJECTIVE,RESULTS
001,021,133,169,BACKGROUND,BMI,COPYRIGHT,DESPITE,FAT,FFM,LABEL,LTD,METABOLISM,METHODS,NUTRITION,OBJECTIVE,RESULTS,SDS,SOCIETY,THEREFORE,UNDER
169,246,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,PRIMARY,SSB
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,RESULTS,USING
BACKGROUND,EXCELLENCE,INSTITUTE,LABEL,OBJECTIVE,OBJECTIVES
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,SIXTY,SURGERY,THERE,THEREFORE
AMONG,BACKGROUND,CAREFUL,CHINA,CONCLUSION,DEPARTMENT,EIGHT,LABEL,MEC,METHODS,RESULTS,SEVEN,SICHUAN
100,169,183,AUSTRALIAN,BACKGROUND,COPYRIGHT,FUNDING,LABEL,LTD,METHODS,OVERALL,RESULTS,ZEALAND
169,BACKGROUND,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,MANAGEMENT,METHODS,OBJECTIVE,PRIOR,RESULTS,SAS,SINCE
169,ALZHEIMER,COPYRIGHT,DRUGS,FINALLY,INC,NAD,PARKINSON,SIRT1,THESE
AMONG,CHINESE,CHM,CONCLUSION,JANUARY,KARNOFSKY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SEVENTY,UNDER,UNIVARIATE,UNIVERSITY
BRAIN,HOWEVER,RAMAN,STIMULATED
CENDR,MTT,PEG,PEI,RGERPPR,RPPREGR,THEREFORE,U87
020,243,AMONG,BACKGROUND,CIE,LABEL,MAY,METHODS,RESULTS,ROC,UNIVARIATE
169,189,236,425,BACKGROUND,LTD,PCA,RESILIENCE,RESULTS,THESE,WILEY
BRATS,CHALLENGE,DATASET,MRF,STRUCTURAL
MULTI
18F,FDG,FLT,PET,SNR
BRAIN,BRATS,CHALLENGE,FIELD,GABOR,MRF
DTI,MRI,WHILE
BAYES
IMAGE,MRI,THERE
AUTOMATIC,FFD,LC2,MRI
AGE,BACKGROUND,CONCLUSION,CYBERKNIFE,INSTRUMENT,LABEL,LEVEL,METHODS,OBJECTIVE,PITUITARY,PURPOSE,QOL,QUALITY,RESULTS,SHORT,SIXTY,SRS,SYMPTOM,THESE,WORLD
169,ASPARAGINE,HOWEVER,LABEL,TAKEN,TARGETING,UNLABELLED,VIABILITY,XENOGRAFT
009,033,GRADE,JANUARY,PERHAPS,TNM
169,379,AMONG,BACKGROUND,CHANG,CLINICALLY,HEARING,HOWEVER,INC,LABEL,METHODS,PEDIATRIC,PROCEDURES,REPORTING,RESULTS,SOCIETY,WILEY
003,005,160,AFTER,HGG,KPS,PFS,PRS,STUDIES,TMZ
160,FLAIR,MEDLINE,OVERALL,RADIATION,TREATMENT
024,029,100,160,583,690,BETWEEN,BRAIN,LESIONS,RESECTION
066,200,268,651,ENDOCAN,HOWEVER,KNOSP,KRUSKAL,THESE,WHITNEY
013,134,600,CAUSE,GAMMA,KNIFE,LOCAL,OVERALL,UNIVARIATE
BACKGROUND,III,LABEL,MEK,METHODS,MIXED,QOL,RAPID,RESULTS,TREATMENT,V600E
FDG,HOWEVER,PET,SUV
23B,945,946,GBM,HIF,THEREFORE,VHL

ERBB1,LAPATINIB
049,123,125,151,157,180,196,200,213,273,275,298,309,316,330,376,401,BACKGROUND,III,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,THERE
120,160,174,180,240,8CI,9CI,A509U,ANTIVIRAL,AZT,GDS,HIV,LABEL,PND,RESULTS,THERE,TOXICOLOGY,TRADE,TWEEN,UNDER,UNLABELLED,ZDV
169,BACKGROUND,DTI,FRACTIONAL,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
BACKGROUND,III,LABEL,METHODS,NF2,OBJECTIVE,OBJECTIVES,RESULTS,SCHWANNOMA
169,BPD,COPYRIGHT,FOCUS,FREESURFER,IRELAND,LTD,MRI,VOLUMETRIC
121,206,ALTAS,CONSORTIUM,GBM,MOLECULAR,PIGEXCLASS
169,BIOLOGY,COPYRIGHT,INC,MOLECULAR,SOCIETY
169,946,COPYRIGHT,TGF,USING
000,100,ACCORDING,AMERICA,AUSTRALIA,BRAIN,DESPITE,DUE,HOWEVER,NORTH,WESTERN,ZEALAND
DVT
EXPERIENCE,GAH,WHILE
CURVE,DISPLAY,GAH,GERMANY,NNS,RADICAL
THERE
ASCL1,ERK,GABAERGIC,GLIOMAS,NEUROG2,PILOCYTIC,RAS,USING
MRI,OCULOMOTOR
169,HOWEVER,INC,MMS,WILEY
AKT,GBM,HSP90,LABEL,METHODS,OBJECTIVE,PI3,PURPOSE,RESULTS
002,007,008,105,169,ADPRT,BACKGROUND,CONCLUSION,ERCC1,ERCC2,LABEL,METHODS,NEURO,PARP1,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,XPD,XRCC1,XRCC3
169,591,BACKGROUND,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESECTION,RESULTS,SOCIETY,UNIVERSITY
001,100,116,125,161,177,180,19Q,206,381,450,499,557,605,649,653,812,814,967,ACCORDING,AFTER,AOA,BESIDES,LABEL,LOG,MAY,MEIER,METHODS,MOLECULAR,OBJECTIVE,PFS,RESULTS,THERE
217,501,ASSESSMENT,CENTRAL,CUMULATIVE,DISEASE,DISTANT,GROUP,INITIAL,LABEL,METHODS,NEURO,OBJECTIVE,PURPOSE,RECURRENCE,REGARDING,RESULTS,SOCIETY,WORKING
BLACK,DIETARY,HOWEVER,PRESENT,THEAFLAVIN
FEMORAL
100,107,113,360,603,740,ACEIS,AFRICAN,AHR,AMONG,ARB,BACKGROUND,LABEL,METHODS,RAS,RESULTS,VTE
DESPITE,THEREFORE
150,215,APOE4,CVD,FHS,FRAMINGHAM,HEART,MAJOR,NON
FDG,MRI,PET,SMALL,THERE
IMAGING
001,004,097,100,215,CONCLUSION,CRS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
124,946,BACKGROUND,GBM,LABEL,LAMB1,METHODS,PCR,RESULTS,U87,WESTERN
BACKGROUND,CONCLUSION,FDA,INCREASED,LABEL,METHODS,RESULTS,THESE,USING
100,BACKGROUND,GADOLINIUM,GCB,LABEL,METHODS,MRI,PCNSL,RESULTS,THESE
165,169,BACKGROUND,DESPITE,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SERIOUS,SOCIETY,UNIVERSITY
CLASS,OVERALL
HOWEVER,PREGNANCY
001,177,57357,BACKGROUND,CASES,CEREBELLAR,COMPARISON,CSF,EGYPT,GROSS,INCIDENCE,IPA,LABEL,METHODS,PAS,PMA,PMSAS,RESULTS,THESE
CONGENITAL
169,946,COPYRIGHT,INC,LUCIFERASE,SMAD3,STUDIES,TGF,WESTERN,WILEY
169,416,465,BACKGROUND,DABRAFENIB,EVALUATION,LABEL,METHODS,PFS,RESULTS,SALVAGE,SOCIETY,SOLID,THERE,TREATMENTS
280,720,CONCLUSION,DISPLAYING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
EXTRANODAL,GKS,GROUP,HOWEVER,PCNSL
CSF,ELM,MRI,MRS,VALIDATION
AMONG,BET,DISRUPTION,EPIGENETIC,GBM,NANOSTRING,NEWLY,NUT,SEVERAL,SIMILARLY,SINCE,THESE,TMZ
120,ADC,ALS,HISTOLOGIC,MRI,MTR,THESE,WHILE
ASL,CBF,WEBER
947,ALTOGETHER,HOWEVER,NOTCH,RO4929097,SILENCING,TMZ
001,003,008,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PURPOSE,RESULTS,SRS,TRT
007,150,169,200,CONCURRENT,COPYRIGHT,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PURPOSE,RADIATION,RESULTS,SVZ,THREE,TMZ
177,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PHANTOM,PURPOSE,RESULTS,SEVEN,SNR,VOXEL
SINCE
FINALLY,GIVEN,NKCC1,SIMILARLY,THESE
FABP3,MALIGNANT,PEPTIDE,SPECT,THEREFORE
125,48HOURS,BACKGROUND,CONCLUSION,CONTROL,FASTING,HOWEVER,LABEL,METHODS,RESULTS
TSE
130,BURKITT,CAPAN,CD3,DNL,NOD,THESE,VARIOUS
169,COPYRIGHT,MALIGNANT
138,169,171,214,4MM,5MM,8MM,BOARD,COPYRIGHT,LTD,TEN,THESE,THREE,TSC
169,COPYRIGHT,DR4,DR5,HOWEVER,INC,PEITC,PUBLISHED,ROS,TRAIL
111,167,188,218,355,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,TREATMENT
351,401,ADP,ALA,ASIAN,BACKGROUND,CBM,DESPITE,HOWEVER,LABEL,MEDLINE,METHODS,OVERALL,PAPR1,PARP1,RESULTS,VAL,VAL762ALA
11Q,17P,20Q,21P,ATAD2,ATM,AURKA,AURKB,CRYAB,DERL1,FOXM1,FREQUENTLY,GENOMIC,HSPB2,ITGAM,KNOWLEDGE,LUMINAL,NEK2A,PAM50,USING,WHILE
BACKGROUND,BESIDES,FOXM1,HOWEVER,LABEL,LUCIFERASE,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,PRIOR,RESULTS,SIRT1,SMALL,WESTERN
125,164,219,CONCLUSION,CRT,HODGKIN,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SURVIVORS,UNENHANCED
645,920,CIS,HWE,MAY,ORS,SCIENCE,SIMILAR,WEB
062,313,734,743,BASED,HOWEVER,INDEX,VIETNAM,WAR
004,135,160,171,215,BETWEEN,KARNOFSKY,MARCH,NSCLC,OCTOBER,RADIOLOGIC,SEVENTY,SRS
160,200,946,AFTER,CEB,CSF,EIGHT,HCG
160,CNS,MTX,PCNSL,SINCE
945,946,954,BV6,CD133,CSLCS,GBM,IAP,III,MOLECULAR,NANOG,THEREFORE
THEREFORE
897,AKT,DIFFUSE,DISRUPTION,EFNA1,EFNA3,EFNA4,EPHA2,GBM,GSC,TAKEN,TKO,USING
NOTCH,PML,USP11
002,009,016,026,032,177,758,845,BACKGROUND,CAJVO,FORTY,HES,ICP,INTRAGROUP,LABEL,LACTATE,METHODS,RESULTS,SVV,THERE,WHETHER
DESORPTION,DUE,IMAGING,IMS,INC,IONIZATION,LASER,MALDI,MRI,PUBLISHED,WHILE
LTD,PUBLISHED,SIRT1,THESE
169,1960S,ALA,BACKGROUND,COPYRIGHT,LABEL,METHODS,PDT,RESULTS,WST
169,COPYRIGHT,GLI,INC,IRREGULAR,KEY,PATCHED,PTC,RND,SMO,SMOOTHENED
169,177,344,432,776,CHARACTER,COPYRIGHT,HOWEVER,INVENTORY,IRELAND,LTD,RAVEN,THEREFORE,VBM
169,AFTER,COPYRIGHT,EMERGENCY,PUBLISHED,SAS
13Q,13Q13,13Q14,13Q21,169,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,INC,INFANTILE,LABEL,METHODS,PATIENT,PUBLISHED,RESULTS
169,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,ENGLISH,FURTHER,INC,LABEL,METHODS,RESULTS
169,COPYRIGHT,DESPITE,INC,PAPERCLIP,THESE,USING
169,COPYRIGHT,FACULTY,LEGAL,LTD,SDH
LASER,WHILE
CENTRAL,CRM,IMPROVING,THESE
400,560,EUDRACT,HGG,LABEL,METHODS,MRI,OBJECTIVE,PENTERO,PHASE,RESULTS,SEPTEMBER,THERE
001,022,127,AFTER,ALA,CONCERNING,CROSS,FIRST,HGG,IMAGING,LABEL,MET,METHODS,MRI,NAVIGATED,OBJECTIVE,RESULTS,THESE,THREE
125,ADDITIONAL,CONVERSELY,DEPARTMENT,FURTHER,GRADE,HOWEVER,ICGVA,III,LABEL,METHODS,OBJECTIVE,OCTOBER,PADUA,RESULTS,SIMPSON,THERE
103,110,458,531,ALA,AMONG,GRADE,III,LABEL,LOW,METHODS,OBJECTIVE,RESULTS
100,785,956,BLZ,CCD,CTX,ICG,INTRALIPID,LABEL,METHODS,NIR,OBJECTIVE,PAINT,RESULTS,THERE
170,COX,DESPITE,EOR,FOLLOWING,INSTITUTE,KARNOFSKY,KPS,LABEL,METHODS,NIH,OBJECTIVE,OVERALL,RECURSIVE,RESULTS,SCALE,USING
000,001,002,004,006,029,076,100,394,HOWEVER,JANUARY,LABEL,METHODS,MRI,NORWEGIAN,OBJECTIVE,OVERALL,PRESUMABLY,RESULTS,THERE
AFTER,DIAGNOSIS,EIGHT,FURTHER,GRADE,LABEL,METHODS,OBJECTIVE,PRESERVING,RESULTS,THERE,TOTAL
100,169,183,DAS,FOLLOWING,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PITUITARY,RESULTS,SURGERY,TREATMENT,TSH,WILEY
169,AFTER,AJAP1,GBM,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,REMBRANDT,RESULTS,U133A,WILEY
ACHIEVING
APART,CB1,CB2,HOWEVER,MARIJUANA,THC,THERE
AFTER,ARIAL
233,BACKGROUND,FDA,IPILIMUMAB,LABEL,METHODS,RESULTS
120,200,BACKGROUND,FORTY,LABEL,METHODS,MRI,ORR,RESULTS,THEIR,TMZ
014,017,169,177,APRIL,BACKGROUND,COX,EFS,INC,LABEL,METHODS,RECORDS,RESULTS,SEPTEMBER,WILEY
169,215,430DUPG,759,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCN,WILEY
160,AFTER,BRAIN,CTX,DCR,LIPOSOMAL,ORR
HEREDITARY,PITUITARY,THEREFORE
STRUCTURAL,THESE
AJAP1,BASED,BAX,CONSISTENT,GBM,HOWEVER,PCR,TUNEL
BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,MONRO,NAVIGATION,OBJECTIVE,PURPOSE,RESULTS,THERE
169,BRITAIN,COPYRIGHT,DISPERSIVE,GASCS,GREAT,IRELAND,LTD,PUBLISHED,SEVERAL,SOCIETY,THESE,U87MG,WILEY
215,BIOLOGICAL,MALIGNANT,MUTATIONS,R17,R273C,SOMATIC
169,BACKGROUND,COANALYSIS,DETECTION,GLYCINE,III,INCREASED,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHILE
MICROGLIAL,THERE
945,EIF3E,EUKARYOTIC,FACTORS,GBM,HIF,HYPOXIA,INDUCIBLE
DESPITE,MRI,RMS,THEREAFTER
169,656,946,BMP,ENGINEERED,NOTABLY,PRESS,PUBLISHED,SEVERAL,THESE,UNIVERSITY
169,COPYRIGHT,CTV,GBM,GTV,LTD,PUBLISHED
169,CHOROID,COPYRIGHT,CPP,LTD,PREVIOUSLY,USING
169,FIFTY,LTD,PUBLISHED
BACKGROUND,DCS,HOWEVER,III,LABEL,METHODS,OVERALL,REPETITIVE,RESECTION,RESULTS,THREE
000,450,BACKGROUND,CONTACT,LABEL,METHODS,MOTIVATION,RESULTS
001,12Q,14Q,169,177,19P,21Q,22Q,CHOROID,CLUSTERING,COPYRIGHT,INC,MIP,RECURRENT,SMARCB1,SNP,THEREFORE,WILEY
NON,OTHER,THEIR
001,MEMBERS,PCR,RAB,RAB18,RAB21,RAB23,RAB3B,WESTERN
ALT,COX,HGG,TELOMERASE
AUTOMATED,BRAIN,LABEL,METHODS,MRI,OBJECTIVE,PRE,PURPOSE,RESULTS
061,169,BACKGROUND,CENTRAL,CONCLUSION,DWI,FDG,FOUNDATION,IMAGE,JANUARY,LABEL,METHODS,MIB,OBJECTIVE,PET,PURPOSE,RESULTS,T1W,T2W
018,AVF,CSC,TAE,THERE
200,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
180,1SURG,A1C,BACKGROUND,CONCLUSION,CONTEXT,LABEL,METABOLIC,METHODS,OBJECTIVE,REGARDLESS,RESULTS
AFTER,BACKGROUND,BRAIN,CONTEXT,DESPITE,LABEL,METHODS,OBJECTIVE,POSTERIOR
181,BACKGROUND,CHRONIC,CONCLUSION,COX,DESPITE,LABEL,METHODS,NSCLC,RESULTS,T2A,UNIVARIATE
001,002,004,006,009,010,011,014,023,025,031,044,107,151,288,381,695,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIS
003,004,053,AVF3708,BRAIN,CONCLUSION,COX,GBM,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE
110,218,CONCLUSION,DFS,DISTANT,IB2,III,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE,THERE,TREATMENT
181,945,946,BACKGROUND,CONCLUSION,HUVEC,LABEL,MCF,MEANWHILE,METHODS,MTT,RESULTS,SCRATCH
GBM,HOWEVER,LIN28,LOG,SIMILAR,SUMMARILY,UNIVARIATE
A769662,AICAR,G2M,METFORMIN,THEREFORE
001,005,008,009,019,035,119,129,131,177,191,956,AFTER,AGE,BACKGROUND,BMI,CCK,CONCLUSION,FASTING,FAT,INSULIN,LABEL,METHODS,PYY,RESULTS
AFTER,CANCERS,IRELAND,OTHER,RISKS,VARIATIONS
160,238,322,ALA,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DTI,EFFECTS,FURTHER,GRADE,IMAGE,ISSUE,JOURNAL,LABEL,MARCH,MEDLINE,METHODS,MRI,NEURO,OBJECTIVE,OBJECTIVES,OTHER,OVERALL,PFS,QOL,REFERENCE,REPORTING,RESULTS,SELECTION,SUBGROUPS,THERE
136,191,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER
169,ORTHOTOPIC,OVERALL
MRI,PRIMARY
132,945,III,MALIGNANT,POINT,R132H
177,956,BICKEL3,BLI,CED,CONCLUSION,DTATEGF,LABEL,METHODS,MTT,MVD,OBJECTIVE,RESULTS,U87
169,COPYRIGHT,HOWEVER,INC,THESE,TOM
KHORANA,PATIENT,PRIMARY,VTE
169,329,887,946,AMONG,CMV,CONFIRMING,COPYRIGHT,HOWEVER,HPA,IGG,INC,PREDICTORS,PUBLISHED,SES,THESE
003,021,032,169,FOLLOWING,KPS,LABEL,LTD,MEIER,METHODS,OBJECTIVE,OVERALL,PAULO,RESULTS,SAO,TMZ
169,JARID1B,LOWER,LTD,ORAI1,PUBLISHED,STIM2,WILEY
HOWEVER,INITIAL,LASER,RANDOMIZED,TREATMENT
150,236,AKT,AMONG,BACKGROUND,BECAUSE,CONCLUSION,III,INHIBITION,LABEL,METHODS,RESULTS
100,169,BACKGROUND,BXD,CD117,CD133,CONCLUSION,CSC,FORMATION,FOXJ1,LABEL,METHODS,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
000,100,435,AREAS,BACKGROUND,BRAIN,CONCLUSION,CUMBRIA,ENGLAND,GLIOMAS,JANUARY,LABEL,LANCASHIRE,METHODS,NORTH,PRESTON,RATES,RESULTS,ROYAL,SERVICE,SMALL,SOUTH,SUPER,THERE
ADIPOCYTE,BACKGROUND,CONCLUSION,GBM,GEFITINIB,LABEL,LN443,METHODS,RESULTS,THESE,THROUGH
001,003,19Q13,BACKGROUND,CNS,LABEL,METHODS,MIP,PNETS,PRIMITIVE,RESULTS,THESE,WHILE
BACKGROUND,COMBINING,CSI,DIFFUSION,DKI,DSC,LABEL,METHODS,MRI,PERFUSION,RESULTS,WHITNEY
004,127,169,ADULT,BACKGROUND,CASES,CONCLUSION,FURTHER,LABEL,METHODS,NEURO,PAS,PRESS,PUBLISHED,RAF,RAS,RECURRENCE,RESULTS,SOCIETY,UNIVERSITY,V600E
DESPITE,FINALLY,HOWEVER
BACKGROUND,CONCLUSION,GLIAL,INNOVATIVE,LABEL,METHODS,PBX,RESULTS
BACKGROUND,CNS,FIFTY,FURTHER,GROUP,LABEL,MACDONALD,METHODS,PATUPILONE,RESPONSES,RESULTS
001,003,005,108,19Q,BACKGROUND,CURRENTLY,IDH,III,LABEL,METHODS,PATIENT,PFR,RESULTS
043,215,250,299,ASSESSING,BACKGROUND,BASED,CONCLUSION,COX,FRANKEL,HARRELL,KARNOFSKY,LABEL,MEDICAL,MEIER,METHODS,PREDICTIVE,RESULTS,SBM
ADULT,AHN,HOWEVER
169,AKT,ASD,HAMARTOMA,NG2,PRESS,PUBLISHED,THESE,UNIVERSITY
169,191,600,900,ACUTE,AFTER,BACKGROUND,BETWEEN,DELAYED,EFS,FOCAL,GUSTAVE,INC,INSTITUTE,JANUARY,LABEL,METHODS,PROCEDURE,RESULTS,SCALE,SEPTEMBER,THESE,WILEY
CHELATION,EARTH,LOW,SUFFICIENT
100,HOWEVER,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
104,144,160,AFTER,CNS,CSF,EBV,EPSTEIN,HOWEVER,LABEL,METHODS,PCR,PRIMARY,RESULTS,THREE,UNLABELLED
HOX,LABEL,MALAT,METHODS,NFPAS,OBJECTIVE,PURPOSE,RESULTS,THERE
AKT,BBB,BCBMS,THERE
177,882,AGE,GBM,JANUARY,PPS,TMZ
001,107,584,COX,GBM,MVA,NEUTROPHIL,NLR,PRIMARY,TTP,WEIBULL
177,424,995,FAVORABLE,GBM,IRB,KPS
002,174,251,CSF,EVALUATION,GROUP,KRYPTOR,LABEL,SERUM,SOCIETY,TRACE,UNLABELLED
623,AGE,DESPITE,ICU,LEVEL
CHI,CHINA,FOUNDATION,LABEL,METHODS,NATURAL,OBJECTIVE,PEARSON,PURPOSE,RESULTS,SCIENCE,SUPPORTED
946,APOPTOSIS,ASC,CRE,EGL,HOWEVER,ND2,P20,P60,SMAD3,SMOA1,SMOM2,SMOOTHENED,SONIC,TAKEN
ALA,BACKGROUND,GBM,HOWEVER,III,IQR,LABEL,METHODS,MRI,RESULTS,THERE,TOTAL
169,ALZHEIMER,COPYRIGHT,LTD
BACKGROUND,CONCLUSION,COX,GAMMA,III,KNIFE,LABEL,MEIER,METHODS,OVERALL,PFS,RECURRENCE,RESULTS,THREE,WHILE
160,169,945,946,954,AKT,COPYRIGHT,F11,IKK,LPS,LTD,MAPKS,MYD88,ROS,SINCE,THESE,TNF
COLLECTED,FIRST,MAP,MAXIMUM,NMF,NON,THIRD
018,028,169,599,AUTHORS,BJU,COGNITIVE,CONCLUSION,CPG,DREYFUS,HOWEVER,LABEL,METHODS,OBJECTIVE,RAS,RESULTS,THERE,VINCI,WHILE
176,ANATOMICAL
169,CD138,CD163,CD3,HPF,IGG,III,LPM,MAXIMAL,SIXTEEN,SOCIETY,THERE,WORLD
675,FINALLY,FURTHER,H19,HOWEVER,UTR
10Q23,10Q24,FIH,GBM,GLUT1,HIF,HYPOXIA,INDUCIBLE,INHIBITING,THEREFORE
CD133,CHR,CSC,DESPR,GBM,PANC1,U87,VEGFSIGNAL
001,BACKGROUND,CONCLUSION,DUE,HOWEVER,JANUARY,LABEL,METHODS,RESULTS,SCIENCE,SEVERAL,WEB
124,128,137,595,946,CDC42,KIT,TGF
001,161,170,681,771,873,ACUTE,BACKGROUND,CAM,ICU,INSTITUTE,IQR,JANEIRO,LABEL,METHODS,RESULTS,RIO,SEVERAL,SURVIVORS,UNIVARIATE
169,184,199,383,CNS,DECREASED,INC,INCREASED,LABEL,METHODS,OBJECTIVE,PROCEDURES,REDUCED,RESULTS,SURVIVORS,TESTS,WILEY,WMV
001,007,936,CXCR4,HOWEVER
169,CENTRAL,CNS,EBL,INC,MRI,NERVOUS,TUMOURS,WILEY
001,018,109,169,246,321,AUTHORS,CARDIOLOGY,CONCLUSION,FAILURE,HEART,HOWEVER,JOURNAL,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS,SOCIETY,SOLUBLE,SWEDISH
169,183,215,BARTH,FURTHER,GEORG,MRI,OVERALL,PITUITARY,STUTTGART
SIMILARITY,SNF
DEVELOPING,GBM,SP1,THEREFORE
AFTER,EYEBALL,TSS
945,BECAUSE,CCL17,CCL22,CHEMOKINE,CSF,CYTOKINES,FURTHER,IL1,IL4,IL5,IL8,THESE
132,196,945,954,BACKGROUND,GBM,HOWEVER,LABEL,METHODS,MIR,ONCOGENIC,PCR,RESULTS,U87MG,UTR
001,003,010,033,074,117,171,675,949,951,BACKGROUND,DESPITE,HOWEVER,KARNOFSKY,LABEL,METHODS,RESULTS,THEREFORE
AKT,ATTENUATED,BACKGROUND,CRT0066101,GBM,GLI25,GM133,LABEL,METHODS,PCR,PKB,PKC,PRKD2,RESULTS,U87MG,WESTERN
219,361,490,764,AFTER,APRIL,BACKGROUND,BESTA,BRAIN,CARLO,EQUIVALENT,FONDAZIONE,GBM,HRS,ITALY,LABEL,METHODS,MILAN,PFS,RESULTS,STUPP
169,CNS,COPYRIGHT,DANIO,GLD,HOWEVER,THESE,ZEBRAFISH
169,BAF,CISPLATIN,COPYRIGHT,DDP,DHA,HOWEVER,INC,MAMMALIAN,SKOV3,TAKEN,TREATMENT
169,19KDA,AG490,AMONG,BCL,BNIP3,COPYRIGHT,E1B,GIVEN,INC,MMP,MT1,PLANT,STAT3,U87
113,169,AFTER,CHECKLIST,CHILD,COPYRIGHT,CRT,EMOTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,PURPOSE,RESULTS,THESE
169,ADC,BACKGROUND,BLAND,CONCLUSION,COPYRIGHT,DIFFUSION,DWI,INC,INTER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROI,THERE,THESE,THREE
140,160,169,243,416,945,946,APRIL,BACKGROUND,BRAIN,COPYRIGHT,CSF,DISORDERS,DUTCH,FONDO,FOUNDATION,FUNDACI,FUNDING,GABAA,GABAERGIC,GAD,INCREASING,INSTITUTES,LABEL,LTD,MARAT,METHODS,MRI,OVERALL,RESULTS,SANITARIAS,SCIENTIFIC,THESE,TV3
160,169,COPYRIGHT,GBM,GLE2P,GLEBS,H2A,INC,INHIBITION,KTS,MTS,SAC,THESE
BACKGROUND,CNS,CONCLUSION,CSF,EATON,HOWEVER,LABEL,LAMBERT,METHODS,PUBLISHED,RESULTS,SERUM,TEXAS,UNIVERSITY
169,COPYRIGHT,CSF,EXTRA,LIMITED,LTD,PRIMITIVE,PROGNOSTIC,PUBLISHED,THEIR,WORLD
169,347,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,DEPARTMENT,DISCUSSION,JANUARY,LABEL,MAY,METHODS,RADIATION,RESULTS,SAS,STRASBOURG,THESE,UNIVERSITY
CMS,CRITICALLY,MRI,SCALE
169,47D,CELLS,CO2,CULTURE,FLASK,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SENSING,WILEY
946,BACKGROUND,BMP,DESPITE,GROUP,LABEL,RESULTS,SHH,TGF,WNT
169,171,BACKGROUND,BLOOD,BRITISH,LABEL,MIDKINE,SOCIETY,THEREFORE,UNLABELLED
ADRENAL,AFTER,CUSHING,HOWEVER
HAUSDORFF
ACUTE,BACKGROUND,CONCLUSION,EORTC,FIFTY,GROUP,LABEL,MEIER,METHODS,MRI,NPC,RADIATION,RESULTS,SEPTEMBER,SUN,THERAPY,THREE,TREATMENT,UNIVERSITY,YAT
053,412,566,761,AIM,AMONG,HOWEVER,KOREA,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,SUMMARY
466,ABOUT,BACKGROUND,III,INDIA,INSTITUTE,JANUARY,LABEL,MANIPUR,MATERIALS,MEDICAL,METHODS,RESULTS
IDH,III,R132H,SEQUENCING,SINCE,THESE
001,005,006,007,014,ELISA,GST,GSTP1,III,PAKISTANI,UNDER,WESTERN
HOWEVER,PGAM5,PROGRAMMED
MRI
001,AIM,ASD,BROCA,DIAGNOSIS,LABEL,METHODS,MOTOR,OBJECTIVE,PURPOSE,RESULTS,WHILE
239,EARLIER,HOWEVER,III,STUDIES
177,916,AIM,BMD,CAG,CONVERSELY,FSH,FT4,IGF,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL,TRT,WHILE
CHINA,DEPARTMENT,EXPRESSION,FOLLOWING,MEDICAL,MTT,TEN,TRANSWELL,TUNEL,UNION,UNIVERSITY
III,MALIGNANT,PRIMARY
013,229,577,ALS,ALZHEIMER,BACKGROUND,CNS,CONCLUSION,HUNTINGTON,INCREASED,ISI,KNOWLEDGE,LABEL,MARCH,MEDLINE,METHODS,PARKINSON,RESULTS,SCZ,SOURCES,THERE,WEB
DOPPLER,PDV,THESE
CONNEXIN43,GSC,ID1,SRC,THESE
945,946,APOPTOSIS,HIF,HOWEVER,MTT,U87MG
945,OCS,PENTRAXIN,THESE,TNF
169,177,BACKGROUND,ENDOSCOPIC,JOURNAL,LABEL,MATERIALS,MATURATION,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY
126,169,215,799,ADC,BACKGROUND,CBV,COX,DIFFUSE,JOURNAL,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
CONCLUSION,ITF,LABEL,MAJOR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,UPS
BRAIN,ELECTRONIC,LABEL,METHODS,NINTH,OBJECTIVE,RESULTS

169,ADC,AUC,CONCLUSION,COPYRIGHT,DTI,III,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS,ROC,SEVENTY
13Q,169,18Q,19Q,945,COPYRIGHT,INC,MET,PDGFR,SMARCB1
169,COPYRIGHT,CTA,INC,MRI,THESE
AFTER,BACKGROUND,BEV,GBM,IRI,LABEL,METHODS,PFS,RESULTS,SECONDARY,SURGERY,TEM
169,3T3,ASIAN,LTD,NOTABLY,OBESITY,PUBLISHED,ROS,VARIOUS
NOVEL,SURGERY
BACKGROUND,CNS,CONCLUSION,HOWEVER,KNS42,LABEL,METHODS,MYC,RESULTS,RHPS4,TELOMERIC,U87
31E,43E,ALDH2,CHINESE,HAN
181,DANIO,GSC,NORDY
BACKGROUND,CONCLUSION,LABEL,LITERATURE,METHODS,RESULTS,STUDIES,TMZ,TOTALLY
FURTHER,SINCE,TARGETING,TIC,USING
100,111,BACKGROUND,CSF,LABEL,METHODS,MRI,RESULTS,ROUTINE
169,189,INITIAL,SUBSEQUENT
131,169,AUSTRALIAN,BACKGROUND,INC,KEY,LABEL,METHODS,MILES,NVIVO,PATIENT,PROCEDURE,QSR,RESULTS,WILEY
051,390,546,978,ASIAN,C118T,CAUCASIANS,CBM,CIS,CRUDE,ERCC1,HOWEVER,LIBRARY,ORS,SCIENCE,STRATIFIED,TAKEN,WEB
169,DIMINISHED,FINALLY,PRMT5,ST7
ADMET,COMPLIANCE,JORGENSEN,MEANWHILE,THREE
HOWEVER,PUBLISHED,RADIATION
127,169,315,442,448,957,ACCOUNTING,BACKGROUND,BETWEEN,GROUP,JANUARY,LABEL,MEDICAL,METHODS,MRI,RADIATION,RESULTS,SOCIETY,SRS,THERAPY
160,JAPAN,KIT,PCR,RAS,REGARDLESS,SOMATIC
BACKGROUND,HOWEVER,LABEL,LGG,METHODS,RESULTS,TEN,THEREFORE,THESE,TOTAL
044,104,BACKGROUND,BASED,FIFTY,GROWING,LABEL,METHODS,MRI,NFPAS,RESULTS
001,12Q,17Q,20Q,22Q,CH1,CH2,CS2,ECRG4,RAB38,RARRES2,VAMP8
100,11R,169,BPA,BSH,COPYRIGHT,CPP,ICP,LTD
575,BACKGROUND,BASED,BRAIN,FSPGR,HOWEVER,LABEL,METHODS,MRI,RESULTS
BMI,CENTERS,CONTROL,DISEASE,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERWEIGHT,PREVENTION,RESULTS,SURVIVORS,UNIVARIATE
169,CENTRAL,NF2,SOCIETY,WORLD
100,BACKGROUND,CK7,CONCLUSION,LABEL,LANGERHANS,LCH,LIGHT,METHODS,TTF
BACKGROUND,CONCLUSION,HODGKIN,LABEL,METHODS,SOMETIMES,TREATMENT,UMS,UVEITIS
500,787,GRADE,III,KPS,MENINGIOMA,MRI,PFS,PTK
106,177,342,638,795,ADVERSE,ALA,BACKGROUND,CONCLUSION,FURTHER,HISTOLOGY,LABEL,METHODS,RESULTS,SIXTEEN
ALA,BACKGROUND,HOWEVER,LABEL,METHODS,MRI,RESULTS

AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THESE
002,028,126,179,277,278,942,976,ALZHEIMER,COMMUNITY,COX,HOWEVER,HRS,NEDICES
112,19Q,CONCLUSION,EMA,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
USING
LABEL,METHODS,NF2,OBJECTIVE,PURPOSE,RESULTS
A549S,AFTER,ISOFORM,LABEL,OPTIMAL,PRF,RATIO,SCIENCE,SWIFT,THESE,USING
M1B,MRI
AFTER,PITUITARY,THEREFORE
169,BSA,COPYRIGHT,HOWEVER,LTD,THEREFORE
003,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,WHILE
001,033,043,320,333,496,674,696,891,940,959,APRIL,BACKGROUND,CFI,CONCLUSION,COX,GAMMA,IDL,KNIFE,LABEL,METHODS,NON,OBJECTIVE,PER,PERFEXION,RESULTS,VARIABLES
160,177,REASONABLE
ECTOPIC,HEARING
169,177,AUTHORS,BIG,COPYRIGHT,ELISA,INC,KEY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERUM,THESE
110,19Q,234,BACKGROUND,CNS,CONCERNING,DETECTION,HOWEVER,LABEL,METHODS,OGD,RESULTS,UNASSIGNED,VIRTUAL
160,400
SLE
169,COPYRIGHT,III,INC,WARBURG,WILEY
169,177,199,278,956,ACTIVATING,CONVERSELY,COPYRIGHT,INC,NPO,SIMILARLY,THESE,WILEY
BECAUSE,HOWEVER,MFH,MRI,PRL,REGARDLESS
19Q,CIC,DIFFUSELY,FUBP1,GBM,H3F3A,HISTOLOGIC,IDH,III,MUTATIONS,NF1,OTHER,PEDIATRIC,PRIMARY
210,241,371,374,960,ADVERSE,AMONG,BECAUSE,DISCUSSION,EASTERN,GROUP,III,LABEL,M1C,METHODS,OBJECTIVE,OCTOBER,ORR,PURPOSE,RESULTS,SEVERAL
039,BACKGROUND,CONCLUSION,EXTRACTED,LABEL,METHODS,NBI,RESULTS,SPECIMENS,VESSELS
306,950,AUSTRALIAN,CASES,CBT,CHILDHOOD,CTS,FEW,GIVEN,INCREASED,LABEL,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS
001,003,005,015,039,061,846,967,HCC,LABEL,LITERATURE,METHODS,OBJECTIVE,PITUITARY,PURPOSE,RESULTS
145,IRINOTECAN,THERE
99MTC,DAT,HOWEVER
169,946,ASTROCYTES,COPYRIGHT,ESTRADIOL,IRELAND,LTD,SERMS,SINCE,THEREFORE
169,CONCLUSION,COPYRIGHT,CURRENT,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,TMZ,WESTERN
169,COLLISION,COPYRIGHT,INC
017,CHINESE,DCS,ENGLISH,LABEL,MCNEMER,METHODS,OBJECTIVE,RESULTS,SIX,SIXTEEN,THERE
10877,10878,169,361,55Y,AGE,CONCLUSION,COPYRIGHT,GTV,IRELAND,LABEL,LINAC,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPA,SRS,THESE,WORLD
DNT,HUC,HUD,MND,MRI,THERE
169,19Q,1P19Q,252,ALT,DESPITE,LOH,SOCIETY,THOSE
CRP,EVALUATION,HOWEVER,METASTATIC,RCC,UPPER,WHOLE
169,60019,ATM,GIC,TAKEN
169,INC,WILEY
ALTOGETHER,AML,AUSTRIA,LABEL,METHODS,OBJECTIVE,PROPORTION,PURPOSE,RESULTS,TYROL
AFTER,BACKGROUND,CONTINUING,INCOMPLETE,LABEL,METHODS,MRI,NTR,RESULTS
GBM,GFP,PCR,TGIFX,U87,U87MG
MALIGNANT,MRI
EORTC,MRI,OVERALL,TMZ,USING
122,ADVERSE,APRIL,BASED,BLOOD,DIETARY,GBM,III,IRB,SERUM,SIX
DISTINCTLY,ENHANCING,GADOLINIUM,MRI,THESE,WHILE
160,ANATOMICAL,CHOROID,CPP,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
DCA,FURTHER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SYNERGY,UNDER
HGG,OVERALL,PFS,SIXTEEN,SORAFENIB
001,452,50S,794,897,AMONG,KEY,KINGDOM,LABEL,LIVERPOOL,OVERALL,RESULTS,SCREENING,THOSE,UNLABELLED

AMONGST,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,PATIENT,RESULTS,THREE
17Q21,LOH,UNUSUAL
006,015,016,189,ANXIETY,COMPLEX,DOULEUR,HOWEVER,OSTERRIETH,REY,THESE,TRAIL
ANATOMY,AVAILABLE,BACKGROUND,GBM,GENIE,LABEL,MATERIALS,METHODS,OBJECTIVE,PROJECT,PURPOSE,RESULTS,SAM,SAV,STAB1,THREE
134,GBM,MET,PDGFR,RTK
160,GLIOMAS,KOLMOGOROV
160,CORRECT,KOLMOGOROV
169,COPYRIGHT,FINALLY
DDM,DIR,ICE,PEARSON,THEREFORE
160,169,397,AUTHORS,COPYRIGHT,GBM,INC,PUBLISHED,THESE,TIC,USING,ZFHX4
169,BORON,COPYRIGHT,GBM,LTD,MST
169,3NM,430,5NM,946,956,BASED,COPYRIGHT,HOWEVER,ISSUE,NCH82,NCH89,PROCESSES,REDOX,SINCE,SPECIAL,THIOL
169,ACTIVATION,ANNEXIN,APOPTOSIS,BBB,CASPASE,COPYRIGHT,FAILURE,IRELAND,LTD,OVERALL,PEI,PROPIDIUM,STAT3
100,169,233,BACKGROUND,BRAIN,CMMRD,COPYRIGHT,DISCUSSION,LABEL,LTD,LYNCH,METHODS,MMR,MOLECULAR,OVERALL,RESULTS,SCREENING,WHILE
169,340,BACKGROUND,BETWEEN,COPYRIGHT,COX,DCR,GUSTAVE,IRELAND,LABEL,LTD,MEIER,METHODS,MUT,NSCLC,PFS,RESULTS
049,100,160,164,169,215,218,231,233,360,3CM,4CM,504,720,7CM,7GY,BECAUSE,BETWEEN,COPYRIGHT,LABEL,MARCH,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SAS
169,BASED,CONCLUSION,COPYRIGHT,CPA,HENCE,ICP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,CONCLUSION,COPYRIGHT,GROSS,KARNOFSKY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,THERE
001,451,INCLUSION,IVN,MEIER,PUBLISHED,RECURRENCE,SIXTEEN,SRS
012,018,029,169,APHASIA,BATTERY,BRAIN,CONCLUSION,COPYRIGHT,DTI,LABEL,METHODS,METICULOUS,OBJECTIVE,RESULTS,THERE,WAB,WESTERN
169,BROCA,COPYRIGHT,DES,DIFFUSION,DISCUSSION,DTI,ELECTRICAL,HOWEVER,IMAGING,LABEL,METHODS,OBJECTIVE,RESONANCE,RESULTS,SINCE
001,169,945,961,ASSESSMENT,BRAIN,FIFTY,FUNCTIONAL,GENERAL,INDEX,ISPOR,LABEL,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIETY,SYMPTOM,THERAPY
BACKGROUND,BRAIN,LABEL,METHODS,RESULTS,USING,WITHOUT
BECAUSE,FLICE,HOWEVER,MSC,THESE,TMZ,TRAIL,TREATMENT
FOLLOWING
001,100,IMPORTANCE,LABEL,METHODS,MONITORING,OBJECTIVE,OCT,OPG,OPTICAL,RELEVANCE,RESULTS,SETTING,USING

AKT,BRAIN,LABEL,LOCAL,MEK,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY
946,DEPLETION,IFN,LABORATORY,PHYSIOLOGY,RIG,STUDIES
169,COPYRIGHT,CURRENT,INC,RHO,THESE
169,COPYRIGHT,DESPITE,INC
169,231,233,AFTER,COPYRIGHT,FDG,MRI,PET,PUBLISHED,SAS,SEVEN
446,BACKGROUND,FDA,GBM,HENCE,LABEL,MDR,METHODS,NCC,NIH,NOTABLY,RESULTS,SCREENS
99M,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,MMP,OBJECTIVE,RESULTS,THESE,U87MG
123,230,301,GBM,GIL,HOWEVER,MED,MOS,ONCOL
100,140,169,78D,BACKGROUND,LABEL,MEIER,METHODS,MRI,NEURO,PFS,PRESS,PUBLISHED,RESULTS,ROI,SOCIETY,UNIVERSITY
FSH,HOWEVER,PITUITARY,TSH
947,AKT,ERK,FAK,PROTO,PTB,SHC,SRC,Y1068,Y1148,Y1173
BACKGROUND,DISCUSSION,FSH,LABEL,METHODS,PITUITARY,RESULTS,THEIR,THREE,TSH
001,113,160,300,359,659,ADDITIONAL,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
150,200,BACKGROUND,CONCLUSION,EVALUATED,FRT,FTM,GBM,KARNOFSKY,LABEL,METHODS,PFS,PRIMARY,RECURRENCE,RESULTS,TMZ
160,ANOTHER,BACKGROUND,CONCLUSION,DWI,HOWEVER,III,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,WORLD
125,BASED
001,047,129,ASCT2,ATP,BASED,GDH,GLYCOLYSIS
BTP,HOWEVER,SIALIDASE,VARIOUS
BACKGROUND,LABEL,METHODS,PATIENT,RESULTS,UNASSIGNED
169,BIM,EGF,FINALLY,GREAT,GSC,TAKEN
169,ID2,INHIBITOR,MATURATION,NOTCH,NSC,OLIG2,OPC,ORTHOTOPIC,THESE
160,945,946,CNS,CSF,MMS,ORR,PDGFR,PFS,RET,SECONDARY,SIMON,SUNITINIB,VEGFR
RESULTS
FINALLY,GLIOMAS,RESULTS
ELISA,LDM,MVD,PRESENT,TMZ,U87
EMA,GTNIS,NIS,PCR
150,169,176,20MIN,ADDITIONAL,BIOBANKING,COLLECTION,COPYRIGHT,HISTOLOGIC,INC,PUBLISHED,RAPID,SOCIETY,TOLERANCE,WHILE
ATP,CSRAS,CTR,TMZ,VARIOUS,WHEREAS
BACKGROUND,CSC,CXCR7,GBM,LABEL,METHODS,RESULTS,SDF,TAC,THESE
177,916,947,D95,DHR,DMEAN,DSR,DVH,NUCLEAR,OAR,PDP,PTV,ROI,SUN
176,916,COMPARABLE,DCA,MLC,NOVALIS,QUALITY,SRS,STUDENT,THESE,USING
177,III,OAR,SIMILAR,SINCE
018,177,956,DIREXGROUP,DVH,LINAC,MLC,OAR,ODYSSEY,PERMEDICS,PLANS,PRECISE,PTV,SEVENTEEN,SRS,SYNERGY,TPS
00001,044,050,082,177,395,AVERAGE,AVR,COMPARING,CYBERKNIFE,GAMMA,KNIFE,LEKSELL,PERIPHERAL,RTOG_CI,V12
PAN
175,177,916,AFTER,BACKGROUND,BMD,CONTEXT,IGF,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS
001,003,004,005,007,015,017,026,038,047,497,AFTER,BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,OUTCOME,PAS,PRE,RESULTS,TORONTO,WESTERN
000,015,745,781,789,967,BACKGROUND,LABEL,METHODS,MVS,PAS,PGCCS,POLYPLOID,RESULTS,THERE
150,206,BACKGROUND,BETWEEN,CTX,DESPITE,HOWEVER,LABEL,METHODS,MRI,PRE,RESULTS,RPA,RTX
DIFFUSION,DNETS,HOWEVER,IMAGING,MRI,RESONANCE,TYPICAL

169,ANG,BBB,BCM,BMECS,BREACHING,BRITAIN,COPYRIGHT,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,TNBCS,TREATMENT,USING,WILEY
ATT20,CUL4A,GH3,HOWEVER,MTT,TRANSWELL
160,CPG,PSQ,STUPP,USING
BACKGROUND,CONCLUSION,DIPGS,FURTHER,ITALY,LABEL,MARCH,MARGHERITA,METHODS,PEDIATRIC,PFS,RESULTS,SEVERAL,TMZ,TURIN,VCR,XRT
NEGLECTING
001,005,026,029,079,133,138,314,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS
111,251,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PCV,PFS,PURPOSE,RESULTS,STATE,THERE
169,AKT,AMP,COA,DESPITE,HOWEVER,INSTEAD,WHILE
AFTER,BRAIN,MAY,MRI
169,1970S,COPYRIGHT,INC,SINCE
BACKGROUND,CLASS,DESPITE,EMT,GBM,HOWEVER,HSP90,LABEL,METHODS,PI103,RESULTS,TMZ,TREATMENT
169,954,AUTHORS,FINALLY,HOWEVER,LTD,MMP,PTY,PUBLISHING,SCIENCE,SHG44,TAKEN,THEREFORE,U87,WILEY
169,COPYRIGHT,MRI,PRIMARY,PUBLISHED,SAS
169,172,954,BACKGROUND,BRITISH,FUNCTIONAL,LABEL,OPIOIDS,SOCIETY,THESE,UNLABELLED
ANY,AVAGLIO,BELOB,CENTRIC,GLARIUS,III,MRI,PFS,PHASE,REGAL
CBM,HOWEVER,LABORATORY,THEREFORE,THESE,VARIOUS,VIDEO
001,101,174,2B3,BBB,BRAIN,DOXIL,EFFECTIVE,FVB,OVERALL,TWICE,U87MG
160,BRAIN,FLAIR,MRI
116,169,263,379,600,AMIFOSTINE,AMONG,BACKGROUND,CHANG,LABEL,METHODS,NEURO,NEWLY,PRESS,PUBLISHED,RESULTS,SCALE,SOCIETY,UNIVERSITY
114,119,120,176,211,424,BEGINNING,HOWEVER,RISKS,SWEDISH
AVOIDANCE,BACKGROUND,HEUBNER,LABEL,METHODS,RESULTS,SYLVIAN
ABSENCE,MRI
200,BACKGROUND,BECAUSE,CONCLUSION,CONTEXT,EUS,FNA,FURTHER,HOWEVER,LABEL,METHODS
100,946,THESE,USING,VAL600GLU
00016,166,177,230,BACKGROUND,BRAIN,LABEL,METHODS,RESULTS,TEN
252,946,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI
ATLAS,GBM,ID1,ID2,ID3,ID4,THESE
169,946,948,AKT,APART,COPYRIGHT,FGR,FYN,HOWEVER,LYN,SRC,TAKEN,TYR,Y1073,Y1112,Y1176
137,169,222,23A,ABCG2,BACKGROUND,BAX,BCL,COPYRIGHT,DIFFERENT,LABEL,MDR,METHODS,MICRORNAS,PCR,RESULTS,THESE,USING
169,177,BIOLOGY,COPYRIGHT,FEDERATION,HAUSDORFF,INC,MHD,PATIENT,PUBLISHED,ULTRASOUND,WORLD
169,BACKGROUND,CONCLUSION,COPYRIGHT,CURRENT,DIAGNOSES,FIFTY,INC,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROCEDURAL,RESULTS
101,10A,10B,137,169,182,20A,221,222,26A,27A,330,34A,COMPARING,COPYRIGHT,FEDERATION,GBM,III,MICRORNAS,PCR,PUBLISHED,SEVERAL,SOCIETIES
160,169,215,638,772,830,930,ADC,CHO,CONCLUSION,COPYRIGHT,DWI,HPC,III,LABEL,METHODS,MRS,NAA,OBJECTIVE,PUBLISHED,RESULTS,SAS,THREE
145,164,169,COPYRIGHT,ICU,INC,JANUARY,LABEL,METHODS,OBJECTIVE,PREVENTION,PROLONGED,PURPOSE,RESULTS
007,022,117,160,169,ALA,COPYRIGHT,EOR,GBM,LABEL,LTD,METHODS,MRI,OBJECTIVE,PFS,RESULTS,TOTAL
169,COPYRIGHT,FINALLY,FIRST,HOWEVER,LTD
169,183,199,200,206,211,322,336,652,655,659,714,AFTER,BACKGROUND,BETWEEN,BOEHRINGER,COPYRIGHT,DEC,FEB,FUNDING,GRADE,INGELHEIM,IQR,LABEL,LTD,METHODS,NINTEDANIB,NSCLC,PFS,RESULTS,SIMILAR
103,110,169,CARLO,COPYRIGHT,LTD,MCNP5,MONTE,Y09
169,COPYRIGHT,DESPITE,GLIOMAS,LTD,THEREFORE,TMZ,WORLD
BACKGROUND,CTV,D40,D60,D80,GBM,GROUP,GTV,INDIVIDUAL,LABEL,METHODS,PTV,RADIATION,RESULTS,STUDENT,THERAPY,THESE
FURTHER,VIRAL
169,945,ASSESSMENT,GBM,IHC,LABEL,LTD,MER,MERTK,METHODS,OBJECTIVE,OLIG2,R132H,RESULTS,TMA,WILEY
215,COPYRIGHT,FURTHER,JADASSOHN,LATER,OPHTHALMIC,SLACK,THERE
OMICS,THESE,THOSE
DESPITE,EGF
001,OFTEN,PRIMARY
ACUTE,AFTER,AIP,ALT,AST,BAL,BLOOD,CHEST,CLINICIANS,FACTS,INSIGHT,LDH,NOVEL
125,177,956,BRAINSTEM,CED,COINFUSED,DIPGS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIMILARLY,VDS,WHILE
130,319,FURTHER,JANUARY,LABEL,METHODS,OBJECTIVE,PEDIATRIC,RESULTS
ATLAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
THESE,USING
111,177,946,CONCLUSION,FURTHER,LABEL,METHODS,PDGFR,RESULTS,SPECT,TARGETING,UNLABELLED
BECAUSE,FDG,HPV,METASTASES,OPSCC,PET
160,AMONG,BACKGROUND,CONCLUSION,JANUARY,KARNOFSKY,LABEL,LATENCY,METHODS,OBJECTIVE,PALLIATIVE,PURPOSE,RESULTS,THERE
ADC,CHO,DWI,LABEL,MATERIALS,METHODS,MRI,NAA,OBJECTIVE,PWI,RESULTS,TESLA
102,CD4,CD8,CSF,FURTHER,GFP,IGA,IGE,IGG,MALIGNANT,NOD,THESE
945
101,177,AFTER,CENTRAL,CNS,EIGHT,HIT,KNOWLEDGE,PBL,PFS,SEVENTEEN
169,COPYRIGHT,INC,MRI,MTT,NPS,PEG,PEGYLATED,THEREFORE
HOWEVER
124,12P70,169,ACTIVATED,CELLS,COPYRIGHT,DCS,HEMATOLOGY,HSP,HSP90,INC,JSI,PUBLISHED,SOCIETY,STAT3,TH1
001,022,036,043,BNP,JAK,JANUS,PULMONARY,RCA,TREATMENT,WILLEBRAND
169,APOPTOSIS,COPYRIGHT,E2F,HOWEVER,LNCAP,P53,PCR,TFDP3
100,GROSS,RESECTION
AFFILIATED,AFTER,ANATOMICAL,DEPARTMENT,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEN,SUN,THIRD,UNIVERSITY,YAT
169,COPYRIGHT,HOWEVER,INC,THESE
006,015,169,946,AFTER,CIT,COPYRIGHT,DEPRESSION,IRELAND,LTD,MDD,MRI,SCALE,SPECT,SSRIS
FOXC2,GBM,THESE
946,BAX,CD133,CYCD1,FURTHER,GSC,INHIBITION,MALIGNANT,MTT,PCR,THESE,WNT,WNT3A
169,COPYRIGHT,INC
EXTENSIVE,ROSENTHAL,THESE,V600E
025,038,569,DELAYED,FORTY,GAMMA,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
001,165,AIM,CONCLUSION,CRP,ESR,GBM,HGG,IHC,LABEL,LGG,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS
110,177,623,AIM,CONCLUSION,III,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
BRAIN,DESPITE,FURTHER
001,006,016,169,272,ADVERSE,AUTHORS,FLAIR,GRADE,III,LCP,LTD,MEIER,SALVAGE,SRT,WILEY,WORLD
005,008,169,AUTHORS,IPILIMUMAB,LTD,SEVENTY,WILEY
169,946,AUTHORS,BRAIN,DUE,INHIBITION,JAR,K252A,LTD,TREATMENT,TRK,WILEY
169,956,AUTHORS,DOCKING,HOWEVER,LTD,NBS,TUNEL,USING,WILEY

000,112,250,LAPATINIB,MBC,OTHER,PATIENT,PFS
945,AMONG,CONCLUSION,FURTHER,GFR,GLIAL,IHC,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
ALA,CD133,CSC,GBM
000,226,258,280,707,CNS,III,JANUARY,MRI,RELAPSE,TAILORING,WORLD
16A,954,ION,KNOCKDOWN,MMP,TMEM16A
3RD,4TH,5TH,III
4EBP1,GBM,MNK,REMARKABLY,SER,SER65,TAKEN,THR
CALORIC,THESE
DTI,EARTHQUAKE,GREAT,JAPAN,THESE
160,956,ATO,CD133,CODON,CSC,GBM,HOWEVER,R273H,U87,U87MG
134,160,CNS,COO,DLBCL,EASTERN,EBV,EPSTEIN,MYC,THREE
160,BAX,BCL,CASPASE,HOWEVER,KANK1
001,016,545,BACKGROUND,CONCLUSION,EXTENSIVE,JAPAN,LABEL,LIMITED,METHODS,RECIPIENTS,RESULTS,RISKS,SIR
131,BACKGROUND,BRAIN,CONCLUSION,GBQ,LABEL,MAY,METHODS,RESULTS,THERE
BECAUSE,DESPITE,THERE
110,190,210,390,956,CRL2522,GEL,STIMULI,THESE
III,LABEL,METHODS,MMP,OBJECTIVE,RESULTS,THESE,WORLD
AMONG,CUSHING,CVS,MRI,PATHOLOGY,VARIOUS
CONSISTENT,EAE,FAIM3,FINALLY,HOWEVER,IGM,TAKEN,UNRAVELING
BACKGROUND,CD3,LABEL,METHODS,MRI,ORBITAL,RESULTS
169,4EBP1,AKT,CAM,HOWEVER,III,INDUCIBLE,RAF,RAS,TSC,WESTERN
ACUTE,BACKGROUND,BLOOD,LABEL,MENINGITIS,METHODS
BACKGROUND,CASES,CENTRES,COMPLETION,CONTROL,HOWEVER,LABEL,LEEDS,MANCHESTER,METHODS,PREVALENCE,PRINCIPAL,RATIO,RESULTS,SUCCESSFUL,TREATMENT,TUMOURS
169,177,230,CONTINUOUS,COPYRIGHT,MIB,PCR,THERE,THESE,WORLD
ALA,ANG,BBB,HOWEVER,MRI,NIR,PEG,UCL,UCNPS
001,004,117,169,GBM,SOCIETY,TMZ
DHA,GLUT1,MALIGNANT
BCL,DARPP,INSP3,PKA,PP1
DESPITE,DISPERSION,GABAA,GABAERGIC
169,HOWEVER,NVP,OLIG2,OPPOSITION,PRESS
001,HOWEVER,LABEL,METHODS,MRI,MTF,OBJECTIVE,PURPOSE,RESULTS
000,169,ATR,COPYRIGHT,GLIOMAS,RBF,SVM,VCH,WILEY
BACKGROUND,CHILDHOOD,HEART,HOWEVER,JAPAN,LABEL,METHODS,NETWORK,ORS,RESULTS
ADDITIONAL
026,176,19Q,22033,26032,EORTC,HOWEVER,NDRG1,THERE,VALIDATION
HOWEVER
COX,HOWEVER,IE1,MEIER,PCR,THESE,USING
HOWEVER,MRI,RESULTS
5MC,TET
001,035,160,177,198,943,AMONG,EMT,GBM,HIGHEST,HOWEVER,IGF,INSULIN,MTT,PCR,THESE
169,COMPARISON,CONCLUSION,FORTY,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIMPLIFIED,WILEY
FDG,PET
324,PDT
169,COPYRIGHT,GIVEN,LTD,OBESITY,OBVIOUSLY
ACCORDING,HOWEVER,PGR,STAGE,TIS
AMONG,BRAIN,STAGE
ASCITES,HOWEVER,JANUARY
IIA,LIVER,RECURRENT,TOPICAL
PARTIAL,QOL
172,SEPTEMBER
169,19Q,BACKGROUND,GLIOMAS,III,LABEL,LNCR1,LNCR2,LNCR3,LOH,LTD,METHODS,REMBRANDT,RESULTS,SET,VARIATION,WILEY
169,COPYRIGHT,DDS,DTX,LTD,NG2,PBS,TAASGVRSMH
HMGA2,MICRORNAS,QUITE,RAF
HOWEVER,TGCTS
GELATIN,HEMOSTATIC,MRI
100,183,CONCLUSION,ELDERLY,FIFTY,FORTY,GEORG,GROUP,KARNOFSKY,KPS,LABEL,METHODS,MEYER,OBJECTIVE,PATIENT,RESULTS,STUPP,STUTTGART,THERE
946,CD133,CELLS,CHINESE,GBM,HSF,III,NANOG,PCR,THESE
001,008,108,206,COX,KARNOFSKY,KPS,MEIER,MIR,PCR
169,FURTHER,PRONEURAL,REMARKABLY,WHETHER
AFTER,TESTICULAR,THERE
053,080,160,967,AMONG,CNS,MEIER,SALVAGE,SRS
785,DECREASED,GBM,RAMAN,TEN,THREE
DIFFUSE,EGF,INHIBITION,THERE,USING
000,100,101,758,880,ASIAN
293,945,946,CBD,CONSISTENT,GLYRS,HEK,HOMOMERIC
022,GBM,HOWEVER,KARNOFSKY,KPS,SVZ
771,BACKGROUND,COMMERCIAL,FURTHER,LABEL,METHODS,RESULTS,SMR
ALK,ANAPLASTIC
CNS,GSC,MALIGNANT,THERE

169,COPYRIGHT,FURTHER,LTD,WHILE
169,COPYRIGHT,CRC,FUNCTIONAL,INC
169,4T1,CD11B,COPYRIGHT,ERK,INC,INCUBATION,SINCE,THESE
BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,COPYRIGHT,LTD,MINIMIZING,QUINONE,THESE
169,COPYRIGHT,INC
169,ACP,GIVEN,LABEL,LTD,METHODS,OBJECTIVE,OSTERIX,RESULTS,RUNX2,WESTERN,WILEY
177,DCE,LABEL,METHODS,MRI,OBJECTIVE,PCS,PURPOSE,RESULTS,ROC
003,021,025,028,049,ASCT2,ATP,BACKGROUND,CONCLUSION,GDH,GLYCOLYSIS,LABEL,MCT,METHODS,RESULTS,SDH
BACKGROUND,CONCLUSION,HOWEVER,IMPORTANCE,LABEL,METHODS,RECURRENT,RMG,RPA,THEREFORE
134,BACKGROUND,FIFTY,KARNOFSKY,LABEL,METHODS,OVERALL,RESULTS,SIXTY
ABDOMINAL,BACKGROUND,LABEL,METASTASES,METHODS,MRI,VATER
ANTICANCER,DESPITE,DUE
SAH,TREATMENT
ANALYSE,CONCLUSION,LABEL,MALDI,METHODS,OBJECTIVE,RESULTS,TOF,WCX
CNS,CSPG4,NG2,THESE,VBM
GBM,KARNOFSKY,KNOCKDOWN,SMALL,STAT3,THEREFORE,U87
018,020,022,248,HOWEVER,NORWEGIAN,OTHER,OVCAR,PFS,SEX,UNIVERSITY,WESTERN
000,ADDITIONAL,EUROPEANS,FUNCTIONAL,GIVEN,NPS,NUCLEOTIDE,SNP,USING
174,BACKGROUND,FURTHER,IMMEDIATE,LABEL,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOPCLOSURE
177,956,BICKEL3,CONCLUSION,DTATEGF,LABEL,METHODS,MTT,MVD,NSCLC,OBJECTIVE,PC9,RESULTS,SUBG0
707,BASAL,THESE
HOWEVER,R132H,THESE
100,169,312,ACADEMY,AMONG,CONFOUNDER,COPYRIGHT,GBM,HOWEVER,INC,JANUARY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OUTCOME,OVERALL,PUBLISHED,RESULTS,SCALE,SETTING,STUPP
GLIOMAS,HENCE,HOWEVER,HRQOL,PALLIATION,VARIOUS
GBM
CTV,GBM,GROUP,GTV,HGG,HOWEVER,LINAC,MRI,MRS,PET,RADIATION,SIB,THERAPY,THESE,TREATMENT
DIVERSE,MRI,MULTIMODAL
CHINESE,DESPITE,EORTC,JOURNAL,TREATMENT
169,COPYRIGHT,INC
169,277,769,912,939,BACKGROUND,HISTOGRAM,HOWEVER,III,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,WORLD
BACKGROUND,BRAGG,LABEL,METHODS,OAR,ORGAN,PBT,RBE,RESULTS,RMPBT,RMPBTRT
ATP,BACKGROUND,DEPLETION,ETC,GBM,HSR,LABEL,ND4,ND6,RESULTS,THESE,USING
LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,QUALITY,RESULTS
001,119,149,169,422PG,BASED,CONGESTIVE,COPYRIGHT,LTD,RECEIVING
001,014,169,210,COPYRIGHT,COX,GLIOMAS,III,INCREASED,KARNOFSKY,LTD,MEIER,PFS,SCORE,THERE,THESE,WORLD
ADDITIONAL,HOWEVER,JANUS,ROS,THEREFORE
149,FURTHER,GBM,HOWEVER,III,STRIKINGLY
1920S,SINCE,THESE,USING,WARBURG,WHETHER
169,COPYRIGHT,GBM,HIMRT,III,KARNOFSKY,KPS,LTD,SIX,THREE,TMZ
001,108,169,COPYRIGHT,COX,III,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,PCR,PURPOSE,RDX,RESULTS,THERE
169,BACKGROUND,BROCA,CONCLUSION,COPYRIGHT,DTI,LABEL,MATERIALS,METHODS,OBJECTIVE,PEAKS,PURPOSE,RESULTS,SAS,SMA,USING

CPA,EPIDERMOID,RESECTION

EXCELLENT,FOLLOWING
ANATOMY,HEARING,IAC,SPECIAL,VII
HOWEVER,LESIONS,STEALTH
STEPS
CPA,VII
GRADE,MRI,PATHOLOGY,VII
VII
CSF,FOLLOWING,IAC
CPA
DWI,EPIDERMOID,FLAIR,HOWEVER,MRI,SMALL,THESE,VII
CHOROID,CPA,CPP
ABCB1,ABCG2,BACKGROUND,C421A,DESPITE,FURTHER,GBM,HOWEVER,LABEL,METHODS,RESISTANCE,RESULTS,THEREFORE
WHILE
ADP,HOWEVER,JNK,QUERCETIN
001,ABSENCE,AMONG,BECAUSE,CONCLUSION,DYNAMIC,FET,FIFTY,INCREASING,LABEL,METHODS,NEITHER,PET,RESULTS,UNLABELLED,WORLD
AKT,BACKGROUND,CUSHING,IGF,INSULIN,LABEL,METHODS,OBJECTIVE,PCR,PI3,RESULTS,RHO,WESTERN
100,160,945,946,947,948,949,950,BTICS,EPO,GBM,HEMOGLOBIN,HOWEVER,M006X,M059J,M059K,PCR,UNDER
001,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTY
242,247,261,358,ALA,DIA,GUANGXI,PCR,SER,THESE,XRCC4
EPH,PROMISING
AKT,CELLS,ERK,JAK,REPORTEDLY,SINCE,ZSGREEN
503,AKT,FURTHER,GBM,HOWEVER,IGF,TAKEN,U87MG
100,177,946,AFTER,CD133,GSC,IDH,III,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,SHG,VEGFR
ACCORDING,BACKGROUND,CHO,CHOLINE,COMBINING,COMPARISON,CSI,DIAGNOSTIC,DICOM,GRADE,III,LABEL,METHODS,MRS,NAA,PRESS,RESULTS,SIMILAR
102,104,106,INTRA,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,THERE
FUNCTIONAL,FURTHER,GPR54,KISSPEPTIN,KPS
BACKGROUND,CONCLUSION,FAVRE,LABEL,OBJECTIVE,RACOUCHOT,RESULTS
BACKGROUND,BRAIN,LABEL,METHODS,RESISTANCE

AVERAGE,CHART,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,VITRECTOMY
196,BACKGROUND,CLASS,GIVEN,LABEL,NON,PRINCIPAL,RESONANCE,RESULTS
945,CD300LG,CD4,TAKEN,TNF,UNDER
155,EDU,GLIOMAS,HOWEVER,MAX,MTT,MYC,THESE,U87,USING,UTR
BACKGROUND,LABEL,METHODS,RESULTS,SMOKERS,USING
169,BRAIN,INC,WILEY
169,HEREDITARY,INC,WILEY
169,956,HOWEVER,MALDI,PARTICULAR,THESE,VCH,WILEY
169,BRAFV600E,FURTHER,INC,THESE,WILEY
169,BACKGROUND,CNS,INC,LABEL,METHODS,MRI,PROCEDURE,RESULTS,WILEY
169,BACKGROUND,CONCLUSION,FURTHER,GIVEN,HISTOLOGY,HPV,INC,LABEL,METHODS,RESULTS,SCC,T2N2BM1,WILEY
169,BACKGROUND,COX,FINALLY,HGG,LABEL,LGG,LOW,METHODS,PRESS,RESULTS
946,ADAM8,TNBCS
169,BASED,HOWEVER,INC,OVERALL,SUMMARY,THESE,WILEY
169,187,816,BACKGROUND,BRITISH,CIS,CONCLUSION,COX,GERIATRICS,LABEL,METHODS,PRESS,PTH,PUBLISHED,RESULTS,SERUM,SETTING,SHR,SOCIETY,THESE,UNIVERSITY
001,CD4,CD8,III,PERCENTAGE,PROGRAMMED,RESULTS,THESE
169,182,COMPARING,CULTURE,FIFTY,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,REGULAR,RESULTS,SOCIETY,STUDIES
BACKGROUND,CLASSICAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
523,DTI,PWI,TLL
100,BASED,CONGENITAL,MIB,MRI,NEOPLASTIC
946,AKT,AVAILABLE,BP1,COLLECTED,EIGHT,ERK,IGF,INR,MEK,PKB,RAS
DESPITE,GGS,TUMOURS
169,INC,MALIGNANT,WILEY
100,150,200,801,956,EAGLE,GBM,INHIBITION,MAJOR,MMP,MTT,NMDAR,U87MG
169,945,FIRST,HIF,HOWEVER,MVD,SIMILAR
001,002,003,007,016,029,038,DIFFUSE,EARLY,EPILEPTIC,HISTORY,OCCURRENCE,PATIENT,PROLONGED
120NM,169,BBB,COPYRIGHT,INC,LABEL,RAMAN,SURFACE,UNASSIGNED,UNLABELLED
169,375,COPYRIGHT,EMEND,LTD,NK1,PUBLISHED,TREATMENT
002,003,012,109,147,169,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,ENDOSTATIN,INC,KDR,LABEL,METHODS,NSCLC,REGARDING,RESULTS,THEREFORE
160,169,AUTHORS,COPYRIGHT,CSC,GBM,INC,JAM,NPC,PUBLISHED,TARGETING
169,AIM,COPYRIGHT,IRELAND,LTD,PKA
160,169,ACHIEVING,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,CSF,DISCUSSION,INC,JANUARY,LABEL,LDH,MARCH,METHODS,MONOCLONAL,MRI,RESULTS
169,BORON,BPA,BSH,LTD,WHEREAS
169,COPYRIGHT,LTD,METASTASES,SRS
169,COPYRIGHT,FDA,ISSUE,LTD,MENOPAUSE,SELECTIVE,SERMS,SPECIAL
169,AGE,AMD,AUTHORS,COPYRIGHT,FIRST,INC,PCR,PUBLISHED,THIRD
MRT,MULTI,NMS,RESOLUTION,WHILE
BILATERAL,MOLECULAR,THERE

EXCESSIVE,HORMONE,SECRETION,TREATMENT
945,MAJOR,MET,UNBIASSED
ADP,ATP,FINALLY,UTP
169,AVERAGING,BASED,GRN,III,MODEL,REGULATORY,RWR,USING
FINALLY,HOWEVER
CONCLUSION,LABEL,METHODS,MRT,OBJECTIVE,RESULTS,THEIR
AMONG,EPIGENETIC,INHIBITION,NOTCH
142,BASED,FUNCTIONAL,NETWORK,PEARSON,SP1,TFS,THESE,THROUGH
169,946,ANOTHER,COPYRIGHT,CROWN,FURTHER,INC,NODAL,PUBLISHED,SMAD2,SMAD3,TGF,THESE,WHILE
C19MC,EMBRYONAL,ETMRS,TTYH1
169,9CC,AFTER,BASED,COPYRIGHT,ECHELON,LTD,USA,USING,WHILE
BACKGROUND,DEPLETION,EXPRESSION,FOLLOWING,HOWEVER,IHC,INTERFERON,KNOCKDOWN,LABEL,METHODS,RESULTS,TRANSWELL
177,CONCLUSION,EFFECTS,GLASGOW,LABEL,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS,VII
BACKGROUND,CONCLUSION,CYTOTOXIC,LABEL,METHODS,RESULTS
022,041,174,485,AGE,FEMALES,FORWORD,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,BESIDES,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,PRIOR,RESULTS
ABRAXANES,APO,DEPOCYT,DOXIL,HOWEVER,LIPOSOMES,RGD,TAT
218,945,BECAUSE,GBM,HIF,JNK,RTK
001,169,289,551,818,946,949,AFTER,AMERICA,BACKGROUND,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,THROUGH,UNIVERSITY,WOMEN
049,088,102,104,437,ADDITIONAL,BACKGROUND,CONCLUSION,IOMRI,LABEL,METHODS,OBJECTIVE,PRE,RESULTS
EARLY,EVALUATION,FLT,MRI,PET
300,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS,SIX,THREE,WHOLE
169,217,AMONG,COMTE,CONCLUSION,COPYRIGHT,EPIDERMAL,FRANCHE,IQR,LABEL,LTD,MBC,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
169,HOWEVER,MRI,PRE,SAS,THEREFORE
082,BACKGROUND,CURRENT,EPIGENETIC,FGFR2,GADD45Y,GNAS1,LABEL,METHODS,PAS,PITUITARY,RASSF1A,RB1,RESULTS,SCHOLAR,SEVERAL,SIXTEEN,THREE
100,CAG,CTG,DM1,SLIPPED,THESE,WHILE
HIF,NDRG1,RESISTANCE
BECAUSE,BMI,DESPITE,THESE
945,ATLAS,BACKGROUND,BTSCS,CONCLUSION,HIF,HOWEVER,IDH,LABEL,METHODS,MUTATIONS,RESULTS,SILENCING,SLC16A3,WARBURG
001,388,430,444,467,555,961,AFTER,BACKGROUND,COMPELLING,HODGKIN,HOWEVER,LABEL,METHODS,PCR,RESULTS,RTL,STRATIFIED
169,CD133,CSC,EGF,HOWEVER
LNCAP,PCA,PCR,PNT1A,THESE
DESPITE
169,ATM,CURRENTLY,DDR,DSB,INHIBITORS,LABEL,METHODS,NOTABLY,NVP,OBJECTIVE,PURPOSE,RESULTS,THESE,U87
AIP,AMP,HOWEVER,PITUITARY,RET
CD133,CSS,MET,WORLD
160,BIOMARKERS,CNS,CURRENTLY,HOWEVER,MALIGNANT,THEREFORE
002,187,195,302,308,388,690,BACKGROUND,COX,CRC,HOWEVER,LABEL,MEIER,METHODS,RESULTS,USING
123,131,160,174,276,600,AMONG,ASSESSMENT,DOSIMETRY,EXM,HYP,LEVEL,MBQ,ORGAN,TGC
AMONG,BBB,BRAIN,METASTATIC,SINCE,TJS
RAMAN
169,COPYRIGHT,MEDICINES,MEK,RAF,SAS,STUDIES
169,BRAIN,CERTAIN,MYASTHENIA,PRE,PREGNANCY,VARIOUS
169,CAREFUL,NEUROLOGIC,SINCE
169,THERE
169,BACTERIAL,DECREASING,NEUROLOGIC
169,945,CNS,HOWEVER,NEUROLOGIC,PERIPHERAL,REGARDING,SEVERAL
169,NEUROLOGY,THEREFORE
169,BRAIN,MRI,OVERALL,SEVERAL
169,246,MONOCLONAL,NEUROLOGIC,PERIPHERAL,POEMS,WALDENSTR
169,EARLY,EATON,LAMBERT,METASTASIS,NEUROLOGIC,THERE
169,AUTHORS,COPYRIGHT,LTD,NPY,PUBLISHED
123,169,ASL,AUR,BRAIN,CNS,COPYRIGHT,DIFFUSION,EXTENSIVE,INC,LABEL,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESTRICTED,RESULTS,VARIOUS
IHC,MRI,OCTOBER,REMOVAL

300,FIRST,FUNCTIONAL
AFTER,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,RCC
FINALLY,GSH,NADPH,ROS,WHILE
AFTER,BECAUSE,CASES,GBM,HISTOLOGY,MARCH,MRI,STUPP
EVERY,III
169,AFTER,FRACTAL
CONSISTENT,EGF,EPIDERMAL,GBM,MET
160,BACKGROUND,BESIDES,CONCLUSION,LABEL,METHODS,RESULTS,THESE
12YEARS,169,60YEARS,7DAYS,CONCLUSION,COPYRIGHT,CURRENT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL,SOCIETY,UNLABELLED
169,BACKGROUND,CONCLUSION,COPYRIGHT,EXCELLENT,GENERAL,GLIOMAS,LABEL,METHODS,NIR,NPS,PEGYLATED,PROMINENT,RESULTS,ROS,THEIR
130,169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OVERALL,RESULTS,THESE
001,004,007,012,021,160,169,440,ALK,AMONG,BACKGROUND,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,PRIMARY,RESULTS,THERE,THESE,TOTAL
024,037,049,100,108,110,129,134,169,211,214,243,250,285,288,340,369,395,421,437,538,548,614,788,AFTER,BACKGROUND,BRAIN,CBA,COPYRIGHT,CSF,DISORDERS,DUTCH,ERASMUSMC,FONDO,FUNDACI,FUNDING,GLUN1,INSTITUTES,LABEL,LTD,MARAT,METHODS,RESULTS,SAMPLES,SANITARIAS,SCALE,SERUM,SOCIETY,THESE,TV3
181,COLLEGE,CONCLUSION,LABEL,LEAKAGE,MEDICAL,METHODS,MINIRIN,OBJECTIVE,PITUITARY,RESECTION,RESULTS,SPECIAL,UNION
AMONG,CONCLUSION,DIGITAL,DSA,LABEL,MCCORMICK,METHODS,OBJECTIVE,RESULTS,THREE
AMONG,BECAUSE,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
470,517,5H1,BACKGROUND,CD274,CD279,CD8,KRUSKAL,LABEL,METHODS,NAT,PCNSL,PD1,PRIMARY,PROGRAMMED,RESULTS
III,SEVERAL,TESTING,THEREFORE
CYRUS,DORMANT
BACKGROUND,BAK,BAX,BCL,BID,BIM,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
160,AFTERWARDS,BACKGROUND,CAUCASIAN,CENTRAL,DESPITE,HISTOLOGY,LABEL,METHODS,THEREFORE
177,215,240,278,956,ACT,BMG,GACL3,HEK,MBQ,PBS,STERN
182,214,BACKGROUND,DESPITE,GLIAL,GLIOMAS,HUNGARY,INSTITUTE,LABEL,MEDICAL,METHODS,PATHOLOGY,RESULTS,SCIENCE,THERE,UNIVERSITY
127,ACCORDING,BACKGROUND,FINALLY,LABEL,LOW,METHODS,RESULTS,THESE
ACCORDING,FURTHER,GP2,IDENTIFIED,ITGB1,KCNG2,KIR3DL3,PCR,PDE4D,PROS1
001,685,ALTOGETHER,BECAUSE,SRC
CCK,HOWEVER,PCR,TRANSWELL,U87MG,WESTERN
946,AMONG,ATLAS,BACKGROUND,CELLS,EMT,GSK,IHC,LABEL,METHODS,MGS,MMP,PCR,RESULTS,SNAIL,TGF,YKL
183,BACKGROUND,GEORG,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUTTGART,THERE,THIRD,WORLD
183,BACKGROUND,DIFFERENT,GEORG,LABEL,METHODS,OBJECTIVE,STUTTGART
CEREBELLUM,CHANGES,CONCLUSION,EVN,EXTRA,GTR,INCREASED,LABEL,LOBAR,METHODS,OBJECTIVE,RESULTS,STR
946,BACKGROUND,CD133,EARLY,LABEL,MATERIALS,METHODS,OVERALL,PAPCP,PCR,PROMININ1,RESULTS,TSC,WNT
100,215,378,751,768,BACKGROUND,BETWEEN,CONSORTIUM,KARNOFSKY,KPS,LABEL,METASTATIC,METHODS,OVERALL,PFS,RCC,RESULTS
ERBB2,HIPPO,HOWEVER,ILK,INHIBITION,LATS1,MYPT1,PDZ,PP1,TAZ,YAP,YES
BTICS,FOXG1,GBM,GROUCHO,THESE,TLE
177,AFTER,BACKGROUND,DESPITE,EIGHT,ENGEL,FUNCTIONAL,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS
169,COPYRIGHT,FIRSTLY,HOWEVER,OTHERWISE,PITUITARY,SAS
169,COPYRIGHT,CRH,CUSHING,HOWEVER,MRI,SAS
000,001,002,012,022,039,129,169,177,956,ATP,BACKGROUND,BASEL,CAB,FASTING,III,LABEL,METHODS,PRL,RESULTS
169,COPYRIGHT,INC,U87
229,946,ATLAS,LNT,REMBRANDT,TGF,U87MG
107,209,309,BACKGROUND,BETWEEN,LABEL,METHODS,RESULTS,SRT,THESE
002,169,333,390,AMONG,COPYRIGHT,COX,ELDERLY,END,GRADE,GTR,HOWEVER,III,LTD,RESULTS,TREATMENT,USA,WORLD
169,COPYRIGHT,CSF,EARLY,IMAGING,LTD
AFTER,CAD,DEFINITIVE,DIG,FURTHER,MRI
177,CNS,MPNST,MRI,OTHER
ASIAN,DURAL,IMAGING
AUTOPSY
AFTER,WHILE
169,ARRAY,INI,LSAMP,SOCIETY,V600E,WORLD
169,AVM,BRAGG,JAMES,LINDA,MEDICAL,TREATMENT,UNIVERSITY,WHILE
169,CES,III,LOW,MRI,SOCIETY,WHILE
169,MITOTIC,SCHERER,SOCIETY,THESE
AFTER,AVAGLIO,GBM,PFS
BASED,CNS,GBM,HUNGARY,SEMMELWEIS,TIA,UNIVERSITY
MANAGEMENT

138,210,COMPARING,EORTC,HUNGARIAN,HUNGARY,III,RPA,SERIOUS,SEVENTY,STUPP,THESE,UNIVARIATE

19Q,946,BESIDES,DESPITE,IDH,THESE
GLIOMAS,WESTERN
001,003,006,19Q,AFFYMETRIX,AOS,BACKGROUND,CONCLUSION,HOWEVER,IDH,LABEL,METHODS,MRI,RESULTS
DIAGNOSIS,EXTENSIVE,HISTOLOGY,MOLECULAR,MRI,V600E
150,DERMATITIS,EPIDERMAL,GBM,III,KARNOFSKY,KPS,PATIENT,PFS,THERE
032,160,486,916,AKT,ANOVA,DETECTION,GAPDH,GBM,INSULIN,LIVAC,PCR
169,CAR,CONCLUSION,FINALLY,HOWEVER,LABEL,METHODS,NEG,OBJECTIVE,PURPOSE,RESULTS,SELECTIVE
AKT,DROSOPHILA,NOTCH,NSC,PINK1
GBM,HOWEVER,WHILE
LABORATORY
ATP,CSA,STUDIES,THERE,THESE,THROUGH
160,ANCIENT,EGYPT,MOUTH,TEETH,THOSE,TOOTH
005,050,23294,323,CAUCASIAN,COX,FURTHER,HAPLOTYPE,RHO,ROCK1,ROCK2,WHETHER,WOMEN
ACCORDING,AFTER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LAPATINIB,METHODS
889,ADC,CBF,CBV,CHO,CONCLUSION,DSC,DTI,FORTY,HGG,LABEL,LGG,METHODS,MRI,MRS,OBJECTIVE,RESULTS,SIXTY
AKT,AMONG,THESE
GBM,IDH,SERUM,SMA
123,309,BMJ,COGNITIVE,GRAFTED,GROUP,HUNTINGTON,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PUBLISHED,PUBLISHING,RESULTS,SCALE,UHDRS,UNIFIED
169,AUTHORS,INC,PUBLISHED,WILEY
001,118,950,986,CHINESE,HOWEVER,ISI,KNOWLEDGE,OCTOBER,SCIENCE,WANFANG,WEB
AFTER,RCC
005,009,169,INC,MYC,U87MG,WESTERN,WHILE,WILEY

169,218,CONCLUSION,COPYRIGHT,DYNAMIC,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
251,F10,GBM,SNB
133,AKT,AMONG,ATLAS,LCM,STAT1,THESE,WHILE

BACKGROUND,CPG,EXPRESSION,LABEL,LOW,METHODS,RESULTS
ALTERED,CRE,DCC,REDUCTION,UNDERLYING,USING,VARIATIONS
169,ALZHEIMER,COPYRIGHT,HOWEVER,INC,NEURONATIN,UNDER
GEL,THESE,XRS
091,BACKGROUND,BRAIN,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,USUAL
003,169,AMONG,PXA,SOCIETY,V600E,VE1
ECS,MALIGNANT
169,AUTHORS,LTD,PTY,PUBLISHING,SCIENCE,WILEY
177,BACKGROUND,BONFERRONI,CSI,DOSIMETRIC,ECLIPSE,HOWEVER,LABEL,METHODS,MFO,PLANS,PSW,PTV,RBE,RESULTS,STUDENT,V95,WHOLE
131,177,293,578,99M,AFTER,CONCLUSION,EMI,GGG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RRL
001,027,AMONG,CDC2B,CSI,DFS,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TISSUES
169,ACC,AUTHORS,BRAIN,DLPFC,HOWEVER,INC,MAPPING,PFC,PUBLISHED,WILEY
164,AUSTRALIA,CONCLUSION,DEPRESSION,DSM,LABEL,MDD,METHODS,OBJECTIVE,PCA,QUEENSLAND,RESULTS,SCALE,THERE,THESE,TREATMENT
000,047,AFFILIATED,CHINA,CONCLUSION,III,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PROVINCIAL,RESULTS,UNIVERSITY
154,238,268,352,446,506,BACKGROUND,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,THERE
200,946,CAV,GAG,GM2,GM3,MPS,RIGIE,THERE,THESE,VII
SOMATIC,STUDIES
169,945,AFTER,COPYRIGHT,GBM,IRNPS,LTD,RGD
ATM,HOWEVER,III,PUBLISHED,WHILE
014,169,BRITISH,CIS,GALBRAITH,HOWEVER,LABEL,METHODS,NSAID,OBJECTIVE,RESULTS,SEPTEMBER,SEVERAL,SOCIETY,STUDIES,TEN
CERAXON,CITICOLINE,FREQUENCY,ICU,NYCOMED,THESE
DOPPLER,USING
042,967,BACKGROUND,BIOLOGICAL,END,EOR,FACTORS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SHARP
916,ACCORDING,ITT,OST,SST
00004,009,169,177,CONCLUSION,CVR,INC,LABEL,MATERIALS,METHODS,MOTOR,MRI,NVU,OBJECTIVE,PURPOSE,RESULTS,WILEY
4KR,CELLS,GTP,HOWEVER,MAMMALIAN,ONCOGENIC,RAS
233,DANDY
306,950,AUSTRALIAN,CASES,CBT,CHILDHOOD,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE
129,818,935,953,AUC,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESENTING,PUBLISHED,RESULTS,ROC,THESE,UNIVARIATE,USING
001,016,021,046,BACKGROUND,CONCLUSION,DTI,FINALLY,GLIOMAS,LABEL,METHODS,OBJECTIVE,PWI,RESULTS,THESE
CLOSE,FLAIR,HOWEVER,MRI
19Q13,CNS,EBL,THESE,THREE
231,ALTOGETHER,MCF,MDA,VGSCS,VOLTAGE
ACCORDING,AIM,BACKGROUD,BRM,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,PPL,RESULTS,UNLABELLED,WHILE
AKT,NOTABLY,SMARCA4,THERAPIES,TMZ
HOWEVER,PCR
095,212,477,492,AMONG,BACKGROUND,CIS,CONCLUSION,GREATER,HRS,INSTITUTES,LABEL,METHODS,RESULTS,SMOKING
100,AFTER,ALA,BACKGROUND,CONCLUSION,DEPENDING,IXPPV,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,UNRESECTED,WORLD
004,235,ACTUARIAL,BACKGROUND,CONCLUSION,FACTORS,HBS,LABEL,METHODS,OPTIMAL,RESULTS,SEVEN,SRS,TEN,VHL
012,BACKGROUND,BETWEEN,CONCLUSION,FOLLOWING,GBM,HSPPC,LABEL,METHODS,OCTOBER,OUTCOME,RESULTS,SECONDARY,THERE
AGILENT,APPLIED,BACKGROUND,BIOSYSTEMS,CONCLUSION,FLA,LABEL,METHODS,PCR,RESULTS,STR
11P,126,19Q,BACKGROUND,CHROMOSOME,CONCLUSION,DIFFUSE,FURTHER,IDH,LABEL,METHODS,NOVEL,RESULTS
BACKGROUND,BECLIN1,CONCLUSION,LABEL,LC3,METHODS,RESULTS,U87
112,162,166,177,328,BACKGROUND,EFS,GROUP,LABEL,METHODS,PEDIATRIC,PROLONGED,RADIATION,REGIMEN,RESULTS,WHILE
010,11C,889,955,ATP,COMBINING,EGF,GBM,IHC,MRI,PET,ROI,THERE,TKI
115,120,A12,BACKGROUND,CXCR4,INHIBITION,LABEL,METHODS,MRI,NOX,RESULTS,SDF
CAPILLARY,CNS,HGB,MOLECULAR,SEVEN,SOMATIC,TISSUES,VHL
FOLFOX6,LABORATORY,STAGE,XELOX
DESPITE,GABAERGIC,HOWEVER,SEVERAL,THESE
BRAIN

169,AZA,CCND2,COBRA,COPYRIGHT,EPIGENETIC,IRELAND,LTD,PCR,THESE,WNT
169,AUTHORS,COPYRIGHT,DEVELOPING,FGF,GBM,HOWEVER,IRELAND,LTD,PUBLISHED,THEREFORE
169,BASED,COPYRIGHT,DDS,EVENTUALLY,FURTHER,PARKINSON
169,AGA,COPYRIGHT,HOWEVER,INC,INSTITUTE,LYNCH,MMR,MSI,PUBLISHED
169,COMPOUNDS,COPYRIGHT,NCI,PALLADIUM,SAS,THESE
169,COPYRIGHT,FINALLY,GOLGI,III,LTD,REMARKABLY,STRIPAK,THESE
169,945,AML,BPTES,CELLS,COPYRIGHT,HEMATOLOGY,IDH,INC,PUBLISHED,SOCIETY,THESE
169,BASED,COPYRIGHT,CYBERKNIFE,DOSIMETRIC,HOWEVER,INC,MARCH,MEDICAL,PUBLISHED,SEPTEMBER,SEVERAL,VSI
169,233,COMPANY,COPYRIGHT,JANUARY,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,OCTOBER,ONCOLOGIE,PEDIATRIC,PUBLISHED,RADICAL,RESULTS,SEVENTEEN,SIXTEEN,UROLOGY,WILMS
169,60MIN,7CM,BSA,LTD,MULTIFORME,PUBLISHED,SHAPING
169,824,ACCORDING,ACUTE,CARDIAC,COPYRIGHT,DWI,FLAIR,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OTHER,RESULTS,TOAST
169,408,AUSTRALIAN,COPYRIGHT,GBM,GSM,HENCE,HOWEVER,LTD,PRIMARY,WESTERN
102,169,AFTER,BETWEEN,COLLEGE,COPYRIGHT,DOSES,GRADE,III,LABEL,LEVEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,ROYAL,THESE,THREE
169,CLINICALLY,COPYRIGHT,EPIGENETIC,GBM,HMGA2,HOWEVER,INC,ORTHOTOPIC,UTR
169,COMPARISON,COPYRIGHT,DM1,DM2,NMD,PCR,SSBP3,STRIKINGLY,WHILE
169,19S,AFTER,CD8,COPYRIGHT,HPV,HPV16,INC,RA190,RPN13
004,10878,169,50GYE,8GY,APRIL,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,EFFECTS,GROUP,GYE,IRELAND,JANUARY,LABEL,LTD,MANAGEMENT,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SUBJECTIVE,THERAPY,TREATMENT,V50
169,177,ANOVA,BACKGROUND,CONCLUSION,COPYRIGHT,GPC,IRELAND,LABEL,LTD,METHODS,MRI,MRS,PUBLISHED,RESONANCE,RESULTS
001,004,106,169,265,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MVA,OBJECTIVE,PFS,PURPOSE,RESULTS,RPA,SRS,THERE,UNIVARIATE
001,008,010,036,048,169,AFTER,COMPETING,COPYRIGHT,COX,INC,KARNOFSKY,KPS,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SRS
BACKGROUND,DESPITE,IRELAND,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SAD,THESE
169,BRAIN,COPYRIGHT,LTD,MRI,PRIMARY
166,169,BACKGROUND,CLEVELAND,CNS,CONCLUSION,COPYRIGHT,CURRENT,GPA,INC,LABEL,MATERIALS,METHODS,RCC,RESULTS,SRS
ACUTE,CELSIUS,CUSHING
169,GBM,HAIFA,INC,LTD,MEDIA,NOVOTTF,PUBLISHED,SINCE
160,169,ALZHEIMER,CANDIDATE,CLINICIANS,FURTHER,INC,THERE,WHILE
169,224,233,COPYRIGHT,ENGEL,GROSS,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,PATIENT,PHYSICIANS,PRESS,RESULTS,UNIVERSITY
CARDIAC,CAUCASIAN,TEX,THEREFORE
160,265,BACKGROUND,BESIDES,CUMULATIVE,DVH,EUD,HOWEVER,LABEL,METHODS,OAR,RESULTS,USING
001,CGH,CNV,EGF,GBM,HGF,HPRT1,INHIBITOR,PCR,RESULTS
945,BACKGROUND,CONCLUSION,EGF,EPIDERMAL,ERBB1,ERBB2,EXPRESSION,FINALLY,INHIBITION,JNK,JUN,LABEL,METHODS,RESULTS,RNASE,U87,UPR
BIFRONTAL,ICU,LABEL,LMS,METHODS,MRI,OBJECTIVE,RESULTS
106,INDIVIDUAL,LABEL,METHODS,MRI,OBJECTIVE,OUTSIDE,RESULTS
034,143,HOWEVER,LABEL,MEIER,METHODS,MINOR,MRI,OBJECTIVE,OVERALL,RESULTS,THERE,TOTAL,TSS
169,ACCORDING,AGAINST,BASED,DNT,EEG,FCD,INC,MRI,WILEY
109,157,169,179,492,AGAINST,FCD,INC,PARTICULAR,WILEY
169,AGAINST,CURRENT,INC,WILEY
169,AED,AGAINST,AMONG,BASED,BECAUSE,BETWEEN,HOWEVER,INC,RESECTION,SEVERAL,THEREFORE,WILEY
169,AGAINST,HOWEVER,INC,MRI,SURGERY,THESE,TUMORAL,WILEY
169,ADDITIONAL,AED,AGAINST,CLASS,DISCORDANT,EEG,INC,MRI,NEWER,RADICAL,SCALP,WILEY
169,AGAINST,INC,THEREFORE,WILEY
169,235,AGAINST,DRAWING,ENGEL,IIA,III,INC,OVERALL,RESECTION,SEIZURE,TUMORAL,WILEY
169,AGAINST,DEPTH,INC,WILEY
169,AGAINST,EEG,ETS,FOLLOWING,INC,MRI,THERE,TRE,WILEY
169,AGAINST,HOWEVER,INC,TYPICAL,WILEY
169,AGAINST,EEG,INC,VIDEO,WILEY
169,AGAINST,DTI,ECS,EEG,FET,FUNCTIONAL,ICTAL,INC,MET,METHIONINE,MRI,PET,REPETITIVE,SPECT,TMS,WILEY
169,AGAINST,INC,MRI,THESE,WILEY
169,AGAINST,CURRENT,INC,WILEY
169,947,AGAINST,BECAUSE,FINALLY,GABAERGIC,GLIOMAS,INC,LOCAL,WILEY
169,19Q,AGAINST,CPG,GIVEN,INC,OTHER,PROGNOSTIC,THERE,WILEY
169,AGAINST,DYSPLASTIC,FCD,INC,WHETHER,WILEY
100,169,AGAINST,DNETS,FOCAL,INC,RECURRENCE,REFRACTORY,WILEY
169,AGAINST,DESPITE,EPILEPTIC,HOWEVER,INC,SEVERAL,WILEY
169,AGAINST,CLEVELAND,COLLOQUIUM,GIVEN,INC,MAY,OFTEN,SIXTH,SURGERY,TRE,TUMORAL,WILEY
100,BACKGROUND,CNS,LABEL,METHODS,RESULTS,TREATMENT
BACKGROUND,DAI,DIFFUSION,LABEL,METHODS,MRI,RESULTS
BACKGROUND,GIC,HOWEVER,LABEL,METHODS,NKG2D,NOTABLY,RESULTS,THERE,THEREFORE,ULBP2
001,005,007,013,016,025,038,BACKGROUND,CONCLUSION,DOSAGES,ELISA,LABEL,METHODS,PFS,RESULTS
BRAIN,CNS,COGNITIVE,DTI,IMAGING,MRI,MRS,PET,STRUCTURAL,STUDIES,THESE
CELYVIR
001,246,333,BACKGROUND,CHEMOKINE,CONCLUSION,CXCR4,EXPRESSION,FIFTEEN,FREQUENCY,HOWEVER,LABEL,MCP,METHODS,RCC,RESULTS
100,160,181,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,RESULTS
16S,BACKGROUND,CONCLUSION,CUTANEOUS,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
BACKGROUND,FURTHER,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,USING
001,018,069,239,BACKGROUND,FEBRILE,LABEL,METHODS,OBJECTIVE,OVERALL,PARTIAL,RESULTS
169,ANIMALS,BPA,BSH,LTD,MV3,U87MG
001,BACKGROUND,COX,KARNOFSKY,LABEL,MEIER,METHODS,MIR,PCR,RESULTS,SLIDE,UNASSIGNED,VIRTUAL
004,028,034,115,169,19Q,19Q13,200,APEX1,BACKGROUND,COPYRIGHT,DESPITE,ERCC1,ERCC2,ERCC6,GENOTYPIC,GLN,HAPLOTYPE,LABEL,METHODS,PUBLISHED,RESULTS,THESE,XRCC1,XRCC3
CURRENTLY,ELDERLY,TMZ
19Q,HOWEVER,IDH,WORLD
92B,APOPTOSIS,BACKGROUND,FINALLY,HOWEVER,JUN,LABEL,METHODS,MIR,MTT,RESULTS,WNT
400,C30,CONCLUSION,EORTC,LABEL,METHODS,OBJECTIVE,QLQ,QOL,QUALITY,RESULTS,TREATMENT,WORSE
169,674,CSI,CTV,DAILY,LOCAL,PTV,SET,THERE,USING
001,177,BACKGROUND,BRAIN,CONCLUSION,DSC,LABEL,MATERIALS,METHODS,MRI,NEOPLASTIC,OBJECTIVE,PURPOSE,PWI,RESULTS
AMONG,BRAIN,CURRENT,FURTHER,INHIBITING,MMP
BACKGROUND,BMS,BRAIN,CONCLUSION,FIFTEEN,LABEL,METHODS,RESULTS
117,133,154,266,533,AFTER,AIM,CONCLUSION,GBM,III,LABEL,METHODS,OBJECTIVE,POH,RESULTS
956,ADP,AIM,ANTARCTIC,BACKGROUND,CONCLUSION,EXPRESSION,HOWEVER,LABEL,LOBARSTIN,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS
ANTIBODIES,BACKGROUND,CONCLUSION,EPIDERMAL,LABEL,MATERIALS,METHODS,PCR,RESULTS,SIMILARLY,THEIR
BACKGROUND,CNS,CONCLUSION,DESPITE,HB1,LABEL,MATERIALS,METHODS,RESULTS
180,956,AFTER,PVA,RAPID,SELECTIVE,SEPTEMBER
001,002,004,356,C4D,PLATELETS,PRIMARY,SECONDARY,SEVENTY,SLE
025,160,47E,55E,57E,63E,CCM,CNS,FOLLOWING,HIPPA,MRI,POTENTIAL,TAPIR,WRITTEN
177,CONCLUSION,DOSIMETRIC,LABEL,METHODS,OBJECTIVE,PEPTIDE,PURPOSE,RESULTS,THERE,TREATMENT
CONCLUSION,CURRENT,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SCANS,SUV,WHITE
160,174,176,557,963,AFTER,ART,BACKGROUND,CRYSTAL,LABEL,METHODS,OBJECTIVE,ORFIT,PATIENT,PURPOSE,RAYCAST,RESULTS,THERE
LABEL,NEWER,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,SUMMARY
AFTER,CUTANEOUS,LANGERHANS,LCH,MRI,TREATMENT,WHITE
160,169,245,295,586,ACADEMY,AFTER,BACKGROUND,CLINICALLY,COMPARING,CONCLUSION,CONTEXT,COPYRIGHT,COX,HOSPICE,INC,INITIATING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PEDIATRIC,PREMIER,PUBLISHED,RESULTS
EGT,PREVIOUSLY,PXA,THESE,V600E
169,ASSESSMENT,AWARD,CHO,COMBINING,CONCLUSION,COPYRIGHT,FDG,GRANT,HOWEVER,IMAGING,INSTITUTE,IRELAND,LABEL,LTD,MAXIMAL,METHODS,MRI,MRS,NAA,OBJECTIVE,OBJECTIVES,PET,RESULTS,ROC,SUPPLEMENT,SUPPORT,SVM,TEAMS,THESE,UNASSIGNED
169,945,BACKGROUND,CONCLUSION,FURTHER,HCC,HEP3B,HIF,HYPOXIA,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIMILARLY,THESE,WILEY
USING
176,946,CARLO,COMPARING,FINALLY,HOWEVER,LABEL,METHODS,MONTE,OBJECTIVE,PCC,PEARSON,PET,PURPOSE,REGARDING,RESULTS,ROTATIONAL,SETUP
177,CTV,DIRAC,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SETTING,SRS,TRILOGY,V80
110,177,ADDITIONAL,LABEL,METHODS,MRI,OBJECTIVE,PAM,PURPOSE,RESULTS,ULTRASOUND
AREAS,AVAGLIO,BACKGROUND,COVERED,EARLY,GBM,LABEL,METHODS,OPINION,ULTIMATELY
EBV,EPSTEIN,HIV,VIRUS
017,160,ADC,BLAND,CHANGES,DTI,FLAIR,GBM,NONLINEAR,RESULTS,SDS
MICRORNAS
ALA,CD133,INTRA,MDB,PRESENTING
169,252,BLOOD,BTB,CACCC,DEPLETION,HOWEVER,INC,PCR,SHORT,SP1,SP3,WESTERN,WILEY
001,160,164,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRM
508,EDU,EXPRESSION,LNCAP,MTT,RAS,TSC2A
169,COPYRIGHT,INC,LEEDS,UNIVERSITY,WILEY
CHEST,GADOLINIUM,JAPAN,MRI,OCCURRENCE,SHRINKAGE,SPE
HOWEVER,THREE
215,CONTINUOUS,SURGERY,THREE
001,002,009,012,021,022,026,528,572,BREATHING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
900,D52,PCR,STRONGEST,THESE,TPD52
FOLLOWING,HOWEVER,U87
ALTERED,MICRORNAS
000,031,219,225,234,502,640,736,791,946,979,BACKGROUND,CHART,CHF,COX,CRUDE,JAPAN,LABEL,METHODS,NCT,RESULTS
C19MC,EMBRYONAL,ETMRS,TTYH1
113,BACKGROUND,COLORECTAL,CONTENT,DCR,DIGITAL,JAPAN,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SIXTY,VIDEO
BRAIN,BTICS,NOTABLY,THESE,USING
169,BLINKIN,COPYRIGHT,EGF,HOWEVER,INC,S10,THESE
100,169,BSCMS,CONCLUSION,COPYRIGHT,HOWEVER,JANUARY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS
000,050,100,150,151,169,186,BBT,BZD,CIS,CONCLUSION,COPYRIGHT,HRS,INSURANCE,JANUARY,LABEL,MBT,METHODS,OBJECTIVE,RESULTS,SIMILARLY
000,003,036,169,177,181,AVERAGE,COPYRIGHT,FURTHER,INC,LABEL,METHODS,OBJECTIVE,OCT,PUBLISHED,RESULTS,SOCIETY,STRATUS,TEN
160,169,AGE,AHS,AMMON,BACKGROUND,EAN,HOWEVER,JOURNAL,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PURPOSE,RESULTS,TLE
169,KARNOFSKY,KPS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,UNIVERSITY,WILEY
001,150,173,177,GTR,LABEL,METHODS,OBJECTIVE,QALYS,QUALITY,RESULTS,SIMILARLY,SINCE,WHILE
CONCLUSION,EMBOLIZING,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE
177,181,491,JANUARY,LABEL,MARCH,METHODS,NORTH,OBJECTIVE,OCTOBER,RESULTS,STOKE,TRENT,UNIVERSITY
BACKGROUND,CONCLUSION,GTD,LABEL,METHODS
FINALLY,UPGRADE
001,006,CONCLUSION,GAMMA,GBM,GKS,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,UNTREATED
GBM,KNOCKDOWN
001,009,499,AMONG,BACKGROUND,CONCLUSION,COX,DISEASE,GERMANY,LABEL,LDH,MEIER,METHODS,PROGNOSTIC,RESULTS,S100B,SERUM,TUEBINGEN
GSC,MTT,SEL1L,TARGETING,UPR,VPA
294,BACKGROUND,III,LABEL,LEV,METHODS,PGB,RESULTS,RETENTION,SEVEN
19Q,408,64257,64258,BACKGROUND,CODELETION,CONCLUSION,HOWEVER,LABEL,LOH,MAY,METHODS,PFS,REFERENCE,RESULTS,THREE
001,034,149,672,BACKGROUND,BRIER,CONCLUSION,GPA,INDIVIDUAL,LABEL,METHODS,OCTOBER,OPTIMAL,RESULTS
100,4T1,946,956,ALCAM,BACKGROUND,CNS,GFP,HOWEVER,LABEL,METHODS,RESULTS,THESE,VLA
001,003,100,112,270,BACKGROUND,CSI,FORTY,LABEL,METHODS,OVERALL,RBE,RESULTS,VERTEBRAL
BACKGROUND,CONCLUSION,CONTINUOUS,DUE,FORTY,IDENTIFIER,KIT,LABEL,METHODS,PFS,RESULTS,SECONDARY
BACKGROUND,CSC,DESPITE,GBM,HOWEVER,LABEL,METHODS,RESULTS,THESE,TMZ,XRT
947,AZD2014,BACKGROUND,BASED,CD133,FINALLY,GBM,GIVEN,GSC,LABEL,METHODS,ORTHOTOPIC,RESULTS,THESE,WHEREAS
BACKGROUND,BT183,C19MC,CNS,EMBRYONAL,ETMRS,FUNCTIONAL,IGF,LABEL,LIN28,METHODS,RESULTS
037,177,945,BACKGROUND,BVZ,CONCLUSION,CPT,EIGHT,LABEL,METHODS,RESULTS,SIX
169,COPYRIGHT,DUE,FIRST,RAMAN,RESULTS,VCH,WILEY
169,HOWEVER,IVC,PRIMARY
GBM,PRIMARY
AFTER,III,MRI,SEPTEMBER
BRBNS,CRANIAL
200,AFS,AIM,CONCLUSION,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,THERE,USING
AIM,CIS,CONCLUSION,CSF,DISABILITY,LABEL,METHODS,MOTOR,MRI,OBJECTIVE,RESULTS,SCALE,TDL
10B,503,523,AIM,CONCLUSION,GREEN,LABEL,METHODS,OBJECTIVE,PCR,RESULTS
ANNEXIN,ANXA2,ECTOPIC,PROTEIN,THESE
037,177,183,1ST,2ND,5TH,BACKGROUND,BIFOCAL,CONCLUSION,GEORG,IIA,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,STUTTGART
CPT
ASSESSMENT,BACKGROUND,CONCLUSION,CRT,LABEL,METHODS,NEURO,PSP,RESULTS,SIX,TTP
BRAIN,LGG,MRI,OVERALL
ATTENUATED,FLUID,HOWEVER,IFOSFAMIDE,INVERSION,MRI,SYSTEMATIC
DNETS

947,ATM,AUTOMATED,BECAUSE,DDR,DIGITAL,MOLES
100,101,120,129,169,258,281,AFTER,AHTRT,BACKGROUND,C000000095,COPYRIGHT,EASTERN,FUNDING,GROUP,IRINOTECAN,JAPAN,LABEL,LTD,METHODS,OCT,RESULTS,THERE,WELFARE
169,ASSAY,BID,BIM,CONCLUSION,COPYRIGHT,DBA,FINALLY,LABEL,LTD,MEC,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SP1,THESE,WESTERN
014,169,489,513,545,808,853,924,99M,ADC,ASSESSMENT,COPYRIGHT,DSC,DTI,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,REGARDING,RESULTS,SPECT,THESE
169,ADC,BACKGROUND,JOURNAL,LABEL,LEVEL,MATERIALS,METHODS,MRI,OBJECTIVE,OCCURENCE,PURPOSE,RESULTS,SHAPE,SUPPORT,THESE
169,CDC42,COPYRIGHT,DUE,GDP,GEF,GTP,GTPASES,HOWEVER,INC,RHO,THESE,TIAM1,WHILE
169,COPYRIGHT,DUE,LTD,MRI,PILOCYTIC
VINCI
DESPITE,HOWEVER,PATIENT,THEREFORE,TREATMENT
BMS,LOCAL
169,AIM,CONCLUSION,GBM,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,URGCP,WILEY
BECAUSE,BRAIN
177,BASED,C57BL,CONTROL,GL261
BBB,CNS,VARIOUS,WHILE
BBB,MRI,USING
EHD,EPS15,SINCE,USING

ADC,BACKGROUND,CAREFUL,LABEL,METHODS,RESULTS
947,BACKGROUND,CD133,CONCLUSION,CONVERSELY,GBM,GSI,HOWEVER,METHODS,MTT,NOTCH,PCR,PRIMARY,RESULTS,WESTERN
001,025,128,207,335,BACKGROUND,III,LABEL,METHODS,MRI,RESULTS,WORLD
001,177,948,969,AMIDE,APT,BACKGROUND,III,LABEL,METHODS,MRI,MTR,REGIONS,RESULTS,THERE,WORLD
BACKGROUND,FET,FORTY,KINETIC,LABEL,METHODS,NEGLECTING,PET,RESULTS,SUV,TAC
BACKGROUND,LABEL,MALIGNANT,METHODS,MRI,MRS,RESULTS,STUDENT,TARQUIN,THERE
22Q,BACKGROUND,CD117,CHILDHOOD,CHORDOMAS,LABEL,METHODS,MIB,OBJECTIVE,PEDIATRIC,RESULTS,SMARCB1
BACKGROUND,COMPARISON,HGG,HOWEVER,LABEL,METHODS,MICRORNAS,PEDIATRIC,RESULTS
BACKGROUND,GBM,LABEL,MATERIALS,MDA,METHODS,PDZ,RESULTS,SRC,THROUGH
001,105,120,150,AGGREGATED,AMONGST,BACKGROUND,FLAIR,GBM,ISOCITRATE,LABEL,METHODS,RESULTS,T1W,T2W,TMZ
SEVERAL,WNT
BACKGROUND,CONCLUSION,GBM,KNOCKDOWN,METHODS,NUCLEAR,RESULTS,THESE
ALTERED,BACKGROUND,CLDN1,CONCLUSION,CPS,LABEL,LOW,METHODS,PCR,RCC,RESULTS,THEIR
ABC,ACCELERATE,BRAIN,DIFFUSE,GBM,JANUARY,LGG,WHILE
001,005,AGILITY,BACKGROUND,BALANCE,BILATERAL,BOT,BRUININKS,CEREBELLAR,EDITION,GROUP,LABEL,METHODS,MOTOR,OSTERETSKY,PEDIATRIC,PFBTS,PRIMARY,RESULTS,RUNNING,SPEED,SURVIVORS,THESE
100,BACKGROUND,COX,EOR,FACTORS,GGS,KPS,LABEL,METHODS,RANGE,RESULTS,SIXTY,WHILE
BACKGROUND,CONCLUSION,HSP70,LABEL,METHODS,MRI,NMR,RESULTS,SPION
328,ATLAS,BACKGROUND,BRAIN,CONCLUSION,DIFFUSELY,FINALLY,FIRST,METHODS,MOLECULAR,NEOPLASIA,REMBRANDT,REPOSITORY,RESULTS,SFRP1,TAKEN,TP365MG,WNT
007,215,947,AGILENT,BACKGROUND,CLONOGENIC,CONCLUSION,DIPGS,FINALLY,HGG,III,LABEL,METHODS,RESULTS,V600E
23A,D10,MMP,SHG44,THESE,U87
001,005,AAS,AOS,CHO,FDG,FIFTY,MET,MRI,PET,RNS,ROC,THESE
CIVIL,COLLOID,CONCLUSION,DEPARTMENT,DOW,JANUARY,KARACHI,LABEL,METHODS,OBJECTIVE,PLACE,RESULTS,TOTAL,UNIVERSITY
000,061,091,100,103,104,107,126,132,156,160,166,181,199,216,564,573,901,956,991,CENTRAL,CHINA,CHINESE,CONCLUSION,HENAN,LABEL,LINZHOU,METHODS,OBJECTIVE,RESULTS,SHENQIU,THERE
000,100,107,116,139,161,176,207,272,320,346,424,560,613,699,763,848,920,954,AGE,CHINESE,CONCLUSION,LABEL,MEANWHILE,METHODS,OBJECTIVE,RESULTS
100,177,916,AFTER,AIM,APTAMER,CONCLUSION,ELISA,GBM,III,LABEL,METHODS,OBJECTIVE,RESULTS,SELEX,THESE,U87,U87MG
100,160,169,APMIS,FURTHER,HOWEVER,LTD,PUBLISHED,WILEY
160,169,AGAINST,DNT,INC,KEY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THEREFORE,WILEY
177,184,304,AMONG,NOTABLY,WARBURG
174,945,947,GBM,HERBERPAG,IFN,INTERFERON,PCR,THEIR,U87MG
PFO,PREVIOUSLY
GAMMA
956,ACCORDING,AFTER,BCL,GLIOMAS,THEREFORE,U87
BACKGROUND,GBM,LABEL,PRINCIPAL,RESULTS,THESE,TMZ,USING
169,CD166,CD9,CXCR4,CXCR6,FINALLY,GFP,GL261,LIN,MSC,PRESS,SCA,THESE
100,118,287,296,500,ARTICLE,CST,DCS,EVALUATION,LABEL,MAPPING,MEP,METHODS,MOTOR,MTS,NEUROSURG,OBJECTIVE,RAABE,RESULTS,SCHUCHT,STEIGLITZ,THEREFORE,UNASSIGNED
169,AKT,ERK,GBM,INCREASING,LABEL,OBJECTIVE,PURPOSE,RESULTS,SHH,THESE,USING,WNT
LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,INSP3R1,INSP3RS,PUBLISHED,THERE
100,169,956,BINDING,COPYRIGHT,IRELAND,LTD,MAP,THESE
169,CHALLENGES,CNS,DESPITE,FINALLY
ABC,ABCB1,ABCG2,AMONG,ATP,BBB,KO143
ACUTE,ALZHEIMER,AVERAGE,ELF,EMF,ENGLAND,HOWEVER,REGARDING
160,CONCLUSION,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SINCE,SURGERY,UNIVARIATE
ACTIVATION,FURTHER,HOG,PAR,PCR,THEREFORE,U87

312,ADVERSE,BACKGROUND,CHRONIC,DCA,EIGHT,GSTZ1,III,INSTITUTE,LABEL,METHODS,RECURRENT,RESULTS,RMBTS,SECONDARY
160,305,83A,CLU,CLUSTERIN,DIFFUSE,DIPGS,EF2,ELONGATION,H3F3A,MYC,PROTEIN,SEQUENCING,SUPERVISED,TALIN,WESTERN
AFTER,HSP27,MAPKAPK,MITOGEN,MK2
ANOTHER,MRI,PET,VARIOUS
APRIL,BACKGROUND,DISCHARGE,DISEASE,FETAL,GLASGOW,LABEL,MARCH,METHODS,OUTCOME,PACO2,RESULTS,SCALE,THERE
169,COPYRIGHT,EWING,FEDERATION,GD2,PUBLISHED,SEVERAL,SINCE,SOCIETIES
169,960MG,AES,AIM,BACKGROUND,BRAIN,COPYRIGHT,GRADE,LABEL,LTD,METHODS,OBJECTIVE,OTHER,RESULTS,SECONDARY
001,169,177,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,MRI,PPV,PUBLISHED,RESULTS,SEVERAL,SIX
160,517,ANOVA,BACKGROUND,CTV,DAILY,IMAGE,LABEL,METHODS,OAR,PTV,RESULTS,THERE
PARKINSON
122,945,946,CNS,CONCLUSION,ECM,INHIBITORS,LABEL,METHODS,OBJECTIVE,RESULTS
CD4,CD8,DESPITE,GL261,OX40L,THESE
100,AMONG,CLASSICAL,EMA,ERG,EWING,EWS,EWSR1,FIFTY,FLI,FURTHER,LCA,NSE,PCR,PNETS,THESE
169,FEW
FIFTY,GBM,PFS
DIFFUSE,EVENT,SINCE
DSC,ICA,MRI,THREE
169,AKT,BIOLOGY,FEDERATION,GTP,HOWEVER,RAB2A,RAP,RAP2A,RAS
DCS,HOWEVER,INVARIANT,THEREFORE,THESE,USING
100,120,BACKGROUND,DLGGS,GROSS,KARNOFSKY,LABEL,METHODS,RESULTS,SCALE,THERE,THESE
GROUP,PHYSICIANS
160,MRI,THERE,VON
001,002,007,008,160,470,BACKGROUND,BMS,BRESLOW,LABEL,MEIER,METHODS,RESULTS,THERE,ULCERATION
ALZHEIMER,BIOMARKERS,FINALLY,HLA,JAPAN,JOHNSON,SJS,STEVENS,TEN
105,BRAIN,HNA,INVENTORY,LABEL,METHODS,OBJECTIVE,PATIENT,PCI,PURPOSE,RESULTS,SEVENTY
100,132,169,177,513,6MM,956,COPYRIGHT,SLC22,SLC22A1,SLC22A2,SLC22A3,THEIR,THEREFORE,WHILE
169,CBP,COPYRIGHT,DROSOPHILA,INC,MYC
169,COPYRIGHT,LTD,MIGRATION
169,COPYRIGHT,HOWEVER,LTD,TMZ
169,CEE,COPYRIGHT,HOWEVER,LTD,MPA
169,ADDITIONAL,AGE,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,PET,RESULTS
169,COPYRIGHT,FEDERATION,HUNTINGTON,SOCIETIES,WHETHER
000,001,100,110,169,173,390,413,626,AVERAGE,BACKGROUND,CONTEXT,COPYRIGHT,ELIXHAUSER,HOWEVER,INC,INFLATION,INPATIENT,LABEL,METHODS,NATIONWIDE,NINTH,NIS,OBJECTIVE,OUTCOME,PATIENT,PURPOSE,RESULTS,SETTING
169,LTD
045,127,129,135,140,146,147,169,197,237,246,262,306,332,360,COPYRIGHT,CVJ,LTD,SIX,THERE
000,100,102,160,169,192,669,773,974,BACKGROUND,COPYRIGHT,FIRST,FOUNDATION,INC,INSURANCE,LABEL,METHODS,NINTH,OUTCOME,PATIENT,PREDICTORS,PUBLISHED,RESULTS,SETTING,USING
000,100,BACKGROUND,FOLLOWING,IRANIAN,ISRAELI,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,THERE,THESE,TURKISH
003,017,1471G,629,641,BACKGROUND,CRS,GLIOMAS,LABEL,MATERIALS,METHODS,PCR,RESULTS,THESE,XRCC1
001,036,946,ACCORDING,BACKGROUND,EVALUATION,GAC,GAT,HAPLOTYPE,ITGB3,K469E,LABEL,MATERIALS,METHODS,PCR,PRIMARY,R241G,RESULTS,SIMILARLY,SNP,TURKISH
157,DCR,JANUARY,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,PFS,RESULTS,RPA,SHORT,THERE,TKI,WHOLE
001,006,007,038,BACKGROUND,CHILD,CONCLUSION,GKS,HCC,HOWEVER,III,LABEL,METHODS,RESULTS,RPA
BACKGROUND,CONCLUSION,LABEL,METHODS,PACO2,TREATMENT
001,003,035,110,121,125,177,247,378,439,475,513,596,599,750,878,946,BNP,CRP,LABEL,LVEDD,LVESD,METHODS,OBJECTIVE,PURPOSE,RESULTS
AFTER,AWARENESS,BACKGROUND,CONCLUSION,LABEL,METHODS,REPORTS,TREATMENT

203,356,528,AFFYMETRIX,ID1,LABEL,METHODS,MN1,MONOSOMIC,OBJECTIVE,RESULTS
FURTHER,MENINGIOMA,RESULTS
647,DUE,GRADE,HOWEVER,III,LABEL,METHODS,OBJECTIVE,PFS,RESULTS
011,CNS,CPA,HOWEVER,JUGULAR,LABEL,METHODS,NOVEL,OBJECTIVE,RESULTS,STUDENT,STUDIES,UNIVERSITY,VARIOUS,VII
ANESTHESIA,CO2
560,AFTER,COX,FINALLY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
CHRONIC,THERE
103,ADULT,BACKGROUND,BRAIN,HOWEVER,LABEL,METHODS,PIQ,PITUITARY,RESULTS,SCALE,VIQ
140,ARM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PIE,PURPOSE,RESULTS,SEQUENTIAL,THERE
009,016,248,252,938AA,CHINESE,HAN,PCR
250,ERBB2,ERBB3,ERBB4,PRL,TARGETING,TKI,TREATED
BACKGROUND,GENERALLY,JANUARY,LABEL,METHODS,OCTOBER,RATES,RESULTS,STUPP
ASSESSMENT,BRAIN,BRC,CONCLUSION,EWB,FORTY,FUNCTIONAL,FWB,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PWB,QOL,RESULTS,SWB,TEN,THERAPY
169,ALZHEIMER,CONVERSELY,COPYRIGHT,INC,PARKINSON,THOUSANDS
169,BARRATT,BIS,CCS,COPYRIGHT,CROWN,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PFC,PUBLISHED,RESULTS,SCALE,VOXEL
ALZHEIMER,BBB,BRAIN,HOWEVER
169,171,BACKGROUND,BRITISH,HOWEVER,ISCHAEMIC,LABEL,MIDKINE,PATHOLOGY,SOCIETY,THEREFORE,THESE,UNLABELLED
175,HOWEVER,LABEL,LOS,METHODS,NSQIP,OBJECTIVE,PROGRAM,PROPENSITY,QUALITY,RESULTS,SIMILARLY
140,144,1P19Q,BECAUSE,CSF,DIFFUSE,DLGGS,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SALVAGE,SIX,THERE,THEREFORE
227,CENTRAL,CNS,COX,END,GIVEN,GTR,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
MRI,PERFORMING,SIX
169,215,COMPARING,CONCLUSION,COPYRIGHT,DSC,GADOLINIUM,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SMS,SNR,TESLA,WILEY
001,004,005,006,008,019,024,030,044,156,203,259,983,990,992,995,998,ADULT,BACKGROUND,CONCLUSION,EOR,GROSS,LABEL,METHODS,RESULTS,SURGERY,THESE,THREE
045,BACKGROUND,FIFTY,FINALLY,GBM,HPV,HPV16,IHC,LABEL,METHODS,PCR,RESULTS,SINCE,STRIKINGLY
005,041,047,19Q,426,BACKGROUND,CONCLUSION,III,LABEL,METHODS,PSP,RESULTS,WORLD
639,BACKGROUND,CONCLUSION,FURTHER,GENOMIC,GLIOMAS,H3F3A,LABEL,METHODS,MUTATIONS,NF1,RESULTS
169,ABC,BBB,BRAIN,COPYRIGHT,LTD,PGP,STUDIES,THESE,WILEY
SUCCESSFUL
160,FOLLOWING,MTT,PCR,THESE,TRANSWELL,WHA
100,945,CD11B,DUE,FINALLY,GREEN,SU3
CUTANEOUS,INI,INTEGRASE,INTERACTOR
947,ACAP4,ACTG1,ASAP3,HOWEVER,SH3,UPLC1
169,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,LABEL,METHODS,RESULTS
169,ALA,COPYRIGHT,LIVER
169,405,6MM,ALA,BACKGROUND,COPYRIGHT,GBM,LABEL,MBT,MET,METHODS,MPR,MRI,ODG,RESULTS,STATION,STEALTH,SURGERY,THERE,UNDER
169,BRAIN,CRANIAL,EMA,MRI,MYOD1,SMA,SOCIETY,THICK
ANEUPLOIDY,CNV,OVERALL
ATLAS,COMPARING,GBM,SVD,THESE
CHEMO,GBM,HOWEVER,THESE,YKL
160,LOW,MRI,THEREFORE
400,FRAMINGHAM,ICE,OVERALL,PREDICTION
ACROMEGALY,COG,FURTHER,PAS,PATIENT,PITUITARY,THESE
208,476,CNS,MEDLINE,REGARDING,VTE
GLIOMAS,MALIGNANT
BASED,CLASS,LABEL,METHODS,OBJECTIVE,OTHER,PEDSQL4,PURPOSE,RESULTS,REVISED,TEN,YSR
002,016,023,BACKGROUND,CONCLUSION,IMAGING,LABEL,METHODS,MRI,RESULTS,SEVEN,SWI
169,AIR,BASEL,DESPITE,MRI,SEVERAL
150,169,1MG,2MG,5HT,COPYRIGHT,INC,THESE
169,BACKGROUND,CHO,COPYRIGHT,DTI,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PARAMETRIC,PURPOSE,RESULTS,SOCIETY,THESE,WHOLE
169,220,ATLAS,BACKGROUND,CHINESE,CONCLUSION,COX,GLIOMAS,LABEL,LTD,MEIER,OBJECTIVE,REMBRANDT,RESULTS,UNIVARIATE,WILEY
500,AFFYMETRIX,ATLAS,CONCLUSION,COX,GBM,HIERATICAL,LABEL,MEIER,METHODS,MICROARRAY,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TMA
181,954,ANEMONE,BAX,BCL,CHINESE,GBM,GIVEN,HEP,IAP,NUCLEAR,SAPONIN,THESE,U87MG,WESTERN
BESIDES,FINALLY,FIRST,FUNCTIONAL,PDB,PPI,PROTEIN
CANAVAN,COA,GTA,HOG,HS683,III,NAA,NEU,OLI
330,AMONG,FURTHER,GBM,MAF,MICRORNAS,MULTIFORM,USING
AFTER,FDG,MRI,PET
DESPITE
001,008,108,214,COX,III,MEIER,THERE,UBIQUITIN
CD4,FOXP3,GBS,USING
001,002,003,CD8,FOXP3,GBM,HOWEVER,MEIER,PFS,TIL,UNIVARIATE
MALIGNANT,TSC
HEPATIC,HOWEVER,THESE,WILMS
ADDITIONAL,BACKGROUND,BRAIN,LABEL,METHODS,RESULTS,SEGAS
916,936,ATO,GAB,GLS,GLUTATIONE,GSH,INHIBITION,KEY,KGA,LABEL,LN229,MESSAGE,ROS,SILENCING,SIMILAR,T98,THESE,UNLABELLED
ADC,ANOVA,III,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY
001,287,AFTER,AIS,AMONG,BACKGROUND,CLINICALLY,DVT,HISTORY,LABEL,LIMITED,METHODS,NETWORK,RESULTS,SECONDARY
169,COPYRIGHT,LTD,OTHER,TREATMENT
169,183,ACCORDING,COPYRIGHT,HODGKIN,HOWEVER,LTD,OVARIAN
169,AUTHORS,FABP7,FATTY,GSC,III,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,USING,WESTERN,WILEY
100,174,204,457,799,820,952,BACKGROUND,CONCLUSION,FORTY,JANUARY,KARNOFSKY,KPS,LABEL,MATERIALS,MEIER,METASTATIC,METHODS,RESULTS,SIX,SRS,THERE,UNASSIGNED
1ST,BACKGROUND,HOWEVER,LABEL,LYL,METHODS,RESULTS,TH1,TOTAL
169,183,ASSOCIATED,DAS,GROUP,ICD,LABEL,LTD,OBJECTIVE,RESULTS,UNASSIGNED,UNTIL,WILEY
100,HOWEVER,SRS

ANSWERS,BACKGROUND,INCIDENTAL,LABEL,METHODS,MRI,RESULTS
JANUS,MYC,RAS,STAT3

GBM,M58,TRAIL
001,005,007,014,038,101,467,474,512,AIM,CONCLUSION,FET,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,SUVMEAN,TBR,TBRMEAN,WORLD
177,CNS,CONCLUSION,FDG,FURTHER,LABEL,MET,METHODS,OBJECTIVE,PET,RESULTS,SUV
ACTUARIAL,CUSHING,INITIAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SRS,TLN
4TH,GAMMA,PITUITARY,SEVEN
GBM,RECURRENCE
203,HOWEVER,MICRORNAS,PCR
945,946,947,948,949,950,GBM,HEMOGLOBIN,HOWEVER,M006X,M010B,M059J,M059K,NGB,PCR
AFTER,AMERICA,LABEL,METHODS,NORTH,NSCLC,OBJECTIVE,PURPOSE,STAGE
945,946,AXL,EPIDERMAL,GBM,GM7,HGG,JNK,NOTABLY,OTHER,PCR,PDGFR,RTK,TAM,TRK,USING
945,954,AKT,BCL10,HOWEVER,LATIN,MALT1,SMALL,THERE
137,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TOP
248,687,BACKGROUND,GROWING,HOWEVER,LABEL,METHODS,RESULTS,THERE,TROMS,VTE,WOMEN
169,945,947,AKT,CANCERS,CETUXIMAB,COPYRIGHT,DOWNSTREAM,ERBB1,ERBB2,ERBB3,ERBB4,FOLLOWING,GEFITINIB,LAPATINIB,LTD,MEK,PKB,PLC,RAF,RAS,SEVEN,SEVERAL,THESE
169,181,ABCG2,FALCARINOL,SF9,THEIR,THESE
106,126,169,946,COPYRIGHT,D22,D23,HOWEVER,LTD,MUTATIONS,PRP,PRPSC
169,CNS,COPYRIGHT,FDA,GENERALLY,PUBLISHED
169,COPYRIGHT,HOWEVER,LTD,MEDLINE,RCC,RECURRENCE,THESE
024,100,114,169,191,206,237,241,490,CHI,COPYRIGHT,LABEL,METHODS,OFTALMOLOG,PEARSON,PUBLISHED,RB1,RESULTS,THERE,UNASSIGNED
169,945,BLI,COPYRIGHT,GX1,SPECT,TUNEL
169,AFTER,COPYRIGHT,IRELAND,LTD,THESE
169,582,COPYRIGHT,CSF,ESR,ICV,INC,STRUCTURAL,WML
160,169,231,233,420,AMONG,BRAIN,COPYRIGHT,LESIONS,METASTASIS,PROGNOSIS,PUBLISHED,SAS,TUMOURS,TUNISIA
INC,MALIGNANT,MEH,PUBLISHED,SEVERAL
141,165,169,COPYRIGHT,CTS,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,WHILE
169,ACCORDING,AMONG,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RCC,RESULTS,SIMON,THERE,THEREFORE,THREE
169,177,ACTUARIAL,FIFTEEN,FLORIDA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THREE,UNIVERSITY
169,LTD,MCNPX,PUBLISHED,RESULTS
169,COPYRIGHT,HO1,TREGS
169,COPYRIGHT,EXCLUDING,FIFTY,GKS,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SRS,TEN
169,19Q,ASSESSMENT,BASED,COPYRIGHT,GBM,GROUP,IDH,INC,LABEL,MATERIALS,METHODS,NEURO,OBJECTIVE,PURPOSE,RESULTS,THERE,THEREFORE,THREE,TMZ,WHILE,WORKING,WORLD
112,169,896,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PADDICK,PURPOSE,RADIATION,RESULTS,THERAPY
19Q,AAVS1,ATLAS,CHROMOSOME,CONSORTIUM,GSC,GSC11,PROTEIN,PXD000563,SEQ,TAKEN
CURRENTLY,ENGLISH,HOWEVER,LABEL,METHODS,OBJECTIVE,PCT,PERFUSION,RESULTS,SAH,THEREFORE
CSF,EARLY,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THREE
215,BRAIN,CPA,CPG,GARDNER,MRI
00001,160,169,183,300,AUTOLOGOUS,BASED,BNP,HOWEVER,LTD,TRANSPLANT,WILEY
MTT,POLYPORIN,SUPER,THESE
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,RCC
DTI,FIRST,FMRIB,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,USING,VBM,VOLUMES
ABC,BACKGROUND,BCL,CANDIDATE,CNS,JAK,LABEL,METHODS,PCNSL,PIM,RESULTS,THERE,WHILE
C18,INCREASED,INHIBITION,S1P,SGPP2,SPHK1,STUDIES
169,COMPR,MCT,MPC,PHYSIOL,REGULATION,SMCTS,SOCIETY
000,100,BACKGROUND,COSTA,LABEL,METHODS,OBJECTIVE,RESULTS
FURTHER,HOWEVER,PML,SCT
AUSTRALIA,BAY,GROUP,PAEDIATRIC,SOCIETY,SONIC,THREE,UNDER,WNT,WORLD
000,HOWEVER
AZA,CDR,CNS,CPG,EPIGENETIC,GENOMIC,KNOCKDOWN,PCR,USING
001,005,011,017,030,032,034,037,045,110,186,19P,19Q,AOA,CHI,COX,GBM,INTERGROUP,LTS,MEIER,PEARSON,PFS,STS
AFTER,CENTRAL,COGNITIVE,FOLLOWING,HGG,HOWEVER,MRI,WMH
003,006,036,ADC,CHILDHOOD,DTI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
103,120,BACKGROUND,BECAUSE,CONCLUSION,FORTY,LABEL,LOCAL,METHODS,OBJECTIVE,PTV,RECURRENCE,RESECTION,RESULTS,SRS,WHOLE
148,AFTER,ANY,BACKGROUND,CONCLUSION,COX,ELOQUENCE,LABEL,MEIER,METHODS,POTENTIAL,RESULTS,TREATMENT,UNIVARIATE
169,956,ALZHEIMER,BBB,BCSFB,CNS,COPYRIGHT,DARBY,HOWEVER,MADIN,MDR,PHENOXY
169,ACCORDING,AFTER,COPYRIGHT,IGF,PRL,SAS
169,ADOLESCENT,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,INC,INITIAL,KNOWLEDGE,LABEL,LATER,LOCAL,METHODS,RESULTS,SIXTY
169,AFTER,COPYRIGHT,GROSS,GTR,KNOSP,LABEL,METHODS,NFPIS,OBJECTIVE,PIS,PITUITARY,RESULTS,WHILE
169,FINALLY,NF2,SOCIETY,THESE,WORLD
169,BERNSTEIN,BIOMETRIC,SAS,SOCIETY,WEIBULL
ATP,BBB,CONCLUSION,FORTY,LABEL,MDR,METHODS,MRP,OBJECTIVE,PCR,RESULTS,WESTERN,YAMEN
DECREASED,JAPAN,MEDICAL
CURRENTLY,GRADE,TDF,THERE
ATLAS,GBM,PCG,PCR,PHF19,WESTERN
202,286,BACKGROUND,CASES,CONCLUSION,END,EPHX1,H139R,LABEL,METHODS,ORS,PAH,RESULTS
CURRENTLY,DABRAFENIB,ENGLISH,EXTRACTION,GSK2118436,III,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,SELECTION,SYNTHESIS,V600E
106,130,144,181,AFTER,CONCLUSION,DISCUSSION,LABEL,METHODS,MTX,OBJECTIVE,SCALE
BRCA2,FANCONI
CHEMOKINES
169,COPYRIGHT,DESPITE,LTD,MRI,WILEY
020,062,110,302,ARG399GLN,ASIAN,CIS,HOWEVER,ORS,SCIENCE,WEB,XRCC1,YET
100,ANGELES,BILIARY,CALIFORNIA,COMPARING,DBD,DCD,DISEASE,END,IMPORTANCE,LABEL,LIVER,LOS,METHODS,MODEL,NEITHER,OBJECTIVE,OLT,OTHER,PEDIATRIC,RELEVANCE,RESULTS,SETTING,STAGE,TEN,UNIVERSITY,WHILE
HOWEVER,RRI
021,042,046,COGNITIVE,GRADE,HOWEVER,RADIATION,TMZ,TREATMENT
CENTRAL,THESE
BACKGROUND,CONCLUSION,INHIBITORS,LABEL,PAE,RESULTS,THEREFORE,TREATMENT,TUM
001,103,COX,DCR,EPIDERMAL,JANUARY,L858R,LTD,MEIER,NSCLC,ORR,PFS,PUBLISHED
142,177,222,GROUP,HOWEVER,LINAC,PHYSICISTS,SRS,SRT,WINSTON
110,114,120,168,177,967,CONCLUSION,GAMMA,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,OCTOBER,RESULTS,SIXTY,THERE
104,169,ADENOMA,BACKGROUND,BELGIAN,CONCLUSION,CONTEXT,LABEL,LTD,METHODS,MRI,OBJECTIVE,PRL,PROLACTIN,RESULTS,THERE,WILEY
AFTER,BETWEEN,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOTAL
LABEL,METHODS,MRI,OBJECTIVE,PLEXIFORM,PNIST,PNS,PURPOSE,RESULTS,VOLUMETRIC
002,003,009,205,250,491,ANTIVIRAL,BACKGROUND,CFS,CHRONIC,CSF,FATIGUE,HOWEVER,INSTITUTE,JANUARY,LABEL,METHODS,RESULTS,THESE
139,843,ASIAN,CAUCASIANS,CIS,ERCC1,ERCC2,HOWEVER,K751Q,LIBRARY,ORS,SCIENCE,SEPTEMBER,STATA,STRATIFIED,TEN,THESE,WEB,WHILE
001,177,200,946,ANXIETY,BACKGROUND,BARTHEL,BIG,DEPRESSION,GREATER,HRQOL,INVENTORY,LABEL,METHODS,RESULTS,SCALE,STATE,TEN
246,BACKGROUND,CAD,INCIDENCES,LABEL,METHODS,OBJECTIVE,OCCURRENCE,PURPOSE,RESULTS
BACKGROUND,BRAIN,CAUSE,CNS,CONCLUSION,LABEL,METHODS,OVERALL,RESULTS,SCHWANNOMA,STILL,VITAL
TET
AETIOLOGY,III
2HG,945,BACKGROUND,ESI,FTICR,IDH,LABEL,POINT,R132H,RESULTS
BACKGROUND,IGF,LABEL,MYC,MYT1L,PTCH1,RESULTS,SHH,STRIKINGLY,TEAD1,TGIF2
100,160,240,956,BACKGROUND,BECAUSE,CONCLUSION,CRK,ICAM1,LABEL,PCR,PILOCYTIC,RESULTS
BACKGROUND,FURTHER,GPCRS,GPR64,HOWEVER,LABEL,RESULTS,SHH,WHILE,WNT
BACKGROUND,LABEL,NPV,PPV,RESULTS,THERE
BACKGROUND,DESPITE,LABEL,NER,RESULTS,THESE,XP1BE
100,AGREEMENT,BACKGROUND,BIOSCIENCE,IHC,LABEL,PCR,PXA,RESULTS,V600E,VE1
100,172,350,830,ANOVA,BACKGROUND,BECAUSE,EUCLIDEAN,LABEL,METHODS,OBJECTIVE,OPTICAL,PC2,PC3,PCA,RAMAN,RESULTS
169,BACKGROUND,CHO,COPYRIGHT,CRE,LABEL,METHODS,MRI,NAA,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDIES
SPITZ,THERE,WHILE
002,024,053,071,100,147,221,256,AFTER,BACKGROUND,EARLY,LABEL,METHODS,RADICAL,RECURRENCE,RESULTS,THERE
AZD8055,FDG,FLT,LABEL,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,THESE,U87
CONCLUSION,DESPITE,HAART,HOWEVER,LABEL,METHODS,MPNST,MULTIFOCAL,OBJECTIVE,PRESENTLY,PRIMARY,PURPOSE,RESULTS
CASES,HOWEVER,IAS,THERE,TSH
12P13,13Q14,169,BACKGROUND,CCND2,CDK,E2F,INC,INITIALLY,LABEL,LOH,METHODS,PCR,PROCEDURES,RB1,RESULTS,SNP,WHILE,WILEY
CNR,FSPGR,GRE,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,PULSE,PURPOSE,RESULTS,SNR,TESLA,THERE,THREE
ADULT,EXPRESSION,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,P53,PURPOSE,RESULTS,SYNTHETIC

945,946,BBB,BCSFB,BMECS,EMT,INCREASED,METASTASIS,SNAIL,THERE,TNF,U87MG
REMARKABLY,SINCE
001,003,004,042,139,BACKGROUND,LABEL,METHODS,NBMST,OBJECTIVE,OUTCOME,RESULTS,SDS
169,573,943,CURES,EORTC,GLIADEL,GRADE,INITIAL,INSTITUTE,KARNOFSKY,KPS,LTD,TMZ,TREATMENT,WILEY,WORLD
100,200,APTNA,FINALLY,HOWEVER,THEREFORE
001,127,189,729,ADC,AFTER,CHINESE,CIS,ENGLISH,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,REGARDING,RESULTS,SUMMARY,THERE
001,002,100,BACKGROUND,FORTY,LABEL,METHODS,MRI,PRE,RESULTS,SRS,T1C,THESE,USING
BASED,DESPITE,FURTHER,HOWEVER,MVP
169,AUTHORS,DROSOPHILA,INC,PUBLISHED,WILEY
956,ARBUTUS,NCI,THESE
002,11Q,205,313,738,CGH,DIFFUSE,H3F3A,MUTATIONS,R132C,R132G,R132H,THEIR,THESE
FURTHER,SINCE,SVZ
30C,786,BACKGROUND,HOWEVER,LABEL,METHODS,MICRORNAS,PCR,RESULTS,THERE,TOTAL
120,852,AML,COX,CUMULATIVE,ELF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,USING
APRIL,EASTERN,FIFTY,FORTY,GRADE,GROUP,OVERALL,PFS,SECONDARY,SIX,SIXTEEN,V600E
METASTASIS,NPC
CONVERSELY,CONVINCING,EPN,FURTHER,GROUP,HOWEVER,KEY,MINIMAL,MOLECULAR
AMONG,PCNSL
922,ATM,TAKEN,TAX,TAX1BP2
HOWEVER,ROC
012,018,347,626,854,BACKGROUND,CONCLUSION,JAPAN,LABEL,METHODS,RESULTS,THERAPY
BAPTA,DAG,DGK,EHT1864,GBM,GIVEN,OAG,PKC,PLC,VOL
002,CONCLUSION,FET,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS,TAC,THERE
ALR,KMT2D,MUTATIONS,SET
CONSISTENT,CURRENTLY,GIC,LABEL,METHODS,NEUTROPHIL,OBJECTIVE,PURPOSE,RESULTS,TARGETING,TRANSWELL
177,ENDOSCOPIC,INC,LABEL,LENGTHS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,USING
004,011,151,169,244,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PNET4,PRE,PURPOSE,RESULTS,SDS
169,COPYRIGHT,HCC,INC,PUBLISHED,WESTERN
169,COPYRIGHT,HODGKIN,LTD,PRIMARY
114,169,946,BIOLOGICAL,CLUSTERONE,COPYRIGHT,DEG,EXPRESSION,FINALLY,GENERAL,GSE4290,LTD,MEANWHILE,MICROARRAY,OMNIBUS,PPI,PROTEIN,REFERENCE,REPOSITORY,TAE,USA
169,MELANIN,MRI,SIX
169,COPYRIGHT,HOWEVER,LTD,SYLVIAN,THESE
144,160,169,ADC,CONCLUSION,COPYRIGHT,CSI,DWI,GLX,IMAGING,INCREASED,LABEL,MATERIALS,METHODS,MRS,OBJECTIVE,POSITIVITY,PRESS,PURPOSE,RESULTS,SAS,SHIFT,THREE
BACKGROUND,CONCLUSION,DDS,LABEL,METHODS,NEOPLASTIC,THESE
169,ASIAN,COPYRIGHT,HOWEVER,LTD,MRS,OCTOBER,THESE
169,1799T,BRAINSTEM,GGS,LARGE,PAS,PEDIATRIC,SOCIETY,V600E,VE1
132,169,197,BACKGROUND,CONCLUSION,CONTINUOUS,COPYRIGHT,DELAYED,FATIGUE,IMMEDIATE,INC,LABEL,METHODS,MOSBY,RESULTS,SYMPTOM
160,FIFTY,GOLDMAN,LTD,PUBLISHED,STROKES
169,COPYRIGHT,FUNCTIONAL,INC,PUBLISHED,SBS,SKULL,THESE
BBB,BRAIN,VARIOUS
953,CD2,MN2,POL,USING,ZN2
795,ADVERSE,FURTHER,GBM,GLIADEL,PROGNOSIS,THEIR,TREATMENT
BETWEEN,EIGHT,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS
001,002,008,916,CLASS,ENGEL,EOR,III,LABEL,LGG,METHODS,OBJECTIVE,RESULTS,VT2T1
CNS,CPA,RTS
HOWEVER,PPP,PRE,SECONDARY
117,200,ATLAS,COMPONENT,GBM,HOXD1,MBP,NUCLEAR,PATHOLOGIC,SCORE,THESE,USING
004,020,154,DMN,III,KPS,RESULTS
EVALUATION,FIRST,MRI,PET
FURTHER,HIV
105,HOWEVER,III
907,HIROSHIMA,JAPAN,KAGOSHIMA,SIX,SOCIETY,TEN,THEIR,UNIVERSITY
THERE,THESE

254,800,COIMBRA,DEPARTMENT,III,TUMORAL,UNIVERSITY
177,ARTHRALGIA,HOWEVER,IGF,LABEL,LEVEL,MEDICAL,METHODS,OBJECTIVE,OUTCOME,QUALITY,RESULTS,SHORT,THESE,UNIVERSITY
GIVEN,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OPG,RELEVANCE,THREE
169,ANGIO,COPYRIGHT,E30,EXPRESSION,GHR,IGF,LTD,THESE,THREE
138,169,223,COPYRIGHT,ELECTRONIC,FACTORS,HPC,III,LTD,PATHOLOGY,RADIATION,SIXTY,UNIVERSITY,WASHINGTON,WORLD
BET,JQ1,MYC,TARGETING,TREATMENT
101,198,1ST,BACKGROUND,COLORECTAL,HEALTHY,LABEL,LTD,MATERIALS,METHODS,OVARIAN,PCR,PUBLISHED,RESULTS,RTEL1,RTL,SCREENING,THERE,THEREFORE,TRIAL
001,100,115,169,186,868,967,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,DISTANT,DSS,GROUP,HOWEVER,III,IRELAND,IVA,LABEL,LTD,MATERIALS,MAY,METHODS,NPC,OBJECTIVE,OCTOBER,PURPOSE,RADIATION,RESULTS,THERAPY,TREATMENT
169,177,1MM,3MM,6MV,947,CONCLUSION,COPYRIGHT,DOSIMETRIC,FFF,FLATTENING,IRELAND,LABEL,LTD,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,EXTENSIVE,HOWEVER,INC,MRI,PUBLISHED,ROUTINE,ULTRASOUND
169,COPYRIGHT,LTD
169,COPYRIGHT,INC,PIRH2
169,COPYRIGHT,INC

MPE,PRIMARY
153,BRAIN,KDM5B,NSCLC,SIRT1
945,GLUT1,HIF,HYPOXIC,LENTIVIRAL,PCR,TAKEN,U87MG,XENOGRAFT
DESPITE,MST,THESE
149,250,286,453,813,ASSESSMENT,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,SECONDARY,SIMILARLY,TCI,THERE
114,894,THERE,THESE
SPECIMENS
955,CSF,ENDOSCOPIC,IGH,MRI,PCNSL,PCR
100,169,AMONG,CONCLUSION,COPYRIGHT,GTR,KARNOFSKY,KPS,LABEL,LGG,LOW,METHODS,OBJECTIVE,PFS,RESULTS,STR
105,6TH,ABR,ACADEMY,AUDIOLOGY,BACKGROUND,BECAUSE,COLLECTION,HEARING,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
RADIATION,WHOLE
169,BRITISH,CALCIUM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,RETICULUM,SARCO,SERCA,SOCIETY,THESE,WHEREAS
126,169,BACKGROUND,BRITISH,LABEL,METHODS,PFS,RESULTS,SOCIETY,STUDIES
178,179,FIFTEEN,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RELATED,RESULTS,SIB
ACCORDING,BACKGROUND,CENTRAL,CIS,CNS,HOWEVER,INCIDENCE,IRR,LABEL,METHODS,NATIONWIDE,RESULTS,THERE,THEREFORE
136,146,222,471,ADDITIONAL,BACKGROUND,EMOTIONAL,LABEL,MATERIALS,METHODS,OVERALL,QOL,RESULTS,STUDIES
KNOWN,RBP,STRA6,THESE,VITAMIN
DUE
BACKGROUND,EG5,LABEL,METHODS,MIB,PITUITARY,PRINCIPLES,RESULTS,VEGFR,WILLEBRAND
169,AUTHORS,ENDOGENOUS,INC,KNOCKDOWN,MBT,PUBLISHED,THESE,WILEY
AUROC,FURTHER,GLX,HOWEVER,NAA,PERSISTENT,PRIOR,ROC,USING
BRAIN,NAC,PHYSICIANS
195,962,BACKGROUND,BRAIN,CHINA,CONCLUSION,LABEL,METHODS,RESULTS,SNP,THESE
BACKGROUND,BCC,LABEL,METHODS,RESULTS
SINCE,SURGERY
MRI
119,A1L,A1R,BASED
AFTER,ENDOSCOPIC,EXPERIENCE
101,123,215,DEPENDING,FINALLY,FRONTAL,THESE,THREE
BACKGROUND,LABEL,METHODS,MISFOLDED,MUTATIONS,P53,PCR,R175H,R273H,RESULTS,SCREENING
ANALYZING,BACKGROUND,GBM,HOWEVER,LABEL,MACC1,MET,METASTASIS,METHODS,PCR,RESULTS,WORLD
005,015,200,239,520,CONTINUED,FIRST,LGG,METABOLIC,NF1,REE,SEVEN,SINCE
160,CUSHING,FURTHER,MEN,R527X
035,120,ACCORDING,AFTER,CUSHING,FIRST,IDENTIFIED,LABEL,METHODS,OBJECTIVE,OTHER,OUTCOME,POTENTIAL,REMISSION,RESULTS,THREE,TSS
956,GLUCOSE
150,CORTONE,ETOPOSIDE,MINIRIN,REPRESENTS,TSH
177,AIM,CLASS,CONCLUSION,DNT,EEG,ENGEL,GROSS,HOWEVER,III,LABEL,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS,SIX,THERE,VIDEO
169,BASEL,COPYRIGHT,HOWEVER
SPECT
18F,BRAIN,MRI,PET
120,HODGKIN,NF1,TEN,THEREFORE,THREE
169,BASED,INC,INTRINSIC
169,COPYRIGHT,INC,LARGE,THESE
001,019,160,169,239,277,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PMD,RESULTS,SMD,THERE,WHILE
CONCLUSION,EORTC,EXCLUSION,GBM,LABEL,METHODS,MRC,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,SURVIVORS,TMZ
BAX,BCL,FURTHER,LENTIVIRUS,PCDH9,THESE,U87

BCL,EFFECTIVE,FINALLY,GBM,MCL,TRAIL,TREATMENT
111IN,FDG,HOWEVER,HPC,MRI,PET
HOWEVER,MULTI,MULTIMODAL
169,26A,ATM,AUTHORS,GBM,HOWEVER,INC,MICRORNAS,PUBLISHED,THESE,U87,UTR
169,PUBLISHED,THERE
169,COPYRIGHT,ICA,IMAGING,LTD,PITUITARY,THERE
169,COPYRIGHT,LTD
169,BRAIN,COPYRIGHT,LTD,MRI,PAGET,THESE
169,COPYRIGHT,CVJ,GLASGOW,GROSS,LTD,OUTCOME,SCALE,THERE
10878,169,BEIJING,COPYRIGHT,JANUARY,KARNOFSKY,LTD,PNEUMONIA,RADICAL,THERE,TIANTAN
169,177,288,947,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRANSIT
169,CEREBELLAR,COPYRIGHT,INC,SOCS7
160,169,231,233,COPYRIGHT,PUBLISHED,SAS,SEVERAL,TREATMENT
001,005,169,241,442,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,NSCLC,PFS,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE,STAGE,UNIVARIATE
169,COPYRIGHT,HOWEVER,LTD,MMP,THESE,THROUGH
130,240,878,946,BACKGROUND,CANCERS,CONCLUSION,LABEL,METHODS,RESULTS,SIRNA,THESE,WNT,WNT3A
169,BACKGROUND,EEG,ICU,IFOSFAMIDE,INITIAL,LABEL,METHODS,MIXED,OBJECTIVE,RESULTS
169,COLLEGE,COPYRIGHT,GROUP,LTD,PUBLISHED,RADIATION,ROYAL,THERAPY,TREATMENT
BACKGROUND,CYP,DESPITE,ECTOPIC,H2DCFDA,LABEL,METHODS,RESULTS,ROS,THESE,UPR


001,705,COX,END,GROSS,GTR,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,STR,THERE,THESE
160,BCL,FURTHER,MMP,PRESENT,PSA,REDUCED,TCE,TINOSPORA
AMONGST,CNS,CXCR4,MOLECULAR
945,IL13R,IPA,PROBING
160,ARF,GBM,GNS,GSK,INK4A,JNJ,USING
215,ALA,BACKGROUND,DIG,III,LABEL,METHODS,MRI,RESULTS,THEREFORE,WORLD
ATLAS,BACKGROUND,CONCLUSION,COX,HOX,LABEL,METHODS,RESULTS
101,182,224,23B,365,592,AGE,BACKGROUND,GROUP,LABEL,METHODS,MOLECULAR,NON,PCR,PREDICTION,RESULTS,SHH,SONCE,WNT
170,181,259,ADDITIONAL,APRIL,BACKGROUND,LABEL,MEDLINE,METHODS,OBJECTIVE,POOLING,POTSDAM,PURPOSE,RESULTS
CK5,GRADE,IHC,PGR,THERE
HOWEVER,III,SVZ,THERE
105,BACKGROUND,CONCLUSION,III,LABEL,METHODS,SYSTEMATIC
100,177,BASED,CONCLUSION,DIFFERENT,HOUNSFIELD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TESTS,THESE,UNITS
AFTER
177,215,5TH,961,ADC,BACKGROUND,CNS,LABEL,MATERIALS,METHODS,MINIMUM,OBJECTIVE,PURPOSE,RESULTS,STUDENT,WORLD
169,946,COPYRIGHT,DESPITE,KNOSP,LTD,MRI,PCR,PITUITARY,THESE
BOWEL,DCR,NON,OAR,RESULTS,V50,V60
BASED,CASES,HOWEVER,SERUM,THESE,THREE
169,221,721,AEH,BLOOD,CD107,COPYRIGHT,HLA,INC,KIR,NKG2A,NKG2C,SIXTEEN
014,063,169,AMONG,AUR,COPYRIGHT,DSC,FORTY,INC,LABEL,MATERIALS,METHODS,MRS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
FGFR1,HOWEVER,MET
100,290,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PREDICTING,RESULTS
MEG,MRI,NON,TECHNIQUES,TMS
GROUP,III,LOCAL,MRI,SVZ
100,177,CBV,CHO,DSC,HGG,HOWEVER,LGG,MRI,PWI,THERE
169,AFTER,CONCLUSION,COPYRIGHT,EVN,INC,LABEL,METHODS,OBJECTIVE,PRIMARY,TOTAL
169,AFTER,CSF,DUE,ISCMS,MRI,PATHOLOGY,SDC
ASAP2,DAVID,EXPRESSION,FUNCTIONAL,ITGA4,OMNIBUS,THROUGH
240,CPG,IDH,SHP,THESE
100,136,248,594,BRAIN,CHINA,MEIER,NSCLC,PFS,SOUTH,THEREFORE,TKI
ALDH1,GBM
012,160,19Q,945,CIC,INA,INTERNEXIN
000,160,250,500,750,AMONG,BRAIN,CNS,DLT,EPIDERMAL,FOLLOWING,GIVEN,LAPATINIB,MTD,ORR,OVERALL
515,BTS,CNS,COGNITIVE,DIF,LABEL,METHODS,OBJECTIVE,PCF,PEDSPCF,PERCEIVED,PURPOSE,RESULTS
100,120,BACKGROUND,BETWEEN,CONCLUSION,LABEL,LYMPH,METHODS,RADPLAT,RESULTS,SCC,T4A,T4B
BAC,BACKGROUND,CONCLUSION,HOWEVER,HSV,LABEL,METHODS,PC8,RESULTS,SIMILAR,THESE,USING
APRIL,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,TEN,THERE,THEREFORE
945,GABAA,GROUP,HOXA5,MYC,QHII066,WHILE
150,ADL,FINALLY,FIRST,HOWEVER,OWING,QOL,THEREAFTER
BAD,BAX,BCL,BH3,BID,CNS,COFILIN,GLUTAMATE,OPC
AIM,AWAKE,BROCA,PRE
AMRUBICIN,BACKGROUND,ERLOTINIB,GIVEN,L861Q,LABEL,LEWIS,METHODS,SERUM,SEVEN,SMALL,STAGE,WHOLE
BIS,BLOOD,CONCLUSION,LABEL,METHODS,OBJECTIVE,QIUXU,RESULTS,THERE,WAIGUAN,ZUSANLI
AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,NMDAR,SOURCES
160,524,628,CHINESE,FUNCTIONAL,HSA,THEREFORE
169,600,900,CBF,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,WILEY
BACKGROUND,COX,GROSS,HOWEVER,LABEL,MEIER,METHODS,RESULTS,SIMPSON,TUMOURS,UNIVARIATE
002,003,012,109,147,CONCLUSION,KDR,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SINCE,THESE
36H,CUCL2,DSF,T98
BACKGROUND,CNS,LABEL,OBJECTIVE,SEVERAL
000,100,GRADE,HEART,III,IMPORTANCE,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OPTIMAL,RELEVANCE,RESULTS,THESE
169,GBM,HENCE,THERE
169,BASEL
DESPITE,DIFFUSE,DIPGS,OTHER,RAS
DELAYED,GENOCEA,HIV,PROMISING
ANAPLASTIC,HOWEVER,MAXIMAL,RECURRENT
ADDITIONAL,BACKGROUND,BASED,BRITISH,CONCLUSION,CURRENT,EMF,LABEL,MAY,METHODS,REGARDING,RESULTS,ROYAL,SOCIETY,SUPPORT,WORLD
BACKGROUND,LABEL,MEANWHILE,METHODS
169,COPYRIGHT,CPS,OTHER,THERE
169,BASEL,MRI,NF1,PRIOR,UBO,USING
001,002,003,005,007,169,CONCLUSION,COPYRIGHT,FDOPA,IRELAND,LABEL,LTD,METHODS,MRI,PET,PURPOSE,RESULTS,UNLABELLED
FINALLY,HOWEVER,III,MRI
945,946,FURTHER,KIT,PDGFR,RTK,SMA
CD138,IGG
001,345,COX,KPS,MEIER

169,BACKGROUND,CONCLUSION,COPYRIGHT,FIRST,ICH,INC,LABEL,METHODS,NCB,PUBLISHED,RESULTS
946,ANOSMIN,ECM,NOTABLY,SHRNA,THERE,THEREFORE
120,169,BRAIN,COPYRIGHT,CSI,FINALLY,INC,MRS,SENSE,THESE
CHANGES,CYBERKNIFE,LOCAL,THERE,V14
150,716,773,BACKGROUND,HRQOL,LABEL,METHODS,QALYS,RESULTS,THREE
MYC,MYCL1,ROUSSEL,SINCE,VENNSTROM
106,547,BETWEEN,LABEL,LVI,MAY,METHODS,OBJECTIVE,OVERALL,RESULTS
AKT,CCK,CHI,HOWEVER,KIT,MOORE,PCR,STEPHANIA,TET,THESE,TRANSWELL,U87,WESTERN
181,BACKGROUND,BILATERAL,BIS,IQR,LABEL,LOC,METHODS,RESULTS,ROC,SECONDARY,THERE
GIVEN,PITUITARY,SURGERY,WHILE
120,BEV,HOWEVER,LTS,TEN,THESE,TMZ,U87,XRT
169,FOXO3,ROS
FINALLY,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,SYSTEMATIC,THESE,UNEXPECTED
IDH,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THROUGH
169,HOWEVER,PUBLISHED
169,1990S,APREPITANT,FINALLY,HT3,NK1
169,AXL,CNS,MERTK,PUBLISHED,RTK,TAM,THERE,TYRO3
001,067,100,954,ABSORBABLE,BACKGROUND,CTS,HEMOSTASIS,HOUNSFIELD,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
AVAILABLE,BACKGROUND,CSF,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,POSTERIOR,PURPOSE,RESULTS
169,COPYRIGHT,HOWEVER,LTD,MRI,NON,THESE
169,24H,AFTER,CCS,COPYRIGHT,CUSHING,DDAVP,HOWEVER,LABEL,LABORATORY,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS
012,169,240,242,245,267,295,577,773,904,AUSTRALIA,BACKGROUND,COPYRIGHT,HODGKIN,LABEL,LTD,METHODS,OTHER,RESULTS,THERE
169,COPYRIGHT,INC
169,344,ACFET,ALA,BACKGROUND,FET,GLY,LABEL,METABOLISM,METHODS,PET,RESULTS,THREE
169,COPYRIGHT,GBM,LTD,SIMILAR,TAKEN,U87MG,USING
169,ADC,CONCLUSION,COPYRIGHT,DTI,LABEL,METHODS,OBJECTIVE,RESULTS,ROI,THERE,UNIVARIATE
001,130,169,175,ALK,CHI,CONCLUSION,COPYRIGHT,FGFR1,HIF1A,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE
169,237,241,BACKGROUND,COPYRIGHT,LABEL,METHODS,NEUROCIRUG,PUBLISHED
169,AFTER,COPYRIGHT,ENDONASAL,PUBLISHED,TSH
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,SOURCES
169,CLASSIC,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PEDIATRIC,SOURCES
169,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES
100,10YEARS,144,169,222,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,WORSENING
169,COPYRIGHT,INC,SEVERAL,UNTIL
167,169,AFTER,COPYRIGHT,HOWEVER,INC,MDD,MRI
108,169,BOUIN,FSH,MEDICAL,PRL,TSH,UMB,USING
169,ALZHEIMER
124,AVERAGE,CSF,GROSS,JANUARY,LABEL,LANGONE,MARCH,MEDICAL,METHODS,MONRO,OBJECTIVE,RESULTS,SEGAS,STR,THERE,TSC,UNIVERSITY
001,177,628,CSF,FORTY,FRONTAL,LABEL,METHODS,OBJECTIVE,RESULTS
IMAGING
125,160,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LUPUS,METHODS,REFRACTIVE,THERE,TSS
133,359,375,659,947,CONCLUSION,EIGHT,ENUGU,LABEL,METHODS,NIGERIA,OBJECTIVE,RESULTS,TCU
AWARENESS,BACKGROUND,BELIEFS,CONCLUSION,LABEL,METHODS,RESULTS,STRATEGIES
446,495,705,III,PRE,ROC,WORLD
GBM,HOWEVER,STUDIES,TMZ
HES,HEY,IHC,NOTCH
118,BACKGROUND,EXPANDS,LABEL,METHODS,MOTIVATION,RESULTS,SEVERAL
176,APPROACHES,BACKGROUND,CNS,CONCLUSION,CUMULATIVE,EXPOSURES,LABEL,METHODS,MHZ,MRI,OBJECTIVE,RESULTS,THESE
001,437,442,AMONG,BACKGROUND,CONCLUSION,END,GBM,LABEL,METHODS,OBJECTIVE,PRIOR,RESULTS
169,COPYRIGHT,ECM,LTD,METASTASIS,METASTATIC,MICRO,NON,NSCLC
0MM,169,190,1MM,231,233,269,3MM,5MM,698,7MM,967,9MM,CONCLUSION,COPYRIGHT,GERMANY,LABEL,METHODS,NOVALIS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,THERE
169,AFTER,COPYRIGHT,DIGIT,KARNOFSKY,KPS,LABEL,LO3,LO4,METHODS,OBJECTIVE,PRIOR,RESULTS,THERE
169,COPYRIGHT,CROWN,LTD,PUBLISHED,THERE
177,CHILDHOOD,DESPITE,YAS,YOUNG
001,005,177,17A,BACKGROUND,ELISA,LABEL,MATERIALS,METHODS,RESULTS,TH1,TH2,THERE
100,125,AMONG,BEIJING,CHB,HOWEVER,PATIENT,SELECTIVE,THERE,TIANTAN
484,975,BACKGROUND,BANARAS,BIHAR,COMPLIANCE,FEMALES,HINDU,INSTITUTE,JANUARY,LABEL,LEADING,MAJOR,MATERIALS,MEDICAL,METHODS,OPD,PRADESH,RESULTS,UNIVERSITY,UTTAR
III,RECURRENT
GBM,THEREFORE,U87
169,INC,INTERVIEW,THESE,WILEY
BCL2L12,BCL2LIKE12,FUNCTIONAL,FURTHER,GBM,SNA
AFTER,BACKGROUND,CARDIAC,CONCLUSION,LABEL,METHODS,MRI,SSR
10Q,466,GROUP,HENCE,HOWEVER,INTEGRATED,OVERALL,SHH,STRIKINGLY,TELOMERASE,WNT
001,004,008,017,315,442,531,784,894,AGE,KARNOFSKY,KPS,SIXTY
003,215,FIFTY,FLAIR,FRS,GBM,INSTEAD,MRI,OVERALL,REGIMEN
026,030,034,047,160,517,781,931,975,BETWEEN,EOR,HOWEVER,PRE,THERE,UNIVARIATE
FIRSTLY,HOWEVER,LEUCINE,PCR,THESE,U87,WNT
AMINO,FDG,FMISO,MET,MOLECULAR,PET,TRACERS
057,307,379,433,434,436,887,AMONG,BACKGROUND,CENTERS,HEALTHCARE,INDICATORS,INPATIENT,LABEL,METHODS,MID,NINTH,OBJECTIVE,PACIFIC,PREVENTION,PROGRAM,PURPOSE,QUALITY,REPORTING,RESULTS,SOUTHEAST
001,003,005,145,AMONGST,BACKGROUND,GBM,III,LABEL,METHODS,PCR,RESULTS,THESE
AKT,AZT,CLASSICAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAT3,THESE,USING
169,CDV,CIDOFOVIR,CONCLUSION,FDA,LABEL,MEIER,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,U87MG,UNTIL,WESTERN
CHRONIC,CSF,HOWEVER,SURGERY
ALONG,DESPITE,RHO,ROCK1,ROCK2,ROCKS,SELECTIVE,THERE,THESE,WHILE
BACKGROUND,CHOROID,CONCLUSION,CSF,LABEL,METHODS
169,CNS,HOWEVER,NPC,OVERALL,PRESS,THESE,VEGFR
13A,13B,268,CNS,COMPOUNDS,MCF,NCI,THEIR
EPIGENETIC,HOWEVER,HPV,OPSCC,UNRAVELING
001,946,GH3,GHOMA,GRK,HOWEVER,NFPAS,NOTEWORTHY,PRLOMAS,SSA,SSTRS
169,BRAIN,COPYRIGHT,HOWEVER,IRELAND,LTD
33342,BACKGROUND,CONCLUSION,ECTOPIC,FURTHER,GMB,HOECHST,HOWEVER,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,MIR,PCR,RESULTS,U87,WESTERN
009,102,373,BACKGROUND,BETWEEN,CONCURRENT,CONTEXT,FCA,LABEL,METHODS,OBJECTIVE,RESULTS
160,956,ALS,BACKGROUND,CAM,CHINESE,FJB,HO1,HOWEVER,IBA,LABEL,METHODS,NISSL,RESULTS,SSM,WESTERN,ZUSANLI
BRAIN,DESPITE,HOWEVER
DESPITE,GBM,THESE,UTILIZING
CES,CPT,HB1,HOWEVER,NSC,THESE
DIFFUSION,MRI
001,AMONG,BRAIN,CONCLUSION,COX,FDOPA,LABEL,MEIER,METABOLIC,METHODS,PET,RESULTS,UNLABELLED
001,002,004,011,014,018,049,150,169,5YR,BACKGROUND,EFS,GTR,INC,LABEL,METHODS,PRIMARY,PROCEDURE,RESULTS,SEVERAL,UPFRONT,WILEY
169,CK2,PROTEIN,TARGETING
000,160,956,AMERICA,BACKGROUND,CONCLUSION,IGF,LABEL,LATIN,METHODS,MRI,OBJECTIVE,OBJECTIVES,PITUITARY,PRIMARY,ULN
001,006,027,102,120,160,CHOROID,COX,CPC,GTR,MEIER,MRI,PFS,WHILE
177,ANAPLASTIC,BACKGROUND,CHO,GLX,HOWEVER,III,LABEL,LAC,LIP,METHODS,MRS,NAA,OBJECTIVE,PURPOSE,REPORTS,RESULTS
CASP8,HOWEVER
ERBB2,OVERALL
UPS
EXCITED,MALIGNANCY
160,33342,400,800,BLEOMYCIN,ECT,HOESCHT,IRE,J3T,MALIGNANT
BRAIN,DESPITE,GAD,MRI,SCREENING
150,160,BACKGROUND,LABEL,METHODS,RESULTS,THESE
169,BAX,BCL,CONCLUSION,FOXM1,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEVERAL,SHH,SMO,U87,WILEY
008,018,222,CANDIDATE,COX,GROUP,HRS,INCREASED,MCG,PRIMARY
ADENOVIRUS,D54,DELTA,E2F,HOWEVER,TRAIL,U87MG
MRI
769,772,778,BACKGROUND,CBF,CBV,CONCLUSION,FORTY,LABEL,METHODS,MRI,RESULTS,ROC,SIRIRAJ,THERE
PCNSL,PRIMARY,TEN
947,INO80,MEANWHILE
058,ACCEPTANCE,COGNITIVE,CONTENT,EOL,HGG,HRQOL,ITEMS,MEASURING,OVERALL,PROXY,RELATIVES,SYMPTOM
BAX,BCL,GH3,JNK,JUN,MMQ,P38,ROS,THESE
004,036,038,055,16P12,17Q,ASC,CASP8,CSF,GATA5,THERE
945,GBM,GIVEN,TALALAY
001,005,19Q,AOA,CHROMOSOME,GRADE,JANUARY,PCV,RESULTS,TMZ
147,19Q,26951,BRAIN,C30,COGNITION,EORTC,FATIGUE,HOWEVER,HRQOL,INITIAL,OVERALL,PCV,QLQ,QUALITY,RESULTS,TREATMENT
FINALLY,FURTHER,THESE
H3F3A,H3F3B
001,160,1980S,BACKGROUND,CENTRAL,END,FREQUENCY,HOWEVER,LABEL,METHODS,POTENTIAL,PROGRAM,RESULTS,USA
MPV,MTX,NIIGATA,PCNSL,RENAL,UNIVERSITY,WHOLE
DESPITE,GBM,THERE
MRI,THERE,THYROID
169,CD133,PUBLISHED
169,963,COPYRIGHT,DESPITE,HENCE,PET,RECEPTORS,SAS,TOMOGRAPHY
003,169,177,CONSENSUS,COPYRIGHT,FDOPA,GTV,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RECURRENT,RESULTS,TEN
169,954,BAX,BCL,COPYRIGHT,HOWEVER,INC,NAD,SIRT2
066,100,169,200,215,244,320,559,600,700,956,BSA,DIFFERENT,FLT,GADOLINIUM,MRI,PET,PUBLISHED,T1W
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION
171,19Q,267,AAS,AOA,AOS,BACKGROUND,FURTHER,GBM,GROUP,HOWEVER,JAPAN,LABEL,MEIER,METHODS,PCR,RESULTS,THESE
CONGENITAL,FURTHER,SURGERY
150,488,DESPITE,ESTIMATING,FINALLY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RECURSIVE,RESULTS,SCALE
100,109,119,FAR,FORTY,GAMMA,GKS,HOWEVER,KARNOFSKY,KNIFE,KPS,LABEL,METHODS,MRI,OBJECTIVE,OCTOBER,RESULTS
100,AMONG,SEVERAL
AKT,HOWEVER,MALIGNANT,SREBP
001,169,183,CHILDHOOD,GEORG,INCREASED,STUTTGART,SURVIVORS
041,264,EARLY,KARNOFSKY,KPS,MST,RPA
160,16F,25M,AMONG,BACKGROUND,LABEL,MEIER,METHODS,PROGNOSIS,RESULTS,SEVEN
106,160,ANAPLASTIC,BACKGROUND,CONCLUSION,III,LABEL,METHODS,MRI,PHOTOFRIN,RESULTS
160,946,ADULT,AKT,CRANIAL,NSC,RADIATION,TGF,TRAIL
BACKGROUND,FDA,LABEL,METHODS,PRS,RESULTS,UNASSIGNED
000,BACKGROUND,EXPRESSION,GBM,III,LABEL,METHODS,RESULTS,SLIT3,THESE
297,945,ADP,BACKGROUND,CONCLUSION,DESPITE,DGK,LABEL,METHODS,PCR,RESULTS,UTR
005,006,19Q,288,BACKGROUND,GBM,LABEL,LOH,METHODS,PRIMARY,RESULTS,THERE,WORLD
BACKGROUND,CONCLUSION,LABEL,LACTATE,MET,METABOLIC,METHODS,MONITORING,MRI,MRS,RESULTS,WARBURG
BACKGROUND,LABEL,METHODS
GBM,PGS,PRIMARY,SEVERAL,THERE
169,HT2,HT3,HT6,III,NK1,OLANZAPINE,PHASE,PUBLISHED
HOWEVER,LITERATURE,SEVERAL,TMZ
BACKGROUND,GALEN,HOWEVER,LABEL,MATERIALS,MAXIMAL,METHODS,OBJECTIVE,PURPOSE,RESULTS
164,177,202,BACKGROUND,CELSIUS,CONCLUSION,DANAILA,LABEL,METHODS,OBJECTIVE,OWING,RESULTS,TOTAL
169,320,AIM,CBF,CBV,COLLEGE,CONCLUSION,COPYRIGHT,CTA,CTP,LABEL,LTD,MATERIALS,METHODS,MIP,MTT,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,THREE,TTP,WBCTP
BBB,CENTRAL,CNS
CNS,LAPATINIB,PHASE
DRUGS,HIF
MARIMASTAT,MMP14,PREVIOUSLY,THEREFORE,TMZ,U87,XRT
STUDIES
BACKGROUND,CONCLUSION,LABEL,METHODS,PEG,POLYMER,RESULTS
221,222,29A,29B,954,FINALLY,FUNCTIONAL,GBM,GIC,MICRORNAS,SPRY1,USING
AKT,ALZHEIMER,CAM,GLUTAMATE,GROUP,PARKINSON,PLC
169,AMONG,BIOLOGY,DUSP1,DUSP4,DUSP6,DUSPS,FEDERATION,GBM,HOWEVER,MAP,MAPKS,SEVERAL
112,148,169,171,177,208,319,BACKGROUND,CCS,CNS,CONCLUSION,EDD,EID,IMT,INC,LABEL,METHODS,PROCEDURE,RESULTS,SURVIVORS,THERE,THEREFORE,THESE,WILEY
169,615,BACKGROUND,INC,JANUARY,LABEL,METHODS,OCTOBER,PRIMARY,RESULTS,TREATMENT,WILEY
169,945,946,CHO,COPYRIGHT,INC,WILEY
142,19Q,327,373,515,HIGHEST,HOT,KNOWLEDGE,RELATED,THESE
DISABILITY,FINALLY,WORLD
100,AFTER,BACKGROUND,LABEL,METHODS,RESULTS,SEVEN,THERE
231,468,47D,945,946,ANNEXIN,BACKGROUND,BRAIN,CLONOGENIC,FOLLOWING,INTEGRINS,LABEL,MCF,MDA,METHODS,MTS,RESULTS,THESE
138,LABEL,OBJECTIVE,PALLIATIVE,PURPOSE,QUALITY,RESULTS,SUMMARY
BRAIN,CSC,GBM,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
215,AGE,CURRENT,III,INSTITUTE,LABEL,NOA,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUMMARY,SWISS,TMZ,TREATMENT
ASSESSMENT,BACKGROUND,CONTEXT,FURTHER,GFP,HOSPITALS,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,SNARE,TSI,UNIVERSITY,VAMP1,VAMP2,VAMPS,VESICLE
MEN,PET
FDG,MUTATIONS,PET,SPECT
DUTCH,HRQOL,KIDSCREEN
MRI,PRIMARY
HOWEVER,INCREASED,THEIR
CNS,MTX,WHOLE
BACKGROUND,BRAIN,HENCE,LABEL,METHODS,PHANTOM,RESULTS,TRACKED
108,203,ANAPLASTIC,CHINA,CHINESE,IDH,III,ISOCITRATE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,AMONG,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,THEIR,THESE
169,COPYRIGHT,CROWN,LTD,NUMERICAL,PUBLISHED,SPF,USING
169,945,EGF,HIF,HYPOXIA,WARBURG
CNS,DESPITE,GTPASES,HENCE,HOWEVER,III,MALIGNANT,RAS,RRAS2,RRAS3,WHILE,WORLD
183,CONCLUSION,CRANIAL,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,RESULTS
100,13RA2,GBM,MAB,SEVERAL
306,DIRAC,EGF,GRADE,INDIVIDUAL,PKC,UTILIZING
ANALYTICAL,FINALLY,GBM,KNOCKDOWN,PCR,PODXL
945,AMONG,CARPS,CNS,PTPRG,PTPRZ,VERTEBRATE
CLOMIPHENE,FAILURE,HORMONE,REDUCTION,RESISTANCE,TREATMENT
612,ACCEPTANCE,ADULT,COMMUNITY,FIFTY,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,THERE,THESE
CONCLUSION,GPC,HOWEVER,LABEL,METHODS,MRS,NSC,OBJECTIVE,RESULTS,STROC05,THESE
CASES,DORFMAN,FEVER,LANGERHANS,OTHER,RDD,ROSAI
AFTER,CNS,DESPITE,ESPECIALLY,FINALLY,HOWEVER,IHC,KUPFFER,PCR,STUDIES,TAM,THEREFORE
19A,INHIBITION,LNA,MOUSE,SHH,SONIC,TREATMENT
954,DISULFIRAM,LABEL,MMP,UNLABELLED
169,ALIPHATIC,BECAUSE,CNS,COPYRIGHT,LTD,METABOLISM,NUTRITION,POLYAMINES,SOCIETY
169,COPYRIGHT,IRELAND,JAPAN,LTD,SOCIETY
169,INC
ABOVE,BSG,GRADE,III,METHODS,OBJECTIVES,OVERALL,PILOCYTIC,RESULTS,SURGERY,THERE
100,169,174,346,481,983,AGAINST,INC,ITALY,JANUARY,KEY,LABEL,METHODS,NEURO,OBJECTIVE,OVERALL,PERNO,PROJECT,PURPOSE,RESULTS,ROMAGNA,SEVEN,THESE,WILEY
177,AB2,DFO,FET,PET,THESE
AMIDE,APT
143,146,APRIL,ASSESSMENT,BRAIN,CHECKLIST,CONSENTING,CPC,DATASET,FUNCTIONAL,GENERAL,MARCH,MINIMUM,PROBLEM,SCREENING,SYMPTOM,THERAPY,USING
169,COPYRIGHT,GSC,HEX,LTD,MYO,NMR,NPC,OTHER,SPECTRA,THESE,UDP,WILEY
3T3,CONSERVED,III,L393H,MUT,NIH,SIMILAR,U87
BACKGROUND,CHO,CONCERNING,FORTY,LABEL,METHODS,MRI,MRS,NAA,RESULTS
100,120,169,954,BCLXL,CURRENT,EXPRESSION,GL261,U87MG
260,CONTROLLED,THEREBY,THESE
132,177,AMONG,BMI,CONCLUSION,GROSS,LABEL,LARGE,METHODS,OBJECTIVE,PERMANENT,RESULTS,THERE,VIS
331,491,ATLAS,FINALLY,GBM,HOWEVER,NRP,USING
AKT,DRR,GBM
SCLEROSING
PARKINSON,THEREFORE
177,AFTER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,MICROSOFT,OBJECTIVE,OPECT,RESULTS,TESTING
TERATOMAS
364,CONCLUSION,FINALLY,HALIFAX,JANUARY,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS
BACKGROUND,CONCLUSION,HOXA9,LABEL,MENINGIOMA,METHODS,PBX,RESULTS,THERE
169,ABOUT,FIRST,GEN,MRI,SEQUENCING,SMARCB1
169,231,946,DUE,HB1,IFN,MCF,MDA,PCR,SCF
001,003,144,169,177,206,AGE,COPYRIGHT,CSS,END,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,PROGRAM,RESULTS
169,BACKGROUND,BRAIN,COPYRIGHT,INC,LABEL,LASER,METHODS,THERE,TREATMENTS
111,332,GROUP,OVERALL,SEPTEMBER,THESE,TMZ,TREATMENT,UNIVERSITY,YOUNGER
HOWEVER,MEP,RESECTION,TEMPORARY,THESE
CONCLUSION,INTRA,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SES,UNENHANCED
CYTOTOXIC,DCS,DENDRITIC
GBM,KNOWN
BETWEEN,GROUP,ICE,NEURO,PFS,THESE,WORKING
A3S,ANAPLASTIC,CLINICALLY,EXOME,FINALLY,GBM,III,NOTCH,OA2,OA3
169,BRAIN,CHINESE,COPYRIGHT,GROSSLY,LTD,MIB,MITOTIC,ONCOCYTIC,THERE
001,169,5MM,AFTER,MEDICAL,NPC,OVERALL,PTV,PUBLISHED
013,169,183,BACKGROUND,COPYRIGHT,INSTITUTE,LABEL,LTD,METHODS,RECURRENT,REFINEMENT,RESULTS,SHH,STUDIES,TORONTO,TREATMENT,WNT
169,26A,COPYRIGHT,GBM,INC,MYC
169,34C,AEROBIC,AKT,COPYRIGHT,FOXO1,FOXO3,GBM,IIA,INC,MYC,THESE,WARBURG
001,006,008,169,BACKGROUND,BMI1N,HOWEVER,KPS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,ALK,AMONG,ANAPLASTIC,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,NSCLC,PERUGIA,PFS,RESULTS,STUDIES
169,ABDOMINAL,BRAIN,LOW,MRI
CARDIOLOGY,NEUROLOGY,PEDIATRIC,PEDIATRICS,ROUTINE,THESE
160,169,BACKGROUND,BMI,COPYRIGHT,DISCUSSION,FINALLY,FURTHER,INS,LABEL,METHODS,OVERWEIGHT,RESULTS,SAS,STEROID
169,COPYRIGHT,LTD
169,947,C57BL,CILOSTAZOL,CONCLUSION,HEP3B,HEPG2,INCREASED,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TAKEN,TOTAL,TREATMENT
169,946,ABC,ALZHEIMER,COPYRIGHT,INC,MESSENGER
169,AUTHORS,BACKGROUND,COMPLEX,CONFERENCE,CONSENSUS,COPYRIGHT,INC,LABEL,MAMMALIAN,METHODS,MONRO,PUBLISHED,SCLEROSIS,VARIOUS
000,353,BACKGROUND,CPG,FINALLY,LABEL,LOW,RESULTS
169,658,AIM,CIS,CONCLUSION,COPYRIGHT,HOWEVER,HRT,LABEL,LTD,METHODS,OBJECTIVE,ORS,RESULTS,SEVERAL,TESTS,USING
3RD,ANTICANCER,AUTOLOGOUS,EVALUATION,HGG,HOWEVER,LASKY,PLANT,RES
1990S,DESPITE,HOWEVER,PHASE
GRADE,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROI,TIC
142,ALDER,FORTY,GROUP,HEY,LABEL,METHODS,MRI,NF1,OBJECTIVE,OPHGS,OPTIC,PATIENT,PRESENTING,RESULTS,SEVEN,SURGERY,TEN,THEIR,THREE
ALZHEIMER,SECRETION
ADDITIONAL,BACKGROUND,DIAGNOSTIC,LABEL,METHODS,RESULTS,THERE,THESE
003,045,956,ADC,BACKGROUND,COX,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS
MOLECULAR,WHILE
A10,ANP,AS2,GAMMA,KNIFE,LGA,PEDIATRIC,PRIOR
NF1
PCR,PITUITARY
001,019,GBM,GREATER,HOWEVER,KARNOFSKY,PFS,RECURRENT
160,PCR
005,008,027,160,441,ARNTL,ATLAS,CLOCK,CONCLUSION,LABEL,METHODS,MYRIP,NPAS2,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,THERE
000,169,238,LABEL,UNASSIGNED,UNLABELLED,WORLDWIDE
169,COPYRIGHT,INC,STAT3,SUBSEQUENT
169,COPYRIGHT,INC,STAT3,WEISS
006,012,HOWEVER
169,AGAINST,CCM,COMMISSION,CRE,EPILEPTIC,FORCE,HOWEVER,INC,WILEY
946,ALZHEIMER,BACKGROUND,DCF,ETHYL,ICR,LABEL,LDH,MDA,METHODS,MTT,PRE,RESULTS,ROS
FGF,FGFR2,GASTRIC
AKT,BRAIN,ERK,HOWEVER,INHIBITION,KIT,MATCHED,MEK,RAF
362,462,AMONG,CIS,CONTROL,COX,IGG,IGM
FURTHER,THEREFORE,THESE,WHORL
001,003,009,020,10F,150,GRADE,PFS,THEREAFTER
945,946,BASAL,BBB,CONCLUSION,HBMEC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TNBCS
169,826,BACKGROUND,CONVERSELY,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,OVERALL,PCA,RESULTS,THERE,THESE,WILEY
103,160,172,BONFERRONI,DELAYED,ESTIMATED,LABEL,LOG,MEIER,METHODS,OBJECTIVE,RESULTS,SAHARAN,SUB,THERE
133,165,ANXIETY,APPEARANCE,BRAIN,COGNITIVE,HRQOL,INVENTORY,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PERCEIVED,PROCEDURAL,PURPOSE,QUALITY,RESULTS,TREATMENT,WORRY
OBR,STAT3,THESE,TMZ
17Q,215,GROUP,HIT,MET,MRI,NEITHER,REGARDING,YET
916,946,ADVERSE,ALZHEIMER,AUC,CAUCASIAN,CSF,IGG,INSTITUTE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PHASE,RESULTS,THERE,WESTERN
947,CD111,DESPITE,FINALLY,NOVEL
BACKGROUND,FINALLY,GBM,GLIOMAS,LABEL,METHODS,MONOCYTES,RESULTS,TAM,TNF
001,003,007,125,148,273,345,BACKGROUND,FAVORABLE,GTR,HISTOLOGY,KARNOFSKY,KPS,LABEL,MEIER,METHODS,PFS,PROGNOSTIC,RESULTS,SURGERY
239,CD137,CD4,CD8,DENDRITIC,DESPITE,INCUBATION
160,ASSESSMENT,BACKGROUND,CONCLUSION,CSF,CYTARABINE,LABEL,LIPOSOMAL,METHODS,OBJECTIVE,RESULTS,SIXTEEN
COMBINING,TRYPTOPHAN
001,010,017,024,CD133,DIFFUSE,EIGHT,FURTHER,PCR
945,946,AFTER,GERMINOMAS,LABORATORY,MRI
DESPITE,PARKINSON,PET,THESE
RCC,SMALL
169,FINALLY,FUNCTIONAL,MEG,MST,RESTING,SEIZURE
169,22Q,BRITISH,CNS,GBS,H3F3A,LABEL,METHODS,OBJECTIVE,PAEDIATRIC,RESULTS,SEQUENCING,SOCIETY,THREE,TUMOURS,UNIVERSAL,V600E

945,947,CCR2LOW,CSPG4,DEPLETION,ED1,GBM,IFN,MHC,NG2,TAKEN,TAM,THERE,TNF
ACUTE,AML,BRAIN,CBFA2T3,CHILDHOOD,DESPITE,DHH,GLIS2,HOMOLOGUE,HOWEVER,MYELOID,RAS,TAKEN,THESE,THROUGH,WHILE
169,BACKGROUND,C30,COX,EORTC,HRQOL,LABEL,METHODS,QLQ,QUALITY,RESULTS,SOCIETY,TREATMENT,WORLD
131,143,169,ADULT,BAY,CNS,FRANCISCO,IGE,ORF2P,SAN,TEN,VZV
169,B55,COPYRIGHT,PPP2R2C,PROTEIN,PUBLISHED,S6K
SYX
169,COPYRIGHT,MRI,U87MG
CNS,EBV,EPSTEIN,PLTDS,PTLDS,SOT
FDG,FDOPA,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THREE
169,183,328,BETWEEN,JANUARY,LABEL,LTD,METHODS,MRI,OBJECTIVE,RESULTS,SIGNS,WILEY
014,049,178,811,892,967,BACKGROUND,BASED,CONCLUSION,CRT,III,LABEL,MARCH,METHODS,PFS,RESULTS,WHOLE
169,BCC,CARDIAC,INC,NBCCS,PTCH1,WILEY,WILMS
169,CONCLUSION,COPYRIGHT,CORRECTION,DISTORTION,DSC,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,SIXTY,TESLA,WILEY
169,AIF,CONCLUSION,COPYRIGHT,DCE,INC,KINETIC,LABEL,MATERIALS,METHODS,MRI,NUMERICAL,OBJECTIVE,PURPOSE,RESULTS,SEVEN,TOFTS,WILEY
169,300,CONCLUSION,COPYRIGHT,ENDOGENOUS,INC,LABEL,LPS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WILEY
169,177,233,CITRATE,CONCLUSION,COPYRIGHT,INC,LABEL,LCMODEL,METHODS,MRS,OBJECTIVE,PRESS,PURPOSE,RAO,RESULTS,WILEY,WORLD
190,269,967,BACKGROUND,CTV,LABEL,MARGINS,METHODS,NECESSARY,NOVALIS,PTV,RESULTS
001,169,292,ACC,AMONG,BACKGROUND,BIRCH,BRAZILIAN,EELES,G245S,LABEL,LFL,LFS,METHODS,PEDIATRIC,R337H,RESULTS,SCREENING,SOCIETY
177,CASES,CENTRAL,HOWEVER,MIB,THREE
001,008,HOWEVER,III,KARNOFSKY,KPS,PCR,THESE
169,CTIP2,HIV,INC,INITIAL,TARGETING,WILEY
003,170,188,416,520,850,929,GST,GSTT1,HOWEVER,THERE
1528C,BIALLELIC,DESPITE,FEW,LYNCH,MRI
CUSHING,DUE,PITUITARY,TREATMENT,WHILE
195,ACCORDING,BACKGROUND,CELLS,EPH,EPHB1,EXTENSIVE,LABEL,MEIER,METHODS,RESULTS,THESE,U87
CSC,CXCR1,CXCR2,GMB,HOWEVER,USING
001,115,COX,DESPITE,MBM,MEIER
230,315,370,AMONG,CHEMO,CUMULATIVE,IMAGING,M1A,M1B,M1C,MRI
AMONG,GROSS,PAPILLARY,THEREFORE,THREE
169,945,AFTER,AUSTRALIA,HFE,PARKINSON,PATHOLOGIC,SLC40A1,TAKEN
169,945,COPYRIGHT,FNDC5,HOWEVER,INC,PGC,PGC1A,TAKEN
13P,169,945,ANCHORING,HOWEVER,IL13R,ILNPS,NPS,U87
169,500,COPYRIGHT,GBM,INC,THESE
AFTER,AMONG,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RESECTION,RESULTS
160,169,AIS,APRIL,BACKGROUND,COPYRIGHT,CROWN,DESPITE,EIGHT,IBR,INC,LABEL,METHODS,NOTTINGHAM,PUBLISHED,RESULTS,SSM
200,BACKGROUND,CONCLUSION,LABEL,METHODS,OVARIAN,SERUM
177,AFTER,ASSESSMENT,BACKGROUND,CONCLUSION,EEA,ENDOSCOPIC,LABEL,MEASURE,METHODS,OUTCOME,QOL,RESULTS,SHORT,T7SSS,VSF
169,COPYRIGHT,LTD,VALPROATE
169,CD42B,CNS,LAT,MYELOID,SOCIETY,V617F
169,946,AKT,FAK,SHIMADA,SRC,UNIVARIATE
169,19Q,FRESH,GTG,MULTICOLOR,MYC,PERIPHERAL,QFISH,SOCIETY,THERE,THREE,TRYPSIN,XXX
169,AUTHORS,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY,VAN,WYK
169,EMA,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SIMILAR,WILEY
169,183,185,BACKGROUND,BRITISH,C57BL,CBD,HENCE,KEY,LABEL,METHODS,MTT,OBJECTIVE,PAC,PACLITAXEL,PURPOSE,RESULTS,SOCIETY
MOLECULAR,NOA

FOLLOWING,MRI,RADIATION
160,169,183,GROUP,HODGKIN,LTD,TCCSG,THERE,TOKYO,WILEY
003,033,122,177,338,BRAIN,JANUARY,KARNOFSKY,LABEL,MAY,METHODS,MRI,OBJECTIVE,REASONS,RESULTS,THERE
500,ALONG,DUE,EEG,FURTHER,RESULTS
K2P,K2P10,K2P12,K2P16,K2P18,POTASSIUM,THEIR,WHILE
945,COATS,CST,HENCE,MUTATIONS,STRIKINGLY,WHILE
169,APC,BIOLOGICAL,INC,PTCH1,RTS,RUBINSTEIN,SHH,SONIC,TAYBI,WHILE,WILEY,WNT
169,ADC,CONCLUSION,COPYRIGHT,FLAIR,INC,INITIALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
001,967,BACKGROUND,CHANNEL,CLIC1,GBM,LABEL,MEIER,METHODS,REDUCED,RESULTS,TAMHANE
022,169,BOARD,CONCLUSION,INC,IRB,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDENT,WILEY
169,ACTIVATION,FINALLY,GBM,MET,NANOG,PRESS
169,615,CPG,EPIGENETIC,INC,MEDIP,NIMBLEGEN,THERE,THEREFORE,THESE,USING,WILEY
169,BSA,COPYRIGHT,ENCOURAGED,LTD,MRI,NOE,OVERHAUSER,THEREFORE,WILEY
169,BRITAIN,COPYRIGHT,DUE,FOLLOWING,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
AVM,CASES,PXA
AE1,AE3,AMONG,BASED,METASTASES,TTF
384,AGREEMENT,BECAUSE,COX,DIPGS,FLAIR,INCREASES,MRI,PROGNOSTIC,READERS,TREATMENT
FIRST,HB1,NSC

876,BACKGROUND,CONCLUSION,DISEASE,FALLS,FOUNDATION,HOEHN,INITIATIVE,LABEL,METHODS,NPF,OBJECTIVE,PARKINSON,QII,QUALITY,RESULTS,TIMED,VARIABLES
169,ACCORDING,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LOCAL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PFS,RESULTS,THERE,THREE,USING
CSC,FOLLOWING
169,COPYRIGHT,HOWEVER,HYPOXIA,INC,THESE,USING
169,CHINESE,COPYRIGHT,LTD,PITUITARY
BACKGROUND,LABEL,METHODS,SECONDARY,TRIAL
169,DECREASED,EMT,EPITHELIAL,GAINING,HOWEVER,MIGRATORY,SOCIETY,SWOZ1,SWOZ2,THESE
169,COPYRIGHT,FACULTY,FSH,LEGAL,LTD,PITUITARY
004,005,038,EOR,LABEL,LEEDS,MEASURING,METHODS,OBJECTIVE,RESULTS,THERE,THREE
261,CONCLUSION,HISTOLOGY,LABEL,MDT,METHODS,OBJECTIVE,RESULTS,SIXTY
001,105,106,CONCLUSION,COX,GBM,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,NHS,OBJECTIVE,RESULTS,SERVICE,STUPP
105,CALCULATOR,CONCLUSION,EORTC,GBM,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,RESULTS,TREATMENT,USING
003,045,100,169,183,650,AMONG,CONCLUSION,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SIXTY,THESE,TRH,WILEY
MULITFORME
BBB,FURTHER,FUS,GBM
99M,ANATOMIST,BRAINVISA,MRI,SESTAMIBI,SPECT,TECHNETIUM
GTV
001,177,AUTOMATIC,CUT,FULLY,HOWEVER,INDEX,MALIGNANCY,RAPID,THEREFORE,THESE
001,066,111,147,177,AFTER,BACKGROUND,BBB,BRAIN,EFFECTIVE,GROUP,KRUSKAL,LABEL,LOCALIZED,METASTASIS,METHODS,RESULTS,THESE,TNF,TNFR1
10001,333,BRAIN,CHRONIC,DISCOVERY,GBM,HOWEVER,MEDICAL,MET,MPS,PUBLISHERS,RAS,SEVENTH,SHH,THESE,USA,WNT
000,120,500,956,BACKGROUND,CHANGES,CST,DCS,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS
CNS,CONCLUSION,CSF,EASTERN,FORTY,GROUP,LABEL,METHODS,OBJECTIVE,PRESENTING,PRIMARY,RESULTS,SEVENTY,SIXTY,TREATMENT
BURKITT,CPG,GEMMS,THESE
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI
215,BACKGROUND,BECAUSE,CNS,CONCLUSION,HODGKIN,INTENSIVE,LABEL,METHODS,MRI,NHL,NON,RESULTS
169,FINALLY,LTD,MALIGNANT,PUBLISHED,WILEY
230,506,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,MORRISTON,OBJECTIVE,RESULTS,SUBSEQUENT,THERE,THESE
169,BESIDES,NANOPROBES,NPS,OVERALL,VCH,WILEY
169,BACKGROUND,CARLO,COSTING,LABEL,METHODS,MONTE,PROPONENTS,RESULTS,SOCIETY
169,MONRO,SURGERY
000,100,101,158,ADDITIONAL,CARLO,CNS,MONTE,ORGAN,OVERALL
ANOTHER,GEFITINIB,HOWEVER,JAPAN,LAPATINIB,MRI
AVASCIN,BASED,CNS,DESPITE,GBM,GLIOMAS,HOWEVER,III,JAPAN,THESE,TMZ,WELFARE
ACCORDING,EORTC,III,MALIGNANT,MAXIMAL,MRI,MULTI,TREATMENT
BACKGROUND,LABEL,MEDLINE,METHODS,MULTI,RESECTION,RESULTS,SIMILAR
001,002,ACCORDING,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE
001,004,022,215,472,AGE,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCORE
022,169,687,ADVERSE,BACKGROUND,BETWEEN,BRAIN,BVZ,CONSORTIUM,CPT,III,INSTITUTE,LABEL,METHODS,OCTOBER,PEDIATRIC,RESULTS,SOCIETY,TOXICITIES
946,MYC,THEREFORE,WNT
DESPITE,HOWEVER,MTT,THEREFORE,THESE,U87,WESTERN
169,BACKGROUND,CONCLUSION,FOUNDATION,LABEL,METHODS,MRI,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,T1W
169,954,CAFFEIC,COPYRIGHT,INC,PLD,TAKEN,ULTIMATELY
001,160,169,BACKGROUND,CONCLUSION,COPYRIGHT,CSC,FACILITIES,INC,JAPAN,LABEL,METHODS,PUBLISHED,RESULTS
169,AIS,COPYRIGHT,INC,PUBLISHED
169,177,237,241,243,AFTER,BACKGROUND,COPYRIGHT,EARLY,FSH,GIVEN,LABEL,METHODS,OBJECTIVE,PEDIATR,PRECOCIOUS,PUBLISHED,PURPOSE,RESULTS,SDS,TSH
177,5TH,8TH,AFTER,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,STENT,THERE
169,BACKGROUND,BRAIN,COPYRIGHT,DISCUSSION,HOWEVER,III,LABEL,LTD,METHODS,NOTABLY,QUALITY,RESULTS
169,3MONTHS,AFTER,ALDEFLUOR,ALDH1,BTICS,CD133,CELLS,COPYRIGHT,LTD,NOTABLY,PRIMARY
135,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCT,VIRAL
AREAS,BACKGROUND,COVERED,CURRENT,HOWEVER,LABEL,METHODS,OPINION,THEREFORE
002,004,204,657,FIFTY,HRV,JANUARY,KARNOFSKY,KPS
132,176,177,188,AFTER,BACKGROUND,LABEL,METHODS,NICUS,PARENTS,PICUS,RESULTS
001,100,108,111,BACKGROUND,CONCLUSION,EPENDYMOMA,FEW,FORTY,GENERAL,GTR,LABEL,METHODS,MINIMIZING,OCTOBER,PRT,RESULTS,SEVENTY,STR
BACKGROUND,EFFECTS,EXTENSIVE,GENERAL,IQS,LABEL,METHODS,RESULTS,SUBSCORES,YET
231,945,946,DEFECTS,MDA,SIMPLECELL
210,246,AIM,CNS,CONCLUSION,FOLLOWING,LABEL,METHODS,MORTALITY,MRI,OBJECTIVE,PITUITARY,RESULTS,THESE
AFTER,TEN,THERE
DUE,GROWING,TYPICALLY
100,BRAIN,MRI,P53,PET,SURGERY
HOWEVER
AFTER,INITIALLY,MRI,TMZ
100,17Q23,ACCORDING,ACE,AIM,CONCLUSION,CUSHING,GENOMIC,HACE3AS,LABEL,METHODS,OBJECTIVE,PCR,PRIMARY,RESULTS
AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RECURRENCE,RESULTS,TOTAL,WAGENEN
140,160,215,FINANCIAL,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
182,BRAIN,C30,CONCLUSION,CONTROLLED,COX,EORTC,GREATER,GROUP,HOPKINS,INVENTORY,LABEL,MDASI,METHODS,MOTOR,NCB,NCF,OBJECTIVE,OVERALL,PFS,PURPOSE,QLQ,QUALITY,RADIATION,RESULTS,REVISED,SYMPTOM,TESTS,THERAPY,THERE,TRAIL,TREATMENT
001,012,173,833,CONCLUSION,GBM,HOWEVER,III,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,THERE
100,ADC,CNS,COGNITIVE,CONCLUSION,FAZEKAS,FIFTY,KARNOFSKY,LABEL,METHODS,MPV,MRI,OBJECTIVE,PFS,PURPOSE,RESULTS
001,176,246,526,BLOOD,CENTRAL,CONTINUOUS,FEVER,IMPORTANCE,JANUARY,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PERCENTAGE,RELEVANCE,REMAINING,RESULTS,SETTING
946,HOWEVER,IHC,JCV,K19,PULMONARY,THESE,USING
BRAIN,COMMITTEE,ERASMUS,JOHAN,KENNETH,MEDICAL,ORGANIZING,PATHOLOGY,SATELLITE,SOCIETY,TEXAS,THESE,UNIVERSITY
007,10B,946,FURTHER,PCR,SHG,TGF,THEREFORE
100,169,COPYRIGHT,EIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
169,COPYRIGHT,LTD
001,002,010,044,099,201,472,630,BACKGROUND,COX,FINALLY,JANUARY,KARNOFSKY,KPS,LABEL,METHODS,PCR,RESULTS,UNIVARIATE
001,006,AMONG,CHINA,CONCLUSION,INDIA,LABEL,METHODS,OBJECTIVE,RESULTS
215,956,GAG,GBM,HEPARAN,III,SEC,STRUCTURES,THROUGH
RESULTS
001,BACKGROUND,BECAUSE,CONCLUSION,HARDY,LABEL,METHODS,PCR,RESULTS,SSTR2,SSTR3,THERE
947,EARLIER,FURTHER,GAMMA,HOWEVER,IMAGE
ASL,THESE
HOWEVER,THERE
544,ATLAS,CONCLUSION,COX,LABEL,LASSO,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
009,025,169,221,265,320,541,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,SCC,TNM,TTF
169,CSB
ATP,USING,WASHING
948,949,BRAIN,CSF,FLAIR,MRI,NMDAR,NR1,SIX
946,BAX,CLU,HOWEVER,NUCLEAR,SEVERAL,TGF,THERE,THESE
CMV,FIRST,GBM,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,STAT3,SUMMARY,THESE
046,391,437,958,CURRENTLY,III,SFRP1
348,ABSENCE,IHC,LABEL,METHODS,OBJECTIVE,PAS,PTC,RCC,RESULTS,SDH,SOMATIC,THEREFORE,THESE,THREE
169,215,24H,90MIN,ANIMALS,COGNITIVE,D14,D18,INC,THERE,THESE,TOTAL,U87MG
005,133,153,160,169,AFFYMETRIX,AUC,COPYRIGHT,CURVE,LTD,REMAGUS,UNDER
169,8TH,COPYRIGHT,PUBLISHED,SAS
132,169,BACKGROUND,COPYRIGHT,GIVEN,GREATER,HOWEVER,INC,INCREASING,LABEL,METHODS,RESULTS,SIXTY,THESE
169,237,241,BACKGROUND,COPYRIGHT,CRANIAL,LABEL,METHODS,MONRO,NEUROCIRUG,PUBLISHED
169,ASL,COPYRIGHT,SAS
001,006,007,012,022,023,056,092,108,160,428,719,844,EVALUATION,FAS,HOWEVER,PCR,TURKISH
169,COPYRIGHT,DISCUSSION,INC
169,COPYRIGHT,GAMMA,GKS,HOWEVER,INC,KNIFE,MRI,STOCKHOLM
169,CAREFULLY,CMS,COPYRIGHT,CROWN,DESPITE,HOWEVER,INC,PUBLISHED,SRS,WAITING
169,BECAUSE,CHORDOMAS,COPYRIGHT,INC,SRS
169,COPYRIGHT,INC,MULTI,SRS
169,BECAUSE,COPYRIGHT,HOWEVER,INC,SRS
169,COPYRIGHT,INC
DIAGNOSTIC,PRIMARY
160,189
169,AUTHORS,EMT,FXS,HOWEVER,LTD,PUBLISHED,THERE,WILEY
200,215,500,956,HOWEVER,MRI,TOTAL
23127,956,BB1,BIM,CETUXIMAB,CONCLUSION,HOWEVER,LABEL,METHODS,NMB,NOVEL,OBJECTIVE,PURPOSE,RESULTS,THESE
BFG,BIFOCAL,CONCLUSION,CSF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
MOWAT,MWS
169,SIMILAR,SONIC,WHILE
BRAIN,FOLLOWING,FURTHER
110,111,136,183,266,COX,INDEX,LABEL,MET,METHODS,OBJECTIVE,POOLING,PURPOSE,RESULTS,RUNNERS,STUDIES,WALKERS
FORMULA,GUI,HAUSDORFF,LABEL,METHODS,MRGLITT,MRI,OBJECTIVE,PURPOSE,RESULTS
34A,53BP1,EFFICIENT,GBM,HOWEVER,R273H,THESE
BBB,MALDI,MSI
100,BASED,DSA,HOWEVER,MIB,MRI,MRS,RIGHT,TMZ
BECAUSE,MRI,SFT,THREE
ACROMEGALY,ADDITIONAL,DESPITE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SETTING
169,AMONG,COPYRIGHT,FEDERATION,FIRST,FURTHER,GLIOMAS,INHIBITION,MCS,MIF,PUBLISHED,SOCIETIES,STAT5,SUBSEQUENT
001,005,029,692,756,885,967,BETWEEN,CONCLUSION,EOR,GTR,LABEL,METHODS,OBJECTIVE,PEARSON,RATES,RESULTS,TOTAL
169,CIP,COLLECTED,CONCLUSION,COPYRIGHT,EIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREGNANCY,RESULTS
1398T,20S,30S,343,345,5825C,70S,ATM,I466M,IVS14,PUBLISHED
169,177,CONCLUSION,CPA,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
169,946,CD248,CD8,HCMEC,HGF,HLA,MALIGNANT,MSC,PDGFR,TGF,THESE,WHILE
169,420,COPYRIGHT,CROWN,III,INTENSITY,JANUARY,LTD,ONCOLOGIC,PUBLISHED,WORLD
169,946,BCSCS,COPYRIGHT,DEFINITION,EMT,EPITHELIAL,LTD,MBC,MDR,SNAIL,TGF,THERE,TWIST
MDP,SPECT
200,BACKGROUND,CONDR,DISCUSSION,FINALLY,HOWEVER,IMAGING,LABEL,METHODS,NEURO,OBJECTIVE,REPOSITORY
324,351,BACKGROUND,CONCLUSION,GBM,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,OCTOBER,OVERALL,PATIENT,RESULTS
BACKGROUND,CONCLUSION,DAT,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SURGERY
BACKGROUND,BECAUSE,DISCUSSION,LABEL,METHODS,UNASSIGNED,VIRTUAL
000,125,956,ANOTHER,CONCLUSION,GIANT,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CCM,DVA,LABEL,METHODS,RESULTS,THERE
BACKGROUND,COX,EOC,GROUP,HOWEVER,JANUARY,LABEL,MEIER,METHODS,RESULTS
ASIAN,GNRHA
BACKGROUND,BASED,CONCLUSION,EVALUABLE,GBM,KPS,LABEL,LIMITED,METHODS,PFS,RESULTS,STUDIES,TMZ,TOXICITIES
CETUXIMAB,HOWEVER,NATURAL,THEIR
008,AGE,CSS,END,GTR,INSTITUTE,MEIER,OLDER,PROGRAM,RESULTS,THERE
000,112,40S,BECAUSE,S12,WESTERN
148,177,BACKGROUND,DIFFUSE,LABEL,METHODS,MRI,RESULTS
946,BCL,THEREFORE
BEDSIDE,HAITIAN
001,033,034,181,450,945,946,BACKGROUND,BRAIN,EXPRESSION,KRUSKAL,LABEL,METHODS,RESULTS,THERE,THREE
046,102,501,778,908,9TH,AMONG,BACKGROUND,CENTERS,CMS,CONCLUSION,HAC,HEALTHCARE,INCREASING,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,PSI,QUALITY,RESULTS,THESE
169,177,AFTER,COPYRIGHT,HOWEVER,IMAGING,LTD,STUDIES,THREE
100,100ML,250,6MG,8MG,BACKGROUND,HOWEVER,IRS,LABEL,MATERIALS,METHODS,RESULTS,TRS,WOMEN
100,ACUTE,BECAUSE,CONCLUSION,CTV,GTV,JANUARY,LABEL,MATERIALS,METHODS,NPC,OBJECTIVE,PURPOSE,REPLANNING,RESULTS,THERE,TPF,V95
19Q,19Q13,229,GBM,PCR,WESTERN
945,946,DUE,FSH,PRL,TSH
169,ATT,BACKGROUND,BASEL,CONVERSELY,CPG,EGF,GH3,HOWEVER,LABEL,METHODS,MMP,OBJECTIVE,PRIMARY,RESULTS,SUBTYPE,TSA
169,C9ORF72,COPYRIGHT,FINNISH,INC,LHERMITTE,TDP
169,954,AKT,ATLAS,COX,GBM,NETWORK,NPTX2,TAKEN
DESPITE,EPN,GBM,HLA,MED,THESE
AIP,ARG325GLN,BECAUSE,SPANISH
FINALLY,FIRST,RESISTANCE,THESE,TMZ
120,678,AUSTRALIA
BRAIN,III,WHILE
008,EPN,RADIATION,THREE
006,100,174,ATTACHMENT,BACKGROUND,CONTROL,CSF,DEPTH,LABEL,METHODS,POSTERIOR,RESULTS
AFTER,BACKGROUND,CONCLUSION,FURTHER,HORNHEIDE,HSI,INSTRUMENT,KARNOFSKY,LABEL,METHODS,RESULTS,SCORE,SCREENING,WOMEN
BACKGROUND,CNS,HIV,LABEL,METHODS,RESULTS,SCORE,UNIVARIATE
100,177,CONCLUSION,FDG,KEY,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,PET,PPV,RESULTS,THEIR,THERE
AGIOS,DAC,DECITABINE,GIC,IDH,INDUCTION,THESE
945,DESPITE,FDA,IDH,ISOCITRATE,SOMATIC,THESE,USING
DESPITE,PKM,SEQ,WARBURG
003,100,BACKGROUND,CHANGES,CONCLUSION,CYBERKNIFE,FIFTY,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,SRS,UNIVERSITY
BACKGROUND,DEVELOPING,LABEL,METHODS,RESULTS
150,169,170,300,ANTITUMOR,BSA,CSF,INITIALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RES,RESULTS,SHH,SONIC,THREE,VISMODEGIB
002,003,006,010,168,169,199,200,259,317,860,875,885,902,933,AKT,COX,FRAP1,HRS,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SNP
169,945,AKT,CURRENTLY,LABEL,METHODS,OBJECTIVE,PI3KS,PURPOSE,RESULTS
CD133,CONSISTENT,CPG,GBM,GFP,HIF,HRE,HYPOXIA,HYPOXIC,INDUCIBLE,METHYLATOR,PHENOTYPE
EGF,GBM,INCREASING,REMARKABLY,SILENCING
BASED,CLASS,DNT,EEG,ENGEL,III,METICULOUS,MRI
008,028,035,047,829,956,AFTER,IME,MCCORMICK,SURGERY
945,CYTOSOLIC,R132H,SMALL,U87
116,124,177,HOWEVER,MAP,SIX
158,BRAIN,DEPARTMENT,GYNECOLOGY,METASTATIC,OBSTETRICS
HISTOLOGIC

ANY,CSF,HOWEVER,MRI
18F,324,FDG,ICC,MRI,PET,SITES,SKULL

946,DIPGS,III,NANOG,OLIG2,STUDIES,WORLD
HOWEVER,S6K,SHH
19Q,CURRENTLY,GROUP,HOWEVER,IDH,III,LABEL,OBJECTIVE,OMICS,PCV,PURPOSE,RADIATION,RESULTS,SUMMARY,THERAPY,TREATMENT,V600E
EPIGENETIC,GROUP,HOWEVER,LABEL,NOVEL,OBJECTIVE,PROFILING,PURPOSE,RESULTS,SHH,SUMMARY,WNT
169,17P13,231,ADRB2,ATOH1,CONVERSELY,COPYRIGHT,CXCR7,EPHA2,FINALLY,INC,MDA,THESE,VLDLR
002,003,169,421,708,ADULT,COPYRIGHT,INC,LABEL,MEIER,METHODS,OBJECTIVE,RECURSIVE,RESULTS,RPA,THESE
169,HOWEVER,MICRORNAS,VIRAL
169,BACKGROUND,CONCLUSION,COPYRIGHT,ENDOSCOPIC,INC,LABEL,METHODS,PATIENT
001,10172,160,169,229,ACUTE,AMONG,BACKGROUND,COPYRIGHT,INC,INSTITUTES,ISP,LABEL,METHODS,NORSTROKE,NORWEGIAN,ORG,PUBLISHED,RESULTS,SCALE,TREATMENT,TRIAL
169,CCAML,CONCLUSION,COPYRIGHT,III,LABEL,METHODS,MOLECULAR,OBJECTIVE,PUBLISHED,TSC
105,169,556,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
123,126,143,160,169,222,AVP,COPYRIGHT,GAMMA,INC,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS,SRS,WORLD
169,192,198,CNP,COG,COPYRIGHT,D9083,D9803,GROUP,ICE,INC,INTERGROUP,IRS,LABEL,MATERIALS,METHODS,OBJECTIVE,PMRMS,PURPOSE,RADIATION,RAY,RESULTS,RMS,THERAPY,THESE,XRT
169,231,COPYRIGHT,E2100,GEMMS,GIVEN,HOWEVER,III,LTD,MDA,OTHER,SEVERAL,TESTING,TKI
0MG,169,AVAILABLE,BECAUSE,COPYRIGHT,DESPITE,EIGHT,FURTHER,IHS,INFANTILE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OCS,RESULTS,THREE
025,037,106,108,109,134,177,1ST,214,956,ACROMEGALY,CUT,IGF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
003,009,140,177,AGE,DEPARTMENT,GERMANY,LABEL,METHODS,MRI,OBJECTIVE,PREDICTORS,RESULTS,UNIVERSITY,WHITNEY
AREAS,BACKGROUND,BECAUSE,COVERED,LABEL,METHODS,OPINION,SELECTINS
HOWEVER,JANUARY,MARCH,MAY,RCC
564,735,BACKGROUND,CURRENT,GRADING,LABEL,LOS,MEDLINE,METHODS,OCTOBER,OTHER,OUTCOME,RESULTS,USING

ENGLISH,PERTINENT
FRANC,MRI
ALONG,ALZHEIMER,NOTCH
150,945,946,CAP,EXPRESSION,HOWEVER,PRY,SIMILARLY
BACKGROUND,BARKHOF,CNS,IMAGING,LABEL,MAGNIMS,METHODS,MRI,NMO,NMOSD,OBJECTIVE,OBJECTIVES,OVOID,RESULTS
137,558,610,818,894,FINLAND,FINNISH,INSURANCE,MORTALITY,POTENTIAL,PWE
DESPITE,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PATIENT,PMG,PURPOSE,RESULTS
FINALLY,GBM,KETOPROFEN
177,ALA,BACKGROUND,DIFFERENT,FGR,GROSS,GTR,LABEL,METHODS,NOTABLY,RESECTION,RESULTS,VEP,WARNING
AGE,BACKGROUND,CNS,DESPITE,LABEL,METHODS,MRS,NAA,PEDIATRIC,RESULTS,SHORT,SMARCB1
BASAL,BGG,DESPITE,MRI,PHI
THERE
CUSHING,WHILE

169,225,956,CD4,DCS,III,SAMPLES
ALZHEIMER,DROSOPHILA,HUNTINGTON,THEREFORE
002,160,169,230,246,AML,BACKGROUND,CONCLUSION,COPYRIGHT,DLBCL,FURTHER,INC,LABEL,MDS,METHODS,RESULTS,SEVERAL,SIR,WALDENSTR
106,269,708,ABOUT,COX,DISCUSSION,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PRIMARY,RCC,RESULTS,RPA,STUDENT,THESE
EIGHT,ENGLAND,HOWEVER
002,006,016,140,231,409,491,523,708,895,ADULT,DISCUSSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
006,015,032,034,048,183,294,COX,DISCUSSION,HIF,HYPOXIA,LABEL,MEIER,METHODS,MRI,NUCLEAR,OBJECTIVE,OBJECTIVES,RESULTS,THERE
AIM,BACKGROUND,CMS,CONCLUSION,CTV,GTV,IMAGE,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,XIO
BECAUSE,FIFTEEN,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,YET
225,635,954,ATLAS,FINALLY,FUNCTIONAL,GBM,HSPA9,MAPK1,OVERALL,PPI,PSMD3
CSPGS,GBM,PTPRF
169,215,900,CBV,CONCLUSION,COPYRIGHT,DSC,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,WILEY
DEFICIENCY,EPM2A,GS1,MUTATIONS,PBS,WITHOUT
MECP2,UTR
GBM,REDUCED
CHOROID,CPC,FURTHER,GIVEN,GROSS,III,WORLD

LYNCH,MMR,THESE
GBM,WHILE
ENDOSCOPIC
001,002,008,029,118,160,169,174,CDK,COPYRIGHT,COX,DEPARTMENT,FPA,INC,JANUARY,LABEL,MEDICAL,METHODS,MIB,OBJECTIVE,RESULTS,SAMSUNG,UNIVERSITY
169,HOWEVER,PLK,SHH,THEREFORE,THESE,TPC
AKT,FURTHER,NADPH,THERE,THEREFORE,THESE,TREATMENT
00149,BACKGROUND,CONCLUSION,CURRENTLY,GBM,HOWEVER,LABEL,METHODS,OVERALL,RESULTS

AFTER
CUSHING
053,100,121,BACKGROUND,COX,INCREASED,IRR,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
19A,210,231BR,29C,70W,CTC1P,MDA,PCR,THESE,THIRD
001,006,018,109,178,290,576,646,BACKGROUND,HOWEVER,INPATIENT,LABEL,METASTATIC,METHODS,NATIONWIDE,OBJECTIVE,PURPOSE,RESULTS,THERE
246,CIRCADIAN,THERE
062,110,177,204,215,348,400,803,956,968,MTT,SHG,TMZ
100,149,BECAUSE,DESPITE,GAMMA,HOWEVER,KNIFE,LOCAL,OVERALL
AKT,INHIBITION,PRIMARY,U87MG
AMSTERDAM,CASES,CSF,ENDOSCOPIC,JANUARY,SETTING,UNIVERSITY
INCREASED,MBT,PEGYLATED,PSS
368,593,996,DIGITAL,EMF,EXPOSURES,FEW,MAY,ORS,THESE,USING
AWAKE,BACKGROUND,LABEL,METHODS,RESULTS,USING
109,398,AFTER,ASPIRIN,PCR,THESE,TREATMENT
002,025,032,059,160,169,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,COPYRIGHT,LTD,SINCE
169,6MONTHS,ADVERSE,COPYRIGHT,CTCAE,INSTITUTE,LTD,SIX,TMZ
AFM,USING,WHILE
AFRICAN,MRI,PATIENT,PITUITARY,THEREAFTER
001,168,650,COX,HOWEVER,KARNOFSKY,KPS,MEIER,MICRORNAS,PCR,RESULTS,THESE,WORLD
THESE,U87,WESTERN
ACROMEGALY,MDS
472,984,CAUCASIANS,HOWEVER,MET,OVERALL,THEREFORE,THR,THR241MET,XRCC3
176,EMA,FEWER,FOCAL,HMB45,HPF,KIT,METASTASES,PECOMAS,SEVENTEEN,SIXTEEN,THREE
102,127,165,193,2N0M0,AFTER,BACKGROUND,BETWEEN,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PET,PFT,PTV,RESULTS,SURGERY,THERE
169,BRAIN,CLINICALLY,DESPITE
GD3,THESE
001,014,029,102,160,169,198,BACKGROUND,CK5,COPYRIGHT,CXCR4,LABEL,LTD,MBC,METHODS,RAD51,RESULTS,THERE,USING
BACKGROUND,EARLY,LABEL,METHODS
BACKGROUND,BETWEEN,CONCLUSION,LABEL,METHODS,MRI,THERE,TREATMENT
CNS,CONCLUSION,FAT,KNOWING,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SWI
METASTASES,SMALL
1536G,AKT,CRE,FSH,FSHWT,HOWEVER,M512I,PKA,SCHMIDT,SEQUENCING,SRC,THERE,THESE,TSH
500,ABCPC,B16,F98,IMS,ION,LAT,MICROSCOPE,SINCE
SEVERAL
DESPITE,EFFICIENT,PROLONGED,THERE
PREVIOUSLY,THERE,USING,WGCNA

AAA,ADP,AFTER,BACKGROUND,CLINICALLY,CONCLUSION,GBM,LABEL,METHODS,RESULTS,U87MG,WESTERN
057,CSI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
160,CPA
GRADE,IDH,PAS,THESE,V600E,WHETHER
038,241,GBM,III,MUSASHI,SAMPLES
112,AFTER,AMONG,END,EPENDYMOMA,ESM,GTR,INCLUSION,RESULTS,WORLD
CNV,CONCLUSION,FOXP1,GBM,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PIK3IP1,PURPOSE,RAP2A,RAS,RESULTS,RUNX3,SIX,SVZ
BACKGROUND,CONCLUSION,DIFFUSION,DTI,GQI,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,EARLY,HOWEVER,LABEL,LESIONS,METHODS,OBJECTIVE,RESULTS,TARGETS,TEN,UNIVERSITY,WASHINGTON
169,BECAUSE,CONGENITAL
169,GALEN,MECHANISMS
CDC,HPV,NOVEL,TEXAS
169,COPYRIGHT,FEDERATION,IRELAND,LTD,MAJOR,MEP,PUBLISHED
100,169,BRAINSTEM,COPYRIGHT,GROSS,LTD,MRI,RADICAL
109,169,COPYRIGHT,GROUP,LTD,REDUCED,THEREFORE
169,AQP,AQUAPORIN8,COPYRIGHT,CROWN,INC,PUBLISHED,THEREFORE,WESTERN
118,169,172,2ND,AAN,AED,CONCLUSION,COPYRIGHT,GBM,INCIDENCE,IRB,LABEL,METHODS,MINIMAL,OBJECTIVE,POSTTAE,RECORDS,RESULTS,ROCHESTER,TAE,THERE,TIE,UNIVERSITY
004,157,165,169,175,COPYRIGHT,INC,LABEL,LMD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,VARIABLES
169,19Q,COPYRIGHT,G395A,INC,MOLECULAR,OLIG2,R132H,THERE,THESE
169,APART,COPYRIGHT,FIRST,HODGKIN,HOWEVER,LTD,PCNSL
169,CAR,COPYRIGHT,III,LTD
169,ASSESSMENT,LTD,MEDLINE,PUBLISHED,REVIEWS,REVISED,SIX,SRS,SYSTEMATIC,TH1,WILEY

001,002,100,CSF,FORTY,GROSS,GTR,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,STR,THESE
DESPITE,HODGKIN,NHL,PCNSL,PRIMARY
769,BACKGROUND,BRAIN,LABEL,METHODS,PCR,RESULTS,UNASSIGNED,VIRTUAL
BACKGROUND,DIFFUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
DTI
557,AIM,ALTOGETHER,BACKGROUND,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTY
100,COMPARING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DESPITE,GBM,THESE,WORLD
149,169,188,518,AFTER,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,III,IVA,LABEL,METHODS,RESULTS,SIXTEEN,TMT
169,AFTER,BACKGROUND,BASEL,CONCLUSION,DDAVP,DELAYED,LABEL,METHODS
169,BACKGROUND,CONTEXT,COPYRIGHT,DIAGNOSTIC,INC,LABEL,LBP,LOW,METHODS,OBJECTIVE,PREGNANCY,PURPOSE,RESULTS
BRAIN
100,169,COPYRIGHT,DEFINITIVE,FORTY,IRELAND,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SRS
120,169,CONCLUSION,COPYRIGHT,FEDERATION,FIFTEEN,INDUCED,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,BESIDES,COPYRIGHT,FINALLY,HOWEVER,IRELAND,LTD,SINCE
740,CONCLUSION,HOWEVER,IMAGING,LABEL,LOW,MBQ,METHODS,PET,RESULTS,TESTICULAR,THERE,UNLABELLED
100,216,AIP,ASIAN,CHINESE,CONCLUSION,HAN,HOWEVER,LABEL,LARGE,METHODS,MULTIPLEX,OBJECTIVE,PAS,RESULTS,SPA
177,BACKGROUND,DIFFUSE,EFS,EVENT,JANUARY,LABEL,METHODS,RESULTS
169,ASSESSING,BECAUSE,COPYRIGHT,LTD
169,CNS,COPYRIGHT,FIRSTLY,HOWEVER,LTD,TAKEN,THIRDLY,WHILE
339,450,BACKGROUND,EARLY,EORTC,INCLUSION,LABEL,LGG,METHODS,NORTH,PFS,RESULTS,THREE,TREATMENT
454,BACKGROUND,HGA,LABEL,METHODS,MOSAICISM,RESULTS
BRAIN,CURRENT,LABEL,OPINION,PCI,QOL,STATEMENT,UNASSIGNED
CNS,TMX
176,220,BACKGROUND,EIGHT,FHP,FIFTY,FRANKFURT,LABEL,METHODS,NOISE,RESULTS,TEN,VALVE,VASALVA
194,280,399,772,886,ARG194TRP,ARG280HIS,ARG399GLN,CHINA,POLYMERASE,THREE,XRCC1
INO
64257,64258,ANEMONE,ANNEXIN,BAX,BCL,FAS,GBM,SAPONIN,THEREFORE,TREATMENT,U87MG
AFTER,BRAIN,LARGE,LCNEC,MRI
159,AFTER,CBDCA,CEA,DOC,PTX,SRS,T2AN0M0,T2AN1,UFT
JAPAN,THEREFORE,VARIOUS
CNS,DIFFUSE,HOWEVER,THESE
100,BACKGROUND,CONCLUSION,DMEAN,DNEAR,LABEL,METHODS,PURPOSE,RESULTS,TECHNICAL,V10
946,947,ALZHEIMER,DESPITE,FDA,LXR,RXR,TARGRETIN
PARKINSON,TBI,TRAUMATIC
100,125,177,BACKGROUND,BETWEEN,CSR,ENGEL,FOLLOWING,HOWEVER,III,LABEL,METHODS,PROCEDURE,RESECTION,RESULTS,SBT,SEIZURE,SPACE,WORLD
10Q,261,ATLAS,BACKGROUND,CLASSICAL,CONCLUSION,HOWEVER,HOX,LABEL,METHODS,RESULTS,THESE
AFTER,BACKGROUND,CIS,GBM,HOWEVER,HRS,LABEL,MEIER,METHODS,RESULTS,SIMILAR,TMZ,VHA
160,268,404,831,AGGRESSIVE,AMONG,APRIL,CERTAIN,COLLEGE,DIFFERENT,EARLY,JANUARY,MEDICAL,MIXED,SLE,UNION
CONNEXIN43
ARG,CAUCASIANS,HOWEVER,PRO
041,100,169,266,400,ADDITIONAL,ASTRO,FAVORED,KWIKSURVEY,MRI,NEUROLOGIC,QUESTIONS,RADIATION,SNO,SOCIETY,SRS
044,062,105,DUE,HEMORRHAGE,III,MRI,SWI,WHETHER
949,954,ACTIVATED,DEPLETION,EGF,GBM,HOWEVER,PKC,THESE
HOWEVER,TRAIL,TREATMENT,U87MG
BACKGROUND,CNS,LABEL,METHODS,RESULTS,SFT
169,ANOTHER,COPYRIGHT,TET
169,CD3,CD8,FOXP3,GBM,INCREASED,PUBLISHED,SEVERAL,TREGS
AKT,BACKGROUND,CONCLUSION,CSC,DELO3,EFFICIENT,GBM,LABEL,METHODS,PBS,PCR,PI3,RAS,RESULTS,RGD,TMZ
FINALLY,FURTHER,GBM
MRI,SWI
PCR,SHG44,STMN1,U87MG,UTR
AKT,CD133,CSC,DESPITE,GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,PI3,PURPOSE,RESULTS
001,047,117,169,843,BACKGROUND,EARLY,HOWEVER,LABEL,LGG,METHODS,PATIENT,RESULTS,WORLD
174,194,945,CNS,MASSARRAY,WORLD
169,CONCLUSION,COPYRIGHT,ETV,ITALIAN,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RESULTS
169,177,24H,BACKGROUND,CONIVAPTAN,COPYRIGHT,CUSHING,LABEL,LOS,METHODS,RESULTS,SIADH,THREE,VAPTANS
33342,AFTERWARDS,AKT,BAD,GFP,HOECHST,MTT,TAKEN,U87MG
100,120,123,169,956,FURTHER,HOWEVER,THESE
169,COPYRIGHT,CUSHING,OCTOBER,PUBLISHED,SEPTEMBER
945,JNJ,SERDEMETAN,TREATMENT,WHILE
BACKGROUND,LABEL,METHODS,POSTCANCER,RESULTS,TRIAL,UNTIL,VOLUMETRIC
001,131,136,138,147,201,269,490,766,ACROMEGALY,BACKGROUND,CONVERSELY,IGF,LABEL,MEDICAL,METHODS,MSA,PITUITARY,RESULTS
231BR,AKT,BRAIN,FINALLY,IGF,KNOCKDOWN,MDA,USING
124,153,644,703,967,ADULT,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,RESECTIVE,RESULTS,RPM,SUCCESSFUL
001,002,007,225,248,966,BACKGROUND,CAF,EDN,HJURP,III,LABEL,PDLI4,PRINCIPAL,RESULTS
ANNEXIN,FINALLY,FMK,HOWEVER,INHIBITION,LC3,NATURALLY,NIGELLA,THERE,VAD
169,61546,61548,62165,ARS,BACKGROUND,CARRIER,CONCLUSION,CPT,CURRENT,ENDOSCOPIC,EXAMINING,HOWEVER,LABEL,LLC,METHODS,MIDWEST,NORTHEAST,PROCEDURE,RESULTS,SOUTH,SUMMARY,TSA,WESTERN
169,AKT,FINALLY,INC,THYMOMA,VARIOUS,WILEY
079,169,319,AUSTRALIAN,BACKGROUND,CASES,CBT,CHILDHOOD,CONCLUSION,CONTROL,GWG,INC,INSTITUTE,LABEL,METHODS,ORS,PROCEDURES,RESULTS,STATE,WILEY
169,ATTENTION,BACKGROUND,BTS,COGNITION,CONCLUSION,EARLY,FORTY,INC,LABEL,METHODS,QUICKTEST,RESULTS,SCALE,WILEY
169,AGE,BACKGROUND,EFS,HIT,INC,LABEL,LGG,METHODS,NFI,PFS,PROCEDURE,RESULTS,SEVERAL,SML,TEN,TREATMENT,VCR,WILEY
169,BACKGROUND,COPYRIGHT,EAGLE,LABEL,LTD,METHODS,PEG,PEGYLATION,PEI,RESULTS,RGD,RGDYK,U87,WILEY
169,CHOROID,CPP,CSI,INC,WILEY
169,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
169,170,177,946,BACKGROUND,CONCLUSION,DOPPLER,FORTY,GENERAL,INC,KUWAITI,LABEL,MATERIALS,METHODS,MRA,MRI,OBJECTIVE,RESULTS,SBI,SCD,SIGNA,TCD,TESLA,THERE,VIVID,WHILE,WILEY
169,947,ATLAS,DLL,GBM,GENOMIC,GIC,HOWEVER,INHIBITION,MAML1,NOTCH,PRESS,RESPONDER
169,COPYRIGHT,HOWEVER,PRESS,RADIATION,SVZ,THESE
169,HOWEVER,MEIER,SUICIDE
169,ESC,GRADE,III,MEIER,MYC,NANOG,THESE,WHILE
169,AUTHORS,BACKGROUND,INC,LABEL,METHODS,NCF,RESULTS,SOCIETY,SRS,THERE,WILEY
169,ABCB1,ABCG2,ALK,AUC,CRIZOTINIB,NSCLC
186,APAF1,APPLIED,BAX,BCL,BIOSYSTEMS,BIRC5,CARD4,CNS,HTB,IAP,NLR,THERE,THESE,TNF
004,012,CHANGES,CONCLUSION,LABEL,MATCHED,METHODS,OBJECTIVE,RESULTS
40P53,916,ACTIVATED,ENDOGENOUS
001,200,CHANGES,PREVIOUSLY,PTV,REDUCTIONS,THESE
169,537,945,946,954,AKT,ATLAS,CK2,CSNK2A1,GLIOMAS,HSP90,INHIBITION,JAK,LABEL,OBJECTIVE,PROJECT,PROTEIN,PURPOSE,RESULTS,WNT
SIX
148,BASED,THEREFORE,TSS
BILATERAL,CSF,EETSA,SIXTY
BACKGROUND,DOPPLER,IMAGE,IMAGING,LABEL,METHODS,NAVIGABLE,RESULTS
HOWEVER
HOWEVER
169,ANEURYSMS,BACKGROUND,COPYRIGHT,DOPPLER,INC,LABEL,MEP,METHODS,RESULTS,VARIOUS,VOLUNTARY
11Q,11Q14,11Q23,169,COPYRIGHT,MCA,SAS
169,AIP,CDH13,COPYRIGHT,GADD45B,GADD45G,IRELAND,LTD,PRKAR1A,RB1,SOCS1,THEIR,THESE
169,4CM,COPYRIGHT,DIAGNOSIS,NON,PUBLISHED,THERE,TMZ
169,ACCEPTANCE,CAREFUL,COPYRIGHT,DISCUSSION,EMPIRICAL,HDMTX,HYPOTHESIS,LABEL,LTD,METHODS,MTX,OBJECTIVE,UNASSIGNED
169,BRAIN,COPYRIGHT,LTD,MRI,POD
169,AUTHORS,BBB,CNP,COPYRIGHT,INC,NF1,NOS,PUBLISHED,RAS,RASOPATHY
169,967,CHILD,COPYRIGHT,EDITION,HOWEVER,III,JAPAN,LABEL,METHODS,MPH,NEUROLOGY,OBJECTIVE,PUBLISHED,RESULTS,SCALE,SOCIETY,THESE,THIRD,VAL,VAL158MET
169,COPYRIGHT,DYNC1H1,LTD
117,177,23R,BACKGROUND,CD3,CD4,CSF,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,THERE
169,BAF47
AMONG,BACKGROUND,CHINA,LABEL,MEDICAL,METHODS,NPC,RESULTS,SOUTHEAST,SUN,UNIVERSITY,YAT
169,COPYRIGHT,FIRST,LTD,MRI
CONCLUSION,EEG,FOURIER,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PERSISTENT,RESULTS,WILEY
013,169,172,203,AFTER,BACKGROUND,COPYRIGHT,DISEASE,END,HBV,HCC,HCV,INC,LABEL,LIVER,METHODS,MILAN,MODEL,OLT,OVERALL,RESULTS
169,4T1,LTD,TH2,THESE,TSLPR,WILEY
169,MATURATION,SOCIETY
001,169,536,AGAINST,FOCAL,INC,KEY,LABEL,METHODS,MRI,NF1,OBJECTIVE,PURPOSE,RESULTS,THESE,WILEY
ALA,BACKGROUND,CALCITRIOL,CHANGES,CONCLUSION,HOWEVER,LABEL,METHODS,PDT,RESULTS
120,169,177,BACKGROUND,CBF,CO2,DOPPLER,FEW,FOUNDATION,LABEL,LTD,MAP,METHODS,PUBLISHED,RESULTS,SJVO2,TCD,THERE,WHILE,WILEY
125,155,291,582,585,608,7CM,CLEAR,LABORATORY,OVARIAN,QN569,RENAL,UROLOGICAL
100,III,REGIMEN
CENTRAL,MEP,TMS
100,465,CUSHING,DUE,MEV,SUSTAINED,THERE
945,CSF,MALIGNANT,MDSCS,SUPPORTING
ALZHEIMER,AMP,CPG,SH3,THESE
CUSHING,GHD,HOWEVER,INCREASED,REPORTS
00001,004,19Q,19Q13,CIC,DROSOPHILA,FUBP1,HOWEVER,SOMATIC,THERE,UNIVARIATE,USING
169,ATP,CC214,ENCODED,LABEL,LIBRARIES,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
CLOSE,CNS,CONCLUSION,EVD,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE
100,169,340,BACKGROUND,BASED,COPYRIGHT,DMD,LABEL,LTD,METHODS,PROCEDURES,RESULTS
130,ACCORDING,CONCLUSION,FDG,LABEL,MBQ,METHODS,PET,RADIATION,RESULTS,UNLABELLED
169,CHINA,FDG,HOWEVER,JOURNAL,KNOWLEDGE,LABEL,MEDLINE,PET,SUBSEQUENT,SUMMARY
169,BACKGROUND,BESIDES,COPYRIGHT,ESM,LABEL,LTD,METHODS,RESULTS
AVAILABLE,EORTC,HOWEVER,LIMITED,POTENTIAL
BRAIN,OPTIMAL
19Q,PRIMARY,THESE
CNS,T790M
169,237,241,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METHODS,NEUROCIRUG,NSE,PGP,PUBLISHED,RESULTS
945,946,ALA,ARG,ASP,GLY,INTRAVITAL,U87MG
CASES
BASED,GIVEN,KNOCKDOWN,MBS,NEUROPILIN,NRP
BACKGROUND,CCI,CLASS,EDEMA,GERIATRIC,GRADING,GSS,INDEX,KARNOFSKY,LABEL,METHODS,RESULTS,SCALE,SCORING,SEVERAL,SEX,SKALE,SOCIETY
105,1980S,BACKGROUND,CONCLUSION,DESPITE,EIGHT,FIFTY,FORTY,LABEL,LOW,METHODS,RESULTS,ULTRASOUND
160,AFTER,BRAIN,THESE
220,CHINESE,GTP,HERMANSKY,HOWEVER,MEIER,RAB,RAB38,REMBRANDT,THESE,THREE,WHOLE
205,CNS,ESTIMATES,HODGKIN,LABEL,MEDLINE,METHODS,ORS,RESULTS
145,160,214,23A,718,720,AGILENT,PCR,SPC,THESE
403,488,720,HOWEVER,MRI,NANOPROBES,SIO,TPF
169,FDG,INCREASING,PET,THESE
001,003,13N,177,250,825,AMMONIA,AMONG,CONCLUSION,FIFTY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS
BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
CD3,KUPFFER,THESE,WEN
BAK,BAX,BCL,BH3,ERBB1,HDACI,KNOCKDOWN,LC3II,MCL,PRE,THESE
127,FIFTEEN,HOWEVER,LESIONS,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,THESE
ADENOMA,HOWEVER,PITUITARY

239,945,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,RESULTS
100,AIM,CONCLUSION,EIGHT,GRADE,LABEL,METHODS,MRI,OBJECTIVE,PFS,RESULTS
BACKGROUND,CONCLUSION,LABEL,METHODS,PANCREATIC,SRS
001,003,005,155,AIM,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS,SIX
003,DR3,FRESH,FSH,LOW,PITUITARY,THERE,TSH
LARGE,LCNEC,NCI,SINCE,THEREFORE,THESE
ALK,ANAPLASTIC,ATP,DESPITE,HOWEVER,NSCLC
100,273,ADENOVIRUS,BACKGROUND,CAR,CONCLUSION,COXSACKIE,EXPRESSION,HOWEVER,LABEL,METHODS,RESULTS,TMA
003,025,169,250,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,FAVORABLE,FORTY,GEFITINIB,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,RESULTS
12A,ABC,ABCG2,ATP,HOWEVER,INHIBITORS,KO143,MDR,THESE
6TH,7TH,AFTER,BACKGROUND,CASES,LABEL,METHODS,TOMOGRAPHY,USUALLY
946,HOLARRHENA,INHIBITORY,RESULTS,ROS
AIF,APOPTOSIS,SURVIVING,TREATMENT
129,169,COX,FINALLY,GROUP,HEADSTART,NANOSTRING,SHH,SONIC,THESE,WNT
169,BACKGROUND,ETF,INC,LABEL,METHODS,PEDIATRIC,PPS,PROACTIVE,RESULTS,THOSE,WILEY
AKT,CIP,ERK,EXPRESSION,KIP,KNOCKDOWN,MALIGNANT,THESE
945,USING
036,177,944,FIG,KRAYENBUHL,TABLE,UNIVERSITY
HIV,PERIPHERAL,THERE
BECAUSE,DEPENDING,DESPITE,DUE,FULLERENOL
169,174,20YEARS,DOXIL,INCREASED,PNM,SINCE
169,COPYRIGHT,LTD
169,252,COPYRIGHT,LTD,MAYER,ROKITANSKY
169,CKB,HOWEVER,ONCONEURAL,PCD,PNS
001,018,028,169,173,177,482,596,AMONG,BRAIN,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,MLR,NOTABLY,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,TREATMENT
112,133,BRAIN,GBM,MMP,PRIMARY,TAKEN,WILLEBRAND
1ST,3RD,KOREA
FURTHER,MRI,TESLA
BMJ,DESPITE,GROUP,LIMITED,MECHANICAL,PAPILLARY,PFE,PUBLISHED,PUBLISHING
145,ALTERATION,AMONG,CPG,DESPITE,HOX,HOXD9,LNM,LOW,MBM,PMD
114,172,223,325,945,BACKGROUND,GBM,GROUP,HGG,HOWEVER,LABEL,METHODS,RESULTS,SECONDARY,THERE
DNETS,HOWEVER

004,155,169,AQUAPORIN,BACKGROUND,CAUCASIAN,COX,DESPITE,FINALLY,FUNCTIONAL,FURTHER,GBM,HOMOZYGOUS,INC,LABEL,METHODS,RESULTS,SEQUENCING,WILEY
183,BACKGROUND,CONCLUSION,DELAYED,GEORG,ICA,LABEL,METHODS,RESULTS,STUTTGART,THESE
169,BRITAIN,C1Q,COPYRIGHT,CTRP8,EMPLOYING,FINALLY,GREAT,HEK293T,IRELAND,LTD,PUBLISHED,RXFP1,SOCIETY,WILEY
FAS,FASTK,HOWEVER,MEIER,MICRORNAS,PCR,THESE,THROUGH
AES,ANY,BACKGROUND,BMS,BRAIN,DISEASE,LABEL,LAPATINIB,METHODS,MRI,MTD,RESULTS
111,160,215,AFTER,CONCLUSION,EVALUATION,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
006,301,BACKGROUND,CELLSEARCH,CNS,CTC,LABEL,MBC,METHODS,RESULTS,UNASSIGNED
MONOMERIC,MYC,PKM,WARBURG
169,CASPASE,CD1,CISPLATIN,COPYRIGHT,IRELAND,LTD,SALMONELLA,SKI,TBARS,THEREFORE
123,127,160,169,174,177,AAG,ABOUT,ALLYLAMINO,DUE,GBM,HSP90,POLYMERIC,U87MG
169,CAREGIVERS,COPYRIGHT,EXTENSIVE,HOWEVER,INC,THESE
169,945,946,AKT,COPYRIGHT,EPIDERMAL,FURTHER,IRELAND,LTD,THESE,VHL
005,169,177,241,AGE,BACKGROUND,BMI,CHM,COPYRIGHT,HBA1C,HOWEVER,IFG,IGF,LABEL,METHODS,NATURAL,OBJECTIVE,RESULTS,THERE
169,COPYRIGHT,LTD,METASTASIS,MRI,PCNSL,PUBLISHED
169,INC,RADIATION,THERE
169,COPYRIGHT,IMAGING,LTD
169,COPYRIGHT,PUBLISHED,SAS
169,231,233,COPYRIGHT,CTV,GTV,MRI,PET,PUBLISHED,SAS
169,BAKER,COPYRIGHT,EVALUATION,JAPAN,LABEL,LANCASHIRE,METHODS,OBJECTIVE,PANSS,PROFILE,QLS,QOL,QUALITY,REHAB,RESULTS,SCALE,THERE
100,169,200,956,AUC,BACKGROUND,BBB,CONCLUSION,COPYRIGHT,CSF,GEFITINIB,ICA,INCREASED,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS,THEREFORE
169,COPYRIGHT,D40,HENCE,HIPPOCAMPI,NSCLC,PUBLISHED,SAS,SPARING
100,100MG,169,21D,28D,AUTHORS,COPYRIGHT,DIFFUSE,FORTY,HOWEVER,KARNOFSKY,LTD,OVERALL,PUBLISHED,THERE,THREE
142,168,169,172,207,244,281,313,457,569,598,666,675,804,ACUTE,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,RESULTS,THERE
100,CNS,CSF,LABEL,METHODS,OBJECTIVE,RASMUSSEN,RESULTS,THESE
THREE
AFTER,BACKGROUND,CSF,EETCA,METHODS,RESULTS
BACKGROUND,BECAUSE,ENGLISH,LABEL,METHODS,THERE
032,214,EXPERIENCE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,027,251,A1207,ABCG2,ALA,ATP,CDH13,CURRENTLY,GLIOMAS,KNOCKDOWN,LABEL,METHODS,NMCG1,OBJECTIVE,PEPT1,RESULTS,SEVERAL
017,046,150,BACKGROUND,BMPFS,C30,CLQ,CONCLUSION,EORTC,III,LABEL,METHODS,MEXICAN,OBJECTIVE,ORR,PURPOSE,QLQ,QOL,QUALITY,RESULTS,SEVENTY,TREATMENT,WBI
CNS,ECM,FURTHER,GBM,III,THEIR,THESE
DEPRESSION,INVENTORY,KARNOFSKY,NOTTINGHAM,PREVALENCE,PROFILE,SCALE,UNIVERSITY
CUSHING,SMALL,THERAPY
100,A15,ELA,III,SELEX,U87
531,813,BBB,BDDCS,CNS,HOWEVER,INSTITUTE,INSTITUTES
109,169,897,ADDITIONAL,AREVA,BACKGROUND,BASED,CONCLUSION,COX,HRS,INC,LABEL,METHODS,MORTALITY,NUCLEAR,RESULTS,WILEY
025,169,254,311,ACCORDING,BASEL,CONCLUSION,COPYRIGHT,FLAIR,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
HARDY,MIB,NOS,THERE,THESE
160,AKT,BAX,BCL,CHG,HOWEVER,RACK1,SRC,THESE,U87

169,208,319,AMONG,BACKGROUND,CCS,CHILDHOOD,CRT,DIAGNOSES,EARLIER,INSULIN,LABEL,METHODS,REGRESSION,RESULTS
ERK,HOWEVER,INHIBITION,JNK,LN229,PHX,ROS,THESE,U0126
BESIDES,INVERSELY,PARKINSON,THEREFORE
169,COPYRIGHT,GIVEN,GROSS,INC,PUBLISHED
169,COPYRIGHT,HOWEVER,INC,PHYSICIANS,PUBLISHED,TROUSSEAU
169,231,233,BRAIN,CONCERNING,COPYRIGHT,DIFFERENT,MRI,PRIMITIVE,PUBLISHED,SAS,THESE
116,CTA,CVT,DSA,DSO,DSS
RADIOLOGIC
CBV,DYNAMIC,III,MEIER,PFS
001,019,169,COX,PRL,RUNX1,RUNX2
CMA,GROWCUT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,T1W,THREE
155,177,776,875,889,946,DARMSTADT,DUE,FRACTIONS,GERMANY,GSI,LABEL,MED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TEN,THERAPY,THREE,TOMOGRAPHY
174,FOLLOWING,FORTY,GAMMAKNIFE,LABEL,METHODS,OBJECTIVE,PURPOSE,QUANTEC,RESULTS,SIMULATION
MALIGNANT

EXOME,FGF23,RAS
ANATOMY,BRAIN,FMA,HENCE,LABORATORY,MODEL,SPL
302,967,AFTER,ALOX5,CHINESE,GBM,HAN,HOWEVER,MASSARRAY,NEIL3,SNP
DEFINITIVE,III,MEDLINE,MRI,SEPTEMBER,SEVEN,WHILE
ATTENUATED,CONCLUSION,FLUID,III,IMAGING,INVERSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,SWI,T2FLAIR
FRONTAL
954,FINALLY,HOWEVER,RAMAN,SRS,SURGERY
259,BIPSS,BMJ,BONFERRONI,CUSHING,EVALUATION,EXPLOITING,FOLLOWING,GROUP,IPS,LIMITED,PUBLISHED,PUBLISHING,SAMPLES,SEVEN,THESE
225,BACKGROUND,BEV,CONCLUSION,GBM,IRI,LABEL,METHODS,PATIENT,RESULTS,TMZ
001,007,026,036,038,234,ARG132HIS,CHINESE,G395A,IDH,IDH1R132H,LABEL,METHODS,OBJECTIVE,PCR,PRIMARY,RESULTS
169,AUTHORS,BACKGROUND,JAPAN,LABEL,METHODS,MRI,MRS,PEDIATRIC,PEDIATRICS,RESULTS,SOCIETY,THESE
169,231BR,BRAIN,CNS,LUC,MDA,MTT,THEREFORE,USING
185,BBB,FINALLY,MRI,TNF,TRAIL,TREATMENT,U87
945,ENGINEERED,HIF,HRE,LABEL,METHODS,MRI,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,THROUGH
001,119,160,ADCY1,COX,DECREASED,IGFBP,IHC,KAZALD1,SAM,SIX,SLMAP
23B,AKT,HMG,HOWEVER,LUCIFERASE,TAKEN
ANTICANCER,FURTHER,NOTABLY,THESE
169,BB2,CNS,COPYRIGHT,GASTRIN,GRP,GRPRS,INC
046,102,ACCURAY,AFTER,BETWEEN,FURTHER,OCTOBER,PNS,ROBOTIC,SCC,SEM,SEVEN,SRS,SUNNYVALE,THREE,USA
023,169,BACKGROUND,INC,LABEL,METHODS,MFO,PBS,PROCEDURE,RESULTS,WILEY
176,CSF,HOWEVER,MRI,RCC
122,160,AMONG,BAF47,BASED,CHIPS,CONCLUSION,FABP7,HOWEVER,INC,INI,LABEL,MALIGNANT,METHODS,MON,MRT,OBJECTIVE,PURPOSE,RESULTS,RTK,SMARCB1,TCF21,USA
CNS,HOWEVER
001,117,212,804,AMONG,CONCLUSION,FEW,LABEL,METHODS,OBJECTIVE,RESULTS
2HG,HENCE,IDH,MRS
169,AUTHORS,DESPITE,FOUNDATION,HSC,JOURNAL,LTD,MOLECULAR,PARALLELS,WHETHER,WILEY
CLOCK
169,956,ACUTE,AKT,BRAIN,CURRENT,GFP,INHIBITION,MER,MYC,THESE,TREATMENT,WESTERN
INITIAL,SUBSEQUENT
169,CANAVAN,GIVEN,GTA,HOG,HS683,NAA,NEU,NSC,OLI,TMZ,TRIACETIN,U87,VORINOSTAT
AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TRANSGENIC,WESTERN
ABC,ABCG2,ATP,BINDING,KNOCKDOWN,SP1,SP3
BBB,PEDIATRIC,THEREFORE
AFTER,HOWEVER,OPTIC
001,008,158,177,571,HOWEVER,MEIER,MSP58
001,100,BACKGROUND,EXACT,FLAIR,LABEL,METHODS,MRI,RESECTION,RESULTS
300,622,628,956,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAMPLES
160,COGNITIVE,MRI,STRUCTURAL,THESE,WHILE
263,945,ACTA2,CONSISTENT,EXPRESSION,FAK,LABEL,MET,METASTATIC,METHODS,OBJECTIVE,PC14PE6,PURPOSE,RESULTS,THEREFORE,THESE
ATP,HOWEVER,PARTIAL,POU,SHH,THESE
CLL,CNS,DIFFUSE,DLBCL,EXTRANODAL,IGH,RICHTER
BTICS,GLUT1,GLUT3
100,COMBINING,DSC,HGG,LABEL,METHODS,MRI,NPV,OBJECTIVE,PCNSL,PPV,PRIMARY,PURPOSE,RESULTS,ROC
914,945,947,ELISA,HSP60,HSP70,THERE
169,24H,630NM,6MM,72H,AMI,MTT,NPY,PCR,PKC,RESULTS,TPA,VPA
169,540,701,783,851,EXPRESSION,GENBANK,PCR
169,362,462,CONCLUSION,CONTROL,COPYRIGHT,COX,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THERE,THESE
169,200,COPYRIGHT,SLN,THESE
169,945,BAX,COPYRIGHT,INC,T11,T11TS,THERE,TNF
169,945,946,COILING,COPYRIGHT,ECS,GUGLIELMI,INC,LABEL,MAJOR,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIMILAR
169,CONCLUSION,COPYRIGHT,FIFTY,FORTALEZA,GENERAL,INC,JANUARY,KNOSP,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL
169,COPYRIGHT,EVENTUALLY,IRELAND,LTD,NOW,SUBSEQUENT
169,946,CHANGES,COPYRIGHT,INC,TGF
169,ASSESSMENT,COPYRIGHT,LTD,NEURO
169,ASSESSMENT,CNS,COPYRIGHT,LTD,NEURO
169,BBB,CHOLINE,COPYRIGHT,DGL,DOX,FIRSTLY,LTD,TRAIL,U87
037,097,103,169,190,293,453,752,895,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,MATCHED,METHODS,OBJECTIVE,RESULTS,TREATMENT,UNTIL
176,177,200,BACKGROUND,GBM,LABEL,LOD,MALDI,METHODS,PCR,RESULTS,TOF
002,169,354,382,822,BRITISH,COPYRIGHT,ENGEL,GROSS,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
963,MOLECULAR,PET,SPECT
016,021,023,028,033,039,043,076,407,475,491,945,AKT,GIVEN,HSP,HSP27,HSP40,HSP60,HSP70,HSP90,LABEL,LARGE,MBS,METHODS,OBJECTIVE,RESULTS
002,100,118,177,395,436,466,FHD,FOCAL,GRE,LABEL,METHODS,MRI,OBJECTIVE,PACKARD,RESULTS,THERE
REGARDING
169,49G,CONCLUDING,LTD,PROTEUS,PUBLISHED,WILEY
027,034,039,533,696,ASIAN,BIOMEDICAL,CBM,CHINESE,CIS,LABEL,LITERATURE,MAY,ORS,OVERALL,SCIENCE,THR241MET,UNASSIGNED,UNLABELLED,XRCC3
010,048,155,463,ACCORDING,CCDN1,G870A,GBM,GENOTYPES,HOWEVER,TURKISH
GFP,MG132,OXIDATIVE,U87MG,UBA
207,236,384,CHINESE,DIEGO,MASSARRAY,ORS,SAN,SIX,THESE,USA,XPF
177,CD133,GRADE,III,LABEL,METHODS,MIB,OBJECTIVE,RESULTS
AREAS,BACKGROUND,COVERED,FURTHER,KE108,LABEL,METHODS,OPINION
CURRENT
ASIDE,BBB,CD4,CNS,DESPITE,EAE
052,678,LABEL,METHODS,NSAID,OBJECTIVE,PURPOSE,RESULTS
001,002,014,017,022,031,032,037,046,160,DUE,FEVER,IDIOPATHIC,IGH,THERE,UNIVARIATE
ACCORDING,BASED,FORTY,III
193,AFTER,AMONG,DFS,HNSCC,HPV,OPSCC,PCR,SEVEN
100,1C2,2B7,4A1,956,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,RG2,SULT1A1,SULTS,TUNEL,UDP,UGT,WESTERN
137,238,BRAIN,CAREGIVERS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,LABEL,METHODS,MIDLINE,RESULTS
CONCLUSION,HEARING,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORN,RESULTS
695,826,828,904,905,948,990,995,997,ADDED,AUTOMATED,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VOLUMETRY
169,ADDICTIVE,BECAUSE,COPYRIGHT,ESTIMATES,LTD
160,CENTRAL,FIFTY,LANGERHANS,LCH,SIXTY
140,170,187,ATLAS,BACKGROUND,CONCLUSION,GBM,LABEL,METHODS,RESULTS,SAM,THESE,USING
169,237,241,AFTER,COPYRIGHT,DISCUSSION,LABEL,METHODS,OFTALMOLOG,PUBLISHED
CNS,HOWEVER
236,298,354,451,513,749,AMONG,BACKGROUND,GENOMIC,III,ITALIAN,LABEL,METHODS,OVERALL,PREVALENCE,RESULTS,SARDINIAN
100,20S,215,300,AFTER,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,POSTERIOR,RESULTS,SCALE,TOTALLY
000,071,177,204,260,BAT,CONCLUSION,EPI,GRE,LABEL,METHODS,MTT,OBJECTIVE,PWI,RESULTS,ROC,TEN,TTP
CURRENTLY,THERE,THEREFORE
APA,EIGHT
015,068,BACKGROUND,DENSITY,DEPARTMENT,EXPRESSION,LABEL,LGG,LOWER,METHODS,MRI,OBJECTIVE,PURPOSE,PWI,RESULTS,SOSNOWIEC,STATISTICA,THREE
946,BECAUSE,GBM,IFN,RECIPROCAL,REMARKABLY,SIMILAR
BACKGROUND,BECAUSE,CEREBELLAR,CHEST,CONCLUSION,CYBERKNIFE,LABEL,MARCH,THEREFORE
150,3RD,4TH,ANXIETY,CBDCA,CPT,OCTOBER,SINCE
001,008,023,037,135,ADC,AIM,BACKGROUND,CHO,CONCLUSION,DWI,III,LABEL,METHODS,MRS,NAA,OBJECTIVE,RESULTS
262,ABC,EARLY,ROC,THEIR
BMI,CONCLUSION,EXPRESSION,INCREASED,MATERIALS,METHODS,OBJECTIVES,PCG,PCR,RESULTS
MALIGNANT
ALS,ALZHEIMER,GLUTAMATE,INHIBITION,NDD,PARKINSON
DESPITE,GAD,PNS
169,215,ANOVA,BLI,EVALUATION,FDG,FLT,GIVEN,HGF,LABEL,LUC,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SEQUENTIAL,TARGETING,THERE,U87,VARIOUS
169,COPYRIGHT,INC,OVERALL,POTENTIAL,THESE,USING,WILEY
001,004,COX,HOWEVER,MACC1,METASTASIS
ACT,CD4,CD62L,CD62LHIGH,HOWEVER,OVA,TEM,THEREFORE
160,CNS,GLIOMAS,NGR,SHORT,TUNEL
100,102,BACKGROUND,CONCLUSION,GROSS,IMAGING,IMMEDIATE,LABEL,METHODS,MRI,RESULTS,SIXTY
001,258,818,BACKGROUND,CONTINUED,GAMMA,GKS,IMAGING,JANUARY,KNIFE,LABEL,MEDICAL,METHODS,RESULTS,SEIZURE
CD117,DESPITE,ENDOSCOPIC,SPINDLE
307,BACKGROUND,BRAIN,LABEL,MULTI,QUALITY,RESULTS,TREATMENT
185,CHANGES,FET,MONITORING,PET,RCX,TAC,TBR,TTP
169,ADP,AFTER,ALZHEIMER,ASD,ATP,CDR,CTE,KREBS,METABOLIC,PARKINSON,PUBLISHED,ROS,TBI,THESE
100,104,169,204,AMONG,AUTHORS,BACKGROUND,CHRONIC,CRP,DWI,ISC,JOURNAL,LABEL,METHODS,OBJECTIVE,RESULTS,WORLD
100,169,ABOUT,CONCLUSION,COPYRIGHT,DWI,LABEL,LTD,METHODS,MRI,NEUROLOGY,OBJECTIVE,PAEDIATRIC,PUBLISHED,RESULTS,SOCIETY,T2W
169,969,COPYRIGHT,DHA,FABP7,INCREASED,LTD,MALIGNANT
002,003,215,ADC,AVERAGE,BACKGROUND,COMPARING,CONCLUSION,DTI,ECLIPSE,ESTIMATES,FOLLOWING,LABEL,METHODS,NIC,NORDICICE,REGIONS,RESULTS,THERAPY
002,005,006,AIM,CONCLUSION,GBM,LABEL,METHODS,OBJECTIVE,RESULTS
100,946,CNV,OBESITY,THESE
126,509,ABILITIES,COGNITIVE,CONCLUSION,EDITION,JOHNSON,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TESTS,THIRD
011,018,041,945,CAUCASIANS,CIS,HOWEVER,ORS,OVERALL,POTENTIAL
283,GLIOMAS,KPS,SECONDARY,USING
433,517,COMPARISON,COX,CRT,CTG,EORTC,GBM,MEIER,ONTARIO,PROGNOSIS,THOSE,TMZ
BASED
10Q,19Q,SMALL
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,WHILE
GBM,ISA27,TMZ
ADT,BACKGROUND,BRAIN,GIVEN,LABEL,MAPPING,METHODS,MRI,PARAMETRIC,RESULTS,VBM
046,177,CONCLUSION,DSC,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RESULTS,ROC,STUDENT,TUMOREX
DEPLETION,LUMINEX,LYN,RHO,SFK,SRC,THESE,TWEAK
011,013,016,034,039,736,793,CHINESE,GBM,THESE
BACKGROUND,CONCLUSION,LABEL,METHODS
177,BACKGROUND,BETWEEN,CAVERNOMAS,FAVOURABLE,GLASGOW,GOS,JANUARY,LABEL,METHODS,OUTCOME,PRIMARY,RESULTS,SCALE,SECONDARY
AFTER,AMONG,CD3,CD4,CD8,COLORECTAL,CRC,DEPRESSION,IAP,NEUTROPHIL,NLR,SCALE,SDS,WHETHER
BACKGROUND,CONCLUSION,ELECTRICAL,LABEL,METHODS
060,078,088,097,123,138,166,186,199,341,360,398,549,885,928,966,970,CAUCASIAN,CIS,GSTP1,HOWEVER,ILE105VAL,ORS
130,134,154,190,474,ALEXANDRA,BMS,BRAIN,III,PATIENT,THERE
132,516,AFTER,CASES,JANUARY,MAY,MRI,QUERY,THERE
160,BACKGROUND,CONCLUSION,III,JANUARY,LABEL,METHODS
104,160,200,AIM,CONCLUSION,GBM,LABEL,METHODS,OBJECTIVE,OCTOBER,PFS,RESULTS,TMZ
004,006,017,099,191,215,984,ADC,FLAIR,GRADE,HGG,III,MINIMUM,MRI,NON,PFS,SMALLER,THERE
COGNITIVE,GLIOMAS,THERE,WHILE
116,160,177,BRAINSTEM,BSCMS,MRI,PRE,SCALE
GGD,KLD,LEIBLER,MRI
169,945,COPYRIGHT,CSF,DCS,HEP,IFN,INC,THESE,TRAIL
169,231,233,ASSESSMENT,COPYRIGHT,GPA,KARNOFSKY,PROGNOSTIC,PUBLISHED,SAS,THEREFORE
001,004,169,215,BESIDES,CONCLUSION,COPYRIGHT,FACTORS,FAVORABLE,HOWEVER,IRELAND,LABEL,LOCATIONS,LTD,MATERIALS,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PTV,RADICAL,RESULTS,SEPTEMBER,TREATMENT
160,169,954,AUTHORS,COPYRIGHT,EGF,GBM,INC,K63,PUBLISHED
169,231,233,386,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SAS,STRAUSS
169,COLLEGE,COPYRIGHT,DISEASE,LTD,PUBLISHED,ROYAL,UNIVERSAL
169,5TH,AUTHORS,BASIC,COPYRIGHT,INITIATIVE,LMICS,LTD,PUBLISHED,REGULAR,THESE,WHILE
001,008,031,046,082,098,AFTER,COX,GAMMA,GKS,KARNOFSKY,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,RESULTS,SCALE,UNIVARIATE
001,181,238,384,CMS,CURRENT,LABEL,LOBAR,METHODS,OBJECTIVE,PEDIATRIC,RESULTS
FSH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE
169,945,DIFFUSE,DIPGS,EXPRESSION,FORTY,HGG,PDGFR,SIX,SOMATIC
160,2ME,945,HIF,RAD51,THESE,TMZ
155,AKT,BASED,THESE,UTR
223,PCR,UTR,VEGFA
218,MIR,MTT,SMALL
177,686,CK666,INHIBITION,LN229,SNB19,TRANSWELL
945,EGF,GPCRS,GTP,RHO,TM7
169,AFTER,BACKGROUND,BASEL,COPYRIGHT,DBS,DIFFUSION,DUE,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,STC
DESPITE,FACED,HOWEVER
001,006,010,020,040,084,177,674,ADC,BACKGROUND,CBV,FIFTY,INTRAVOXEL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
161,169,COPYRIGHT,DIAGNOSTIC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,COLLEGE,COPYRIGHT,DWI,LTD,MRI,PUBLISHED,ROYAL
169,APL,AS2O3,AT094,BAX,CATHEPSIN,DESPITE,GBM,INC,U87MG
ACCOUNTING,AEI,BACKGROUND,DEPLOYING,DLPFC,FURTHER,LABEL,MEASURING,RESULTS,SEQ,THESE,USING,WHOLE
004,110,119,BACKGROUND,CIL,CONFORMITY,CYBERKNIFE,FINALLY,GSI,LABEL,LOMAX,METHODS,NEITHER,RESULTS,TPS
137,153,176,223,281,700,BIRTH,CATEGORIES,HOWEVER,INCIDENTAL,INDIVIDUAL,LABEL,LOTHIAN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PREVALENCE,PRIMARY,RESULTS,SECONDARY,SETTING,THERE,WMH
300,ACUTE,APRIL,COMPARISON,COV,FINALLY,HCOVS,RBV,WHILE
CNS,IRANIAN
160,720,AFTER,CROSS,DESPITE,EBI,GIVEN,LEAVE,LOO,THESE,THREE,VALIDATION
BRAIN
BRAIN,CJD,CSF,CSR,DWI,EEG,GENETICAL,JAKOB,MRI,NSE,PSD
BASED,FIRSTLY,MRI,POLYMER
737,ABT,BCL,DESPITE,FINALLY,GBM,PDCD4
177,183,BACKGROUND,CONCLUSION,CUSHING,FIFTY,GAMMA,GEORG,LABEL,METHODS,RESULTS,STUTTGART,TSA
10Q21,21Q22,DIA,DIG,FOCAL,MET,MIP,MOLECULAR,NOTABLY,PRINCIPAL
DECREASED,PROLACTIN,SEX,THESE
276,657,814,DISCUSSION,LABEL,METHODS,OBJECTIVE,RESULTS,RETIREMENT,STUDIES,THESE,TOTAL
BACKGROUND,BORTEZOMIB,CONCURRENT,CONTINUAL,CRM,EVENT,LABEL,METHODS,MRI,RESULTS
DUE,MRI
000,001,002,006,023,025,070,096,144,145,202,221,236,275,279,310,413,419,491,590,600,61A,727,759,836,888,ASIAN,CAUCASIANS,CIS,EGF,HOWEVER,ORS,OVERALL,STATA
HOWEVER,RELAXIN,RXFP1,RXFP3,TAKEN
160,ADULT,ATTENTION,CALIFORNIA,DELIS,EMOTIONAL,EXECUTIVE,HOWEVER,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,WMH
251,373,ECM,FNIII,III,SHORT,THREE,TNFNALL
107,131,160,FDG,HBO,MRI,PET,SUSPICION,TREATMENT
CISPLATIN
169,CONCLUSION,COPYRIGHT,CURRENTLY,LABEL,METHODS,MRI,OBJECTIVE,REGULAR,RESULTS
107,260,CONCLUSION,CTC,GRADE,HEIDELBERG,HIT,III,INDICATION,ION,LABEL,LOCAL,METHODS,QOL,RESULTS,THERAPY,TREATMENT,UNLABELLED
GRADE,HOWEVER
005,023,160,169,215,CSF,PBSCS,WILEY
HOWEVER,THERE
DTI,MRI
001,CT0,CT1,CT2,GTR
169,CONVERSELY,CXORF67,ESS,JAZF1,MBTD1,MEAF6,SUZ12,UES,YWHAE,ZC3H7
183,CONCLUSION,DVT,FORTY,GEORG,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART
183,BACKGROUND,GEORG,HOWEVER,LABEL,METHODS,RESULTS,STUTTGART,TOTAL
100,116,136,141,BELLO,BETWEEN,BURKITT,CONCLUSION,DEPARTMENT,EWING,GEOGRAPHIC,HODGKIN,JANUARY,LABEL,MATERIALS,METHODS,NIGERIA,OBJECTIVE,OBJECTIVES,PAEDIATRIC,PALLIATIVE,PATTERN,RESULTS,SUMMARY,UNIVERSITY,UNLABELLED,ZARIA
169,BAK,BCL,CHANG,COPYRIGHT,DECREASED,EXPRESSION,HEP,HOWEVER,LTD,OVERALL,SKHEP,TUNEL
BACKGROUND,FINAL,HOWEVER,ICG,LABEL,METHODS,RESULTS,THREE
169,DRUGS,ERP,EVENT,P2A,RESULTS,THESE
169,CHILD,COPYRIGHT,NEUROLOGY,PUBLISHED,SOCIETY,TAPIA
CNS,FOLLOWING,IHC,METASTASES,MGA,THESE
169,COPYRIGHT,LAR,LTD,SINCE
128,169,AUTHORS,COPYRIGHT,INC,MICRORNAS,PUBLISHED
005,010,028,049,169,COMMITTEE,COPYRIGHT,DISEASE,JOINT,LTD,MEIER,OVERALL,PUBLISHED,SURGERY,THERE,TNM,TOBACCO,TUMOURS
120,ACCORDING,BACKGROUND,CELSIUS,GOS,LABEL,METHODS,RESULTS
001,003,004,009,010,011,022,275,698,699,HOWEVER,NSCLC,UNIVARIATE
081,186,880,905,AYA,CAREGIVER,CAREGIVERS,CFI,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,RMSEA,SEM,STRUCTURAL,TELEPHONE,TFI
CNS,EPSTEIN

DU145,HOWEVER,LITERATURE
ARB,AREAS,B1R,B2R,BACKGROUND,COVERED,JANUS,KKS,LABEL,METHODS,OPINION,RAS,WHETHER

CUSHING,HOWEVER,PRL,SCIENTIFIC,TSH,WHILE
008,059,149,508,554,ADULT,BACKGROUND,CT00566852,GRADE,LABEL,MEMANTINE,METHODS,OVERALL,RESULTS,THERE
169,946,ABR,BACKGROUND,BITHERMAL,CHELATION,INC,LABEL,LOWER,METHODS,POTENTIAL,PROCEDURE,PTA,RESULTS,SEVEN,SIXTEEN,TEOAE,THEREFORE,WILEY
113,150,151,169,177,194,300,301,343,363,450,451,487,600,BACKGROUND,CCD,CONCLUSION,EFS,EIGHT,INC,LABEL,METHODS,PROCEDURE,RESULTS,THERE,TOTAL,WILEY
115,169,ANGELES,BACKGROUND,CENTRAL,FORTY,GRADE,III,INC,LABEL,LOS,METHODS,PROCEDURE,RESULTS,THERE,THESE,VZV,WILEY
169,177,BACKGROUND,GIVEN,INC,LABEL,MET,METHODS,PROCEDURE,RESULTS,SURVIVORS,VAL,WILEY
MRI,VAI
JAPAN,PITUITARY,SOCIETY,THERE,TMZ
150,956,GSC,INCREASING,NAD,NSC,SIRT1,SIRT2,SIRT3,WESTERN
003,1P19Q,ACCORDING,AFTER,HOWEVER,MTD,R132H
001,120,233,AED,AGE,CHRONIC,CLASS,ENGEL,GIVEN,III,THERE,TLE
015,041,043,048,187,322,358,C228T,C250T,HOWEVER,MUTATIONS,TELOMERASE,THESE
BACKGROUND,LABEL,METHODS,RESECTION,RESULTS,THERE,THESE
DSM,WOMEN
001,004,009,021,031,048,429,439,607,741,BCS,COGNITIVE,DIGIT,OUTCOME
251,282,308,583,945,954,CRE,EAAT2,GLT,PKA,TAKEN,TAMOXIFEN,TGF
AWARENESS,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THOSE
HENCE,HOWEVER,THEREFORE
MBM,METASTATIC,SURGERY
169,NOD,NR2F1,NR2F2
0354X10,113X1,169,2022X11,AMONG,BACKGROUND,CLINPRO,LABEL,LDA,MALDI,METHODS,PLS,RESULTS,SERUM,TOF,TOOLS,USING,WCX
169,GDT,HOWEVER,IGT,THERE
145,169,COPYRIGHT,INHIBITION,IRELAND,LTD,NEITHER,PROMINENT,THESE
001,004,008,015,032,038,039,049,135,160,169,565,BACKGROUND,BARTHEL,COPYRIGHT,DESPITE,INC,INDEX,INSTITUTES,LABEL,METHODS,NIHSS,PUBLISHED,RESULTS,SCALE
169,CNT,DDS,WHILE
169,2MM,BSA,CARLO,COPYRIGHT,FOM,LTD,MEV,MONTE,OPTIMAL,RESULTS,SHAPING
169,BACKGROUND,CIS,HRS,JAN,LABEL,LIBRARY,MAY,METHODS,RESULTS,SCIENCE,TOTALLY
001,028,169,196,CONCLUSION,COPYRIGHT,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THESE
169,BACKGROUND,CASES,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,REPORTS,RESULTS
169,BACKGROUND,COPYRIGHT,DISCUSSION,GOLDENHAR,HISTORY,LABEL,LTD,MAXILLO,PUBLISHED,SURGERY,THERE,UNASSIGNED
100,169,CONCLUSION,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SURGERY
009,012,018,029,036,042,10878,169,AFTER,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DISRUPTION,DMEAN,FATIGUE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SIXTY
169,BACKGROUND,COPYRIGHT,FET,GTV,IRELAND,LABEL,LTD,METHODS,MRI,NON,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL
169,COPYRIGHT,HOWEVER,SAS,THEREFORE
112,147,242,CLOSE,CMS,FAVORABLE,LABEL,METHODS,OBJECTIVE,PATIENT,PERMANENT,RESULTS,SCALE,TOTAL
100,150,664,862,AMONG,APP,GBM,JMA,JMACTRS06,LABEL,METHODS,OBJECTIVE,PDT,PFS,RESULTS
CUSHING,GAMMA,KNIFE,LABEL,MEIER,METHODS,MRI,OBJECTIVE,RESULTS,SRS,THESE
AVASTIN,BASED,BEV,GLIADEL,RECURRENT,SOC,THERAPY,TREATMENT,USA
2ND,5TH,CAVERNOMAS,CNS,THESE,THOSE
AFTER
ADC,AUC,CONCLUSION,DTI,FORTY,HGG,LABEL,LGG,METHODS,MRI,OBJECTIVE,RESULTS,ROC,ROI
105,213,COMPARISON,DEVELOPING,HOWEVER
000,BACKGROUND,FURTHER,GBM,LABEL,METHODS,RESULTS
181,1A2,1Y2,293,6TM,7TM,DAMGO,GFP,GLY,HEK,HOWEVER,NOTABLY,OPRM1,PCR
BLAND,CONCLUSION,DSC,ICC,INTERCLASS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
AQUAPORIN,BAD,BCL,CYTOCHROME,GBM
218,FINALLY,MALIGNANT,PCR,TAKEN,WESTERN,WNT
COGNITIVE,THERE
CURRENT,EXOGENOUS,FGF10,FIBROBLAST,III,MEK,PCR,UROTHELIAL,WESTERN
169,BASEL,CONCLUSION,DIFFUSION,DTI,HENCE,LABEL,OBJECTIVE,THESE,THREE
FDG,GBM,PET
AFTER,EFFORTS,GBM,SIMILAR,TAKEN
AUTOPHAGY,GBM,TAKEN,THEREFORE
AFTER,AGAINST,BIOTECH,BRAIN,CORNELL,MRI,SPINE,WEILL
100,169,215,813,945,946,956,EFFECTS,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THESE
169,CD5,CD62L,CLL,CONCLUSION,DESPITE,LABEL,METHODS,OBJECTIVE,PBMCS,PURPOSE,RESULTS,THESE
ALZHEIMER
120,169,AFTER,BASEL,GROSS,MRI,PEDIATRIC,THESE
169,243,311,374,BASEL,CARDIAC,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
169,BASEL,COPYRIGHT,EXTENSION
169,231,233,ACCORDING,COPYRIGHT,PUBLISHED,SAS
169,174,ACCURAY,ARC,BACKGROUND,CONCLUSION,COPYRIGHT,HELICAL,HOWEVER,INTENSITY,LABEL,LTD,MEDICAL,METHODS,MODULATED,PRV,PTV,PUBLISHED,RAPID,REGARDING,RESULTS,STUDENT,THERAPY
AFFYMETRIX,AMONG,BACKGROUND,CNS,DESPITE,DIG,LABEL,METHODS,MOLECULAR,PAEDIATRIC,PAS,PILOCYTIC,RESULTS,TGF,WORLD
189,AFTER,BACKGROUND,CONCLUSION,DEPENDING,LABEL,METHODS,MRI
CLASS,DESPITE,FACTORS,LABEL,METHODS,OBJECTIVE,RESULTS,TESTS
ABSORPTION,DESPITE,EXAFS,HOWEVER,SIXTEEN,TRANSITION
139,141,BACKGROUND,BRAIN,CONCLUSION,DISEASE,EPSCC,IRELAND,LABEL,MANAGEMENT,METHODS,PATIENT,PCI,RESULTS
012,021,034,090,170,192,219,298,445,452,903,980,BACKGROUND,BESIDES,DIFFERENT,HOWEVER,L858R,L861Q,L861R,LABEL,METHODS,PFS,RESULTS,TKI
185,BACKGROUND,BBB,CHINESE,CPA,FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,YANG1
003,012,370,614,864,955,ANOVA,BACKGROUND,LABEL,MATERIALS,METHODS,NORMALIZED,OBJECTIVE,PURPOSE,RESULTS,WORLD
CSF,DILATED,LABEL,OTHER,PATHOLOGY,SUMMARY,THESE
169,ALZHEIMER,CED,CONVECTION,DESPITE,PARKINSON,SOCIETY
000,169,300,AUSTRALIA,AUSTRALIAN,OPTOMETRY,PITUITARY
100,1HMRS,ALA,CHO,COMPARING,COMPARISON,GIX,LAC,LIP,MRI,NAA,PRESS,SIGNA,SVS
007,117,AUTOMATED,BACKGROUND,CONCLUSION,LABEL,METHODS,PATIENT,RESULTS
169,FINALLY,GLI,INHIBITION,KAT2B
BACKGROUND,CONCLUSION,FIFTEEN,HARDY,LABEL,METHODS,OTHER,REGARDLESS,RESULTS
29C,967,HOWEVER,MMP,PCR,USING
AKTER,CDK,THESE,TMZ,U87MG
105,124,134,177,198,APRIL,CHI,CNS,KOLMOGOROV,LABEL,MAHAK,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,SMIRNOV,THERE,TREATMENT
160,GOS,H3K9ME3,HKMTS,SUV39H1,THESE,TREATMENTS,U87MG
000,169,9TH,ADULT,BACKGROUND,COPYRIGHT,DISEASE,INC,LABEL,METHODS,RESULTS,TEN,WHITE
BRESLOW,FIFTEEN,HODGKIN,RITUXIMAB,THESE
169,174,180,BACKGROUND,BASEL,CONCLUSION,CONVERSELY,COPYRIGHT,EVD,ICP,LABEL,LOS,METHODS,OBJECTIVE,RESULTS,TRAUMATIC,VPS,WHILE
169,IHS,LTD,OTHERWISE,SIMILARLY,SOCIETY,WHEREAS,WILEY
001,169,174,EXPRESSION,GGS,GNT,SOCIETY,V600E
BASED,CNS,IL4,NOVEL,POM,PRIMARY,STAT1,STAT6
ANDROGENS,LUC,LUCIFERASE
17126,246,703,CONCLUSION,COX,DIETARY,GUIDELINES,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,SWEDISH,TOTAL
005,006,EORTC,GBM,GROSS,INSTITUTE,LABEL,METHODS,NCI,OBJECTIVE,PFS,PURPOSE,RESULTS,TMZ,WHILE

INDUCED,INTRACRINE,LOCALLY,PITUITARY,PREMATURE
ATLAS,FURTHER
110,325,ALONE,CONCLUSION,III,LABEL,LOMUSTINE,METHODS,MRI,OBJECTIVE,PFS,PURPOSE,REGAL,RESULTS
169,AFTER,CONCLUSION,GCT,INC,LABEL,METHODS,NSGCT,OBJECTIVE,PURPOSE,RESULTS,TGM95,WILEY
100,129,169,BACKGROUND,BBB,D1870,HOWEVER,INC,INHIBITING,LABEL,METHODS,MOLECULAR,NANOSTRING,NOTABLY,ONS76,PCR,PROCEDURE,RESULTS,RSK,SHH,SONIC,UW228,UW426,WILEY
169,177,215,ADC,BACKGROUND,CONCLUSION,COPYRIGHT,DWI,III,INC,LABEL,MBS,METHODS,MRI,OVERLAP,PROCEDURES,RESULTS,WILEY
068,134,644,678,863,ASIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SPM,THERE,THYROID,USA,WESTERN
160,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,INCLUDING,IRCCS,ITALY,LABEL,LCM,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SAN,SEVENTY,THREE,TSE
GBM,GENOMIC,HOWEVER
BROCA,GROSS
009,021,037,ADC,BACKGROUND,CONCLUSION,DIFFUSION,DWI,LABEL,METHODS,MRI,OBJECTIVE,REGIONS,RESULTS,SEVEN,WHITNEY
8TH
110,945,FDG,FPAMT,THERE
DIFFUSION,DWI,MRI,THESE
INSTEAD,LLL12,STAT3,THESE
EXPRESSION,FBS,GBM,LYN,MEMBERS,SFK,SIMILAR,SRC,U87
BESIDES,TREATMENT
CONVERSELY,DEPLETION,EMT,MECHANISMS,TWIST
001,788,AFTER,BACKGROUND,FUNCTIONAL,HOWEVER,LABEL,METHODS,PRINCIPAL,RESULTS,THERE,THESE
124,27632,BACKGROUND,LABEL,RESULTS,ROCK1,THESE,U87MG,USING,UTR
ISSAC,LOOKING,SIGNATURES,STRUCTURED,THESE
100,BACKGROUND,CELLS,CXCR4,FINALLY,LABEL,METHODS,NIG,RESULTS
AFTER,EARLY,GHD,HOWEVER,HYPOCCS,OVERALL,SINCE
HOWEVER,SEQ,SIMILAR
169,231,231BRM2,4T1,945,ANG,BBB,BCC,BMECS,GFP,III,MDA,THEREFORE,TJS,TNF,USING
HOWEVER,LABEL,OPINION,PCNSL,STATEMENT,THERE,UNASSIGNED
001,041,AIM,BACKGROUND,CASES,CONCLUSION,GBM,III,LABEL,METHODS,METHYLATED,OBJECTIVE,PCR,RESULTS,RUNX3,THERE
FIRST,RAMAN
IDH,SURGERY,THERE,WHOLE
160,BACKGROUND,BETWEEN,CONCLUSION,CTV,DBC,DISTANT,FRAMELESS,LABEL,LINAC,LOCAL,MARCH,MATERIALS,METHODS,OVERALL,PTV,RESULTS,SRS
160,CNS,CROSS,FUNCTIONAL,MRI,THESE
100,160,BETWEEN,END,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PROPORTION,PURPOSE,RESULTS
110,111,158,967,ANOVA,GLIOMAS,HOWEVER,MUTATIONS,R132H,SNP
BACKGROUND,COLLEGE,LABEL,METHODS,MORTALITY,PROGRAM,QUALITY,RESECTION,RESULTS
FDA,IPILIMUMAB,SINCE,THESE
005,006,160,169,389,ARTESUNATE,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METASTASIS,METHODS,MOLECULAR,MOSBY,OBJECTIVE,RESULTS,TGF,USING,WNT
169,201,231,ANY,COPYRIGHT,FRONTAL,KALLMAN,MRI,PARKINSON,PUBLISHED,SAS
169,BASED,C12,CLEOPATRA,COMPARING,COPYRIGHT,GBM,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PER,PFS,PHASE,PURPOSE,RESULTS,THERE,TMZ,TREATMENT,TRIAL
BASED,BSA,EGF,HOWEVER
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,METHODS,OPINION,VEGFI
ALZHEIMER,FINALLY,HEART,SIMILARLY,THERE,THEREFORE
CUSHING
FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
012,165,209,CUSHING,DELAYED,GAMMA,GKS,III,KNIFE,LABEL,METHODS,OBJECTIVE,RATES,RESULTS,THOSE,UNIVERSITY
000,450,578,970,BRAIN,CPG,GRADE,IGF2BP1,III,INC,LABEL,METHODS,OBJECTIVE,PDCD1,RESULTS,WESTERN
HOSPITALS,HOWEVER,NSCLC,THESE,UNIVERSITY
131,312,CONCLUSION,CSF,LABEL,METHODS,NCI,OBJECTIVE,RESULTS
CD133,NANOG,POMIFERIN,TAKEN
AFTER,FLAIR,INITIAL,SRS
169,DESPITE,INC,MICRORNAS,SEVERAL,UTR,WILEY
183,BACKGROUND,EIGHT,GEORG,LABEL,METHODS,RESULTS,STUTTGART,THREE
768,RAF,UTR
BACKGROUND,CENTRAL,CONTEXT,LABEL,LABORATORY,METHODS,PATIENT,TMZ,USING
169,946,COPYRIGHT,HOWEVER,INC,LN229,PATHOLOGY,PUBLISHED,SIMILARLY,SOCIETY,THESE,U87MG
946,CHROMATIN,EMT,H3K4ME2,HOWEVER,KDM1A,MBT,SNAI1,TGF,THESE,THROUGH
169,945,947,CHANGES,COPYRIGHT,CRF,CRP,HEIGHTENED,IFN,INC,THESE,TNF
169,COPYRIGHT,INC,MRS
169,COPYRIGHT,INC,PEDIATRIC
001,120,169,214,277,491,COPYRIGHT,EEG,ENGEL,OTH,RINCH,THERE,TLE
000,144,827,870,BACKGROUND,CHO,CNS,FORTY,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,FDG,HOWEVER,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
BACKGROUND,FINALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOLID
001,011,016,031,061,084,127,177,900,BACKGROUND,CBV,INTRAVOXEL,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,REGIONS,RESULTS,STUDENT
169,ANOTHER,BACKGROUND,COPYRIGHT,DISCUSSION,ENGLISH,EXPERTS,FINALLY,FIRST,KLIBANSKI,LABEL,LITERATURE,MONITORING,PROLACTIN,PUBLISHED,RESULTS,SAS,SOMETIMES
169,334,AVERAGE,COPYRIGHT,COX,KARNOFSKY,LTD,SCALE,USING
005,160,161,169,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,HOWEVER,IGF,INITIAL,LABEL,LINAC,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SRS
004,105,114,115,169,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DNR,HOSPICE,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TAIWANESE
ADDITIONAL,CNS,CURRENT,EGF,GBM,III,WHILE
009,016,074,100,185,215,CARLO,EXCELLENT,GAFCHROMIC,LABEL,METHODS,MONTE,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THESE,TLD
GBM,GBM43,HB1,NSC,TMZ,XRT
BACKGROUND,BRAIN,CONCLUSION,HOWEVER,LABEL,METHODS,NEURO,OBJECTIVE,RESULTS
1980S,AAIRS,AFTER,APC,CBT,CHANGES,END,FURTHER,NOS,RESULTS
206,CD147,COX,GBM,MEIER,RESULTS,THESE
BACKGROUND,COMBINING,LABEL,METHODS,MRI,NON,RESULTS,THEREFORE,USING
001,008,010,021,027,036,040,043,400,AFTER,BACKGROUND,CES,CHECKLIST,CIS,COMPONENT,DEPRESSION,FATIGUE,HRQOL,INDIVIDUAL,LABEL,MEDICAL,METHODS,MODAFINIL,MOS,OTHER,PATIENT,PBT,RESULTS,SCALE,SHORT,STUDIES,SUMMARY
ALS,FUS,SCN8A,STX1A
215,ABOUT,CDR,D2224MG,D54MG,DMAB14M,THERE
CHEST,DESPITE,PRIMARY
SII,THESE
DEC
ALCLS,ALK,ANAPLASTIC,CD3,CNS,EMA,HOWEVER,PATIENT
ANGULAR,DIFFUSION,DTI,EIGHT,FIBER,HARDI,HOWEVER,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,OVERCOMING,RESOLUTION,RESULTS,THESE,USING
289,EXPRESSION,IHC,RFS,SH3
HOWEVER,SIMULATION
001,004,AFTER,AIM,BLOOD,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PERIPHERAL,RESULTS
181,215,747,CONCLUSION,HOWEVER,IGF,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PITUITARY,SELLA,VARIOUS
AFTER,GCT,HENCE
028,032,138,169,BACKGROUND,COX,END,LABEL,MEIER,METHODS,OVERALL,PCI,RESULTS,SOCIETY,USING
169,215,BACKGROUND,CONCLUSION,LABEL,METHODS,PRIMARY,WHILE
005,010,231,282,728,BACKGROUND,BETWEEN,BUNDANG,LABEL,METHODS,RESULTS,SEOUL,UNIVERSITY
001,100,133,CNS,EMBRYONAL,JANUARY,MRI,RELAPSE,THESE,WHILE
186,AMONG,BNP,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
169,177,ADC,ANAPLASTIC,AUC,FDOPA,HOWEVER,IMAGING,MRI,PET,THESE,TRACK,TWI
114,116,169,177,BASEL,CONCERNING,CONCLUSION,COPYRIGHT,ETV,ETVSS,JANUARY,LABEL,METHODS,OBJECTIVE,REGARDING,RESULTS,SCORE,SUCCESS
169,177,254,COPYRIGHT,CTV,FIRST,GIVEN,HAUSDORFF,INC,LABEL,MATERIALS,MEANS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
001,002,049,10172,169,236,462,ACUTE,COMMUNITY,COPYRIGHT,DUTCH,GRONINGEN,HOWEVER,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,ORG,PROJECT,PURPOSE,RADIATION,RESULTS,THERE,TOAST,TREATMENT,TRIAL,UNIVERSITY
ALZHEIMER,APP,MENDELIAN,PSEN1,PSEN2
169,AUTHORS,COLLEGE,GBM,JOURNAL,MELBOURNE,PHYSICIANS,ROYAL
COLLISION,INSTEAD
150,AES,CONCLUSION,DABRAFENIB,GSK2118436,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SECONDARY,SEVENTY,V600E,V600K
956,CY5,EPHB4,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RAW,RESULTS,U87
169,19Q,257,IDH,III,ISOCITRATE,LABEL,LTS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,WORLD
A2BP1,GBM,INTEGRATED,MYT1L,USING
010,011,059,111,123,136,179,233,258,455,566,717,747,795,LIBRARY,MEDLINE,STATA,SUMMARY,THR241MET,XRCC3
001,003,007,045,1779C,620,630,CHINESE,HAN,XRCC1
945,CBV,FOCAL,FORTY,FURTHER,HIF,HYPOXIA,MRI,SYSTEMATIC,VOI
LZTR1,MUTATIONS,STAT3,THESE
169,CED,DOX,LABEL,NDS,UNASSIGNED,UNLABELLED
119,169,AWARENESS,BACKGROUND,BUB1B,COPYRIGHT,DANDY,INC,LABEL,MENDELIAN,METHODS,PATIENT,RESULTS,WILMS
169,COPYRIGHT,PUBLISHED,SIMILAR,THESE
169,201,231,CISTERNAL,COPYRIGHT,FINALLY,MRI,PUBLISHED,SAS,WALLENBERG,XII
169,ABSENCE,BACKGROUND,BECAUSE,CDI,CONCLUSION,COPYRIGHT,DEPARTMENT,LABEL,LANGERHANS,METHODS,OBJECTIVE,PEDIATRICS,PUBLISHED,PURPOSE,RESULTS,TAIWANESE,THEIR,UNIVERSITY
169,ALZHEIMER,COPYRIGHT,INC
169,4TH,ALA,AQUAPORIN,BACKGROUND,CANTO,CONCLUSION,COPYRIGHT,EXPRESSION,LABEL,METHODS,RESULTS,U87
001,530,DISCHARGE,FIM,HOWEVER,INSTRUMENT,LOWER,OLDER,ONTARIO,REPORTING,RESULTS,TBI
BACKGROUND,LABEL,METHODS,RESULTS
022,033,ADC,BACKGROUND,BECAUSE,EARLY,EVALUATION,F98,LABEL,MACDONALD,METHODS,MRI,OTHER,RADIOLOGIC,RESULTS,SOLID
THERE,VESICLE,ZN2BDPA
IRELAND,MAY,RACK1,THESE,UNIVERSITY
001,07787,ALTERED,APA,CONCLUSION,CORRECTION,ERRATUM,FIFTY,LABEL,METHODS,OBJECTIVE,PSYCHOLOGY,REDUCED,RESULTS,THESE,UNLABELLED,VOL,WOMEN,WORRY
169,DESPITE,SRC
MRI,PITUITARY,SHORTLY,TREATMENT,WHILE
132,CONCLUSION,III,LABEL,METASTASES,METHODS,OBJECTIVE,OST,RESULTS,RPA,SIX,SURGERY,TREATMENT
002,011,101,160,ASIAN,COX,GBM,GIVEN,PFS,TMZ
181,ALTERED,CCK,CELLS,CHANGES,DESPITE,FOXM1,INHIBITION,TRANSWELL
HISTOLOGY,MRI,THREE
19Q,215
658,947,DETERMINE,DISCUSSION,EEG,FOUNDATION,KETTERING,LABEL,MARCH,MEDICAL,METHODS,MORTALITY,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,SLOAN,THREE,TREATMENT,USING
CPG,ERK,PANCREATIC,PANIN,PDACS
936,945,ATP,BACKGROUND,CONCLUSION,HIF,KNOCKDOWN,LABEL,METHODS,NODAL,PDH,PDK,RESULTS,TAKEN,THESE,TREATMENT,U87MG
22981,26981,ADULT,BACKGROUND,EORTC,LABEL,METHODS,PFS,RESULTS
145,169,CONCLUSION,COPYRIGHT,EIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PNS,RESULTS,SEPTEMBER,THEREFORE,THREE,TSA
169,COPYRIGHT,INC
160,169,215,AGING,ANATOMICAL,AUTHORS,DETECTION,DIGITAL,DUE,LTD,PCR,SOCIETY,USING,WILEY
169,COPYRIGHT,FACULTY,HERNIATION,LEGAL,LTD,PPR,PRIMARY,RMS,SUBSEQUENT
005,006,028,034,038,169,COPYRIGHT,CRC,GKS,GSK,LOCAL,LTD,SURGERY
169,AUTHORS,JAPAN,PEDIATRIC,PEDIATRICS,SOCIETY
169,CARLO,COPYRIGHT,ESTIMATES,FFP,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,OUTCOME,PURPOSE,RESULTS
169,FDG,FEDERATION,PET,PUBLISHED,THESE
169,215,AFTER,CHEST,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,BIOMETRIC,ROI,SOCIETY,THESE
AHR,CNS,GENERALLY,INDUSTRIAL,THEREFORE,XME
215,MIB,RESECTION
169,183,3RD,6TH,COMMONEST,ENDOCRINE,FIFTY,KINGDOM,LABEL,LIVERPOOL,LTD,METHODS,OBJECTIVE,PAS,PITUITARY,RESULTS,SCORE,THERE,WILEY
135,AMONG,APRIL,CSF,EES,ENDOSCOPIC,FORTY,LABEL,METHODS,OBJECTIVE,OVERALL,PERMANENT,RESULTS,SIXTY,THERE
AWARENESS,BACKGROUND,CAREFUL,CAUCASIAN,CONCLUSION,LABEL,METHODS,RADICAL,RESULTS
19Q,DIFFUSE,IDH,III,MUTATIONS,ULTIMATELY,WORLD
THERE
954,CONSISTENT,GBM,IHC,INCREASED,PFS,TNFR1,TRADD
160,169,954,LABEL,MECHANISM,METHODS,NOTCH,OBJECTIVE,PURPOSE,RESULTS,SCREENING,WNT
448,CONCLUSION,LABEL,MEASURING,METHODS,OBJECTIVE,RESULTS,WEANING
001,049,169,400,COX,DCD,DISEASE,END,HCC,JANUARY,LIVER,MODEL,OCTOBER,RECIPIENTS,SCIENTIFIC,STAGE,TRANSPLANT
946,HOWEVER,LABEL,MEF,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS,ROS,TIS21
190,237,238,290,359,555,CSF,EEA,ICA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DROSOPHILA,GTICS,INCREASED,LGL
DEARING,DESPITE,GSC,JAM,SEVERAL,T3D,WHILE
5CM,AFTER,CRANIOTOMY,MCA,PYOKTANIN,STA,TEARING,USING
105,METASTATIC,RPA,SEPTEMBER,TREATMENT
19Q,26961,ANAPLASTIC,EORTC,HOWEVER,LABEL,NEITHER,NOA,OPINION,OUTSIDE,PCV,STATEMENT,THEREFORE,UNASSIGNED
CHALLENGES,CNS,DABRAFENIB,FURTHER,III,INCREASING,LABEL,LIMITED,MOLECULAR,NEWER,NSCLC,OPINION,PHASE,RANDOMIZED,STATEMENT,UNASSIGNED
160,ECTOPIC,HOWEVER,IGSF4,TREATMENT,TSLC1
ATLAS,CNV,CPG,DECADES,FINALLY,FUNCTIONAL,GBM,GSTM1,HOWEVER,MODULES,NF1,THESE
160,HADAD,OLFACTORY,SIMPSON,THERE,THREE,TNE
001,014,177,BACKGROUND,III,LABEL,MATERIALS,MAXIMAL,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,ROI,THERE
100,178,BACKGROUND,LABEL,METHODS,NSCLC,OAS,RCT,RESULTS,TMZ,TREATMENT,TTP
100,ASPIRIN,THERE
3K27M,GBM,H3F3A,H3K27,LYS,LYS27,MET,REMARKABLY
169,947,ANALYZING,BLM,BMG,COPYRIGHT,NCI
169,209,350,568,AUSTRALIA,BRAIN,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,RESULTS,ROYAL,SEVENTEEN,WHOLE
115,169,DTI,DWI,HENCE,MRI,ROC,SVM,WHITNEY
169,945,946,ASTROCYTES,CNS,DESPITE,FURTHER,GSK,TCF,THESE,USING,WNT
002,003,015,106,128,243,250,266,500,550,956,CLINICIANS,CONCLUSION,HPA,LABEL,METHODS,MORNING,OBJECTIVE,PURPOSE,REGRESSION,RESULTS,THESE
632,DFG,EVENTUALLY,HMVII,RAF,REFLECTING,TAK,V600E
BASED,CONDITIONS,DIFFUSE,NUMERICAL

AMERICA,HOWEVER,MRI,NORTH,PCNSL,PET,PRIMARY,THERE
AFTER,CASPASE,MIR,PCR,PDCD4,U87MG,WESTERN
001,100,301,531,CENTRAL,ELECTRONIC,GKS,III,LABEL,MEDLINE,METHODS,NFPAS,OBJECTIVE,RESULTS,RRIED,RTC,THERE
001,AFTER,COE,COH,GHD,HBA1C,LABEL,LDL,METABOLIC,METHODS,OBJECTIVE,OVERALL,QOL,RESULTS
001,669,IDH,OVERALL,STUDIES,THEREFORE
169,244,284,BACKGROUND,COPYRIGHT,DEPRESSION,HOWEVER,INVENTORY,LABEL,LTD,METHODS,RESULTS,VARIOUS,WILEY
133,19Q,ALT,AOA,COX,IDH,NOA
001,843,BACKGROUND,COMPARISON,CONCLUSION,GBM,HGG,HISTOLOGY,KEY,KRUSKAL,LABEL,MATERIALS,METHODS,MRI,RESULTS,SWI,T1W
974,BASED,CONCLUSION,DORELLO,DSC,KEY,LABEL,LESIONS,METHODS,OBJECTIVE,OBJECTIVES,OTHER,RESULTS,THIRD
023,032,ADDITIONAL,EBV,EPSTEIN,FORTY,GRADE,MVP,OPTIMAL,PCNSL,TEN,THERE,TREATMENT
851,977,AIC,JOINT,REPORTING,STRATIFIED
111,AIM,BACKGROUND,CONCLUSION,COX,LABEL,MATERIALS,MEANWHILE,MEIER,METHODS,MIB,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
160,AFTER,BRAIN,DTI,HISTOLOGIC,INSTEAD,LEVAMISOLE,MIL,MRI,MULTIFOCAL,THEREFORE
AIM,AURKA,BAK,BPV,CONCLUSION,CTSL1,HDAC6,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
EFFORTS,HOWEVER,PREVENTING
TRB,TRILATERAL
AGA,APRIL,CONCLUSION,DEPARTMENT,INCLUSION,KARACHI,LABEL,METHODS,OBJECTIVE,PITUITARY,RADIOLOGY,RESULTS,SEVENTY,THEREFORE,UNIVERSITY
011,044,215,5TH,840,880,892,907,ADC,CONCLUSION,INTER,INTRACLASS,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,RESULTS,STUDENT,THERE,TMZ
160,169,183,4TH,CONCLUSION,DIFFERENT,GEORG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROI,STUTTGART,SUBJECTIVE
AFTER
NOVOTTF,PROMISING,TTF
1N9,2TT,4N6,5N3,6N3,964,BACKGROUND,BETWEEN,INITIATIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WOMEN
AFTER,ECT,PSYCHOSIS,THERE,TREATMENT
169,DAILY,INC
169,HOWEVER,INC,STUDIES
100,169,ENT,LTD,NOTABLY,THROUGH
180,BACKGROUND,CANCEROUS,DELTA,GASTRIC,LABEL,METHODS,NOTCH,RESULTS
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
400,BACKGROUND,BASED,CONCLUSION,FORTY,GBM,GRADE,LABEL,METHODS,PRE,RESULTS,TMZ
BACKGROUND,CONCLUSION,FEW,FIFTY,LABEL,METHODS,PROLONGED,RESULTS
150,BACKGROUND,CONCLUSION,GBM,IMAGING,KARNOFSKY,KPS,LABEL,METHODS,MRI,RESONANCE,RESULTS,SCORE,STUPP,TAMOXIFEN,TMZ,TTP
008,022,026,624,795,810,850,BACKGROUND,CONCLUSION,HGG,LABEL,MATERIALS,METHODS,PATIENT,RESULTS,USING
006,039,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OVERALL,PFS,RESULTS
HSE,HSV,PCI,SMALL
AGGRESSIVE,BACKGROUND,CONCLUSION,HODGKIN,KARNOFSKY,KPS,LABEL,METHODS,PCNSL,PFS,PRIMARY,RESULTS,UNTREATED
044,FINALLY,FRESH,FSH,HARDY,HORMONE,HOWEVER,KNOSP,PITUITARY,THERE,THYROID,TSH,USING
001,105,139,164,169,239,469,ALK,BETWEEN,COX,EGF,HOWEVER,LABEL,LOCAL,METHODS,MOLECULAR,NON,NSCLC,OBJECTIVE,PURPOSE,RATES,RESULTS
BACKGROUND,ENGEL,III,LABEL,METHODS,MRI,RESULTS,SEIZURE
946,ABCB1,BACKGROUND,LABEL,METHODS,PGP,RESULTS,WNT3A
CD4,CD8,MRI,PML
AFTER,GIVEN,MRI,PRIMARY
HOWEVER,LYNCH
169,CARIBBEAN,COPYRIGHT,FAR,LTD,MRI
169,COPYRIGHT,DESPITE,LTD,MRI,SYLVIAN,VASOSPASM
169,COPYRIGHT,CURRENTLY,INC
169,19Q,26951,368,AOA,AOD,BACKGROUND,BIOMARKERS,COPYRIGHT,DIFFERENT,EORTC,ISOCITRATE,LABEL,LTD,METHODS,PCV,PEV,PFS,PROGNOSTIC,RESULTS,TREATMENT,WORLD
169,19Q,CIC,CNS,COPYRIGHT,HOWEVER,LTD,PRIMARY,SIMILARLY
11Q,12Q,14Q21,15Q11,169,16P11,17P13,17Q,17Q21,17Q22,18P11,19P12,19Q13,21Q11,223,COPYRIGHT,SNP,SYSTEMATIC,THEREFORE,WNT
142,169,BWT,COPYRIGHT,INC,LABEL,MARCH,METHODS,NEPHRON,NSS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,SEVEN,THESE,WILMS,XRT
169,1FT,ABR,ASSFS,CONCLUSION,COPYRIGHT,FEDERATION,IRELAND,LABEL,LTD,METHODS,N1M,OBJECTIVE,PUBLISHED,RESULTS
ACCORDING,CONCLUSION,FDG,LABEL,MAY,METHODS,OBJECTIVE,PET,RESULTS
100,DIAGNOSTIC,JANUARY,LABEL,METABOLISM,METHODS,MRS,OBJECTIVE,OBJECTIVES,PET,RESULTS,VARIOGUIDE
169,APRIL,BIOMEDICAL,BOARD,CD147,CDC,CHINA,CONCLUSION,COPYRIGHT,CXCR4,DEPARTMENT,EDITORIAL,EXPRESSION,FRESH,IPA,JANUARY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THEREFORE
000,169,INC,WILEY
011,100,131,244,905,BACKGROUND,FARNSWORTH,LABEL,METHODS,MUNSELL,OBJECTIVE,RESULTS,THERE
THESE
HOWEVER,JNK,K252A,MMP,SP1,TRK
CASZ1,CYCLINB,E2F,SIMILAR,SUBSEQUENT,TAKEN
143,ASP,CNS,FLA,L858R,LNA,NSCLC,PCR,PNA,THERE
169,92B,COPYRIGHT,GBM,HOWEVER,MICRORNAS,PCR,PUBLISHED,SILENCING,SMAD3,TGF,U87,USING,UTR
169,CED,CONVECTION,GBM,LABEL,MRI,TMZ,UNASSIGNED,UNLABELLED
169,AMONG,THEREFORE,WHILE
169,98G,COPYRIGHT,CURRENTLY,GBM,PUBLISHED,TREATMENT
169,COPYRIGHT,CURRENT,GROUP,HOWEVER,INC,NATURAL,NKT,NOD,PCR,SHH,SONIC,THEREFORE
140,169,251,956,COPYRIGHT,HV1,INC,INHIBITION,SHG
169,ASPARTAME,CALIFORNIA,COPYRIGHT,DENMARK,HODGKIN,ITALIAN,JANUARY,LOW,LTD,NIH
169,ADDITIONAL,BACKGROUND,COPYRIGHT,INHIBITION,IRELAND,KNOCKDOWN,LABEL,LTD,METHODS,OBJECTIVE,OPN,OPNAC,PURPOSE,RESULTS
169,201,231,COPYRIGHT,MRI,PUBLISHED,SAS
169,AEG,ASTROCYTE,CNS,COPYRIGHT,HIV,HUNTINGTON,INC,LYRIC,TNF
100,188,672,856,BACKGROUND,LABEL,RESULTS,THERE,THESE,USING
117,169,231,AMYLOID,APP,MCF,MDA,SUBSEQUENT,THEREFORE,THESE
169,CNS,DUE,GASSERIAN,MRI,SOCIETY,THESE
001,169,SHH,SOCIETY,SONIC
126,ADDITIONAL,CD3,CNS,DESPITE,FURTHER,HMB,SURGERY
CHOROID,CPP,MRI
008,CALIFORNIA,FRANCISCO,JANUARY,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,SAN,STUDENT,THERE,UNIVERSITY
BACKGROUND,CONCLUSION,DUE,LABEL,METHODS,PRIMARY
183,BACKGROUND,EXAMINEES,EXECUTION,FORTY,GEORG,HORIZONTAL,JAPAN,LABEL,LTD,METHODS,OPTICAL,RESULTS,SIXTEEN,STUTTGART,TOKYO
CONVERSELY,FOXP3,MYC,PCR,THESE
169,BRAIN,USING
946,BACKGROUND,BTICS,GBM,KNOCKDOWN,LABEL,MECHANISMS,METHODS,PCR,RESULTS,THESE,WHILE
169,HEALTHY,PRESS,PUBLISHED,UNIVERSITY,USING
GBM,GSK461364,GW843682X,SF188,TREATMENTS
102,103,CONCLUSION,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,RCC,RESULTS
BACKGROUND,BMI,CD133,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,OLIG2,RESULTS,ULTRASONIC,WILLEBRAND
DIFFUSE,EMA,OLIG2,PITUICYTES,R132H,SPINDLE,TTF,V600E,WHEREAS
007,008,056,169,CONCLUSION,COPYRIGHT,CSI,CSS,KGS,KNOSP,LABEL,METHODS,MRI,OBJECTIVE,PDW,PEICA,PURPOSE,RESULTS,SAS,TESLA
169,COPYRIGHT,MRI,SAS,WEBER
169,205,AKT,CHEMICALLY,KLN,RESULTS
000,086,100,BACKGROUND,CNS,IRANIAN,LABEL,MARCH,MATERIALS,METHODS,NCR,PRIMARY,RESULTS,THESE
001,168,177,ADANA,BACKGROUND,BECAUSE,DISCUSSION,III,KAYSERI,LABEL,MATERIALS,METHODS,NSCLC,PET,PFS,RESULTS,TODAY,WHILE
BACKGROUND,CISPLATIN,GRADE,HOWEVER,III,LABEL,MATERIALS,METHODS,ORR,OVERALL,PFS,RESULTS
IMT,LABEL,METHODS,OBJECTIVE,PATHOLOGY,RESULTS
FEDERATION,HODGKIN,NERVE,PERIPHERAL,SIX,SOCIETIES,SOCIETY,THESE
AVPRS,BACKGROUND,CONTEXT,CUSHING,HOWEVER,LABEL,METHODS,NPS,OBJECTIVE,PCR,PRIMARY,REMARKABLY,RESULTS,THESE
ACTIVATION,AKT,IDH,THESE
GSC,METABOLIC,NAA,NADC3,NEU,OLI,THEREFORE,TREATMENT
100,954,DWI,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTY
160,CATALAN,EXPERTS,FIRST,GERMANY,HEIDELBERG,IMPPC,MEDICAL
1990S,FDG,MET,PET,THESE
177,CUSHING,FURTHER
100,FLAIR,III,INCREASED
001,CPA,THESE
CLINICALLY,EVANS,GBM,HYDRO,KARNOFSKY,KPS,LOW,NON,PATIENT,RPA,VARIOUS
395,MMT,RATES,SERUM,TOTAL,VTE,WORLD
681,985,AWAKE,GROSS,MORTALITY,UNIVERSITY
EOR,FINALLY,HOWEVER,III,JANUARY,LGG,MAY,THEREFORE,THESE,UNIVERSITY,WORLD
GIIGS,PFS,WORLD
GLUTAMATE,INSTITUTE,LIBRARY,USA,USING
BCL,BIK,THEREFORE,U87MG
CLINICALLY,GOOSE
001,003,BACKGROUND,BRAIN,CONCLUSION,IMSRT,LABEL,METHODS,OAR,PTV,QOC,RESULTS,SVZ
AFTER,CD4,CPG,ESO,HOWEVER,IGG,MELAN,MHC
004,169,948,AKT,COLORECTAL,CONTINUOUS,ERK,KIT,LABEL,METHODS,OBJECTIVE,PKC,PURPOSE,RESULTS,RTK,SCF
169,MAP,MYB,MYBL1,NOTABLE,PEDIATRIC,RAS,TARGETING,WHILE
169,COPYRIGHT,DCE,LTD,MRI,STUDIES,SYSTEMATIC,WILEY
ACP,CENTRAL,ENGLISH,FLORIDA,KNOWLEDGE,LATINOS,SPANISH,USA,VENEZUELA
160,174,233,DABRAFENIB,FDA,III,PHASE,PRE,V600E
169,BMG,INC,THREE,WILEY
WHILE
DNT,MRI
136,GAP,GLEASON,PKP,SH3,UNTIL
945,CLANTOX,LY6,SEARCHING,THESE

100,169,COPYRIGHT,SMARCA4,SMARCB1
BACKGROUND,BASED,GLIOMAS,LABEL,METHODS,RESULTS,SEVERAL
AMONG,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,ROBO1
000,100,110,118,129,150,BACKGROUND,BED,CHI,COX,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,SRS,UNIVARIATE
169,AUTHORS,CLINICIANS,FURTHER,ILLNESS,JOURNAL,WORLD
288,CARLO,LABEL,LENGTHY,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,SCATTER,SEVERAL,THREE,XVI
169,314,APMIS,BFABP,FAS,FEW,LTD,MENINGIOMA,PUBLISHED,WILEY
BACKGROUND,BASED,LABEL,METHODS,RESULTS,SCHWANNOMA,THESE,TOTAL
112,115,124,215,BECAUSE,CONCLUSION,HEIDELBERG,LABEL,MATERIALS,METHODS,MHZ,NOMINAL,OBJECTIVE,PURPOSE,RELAXATION,RESULTS,THREE,UNIVERSITY,WRITTEN
FURTHER,PAPILLARY,PTC
99M,MRI,NAF,PET
229,CIT,DEPARTMENT,MBQ,NUCLEAR,PARKINSON,PET
FDG,MRI,PET
EGF,GBM,TARGETING
001,003,004,160,HIF,HOWEVER,MRI,STEINHOFF,THERE,THEREFORE
CNS,CURRENT,POTENTIAL
19Q,GLIOMAS,HOWEVER,IDH,ISOCITRATE
BACKGROUND,EXPRESSION,FURTHER,ID1,LABEL,METHODS,MTT,RESULTS,TARGETING
110,948,BACKGROUND,BS153,ERLOTINIB,FOXN1,FUNCTIONAL,III,INSTITUTE,KNOCKDOWN,LABEL,MEDICAL,METHODS,NAVAL,POTENTIAL,RESISTANCE,RESULTS,TARGETING
532,645,664,AIM,CHINA,CHINESE,CONCLUSION,FEW,FSH,HUBEI,LABEL,METHODS,OBJECTIVE,PAS,PRL,RESULTS,TSH
AIM,BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STUDIES,THESE
CSC,EXPRESSION,GBM,HOWEVER,LY29002,RECURRENCE,THESE,U0126
ANATOMICAL,BACKGROUND,BRACKMANN,CONTINUOUS,DTT,EMG,FNS,GRADE,HOUSE,LABEL,METHODS,RADICAL,RESULTS,TOTAL,VSS
ACT,AMONG,CID,DUE,GT1
571,AFTER,BARCELONA,BRAIN,FREQUENCY,IGG,IMPORTANCE,LABEL,METHODS,NMDAR,NR1,OBJECTIVE,RELEVANCE,RESULTS,SETTING,UNIVERSITY
13064FP,372,956,THESE,U87MG
10R,11R,13S,14R,866,AKT,BECLIN1,CELLS,EXPRESSION,FLICE,GFP,KNOCKDOWN,LAMP2,LC3,LC3II,SIMILAR,TREATMENT
156,169,252,408,AMONG,COMPARISON,COPYRIGHT,EYE,INC,INSTITUTE,JANUARY,LABEL,MANAGEMENT,METHODS,MRI,OBJECTIVE,OUTCOME,OVERALL,PROCEDURE,PURPOSE,RESULTS,SETTING,USA,WILLS
169,201,231,COPYRIGHT,MRI,PERFUSION,PUBLISHED,SAS
169,CONSENSUS,COPYRIGHT,LTD,PUBLISHED
169,COPYRIGHT,LTD
AMINO,HARTNUP,MUTATIONS,TCA
001,400,519,600,BACKGROUND,BID,DISCUSSION,ENROLLMENT,EVALUATION,GRADE,LABEL,METHODS,PFS,PRIOR,RESILIENCE,SECONDARY,SOLID,SORAFENIB,THESE,TRIAL
102,BRISTOL,CENTRAL,CHAIN,CLONALITY,CNS,DUE,METHODS,NERVOUS,NHS,OVERALL,PCNSL,PCR,POLYMERASE,PRIMARY,RESULTS

PROGRAMMED,RIPK3
011,945,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PCR,RESULTS,THERE,TNF
CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THESE,UPDATED
100,120,160,210,240,CONCLUSION,GBM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TES,VASOGENIC
ADC,AFTER,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
766,954,COHEN,FOLLOWING,INSTITUTES,MARCZEWSKI,NIHSS,SCALE,STEINHAUS
001,181,FOXO1,NUCLEAR,RTK,UNIVARIATE
COMBINING,GBM,THESE
946,954,AKT,BRAIN,HOWEVER,TAKEN
500,ASSURANCE,CENTRES,CONSORTIUM,EFFECTIVE,GROUP,QUALITY
169,COPYRIGHT,DOX,FDA,MSN,NSC,VCH,WILEY
CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,SUV
BACKGROUND,LABEL,MELANOTIC,MES,METHODS,MRI,RESULTS
169,AFTER,MRI
15Q25,EMSAS,PUBLISHED,RESULTS,SNP
169,1940S,COPYRIGHT,LTD
169,AWAKE,CHINA,COPYRIGHT,GHANA,INC,INDONESIA,LABEL,METHODS,NIGERIA,OBJECTIVE,RESULTS
169,AFTER,ALA,BECAUSE,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
000,007,030,033,052,160,169,COPYRIGHT,INC,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,SIMPSON,WORLD
001,002,005,009,033,139,169,180,505,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EPIDERMAL,FURTHER,IRELAND,JANUARY,LABEL,LTD,METHODS,RESULTS
001,169,172,ACCORDING,COPYRIGHT,KARNOFSKY,LABEL,METHODS,MONTH,OBJECTIVE,PRIMARY,RESULTS,SCORE
001,009,116,169,ACCORDING,AIM,BACKGROUND,COPYRIGHT,III,INHIBITING,KARNOFSKY,KPS,LABEL,LTD,METHODS,MMP,OBJECTIVE,RESULTS,WORLD
000,002,169,174,237,241,251,ALA,COPYRIGHT,GLIOLAN,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RATES,RESULTS,SPAIN
169,26A,CONCLUSION,HOWEVER,LABEL,LTD,METHODS,MIR,NOVEL,OBJECTIVE,PHB,RESULTS,THESE,WILEY
001,169,263,411,448,607,645,659,AFTER,AMENORRHEA,ANESTHESIA,ASA,ASAP1,ASAP2,ASAP3,ASAP4,ASAP5,ASAP6,BIPOLAR,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MEIER,METHODS,MIDWEST,OBJECTIVE,OUTCOME,PUBLISHED,RESULTS,SETTING,SEVEN,SOCIETY,UPPER
169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,GAMMA,III,KNIFE,LABEL,MEIER,METASTASES,METHODS,MRI,RESULTS,RPA,SEVENTEEN,THERE,UNIVARIATE
100,160,368,376,709,BACKGROUND,EXPOSURES,LABEL,METHODS,RESULTS,THERE
ADVERSE,FORTY,GAMMA,GRADE,KNIFE,LABEL,METHODS,MOTOR,OBJECTIVE,RESULTS,SRS,THREE
169,945,ANATOMICAL,COATS,CST,LTD,POL,SEVERAL,SOCIETY,TELOMERES,THESE,WILEY
AMERICA,ANA,CONCERN,CONCLUSION,END,LABEL,MANAGEMENT,METHODS,NEUROMA,OBJECTIVE,REGARDLESS,RESULTS,SEVERAL
MICRORNAS,PXD000190,THESE
26S,326,AFFYMETRIX,MALIGNANT,MIR,NIN,SIMILAR,TAKEN
ABC,ABCG2,ATP,CHRYSIN,INHIBITORS,KO143,STUDIES
169,BACKGROUND,BETWEEN,COPYRIGHT,END,LABEL,METHODS,PROGRAM,RESULTS,SOCIETY
001,019,028,177,180,APA,BACKGROUND,CONCLUSION,COX,GBM,HGG,HIT,LABEL,METHODS,RESULTS,SINCE
107,518,57906,58102,BACKGROUND,C30,CHANGES,CONCLUSION,CONVERGENT,ELD14,ELD15,EORTC,HRQOL,LABEL,METHODS,OLDER,QLQ,RCA,RESULTS,TREATMENT
603,AFTER,APO,TAMOXIFEN,TMX,WHETHER
BPS,BRIEF
169,AMONG,BBB,BTB,COPYRIGHT,CROWN,HOWEVER,PUBLISHED,U87
ACC,ACUTE,DISCUSSION,GROUP,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SITES,TEN,THERAPY,TREATMENT
169,CHROMOSOME,CHRONIC,CML,COPYRIGHT,LTD,RESULTS
BACKGROUND,BELGIUM,DCS,DISCUSSION,LABEL,METHODS,OBJECTIVE,OVERALL,USING
104,177,ARGON,BACKGROUND,GLYCINE,LABEL,METHODS,PATCH,RESULTS,SEM,XENON
14Q32,329,AKT,BACKGROUND,GBM,LABEL,METHODS,MICRORNAS,MIR,MTT,PCR,RESULTS

BRAIN,CREATIVITY
150,ABOUT
RADIATION
2J2,CYP,CYTOCHROME,EET,FURTHER,SEVERAL
945,AKT,BACKGROUND,CXCR4,CXCR7,INHIBITING,LABEL,LN229,LN308,METHODS,RESULTS,SDF,TAKEN,THEREFORE,U87MG,WESTERN,WHILE
169,19Q13,CD133,EMBRYONAL,PROMINENT,SOCIETY,THESE,TSC
100,23A,APAF1,BACKGROUND,FINALLY,LABEL,MATERIALS,METHODS,PCR,RESULTS,TOTAL
GBM,MALIGNANT,THEIR,THERE,THESE
945,946,CSF,FGF,THESE,TNF,USING
169,171,ATLAS,CONVERSELY,CPG,EGF,LABEL,METHODS,NF1,OBJECTIVE,PURPOSE,RB1,RESULTS,THESE,TIL
001,005,240,AGE,BACKGROUND,C00,C96,CONCLUSION,ICD,JANUARY,LABEL,MASTORA,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,THEREFORE
53BP1,BRCA1,DSB,USP34
001,103,155,338,400,470,500,956,BACKGROUND,COMBINING,CONCLUSION,CST,CURRENT,DTT,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS
AFTER,CLINICIANS,FOLFIRI,THROUGH
BRONJ,DESPITE
301,JAPAN,OBP,ONCOLYTIC,ONCOVEX
CALCIFYING,CNS,CPN,DUE,HOWEVER,THESE
19Q13,BIOLOGICAL,C19MC,CGH,EBL,EMBRYONAL,MYC,OLIG2,PNETS,THEIR
945,946,CLASS,EMT,III,NEU,TWIST
DIFFUSION,DTI,FIFTEEN,MRI,NON,SRS,VOI
RESULTS,SORTING,WISCONSIN
GPCRS,GPR40,GPR41,GPR43,GPR84,THESE

FLT,GBM,GLI36DEGFR,HOWEVER,IMAGING,LABEL,METHODS,MRI,PET,RESONANCE,RESULTS,TMZ,TOMOGRAPHY,TREATMENT,UNLABELLED,VARIATIONS
015,017,060,089,104,148,19P,19Q,213,263,756,771,BACKGROUND,COX,LABEL,LOG,MEIER,METHODS,RESULTS,THERE
ECM,FINALLY,MALIGNANT,WHEREAS
001,006,008,039,167,169,184,BACKGROUND,C282Y,COPYRIGHT,HFE,LABEL,LATER,METHODS,PERIPHERAL,RESULTS,SCREENING,SERUM,SOCIETY
176,ACCORDING,BACKGROUND,CONCLUSION,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
THEIR
026,17P13,581,614,785,799,993,ACCORDING,ARG,CAUCASIAN,ORPRO,OVERALL,P53,PRO
160,369,376,BASED,BRATS,CONCLUSION,DETECTION,FINALLY,GABOR,GBM,LABEL,LECTURE,METHODS,MRI,MULTIMODAL,OBJECTIVE,PURPOSE,RESULTS,SVM,ZIKIC
766,BACKGROUND,HOWEVER,III,LABEL,MALLORY,METASTATIC,METHODS,RESULTS,SEVEN,THERE,VII
169,BACKGROUND,BASEL,CASES,CENTRAL,CNS,CONCLUSION,COPYRIGHT,ENGLISH,HODGKIN,LABEL,METHODS,OTHER,SEVEN,THREE
177,LABEL,LEKSELL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,TEN
100,200,AIM,BACKGROUND,CNS,CONCLUSION,HODGKIN,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,MRI,MTX,NEWLY,OBJECTIVE,PCNSL,PFS,PRIMARY,RESULTS,SCALE,SECONDARY,TNV,TREATMENT
169,460,ASSESSMENT,BASEL,COMPARING,COPYRIGHT,EVALUATION,GRADE,QUALITY,REPORTING
169,BECAUSE,BYSTANDER,DEOXY,DHA,GLUT1,ROS,SOCIETY,SVCT2,TC620,VITAMIN
MRI
DSC,DTI,FLAIR,MRI,PREDICTION,THESE

HOWEVER,LSF,MRI,RSF,THEREFORE
CHANG,CONCLUSION,CT1,EFS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RT1,T3B
160,177,275,450,600,ALT,CONCLUSION,DCE,FIFTY,LABEL,METHODS,MRI,MTD,OBJECTIVE,PAZOPANIB,PLACENTAL,PURPOSE,RESULTS,STS,TEN
100,125,BACKGROUND,GRADE,HOWEVER,LABEL,METHODS,OPTIMUM,RESULTS,SEVEN,SIMON,SIXTY
SPY
001,002,006,166,169,215,292,310,346,583,637,AAS,D08,D2159MG,EGF,LABEL,METHODS,NR6,OBJECTIVE,PURPOSE,RESULTS
AVERAGE,BACKGROUND,BED,CONCLUSION,DOSIMETRY,GBQ,LABEL,LESIONS,METHODS,PET,PRIMARY,RESULTS,SST,SSTRS
HGG
ALZHEIMER,MRI,PET
169,AMONG,CLN,COPYRIGHT,HOWEVER,IGG,LTD,RESTRAINT,SINCE
AREAS,BACKGROUND,COVERED,EPIDERMAL,FURTHER,LABEL,METHODS,OPINION
BACKGROUND,GBM,HOWEVER,LABEL,METHODS,NOTABLY,RESULTS,U87,USING,WESTERN
107,500,ANALYSING,ASSESSMENT,BACKGROUND,DISCUSSION,DUE,GUIDELINE,HOSPITALS,HOWEVER,HTA,IMPROVING,ITALIAN,LABEL,LIBRARY,METHODS,NHS,OBJECTIVE,OBJECTIVES,OUTCOME,PROGRAMME,REGARDING,RESULTS,SINCE,STUDIES,SYSTEMATIC,TAX,TECHNOLOGY,THERE,WHERE
CARLO,EXAMPLE,ION,LEM,MONTE,RBE,USING
174,186,931,963,CONCERNING,GERMANY,JANUARY,PATIENT,PEARSON,REGARDING,SIEMENS,THESE
RENAL,TSC
CRUCIAL
160,COGNITIVE,DECREASED,FUNCTIONAL,HOWEVER,IPS,PCC,RESULTS,THESE
169,177,AFTER,BACKGROUND,CNS,COPYRIGHT,CSI,EFFORTS,EFS,EIGHT,INC,LABEL,LOCAL,METHODS,PFS,PROCEDURE,RESULTS,THERE,WILEY
169,860,FINNISH,HENCE,HRS
169,N1ICD,NOTCH,RES,WHILE
000,100,956,ACCORDING,ANOTHER,CD133,IMPORTANT,NANOG,PVS
BACKGROUND,CHOROID,CONCLUSION,CPC,CPP,GROSS,LABEL,METHODS,MULTI,RESULTS,SEVEN
177,300,ADC,BACKGROUND,BLAND,CONCLUSION,DWI,III,LABEL,METHODS,RESULTS
177,956,GSPCS,PCR,U87
CURRENT,NEWER,PCI,SMALL
133,946,HOWEVER,POMGNT1,U87,WESTERN
CSF,THERE
PEMETREXED
945,949,IFN,INCUBATION,STUDIES,UTR
169,AMONG,BACKGROUND,COPYRIGHT,GLASGOW,INC,LABEL,METHODS,OUTCOME,RAPID,RESULTS,SCORE,SURGERY,THREE
169,APRIL,BASED,CONCLUSION,COPYRIGHT,CRANIAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,267,ALA,COPYRIGHT,DIFFERENT,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,REGULATORY,RESULTS,TECHNIQUES,THESE
169,257,600,746,COPYRIGHT,HODGKIN,HOWEVER,INC,NADPH,PUBLISHED,USING
115,169,956,COPYRIGHT,FINALLY,PBS,PROTEIN,RSD,UNDER
100,169,BPTES,COMPOUNDS,COPYRIGHT,DON,EBSELEN,HIV,HOWEVER,INC,LIBRARY,LOPAC
169,BASED,BCL,COPYRIGHT,DEPLETION,FINALLY,INC,LRIG1,REVERSELY,TMZ
169,COPYRIGHT,INC,LOW,SUBSEQUENT
006,008,117,119,124,126,169,183,210,215,250,268,283,308,313,369,373,437,452,497,558,574,APRIL,ARK,BACKGROUND,BESIDES,BETWEEN,COPYRIGHT,EUDRACT,FUNDING,HOWEVER,ITT,KARNOFSKY,LABEL,LOCAL,LOCALLY,LTD,METHODS,NOV,RESULTS
169,226,433,657,705,978,COPYRIGHT,IRELAND,LTD,PMP
ADULT,BSG,CAUCASIAN,DUE,FOLLOWING,LTD,PUBLISHED,RESECTION,WHILE
169,CHOROID,COPYRIGHT,GRADE,III,LTD,WORLD
100,169,APHASIA,AWAKE,BATTERY,CHINESE,COPYRIGHT,EOR,GROSS,HOWEVER,LTD,MARCH,MRI,TESLA
000,005,006,016,066,078,121,169,COPYRIGHT,COX,GPA,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBM,THERE
169,BAYES,COPYRIGHT,INC,MACHINE,NAIVE,NEAREST,SUPPORT
000,014,100,169,COPYRIGHT,CTS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
1295G,13Q34,215,218,345,ADPRHL1,AFFYMETRIX,ARRAY,ATM,BACKGROUND,BRCA1,BRCA2,CONCLUSION,DBS,DCUN1D2,GENOMIC,GPI,HOWEVER,LABEL,LTR,METHODS,NM_007111,NR_026580,PCR,SECONDARY,SER432HIS,SNP,TFDP1,THAP1,TMCO3,WHOLE
169,BECAUSE,FIRST,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,RECURRENCE,RESULTS,SSA,THREE,TSH,WILEY
001,120,170,180,AFTER,BACKGROUND,CONCLUSION,FSH,INFERTILE,LABEL,METHODS,MICRO,OBJECTIVE,PRL,RESULTS
GSC,STAT3
169,945,DGK,DISCOVERY,DOMINGUEZ
001,018,043,059,324,C677T,CAUCASIANS,COLLEGE,EIGHT,MTHFR,ORS,SCIENCE,STATA,STATION,USA,WANFANG,WEB
ACTIVATION,ATM,CD133,GCS
DCX,PREVIOUSLY,SPARC,THEREFORE
EXPRESSION,GBM,HMGA2,INCREASING,KNOCKDOWN,R248W,RESULTING,SIMILAR,SNAI1,TAKEN
169,BBB,COPYRIGHT,HOWEVER,LTD
169,177,956,ABC,BACKGROUND,BBB,BCRP1,CONCLUSION,COPYRIGHT,FVB,HOWEVER,INC,LABEL,MDR1A,METHODS,PET,PGP,RESULTS,THERE
169,237,241,ADMISSION,COPYRIGHT,DIAGNOSTIC,NEUROCIRUG,PUBLISHED
169,OCULOMOTOR
169,COPYRIGHT,LTD
005,009,015,026,616,ASSESSMENT,CONFOUNDS,FOLLOWING,LABEL,METHODS,NEURO,OBJECTIVE,QOL,RESULTS,SCALE,SHERBROOKE
169,BIOMETRIC,SOCIETY
FDG,HOWEVER,PCNSL,PET
001,002,106,BILATERAL,DBS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS,STN,THESE,THOSE
ABO,THESE
CHINESE,DANSHEN,ROS,U87,WESTERN
008,025,027,057,138,271,552,ACA,BACKGROUND,BETWEEN,CONCLUSION,GAMMA,KNIFE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC
945,COMPLEX

160,169,BIOLOGICAL,CONCLUSION,FIFTY,INCREASED,LABEL,LGG,LTD,METHODS,OBJECTIVE,PCR,RESULTS,THESE,WILEY
132,172,CHINESE,MALIGNANT,PFS,R132H,RECURRENCE
ADC,MRI,NONTYPICAL,SVM,THEREFORE,TYPICAL
FABP7,FINALLY,III,MALIGNANT,NFI,NUCLEAR,THESE,USING
169,437,ASSESSMENT,BACKGROUND,COPYRIGHT,COX,KARNOFSKY,LABEL,LOUIS,MATCHED,MEIER,METHODS,NSCLC,PROGNOSTIC,RESULTS,SOCIETY,SRS,UNIVERSITY,WASHINGTON
HENCE,SIADH
001,015,177,191,267,ADDITIONAL,COX,DYNAMIC,III,KARNOFSKY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS
169,BASEL,COPYRIGHT,PONTINE
ALZHEIMER,SCIENCE,SIGNALING
100,956,BASED,CEA,CONCLUSION,CSF,CYFRA,CYFRA21,ESPECIALLY,LABEL,METHODS,MRI,NSE,OBJECTIVE,RESULTS,THREE
AUC,CONCLUSION,CRC,DUKES,ELISA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,AFTER,BASEL,CONGENITAL,COPYRIGHT,MRI
FINALLY,FULLERENES,GADOLINIUM,MRI,THESE
HENCE,HOWEVER,THEREFORE
EAC,LABEL,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,THESE
169,559,INC,SIMILAR,TAKEN,WILEY
160,177,ACROMEGALY,AGE,IGF,MALIGNANCY,RENAL,THEREFORE,THYROID
106,177,ACROQOL,BACKGROUND,HRQOL,LABEL,MEN,METHODS,QLS,REDUCED,RESULTS,SCL,THERE,USING
169,CD133,COPYRIGHT,CSC,FURTHER,GBM,INCREASING,LTD,WHEREAS,WILEY
178,900,CNS,EIGHT,ERBB2,HGG,LAPATINIB,SEVEN,WESTERN
001,002,029,040,160,177,1RA,AFTER,CRP,FDG,METABOLISM,PET,PRO,RII
169,CHI,COPYRIGHT,DISKETTES,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OLFACTION,OLFACTORY,OTOLOGICAL,RESULTS,SMELL,SOCIETY,THERE,WHITNEY
001,145TH,33695,AGE,CONCLUSION,COX,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SOUTH
001,012,156,177,397,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,REPORTS,RESULTS,SHH,WNT
ADDITIONAL,AFTER,EASTERN,FIG,GROUP,MOLECULAR,NSCLC,PET,TREATMENT
AUTOPSY,DVT
128,DESPITE,EPH,EPHB1,EPHB2,LUCIFERASE,MICRORNAS
169,946,AMONG,COPYRIGHT,HCG,HOWEVER,INCREASED,LTD,REVIEWING
177,3MM,CYBERKNIFE,GAMMA,GTV,KNIFE,NCI,OAR,RESULTS,SRS,TLD
177,DUE,ISO,LOCALIZER,UNDER
160,169,BACKGROUND,COMPLEX,COPYRIGHT,INC,LABEL,METHODS,PATIENT,RESULTS
10YEARS,169,177,1CM,47ADULT,BACKGROUND,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS
169,1990S,BRITISH,DESPITE,LOW,SOCIETY,THEREFORE
169,507,BECAUSE,DIFFERENT,LTD,WILEY

ALZHEIMER
022,169,200,945,ADC,AMONG,DUE,FIFTY,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,SNP
014,120,177,AFTER,BBB,CONCLUSION,DESPITE,HEALTHY,LABEL,LOW,METHODS,MODEL,PET,PGP,RESULTS,THERE,UNLABELLED

1950S,1970S,AKITA,JAPAN,ONSET,THESE
177,ACCORDING,AMONG,ART,BACKGROUND,CAUTION,COMPETING,COS,EMERGENCY,FUNDING,GROUP,HOWEVER,IVF,LABEL,MATERIALS,METHODS,OBJECTIVE,OVARIAN,PREGNANCY,REASONS,RESULTS,SETTING,SUMMARY,TESTICULAR,THEREFORE,THREE,UNIVERSITY,WIDER
HOWEVER,III
169,AC133,AKT,BMI,CD133,COPYRIGHT,HES,INC,NOTCH,WILEY
169,CNS,COPYRIGHT,CXCR4,INC,WHILE,WILEY,WNT
169,COPYRIGHT,DCE,LTD,MRI,THESE,VARIOUS,WILEY
ATT,FINALLY
PCNSL
BECAUSE,EGF,HOWEVER,SEEKING,T98MG,THEREFORE,U87MG
851,883,916,930,BESIDES,COX,FURTHER,HOWEVER,MEIER,MRI,PCNSL,ROC,SIMILAR,TAKEN
1P19Q,GLIAL,HOWEVER,IDH,III,MAJOR,PILOCYTIC,V600E
117,160,177,CONCLUSION,DISEASE,GRADE,HIT,LABEL,LGG,LOW,METHODS,NF1,NORMALIZED,OBJECTIVE,PFS,PURPOSE,RESULTS,SBT,TREATMENT
100,160,ATR,BIOPLEX,CURRENT,HGF,PECAM,RBF,SVM
169,COPYRIGHT,INC,INHIBITION,MALIGNANT
169,HOWEVER,STRATEGIES
169,945,ANCILLARY,BMP,HIF,HOWEVER,LIF,MBRCS,NANOG,NOTABLY,STAT3,THESE
169,237,241,COPYRIGHT,CSF,ENDOSCOPIC,ENGLISH,JANUARY,LABEL,MEDLINE,METHODS,NEUROCIRUG,OBJECTIVE,PUBLISHED,RANDOMIZED,RESULTS
169,ABSTRACTS,ATTENTION,CONCLUSION,COPYRIGHT,CURRENT,DESPITE,FURTHER,LABEL,LTD,METHODS,MPH,OBJECTIVE,PURPOSE,RESULTS,SHORT,WHILE
169,COPYRIGHT,GBM,GREAT,HOWEVER,LTD,RADIATION
038,168,169,177,502,522,946,AS2O3,COMPLEXED,COPYRIGHT,NMR,STB,U87
108,169,541,ALU,MIM,MRI,MUTATIONS,PCR,PRL,PROP1,PUBLISHED,SAS,SDS,THEREFORE,TSH
001,169,250,BACKGROUND,BIOLOGICAL,BRAIN,COPYRIGHT,LABEL,LOCAL,LTD,METHODS,RESULTS,RPA
169,COLLEGE,COPYRIGHT,ESTIMATING,LABEL,LARGE,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
160,169,ALTEPLASE,COPYRIGHT,DESPITE,INC,INSTITUTES,INTRA,NIHSS,PUBLISHED,SCALE
000,100,113,151,169,220,462,487PY,982PY,AMONG,BACKGROUND,COPYRIGHT,COX,HRS,LABEL,LTD,METHODS,NPC,RESULTS,USING
169,APC,COPYRIGHT,FAP,GARDNER,LTD,MAML2,MAXILLO,MECT1,POLYPOSIS,PUBLISHED,SURGERY
169,COPYRIGHT,LTD,MPNST
169,BACKGROUND,COPYRIGHT,LABEL,MATERIALS,METHODS,RESULTS,SSS,THESE,UNASSIGNED
169,COPYRIGHT,IRELAND,LTD
001,169,215,3GY,441,BACKGROUND,COPYRIGHT,EIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE
169,AREAS,CONCLUSION,COPYRIGHT,CROSS,INC,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,SOCIETY,UNIVERSITY,WOMEN
ADC,AMONG,BETWEEN,DWI,FACTORS,FORTY,IOM,JANUARY,LABEL,MEP,METHODS,MRI,OBJECTIVE,RESULTS,SIXTEEN,SURGERY
102,AMONG,BEIJING,KNOWLEDGE,LABEL,MALIGNANT,METHODS,MPNST,OBJECTIVE,PFS,PNSTS,RESULTS,TIANTAN,TOTAL,UNIVARIATE
120,200,214,3MM,GBM,GROUP,NRI,PTV,RADIATION,SPATIAL,THERAPY,TPS
INDEX,INVENTORY,IQR,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PERMANENT,PFBTS,QOL,QUALITY,RESULTS,UTILITIES
155,203,860,AFTER,LABEL,METHODS,OBJECTIVE,RESULTS,SDS,SERUM,TORANOMON
NOVEL,SOMATIC
COGNITIVE,HOWEVER,THESE
CURRENT,CURRENTLY,DECREASED,HOWEVER
2G4,GBM,HIV,HOWEVER,LABEL,METHODS,OBJECTIVE,PA2G4,PURPOSE,RESULTS,U87MG,VPR
170,231,956,AFRICAN,BLACK,HOWEVER,MCF,MDA,MTT,MURASHIGE,NEURO,SKOOG
CAVERNOUS,CMS,FEW,GENOMIC,KRIT1,MRI
191,490,AIM,DEPARTMENT,DISEASE,INCLUSION,INDEX,KNOSP,PITUITARY,RECURRENCE,UNIVERSITY
001,005,160,627,CNS,CUMULATIVE,END,RESULTS,SMN,USING
160,CNS,GRADE,PCNSL,PEMETREXED,PFS,SCNSL,THERE
017,BACKGROUND,EXPRESSION,GBM,HMGB2,LABEL,METHODS,RESULTS,TIMP2,TRANSWELL,WESTERN
BECAUSE,CD11B,CD163,THESE
BACKGROUND,DYNAMIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,THERE
435,FUR,MDA,NSC,PREVIOUSLY
916,ONCOLYTIC,PREVIOUSLY,RAMBO,RAPID,THESE,U87
001,002,004,169,376,513,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,HOWEVER,INC,INDEX,LABEL,MAY,METHODS,MOLECULAR,NEITHER,NSCLC,RESULTS,UNIVERSITY
169,COPYRIGHT,HOWEVER,PUBLISHED
003,024,075,169,259,299,603,741,819,946,ABCG2,ALZHEIMER,ATP,C421A,COPYRIGHT,FURTHER,HUNGARIAN,IRELAND,LTD
169,CLUSTERING,CONTACT,COPYRIGHT,CRITICALLY,LTD,MMP,PEG,THREE,U87MG
169,COPYRIGHT,FEW,LTD,PXA
169,ABCB1,ABCG2,BCRP1,COPYRIGHT,DESPITE,JAK,JANUS,KO143,LTD,MDR1A,PHASE,THESE
002,029,035,049,169,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LANCASTER,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SIXTY,THERE
BACKGROUND,CD117,CONCLUSION,FDG,LABEL,METHODS,MRI,PET
112,CD133,EXPRESSION,TARGETING
GROUP,SHH,WNT
ALTOGETHER,GSC,PULSE,S1P,TMZ,U87
10Q,10Q23,17P,17P13,19Q,19Q13,22Q,22Q12,ADDITIONAL,AFTER,CPG,EPIGENETIC,III,P16,RASSF1A,RB1,WHETHER,WORLD
BLCAP,BLCAP_V2A,CCCTC,H19,HOWEVER,WILMS
149,177,588,AFTER,CAB,CONCLUSION,CUMULATIVE,FORTY,LABEL,METHODS,OBJECTIVE,PARKINSON,PROLACTIN,RESULTS,SOCIETY,VALVE
CARDIAC,HOWEVER,SERTOLI,TESTICULAR
160,1H153,201,205,ADP,BRCA1,BSI,GLV,NOTCH
183,474,BASED,BOERHAAVIA,DIFFERENT,GEORG,HOWEVER,INDIA,STUTTGART,UNANI
125,160,AGE,ELISA,FURTHER,HGG,SAMPLES
001,013,028,041,160,213,CLL,CNS,HGG,HRQOL,LGG,MCS,NHL,NSCLC,SHORT,SOS
160,177,BECAUSE,CENTRAL,FORTY,GROSS,HPC,SIXTEEN,UNIVARIATE
174,181,JASON,MTX,PRIOR,THERE,THESE,THROUGHOUT
177,CONCLUSION,FDG,LABEL,METHODS,MRGLU,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
101,154,HOWEVER,IPILIMUMAB,PROGRAM,THREE,TREATMENT
BRAIN,CALCULATED,CONCLUSION,EVALUATION,FAS,FIFTY,KEEPING,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
100,150,160,BACKGROUND,CONCLUSION,CURRENTLY,DIFFERENT,FIFTEEN,FURTHER,LABEL,METHODS,OBJECTIVE,PBT,PURPOSE,RESULTS,SRT
177,BACKGROUND,DTI,FLS,KARNOFSKY,KPS,LABEL,METHODS,MRI,NOVEL,RESULTS,THERE,TOTALLY
DESPITE,IMAGING,MRI,RESONANCE
BRAIN,HMB45,MELANOTIC,THERE
204,ADULT,APL,CNS,CSF,GROUP,JALSG,JAPAN,MARCH,PML
169,BRITISH,CASES,CONCLUSION,DIA,DIG,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,THREE,V600E,VE1
169,BRITISH,GPER1,GPR30,OESTROGENS,SOCIETY,THERE
001,149,BACKGROUND,CONTROL,III,KPS,LABEL,LOCAL,LUEBECK,METHODS,MRI,PROGNOSTIC,RESULTS,RPA,UNIVERSITY,WBI
110,177,CONCURRENT,DESPITE,FIRST,III,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,OVERALL,RESULTS
177,OVERALL,PRIMARY,SIX
DSC,HAUSDORFF,HSD,LABEL,METHODS,MSD,OBJECTIVE,PURPOSE,RESULTS,THESE
ANTIGLIOMA,BACKGROUND,GBM,GBM12,GBM43FL,HB1,LABEL,MEIER,METHODS,NSC,ONCOLYTIC,RESULTS
001,009,013,036,169,BACKGROUND,COPYRIGHT,COX,DESPITE,FLAIR,LABEL,METHODS,MRI,OVERALL,PFS,RESULTS,SOCIETY,VOLUMETRIC
945,946,947,ALA,BACKGROUND,CHO,GLX,LABEL,LAC,LIP,METHODS,MRS,NAA,OBJECTIVE,PRESS,PURPOSE,RESULTS,STEAM,THERE

111,160,177,STX,USAGE
BBB,C51,CNS,DM101,DM113,EWING,FOLLOWING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SF295,THESE,WHILE
160,ENGLISH,GLIOMAS,THEREFORE
EEG
169,COPYRIGHT,LTD,MALIGNANT,MMP,PACLITAXEL,PEI
8TH,ACCURAY,CHORDOMAS,CYBERKNIFE,HOWEVER,INC,SUNNYVALE,THERE
ATLAS,GBM
003,BRAIN,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
003,CONCLUSION,LABEL,METHODS,OBJECTIVE,PTE,PURPOSE,RESULTS,TREATMENT
CONCLUSION,CSI,EFS,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SITES
169,DORFMAN,INC,OTOLOGICAL,ROSAI,SOCIETY
169,200,AUTHORS,CD133,LTD,MYB,OLIG2,PUBLISHED,ROBO1,WILEY
MRI,PATHOLOGY,ROSETTE,WORLD
AGGRESSIVE,BACKGROUND,CONCLUSION,DTI,LABEL,METHODS,OCULOMOTOR,PFS,POSTERIOR,RESULTS,SCP,THESE,USING
124,DESPITE,ERK,GBM,MICRORNAS,PCR,RAF,RAS,SOS,U87,USING,UTR
AMONG,CHINESE,CONGO,EMA,FAP,FINNISH,HGA,MRI,REMARKABLY
003,160,EGFRS,IGF,JANUARY,UNIVERSITY
COX,DENMARK,LGG,LOW,MUTATED,PATHOLOGY,R132H,SEVENTY
00001,008,048,053,842,ANALYZING,EMMPRIN,EXPRESSION,GBM8401,HOWEVER,IHC,III,LN229,MEIER,OMNIBUS,U87MG
236,694,AUTOLOGOUS,BACKGROUND,BRAIN,CONCLUSION,CSC,DCS,LABEL,METHODS,RESULTS,SEVEN,THESE
CONSORTIUM,FGFR1,H3F3A,NF1,NOTABLY,NTRK2,PILOCYTIC,PROJECT,SURGICALLY
400,956,BLEBS,CELLS,STRUCTURAL
HOWEVER
169,BACKGROUND,BRAIN,COPYRIGHT,HOWEVER,LABEL,LTD,MEETING,METHODS,RESULTS,THEREFORE
169,945,BACKGROUND,BASEL,BAX,CONCLUSION,COPYRIGHT,FOLLOWING,FURTHER,HOWEVER,LABEL,MALIGNANT,METHODS,PFT,RESULTS,THESE,U87,VAD
169,BACKGROUND,BASEL,BRAIN,COPYRIGHT,EIGHT,GCT,JANUARY,LABEL,METHODS,RESULTS,SEPTEMBER,THREE,TREATMENT
THERE
169,AUTOMATING,BRAIN,COPYRIGHT,CROWN,DSC,JACCARD,LTD,PUBLISHED
169,252,AUTHORS,FEDERATION,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY
NF1
MRI
CSC,GBM,PKH,THROUGH
605,BACKGROUND,CLOSE,LABEL,MEDICAL,METHODS,NETWORK,RESULTS,WHILE
145,BACKGROUND,CONCLUSION,CPG,FUNCTIONAL,GBM,INHIBITING,LABEL,METHODS,MICRORNAS,REDUCED,RESULTS,USING
AFTER,BACKGROUND,CURRENTLY,FLAIR,GADOLINIUM,LABEL,METHODS,MRI,RESULTS,SRS,STEROID
ACTIVATION,BACKGROUND,GBM,LABEL,METHODS,RESULTS,RTK,THEIR,THESE
852,BACKGROUND,BECAUSE,FACTORS,GTR,LABEL,LGG,METHODS,MRI,PFS,RECORDS,RESULTS,WORLD
RCC,RENAL,THERE
MENINGIOMA,SUCCESSFUL
001,008,169,203,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,III,INC,KPS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,WILEY

HOWEVER,MICROGLIA,THESE
AGE,BMI,FLAIR,MRI,WHITE,WMC
010,040,089,160,177,254,419,624,725,CLASS,HCC,RPA,SRS
160,CONTROL,MEIER,SEVENTY,SRS
191,BLINDED,DIFFUSE,MAY,OCTOBER,THESE,THREE
001,037,048,801,888,911,BRAIN,C30,EORTC,GRADE,PFS,QLQ,QOL,SINCE
BACKGROUND,CONCLUSION,COX,FOLLOWING,GRADE,III,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,WORLD
156,956,ANALGESICS,BACKGROUND,LABEL,METHODS,RESULTS,TEMPORARY
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
CHINA,CHINESE,HOWEVER,RTEL1
CD105,CD133,CELLS,CONCLUSION,LABEL,METHODS,MSLCS,OBJECTIVE,PNETS,PURPOSE,RESULTS,THESE
DIAGNOSIS
142,147,ADC,ADCMEAN,ADDITIONAL,BACKGROUND,DWI,EPIDERMAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESTRICTED,RESULTS
002,181,BACKGROUND,EARLY,GCT,INITIAL,LABEL,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,REMOVAL
001,005,169,203,BASED,CONCLUSION,COPYRIGHT,CSF,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,1980S,CENTRAL,COPYRIGHT,CURRENTLY,DESPITE,LTD,MRI,SINCE,VARIOUS
169,AUTHORS,COPYRIGHT,CURRENTLY,CYBERKNIFE,GAMMA,IDEALLY,KNIFE,LINAC,LOCAL,LTD,PUBLISHED
169,ASL,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MRI,RESULTS,SIX
169,COPYRIGHT,DESPITE,LTD,OPTIC
211,CONVERSELY,TAT,TAVAT,THESE
DEPTH
032,421,463,526,688,737,CPPRH,CSF,HOWEVER,LABEL,METHODS,OBJECTIVE,PREDICTION,RESULTS,SEVENTY
109,BORON,BPA,CSF,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SEPTEMBER,SIMILAR,SIX,THESE
APART,COMBINING,THREE
CAESAREAN,PATIENT
APOPTOSIS,CASPASE
COMBINING,COPYRIGHT,DABRAFENIB,HOWEVER,MEK,PROUS,SCIENCE,SIMILAR,THERE,V600E,V600K
LABEL,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SPARING,SUMMARY
947,CASPASE,CCK,PCR,TELOMERASE,WESTERN
215,ABDOMINAL,CONCLUSION,DESPITE,IGF,LABEL,LAR,LIVER,METHODS,MRI,OBJECTIVE,RESULTS
SHORT
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS
300,BRATS2012,DUE,FINALLY,GABOR,MRI
FINALLY,HSP60,HSP70
ALARMINGLY,ATLAS,CENTRAL,GBM,TMZ
00001,121,ERP,P3A,P3B,STUDIES
195,ADP,GTP,HOWEVER,NOTABLY,NPC,SILENCING
100,169,945,956,BIP,BIX,COPYRIGHT,DUE,EBP,HOWEVER,INC,MTS
EIGHT,GBM,GMB,HOWEVER,IHC,MRI,PET
BACKGROUND,CISPLATIN,DESPITE,KNOCKDOWN,LABEL,METHODS,MICROARRAY,MIRNA,PCR,RESULTS,U251R,UTR
114,BACKGROUND,CAREFUL,CONCLUSION,LABEL,METHODS,MRI,NSCLC,OVERALL,PRIMARY,RESULTS
169,GSC,LABEL,METHODS,NSC11,OBJECTIVE,PURPOSE,RESULTS,U87
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,PITUITARY,RESULTS,WILEY
183,BACKGROUND,CONCLUSION,GBM,GEORG,HOWEVER,LABEL,METHODS,STUTTGART
012,BACKGROUND,CONCLUSION,CYTOLOGIC,FURTHER,GEFITINIB,LABEL,LMC,METHODS,NSCLC,RESULTS,SEOUL,TEN,TKI,UNIVERSITY
GIANT,INITIAL,MEDICAL
MANAGEMENT
CD62E,GBM,GLIAL,MPS,SIXTY,VTE
BACKGROUND,DFS,III,LABEL,MATERIALS,METHODS,RECORDS,RESULTS,SIXTEEN,SURGERY
001,002,020,032,147,177,239,436,546,721,924,946,961,BACKGROUND,LABEL,METHODS,OBJECTIVE,PRL,RESULTS,TGF
015,018,036,045,378,856,963,989,CBV,CONCLUSION,COX,FDG,KPS,LABEL,METHODS,PET,PFS,RESULTS,ROI,THERE,THREE,UNLABELLED
169,ASPECTS,COPYRIGHT,INTERVIEWS,LABEL,LTD,METHODS,OBJECTIVE,OVARIAN,OVERALL,RESULTS,SCREENING,UKFOCSS,UNTIL,WILEY,WOMEN
BTSCS,GBM,HOWEVER,PCR,SDF,THESE,XENOGRAFTS
MEN,RET,THESE,UNTIL
025,078,AFTER,BACKGROUND,COX,KARNOFSKY,KPS,LABEL,MEIER,METHODS,RESULTS
169,924,AIM,CIS,COPYRIGHT,DENMARK,HRT,LABEL,LTD,METHODS,OBJECTIVE,ORS,RESULTS
174,176,177,AFTER,AFTERWARDS,BACKGROUND,CONCLUSION,CRAWLEY,D95,HEXAPOD,LABEL,LTD,MAXIMUM,METHODS,PATIENT,PTV,RESULTS,REUTHER,TEN,TREATMENT,XVI
ACC,BACKGROUND,BASAL,BBC,COMPARISON,CONCLUSION,DIAGNOSTIC,FOXA1,GIVEN,GPM6B,LABEL,MEL,METHODS,MIA,PCR,RESULTS,ROPN1,SOX10,TRIM2
BACKGROUND,BRAIN,CLEVELAND,LABEL,MATERIALS,METHODS,MRI,NEURO,RESULTS,THERE,TREATMENT,USING
004,029,169,ANIMALS,AUC,AUCOE,CHANGES,CONCLUSION,COPYRIGHT,DCE,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,U87MG,WILEY
028,030,177,BACKGROUND,CONCLUSION,LABEL,MEG,METHODS,RESULTS,THERE,WHITNEY
046,AMONG,SPITZ
954,PHF20
169,BASEL,COPYRIGHT,ELECTRICAL,MEG,RESULTS
169,946,AMONG,CONVERSELY,COPYRIGHT,COX,EP2,LTD,MODULATION,PKA,PTGS2
169,BASEL,COPYRIGHT,MEDICAL
169,BASEL,COPYRIGHT,THERE
169,8MG,956,AKT,COPYRIGHT,ERK,GBM,INC,JNK,LN229,NAC,ROS,THESE,U87
150,FOLLOWING,MPI,NOTABLY,THESE
169,ENRICHMENT,EVOLUTION,LIGANDS,SELEX,SYSTEMATIC,THESE,TIC
169,946,BECAUSE,BISPHENOL,BPA,COPYRIGHT,HOWEVER,PUBLISHED,SAS,SIMILAR
SAM,SURGERY

CNS,FXTAS,INITIALLY,SINCE,TAKEN,THERE
AFTER,DIFFUSION,EARLY
GUILLOU
169,946,947,ALZHEIMER,APP,COPYRIGHT,HOWEVER,ISSUE,PROTEASES,PUBLISHED,SECRETASE,SPECIAL
CONCLUSION,DYNAMIC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
AGE,BACKGROUND,CONFIDENCE,HODGKIN,HOWEVER,INCREASED,INTERVALS,ITALIAN,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PCB,PLANT,RESULTS,SMR,VITAL
124,601,693,732,754,765,772,783,827,882,AIM,AUC,BACKGROUND,CONCLUSION,GROUP,III,KARNOFSKI,KPS,LABEL,MAS,METHODS,MRC,OBJECTIVE,RADIATION,RESULTS,ROC,THERAPY
32D,EGF,ERBB3,ERBBS,FINALLY,HOWEVER,MET,NSCLC,OVERALL,USING
123,169,COPYRIGHT,GLIOMAS,HOWEVER,INC,RHODAMINE,U87,WILEY
005,006,160,837,CIA,COGNITIVE,FUNCTIONAL,FURTHER,MRI,THESE
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,RESULTS
334,BACKGROUND,CEREBELLAR,HOWEVER,LABEL,METHODS,PILOCYTIC,RESULTS
AFTER,BACKGROUND,CONCLUSION,CSF,LABEL,METHODS,OPERATING,PERFORMING,PITUITARY
BACKGROUND,CONCLUSION,GENERALLY,LABEL,METASTASIS,METASTATIC,METHODS,WHEREUPON
BIOLOGICAL,GPR49,GSC,OLIG2,PRONEURAL,THEREFORE
CUT,IHC,OPN,RECURRENCE,WORLD
160,292,BASED,HOWEVER,INSURANCE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN,SPANISH
945,BCAAS,BCAT1,EXPRESSION,THESE
169,COPYRIGHT,DLPFC,DMN,INC,PCC,SCN,SMC,TAKEN,TEI
947,BACKGROUND,BASED,BRAIN,CONCLUSION,GBM,LABEL,METHODS,NOTCH,NSC,RESULTS
B1R,B2R,BBB,F98,ICP,KININ,MRI
BASED,COLORECTAL,FDA,FOLFIRI,FURTHER,SEPTEMBER,SORAFENIB,V600E
ACTIVATING,AKT,ANTICANCER,CPG,HOWEVER,MPE,PTGS2,QUESTIONS,REGULAR,THEREFORE
169,COPYRIGHT,CURRENT,GBM,LTD,PUBLISHED
124,169,954,CLOCK,COPYRIGHT,FURTHER,PUBLISHED
169,AUTHORS,COPYRIGHT,INC,PUBLISHED,WNT
169,BESIDES,COPYRIGHT,INC,INCREASED,PUBERTY
169,ALTERED,COPYRIGHT,IRELAND,LTD
169,CNS,COPYRIGHT,DLBCL,HODGKIN,IGM,LOW,LPL,NHL,PCNSL,PRIMARY,PUBLISHED,SPECIALIST
001,142,151,169,173,249,457,967,COPYRIGHT,INC,LABEL,LLNRS,LPARS,LPERS,METHODS,OBJECTIVE,OVERALL,PFI,PRS,RESULTS,SCS,SECONDARY
083MG,107,169,5GY,945,956,COPYRIGHT,CPG,HIF,MALIGNANT,MVD,ODN,U87
169,177,8DAYS,9DAYS,ANIMALS,BACKGROUND,BRAIN,COPYRIGHT,FDG,GBM,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SRT,U87MG
169,AUTHORITY,COPYRIGHT,FURTHER,IRELAND,LTD,OVERALL,SOLID,THESE
169,200,500,COPYRIGHT,INC,UNIVERSITY
169,19Q13,ANAPLASTIC,COPYRIGHT,EPENDYMAL,III,INC,MOLECULAR,WORLD
169,219,COPYRIGHT,CPT,FIFTEEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPNET
169,COPYRIGHT,GIVEN,INC,NOVEL
138,169,230,403,COPYRIGHT,DCS,GBM,LABEL,LTD,METHODS,OBJECTIVE,PFS,RESULTS,THEREFORE
169,COPYRIGHT,LTD,MRI,PCD
001,100,169,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SERAM
947,AMERICA,FURTHER,GBM,GSK461364A,INHIBITION,LOW,LTD,PUBLISHED,USA
150,169,220,COPYRIGHT,DIAGNOSTIC,INFECTIOUS,POSTERIOR,SAS
169,BRAIN,COPYRIGHT,CSF,GIVEN,HOWEVER,INC,MRI
001,009,034,142,170,195,ACCORDING,BACKGROUND,III,LABEL,THERE,UNLABELLED
005,100,568,955,IMAGING,IOI,LABEL,METHODS,OBJECTIVE,OPTICAL,RESULTS
945,ABC,ABCB1,ABCG2,ATP,CNS,PKC,THREE,TNF
BBB,CNS,WHILE
BRAIN,SIX,SMART,THESE,THREE
ADC,BACKGROUND,DIFFUSION,INCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE
107,114,117,123,201,214,223,276,278,303,306,321,426,448,ACRIN,BACKGROUND,CONCLUSION,EARLY,FLAIR,GBM,LABEL,MACDONALD,MEIER,METHODS,MRI,RADIOLOGIC,RESULTS
118,142,260,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,STUDIES
101,CPEB1,EED,EPIGENETIC,H3K4ME2,H3K9ME3
533,COMMITTEE,DFS,DIFFERENT,GRABOWSKI,IMPORTANCE,JANUARY,JOINT,LABEL,MEASURE,METHODS,OBJECTIVE,OMISSIONS,OUTCOME,RELEVANCE,RESULTS,SETTING,STAGING,TNM
AKT,BACKGROUND,GBM,JAGGED1,LABEL,MAJOR,METHODS,MVD,NOTCH,PCR,RESULTS,THESE,WESTERN
945,AKT,AUTOPHAGY,BACKGROUND,GADD153,GRP78,KNOCKDOWN,LABEL,LC3,METHODS,RAPAMYCIN,RESULTS,SHORT,THESE,WESTERN
050,055,795,867,BACKGROUND,CRT,FEW,GBM,GIVEN,HOWEVER,LABEL,MEIER,METHODS,PFS,RESULTS
BACKGROUND,CST,DTI,DTT,FMT,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,ROI,SEVENTEEN
179,AVERAGE,BACKGROUND,FSH,GAMMA,KNIFE,LABEL,LOCAL,METHODS,NOV,PERMANENT,PRL,RESULTS,TEN,THERE
100,CCK,DLC,DOX,TAKEN
145,725,BEV,CONCLUSION,COSTS,FET,HOWEVER,INSURANCE,LABEL,METHODS,PET,RESULTS,STATUTORY,UNLABELLED
CAREFUL,METASTASIS
CLINICALLY,CNS
946,ALK,ATAD2,EMT,GENOMIC,IBC,IBC02,MYC,REMARKABLY,SINCE,THESE,TSPAN24
AFTER,CONCLUSION,LABEL,METHODS,NEUROTOUCH,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,VALIDATION
120,180,240,ADR,BRAIN,CONCLUSION,DYSARTHRIA,IRINOTECAN,LABEL,NARANJO,OBJECTIVE,PURPOSE,SUCCESSFUL,SUMMARY
AMONG,GBM,HOWEVER,MEK,RG3,RG5,RK1,THEREFORE
103,173,BACKGROUND,CHINESE,GENOMIC,GLIOMAS,HOWEVER,HPAII,LABEL,METHODS,OBJECTIVE,OCCURRENCE,RESULTS,THEIR,UNASSIGNED,VIRTUAL,XCI
FINALLY,THIRD
132,172,945,ELISA,HOWEVER,IDH,MSMAB,MUTATIONS,R132C,R132G,R132H,R132L,R132S,R172M,WESTERN
200,BACKGROUND,CENTRAL,CUBAN,EPIDERMAL,LABEL,METHODS,NERVOUS,RESULTS,TREATMENT,TRIAL,WHILE
19Q,26951,ANAPLASTIC,AOS,CEENU,DESPITE,EORTC,GROUP,III,NOW,PCV,RADIATION,TEMODAR,THERAPY,THESE,TREATMENT
169,231,231BR,947,ALLOCTL,CONCLUSION,HLA,IFN,INDIVIDUAL,LABEL,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,RRV
048,137,BETWEEN,GBM,NEUTROPHIL,NLR,THESE
160,BMI,CNS,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SDS,THERE
107,260,350,ACT,AMENDMENT,BRAIN,CNS,HOWEVER,REGISTRIES
169,ACCESSING,COPYRIGHT,LTD,THESE
039,169,BACKGROUND,BROWN,COPYRIGHT,CSF,DEFINITION,ERASMUS,FACTORS,IMAGING,IMBCM,LABEL,MED,MEDLINE,METHODS,OBJECTIVE,PUB,RESONANCE,RESULTS,SEQUARD,TREATMENT
169,COPYRIGHT,CTV,DRR,FREQUENTLY,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
DCA
093,169,AUSTRALIAN,BACKGROUND,COLLEGE,FORTY,LABEL,METHODS,N95,OUTCOME,P50,PATTERN,RESULTS,ROYAL,THERE,TUMOURS,ZEALAND
BACKGROUND,FINALLY,HOWEVER,LABEL,RESULTS
169,300,AMONG,CNS,FINALLY,GLI,NEOGENIN1,SHH,SONIC,TAKEN
007,169,BACKGROUND,CNS,COPYRIGHT,INC,LABEL,METHODS,PROCEDURE,RESULTS,STORY,SURVIVORS,WILEY
001,005,169,700,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,FATIGUE,GREATER,INC,LABEL,METHODS,PEDIATRIC,PROCEDURE,RESULTS,SLEEP,WILEY
NOA,WHILE
169,NMR,VCH,WILEY
473,CNS
GTPASES,RHO,SRC,TNF,TRAF2,TWEAK
177,BEGINNING,FURTHER,IGF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SDS,SERUM
169,BACKGROUND,CONCLUSION,LABEL,LIMITED,METHODS
177,577,AFTER,ALDRETE,ANALOGICAL,ANESTHESIA,BACKGROUND,BIS,BISPECTRAL,CONCLUSION,GLASGOW,IRB,LABEL,MATERIALS,METHODS,MMS,RAPID,RESULTS,SCALE,SCORE,SECONDARY,SHORT,STATE,STT,TIMES

169,COPYRIGHT,FEDERATION,HOWEVER,LATERAL,MITOPHAGY,PARKINSON,PRODUCTION,PUBLISHED,ROS,SCLEROSIS,SOCIETIES
0MM,177,2MM,5MM,BACKGROUND,LABEL,PTV,RESULTS,SET,SEVEN
160,169,183,CNS,DPACE,IMIDS,JANUARY,LTD,WILEY
100,120MG,5HR,ANESTHESIA,BLOOD,BRAIN,THEREAFTER
006,014,407,BACKGROUND,CHECKLIST,COMPARISON,CONTEXT,EQUALLY,INTERVIEW,LABEL,MEDICAL,METHODS,NETWORK,OBJECTIVE,OUTCOME,RESULTS,SETTING,SOUTH,SYMPTOM
001,016,049,169,224,ADC,ADC1000,ADC3000,CONCLUSION,HISTOGRAM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEOUL,STUDENT,UNIVERSITY
DISRUPTION,WHETHER
945,946,AKT,PI3,STUDIES
053,185,III,LGG,MET,MRI,PERFUSION,PET,REGIONS,TAKEN
CNS,DYNAMIC,GBCAS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,USPIO
AVOIDABLE,CONCLUSION,ITALIAN,ITALY,JOINPOINT,LABEL,MATERIALS,METHODS,MORTALITY,OBJECTIVE,OVERALL,RATES,RESULTS
9OLFACTORY,CONVEXITY,SINONASAL,SKULL,THERE
124,177,378,740,BACKGROUND,BSS,HOWEVER,LABEL,METHODS,MRI,RESULTS
BACKGROUND,CLEAR,FINAL,IMAGING,INITIAL,LABEL,METHODS,MRI,PATIENT,RESULTS
169,COPYRIGHT,EXTRACTING,FICKIAN,LTD,TRANSPORT
169,COPYRIGHT,DROSOPHILA,GTPASES,HOWEVER,INC,PARKINSON,RAS,RIC,RIN,RIT
169,AUTHORS,CBL,COPYRIGHT,EGF,EGFRS,GTP,INC,LN229,PUBLISHED,THESE,U87
169,COPYRIGHT,EEG,HOWEVER,INC,INCREASING,LESIONS,MEG,PDA,THESE
000,002,003,010,012,050,169,224,232,311,350,687,898,924,AGE,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,RESULTS
169,635,AMONG,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,DIAGNOSTIC,LABEL,MATERIALS,METHODS,MINOR,MORTALITY,RESULTS,THERE
001,006,037,043,104,169,449,553,ADVANTAGE,COPYRIGHT,GBM,INDEX,LTD,PUBLISHED,SIMILARLY
013,BACKGROUND,CPG,LABEL,MEIER,METHODS,MICROARRAY,RESULTS,TES,U87
100,CEA,CGA,CK5,CK8,EMA,LABEL,METHODS,NSE,OBJECTIVE,PAS,RESULTS,THREE
169,CENTRAL,COPYRIGHT,DESPITE,EARLY,LTD
169,946,COPYRIGHT,GBM,GLIOMAS,GSK,LTD
169,BECAUSE,COPYRIGHT,IPT,LTD,STILL,TREATMENT
169,CNS,COPYRIGHT,FEW,IRELAND,LTD
169,COPYRIGHT,INC,MRI
107,169,326,AED,BRITISH,COPYRIGHT,CYBERONICS,ENGEL,HOUSTON,HOWEVER,INC,LABEL,LTD,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,PURPOSE,RESULTS,THERE,USA,VAGUS,VNS
BACKGROUND,GROUP,ID3,KNOCKDOWN,LABEL,METHODS,RESULTS
APRIL,CLASS,ENGEL,GRADE,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,RESECTION,RESULTS
076,733,781,786,870,902,959,CAUCASIANS,CIS,MTHFR,ORS,SCIENCE,TEN,THERE,WEB
SELDI,SURFACE
IMAGING,PITUITARY
003,004,134,154,157,167,169,179,187,201,219,225,281,297,404,ANOVA,BACKGROUND,COPYRIGHT,DICOM,FPA,GLM,INC,INDUCED,INTRA,IPA,LABEL,LASER,METHODS,MINIMAL,OBJECTIVE,OBJECTIVES,OPERATIVE,RATER,RESULTS,SIXTEEN,THERAPY,THERE,THERMAL,USING,WILEY
EVIDENTLY,JANUS,KALLIKREIN,KLK,REGARDING
ALT,SIMILAR
ASICS,HOWEVER,HYPOXIA,SINCE
ENDOG,HOWEVER,HSC,HSP70,OXIDATIVE,TAKEN,UNDER
1P19Q,546,C228T,C250T,IDH,OTHERWISE,TELOMERASE
018,025,BACKGROUND,EVENTUALLY,EXPRESSION,IMAGING,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SURPLUS
169,COPYRIGHT,INC
160,169,177,COPYRIGHT,GAMMA,KNIFE,LTD,PUBLISHED,RMS,THREE
119,128,156,169,175,183,219,AFTER,BACKGROUND,COPYRIGHT,DESPITE,FUNDING,HOWEVER,INSTITUTE,IQR,LABEL,LTD,METHODS,RESULTS,SINCE
169,946,ARRBS,COPYRIGHT,INC,NOWHERE,STUDIES
169,1MG,BACKGROUND,CLINICALLY,CONCLUSION,COPYRIGHT,GRADE,LABEL,METHODS,MULTI,MYELO,RESULTS,SEVEN,TMZ,UNI
169,ACTIVATED,COPYRIGHT,INC,KIM,STAT3
169,201,231,CONGENITAL,COPYRIGHT,PUBLISHED,SAS,TUMORAL
169,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,MEDLINE,METHODS,PUBLISHED,RESULTS,SCHOLAR,THEREFORE
EXTENSIVE
169,954,CRP,HUVEC,JUN,NEURO,SOCIETY,THESE
MRI
BRAIN,M153R,MHC,THESE,U87,USING
111,AFTER,CLUSTERING,COX,CSA,FK506,GBM,MEMBERS,MMP,NFAT1,PCR,PEARSON,THESE,U87
PCR
AKT,CONVERSELY,EGF,ERK,GLI,SMOOTHENED,SONIC,TREATMENT,VEGFA
HOWEVER,SECONDARY
LOCAL
DISCOIDIN,HOWEVER,III,MMP,NSCLC
124,CDA,HOWEVER,MIR
100,179,BECAUSE,CNS
478,BACKGROUND,III,LABEL,METHODS,OBJECTIVE,PATIENT,PCI,PFS,RESULTS,WHITFIELD
956,SUFFICIENT
11C,945,AMT,MRI,PET,SUV,THESE,TUMORAL
18F,ASSESSMENT,FET,FLAIR,HOWEVER,NEURO,NEWLY,PET
169,239,ANORECTIC,COPYRIGHT,INC,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SPM,THESE
007,AFTER,BACKGROUND,COX,FORTY,LABEL,LOCAL,MAY,MEIER,METHODS,PFS,PTV,RESULTS,SRS
6MV,AAA,ALGORITHM,BACKGROUND,BRAIN,COLLAPSED,COMPASS,DOSIMETRY,IBA,LABEL,METHODS,RELEVANCE,RESULTS,USA
001,002,169,22G,466,473AA,502,APMIS,CHINESE,LOX,LTD,LYSYL,PUBLISHED,RESULTS,THESE,WILEY
946,ANXA2,EIF4E,GAPDH,HSP90,HSPA8,IPA,NAMPT,PROTEOMIC,U87
001,003,169,BASEL,BRAIN,COPYRIGHT,HEPATIC,III,LYMPH,MRI,NMR,OVERALL,PET
CONCLUSION,EIGHT,HODGKIN,LABEL,MEDICAL,METASTATIC,METHODS,OBJECTIVE,RESULTS,SECONDARY,SEVENTY,UNIVERSITY
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
373,945,BRADYKININ
243,CAJAL,RAM,SINCE,THESE
402,462,880,AID,BACKGROUND,BRAIN,HOWEVER,HRS,LABEL,METHODS,OVERALL,RESULTS
000,169,AUNRS,COPYRIGHT,CSC13,DU145,NIR,THEREFORE,VCH,WESTERN,WILEY
169,BIOLOGY,COMBINING,COPYRIGHT,INC,MOLECULAR,OWING,SOCIETY,STUDIES,UNION
169,COPYRIGHT,DESPITE,LTD,MRI,SEVERAL,WILEY

177,AIM,CONCLUSION,CSF,ETV,LABEL,METHODS,OBJECTIVE,PRIOR,RESULTS
EARLY,HENCE,HOWEVER,PFEDH,SIEDH,SUPRA
001,100,177,916,PRL,THERE,THESE
001,027,069,525,527,576,589,652,804,ADDITIONAL,FMD,HDL,IMT,MEANWHILE,SERUM
GRADE,MEK,PXA,V600E,WORLD
024,100,178,AMONG,APRIL,HOWEVER,KARNOFSKY,KPS,MAY
FINALLY,MSC,THESE
CYP11A1,NUSAP,P450SCC,PCR,SURGERY,THEIR
169,APMIS,COX,FORTY,GRADE,III,LTD,PUBLISHED,SEVERAL,THEIR,WILEY
009,131,169,APMIS,BONFERRONI,CHI,FIFTY,FURTHER,LTD,NSCLC,PUBLISHED,SIXTY,WILEY
AFTER,DEFECTS,LABEL,MEANWHILE,METHODS,OBJECTIVE,RESULTS,SEVEN,TOTAL,USING
956,BETWEEN,CBV,CONCLUSION,FLT,GBM,IMAGING,LABEL,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,THREE,TOTAL
100,169,177,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SMALL,SNR,WILEY
956,BCL,FINALLY,HOWEVER,MYC,RESULTS,U87MG
001,INHIBITING,SMC1A,THEREFORE,U87MG
160,COMBINING,CSI,HOWEVER,III,MRI,PRIMARY
AMONG,MLL,PCR,SET
708,CCND1,GBM,PCR,TAKEN
BASAL,BCC,HOWEVER,MUTATIONS,PREVIOUSLY,PTCH1,TAKEN,WHILE,WHY
169,ASSOCIATED
169,COPYRIGHT,LTD
177,394,CONCLUSION,FDG,HODGKIN,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROVER,SUV,THESE
169,177,1CM,237,241,BACKGROUND,CARDIAC,COPYRIGHT,FEW,LABEL,MARCH,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,INC,MTT,PCDH7,PCR,THESE
169,201,213,220,AED,COPYRIGHT,JME,MVP,SOUTH
ANTIBODIES,AREAS,BACKGROUND,BBB,BRAIN,CNS,COVERED,HOWEVER,LABEL,METHODS,OPINION,THERE,VIRTUALLY
169,EFFECTIVE,GENOMIC,JOURNAL

BECAUSE,DESPITE,FDA,FURTHER,GBM
105,162,212,400,600,AIM,CONCLUSION,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS
BBB,BRAIN,JUNCTIONAL,THERE,TIGHT,TJS
002,012,017,038,047,651,AFTER,BACKGROUND,LABEL,LAR,METHODS,OBJECTIVE,OCT,PROTEIN,RESULTS,SSTR2,THERE
160,AML,CUMULATIVE,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR,SURVIVORS
ANY,HPA,MOLECULAR,MYASTHENIA
001,018,127,HOWEVER,MEIER,WESTERN
007,GTVND,GTVNX,HOWEVER,LABEL,MATERIALS,METHODS,MRI,NPC,OBJECTIVE,PURPOSE,REMARKABLE,REPLANNING,RESULTS,THERE
169,COPYRIGHT,HAP40,INC,INR,MCH,RONCORONI,USING,WILEY
945,FINALLY,IFS
HOWEVER,ICP
160,AUCPLASMA,ECF,HOWEVER,LABEL,LETROZOLE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPRAGUE
BACKGROUND,CNS,DISCUSSION,LABEL,METHODS,REPORTS,SUSTAINED
AMONG,DIAGNOSTIC,RYK,WNT5A
001,002,068,100,120,153,1R4,255,260,357,422,480,502,597,753,790,890,946,948,984,COX,IGFBP,III,IL1R4,MCP,MIP,ST2,TEN
000,100,111,300,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,008,130,177,197,540,CERRAHPASA,CONCLUSION,LABEL,MEDICAL,METHODS,NPC,OBJECTIVE,PLANS,PURPOSE,RESULTS,SIB,UNIVERSITY
000,234,BURKITT,EPSTEIN,MYC,THESE
003,109,169,ACADEMY,AMONG,BRAIN,COPYRIGHT,GCA,III,INC,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,PUBLISHED,PURPOSE,RESULTS,TESTING
169,COPYRIGHT,CRANIAL,GRADE,III,LTD,MRI,PATHOLOGY,THESE,UNUSUAL
ATP,HOWEVER,OFF,SAMFS,SIMILARITY,SWITCHABLE,THESE
145,497,MICRORNAS
000,177,200,300,823,AMONG,CAD,RADIATION
156,227,238,268,460,471,554,ANGSTROMS,BRAIN,LOG,PRINCIPAL,THESE
CNS,DUE
169,ABS,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,MRI,RESULTS,WILEY
29C,III,SNB19,THEREFORE
ROS
150,BACKGROUND,ERBB2,LABEL,METHODS,NSCLC,PCR,RESULTS,THEREFORE
007,110,150,331,ASIAN,BACKGROUND,BID,COX,LABEL,MAJOR,METHODS,OBJECTIVE,PURPOSE,RATES,RESULTS,THERE,TRIAL,URL
AUNPS,BECAUSE,BESIDES,CATALYTIC,DUE,HOWEVER,SEVERAL,THESE,ULTRASMALL
BACKGROUND,BRD,CRT,DIAGNOSIS,EBV,EPSTEIN,LABEL,METHODS,MMF,PRIMARY,PUV,TREATMENT
CONCLUSION,EVEROLIMUS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEGAS,STUDIES,TSC
FINALLY,MRI,WHILE
177,AIP,BASAL,R304X,SELLA,SEVEN,THREE,TURKISH
DUE,GBM,GCL,GLUTAMATE,GSH,HOWEVER,PTM,U87
021,819,ASSESSMENT,BMS,GPA,GROUP,III,KARNOFSKY,KPS,PROGNOSTIC,RADIATION,RPA,THERAPY,UNIVARIATE,WHOLE
DEPLETION,ICK,MAK,THESE
169,241,COPYRIGHT,FDG,MRI,PCNSL,PET,PRIMARY
169,APRIL,BACKGROUND,CONCLUSION,COPYRIGHT,JINLING,LABEL,METHODS,RESULTS,SEPTEMBER
10878,169,COPYRIGHT,INC,NSCLC,PCR,THESE
113,169,191,4CM,7MONTHS,BRITISH,COPYRIGHT,DIAGNOSIS,IRELAND,JANUARY,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,THERE
CD163,CD204,FINALLY,GRADE,III,LABEL,MDA,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS
775,ATLAS,DETECTION,EBV,EPSTEIN,HEPATITIS,HPV,SEQ,VIRAL,WHILE
BRAIN,CNS,METASTASIS,TREATMENT
12G04,13W,AXIOCAM,C4742,C7190,CCD,HAMAMATSU,HOWEVER,IOI,MRM,THREE,ZEISS
BUNGE,CTS,FOLLOWING,HOWEVER,MALIGNANT,MGS,STAT3,THESE,U87
99M,CARLO,CONCLUSION,LABEL,METHODS,MONTE,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SPECT,THESE,THREE
001,115,160,230,ACCORDING,BACKGROUND,CONCLUSION,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,THEREFORE,THREE,TOTAL
160,257,514,BACKGROUND,CONCLUSION,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THREE
160,177,BMI,HOWEVER,OUTCOME,REGARDING,TAQ1A,TREATMENT
174,200,215,AFTER,DOTATOC,LOW,MARCH,MIB,MRI,NON,OCTREOSCAN,THERE
177,AFTER,BACKGROUND,BECAUSE,BETWEEN,COX,DEPARTMENT,GBM,GMB,LABEL,MARCH,MAY,MET,METHODS,OBJECTIVE,PFS,RESULTS
006,148,233,364,386,601,967
145,181,BLOOD,CHOLINE,DECREASED,FOURIER,GNP,ICP,LABEL,METHODS,MTT,OBJECTIVE,PEI,PURPOSE,RESULTS,TEM,USING,XPS
DISCUSSION,LABEL,METHODS,OBJECTIVE,PRIMARY,RADIOLOGIC,RESULTS,THERE
136,169,268,730,922,AMONG,BACKGROUND,HOSPICE,INSURANCE,LABEL,METHODS,PEDIATRIC,RESULTS,THERE,UNDERLYING
138,194,ACY,EARLY,FOLLOWING,ROC
AREAS,BACKGROUND,CHALLENGES,COVERED,DESPITE,GLIOMAS,LABEL,METHODS,OPINION
MALIGNANT
MREIT,MRI,SNR
THEREFORE
BRAIN,MRI
BACKGROUND,CD4,LABEL,METHODS,RESULTS
169,946,ALZHEIMER,AUTHORS,AVS,BOSUTINIB,FDA,ISOLATION,LTD,NILOTINIB,PUBLISHED,TAU,THESE,WILEY
256,ACTIVATION,ALLOGENIC,CD111,CD11A,CD11C,CD123,CD133,DCS,DETECTING,GBM,PCR,THERE,UCB
001,010,177,COMPARABLE,CPF,HOWEVER,OVERALL,PATIENT,STUDIES,THERE,THESE
175,245,248,249,273,282,ARF,DESPITE,GBM,MUTATIONS,REGARDING,SIGNALING,THESE,VARIOUS,WHILE
SIMILARLY
200,250,BACKGROUND,CONCLUSION,GTR,HOWEVER,LABEL,METHODS,RESULTS
23766,CONCLUSION,LABEL,METHODS,NOTCH,NSC,OBJECTIVE,PURPOSE,RESULTS,SELECTIVE
945,CURRENTLY,ERCC1,HOWEVER,THESE
169,1BETA,B12,BASEL,COPYRIGHT,CRH,CRP,DEPRESSION,FGF,HENCE,NGF,NT3,TNF,TSH
169,215,ACTIVITIES,ADL,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,DAILY,DESPITE,EIGHT,GERIATRIC,LABEL,LTD,MBC,METASTATIC,METHODS,OVERALL,PLD,RESULTS,TREATMENT
001,116,169,198,956,BACKGROUND,COPYRIGHT,COX,CRP,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SCALE,SUBSEQUENT,THERE,YOUNG
AMONG,BACKGROUND,BRAIN,DTC,LABEL,MEIER,METHODS,OVERALL,PATIENT,RESULTS,SRS,SURGERY,THEREFORE,WORLD
ADVERSE,AFTER,AML,CTCAE,ICH
CD133,EMT,FIRST,GBM,HOWEVER,TAKEN,THIRD,WHILE
169,ANGELES,BACKGROUND,CONNERS,COPYRIGHT,FEW,FURTHER,INC,LABEL,LOS,METHODS,PROCEDURE,RESULTS,SPANISH,USING,WILEY,YOUNGER
206,945,GATA3,HOWEVER,MICRORNAS,USING,WNT
128,BACKGROUND,COMPLEX,FINALLY,LABEL,METHODS,MIR,PCR,PRC,REPRESSOR,RESULTS,SUZ12,WESTERN
215,852,BACKGROUND,CALIFORNIA,CAUCASIAN,FRANCISCO,HOWEVER,LABEL,METHODS,REGRESSION,RESULTS,RTEL1,SAN,SNP,THESE,UNIVERSITY
160,DETECTION,EGF,FURTHER,GOX,HRP,III,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,SPECT
CRANIAL,ELECTRODES,EMG,THESE,VII,XII
320,410,500,570,HOWEVER,SURGICALLY
APART,GBM,INCREASED,SAPOSIN,USING
248,HOWEVER
100,ARCHIVE,BIOMEDICAL,DIFFUSION,IMAGING,IRB,MRI,OVERALL
11C,CNS,III,MRI,PET
005,CHI,IMAGING,MEDICAL,SIXTY,UNIVERSITY
115,300,415,AFTER,BACKGROUND,CONCLUSION,HOWEVER,IRB,JANUARY,LABEL,METHODS,RESULTS
103,283,386,AFTER,BACKGROUND,CONCLUSION,IRB,JANUARY,LABEL,METHODS,MRI,PON,RESULTS,THERE,UNIVARIATE
2HG,945,HOWEVER,IDH,NADPH,R132H,Y139D
AKT,AMONG,AREAS,BACKGROUND,BBB,COVERED,GBM,LABEL,METHODS,OPINION,RAF,RAS,SEVERAL,STRATEGIES
MRI,THERE
916,G47,GBM,HOWEVER,ONCOLYTIC,THESE,U87
1B1,215,250,293,956,ABC,ATP,DARBY,GASTROPLUS,HOWEVER,MADIN,MOUSE,OATP1B1,OATP1B3,ORGANIC,SLC
169,CMV,EARLY,NF1,NSC,STAT3,THESE,TRP53
CATALOGUE,LABEL,METHODS,MOLECULAR,MUTATIONS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOMATIC
PITUITARY,POSITIVITY,WEGENER
AFTER,BRAIN,DDAVP,MRI
130,IOI
169,BURKITT,COPYRIGHT,INC,WILEY
100,CHANGES,COMPLIANCE,EORTC,GBM,HRQOL,TMZ
000,005,006,250,MBC,PFS
CONCLUSION,LABEL,METHODS,MRI,NEC,OBJECTIVE,RESULTS,ROUTINE
MALIGNANT,PRESENTING,SINONASAL,THERE,TREATMENT
526,BACKGROUND,CONCLUSION,CURRENT,LABEL,METHODS,PCA,RESULTS,THESE,TOTAL
160,ABSTRACTS,AUTHORS,BACKGROUND,BIOLOGICAL,BRITISH,CENTRAL,COLLECTION,CONTROLLED,HOWEVER,INDEX,ISSUE,JOURNAL,KNOWLEDGE,LABEL,LIBRARY,MEDLINE,METHODS,NEURO,NEUROLOGY,NHS,NURSING,OBJECTIVE,OBJECTIVES,OCTOBER,PSYCHIATRY,PSYNDEX,RESULTS,REVIEWS,SCIENCE,SCISEARCH,SELECTION,SINCE,WEB
BASED,FSH
947,APOPTOSIS,BUB,BUBR1,CONCLUSION,DECREASED,DESPITE,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SF188,TMZ
BACKGROUND,CONCLUSION,DAT,DESPITE,FIFTEEN,FORTY,IMMEDIATE,LABEL,METHODS,OBJECTIVE,RESULTS
946,BCC,TGF,THESE
186,494,CPG,FURTHER,HOWEVER,MMP,MSP,OVERALL,PCR,UTR
7EGFR,916,AKT,DHR,DOCK180,EXPRESSION,GBM,GEF,PKA,PKI,S1250,TREATMENTS
ACTIVATION,CNS,CPG,FURTHER,THESE,TREGS
FAILING,JCI,MARABELLE,TREGS
169,AFTER,ATTENTION,CENTRAL,CNS,COPYRIGHT,CPT,CRT,INC,KEY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SES,THESE
169,AUTHORS,COPYRIGHT,DACH2,GLIAL,INC,MESSENGER,PUBLISHED,SMALL,WORLD
169,BRAINSTEM,COPYRIGHT,DTI,MRI,PSG,SDB
001,101,106,107,169,213,ATLAS,BASED,COPYRIGHT,EXPRESSION,FURTHER,GBM,GEO,INC,OMNIBUS,USING
169,COPYRIGHT,HOWEVER,INC,MOSBY,PUBLISHED,THEIR
150,169,200,BETWEEN,COPYRIGHT,DAILY,DLT,EVEROLIMUS,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OTHER,PURPOSE,RADIATION,RESULTS,THERAPY
169,ASSESSMENT,BRAIN,BVZ,CNS,COPYRIGHT,DCE,FIFTEEN,FUNCTIONAL,INC,KARNOFSKY,LABEL,LESIONS,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SRS,THERAPY,TRAIL,TREATMENT,VIRTUALLY
169,AMERICA,BASIC,COLOMBIAN,IMAGING,LATIN,MEDICAL
AMONG,GSH,HENCE,MALIGNANT,SOD,THEREFORE,U87MG
215,CEA,HCC70,MCF
135,BACKGROUND,DOHME,EVALUATION,LABEL,MARCH,MERCK,METHODS,RESPONSES,RESULTS,SHARP,SOLID
DESPITE,GROSS,REPORTS,STR,TREATMENT
ACC,CONVERSELY,GEF,GST,RHO,RVD,SH3,THESE,USING,XENOPUS
150,ALA,AUC,BACKGROUND,BASED,CONCLUSION,LABEL,LIBRARY,MEDLINE,METHODS,RESULTS,SUMMARY
AKT,BACKGROUND,CONTINUOUS,LABEL,LRIG1,MAP,METHODS,RESULTS
169,COPYRIGHT,HOWEVER,INC,MRI,WILEY
GBM,HOWEVER,MG132,THESE,VCP
100,BACKGROUND,CONCLUSION,CPA,ESTIMATION,HOWEVER,LABEL,METHODS,MVA,OBJECTIVE,RESULTS,VOF
BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
036,160,169,ASSOCIATES,COPYRIGHT,INK4A,LTD,PCR,PUBLISHED
BACKGROUND,CONCLUSION,CSF,HOWEVER,IMPORTANT,LABEL,METHODS,TECHNIQUE
169,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,D95,IDBRAIN,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,NSC,OAR,PTV,PTV46GY,PTV60GY,RADIATION,RESULTS,ROYAL,SELECTIVE,SPA,STD,THERE,ZEALAND
169,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,DESPITE,FIFTY,III,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,MRI,RADIATION,RESULTS,ROYAL,WORLD,ZEALAND
DILATED,DOPPLER
945,ATAT1,LYS,MEC,THERE,THESE,TUBULIN,ZEBRAFISH
EXPRESSION,ION,THESE,WHILE
008,027,048,138,177,ABOVE,CCA,HOWEVER,ICD
169,COPYRIGHT,CURRENTLY,TKI
023,103,114,116,143,147,155,173,669,ADDITIONAL,CENTRAL,CURRENTLY,ELDERLY,END,EOR,PNETS,PRIMITIVE,RESULTS
169,GSC,NANOG,PATHOLOGIC
109,160,176,177,APRIL,BACKGROUND,BETWEEN,EVANS,GREEN,GRICE,ICP,JOINT,LABEL,METHODS,OBJECTIVES,OCTOBER,RESULTS,TMT
CONTINUING,DESPITE,DIPGS,HOWEVER
ATLAS,GL261,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,S100B,STAT3,TAM,THESE
001,004,570,AGE,AMONG,BACKGROUND,CONCLUSION,COX,END,FIRST,III,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY
DENMARK,FURTHER,INTERPHONE,JAPAN,MAY,REGARDING,WORLD
100,AGE,BACKGROUND,CONCLUSION,COX,GAMMA,GKS,KNIFE,LABEL,MARCH,METHODS,OVERALL,PROGNOSTIC,RESULTS
001,004,009,114,169,CONCLUSION,DESPITE,INSTITUTES,KRUSKAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,UNIVARIATE,WHITNEY,WRITTEN
001,002,227,973,AFTER,AVAILABLE,CHINESE,DISEASE,FORTY,NSCLC,PREVALENCE,THERE,TKI
BECAUSE,HOWEVER,INSTEAD,NCF,SRS
PRIMARY
HOWEVER
004,BACKGROUND,BLOOM,GTR,LABEL,METHODS,OTHER,PERMANENT,PRIMARY,RESULTS
ENT,EXTENSIVE,MOURE
BRESLOW,PRIMARY,THREE,V600E
169,AUSTRALIA,AUSTRALIAN,CONCLUSION,GBM,GROUP,LABEL,LTD,METHODS,NEURO,OBJECTIVE,PROVISION,PTY,PUBLISHING,RESULTS,THERE,TREATMENT,WILEY
137,CXCR4,GBM,GSC,NANOG,SHH,SILENCING,THESE,UTR
102,105,106,122,177,181,187,215,BNP,BRAIN,CARDIAC,DEX,EPI,LABEL,METHODS,OBJECTIVE,RESULTS
169,500,956,U87
CNS,FINALLY,NSCLC
19Q,EORTC,PCV,THESE
19Q,TECHNICAL
GENOMIC,GISTS,LFS,SDH,TCA
014,169,946,AFTER,AKT,HOWEVER,SHG44,SOCIETY,SWO,U87,WESTERN
100,BACKGROUND,EARLY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRE,RESULTS,REVIEWING
MRI
001,107,551,DFS,EZRIN
945,EXPRESSION,GBM,HIF,HUVEC,TAKEN,U87,WHETHER
018,031,037,048,068,108,118,152,169,177,183,185,383,422,910,COPYRIGHT,INC,MDR1A,TAKEN,WILEY
144,356,616,760,883,971,ARG194TRP,ARG280HIS,ARG399GLN,ASIAN,BASED,CAUCASIAN,EBSCO,HOWEVER,ISI,KNOWLEDGE,THREE,WEB,XRCC1
169,800CW,BBB,BECAUSE,COPYRIGHT,INC,IRDYE,ND2,PRIMARY,RESULTS,SMOA1
169,COPYRIGHT,HMGB1,PUBLISHED,STRATEGIES
18F,215,CHEST,FDG,LOCAL,PULMONARY,SEVEN,SFT
169,AGING,ANATOMICAL,LTD,SOCIETY,WILEY
169,19Q,AMONG,III,LOH,OUTSIDE,SOCIETY
645,700,873,946,BACKGROUND,CHINESE,LABEL,MEIER,PCR,RESULTS,SNP,WOMEN,YY1
044,050,074,102,108,131,149,151,201,262,276,372,390,454,549,672,709,931,APRIL,FIFTEEN,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,P53,RESULTS,THERE
CD11B,CD4,GL261,HENCE,TREGS
120,139,176,280,AFTER,BIT,GAMMA,KNIFE
ASPIRATION,BACKGROUND,ETV,LABEL,METHODS,RESULTS,SMALL
ALA,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,RESULTS,WHEREAS
100,AIM,DIAGNOSIS,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS
ENGLISH,MENINGIOMA,TREATMENT
ABCG2,BMI,CD133,CSC,HOWEVER,MTS,MYC,NANOG,PCR,THESE
160,ERK,FINALLY,THEREFORE
HOWEVER,PCOMA,SAH,UNDER
AAS,PET,SPECT
945,ALEXANDER,FXR,LABEL,METHODS,OATP1B1,OBJECTIVE,OWING,PURPOSE,RESULTS,RXR,SVCT1,SVCT2
BL6,C57,GBM,GIC,GL261,HOWEVER,NOD,SYNGRAFTS,TIC,WHETHER
169,421,BIM,COPYRIGHT,FOXO4,HENCE,INC,TAKEN,UTR
001,003,007,169,CHD,COPYRIGHT,COX,HOWEVER,KARNOFSKY,LTD,PCR,WESTERN
138,169,ATLAS,AUTHORS,COPYRIGHT,ECTOPIC,GBM,MECHANISM,PUBLISHED
169,COA,COPYRIGHT,FILIPIN,GROWING,HMGCR,KNOWLEDGE,LAMP2,LDL,TEM
169,COPYRIGHT,MICROGLIA,MMP,MT1,TAKEN
169,COPYRIGHT,DELTA,FINALLY,GBM,HNRNPA1,INC,MAX,MYC,THESE
865,ALZHEIMER,AMONG,CUMULATIVE,HODGKIN,INDIANA,MORTALITY,PARKINSON,PCB,POISSON,PUBLISHED,THROUGH
160,169,ADAPTATION,AMP,COPYRIGHT,EXPRESSION,FINALLY,INC,METABOLIC,PAPERCLIP
169,CALIFORNIA,CONCLUSION,COPYRIGHT,FRANCISCO,GBM,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,REPORTS,RESULTS,SAN,SEVENTY,THERE,THEREFORE,UNIVERSITY
150,169,250,500,945,AMONG,AZA,CA9,CAI,COPYRIGHT,FURTHER,GBM,HIF,HYPOXIA,INHIBITION,LTD,U87,WHEREAS
028,247,CAUCASIAN,CEREBELLAR,CURRENT,END,GBM,LTD,OVERALL,PUBLISHED,RESULTS
176,AFTER,HAKIM

DUE
HOWEVER,IFN,TRAIL
COMMITTEE,FURTHER,HARDELL,HOWEVER,THERE,UNIVERSITY,WHILE
CAP,DESPITE,GBM,HOWEVER,TMZ
000,001,014,016,APRIL,BACKGROUND,C99,CBV,COCHRAN,CONCLUSION,CUMULATIVE,III,LABEL,MCNEMAR,METHODS,MRI,REGIONS,RESULTS,USING,VALIDATION
471,857,945,ECM,GIC,LAMA2,RGD,THESE,TMZ
HODGKIN,PBL,PRIMARY
MRI,SHARP
CED,RRV,THESE,TREATMENT,U87MG,UNTREATED
AIM,BACKGROUND,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
BRAIN,HODGKIN,STATE,TESTICULAR,THERE
CUNNINGHAM,HIV,JCV,LABEL,OBJECTIVE,PURPOSE,RESULTS
100,160,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORT,USING
169,CONCLUSION,COPYRIGHT,DCS,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TMS
169,CD3,CD4,CD8,COPYRIGHT,EXPRESSION,FINALLY,FIRST,FOXP3,HOWEVER,INC,MBC,PBC,THESE,THIRD
169,221,260,529,CONCLUSION,COUNTRY,DESPITE,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,THOSE,WILEY
169,BRAIN,COPYRIGHT,IIH,MRI,PXA,SOCIETY,TREATMENT
169,SOCIETY,WORLD
001,118,129,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PRETHERAPY,RESULTS,SEVERAL
956,BBB,OQCMC,RESULTS,THESE
001,003,007,031,395,426,708,ADULT,ADVANTAGE,ANOVA,APR,BRAIN,CHI,INCLUSION,JAN,POISSON,TOTAL
PROFILING
BACKGROUND,CENTRAL,CONCLUSION,LABEL,METHODS,RESULTS
169,865,954,AKT,EXPRESSION,INHIBITION,KNOCKDOWN,LABEL,MOL,RES,TARGETING,THESE,TMZ,TNF,UNLABELLED
CULTURE,MRI
010,177,3HRLACTATE,799,916,ASSOCIATED,BACKGROUND,BMI,CONCLUSION,HOWEVER,INDEX,LABEL,METHODS,RESULTS,SECONDARY,SERUM,SIX,THESE
DUE,PET
13N,18F,910,943,AMMONIA,CONCLUSION,FDG,FORTY,III,IMAGING,LABEL,METHODS,OBJECTIVE,PET,RESULTS
240,BASED,DBD,HEK,NON
HDAC1,HDAC2,HDACS,THEIR
284,BRAIN,EXPOSURES,FOLLOWING,OVERALL,SMR
ADAR2,BACKGROUND,HOWEVER,III,LABEL,METHODS,PCR,RESULTS,TOTAL
000,116,163,242,252,ASSESSMENT,BACKGROUND,CONTEXT,FAILURE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORGAN,OVERALL,RESULTS,SEPTEMBER,SEQUENTIAL,TECHNIQUES,THERE,THESE,TYPICAL
118,3HZ,EEG,FOLLOWING,MRI,OPERATION,OTHER,THERE
CONCLUSION,COX,HODGKIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTHER,PCNSL,PRIMARY,RESULTS,UNLABELLED
001,105,SMALL,SPAG9,SPERM,TIMP1,TIMP2,U87,USING
169,BACKGROUND,CD3,CD8,ECM,LABEL,MBM,METHODS,PATHWAY,PRM,RESULTS,SOCIETY
AFTER,MUCIN
001,177,DIFFUSE,MRI,PCNSL,TESLA
AFTER,OBSTACLES,THESE
BRCA1
169,COPYRIGHT,DESPITE,FURTHER,INC,MALIGNANT,SEVERAL,THESE
10YEARS,133,169,18YEARS,AIM,CHILD,CONCLUSION,COPYRIGHT,ICU,JANUARY,LABEL,METHODS,NEUROLOGY,NMDAR,OBJECTIVE,PND,PUBLISHED,RESULTS,SIX,SOCIETY,THERE,THREE,TREATMENT
000,001,100,147,211,356,608,674,680,AUSTRALIA,AUSTRALIAN,BECAUSE,CANCERS,IRR,JANUARY,LABEL,MEMBERS,METHODS,OBJECTIVE,OUTCOME,OVERALL,POPULATION,RADIATION,RESULTS,THERE
169,215,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MACDONALD,METHODS,MPS,PRECISION,RESULTS,SPEED,UNLABELLED
169,ATP,COPYRIGHT,DGC,GBM,GRK,GSC,LTD,PDGFR,PUBLISHED,USING
100,BACKGROUND,CONCLUSION,CSF,INTRA,JANUARY,LABEL,MATERIALS,METHODS,NSF,PRIOR,RESULTS,SEPTEMBER,THREE
BPM,BRAIN,CPM,STRATEGIES
GBM,THEREFORE
100,122,FOK,METHODS,OBJECTIVE,RESULTS,TAQ,THERE,VDR,VITAMIN
BRAIN,HOWEVER,POTENTIAL,THESE
ALZHEIMER,HOWEVER
ADP,ANAPLASTIC,BACKGROUND,CONVERSELY,EIGHT,GBM,GRADE,LABEL,LGA,LOW,MATERIALS,METHODS,MULTIFORME,NBT,OBJECTIVE,PCR,RESULTS,TANKS,TELOMERASE,TELOMERES,THREE,TRF
945,947,FDG,FLT,GBM,HIF,METHODS,MULTIFORME,PET,RESULTS,THESE
001,002,010,015,050,170,ADC,CONCLUSION,DCE,DWI,HOWEVER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
012,013,090,177,ATP,CONCLUSION,LABEL,MATERIALS,METHODS,MRS,OBJECTIVE,PCR,PDE,PME,RESULTS
001,005,116,11Q23,125,177,186,642,ACUTE,ALLOGENEIC,AML,CONCLUSION,HODGKIN,LABEL,MDS,METHODS,MLL,MYELOID,OBJECTIVE,PURPOSE,RESULTS,SOLID
AWAKE,BACKGROUND,CONCERNING,DISCOMFORT,GRADE,GROSS,HOWEVER,LABEL,LOW,METHODS,NETWORK,OBJECTIVE,RESULTS,WOMEN
CENTRAL,CNS,CONCLUSION,GROSS,GTR,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE,SOCIETY,STR,SURGERY,THESE,UNDER
BACKGROUND,DSS,FIFTY,LABEL,METASTATIC,METHODS,PRIMARY,RESULTS,SAMPLES,THREE,UNIVARIATE,UNUSUAL
19Q,CPG,IDH,OTS,THEREFORE
HOWEVER,KNOWLEDGE
177,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
WNT
169,AED,CHILD,CONCLUSION,COPYRIGHT,ENGEL,JANUARY,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SHORT,SOCIETY,TEN,THERE,THEREFORE
169,ANNEXIN,BAX,BCL,COPYRIGHT,CURRENT,EXPRESSION,GAP,GBM,HOWEVER,ISSUE,LN229,LTD,PUBLISHED,SECTION,SPECIAL,TMZ
169,600,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,CERTAIN,COPYRIGHT,DESPITE,GLIOMAS,LTD,MOLECULAR,THEREFORE,VARIOUS
104,169,956,AIR,ARC,CONVERSELY,COPYRIGHT,EXPRESSION,PCR
160,169,182,AGE,COLLEGE,COPYRIGHT,FIFTY,HOWEVER,LABEL,LGA,LTD,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,RESULTS,ROYAL
169,COPYRIGHT,HOWEVER,LTD,MRI
169,COPYRIGHT,GBM,LTD,SEVERAL,STAT3
EMBRYONAL,FEW,FOCAL
169,COPYRIGHT,INC
945,AKT,BACKGROUND,HOWEVER,IMD,LABEL,LOW,METHODS,RESULTS,THERE,TNF
166,209,AMONG,BACKGROUND,CONCLUSION,HORMONE,LABEL,METHODS,RESULTS
UPS
ABC,ABCB1,ABCC1,ABCG2,ATP,MDR,MULTIDRUG
DESPITE,EFFECTIVE,GBM,HOWEVER,ONCOLYTIC
CNS,THESE,THROUGH
169,945,BIOLOGY,EPH,EPHA2,EPHRINS,FEDERATION,HOWEVER,SITES,SOLUBLE
956,ADP,APOPTOSIS,ATHYMIC,CASPASE,GLO,SP1,THESE,WESTERN
174,224,BACKGROUND,BETWEEN,CONCLUSION,DEPARTMENT,FACULTY,JANUARY,KOCAELI,LABEL,MAY,METHODS,REMISSION,RESULTS,SINCE,UNIVERSITY
160,ECTOPIC,MRI,THESE
160,215,370,CONCLUSION,GCS,LABEL,METHODS,MIB,MRI,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
124,239,AFTER,BSC,GPA,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
AVAILABLE,FURTHER,INHIBITION,MATES,OATPS
ALK,INCREASING
AKT,EGF,EMT,RELATIVELY,SIGNALS,STAT3,THESE,TRPM7,TWIST
108,377,CONCLUSION,III,KEY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROC,WORLD
967,CLASS,CNS,III,LABEL,METHODS,MRI,OBJECTIVE,PCNSL,PEARSON,QOL,RESULTS,SURVIVORS,TOTAL
EUCLIDEAN,IMAGE,THESE
185,ADDITIONAL,CONCLUSION,FDG,HIV,LABEL,METHODS,MRI,OBJECTIVE,PCNSL,PET,PURPOSE,RESULTS,TEN,THREE
160,DU145,HISTONE,MCL,PC3,SINCE,SP1,THESE
015,041,118,267,BACKGROUND,CONCLUSION,GBM,KARNOFSKY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SCALE,THERE
BLOOD,CLASSIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEG,PRL,RESULTS,TREATMENT,WOMEN
169,BACKGROUND,COPYRIGHT,ECTOPIC,EXPRESSION,HDAC3,HOWEVER,LABEL,MEIER,PCR,U87
169,COPYRIGHT,HISTOLOGIC,LTD,METASTASES,SEVERAL,THREE,TREATMENT
169,954,AKT,COPYRIGHT,ELISA,FURTHER,LTD,MALIGNANT,MMP,PCR,PMA,RH1,U87MG,WESTERN
169,AUTOPHAGY,BAX,BCL,COPYRIGHT,FINALLY,HOWEVER,INC,ING,LC3,LN229,MDC,ROS
PUBLISHED
169,BBB,BNB,CLEARLY,CNS,COPYRIGHT,HENCE,PNS
106,169,705,BACKGROUND,CARCINOMA,CONSORTIUM,COPYRIGHT,FORTY,INC,KARNOFSKY,KPS,LABEL,LOCAL,METASTATIC,METHODS,OVERALL,RCC,RENAL,RESULTS
001,629,645,967,ASIAN,ATT,CHINESE,GCT,HAN,LABEL,MAF,MASSEXTEND,PEARSON,RTEL1,SNP,TEN,UNASSIGNED,UNLABELLED,VIRTUAL
101,169,215,BETWEEN,BRAIN,COPYRIGHT,COX,INC,KARNOFSKY,LABEL,LOCAL,MARCH,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SRS
001,008,169,205,ALTERED,COPYRIGHT,COX,III,KARNOFSKY,LTD,WORLD
169,ANEUPLOIDY,CONCLUSION,COPYRIGHT,DIAGNOSED,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WORLD
CLL
005,051,055,160,169,BRAIN,DFS,NEITHER,OVERALL,PFS,REPEATING,SIX,SRS
169,COPYRIGHT,CSF,CTC,HOWEVER,VCH,WILEY
ANAPLASTIC,GLIOMAS,GREAT,HOWEVER,III,SEVERAL
128,19Q,COMBINING,IDH,IHC,PFS,R132G,R132H,R172K,THESE,THREE
003,169,173,229,CLINICALLY,CNS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PHASE,PRIMARY,PURPOSE,RESULTS,THREE,WILEY
CNS,LABEL,SUMMARY,THESE
GBM,THESE
946,LEWIS
160,AFTER,BRAGG,CARLO,DECAY,FINALLY,MONTE,PET,THEIR,THESE
540,717,AHD,EDINBURGH,GENERAL,HANDEDNESS,IMPORTANCE,INVENTORY,LABEL,LHD,LITERATURE,MEASURE,METHODS,OBJECTIVE,OUTCOME,RELEVANCE,RESULTS,SETTING,SEVENTY,SIMILARLY,SIXTY
956,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THERE
016,100,108,116,137,143,165,181,291,BACKGROUND,COX,GBM,INITIAL,LABEL,LEV,METHODS,RESULTS,VPA
AFTER,DIGITAL,INC,PUBLISHED,REMOVAL,THEREFORE
169,COPYRIGHT,HOTSPOT,INC
006,022,027,029,030,101,128,129,140,142,147,154,161,169,174,177,237,708,737,790,848,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
001,027,048,950,BACKGROUND,COMPARISON,EBC,LABEL,LNR,MATERIALS,METHODS,RESULTS,TEN
136,160,169,BACKGROUND,GBM,HOWEVER,JOURNAL,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PURPOSE,RESULTS,TMZ
LABEL,MENSTRUAL,METHODS,MRI,RESULTS,UNLABELLED
BIOLOGICAL,ROS
001,011,193,241,ADVERSE,AMONG,FORTY,KOREA,LES,SEVERANCE
CNS,HISTONE
ACTIVATED,ASP,EXPRESSION,HOWEVER,JUN,MEKK1,THESE
109,COGNITIVE
001,183,186,417,ADULT,FACTORS,NEWLY,PROFILE
FURTHER,MRI,SINCE,SIX,THERE,VISUALASE
FEW,MRI
CRC,IAM,INGENUITY,OXIDATIVE,THESE,USING
001,240,340,353,BACKGROUND,CNS,CONCLUSION,LABEL,METHODS,RESULTS,SHH,THESE
AZA,CHINA,CPG,EPSTEIN,FEZ,FEZF2,NPC,TSG
GNT,HOWEVER,TEMPORO

BNP,CUSHING,REVERSIBLE
169,HOWEVER,III,REDUCTION,SIMILAR,SOCIETY
285,300,USA
BECAUSE,FDG,FLT,FURTHER,PET,RAPID,SEVERAL,THYMIDINE
169,AFTER,ASTE1,CYHR1,FRAMESHIFT,HOWEVER,LABEL,METHODS,MSI,NMD,OBJECTIVE,PTC,PURPOSE,RESULTS,THESE,TTK
169,945,ATPASES,BBB,DISEASE,HSP90,LABEL,MECHANISM,METHODS,NMS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
000,100,150,GFRA4,NFRKB,SEVERAL,STAT3,USING,WESTERN
ASL,BACKGROUND,CBF,DCE,LABEL,MATERIALS,METHODS,MRI,PCASL,PEARSON,RESULTS,SIXTY,STUDENT,THREE
GBM,HOWEVER,MVD,NOTABLY,THESE
003,CONCLUSION,EARLY,FOLLOWING,GROUP,LABEL,METHODS,MRI,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SEPTEMBER
945
ADVERSE,CUSHING,FIRST,PITUITARY,UFC
002,013,114,123,177,192,215,400,562,ADC,DWI,EVALUATION,KRUSKAL,MRI,OPG,OPTIC
BETWEEN,IMMEDIATE,MAMMOSITE,THERE,WHILE
MELANOTIC
001,037,079,169,COPYRIGHT,DCE,III,LTD,MRI,ROC,WHITNEY
001,BACKGROUND,DCE,III,LABEL,METHODS,MRI,RESULTS,ROC,THERE,WHITNEY
947,AZA,BACKGROUND,CONCLUSION,DSB,FURTHER,INDUCTION,LABEL,METABOLIC,METHODS,RESULTS,THREE,WST
001,152,153,177,24S,493,FFF,GAMMA,LABEL,METHODS,MUS,NPC,OBJECTIVE,PTV60,PTV66,PTV70,PURPOSE,RESULTS,TECHNICAL,TEN,THREE
177,AFTER,DIFFERENT,DIFFUSION,DSC,DTI,IMAGING,ROI,SIMILARITY,SINCE,THEREFORE,WHOLE
169,177,COPYRIGHT,HOWEVER,INC,QOL,QOLMQ,QUALITY,THESE,WILEY
160,408,BRAIN,CONCLUSION,FOCAL,KEY,LABEL,MELANIN,METHODS,MRI,OBJECTIVE,RESULTS,SWI,WHILE,WITHOUT
183,ALA,BACKGROUND,DUE,EXTENSIVE,FINALLY,GEORG,LABEL,LOW,MALIGNANT,METHODS,MRI,NF1,STUTTGART,WHEREAS
169,COPYRIGHT,HYPOTHESIS,INC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PROCEDURES,RESULTS,ROUTINE,SEPTEMBER,SIXTH,SOCIETY,SYSTEMATIC
000,100,THERE
CELLS,GSC,SVZ,THREE,Y02,Y10
CNS,OUTCOME,OWING,PCNSL,PRIMARY,WHOLE
BBB,MALIGNANT,MRI,NEWER,PET
947,CK2,DU145,INCREASED,INHIBITION,LNCAP,RWPE1,THESE
169,COPYRIGHT,INTRANASAL,LTD
169,COPYRIGHT,DIAGNOSIS,FEWER,INC,PATHOLOGIC,SCHWANN,SCHWANNOMA,SINCE
AREAS,BACKGROUND,CNS,COVERED,DESPITE,FDA,GBM,III,LABEL,METHODS,OPINION,PHASE,PRIMARY,THESE
ASM,ATLAS,BACKGROUND,CONCLUSION,FINALLY,GCS,INCREASED,LABEL,METHODS,MICROARRAY,MODULATION,OBJECTIVE,REMBRANDT,RESISTANCE,RESULTS,TMZ
ATR,EARLY,MMR,THESE,TMZ
000,150,METASTATIC,PATIENT

ERM,NF2,SCHWANN
AUSTRALIA,BRAIN,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE
000,001,024,122,124,175,AFTER,BST,CONCLUSION,DIPGS,EFS,HISTOLOGY,IMAGING,LABEL,LGG,METHODS,OBJECTIVE,PEDIATRIC,PFS,PURPOSE,RESULTS,SINCE,VARIABLES
AGE,DIFFUSE,DIPGS,HOWEVER,III,LABEL,METHODS,OBJECTIVE,OFTEN,PATHOLOGIC,PURPOSE,RESULTS,THEIR,THERE
HRQOL
118,120,150,COHORTS,DLT,III,MTD,THERAPY,THEREFORE,TMZ
003,162,984,ANOVA,AXIAL,BRAIN,FLAIR,MRI,THERE,TSE,WMH
004,853,BMI,CIS,CONSISTENT,GREATER,OVERALL,PREMORBID
177,500,COX,PATHOLOGIC,PATIENT,SEVENTEEN,THESE
AFTER,CONCLUSION,KRUSKAL,LABEL,METHODS,OBJECTIVE,PURPOSE,PWI,RESULTS,TCMRA
111,130,241,544,567,ABSENCE,DWI,FLAIR,HOWEVER,JANUARY,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,WIS
169,AFTER,SEIZURE,THERE

ATP,BTB,HOWEVER,SERTOLI,THESE,TJS,VII
AIM,EARLY,GLUCOSE,IGF,IGI,LABEL,METHODS,OBJECTIVE,OGTTS,RESULTS
078,169,APRIL,BACKGROUND,CARDIOLOGY,COLLEGE,CONSORTIUM,COPYRIGHT,FOUNDATION,HOWEVER,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCI,PUBLISHED,RESULTS
169,BRAIN,COPYRIGHT,INC,PATHOLOGY,PUBLISHED,SOCIETY,THOSE
169,COPYRIGHT,GD3,HOWEVER,INC,LAM,NKT,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY
110,169,BCS,COPYRIGHT,CURRENT,INC,PATHOLOGY,PRIMARY,PUBLISHED,SOCIETY,THESE
169,ATP,COPYRIGHT,DYRK2,DYRKS,LTD,SER,THR,Y321F,YXY
169,COPYRIGHT
169,233,597,COPYRIGHT,FINALLY,INC,ONCOCYTIC,TEN
169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,RESULTS,THERE,TLT,TOTAL
169,COPYRIGHT,CROWN,LTD,PUBLISHED,SHORT,SUNCT
169,CNS,COPYRIGHT,DEPARTMENT,EMERGENCY,LTD,MRI,VII
169,ALZHEIMER,AUR,CBF,COPYRIGHT,HCS,INC,LABEL,MATERIALS,MCI,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,USING
169,COPYRIGHT,INTRADURAL,LTD,MALIGNANT,MPNST
BACKGROUND,ENDOSCOPIC,LABEL,MEDICAL,METHODS,OUTCOME,PPITF,RESULTS,SALVAGE,SETTING
BACKGROUND,LABEL,LIPOMAS,METHODS,OBJECTIVE,UNASSIGNED
015,037,967,BACKGROUND,CHINESE,GBM,HAN,LABEL,METHODS,RESULTS
384,54C,ATM,BACKGROUND,BRCA2,CHINESE,EX2,GENOTYPES,HAN,LABEL,METHODS,OPENARRAY,RESULTS,THESE,THR9ILE,XRCC3,XRCC4,XRCC5
169,ATLAS,BACKGROUND,COX,GBM,LABEL,LTD,OBJECTIVE,REMBRANDT,RESULTS,SET,VARIATION,WILEY
160,169,APRIL,BACKGROUND,CONCLUSION,GIANT,HOWEVER,LABEL,LTD,METHODS,REGARDING,RESULTS,THERE,WILEY

LABEL,METHODS,OBJECTIVE,RESULTS
004,074,089,AGE,CNS,FIFTY,GAMMA,KARNOFSKY,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTY,SIXTY,SRS,UNIVARIATE
018,074,145,326,500,BIVARIATE,END,GRADE,HOWEVER,LABEL,LOW,MEIER,METHODS,OBJECTIVE,RESULTS,STUDENT,UNIVARIATE,VARIOUS
105,OWING,TMZ
241,CTV,E1A,GBM,HDACI,HENCE,MDA,PEG,QUENCHING
DESPITE,PCR,RASSF1A,SINCE
124,160,187,215,277,BRAIN,ERCC2,GSTM1,GSTT1,INS,MTHFR,TAKEN
EMA,WHILE
169,177,186,BACKGROUND,BRAIN,ILLNESS,INVENTORY,LABEL,LOWER,MDASI,METHODS,PROFILE,RESULTS,SCALE,SHORT,SOCIETY,STRUCTURAL,SYMPTOM
ALM,EARLY,ENGLISH,HMB45,MITOSIS
001,169,945,946,COPYRIGHT,INHIBITORS,INTEGRINS,LABEL,SIMILARLY,UNLABELLED
232,245,BELLO,BETWEEN,BONES,CLINICO,CONCLUSION,DEPARTMENT,EDITION,EPI,GLEASON,HIV,JANUARY,LABEL,MATERIALS,METASTATIC,METHODS,NIGERIA,OBJECTIVE,OBJECTIVES,PSA,RESULTS,THERE,UNIVERSITY,VERSION,VIRCHOW
CHECKLIST,CHILD,HOWEVER,RESULTS,SCT,SURVIVORS
001,006,007,033,034,041,236,326,409,435,798,CNS,COMPETING,KARNOFSKY,KPS,PRESCRIBED,PTV,SRS
400,560,BACKGROUND,BLU,CONCLUSION,EUDRACT,GERMANY,LABEL,METHODS,MRI,PENTERO,REGULATORY,RESULTS,SEPTEMBER,ZEISS
000,100,BACKGROUND,BRAIN,CENTRAL,CONCLUSION,EPENDYMOMA,HOWEVER,LABEL,METHODS,OVERALL,PAEDIATRIC,RESULTS
EN2,NR2E1,PAS,PILOCYTIC,SUZ12,TAKEN,THESE
FIBULIN,METFORMIN,TAKEN
169,COPYRIGHT,LTD
DWI,GROSSLY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
100,BIOMARKER,DIAGNOSTIC,NEWLY
100,160,169,300,ACADEMY,FDA,III,ONGOING
116,BACKGROUND,BRAIN,FIG,LABEL,LOG,METHODS,NATIONALLY,OBJECTIVE,RESULTS,SRS,THERE,THESE,TREATMENT
ULYANOVSK
126,BRAIN,INSTITUTE,KARNOFSKY,SOL
100,17Q,ANOTHER,INSTITUTE,MYC,PERFORMED
AGE,ATLAS,GBM,REMBRANDT,SNP,THESE
007,ATLAS,FUNCTIONAL,GBM,KNOCKDOWN,MECHANISMS,MEIER,MIGRATION,THESE
151,BACKGROUND,CHBAH,CMJAH,CONCLUSION,DIFFERENT,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,WORLDWIDE
243,251,ABS,BRAIN,CONCLUSION,CSF,HOWEVER,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,PNS,PROTEIN,REFERENCE,RESULTS
038,10Q,112,AMONG,BACKGROUND,CD133,KPS,LABEL,METHODS,RESULTS,WESTERN
DISCOVERY,G34,H3F3A,K27,RECURRENT
HB1,NSC,THESE
160,789,861,882,933,ALU,IQR
169,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SPATIAL,STATISTICS,THESE,TRACT,WILEY
261,680,710,791,BACKGROUND,CIS,CNS,COX,LABEL,METHODS,MILLION,RESULTS,RRS,WOMEN
18F,99MTC,FDG,HOWEVER,PET,SPECT
106,947,950,BACKGROUND,CAR,CD3,EPIDERMAL,IFN,III,LABEL,LENTIVIRAL,METHODS,RESULTS,U87,WESTERN
CSC,EMT,K252A,MPE,NTS,THESE,TREATMENT,TRK
AUS,AUSTRALIA,BACKGROUND,CBT,LABEL,RESULTS,STUDIES,WILMS
AUSTRALIAN,HOWEVER,MEN
169,COMMENT,CONCLUSION,HOWEVER,KNOWN,LABEL,LTD,OBJECTIVE,WILEY
MAJOR,SEIZURE
BACKGROUND,LABEL,MEDLINE,METHODS,RESULTS,THESE
BACKGROUND,BOARD,CAREFULLY,CHEST,COLLEGE,COMMITTEE,FINALLY,GUIDELINES,LABEL,M1A,MEDLINE,METHODS,NETWORK,OVERSIGHT,PHYSICIANS,REGENTS,RESULTS,WHERE
BACKGROUND,CHEST,COLLEGE,EASTERN,EPIDERMAL,GROUP,GUIDELINES,LABEL,METHODS,NSCLC,PALLIATIVE,PHYSICIANS,RESULTS,SIMILARLY,STAGE
THERE
EVALUATION
169,AIP,ALTERED,BASEL,COPYRIGHT,MAS,OCCURRENCE,PITUITARY,PRL
169,BASEL,COPYRIGHT,MEN
169,17Q22,BASEL,COPYRIGHT,CUSHING,PRKAR1A,R1A
352,646,BACKGROUND,CASES,DENMARK,INFECTIOUS,LABEL,METHODS,RESULTS,THERE
945,BACKGROUND,CD133,CONCLUSION,ERK,GBM,GSC,LABEL,METHODS,RESULTS
105,122,D98,DMEDIAN,GAMMA,INTENSITY,PTV,TEN,THESE,TPS
177,ANOVA,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PRODUCTION,RESULTS,STUDENT,WESTERN
HIPPO,HOWEVER,MOB,NDR,THESE
ATP,GBM,GIVEN,GSC,MYC,NOTABLY,PHD,PHF5A,THESE
GBM,METASTASES
101,128,229,477,605,695,BASED,FINALLY,FORTY,FURTHER,GAPDH,III,MRI,NEUROPILIN,NON,PAPER,PCR,VEGFR,WHETHER
169,CD105,COPYRIGHT,INC
169,COPYRIGHT,GSC,MG132,NANOG
169,197,AMONG,BIOLOGICAL,COPYRIGHT,HOWEVER,LABEL,PBZ,THERE,UNASSIGNED,UNLABELLED
169,ACADEMY,CONVERSELY,FINALLY,IFN,IFNA8,TAKEN
006,083,215,231,26D,35D,500,888,ABT,ATHYMIC,AUC,BACKGROUND,LABEL,MDA,METHODS,PEGYLATED,PLD,RESULTS,SAMPLES,TREATMENT
ALDH1A3,EXPRESSION,FURTHER,GLYCOLYTIC,GSC,HGG,HOWEVER,INHIBITION,MES,TAKEN
GHD,TESTING,THERE
ELIZABETH,IMMEDIATE,OBJECTIVES,OCTOBER,QUEEN,RESULTS,SETTING,TEN,THREE
169,BBB,COMPARISON,COPYRIGHT,INC,SPRAGUE,WILEY
179,BACKGROUND,DEPARTMENT,INCREASED,KARNOFSKY,LABEL,LGG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,SIXTEEN,SOSNOWIEC
150,178,200,BACKGROUND,FIFTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMZ
APRIL,BACKGROUND,CONCLUSION,LABEL,LOW,METHODS,RESECTION,RESULTS
177,956,AFTER,AUC,BACKGROUND,BBB,CEDIRANIB,COMBINING,ECF,LABEL,METHODS,MRI,RESULTS,SEVEN,TEN,TMZ,U87
000,100,200,ARL,CNS,CONCLUSION,CSF,EBV,EPSTEIN,HIV,JANUARY,LABEL,METHODS,OBJECTIVE,PCNSL,RESULTS,SIXTY
001,GIVEN,USING
METASTATIC
169,BACKGROUND,CHILD,CONCLUSION,COPYRIGHT,GASTAUT,LABEL,METHODS,NEUROLOGY,PUBLISHED,RESULTS,SOCIETY,THESE
169,947,BACKGROUND,CELLS,CLONOGENIC,CONCLUSION,COPYRIGHT,FINALLY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MICROSCOPY,OBJECTIVE,PURPOSE,RESULTS,SF2,SNB,TEM,U87MG
169,302,ACCORDING,ANAEMIA,ENGLISH,HEADING,JOURNAL,LIBRARY,MEDICAL,MEDLINE,NEUROLOGY,SUBJECT
169,CSF,DHA,FINALLY,GLUT1,GLUTS,HOWEVER,PMA,SOCIETY,SVCT2
174,HRT,NESTORONE,NEWER


AVAILABLE,BRAIN,COMMUNITY,INITIAL,KINGDOM,SMART
945,AIF,APOPTOSIS,BAK,BAX,GAPDH,HIE,HYPOXIA,PHOSPHATE
001,006,009,012,013,020,AIM,BACKGROUND,CONCLUSION,CONFIDENCE,HOWEVER,INCIDENCE,LABEL,METHODS,MMS,OBJECTIVE,PATIENT,RESULTS
100,428,865,967,BACKGROUND,CONCLUSION,DIMER,LABEL,METHODS,RESULTS,THESE,VTE
215,DENDRITIC,HGG,PERIPHERAL,PRE,TOXICITIES
947,WHILE
016,048,ACRIN,BACKGROUND,CHANGES,CHO,CONCLUSION,LABEL,METHODS,MRI,NAA,RESULTS,SIMILAR,SPECTRA
945,BACKGROUND,CD144,GBM,GSC,HIF,HOWEVER,LABEL,METHODS,RESULTS
GRE,TSE
160,428,ANN,EIGHT,GBM,HENCE,MED,MEN,MET,MULTICLASS,PCA,SROIS,THESE,THREE
AFTER,MRI,SELECTION,THEIR,TSM
100,140,215,IGF,LAR,MIB,OCTREOTIDE,PITUITARY,PROLACTIN
177,BACKGROUND,BECAUSE,BETWEEN,BLOOD,GHRELIN,LABEL,MAY,METHODS,PRESERVED,RESULTS,THERE
FINALLY,GLIOMAS,USING
160,600,BACKGROUND,BLOOD,CONCLUSION,EIGHT,EMBOSPHERE,LABEL,MATERIALS,METHODS,RESULTS,SURGERY,TECHNICAL
169,239,946,BNG,BRG,FAK,GFP,HYPOXIA,ITGB1
BACKGROUND,CONCLUSION,DECREASED,FUNCTIONAL,IMAGING,LABEL,MATERIALS,METHODS,RESONANCE,RESTING,RESULTS
AED,AIM,BACKGROUND,BECAUSE,CRANIOTOMY,FURTHER,LABEL,LEV,MATERIALS,METHODS,OBJECTIVE,PATIENT,RESULTS,YOUNGER
BACKGROUND,BETWEEN,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
169,34A,COPYRIGHT,EPSTEIN,LTD,NOTABLY
008,169,177,375,BACKGROUND,CARDIOLOGY,COLLEGE,COPYRIGHT,FOUNDATION,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,QOL,RESULTS,THERE
169,946,COPYRIGHT,GAPDH,HOWEVER,IRELAND,LTD,NON,NORMFINDER,PCR,SMALL,TBP,USING
001,003,014,15M,169,19F,BACKGROUND,BRAIN,COPYRIGHT,DISCUSSION,HOWEVER,LABEL,MEIER,METHODS,PATIENT,PROGNOSIS,RESULTS,SIMILARLY,THESE
ABDOMINAL,BRAIN,CHEST,LABEL,LIVER,METHODS,OBJECTIVE,RESULTS
169,BRAIN,C30,CHANGES,COPYRIGHT,EORTC,GBM,HRQOL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QLQ,QOL,QUALITY,RESULTS,SIXTY,TMZ,TREATMENT
169,CERTAIN,COPYRIGHT,FUNCTIONAL,HOWEVER,INC
169,COPYRIGHT,INC,THERE,THESE
169,COPYRIGHT,INC,PUBLISHED
160,169,COPYRIGHT,FURTHER,GFP,INC,SHH
169,5MM,BASED,COPYRIGHT,EVALUATION,INC,INITIALLY,MEDICAL,NPC,PLANS,PUBLISHED,RA2,RA3
493,504,AAG,AREAS,BACKGROUND,COVERED,CURRENTLY,HSP90,IPI,LABEL,METHODS,OPINION,SEVERAL,THERE
ADDITIONAL,BMP,CPP,MRI
ICP,THERE
003,DUE,GBS,LABEL,MEDICAL,MEIER,METHODS,OBJECTIVE,RESULTS,THESE,UNIVERSITY
120,CLASS,ENGEL,FCD,FINALLY,GCP,GROUP,LABEL,METHODS,MTS,OBJECTIVE,RESULTS
MONRO,THESE
100,200,AFP,BACKGROUND,GENERAL,GIVEN,LABEL,METHODS,NGGCT,RESULTS,SEVENTY
177,APRIL,BACKGROUND,GTR,HOWEVER,LABEL,METHODS,REDUCED,RESULTS,TOTAL
945,947,954,ABROGATION,AKT,ATM,ERK,GBM,GLIOMAS,HEIGHTENED,METABOLIC,NCS,NUCLEAR,RADIATION,ROS,TIGAR,TNF,WHILE
ULTRASOUND
001,005,138,177,18F,AIM,BETWEEN,FDG,HGG,LABEL,LGG,METHODS,OBJECTIVE,PET,RESULTS
AFTER,IDH,PCR,RIN,SDS,WESTERN
169,COPYRIGHT,FURTHER,HENCE,IRELAND,LTD,NOISE
169,COPYRIGHT,HOWEVER,PERIPHERAL,PUBLISHED
001,046,169,542,AGE,COPYRIGHT,DISEASE,GBM,LTD,SIXTY
169,BAX,BCL,CBF,EVANS,LABEL,LTD,MEANWHILE,METHODS,OBJECTIVE,PDCD5,PROGRAMMED,RESULTS,RHPDCD5,SPRAGUE,WESTERN,WILEY
01745,04535,49978,CONCLUSION,HOWEVER,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
LABEL,UNASSIGNED,UNLABELLED,VIRTUAL
BECAUSE,BRAIN,EIGHT,GRADE,GROSS,III,MIB,PAPILLARY,RADIATION,SEVEN,UNIVARIATE,WORLD
COHESIN,RAD21,SMC1A,THESE
945,HIF,STROMAL,VEGFR
AFP,HCC,HEPPAR1,THESE,UNUSUAL
945,946,DYNAMIC,HYPOXIA,III,INTRINSIC,KIT,MLN0518,MRI,PDGFR,THESE
004,946,APC,AXIN1,BACKGROUND,CANONICAL,CCND1,CHP,DAAM1,DVL,JNK,LABEL,MAPK8,MATERIALS,METHODS,MYB,MYC,NFAT5,OBJECTIVE,PLCB1,PRICKLE,PRKCA,RESULTS,SPRY1,THERE,WISP2,WNT,WNT11,WNT5A
BACKGROUND,DIFFUSE,HJURP,III,LABEL,PRINCIPAL,RESULTS,THESE
BCRP1,PEDIATRIC,RESULTS,THEREFORE,TREATMENT,WHILE
003,143,419,BACKGROUND,INITIAL,LABEL,MBL,METHODS,ML2,NOMINAL,OBJECTIVE,OVERALL,RESULTS,USING
EXTRA,GBM
BACKGROUND,ENGLISH,KPS,LABEL,MEDLINE,METHODS,RESULTS,SRS,THEREFORE
177,215,360,533,946,BACKGROUND,BMI,CONCLUSION,CONSORTIUM,DIETGEN,FGF21,FRAMINGHAM,FTO,GWA,HEART,INCHIANTI,LABEL,METABOCHIP,METHODS,MULTI,OBJECTIVE,RESULTS
DESPITE,GBM,WHILE,YET
124,169,945,947,CD4,CD8,FOXP3,IFN,STAT3,THESE,TNF,TREATMENT
ADDITIONAL,III,WORLD
160,169,COPYRIGHT,INC,PUBLISHED
GBM,SINCE
200,ASSESSMENT,BRAIN,FORTY,III,MRI,THERAPY,TMZ,TREATMENT
001,005,177,956,B16,BLOOD,BRAIN,CD3,CD4,CD8,GFP,HPF,SIMILAR
3T3,DIFFUSE,IIS,MYB,MYBL1,PEDIATRIC,PLGGS,TRUNCATED,WHOLE
169,2TV,BACKGROUND,CTV,DIFFERENT,GTV,LABEL,LGG,MARGINS,METHODS,RESULTS,SEVEN,SOCIETY,THREE
100,150,169,178,200,AFTER,AMONG,BACKGROUND,FIFTEEN,LABEL,LONAFARNIB,METHODS,MTD,PFS,RESULTS,SOCIETY,THERE,THESE,THREE,TMZ
AUTHORS,BACKGROUND,CCT,CENTRAL,COLLECTION,CONTROLLED,CURRENTLY,DTI,FIS,ISSUE,LABEL,LGG,LOW,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PFS,PHYSICIANS,QOL,QUERY,RCT,RESECTION,RESULTS,SELECTION,TEN,THERE,THEREFORE,THREE
008,664,672,745,ADVERSE,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,GBM,HGG,INDEX,ISSUE,JOURNAL,LABEL,MEDLINE,METHODS,NEURO,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,PFS,PHYSICIAN,QOL,QUERY,RANDOMISED,RCT,REFERENCE,RESULTS,SCIENCE,SELECTION,TREATMENT,TTP
004,528,747,756,889,915,BACKGROUND,BMI,CONTEXT,ERS,HSS,LABEL,LIMITED,METHODS,OBJECTIVE,OUTCOME,PARIS,RESULTS,SETTING
1865G,1873C,BACKGROUND,CONTEXT,HIS625TYR,LABEL,METHODS,OBJECTIVE,REPORTS,RESULTS,SDH
BASED,MRI,NF1
133,169,COPYRIGHT,FURTHER,INC,SHORTER,SLEEP,WILEY
160,169,189,215,3F8,BACKGROUND,GD2,LABEL,METHODS,POSTERIOR,PRIOR,RESULTS,SOCIETY,SUCCESSIVE
004,160,COX,CSI,FURTHER,LABEL,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS
001,122,170,BACKGROUND,BRAIN,CONCLUSION,CONVERSELY,FACTORS,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS
160,AMONG,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX
ABOUT,CNS,FOLLOWING,HODGKIN,MRI
ABC,ABCG2,BACKGROUND,BTSCS,CONCLUSION,CURRENT,LABEL,MELATONIN,METHODS,PCR,RESULTS
169,400,COPYRIGHT,LTD,VHL,VON
169,BRAIN,COPYRIGHT,DESPITE,LTD,THERE

AIM,CONCLUSION,EGF,ILS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
19Q,BRAIN,FIBROBLAST,FURTHER,HOWEVER,LOH,MOLECULAR,NEOPLASIA,REMBRANDT,REPOSITORY,SIGNALING,SNP,UNDER,USING
947,EXPRESSION,LABEL,METHODS,NOTCH,OBJECTIVE,PURPOSE,RESULTS
100,150,169,AFTER,BACKGROUND,COPYRIGHT,EWING,INC,LABEL,METHODS,PHASE,RESULTS,SIX,TOXICITIES,WILEY
169,945,946,COPYRIGHT,DUE,GBM,HOWEVER,ICP,MEANWHILE,MRI,NIR,PEGYLATION,RGD,SMALL,U87MG,VCH,WILEY
000,138,169,19Q,1P19Q,COPYRIGHT,CPG,INC,LOH,OTHER,WILEY
169,223,COPYRIGHT,INC,LYNCH,THESE,WILEY
183,ADDITIONAL,BACKGROUND,DESPITE,GEORG,LABEL,METHODS,RESULTS,STUTTGART,WHILE
169,BBB,COPYRIGHT,DOX,EFFECTIVE,LTD,THESE
169,ANTIBODIES,BACKGROUND,BROAD,CNS,CONCLUSION,COPYRIGHT,GAMMA,LABEL,METHODS
169,COPYRIGHT,CXCR6,MUSASHI,NANOG,SINCE
137,CURRENTLY,THESE
GBM,HOWEVER,TARGETING
CURRENT,DUE,GROUP,III,PEDIATRIC
124,988,CONCLUSION,DM2,GBM,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE,SIXTY
100,945,AIM,CONCLUSION,FOLLOWING,IFN,LABEL,LIMITED,METHODS,OBJECTIVE,PFS,RESULTS,THERE
169,177,BACKGROUND,CHRONIC,COPYRIGHT,DOPPLER,HBS,HOWEVER,INC,LABEL,METHODS,MRA,MRI,PROCEDURE,RESULTS,SCA,TCD,WILEY
169,ASSESSMENT,COPYRIGHT,INC,MRI,NEURO,RAPNO,WILEY
100,169,808,945,946,956,957,COPYRIGHT,CY7,FIRST,GONMS,GONPS,NIR,PEG,REDUCED,RGD,U87MG,VCH,WILEY
00001,169,AMONG,BACKGROUND,CENTERS,EFFECTIVE,FORTY,HEMATOLOGY,INITIAL,LABEL,LGG,MEDICAL,METHODS,OPTIMAL,PFS,RESULTS,SOCIETY,TEXAS
ALZHEIMER,CSF,PARKINSON
160,ACCORDING,BACKGROUND,BESTA,CTCAE,GBM,JANUARY,KARNOFSKY,KPS,LABEL,METHODS,RESULTS
CARLO,DCE,MONTE
CHT,CURRENT,III,PCI
GBM,INEVITABLY
435,DESPITE,EFFECTS,EMT,EXPRESSION,MDA,MET
GEM,NF1,PILOCYTIC,SEVERAL
ADH,ALCOHOL,III
DESPITE,ELISA,MPE
100,COX,EPIGENETIC,MEIER,NDRG2,NTPX2,TES
101,162,319,SURVIVORS
004,006,100,160,177,687,BASED,CONCLUSION,DIAGNOSTIC,FDOPA,HOWEVER,KEY,LABEL,MCNEMAR,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RECURRENT,RESULTS
001,071,246,346,447,492,564,802,BMI,COX,CVD,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,THERE
916,AW2,AW3,AW4,BACKGROUND,CONCLUSION,DSC,EVALUATING,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,THERMAL,THERMOGRAM,TM4,WORLD
169,COPYRIGHT,CRP,EAC,EMOTION,EMOTIONAL,FORTY,INC,LABEL,METHODS,OBJECTIVE,PROBING,RESULTS,RII,YET
169,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,MRI,PITUITARY,PUBLISHED,SAS
004,015,169,177,193,CHOROID,COPYRIGHT,COX,GTR,LTD,MEIER,PFS,STR,THESE
169,COPYRIGHT,DUE,LTD,METASTASIS
169,8MM,COPYRIGHT,DESPITE,III,IMMEDIATE,MRI,PUBLISHED,SAS,WORLD
111,169,209,COPYRIGHT,CSF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,COPYRIGHT,CSA,CSB,DEFICIENT,MUTATIONS,THREE,TTD,XERODERMA,XPA,XPC,XPD
169,COPYRIGHT,DISEASE,OPSOCLONUS,SUCCESSFUL,THERE
169,BECAUSE,CNS,COPYRIGHT,THERE
169,CENTRAL,COPYRIGHT,DIAGNOSIS,POSTERIOR,THESE
169,APART,COPYRIGHT,DETECTION,GAD,HASHIMOTO,NMDAR,OVARIAN,RASMUSSEN,SREAT
169,CAREFUL,COPYRIGHT,EEG,EXPERIENCE,MRI,MTS
169,COPYRIGHT,ENS,EPIDERMAL,FGFR3,HEIDE,HME,SEVERAL,THESE
169,BRAIN,COPYRIGHT,INC
AFTER,CNS,DESPITE,GRADE,THESE,USING
ANOTHER,BKPYV,DUE,HOWEVER,HPYVS,INFECTIONS,INSTITUTE,JCPYV,KAROLINSKA,LOUIS,MCPYV,MOUSE,MWPYV,MXPYV,SAINT,SEVERAL,SIMILARLY,SPINULOSA,THESE,TSPYV,UNIVERSITY,WASHINGTON
AQ4,BBB,LABEL,METASTASES,METHODS,MRI,OBJECTIVE,REGIONS,RESULTS
215,EBV,EPSTEIN,HIV,HODGKIN,LMS,MRI,PET,SMT,STERNBERG,SUBSEQUENT
106,CERTAIN,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,WHILE
HOWEVER
006,064,223,479,512,CONSORTIUM,DELAYED,FAVORABLE,FIFTY,GAMMA,GKS,HISTORY,KNIFE,LABEL,METHODS,NORTH,OBJECTIVE,OVERALL,PITUITARY,PRIOR,RESULTS,SMALLER,UNDER
AREAS,BACKGROUND,BREAK,COVERED,III,LABEL,METHODS,OPINION,PHASE,V600E,WHILE
HOWEVER,THERE
DESPITE,GSC
27A,CONCLUSION,EDU,LABEL,METHODS,MIR,MTT,OBJECTIVE,PCR,RESULTS,WESTERN
184,COX,FEMALES,LABEL,METHODS,MST,OBJECTIVE,RESULTS,THOSE
MAB,NRP,U87,WESTERN
IMAGING,MAB,MTT,NEUROPILIN,NRP,OPTICAL,THEREFORE,U87,XENOGRAFTS
ANNEXIN,LNC,RSV,TAKEN
ACCORDING,AIM,LABEL,METHODS,MNSOD,OBJECTIVE,PRL,RESULTS,SOD,THERE,WESTERN
60019,ATM,CURRENT,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TAKEN,USING
BACKGROUND,KNOWLEDGE,LABEL,METHODS
132,BACKGROUND,CLUSTER,LABEL,MET,METHODS,R132H,RESULTS,SOX11,THREE
946,AFTER,APC,GBM,THEREFORE,THESE,WNT,XENOPUS
184,320,BECAUSE,COLOSEQ,CONCLUSION,LABEL,LHERMITTE,METHODS,OBJECTIVE,PURPOSE,RESULTS
NOTABLY,THEREFORE
OTHER,SWI
169,COPYRIGHT,FINALLY,GBM,GEM,MULTIFORME
169,COPYRIGHT,DEPENDING,SAS,THERE
150,215,BACKGROUND,BEV,CONCURRENT,FLAIR,FURTHER,GAD,GBM,LABEL,METHODS,PTV54,PTV60,RESULTS,THESE,TMZ,TREATMENT
1P19Q,946,CCC,CENTRAL,CNS,HOWEVER,NERVOUS
11P13,DENYS,DRASH,FRASIER,GFR,HOWEVER,PCR,RENAL,USING,WILMS,WT1
AIM,BACKGROUND,FEW,LABEL,METHODS,MIB,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
005,030,036,5CM,945,BACKGROUND,GABAA,GABAB,GABRE,GAMMA,H1299,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,SIXTY
001,037,169,AGGRESSIVE,BLACKWELL,CASTLEMAN,LABEL,LTD,MEIER,METHODS,MIB,OBJECTIVE,PFS,PUBLISHING,RESULTS,THERE
019,022,034,048,411,AUC,CBV,CONCLUSION,COX,HGG,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,STUDENT,THERE
CONCLUSION,MRI,OBJECTIVE
CNS,CONCLUSION,DIAGNOSIS,IMAGING,LABEL,MRI,OBJECTIVE
945,BORON,THERE
AMONG,BORON
3CTAS,BORONATED,FAVORABLE,PRESUMABLY,TK1
CNS,NEWER
DESPITE,FINALLY,FURTHER,WHILE
ADC,DCE,GTV,MRI,OAR,THERE,TPS,WHILE
BASED,CONCERNING,CRT,GBM,INTENSITY,OAR,PTV,SEVENTEEN,V95
CARCINOMA,NPC,OAR,SWO,XIO
100,GRADE,HCSRT
169,COPYRIGHT,DESPITE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRINCIPAL,RESULTS,SLF,WILEY
160,AFTER,CDA,HOWEVER,LANGERHANS,LCH,MDS,SECONDARY
MEANWHILE
206,BRAIN,GPA,NOTABLY,RPA,SURGERY
INDIVIDUAL,ITC
GAMMA,THREE
CHINESE,MPE,SHORTLY

FIFTY,SOCIETY,TOF,TRAIN,VECURONIUM
916,BOX,FINALLY,FOXM1,HDF,HEP3B,HEPG2,MB231,REVERSE
CAREGIVERS,CLINICIANS,KNOWLEDGE,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,ONGOING,PMBTS,PURPOSE,REPORTS,RESULTS,SETTING,VARIABLES
ADAPTATION,ASSESSMENT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PMBTS,PURPOSE,RESTORING,RESULTS,SETTING,SIX,STABILITY,SURVIVORS,SYMPTOM,THOSE,THROUGH,USING
272,BRAIN,FUNCTIONAL,KNOWLEDGE,LABEL,METHODS,MIDWEST,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,SURVIVORS,VARIABLES,VOLUNTARY,WOMEN
003,008,045,177,477,549,ACS,AWAKE,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SHORT,SIXTY,TEL
BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL
100,176,AGE,AWARENESS,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NORMATIVE,OBJECTIVE,PEARSON,RESULTS,SYLVIUS,TALAIRACH,THERE
009,132,848,AMONG,BACKGROUND,CEREBELLAR,CONCLUSION,END,GBM,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
201,AUC,CONCLUSION,III,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RIS,ROC,SEVENTY,SPECT,THREE
946,947,ALZHEIMER,APP,DESPITE,GSM,HOWEVER,NICASTRIN,NOTCH,NSAID,SECRETASE,THEREFORE,VARIOUS
GBM
2D6,ANXIETY,C57BL,CYP2D,CYTOCHROME,OVERALL
7TH,8TH,ACCORDING,ADDITIONAL,CENTRAL,CONCLUSION,CONTROLLED,FURTHER,LABEL,MEDLINE,METHODS,OBJECTIVE,PCI,PREVIOUSLY,PURPOSE,RESULTS,SCC,SMALL
ELISA,GBM,GLIOMAS,INHIBITION,LABEL,METHODS,OBJECTIVE,PRODUCTION,PURPOSE,RESULTS,TREATMENT
CONSISTENT,FGF
169,211,249,AMONG,THESE,WHEREAS
MRI,SWI,TOF
VASOSPASM
160,LOW,V600E
ANATOMY,BACKGROUND,DIAGNOSIS,DISCUSSION,LABEL,MANAGEMENT,METHODS,MRI,SYLVIUS,YET
026,181,226,945,CD133,GBM,HIF,NANOG,NOTABLY,OLIG2,PREVIOUSLY,SCS,STAT3,STX,THESE,THREE
18F,BILATERAL,BRAIN,CHEST,CUSHING,EAS,ECTOPIC,MRI,NET,PATHOLOGY,ULTRASOUND
600,CGH,CNV,FOCUSED,KDM1A,LFS,REMARKABLY,SIRT3,TRRAP,USING
DESPITE,LGG,LOW,SURGERY,WHERE
947,A20,CD8,GFP,IIA,LABEL,METHODS,OBJECTIVE,PCL,PRIMARY,PURPOSE,RESULTS,RIIIA,RITUXIMAB,THESE
232,CHROMATIN,MECP2,OVERALL,RHO,USING
CUSHING
BRAIN,SOCIETY,THEREBY
001,288,435,938,AUSTRALIA,BACKGROUND,HIV,LABEL,LGA,METHODS,PEARSON,RESULTS,SCC,THERE,VICTORIAN
002,169,423,716,AMONG,BACKGROUND,CONVERSELY,COPYRIGHT,E1594,III,IRELAND,LABEL,LCC,LOGRANK,LTD,MEN,METHODS,NOS,NSCLC,PFS,RESULTS,SCC
AFTER,PAI
169,400,ACUTE,ADVERSE,BACKGROUND,CNS,COPYRIGHT,INC,INSTITUTE,LABEL,MAXIMUM,METHODS,PBT,PROCEDURE,RBE,RESULTS,WILEY
009,AIM,BACKGROUND,BIOMEDICAL,CHINA,CHINESE,CNS,JOURNAL,LABEL,LIBRARY,LITERATURE,MATERIALS,MAY,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,REVMAN5,STATISTIC,THERE
DESPITE,FIFTEEN,V600E,WORLD
CNS
153,BACKGROUND,CLEVELAND,COX,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,PCNSL,PROGNOSTIC,RECURSIVE,RESULTS
169,178,BACKGROUND,CIS,COPYRIGHT,ENGLISH,GBM,HRS,INC,JANUARY,LABEL,METHODS,OBJECTIVE,PFS,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,INC
169,COPYRIGHT,INC
169,BRAIN,COPYRIGHT,H2O,IGA,INC,POEMS,SERUM
FDG,HOWEVER,PET
ALA
APS,BASED
HOWEVER,THESE
AUC,BBB,EVANS,FUS,MRI
946,CONVERSELY,ETS,GLIAL,HOWEVER
30A,ISH,PCR
THERE
10Q,19Q,III,MANAGEMENT
945,ALZHEIMER,IP4,JANUS,NARDILYSIN,P42
320,33258,956,AIM,BAX,BCL,BID,CONCLUSION,HOECHST,LABEL,LC3,METHODS,MTT,NVP,OBJECTIVE,RESULTS,TREATMENT,WESTERN
BMP,CUSHING
600,967,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS
016,BACKGROUND,BIS,BISPECTRAL,DUNNS,INDEX,LABEL,LMA,METHODS,RESULTS,WHITNEY
110,116,165,168,321,324,411,444,477,520,540,951,AWAKE,GIVEN,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,SURGERY
FDG,METASTASES,MRI,PET
FDG,HOWEVER,MRI,PET
BRAIN,CHEST,FLAIR
BRAIN,MRI,THERE
14Q,14Q11,17Q11,BACKGROUND,BRAIN,CONCLUSION,DELETIONS,ERBB2,HER2NEU,LABEL,METHODS,RESULTS,SCIENCE,THESE
946,BACKGROUND,LABEL,METHODS,RESULTS,WESTERN,WNT
001,005,009,108,120,150,APRIL,BEIJING,CHINA,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,TIANTAN
169,COPYRIGHT,FOLLOWING,INC,PITUITARY,THESE,TREATMENT
169,237,241,ALA,AMONG,COPYRIGHT,HOWEVER,MEMBERS,NEUROCIRUG,PUBLISHED,SENEC,SOCIETY,SPANISH
169,949,COPYRIGHT,ECM,FAK,FERET,GBM,IDEALLY,LTD,PCL,SIMILARLY,THESE
BAX,BCL,LABEL,METHODS,OBJECTIVE,RESULTS,REVERSE,RHODAMINE,STAT1,THESE,TUNEL,U87MG,WESTERN
039,069,105,133,176,240,312,331,394,409,490,496,548,577,608,636,868,910,945,BECAUSE,COMPETING,GROUP,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SCALE,SRS,THERE,THESE,ULTIMATELY
002,008,AED,CLASS,EIGHT,ENGEL,HOWEVER,III,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SEIZURE,SIXTEEN,THERE,VAGUS,VNS
169,JOURNAL,PARKINSON,WHEREAS
CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,THERE
111,169,183,203,505,AMONG,BACKGROUND,CHILDHOOD,CONCLUSION,GEORG,GERMANY,HOWEVER,LABEL,METHODS,STUTTGART,SURVIVORS
EWING,HODGKIN,HOWEVER
ATM,GIVEN,WHILE
CONCLUSION,LABEL,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,USING
AKT,CAV,FINALLY,THESE,USING
100,145,169,201,280,BACKGROUND,COPYRIGHT,CPG,FINALLY,FOUNDATION,FOX,FUNDING,GERMANY,HEIDELBERG,INSTITUTE,LABEL,LTD,METHODS,PCR,RESULTS,TERRY,THEREFORE,TORONTO
CST,DIFFUSION,DTI,MRI,SLF,THESE
002,169,173,410,C30,COPYRIGHT,DECLINE,DELAYED,EORTC,GROUP,HOPKINS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,QLQ,QUALITY,RADIATION,RESULTS,THERAPY,TREATMENT
CHANGES,HOWEVER,PET,SEVERAL
CENTRAL,GROSS,NERVOUS,TUMOURS,WORLD
169,188,CGNPS,HOWEVER,SHH,SONIC
BACKGROUND,BBB,CED,CONVECTION,HOWEVER,INFUSIONS,LABEL,METHODS,MRI,PLC,RESULTS,USING
000,072,108,131,169,183,239,BACKGROUND,BARTH,GEORG,LABEL,METHODS,OBJECTIVE,PEG,PRL,RESULTS,STUTTGART
160,177,214,384,FACBC,FDG,LABEL,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,TEN,THERE
103,126,170,ATLAS,BACKGROUND,DESPITE,H3F3A,HOWEVER,IDH,LABEL,MASSARRAY,METHODS,MUTATIONS,NEITHER,NOA,PRDX1,PROGNOSIS,R132H,RESULTS,THESE
007,040,186,335,AMONG,ATLAS,BACKGROUND,BRAIN,CHINESE,HOWEVER,INSTITUTE,LABEL,METHODS,MOLECULAR,NEOPLASIA,REMBRANDT,REPOSITORY,RESULTS,TEXAS,THREE,UNIVERSITY,ZNT10
946,AKT,BACKGROUND,BOOSTED,CONCLUSION,EGF,ERBB1,GRADE,GREAT,INCREASED,LABEL,METHODS,RESULTS,TREATMENT
BACKGROUND,CONCLUSION,DUE,HOWEVER,LABEL,LARGE,LYNCH,METHODS,PCR,RESULTS
AUTOLOGOUS,COX,DCS,EGF,FINALLY,GBM,TARGETING,THERE
CUSP9,FOCUS,PATHS,STUPP
DESPITE,HOWEVER,THEIR
495,BACKGROUND,EXPRESSION,GBM,LABEL,METHODS,PCR,RESULTS,T98,THERE,U87,WESTERN
169,DISORDERS,HOWEVER,THEREFORE,UROLOGICAL
169,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,EYT,INNOVATIVE,LABEL,LTD,METHODS,PEDIATRIC,RESULTS,SEVEN
FURTHER,GBM,HCFC1,INCREASING,KHSRP,MULTIFORME,THESE
001,CCO,COX,CUMULATIVE,CYTOCHROME,GBM,MEIER
239,HOWEVER,IGF,LOW,OVERALL,REGRESSION,RESOLUTION,TOMOGRAPHY
117,169,ASL,BACKGROUND,CONCLUSION,DSC,FOUNDATION,GBM,III,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIXTY
030,500,650,850,BACKGROUND,FOLLOWING,LABEL,METHODS,RESULTS,SIX
169,251,AMSTERDAM,BRAIN,BTICS,COPYRIGHT,CURRENT,FOXG1,MBS,MEMPHIS,NANOSTRING,PRESS,SHH,SINCE,TORONTO,VANCOUVER,WNT
001,010,017,044,153,ACTL8,AMONG,BACKGROUND,CTA,CTCFL,GBM,LABEL,METHODS,PCR,RESULTS,XAGE3
169,2HG,COPYRIGHT,IDH,LTD,WILEY
009,078,400,500,BLOOD,D21,D42,D63,FEC,HOWEVER,LABEL,LDH,METHODS,NEITHER,OBJECTIVE,RESULTS,SERUM,SHORT
000,THESE,TMZ
001,121,177,435,BR1,CMV,CURRENTLY,CURVE,LUC,MEIER,THEREFORE
DSCPAIR,SEVERAL,VALIDATION
ACCORDING,COMMISSION
EVN,GANGLIONIC,MRI
946,BACKGROUND,CENTRAL,CNS,CONCLUSION,CURRENT,GENOMIC,LABEL,METHODS,PATHWAY,PNETS,RESULTS,WNT
169,COPYRIGHT,ENGLISH,LTD
BTSCS,STAT3
ALZHEIMER,ASIAN
123,220,ATLAS,BACKGROUND,BMP,CHINESE,CONCLUSION,GBM,GRADE,HOWEVER,III,ISOCITRATE,LABEL,MEIER,METHODS,PRONEURAL,RESULTS,THREE
PET
FOLLOWING,PITUITARY,PREVIOUSLY,SUBSEQUENT
AKT,GBM,HOWEVER,HYPOXIA,PDGFS,THESE
BACKGROUND,BASED,CONCLUSION,DIAMIDINO,JDK,LABEL,METHODS,PAM,RESULTS,RG4,STUDIES,TUNEL,U87MG
ELISA,III,WORLD
BETWEEN,CINCINNATI,GRADE,III,OCTOBER,SRT,THREE,UNIVERSITY,USING
177,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,RESULTS,SWI,WHOLE
ACCORDING,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
253,ALA,BACKGROUND,FGS,FURTHER,LABEL,METHODS,OAS,RESECTION,RESULTS,STUPP
001,AGE,BACKGROUND,FORTY,LABEL,METHODS,RESULTS
001,048,104,261,311,529,AGAIN,BARRETT,EAC,GEJ,HPV,IRR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SCJ,THESE
946,AMONG,METASTASIS,METASTATIC,TGF,THESE
169,COPYRIGHT,DESPITE,MRI,SAS
169,COPYRIGHT,FIFTEEN,GYE,LTD,MRI,PARTIAL,SUBSEQUENT
HCC,METASTATIC
ABT,CHRISTIAN,CNS,CURRENTLY,DISEASE,HASHIMOTO,LANGERHANS,LCH
215,GROSS,HISTOLOGIC,THESE,VEROCAY

160,800,BACKGROUND,CONCLUSION,JEM,LABEL,METHODS,POPULATION,RESULTS,USING
160,BACKGROUND,CAUCASIAN,CLINICIANS,CONCLUSION,LABEL,METHODS,RCC,RENAL,THERAPY
318,946,ERBB1,GBM,MICRORNAS,NOTCH,PATHWAY,TGF,THESE,WNT
169,AUTHORS,CHILD,COLLEGE,JOURNAL,PHYSICIANS,ROYAL
DISEASE,GTPASES,HOWEVER,NDV,NEWCASTLE,ONCOLYTIC,RHO,VIRUS
ASSESSMENT,HOWEVER,NEURO,REBOUND,THEREFORE
176,951,ADC,ASSESSMENT,BACKGROUND,LABEL,METHODS,MRI,RESPONDERS,RESULTS,ROC
BACKGROUND,BTICS,GBM,LABEL,METHODS,ONCOLYTIC,RESULTS,TMZ
262,324,356,ACTIVATED,ALZHEIMER,NOTABLY,PSK,SER,TAOKS
KNOCKDOWN,LIM,PCBP2,RIP,SEVERAL
106,CONCLUSION,DISABILITY,GENERAL,ICF,LABEL,METHODS,OBJECTIVE,RESULTS
GSC
001,ASSESSMENT,BACKGROUND,BRIEF,BSI,CHRONIC,COG,COGNITIVE,EEG,FACIT,FATIGUE,FUNCTIONAL,HYPOTHESES,ILLNESS,INDEX,INITIALLY,INVENTORY,LABEL,METHODS,PITTSBURGH,POSTCANCER,QOL,QUALITY,RESULTS,SLEEP,SYMPTOM,THERAPY,UNLABELLED
001,008,127,138,ADULT,BACKGROUND,BRIEF,COGNITIVE,CRANIAL,CRT,EMPLOYMENT,IMPAIRMENT,LABEL,LOWER,METHODS,REDUCED,RESULTS,SCALE,SURVIVORS,WMS
TSS
MALIGNANT
ALK,AMONG,BACKGROUND,CNS,HOWEVER,LABEL,METHODS,RESULTS
143,19Q,EVALUATION
100,151,ERK,FGFR1,H3F3A,INTRAGENIC,MYB,MYBL1,TKD,TRP53
169,BASED,COPYRIGHT,HOWEVER,INC,RRP,URINARY
023,169,231,751,946,BRAIN,COPYRIGHT,INC,MDA,PATHOLOGY,PAZOPANIB,PDGFR,PREVIOUSLY,PUBLISHED,SOCIETY,USING
169,COPYRIGHT,INC,THESE
169,BACKGROUND,COPYRIGHT,FURTHER,GREEN,HOWEVER,LABEL,LTD,METABOLISM,METHODS,NUTRITION,OBJECTIVE,RELEVANCE,RESULTS,SOCIETY
001,002,003,004,007,169,777,CONCLUSION,COPYRIGHT,ECM,GPA,III,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA
169,COPYRIGHT,EARLIER,INC,MOSBY
265,275,293,FIFTY,HOWEVER,INFECTION,LABEL,METHODS,NEB,OBJECTIVE,RESULTS,SEVENTY,SIXTY,THESE,THROUGH
IVS,LABEL,METHODS,OBJECTIVE,RESULTS
HOWEVER,ISOCITRATE
CRANIAL
160,361,BACKGROUND,CHEMOTAXIS,EGF,ERBB1,KIT,LABEL,METHODS,MIGRATION,MTS,NEURITE,RECEPTORS,RESULTS,TARGETING,U87,WESTERN
HSP27,HSP72,INCREASED
044,045,100,250,369,371,BASED,FDOPA,III,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SPECT
160,FOXP3,LABEL,METHODS,OBJECTIVE,RESULTS,STUDIES,U87,WESTERN
001,100,19Q,228,230,ALPHA,GBM,INA,ODG,PFS,THEREFORE
001,003,007,017,177,916,BMI,BMI_Z,DESPITE
960,BRAIN,PCR,SIX
BCL,BH3,BNIP3,DR5,GBM,TAKEN,TMZ,TRAIL,USING
ADC,ANOVA,BACKGROUND,DWI,FLAIR,LABEL,MATERIALS,METHODS,NORMALIZED,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,FURTHER,INC,WHOLE
APRIL,BRAIN,CONCLUSION,FDG,III,JANUARY,LAB,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,SIX,SUV
100,122,CONCLUSION,COX,III,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,THERE
123,220,AMONG,ATLAS,CHINESE,CONCLUSION,CSMD3,HGG,HOOK3,IGFBP,LABEL,LGG,METHODS,MICROARRAY,OBJECTIVE,OSTCL,PTTG1,PTTG2,RESULTS,RRP7B,SAM,SEC31,SNRPN,VALIDATION
FAR,FLTJP,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THERE,TOTAL,TRANSIENT
057,137,234,389,414,431,440,838,891,967,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR
ACCORDING,BACKGROUND,BRAIN,FIFTEEN,JANUARY,LABEL,METHODS,MRI,NPC,RESULTS,THREE,TREATMENT
BMSMS,BRAIN,CELLSEARCH,CTC,DESPITE,EPCAM,NOTABLY,THESE
008,CLIMP63,HCA,HCC,THEIR
BACKGROUND,LABEL,METHODS,NTR,PCR,RESULTS,SINCE,USING,WESTERN
947,BACKGROUND,CONCLUSION,FIRST,LABEL,METHODS,RESULTS,THEREFORE,TREATMENTS
169,ECTOPIC,FINALLY,IMR90,SILENCING,TAKEN,YAP,YES
001,177,945,AKT,HGF,PAS,STAT3,THERE,THESE
AMONG,BECAUSE,ENGAGEMENT,ONCOGENIC,STUDIES,THESE,TREATMENT,WHILE
648,ALZHEIMER,DESPITE,FAD,FUNCTIONAL,HUNTINGTON,INHIBITION,KMO,PARKINSON,UPF
169,215,956,CD133,FINALLY,GBM,III,LABEL,LTD,METHODS,NOD,OBJECTIVE,PCR,RESULTS,WILEY
BRAIN,HGG
800,ANTIBODIES,BARRIER,BIOLOGY,BLOOD,BRAIN,CNS,COMPLEX,CONFERENCE,CONJUGATES,DIEGO,EARLY,FOCUS,GIATE,IBC,LIBRARIES,MEETING,MODULATING,NOVEL,SAN,SCIENTIFIC,SEQUENCING,SOCIETY,STAGE,SYSTEMATIC,SYSTEMS,TARGETS,THERAPIES,THERAPY,UPDATES,VALIDATION
014,301,302,CHINA,CHINESE,HAN,OVERALL
TEM,THEIR

125,AMS,DWI,GROSS,III,MRI,OVERALL,SIMPSON,THEIR,THESE
BMI,CD133,GLIOMAS,U87MG
EPT,PROPERTIES,TOMOGRAPHY
107,CD133,MICRORNAS,THESE,U87GSCS
114,203,FURTHER,INITIAL,LABEL,METHODS,NGGCT,OBJECTIVE,PATHOLOGIC,PURPOSE,RESULTS,SIX
100,956,CNS,CONCLUSION,DYNAMIC,FDG,FIFTY,GMR,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,SUV,THESE,USING
013,215,BACKGROUND,CONCLUSION,DESPITE,GBM,LABEL,METHODS,RESULTS,SNP
19Q13,KLK,PSA
AVS,DESPITE,INABILITY,LABEL,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SUMMARY,UNRESOLVED
220,BIVARIATE,CNS,CSF,CXC,EXPRESSION,JANUS,THESE
215,946,950,AMONG,PBAES,POLYMERIC,UTILIZING
291,352,456,853,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS
ACC,BACKGROUND,BRAZILIAN,CONCLUSION,HAPLOTYPE,LABEL,LFL,LFS,METHODS,MRI,R337H
ASP,GLIAL,STAINED
224,34A,CCK,ETHER,HOWEVER,MICRORNAS,TAKEN
50202,CALGB,CNS,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCNSL,PFS,PURPOSE,RESULTS
398,800,BRAIN,CHINESE,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRE,RESULTS
AUTOIMMUNE,CD8,HOWEVER,NON
140,155,CADM140,COA,HMG,IDIOPATHIC,NXP,RAYNAUD,SAE,SRP,STUDIES
100,1970S,ANTIBODIES,EATON,FIFTY,LAMBERT,PREDNISONE,SINCE,THESE,VGCCS
945,CENTRAL,GAD65,HOWEVER,OTHER,SPS
1980S,ADDITIONAL,BECAUSE,GENERALLY,PNS,SEVERAL,THESE
AKT,ATM,DESPITE,THEREFORE
ENDOSCOPIC,HOWEVER,JANUARY,SERIOUS,THERE
160,AIH,HOWEVER,LARGE,MONRO
160,BACKGROUND,CNS,CONCLUSION,EIGHT,LABEL,METHODS,OBJECTIVE,RESULTS,TERATOMAS,THIRD
HOWEVER

169,AMERICA,COPYRIGHT,JANUARY,LABEL,LTD,MEDLINE,METHODS,NORTH,OBJECTIVE,RESULTS,SOR,SRR,STUDIES,SUMMARY,THESE
001,11P15,355,DKK,GROUP,MBS,SHH,SINCE,TSA,WNT
169,1NM,AKT,BBB,COPYRIGHT,INC,JAK,OBR,SER,STAT3
001,036,047,102,169,200MG,945,946,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FAK,FGFR1,ILK,LABEL,LTD,METHODS,OVERALL,RESULTS,TIPIFARNIB,TTP
BACKGROUND,BRAIN,LABEL,RESULTS,SHORT,THERE
BECAUSE,BRAIN,THREE
BACKGROUND,LABEL,METHODS,PTV,SIB
ADULT,AKT,BACKGROUND,BLOOD,CONCLUSION,GBM,III,LABEL,METHODS,OTHER,PFS,PROTEIN,RESULTS,SAE
005,006,011,018,239,AIM,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,TKI
124,946,CISPLATIN,ELEMENE,SIMILARLY
GFP,MITOSIS,RFP
GBM,HDACI,HISTONE,MIC,NKG2D,TSA
183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,RESULTS,STUTTGART
041,154,195,466,BACKGROUND,CNS,CONCLUSION,FDA,LABEL,METHODS,RESULTS,SIXTEEN
383,AKT,IGF1R,TAKEN
100,364,AFTER,BETWEEN,DISEASE,FTM,JANUARY,SIXTY,TMZ
MRI,THEREFORE
BACKGROUND,BRAINSTEM,BSM,CBT,CMF,CONCLUSION,FIFTY,GROSS,LABEL,MEP,METHODS,RESULTS

AKT,BASED,GIVEN,INC,PUBLISHED,RHO,SPECIALLY,YIN
FINALLY,FINDR,FOURIER,RAMAN,SVM
LABEL,LARGE,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SRS
ARHGEF7,CDC42,GTPASES,HOWEVER,PDZ,RHO,TAX,TIP
169,954,COPYRIGHT,CRT0066101,FINALLY,GBM,INC,ITGA2,JNK,JUN,PLAUR,PRKD2,S1P,S73,SILENCING,TRANSWELL,U87MG
169,946,ALZHEIMER,COPYRIGHT,CURRENTLY,DYNAMIC,EPIGENETIC,INC
169,955,CHINESE,COPYRIGHT,EGLOB,HOWEVER,IRELAND,LGG,LOW,LTD,RESTING,SPECIALLY
169,945,947,COPYRIGHT,ELISA,HOWEVER,IFN,INF,LTD,PITUITARY,TH1,TH2,THESE,TNF
000,100,169,ASTROCYTIC,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,IRANIAN,LABEL,LTD,MAJOR,METHODS,NCR,RESULTS
169,COPYRIGHT,INC,KREBS,PUBLISHED,SLC25A1,SOCIETY
001,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS,SBS,TBI,THEIR,THERE
169,COPYRIGHT,DISCREPANT,IHC,KAPPA,PCR,PNA,SBE
BACKGROUND,CPG,HODGKIN,HOWEVER,LABEL,LOCALLY,METHODS,PCL,RESULTS,SCL,SEVERAL,TLR
169,LTD,PUBLISHED,RET,TRANSGENIC,WILEY
169,AIM,ATTENTION,AUTHORS,CHILD,COLLEGE,GROSS,JOURNAL,LABEL,METHODS,OBESITY,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,SEVEN
AREAS,BACKGROUND,COVERED,FTM,LABEL,METHODS,NSCLC,OPINION,QOL
001,114,166,169,EOL,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
946,FINALLY,MOLECULAR,WNT
177,316,767,AFTER,CLEVELAND,GRADE,HOSPITALS,KARNOFSKY,LABEL,LASER,MEDICAL,METHODS,MRI,NEUROBLATE,OBJECTIVE,PHASE,RESULTS,STEROID,TEN,THEIR,THREE,TREATMENT,TRIAL,UNIVERSITY
ABOUT,BRAIN,CHECKLIST,CHILD,LABEL,METHODS,OBJECTIVE,RESULTS,TBI,THREE
FURTHER,GAINS,HOWEVER,METASTATIC,SINCE
945,AMP,DGK,FINALLY,HIF
100,108,BACKGROUND,BETWEEN,CEREBELLAR,CONCLUSION,DESPITE,ISH,LABEL,METHODS,QOL,RESULTS,SHORT,SURGERY,THEIR,TUMORAL
ACUTE,AIM,BACKGROUND,BARTHEL,CONCLUSION,DESPITE,FURTHER,HACETTEPE,HOWEVER,INDEX,LABEL,LOS,METHODS,OAI,OBJECTIVE,POPULATION,RESULTS,SETTING,TBI
AUSTRALIAN,CASES,CBT,LABEL,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,STATE,THESE
169,6MV,CARLO,COPYRIGHT,EBT,GAFCHROMIC,HOWEVER,INC,MEDICAL,MONTE,PUBLISHED,V95
215,CLINICALLY,CYTOLOGIC,EWSR1,REGARDLESS
BCELL,CNS,IGH,MOLECULAR,MZL,SDH
169,CANDIDATE,COPYRIGHT,EVENTUALLY,FOURIER,ICR,LOWER,LTD,MS1,MS2,PEPTIDE,PEPTRIX,POTENTIAL,PRODUCTION
169,COPYRIGHT,HAVERSIAN,MSS,MYELOID,PUBLISHED,VARIOUS
295,BACKGROUND,LABEL,LUMINAL,METHODS,MRI,RESULTS,THESE
169,AIM,CONCLUSION,FOUNDATION,LABEL,LTD,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,WILEY
FIRST,HOWEVER,LABEL,METHODS,MULTI,OBJECTIVE,OOA,PURPOSE,RESULTS,THESE,USING
015,035,056,065,066,134,159,306,ACCURAY,CYBERKNIFE,GONAD,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RANDO,RESULTS,SRS,SUNNYVALE,TLD
100,150,300,400,450
MRI,NF2,THERE,THESE
CHEMOKINE,CXCR4,CXCR7,GBM,PCR,THERAPY
154,283,AMONG,BACKGROUND,CONCLUSION,FIFTY,GROUP,LABEL,METHODS,OVERALL,RESULTS,SELECTION
ALTERED,BROCA,CONCLUSION,GROUP,ICA,LABEL,LATERALITY,METHODS,OBJECTIVE,PATENTS,RESULTS
ADDITIONAL,FLAIR,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,QSM,RESULTS,SBS,SINCE,SWI
CD133,CD271,HOWEVER,MAJOR,SHH
169,INC,WILEY
150,169,300,CNS,CONCLUSION,COPYRIGHT,DLT,INC,LABEL,METHODS,MTD,NON,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THERE,THREE,VORINOSTAT,WILEY
AGGRESSIVE,BACKGROUND,DTC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RTH,TSH,TSHOMAS
1204831,1214063,169,242,EMD,HGF,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
160,176,CEM43,CONTROLLED,KEY,LABEL,METHODS,MONITORING,MRI,OBJECTIVE,PERSONS,RESULTS,THERMAL,THESE
169,709,APRIL,COPYRIGHT,ENGLISH,HYPOTHESIS,INC,JANUARY,JNA,LABEL,LEVEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,OVERALL,RECURRENCE,RESULTS,SOCIETY,SYSTEMATIC
100,AMONG,BACKGROUND,BECAUSE,ERCC1,FIFTY,GBM,HOWEVER,KARNOFSKY,LABEL,METHODS,PFS,RESISTANCE,RESULTS,THERE,TREATMENT
BACKGROUND,BECAUSE,CONCLUSION,FEWER,FORTY,ICU,LABEL,METHODS,RESULTS

005,19Q,DELETIONS,DIFFUSE,FRONTAL,LGG,THEIR,USA,WESTERN
2ND,AFTER,DIAGNOSIS,PET,RCC
GBM,IDH,PXA,V600E,WORLD
169,BACKGROUND,BRAIN,CNS,COPYRIGHT,LABEL,METHODS,MRI,MRS,NAA,OBJECTIVE,PATHOLOGY,PURPOSE,RESECTION,RESULTS,SOCIETY
169,AUSTRALIAN,AUTHORS,BACKGROUND,CHOROID,COLLEGE,CONCLUSION,CPT,IMAGING,JOURNAL,LABEL,LESIONS,MEDICAL,METHODS,RADIATION,RESULTS,ROYAL,ZEALAND
139,169,BCL,CONCLUSION,FINALLY,LABEL,LTD,MCL,METHODS,OBJECTIVE,RESULTS,TMZ,USING,WILEY
169,BACKGROUND,CAREFUL,CNS,CONCLUSION,LABEL,LTD,METHODS,RESULTS,THREE,TUMOURS,WILEY
001,008,169,183,268,616,637,BACKGROUND,CONTEXT,FIFTY,FORTY,LABEL,LTD,METHODS,OBJECTIVE,PRL,PROLACTIN,RESULTS,TPO,TSH,WILEY
007,014,031,032,045,046,100,ACCORDING,AFTER,BRAINSTEM,CEREBELLAR,CHINA,GAMMA,GBM,KARNOFSKY,KNIFE,PFS,SIXTEEN,UNIVARIATE
104,AMONG,CONCLUSION,HIF,LABEL,LOW,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS

ALK,BRAIN,DIAGNOSIS,MRI
203,CONCLUSION,FORTY,HOWEVER,IDC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,THEREFORE
JAGGED1,NOTCH,THESE,USING
160,CONCLUSION,CRT,FIF,FINALLY,INVERSE,LABEL,METHODS,OAR,OBJECTIVE,PTV,PTV95,PURPOSE,RESULTS,THESE
BACKGROUND,CENTRAL,CONCLUSION,LABEL,METASTATIC,METHODS,MRI,OBJECTIVE,PSA,RESULTS,SINCE
008,169,221,511,561,AIM,BASEL,BMS,COPYRIGHT,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,WHILE
169,CALIFORNIA,COPYRIGHT,ENDOSCOPIC,EPIDERMOID,GROSS,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,UNIVERSITY
169,ATTEMPTING,COPYRIGHT,FGF,LTD,NOTCH,WNT,XENOPUS
168,169,AFTER,BASEL,CML,CNS,COPYRIGHT
169,954,APART,CASPASE,COPYRIGHT,ERK,INHIBITION,IRELAND,LTD,RAS,SHH,SINCE,THEREFORE
169,BASEL,COPYRIGHT,FOLLOWING,PITUITARY
169,BACKGROUND,BASEL,BAX,BCL,CONCLUSION,COPYRIGHT,GH3,GT1,HEPN1,LABEL,METHODS,MMP,OBJECTIVE,PCR,RESULTS,TAKEN,WESTERN
124,145,CY3,MICRORNAS,SCP,THESE,USING
169,ALZHEIMER,HAO,HUNTINGTON,NAD,OXIDATIVE,PATHOLOGIC,QUINOLINIC,THESE
167,199,289,AVM,AXIAL,COUCH,DYNAMIC,HELICAL,HOWEVER,JAW,LINAC,NEITHER,REG,RSS,RUNNING,START,TREATMENT,V10,V60
19Q,4TH,LOCATED,MOLECULAR,NUCLEOTIDE,RGNTS,ROSETTE
120,CNS,HOWEVER,IDH,THERE
125,ECV,EMBRIONIC,IFT
CENTRAL,CNS,NERVOUS,WORLD
PRIMITIVE
174,AFTER,EIA,MRI
MRI,NF2,SCHWANN,SCHWANNOMA
133,146,AIM,APA,CONCLUSION,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS
AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
CLOSE,GROSS,TEN,THEREFORE
CONCLUSION,DEPARTMENT,FORTY,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
AMONG,BACKGROUND,CONCLUSION,ENDOSCOPIC,LABEL,METHODS,MONRO,NAVIGATION,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,SUBSEQUENT
169,AFTER,KARNOFSKY,KPS,TREATMENT
169,954,COPYRIGHT,CURCUMA,DAPK1,INC,STAT3
TYPICAL
CNS,THERE

DESPITE,HGG,RESULTS,SEVERAL
160,AFTER,APPROACHES,ATLANTA,BALTIMORE,BRAIN,CHAIR,COMMITTEE,DEPARTMENT,EASTERN,EMORY,EPENDYMOMA,FOUNDATION,GILBERT,GROUP,HOPKINS,HOUSTON,INTERVIEW,JOHNS,MEDICAL,NETWORK,NEURO,PITTSBURGH,PROGRAM,RADIATION,THERAPY,TREATMENT,UNIVERSITY,USA,WILLIAMSON
AKT,CD133,DESPITE,GBM,GLI,IGF,KRUPPEL,MYC,RAS,SHH,TMZ
COX,FINALLY,FUNCTIONAL,LABEL,LAD,METHODS,MRI,OBJECTIVE,RESULTS,SMA,THESE
BROCA,FUNCTIONAL,LABEL,LAD,METHODS,MRI,OBJECTIVE,OVERALL,PATIENT,RESULTS,THERE,THESE,WHEREAS
CROSS,DES,LABEL,METHODS,NAVIGATED,OBJECTIVE,OCTOBER,QUALITY,RESULTS
CNS,CURRENT,DIFFUSION,DTI,MRI,WHEREAS
000,002,133,151,344,380,610,750,ANESTHESIA,PATHOLOGY,TEN
PARKINSON
169,AGING,ANRIL,COPYRIGHT,MCV,RAF,SAS,TH2,UVB
CDK,HOWEVER,INHIBITION,UBIQUITIN,UCH,USING
140,BACKGROUND,CALCULATOR,EORTC,GBM,INSTITUTE,LABEL,METHODS,RESULTS,THERE,THESE,TREATMENT,WORLD
CONCLUSION,CUSHING,HOWEVER,INCIDENTAL,LABEL,MATERIALS,METHODS,NET,NON,OBJECTIVE,PET,PURPOSE,RESULTS,SSTRS,UPTAKES
AMONG,HENCE,HOWEVER,THESE
558,932,FURTHER,GCS,IPC,LIBRARY,LMWHS,MEDLINE,OVERALL,UFH,VTE
AKT,ALK,HGF,MET,RAS,RTK,STAT3
CREB1,ECTOPIC,MICRORNAS,THESE
SIMILAR
ALONG,GADOLINIUM,HOWEVER,MRI
500,OVERALL
191,ANXA1,CASP4,FURTHER,HOWEVER,OVERALL,PLAC1,SATB1,SOCS2
169,177,946,947,954,AKT,CON,COPYRIGHT,ERK,FURTHER,GPX,GST,IFN,INC,NGF,PBMCS,PERIPHERAL,SALIENT,SERUM,SOD,THESE
169,AKT,ATO,COPYRIGHT,CSLCS,GBM,IRELAND,LTD,NOTCH,STAT3,THESE
169,COPYRIGHT,IRELAND,LTD,MEANWHILE
169,183,945,946,CH25H,COPYRIGHT,GBM,GM133,IL1,INC,OHC,OXYSTEROLS,THESE,THP,TNF,U87MG,USING
160,169,946,BECAUSE,COPYRIGHT,CXCR4,GBM,GSC,INC,SDF,SELECTIVE
182,ENGLISH,EPENDYMOMA,GRADE,GTR,HOWEVER,III,LABEL,METHODS,MORTALITY,OBJECTIVE,PFS,PRIOR,REGARDLESS,RESULTS,STR,THESE
233,BECAUSE,GIVEN,MRI
HOWEVER,JPOFS
103,169,CBCTSETUP,COPYRIGHT,CRANIAL,D99,INC,MEDICAL,PUBLISHED,SIMULATION
027,028,116,165,169,385,895,901,AGE,AMONG,CONCLUSION,COPYRIGHT,COX,GBM,GTR,HOPKINS,INC,JOHNS,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,STR,SVZ
JANUARY,JAPAN,LABEL,LPCHA,METHODS,OBJECTIVE,RESULTS,ROUTINE,THESE
109,130,176,875,CPS,LABEL,MBA,MBS,METHODS,MRI,OBJECTIVE,RESULTS,THESE
038,263,704,ACTUARIAL,ASSESSMENT,BETWEEN,CLASS,GAMMA,GKS,KNIFE,LABEL,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PROGNOSTIC,RECURSIVE,RESULTS,RPA
945,946,954,956,ALZHEIMER,DROSOPHILA,MT1,MT2,MT3,MTS,PARKINSON,PKC,REGARDING
ATT,BMP,CPG,D2R,EPIDRUG,GH3,HOWEVER,KNOCK,REDUCED,THESE
DIPGS,H3F3A,H3K36,SEQUENCING,SET,VAL
945,954,BV6,CXC,GBM,IAP,MOLECULAR,NIK,SIMILARLY,TNF,TNFR1
BIPOLARIS,GBM
169,AMONG,COPYRIGHT,OBESITY,PUBLISHED,SLEEP
AFRICAN,NURSING
100,EATON,ELKS1,LAMBERT,PCD,RIA
169,177,184,70S6K,CSF,DASATINIB,INHIBITION,LABEL,METHODS,MTD,OBJECTIVE,OTHER,PBMCS,PDGFR,PURPOSE,RESULTS,TESTING,THREE,TREATMENT,VANDETANIB,VEGFR
160,17P13,247,FASAY,FIFTEEN,RAS,RTK,SEVENTEEN,THERE
CHO,NAA,RESULTS,THESE,WOMEN
CURRENT,HOWEVER,STUPP
18F,FCH,MRI,PET
001,169,177,AAA,AIR,BESIDES,CARLO,COPYRIGHT,ECLIPSE,INC,MAPES,MEDICAL,MGS,MONTE,PUBLISHED,XIO
DESPITE
1055C,1295G,HARDY,HOWEVER,LOW,P4502E1,PRADESH,SNP
HISTONE,SINCE,SONGS,STUDIES,THERE,UNDERSTAND,YEAST,YTH
178,AFRICAN,DONOR,MANAGEMENT,METASTATIC,TACROLIMUS
ENRICHMENT,OXIDATIVE,STRUCTURAL,SYSTEMS,THOSE
946,EGF,GBM,HOWEVER,LABEL,PDGFR,RTK,THESE,TKI,UNLABELLED
AFTER,BARIATRIC,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
152,BACKGROUND,CONTEXT,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PITUITARY,RESULTS,ROCHESTER,SECONDARY,THERE
169,181,ALA,BACKGROUND,COPYRIGHT,INC,INTRA,LABEL,MATERIALS,METHODS,OBJECTIVE,OUTCOME,PRIOR,RESULTS,WILEY
160,169,183,ADMISSION,GEORG,HISTORY,HOWEVER,LABEL,METHODS,MRT,STUTTGART,TREATMENT,UNLABELLED
169,LABEL,METHODS,MMP,MRI,OBJECTIVE,PURPOSE,RESULTS,THEIR,TRA
183,BACKGROUND,CONCLUSION,CSF,GEORG,LABEL,MATERIALS,METHODS,RESULTS,SKULL,STUTTGART
183,945,946,GEORG,STUTTGART
10001,333,HOWEVER,MEANINGFUL,MECHANISMS,MEDICAL,PUBLISHERS,SEVENTH,USA
BRAIN,EIGHT,GROSS,PTC,SIX,THREE
GLIOMAS,IDH,MUTATED,MUTATIONS,NADPH,THESE
BACKGROUND,DESPITE,LABEL,METHODS,RESULTS,TEN
EEG,METABOLIC,MRI
BACKGROUND,COX,DSS,HOWEVER,LABEL,MEIER,METHODS,RESULTS,SIMILARLY,UNIVARIATE
169,CNS,HODGKIN,SOCIETY,STERNBERG
169,DENSITIES,DNT,OLC,OLIG2,SOCIETY,WHILE
100,136,143,271,AMONG,BAF47,CNS,EWING,III,SIMPSON,SMARCB1,THESE,WHILE,WILMS
169,19Q,GBM,HOWEVER,MOLECULAR,SOCIETY,TMZ,WORLD
DERMOID,DESPITE,DUE
ACETYLOME,NAD,SINCE,STATE
DESPITE,GSC,HOWEVER,SINCE
250,BECAUSE,DIFFUSE,DLBCL,HODGKIN
230,MALIGNANT
CHATELIER,GBM,HYPOXIA,THESE
200,900,956,HOWEVER,IGF,MRI,PHASE
146,34A,BCL,III,THESE,UNIVARIATE,WORLD
ASSESSMENT,AVAGLIO,GROUP,MACDONALD,NEURO,SINCE,WORKING
DESPITE
TUMOURS
CURRENTLY,DESPITE,MBS,MICRORNAS
946,AFP,BACKGROUND,CONCLUSION,CURRENTLY,GADOLINIUM,GERMINOMAS,HCG,HOWEVER,LABEL,METHODS,MRI,NON,PARINAUDS,PRIMARY,RADICAL
948,ATP,CK1,DOCKING,FURTHER
COMPARISON,ECM,METHODS,TAKEN
169,880,COPYRIGHT,EASTERN,EMOTIONAL,GROUP,IMPROVING,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEVERAL,THESE,WILEY
119,145,169,205,COPYRIGHT,FIFTY,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,VEGFR,WILEY
033,050,163,CRT,KARNOFSKY,PFS,THOSE,TREATMENT
DIAGNOSTIC,PRIMARY
169,421,486,503,720,804,AMONG,IBC,METASTASIS,MICRORNAS,PCR
183,AMONG,GEORG,STUTTGART
114,147,150,183,ANY,BACKGROUND,CONCLUSION,GEORG,HEMORRHAGE,IMAGE,LABEL,METHODS,MRI,RESULTS,ROUTINE,SEDAN,SPIEGEL,STUTTGART,THERE,USING,WYCIS
177,ADDITIONAL,ADVANTAGES,ASSESSMENT,CNS,COGNITIVE,CONCUSSION,CSF,DESPITE,IMMEDIATE,PEARSON,TESTING,UNIVARIATE
143,166,419,562,BLOOD,CAUCASIAN,HOWEVER,SNP
AFTER,AMONG,BRAIN,CHT,OVERALL,RESULTS,SRS
HUR,MALIGNANT,TTP
174,180,300,ARA,CSF,IMAGING,MRI,NEOPLASTIC
160,BAX,BCL,BID,HNK,MALIGNANT,MCL,MPM,NOVEL,SP1
100,177,250,BASED,CONCLUSION,FDG,FDOPA,LABEL,MCNEMAR,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
946,APC,AXIN1,LABEL,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,THESE,WNT
122,177,ASB,BACKGROUND,LABEL,METHODS,RESULTS,THESE
BMP,CONSISTENT,GBM,MOLECULAR,SNAIL
169,945,946,COPYRIGHT,LTD,MMQ,PREVIOUSLY,PROLACTIN,THERE,WNT
001,064,065,100,169,354,824,873,COPYRIGHT,INC,MEDICAL,PTV,PUBLISHED
047,057,169,217,403,544,AED,AMONG,COPYRIGHT,FURTHER,GROUP,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RPA,THERAPY,TMZ
169,COPYRIGHT,MRI,OPTIMAL,PARANASAL,PUBLISHED,SAS,STAGING,THESE,TREATMENT,TUMOURS
169,COPYRIGHT,FURTHER,THEREFORE
169,COPYRIGHT,GROSS,HOWEVER,LTD,MRI,NEURO,THERE
169,CLINICIANS,COPYRIGHT,INC,INSTITUTE,LANGONE,MANAGEMENT,MEDICAL,NURSING,PUBLISHED,SOCIETY,UNIVERSITY
169,COPYRIGHT,FINALLY,FIRST,HOWEVER,INC
169,COPYRIGHT,EMBRYONIC,INC,THEREFORE,WORLD
169,1980S,COPYRIGHT,INC,SINCE
160,169,AFTER,COPYRIGHT,IMAGE,PUBLISHED,THEREFORE
169,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,ESOPHAGEAL,INC,PUBLISHED,SOCIETY
001,169,380,COPYRIGHT,GGS,GPA,IRELAND,LABEL,LTD,METHODS,NEWER,OBJECTIVE,PURPOSE,RADES,RESULTS,ROTTERDAM,RPA,SIR,USING
048,160,169,COPYRIGHT,LTD
IATROGENIC,PCA,SCA
206,BETWEEN,CLASS,CONTINUOUS,HOWEVER,IOM,LABEL,MEP,METHODS,MOTOR,OBJECTIVE,REDUCTION,RESECTION,RESULTS,SINCE
001,004,022,026,046,053,056,127,150,177,215,464,630,733,935,ADC,CENTRAL,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,NERVOUS,OBJECTIVE,RESULTS,SIMILARLY,THESE,TUMOURS,WHITNEY,WORLD
ARNDT,DEPARTMENT,ENDOSCOPIC,ENTRAPMENT,ERNST,HOWEVER,MARCH,UNIVERSITY
169,19Q,BRITISH,CIC,CONCLUSION,CPG,DESPITE,FUBP1,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SOCIETY
HOWEVER
9NG,FORTY,FURTHER,HAWAI,PERCENT,STUDIES,THESE,VITAMIN
003,004,031,047,BVZ,CONCLUSION,GBM,GPC,GPE,LABEL,METABOLIC,METABOLITE,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SINCE,THESE,UNDER
001,162,397,700,DISEASE,NSCLC,PROGNOSTIC,RECURRENCE,THERE,USD32
001,160,169,ARS,BACKGROUND,CONCLUSION,ENDOSCOPIC,HOWEVER,LABEL,LLC,METHODS,QOL,RESULTS,SKULL,THESE,WHILE
169,BRITAIN,COPYRIGHT,CSF,DEFICIENCY,GL261,GLIOMAS,GREAT,IRELAND,KNOCKDOWN,LTD,PUBLISHED,SOCIETY,THEREFORE,THESE,WILEY
BACKGROUND,CONCLUSION,LABEL,METHODS
946,956,ALZHEIMER,ASTROCYTES,BESIDES,ELISA,GEN,GENISTEIN,GSH,MNSOD,PCR,ROS,THESE,WESTERN
FINALLY,GBM,MTT,PRIMARY,THEREFORE,TMZ
231BR,947,BACKGROUND,LABEL,MDA,METHODS,MITOTIC,RESULTS,THESE
225,359,AML,BACKGROUND,DESPITE,JANUARY,JAPAN,LABEL,MDS,METHODS,RESULTS,THREE,TMZ
CONVERSELY,FIFTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
ADC,CONCLUSION,DERIVED,DIFFUSION,DWI,KEY,LABEL,MDP,METHODS,MIB,MRI,OBJECTIVE,OBJECTIVES,PEARSON,QSI,RESULTS,TCC
AFTER,APRIL,BACKGROUND,CONCLUSION,CPP,CVP,DOPPLER,H2O,ICP,LABEL,MAP,METHODS,PACO2,PARTIAL,RESULTS,RRS
BACKGROUND,BZS,GBM,LABEL,METHODS,MTT,PK11195,RESULTS,WESTERN
BACKGROUND,CNS,CONCLUSION,EWING,HOWEVER,INTENSIVE,LABEL,METHODS,RESULTS,THREE
001,160,350,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,TOTAL
215,MA2
169,18F,18FDG,429,BACKGROUND,COPYRIGHT,CURRENT,HOWEVER,III,IRELAND,JANUARY,LABEL,LTD,METHODS,MRI,NSCLC,PET,RESULTS,SEPTEMBER,STAGE,THREE
BRAIN,MANAGEMENT
169,237,241,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,LABEL,METHODS,NEUROCIRUG,PUBLISHED,SURGERY
LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROC,SUBJECT
007,BACKGROUND,GBM,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PERFUSION,RESULTS,TESLA,THERE
306,CD147,EMMPRIN,KARNOFSKY,KPS,THESE
243,AFTER,BRAIN,CONCLUSION,CSF,DIAGNOSIS,EIGHT,HHV,LABEL,METHODS,MRI,NIH,OBJECTIVE,PCR,RESULTS,SEVEN
BACKGROUND,FINALLY,GBM,LABEL,METHODS,RESULTS
FINALLY,GRIA2,HISTONE,INCREASING,NAB,THESE
CONCLUSION,FINALLY,GPU,LABEL,METHODS,MNI,OBJECTIVE,PURPOSE,RESULTS
GBM,HPA,ORAI1,ORAI3,OVERALL,STIM1,USING,UTILIZING
ALZHEIMER,SINCE
BACKGROUND,DEPARTMENT,GTR,ITALY,LABEL,METHODS,PFS,PXA,RESULTS,YOUNG
BACKGROUND,COX,GBM,LABEL,METHODS,MSP,OVERALL,RESULTS,THESE,TMZ,WESTERN
180,COMPLEX,FIFTY,INTENSIVE,LABEL,METHODS,MFF,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,VARIABLES
THERE,THESE
AWARENESS,INITIAL,MRI
METASTASES,PITUITARY,TREATMENT
001,169,BACKGROUND,COPYRIGHT,GROUP,INC,LABEL,MBS,METHODS,PROCEDURE,RESULTS,SHH,SONIC,WILEY,WNT
DREZOTOMY
APOPTOSIS,HOWEVER
039,100,160,177,22R,CYTOKINES,IHC,IL22R,NFPAS,PRL,SERUM
160,BGS,BRAINSTEM,EXOPHYTIC,INHIBITORS

155,160,945,946,947,ADDITIONAL,CYTOKINES,GBM,IFN,LPS,SNB,TNF,U87
174,183,GEORG,GERMANY,RIGID,STUTTGART
CONCLUSION,LABEL,LAR,METHODS,OBJECTIVE,RESULTS,THERE,TSH
WHOLE
001,160,ACCORDING,SOMATIC
CUSHING,ENDOCRINE
AVASTIN,GBM,HOWEVER,MET,SUCCESSFUL,THEREFORE

BACKGROUND,CONCLUSION,FUNCTIONAL,GROUP,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,TRANSIENT
FDG,GAEMPERLI,PET,PK11195
169,BACKGROUND,CHOROID,COPYRIGHT,CPP,INC,LABEL,METHODS,MONRO,RESULTS,THEREFORE,YOUNG
GBM,THESE
001,169,COPYRIGHT,FOX,FOXA1,KARNOFSKY,LTD,PCR,WESTERN,WORLD
169,COPYRIGHT,LTD
BACKGROUND,CONCLUSION,LABEL,METHODS,PATIENT,SMARCB1,SUCCESSFUL
017,021,BACKGROUND,BED,BED10,DIF,FACTORS,LABEL,LIMITED,LOCAL,METHODS,NSCLC,RECURSIVE,RESULTS,SRS,THESE,TREATMENTS
200,BACKGROUND,BCG,BETWEEN,BRESLOW,CAT,CLARK,CONCLUSION,CSF,IFN,III,LABEL,MARCH,MAY,METHODS,PHASE,TH1
AMINO,FINALLY,LARGE,LAT,THESE
ADOLESCENT,CROSS,DEPENDENT,HIV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THOSE
005,169,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY

100,177,AFTER,APRIL,BETWEEN,EFS,GROSS,III,START,THREE
GBM
169,241,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRUDENT,RESULTS,THERE
150MG,18G,ABOUT,BRA,OSS,T790M,TKI
169,COPYRIGHT,LTD,NUCLEOSIDE,SLC28,SLC29,THESE
169,946,COPYRIGHT,LTD,MCT,MCTS1,SLC16,SLC16A1,SLC16A2,SLC16A3,SLC16A7,SLC16A8,THEIR,TMS
169,COPYRIGHT,INTESTINAL,LTD,SLC11,SLC11A1,SLC11A2,SLC40,SLC40A1
001,002,009,011,018,022,024,169,177,183,AUC,AUCINSULIN,BMI,CAB,CURRENTLY,DIO,FORTY,HBA1C,ISI,LABEL,LTD,MATSUDA,METHODS,OBJECTIVE,RESULTS,VAI,WILEY
105,169,ADVERSE,AUSTRALIA,AUTHORS,BACKGROUND,COLLEGE,EIGHT,JANUARY,JOURNAL,LABEL,METHODS,NSCLC,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,THREE
169,EVS,MEETING,MRM,NMR,STILL,VCH,WILEY
FND
APART,EXTENSION,GEOMETRIC,GHOMA,INTENSITY,MRI,NFOMA,PITUITARY,PRE
CNS,CYBERKNIFE,DESPITE,FDA,GAMMA,KNIFE,MALIGNANT,MAP,PHYSICIANS,SRS,THERE,THESE,TREATMENT
129,BRAIN,IIB,PROTEOMIC,THEREAFTER,TPI,TRANSGELIN
025,376,585,911,937,IDH,MUTATIONS,OVERALL,VARIOUS
160,AKT,GBM,MIB,MMP,MRI,TMZ,VEGFR
160,945,ACTININ,NOTABLY,WORLD
BACKGROUND,GROSS,LABEL,METHODS,PAS,PILOMYXOID,PMA,RESULTS
AFTER,CSF,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,RESTORING,RESULTS,USING
160,946,BACKGROUND,DUE,ESI,LABEL,METHODS,RESULTS,SURGERY,THESE
INSTITUTE
MRI
AMONG,CONCLUSION,FDG,INCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,PET,RESULTS,SIX
018,127,173,ATLAS,BACKGROUND,CNA,COX,GBM,GSE4290,LABEL,MEIER,METHODS,RESULTS
AES,BACKGROUND,CLINICALLY,CLINICIANS,COMPOSITE,DIAGNOSTIC,EVALUATION,INTERVIEW,LABEL,MARIN,METHODS,PFT,RESULTS,SCALE
160,ANATOMICAL,ASTROCYTIC,HCLGG,HGG,NF1,PNMDT,PRIMARY,WORLD
CNS,ENGLISH,STRATEGIES,THESE
169,COPYRIGHT,HOWEVER,INC,OPTIC,PPC
100,169,200,CDR62,COPYRIGHT,CV2,HUD,LUMINEX,MA2,PNS,SINCE,USING,WESTERN
169,COPYRIGHT,GOLGI,HOWEVER,INC,TAKEN
169,BRUCINE,COPYRIGHT,FINALLY,MRT,PBS
106,114,164,169,177,254,956,ANG,BACKGROUND,CONCLUSION,COPYRIGHT,INTRAVITAL,LABEL,LTD,MATERIALS,METHODS,NOTCH,PCR,RESULTS,SEQUENTIAL,TIE,TMZ
000,001,003,009,013,141,169,223,289,304,696,711,BACKGROUND,CONCLUSION,COPYRIGHT,GBM,HOWEVER,LABEL,METHODS,PRODUCTION,RESULTS,SURGERY,THERE
001,004,011,013,019,041,169,214,AFTER,AUR,BLOOD,COPYRIGHT,DESPITE,III,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PCT,PUBLISHED,RATIONALE,RESULTS,WORLD
169,COPYRIGHT,CPT,FRANCES,GENERAL,INC,INITIAL,LABEL,MATERIALS,METHODS,MGH,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TEN,THERAPY
004,007,138,169,213,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTY
BACKGROUND,CONCLUSION,DUE,FIFTY,FINALLY,HOWEVER,LABEL,MET,METHODS,MRI,MRS,PET,PWI,SRS,STRUCTURAL
BACKGROUND,FORTRAN,HOWEVER,LABEL,MENDELIAN,MULTIGRAPH,PROPCLUST,RESULTS
BMS,GTV,LABEL,MARCH,MATERIALS,METASTASES,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,RESULTS,SIB,SRT,TREATMENT,VOLUMETRIC
AMD3100,BACKGROUND,CXCR4,FBS,GFS,GPCRS,HOWEVER,LABEL,LENTI,METASTASIS,METHODS,MICROARRAY,PCR,PDGFR,RESULTS,SHH,SRC,WESTERN
ACCORDING,DESPITE,FINALLY,GBM,HOWEVER,TODAY
174,176,284,ALZHEIMER,BACKGROUND,COOMASSIE,FOLLOWING,LABEL,PONCEAU,RESULTS,SDS,THESE
MRI,SPINE,SRS,THESE,VCF
CSF,GADOLINIUM,MRI
CASES,COX,FACTORS,GIIGS,GRADE,INCLUSION,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
015,037,056,095,131,323,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,REDUCTION,RESULTS,THESE
100,138,DLGGS,GROSS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,THERE,THEREFORE
BAF47,CRIBRIFORM,EMA,INI11,SMARCB1
CURRENT,DOX,GSPID,THESE
169,946,AUTHORS,BRAIN,COPYRIGHT,HOWEVER,LTD,NOTCH,PUBLISHED,THESE,WILEY
10Q,11Q,169,BINDING,COPYRIGHT,IGLON,INC,NTM,OPCML,PROTEIN,THESE,WILEY
CXCR4,GIVEN,ULTIMATELY
017,039,19Q,GBM,LOH
945,CONSISTENT,CXCR4,PTHRP,RANKL,THESE,TNF
ASSESSMENT,BACKGROUND,CAUSALITY,CONCLUSION,DISCUSSION,LABEL,LIVERPOOL,MATERIALS,METHODS
249,268,AFTER,BASED,FURTHER,GENOMES,KYOTO
19Q,IDH,ISOCITRATE,MUT,THERE,THESE
161,BACKGROUND,CONCLUSION,CONTEXT,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME
DETECTION,FORTY,GBM,LABEL,LCMODEL,MET,METHODS,MMS,MRS,OBJECTIVE,RESULTS,SHORT,SPECTRA
169,GBM,GIC,HSP90,INHIBITION,NVP,OLIG2
169,ANOVA,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LCMODEL,LOW,LTD,METHODS,MRI,MRS,PUBLISHED,RESULTS,SHORT
169,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
ALZHEIMER,ASL,CBF,PET,SPECT
ADULT,HOWEVER
AFTER,BLOOD,SIX,T2AN0M0,THESE
100,140,160,176,1CU,1IN,2A3,760,AMAZINGLY,BXPC3,CUI,DDT,EG2,MUA,NCS,NMR,OAC,QDS,U87MG,ZNS
MA2,PLE,SWYER
003,228,265,ADJUSTING,HEADACHES,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,TIA
132,ABOUT,BACKGROUND,BECAUSE,DIA,FIFTY,H09,IDH,IHC,LABEL,MATERIALS,METHODS,MUTATIONS,R132C,R132G,R132H,R132L,R132P,R132S,R132V,RARER,RESULTS,WHILE
004,028,177,BACKGROUND,COMPARISON,LABEL,METHODS,OVERALL,RESULTS
001,169,19Q,271,369,523,ACCORDING,ANAPLASTIC,AOA,BACKGROUND,III,LABEL,MEIER,METHODS,MOLECULAR,PFS,RESULTS,THERE,WORLD
169,BACKGROUND,CONCLUSION,FOUNDATION,HOD,ION,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
18F,FDG,MRI,PET,RESECTION
100,HRECS,NON,NTA,PBAES,PEI
510,CBV,CNS,DSC,DYNAMIC,MRI
169,491,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DEPRESSION,DEPRESSIVE,DSM,EMOTIONAL,EPISODE,HOWEVER,LABEL,MAJOR,METHODS,RESULTS,SCALE,SOMATIC,THEREFORE,VALID
169,945,COPYRIGHT,HIF,HYPOXIA,INC,MENINGIOMA
169,AMONG,CCM,COPYRIGHT,GENOMIC,KRIT1,LTD,MGC4607,MRI
169,COPYRIGHT,LAGRANGIAN,LTD,SIMILARLY
CFM,CONCLUSION,KUPFFER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
313,359,ACUTE,AUTHORITY,BACKGROUND,BRAIN,CONCLUSION,EPILEPTIC,FEWER,FUNDING,LABEL,MEDICINES,METHODS,MRI,PRIMARY,PRIOR,PROGRAM,RESULTS,TRIAL,UNIVERSITY
169,ADT,COPYRIGHT,IRELAND,LTD,PCA
ROUTINE
285,AGE,BEIJING,CHINA,III,KARNOFSKY,KPS,OCTOBER,PFS,TIANTAN
150,180,945,946,IPT,PROGNOSCAN,PSI,RECEPTEUR,RON,RTK,SIX
CHINA,HAUSP,HOWEVER,PCR
GBM,HOWEVER,MSLCS,TUNEL
FDG,MRI,PET,PRIMARY,WHOLE

945,BACKGROUND,BMS,BRAIN,CONCLUSION,HIF,LABEL,MATERIALS,METHODS,RESULTS,THREE,V600E
128,200,225,945,ADP,BACKGROUND,CONCLUSION,DR4,DR5,FAS,FINALLY,GIC,GLI,LABEL,LDE,METHODS,NANOG,NPV,PCR,RESULTS,SHH,SMOOTHENED,SNAIL,TRAIL,WESTERN,XTT
AMONG,APVTS,BACKGROUND,DLBCL,EXTRANODAL,GROUP,IELSG,LABEL,METHODS,ORR,PRIMARY,RESULTS,RPVIS,THESE
956,CHINESE,CHO,COXSACKIE,IGG,OVERALL,PCR,SUSD4,SUSHI
ALTOGETHER,BACKGROUND,CONTEXT,CPG,EEC,EXPRESSION,LABEL,METHODS,OBJECTIVE,OREXINS,RESULTS,THERE,WESTERN
13A,268,ANTITUMOR,CNS,MCF,NCI,TREATMENT
945,GIC,NG2
169,COPYRIGHT,CURRENT,ERBB2,FURTHER,LTD,OVERALL
169,AUTHORS,BACKGROUND,DIAGNOSIS,JAPAN,LABEL,METHODS,PEDIATRIC,PEDIATRICS,PSI,RESULTS,SEVENTY,SOCIETY
001,002,004,AFTER,ANXIETY,DEPRESSION,GLASGOW,GOS,LABEL,LOW,LOWER,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCALE,THEIR
ALCOHOL,ASSESSING
046,ACTIVATION,CD340,CPP,CPT,EGFR2,ERBB2,EXPRESSION,MEMBRANOUS,NOTCH,NUCLEAR
947,AMP,DCC,DSCAM,HOWEVER
BACKGROUND,GBM,GBM12,GBM14,GBM43,LABEL,METHODS,PROTRACTED,RESULTS,SIMILARLY,TMZ
ANY,BACKGROUND,FDI,LABEL,METHODS,NAVIGATED,RESULTS,THERE
001,007,100,180,660,742,954,961,ACP,ADVANCE,AFRICAN,ASIAN,CHOICES,CONTROL,DECISIONAL,DIAGNOSES,IMPORTANCE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OUTCOME,RESPECTING,RESULTS,SCALE,SETTING,SIXTY,STATEMENT
001,1P19Q,DLGGS,FURTHER,IDH,SEVENTEEN,SIX,VDE
CENTRAL,FDG,MRI,PET
ADC,DWI,TRB,TRILATERAL
169,ASSESSMENT,COPYRIGHT,EVALUATION,FINALLY,GRADE,GRADING,GROUP,LABEL,MEDLINE,MEMBERS,METHODS,OBJECTIVE,PUBLISHED,SOCIETY,SPANISH,WORKING
004,19Q,GEMININ,GROUP,IQR,LABEL,LIS,MCM,MEIER,METHODS,OBJECTIVE,RESULTS,THESE
AMONG,PREDICTIVE,TMZ
133,CD133,CONCLUSION,FURTHER,GLIOMAS,GPC,INDEX,INNOVATION,LABEL,MAP,OBJECTIVE,PRONEURAL,RESULTS,ROS,THESE
CNS,DESPITE,NK1,VASOGENIC
LABEL,MEDLINE,METHODS,NORTH,OBJECTIVE,PURPOSE,RESULTS,REVIEWS,SUMMARY,TTD
ABOUT,AMONG,CVD,HIV,OTHER,THESE
136,FURTHER,IGF,THEIR
945,946,HIF,HOWEVER
FURTHER,HIGHEST,III,LABEL,METHODS,OBJECTIVE,RESULTS,SUNITINIB
LOF,THERE,THESE,YET
CNS,FINALLY
12A,12B,169,COMPOUNDS,COPYRIGHT,NAK,POH,RAS,SAS
916,HOWEVER,MOUSE
169,956,COPYRIGHT,D54,HOWEVER,III,INC,PCR,TOTAL,TSA,WESTERN
001,093,169,CHANGES,COPYRIGHT,CST,DTI,FMRIB,FSL,INC,LABEL,MATERIALS,MCP,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THESE,TPF
169,COPYRIGHT,HOWEVER,INC,PROTONS,TREATMENT
169,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,EMERGENCY,HOWEVER,INC,LABEL,METASTASIS,METHODS,OBJECTIVE,OBJECTIVES
169,COPYRIGHT,PAPILLARY,PUBLISHED,SAS
800,ALZHEIMER,HIV,HOWEVER,NAC,PARKINSON,TARDIVE,THEREFORE
GBM,MRI,THESE,TREATMENT
EIGHT,EMERGENCY
AFFYMETRIX,AMONG,ARRAY,CGH,GBM,KLRC1,OTHERWISE,SEVERAL
27A,LOH,MCPH1,MUTATIONS,THREE,USING,UTR
CD133,CONCLUSION,HYPOXIA,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,TRANSWELL,U87,WESTERN
BRAIN,RADIATION
AFTER,THESE
945,946,BASED,DESPITE,DVH,GTV,HOWEVER,RBE,VARIATIONS
169,946,AGING,AKT,ALZHEIMER,COPYRIGHT,IGF,INC,NOTABLY,PI3
169,AKT,CD133,COPYRIGHT,ERK,GSC,HOWEVER,MEK,THESE,U87
MENINGIOMA,PEDIATRIC,PRIMARY
001,00385,177,BRAIN,CHANGES,DTI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THREE
GBM,GSC,MDR,MEDIP,RB1,THEREFORE,THROUGH
FURTHER,GDF15,MIC,TAKEN,TGF
001,002,023,100,207,212,223,240,245,246,274,280,967,CONCLUSION,FDG,FLT,LABEL,MARCH,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
114,204,732,FORTY,MRI,PRL,REPETITIVE,SIXTY
160,946,BMI,FOLLOWING,GBM,TGF,U87
100,ALA,BACKGROUND,DEPARTMENT,FIRST,GTR,HGG,KPS,LABEL,METHODS,NEWLY,RESECTION,RESULTS,STUDIES
ATTEMPTED,BRAIN,CALIFORNIA,CHOROID,CPP,FRANCISCO,GROSS,GTR,MRI,SAN,SINCE,STR,THERE,UNIVERSITY
001,135,160,AKT,ANNEXIN,BCL,CANCEROUS,CIP2A,MTT,MYC,THESE,U87
160,177,215,ADC,BACKGROUND,DWI,LABEL,MATERIALS,METHODS,MRI,MRS,NAA,OBJECTIVE,RESULTS,RTS,SEVEN,SIX
220,AGILENT,DAVID,FUNCTIONAL,LN229,MICROARRAY,MMP,OLIGO,POSTN,U87,WHOLE
134,EARLY,GBM,MIR,NANOG,ODG,PCR,THESE,U87
BENZENE,FINALLY,FINNISH,JEM,JOB,SIMILARLY
001,196,ANN,ARTIFICIAL,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,THEIR
169,COPYRIGHT,LTD,NOVEL,PUBLISHED,THOUSANDS,WHILE
CONTINUED
ERBB2,ERBB3,ERBB4,NEUREGULIN,SKOV3,THESE,TYR1121,TYR1396
169,CODON,COPYRIGHT,INC,SYSTEMATIC
169,BCL,COPYRIGHT,CROWN,MDR,PRESENTLY,PUBLISHED,TMZ
169,COPYRIGHT,HDACS,LTD,NON,PUBLISHED
169,COPYRIGHT,FPS,GBM,HOWEVER,HOXA9,LTD,TMZ
019,026,169,COPYRIGHT,FORTY,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,PURPOSE,PWI,RESULTS,THERE
169,2MM,COPYRIGHT,DTI,FUNCTIONAL,IMMEDIATE,LABEL,MAJOR,METHODS,MRI,OBJECTIVE,RESULTS,SEVENTEEN
169,1MM,956,ABCG2,ALA,ATP,BACKGROUND,CONCLUSION,COPYRIGHT,GEFITINIB,LABEL,LEE,MATERIALS,METHODS,PDT,RESULTS,SINCE,U87MG
169,COPYRIGHT,DESPITE,LTD,VBM
125,168,169,CONCLUSION,COPYRIGHT,GERMANY,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,TEN,UNIVERSITY
160,169,BACKGROUND,CAREFUL,DIFFERENT,EIGHT,INC,LABEL,LOCAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,SUBUNGUAL,SURGERY,WILEY
169,556,804,BACKGROUND,CONCLUSION,FOUNDATION,FOV,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIMILARLY
104,116,127,169,177,215,875,991,ADC,CONCLUSION,COPYRIGHT,DWI,HPC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
AFFAIRS,COMMITTEE,CONSENSUS,COUNCIL,ENDOCRINE,LABEL,MEDLINE,METHODS,OBJECTIVE,PROCESS,SCHOLAR,SOCIETY
169,946,COPYRIGHT,GBM,INDUCTION,SOX21,TAKEN
DEPENDING,III,SURGERY,THESE,WORLD
FEW,GCT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
1MM,945,DOX,NFPAS,THERE
100,FIFTEEN,KARNOFSKY,MEN,SUFFICIENT
343,AGE,AMONG,COX,DFS,GROSS,HOWEVER,LOG,MEIER
119,383,865,AFTER,ASSESSMENT,BASAL,DIAGNOSIS,GPA,LUMINAL,PROGNOSTIC,SEVERAL,TPDBM
169,AMONG,ASF,COPYRIGHT,GH3,PITUITARY,SF2,SILENCING,THEREFORE
COPYRIGHT,CUSHING,PROUS,SCIENCE
CBV,MTT,PERFUSION
042,169,173,BECAUSE,CONCLUSION,COPYRIGHT,COX,CSC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SVZ
160,169,ARGENTINA,BORON,CAPTURE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,NEUTRON,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERAPY
215,AFTER,CUSHING,IGF
BETWEEN,CNS,JANUARY,LOCAL,SIX,SRS
FURTHER,LABEL,METHODS,MRS,OBJECTIVE,RESULTS
005,APRIL,BACKGROUND,CURRENT,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RCT,RESULTS,RPA,THERE,THEREFORE
ATP,CD133,SINCE,USING
BACKGROUND,LABEL,METHODS,MRI,PET,RESULTS
BACKGROUND,CNS,CONCLUSION,LABEL,LOCAL,METHODS,OVERALL,RESULTS,SURGERY,WHOLE
18F,BACKGROUND,LABEL,METHODS,MRI,OPTIMAL,PATHOLOGIC,PET,RESULTS,SUV,THERE,USING
023,125,177,190,BACKGROUND,CSI,LABEL,LOCALIZED,METASTATIC,METHODS,REDUCED,RESULTS,SEVEN
006,034,042,055,396,834,AFTER,BACKGROUND,GBM,LABEL,METHODS,MRI,RESULTS,SPAIN,SPANISH,THERE
ARSENIC,ATO,BACKGROUND,LABEL,METHODS,RESULTS
215,BACKGROUND,CONCLUSION,DIFFERENT,IMPORTANCE,LABEL,METHODS,PXA,RADIATION
100,HOWEVER,IRINOTECAN
001,003,025,127,406,AFTER,AMONG,HGG,KARNOFSKY,MRI,SCALE
BACKGROUND,DIFFERENT,LABEL,METHODS,RESULTS,TECHNIQUES
GROSS,MRI
967,DESPITE,GROUP,HOWEVER,LABEL,MATERIALS,MEP,METHODS,OBJECTIVE,RESULTS
SRS
5MC,BCN,BRESLOW,CMD,DCN,SEVERAL,SSM
BARRIER,BBB,BLOOD,BRAIN,CENTRAL,CNS,DISORDERS,FDA,LYSOSOMAL,NERVOUS,NPS,SINCE,STORAGE
BRAIN,BRILLIANT,PET,SPECT
ACCORDING,AFTER,DESPITE,RAMAN
102,114,164,CEL,CONCLUSION,EVOLUTION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RBI,RESULTS,WML
177,BACKGROUND,CAREFUL,DES,DTI,LABEL,METHODS,MOTOR,RESULTS,TEN,TESLA
EMA
ADDITIONAL,BRAIN,TREATMENT
FATIGUE,FUNCTIONAL,HEALTHY,LOW,NEITHER,POSTE,POSTH,PRE,TASKS
FURTHER,GBM,SFK,SRC,THEREFORE,USING
120,ANOTHER,BACKGROUND,CAUSE,CONCLUSION,CONTEXT,EIGHT,FIFTEEN,INFECTIONS,LABEL,METABOLIC,METHODS,OBJECTIVE,OUTCOME,RESULTS,SIX,SMR,SWEDISH
169,COPYRIGHT,CURRENTLY,LABEL,LTD,MEASURE,METHODS,MRI,OBJECTIVE,RESULTS,WILEY
CSF,GBM,IDH,III,MRI,SIXTY,WORLD
169,UNILATERAL
231,231BR,946,BMP,BRAIN,CONVERSELY,HOWEVER,MDA,NPC,SINCE,TGF,USING
340,ARA,DIAGNOSIS,GROUP,KETTERING,MSKCC,MVP,NEWER,OTHER,PCNSL,PFS,PRIMARY,RADIATION,RITUXIMAB,SLOAN,TREATMENT,USING
CNS,HOWEVER,MRI,NON,THESE
BASED,CRP,ESR,LDH,TRANS
AFTER,IMAGING,PRIMARY
AIM,HELICAL
DIAGNOSTIC,FDG,FINAL,FLT,HNSCC,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PET,RESULTS,THERE
ACTIVATED,ACTIVATION,AKT,PNETS,SSR,THESE
169,COMPLEX,COPYRIGHT,INC,JANUARY,LOUISVILLE,MEDTRONIC,MRI,NAVIGATION,SIMPSON,TEMPORARY,USA
151,169,175,221,ALK,AMONG,ASC,BACKGROUND,COPYRIGHT,FURTHER,INCREASED,IRELAND,LABEL,LCC,LTD,METHODS,NSCLC,RESULTS,SCC,WHILE
169,BBB,CNS,COPYRIGHT,HOWEVER,IRELAND,LTD,NSCLC,TKI
169,COPYRIGHT,LTD,THEREFORE
169,CAVERNOUS,CHS,COPYRIGHT,DIAGNOSING,INC
169,COPYRIGHT,FURTHER,INC
169,COPYRIGHT,INC
169,237,241,AFTER,ARACHNOID,COPYRIGHT,GIVEN,NEUROCIRUG,PUBLISHED
169,COPYRIGHT,III,IRELAND,LTD,PHASE,TMZ,TOTALLY
001,101,102,105,169,COPYRIGHT,DESPITE,LTD
169,COPYRIGHT,DESPITE,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,DESPITE,GBM,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PFS,QOL,RECURSIVE,RESULTS,RPA,SIXTY,STUPP,SURGERY,TMZ
169,COPYRIGHT,INC,SHH,SONIC
169,AMP,ATP,BRITISH,CB1RS,CENTRAL,PERIPHERAL,SOCIETY
169,238,AMONG,COX,HOWEVER,III,PFS,SIMILAR,SOCIETY,TAKEN,WORLD
AED,FIFTY,FORTY,LABEL,LACOSAMIDE,METHODS,OBJECTIVE,RESULTS
CSL,DELTEX1,DIFFERENT,ERK,GBM,LOW,MAML1,MCL,MICROARRAY,NOTCH,PKB,RTK
954,GBM,HOWEVER,MES,OLIG2,YKL
10P,11P,11Q,13Q,14Q,15Q,17P,17Q,18Q,19Q,20Q,21Q,BACKGROUND,CHINESE,CNV,CONCLUSION,DISCOVERED,HGG,HYAL4,KIT,LABEL,LEVEL,LGG,MAPPING,METHODS,RESULTS,SPAM1,VN1R2,VN1R4
BAX,BCL,HOWEVER,NDRG2,OGD,THESE,TUNEL
CORRECT,MRI,PITUITARY
945,BACKGROUND,CONTEXT,LABEL,METHODS,MUTATIONS,NDRG4,OBJECTIVE,PDGFD,PITUITARY,RESULTS,SOMATIC,WHOLE,ZAK
946,CYTOTOXIC,HCC,JNK,JUN,MKP,TGF
100,150,848,BACKGROUND,CIS,CONCLUSION,DENMARK,FEW,LABEL,METHODS,NSAID,ORS,RESULTS
BRAIN,RAPID,RBD,REM
111,113,133,CAREGIVERS,CROSS,KNOWLEDGE,LABEL,METHODS,NEURO,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,SLEEP,SUBJECTIVE,VARIABLES
005,893,BACKGROUND,COX,INCREASED,INSTITUTES,INSURANCE,LABEL,MEIER,METHODS,NHIRD,RESULTS,STRATEGIES,THESE,TOTALLY
SUBLETHAL
945,BACKGROUND,BACTERIAL,BCSFB,CNS,CYTOKINES,FURTHER,LABEL,METHODS,NEISSERIA,PMN,RESULTS,USING
BACKGROUND,HSP90,LABEL,METHODS,MIA,NVP,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,TREATMENT
001,169,ACUTE,BACKGROUND,CLINICALLY,COPYRIGHT,DESCRIBING,EIQ,GRADE,INDEX,LABEL,LTD,METHODS,PROCEDURE,PROCESSING,PSI,RESULTS,SCALE,SPEED,SURVIVORS,WILEY
DIFFUSE,MAXIMAL,PRESERVING,QOL
169,BASEL,COPYRIGHT,WHEREAS
169,AFTER,BACKGROUND,BASEL,BECAUSE,CNS,COPYRIGHT,GAMMA,KNIFE,LABEL,METHODS,OBJECTIVE,PAPILLARY,RESULTS
010,278,605,820,AIM,BACKGROUND,CONCLUSION,DIFFUSION,DTI,EORTC,GBM,LABEL,LOG,MATERIALS,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,THEIR,THREE
THEREFORE
100,125,240,AIM,CONCLUSION,CSF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIMILARLY
400,CNS,MEETING,NEURO,SCIENTIFIC,SNO,SOCIETY,USA
470,AIM,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,OCTOBER,OTHER,PITUITARY,PRL,THEREAFTER
110,169,192,379,A9961,COG,CONCLUSION,COPYRIGHT,DESPITE,INC,LABEL,MAJOR,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,THESE,WILEY
169,AFTER,ALZHEIMER,BECAUSE,COPYRIGHT,VCH,VIEWPOINT,WILEY
001,BACKGROUND,FLAIR,GBM,KPS,LABEL,MES,METHODS,MRI,RESULTS,THESE,WHITNEY
001,103,154,177,304,312,882,967,BACKGROUND,EMOTIONAL,IQR,LABEL,METHODS,NETWORK,RELATIVELY,RESULTS,YOUNG,YOUNGER
BACKGROUND,CLINICALLY,D54,GBM,LABEL,METHODS,RESISTANCE,RESULTS,TMZ,U87
001,040,101,169,946,B4GALT3,CONVERSELY,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHIMADA
000,100,102,183,256,358,BACKGROUND,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,RESULTS,STUDIES,STUTTGART,THERE
BASIC,GAMMA,KARNOFSKY,KPS,LOCAL,RECURSIVE,SRS
000,001,100,AFRICAN,BASED,CONCLUSION,END,IMPORTANCE,INCIDENCE,INSTITUTE,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,RELEVANCE,RESULTS,SETTING
394,520,793,832,AUSTRALIA,CIS,HOWEVER,INTERPHONE,INVERSE,LABEL,METHODS,OBJECTIVE,ORS,PURPOSE,RESULTS,WHILE,ZEALAND
001,002,007,GPA,KPS,RPA,THREE,TREATMENT,USING
COLORECTAL,HOWEVER,OWING
IDH,ISOCITRATE,R132H,THESE
108,BACKGROUND,HUTCHINSON,LABEL,MEDICAL,METHODS,OVERALL,RESULTS,TDM,THERE,UNIVERSITY,WASHINGTON
169,DNT,NEITHER,PEDIATRIC,PXA,SOCIETY,V600E
129,BASED,CUMULATIVE,DDW,MST,MYC,THEREFORE
COGNITION,THERE,THESE
600,768,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PITUITARY,PROLACTIN,RESULTS
GBM,HOWEVER,SIMILARLY
CPG,DNMT1,ERK,FURTHER,HOWEVER,INITIALLY,MAP,MBD,MEK,NAC,SP1,U0126
001,169,177,AFTER,APT,CONCLUSION,COPYRIGHT,INC,INCREASED,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,TESLA,WILEY
AUTHORS,BACKGROUND,BRAIN,CENTRAL,COLLECTION,CONTROLLED,DISEASE,FURTHER,GROUP,HOWEVER,ISSUE,LABEL,LIBRARY,MARCH,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,PEDRO,RESULTS,SELECTION,THESE,THREE
946,AKT,CD133,CDK,DESPITE,GBM,GSK,INDOH,LNC,TAKEN,THERE
FRAMELESS,FRS,SRS
001,BACKGROUND,CONCLUSION,DIVERSITY,INCOMPLETE,LABEL,LEXICAL,METHODS,OBJECTIVE,PRE,RESULTS,SENTENCES,THERE,UTTERANCE
946,COA,NADPH,NB4,PPP,TCA,THESE,THP
ACTIVATING,NF1,PILOCYTIC,V600E
INITIAL
169,177,CONCLUSION,COPYRIGHT,ENGEL,INC,LABEL,METHODS,MRI,MULTIMODAL,OBJECTIVE,PET,PRIOR,RESULTS,USING
001,DESPITE,FIFTY
169,COPYRIGHT,INDIA,PUBLISHED,SCLEROSIS,SOCIETY
123,169,263,GBM,III,R132H,SOCIETY,USING,WORLD
DEPARTMENT,DIAGNOSIS,DRAWS,EDUCATION,LABEL,MEDICAL,METHODS,NEUROLOGY,OTHER,RESULTS,SUCCESS,UNLABELLED
169,181,191,205,775,BASED,BASEL,BECAUSE,CHINESE,CONCLUSION,COPYRIGHT,DISEASE,GROUP,HCC,III,IVC,KOREA,LABEL,LIVER,METHODS,NETWORK,OBJECTIVE,RESULTS,SOCIETY,WESTERN
000,ALZHEIMER,ASSESSMENT,DRA,PARKINSON,SCORING,THEIR
004,ADC,CONCLUSION,LABEL,LOW,MATERIALS,METHODS,OBJECTIVE,RESULTS
109,169,674,ELITE,LCM,PROTEOMIC,USING,VCH,WILEY
ASSAY,NSA,NSC
169,691,BACKGROUND,COPYRIGHT,GENERATION,HOWEVER,LABEL,LARGE,METHODS,MULTI,POISSON,RESULTS,SBR,SOCIETY,SWEDISH
457,679,687,746,749,834,929,COLLEGE,CTR,PRECISE,PROJECT,QUALITY
013,016,MDD,PATIENT,PHQ,PROXIES,SUM,THERE
BONHOEFFER,RHO
APART,BACKGROUND,DIPGS,HOWEVER,IMAGING,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE
000,100,CNS,GERMINOMAS,JAPAN,PRIMARY
HOWEVER,MPLSM,REMARKABLY
000,007,BACKGROUND,BECAUSE,EXTENSIVE,HOWEVER,LABEL,METHODS,MIB,RESULTS,SEPTEMBER,THERE
177,BACKGROUND,EXCEL,LABEL,LOW,METHODS,MRI,RESULTS,SEVENTY
011,018,042,053,CNS,ERK,EXTENSIVE,INK4A,USING,V600E,VE1
11Q13,610,MEN,MENIN,NET,OCCURRENCE,TREATMENT,UNTREATED
BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,RESULTS,SEVEN
INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,TREATMENTS
001,169,CONCLUSION,COPYRIGHT,DTI,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAS,THESE,VARIOUS,WALLERIAN
15F,169,177,23M,718,785,874,936,938,COPYRIGHT,DISCUSSION,FDG,LABEL,METHODS,PET,RESULTS,SAS,SECONDARY,THERE,UNLABELLED
001,004,009,103,169,COPYRIGHT,CSI,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEXAS,UNIVERSITY
169,BECAUSE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PARENTS,PROVIDING,RESPONSES,RESULTS
169,945,AMPLIFIED,BECAUSE,COPYRIGHT,ESTROGENS,HOWEVER,SRC
215,ARMED,ATC,BACKGROUND,BIABS,CD133,CD3,CONCLUSION,ENGAGEMENT,LABEL,METHODS,MTT,RESULTS,SINCE,TARGETING,TH1,TH2,THESE,TMZ,U87,U87MG
100,BACKGROUND,BETWEEN,CONCLUSION,ENGLISH,GLASGOW,KARNOFSKY,LABEL,LSO,METHODS,PITUITARY,RESULTS,SEEMINGLY
169,AVM,BACKGROUND,CAPTOPRIL,CONCLUSION,DIFFUSE,DISCUSSION,FOUNDATION,FRUSEMIDE,LABEL,MATERIALS,METHODS,SUPPORTIVE,THERE
169,BACKGROUND,CUTANEOUS,LABEL,METHODS,RESULTS,SOCIETY

BRAIN,HOWEVER,MRI
169,AUTHORS,BRAIN,CCND1,CPG,HDAC3,III,MYC,PATHOLOGY,SOCIETY,T11
000,100,169,AMONG,AUTHORS,BRAIN,DESPITE,GBM,IDH,PATHOLOGY,PRIMARY,RECURRENT,SOCIETY,THESE
169,AUTHORS,BRAIN,CANDIDATE,EPENDYMOMA,PATHOLOGY,SOCIETY
169,AUTHORS,BRAIN,DESPITE,GIVEN,PATHOLOGY,RTS,SMARCB1,SNF,SOCIETY,SWI
169,AUTHORS,BRAIN,GROUP,PATHOLOGY,SHH,SOCIETY,THESE,WNT
169,ASA,FORTY,HAUKELAND,HGG,HOSPITALS,KARNOFSKY,KPS,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,THERE,TREATMENT,UNIVERSITY,WILEY
ADDITIONAL,DNETS,GRADE,III,MRI,THESE
177,328,941,GRADE,III,LABEL,METHODS,OBJECTIVE,RESULTS
CUSHING,EISENHARDT,LABEL,METHODS,OBJECTIVE,RESULTS
100,GRADE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
169,BASED,CURRENTLY,DNT,FCD,MITOTIC,SOCIETY
ACH,ALZHEIMER,DONEPEZIL,RAPID
002,213,AGGRESSIVE,BACKGROUND,BETWEEN,FORTY,LABEL,MATERIALS,METHODS,MST,NON,NSCLC,OCTOBER,RESULTS,SRS
003,146AG,196A2CC,215,AMONG,BESIDES,CHINA,CHINESE,HAN,HOWEVER,OVERALL,SNP,THESE
METASTASES,PATIENT
BACKGROUND,CONCLUSION,DISCUSSION,LABEL,NAVIGATION
200,560,ALA,CONCLUSION,EOR,GERMANY,HOWEVER,III,LABEL,MAY,MEDITEC,METHODS,OBERKOCHEN,OBJECTIVE,PRESUMABLY,RESULTS,ZEISS
BACKGROUND,BECAUSE,LABEL,METHODS,MONRO,OBJECTIVE,RESULTS
GBM,USING
380,536,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,RPA,SRS,THREE
110,118,19Q,333,561,ASSESSMENT,HOWEVER,MARKERS
ADP,GBM,MTT,U87
129,338,BECAUSE,BRAIN,DIFFUSE,H3F3A
19Q
PREVIOUSLY
BACKGROUND,BIPOLAR,BRAIN,CADASIL,CONCLUSION,FRIEDRICH,GENERAL,HEREDITARY,LABEL,LITERATURE,MEDLINE,MELAS,METHODS,NIETZSCHE,PARALYSIS,RESULTS,SCIENCE,SIX,WEB
169,AFTER,BACKGROUND,BASEL,BEP,BRAIN,CAROTID,CISPLATIN,CONCLUSION,COPYRIGHT,GCT,HOWEVER,LABEL,METHODS,MRI
169,700,BACKGROUND,BASEL,COPYRIGHT,CSF,LABEL,METHODS,PLACENTAL,RESULTS
HOWEVER,INR,SCORE,THERE
135,240,BRAIN,COX,EMORY,KARNOFSKY,KPS,LABEL,LDH,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SRS,UNIVERSITY
169,COPYRIGHT,GSI,INC,LINAC,MEDICAL,PUBLISHED
CBX,HOWEVER,HSV,MSC,SIMPLEX,TRAIL,VIRUS
BACKGROUND,CONCLUSION,EARLY,JANUARY,LABEL,METHODS,MPV,PCNSL,PFS,RESULTS
183,CONCLUSION,GBM,GEORG,LABEL,METHODS,MRI,OBJECTIVE,PATIENT,RESULTS,STUTTGART,THREE
183,CHOROID,CPC,GEORG,STUTTGART,THERE
183,BACKGROUND,CONCLUSION,ENDOSCOPIC,GEORG,IMMEDIATE,INITIAL,LABEL,METHODS,OBJECTIVE,PATIENT,STUTTGART
183,GEORG,SIGNS,STUTTGART
169,956,COPYRIGHT,DNAZYME,ENZYMATIC,SINCE,SUBSEQUENT,TELOMERASE,VCH,WILEY
173,371,HOWEVER,LABORATORY,TREATMENT
CONVERSELY,DESPITE,MUTATIONS,NAD
BACKGROUND,CONCLUSION,EXPRESSION,IDO,III,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SIX
011,BACKGROUND,BSG,BST,CONCLUSION,HENCE,LABEL,METHODS,MRI,OBJECTIVE,OTHER,PRIMARY,RESULTS,SCIENCE,WEB
CETUXIMAB
PROGNOSIS,THESE
AFTER,CONCLUSION,LABEL,METHODS,MIB,MRI,OBJECTIVE,PATHOLOGY,PITUITARY,RESULTS
027,ADULT,BASED,CONCLUSION,CONCURRENT,FIBONACCI,GBM,GRADE,GTV,III,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,RPA,SECONDARY,STUPP,THREE,TMZ
BRAIN,HENCE,MRI,SCHEDULED,SEVEN,SMALL
800,BESIDES,DIFFERENT
CARROLL,CLUSTERING,DCG,FIRSTLY,LEWIS
001,169,547,686,708,921,METASTASIS,MRI,SPION,VALIDATION
169,ANALOGIES,EFFECTS,EXPRESSIVE,GROUP,INC,SUPPORTIVE,THERAPY,WILEY
003,022,120,143,169,426,BACKGROUND,COPYRIGHT,JANUARY,LABEL,METHODS,MRI,NSCLC,PET,RESULTS,SOCIETY
948,CATENIN,CRC,III,MTT,SIMILAR
169,COPYRIGHT,HOWEVER,INC,MRE,MRI,SINCE,WILEY
007,010,013,015,017,018,031,036,039,041,049,CLDN2,CLDN3,CLDN4,CLDN5,CLDN7,EVIDENTLY,III,TWIST
ADDITIONAL,ALZHEIMER,HOWEVER,THEREFORE
954,956,CRABPII,EXPRESSION,FABP5,PRIMARY
BIOTECH,BRAIN,CORNELL,WEILL
BBB,DEOXY,DYNAMIC,FLT,PET,THERE
CLINICIANS,CNS,FOLLOWING,HODGKIN,LABEL,MRI,OBJECTIVE,PRIMARY,RESULTS
176,350,470,725,770,891,BACKGROUND,BECAUSE,CONCLUSION,FOLLOWING,HEADACHES,LABEL,LABORATORY,MALIGNANT,METHODS,MRI,PATHOLOGY,PROLACTIN,SIMILARLY,SIXTY
PITUITARY,SUCCESSFUL
PFT
148,182,APA,DROSOPHILA,GBM,RBP,RIP,THESE,USING
169,AUTHORS,BACKGROUND,BJD,BRITISH,CD8,CONCLUSION,LABEL,MAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PITUITARY,RESULTS,VFS
CNS,HODGKIN,IVL
169,954,BECAUSE,COCULTURE,COPYRIGHT,ERK,MYELOMA,OPG,OSTEOLYTIC,RANKL,THESE
ASTROCYTIC,BASED,CNS,WHILE
500,FORTY,FURTHER,NSCLC,PEMETREXED,PFS,PRIMARY,SECONDARY
10B,195,221,222,COMPARISON,COX,EXPRESSION,MICRORNAS,NON,THERE,THESE
HOWEVER,IOI,SEVERAL
169,ACH2A,ACH2B,BACKGROUND,CAG,CONCLUSION,COPYRIGHT,HDACS,HISTONE,HOWEVER,HUNTINGTON,LABEL,OBJECTIVE,RESULTS,THEREFORE
169,946,ALZHEIMER,COPYRIGHT,FINALLY,GXXXG,GXXXGXG,HOWEVER,INC,LATERAL,MAMMALIAN,MEANWHILE,NOTEWORTHY,PARKINSON,REGARDING,SCLEROSIS,VDACS,WHILE
169,215,BASED,CONVERSELY,COPYRIGHT,EMA,FSH,TTF,WHILE
169,ATL,COPYRIGHT
BACKGROUND,LABEL,METHODS,PFS,RESULTS,TEN
946,INCREASED
146,150,169,COPYRIGHT,INTRA,IRELAND,LTD,MSC
169,177,COPYRIGHT,GBM,GIVEN,INC,PHYSICIANS,THESE
001,008,044,102,168,197,327,343,929,BACKGROUND,BETWEEN,CONCLUSION,GBM,GROUP,HENCE,KARNOFSKY,KPS,LABEL,METHODS,PFS,RESULTS,SCALE,TMZ
102,1ST,294,361,379,BACKGROUND,CENTRAL,CONCLUSION,GBM,JANUARY,LABEL,LOG,MATERIALS,METHODS,NERVOUS,RESULTS,THERE,THREE,TUMOURS
AFFYMETRIX,COMPONENT,ECM,HOWEVER,MOLECULAR,PATHWAY,PCA,PCR,PRINCIPAL,SEVEN,SSTR1,TYRO3
141,BACKGROUND,BRAIN,CD133,DESPITE,H1915,LABEL,METHODS,NCI,PATIENT,RESULTS,THROUGH
169,BACKGROUND,COPYRIGHT,GROUP,GUIDELINES,INC,LABEL,LES,METHODS,PROCEDURE,RESULTS,SCREENING,SPBTS,TREATMENT,WILEY
169,COPYRIGHT,DIFFUSION,FIBER,IMAGING,INC,LABEL,METHODS,OBJECTIVE,PRINCIPAL,RESULTS,SEVEN,SPATIAL,WILEY
ANNEXIN,APG,BE2,IMR,SEQUENTIAL,WESTERN
001,029,123,543,FDR,H3F3A,H3K36,HGG,IDH,LYS27,LYS36,RECURRENT,SEQUENCING,SETD2,TAKEN,THESE,WES
MRI,SEVERAL,SRS,THEREFORE
AMONG,FUNCTIONAL,HOWEVER,MRI
GAMMA,GAMMAPLAN,KNIFE,LEKSELL,LGP,THEREFORE
174,BACKGROUND,CONCLUSION,FLUID,GAMMA,HOWEVER,KNIFE,LABEL,METHODS,MRI,NON,OPTIMAL,RESULTS,ROUTINELY,USUALLY
112,AFTER,BETWEEN,CONCLUSION,GAMMA,HOWEVER,KNIFE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
CCM,CRANIAL
135,BACKGROUND,GAMMA,GKS,III,KNIFE,LABEL,LINAC,LOCAL,METHODS,NON,RESULTS,SRT,THEIR,WORLD
BECAUSE,CURRENTLY,SRS,THESE
095,283,GAMMA,GKS,HOWEVER,KNIFE,LEKSELL,MEDICAL,TOKYO,UNIVERSITY,WOMEN
164,436,BACKGROUND,CONCLUSION,CPH,GAMMA,KNIFE,LABEL,LEKSELL,MATERIALS,METHODS,PAS,PERFEXION,RADICAL,RESULTS
BACKGROUND,CONCLUSION,HEADFIX,LABEL,LEKSELL,METHODS,OTHER,RADIATION,RESULTS,SRS,SRT,THREE,TREATMENT,VARIOUS,VSS
002,026,135,413,ADC,AFTER,CHANGES,DWI,HOWEVER,HT2,MRI,PFS,THEREAFTER
163,DTI,ETP,FLAIR,MRI,PSP,THERE
017,COX,GBM,HOWEVER,KARNOFSKY,KPS,MEIER,UNIVARIATE
147,177,61F,86M,BRAIN,HENCE
AUTOPHAGY,SIRTUIN,THEREFORE
92B,BACKGROUND,LABEL,LUCIFERASE,METHODS,MTT,NLK,RESTORING,RESULTS,TCF,TRANSWELL,WESTERN,WNT
001,011,114,132,156,823,849,BACKGROUND,COX,GBM,LABEL,METHODS,MIR,PCR,PEARSON,RESULTS,THEIR
169,COPYRIGHT,EXPRESSION,INC,LABEL,LESIONS,METHODS,OBJECTIVE,RESULTS,THREE
169,COPYRIGHT,INC,SRY,THEREFORE,THESE,WHILE
000,014,065,089,105,135,159,169,177,1ST,3RD,COPYRIGHT,HOWEVER,IGF1R,LABEL,MATERIALS,METHODS,NCN,OBJECTIVE,PCR,PUBLISHED,RESULTS
169,COPYRIGHT,LTD,RADIATION,SEVERAL
169,COPYRIGHT,GLIOMAS,III,LTD,PCR,PUBLISHED,THESE,USING,USP2A,WESTERN,WORLD
169,COPYRIGHT,LEDDERHOSE,LGFMS,LTD,MRI,T1WMR,T2W
169,AKT,CHRONIC,COPYRIGHT,ERK,LTD,SOS
169,ADVERSE,APRIL,COPYRIGHT,DAILY,GRADE,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PUBLISHED,PURPOSE,QUALITY,RESULTS,SIMON,SOCIETY
10878,169,18YEARS,20YEARS,225,25YEARS,306,312,76YEARS,CHILD,COPYRIGHT,NEUROLOGY,NF2,PUBLISHED,SOCIETY,THERE
PROGNOSIS
008,013,018,BACKGROUND,BASED,BRAIN,CNS,EOC,FFP,III,KARNOFSKY,LABEL,LMD,METHODS,RESULTS,WHETHER
169,GBM,H3F3A,H3K27,HOWEVER,PCG,SEQUENCING,SIXTEEN,SOCIETY,THEREFORE
BACKGROUND,LABEL,METHODS,MSI,PCR,PTC,RAS,RESULTS,RET,SAMPLES,V600E
20S,AWARENESS

239,BACKGROUND,GBM,LABEL,MATERIALS,METHODS,NUMERIC,OBJECTIVE,PURPOSE,RESULTS,SUPER,TDI,TRACK
001,037,176,945,ANOVA,BACKGROUND,DSC,FIRST,LABEL,MATERIALS,METHODS,OBJECTIVE,PSR,PURPOSE,RESULTS
ADC,BACKGROUND,CHO,DWI,EBV,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PCNSL,PURPOSE,RESULTS
224,EAG,EGF,ERBB1,ERBB2,ERBBS,ETHER,HOWEVER,PITUITARY
10Q,22Q,ARRAY,CGH,NANOSTRING,NF2
003,007,009,011,19Q,BASED,CD151,GBM,GBMOS,HOWEVER
AMSTERDAM,AUSTRIA,EOL,GBM,MEDICAL,QOL,UNIVERSITY
001,002,008,DESPITE,END,GBM,NCI,RESULTS
AUC,LABEL,LAROTAXEL,LTX,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
001,BETWEEN,CRANIAL,DEPARTMENT,FUDAN,HUASHAN,JANUARY,NON,PROGNOSIS,SECRETORY,SIMPSON,SMS,UNIVERSITY
131,177,185,316,CARDIAC,CLOSURE,CONGENITAL,CPSSS,DIAGNOSIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
CD133,CSC,ESPECIALLY,EVALUATION,ID1,MUSASHI,OCT,REGARDING,USING
HOWEVER
BECAUSE,PCNSL,PERFORMING,SIX
169,945,COPYRIGHT,LTD,PCR,TAKEN,TAP,TOCOPHEROL,TOS
169,COPYRIGHT,GLASS,HOWEVER,LTD,WAVELET,WNS
169,617NM,946,99M,COPYRIGHT,LTD,PET,PIB,SPECT,THESE,WHILE
169,COPYRIGHT,EPHA3,GBM,INC,THESE
AFTER,CISPLATIN,ERLOTINIB,GEFITINIB
169,177,CHO,CNS,CONCLUSION,COPYRIGHT,DWI,EIGHT,FLAIR,GLY,LABEL,MATERIALS,METHODS,MONRO,MRI,MRS,NAA,OBJECTIVE,OBJECTIVES,RESULTS,SAS,THREE
COPYRIGHT,FURTHER,GIVEN,SLACK
169,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,EOR,ESPECIALLY,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SAS,SURGERY,THESE
463,BACKGROUND,CK2,KNOCK,LABEL,METHODS,OVERALL,RESULTS,S463A,S463D
003,009,BACKGROUND,GBM,GLUTAMINE,LABEL,METHODS,MGM,RESULTS,RPA,SEVERAL,STUPP,UNIVARIATE
945,CONCLUSION,HOWEVER,IDH,INCREASED,LABEL,LGG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAMPLES
METASTASIS
GTP,GTPASES,NMR,RAS
BACKGROUND,CONCLUSION,FDG,LABEL,MET,METHODS,MRI,PET,RESULTS,SEVEN,SUV,TEN,THERE
001,19Q,210,916,AIC,BACKGROUND,CONCLUSION,FORTY,IDHWT,LABEL,LGG,LOW,METHODS,MGMTMET,MOLECULAR,RESULTS,TP53POS
169,AKT,ANNEXIN,ATG12,AUTOPHAGY,CISPLATIN,CLC,COPYRIGHT,DPI,INC,LC3,MDC,NADPH,ROS,WILEY
169,177,ASL,CBF,COPYRIGHT,GLM,INC,PVE,RESULTS,WILEY
140,297,9276A,AICDA,KOREA,SEOUL,TAG
169,AFTER,COPYRIGHT,INC,MRI,WILEY
AMP,COA,GBM,STRUCTURE,THROUGH,WARBURG
119,COX,GBM,MEIER,PCR
COGNITIVE,INCREASED
CASES,DISTANT,FOLLOWING,HNSCC,HOPKINS,HPV,JOHNS,P16,SCC
119,BETWEEN,GKS,JANUARY
133,137,141,178,193,BACKGROUND,HOWEVER,LABEL,METHODS,NEITHER,OCCURRENCE,OPENING,PMA,RESULTS
242,8GY,LABEL,LOW,METHODS,NTD,OBJECTIVE,PURPOSE,RESULTS
FUNCTIONAL,LIM
BACKGROUND,FURTHER,LABEL,LOCAL,METHODS,PFS,RESULTS,THERE,TKI
147,160,174,229,239,BACKGROUND,COMPARING,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,STORZ,THERE,THESE,THREE
164,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NEUROGENIC,OBJECTIVE,REMOVAL,RESULTS,SIX,VHL,WORLD
256,EMEND,INOCULATED,NK1,THESE
DESPITE,HOWEVER,OBESITY,SEVERAL
169,AFTER,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,D10,IMPORTANCE,LABEL,METHODS,MRI
197,492,788,BACKGROUND,BBT,INSURANCE,LABEL,MATERIALS,MBT,METHODS,RESULTS
ALZHEIMER,BACKGROUND,CNS,CPE,ENRICHMENT,FINALLY,HIV,HOWEVER,LABEL,METHODS,NCI,NEUROAIDS,RESULTS,THESE,VIRUS,WGCNA,WHILE
169,BECAUSE,CNS,CPG,GBM,SOCIETY
000005618,AGE,BACKGROUND,BRAIN,DISCUSSION,HOWEVER,LABEL,METHODS,RESULTS,TRIAL,YET
945,CWR22,DHT,EXPRESSION,LUCIFERASE,THESE,USING,UTR
945,947,CBA,ELISA,IFN,OCL,PRIMARY,TH1,TH2,TNF
169,COPYRIGHT,FOXM1,GBM,GSC,NPC,PRESS,TREATMENT,USING
267,CPA,ESPECIALLY,MALIGNANT,MRI,PATIENT
183,BRIGHAM,CASES,CONCLUSION,DIGITAL,GEORG,INC,LABEL,METHODS,OBJECTIVE,OPTICAL,POLARIS,RESULTS,STUTTGART,USA,WEB,WOMEN
160,HOWEVER,PAMAM,THESE
169,430,COPYRIGHT,FORTY,PROLONGED,VAL
177,179,PCR
267,409,K409Q,NF2,TRAF7,VALIDATION,WHILE
160,169,183,215,ADMISSION,CONCLUSION,FOLLOWING,GEORG,HISTORY,HOWEVER,LABEL,METHODS,RTH,SERUM,STUTTGART,THYROID,TPO,TREATMENT,TSH
BECAUSE,DUOX1,DUOX2,MAB,NADPH,ROS
137,143,145,CHANGES,CYBERKNIFE,LOCAL,THERE,V14
122,126,169,AVERAGE,COPYRIGHT,FAVORABLE,GTR,INC,LABEL,METHODS,OBJECTIVE,RATES,RESULTS,THERE
169,ADDITIONAL,AFTER,BACKGROUND,COPYRIGHT,GAMMA,HOWEVER,III,INC,KARNOFSKY,LABEL,METHODS,PREVIOUSLY,RESULTS
169,AFTER,BACKGROUND,COPYRIGHT,HISTOLOGY,HOWEVER,INC,LABEL,METHODS,RESULTS,SINCE,SYLVIAN,T11,T12,WORLD
169,CASES,COPYRIGHT,CSF,FORTY,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,WORLD
169,215,ADENOVIRAL,ADS,BECAUSE,COPYRIGHT,FLT3L,INC,TETON
009,169,179,COPYRIGHT,DUSP5,GCS,HOWEVER,INC,PATHOLOGY,PUBLISHED,RESTORING,SOCIETY,THESE
108,129,169,188,ACTUARIAL,COPYRIGHT,DBF,DISTANT,FIFTY,FREEDOM,INC,LABEL,LBF,LOCAL,METHODS,OBJECTIVE,RESULTS,SEVENTY
169,AIF,COPYRIGHT,EM011,G2M,INSTEAD,IRELAND,JUN,LOW,LTD,THESE
169,AMONG,BACKGROUND,CNS,DEPARTMENT,HCC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SORAFENIB,THESE,WILEY
001,005,007,009,013,048,169,352,436,453,468,485,582,AIM,BACKGROUND,COGNITION,HBV,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OHE,RESULTS,WILEY
FIRST,HOWEVER,SIX,TKI
169,945,946,CONSISTENT,COPYRIGHT,GBM,GIC,PRESS,RAC,RHO
169,BETWEEN,CAREFUL,COPYRIGHT,CPA,EIGHT,HYPOTHESIS,IAC,INC,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OTOLOGICAL,OWING,RESULTS,SOCIETY,WHILE
040,177,206,688,713,765,769,842,ROC

BBB,CNS,COX,CSF,ELISA,HOWEVER,OTHER
BACKGROUND,III,LABEL,MENINGIOMA,METASTATIC,METHODS,MRI,WORLD
169,AFTER,BECAUSE,MRI
BUB1B,BUBR1,DISCOVERY
897,AIC,AMONG,APRIL,BMS,ECM,GPA,KARNOFSKY,KPS,RPA,SIR
FINALLY,HIF,VHL,VON
001,125,160,195,215,410,FSH,PITUITARY,PRL,TSH,USING
945,946,SHG,SIMILAR,U87,USING,WORLD
016,324,945,946,GLIAL,IHC,III,INTEGRINS,ITGB3,ITGB6,ITGB8,MEIER,WORLD
169,945,946,COPYRIGHT,ECM,INC,LUMICAN,MMP,MT1,OVERALL,PCR
169,946,AKT,COPYRIGHT,ERK,HIF,HYPOXIA,U87
11C,457,BBB,FLB,FURTHER,HOWEVER,PET
946,ABCB1,ABCC4,ABCG2,ATP,BBB,BCSFB,CNS,DRUGS
BACKGROUND,DISCUSSION,FOLLOWING,ITALY,LABEL,METHODS,PHYSICIANS,PROBLEM,RESULTS
169,215,BEV,CONCLUSION,COPYRIGHT,FLAIR,GBM,IRELAND,LABEL,LTD,MATERIALS,MCDONALDS,METHODS,MRI,OBJECTIVE,PFS,PRE,PURPOSE,RESULTS,ROI,SIEMENS,VOLUMETRIC
169,CEREBELLAR,COPYRIGHT,INC,WHILE
169,218,605,695,APMIS,AUTHORS,ELISA,FORTY,FURTHER,MIB,NEUROPILIN,VEGFR
PRIMARY
509,ALZHEIMER,CONCLUSION,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OTHER,PARKINSON,PURPOSE,RESULTS,ROSMARINIC,ROSMARINUS,THERE
BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTEEN,SIXTY,SRS
031,963,FIRST,JANUARY,LABEL,LIBRARY,MAY,MEDLINE,METHODS,OBJECTIVE,RESULTS,THIRD
150,286,FLAIR,MRI,RESULTS,THESE
160,HLH,ID1,ID2,ID3,ID4,INHIBITOR
153,ALTOGETHER,CD133,FIRST,GBM,MEANWHILE,MICRORNAS,PCR,SCS,THESE
011,012,025,035,365,676,III,MVD,THESE,TROP2,WORLD
177,178,750,AMONG,CAVALIERI,DEPARTMENT,III,MAYIS,ONDOKUZ,PATHOLOGIC,PITUITARY,UNIVERSITY
986,ALKYLATING,GBM,PFS
BBB,BCRP1,CNS,ELACRIDAR,HOWEVER,INITIALLY,MDR1A,OVERALL,THESE
DESPITE
AFTER,CSF
ARCHIVE,ATLAS,BACKGROUND,BECAUSE,COX,GROUP,IMAGING,KPS,LABEL,METHODS,MRI,PHENOTYPE,RESULTS
169,AFTER,BEIJING,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OCTOBER,PITUITARY,PRIMARY,RESULTS,SIX,SIXTEEN,TIANTAN
169,647,653,BECAUSE,BRIEFLY,COPYRIGHT,INC,LABEL,METHODS,MIB,OBJECTIVE,PBS,PCS,PPTID,RESULTS,THERE,WORLD
160,169,COPYRIGHT,ICG,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,TEN
001,005,046,048,160,169,177,329,AMONG,ASIAN,BECAUSE,CGB,CONCLUSION,COPYRIGHT,END,INC,LABEL,METHODS,OBJECTIVE,PACIFIC,RESULTS,STUDIES
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS
169,COPYRIGHT,GABAERGIC,INC
169,945,ASIAN,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,OVERALL,RESULTS
169,947,COPYRIGHT,GABAERGIC,LTD,SIMILARLY,STUDIES
001,169,ANOVA,CHI,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MAJOR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,VARIATION
159,250,AFTER,BACKGROUND,COX,GPA,HARRELL,LABEL,LDH,METHODS,RESULTS,RPA,SCORE,SEVERAL
CALCIFYING,CNS,MRI,THEIR
003,123,142,997,HOWEVER,LABEL,METHODS,OBJECTIVE,PHENYTOIN,PRIMARY,RESULTS,THEREFORE,USING
044,095,124,177,CARCINOID,COX,FIFTEEN,LABEL,MEIER,METASTATIC,METHODS,MINNESOTA,OBJECTIVE,PFS,RESULTS,ROCHESTER,THEIR,THOSE
006,GOALS,LABEL,METHODS,OBJECTIVE,PROCEDURAL,RESULTS,SHORT
ANOTHER,SERIOUS
178,456,969,ADC,ADCMEAN,BACKGROUND,DWI,INCLUSION,LABEL,METHODS,MRI,RESULTS
AQUAPORIN,DESPITE,III,INTENSITY,NON,THERE
908,915,940,942,943,945,966,968,976,988,994,BACKGROUND,COX,KPS,LABEL,METHODS,PFS,RESULTS,SWI,THESE
001,103,177,209,249,407,BACKGROUND,LABEL,METHODS,RESULTS
ASSOCIATED,BACKGROUND,CHO,CNI,COX,EVALUATED,GBM,LABEL,METHODS,NAA,RESULTS,SIXTY,THESE
005,100,BACKGROUND,BECAUSE,GBM,IDH,LABEL,MEIER,METHODS,PCR,RESULTS,STUDENT,TELOMERASE,WHILE
AQP,AQUAPORINS,ESSEN,GENOTYPES,III,OTHER,UNIVERSITY
159,830,CNS,END,MPNET,RESULTS,SUBSEQUENT,VARIATION
AKT,ESPECIALLY,GSLCS,HAR,HARMINE
400,AFTER,BORON,CAPTURE,INSTITUTE,KURRI,KYOTO,NEUTRON,REACTOR,SINCE,THERAPY,UNIVERSITY
GADOLINIUM,III,MRI
160,BACKGROUND,ESPECIALLY,LABEL,METHODS
113,BSC,FURTHER,HOWEVER,SEVERAL,THEREFORE,WHETHER
ALA,BACKGROUND,FURTHER,ICG,LABEL,METHODS,RESULTS,THEREFORE
00973,169,945,ATLAS,BECAUSE,CONCLUSION,COX,GBM,HIPAA,INTERRATER,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRONEURAL,PURPOSE,RESULTS
177,BACKGROUND,CONCLUSION,EIGHT,GLP,HBA1C,INSULIN,LABEL,METHODS,RESULTS
235,BRESLOW,CLARK,MEIER,SEVEN,SLN,TEN
035,AMONG,AUDIT,BACKGROUND,CONCLUSION,DEVELOPING,DIAGNOSIS,LABEL,METHODS,PRIMARY,RESULTS
HOWEVER
ASIAN,THYROTOXIC
001,126,150,169,200,215,AFTER,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,ETN,GRADE,GROUP,INC,LABEL,MATERIALS,METHODS,MST,NSCLC,RADIATION,RESULTS,SRS,THERAPY,TMZ
003,036,100,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,GBM,IHC,KAROLINSKA,LABEL,LOW,MEIER,METHODS,RESULTS,TTP,TUMOURS,UNIVERSITY
CHO,GBM,HGG,LGG,MRI,MRS,NAA
AGE,HOWEVER
143,145,DESPITE,FAK,GBM,PCR,SIMILARLY,SPARC,THEREFORE,THESE,USING,UTR,WESTERN
AKT,ERK,TIC10,TRAIL
CALIFORNIA,COMPLEX,CONTROLLED,DIGIT,DVH,HOPKINS,LABEL,METHODS,OBJECTIVE,OSTERREITH,REGIONS,RESULTS,REY,ROI,TESTS,TRAIL
ASSOCIATED,BACKGROUND,ELECANS,LABEL,METHODS,MOTIVATION,RESULTS
169,3PRNA,CNS,COPYRIGHT,GBM,GRANTED,PRESS,RIG
002,007,008,015,100,169,177,182,215,CONCLUSION,COPYRIGHT,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RESULTS,ROC,STUDENT,TBF,WILEY
169,184,AIF,CONCLUSION,COPYRIGHT,DCE,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WILEY
169,500,916,ADC,CONCLUSION,COPYRIGHT,FUNCTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERFUSION,PURPOSE,RESULTS,WILEY
169,18F,COPYRIGHT,GBM,GCV,HOWEVER,HSV,MSC,PRESS,THESE,TRAIL
METASTASIS
001,006,011,012,025,BACKGROUND,LABEL,METHODS,OBJECTIVE,RECURSIVE,RESULTS,TREATMENT
BACKGROUND,D0PATIENT,LABEL,METHODS,OBJECTIVE,PALLIATIVE,PCPATIENT,PWT,RADICAL,REFERENCE,RESULTS,WAITING
KIF3A,MBS,SHH,SONIC,THESE
009,111,122,201,AGE,CCI,COMPLIANCE,ELDERLY,GBM,INDEX,INSTITUTE,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TMZ
HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PACLITAXEL,PPX,PRIOR,RESULTS,SEVEN
000,169,200,945,947,CLINICALLY,EARLY,RADIATION,RAS,THESE
169,CNS,COPYRIGHT,FINALLY,FURTHER,HOWEVER,ISSUE,LIPID,LPA,LPP,LPPR4,LPPRS,PLASTICITY,S1P,SPECIAL,THEREFORE
BERNARD,HIV,THESE
ACCORDING,BACKGROUND,C32,C34,CODES,CZECH,F17,INSTITUTE,LABEL,METHODS,P04,RELATED,RESULTS,SMOKING,STATISTICS,T65,THERE,THESE,Z72
800,DOSIMETRIC,GAMMA,HOWEVER,KNIFE,LABEL,METHODS,OBJECTIVE,PEI,PLANS,PURPOSE,RESULTS
177,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
CTV,LABEL,METHODS,OAR,OBJECTIVE,PRV,PTV,PURPOSE,RBE,RESULTS,USING
EGF,ERK,HGF,JAK,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTK,THESE
169,916,DRONABINOL,HOWEVER,III,INC,MEDICAL,SEVERAL,STUDIES
HIV
552,AFTER,FURTHER
000,014,019,102,160,BIVARIATE,LABEL,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS
105,CENTRAL,CONCLUSION,DIFFERENT,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,OUTCOME,RESULTS,TMZ
100,BACKGROUND,BROCA,CONCLUSION,DCS,LABEL,METHODS,NAVIGATED,OBJECTIVE,REPETITIVE,RESULTS,YET
250,LABEL,METHODS,OBJECTIVE,OVERALL,PRL,RESULTS,SERUM
169,AFTER,CONCLUSION,COPYRIGHT,INC,INITIAL,LABEL,METHODS,OBJECTIVE,RATES,RESULTS,SRS,THREE
160,956,BBB,CELLS,FGF,FIBROBLAST,GBM,H1299,NCI,RBECS,THESE
169,CNS,COPYRIGHT,LTD,THESE
CSC,DESPITE,ESA,THESE
945,ADP,AKT,BCL,GH3,MMQ,PAS,THEREFORE,TMZ,XL765
133,169,COPYRIGHT,FIRST,INC,LABEL,METHODS,OBJECTIVE,PARENTS,PEDIATRIC,PUBLISHED,RESULTS
169,946,COPYRIGHT,IFN,PAMAM,THESE,TUNEL,U87MG
10H10,169,SOCIETY,TF9,THEREFORE
SIGNALING,STEINER
169,OXIDATIVE,ROS,SOCIETY
042,373,BACKGROUND,CHROMATIN,CONCLUSION,FOXQ1,HOWEVER,LABEL,METHODS,MTT,NEUREXINS,NRXN3,PCR,RESULTS,REVERSE,WESTERN
B16,CHINESE,CHO,GD3,MEL,R24
AMONG,CHEMOKINES,CXCR4,NSCLC
453,BRAIN,HSV,IL2RG,LM249,MDA,ONCOLYTIC
001,100,200,CONCLUSION,CRA,CUSHING,DEX,INITIALLY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PBE,PURPOSE,RESULTS
100,956,KO134,PCA,PCB,THESE
001,153,197,348,399,916,BACKGROUND,CHANGES,DYNAMIC,GBM,III,LABEL,MEIER,METHODS,MRI,RESULTS,TREATED
AKT,BACKGROUND,CONCLUSION,CONTROL,EQUAL,HSP,HSP27,LABEL,MEK,METHODS,P38,RAF,RAS,RESULTS,SER,SER78,SHC,SPARC,THEREFORE,THESE,WESTERN,WORLD
169,187,209,275,539,610,663,841,AMONG,BACKGROUND,COPYRIGHT,DRUGS,GEO,INC,LABEL,METHODS,MYC,PROCEDURE,REGARDLESS,RESULTS,RTS,SIMILAR,SMARCB1,SNF,SWI,WILEY
169,COPYRIGHT,EHRLICH,LTD,WILEY
2341066,HGF,MET,RESISTANCE,TAKEN,UTILIZING
500,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
GADOBUTROL,GBCAS,MANAGEMENT,MRI,SRS
144,15F,160,CUSHING,FIFTEEN,LOW,RECORDS,REMISSION,TSS
160,BAX,BCL,CLIC4,HOWEVER
ACADEMY,CHALLENGES,CONFERENCE,DESPITE,FIRST,GRAND,OCTOBER,WASHINGTON
169,COPYRIGHT,FOLLOWING,LTD,PEG,PTX,RGD,RGDYK,TAXOL,THEREFORE,U87MG
143,169,177,240,247,24H,360,ABL,BAFETINIB,BCR,COPYRIGHT,DIALYSATE,LABEL,LTD,LYN,METHODS,OBJECTIVE,PURPOSE,RESULTS

000,100,CURRENT
100,110,GOS,GROUP,HOWEVER,ICU,III,INCLUSION,JANUARY,LOS,MECHANISM,SCVO2,SJVO2,SRT,THERE
AGE,BITHALAMIC,CSF,DIFFUSE,GRADE,INSTITUTE,MRI,THERE,TREATMENT
946,956,ADSCS,ALZHEIMER,HOWEVER,N2A,NEP,NEPRILYSIN
215,FEW
BACKGROUND,EWING,LABEL,MATERIALS,METHODS,RESULTS,STUDIES
BRAIN,GROSS,METASTASES
001,177,18F,FDG,GBM,HOWEVER,PCNSL,PET,PRIMARY,ROC,THESE,TYPICAL
945,946,EMD,INTEGRINS,RGD,SMAD2,THESE
169,COPYRIGHT,LTD,WILEY
169,COPYRIGHT,INC,WILEY
947,GBM,ID1,INHIBITOR,TAKEN,U87
AGO,ARGONAUTE,DEGRADOME,HOWEVER,MICRORNAS,PAR,PERFORMING,SEQ
001,134,287,411,475,BMS,BRAIN,BRESLOW,GENERAL,MEIER,PERFORMING,REGARDING,SLN,SNL
HOWEVER,ISH,LN229,MEANWHILE,PCR,RB1,THESE,TJ905
HOWEVER,PFS,TMZ,WHETHER
100,13R,17S,23S,24R,25S,49R,99M,CONCLUSION,FDG,LABEL,MDP,METHODS,MRI,NPV,NSCLC,OBJECTIVE,OBJECTIVES,PET,PPV,RESULTS,SEVENTY
160,DIPGS,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SEVEN
ADDITIONAL,ENGLISH,LITERATURE,SYSTEMATIC,TYPICALLY
A12,BEGINNING,CD3,CD8,MOLECULAR,NANOSTRING,PARKINSON,PATIENT,TCR
004,ATL,BECAUSE,DCS,DECREASED,DENDRITIC,GAA,HLA,HOWEVER
100,160,BACKGROUND,CBV,CONCLUSION,FIFTY,LABEL,METHODS,RESULTS
MRI,NF2,VSS
169,AGA,AKT,ALB,BACKGROUND,BASED,COPYRIGHT,CRE,INC,INHIBITION,INSTITUTE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RAS,RESULTS,TSC
ASIAN,BBB,NSCLC
BRAIN
169,COPYRIGHT,DIFFUSION,DTI,LTD,MISES,VIA
FINALLY,GIVEN,HOWEVER,III
169,BRAIN,BTSCS,COPYRIGHT,FINALLY,GEM,INC,LESSONS,NSC,SIGNALS
001,169,985,993,ABC,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,PEARSON,RESULTS
169,945,COPYRIGHT,LTD,SDF
169,COPYRIGHT,IRELAND,LTD,NSCLC,SEVERAL
169,COPYRIGHT,DUE,LTD,RESECTION,TREATMENT,VARIOUS
169,COPYRIGHT,LTD
BACKGROUND,CSI,DVH,HOWEVER,LABEL,METHODS,OVERALL,RESULTS
AWAKE,BACKGROUND,BETWEEN,HOWEVER,III,IOM,KARNOFSKY,LABEL,METHODS,RESULTS,SCALE,THEREBY,TODAY
GBM
HISTOLOGY,MRI,PATIENT,PRIMARY
005,177,956,APRIL,CONCLUSION,KARACHI,LABEL,MAY,MEDICAL,METHODS,OBJECTIVE,PLACE,RESULTS,S100B,SERUM,WHITNEY
134,BACKGROUND,BRAIN,CONCLUSION,INSTITUTE,LABEL,METHODS,NEUROLOGY,OBJECTIVE,RESULTS,THEIR
100,169,COPYRIGHT,GIVEN,HOWEVER,INSPECTION,TREATMENT,WHILE
100,169,177,916,945,946,947,954,CD1,CRTH2,GRO,HOWEVER,LPS,LTD,WILEY
001,004,011,029,205,MEIER,ROUTE
AKT,ENHANCING,ERK,MALIGNANT,MICRORNAS,STAT3,UTR,WESTERN
ADC,DWI,INCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RADIOGENIC,RESULTS
AFTER,BETWEEN,CHINA,GRADE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SICHUAN,UNIVERSITY
125,BRAIN,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,SCALE,SEVEN,SEVENTEEN,THERE,THESE
CIC,FUBP1,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
001,028,166,COX,END,GRADE,LABEL,LGG,LOG,LOW,MEIER,METHODS,OBJECTIVE,RESULTS,TAKEN
DESPITE,INSULAR,MAXIMIZING
AGGRESSIVE,AWAKE,CLASS,EARLY,ENGEL,GROSS,LABEL,METHODS,MRI,OBJECTIVE,RESECTION,RESULTS,SEVEN
GRADE,LABEL,METHODS,OBJECTIVE,RESULTS
109,ADDITIONAL,FET,FLAIR,HOWEVER,LGG,MRI,PET
IDH,RAPIDLY
FINALLY,GRADE
HOMONYMOUS
HOMONYMOUS
129,COHABITEES,EXPOSED,HOWEVER,INCIDENCE,IRR,NETWORK,POISSON
100,117,APPLIED,BASED,GBM,MEIER,MRI,USING
001,002,016,033,766,BACKGROUND,BASED,HOWEVER,III,INCREASED,LABEL,METHODS,MIF,MVD,OBJECTIVE,RESULTS
106,177,189,195,200,956,BACKGROUND,BECAUSE,CONTEXT,CUSHING,EARLY,FACTORS,INSTITUTES,LABEL,METHODS,NIH,OBJECTIVE,RESECTION,RESULTS,SETTING,YOUNGER
200,AIP,CUSHING,EARLY,EXTENSIVE,FEW,GIGANTISM,PITUITARY
EXPRESSION,HOWEVER,NTRK1
167,946,BACKGROUND,CATENIN,E12,LABEL,METHODS,NUCLEAR,RCC,RESULTS,SIX
169,CONCLUSION,HYPOTHESIS,INC,LABEL,MALIGNANCY,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SINONASAL,SOCIETY,THREE
945,BCAAS,COA,DIFFERENT,HEPATIC
THESE
185,19Q,BACKGROUND,CBV,CHO,FLAIR,FORTY,GLX,LABEL,LOH,MATERIALS,METABOLITE,METHODS,MRS,NAA,OBJECTIVE,PURPOSE,PWI,RESULTS,VOI
19079,AUSTRALIA,AWARENESS,BACKGROUND,BELIEFS,CONCLUSION,DENMARK,LABEL,METHODS,PERCEIVED,RESULTS,SYMPTOM,THERE
169,215,956,COPYRIGHT,DCE,INC,MRI,ODQ,TAKEN,U87,USING
126,169,177,295,464,BRAINSTEM,COPYRIGHT,EIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
112,169,AFTER,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,INHIBITION,LABEL,METHODS,OPTIMIZING,THERE,THESE,TRIAL
169,BECAUSE,COPYRIGHT,FOLLOWING,INC,PATHOLOGY,PUBLISHED,SOCIETY,STUDIES
946,ACTIVATOR,ALZHEIMER,AP2,APP,BACKGROUND,ELISA,FUNCTIONAL,GIVEN,LABEL,PRE,PROTEIN,PUF,RESULTS,SNP,SP1,THESE
451,FIRST
185,AIM,FDG,PET
FEM,FIRST,HOWEVER,MRI,SAR,THEREFORE,THIRD
FEATURE,LIPID
HOWEVER,MHZ
DOPPLER,LABVIEW,RECORDINGS,TLI

BRAIN,FBB,FCM,HAUSDORFF,MHD,MRI
FOCUSED,HOWEVER,INTENSITY,POC,TYPICALLY,ULTRASOUND,USING

CUSHING
169,946,DELTA,GSC,RGD,TGF,THESE,USING
015,APA,BACKGROUND,CONTEXT,EVALUATION,HOWEVER,JAPAN,LABEL,MEMBERS,METHODS,OBJECTIVE,PCS,PITUITARY,RESPONSES,RESULTS,SOCIETY,SOLID,THREE,TMZ
001,002,178,ACUTE,CLINICALLY,INSTITUTES,SEVENTY,THESE
DEFECTS,HOWEVER
706,728,739,748,COMPETENCE,CONCLUSION,FIQ,FURTHER,HRQOL,III,INDEX,INVENTORY,LABEL,MATERIALS,METHODS,OBJECTIVE,PARENTING,PEDIATRIC,PIQ,PURPOSE,QUALITY,RESULTS,SCALE,SENSE,SHORT,VERSION,VIQ
ATTACKS,SMART
H3K36,HOWEVER,MALIGNANT,MRT,SMARCB1,SNF,SWI,TSS
SIX
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
000,169,400,600,EGF,EIACS,ERBB1,EVALUATION,GREEN,INCREASED,LABEL,METHODS,MTR,OBJECTIVE,PFS,PURPOSE,RESULTS
22042,26042,ASSURANCE,BACKGROUND,CONSORTIUM,CTV,DEVIATIONS,DUMMY,EORTC,ICR,IMAGE,INDIVIDUAL,LABEL,MAJOR,METHODS,PTV,QUALITY,RESULTS,RUN,TECHNOLOGY,THERAPY,THESE
ALA,ARG,ASP,DEXTRAN,EGF,EPIDERMAL,FDA,GLY,ICG,RGD,THERE,UNDER
HYPOXIA,LABEL,METHODS,OBJECTIVE,RAS,RESULTS,U87
1940S,CSF,FIFTY,FINALLY,THERE
10Q,169,19Q,491,APPLIED,AUTHORS,BRITISH,GBM,LABEL,LOH,METHODS,NEITHER,OBJECTIVE,PCR,R132H,RESULTS,SOCIETY,THESE,UPFRONT
DCC,HGG,LABEL,MAJOR,MATERIALS,METHODS,NOVEL,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,TRL
DIFFUSION,DTI,USING
ACTIVATION,GBM,HOWEVER,MYC,TAP63,THEREFORE,TMZ
11Q23,ADULT,BACKGROUND,BECAUSE,CONCLUSION,FRANCISCO,IDH,LABEL,METHODS,RESULTS,SAN
10001,333,MEDICAL,PUBLISHERS,SEVENTH,USA
10001,333,FDG,MEDICAL,PET,PUBLISHERS,SEVENTH,SEVERAL,USA
10001,333,MEDICAL,MRI,PUBLISHERS,SEVENTH,USA
10001,333,MEDICAL,MRI,PATHOLOGY,PUBLISHERS,SEVENTH,USA
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTEEN
AMONG,DNT,MRI,THESE
184,195,BACKGROUND,CONCLUSION,GBM,LABEL,MATERIALS,METHODS,MONOCLONAL,MUTATIONS,R132H,RESULTS,TMA
1LI,945,AQP,AUTOPSY,BRAIN,CNS,FURTHER,HIF,LABEL,MATERIALS,METHODS,MIB,MVD,OBJECTIVE,OBJECTIVES,RESULTS
AMONG,BACKGROUND,JANUARY,LABEL,MATERIALS,METASTATIC,METHODS,RESULTS,THERE
AEG,CPEB1,LYRIC
AED
169,ALZHEIMER,COPYRIGHT,INC,RAF,WILEY
916,CONSISTENT,GBM,HGF,MES,MET,SILENCING,STAT3,SU11274,THESE,USING
160,CTV,CTVCT,GTVCT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,V95
AIM,BACKGROUND,DIFFUSE,HOWEVER,III,LABEL,METHODS,NOW,OBJECTIVE,WORLD
426,BACKGROUND,CAROTID,LABEL,METHODS,OBJECTIVE,RESULTS,TEN,YET
AFTER,BASED,IDH,IHC,ISOCITRATE,QUALITY,R132G,R132H,RESULTS,THREE
160,BACKGROUND,CONCLUSION,DISCUSSION,EMBRYONAL,LABEL,METHODS
001,160,3ZETA,945,FURTHER,HIF,III,IRS,SIMILAR,THESE
229,240,947,956,AFTER,CONTINUOUS,LABEL,METHODS,OBJECTIVE,PPM,PRKDC,PURPOSE,RESULTS,THESE
KARNOFSKY,MALIGNANT,PRIMARY
DESPITE,DUE,GBM,MULTIFORME,PKC,RESULTS
169,LIPPINCOTT,LMD,V600E,WILKINS,WOLTERS
100,110,AIM,CONCLUSION,DOTATOC,FINALLY,IMAGING,LABEL,MBQ,METHODS,OBJECTIVE,PET,RCS,RESULTS,SPECT
045,047,190,2677G,2677T,3435C,ABCB1,ATP,GENOTYPING,RESISTANCE,SIXTY
003,014,028,215,989,GIVEN,POLYGENIC,RESULTS
BECAUSE,FOX,FOXA1,FOXA2,HOWEVER,LHX,SCLCS,THESE,THYROID,TRU
002,009,BACKGROUND,GROSS,JANUARY,LABEL,LGG,MEDICAL,METHODS,PFS,RESULTS
169,COPYRIGHT,FETAL,SAS
169,CD133,COPYRIGHT,IRELAND,KNOCKDOWN,LTD,NOTCH,U87
169,CD163,CD4,CNS,COPYRIGHT,INC
169,AUTHORS,BRAIN,IMAGING,PATHOLOGY,ROBIN,SOCIETY,VIRCHOW,WORLD
745,881,BACKGROUND,CUP,HRS,LABEL,METHODS,OVERALL,RESULTS,SWEDISH,THESE
131,188,193,200,548,978,BACKGROUND,CVD,HEINZ,LABEL,METHODS,NIXDORF,NUTRITION,POTSDAM,RESULTS,THEREBY,THEREFORE
150,FEMALES,MRI
169,COPYRIGHT,FUNCTIONAL,HOWEVER,LABEL,LTD,MACMILLAN,METHODS,OBJECTIVE,RESULTS,VOCATIONAL,WILEY
169,COPYRIGHT,DCE,DWI,INC,MRI,MRS,OWING,THESE,WILEY
LFS,PREVALENT,SEVERAL
001,018,046,ADC,AVERAGE,BACKGROUND,KARNOFSKY,KPS,LABEL,METHODS,PARTIAL,RECURRENT,RESULTS,SCALE
169,ANIMALS,COPYRIGHT,U87MG
001,160,III,RADICAL,RESECTION,TAILORING
DURAL,ENGLISH,MTC,THYROID
050,500,750,900,BRAIN,CNS,CSF,KPS,LIMITED,MATCHED,NEURO,PEMETREXED,PFS,PRIMARY,RESPONSES
123,AAG,AGG,ATG,CNS,G34,GGG,HOWEVER,MULTIPLEX,MYC,PDGFR,PEDIATRIC,PNETS
AGE,GBM,HOWEVER,KARNOFSKY,KPS,PRIOR,THESE
ABDOMINAL,ENDOSCOPIC,HOWEVER,PLAIN,TTF
007,183,BACKGROUND,BRAIN,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,THERE
169,AIS,COPYRIGHT,ESTROGENS,INC,SERMS
ANNEXIN,APOPTOSIS,CONCLUSION,ETOPOSIDE,HOWEVER,LABEL,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTS,UKF,VEPESID,VPA
169,COPYRIGHT,GROSS,INC,LABEL,METASTATIC,METHODS,OBJECTIVE,RESULTS,THERE
169,181,CONCLUSION,COPYRIGHT,EOC,FAVORABLE,FEDERATION,FSS,GYNECOLOGY,IRELAND,JAPAN,LABEL,LTD,METHODS,NIIGATA,OBJECTIVE,OBSTETRICS,PUBLISHED,RESULTS,UNIVERSITY
169,COPYRIGHT,CUSHING,LTD,PUBLISHED
169,5TH,COPYRIGHT,CRS,END,GBM,LTD,RESULTS,USING
001,007,025,035,111,125,169,175,177,203,571,724,CONCLUSION,COPYRIGHT,DIFFUSION,DTI,FRACTIONAL,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,ROC,TII,USING
AGE,BRIEF,CHILDHOOD,EXECUTIVE,HOWEVER,INVENTORY,PARENTS,RATER
AFTER,FGF,PMTMCTS
AFTER,CD4,DUE,EARLY,GRADE,HOWEVER,KARNOFSKY,LABEL,LEGIONELLA,METHODS,MRI,OBJECTIVE,OVERALL,PFS,RESULTS,SCALE,STUPP,THREE
GLIOMAS,USING,VECTORIZED
001,022,069,115,160,169,201,INC,LAPATINIB,MBC,MEDICAL,UNIVERSITY,WILEY
DESPITE,PHASE
200,EVERY,THEREFORE,UKRAINE
CD133,FINALLY,GBM,GSC,SIMILAR,THESE,TOWARDS,USING
6ST,950,HAPTOTAXIC,PCR,PTN,PTP,SIMILAR
CLUSTERING,CPG,DESPITE,HOXA6,HOXA9,PRC
1170I,ADP,AKT,CSC,HBE,HOWEVER,PKC,THEREFORE,WNT5A
ABL,BCR,JAK2V617F,V617F
BRAIN,EXTENSIVE
109,166,563,693,866,871,946,SPECIMENS,THERE
THEREFORE
200,420,650,700,BBB,CONCLUSION,DOSES,EIGHT,FIBONACCI,GRN1005,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERAPY,THERE
020,177,BACKGROUND,CONTROL,CONVERSELY,KIM,LABEL,LIGHT,METHODS,OBJECTIVE,OBJECTIVES,RAPID,RATIONALE,RENAL,RESULTS
200,500,945,956,FDG,GLUT1,HIF,IMAGING,PET,TREATMENT
215,945,946,99M,IMAGING,RGD,SPECT,U87MG,UTRECHT
001,788,940,984,BACKGROUND,CBV,CORRECTED,DSC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCNSL,PERFUSION,PURPOSE,RESULTS
169,30A,946,COPYRIGHT,HOWEVER,IRELAND,LTD,PRDM1,USING,WNT
241,AIM,BACKGROUND,BNP,DOPPLER,LABEL,LVPWT,METHODS,MPI,OBJECTIVE,RESULTS
300,K409Q,MUTATIONS,NF2,SMO,THESE,TRAF7
169,177,183,AUC,BACKGROUND,CONTEXT,INTENSIVE,LABEL,LTD,MEASURE,METHODS,NCT,OBJECTIVE,OUTCOME,RESULTS,TRIAL,WILEY
169,AUTHORS,BACKGROUND,BRITISH,JOURNAL,KEY,LABEL,MALIGNANT,METHODS,OBJECTIVE,PHA,PURPOSE,RELEVANTLY,RESULTS,SOCIETY
250,386,692,BASED,CHEST,ESR,EXTENSIVE,FONTANA,GENERAL,PEARL,THERE,TREATMENT,WESTERGREN
100,ABOUT,BACKGROUND,FDG,LABEL,MEANWHILE,METHODS,MRI,OBJECTIVE,PET,RESULTS,SUV
VHL,VON
002,045,116,160,AMONG,CHANGES,COX,ELISA,IL6,INCREASES,OBJECTIVES,PROFILING
160,MRI
HOWEVER,MIXED,THEIR
350,946
ATLAS,GBM,HOWEVER,RTK

946,ACP,AIM,COLLEGE,CONCLUSION,ERBB2,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
435,AFTER,BASED,DUE,HOWEVER,MRI,OVERALL,SPECT
215,ADDITIONAL,CNR,DIR,DSC,FLAIR,FLUID,MRI,RESULTS
178,215,917,978,ADC,CHANGES,DTI,GBM,MRI
GIVEN
FINALLY,GL261,IMPLANTED,MICROGLIA,MOUSE,THEIR,WHILE
BBB,SINCE
075,128,159,189,287,394,COX,KOREA
165,208,ACCORDING,BACKGROUND,INDEX,LABEL,METHODS,MISSING,NATIONS,OBJECTIVE,OBJECTIVES,READILY,RESULTS,SCORE,THERE,WORLD
169,C30,COPYRIGHT,EORTC,GIVEN,INTERVIEWS,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,QLQ,QOL,QUALITY,RESULTS,THESE,THREE
AFTER,DIMINISHED,DTI,GMV,LABEL,MEANWHILE,METHODS,MRI,OBJECTIVE,RESULTS,VBM,WHOLE,WMV
120,152,240,BACKGROUND,EARLY,FOLLOWING,LABEL,LOCAL,MEIER,METHODS,QOL,RESULTS
AFTER,BACKGROUND,HOWEVER,LABEL,PRINCIPAL,RESULTS,SINCE,TGF
150,ADDITIONAL,BRAIN,CONCLUSION,ERLOTINIB,FORTY,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,REASONING,RESULTS
AGE,III,INCLUSION,KARNOFSKY,KPS,LOWER,PFS,RADIATION,ROCHESTER,SURGERY
169,AE1,AE3,COPYRIGHT,CSF,GIVEN,INC,LMM,WILEY
648,767,ATLAS,FAVORABLE,TAKEN,USING,UTR,WHILE
005,AC133,CD133,CSC,GBM,GMI,HYPOXIA,ICC,IN699,PCR
BRAIN,METASTASIS,UNTREATED
MAS,METASTASIS,METASTATIC,MRS,PCA,RED
CRANIAL
169,COPYRIGHT,DESPITE,HGG,III,IRELAND,LTD,WORLD
169,COPYRIGHT,DECREASED,FAK,HSP90,IRELAND,LTD,NVP,SNB19
COGNITIVE,CONTROLLED,DIGIT,GROOVED,HEADACHES,HOPKINS,III,KARNOFSKY,PERFOMANCE,SCALE,STATE,THESE,TMT,TRAIL
DESPITE,SEVERAL,WHOLE
ACADEMY,PEDIATRICS,YOUNG
169,CLINICALLY,COPYRIGHT,GSC,HGG,JNK,JUN,PRESS
916,DUE,GOLGI,TAP73
00001,783,AGE,COX,END,EOR,GBM,GTR,HOWEVER,MEIER,RESULTS,STR,SURGERY,THEREFORE,USING
BESIDES,GBM,LIMK1,MAPK1,PROGNOSTIC,RHO,THERE,THESE
946,AKT,AUTOPHAGY,CONVERSELY,HOWEVER,KNOCKDOWN,SMALL,TAKEN,THEREFORE,THESE,TREATMENT
124,128,218,HOWEVER,LUCIFERASE,TRAIL
AKT,FINALLY,GBM,HOWEVER,SRC,THESE
109,240,267,C15,C30,CONCLUSION,EORTC,LABEL,METHODS,OBJECTIVE,PAL,PALLIATIVE,QLQ,QOL,QUALITY,RESULTS,SPECIAL,THREE,TREATMENT,UNIVARIATE
005,657,CONCLUSION,KIT,LABEL,METHODS,MVD,OBJECTIVE,PURPOSE,RESULTS
100,202,507,600,AFTER,BACKGROUND,CONCLUSION,ENGLAND,EXTREMELY,LABEL,METHODS,ORS,RESULTS,THERE,WALES
FLAIR,MRI,OTHERWISE,SAS
169,946,AMONGST,COPYRIGHT,GBM,INC,TAKEN,WNT,WNT3A
169,COPYRIGHT,INC,PROCEDURE,REVERSIBLE,SUBSEQUENT
169,BACKGROUND,BASED,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,SEP
029,048,066,511,862,AMONG,DCR,EIGHT,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE,THERE
001,10C,219,259,870,BACKGROUND,LABEL,METHODS,MRI,NPC,PREDICTIVE,RESULTS,TLN
002,005,006,020,026,033,040,046,052,126,176,180,183,244,465,699,702,763,785,854,DISCUSSION,DVT,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PES,RESULTS,STUDIES,THEIR,THESE,VTE
155,BACKGROUND,EOL,HGG,LABEL,METHODS,PHYSICIANS,RELATIVES,RESULTS,THESE
AVAILABLE,DFI,ENGLISH,FACTORS,FINALLY,LABEL,LIBRARY,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STAGE
169,EVS,FINALLY,MSC,VCH,WILEY
169,COPYRIGHT,HIE,INC,WILEY
001,015,018,056,100,157,177,236,299,393,BACKGROUND,FET,GLIOMAS,III,LABEL,LBR,LOW,MAXIMUM,METHODS,MRI,PET,RESULTS,WORLD
039,332,405,DISCUSSION,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
METASTASIS,OSTEOLYTIC
123,189,801,BASED,CXC,ELISA,IRANIAN,PCR,SDF,THEREFORE,THESE,WESTERN
102,169,BT474M1,CL6,COPYRIGHT,EBC,GENENTECH,INC,MCF,OVERALL,PC3,PHARM,REGRESSION,SCI,WILEY
169,355,COPYRIGHT,CREMOPHOR,DARBY,ELACRIDAR,FVB,INC,MADIN,VIRUS,WILEY
144,160,D180A,ENDOCRINE,MEDICAL,NEOPLASIA,PHP,SINCE,UNESP
239,BAYES,CHO,CONCLUSION,DSC,FORMULA,KNN,LABEL,LAC,LIP,MACHINE,MATERIALS,METABOLIC,METHODS,MRI,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS,SUPPORT,SVM,THREE
AFTER,BAX,BCL,BORON,CURRENTLY,HOWEVER,NFPAS
000,100,473,BRAIN,CENTRAL,CRUDE,GEORGIA,MARCH,NON
HOWEVER,NF2,SMO,THESE,TRP535LEU
ANOTHER,THESE
26S,945,954,TAKEN,THESE
001,FDG,LABEL,METHODS,OBJECTIVE,PCNSL,PET,RESULTS,STUDENT,TEN
100,BASED,DYNAMIC,FDOPA,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
EMBRYONAL
BRAIN,INC,PNI,PUBLISHED
10878,169,232,6MONTHS,BACKGROUND,CHALDER,CHRONIC,CONCLUSION,COPYRIGHT,DESPITE,FATIGUE,FGF,HODGKIN,INC,LABEL,METHODS,NHL,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,CTS,HOWEVER,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SINCE
169,COPYRIGHT,DROSOPHILA,FINALLY,HIPPO,LTD,SCALLOPED,YAP,YES,YKI
169,ANOTHER,AUTHORS,COPYRIGHT,GBM,INC,PUBLISHED,THESE
007,011,045,068,143,167,169,200,219,308,316,443,982,COPYRIGHT,COX,ELDERLY,GBM,GTR,LABEL,METHODS,MOS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,STR,TREATMENT
100,169,276,283,COPYRIGHT,FIFTEEN,HNPGL,IRELAND,LTD,MARCH,PREMIER,SCIENCE,WEB
160,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,EVN,FLAIR,HOWEVER,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SIX
169,237,241,BACKGROUND,COPYRIGHT,LABEL,METHODS,NEUROCIRUG,PATHOLOGIC,PUBLISHED,ROSETTE,STUDIES,TBI,WORLD
169,COPYRIGHT,EXTRA,HOWEVER,INC
001,175,CXC,CXCR4,HOWEVER,IHC,TAKEN,TNBCS,TNM
008,088,100,1P19Q,CONVERSELY,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,TEN,THERE,THESE

252,BOZF1,BTB,POK,POZ,SP1
AMONG,PEDIATRIC,PIP,REGULATION
DIAGNOSTIC,PTC
177,AFTER,BACKGROUND,BRAIN,CONCLUSION,LABEL,METHODS,MRI,SOMETIMES
AMONG,CENTRAL,CPP,GNRHA,MRI
177,MEDICAL,SURGERY,THERE
CLINICALLY,RESISTANCE,THESE
130,CONCLUSION,HGB,LABEL,LINDEAU,METHODS,OBJECTIVE,PURPOSE,VON
CURRENTLY,IHC,MMIHC
947,AKT,APPROACHES,FURTHER,HGG,LGG,NOVEL,PRIMARY,RAS,SURGERY,THERE
HOWEVER,INDEX,SIMILAR,TBI,THERE
DTI,ISSUE,SPECIAL,STUDIES,THERAPY,THESE,TREATMENT
100,177,215,CONCLUSION,CST,DIFFUSIONS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
945,CENTRAL,HOWEVER,NERVOUS,NEUROCYTIC,OLIG2,PDGFR,ROSETTE,THESE
946,INCREASED,PCR,WNT
177,BACKGROUND,ECS,LABEL,METHODS,MRI,RESULTS,TMS
150,400,BACKGROUND,CLEARANCE,CONCLUSION,ERLOTINIB,GBM,LABEL,METHODS,RAS,RESULTS
946,BACKGROUND,CONVERSELY,FAK,GSC,IKVAV,LABEL,METHODS,PAS,RESULTS,THESE
418,ANGELES,BACKGROUND,BISEQ,CALIFORNIA,CPG,GBM,HOWEVER,IHC,INCREASED,INTER,LABEL,LOS,METHODS,MSP,OPTIMAL,PCR,PERMANENTE,PFS,RESULTS,UNIVERSITY
001,007,945,AFTER,BACKGROUND,F98,HIF,LABEL,METHODS,MIB,MRI,MVD,OKN,RESULTS,U87,WORLD
SFT
ADI,ASL,CD133,CPG,PEG20
001,009,013,015,018,026,027,135,BACKGROUND,CSF,EASTERN,GROUP,ITC,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SAMSUNG,TKI,TREATMENT,WBC
151,172,801,905,AFTER,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,RISKS,STUDIES
100,CONCLUSION,DEPARTMENT,LABEL,METHODS,MMP,MMS,OBJECTIVE,PATHOLOGY,RESULTS,SMS,WORLD
003,008,CBM,III,LABEL,LIBRARY,MEANWHILE,MEDLINE,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,TMZ
177,AMONG,CCS,CONCLUSION,CSF,DWI,FLAIR,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,T2FLAIR,THEIR,THERE,THEREFORE
CONCLUSION,CPG,GENOMIC,III,LABEL,METHODS,MMS,MSP,NF2,OBJECTIVE,RESULTS,SMS,THBS1
001,B27,CD133,HOWEVER
100,BRAIN,SRS,TREATMENT
100,ACCORDING,G4S,KCL,MNSG4,TSS
947,948,AGT,CLASSICAL,GBM,NKG2D,SNB,THEREFORE,THESE,TMZ
946,AKT,BACKGROUND,LABEL,METHODS,ONGOING,PTF1A,RESULTS,TRANSGENE
THESE
155,250,737,ABT,BCL,BECAUSE,EGF,HOWEVER,LN229,MCL,U87,WHILE
001,016,022,032,047,075,109,157,AMONG,BACKGROUND,GTR,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,OVERALL,RESULTS,RPA,STR
CPG,EP300,NANOG,NON
001,005,CNS,MTX,THEREFORE,THESE,WBI,WHETHER
160,BILATERAL,CUSHING,JANUARY,MAY,MRI,TREATMENT
13Q26,160,1QTER,23P11,2PTER,2QTER,300,31Q13,3PTER,3QTER,LOH,R132H,SAMPLES,SNP
ADAMS,HOWEVER,III,PCR
AKT,GBM,MCL,OLIG2,SINCE,SORAFENIB,THESE
BACKGROUND,CHO,DTI,FORTY,LABEL,METABOLIC,METHODS,MRS,NAA,OBJECTIVE,RESULTS
002,020,022,10Q,946,AFFILIATED,ASSESSMENT,COX,FIRST,LABEL,LOH,MEDICAL,MEIEN,METHODS,OBJECTIVE,RESULTS,THERE,UNIVARIATE,UNIVERSITY
169,HUC,HUD,MOLECULAR,MRI,POPULATING,R132H,SIX,SOCIETY,V600E,WORLD
DAN,FOURIER,FTICR,HOWEVER,ISD,MALDI,MSI
HOWEVER,OTHER,THESE
022,035,038,BACKGROUND,LABEL,METHODS,RESULTS,THERE,THESE
183,GEORG,STUTTGART
BRAIN,CURRENT,NOVEL,SEVERAL
ACTIVATION,BACKGROUND,CHEMOTAXIS,CHIPS,CONCLUSION,INHIBITORY,LABEL,METHODS,NOD,PROTEIN,RESULTS,TARGETING,THEREAFTER,TREATMENT,U87
480,BACKGROUND,CIS,CONCLUSION,DENMARK,LABEL,LABORATORY,METHODS,ORS,PRIOR,RESULTS,THESE
U87,ZFX
CXCR4,NSCLC
129,FLAIR,LABEL,METHODS,OBJECTIVE,RESULTS,VISTA
ACTIVATION,CONVERSELY,HOWEVER
174,AIP,BACKGROUND,CENTERS,CONCLUSION,CONTEXT,LABEL,MEN1MUT,METHODS,MUTATIONS,OBJECTIVE,OTHERWISE,PRL,RESULTS,UNIVERSITY
FURTHER,HOWEVER,INC,LABEL,LGG,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,WORLD
169,BACKGROUND,COPYRIGHT,DECREASED,FDG,HOWEVER,LABEL,METHODS,PET,RESULTS,SOCIETY
HOWEVER,INTERPHONE,THREE
027,BACKGROUND,EPIGENETIC,GATA4,HOWEVER,LABEL,METHODS,PCR,RESULTS,UNASSIGNED,VIRTUAL
123,CURRENTLY,FDG,MULTIMODAL,PET,SPECT,WHILE
JOHNSON,RAYNHAM,RICKHAM,SUBSEQUENT
183,BACKGROUND,CONCLUSION,GEORG,JOHNSON,LABEL,METHODS,SJS,STEVENS,STUTTGART,TEN,TOXIC
433,AMONG,BACKGROUND,DESPITE,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THESE

BECAUSE,CHORDOMAS,CLASSICAL,DEPARTMENT,INTRADURAL
THESE,TLR
CD133,GBM,HOWEVER,STRIKINGLY,THESE
GBM,GCA,HGG,SCA,SINCE,WORLD
946,CENTRAL,CNS,CSF,CURRENTLY,OCTOBER
137,EFFICIENT,FINALLY,FIRST
047,169,ASPIRATION,CONCLUSION,COPYRIGHT,EFD,INC,LABEL,LATERAL,METHODS,OBJECTIVE,OLDER,RESULTS,USING
184,198,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,MRI,OVERALL,RESULTS,SUSPICIOUS,THOSE,TSS
177,EFS,SCT
CRE,FIRST,HOWEVER,LOW,NF1,NG2,THESE,THIRD
169,AFTER,BACKGROUND,BETWEEN,COPYRIGHT,FOLLOWING,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OPTIMAL,PURPOSE,RESULTS,SAS,SEVERAL,SSP
169,3MONTHS,7DAYS,ALTEPLASE,BACKGROUND,COPYRIGHT,INSTITUTES,LABEL,METHODS,RESULTS,SCALE
ACC,THEREFORE,THESE
169,320,956,COPYRIGHT,EEG,FINALLY,FURTHER,INC,MRI,MULTI,PET,STEPS
169,COPYRIGHT,LTD,PCR,SATB1,SPECIAL
004,019,100,169,AUSTRALIA,COPYRIGHT,CROWN,DFS,JANUARY,LTD,NGGCT,PUBLISHED,SURGERY
ATBF1,BASED,BCC,BOWEN,PIAS3,SCC,STAT3
000,100,BACKGROUND,HGG,LABEL,LGG,MATERIALS,METHODS,PREFERRED,RESULTS,SECULAR
021,384,GROWING,HOWEVER,III,THEREFORE,USING
DESPITE,GBM,HOPEFULLY,NOVEL,THEREFORE
108,169,ESOPHAGUS,INC,LIBRARY,SCIENCE,SOCIETY,TAKEN,WILEY
17P13
183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,STUTTGART,TRANSNASAL
DIAGNOSING
FURTHER,MICRORNAS,THEREFORE,THESE
112,ERM,PCR,SIMILAR,THESE,UNIVARIATE
FDA,FINALLY,LAPATINIB,USING
192,BNP,COX,HOWEVER,LABEL,METHODS,NORFOLK,OBJECTIVE,RESULTS,THERE
001,AZD1152,BARASERTIB,BCRP1,LLCPK,MDR1A,PGP,SF9
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,026,046,127,ACCORDING,AGE,BACKGROUND,FAVOURABLE,III,KPS,LABEL,METASTASES,METHODS,MST,RESULTS,RPA
140,183,190,257,803,956,BACKGROUND,CUSHING,FORTY,HOWEVER,HPA,LABEL,METHODS,PRE,RESULTS,SEPTEMBER
DISEASE,IMAGING,MRI,VHL,VON
000,100,200,500,945,BBB,LABEL,METHODS,NPS,OBJECTIVE,PURPOSE,RES,RESULTS,VARIOUS
HOWEVER,PAPILLARY,PFS
101,110,KARNOFSKY,OTHER,PFS,TEN
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,MRI,RESULTS,SIX,SIXTEEN,THESE
ADP,APOPTOSIS,CONCLUSION,ENHANCERS,GENERATION,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,RESULTS,SCHWANN,STUDIES
125,ABSENCE,AFTER,CONCLUSION,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESECTION,RESULTS
AKT,BASED,MALIGNANT,STAT3,THESE,USING
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,SMART,STROKELIKE

003,017,022,038,060,0MONTHS,124,169,236,693,70YEARS,8MONTHS,922,BASED,COPYRIGHT,EASTERN,GBM,GROUP,GTR,III,LTD,THEREFORE,UNIVARIATE,WORLD
169,5MONTHS,COPYRIGHT,GAMMA,KNIFE,LTD,MRI,REPORTS,SRS
169,BIS,COPYRIGHT,EISAI,GLIADEL,JAPAN,LTD,MEDICINES,THESE,TOKYO
130,163,169,956,CONCLUSION,COPYRIGHT,IGF,INC,LABEL,LARGE,METHODS,OBJECTIVE,RESULTS
169,CONCLUSION,COPYRIGHT,DOPPLER,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PERFORMING,RESULTS,TEN,THERE,THROUGH,TRANSIENT
169,BACKGROUND,COPYRIGHT,CSF,INC,LABEL,METHODS,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,MEIER,METHODS,OVERALL,RESULTS
169,CNS,COPYRIGHT,FZD,LTD,WNT
104,169,COPYRIGHT,EXOGENOUS,IRELAND,LCNEC,LTD,NET
169,358,464,519,694,784,972,CONCLUSION,COPYRIGHT,FRACTURES,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
043,068,100,169,945,946,ADULT,AFTER,CONCLUSION,COPYRIGHT,EQD,GIVEN,GROUP,III,INC,LABEL,MATERIALS,METHODS,NCF,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,REGRESSION,RESULTS,SCALE,THERAPY,WMS
1920S,AFTER,AMSTERDAM,BALTIMORE,BERNARD,BROUWER,CHESNEY,CUSHING,DANDY,DUTCH,ENCOURAGED,FERDINAND,GRONINGEN,HAVEN,HOWEVER,IGNAZ,LIBRARY,MASON,MEDICAL,UNIVERSITY,VERBEEK,WAR,WHITNEY,WORLD
945,AKT,AMPAR,INHIBITING,INHIBITION,LABEL,METHODS,OBJECTIVE,PDGFR,RESULTS,THESE,WESTERN,YM872
169,GBM,PCR,SIXTY,SOCIETY,THERE
SLF,THESE
BACKGROUND,CRANIAL,CSI,CUMULATIVE,LABEL,METHODS,OAR,PRV,RESULTS,RIGHT,TREATMENT
AIP,PRL,WHILE
FURTHER,HOWEVER,JCV,NF2,PREVIOUSLY
100,BACKGROUND,HOWEVER,LABEL,MRI,NPV,PPV,PRINCIPAL,RESULTS,SWI
BROCA,GIBBS,PRE,THEREFORE,UNDER
AFFAIRS,MRI,PET,TNM
GUIDELINES,THESE
169,CD133,COPYRIGHT,GBM,HOWEVER,PRESS,SILENCING,THESE
BACKGROUND,CNS,EASTERN,GBM,GROUP,KALLIKREIN,LABEL,METHODS,RESULTS,TAKEN
048,IGF,LOWER,MENINGITIS,THERE
CRANIAL,DESPITE,EXTRA,MRI
BACKGROUND,DESPITE,FURTHER,ICG,LABEL,MAXIMAL,METHODS,RADICAL,RESULTS,SSS,SURGERY
10B,ALTOGETHER,ATLAS,GBM,INHIBITION,MICRORNAS,TARGETING
016,043,161,797,882,ADDITIONAL,AMERICA,AMONG,CNS,OCEANIA,PERSONS,PNETS,POISSON
14Q,14Q32,22Q,22Q12,EXPRESSED,HOWEVER,MATERNALLY,NF2,THESE
183,EFFICIENT,GEORG,LEKSELL,STUTTGART
183,GEORG,STUTTGART
GBM,III,NOVOTTF
MMP,TJ905
IDH,III,MUTATIONS,R100Q,R132L,R132S
BRAIN,INITIAL,MRI,THEREFORE,THESE
100,GADOLINIUM,MRI,NERVE,SCHWANN,TH8
BACKGROUND,BRAIN,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PEDIATRIC,PROGNOSIS,PURPOSE,RESULTS,SYSTEMATIC
EHV,HISTONE,OVERALL,SNB19,VPA
115,ANOTHER,BACKGROUND,DIGITAL,LABEL,METHODS,OBJECTIVE,OCCLUSIVE,ORV,PURPOSE,RESULTS
169,ALZHEIMER,CNS,COPYRIGHT,DEPRESSION,HENCE,HOWEVER,HTP,LTD,PARKINSON,SSRIS,TREATMENT,TRYPTOPHAN
169,AMD,CNS,COPYRIGHT,MRI,SAS,VEGFS
AMONG,FEW,NSCLC,PCI,SEVERAL,STUDIES,THERE
BRAIN,LANDSCAPE,PREVALENCE,PROMOTING
169,946,CNS,COPYRIGHT
INSTITUTE,WHILE
KARNOFSKY
BBB,BIOLOGY,CTC,HOWEVER,INCIDENCE,MRI,PREVALENCE,PRIMARY
DIAGNOSIS,GROWING,INSTITUTE,NSCLC,SEVERAL,THESE
BRAIN
169,946,AKT,BAD,BAK,BAX,BCL,BIOLOGY,COPYRIGHT,COX,EGF,INC,MCP,MOLECULAR,PKC,SEVERAL,STAT3,TNF,UNION
125,169,177,215,COPYRIGHT,CURRENT,FINALLY,FLAIR,LTD,SUPPORT,SVM,WILEY,WMH
945,A168V,ALZHEIMER,G396V,GROUP,HOMER,HOWEVER,HUNTINGTON,PARKINSON,PKC,R375G,R696W,TAKEN
003,005,010,023,066,093,097,125,135,24H,397,402,512,916,975,HOWEVER,PRE
124,174,956,AFTER,AMIES,BAUER,BHI,BRAIN,DICKINSON,HEART,INSTITUTE,KIRBY,MIC,MICROSCAN,MUELLER,OXOID,SAMPLES,SIEMENS,THOSE,VALENCIAN,VISCOSE
131,AFTER,AIM,BASED,CONCLUSION,FET,GBM,GBQ,IPA,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SPECT
CNS
181,AIM,ANNEXIN,CELLS,CONCLUSION,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,PROTECTIVE,RESULTS,UNLABELLED
BACKGROUND,HODGKIN,HOWEVER,LABEL,METHODS,NEWER,PHYSICIANS,RESULTS,RIT,SEVERAL
BACKGROUND,DESPITE,III,LABEL,METHODS,RESULTS,SUICIDE
INSTEAD,NETRIN1,SLIT2,THESE
001,128,176,307,441,AMONG,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,WOMEN
216,ABERRANTLY,BSG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,THERE
160,180,METAL,MRI,THESE
155,210,323,326,329,480,AGE,ATLAS,BACKGROUND,BIOLOGICAL,COX,EXPRESSION,GBM,LABEL,MEIER,METHODS,PFS,RECURRENCE,RESULTS,THEREFORE,TTP
047,106,126,967,APRIL,CAS,LABEL,METHODS,MRI,MRS,OBJECTIVE,OPERATION,RESULTS,THREE
101,113,114,177,181,279,357,369,375,681,691,735,797,900,BEIJING,COMPARING,GCC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCT,OCTOPUS,RESULTS,RTVUE,THERE,TIANTAN
000,100,551,BBB,FUS,MPA,MRI,NATURAL
373,BACKGROUND,CELLPHONE,HARDELL,INTERPHONE,LABEL,METHODS,PEARSON,RESULTS,SMS,WELLINGTON,WHILE,ZEALAND
THEREFORE,WHOLE
HISTOLOGY,PROGNOSIS
ADDITIONAL,CHOROID,CPC,HDC,REMARKABLY
016,101,215,ANOTHER,BACKGROUND,CONCLUSION,INSTITUTE,LABEL,MASARYK,METHODS,QUALITY,RADIATION,RESULTS,THEIR,THERE,THESE,TOTAL
AMONG,BACKGROUND,CNS,CONCLUSION,ENM,INSTITUTE,LABEL,METHODS,OBJECTIVE,RADIOLOGY,RELAPSE,RESULTS,THREE
AFTER,BAERS,EMG,MRI,PRE,SSEPS,TCEMEPS,TOTAL,VII,XII
BACKGROUND,DESEQ,DFI,EDGER,FEATURE,INDEX,LABEL,PCR,RESULTS,SEQ,VALIDATED
139,159,BASIC,FOS,FRA,MB231,MDA,STRIPPING,TAKEN
945,AHR,AIP,EDDVE,HSP70,HSP90,MEEVD,MUTATIONS,R304Q,R325Q,THESE,TPR
118,ANALYTE,FEW,GBM,INFERENCE,MAPIT,MULTI,PATHWAY
11Q23,200,215,983,ACRN1,AMONG,ARCN1,BACKGROUND,CHINESE,HAN,LABEL,PRINCIPAL,RESULTS,SNP,UTR
288,599,AGE,BACKGROUND,CNS,HOWEVER,INCIDENCE,LABEL,METHODS,RER,RESULTS,SEX,WOMEN
HOWEVER,THYMIDINE,TKS
HOWEVER,MRI,RESULTS
105,121,AFTER,KETTERING,OVERALL,SLOAN
169,COPYRIGHT,HOWEVER,INHIBITION,LN229,TMZ,VCH,WILEY
177,FINALLY,FIRST,G_MAX,HERTZ,LABEL,METHODS,OBJECTIVE,PALPATION,RESULTS
150,178,434,ADVERSE,AFTER,BLOOD,CTCAE,HGG,JANUARY,MACDONALD,MRI,PFS,TMZ
945,AMT,GAD,GADOLINIUM,MRI,PET,THESE,WHILE

036,080,102,165,177,277,AMONG,BETWEEN,JANUARY,KOREA,SEOUL,UNIVERSITY
160,916,EX3,GBM,M4N,PCR,SP1,TALALAY,TETRA,TMZ,XTT
160,CEREBELLAR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COLLAPSIN,COPYRIGHT,CRMP5,H69,INC,NLS,PROTEIN
APART,GCT,GERMINOMAS,THEIR,THESE
PALLIATIVE,THESE
ALLEN,ATLAS,BRAIN,CSF,EXPRESSION,HENCE,HOWEVER,MICROARRAY,MOUSE,NERVOUS
99A,FGFR3,JCI,TACC3,THESE,UTR
99A,ASIAN,FGFR3,FUSIONS,MET,PDGFR,SEVERAL,TACC3,THESE,USING,UTR
149,AKT,GBM,MICRORNAS,MMP,MTT,PCR,TRANSWELL,USING,WESTERN
001,008,372,COX,HOWEVER,KARNOFSKY,KPS,LABEL,PCR,TAKEN,UNASSIGNED,UNLABELLED,VIRTUAL
160,167,INCREASING,LABEL,MED,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TUDOR,WHERE,WHILE
BACKGROUND,CHERNOBYL,EXCESSIVE,FUKUSHIMA,HIROSHIMA,LABEL,METABOLISM,NUCLEAR,SYNTHESIS,THREE,THYROID,WORLD
AKT,ALTERATION,AMONG,ERK,FIFTY,HOWEVER,INITIATING,KNOSP,PRESENTED
001,002,003,004,018,FACTORS,JANUARY,MST,SRS
100,125,150,177,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOXICITIES
FDG,FLT,HOWEVER,PET,RAPID,SIMULATION,SUV,USING
001,015,961,AFTER,BACKGROUND,CHO,III,INCREASED,LABEL,MATERIALS,MET,METABOLIC,METHODS,MRS,NAA,OBJECTIVE,PET,PURPOSE,RESULTS,THREE,WORLD
949,BBB,DLN,FOCUSED,GBM,USING
ASIAN,ATLAS,BACKGROUND,FINALLY,FURTHER,GBM,HOWEVER,LABEL,METHODS,RESULTS,STAT3,WESTERN
102,BACKGROUND,DODGE,LABEL,METHODS,OPTIMAL,RESULTS,SEVENTEEN
013,022,026,ADDITIONAL,BACKGROUND,CONCLUSION,CONTEXT,INCIDENCE,LABEL,METHODS,OBJECTIVE,OUTCOME,PITUITARY,RELATED,RESULTS,SETTING,SWEDISH,TSH,TSHOMAS,WORLD
AIP,LAR,SSTR2,SSTR5,THESE
12Q13,AREAS,BACKGROUND,COVERED,CPM,GEO,LABEL,METHODS,OPINION,THERE,THESE,WHETHER
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,SMO,WHILE
BACKGROUND,CHANGES,CONCLUSION,CUMULATIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SEX,THREE
001,108,326,COX,HOWEVER,III,KARNOFSKY,KPS,MEIER,PCR,THEREFORE
228,534,AFTER,AGGRESSIVE,DFS,FACTORS,JANUARY,MEIER
169,174,177,ARS,BACKGROUND,CONCLUSION,KALAMAZOO,LABEL,LLC,METHODS,RESULTS,SONOPET,STRYKER,TSA,UBA
BACKGROUND,CONCLUSION,LABEL,OBJECTIVE,OCCURRENCE,PATCH,PURPOSE,RUBENSTEIN,TARBI,THERE
000,200,250,500,BETWEEN,JANUARY,MTD,PFS,THREE,TMZ
106,ABOUT,ANXIETY,AUSTRALIAN,DEPRESSION,EVALUATION,FACTORS,FIM,FUNCTIONAL,MEASURE,NEEDS,OTHER,PERCEIVED,PROBLEM,PROFILE,SCALE,SHORT,UNMET
HENCE,MRI,MULTIMODAL
230,HOWEVER,IL8,MOLECULAR,PNET3,SHH,THESE,WNT
000,062,101,293,480,638,890,946,BEADCHIPS,CLUSTER,CPG,EPIGENETIC,GBM,HOWEVER,HOXC4,HOXD8,LTS,NR2F2,STS,USING
BRAIN,CAE,MRI,USUALLY
169,945,946,C16,C18,COPYRIGHT,FLORIDA,IMR,INC,INCREASED,KEAP1,MUFAS,NAD,NMR,ROS,SUBSEQUENT,THEIR,TREATMENT
INSUL,RECURRENT,WHIPPLE
169,241,90Y,COPYRIGHT
000,100,449,454,573,CHINA,CONCLUSION,INCIDENCE,LABEL,METHODS,OBJECTIVE,PREDICTION,RESULTS,THIRD
012,125,169,177,183,186,203,211,221,243,251,252,394,472,501,577,BACKGROUND,BARCELONA,BRAIN,COPYRIGHT,CSF,DISORDERS,DUTCH,FONDO,FUNDACI,FUNDING,INSTITUTES,IQR,JAN,LABEL,LTD,MARAT,METHODS,NMDAR,PREDICTORS,RESULTS,SANITARIAS,SOCIETY,SPAIN,TREATMENT,TV3,USA
169,AVM,CONCLUSION,COPYRIGHT,DUE,GLIOMAS,INITIAL,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE,TOTAL
169,COPYRIGHT,INC,MEDICAL,PUBLISHED
177,ADENOVIRUS,CCK,CONCLUSION,D2S,LABEL,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,GCS,LABEL,METHODS,RESULTS,VARIABLES
169,COPYRIGHT,HOWEVER,INC,PASCUAL,RAPID,ROUTINE
168,169,CAJAL,COPYRIGHT,DIFFUSE,GISTS,INC,OVERALL,PREVIOUSLY,THESE
169,19Q,AMONG,AUTHORS,BRAIN,GBM,IHC,PATHOLOGY,PCR,SOCIETY,WORLD
054,147,BECAUSE,DISEASE,EFS,EVENT,FIFTY,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,SURGERY,UNIVARIATE,WHEREAS
002,045,114,CAVERNOUS,CSF,EES,ENDOSCOPIC,GIANT,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
BACKGROUND,BASED,LABEL,OBJECTIVE,RESULTS,SUMMARY,THERE,VINPOCETIN
197,BECAUSE,BIC,CYP46A1,CYTOCHROME,DUE
10Q,133,17Q,19Q,290,700,NEWER,PDGFR,PRIMARY,SEVERAL,THREE,WNT
CNS,CONCLUSION,III,LABEL,METHODS,MORTALITY,RESULTS,UNLABELLED
013,GTR,LGA,OVERALL,PFS,STR

169,COPYRIGHT,SAS,SMALL
169,AKT,BAD,COPYRIGHT,GBM,INC
BACKGROUND,CONCLUSION,III,LABEL,MATERIALS,METHODS,MVD,PCR,RESULTS,THESE,WESTERN,WORLD
AIP,HOWEVER
BESIDES,DTI
EFFICIENT,STATE
GBM,GLIOMAS,INSTEAD,OPG,OPTIC
750
001,616,672,946,AFFYMETRIX,AKT,ARRAY,ECM,EGFL6,ELISA,HEALTHY,MOLECULAR,PCR,TGF
204,AKT,INCREASING,MIR,THESE
001,014,024,086,116,161,204,273,353,359,390,540,885,946,985,BRAIN,COX,INHBC,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMAD6,TGF
945,946,CDC42,GBM,GDP,GTPASES,HENCE,RHO,RHOGDI1,SILENCING,THESE
G55T2,GL261,INTRANASAL,NCE,NSPCS,OPTIMIZED,U87
001,107,644,COMBINING,GBM,IHC,MSP,PEARSON,PROTEIN,TMZ
CHOROID,FOCUS12332,HENCE,THESE
AFTER,CLOSURE,FOCUS12330,GROSS,MONRO,PITUITARY
FOCUS12347,MONRO
FOCUS12348,SYLVIUS,THROUGH
FOCUS12352
CENTRAL,CURRENTLY,FOCUS12353
ADDITIONAL,FOCUS12354,HOWEVER
169,ATLAS,AUTHORS,BASED,JOURNAL
DIAGNOSTIC,GRADE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PILOCYTIC,PILOMYXOID,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,LABEL,LCD,METHODS,OBJECTIVE,RESULTS,SURGERY
1990S,208,AMT,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SINGAPORE
DIFFERENT,FSL,FURTHER,SINGAPORE,VIRTUAL
136,BACKGROUND,CONCLUSION,CONTINUOUS,CRANIAL,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,DTI,FIBER,HARDI,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
FEPPA,SEVERAL
169,176,CONCLUSION,COPYRIGHT,DSC,ESTIMATES,GBM,IHC,INC,LABEL,MATERIALS,METHODS,MRI,NON,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,WILEY
169,187,374,CMF,COPYRIGHT,DIFFUSION,DTI,HOWEVER,INC,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OUTCOME,PRINCIPAL,RESULTS,THESE,WILEY
169,BALLOON,BCS,COPYRIGHT,FOCAL,HPV16,IIB,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,U87
169,945,COPYRIGHT,ECM,ECS,GBM,GSC,LABEL,METHODS,OBJECTIVE,RESULTS
169,302,941,AUSTRALIAN,CASES,CBT,CHILDHOOD,COPYRIGHT,OVERALL,TOBACCO
169,COPYRIGHT,DISCUSSION,INC,LABEL,METHODS,OBJECTIVE,RESULTS,WILEY
169,BECAUSE,CERTAIN,COPYRIGHT,COX,EBP,GRP78,INC,MALIGNANT,SERCA,WILEY
160,176,BACKGROUND,CRT,DELIVERING,DOSIMETRY,III,LABEL,METHODS,RESULTS,SIB,TPS
169,APART,CHEMOKINES,COPYRIGHT,CXCR4,CXCR7
169,AIM,CONCLUSION,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,TMZ,WILEY
169,BACKGROUND,BRAIN,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
169,947,BRAIN,CD3,CD8,CNS,EBV,EPSTEIN,MRI,PCNSL,PRIMARY,SOCIETY,THESE,TIA
100,169,FOLLOWING,MALIGNANT,MPNST,MRI,SMARCB1,SOCIETY
123,131,169,BACKGROUND,COPYRIGHT,GUANIDINE,LABEL,METHODS,SOCIETY
000,145,160,169,ABOUT,INC,PREVIOUSLY,THERE,WILEY
169,AIM,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,EASTERN,GROUP,JANUARY,JOURNAL,LABEL,MAY,METHODS,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,SEVENTEEN,THERE,TREATMENT
169,946,GROUP,PCR,SHH,SOCIETY,THERE,WNT,WNT5A
169,AVP,BRAIN,SCN,SOCIETY,THESE,TOTAL,VIP
169,AMP,AUTHORS,BAX,BCL,INCREASED,JPP,KEY,LABEL,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,ROYAL,SOCIETY,SUMMARY,WHILE
001,004,148,169,AGE,AIM,APPLIED,AUTHORS,BACKGROUND,BRITISH,CONCLUSION,INFANTS,LABEL,METHODS,OBJECTIVE,PAS,PCR,PFS,PILOCYTIC,PILOMYXOID,PMA,RESULTS,SOCIETY
946,AFTER,BACKGROUND,CONCLUSION,GCT,IMPORTANCE,LABEL,METHODS,SERUM,THESE
THROUGH
144,150,199,262,ASSESSMENT,BACKGROUND,CONCLUSION,CUSHING,ENDOCRINE,GAMMA,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,STUDIES,UNIVERSITY
945,946,LXXLL,MIER1,THESE,WHILE
DESPITE,GBM,OTHER,SURGERY
CONVERSELY,INHIBITION,INSTEAD,JNK,RHO,THESE,U87
014,031,169,26S,COPYRIGHT,ERBB2,HOWEVER,INC
011,030,035,048,169,561,574,ATLAS,BACKGROUND,CONCLUSION,COPYRIGHT,FALSE,FDR,FURTHER,GBM,HOWEVER,LABEL,LTD,METHODS,NON,RESULTS,SMARCA2,SMARCA4,SNF,SUCROSE,SUGGESTIVE,SWI
169,CONCLUSION,COPYRIGHT,DNT,EEG,FCD,FEDERATION,INTRINSIC,IRELAND,LABEL,LTD,METHODS,NON,OBJECTIVE,PUBLISHED,RESULTS,THESE
CONTENT,MRI,SVM
103,174,BACKGROUND,CELLSEARCH,CTC,EXPRESSION,RESULTS
BACKGROUND,DTI,FLAIR,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSI
143,ADC,BACKGROUND,DESPITE,FUNCTIONAL,LABEL,MEIER,METHODS,PFS,RESULTS,UNIVARIATE
100,FUNCTIONAL,MEG,SM1HA,TEN
CD105,HOWEVER,KGS,LABEL,METHODS,MSLCS,NG2,OBJECTIVE,PURPOSE,RESULTS
CONCLUSION,LABEL,METHODS,OBJECTIVE,TOTAL
MTX
144,340,CONCURRENT,FINALLY,III,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PATIENT,PCI,PUBLISHED,PURPOSE,QUALITY,RADIATION,RESULTS,TWICE
169,COPYRIGHT,END,HODGKIN,HOWEVER,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,THERE,WILMS
160,169,215,ADC,COMBINING,CONCLUSION,COPYRIGHT,CUT,HOWEVER,III,LABEL,LTD,METHODS,MINIMUM,NEUROLOGY,OBJECTIVE,PAEDIATRIC,PUBLISHED,RESULTS,SOCIETY
150,169,174,BACKGROUND,COPYRIGHT,ERLOTINIB,FIFTY,IRELAND,LABEL,LTD,METHODS,NSNSCLC,PARTIAL,PFS,RESULTS,VERISTRAT
169,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,CSF,DISCUSSION,DUE,LABEL,METHODS,MRI,SAS
HEMICHOREA,OTHER,PROGNOSIS
000,200,CNS,USA
METASTATIC,SURGERY,VASOGENIC
III
000,AUSTRIA,MEDICAL,OCTOBER,SEPTEMBER,SOCIETY
BECAUSE,EARLY,PARTICULAR
FINALLY,LDDMM,SHAPE

BCC,GIANT,RELAPSE,TNM,TREATMENT
CURRENTLY,DESPITE,GBM,GIVEN,HIF1ALPHA,THERE,THEREFORE
100,APPEARANCE,MUTATIONS,SEVERAL,TMPRSS2,VHL
114,ADJUSTMENT,ASSESSMENT,BACKGROUND,CAREGIVER,CAREGIVERS,CONCLUSION,CONVERGENT,CRA,LABEL,LEISURE,LOCKE,MARITAL,METHODS,OBJECTIVE,PHILOSOPHY,PURPOSE,RESULTS,SECONDARY,SHORT,SOCIALITY,WALLACE
FURTHER,POSTMORTEM,THEREFORE
BAERGEN,PROFESSOR,WHILE,WOODHOUSE

HOWEVER,NOS
137,BACKGROUND,DISCUSSION,EARLY,LABEL,MALIGNANT,METHODS
125,378,596,DEPARTMENT,FUNCTIONAL,JANUARY
002,177,CONCLUSION,FET,HIGHEST,HUR,IMAGING,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS
BACKGROUND,CNS,CULTURE,KNS42,LABEL,METABOLIC,METHODS,RESULTS,THERE,U87,VORINOSTAT
AMONG,INJECTING,THESE
169,ALTOGETHER,DIFFUSE,E98,FINALLY,INHIBITION,THEREFORE
000000914,177,215,443,945,946,947,A24,AFTER,BACKGROUND,CD11C,CSF,CTR,CURRENT,DC1,DCS,ELISPOT,GBM,HLA,IFN,KLH,LABEL,METHODS,RESULTS,SIX,THEREFORE,THESE,TNF,TRIAL

140,19Q,26951,COMBINING,CONCLUSION,EORTC,IGS,III,INTRINSIC,LABEL,LOH,METHODS,OBJECTIVE,PCV,PFS,PURPOSE,RESULTS,TREATMENT
BACKGROUND,CNS,CONCLUSION,INCREASING,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,SEVEN
19Q,AGE,BASED,BEIJING,COX,III,LOG,MAY,MEIER,PFS,TIANTAN
BACKGROUND,LABEL,METHODS,RESECTION
169,CCS,GBM,GSC,POTTS,U87
HOWEVER,MRI,SAH,SUBSEQUENT
177,GDC,GUGLIELMI,HBS,PARTIAL,PVA,TOTAL
HOD,ION
169,946,COPYRIGHT,EMT,EPITHELIAL,FRIZZLED4,IRELAND,LTD,WNT
AFTER,FOLLOWING,TROUSSEAU
ABCDE,AFTER,BECAUSE,IIA,LIVER,NAC,PGR,STAGE,THERE
GADOLINIUM,JAPAN,MENINGEAL
CURRENTLY,SINCE
BACKGROUND,FINALLY,INTENSITY,LABEL,MENDELIAN,MOTIVATION,OVERLAP,RESULTS,SEVERAL
BACKGROUND,CONCLUSION,EXPRESSION,GBM,III,LABEL,MATERIALS,METHODS,NUCLEAR,PITUITARY,PTTG1
GLIOMAS,MALIGNANT,RFP,THESE,U87
001,100,AFTER,GFP,LEWIS,LLC,NOVEL,RFP,TUNEL,U87
946,APOPTOTIC,BAX,BCL,CCF,DESPITE,ELEMENE,ELISA,MALIGNANT,OVERALL,STTG1,THERE,TUNEL,UTP
CORRECT,HOWEVER,MUTATIONS,THESE
BECAUSE,CONSENSUS,DESPITE,HOWEVER,IHS,INFANTILE,PHACE,WHERE,WORKGROUPS
177,DCS,WHILE
ASYMMETRIC,BRAIN,PARKINSON,ROUTINE,THERE
218,MEIER,TMZ
CASES,COPENHAGEN,DEPARTMENT,HOWEVER,MRI,NUCLEAR,PET,PHYSIOLOGY
001,100,169,177,233,258,COPYRIGHT,CRP,LABEL,METHODS,OBJECTIVE,RESULTS,SEIZURE
169,177,AMONG,COMPARISON,COPYRIGHT,DSC,IRELAND,LTD,MRI,SIMILARITY
169,AMONG,COPYRIGHT,CUSHING,HOWEVER,MRI,PREDICTORS,PUBLISHED,THERE
169,BESIDES,CENTRAL,CNS,COPYRIGHT,EBV,EPSTEIN,INC
108,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,TKI,TRANSPORT
169,COPYRIGHT,DESPITE,III,INSTEAD,LTD,MAXILLO,PUBLISHED,RANKL,SINCE,SURGERY
120,135,169,667,733,CONCLUSION,COPYRIGHT,CSF,DURAL,FIRST,IRELAND,JANUARY,LABEL,LTD,MAY,METHODS,OBJECTIVE,RESTORING,RESULTS,THERE,THIRDLY
169,COPYRIGHT,GROSS,PAS,PILOCYTIC,PROGNOSIS,RECURRENCE,ROSENTHAL,WORLD
169,COPYRIGHT,EYE,LABEL,MAY,METHODS,MPCHA,OBJECTIVE,OTA,RESULTS
100,300,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
160,956,OPIOIDS
ACUTE,OTHERWISE
MENINGIOMA
AREAS,MRI
001,005,006,108,224,COX,DFS,HOWEVER,III,KARNOFSKY,KPS,LABEL,MEIER,METHODS,MIR,OBJECTIVE,RESULTS

073,160,177,209,BASED,KNOSP,MRI,PITUITARY,THEIR
HLA,THESE,TNC
183,945,HIF,MICRORNAS,PCR,THEREFORE,THESE,UTR
AREAS,BCS,GMD,IMAGING,MRI,PCI
028,945,CA9,CONCLUSION,HIF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS

004,160,ASSESSMENT,CNS,COX,GPA,GROUP,JANUARY,LMD,PROGNOSTIC,RADIATION,RECURSIVE,THERAPY,THERE,TREATMENT
100,BACKGROUND,BBB,CBF,CBV,CONCLUSION,DCE,FDG,LABEL,METHODS,MRI,PET,RESULTS
BACKGROUND,BTSCS,CONCLUSION,ENDOGENOUS,GBM,JAK,JANUS,LABEL,METHODS,RESULTS,STAT3,WESTERN
BACKGROUND,CED,HOWEVER,LABEL,LIPOSOMAL,METHODS,RESULTS
169,COPYRIGHT,LTD,NEDD4
169,AKT,COPYRIGHT,HOWEVER,INHIBITION,IRELAND,LTD,MOLECULAR,NOTCH,U87
169,COPYRIGHT,GBM,HOWEVER,RAPAMYCIN,THESE,U87MG
133,BECAUSE,EGR,FURTHER,INC,MG132,NAG,PROTEASOME,PUBLISHED,TRANSGENIC
169,173,COPYRIGHT,CYTOSCAPE,DAVID,DUE,FACTORS,GBM,GEG,GEI,INC,PROJECT,RSPIDER,SEATTLE,SIXTY,THESE,TOXICOLOGY,USING
169,AFTER,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,OPTOMETRIC,RESULTS,THESE,TREATED
113,5CC,9CC,BACKGROUND,CONCLUSION,CTV,FLAIR,GROSS,GROUP,GTV,HGG,LABEL,MATERIALS,METHODS,MRI,RADIATION,RESULTS,THERAPY,THERE,TMZ,TREATMENT
095,100,956,ABDOMINAL,AWARENESS,ENGLISH,OVARIAN,SERUM,THYROID,TREATMENT
001,384,BACKGROUND,CAT,CHINESE,GENOTYPES,LABEL,METHODS,MNSOD,OPENARRAY,POTENTIAL,RESULTS,TAQ,THESE,USING,UTR
BACKGROUND,CAM,CD147,CHC,GLIOMAS,HOWEVER,LABEL,MCT,METHODS,RESULTS,THERE
177,BACKGROUND,HOWEVER,LABEL,METHODS,OCTOBER,RESULTS,SEPTEMBER,THEREFORE
946,BACKGROUND,CONCLUSION,GBM,GSC,LABEL,MET,METHODS,RESULTS,THESE,THROUGH,WNT
BACKGROUND,CONCLUSION,CONVERSELY,DESPITE,GBM,LABEL,METHODS,PCR,RESULTS,U87,WORLD
160,CLONOGENIC,MTT
169,330,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,ENDONASAL,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
ALZHEIMER,P21,PAK,PARKINSON,THEREFORE
169,AGGRESSIVE,BASEL,CHINA,COPYRIGHT,THERE
007,012,CBV,CHANGES,CONCLUSION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROC,WHITNEY
ETX6D,FINALLY,INITIALLY,NOVALIS,RMS,SETUP,THESE,THIRDLY
AFTER,DRF,EXCRETION,NOVEL
BRAIN,NPS,WHILE
AKT,ERK,P2Y
AFTER,AIF,ICA69,MALDI,NCK,PCR,PRSS1,SEVEN,THESE,THREE,TOF,WESTERN,WHILE
CAA,CONCLUSION,LABEL,MRI,OBJECTIVE
169,COPYRIGHT,HNPCC,INC,LYNCH,MMR,WILEY
169,ANY,COPYRIGHT,INC,RAPID,WILEY
000,169,CLINICIANS,COPYRIGHT,INC,MRI,WHETHER,WILEY
169,500,COPYRIGHT,HGG,III,INC,PHASE,SIXTY,THEIR,WILEY
169,COG,COPYRIGHT,GROUP,INC,QOL,WILEY
001,012,014,154,191,717,AES,BACKGROUND,CONCLUSION,GBM,GIVEN,KARNOFSKY,KPS,LABEL,MATCHED,METHODS,PFS,RESULTS,STUPP,TMZ
177,BACKGROUND,CONCLUSION,DES,EOR,LABEL,MATERIALS,METHODS,RESULTS,SIX
169,CD133,COPYRIGHT,HOWEVER,INC,LITERATURE,MALIGNANT,WILEY
025,949,ARNTL,BACKGROUND,CK1,CLOCK,DISRUPTION,ELEVATION,LABEL,MEIER,METHODS,PDA,RESULTS,TIM,TIPIN
945,946,ERBB2,GLIOMAS,INDIVIDUAL,MMP,PCR
169,AFTER,ALK,BRAIN,CHEST,COMMITTEE,COPYRIGHT,DEPARTMENT,IRELAND,LTD,MEANWHILE,MRI,PET,TREATMENT
1P19Q,FIFTEEN,GRADE,LOH,R132H,SNP,THERE
AFTER

158,161,1990S,373,BACKGROUND,CHINA,CONCLUSION,HUASHAN,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER,THERE
BACKGROUND,KNOCKDOWN,LABEL,MALIGNANT,METHODS,RESULTS
182,183,AKT,CPEB1,FOXO1,KNOCKDOWN,ROS,THEREFORE
137,169,CSE1L,KNOCKDOWN,LOWER,LUCIFERASE,OVERALL,SOCIETY,TC620,U87,UTR
183,C30,DESPITE,FIFTEEN,MEDLINE,QLQ,QOL,STUDIES
042,100,154,AFTER,CONCLUSION,LABEL,LINAC,OBJECTIVE,RESULTS,SRS
COMPARISON,GBM,MRI,SIMILARLY,TEN,THESE
181,595,635,ALA,BACKGROUND,CONCLUSION,FORMULA,HYP,HYPERICIN,INCUBATION,LABEL,MED,METHODS,RESULTS,THEREFORE
001,022,153,AFTER,BACKGROUND,C30,CONCLUSION,ELOQUENTLY,EORTC,EUROQOL,LABEL,LGG,METHODS,NORWEGIAN,OBJECTIVE,QLQ,RESULTS,THERE
CUTANEOUS,DABRAFENIB,FIFTY,GSK1120212,GSK2118436,MEK,V600E,V600K
183,BACKGROUND,BRAIN,CONCLUSION,GEORG,IMPORTANCE,JANUARY,LABEL,METHODS,RESECTION,STUTTGART
BECAUSE,CHROMATIN,FZD,PITUITARY,PITX2,REMARKABLY,WNT,WNT5A
001,003,005,008,101,160,169,198,241,280,320,341,390,431,480,638,690,771,824,AKT,BASED,DARPP32,IDH,III,PFS,PKB,PPP1R1B,STAT1,STAT3,STAT5,THESE
160,EVN,HOWEVER,MIB,MRI
160,COX,GRADE,III,MIB,PGS
160,BACKGROUND,CNS,CONCLUSION,DISCUSSION,HISTORY,LABEL,METHODS,THERE,WORLD
MRI,PXA
200,BACKGROUND,DIFFUSE,LABEL,METHODS,PFS,QUALITY
006,018,131,CNS,CONCLUSION,COX,FDG,FORTY,HODGKIN,INCREASED,LABEL,METHODS,MILAS,PET,PFS,PRIMARY,RESPECTIVE,RESULTS,THERE,UNLABELLED
EMOTIONAL,MRI,SINCE,VARIOUS
CUSHING,FOLLOWING,WHILE
160,ACE,AKT,ANG,ANGII,COX,ERK,FINALLY,FOXO1,HOWEVER,MAS,RAS,THOSE,THROUGH
BACKGROUND,BRAIN,CONCLUSION,CSF,DEPARTMENT,EARLY,EYE,FUNDUSCOPY,INDICATED,LABEL,MENINGEAL,METHODS,MRI
MSI
178,974,975,984,986,996,AMINO,ASP1056,BBB,CHINESE,COCLAURINE,COGNITIVE,COMFA,CONTOUR,GLY1055,IGF,LINDERA,PROPERTIES,TCM,VERSATILE
AVAILABLE,EGF,HOWEVER,NOVEL,PHASE,TKI
DESPITE,GBM
FINALLY,GBM,THERE
CD133,FURTHER,GBM,INHIBITION,KNOCKDOWN,MOUSE,NCL,PATIENT
003,045,047,152,180,AKT,E542K,E545K,RATES,THERAPY
002,004,008,009,016,177,279,31P,ADVERSE,ANXIETY,BASED,C30,EORTC,HAM,LABEL,MATERIALS,METHODS,OBJECTIVE,PGB,PROFILE,QLQ,QOLIE,RESULTS,SCALE,TEN,THESE
160,19Q,ABOUT,ANAPLASTIC,EARLY,HOWEVER,IDH,III,PCV
BACKGROUND,CIS,LABEL,METHODS,RESULTS,RRS,SEPTEMBER,SIX,TEA
302,388,396,690,AUSTRALIAN,CASES,CBT,CHILDHOOD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WHILE
ACCORDING,ENGLISH,LABEL,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,BACKGROUND,CAPILLARY,COPYRIGHT,IMAGING,INC,INDEX,LABEL,METHODS,PATIENT,RESULTS,SCIENCE,SYSTEMATIC
169,CARDIFF,COPYRIGHT,INC,MRS,PRESS,THERE,UNIVERSITY
177,AFTER,ASSESSMENT,BACKGROUND,BARCELONA,CONCLUSION,EEA,ENDOSCOPIC,LABEL,MCT,METHODS,OBJECTIVE,RESULTS,SCALE,SMELL
169,COPYRIGHT,GBM,INC,MOSBY,THEREFORE
169,668,ACROMEGALY,COPYRIGHT,OASIS,PREVALENCE,PUBLISHED,REA,SPAIN,SPANISH,STUDIES,SURGERY
169,COPYRIGHT,IRELAND,LTD,MICRORNAS
169,COPYRIGHT,CURRENT,GBM,GSH,HOWEVER,IRELAND,LTD,PCR,THESE,TMZ
075,138,169,ABOUT,BACKGROUND,CONCLUSION,COPYRIGHT,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NINTH,PREVALENCE,PUBLISHED,RELATIVELY,RESULTS
169,AFTER,COPYRIGHT,HCC,LTD,MNO
169,BRAIN,CNS,COPYRIGHT,DIAGNOSIS,EARLIER,PROGNOSIS
169,CHRONIC,COPYRIGHT,INC,SHORT
169,ATTENTION,CHANG,COLLEGE,COPYRIGHT,CSF,LTD,PUBLISHED,ROYAL,SEVERAL,STAGING,THERE
AMONG,BACKGROUND,CD133,GBM,LABEL,MEIER,METHODS,OVERALL,RESULTS,SEVENTY,TMZ
169,COMPOSITE,COPYRIGHT,DAILY,EARLY,INC,INDICES,LABEL,LGG,MATERIALS,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS,THERE
160,169,177,CAUCASIAN,COPYRIGHT,CTV,DISEASE,FACTORS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,THERE,THESE
169,CENTRAL,CLINICALLY,CONCLUSION,COPYRIGHT,EPENDYMOMA,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEIZURE,THESE
169,COPYRIGHT,ELEVATION,LTD,SERUM
006,009,022,149,233,CNS,LISCH,NF1

MRI,PITUITARY,RESULTS,THEREFORE
169,ACADEMY,COPYRIGHT,INC,MOSBY,PUBLISHED
ANOVA,CHINA,CXCR7,GIVEN,HOWEVER,LABEL,LOCATED,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SDF,SICHUAN,THERE,THEREFORE,TOTAL,UNIVERSITY
HOWEVER,III,PCR,U87,UHRF2,USING
197,AIM,AMONG,ASSAY,CONCLUSION,LABEL,MAF,MASSARRAY,METHODS,OBJECTIVE,RESULTS,SNP,THESE,XRCC1,XRCC3
AFTER,ASGCT,AWARD,CALIFORNIA,COH,DISEASE,FDA,GENERAL,HARVARD,INC,INSTITUTE,KAREN,MEDICAL,MOLECULAR,MOUNT,NCI,NIH,PHASE,SINAI,YOUNG
MRI
ENDOSCOPIC,ENGLISH,WHILE
169,DBTRG,FAK,MALIGNANT,THEREFORE,U87,Y15
218,954,APOPTOSIS,BACKGROUND,CONCLUSION,ECTOPIC,EPIDERMAL,INCREASING,LABEL,MALIGNANT,METHODS,PCR,RESULTS,THESE,WESTERN
001,AMONG,BACKGROUND,ERBB2,III,KARNOFSKY,KPS,LABEL,METHODS,MGS,MUTATIONS,RESULTS,TREATMENT
169
160,BRAIN,COGNITIVE,FINALLY,PRE
145,172,NORTH,PREDICTING,THESE
160,GBM,IHC,INTRA,MRI
001,CONCLUSION,EGYPT,LABEL,RESULTS,THERE,UNLABELLED
THESE
018,115,154,166,177,19Q,342,945,MET,MUTATIONS,WORLD
BECAUSE,DEPENDING,RAF,V600E
160,BASED
AFTER,ATTENTION,BELIEVING,DEFICIT,MRI
GIC,HGG,RAP1GAP
CUTANEOUS
CYBERKNIFE,GAMMA,KNIFE,LINAC,PROTONS,SEVERAL,SRS
100,120,210,284,403,CED,CONVECTION,DIFFUSE,DIPGS,KARNOFSKY,KPS,MRI,TOPOTECAN,WHILE
HOWEVER
100,113,1ST,BARTHEL,GROSS,INDEX,LABEL,LOW,METHODS,MRI,OBJECTIVE,RESULTS,THERE
110,140,AFTER,AUTHORS,ENDOSCOPY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THESE
KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,VINCI
946,BRAINSTEM,THESE
109,188,238,ASA,BACKGROUND,LABEL,LOW,METHODS,N20,OBJECTIVE,OBJECTIVES,OCTOBER,RESULTS,SOCIETY
DEALING,HOWEVER,TSH
FINALLY,HB1,NSC,PURAMATRIX,USING
177,DSC,GROWCUT,MRI,RESULTS,SIMILARITY,THEREFORE,VOLUMETRIC

CHANGES,CURRENTLY,IMAGING,THESE
169,COPYRIGHT,FUNCTIONAL,LTD,MRS,OTHER,RSFDA,WILEY
ACCORDING,CNS,LOCAL,NOVEL,THEREFORE,TODAY,WHILE
160,BACKGROUND,CONCLUSION,DISCUSSION,FOLLOWING,LABEL,ROSETTE,THERE,WHILE
APRIL,BACKGROUND,LABEL,MARCH,METHODS,NSCLC,RESULTS
000,001,100,104,FEMALES,PAS,PREVALENCE,SIR,THESE
424,945,946,CNS,EXPRESSION,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
BACKGROUND,ITGB1,LABEL,METHODS,OPN,RESULTS,TMA,USING
BACKGROUND,GAMMA,JANUARY,LABEL,LEKSELL,METHODS,RESULTS,UCC
176,ANXIETY,DEPRESSION,GERMANY,HOWEVER,III,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE
PRESENTLY,SINCE
008,106,109,117,169,938,954,ADDITIONAL,APPEARANCE,BACKGROUND,BCELL,CNS,COHEN,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,PCNSL,RESULTS,SWI,TESLA
169,COPYRIGHT,DESPITE,DIFFUSE,GLIOMAS,INC,THROUGH,WHILE
ATLAS,CONCLUSION,COX,FIFTY,GBM,HIPAA,HOWEVER,LABEL,MATERIALS,METHODS,NEL,OBJECTIVE,PURPOSE,RESULTS,VERHAAK
169,946,CATENIN,COPYRIGHT,INC,SIMILARLY,WHILE,WNT
001,128,177,335,611,BACKGROUND,DESPITE,FUROSEMIDE,LABEL,METHODS,RESULTS,THERE
169,AWARENESS,CLINICALLY,COPYRIGHT,DIAGNOSIS,GRADE,SINCE
GBM,NETWORK,STRUCTURAL
100,110,169,682,CONFORMITY,COPYRIGHT,FORWARD,INC,MEDICAL,PTV,PTVWBRT,PUBLISHED,TEN,TREATMENT,WHOLE
169,BACKGROUND,COPYRIGHT,CROWN,GLIOMAS,III,LABEL,LOW,MALIGNANT,METHODS,MRS,PUBLISHED,RESULTS,THERE
103,150,BACKGROUND,CANCERS,CONFIDENCE,END,LABEL,METHODS,POISSON,RESULTS,SIR,THYROID
177,501,536,FFF,MUS,NPC,TEN,THERE
EDEMA,EXPLORING,GRE,MOLECULAR,THERE
PITUITARY
PROTEIN,PTP
234,359,CONCLUSION,HOWEVER,III,LABEL,MUTATED,PATHOLOGY,UNLABELLED,USING,YOUNG
300,SNP,THESE
CONCLUSION,FDG,FINALLY,LABEL,METHODS,RESULTS,THEREFORE,UNLABELLED
RENAL
SUNITINIB
HEIDELBERG,HIT,ION,THERAPY
ACUTE,BACKGROUND,HELICAL,LABEL,MATERIALS,METHODS,RESULTS,THREE
176,177,AFTER,BACKGROUND,LABEL,METHODS,NON,OBJECTIVE,PRECISE,RESULTS,SRS,WHILE
BACKGROUND,LABEL,MALIGNANT,METHODS,NCI,OBJECTIVE,PRIMARY,RESULTS,SEVEN,SIXTY,THESE
169,591,AMONG,BASEL,CNS,CONCLUSION,COPYRIGHT,COX,III,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN
AMONG,CRX,HOWEVER,OTHER,OTX
118,132,258,549,IHC,WESTERN
BRAIN,EPIRUBICIN,MEN,MRI,NEDAPLATIN,THREE
HOWEVER,TSH
104,177,3HR,CONCERNING,DISCUSSION,DISTANT,FEC,LABEL,MAY,METHODS,OBJECTIVE,RESULTS
126,AMONG,BACKGROUND,CONTEXT,EVALUATION,HOWEVER,LABEL,MAPPING,RECON,RESULTS,USING
AED,BACKGROUND,COGNITIVE,HGG,LABEL,METHODS,NEITHER,RESULTS,TREATMENT
001,169,177,196,206,226,ANXIETY,BDI,COPYRIGHT,DEPRESSION,GREATER,INVENTORY,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PHQ,PPV,RESULTS,SCALE,WILEY
183,BACKGROUND,BETWEEN,CONCLUSION,DIAGNOSTIC,GEORG,LABEL,MATERIALS,METHODS,RESULTS,STUTTGART
BLOOD,BMI,CRP,INSULIN,LDL
109,BETWEEN,COX,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE,THESE,TREATMENT,VALPROATE
100,BESIDES,BRAIN,CASES,CONCLUSION,HIF,HYPOXIA,METHODS,MMP,RESULTS
1ST,EASTERN,GIMATECAN,GROUP,MACDONALD,PFS,SIMON,TREATMENT
100,CD276,DIFFUSE,GIVEN,TARGETING
177,237,946,956,ELISA,GELATIN,HOWEVER,MEANWHILE,MMP,PD98059,THESE,THROUGH,U87MG,WESTERN
945,ACTIVATION,APART,IDH,THROUGH
BECAUSE,FINALLY,MET,PET
001,168,174,177,AUC,CONCLUSION,FET,HGG,INITIAL,LABEL,LGG,LOW,METHODS,NEOPLASTIC,NNL,NPV,PET,PPV,RESULTS,ROC,TBR,UNLABELLED

310,DESIGNING,HOWEVER,PRESENTLY,THREE
BRAIN,HOWEVER
AFTER,GEOMETRIC,LABEL,LSR,METHODS,OBJECTIVE,OSG,PCA,PDF,PRINCIPLE,PURPOSE,RESULTS,THESE
GBM,HOWEVER,MSC,SDF,TRAIL,UCB,UTP
163,CONCLUSION,DOS,GAB,GLIOMAS,HOWEVER,IGF,METHODS,RESULTS,WESTERN
AUTOIMMUNE,MRI,TSH,XRT
ABSENCE,ADDITIONAL,ALA,GRADE
055,074,129,133,154,177,4TH,915,931,945,ANXIETY,AUC,CLINICIANS,DEPRESSION,DIAGNOSTIC,DUE,MDD,PATIENT,PHQ,SCALE,THERE
177,ABOUT,AUSTRIA,CENTRAL,CWS,DUE,EARLY,ESTIMATED,GERMANY,HIT,SEVEN
FOXM1,HOWEVER,INHIBITION,MMP,PHDGH,PHGDH,USING
001,003,009,011,BBB,CONCLUSION,FLT,IHC,LABEL,MAXIMUM,METHODS,OBJECTIVE,PCR,PET,PURPOSE,RESULTS,THESE
160,946,AKT,ERK,HOWEVER,III,MTT,SHG,THEREFORE,THESE
111,310,AFTER,C000000108,CTR,DAILY,GBM,GRADE,III,JAPAN,LABEL,METHODS,OBJECTIVE,PCZ,PFS,PURPOSE,RESISTANCE,RESULTS
169,COPYRIGHT,EEG,FEDERATION,IRELAND,LABEL,LTD,METHODS,MONITORING,N20,OBJECTIVE,PRE,PUBLISHED,RESULTS
169,372,BACKGROUND,BGL,CHANGES,COPYRIGHT,FDG,INC,INCREASED,LABEL,METHODS,OBESITY,PET,RESULTS,SUV,TUMORAL
169,237,241,CONCLUSION,COPYRIGHT,EPIDERMOID,GROSS,LABEL,MEDLINE,METHODS,NEUROCIRUG,OBJECTIVE,PUBLISHED,RESULTS
169,COPYRIGHT,LTD,MSC,PUBLISHED,RAPID,U87MG,USING
169,193,CHD,COMPARING,COPYRIGHT,CRP,CVD,GREATER,HRS,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TNT,TOTAL
RCC,WHILE
947,AKT,BACKGROUND,BLOOD,BUN,DESPITE,ERK,FTI,IFN,INHIBITION,LABEL,METHODS,R115777,RESULTS,THERE
100,169,383,BASED,ECTOPIC,LUCIFERASE,MIR,PCR,PRDX3,SOCIETY,UTR,WESTERN
231,ASSESSMENT,PETERSBURG
231,MRI,PETERSBURG,SCT
001,006,008,108,AIM,COX,III,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,PCR,RESULTS
FIFTY,FORTY,INSTITUTE,MNI,READING,THESE,USING
CGH,HOWEVER,THESE
000,013,CONCLUSION,COX,GBM,LABEL,MARCH,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THEREFORE
947,AFTER,CD11C,CONCLUSION,DCS,DENDRITIC,ELISA,IFN,LABEL,LEVEL,MATERIALS,METHODS,MHC,OBJECTIVE,PURPOSE,RESULTS
CONCLUSION,DTT,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
007,027,208,612,685,870,BACKGROUND,CONCLUSION,GBM,LABEL,METHODS,OVERALL,PCV,REGARDLESS,RESULTS,THEREFORE,VINCRISTIN
BACKGROUND,CONCLUSION,CRF,EXPRESSION,KNS42,LABEL,MATERIALS,METHODS,RESULTS,UROCORTIN
011,AFTER,HOWEVER,III
001,150,189,ACUTE,CHILDHOOD,INTRA,MEDICAL,POTENTIAL,THERE
160,946,AXIN2,IHC,SAMPLES,THEIR,THESE,WNT
160,BETWEEN,GROSS
001,192,460,547,582,ASSESSMENT,BMS,CIS,DIAGNOSIS,FORTY,GIC,GPA,HOWEVER,MST,NSCLC,PRIMARY,PROGNOSTIC,RCC,RECURSIVE,RPA,SRS,THERE
100,120,ANIMALS,LTS,ONCOGEL,REGEL,THESE,TMZ,XRT
001,002,004,426,447,664,714,832,878,AUC,FURTHER,GRADE,III
0000034,021,KNOCKDOWN,PCR,SYNTHETIC,THREE,U87
FURTHER,HOWEVER
AMONG,BACKGROUND,HOD,JANUARY,LABEL,MAY,METHODS,MRI,OVERALL,RESULTS,SIX
AIM,BECAUSE,CONCLUSION,FURTHER,KNOWN,LABEL,MATCHED,METHODS,OBJECTIVE,PURPOSE,RESULTS
005,013,018,160,BACKGROUND,BETWEEN,CONCLUSION,FIFTY,HENCE,INSTITUTE,LABEL,MAY,METHODS,RESULTS,SINCE,TMZ,UNIVERSITY
AVM,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
GBM
1950S,1990S,EVALUATION,MONITORING,TYPICAL

405,GROWING,OFTEN,ORGANIC,THESE
100,AE1,AE3,BCL,EMA
160,194,BASED,DUE
DCC,DSCAM,HOWEVER,INHIBITION,JNK,KNOCKDOWN,MAPKS
BACKGROUND,GBM,IDH,LABEL,METHODS,NEITHER,R132H,RESULTS,TTP,YOUNG
177,BACKGROUND,CNS,CSI,ESPECIALLY,HIT,JANUARY,LABEL,METHODS,RESULTS,SHORT,SKK,THREE
GEM,HOWEVER,LOW,NF1,THESE,WGS
19Q,ADC,BACKGROUND,DWI,III,LABEL,MATERIALS,METHODS,MULTIMODAL,OBJECTIVE,PURPOSE,PWI,RESULTS,SEPARATION,UNIVARIATE
CHRONIC,CNS,CSF,KEY,LABEL,MENINGITIS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
146,377,ATLAS,AUTOMATED,GBM,HOWEVER,MULTIFORME
ASSESSMENT,LABEL,METHODS,MEYER,OBJECTIVE,RESULTS
946,ERM,INCREASING,NF2,WNT
BASED,COATS,EXUDATIVE,MRI,MUTATIONS,NDP
107,169,COPYRIGHT,GFP,IRELAND,LENTI,LTD,MICRORNAS,NOTABLY,NOTCH
946,EGR,GSK,INC,LABORATORY,NAG,NSAID,PUBLISHED,STUDIES,TGF
169,BRAIN,CELLS,COPYRIGHT,ELECTRICAL,ENDPOINTS,HBMEC,HUVEC,INC,PECAM,RADIATION,RESISTANCE,TRANS,UMBILICAL
148,187,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,RCC,RESULTS
169,COPYRIGHT,LEIOMYOMAS,LTD,PUBLISHED
169,AGE,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
160,169,COPYRIGHT,FINALLY,FURTHER,IMAGING,INC,PATHOLOGY,PUBLISHED,SOCIETY
108,169,947,COPYRIGHT,DENMARK,HLA,IFN,INC,INDUCTION,MHC,PATHOLOGY,PUBLISHED,SEVERAL,SOCIETY,THEREFORE,THESE
169,AVERAGE,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,TREATMENTS,WHILE
001,119,169,178,381,500,ADJUSTING,COPYRIGHT,COX,IRELAND,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,SIB,SRS
120,169,381,501,COLLEGE,COPYRIGHT,COX,DCA,GGS,GROUP,IDI,LABEL,LTD,MATERIALS,MEIER,METHODS,NRI,OBJECTIVE,PROGNOSTIC,PUBLISHED,RADES,RADIATION,RESULTS,ROTTERDAM,ROYAL,RPA,THERAPY
169,237,241,COPYRIGHT,NEUROCIRUG,PUBLISHED
169,BACKGROUND,BCT,CONCLUSION,COPYRIGHT,CUMULATIVE,INC,LABEL,METHODS,NON,RESULTS,THESE,UNIVARIATE
169,COPYRIGHT,FEDERATION,FINALLY,PREVENTION,PUBLISHED,SOCIETIES,THESE,TOBACCO,WIDER
169,COPYRIGHT,HUNTINGTON,INC,WHILE
169,COPYRIGHT,FINALLY,INC,SIN3A
169,COPYRIGHT,ELF,INC,MEF,TAKEN
231,945,BACKGROUND,BR3,BRAIN,HOWEVER,LABEL,MDA,METHODS,MMP,REDUCTION,RESULTS,SHORT,TGF,THERE
BACKGROUND,DISCUSSION,INCLUSION,LABEL,METHODS,STUDIES,THEREAFTER,TRIAL
169,BACKGROUND,GRADE,GUIDANCES,GUIDELINES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,SPECIAL,THROMBOSIS,UFH,VCF,VKA,VTE
CHONDROMAS,THEIR
CNS
HOWEVER,MALIGNANT
BACKGROUND,LABEL,RESULTS,SEARCHING,UNDER
169,DEPARTMENT,FSH,LABEL,LTD,METHODS,OBJECTIVE,PITUITARY,RESULTS,TSH,WILEY
CLASS,CLASSES,ENGEL,GROUP,III,LABEL,LGT,LOW,METHODS,OBJECTIVE,RESULTS,SIXTEEN
MRI
GIVEN,RESISTANCE,RTH,SITSH,TSH
18FDG,DOPPLER,MRI,PET
343,AFTER,CIS,GAMMA,KNIFE,LABEL,MEDICAL,METHODS,OBJECTIVE,PITTSBURGH,RESULTS,UNIVERSITY,VSS
CONTOUR,LABEL,METHODS,OBJECTIVE,RESULTS,SPHERES,SRS
CNS,DESPITE,GAMMA,GKS,HOWEVER,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS
AMONG,GAMMA,JANUARY,KNIFE,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS
001,100,177,ACCORDING,AFTER,ANOVA,BETWEEN,BRACKMANN,FURTHER,GAMMA,GKS,GRADE,GRADING,GROUP,HOUSE,HOWEVER,KNIFE,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SEM,SHORT,STUDENT,VSS
177,215,ADC,GAMMA,GKS,IMAGING,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,VSS
102,109,122,134,190,195,200,BASED,BETWEEN,GAMMA,GKS,KNIFE,LABEL,LEKSELL,MEIER,METHODS,MRI,OBJECTIVE,RESULTS,USING,VSS
001,009,010,031,044,114,117,125,165,261,397,438,ACCORDING,ASSESSMENT,CLASSES,FIFTY,GPA,GRADE,III,LABEL,MEIER,METHODS,MST,NSCLC,OBJECTIVE,PROGNOSTIC,RECURSIVE,RESULTS,RPA,UNIVARIATE
108,BETWEEN,GAMMA,GKS,HEMORRHAGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE,TRANSIENT
216,223,251,ASSESSMENT,BRAIN,CLASS,DIAGNOSIS,GAMMA,GPA,GROUP,KARNOFSKY,KNIFE,LABEL,LEKSELL,METHODS,NEITHER,OBJECTIVE,PROGNOSTIC,RADIATION,RECURSIVE,RESULTS,RPA,SCALE,SCORE,SRS,THERAPY
001,729,APRIL,ASSESSMENT,BASIC,BRAIN,CHIBA,CLASS,COX,GAMMA,GKS,GPA,GROUP,HOWEVER,INDEX,JANUARY,KNIFE,LABEL,MARCH,MEIER,METASTASES,METHODS,OBJECTIVE,PROGNOSTIC,RADIATION,RECURSIVE,RESULTS,RPA,SCORE,SIR,THERAPY,TOKYO
005,121,122,129,137,171,200,222,AMONG,BECAUSE,CLASS,GAMMA,GAMMAHOUSE,GKS,III,KARNOFSKY,KNIFE,KPS,LABEL,METHODS,MST,OBJECTIVE,RECURSIVE,RESULTS,RPA,SCALE,SMALLER,SRS,THEREFORE,THESE
BETWEEN,GAMMA,GKS,KNIFE,LABEL,LEKSELL,MEDICAL,METHODS,MRI,OBJECTIVE,RESULTS,UNIVERSITY
GAMMA,GKS,KNIFE,LABEL,LEKSELL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS
004,128,158,CLEVELAND,GAMMA,GKS,KARNOFSKY,KNIFE,KPS,LABEL,LOWER,MEDICAL,METHODS,OBJECTIVE,PATIENT,RESULTS,SCALE
BRAIN,C30,COMPLIANCE,CONCLUSION,EORTC,HRQOL,III,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,QUALITY,RESULTS,TREATMENT
218,618,ADDITIONAL,ARGONAUTE,C17,MICRORNAS,TARGETS,THESE,UTR
160,174,AFTERWARDS,CARMUSTINE,GLIADEL,KARNOFSKY,LABEL,METHODS,MULTIMODAL,OBJECTIVE,OBJECTIVES,RESULTS,SCALE,TEMODAR,THESE
177,334,AGE,AWAKE,BACKGROUND,GROSS,HGG,KARNOFSKY,LABEL,MAXIMAL,METHODS,OLDER,RESULTS,SCALE
CMS,FIFTY,HGG,HRQOL,MOS,OFTEN
126,155,26A,946,EXPRESSION,GENOMES,HOWEVER,KYOTO,OMNIBUS,RB1,SMAD7,TFS,TGF,USING
CD171,FGFR1,FGFRS,L1CAM,THESE
177,CAM,DESPITE,OFC,THESE
169,945,ADP,AFTER,COPYRIGHT,FOXP3,HOWEVER,INC,PCR,SINCE,TREGS
151,160,169,534,APRIL,BETWEEN,COLLEGE,CONCLUSION,COPYRIGHT,III,KARNOFSKY,LABEL,LTD,MARCH,MATERIALS,METHODS,NSCLC,OBJECTIVE,OSC,PUBLISHED,QALYS,QUALITY,RESULTS,ROYAL,THESE
100,200,ACA,DOPPLER,ICA,MCA,MRA,MRI,RED,SCD,TCD,THESE,VELOCITIES
AUROC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,AMONG,COPYRIGHT,DESPITE,HOWEVER,IRELAND,LTD,NOTCH,PHASE
5XFAD,690,946,964,ALZHEIMER,ELISA,MIA,MWM,PCR
161,967,BETWEEN,CTV,FORTY,GBM,LABEL,MAY,MEIER,METHODS,OBJECTIVE,RESULTS,THERE
135,825,APRIL,BACKGROUND,EASTERN,FIFTEEN,FORTY,GROUP,LABEL,MBC,METHODS,PACLITAXEL,RESULTS,SIX,THREE,TREATMENT
AMONG,BRAIN,CCR,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,RESULTS,SEPTEMBER

ATP,LDI,MNO,THESE
169,BLACKWELL,CONCLUSION,KNOWN,LABEL,LTD,METHODS,OBJECTIVE,POSTERIOR,PUBLISHING,RCC,SUMMARY,THERE
JNK,JUN
916,BLOOD,CO2,HRI,REFERENCE,VRM
169,DESPITE,SECONDARY
AIM,CONCLUSION,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PATIENT,PITUITARY
CHRONIC,CML,SDH
AIM,CNI,CONCLUSION,LABEL,METHODS,MRI,MRS,OBJECTIVE,RESULTS,TEN
BACKGROUND,CAVERNOMAS,DISCUSSION,LABEL,METHODS
109,177,BACKGROUND,CONCLUSION,ENB,HYAMS,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SIX,SIXTY,SRS,THERE,THEREFORE
629,728,766,BACKGROUND,CONCLUSION,DISTANT,LABEL,LOCAL,MEDLINE,METHODS,OBJECTIVE,OPTIMAL,PATIENT,PEARSON,RESULTS,STUDENT
119,245,304,BACKGROUND,CONCLUSION,FIFTY,HOWEVER,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS
160,FIFTY,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,PILOCYTIC,PURPOSE,RESULTS,SIX,TEXAS,TREATMENT,UNIVERSITY
TREATMENT
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THREE
129,HBL
BACKGROUND,CDC,COLLECTING,CONCLUSION,CRITICALLY,HERCEPTEST,LABEL,METHODS
AIM,CONCLUSION,EPHB4,HOWEVER,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS,SMA,VMI
000,203,250,BACKGROUND,BMS,CONCLUSION,GRADE,LABEL,MAY,MBC,METHODS,RESULTS,SEPTEMBER,THERE
169,COPYRIGHT,INC
250,403,ABC,AEU,BACKGROUND,ECM,EGF,FDR,GBM,GPR98,LABEL,METHODS,RESULTS
169,CHEST,COPYRIGHT,HOWEVER,INC,MRI
169,BRAIN,COPYRIGHT,INC,MRI,UNENHANCED
BACKGROUND,BUN,C30,CEA,CHINESE,DISCUSSION,EASTERN,EORTC,EXCLUSION,GENERAL,GINSENG,GOT,GPT,GROUP,HCT,HRV,LABEL,LIRIOPE,MAI,METHODS,QOL,QUALITY,SAN,SMS,TCM,THESE,TREATMENT,TRIAL
055,060,065,086,126,168,169,964,COPYRIGHT,EDUCATION,END,INC,KENDALL,LABEL,MATERIALS,MEN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEX,UROLOGICAL
169,960,COPYRIGHT,DHA,EXPLOSION,LTD,SINCE,SIX,WHILE
COPYRIGHT,SLACK
169,GBM,MRI,TMZ,WILEY
003,004,093,098,156,163,171,339,474,591,CONCLUSION,COX,GBM,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
CLEAVED,CSF,GBM,HOWEVER,OPN,RAA,RGD,SVVYGLR
2HG,DISRUPTION,EXPRESSION,III,IMA,POINT,THESE,WORLD
204,EPHB2,FURTHER,HOWEVER,PHENOTYPIC,RESTORING
169,AFTER,BRIEF,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURVIVORS,WILEY
001,109,197,275,347,544,815,AMONG,CLEVELAND,CVA,DVT,HOWEVER,PROLACTIN
THESE
RIGHT
160,169,CONCLUSION,COPYRIGHT,FINALLY,HOWEVER,IMAGING,INC,LABEL,METHODS,MORAXELLA,OBJECTIVE,PATHOLOGY
177,AUC,FLAIR,GLGCM,HOWEVER,IHC,MFS,MIB,MINKOWSKI,MRI,RLM,ROC
128,ATLAS,FINALLY,GBM,OVERALL,PDCD4,U87
169,COPYRIGHT,PUBLISHED,SINCE,U87
169,945,BITEMPORAL,COPYRIGHT,FSH,INC,LABEL,METHODS,OBJECTIVE,PATHOLOGIC
169,946,AIF,BAX,COPYRIGHT,CTSL1,FURTHER,HENCE,IRELAND,LTD,MAPK8,PEDIATRIC,PRKCA,STEROID
169,COPYRIGHT,DESPITE,DREBRIN,GBM,INC,THEREFORE,U87
169,COPYRIGHT,DISRUPTION,INC,PUBLISHED,SOCIETY,UBE3A,UBE3B
000,169,174,AUC,AVASTIN,COPYRIGHT,DCE,DYNAMIC,GPU,HOWEVER,INC,IRF,MRI,MRT
160,169,ACCORDING,BIOLOGY,COPYRIGHT,EUCLIDEAN,FEDERATION,INC,PUBLISHED,ULTRASOUND,VALIDATION,WORLD
001,014,016,034,041,102,BACKGROUND,C4D,CONCLUSION,HOWEVER,KRUSKAL,LABEL,METHODS,PEARSON,RESULTS,THERE,WHITNEY
001,181,BIFOCAL,LABEL,METHODS,OBJECTIVE,RESULTS
100,500,956,CST,DCS,EVALUATION,LABEL,MAPPING,MEP,METHODS,MOTOR,MTS,OBJECTIVE,RESULTS,THEREFORE
916,945,947,CD133,G47,GBM,GSC,ONCOLYTIC,SINCE,THESE,USING
STRATEGIES,THESE
AMP,CONTROL,FOXO3,METFORMIN
243,BACKGROUND,EFFECTIVE,LABEL,METHODS,RESULTS,SOUTH,THESE,THREE,TREATMENT
OFC,OROFACIAL,USING
150,CNS,CSF,GIVEN,HODGKIN,KEY,LABEL,MTX,NHL,PHASE,RECURRENT,UNLABELLED
200,300,ANOTHER,ASSESSMENT,BACKGROUND,CALGARY,CONCLUSION,LABEL,MANAGEMENT,MEDICAL,METHODS,MRI,OBJECTIVE,PATHOLOGY,PROGRAM,RESULTS,SHORT,SIX,SUNCT
169,CNS,COPYRIGHT,MALIGNANT,MRT,SMARCB1
160,169,183,CONCLUSION,GBM,GEORG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROC,STUTTGART
160,270,AFTER,CRF,YTX
CLOSE,CNS,DIAGNOSIS,METASTATIC,PRIMARY,RPE,THERE,TREATMENT
946,947,ALZHEIMER,APP,HOWEVER,III,NOTCH,PHASE,SEVERAL
ASP,FURTHER,GLN,LEU,MET,OME,PDT,THESE
100,160,EOM,HOWEVER,PERMANENT,TSS
169,BACKGROUND,CANCERS,CELLS,COPYRIGHT,GENERAL,HOWEVER,ISSUE,LABEL,MAJOR,METHODS,NOTCH,SCOPE,SPECIAL,WNT
169,AWARENESS,COPYRIGHT,FRONTAL,LTD
ADDITIONAL,BASED,GRADE,III,NF1,PILOCYTIC,V600E
074ME,AMP,ANXA2,SILENCING,TARGETING
DEPENDING,MRI,OWING
169,COPYRIGHT,ESC,HOWEVER,PARKINSON,PROTOCOLS
169,BBB,BRAIN,COPYRIGHT,LTD
CNS,HOWEVER,SUCCESS
100,BACKGROUND,CONTEXT,INFECTION,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,QOL,RESULTS,THERE
CNS,CONCLUSION,CSF,FORTY,ICGCT,LABEL,MEIER,METHODS,MRI,OBJECTIVE,PATIENT,RADIOLOGY,RESULTS
001,025,481,BACKGROUND,HOWEVER,LABEL,MASSAGE,MATERIALS,METHODS,NETWORK,QOL,RESULTS
BACKGROUND,CAUCASIAN,IMAGING,LABEL,METHODS,NCC
169,234,BACKGROUND,COPYRIGHT,DIAGNOSES,INC,LABEL,METHODS,PROCEDURE,RESULTS,SINCE,VITAMIN,WILEY
169,AYURVEDIC,BAX,BESIDES,CCNE1,COPYRIGHT,CURCUMA,INC,WILEY
DIFFERENT,ERROR,RGB,TESTS
CDC20,FINALLY,FOXM1,HSF,KNOCKDOWN,PRIOR
CAREFUL,CLOSE,DYSARTHRIA,LABEL,METHODS,OBJECTIVE,OUTSIDE,RESULTS
161,177,EIGHT,GAMMA,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PARAMETERS,PURPOSE,RESULTS,SEVENTEEN,SNR,SPACE
008,156,193,253,BACKGROUND,BORDETELLA,LABEL,METHODS,MYCOPLASMA,RESULTS
176,177,945,946,BACKGROUND,CONCLUSION,DE1,DE2,DI1,DI2,FISCH,JUGULAR,LABEL,METHODS,OBJECTIVE,RESULTS,TEN,UNDER,VARIOUS,XTH
160,CTV,FRONT,MRI,OPTIMIZED
BACKGROUND,DEPENDING,LABEL,METHODS,MRI,RESULTS,VIRTUAL
ATRTS,BACKGROUND,E2F,GIVEN,LABEL,METHODS,MICROARRAY,RESULTS,SMARCB1,USING,ZESTE
946,CNS,HOWEVER,HSP,IDE,INSULIN,VARICELLA,VIRUS
THREE
169,COPYRIGHT,INC,MRI,WILEY
AUTOPSY,DESPITE,DIAGNOSIS
HODGKIN,NHL,NON
DTI,FUNCTIONAL,WHILE
102,BETWEEN,EVALUATION,FORTY,INITIAL,OCTOBER,SECONDARY,SRS,STATE
AFTER,AMPUTATION
167,169,AMONG,CES,COPYRIGHT,DELAYED,DEPRESSION,DEPRESSIVE,FCS,GMM,IL1R2,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESILIENT,RESULTS,STUDIES,VARIATION,VARIATIONS,WHILE
214,FURTHER,HOWEVER,THESE,UTR
CONCLUSION,DTC,EXOGENOUS,FDA,JANUARY,LABEL,METHODS,OBJECTIVE,RAI,RESULTS,THERE,THW,TSH
176,AWARENESS,CONCLUSION,HORMONE,LABEL,MANAGEMENT,METHODS,MRI,OBJECTIVE,RESULTS,SMA,WHILE
196,395,601,COX,GREEK,NUTRITION,THESE,USING
006,036,202,337,BACKGROUND,BRAIN,CONCLUSION,DESPITE,FIFTY,JANUARY,LABEL,MATERIALS,METHODS,NEITHER,OBJECTIVE,OBJECTIVES,PSI,RESULTS,SEPTEMBER,SEVERAL
13R,945,947,BACKGROUND,CD3,CD4,CLASS,ELISA,GBM,HLA,IFN,LABEL,MBP,METHODS,PBMCS,PRIMARY,RESULTS,TH1,TH2,WHILE
ALT,SOMATIC,TELOMERES
CD133,HOWEVER,HSP27,HYPOXIA,TIC
AMP,MIGRATION,MIR,NF1,TAKEN
160,ICP,MBP,SIMILAR
169,GLYCATION,VCH,WILEY
169,177,200,COPYRIGHT,OTHER,POLYMER,POLYMERIC,VCH,WILEY
169,306,950,AUSTRALIAN,CBT,CHILDHOOD,COPYRIGHT,INCREASED,PARENTS,SINCE
160,239,2DG,BBB,CONCLUSION,LABEL,METHODS,MNP,MRI,OBJECTIVE,PROCEDURE,PURPOSE,RESULTS
175,220,GROUP,H3K27,H3K4ME3,K27,KDM6A,KDM6B,MBS,NOTABLY,SNV,THROUGH,WHILE
ACCORDING,EIGHT,KNIFE,MRI,PRL,WORLD
APRIL,CTC,GBM,INSTITUTE,JANUARY,LABEL,MATERIALS,METHODS,NCI,OBJECTIVE,PFS,PURPOSE,RCT,RECURSIVE,RESULTS,RPA,TMZ
200,945,946,BEV,CTCAE,GBM,III,NINTEDANIB,PDGFR,STUPP,VEGFR
003,4150G,69G,CHINESE,HOWEVER,THERE,THEREFORE
ADDITIONAL,AMONG,DDT,EXPOSURES,HOWEVER,PESTICIDES,RELATED
123,140,211,CASPASE,CPG,CSC,GBM,GIVEN,MMP,RHODAMINE,THESE
DESPITE
169,COPYRIGHT,TFR
169,BRISTOL,COMPLEX,CONCLUSION,COPYRIGHT,INCREASING,LABEL,LTD,METHODS,NEUROLOGY,OBJECTIVE,OBJECTIVES,PAEDIATRIC,PUBLISHED,RESULTS,SCLEROSIS,SEGAS,SOCIETY,SURGERY,THERE,TSC
169,BACKGROUND,BASED,BASEL,BEV,CONCLUSION,COPYRIGHT,III,LABEL,MACDONALD,METHODS,OUTCOME,PFS,RESULTS
00047,021,032,041,169,APRIL,BOARD,COPYRIGHT,EXCLUSION,FOLLOWING,FURTHER,GENERAL,ICU,INC,INCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
147,169,500,750,BETWEEN,COPYRIGHT,GBM,GROUP,INC,LABEL,MARCH,MATERIALS,MAY,METHODS,MTD,OBJECTIVE,PER,PURPOSE,RADIATION,RESULTS,RPA,THERAPY,THERE,TREATMENT,YOUNGER
006,011,169,177,ABSENCE,BACKGROUND,COPYRIGHT,EFS,HIT,KNOWLEDGE,LABEL,LATERAL,LTD,METHODS,PERIPHERAL,RESULTS,SEVENTY,TREATMENT
169,BBB,BRITISH,CONCLUSION,COPYRIGHT,DNT,FCD,GLIAL,IIB,LABEL,LOW,LTD,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STRIKINGLY,THEREFORE
EARLY,HOWEVER
160,ADHERENCE,III,IPILIMUMAB,PHASE,PREDICTIVE
700,BETWEEN,CSF,ETTAS,EXPERIENCE,FEW,GROSS,THERE,THREE
BACKGROUND,BASED,FOLLOWING,FRAMELESS,LABEL,METHODS,MRI,PROVIDING,RESULTS,TEN
946,ABC,ABCA1,ABCB1,ABCC1,ABCG2,ALZHEIMER,ATP,BBB,HOWEVER,THEREFORE
BACKGROUND,DESPITE,GROUP,III,INTEGRATED,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY
304,656,INTERPRET
AMONG,AWAKE

003,045,135,147,151,160,185,365,INSTITUTES,SCALE
DESPITE,THESE
BACKGROUND,GRADE,HISTOLOGY,III,IRRIGATION,LABEL,METHODS,MRI,NEURO,RESULTS,TUMOURS,USING,UTILISING,WORLD
154,450,920,956,ON123XX,OVERALL
160,AMONG,ANOTHER,HPC,SINCE
AFTER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,UNDER
166,COX,MBT
001,547,AMONG,CAVERNOUS,CLINICALLY,HORMONE,SEX
EEA,HARDY,IGF,KNOSP
13R,945,DESPITE,EPHA2,PEDIATRIC,WILMS,WT1
946,ENP,GLIOMAS,IBA
DUE
169,COPYRIGHT,CURRENT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
160,169,BACKGROUND,CHOUDHURY,COPYRIGHT,COUNCIL,FURTHER,INC,LABEL,METHODS,NEUROTOUCH,PUBLISHED,RESULTS,SIMULATION,SURVEYS,TECHNICAL,THESE
160,429,431,945,946,GLUT1,ILE,LEU,MYC,NUCLEAR,PTB,SER,WARBURG
MRI
169,COPYRIGHT,INC
399,479,954,CHROMATIN,GBM,HOWEVER,JSH,STAT3
CD133,EGF,GBM,HOWEVER,KNOCK,MEANWHILE,TAKEN,THESE
169,CLINICALLY,COPYRIGHT,INC,PET,SEQUENTIAL
169,237,241,BACKGROUND,CONCLUSION,COPYRIGHT,DIAGNOSTIC,DUE,LABEL,METASTASES,METHODS,NEUROCIRUG,PUBLISHED,TORRE
169,ACRAL,COPYRIGHT,DIGITAL,SAS
169,ADDITIONAL,CONCLUSION,COPYRIGHT,HEADACHES,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,THERE
169,883,AWAKE,CONCLUSION,COPYRIGHT,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTEEN,SIXTY,THERE
177,675,818,AFTER,CHANGES,ECS,LABEL,LASER,LSI,METHODS,OBJECTIVE,RESULTS
105,FORTY,GBM,GRADE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OPTIMUM,PFS,RESULTS,TMZ
001,210,236,303,506,617,AED,AUTHORS,COX,DESPITE,GBM,HDI,LABEL,METHODS,OBJECTIVE,RESULTS,THOSE,VPA
DYSMORPHIC,SYNDROMES
29YEARS,3RD,BLA,BLC
AUTOMATED,CONCLUSION,DESPITE,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
169,AFTER,ANNEXIN,CCK,COMPELLING,COPYRIGHT,INC,MICRORNAS,PCR,U87,WILEY,ZYXIN
160,945,EFFECTIVE,HIF,HYPOXIA,INCREASED,THESE
BACKGROUND,BRAIN,CONCLUSION,GASTRIC,INCREASED,K252A,LABEL,METHODS,PCR,RESULTS,THESE,TRK
NOW,THESE
215,60S,954,MRI,PITUITARY

AMONGST,DESPITE,HEK,ILS,MTT,TREATMENT
181,1ARGD,945,946,AKT,ANNEXIN,ARG,ASP,ERK,FAK,GLY,HOWEVER,PROLONGED,RGD,TREATMENT
LOCAL
174,ACCURAY,ACTUARIAL,ASSESSMENT,COX,CYBERKNIFE,DESPITE,GPA,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PCI,PROGNOSTIC,PURPOSE,REGRESSION,RESULTS,SRS,SUNNYVALE
128,342,FINALLY,GBM,HOWEVER,LABEL,MATERIALS,METHODS,MICRORNAS,OBJECTIVE,RESULTS,THESE
GRADE,PAPILLARY,WORLD
075,215,BACKGROUND,DAC,GRADE,LABEL,M1C,METHODS,ORR,RESULTS,SIMON,TMZ
185,AIM,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS
RADIATION,THESE
DISTANT
ACCORDING,THERE,TOTAL

124,FURTHER,MIR
CHOROID,IMPROVING,WHILE
169,233,ANGIOCHEM,BBB,INC,THESE,TRANSCEND,VARIOUS
004,FSH,HOWEVER,MEDICAL,MRI,PRL,RCC,SURGERY,TSH,USING
169,AFTER,HMB45,LOCAL,MALIGNANT,MAXIMALLY,PATIENT,WILEY
BRAINSTEM,DEPENDING,MRI
CRANIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
ATTRACTOR,BOOLEAN
169,BNP,CONGEST,EXTREMELY,HEART,INC,THROUGH,WILEY
ACTINIA,AKT,CYTOLYSINS,EXTENSIVE,FINALLY,GBM,MRI,THESE,TMZ
BACKGROUND,CONCLUSION,CSF,EGYPT,LABEL,METHODS,OBJECTIVE,ORS,RESULTS,TEN,THOSE,TREATMENT,UNIVERSITY
AMONG,HOWEVER,OBVIOUSLY,PFS
PFS
COGNITIVE,CONCLUSION,FINALLY,HGG,LABEL,LGG,MEG,METHODS,NETWORK,NGL,NORMALIZED,OBJECTIVE,RESULTS
860,CSF,HIV,HOWEVER,MACHINE,THESE
251,73122,954,AKT,ERK,HOWEVER,JNK,JUN,MEANWHILE,MMP,MT1,NEUROKININ,PLC,TAKEN,TREATMENT
001,581,AFTER,COX,INPATIENT,JANUARY,LABEL,MEASURE,METHODS,NATIONWIDE,OBJECTIVE,OUTCOME,RESULTS,SETTING,THESE,THREE,UNINSURED
000,DSF,FDA,GBM,GIVEN,GSC,HTS,MULTIFORME,SEVERAL
ACUTE,GIVEN,NOW,THERAPY,WHETHER
CNS,DESPITE,OLIG1,OLIG2
169,COPYRIGHT,HPA,INC,INITIALLY,THESE
169,COPYRIGHT,LTD,MRI
169,COPYRIGHT,CUTANEOUS,IRELAND,LTD
169,CNS,DNT,SOCIETY
CSF,IMAGE,VENOGRAPHY
MEANWHILE,RADIATION
CPA
000,102,124,128,140,141,146,150,170,181,193,218,245,268,272,277,284,297,300,312,339,350,351,357,392,408,419,431,500,505,70S,811,90S,AGE,AIR,AMONG,ARPAT,BACKGROUND,BHR,BIRTH,BMR,CONGENITAL,GEOTHERMAL,HOWEVER,LABEL,LGS,LOW,METHODS,MORTALITY,NGA,OBJECTIVE,OLFACTORY,OUTCOME,PC2,POPULATION,PROJECT,PROTECTION,RESULTS,SETTING,SGA,SHR,SIENA,SIXTEEN,SMR,TRUNCATED,TUSCANY
800,BACKGROUND,CLUSTER,CPG,DIRICHLET,DPBMM,GBM,GIBBS,HOWEVER,LABEL,LARGE,METHODS,RESULTS,SINCE
126,143,177,BACKGROUND,CAB,CONTEXT,FETAL,LABEL,METHODS,PREGNANCY,RESULTS,THREE
231,945,946,947,948,949,GTP,MDA,PAQR6,PAQR9,R5020,THREE
10Q,19Q,ADJUSTING,BACKGROUND,CONCLUSION,IDH,INK4A,LABEL,MATERIALS,METHODS,RESULTS,RTEL1
169,BACKGROUND,COPYRIGHT,DCC,INC,LABEL,RESULTS,ROBO1,ROBO2,SLIT1,SLIT2,SLIT3,SLITS,THESE,VAGAL,WILEY
PRIMARY
141,160,166,AFTER,AUSTRIA,C15,DBM,DEGRO,EORTC,GERMANY,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PAL,PROXIES,PURPOSE,QLQ,QOL,RESULTS,SIXTY
19Q13,400,800,CNS,EMBRYONAL,INI,USING
AFTER,AMR,AMRUBICIN,CPT,SALVAGE,SMALL,SMCCE
19Q,AMERICA,HOWEVER,IDH,III,ISOCITRATE,LABEL,LGG,MOLECULAR,NORTH,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,V600E
LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
945,947,956,AIM,ASTER,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,OEL,PCR,PFT,RESULTS,TREATMENT,U87,WESTERN
7TH,ADH,BACKGROUND,CASES,CSF,LABEL,METHODS,OPENING,THESE
169,946,AVAILABLE,COPYRIGHT,CSC,FOLLOWING,GBM,INC,SEVERAL,TGF
001,169,CONCLUSION,COPYRIGHT,CRT,DOSIMETRIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVENTEEN,SRT
169,237,241,COPYRIGHT,DIFFERENT,ENDOSCOPIC,ETV,NEUROCIRUG,PAEDIATRIC,PUBLISHED,SUCCESSFUL
169,AFTER,COPYRIGHT,MRI,SAS
135,169,239,ADC,BACKGROUND,CONCLUSION,COPYRIGHT,CUT,DWI,FRACTIONAL,INC,LABEL,METHODS,MIB,RESULTS,ROI,WHITNEY
10Q,LABEL,LOH,METHODS,OBJECTIVE,RESULTS,THERE,UNIVARIATE
000,177,315,353,383,ANNEXIN,CCK,KIT,LABEL,METHODS,OBJECTIVE,PCR,PRDX3,RESULTS,ROS,SYNTHETIC,USING,WESTERN
100,CORRECT,DNT,EEG,FLAIR,LABEL,METHODS,MRI,OBJECTIVE,OLIG2,RESULTS,THERE
169,COPYRIGHT,GADOLINIUM,RADIOLOGIC,SOCIETY
14S,18S,700,800CW,COMPOUNDS,CY5,CY7,ICG,IRDYE800CW,IRDYE800RS,NIR
001,017,029,043,136,169,176,BACKGROUND,COPYRIGHT,ICA,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
001,169,16Y,372,3RD,710,AIM,AUTHORS,CHILD,COHEN,CONNERS,CONTINUOUS,CPT,CRANIAL,III,KEITH,LABEL,MAC,METHODS,NEUROLOGY,OBJECTIVE,PRESS,RESULTS,SCALE,STUDIES
012,102,CNS,DIEGO,FORTY,LABEL,LGG,METHODS,MRI,OBJECTIVE,PEDIATRIC,RESULTS,SAN,SIXTY
BASED,FOLLOWING,LABEL,METHODS,OBJECTIVE,RESULTS
AFTER,BAPTIST,CNS,CSF,CUTANEOUS,ETIOLOGIES,MEDICAL,VAC
APART,BECAUSE,CUSHING,ENDOGENOUS,REMARKABLE
100HZ,2HZ,2MS,6MS,BEIJING,CHINA,LI4,LR3,QIUXU,SJ5,WAIGUAN,ZUSANLI
317,CARIBBEAN,ENGLISH,ITR,JAMAICA,MARCH,UNIVERSITY

BACKGROUND,DTI,HENCE,LABEL,LINES,MONRO,PRINCIPAL,PTS,RESULTS,SIX,THESE
100,ANAPLASTIC,CONCLUSION,LABEL,RESULTS,SIX,THESE,UNLABELLED
BACKGROUND,CONCLUSION,EPC,FACTORS,HSC,III,LABEL,MALIGNANT,MATERIALS,METHODS,RESULTS,SEVERAL,THESE
946,BACKGROUND,DISCUSSION,FURTHER,LABEL,MBS,METHODS,MMB,RESULTS,SINCE,THEREFORE
34A,HOWEVER
BRAIN,INITIALLY,THEIR
THEREFORE
BUB1B,BUBR1,CURRENTLY,GLE2P,GLEBS,KNOCKDOWN,LABEL,NSC,THESE,UNLABELLED
100,532,CH2,CH3,FORTY,III,RAMAN,USING
100,118,169,246,321,BASEL,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,RAMAN,RESULTS,SAMPLES,SUPPORT,THESE
ALK,BACKGROUND,CNS,DISCUSSION,INITIAL,LABEL,LAT,METHODS,NSCLC,RESULTS
169,237,241,AFTER,COPYRIGHT,LABEL,LOW,MAXIMAL,METHODS,MRI,NEUROCIRUG,OBJECTIVE,PUBLISHED,RESULTS,SPANISH,SURGERIES
152,169,CONCLUSION,COPYRIGHT,FINALLY,HOWEVER,INC,LABEL,METHODS,MRI,MRS,OBJECTIVE,PREDICTING,RESULTS,THERE,WRONG
169,177,ADC,CHANGES,CHO,COPYRIGHT,DWI,FLAIR,FSE,INC,LABEL,LIP,METHODS,MINIMUM,MRI,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS
169,CBV,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
FOV
945,946,NFL,TBS,THESE
945,ECS,HSPGS
5HT,CHANGES,CNS,EPSPS,GABAERGIC,SELECTIVE,USING
100,956,HOWEVER,MACCONKEY,PRIOR,THERE,THEREFORE
APOPTOSIS,BAD,BAK,BAX,BCL,BH3,BID,BIK,BIM,BMF,BOK,GBM,HOWEVER,HRK,MCL
150MG,CMF,DOCETAXEL,FEC,FORTY,LAPATINIB,UFT
000MG,250MG,2MG,4MG,AFTER,CAP,LAP,PTX,TRA,ZOL
057,100,24W,BRAIN,LAPATINIB,MBC,ORR,THERE,TTP
ADDITIONAL
AFTER,BACKGROUND,CNS,CONCLUSION,FURTHER,LABEL,METHODS,MRI,PET,RESULTS,SECONDARY,SYSTEMATIC
160,18F,BASED,CBV,CONCLUSION,EIGHT,FET,HOWEVER,LABEL,LESIONS,METHODS,MRI,OBJECTIVE,PARTIAL,PET,PURPOSE,THESE
005,007,100,103,ACTUARIAL,COX,EASTERN,GAMMA,GROUP,KARNOFSKY,KNIFE,LOCAL,LOG,MEIER,NETWORK,OCTOBER,ONTARIO,RADIATION,RCC,RENAL,SMALLER,SRS,THERAPY,TORONTO,UNIVERSITY
169,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,METHODS,MRI,RESULTS
001,009,039,169,COPYRIGHT,DSC,INC,MRI,PSR
ADRENAL,CNS,NEOPLASTIC,PRECOCIOUS,SERTOLI
AIC,TMZ
001,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PERCENT,RESULTS,SRS,THEREFORE
ACC,AWAKE,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
001,005,007,015,016,019,034,111,161,BACKGROUND,CONCLUSION,CSS,END,GROSS,GTR,HPC,INSTITUTE,LABEL,METHODS,MVA,OBJECTIVE,PROGRAM,RESULTS,STR
18F,HOWEVER,IMAGING,MRI,PET,THESE
176,DOF,FRAMELESS,ISOCENTERS,PATIENT,PTV,SINCE,THESE
FINALLY,HOWEVER,JANUS
CURRENTLY,DIA,DIG,GTR,PATHOLOGIC,UNUSUAL
000,001,100,349,613,BETWEEN,MEIER,TNM
169,COPYRIGHT,HBS,IRELAND,LIMITED,LTD,SALVAGE,TOTAL,VHL
169,AUTHORS,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY
946,CHEST,HOWEVER,MRI
123,177,205,ALTOGETHER,ATC,AUTOPSY,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,RESULTS
ARGENTINE,CATCHESIDE,LEA,RBE
169,945,CD4,GBM,GL261,INJECTION,LABEL,METHODS,MRI,OBJECTIVE,PULSING,PURPOSE,RESULTS,THERE,VACCINE
002,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PERFUSION,RESULTS
001,BACKGROUND,CONCLUSION,GBM,LABEL,METHODS,MRS,OBJECTIVE,PRIMARY,RESULTS,WORLD
001,011,214,BACKGROUND,CONCLUSION,DWI,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,MYELOID,POTENTIAL
BNIP3,BTSCS,CD133,E1B,THESE
ADDITIONAL,BACKGROUND,LABEL,MARCH,MAXIMUM,METHODS,NETWORK,ONTARIO,OUTCOME,OVERALL,RESULTS
BRAZILIAN,MEMBERS
169,ACCEPTABLE,BASEL,COPYRIGHT,FIFTEEN,PGP,TQD
BEIJING,LABEL,METHODS,OBJECTIVE,RESULTS,RMS,SEVEN,TONGREN

275,DR4,MBS,MSC,TRAIL,USING
ACTININ,ACTN1,BASED,CPG,THEREFORE
100,105,125,286,ACTUARIAL,BACKGROUND,DUE,IBT,III,LABEL,METHODS,RESULTS,SIXTEEN,TREATMENT
169,945,946,949,ACMSD,AHR,BRAIN,DESPITE,FURTHER,GIVEN,HAA,IDO,KYN,NAD,PIC,TARGETING,TDO,TRYPTOPHAN
945,946,TOBACCO
JANUARY,RADIATION
160,ATRTS,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
001,002,ADULT,BTS,CHI,CIS,HRQOL,ORS,OVERALL,RESTRICTED,SURVIVORS
160,500,750,BACKGROUND,COX,LABEL,METHODS,PRIMARY,RESULTS,TREATMENT
CNS
AVASTIN,CURRENTLY,HOWEVER
100,160,352,785,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RAMAN,RESULTS,SPECTRA,THESE
AMONG,HOWEVER,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
CURRENTLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TUNEL
ANALYZING,ATLAS,BACKGROUND,CONTACT,CURRENT,LABEL,MODEL,MOTIVATION,RESULTS,USING
AFTER,PURPOSE
169,BBB,BRAIN,COPYRIGHT
169,CIDOFOVIR,COPYRIGHT,HPV,IRELAND,LTD
169,COPYRIGHT,COX,INC,MARIJUANA,STUDIES
169,COPYRIGHT,EWING,INC,MICROARRAY,STEAP,TAKEN
169,946,COPYRIGHT,IRELAND,LTD,MICRORNAS,PCR,TCF,USING,UTR
139,169,CONCLUSION,COPYRIGHT,INC,KPS,LABEL,METHODS,OBJECTIVE,RESULTS
100PT,112,132,169,215,80YEARS,BACKGROUND,CONCLUSION,COPYRIGHT,ELDERLY,EPICA,HISTORY,HOWEVER,LABEL,LTD,METHODS,RESULTS,TIA,VKA
ADRENAL,BACKGROUND,CRH,CUSHING,LABEL,LT4,SIX,SUMMARY,THESE
176,463,BACKGROUND,CONCLUSION,FURTHER,GYE,LABEL,METHODS,REGARDING,RESULTS
AMONG,BACKGROUND,DISCUSSION,GIVEN,LABEL,METHODS,MRI,PET,PRIMARY
ALABAMA,CSF,ENDOSCOPIC,ETV,FAILURE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
CNV,EBV,LCL,SNP
100,267,BRACKMANN,FNS,GRADE,HOUSE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SMS,THERE,THESE,UNIVARIATE
BRAIN,THESE
CPG,GBM,MULTIFORME,THESE,WHILE
169,946,FOXM1,WNT
CONCURRENT,DESPITE,LABEL,OPINION,SMALL,STATEMENT,UNASSIGNED
1960S,1980S,775,BACKGROUND,BORGO,BRAIN,CENTRAL,GARIGLIANO,GIS,HOWEVER,INCIDENCE,INDIVIDUAL,ITALY,LABEL,METHODS,MORTALITY,NPP,NUCLEAR,OBJECTIVE,POISSON,RESULTS,SIR,SMR
BECAUSE,CNS,HODGKIN,PRIMARY,RICHTER
500,ADC,AUC,BACKGROUND,CMS,CNS,DWI,GREATER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSE,RSI
METASTATIC
CWR22,ONCOLYTIC,THESE

EPHB4,HOWEVER,TAKEN
160,BEIJING,BETWEEN,CHINA,COX,FOCAL,KARNOFSKY,MEIER,OVERALL,TIANTAN
160,CURRENT,FINALLY,INHIBITION,PD0332991
BRAIN
001,138,215,365,777,812,ADC,BACKGROUND,BASED,BETWEEN,CONCLUSION,COX,GBM,GROUP,JANUARY,KARNOFSKY,KPS,LABEL,MEIER,METHODS,MRI,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RPA,SEPTEMBER,THERAPY
169,173,CALIFORNIA,COPYRIGHT,DESPITE,FRANCISCO,GTR,LTD,MEIER,MIB,RECURRENCE,SAN,STR,UNIVERSITY,XRT
169,967,AFTER,COPYRIGHT,DEPENDING,GROUP,LTD,SEVENTEEN
169,BACKGROUND,COPYRIGHT,LABEL,LTD,MEIER,METHODS,PEARSON,RESULTS
169,CNS,COPYRIGHT,CSF,ELISA,LTD,METASTASIS
BACKGROUND,CONCLUSION,FIRST,HOWEVER,IMAGING,LABEL,LGG,METHODS,MRI,RESULTS
100,300,HEPARIN,LAMR1
277,BACKGROUND,KARNOFSKY,KPS,LABEL,LIMITED,METHODS,RADIATION,RESULTS,SOCIETY,SRS,TREATMENT,VIGNETTES
JANUARY,NEWLY,SOCIETY
101,105,148,BACKGROUND,LABEL,METHODS,N20,OBJECTIVE,PITUITARY,RESULTS,THERE
CCNB2,CHAIN,GSE2223,GSE4290,MICROARRAY,P53,PCR,POLYMERASE,THEREFORE
AFTER,ANTIBIOTIC,MENINGITIS,MRI,STEROID
CNS
INDIA,INHERITED,PDE4D,PRADESH,REPORTS,THERE
946,AMONG,CD133,CHI,EFS,FIFTY,FORTY,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,SIXTY,THEIR,THERE
100,AIM,BACKGROUND,CONCLUSION,CPG,HOWEVER,LABEL,MATERIALS,METHODS,MSP,OBJECTIVE,RESULTS,SIXTEEN,THERE
177,607,627,868,898,ADC,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
ATHYMIC,BACKGROUND,D283MED,LABEL,LUC,METHODS,NIS,RESULTS,SUBSETS,THESE
500,ABOUT,MUTATIONAL,NSCLC,PFS,THESE,TKI
169,AUTHORS,AUTOPSY,BRISK,CUSHING,DOTATOC,FOLLOWING,FOUNDATION,JOURNAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STICHTING,WHILE,YTTRIUM
435,BCL,MDA,PRION,PRP
2OHOA,767,945,BACKGROUND,CONCLUSION,FINALLY,HOWEVER,LABEL,LC3BI,MRC,PCR,PRINCIPAL,RESULTS,UPR
HOWEVER,MALIGNANT,TMZ
169,ATP,COPYRIGHT,FURTHER,PRESS,THESE,TMZ
169,946,BACKGROUND,COPYRIGHT,FINALLY,GBM,GLA,ID1,ID4,INHIBITORS,LABEL,METHODS,MGP,PCR,RESULTS,SOCIETY,TGF,THESE,WILLEBRAND
BACKGROUND,FOLLOWING,LABEL,METHODS,RESULTS,SIX
1A1,ALDH1A1,GBM
010,023,035,116,196,222,279,340,400,422,626,640,642,662,764,801,804,927,940,950,BACKGROUND,DESPITE,HOWEVER,IES,LABEL,METHODS,QALYS,RESULTS,TOTAL
100,150,160,300,BACKGROUND,CONCLUSION,GBM,LABEL,METHODS,PCR,PFS,PRIMARY,RESULTS,THERAPY
SINCE
409,823,BACKGROUND,BECAUSE,DISCUSSION,LABEL,METHODS,RECORDS,RESULTS,THERE,WHEREAS
946,CSF,HOWEVER,PCNSL,THESE,TREATMENT
ATP
169,ANXIETY,BACKGROUND,COPYRIGHT,EEG,FURTHER,INVENTORY,LABEL,LTD,MONOCHORD,PMR,PRINCIPAL,RESULTS,SAI,STATE
GBM

191,228,419,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,VTE
500,AIM,BPA,DISCUSSION,FINALLY,FUS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
945,MYC,RAS,THESE
PROTEIN
169,177,ACCORDING,ANXIETY,COPYRIGHT,DEPRESSION,ITALIAN,KNOWLEDGE,LTD,PERCEIVED,SCALE,WILEY
169,ART,CBF,CHECKLIST,COPYRIGHT,LTD,REVISED,THERAPY,WILEY
HIT,PITUITARY,SEGREGATED,THESE
000,100,169,181,600,BACKGROUND,CARCINOGEN,COPYRIGHT,DISABILITY,INC,LABEL,METHODS,MFS,RESULTS,WHERE,WILEY,YEARS
160,169,183,215,7IO,BOTHELL,CONCLUSION,EOR,FOLLOWING,GEORG,GROSS,L15,LABEL,MATERIALS,METHODS,MHZ,OBJECTIVE,PHILIPS,PURPOSE,RESULTS,STUTTGART,USA
160,ALDER,BACKGROUND,CONCLUSION,EIGHT,EVT,FIFTEEN,HEY,HISTOLOGY,LABEL,METHODS,RESULTS,SIXTEEN,SURGERY,THERE
BETWEEN,GBM,KARNOFSKY,KPS,MAY,PFS,TMZ,UNIVERSITY
169,COPYRIGHT,INC,PKA,PROTEIN,RD1,TAKEN,WILEY
000,100,160,181,500,CASPASE,DETECTION,GREEN,MMP
150,BACKGROUND,EASTERN,FORTY,FURTHER,GROUP,LABEL,METHODS,NSCLC,OVERALL,PFS,RESULTS,TREATMENT
177,20YEARS,BACKGROUND,CONCLUSION,LABEL,MEDICAL,METHODS,MRI,RESULTS,SKULL,TEN,THREE
113,ABCAM,ATM,BACKGROUND,BRCA1,CONCLUSION,DDR,DETECTION,DFS,III,LABEL,METHODS,MS110,NSCLC,PREVIOUSLY,RESULTS,S1524
SEVEN
100,160,181,CCK,ECH,GBM,HOWEVER,KEAP1,KELCH,KNOCKDOWN,OXIDATIVE,TAKEN,TEM,TMZ
GBM,GBMSC,THEREFORE
APERTURES,EMPLOYING,FILMS,GAFCHROMIC,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS
235,ASIDE,LABEL,MAXIMUM,METHODS,MID,MPP,MRI,OBJECTIVE,PRECISION,PROJECTION,PURPOSE,RESULTS,USING
BACKGROUND,DIAGNOSIS,DISCUSSION,DUE,LABEL,LBP,METHODS
002,015,032,100,1ST,429,5TH,DOS,LABEL,METHODS,OBJECTIVE,PCH,PURPOSE,RESULTS,VAS
169,AFTER,COPYRIGHT,CTX,FURTHER,INC,THESE,TMZ,WILEY
BIOMARKERS,TREATMENT,WHILE
BACKGROUND,FDG,FET,FEW,FLT,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,STUDIES,THESE
AKT,LRIG1,MYC
TSC
186,ASIAN,BRAIN,CHINA,FIFTY,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,INC,MRI,WHILE
169,945,946,947,949,954,ACTIVATED,COPYRIGHT,EGF,HOWEVER,IKK,INC,PKC,PKM,PLC,THESE,TNF
169,183,APRIL,AUG,BACKGROUND,BETWEEN,BRAIN,CNS,COPYRIGHT,FEW,FUNDING,LABEL,LTD,METHODS,RESULTS,TRETAMENT,UNICANCER
169,COPYRIGHT,HOWEVER,IRELAND,LTD,MALIGNANT,THESE
169,COPYRIGHT,INC
169,CNS,COPYRIGHT,IMAGING,INC
BRAIN,LITHIUM
BACKGROUND,DIRECTIONS,FAILURE,LABEL,MMR,RESULTS,STUDIES
AFTER,DYSPHASIA,FIFTEEN,LABEL,MEP,METHODS,MOTOR,OBJECTIVE,RESULTS,THESE,VAGAL
001,008,037,177,397,424,488,AWAKE,HISTORY,HOWEVER,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,TEL
ANN,CHICAGO,HOWEVER,JPA,LABEL,LURIE,METHODS,MRI,OBJECTIVE,RESULTS,SMV
PEDIATRIC,UNTIL
AUTOPSY,BACKGROUND,LABEL,UNLABELLED
BACKGROUND,LABEL,UNLABELLED
ALK,LMC,MRI,PAS,PREMORTEM,SRC,THESE,TTF
001,154,270,549,574,637,BSP,CONCLUSION,COX,CUMULATIVE,GBM,III,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PCR,PFS,RESULTS,SMALL,UNIVARIATE
002,11P15,CGH,PCR,PRKCDBP
BACKGROUND,EARLY,ELISA,FINALLY,HSPD1,LABEL,METHODS,PDIA3,RESULTS,SPATA20,WESTERN
10001,333,DM1,DM2,MEDICAL,OPTIMAL,PUBLISHERS,SEVENTH,USA
697,AMONG,BETWEEN,MRI
100,123,AMONG,CENTRAL,CNS,EORTC,GENERAL,GROUP,MGH,MSG,MYCOSES,NOTABLY,TREATMENT
100,128,177,192,215,948,ASL,BACKGROUND,BLOOD,CONCLUSION,INVERSION,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SNR
169,200,207,945,COPYRIGHT,TIO
120,130,169,351,AFTER,AGE,CHINESE,COPYRIGHT,FURTHER,LTD,REDUCED
100,169,AKT,COPYRIGHT,EXPRESSION,GHR,HORMONE,IGF,LTD,PRIMARY,WESTERN
169,APRIL,COPYRIGHT,CPA,LTD,SURGERY,TOTAL
169,177,233,313,400,956,COPYRIGHT,FIRST,FURTHER,HIGUCHI,HOWEVER,INC,LABEL,NOS,NOSCAPINE,PEG,SLN,UNASSIGNED,UNLABELLED
169,J3T,PCR,SOCIETY,THESE
DISCUSSION,DVT,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RATES,RESULTS,STRATEGIES,SYSTEMATIC,THERE,WHETHER
FINALLY,METHODS,MRI
CSF,DISRUPTION,THESE,TSH
CLINICIANS,DISCUSSION,LABEL,METHODS,NARANJO,OBJECTIVE,SUMMARY
001,181,FDG,FLT,MRI,PET,THESE,U87,WHILE
002,007,100,108,ACTIVATED,COX,GBM,KARNOFSKY,KPS,NUCLEAR
AMONG,MUTATIONS,R132H,R172K,ROS,THESE,U87MG
CUSHING,DESPITE,MORTALITY,MRI,SELECTIVE,TSS,UNTREATED
104,169,20Q13,215,868,AFTER,BONFERRONI,COPYRIGHT,DENMARK,ORTREND,RTEL1,THESE,USA
000,169,200,BACKGROUND,BRAIN,CHEMISTRY,CONTENT,FAVORABLE,LABEL,SUMMARY,THERE
169,COPYRIGHT,ERBB1,ERBB2,GBM,INC,RESULTS,SIMILAR,TAKEN,THESE,WESTERN,WILEY
001,169,176,215,COPYRIGHT,CRUCIALLY,D08,D2159MG,D283MED,D425MED
946,ALZHEIMER,CNS,LEF,NEUROAIDS,TCF,THESE,WNT
BRAIN,CURRENT,DYNAMIC
AFTER
PHOTOFRIN,SEVERAL,STRATEGIES,THEREFORE,TIC,YET
HOWEVER,LYS36,SELECTIVE,XENOPUS
948,952,EEG,LOW,MRI,NMDAR
BACKGROUND,LABEL,METHODS,MRS,NF1,OBJECTIVE
ASIDE,BACKGROUND,BASED,CAREFUL,LABEL,METHODS,MRI,OPHTHALMIC,THERE
946,AAT,APO,BACKGROUND,CHAIN,CSF,LABEL,METHODS,PTGDS,RESULTS,TTR,WESTERN,YPSILANTI
AFTER,ASIAN,BASED,CONCLUSION,LABEL,NARANJO,OBJECTIVE,PER,PURPOSE,SUMMARY
100,COX,FIFTY,FORTY,GROSS,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PFS,RESULTS,THESE
3X3,CEREBELLAR,GBM,MRI,PRIMARY
018,132,139,172,19Q,964,IDH,III,ISOCITRATE,KENDALL,MUTATIONS,SEVERAL,WORLD
169,20S,24S,CONCLUSION,COPYRIGHT,DISCUSSION,EFFECTIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
025,026,032,037,061,076,BACKGROUND,COX,FORTY,HOWEVER,LABEL,LOG,METHODS,NSCLC,RESULTS,RPA
BACKGROUND,CONCLUSION,DUE,LABEL,METHODS,MRI
CHRONIC,INCREASING,THESE
002,003,CONCLUSION,HEMOGLOBIN,LABEL,METHODS,OBJECTIVE,PFS,RECURSIVE,RESULTS,RPA,TOTAL
EXPRESSION,PEDIATRIC,SMARCB1
177,ACCORDING,DIGIT,HOWEVER,MARCH,SORTING,TAPPING,THESE,WISCONSIN
QOL,SEVERAL
ACTIVATION,HGG,INITIAL,VTE
GROSS,NEWER
000,100,CNS
001,002,004,100,MRI,REDUCED,SEVENTY,SURVIVORS

19Q,26951,GROUP,HOWEVER,IDH,III,NOA,RADIATION,THERAPY,THESE,TREATMENT,WORLD
GBM
MEDICAL,METICULOUS
CNS,DIFFUSION,LIBRARY,MRI,USA
PEDIATRIC
130,CNS,SOCIETY,USA
945,GBM,SOX,THESE,USING
231,468,946,DOX,HOWEVER,MDA,PEG,U87MG
19Q,CPG,DIFFUSE,IDH,STUDIES
169,428,856,CAD,COPYRIGHT,LTD,PCA,SROIS,WILEY
FURTHER,MAPKS
AFTER,BACKGROUND,DISCUSSION,HOWEVER,LABEL,METHODS,MRI,NF1
160,AMONG,BACKGROUND,ENDOSCOPIC,LABEL,LANGERHANS,LESIONS,METHODS,NIIGATA,OTHERWISE,RESULTS,TPS,UNIVERSITY
916,CESAMET,HUNTINGTON,MARINOL,PARKINSON,SATIVEX,THC,THESE,THREE
145,LEE,PCR
024,120,215,CD3,FOXP3,GBM,IHC,PCR,TREGS
BRAIN,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
FINALLY,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ADC,CHO,DTI,DWI,LABEL,METABOLITE,METHODS,MRI,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS,ROI
MLL,TRITHORAX
160,169,CHEMOBRAIN,COGNITION,COPYRIGHT,FORCE,HOWEVER,ICCTF,SAS
169,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,CVA,GLIOMAS,GRADE,INTERMODAL,LABEL,LGG,LOW,METHODS,PUBLISHED,RESULTS,SAS
169,19Q,AUTHORS,BRAIN,DISCREPANT,PATHOLOGY,PCR,SOCIETY
122,169,215,352,ASSOCIATED,COX,HUVEC,III,SALVAGE
169,AC133,BLACKWELL,CD133,LTD,PUBLISHING
131,DTC,IMAGING,METASTASES,THESE,TREATMENT,WBS
361,398,APRIL,DEPARTMENT,FDG,PET,RESULTS,ROUTINE
SINCE
19Q,945,ALT,FINALLY,HOWEVER,IDH,LGG,MUTATIONS
798,904,ADDITIONAL,GST,GSTM3,GSTP1,GSTT1,HOWEVER,LABEL,LARGE,METHODS,MINNESOTA,OBJECTIVE,OBJECTIVES,ORS,RESULTS,SOLVENT,WISCONSIN
INCREDIBLY
156,183,AMONG,AUDIOMETRY,GEORG,LOWER,MRI,STUTTGART
002,015,027,049,160,161,193,301,381,545,III,ISH,LNA,MICRORNAS,USING
001,110,160,FACTORS,III,PREDICTIVE,SEVEN,VARIOUS,WORLD
001,181,CD133,CONVERSELY,EPIDERMAL,GBM,INHIBITION,OCT,OVERCOMING
ANXIETY,ASSESSMENT,BRAIN,CAREGIVER,CRA,DEPRESSION,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SCALE,SHORT,THERAPY,THEREFORE
905,914,ACTIVATED,HYPOXIA,SOCS3,STAT3,THESE
001,008,123,133,143,160,401,571,855,889,AMONG,BEV,DVT,ICH,III,MRI,NETWORK,OUTCOME,RATES,RELATIVELY,WORLD
003,169,375,AIM,BACKGROUND,COPYRIGHT,COX,HOWEVER,IRELAND,KARNOFSKY,KPS,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,THESE
001,003,059,204,274,ASA,BACKGROUND,FRAME,HOWEVER,INCLUSION,LABEL,MAY,METHODS,RESULTS,SECONDARY,SOCIETY,THERE
169,189,954,AKT,CBR,CLNAS,COPYRIGHT,DHA,EPA,FURTHER,JUN,LTD,PI3,PPARS,TRPV1
169,241,COPYRIGHT,HOWEVER,IGF,INCREASING,THESE
004,169,BACKGROUND,COPYRIGHT,INC,INDUCTION,LABEL,METHODS,PUBLISHED,RESECTION,RESULTS,SOCIETY,THERE
169,916,945,947,967,COPYRIGHT,DTI,HOWEVER,INC,RESULTS,THESE
100,111,169,ADVERSE,APRIL,COPYRIGHT,FACTORS,INC,LABEL,MARCH,MATERIALS,METHODS,MRI,OBJECTIVE,OLDER,PURPOSE,RESULTS
169,19Q,215,4CM,COPYRIGHT,FOLLOWING,MOLECULAR,R132H,SIMILARLY,WHEREAS
100HZ,169,COPYRIGHT,FOSSA,HOWEVER,LTD,POSTERIOR
GENERALLY,HOWEVER,INC,OVERALL,PUBLISHED,RAPID,THYROID
101,ADULT,BACKGROUND,CONCLUSION,DOSES,FIFTEEN,LABEL,LEVEL,METHODS,NHP,NOTTINGHAM,PROFILE,QOL,RESULTS,SCL,SYMPTOM,WHETHER
085,362,399,BACKGROUND,CAUCASIAN,CAUCASIANS,EXCLUSION,GRADE,III,LABEL,METHODS,RESULTS,SIX,XRCC1
MRI,NAVIGATED,TMS
ANTIVIRAL,CAREFUL,HSE
BRCA2,SLE
10A,HOWEVER,INCREASED,MCF,NEUTROPHIL
BRAIN,KOMAI,MRI
001,012,100,249,264,278,295,ABL,BACKGROUND,CDK,CONCLUSION,GRADE,LABEL,MEK,METHODS,PI3KINASE,RESULTS,SRC,THERE,TOR,VEGFR
177,CNS,EVENT,FEW,FIFTEEN,SEVEN,THREE
300,400,500,AGS,GBM,MTD,QTC,SIX,VANDETANIB
215,779,800,946,BRAIN,CCI,CONSORTIUM,MINIMAL,MTD,NORTH,PFS,RAF
222,MICRORNAS,RSD,TOTAL
001,153,APRIL,BACKGROUND,CONTEXT,ESTIMATED,INITIAL,LABEL,LGG,MEASURE,METHODS,NORWEGIAN,OBJECTIVE,OUTCOME,OVERALL,RESULTS,SETTING,THERE
CUSHING,INC,PUBLISHED
169,COPYRIGHT,INC
10YEARS,160,169,177,BACKGROUND,COPYRIGHT,DESPITE,DISCUSSION,LABEL,MA2,MARCH,MERCKEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OCTOBER,PET,RESULTS,SAS,SPECT,SSA,TPO
LABEL,MALDI,METHODS,OBJECTIVE,RESULTS,THESE,TOF
177,183,215,956,CURRENTLY,FDA,ICG
001,004,012,019,026,108,5X6,6X5,7X5,945,946,BACKGROUND,COMPARING,CONCLUSION,COX,DESPITE,EARLY,GROSS,GTV,LABEL,METHODS,RESULTS,VARIABLES
161,189,FURIN,PCS,TRP
BAC,CRE,GSK3B,RCAN1,TG1,TG2,WAP
309,606,ARG,ORS,PRO,TAKEN,UNDER
CCM,INHIBITION,RHO
LABEL,METHODS,OBJECTIVE,OWING,PITUITARY,PURPOSE
001,134,525,729,839,863,865,BACKGROUND,CONCLUSION,COX,FORTY,GBM,GLUTAMATE,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PATIENT,R132H,RESULTS,SCALE,STATE,THESE
001,945,BACKGROUND,CONCLUSION,ELTD1,F98,GBM,LABEL,METHODS,OBJECTIVE,RESULTS,VALIDATION
005,177,CAM,CSF,III,NEO,THERE
141,238,241,249,BMS,DEPARTMENT,MEDICAL
160,PCR,PXA,SEVERAL,TEN,V600E
GBM,HS683,STAT3,U87
002,015,169,AMONG,BASED,BASEL,CONCLUSION,COPYRIGHT,CSM,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
100,300,FDA,GBM,RECURRENCE,TTFIELD
002,169,251,426,BACKGROUND,BASEL,COPYRIGHT,DECREASED,LABEL,MAY,METHODS,RESULTS
BECAUSE,HOWEVER,SCD,SEVERAL,TBI
DESPITE,MODERATOR,RESULTS,THESE
HOWEVER
002,006,025,114,177,ASPIRATION,DEPARTMENT,INSTITUTE,KASHMIR,MEDICAL,OCTOBER,SIMILARLY
120,APSTM,AUTOMATIC,MAJOR,STOCKHOLM,TREATMENT
002,003,GBM,III,MEIER,MRI,PFS,SVZ
COMPONENT,FCM,FUZZY,JACCARD,PCA,PRINCIPAL,ROI,SVM
AMP,ATP,FURTHER,IMPORTANT,NUCLEAR,ONS76,SONIC,WNT
DIFFUSIVE
CHOUDHURY,JCI,RAP2A,WHILE
376,CLINICALLY,RAP2A,THESE,USING
169,EARLY,HOWEVER,MRI
169,177,COPYRIGHT,EFS,INC,LABEL,MATERIALS,METHODS,MGD,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SIXTY
001,169,299,573,945,946,BED,BED10,BETWEEN,COPYRIGHT,INC,LABEL,LOCAL,MARCH,MATERIALS,MEIER,METHODS,MRI,NOVALIS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX
BBB,THEREFORE,THESE,TREATMENT
CNS,HOWEVER,IVL
BRAIN,CORTICOIDS,QOL,QUALITY,THERE,WHOLE
BELGIUM,CREATED,GAMMA,KNIFE,ULB
PDT
108,500MG,5FU,BACKGROUND,BNP,CHD,CHINA,CHRONIC,CROSS,FORTY,INSTITUTE,LABEL,LACTATE,LDH,MEDICAL,METHODS,PERIPHERAL,RED,RESULTS,SICHUAN,STUDIES,UNIVERSITY
033,047,BBB,CONCLUSION,EXACT,GTR,IMAGING,KARNOFSKY,KPS,LABEL,METHODS,MRI,OBJECTIVE,QUALITY,RESONANCE,RESULTS,SCALE,STUDENT,THREE
001,118,177,CONCLUSION,IDENTICAL,LABEL,METHODS,MLC,OBJECTIVE,PTV,RESULTS,SRS,TCP
100,110,200,DLT,GRADE,OVERALL,PFS
19Q,ACS,BTV,COMPARABLE,FET,HOWEVER,III,KINETIC,LOH,MRI,PET,SUSPICION,SUV,THESE
MEDLINE,WORLD
19Q,225,ASIAN,CHINESE,CLASSICAL,CONSENSUS,HOWEVER,REMBRANDT,THREE
177,946,99M,HYNIC,MALDI,METABOLIC,NMR,OCTREOTATE,THESE,TOC,TRICINE,USING
CURRENTLY,MRI,PITUITARY,PRL
231,931,963,COMMISSION,DIGITALLY,INTENSITY,LABEL,MARGINS,MATERIALS,METHODS,MODULATED,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SDS,SETUP,THERAPY,UNITS
003,109,377,531,CHI,CONCLUSION,COX,CURRENTLY,GTR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PFS,RECURRENCE,RESULTS,STR,THERE,THESE,TREATMENT,XRT
169,BIOLOGICAL,COPYRIGHT,LDH,PAMAM,PBECS
169,947,ADENOVIRAL,ATM,BAX,COMET,COPYRIGHT,DSB,EXPRESSION,MRE11,PRMT1,S15,S1981,S20,T68,THEREFORE,THESE,TIS21
AFTER,BACKGROUND,CONCLUSION,FDA,III,KIT,LABEL,METHODS,MRI,PAZOPANIB,THERE,UNTIL
CASES
00075,120,BACKGROUND,BBB,BNP,CONCLUSION,LABEL,METHODS,RESULTS,VAS
NAD,ORIGINALLY,THESE
101,169,CONCLUSION,COPYRIGHT,DCE,ESTIMATED,INC,INCREASING,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE,TOFTS,USING,WILEY
ALZHEIMER,GLYCOLYSIS,METABOLIC,NATURAL,ROS,WARBURG
GBM
157,160,HOWEVER
BRAIN,NSCLC,TKI
160,239,BEV,CONTINUOUS,FDG,PET,SECONDARY,SIX,SIXTY,SUNITINIB,TARGETING
100,160,200,GROUP,III,MST,RADIATION,RPA,THERAPY
001,160,ENDOGENOUS,EXPRESSION,GBM,GBM28,MRI,PCR,PET,T98,THESE,TRANSIENT,WESTERN
001,024,BACKGROUND,LABEL,METHODS,MRI,RESULTS,VARIABLES
001,ANOVA,AUROC,DTI,GBM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
177,764,CNR,GADOBUTROL,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SNR
GEMMS,THESE
120,150,160,169,AUR,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SYSTEMATIC
169,COPYRIGHT,PELORUSIDE,THEREFORE,VARIATIONS
169,AFTER,CAUDA,CES,COPYRIGHT,EARLY,MRI,PUBLISHED
054,169,567,578,BACKGROUND,BRAIN,COPYRIGHT,FIFTEEN,LABEL,LTD,METHODS,RESULTS,SEVENTY,THROMBOSIS,VTE
169,ALDH1,COPYRIGHT,LTD,PFS,THESE
169,COPYRIGHT,LTD
001,169,422,AFRICAN,AMONG,CAUCASIAN,COPYRIGHT,LOS,LTD,MARKETSCAN,MORTALITY,THOMSON,UNIVARIATE
169,COPYRIGHT,GBM,LTD,PRIMARY
185,GROUP,KARNOFSKY,MET,MRI,PET,RADIATION,RPA,SCALE,THERAPY,UNIVARIATE
169,AFRICAN,BACKGROUND,BONES,COPYRIGHT,EWING,INC,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THREE
CONCLUSION,EARLY,LABEL,OBJECTIVE,REGULAR,RESULTS,SMALL
169,COPYRIGHT,HOWEVER,SAS
009,169,1ST,CONCLUSION,COPYRIGHT,FACTORS,IRELAND,LABEL,LTD,LTS,MARCH,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STS,THERE,THESE,WHILE
HOWEVER,PROTOCOLS,THESE
023,089,BLINDED,LABEL,METHODS,MRE,MRI,OBJECTIVE,RESULTS
168,238,354,388,400,423,525,600,614,688,774,853,898,929,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,THESE
DIFFERENT,GROSS,R132H,V600E
130,AFTER,ANXA2,BIOMARKERS,COX,LABEL,MEIER,METHODS,OBJECTIVE,PGAM1,PROTEIN,RESULTS,U87
945,CELLS,DESPITE,HIF,HOWEVER,HYPOXIA,HYPOXIC,LABEL,MED,METHODS,MYC,NEITHER,OBJECTIVE,RESULTS,TARGETING
945,CNS,GCT,HENCE,HOWEVER,SERUM,THEREFORE
ADDITIONAL,CNS,DESPITE,FDA,HOWEVER,SURGERY,THEREFORE,V600E
CNS,FIRST,PRIMARY
ACSONAL,ACUTE,AUTHORS,BARRE,MOTOR,NEUROPATHY,TREATMENT

PICCOPLUS
100,ELEVATION
HISTORY
CONCLUSION,FLT,LABEL,METHODS,PET,RESULTS,THERE,UNLABELLED
MRI,THEREFORE
142,EETSA,EVALUATION,HOWEVER,NASAL,OUTCOME,STUDENT,SYMPTOM,THEREFORE,VAS
FURTHER
160,379,404,A114V,GBM,GST,GSTM1,GSTP1,GSTT1,HOWEVER,I105V,JANUARY
169,COPYRIGHT,FOXG1,G34,GBM,H3F3A,INC,K27,OLIG1,OLIG2,THREE
169,BACKGROUND,CELLS,COPYRIGHT,GENERAL,GSC,ISSUE,LABEL,MAJOR,OBJECTIVE,SCOPE,SPECIAL,THESE
169,COPYRIGHT,HCY,HOWEVER,INC,THEREFORE
169,COPYRIGHT,DMN,EAS,FURTHER,HOWEVER,LTD,THESE,WMT,WORKING
066,108,150,198,250,400,956,BACKGROUND,BETWEEN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,PVA,RESULTS,SEPTEMBER,THERE
177,ADC,BACKGROUND,CAUTION,FDOPA,GBM,III,LABEL,MATERIALS,METHODS,MINIMAL,OBJECTIVE,PET,PURPOSE,REGIONS,RESULTS,THERE
CBD,GBM,OVERALL,SEVERAL,THEREFORE,TMZ,TRP,TRPV2
177,COMPETENCE,CONNERS,INCREASED,INDEX
BACKGROUND,ERUFOSINE,FURTHER,HOWEVER,LABEL,METHODS,RESULTS
017,150,169,178,183,302,313,320,334,350,657,APRIL,BACKGROUND,BETWEEN,COPYRIGHT,EASTERN,FUNDING,GRADE,GROUP,LABEL,LTD,MARCH,METHODS,NSCLC,RESULTS,ROCHE,TOPICAL
CBN,COLLOID,LABEL,PAS,UNASSIGNED,UNLABELLED,VIRTUAL
169,SOCIETY
169,ANY,GRADE,SMALL,SUMO1,SUMO2
AIM,BRAIN,DESPITE,DISEASE,III,IMAGING,LABEL,METHODS,MONITORING,MULTIMODAL,OBJECTIVE,RESULTS,SEVEN,UNLABELLED
BACKGROUND,CONCLUSION,CRE,LABEL,PRINCIPAL,RESULTS,SVZ,THESE
947,AKT,GFP,HOWEVER,LC3,LN428,RADIATION,RADIO,U87
328,GBM,MICRORNAS,MIR,U87
ARTIFICIAL,CNS,PERIPHERAL,SEMLIKI,SFV,SINDBIS,TAKEN
002,024,204,397,577,CONCLUSION,FLT,LABEL,MEIER,METHODS,MRI,PET,PVS,RESULTS,RTL,SBR,SUV,UNLABELLED
001,HOWEVER,IMAGING,MPNST
118,129,GPA,HIF1A,KARNOFSKY
2ND,494,ADVERSE,DESPITE,EIGHT,MRI,THERE
10Q,10Q23,11P,12Q,15Q,160,17Q,17Q23,22Q,64257,ACTA2,ADC,CNA,FAS,ICAM2,INVERSION,MIP,MOLECULAR,NEURL1B,NSCLC,PROBE,SQCCS,THOSE
CHROMOSOME,DELETIONS
145,MICRORNAS,USING
LABEL,METHODS,OBJECTIVE,PARK7,PRX,RESULTS,THERE,WHILE
160,APOPTOSIS,BCL,GBM,SAMPLES,SATB1,SPECIAL,THEREFORE
945,GBM,HIF,TMZ
004,005,011,090,AMONG,CD133,COX,HEMATOLOGY,HRS,HTERT,ITALIAN,NCL,PCR,PEDIATRIC,PROM1,RFS,SEVERAL,UNIVARIATE
GBM,MMP
100,169,181,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,GCA,HISTOLOGY,LABEL,METHODS,MRI,THESE,WORLD
BACKGROUND,EVALUATED,LABEL,MALIGNANT,METHODS,MRI,MSM,RESULTS,THERE,TIC
001,ACCORDING,AFTER,ASSESSMENT,BLOOD,HTN,MRI,NEURO,PFS,RADIOLOGIC,TREATMENT
BACKGROUND,CONCLUSION,LABEL,METHODS
12054,12062,189,928,956,ATP,P2X,PSB
100,ADVERSE,AFTER,BACKGROUND,CONCLUSION,CSF,HOWEVER,IGF,LABEL,METHODS,OPERATING,RESULTS,SIXTY,THERE,TOTAL
NGF,NTR,THESE
138,167,168,284,619,BAC,HOWEVER,III,KDR,PCR,SIMILAR
AKT,ERK,EXPRESSION,MALIGNANT,MEK,MIGRATION,PCR,THESE,WESTERN
FINALLY,THESE
GBM,LARGE,RINT1
169,22Q11,AFFYMETRIX,COPYRIGHT,INC,LOH,MIB,MIP,R158X,REMARKABLY,RESULTS,SMARCB1,SNP,THESE,WILEY
CDC42,HOWEVER,INHIBITION,RHO,THESE
001,169,COPYRIGHT,DCE,DYNAMIC,EVALUATION,LTD,MEIER,MRI,SOLID,TMR,WILEY
002,745,947,ADP,ADPRT,ARG399GLN,BONFERRONI,CAUCASIANS,CHINESE,HARDY,INDIVIDUAL,ORS,PARP1,THESE,VAL762ALA,XRCC1
AMONG,DESPITE,DRUGS,FDA,FOLKMAN,THROUGH
947,948,BF1,CD3,CD4,CD5,CD7,CD8,DISEASE,EPSTEIN,FIFTY,LDH,THESE,TIA
100,945,HDACI,JNJ,SMA,SMN,TAIWANESE
100,BRAFV600E,EMA,OWING
169,CNS,COPYRIGHT,DESPITE,INC,ISSUE,METASTATIC,SPECIAL
ACC,BACKGROUND,BESIDES,CONCLUSION,DEPARTMENT,HEIDELBERG,HIT,ION,LABEL,MATERIALS,METHODS,RESULTS,THERAPY,TREATMENT
016,138,141,169,AUTHORS,BRAIN,IHC,MUTATIONS,PATHOLOGY,PCR,PNA,SOCIETY,USING
169,HOWEVER,UROLOGICAL
19Q,ANAPLASTIC,AOD,CIC,CNLOH,DESPITE,FUBP1,NEWLY,NOVEL,PRISE,RECURRING,STUDIES
BECAUSE,BRAIN,BT474,THESE
124,160,859,GRADE,HIPK1,III,LABEL,METHODS,NON,OBJECTIVE,RESULTS
001,143,148,19Q,ANAPLASTIC,AOA,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PCV,PURPOSE,RESULTS
112,140,19Q,368,ADULT,ANAPLASTIC,CONCLUSION,IDH,III,LABEL,METHODS,OBJECTIVE,PCV,PFS,PURPOSE,RESULTS
001,220,CHECKLIST,CHILD,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PARENTS,PATIENT,PURPOSE,RESULTS,SEVERAL
DEPENDENCE,FDA,SMOOTHENED
BRAIN,CHI,MRI,NF1,THESE
169,ASB,COPYRIGHT,CSF,HOWEVER,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,RIGID,SOCIETY,THERE
2ND,945,947,AFTER,IFN,INTERFERON,KNIFE,THEREFORE
169,916,COPYRIGHT,CTV,FDG,FLT,GTV,IMAGE,IRELAND,LABEL,LTD,METHODS,PEARSON,PET,RESULTS,SPATIAL,SUV,THESE,UNLABELLED,VOXEL
169,AMONG,COPYRIGHT,HOWEVER,INC,PCR,RUNX2,SP3
169,757,829,943,ASSESSMENT,COPYRIGHT,DSC,FDG,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV,SUVLESION,SUVNORMAL
100,169,222,241,ALARA,CEA,CONCLUSION,COPYRIGHT,CRC,FDG,FINALLY,LABEL,MBQ,METHODS,NPV,OBJECTIVE,PET,PPV,RECURRENCE,RESULTS,SEVEN
141,469,498,BACKGROUND,CTD,ENRICHMENT,EXTENSIVE,GENERATION,HOMER,HOWEVER,INTEGRATED,JAN,KNOWLEDGE,LABEL,NCI,NGS,PATHGUIDE,PATHWAY,RESULTS,SEQUENCING,STUDIES,SYSTEMATIC,THERE
160,MINIMAL,QOL,SEVENTY,YOUNGER
110,130,169,174,COPYRIGHT,CYTOTOXIC,ETOPOSIDE,F98,INC,NPS,WILEY
183,AFTER,BACKGROUND,CONCLUSION,FOLLOWING,GEORG,HEMOSTASIS,HOWEVER,IRRIGATION,LABEL,METHODS,MRI,PATHOLOGY,REMOVAL,RESULTS,STUTTGART,SURGIFOAM
005,105,106,169,BACKGROUND,COPYRIGHT,GENOTYPING,GST,GSTP1,GSTPI,HUMANOMNI1,INC,LABEL,MEIER,METHODS,PROCEDURE,RESULTS,TEXAS,WILEY
134,169,970,BACKGROUND,COLLEGE,COPYRIGHT,DISPARITY,LABEL,METHODS,NSQIP,PROJECT,QUALITY,RESULTS,SOCIETY,THESE
GCP,GROUP,LEF,MYC,TRP53
MEDLINE
AGAINST,DESPITE,STRIKINGLY,THEREFORE

364,519,BACKGROUND,BLINDED,COX,GENERAL,LABEL,METHODS,RESULTS,THERE,TRICYCLIC
100,160,BACKGROUND,FORTY,GKS,KARNOFSKY,KPS,LABEL,METHODS,PCI,RESULTS,TEN
FAS,IDH1R132H
005,109,174,177,181,BMD,EBC,MAXMARVIL,SEVERAL
AFTER,FURTHER,HOWEVER,PFS,THERE
169,COPYRIGHT,LTD,THESE
169,946,947,ALZHEIMER,COPYRIGHT,GIVEN,HDACI,HISTONE,HOWEVER,IIHDACI,INC,SIMILARLY
169,APART,BECAUSE,COPYRIGHT,DESPITE,GPR55,LTD
169,COPYRIGHT,GBM,GSC,INC,THESE
152,169,242,745,956,ABCB1,ABCC1,ABCC2,ABCG2,AUC,COPYRIGHT,HOWEVER,INC,LOWER,REDUCED,RESULTS,THESE,WHILE,WILMS
001,169,COPYRIGHT,DESPITE,LTD,WORLD
169,BACKGROUND,CENTRAL,COLLEGE,CONCLUSION,COPYRIGHT,COSECSA,HAUKELAND,INC,KCH,LABEL,METHODS,MOSBY,NORTH,RESIDENCY,RESULTS,SAHARAN,SURGERY,THERE,UNIVERSITY
100,169,CHERNOBYL,CHILD,COPYRIGHT,DAIICHI,EARTHQUAKE,FINALLY,FIRSTLY,FUKUSHIMA,GREAT,JAPAN,MARCH,NEUROLOGY,NUCLEAR,PUBLISHED,SOCIETY,THEREFORE,THREE
169,494,709,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PUBLISHED,RESULTS,ROYAL,STRATEGIES,THERE,UNIVARIATE,YOUNGER
003,100,169,AIM,COPYRIGHT,FIFTY,FOLLOWING,JANUARY,LABEL,LTD,METHODS,MINIMUM,OBJECTIVE,RESULTS,SST
169,956,AUTHORS,BACKGROUND,BECAUSE,BRITISH,JOURNAL,KEY,LABEL,METHODS,MOLECULAR,MPP,NOS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,VEGFR
945,956,ANOTHER,GTR,LABEL,METHODS,MRI,OBJECTIVE,PEGYLAION,RESULTS,STR
001,144,ADDITIONAL,AGE,BETWEEN,GAMMA,GRADE,III,KARNOFSKY,KNIFE,LABEL,LESIONS,METHODS,OBJECTIVE,RESULTS,SCALE,WHILE,WORSE
100,169,BACKGROUND,BIPSS,CASES,CONCLUSION,CRH,CUSHING,LABEL,LTD,METHODS,MRI,OBJECTIVE,RESULTS,SGE,SIX,VARIOUS,WILEY
128,342,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,S100B,THERE
945,AMONG,PKC,PROTEIN,THESE,TNF
177,CSF,KARNOFSKY,LABEL,METHODS,MRI,NONVISUAL,OBJECTIVE,OLFACTORY,RESULTS,SCALE,TSM,VAS
945,CILIARY,CNTFR,FINALLY,FUNCTIONAL,LABEL,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SEQUENCING,THESE,TREATMENT,WESTERN
387,AUTOPSIES,CONCLUSION,HIV,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,THREE
00015,AIM,BACKGROUND,CONCLUSION,DRUGS,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
945,946,ARG,GLU,GLY,INHIBITORY,RGD
215,ABDOMINAL,AVM,OCCLUSION,UTERINE
GIVEN,HOWEVER,SMARCB1,TEN,THESE
BRAIN,CONCLUSION,IMAGE,LABEL,METHODS,RESULTS,TECHNICAL,UNLABELLED
169,AFTER,COPYRIGHT,INC,WILEY
005,013,186,551,AMONG,BACKGROUND,CONCLUSION,CONTINUOUS,COX,EASTERN,GROUP,L858R,LABEL,METHODS,NSCLC,RESULTS,THERE,TKI
164,169,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PEDIATRIC,PRIOR,PURPOSE,RANGE,RESULTS,SCALE,THESE,TREATMENT,WILEY
045,AIM,CLUSTER,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS
169,ALA,COPYRIGHT,CROWN,LTD,PUBLISHED
13Q,169,19Q,22Q,ARRAY,COPYRIGHT,HOWEVER,INC
169,237,241,COPYRIGHT,DISCUSSION,LABEL,METHODS,OFTALMOLOG,PUBLISHED,VHL,VON
169,AIM,BACKGROUND,COPYRIGHT,LABEL,LTD,MATERIALS,MAXILLO,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIX,SURGERY,THEIR
169,469,AFTER,COPYRIGHT,END,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SRS,USING
ANT,BACKGROUND,DOPPLER,EARLY,ELECSYS,LABEL,METHODS,RESULTS,ROCHE,SERUM,SURVIVORS
002,324,AMONG,G268A,GBM,LITERATURE,MMR,SNP,TMZ
169,ERDHEIM,SOCIETY,THEREFORE
945,BASED,HOPEFULLY,IGF,PIK75,R1507,RTK
ACTIVATION,GBM,HOWEVER,RTK,SUBSEQUENT,SUNITINIB,WHOLE
BACKGROUND,CONCLUSION,DISCOVERY,EVOLUTION,LABEL,LIGANDS,METHODS,PRINCIPAL,RESULTS,SELEX,SYSTEMATIC,THESE
BACKGROUND,CONCLUSION,CONTEXT,DESPITE,FDG,LABEL,LITERATURE,METHODS,STAGING,THERE,WARBURG
CNS,NF1,RAS,SOCIETY,USING
134,177,209,AIM,BACKGROUND,INTENSIVE,LABEL,METHODS,PLCNS,PRIMARY,RESULTS
PATIENT,PRIMARY,QOL
163,253,BECAUSE,CLEARLY,FURTHER,GBM

160,GBM
FET,FIFTY,KARNOFSKY,KPS,PET,SCORE,SUV
001,002,004,005,177,55933,947,ATM,GBM,GBM12,SIMILAR,THESE,TMZ,U87,WHILE
17Q,GROUP,HDACS,HR23B,MYC,PROTEIN,SHH,WNT
BESIDES,CANDIDATE,FURTHER,GLIOMAS,HOWEVER,RESULTS
945,946,957,IMAGING,MOLECULAR,MRI,TESLA,U87
160,AFTER,BRAIN,EMERGENCY,EYE,MASON,MRI,NIKOOKARI,PREVIOUSLY,RETINAL
ALONG,ALTERED,DESPITE,FINALLY,FUNCTIONAL,HOWEVER,WOMEN
160,CHINA,FAILURE,HUASHAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,TSH
CMV,FINALLY,GRP78,HSVTK,THESE,WESTERN
19Q,CHANGES,IDH,III,MALIGNANT,WORLD
GBM,HOWEVER,MRI
BACKGROUND,BASED,DISCUSSION,DUE,LABEL,METHODS,PAPILLARY,THREE
BACKGROUND,DISCUSSION,DPG,LABEL,METHODS,RESULTS
001,002,018,160,177,ASSESSMENT,BEV,CONCLUSION,FET,LABEL,METHODS,MRI,NEURO,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,TBR,TEN,TTP,USING
BACKGROUND,CONCLUSION,LABEL,METHODS,SINCE
GAMMA,GKS,KNIFE
FOURIER,LABEL,MACULAR,METHODS,OBJECTIVE,OCT,PEARSON,PURPOSE,RESULTS
19Q,BACKGROUND,DESIGNING,LABEL,METHODS,RESULTS
150,177,180,AFTER,ALERTNESS,ASSESSMENT,BACKGROUND,BLOOD,CO2,FORTY,LABEL,METHODS,OAA,PROLONGED,RESULTS,STATE
DUE,HOWEVER,PILOMYXOID,SURGERY
CONCLUSION,FINAL,LABEL,METHODS,OBJECTIVE,RESULTS
800,947,RCC
950,HOWEVER
169,IDO
BINDING,SH2
139,150,169,172,183,AUG,BACKGROUND,BETWEEN,BRAIN,COPYRIGHT,DABRAFENIB,EASTERN,EVALUATION,FEB,FUNDING,GROUP,LABEL,LTD,METHODS,RESULTS,SOLID,TREATMENT,VAL600GLU,VAL600LYS
176,BRAIN,BTICS,EGF,NSC,PCR,SERUM
946,CPG,DNMT1,DNMTS,EBP,HDAC2,HDAC3,HDACS,PCR,THESE,TREATMENT
GBM
946,CLU,FOXL2,IGF,PITUITARY
COMMITTEE,MELATONIN,NON,OWING,PROTECTION,RADIATION,REGARDLESS
750,947,ALTOGETHER,CPT,NMR,PEG,WATER
AMONG,BACKGROUND,CHANGES,CONCLUSION,ELISA,LABEL,METHODS,RESULTS,SEREX
100,ANTIGEN,EPITHELIAL,MIB,NEU
MRI,PRE,PXA
CNS
131,200,BACKGROUND,CEA,DIFFUSE,HOWEVER,LABEL,LNS,PTC,SUMMARY
946,ALZHEIMER,APP,CLUSTER,OVERALL,PCA,PRINCIPAL,SWEDISH
785,AFTER,FURTHER,RAMAN,SIMILARLY,SINCE,SIX,VCA
ALZHEIMER,DYS14,FETAL,PCR,RESULTS,TARGETING
BACKGROUND,KNOCK,LABEL,LAMIN,PRINCIPAL,RESULTS
100,ALA,DESPITE,DIV,FURTHER,HOWEVER,III,MRI
OWING,PCR,USING
001,007,104,222,BACKGROUND,BRAIN,ECM,LABEL,MBC,METHODS,OESTROGEN,RESULTS
183,CONCLUSION,GEORG,LABEL,METHODS,OBJECTIVE,REWARMING,SOURCES,STUTTGART,SUMSEARCH
001,169,947,BIOLOGY,COPYRIGHT,FURTHER,IMR,INC,INCREASED,MOLECULAR,UNION
169,CD133,COPYRIGHT,DCX,GBM,INC,MYC,NEUROD1,OLIG2,SHH,SIMILAR,THESE,U87,WILEY
000,013,046,169,183,297,480,487,COMBINING,COPYRIGHT,CROWN,GBM,LTD,PFS,PUBLISHED,THEREFORE
100,CONSISTENT,DSF,GBM,THESE,TMZ
169,COPYRIGHT,DSA,GERMANY,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SKY
169,ACCORDING,COPYRIGHT,GROSS,INC,LABEL,METHODS,OBJECTIVE,RESULTS
000,100,246,292,316,462,980,BACKGROUND,COX,DEC,HRS,JAN,LABEL,METHODS,RESULTS,THERE
ACCORDING,AIM,BACKGROUND,CONVERSION,DIAGNOSIS,DSM,ICD,LABEL,OBJECTIVE
138,CAVERNOMAS,LABEL,METHODS,MORBIDITY,OBJECTIVE,PONTINE,RESULTS
200,DARWINIAN,FINALLY,GBM,HOWEVER,MET,NF1,USING
000,578,CPG,HOXB1,OVERALL,PRL,USING
160,169,BASED,COPYRIGHT,FIFTY,HELICAL,IEC,LTD,PUBLISHED,THESE
104,169,COPYRIGHT,GENERAL,INC,LABEL,METHODS,MRI,NFPAS,OBJECTIVE,OVERALL,RECURRENT,RESULTS,THERE
AKT,BOOLEAN,CONCLUSION,CURRENT,ERB,IGF,LABEL,MEDLINE,MET,METHODS,MYC,NOTCH,NOVEL,OBJECTIVE,PHASE,PRE,PRINCIPAL,PURPOSE,RESULTS,STAT3,WNT
100,150,169,200,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,DVH,GBM,IMAGING,JOURNAL,LABEL,MAJOR,MEDICAL,METHODS,MRI,OCTOBER,PDVOL,RADIATION,RESULTS,ROYAL,ZEALAND
169,200,ADDITIONAL,AUSTRALIAN,AUTHORS,BACKGROUND,BETWEEN,COLLEGE,GAMMA,IMAGING,JOURNAL,KNIFE,LABEL,LIKELIHOOD,MATERIALS,MEDICAL,METHODS,MRI,RADIATION,RESULTS,ROYAL,ZEALAND
HOWEVER,TARGETING
99M,FOLLOWING,MMP
ADULT,AREAS,BACKGROUND,COVERED,GBM,LABEL,METHODS,OPINION,PENDING
DESPITE
EIGHT,EVN,LESIONS
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,MRI,PROCEDURE,RESULTS,WILEY
110,MAY,MRI
13935,190,FSH,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
183,BACKGROUND,ETIOLOGIES,FLUID,GEORG,INO,LABEL,METHODS,MRI,PATIENT,RPL,STUTTGART
233,ASSOCIATED,FURTHER,HOWEVER,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,VESTIBULAR
169,AFTER,BECAUSE,COPYRIGHT,CSF,HIV,HOWEVER,INC,MICRORNAS,WILEY

DESPITE
167,HOWEVER,OLIG2,PNETS,R132H,THEREFORE
169,215,CARLO,COPYRIGHT,LTD,MONTE,TIF
ALCOHOL,BACKGROUND,LABEL,MATERIALS,MEDLINE,METHODS,RESULTS,RRS,SEVERAL
BACKGROUND,CD133,LABEL,METHODS,NANOG,RESULTS,THESE
169,19Q,449,ALLELIC,COPYRIGHT,GENOMES,HMGB1,KYOTO,LOH,THEREFORE
169,BETWEEN,CONCLUSION,COPYRIGHT,CURRENT,INC,INJECTION,LABEL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,SIXTEEN
169,CLOSE,COPYRIGHT,INC,PITUITARY
169,COPYRIGHT,INC
169,COPYRIGHT,CUSHING,INC
169,COPYRIGHT,INC
169,COPYRIGHT,INC,PITUITARY,SEVERAL,TREATMENTS
169,COPYRIGHT,INC,PITUITARY,PROGNOSIS
169,AGGRESSIVE,COPYRIGHT,INC,PITUITARY
169,COPYRIGHT,INC
EXPERIENCE,INC,PUBLISHED,STUDIES
169,CLINICALLY,COPYRIGHT,INC,POTENTIAL
169,COPYRIGHT,CORRECT,INC
007,169,BACKGROUND,COPYRIGHT,HISTOLOGY,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,PATHOLOGIC,RESULTS,UNIVARIATE
100,160,169,COPYRIGHT,PHYSICIAN,SAS,THEIR
106,169,AFTER,AGE,AIM,AUTHORS,CHILD,COLLEGE,CONCLUSION,END,JOURNAL,LABEL,METHODS,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,SMN,UNIVARIATE
AUTOMATED,DSC,HENCE,INDIVIDUAL,LABEL,MALIGNANT,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,T1W,T2W,YET
BIOLOGICAL,COMPLEX,CONFORMAL,DAILY,DELINEATED,DOSES,EFFECTS,INTENSIVE,LABEL,LAR,METHODS,OBJECTIVE,PHANTOM,PURPOSE,RADIATION,RESULTS,SIB,TECHNIQUES,THERE,VII
004,107,CALIFORNIA,COX,EOR,FIFTY,FRANCISCO,GBM,GTR,INITIAL,JANUARY,KARNOFSKY,KPS,LABEL,MEDICAL,METHODS,OBJECTIVE,OVERALL,RESULTS,SAN,STR,UNIVERSITY,VOLUMETRIC
001,003,005,190,916,BETWEEN,EOR,FINALLY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE,VT2T1
1ST,AWAKE,CAS,HOWEVER,LABEL,MAXIMAL,METHODS,OBJECTIVE,RESULTS,THERE,THESE,TOTAL

CENTRAL,CNS,DUE,FURTHER,HPC,HPCTO,NERVOUS,RESULTS,UPR
BROYDEN,LABEL,LBFGS,METHODS,NUMERICAL,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,CTK,DIFFUSION,IMAGING,ITK,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THERE,TOOLKIT,VTK
169,BACKGROUND,BASEL,COPYRIGHT,ENGLISH,HOWEVER,LABEL,LMS,MARCH,MEDLINE,METHODS,PRIMARY,RESULTS,THESE
169,BASEL,COPYRIGHT,MRI
001,008,016,169,AWARENESS,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,CSF,EVD,LABEL,METHODS,PEDIATRIC,RESULTS
014,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
100,SEVERAL,SYMPTOM
155,24H,AFTER,ALTEPLASE,HOWEVER,NEITHER
HEMORRHAGE,HOWEVER,MOLECULAR,PET
HOWEVER,PALIATIVE
169,BASEL,CONCLUSION,COPYRIGHT,CRANIAL,INFECTION,LABEL,MEDICAL,METHODS,OBJECTIVE,POSTERIOR,RESULTS,THEIR
105,114,115,177,182,AARAU,BACKGROUND,CUSHING,DEPARTMENT,LABEL,METHODS,MRI,PRINCIPLES,RCC,RECURRENT,RESULTS,SWISS
GCS,GLASGOW,MED,PUB,REMOVAL,SCALE
169,947,COPYRIGHT,CUSHING,PUBLISHED
135,136,169,BAR,BRAIN,CONCLUSION,COPYRIGHT,LABEL,LDA,LTD,METHODS,MRS,OBJECTIVE,OTHER,POINT,PRESS,PROBE,RESONANCE,RESULTS,SEVENTY,STEAM,STIMULATED,TARQUIN,TES,TUKEY
115,169,BACKGROUND,BIRMINGHAM,BRAIN,COPYRIGHT,COX,LABEL,LTD,METHODS,MRS,REGRESSION,RESULTS,SHORT
169,BACKGROUND,CASES,COPYRIGHT,FIFTY,INC,LABEL,METHODS,RESULTS,THESE
169,COPYRIGHT,PUBLISHED,SAS,WHILE
169,BRAIN,COPYRIGHT,EDUCATION,FOUNDATION,FURTHER,HOWEVER,INC,MEDICAL,PUBLISHED,V600E
146,AFTER,ANECDOTAL,FCD,IIA,JANUARY,MAY,PALMINI,RESECTION
169,COPYRIGHT,LTD,THERE
169,COPYRIGHT,ENGLISH,FEW,INTERDURAL,LTD,MRI,TOTAL,TRIGEMINAL,UNIVERSITY
105,154,357,439,488,593,AIM,AMBULATORY,AUTHORS,BACKGROUND,LABEL,MEDICAL,METHODS,OBJECTIVE,OTHER,PARTNER,PHONIATRY,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE,UNIVERSITY,URBAN,VOCAL
DIAGNOSTIC,POSTMORTEM
001,004,013,021,053,AGE,CONCLUSION,DNT,EARLY,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RESULTS,TREATMENT
100,150,250,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PCR,R132H,RESULTS,SMALL
166,FOLLOWING,GTP
146,155,169,946,AKT,CELLS2013,COPYRIGHT,EPC,FURTHER,HOWEVER,HUVEC,MSC,PDGFR,PRESS,TAKEN,USING
183,AFTER,CONCLUSION,GEORG,HOWEVER,INFLUENCED,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART
10001,129,177,333,BACKGROUND,CONCLUSION,ENT,LABEL,MEDICAL,METHODS,PUBLISHERS,RESULTS,SEVENTH,SRE,TRE,USA
AFTER,LABEL,METHODS,OBJECTIVE,PACIFIC,PURPOSE,THESE
10B,ATLAS,FOXO3,GBM,PTCH1,REMBRANDT
945,954,CANCERS,HIF,MYC,NOTABLY,RAS
009,154,BACKGROUND,CPG,INSTEAD,LABEL,PREVIOUSLY,RESULTS
150,INCOMPLETE
EVALUATION,SURGERY
AUTHORS,CNS,METHODS,THREE
139,163,302,EARLY,ENGEL,FUNCTIONAL,LABEL,METHODS,RESECTION,SURGERY,UNLABELLED

BACKGROUND,CONCLUSION,CSC,DISULFIRAM,FURTHER,GBM,JNK,LABEL,METHODS,MTT,RESULTS,ROS
037,047,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
MALIGNANT,MFH
105,EARLY,GLASGOW,SCALE
147,271,523,AFTER,BACKGROUND,DEVELOPING,ENGLISH,JANUARY,LABEL,LITERATURE,METHODS,NEURO,RESULTS
169,AGAINST,APMIS,AUTHORS,BCL,FCD,THESE
CNS,DESPITE,THESE
BACKGROUND,CNS,DISCUSSION,IMAGING,LABEL,METHODS,MRI
BCL,CNS,EBV,EPSTEIN,IRF,MUM,PRIMARY,SEVEN,TURKISH,WESTERN
EVENTUALLY
PREVIOUSLY,THESE
296,ALTERED,CNDP1,ELISA,FORTY,FTL,GBM,THESE
ATO,BLI,DOPPLER,DYNAMIC,FLI,PC3,POWER,SIMILAR,SMALL,U87
330,MICRORNAS,MIR,U87
BACKGROUND,CONCLUSION,KIT,LABEL,MAXILLARY,METHODS,MSC,RESULTS,THERE
AMONG,CXCR2,HOWEVER,INCREASED
100,CLASSICAL,GBM,IHC,PNL,PRONEURAL,THESE
111,BBB,COMBINING,DOX,FUS,GBM,NOD,SPECT
945,DIFFERENT,HOWEVER,MEL,PARKINSON,SYN,SYNUCLEIN,TYR,ULTRA,UVB,UVR
110,AMONG,BACKGROUND,DIFFERENT,EFFORTS,HOWEVER,LABEL,OVERALL,RESULTS,THEIR
DUE,HOWEVER,NSC,TAKEN,TLX,WHILE
183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,OBJECTIVE,OGM,RESULTS,SEVERAL,STUTTGART,TFSSA
183,BACKGROUND,CONCLUSION,GEORG,HOWEVER,LABEL,METHODS,STUTTGART
169,ACTIVATED,COPYRIGHT,LTD,PLATELETS,PMP
130,137,169,177,623,682,BACKGROUND,BETWEEN,COPYRIGHT,DESPITE,HCC,INC,LABEL,LIVER,MAY,METHODS,MILAN,OLT,ORTHOTOPIC,RECURRENCE,RESULTS
169,AMINO,COPYRIGHT,INC,LIGANDS,PET,TRACERS
101,169,366,642,AMSTERDAM,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,FORTY,HOWEVER,INC,LABEL,LYNCH,MEDICAL,METHODS,MMR,RCC,RESULTS,SMALL,UNLABELLED
001,002,005,015,033,379,394,458,BACKGROUND,CHI,CONFIDENCE,COX,III,LABEL,METHODS,NETWORK,PRESENTING,RATIO,RESULTS,THESE
169,945,AMONG,GNT,OLIG2,PDGFR,PGNTS,RGNTS,SOCIETY,THESE,USING
169,CNS,CSF,EBV,HIV,SOCIETY
400,CNS,THESE
169,177,BACKGROUND,COPYRIGHT,DESPITE,DISTANT,INC,LABEL,METHODS,PROCEDURE,RESULTS,WILEY
169,COPYRIGHT,FURTHER,LTD,WILEY
001,011,015,017,025,036,169,177,5TH,ACT,ADC,BOARD,CONCLUSION,COPYRIGHT,HIPAA,INC,INSURANCE,LABEL,MATERIALS,MEIER,METHODS,MSP,NEWLY,OBJECTIVE,PFS,PURPOSE,RESULTS,WILEY
169,BECAUSE,CHANGES,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
BACKGROUND,CMS,CONCLUSION,GRE,LABEL,LESIONS,METHODS,OTHER,RESULTS
BACKGROUND,EIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,STILL,THERE
006,015,018,022,AMONG,ATP6V1E,B2M,BACKGROUND,EIF3S10,EXPRESSION,FOLR1,GUS,LABEL,LAPTM4B,METHODS,NFA,PCR,PRL,RESULTS
500,950,ABUNDANCE,ALS,DEPLETION,EXPRESSION,FUS,GUGGU,TDP,TLS
PERSISTENT
ASSESSMENT,MRI,UNTIL
001,463,945,ALPHA,CONCLUSION,D14,D21,D42,D72,ELISA,FATIGUE,INC,LABEL,METHODS,MICROARRAY,OBJECTIVE,PARKINSON,PUBLISHED,PURPOSE,RESULTS,SIXTEEN
169,BACKGROUND,COPYRIGHT,DORELLO,IMAGING,INC,LABEL,MALIGNANT,METHODS,PATHOLOGY,PROGNOSIS,RESULTS,THEIR,THESE,TREATMENT
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS
114,169,205,415,ASB,COPYRIGHT,CSF,GROUP,INC,LABEL,METHODS,NSF,OBJECTIVE,RATES,RESULTS
169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,USING
001,488,670,AMONG,LESIONS,METASTATIC,NSC,PCI,SVZ
169,AMONG,BASED,COPYRIGHT,STUDIES
131,169,BLOOD,CNS,COPYRIGHT,INC,PAH,PAV,PUBLISHED,SCT,SOCIETY,THERE,THREE
169,211,ACADEMY,COPYRIGHT,DISCUSSION,EXTRACTION,GUIDELINES,III,INC,LABEL,MEDLINE,METHODS,NEUROLOGY,OBJECTIVE,OBJECTIVES,OPTIONS,PUBLISHED,RESULTS,SELECTION,SOURCES,STANDARDS,SYNTHESIS,THESE
169,COPYRIGHT,EPSTEIN,INC,THREE
169,COPYRIGHT,GEFITINIB,NSCLC,PUBLISHED,SOCIETY,THESE
169,945,946,BACKGROUND,BLOOD,COPYRIGHT,FORTY,GLUCOSE,INC,LABEL,METHODS,OXIDATIVE,RESULTS,TAB
ABCB1,ABCC2,ABCG2,AUC,BRAIN,PLX4032,V600E
LESIONS,MANAGEMENT,MULTIFOCAL
169,THESE,TIETZ,WHITE,WILEY
CNS
THEREFORE
001,004,972,BACKGROUND,CONCLUSION,CONTEXT,LABEL,MEASURE,METHODS,N1A,N1B,OBJECTIVE,OUTCOME,PTC,RESULTS,SETTING,TNM
169,945,DESPITE,IL13R
945,BVZ,CPT,EPN,III,PFS,SIX
169,526,ANHEDONIA,BECAUSE,CONCLUSION,COPYRIGHT,DEPRESSION,DEPRESSIVE,DSM,EPISODE,LABEL,LTD,MAJOR,METHODS,OBJECTIVE,PCA,RESULTS,SCALE,SDS,THESE,WILEY
181,AMONGST,DESPITE,HEK,MTT,TREATMENT
169,945,COPYRIGHT,INC,PUR,WILEY
001,004,007,031,075,121,169,268,291,BACKGROUND,BASEL,COEXISTENT,COPYRIGHT,DEPARTMENT,ESR,LABEL,METHODS,NEUROLOGY,RESULTS,SIXTEEN,TOAST
GCV,NSC
012,013,014,017,021,027,148,173,177,363,BLOOD,BNP,DOPPLER

169,AFTER,BETWEEN,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,186,AFTER,AVAILABLE,COPYRIGHT,FEW,GTR,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN
169,COPYRIGHT,GRADE,LTD,MSI,MVD,THERE
169,AUTOMATIC,BACKGROUND,CHANGES,CONCLUSION,COPYRIGHT,CURRENT,IRELAND,LABEL,LTD,MACDONALD,MATERIALS,METHODS,MRI,NEAREST,NEIGHBORS,RESULTS
946,ALZHEIMER,APPSWDI,FIBRILLAR,GOVERNMENT,MMP,PUBLISHED,REGULATION,USA
MALIGNANT,THEREFORE
DESPITE,EARLY,MRI
BBB,BTB,TREATMENT
AMT,BBB,LARGE
ASP,FSH,GLP,GLY,III,LAMPREY,LYS,NH2,PETROMYZON,PRO,SER,THESE,TRP
003,169,633,BROCA,COPYRIGHT,ESM,FORTY,INC,OVERALL,THESE,WILEY
169,946,BACKGROUND,CONCLUSION,HOWEVER,IFN,IL8,LABEL,MX1,OAS,PMN,RESULTS,RIG,SOCIETY,TAKEN
100,ADVERSE,AED,AIM,CONCLUSION,LABEL,METHODS,NEWER,OBJECTIVE,PRE,RESULTS
001,014,018,180,372,956,AIM,CONCLUSION,IGF,LABEL,METHODS,OBJECTIVE,REMISSION,RESULTS
AIM,ASSESSMENT,COMPARISON,CONCLUSION,COX,DEPARTMENT,DETECTION,DIFFERENCE,ERCIYES,LABEL,LOG,MALIGNANT,MAY,MEIER,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
ADC,AIM,CHO,CONCLUSION,DTI,ELEVATION,LABEL,METHODS,MRS,NAA,OBJECTIVE,RESULTS,THERE,THREE
009,330,829,GROUP,HOWEVER,IDH,PFS,REPORTS

BACKGROUND,DISCUSSION,HOWEVER,LABEL,METHODS,TOTAL
BSO,OCS,THESE,WOMEN
470,530,AIM,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,PARTIAL,RESULTS,SRS
AZD1480,JAK,STAT3
ACE,ALZHEIMER,BRAIN,RAS,THERE
DESPITE,ENB,GBM,SCS,TRAIL
ANNEXIN,APOPTOSIS,IAP,NOVEL,PCR,THESE,TREATMENT,TUNEL,XENOGRAFT
AIM,ALZHEIMER,BACKGROUND,IAA,LABEL,METHODS,OBJECTIVE
001,038,100,160,224,BETWEEN,CONCLUSION,CSF,EBV,EMB,FIFTEEN,LABEL,METHODS,OBJECTIVE,OPERATIVE,RESULTS
100,137,152,173,177,276,300,CSF,ENDOSCOPIC,EPISTAXIS,FULLY,INITIAL,NON,THREE
916,ADC,CBF,CBV,CHANGES,CONCLUSION,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,ROI,SIXTEEN,TTP
172,947,954,ADP,CAS,DPQ,HIF,INTERFERON,LDH,LSM,NAD,OCT,PARPS,SIMILAR,SNB,THESE
ADC,APT,MRI,SEVERAL,SF188,THERE
750,BACKGROUND,CNS,CONCLUSION,FREQUENTLY,HOWEVER,LABEL,MBC,METHODS,RESULTS,THESE,THREE
169,BRITISH,CCS,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEIZURE,SEVEN,THERE
169,COPYRIGHT,IRELAND,LTD,TIP
169,COPYRIGHT,GCT,INC,MOSBY,TERATOMAS
ACCORDING,MRI,PITUITARY,REGARDING,THEIR,TSH
239,ADVERSE,FDA,HUNGARY,REDUCTION
CNS
169,215,AMIDE,APT,INC,WILEY
CRANIAL,PITUITARY,PROGNOSIS
APRIL,HOWEVER,INGENUITY,JANUARY,MRI,PET,PHILIPS
169,ALTERED,BRITAIN,COPYRIGHT,GREAT,HOWEVER,IRELAND,LTD,PUBLISHED,SOCIETY,USING,WILEY
AKT,CK2,HOWEVER,INDUCTION,LC3,M059K,PROTEIN,TAKEN
177,956,COMET,IRINOTECAN,LABEL,METHODS,MTT,NAMITECAN,OBJECTIVE,PROPIDIUM,PURPOSE,RESULTS,STUDIES,TAILDNA
EFFECTIVE,EPENDYMOMA,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
HOWEVER,LABEL,NOVEL,OBJECTIVE,OVERALL,PURPOSE,QOL,RESULTS,SUMMARY,VALIDATED
FINALLY,FURTHER,HOWEVER,LABEL,MOLECULAR,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
280,28080,CURRENT,EXPLORING,GBM,LOPAC1280,SCH
VHL

169,956,AUTOPHAGIC,COPYRIGHT,FHV,FINALLY,GBM,LTD,PAS,PEPTIDE
182,30E,945,946,954,HOWEVER,PREVIOUSLY,TGF,THESE
GROWING
BEV,FOLLOWING,FORTY,GBM,THERE,THREE
100,150,AUDIOGRAM,DIAGNOSIS,EMA,LABEL,METHODS,MRI,UNLABELLED
MOLECULAR
DESPITE,GLIOMAS
946,CXCR4,PTHRP,SD208,SMAD7,TGF
116,375,ADMISSIONS,GENERAL,GLASGOW,HSU,MARCH,MRI,SEPTEMBER
169,215,CONCLUSION,COPYRIGHT,CSF,INC,INDUCTION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WILEY
000,117,150,169,258,412,600,AFTER,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,CUMULATIVE,EARLY,INC,LABEL,METHODS,PROCEDURE,RESULTS,THREE,VARIATIONS,WILEY
NSF,THERE
001,007,066,154,554,BASAL,BETWEEN,COX,GAMMA,KNIFE,LUMINAL,MEIER,WOMEN
DESPITE,ECTOPIC,EMT,MET,METASTASIS,PREVIOUSLY,THEREFORE
100,108,BACKGROUND,HOWEVER,LABEL,METHODS,NF1,PILOCYTIC,RESULTS,REVISED,SCALE,SPANISH
169,200,435,946,956,COPYRIGHT,CY5,HSA,LTD,MDA,PAE,PEG
044,169,ANIMALS,BBB,BT474,BTB,CNS,COPYRIGHT,FOCUSED,FUS,MRI,OVERALL,TREATMENT
169,BBB,BCSFB,BESIDES,CBA,CNS,COPYRIGHT,CSF,CXCL1,CXCL2,CXCL3,ECHOVIRUS,HOWEVER,IL8,PCR,THEREFORE
001,005,008,169,AIM,BACKGROUND,COPYRIGHT,COX,KARNOFSKY,KIF14,KPS,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,THESE,WESTERN
169,916,946,AKT,COPYRIGHT,GBM,GLIOMAS,GSK,INCREASED,LTD,MTT,PUBLISHED,TREATMENT,U87MG,WNT
169,CNS,COPYRIGHT,JXG,LANGERHANS,LTD
169,30YEARS,48HOURS,AED,COPYRIGHT,CURRENTLY,HOWEVER,PUBLISHED,SAS,YET
169,224,296,COPYRIGHT,ECTOPIC,GBM,KCNH1,LTD,MDR,MICRORNAS,PCR,TAKEN,WESTERN
169,ALK,CLINICIANS,COPYRIGHT,FEW,IRELAND,LTD
CTV,GTV,HOWEVER
1A4,946,ANION,BBB,ETA,GSK,ICV,ORGANIC,PEPTIDE,PROTEIN,RESISTANCE,THESE
LABEL,METHODS,OBJECTIVE,PROCEEDING,RESULTS,STRUCTURAL,TEN
143,267,473,545,557,592,639,CNR,CONCLUSION,LABEL,MAGENETOM,METHODS,MRI,OBJECTIVE,RESULTS,SIEMENS,SNR,THERE
DIAGNOSIS,PRIMARY,THERE
115,169,983,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,ONCOMAP,OTHER,PROCEDURE,RESULTS,SMARCB1,WILEY
507,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
CD133,GDSCS,RESULTS,U87MG
MYELOMA,THEREFORE
945,947,954,CD40L,FLT3L,FOXP3,IFN,IGG,RG2,THESE,TREGS
169,ACC,COPYRIGHT,INC,OBSESSIVE,OCD,WASHERS
BACKGROUND,CONCLUSION,CONGENITAL,EXOTROPIA,FIELD,LABEL,METHODS,RAREBIT,RESULTS,THREE
169,COPYRIGHT,LTD,PITUITARY,SEVENTY,THESE,WHILE
004,092,169,956,BLOOD,CD4,CD8,COPYRIGHT,IGG,IGM,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SOCIETY
169,CAOV3,COPYRIGHT,INC,MHC,NATURAL,NKG2D,THESE
001,343,AFTER,CBM,CENTRAL,CONCLUSION,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,THERE,VIP
CHILDHOOD,EPHX1,HOUSTON,HOWEVER,LOG,PREVENTION,SNP,TEXAS,THEREFORE,USA
169,FOCAL,FURTHER,HOWEVER,MRI,OLIG2,SOCIETY
169,CD5,CNS,EBV,HIV,IGM,MRI,MZBCL,SOCIETY,SUBSEQUENT,TDT
100,169,GCA,ISOCITRATE,MRI,PAS,SOCIETY
HOWEVER,MINIMALLY,THERE,THROUGH
455,BRAIN,CONCLUSION,EXCELLENCE,III,INSTITUTE,KNOWLEDGE,LABEL,METHODS,NSCLC,OBJECTIVE,PCI,RESULTS,STAGE,THERE
DESPITE,MPM
HOWEVER,TREATMENT
010,434,671,AIM,CONCLUSION,CONFIDENCE,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS
018,021,106,117,223,BACKGROUND,CONCLUSION,COX,DGC,GCS,HIPPO,IGC,III,LABEL,MATERIALS,METHODS,RESULTS,YES
VIDEO
AFTER,GLIAL,GORELIK,HOWEVER,PARKINSON,VLA
AKT,ATP,GBM,THEREFORE,UTILIZING
160,19Q,19Q13,CPG,DISEASE,GBM,LOH,OII,PCR,SEVENTEEN
016,ADC,DIFFUSION,DTI,FRACTIONAL,LABEL,METHODS,OBJECTIVE,REGIONS,RESULTS,SEVERAL
169,317,BBB,FOLLOWING,GBM,GBM10,GNE,GS2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THESE,U87
CHINESE,ENGLISH,LABEL,MALIGNANT,SLIDE,UNASSIGNED,UNLABELLED,VIRTUAL
136,BACKGROUND,CONCLUSION,DESPITE,ENDOSCOPIC,LABEL,METHODS,RESULTS,TOTAL
AREAS,BACKGROUND,BMI,COVERED,GLI,LABEL,METHODS,OPINION,OTHER,SFRP1,SHH,SMO,THEREFORE
001,002,240,ADVERSE,BACKGROUND,CONFIRM,LABEL,LYMPHOCYTE,METHODS,REDUCTIONS,RESULTS,THERE
000,740,SAVER,TOTAL
005,033,135,160,CHOROID,CONCLUSION,CSF,EMB,EVD,HISTOACRYL,HOWEVER,LABEL,METHODS,OBJECTIVE,OPERATIVE,RESULTS
HOWEVER,TROPISM
169,COPYRIGHT,ILLNESS,LABEL,LEVENTHAL,LTD,METHODS,OBJECTIVE,RESULTS,REVISED,USING,WILEY
DNT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SINCE,THEREFORE,UNLABELLED
GLN
100,108,177,AFTER,ASL,CBF,DWI,IMAGING,THESE
002,006,007,008,032,036,222,750,KDR,NCN,PCR,THESE
03012,17AAG,AIF,AKT,ALLYLAMINO,BIK,DOWNSTREAM,ERBB1,ERBB2,HSP90,INHIBITION,KNOCK,LAPATINIB,MCL,OSU
169,BACKGROUND,COPYRIGHT,INC,LABEL,METASTATIC,METHODS
115,ACTUARIAL,BACKGROUND,CONCLUSION,FRAMELESS,GRADE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,RESULTS,SIG
140,ASPECTS,AWAKE,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
18F,949,FLAIR,MA2,MRI,PET
123,EEG,EPILEPTIC,IMP,MRI,SPECT
002,124,137,169,261,564,ADDITIONAL,BSC,COPYRIGHT,COX,FOLLOWING,KARNOFSKY,KPS,LTD,RPA
169,CNS,COPYRIGHT,CURVULARIA,LTD
169,COPYRIGHT,LMC,LTD,MRI,THREE
APPLIED,BIOSYSTEMS,ELISA,EXPRESSION,LABEL,MALDI,METHODS,NGB,OBJECTIVE,PDQUEST,RESULTS,SIX,TOF,VOYAGER
169,BLACKWELL,CONCEPT,LTD,OVERALL,PUBLISHING,THESE,USING
169,MRI,RADIATION,SOCIETY,THREE,TTM
160,169,203,METASTASES,MRI,REGRESSION,SMALL,SMALLER
IRANIAN
ACTIVATION,GTP,RAG,RAS

215,40K,440,GBM,HOWEVER
DREAM,GIBBS,HOWEVER
169,BASEL,COPYRIGHT
HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THERE
169,CONVERSELY,MYOD1
250,AFTER,BACKGROUND,BECAUSE,CONCLUSION,LABEL,METHODS,PARONYCHIA,PRP
177,BACKGROUND,CONCLUSION,DTI,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PTS,RESULTS,SEVENTEEN
048,CONVERSELY,COX,DROSOPHILA,FAT,GBM,III,INCREASED,JUN,PDCD4,TAKEN,U87MG
039,169,945,946,967,CONVERSELY,GBM,SPARC,TAKEN,U87MG,USING
0MM,169,177,2MM,6MM,COPYRIGHT,DCS,FEDERATION,HOWEVER,IRELAND,LABEL,LTD,METHODS,MRI,NAVIGATED,OBJECTIVE,PUBLISHED,RESULTS
ALK,CNS,CRIZOTINIB,NSCLC,RAS,RESULTS,TARGETING,THESE,WHILE
169,CAP,CARLO,CHAIN,COPYRIGHT,HOWEVER,MAP,MONTE,MPM,MRF,MRI,MWMAP,MWMPM,SIMILARLY,TESLA
169,COPYRIGHT,INC,NOTABLY,PATHOLOGY,PRL,PUBLISHED,RIP,SDCBP,SOCIETY,SRC
169,233,237,241,243,CHANGES,COPYRIGHT,DOLOR,PUBLISHED,REANIMACI,TERAP
CONCLUSION,IMAGE,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL,TRANSIENT
CONCLUSION,III,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
169,COPYRIGHT,INC,RAPIDLY,THESE
124,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,YOUNGER
001,181,348,562,AMONG,BACKGROUND,CONCLUSION,DWI,LABEL,METHODS,MRI,REGARDING,RESULTS,THESE
945,954,BAX,BCL,GBM,HOWEVER,MEIER,NIX,NUCLEAR,THESE,USING,WHILE
005,009,024,085,526,GROUP,III,KARNOFSKY,KPS,PCNSL,THEREFORE
BETWEEN,CONCURRENT,CTCAE,ELDERLY,GRADE,HGG,KARNOFSKY,MEIER,TMZ
CXCR4,LABEL,METHODS,OBJECTIVE,OBJECTS,RESULTS,THESE
160,CONCLUSION,CONGENITAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USUALLY
BECAUSE,DIFFUSE
351,BACKGROUND,GROUP,GTR,LABEL,LGG,METHODS,OVERALL,PFS,RECORDS,RESULTS,ROCHESTER
AKT,HOWEVER,THEREFORE,THESE
64257,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,THESE
AMONG,DISRUPTION
103,MRI,RAPIDLY,USING,VMY
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,UNEVENTFUL
177,BACKGROUND,CONCLUSION,FORTY,III,LABEL,METHODS,NSCLC,PFS,RESULTS,STAGE
001,004,009,307,522,ADDED,AMONG,APRIL,BACKGROUND,BETWEEN,BIOLOGICAL,CARCINOMA,COX,EPIDERMAL,ERMETIC,EVALUATION,FACTORS,HOWEVER,KIRSTEN,LABEL,MARCH,METHODS,PFS,RESULTS,SIMILAR,THESE,TKI
169,23B,COPYRIGHT,CROWN,FURTHER,IRELAND,LTD,MEANWHILE,MICRORNAS,PUBLISHED,TMZ,U87
169,ALB,COPYRIGHT,INC,LABEL,MASP2,METHODS,OBJECTIVE,RESULTS,SWISS,WESTERN
169,530,BETWEEN,COPYRIGHT,END,LTD,RESULTS,USA
169,COPYRIGHT,FACED,FURTHER,POSER,PUBLISHED,SAS,YET
ANGELIS,CD4,CNS,EBV,EPSTEIN,HODGKIN,LATER,PCNSL,PRIMARY,VIRTUALLY
339,425,662,709,BACKGROUND,CD133,EXPRESSION,LABEL,MINIMAL,NORMFINDER,NPC,NSC,PCR,RESULTS,RNU24,RNU44,THESE
001,108,161,791,AFFYMETRIX,AGILENT,BACKGROUND,GBM,LABEL,METHODS,PCR,RESULTS,SEVERAL
005,014,031,042,AMONG,EOR,FORTY,GTR,HOWEVER,IMAGE,LABEL,MEIER,METHODS,MRI,OBJECTIVE,PERCEPTION,RESULTS,THERE,USING
169,SOCIETY,THESE
946,ATP,ROS,UNDERLYING
100,1P19Q,BACKGROUND,CGH,CONCLUSION,DNT,LABEL,LGG,METHODS,MRI,OBJECTIVE,OVERALL,RESULTS,TUMOURS
ANY,TESTING
PALLIATIVE
DIFFUSION,EARLY,PAEDIATRIC
KNOWLEDGE,RADIATION
POTENTIAL,THREE
169,BACKGROUND,BECAUSE,COPYRIGHT,INC,LABEL,LGG,METHODS,PROCEDURE,RESULTS,TOXICITIES,WILEY
1580W,220,956,BACKGROUND,CONCLUSION,D283MED,D341MED,D425MED,EXPRESSION,LABEL,METHODS,MMR,RESULTS,TMZ,TUMOURS
INCIDENCE
169,COPYRIGHT,INC,WILEY
AFTER,CORRECT,ENDOSCOPE
IMAGING,SURGERY
BASED,HOWEVER,IMAGING
SCO
ADDITIONAL,FURTHER,THERE,TREATMENT,VHL
ICH,PITUITARY
100,AGGRESSIVE,HOWEVER
003,009,027,047,107,BASED,ELDERLY,KARNOFSKY,KPS,OSS,THERE
177,MIB,THERE,WHITNEY,WORLD,YOUNGER
201,252,AMONG,CORTINA,TORANOMON
200,COMBINING,EXTENSIVE,MEP,MOTOR,TRANSIENT,UNIVERSITY,USING
HOWEVER,RADIATION,TREATMENT
945,946,AMONG,III,INTEGRINS,MALIGNANT,SEVERAL,TREATMENT
BBB,CED,CNS,CONVECTION,HOWEVER
160,FIFTEEN,SURGERY,USING
101,113,122,140,150,169,269,279,288,337,568,776,COMMITTEE,COPYRIGHT,III,INC,JOINT,LABEL,MATERIALS,METHODS,N2A,N2B,N2C,OBJECTIVE,PAROTID,PRIMARY,PURPOSE,RESULTS,SEVENTY,TEXAS,UNIVERSITY
EXTENSIVE,SCC
HOWEVER
126,135,169,177,213,COPYRIGHT,HOWEVER,INC,JOURNAL,PRESS,PREVIOUSLY,RESONANCE,SHINNAR
169,56C,COPYRIGHT,CROWN,LTD,PUBLISHED,SNP
155,169,COPYRIGHT,FUHRMAN,INC,RCC,SMALL,TRANSPLANT
BACKGROUND,HOWEVER,LABEL,LEIGH,METHODS,RESULTS,SDH,SER509LEU,THR508ILE,WESTERN
169,185,COPYRIGHT,GBM,LTD,NMF,RESULTS,WILEY
169,955,AFTER,CHO,CONCLUSION,COPYRIGHT,DTI,INC,LABEL,MATERIALS,METABOLIC,METHODS,NAA,NPC,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,WILEY
009,015,COX,GBM,GOLGI,HOWEVER,LOG,PFS,POTENTIAL,THESE,U87,UNIVARIATE
010,023,029,AMONG,DEPARTMENT,ENGLISH,FACTORS,FURTHER,ICU,JAPAN,PEDIATRICS,PLACE,PREFERENCE,UNIVERSITY
358,AUTHORS,BACKGROUND,CANCERLIT,CENTRAL,CLASS,COLLECTION,CONTROLLED,GENERIC,GIVEN,HOWEVER,INVERSE,ISSUE,KARNOFSKY,KPS,LABEL,MAY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RPA,SCALE,SELECTION,SINCE,SRS,UNCHANGED
ROSETTE
ACUTE,INITIALLY
946,LABEL,METHODS,OBJECTIVE,RESULTS,TGF,THESE,TSP,WESTERN
169,ARRAY,AURKB,AUTHORS,BRAIN,DIPGS,HGA,INHIBITION,PATHOLOGY,PCR,PEDIATRIC,SOCIETY,THESE
169,AIM,BACKGROUND,BRAIN,CAREGIVERS,CONCLUSION,INTERVIEWS,LABEL,LTD,METHODS,OBJECTIVE,PROVISION,RESULTS,SCALE,SIX,WILEY
BASED,ESM,ISOLATING,THESE
117,177,BACKGROUND,CENTERS,CONTEXT,DESPITE,DUE,EFS,INCLUSION,LABEL,METHODS,OBJECTIVE,OUTCOME,OVERALL,QOL,RESULTS,TREATMENT
006,108,160,434,BCT,GIVEN,MRI,OVERALL,WOMEN
000,035,045,100,431,548,BACKGROUND,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RADIATION,RESULTS
108,169,CCND1,COPYRIGHT,G870A,HOWEVER,RATES
AFTER,HOWEVER,MRI,OTHER,PREVIOUSLY,THESE
BACKGROUND,EGF,HGF,LABEL,RESULTS,RHO,THESE
169,946,AUTHORS,BRAIN,EXPRESSION,MBS,PATHOLOGY,PRIMARY,SIMILARLY,SMAD3,SMO,SOCIETY,TGF
169,945,947,950,CAR,CD3,GBM,IFN,IL13R,IL13RA1,IL2,LABEL,METHODS,OBJECTIVE,PURPOSE,R109K,RESULTS,THESE
186,BASED,INITIALLY,MODIFYING,PBT,SIX
BETWEEN,CONCLUSION,CTX,HOWEVER,LABEL,MATERIALS,METHODS,NEO,OBJECTIVE,THERE,THESE
169,248,COPYRIGHT,GMC,HOWEVER,INC,THESE,WILEY
149,AMONG,KNUDSON,LOH,MENINGIOMA
946,HBXIP,HOWEVER,INDUCTION
CD11B,GR1,HOWEVER,INHIBITING,VEGFR
ASSESSMENT,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,QUOTATIONS,RESULTS
121,128,946,GRADE,III,LTBP2,OVERALL,SFRP1,SFRP4,TMEM30B,UCHL1,WNT,WORLD

30B,DESPITE,TAP63,TRAIL
CD133,HOWEVER,TAKEN
169,COPYRIGHT,FATIGUE,HOWEVER,INC,NAMED,THESE
CRT,PAEDIATRIC
139,149,169,173,206,CHINA,COPYRIGHT,HOWEVER,INC,JANUARY,SEPTEMBER,THOSE
7EGFR,916,CAIII,GBM,III,INCREASED,S100A10
DUE,SPECIES,THESE
GBM,GSC,THERE
169,SOCIETY,TRIGEMINAL
123,177,215,947,956,HOWEVER,MET,MGL,NLV,PEGYLATED,SINCE
ACTIVITIES,ASSESSMENT,BRAIN,COGNITIVE,COMPENDIUM,HEALTHY,HOWEVER,METABOLIC,QUALITY,TASKS,TESTS,YET
945,947,ASI,CURRENTLY,FINALLY,GBM,GSI,HOWEVER,MICROARRAY,MRI,NOTCH,PCR,YKL
281,BACKGROUND,FIRST,LABEL,LOD,METHODS,RESULTS,SHETE,USING
ECG,INITIAL,MRI
MK886,MSC,TRAIL,TREATMENT
001,006,013,130,AFTER,BACKGROUND,BASIC,CHINESE,INSTITUTES,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RHD,RHEUMATIC,SCALE
057,169,188,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,INITIAL,LABEL,METHODS,PATHOLOGIC,PROCEDURE,PROTOCOLS,RESULTS,RMS,SIX,WILEY
169,COPYRIGHT,GFP,INC,LEWIS,LLC,RFP,U87,UVC,WILEY
152,BETWEEN,CNS,CONCLUSION,EASTERN,GROUP,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CLOSE,CNS,CONCLUSION,DUE,LABEL,MAXIMAL,METHODS,PRESENTLY,RESULTS,SINCE
154,160,233,BACKGROUND,BETWEEN,BRAINSTEM,GOS,III,LABEL,METHODS,RESULTS,SEVERAL,TEN,THERE
005,100,177,215,768,810,848,888,ASL,AUC,BACKGROUND,CONCLUSION,DWI,FDG,FIFTY,GBM,KRUSKAL,LABEL,METHODS,PCNSL,PET,RESULTS
BECAUSE,PEG,RGD,TAT
169,BACKGROUND,BASSO,BBB,BEATTIE,BEHAVIORAL,BRESNAHAN,COPYRIGHT,LABEL,LOCOMOTOR,METHODS,OBJECTIVE,PBS,PURPOSE,RESULTS,SCI,STUDIES,TAXOL,TREATMENT
169,CNS,COPYRIGHT,FURTHER,GBM,GLIAL,LTD
100,100ML,169,177,BACKGROUND,CBF,CBV,CONCLUSION,COPYRIGHT,HOWEVER,III,IRELAND,LABEL,LTD,METHODS,MRI,RESULTS,SIXTY,VOI,VOLUMES,VOLUMETRIC
169,243,AFTER,ALA,COPYRIGHT,CROWN,III,INCREASING,LTD,PUBLISHED
169,COPYRIGHT,LTD
169,COPYRIGHT,GROSS,INTRA,LTD,SCHWANNOMA
001,006,169,ACCORDING,ADAM8,AIM,CONCLUSION,COPYRIGHT,DETECTION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
001,169,CONCLUSION,COPYRIGHT,COX,JANUARY,KARNOFSKY,KPS,LABEL,MAJOR,MEIER,METHODS,OBJECTIVE,RESULTS,TREATMENT
169,COMPONENTS,COPYRIGHT,COR,CSL,DELTA,HOWEVER,INC,MAML1,NOTCH,SERRATE,THERE
169,COPYRIGHT,INC
10A,169,AFTER,AUTHORS,BASIC,HOWEVER,MDR,MDR1A,MDR1B,RENAL,SOCIETY,THESE,TOXICOLOGY
169,AGING,ANATOMICAL,AUTHORS,BLACKWELL,BRITAIN,GREAT,GREATER,HIF,HOWEVER,HRG,INCREASING,IRELAND,LTD,NSPCS,PUBLISHING,SOCIETY,SUBSEQUENT
AVERAGE,GBM,HOWEVER,WHILE
169,THESE,WILMS
038,117,DESPITE,FEW,FIFTY,HOWEVER,INDIA,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OVERALL,PEDIATRIC,RESULTS,SCALE,WOUND
001,DIFFUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROI
CHAVANY,FAT,MARIE,WHILE
AFTER,DBS,IMPLANTED,LABEL,METHODS,OBJECTIVE,PARKINSON,RESULTS
142,416,FIFTEEN,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RADIATION,RESULTS,STR,THEREFORE
ART,D54,EPHA2,FOSL1,GROWING,HYPOXIC,INCREASED,PCR,PTH,SOX,WHSC2,YKL
000,DESPITE
5MC,BASED,SEVERAL,TET
DESPITE,DIFFUSE,GBM,LABEL,MOLECULAR,NEWLY,OPINION,STATEMENT,UNASSIGNED,WORLD
CONCLUSION,FLT,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,RESULTS
COLLIMATOR,CYBERKNIFE,OPTIMAL,PLANS,PROLONGED,SIMILARLY,STUDIES,USAGE
169,285,ADVERSE,AES,CONCLUSION,COPYRIGHT,COX,CRT,CSI,DUTCH,EQD,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURVIVORS,TBI,THERE,USING

169,COPYRIGHT,HISTONE,LTD,MBT
001,ADC,DWI,EMBRYONAL,MEIER,RESULTS,SIXTY
016,ADC,CONCLUSION,DWI,HEALTHCARE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SCANNER,TOTALLY
ANNAS,CSF,DIAGNOSIS
215,947,HOWEVER,PBS,RAG,SVZ
115,122,124,254,404,AIMPS,AMINOACYL,ARS,ATLAS,GBM,KRT10,MED12,MEIER,NCI,PARD3,TAKEN,THEIR,TRAF2
169,946,BECAUSE,CPT,CPT1C,CTP1C
103,120,156,AST,CAH,CONCLUSION,GGL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEIZURE,SURGERY,SWEDISH,UNIVARIATE
231,BEH,CNS,MRI
BILATERAL,CEREBELLAR,CMS,RIGHT,SEVENTEEN
AVERAGE,CNS,EIGHT,ERR,GENERALLY
AGGRESSIVE,CNS,DESPITE,KETTERING,MTX,MULTIDRUG,PCNLS,PCNSL,SLOAN,THREE
945,BIACORE,GBM,IL13R,SPR,SURFACE,TQM13
169,ALTOGETHER,ASTROCYTES,COPYRIGHT,EXPRESSION,GBM,GPX,INC,MAPPING,MNSOD,REGARDLESS,RNS,ROS,SOD,WILEY
169,AAV,COPYRIGHT,FEDERATION,HOWEVER,PUBLISHED,SOCIETIES
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,LIPID,METHODS,OPINION
APRIL,AVENTIS,BBB,FDA,JEVTANA,MARCH
EARLY,LFS,MRI,PREDICTIVE
233,BIALLELIC,CAF,HEREDITARY,HNPCC,LYNCH,NF1,THEREFORE
AE1,CEA,EMA,HMB45,IMAGING,METASTATIC,MRI,RCC
ARC,BAX,KNOCKDOWN,THESE
CAM,HOWEVER,OTHER,OVCAR
100,945,956,ANNEXIN,CALPAIN,GRP,NAC,ROS,TREATMENT,U87,WOGONIN
107,306,331,474,504,842,BACKGROUND,BOARD,BRAIN,CENTRAL,ENGLAND,GENERATING,LABEL,LEUKAEMIA,METHODS,OBJECTIVE,OBS,OVERALL,RESULTS,SRR,WALES
001,003,004,006,007,CNS,CONCLUSION,HODGKIN,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SURVIVORS,THESE,WORKING
169,177,ANY,BECAUSE,BETWEEN,BLOOD,COPYRIGHT,EFS,GROUP,INC,LABEL,METHODS,OBJECTIVE,PEDIATR,PHASE,PURPOSE,RESULTS,WILEY
100,BACKGROUND,CONCLUSION,FURTHER,LABEL,MEP,METHODS,PATIENT,RESULTS,RMT,TMS
149,160,BACKGROUND,BETWEEN,CENTRAL,CONCLUSION,LABEL,METHODS,RESULTS
CONCLUSION,GBM,LABEL,METHODS,MRI,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,WESTERN
233,CCL17,CCL26,CCL27,IGE,LDH,NGF,SERUM
THERE
169,946,COPYRIGHT,GBM,INHIBITION,L1CAM,LTD,TGF,THESE
946,ALZHEIMER,AMYLOID,BASAL,BECAUSE,HOWEVER,ROS
BACKGROUND,LABEL,METHODS,PATIENT,RESISTANCE,SUMMARY,TRH,TSH,TSHOMAS
169,ALZHEIMER,COPYRIGHT,DIFFUSION,DTI,IRELAND,LTD,MCI,MRI,PRIOR,SINCE
945,BBB,GBM,INHIBITION,WHILE
100,150,ADVERSE,BID,DESPITE,DISEASE,EIAED,GBM,PFS
003,005,015,BASED,BLI,GBM,LABEL,LUC,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,U87
33342,945,ABCB1,CYCLING,HIF,HOECHST,HOWEVER,MTT,WESTERN
001,006,102,116,124,198,AMONG,ATLAS,BACKGROUND,BECAUSE,CONCLUSION,COX,CPG,LABEL,MEIER,METHODS,METHYLOME,MUT,MUTATIONS,REDUCED,RESULTS
BACKGROUND,LABEL,METHODS,PITUITARY,STUDI,UNIVERSITA
160,COMPARING,DCS,LGG,NBS,PLASTIC
000,160,ADC,BACKGROUND,CNS,CONCLUSION,DWI,EIGHT,EVN,LABEL,METHODS,RESULTS,SEVEN,T1WIS,WORLD
181,BAX,BCL,CUR,ETP,MED,POTENTIAL,THESE,TMZ,TREATMENT,WHILE
001,177,CONCLUSION,EOR,FIFTY,INITIAL,LABEL,METHODS,OBJECTIVE,RESULTS
001,141,163,167,169,242,912,951,CA125,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVARIAN,RESULTS,THESE,WOMEN
210,BACKGROUND,COM,EARLY,LABEL,METHODS,NEURO,NPC,RADIATION,RESULTS,THEIR
946,HOWEVER,TGF
108,138,147,210,216,668,BETWEEN,EFS,FOLLOWING,HIT,INFANTS,LGG,MARCH,OCTOBER,SIXTY,TEN,THREE
169,COPYRIGHT,HOWEVER,INC,T98,U87,WILEY
946,947,DSB,TGF,THESE
100,160,HIV,HOWEVER,ROS
CNS,CSI,EARLY,EMBRYONAL,FOLLOWING,TEN
AMONG,CENTRAL,CONCLUSION,LABEL,METHODS,MONRO,OBJECTIVE,RADIATION,RESULTS,THEREFORE,THREE,TUMOURS
169,327,867,AUSTRALIAN,B12,BACKGROUND,CBT,LABEL,METHODS,MOTHERS,ORS,RESULTS,THERE,THESE
17AEP,AFTER,AKT,ANNEXIN,BASED,GAS,GBM,HGF,HSP90,MET,SINCE
19Q,1P19Q,EMA,MRI,OLIG2,R132H,SNP
HOWEVER,OBESE,THREE
AFTER,BRAIN,ECG
143,145,200,JANUARY,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,VARIABLES,WHILE
169,555,ABCB1,ABCG2,ALEXA,BBB,COPYRIGHT,CTX,SINCE,STUDIES,WESTERN
169,COPYRIGHT,GLIOMAS,HOWEVER
169,COPYRIGHT,CROWN,EXTENSIVE,LTD,PFO,PUBLISHED
169,COPYRIGHT,INC,LIGHT
199,AIM,AMONGST,BACKGROUND,CONCLUSION,COX,GBM,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL
BASED,BRAIN,DIFFERENT,EUCLIDEAN,TESLA
001,005,014,BACKGROUND,CONCLUSION,LABEL,MEDICAL,METHODS,PRL,RESULTS,TSS
397,576,861,925,AKT,CHG,FAK,HOWEVER,JNK,MDA,SRC,THEREFORE,WESTERN
946,ELISA,FAS,HOECHST,IFN,LIPOSOMES,SHG44
118,393,410,8092C,ABI,ASP312ASN,CHINESE,CONCLUSION,DETECTION,ERCC1,GENOTYPING,GLN,HOWEVER,LABEL,LYS,MARCH,METHODS,OBJECTIVE,PRISM,RESULTS,STATA,XPD
100,177,CHOROID,CPC,CPP,GROSS,GTR,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,THERE,WHILE
BECAUSE,CSF
176,BACKGROUND,BESIDES,DISCUSSION,HPC,III,LABEL,METHODS,RESULTS,SURGERY
AFTER,APHASIA,BATTERY,BECAUSE,DTI,LABEL,METHODS,OBJECTIVE,RESULTS,WAB,WESTERN
022,027,029,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
001,100,BRAINSTEM,COX,LABEL,MEIER,METHODS,MRI,OBJECTIVE,RESULTS,THERE
102,1ST,BACKGROUND,BRAIN,CNS,CONCLUSION,DISCUSSION,DUE,JANUARY,LABEL,METHODS,MRI,NEUROLOGY,OBJECTIVE,RESULTS,UNIVERSITY
CD133,EQUALLY,THESE,U87
173,573,ATLAS,CD4,CONSISTENT,EXPRESSION,GBM,OMNIBUS,PROJECT,RESULTS,THESE,USING,UTILIZING
CLASS,THESE,U87MG
215,384,ADC,BACKGROUND,COX,DSC,DWI,LABEL,MATERIALS,METHODS,OBJECTIVE,PCNSL,PFS,PRETHERAPY,PURPOSE,RESULTS
CENTRAL,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,THREE
003,006,017,187,251,589,791,ANY,FIFTY,LABEL,METHODS,MONRO,MRI,NMI,OBJECTIVE,PURPOSE,RESULTS,SEN,SGCTS,TSC
177,956

THERE
100,162,169,174,177,200NM,5NM,ATP,COPYRIGHT,EFFICIENT,IRELAND,LTD,TAXOL,THESE
169,ACC,COPYRIGHT,DUE,EVENT,INC,NOVELTY,ODDBALL,P3B,PFC,POTENTIALS,RELATED,THESE,WHEREAS
169,BECAUSE,COPYRIGHT,LTD,THESE
945,BACKGROUND,LABEL,RESULTS,SINCE,TGF,THESE,TKI
CURRENT,GBM,TODAY
ANTIBODIES,BANGHAM,SINCE
168,BACKGROUND,BECAUSE,CONCLUSION,LABEL,MALIGNANCY,METHODS,OBJECTIVE,OCTOBER,RCC,RESULTS
CNS
AWAKE
CURES,CYTOTOXIC,DESPITE,GIVEN,GLIADEL,III,PHASE,TMZ,USA
ASSESSMENT,CONCLUSION,HOWEVER,INEVITABLE,INNOVATIVE,LABEL,MATERIALS,METHODS,OBJECTIVE,ONGOING,RESULTS,THROUGH,UNLABELLED
THERE
169,ANIMALS,EBP,GRP78,HOWEVER,POH,RAS,TMZ
169,CARLO,COPYRIGHT,LTD,MONTE,NUMERICAL,WILEY
TGF
AUC,GBM,MACDONALD,MPC,PFS,THREE,VERUBULIN
169,CD4,FOXP3,GBM,IDO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TREGS
HOWEVER

001,177,AFTER,BACKGROUND,BEIJING,CONCLUSION,FIFTEEN,FT3,FT4,LABEL,METHODS,RESULTS,TIANTAN,TSH
DURAL
006,126,225,271,519,AMONGST,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,OTHER,RESULTS,SHERBROOKE
CD4,CD8,HOWEVER,HSP,LABEL,METHODS,OBJECTIVE,RESULTS,RTS,SCHONLEIN,THESE
177,2MM,5MM,6MM,9MM,AVERAGE,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,RESULTS,THEREFORE
SRS
CURRENTLY,DIFFUSION,DTI,GIVEN
BACKGROUND,EXPRESSION,GLEEVEC,LABEL,LNA,METHODS,MICRORNAS,RAPAMYCIN,RESULTS,STUDENT,U0126,WESTERN
BEGINNING,EIT,ELECTRICAL,IMPEDANCE,TOMOGRAPHY
053,19Q,320,COMMUNITY,GBM,MOLECULAR,NEURO,P53,PDGFR
008,160,ALA,BACKGROUND,FGS,GBM,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,MRI,RESULTS,SCALE,SELECTIVE
117,131,169,ASSESSMENT,BACKGROUND,COPYRIGHT,FUNCTIONAL,GENERAL,LABEL,METHODS,QOL,RESULTS,SOCIETY,THERAPY,THERE
BACKGROUND,BRAIN,DEFINITIVE,LABEL,METHODS
BACKGROUND,CONCLUSION,EFFECTIVE,EPILEPTIC,LABEL,METHODS,RESULTS,SEIZURE
003,004,011,027,169,5GY,APRIL,CONCLUSION,COPYRIGHT,DEPARTMENT,EGYPT,III,INSTITUTE,KARNOFASKY,LABEL,METHODS,OAS,OBJECTIVE,PFS,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOUTH,UNIVERSITY
169,BIOMARKERS,COPYRIGHT,INC,THERE
ERK,GBM,GSC,JNK,JUN,TRAIL,USING
006,030,069,078,471,666,697,945,946,947,948,952,AMSTERDAM,ANT,BACKGROUND,CRT,LABEL,MEG,METHODS,POWER,RESTING,RESULTS,TASKS
002,004,116,169,ALT,AUTHORS,BRAIN,CONVERSELY,P53,PATHOLOGY,R132H,SOCIETY,THERE
FINALLY,GLIOMAS,GPC,HOWEVER,THESE,TREATMENT
ABDOMINAL,CUSHING,DESPITE,OVERNIGHT,THERE
169,BRITAIN,COPYRIGHT,FIRST,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
001,002,006,008,CCL20,KARNOFSKY,THERE,WORLD
001,002,009,012,014,043,169,211,BACKGROUND,CD151,COPYRIGHT,III,INC,LABEL,METHODS,PCR,PFS,RESULTS,WILEY
177,186,AFTER,BNP,THEREFORE
THERE,YTTRIUM
169,177,COPYRIGHT,INC,INDIVIDUAL,NFU,STS,THESE
169,2000S,COPYRIGHT,LTD,MRI,SINCE
ADT,AFFAIRS,AMONG,BACKGROUND,DESPITE,LABEL,METHODS,RESULTS
160,169,BACKGROUND,CD4,CD8,CONCLUSION,COPYRIGHT,HOWEVER,III,INC,LABEL,MDLNS,METHODS,MOSBY,OVERALL,RESULTS
LABEL,METHODS,OBJECTIVE,PURPOSE,RB1,RESULTS
177,945,949,HIF,HYPOXIA,MNP,PC3,PCL,PEG,PPEEA,THEREFORE
MRI,SURGERY,TREATMENT,UCH,WITHOUT
SCC
169,945,946,CBP,HIF,HRE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
150,169,200,400,500,ALT,CONCLUSION,DLT,HGG,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,THERE,TMZ,VORINOSTAT
177
DOTANOC,PET,SSTRS
GSLCS,MTT,SERUM,SIX
250,400,956,ADRENAL,BACKGROUND,CONCLUSION,FURTHER,HOWEVER,HPA,ITT,LABEL,METHODS,MSC,OBJECTIVE,RESULTS,THERE,TSS,USING
BACKGROUND,GHQ30,LABEL,METHODS,NRS,QOL,RESULTS,TSS
CHOROID,CPP,MRI,TH9
012,041,044,COX,EXPRESSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE
132,134,19Q,587,AOS,ARG132HIS,HOWEVER,LOS
169,BASEL,COPYRIGHT,THERE,THREE
139,177,AVM,BACKGROUND,CONCERNING,CONCLUSION,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SIZES
169,945,BASEL,COPYRIGHT,CXCR4,SDF,STUDIES
100,169,BACKGROUND,BASEL,COPYRIGHT,GAMMA,KNIFE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS
169,BASEL,COPYRIGHT,GROSS,III,WORLD
MANGANESE
169,174,231,233,COPYRIGHT,GAMMA,HOWEVER,KNIFE,OVERALL,PUBLISHED,SAS
169,231,233,COPYRIGHT,M1A,PUBLISHED,SAS
000,018,019,160,169,215,468,572,COPYRIGHT,HODGKIN,LTD,PERIPHERAL,PUBLISHED,VII
10000,169,AMONG,CONCLUSION,COPYRIGHT,GLASGOW,INC,LABEL,METHODS,MOSBY,OBJECTIVE,RESULTS,SCALE
169,AVP,COPYRIGHT,FACTORS,NEUROGENIC,VIGILANCE
169,COPYRIGHT,INC
169,COPYRIGHT,CSF,GIVEN,INC,LABEL,METHODS,OBJECTIVE,PERSISTENT,PURPOSE,RESULTS
368,946,AGE,KARNOFSKY,KPS,LABEL,MEIER,METHODS,MRI,OBJECTIVE,RADIATION,RESULTS,SCALE
HSP70,WHEREAS
001,006,109,531,CURRENTLY,GROSS,GTR,LABEL,METHODS,OBJECTIVE,RESULTS,STR
174,AFTER,BACKGROUND,CONCLUSION,LABEL,LGG,LOW,METHODS,MRI,MRS,OWING,PET,RESULTS,TEMODAL,TTP
BRAIN,INITIAL,LOW,OTHER
ECM,MDE,THEREFORE
283,946,ALTOGETHER,APC,EXPRESSION,GSK,INCREASED,PCR,TCF
CHO,CONCLUSION,DIAGNOSTIC,LABEL,METABOLITE,METHODS,MRS,NAA,OBJECTIVE,OVERALL,PURPOSE,RESULTS,ROC,TES
GBM,HOWEVER,THERE,THESE,TMZ
946,AKT,ANIMALS,EXTENDING,HOWEVER,NF1,RAS,RII,SCHWANN,TGF
BROCHURES,DISCERN,WRITTEN
124,CDA,FURTHER,INHIBITION,PCR,SWO,TWIST
150,DLT,III,MTD,SIROLIMUS,TREATMENTS,WORLD
DESPITE,DOTATOC,PET,SPECT
210,AIM,CARDIAC,LABEL,LESIONS,METHODS,MRI,OBJECTIVE,PET,RESULTS
002,280,AFTER,ASIAN,BACKGROUND,CONCLUSION,JANUARY,LABEL,METHODS,RESULTS,THESE
586,FORGE,LABEL,METHODS,OBJECTIVE,RESULTS,SIR
001,003,006,BACKGROUND,CAB,CONCLUSION,DESPITE,DOSES,EIGHT,LABEL,METHODS,MORTALITY,PRL,RESULTS
126,916,TRP53,VIA
169,500,BACKGROUND,BMS,COPYRIGHT,FIFTY,GRADE,HRQOL,IRELAND,LABEL,LTD,METHODS,ORR,PFS,RESULTS,THERE,TTP
160,AAV,MSC,SYSTEMATIC,TAKEN,U87
GBM,PRDX4,ROS,THESE
53BP1,DDR,GBM,PRONEURAL,THESE
169,DAILY,IMMEDIATE,MENIN,MRI,PITUITARY
CRANIAL,GRADE,MIB,MRI,OVERALL,PILOCYTIC,THERE
945,ADENO,FINALLY,FOLLOWING,HOWEVER,RGD,THESE,USING
005,208,956,CUSHING,DISEASE,FIFTY,MORNING,POD,RECORDS
MMP,MTT,SAM,SASH1,SH3,USING
139,177,528,635,662,AGE,CAUSE,CSS,GTR,ICD,INCIDENCE,INITIAL,JANUARY,NEITHER,OVERALL,PROGRAM,RADIATION,STR,SURGERY,THERE
120,246,390,484,500,956,CD4,HLA,JANUARY,THREE,WALDENSTR
001,002,006,036,160,III,SEVENTY,STAGE
CSF,HOWEVER,MRI,SEVEN,THESE
LABEL,METASTASES,METHODS,RENAL,SUMMARY,UNDER,UNLABELLED
003,031,048,275,AGE,FIFTEEN,LABEL,MATERIALS,METHODS,NETWORK,OBJECTIVE,PNB,PURPOSE,RESULTS,SIX
169,177,800,800CW,945,946,IRDYE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RGD,TS543
AVERAGE,LABEL,MEDLINE,METHODS,OBJECTIVE,PITUITARY,RESULTS,THERE,VASOSPASM

CD133,CEA,GBM,GBM12,GBM44,GFP,GIVEN,GSC,MEASLES,NIS,OLIG2,USING

19Q,ABOUT,ASSESSMENT,DYNAMIC,HOWEVER,III,LABEL,NEURO,OBJECTIVE,ONGOING,PCV,PURPOSE,RESULTS,SUMMARY
19Q,19Q13,ADDITIONAL,BINDING,CAPICUA,CIC,DROSOPHILA,FAR,FINALLY,FUBP1,IDH,LABEL,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,SINCE,SUMMARY,THEIR
BACKGROUND,CHANGES,JANUARY,KARNOFSKY,KPS,LABEL,MARCH,METHODS,MRI,RESULTS,SRS,THESE
138,BACKGROUND,INCREASED,KPS,LABEL,METHODS,P28GANK,RESULTS,UNIVARIATE
073,275,282,516,BACKGROUND,LABEL,PRINCIPAL,RESULTS,SILAC,THROUGH
169,ATLAS,CLASSICAL,CONCLUSION,CPG,GBM,JOINT,LABEL,METHODS,OBJECTIVE,PRONEURAL,PURPOSE,RESULTS,THERE,THREE
009,MYC
AIM,CLE,CURRENTLY,DIFFERENT,EARLY,HEALTHY
AMONG,THESE
BECAUSE,K252A,K252B,PCR,TRK,USING,UTERINE
002,005,009,138,142,164,190,236,280,512,572,631,691,HTT,MSI,PROGNOSIS,WHILE
AIM,CHANGES,CONCLUSION,D22S444,D22S929,LABEL,LOH,METHODS,NF2,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,DOPPLER,LABEL,METHODS,RESULTS,TCD,VASOSPASM
233,478,488,726,EXCESSIVE,FINALLY
BACKGROUND,CONCLUSION,CSI,DFS,FURTHER,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE
100,150,200,215,CRUDE,GRADE,HOWEVER,KARNOFSKY,LOCAL,SECONDARY,SRS
169,AMONG,CHARCOT,CONCLUSION,COPYRIGHT,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCHOLAR,SKULL
AKT,AXL,ERK,THESE
169,956,AIF,ALDH1,APOPTOSIS,BAX,BCL,BID,CCM,CD133,COPYRIGHT,HBTSC,INCREASES,LTD,PTX
169,ANXIETY,BECAUSE,CAUCASIAN,CHECKLIST,COPYRIGHT,DELAYED,DEPRESSION,GIVEN,HCT,INC,PRE,SCL,SYMPTOM,TREATMENT,WBC
169,787,832,876,893,AUC,COPYRIGHT,DESPITE,GBM,INC,THERE
169,COPYRIGHT,DLT,EASTERN,GRADE,GROUP,INC,LABEL,MATERIALS,METHODS,MTD,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RPA,SHORT,THERAPY,THREE,TREATMENT
105,226,600,980,BACKGROUND,CEF,CHF,CMF,CONCLUSION,DOPPLER,FIFTY,HOWEVER,INCIDENCE,LABEL,METHODS,NEWER,RESULTS,TDI
001,BACKGROUND,CCNA1,CONCLUSION,FINALLY,KPS,LABEL,LATS1,METHODS,PCR,RESULTS,THESE,USING
633,APART,SKYLINE,SRM
APART,FOLLOWING,HOWEVER
CSF
AMD3100,CHO,CXC,CXCR4
189,209,AFFYMETRIX,BACKGROUND,BROADLY,CONCORDIA,FINALLY,FURTHER,LABEL,RESULTS,USING,WHILE
946,BBB,GL261,NOTCH,THESE,WNT
002,946,FSH,LABEL,METHODS,NFPAS,OBJECTIVE,OIS,PCR,PRL,RESULTS
122,BASED,HENCE
FOLLOWING,MRI,SEVERAL
CHEST,INFECTIOUS
AKT,GBM,MICRORNAS,PDCD4,PROGRAMMED,SILENCING,TAKEN,U87MG
BEX,MEANWHILE,MMP,TAKEN
039,232,336,LARGE,THEREFORE
CRI,HOWEVER,RAMAN,THESE
169,COPYRIGHT,FDA,FOLKMAN,GBM,HOWEVER,IRELAND,JUDAH,LTD,SINCE,THERE
169,COPYRIGHT,DUE,FLT3L,FMS,GBM,IRELAND,LTD,PHASE,SIMPLEX,THYMIDINE
169,COPYRIGHT,GBM,HYPOXIA,INC
169,CONCLUSION,COPYRIGHT,DSA,EMPLOYING,GENERAL,HOWEVER,LABEL,METHODS,MRI,NOTABLY,OBJECTIVE,RESULTS,SURGERY
002,004,010,015,068,102,169,335,534,560,735,963,COPYRIGHT,FINALLY,IRELAND,LTD,NSCLC
MRI,PRIMARY
HBO,LABEL,METHODS,MRP,MTT,OBJECTIVE,PROTEIN,RATES,RESULTS,TMZ
10B,ACTIVATION,CASP9,CDX,CONCLUSION,GLIOMAS,HS683,ID3,LABEL,METHODS,MYC,NDRG1,OBJECTIVE,RESULTS,SNAKE,THESE,USING
129,131,135,145,149,ADH,FOLLOWING,INCREASED,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
012,027,376,403,ANTIGEN,CLOCK,GROWING,HOWEVER,III,NUCLEAR,THEREFORE,USING
177,945,BACKGROUND,ICC,IMAGERY,IMAPRAX,LABEL,METHODS,PARKINSON,RESULTS,SCLEROSIS
EGL,EGLN3,GRADE,H196A,HIF,THESE,THROUGH
380,EPHA3,THEREFORE,THESE
MICRORNAS,THESE
COMPOUNDS,H3K27,HISTONE,HMT,SEVERAL
001,100,132,AAS,CAT,CGT,DAS,GBM,III,MUTATIONAL,R132H,WORLD
169,ANTITUMOR,CNT,CPG,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TLR
100,ADC,DWI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PWI,RADIATION,RESULTS,SIXTEEN
003,077,160,AGREEMENT,BRIEF,HOWEVER,INVENTORY,LABEL,LOW,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,SURVIVORS,SYMPTOM,THEIR,USING,UTILIZING,YOUTH
013,086,177,247,278,358,413,682,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,RESULTS,SWI
GREIG,MUTATIONS,PALLISTER,PHS,PPD,THEREFORE
200,956,GBM,HSP27,U87
002,119,177,BACKGROUND,CLINICO,CONCLUSION,FORTY,GROSS,HENCE,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS
169,ALZHEIMER,BACKGROUND,CONVERSELY,COPYRIGHT,DISCUSSION,EPIGENETIC,HDACS,HISTONE,HUNTINGTON,INC,LABEL,METHODS,PARKINSON,RESULTS,TREATMENT
119,139,160,169,177,207,956,COPYRIGHT,CUSHING,INC,LABEL,METHODS,OBJECTIVE,OVERALL,RCC,RESULTS,SUBSEQUENT,USING
COLLEGE,OPTIMAL,PITUITARY
BACKGROUND,BASED,CENTRAL,CONCLUSION,HOWEVER,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,THERE
BACKGROUND,CONCLUSION,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENT
BACKGROUND,LABEL,MASTERPLAN,METHODS,MRI,RESULTS
169,946,BMP,COPYRIGHT,INC,TGF,THESE,WHEREAS
169,CCND1,COPYRIGHT,EGF,HDAC3,HOWEVER,INC,MYC,T11,THESE,WARBURG
169,COPYRIGHT,INC
169,COPYRIGHT,INC
GBM,LTD,PUBLISHED,STUDIES,WIF,WNT
169,191,240,COPYRIGHT,INC,KARNOFSKY,KPS,LABEL,LDH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNI
169,53BP1,946,947,CLONOGENIC,COPYRIGHT,FAK,INC,JNK,LABEL,MATERIALS,METHODS,MIGRATION,NEITHER,OBJECTIVE,PURPOSE,RESULTS,THESE
ANTONIO,BACKGROUND,CNS,GBM,LABEL,METHODS,MONTICONE,PCR,RESULTS,SAM,UNVEILING
001,003,010,035,095,148,216,238,BACKGROUND,CHINESE,HOWEVER,LABEL,METHODS,RATIO,RESULTS,THEIR,TNC
164,BACKGROUND,BETWEEN,BRAIN,CCA,CONCLUSION,JANUARY,LABEL,METHODS,RESULTS,RPA,THREE,UNIVERSITY
158,175,187,190,BACKGROUND,DEC,HOWEVER,LABEL,METHODS,MST,NSCLC,QOL,RESULTS,SUN,THERE,TREATMENT,TTP,UNIVERSITY
121,945,946,CORNEAL,EXPRESSION,GBM,GLEEVEC,INSTITUTE,LABEL,MARMARA,METHODS,NF2,OBJECTIVE,PDGFR,RESULTS,UNIVERSITY,VSS,WESTERN
BASED
136,177,AUSTRALIAN,CSF,ENDOSCOPIC,GROSS,GTR,INTRA,PRIVATE,SEPTEMBER,THERE
BACKGROUND,GBM,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,SCORE,SIXTY
22Q12,ENGLISH,HOWEVER,LABEL,MEDICAL,METHODS,MIB,OBJECTIVE,RADIATION,RESULTS,THERE
946,ALZHEIMER,CDC25,CDK,INHIBITION,SELECTIVE,SIMILARLY,THESE,USING
100,AFTER,ALM,DES,EBV,EMA,HMB,MITOSES,SMA,STAININGS
000,842,CPG,FURTHER,IDH,R132H,THESE,USING
10001,282,333,339,363,CSF,FAILURE,HOWEVER,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHERS,RESULTS,SEVENTH,THERE,USA
DIG,HOWEVER,INI,LABEL,METHODS,MIB,MITOSES,OBJECTIVE,PURPOSE,RESULTS
CSC,DEPLETION,DESPITE,GBM,IGF2BP2
169,1PG,3PG,916,956,COPYRIGHT,EIS,ELISA,PBS,PDITC
001,002,169,251,COPYRIGHT,COX,DBF,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SRS
DIFFUSION,INDIVIDUAL,MRI
000,CDC,CENTERS,CONTROL,DISEASE,END,FEW,INCIDENCE,PREVENTION,PROGRAM,RESULTS,THESE,WEB
001,021,120,945,BACKGROUND,CONVERSION,LABEL,METHODS,RESULTS,USING
169,313,ABOUT,AUSTRALIA,COPYRIGHT,CROWN,LTD,PAEDIATRIC,PILOCYTIC,PUBLISHED,SOUTH,WALES
100,169,AFTER,COPYRIGHT,CRANIAL,EPENDYMOMA,HOWEVER,LTD,MRI,THERE,WORLD
169,AUSTRALIA,AUSTRALIAN,CAUCASIAN,COPYRIGHT,HCC,LTD,SAHARAN,WESTERN
169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,LTD,PTY,PUBLISHING,RECURRENT,WILEY
001,014,016,169,177,237,AFTER,AIM,CARDIAC,CONCLUSION,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,THERE,WILEY
169,HODGKIN,LTD,MARCH,PTY,PUBLISHING,WILEY
AUTHORS,BACKGROUND,CBT,CENTRAL,COLLECTION,FINALLY,FIRST,FURTHER,LABEL,MARCH,MEDLINE,METHODS,MST,OBJECTIVE,OBJECTIVES,PST,RESULTS,SELECTION,THERE
181,945,BAX,BBB,BCL,BCSFB,MTT,TAKEN,TNF,TUNEL

231,BRAIN,KNOCKDOWN,MCF,MDA,PCR
001,007,014,016,024,027,126,318,526,633,AMONG,CNS,ELDERLY,HOWEVER,III,LABEL,LOWER,METHODS,MTX,OBJECTIVE,PCNSL,PFS,RESULTS
92A,BCL2L11,BIM,FURTHER,UTR
BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESTING,RESULTS,THESE
175,BACKGROUND,CONCLUSION,FIFTY,GTR,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,USING,VARIOUS
GBM
100,169,183,APRIL,BACKGROUND,BRISTOL,COPYRIGHT,EASTERN,EUDRACT,FUNDING,GROUP,III,IPILIMUMAB,LABEL,LTD,METHODS,MYERS,RESULTS
PATIENT
BAO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THREE
111,CARESTREAM,CATPHAN,GREENWICH,GROUP,HOUNSFIELD,IMAGING,LABEL,LABORATORY,MADISON,METHODS,MTF,OBJECTIVE,PHANTOM,PURPOSE,RESULTS,RMI,ROCHESTER,SPATIAL
001,177,CARLO,COMPARE,EXCLUDING,LABEL,METHODS,MONTE,OBJECTIVE,OVERALL,PLANS,PURPOSE,RESULTS,THESE,TPS
CHART,CHECK,DICOM,ELECTRONIC,GENERATED,LABEL,METHODS,MICROSOFT,OBJECTIVE,PDF,PURPOSE,RESULTS,USERS,WHILE
ANOVA,BACKGROUND,CONCLUSION,DIFFUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,THERE
000,22Q12,CHINESE,DROSOPHILA,HAN,HORMAD2,PCR
169,CYP,GABAB,HOWEVER,INC,SAR,WILEY
169,500,APRIL,CNS,COPYRIGHT,HOWEVER,INC,MOLECULAR,SIMPSON,THEREFORE,WHILE,WILEY,WILMS
PAPILLARY
160,169,183,ADMISSION,CNS,DIAGNOSIS,GEORG,HISTORY,LABEL,METHODS,STUTTGART,TREATMENT
AFTER,BACKGROUND,BED,DLT,FORTY,LABEL,METHODS,MTD,RESULTS,SIB,TMZ,WHILE
2OHOA,MRC,RAS,SF767,TMZ
216,BMS,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROGNOSTIC,RCC,RESULTS,TKI
554,ADVERSE,COMPARING,HISTOLOGY,INITIAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFS,RECORDS,RESULTS,STR
169,BACKGROUND,COPYRIGHT,CPS,INC,LABEL,METHODS,RAPID,RECURRENCE,RESULTS,SPECIMENS,THIRD
176,915,BACKGROUND,LABEL,METHODS,MHZ,RESULTS,SAR
BACKGROUND,DISCUSSION,LABEL,METHODS,MICRORNAS,OBJECTIVE,RESULTS
AGE,CNS,LABEL,METHODS,OBJECTIVE,PACKETS,PURPOSE,RESULTS,YOUNG
GBM,SRC,THESE
MALIGNANT,PGP,THESE
ANAPLASTIC
FOLLOWING,MRI
001,007,100,1P19Q,ADULT,GROUP,IDH,INA,INTERNEXIN,LGG,LOW,R132H,THESE,VPP
169,699,COPYRIGHT,FDG,NSCLC,PET,TOTALLY
LABEL,METHODS,OBJECTIVE,ORR,PURPOSE,RESULTS,THREE,TMZ,VNB
HEARING,MRI,PALLISTER,PHS
002,004,030,233,AGGRESSIVE,BACKGROUND,CENTRES,FIFTY,INCREASED,LABEL,LUTTE,MARGINS,METHODS,MFS,NATIONALE,RESULTS,SIXTY
169,ANIONIC,APOE3,COPYRIGHT,HOWEVER,PRESENT
AMM,BRAIN
MENINGIOMA,MRI,SPECT
001,945,AMT,INCREASED,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TUMORAL,WORLD
KREBS,MUTATIONS,PHEOS,SDH,STRATAKIS,SUCCINATE
HOWEVER,THESE
169,COPYRIGHT,GENERALLY,HOWEVER,ICG,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,EXPRESSION,GALANIN,GALR1,GALR2,GALR3,LTD,PCR,TRANSCRIPT
100,160,169,ANG,BARRIER,BBB,BLOOD,BRAIN,COPYRIGHT,LRP,LTD,PCL,PEG,PTX,RESULTS,TAXOL
169,340,AIM,AMONG,AUTHORS,BRAIN,BRCA1,CONCLUSION,FURTHER,GYNECOLOGY,HOWEVER,JAPAN,JOURNAL,LABEL,LOH,METHODS,OBJECTIVE,OBSTETRICS,RESULTS,SOCIETY,THEREFORE
181,24S,945,946,HEP,MCF,NUGC3
007,038,122,169,183,BLACKWELL,FEW,LABEL,LTD,METHODS,MRI,NFPMA,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHING,RESULTS,THERE
100,169,956,AUTHORS,HOWEVER,JOURNAL,LGA,MTT,SOCIETY,SZELIGA,TMZ
396,TFD,THERE
100,396,III,KARNOFSKY,PARTITION,RECURSIVE,RPA,TFD
BCBMS,FINALLY
ALTERED,BECAUSE,FINALLY,FURTHER,METABOLIC,ROS,TARGETING,THESE,TIGAR,TKTL1
169,17P11,33B,COPYRIGHT,FDA,MICRORNAS,MOLECULAR,MYC,THROUGH
169,BACKGROUND,CNS,COPYRIGHT,INC,INDIVIDUAL,LABEL,METHODS,PROCEDURE,RADIATION,RESULTS,TAKEN,THESE,WHOLE,WILEY
155,169,177,BACKGROUND,CAROTID,COPYRIGHT,INC,JANUARY,LABEL,MAY,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RESTENOSIS,RESULTS,THERE,WILEY
169,217,218,460,AUSTRALIAN,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,RESULTS,THERE,WESTERN,WILEY
100,169,233,BOUND,COPYRIGHT,INC,LCMODEL,LOWER,RAO,THESE,WILEY
160,946,CATENIN,EXPRESSION,HOWEVER,MUTATIONS,THESE,WNT
100,956,LOWER
102,EXPRESSION,KNOCKDOWN,LVD,MVD,OSCCS,RUNX3,THESE,TRK
015,11Q23,160,20Q,20Q13,601,856,955,GLIOMAS,SNP
102,132,169,AMONG,CNS,COPYRIGHT,CSF,EXTRANODAL,GROUP,IELSG,LDH,LTD,PCNSL,THESE,WHETHER,WHILE,WILEY
GBM,HOWEVER,MRI,TREATMENT
335,FURTHER,RB1
021,122,339,389,ARG,BRAZILIAN,PRO,SNP,THESE
ENGLISH,INCLUDING,MEDLINE,THERE,TOTAL
CARDIAC,REGULARITY,THESE
DCS,NAVIGATED,SPECIAL,USING
140,945,GBM,GLIOMAS,H3F3A,III,USING
018,046,BACKGROUND,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,RADIATION,REGARDING,RESULTS,RPA,THERAPY,THERE
CER,GOLGI,M1A,MCF,SAT
140,168,169,185,1ST,239,367,394,939,AOR,APD,ASP,COPYRIGHT,ICD,THESE,WYS
HOWEVER,R132C
169,CNS,COPYRIGHT,HODGKIN,INC,LABEL,METHODS,OBJECTIVE,PCNSL,PRIMARY,RESULTS
111,FIFTY,GAMMA,INC,KNIFE,LABEL,LESIONS,LOCAL,METHODS,MRI,OBJECTIVE,PREDICTORS,PRIOR,PUBLISHED,PURPOSE,RESULTS,SRS
169,COPYRIGHT,ELEVATIONS,INC,OVARIAN,THESE
00003,158,169,176,19Q13,BW4,CAUCASIAN,COPYRIGHT,HAPLOTYPES,HLA,INC,KIR,THERE,UTILIZING
003,169,177,945,AMONG,COPYRIGHT,CRP,INC,RII,THESE,TNF
004,009,012,035,046,169,AFTER,BACKGROUND,CAR,COPYRIGHT,COX,EARLY,FLATTENED,FLATTENING,HAZARDS,INC,LABEL,LYMPHOCYTE,METHODS,RESULTS
027,169,215,AUR,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
945,AEG,BACKGROUND,BASED,HOWEVER,LABEL,METHODS,RESULTS
169,BRAIN,COPYRIGHT,EORTC,LTD,TREATMENT
177,7GENE,AKT,APOPTOSIS,CONCLUSION,LABEL,METHODS,MMP,MRI,OBJECTIVE,PAMAM,PCR,RESULTS,WESTERN
169,BASED,COPYRIGHT,HOWEVER,INC,MARCH,TEN,THERE
COGNITIVE,ENGLISH,FEBUARY,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTION,SOURCES
177,AFFILIATED,BACKGROUND,CONCLUSION,FIRST,HARDY,HOWEVER,KNOSP,LABEL,METHODS,RESULTS,UNIVERSITY
169,AUTHORS,FORTY,LARGE,SLEEP,SOCIETY,WHETHER
152,169,EWING,GCT,PBSCS,PREDICTION,WBC,WILEY,WILMS
100,139,169,BLACKWELL,HOWEVER,III,LABEL,LIM,LIMITED,LMX1A,METHODS,OBJECTIVE,OPN,PUBLISHING,RESULTS,SIMILARLY,WORLD
169,AFTER,AUTHORS,BRAIN,PATHOLOGY,SOCIETY,THESE
BASED,FINALLY
ETHICAL
ACCORDING,MORPHOLOGY
009,828,AMONG,APC,BACKGROUND,CHINA,HODGKIN,HOWEVER,LABEL,METHODS,OVERALL,RESULTS
24G,25G,BRAIN,CONCLUSION,LABEL,METHODS,MIE,MRI,OBJECTIVE,PURPOSE
CB1,CB2,INCREASED,INDUCTION,THERE
JAK,JANUS,STAT1,STAT3,STAT5,STATS,WHILE
946,INCREASED,INHIBITORS,SMAD2,SMAD4,SMAD6,TGF
AXL,EPH,MET,PDGFR,PROTEIN,RTK,TIE
ADAMS,AKT,CDC42,GTPASES,INCREASED,KEY,MAP,RAC,RHO,THESE,TRANSIENT
945,946,ATP,INHIBITION,P2Y,PIP,RHO,SIGNALING,UTP
ADP,AMONG,AMP,ATP,GLIOMAS,P2X,STUDIES
CALCIUM,CHANGES,CHAPTER,FINALLY,P2Y
ADP,AKT,P2X,P2Y,PLC
PURINES
ADENOSINE,ATP,CNS,P2X,P2Y,PURINERGIC,THERE
000,100
ALA,EXOGENOUS,SELECTIVE
008,174,740,874,ASIDE,BACKGROUND,BRAIN,END,FACTORS,GUIDELINES,LABEL,METHODS,MRI,PET,RESULTS,THERE
169,COPYRIGHT,INC,MRI
169,COPYRIGHT,INC
169,BACKGROUND,CENTRAL,CNS,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,SOLID,THERE
160,174,AMONG,HOWEVER,III,JEVTANA,MDR,STUDIES,TODAY,TREATMENT
100,119,123,169,183,200,229,242,291,342,AUSTRIA,BACKGROUND,COPYRIGHT,DENMARK,FOUNDATION,FUNDING,GRADE,LABEL,LTD,MERCK,METHODS,RESULTS,SOCIETY,SWEDISH,UME,UNIVERSITY
169,COPYRIGHT,FINALLY,RELATED,WORKING
169,24H,COPYRIGHT,HOWEVER,ORIGINALLY,PER,PERIOD2
AREAS,BACKGROUND,COVERED,DESPITE,GBM,HENCE,LABEL,METHODS,OPINION,TARGETING
007,021,155,178,ADOLESCENT,AIM,DOKUZ,EYLUL,FACULTY,LABEL,LANGERHANS,METHODS,OBJECTIVE,ORGANIC,PEDIATRIC,RESULTS,UNIVERSITY
AFTER,FINALLY,HOWEVER,MIXED
233,AKT,BAD,DESPITE,GBM,GOLGI,MEK,STAT3,THESE,TREATMENT,U87MG
AOA,ATO,DLT,KPS,MTD,QTC,TMZ
007,FEW,KPS,PFS,RESECTION,SIMILARLY,SIXTEEN
177,743,ANGELES,HOWEVER,III,LOS
CT322,SINCE,THESE,U87,USING,VEGFR
160,APRIL,AWAKE,BACKGROUND,FURTHER,INSTITUTE,LABEL,METHODS,MRI,NEUROLOGIC,NIHSS,PRE,RESULTS,SCALE,SURGERY,THEREFORE
ADC,COX,DWI,GBM,LABEL,MEIER,METHODS,MINIMUM,OBJECTIVE,PFS,PSF,RESULTS,STUDENT
049,FETAL,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,PREGNANCY,RESULTS,VHL
169,AKT,CANDIDATE,CHALLENGED,MOBILIZING,PATCHED,SHH
GLIOMAS
FINALLY,FIRST,NFI,THIRD
CLINICIANS,FURTHER,HOWEVER,THERE,WHILE
001,100,177,215,822,851,959,AUC,CONCLUSION,FET,III,LABEL,MAXIMUM,METHODS,MRI,PET,RESULTS,ROC,TBR,TTP,UNLABELLED
001,006,009,029,105,177,AVERAGE,BACKGROUND,CONCLUSION,CONTEXT,COX,CURRENT,HPA,LABEL,MEIER,METHODS,MORTALITY,OBJECTIVE,OUTCOME,RESULTS,SETTING
160,169,177,183,247,308,318,326,622,AFTER,AGE,BETWEEN,BLADE,CONCLUSION,GEORG,III,INTER,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,STUTTGART
947,BRAIN,CD4,CD8,GBM,HSP,HSPPC,IFN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TESTING,THESE
BLADDER
005,CBV,EIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PCT,PURPOSE,RESULTS,THESE
524,HES,HOWEVER,NOTCH,RESTORATED,USING
169,COPYRIGHT,LABEL,METHODS,OBJECTIVE,POSTERIOR,RESULTS,TOTAL
CNS,GKSRS,THERE
177,ADC,DIFFUSION,MRI
001,007,008,AGE,ARCHIVE,ATLAS,BACKGROUND,GBM,HOWEVER,IMAGING,INGENUITY,KARNOFSKY,KPS,LABEL,METHODS,MULTIFORME,P53,PATHWAY,REMBRANDT,RESULTS,SEVERAL,VAK
001,GBM,JANUARY,NORWEGIAN,TMZ
000,030,046,100,118,143,160,BRAIN,CNS,END,GROUP,INCIDENCE,JAPAN,PROGRAM,RESULTS,THEIR
ABOUT,ACTIVATING,NEUROD2,SHH,SMO,SMOA1,SMOA2,SMOOTHENED,SONIC,WHILE
150,166,177,182,223,332,946,FSH,LABEL,PITUITARY,THESE,TSH,UNLABELLED
363,CIC,FUBP1,HOWEVER,III,MUTATIONS
145,CAS,EMPTY,LGG,NEDD9,PFS,USING
157,EFFECTIVE,LEE,MYC,NDRG4
006,016,101,110,177,AMPLITUDES,BLACK,LABEL,METHODS,OBJECTIVE,RESULTS,VEP
AFTER,RADIATION
19Q,CNS,CONCLUSION,DESPITE,JANUARY,LABEL,METHODS,MIB,MULTI,OBJECTIVE,PAPILLARY,PURPOSE,R132H,RESULTS,THEIR
169,AFTER,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,ESS,FEDERATION,GYNECOLOGY,IIB,INITIALLY,LABEL,METHODS,OBSTETRICS,PIVER
PULMONARY
2ND,CHEST,DELAYED,EMERGENCY,JAPAN,SOCIETY,SURGERY
BESIDES,CNS
002,1H153,215,245,BACKGROUND,GLV,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR,TNBCS
CSF
169,CALIFORNIA,COPYRIGHT,CRT,HOWEVER,INC,LABEL,LGG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VARIABLES,VERSION
004,169,APS,BECAUSE,COPYRIGHT,CPS,FORTY,GEE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVH,PTV,PURPOSE,RESULTS,SIB
169,946,ABC,ALZHEIMER,AMYLOID,COPYRIGHT,HOWEVER,INC,TYING
169,AIM,COPYRIGHT,DESPITE,DTI,ERT,HCT,INC,LABEL,MEDICAL,METHODS,MPS,MRI,OBJECTIVE,RESULTS,THEREFORE
DESPITE,EMC,EPITHELIAL,TREATMENT
AFTER,CARCINOMA,PITUITARY
40S,THESE
GPR17,OLIG2,OPC,SYSTEMATIC,TREATMENT
169,A192621,CNS,EDNRB,INDUCED,METASTATIC,USING
CURRENTLY,RESULTS
ABOUT,HOWEVER,KARNOFSKY,KPS,PCR,PRIMARY,Q136X,R273H,R306X,THERE,THESE
122,134,149,169,177,182,183,195,239,391,GEORG,GROUP,III,STUTTGART,THESE
FIRST
GDP,GTP,INSTEAD,RAC,RHO
197,489,799,ARIZONA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THERE
HCC,HOWEVER,MAY,PET,SEPTEMBER,THEREAFTER
PRIMARY,UNIVERSITY,WASHINGTON
ANNEXIN,ANX,GBM,HOWEVER,PUBLISHED
169,COPYRIGHT,HOWEVER,LTD,PITUITARY
160,169,CONVERSELY,COPYRIGHT,LTD
215,300,400,498,744,BACKGROUND,BRM,LABEL,METASTASES,METHODS,PALLIATIVE,RADIATION,RESULTS,SPAIN,THESE
169,ALZHEIMER,AUTHORS,CNS,ECM,HOWEVER,JOURNAL,MMP,PARKINSON,SOCIETY
001,020,118,124,135,189,ACTUARIAL,AFTER,AIM,BEGINNING,COX,MULTIMODAL,PFS,TMZ,WITHOUT
000,162,200,247,AMONG,BACKGROUND,INCIDENCE,JANUARY,LABEL,MEDLINE,METHODS,RESULTS,VTE
100,243,252,ALLENDE,ENGEL,III,SANATORIO,THERE
HOWEVER,LABEL,SUMMARY,THESE,WHILE
001,002,007,123,177,215,500,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WARTHIN
001,104,153,174,177,250,284,414,500,ACT,ANGIO,BACKGROUND,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
THESE
169,COPYRIGHT,LTD,PDT
169,COPYRIGHT,FINALLY,GBM,INC,PATHOLOGY,PUBLISHED,SOCIETY
FINALLY,NUCLEOSIDE,PARTICULAR,THESE
ATP,BACKGROUND,BBB,CONCLUSION,CSP,GLUCOSE,HOWEVER,LABEL,RESULTS
001,003,007,BACKGROUND,CONCLUSION,GPA,HOWEVER,LABEL,METHODS,PRIOR,RESULTS,RPA,TOTAL,TREATMENT
001,120,186,770,955,ERR,HODGKIN,MORTALITY,POISSON,RADIATION,STUDIES
INSTITUTE
100,594,AMONG,BACKGROUND,BLOOD,CIS,CONCLUSION,IGE,JANUARY,JANUS,LABEL,METHODS,ORS,RESULTS,SERUM,TESTING
009,031,036,107,160,ACCORDING,BACKGROUND,CHT,KARNOFSKY,KPS,LABEL,METHODS,RESULTS
AVAILABLE,DUE
001,006,008,128,AIM,COX,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,MMP,OBJECTIVE,RESULTS,THESE
160,243,ACUTE,AFTER,BACKGROUND,CONCLUSION,EXPERIENCE,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS
160,BACKGROUND,FRANCISCO,INTRA,IOERT,JANUARY,KPS,LABEL,MATERIALS,METHODS,RESULTS,SAN,SPAIN,THERE,THREE
012,018,025,160,578,APRIL,COX,DIR,FORTY,KARNOFSKY,LABEL,MAY,MEIER,METHODS,MST,OBJECTIVE,PURPOSE,RESULTS,SCORE,SRT
001,ALI,BACKGROUND,CONCLUSION,DESPITE,INPATIENT,LABEL,METHODS,MIDWEST,MORTALITY,NATIONWIDE,OBJECTIVE,PREDICTORS,RESULTS,SOUTH,TBI,TRAUMATIC
001,AGE,AIM,CONCLUSION,DEPRESSION,FINALLY,INVENTORY,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS
169,177,606,621,BACKGROUND,BASEL,COPYRIGHT,FURTHER,HANDL,INSTITUTES,JANUARY,LABEL,METHODS,MULTIMODAL,NIHSS,RESULTS,SCALE,SOMATOFORM
1960S,EARLY,LESIONS,THESE
1900S,CUSHING,DEVELOPED,EDINBURGH,GUIOT,HARDY,HOWEVER,JULES,OSKAR
CUSHING,DESPITE,HERMANN,INNSBRUCK,OSKAR,SCHLOFFER,UNIVERSITY
CMS,CSF,INCLUDING,LABEL,METHODS,OBJECTIVE,RESULTS
COLLECTIVE
SURGERY
177,AFTER,CONCLUSION,CRT,EFS,GROUP,LABEL,METHODS,OBJECTIVE,P9934,PEDIATRIC,POG,PURPOSE,RESULTS,SEVENTY,WHEREAS
100,122,177,340,AFTER,CONCLUSION,EFS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
005,211,251,AFTER,CONCLUSION,GROUP,LABEL,LGG,METHODS,OBJECTIVE,PCV,PFS,PURPOSE,RADIATION,RESULTS,THERAPY
169,COMPRESSED,COPYRIGHT,INC,WILEY
169,183,BACKGROUND,BARTH,DISCUSSION,GEORG,IGG,LABEL,METHODS,PHYSICIANS,STUTTGART
135,168,303,DESPITE,EFEES,EXECUTIVE,NON,OFC,USING
BACKGROUND,BLOOD,CASES,CONCLUSION,DEGREES,LABEL,METHODS,MRI,OBJECTIVE,PMC,PURPOSE,RESULTS,TTP
000,500,EARLY,ENGLISH,IDR,SEVENTY,TMZ
946,BASED,BRAIN,FLAIR,HENCE,IMP,MRI,SPECT
AALBORG,ALA,BACKGROUND,CONCLUSION,DENMARK,DEPARTMENT,FUNDING,GLIOLAN,LABEL,MALIGNANT,METHODS,RESULTS,TOTAL,TRIAL
001,160,169,183,214,BLACKWELL,CENTRAL,CNS,DLBCL,LTD,PUBLISHING
CEREBELLAR,WORLD
CAS,COX,XII
ASPECTS,D283MED,FURTHER,HNF4A
185,956,CYS,FOURIER,MALIGNANT,MTT,NOVEL,NPS,TEM,THEREFORE,U87
ESOTROPIA
275,BECAUSE,CURRENT,HDACI,HOWEVER,MEIER,TSA,VPA
169,172,ACUTE,AFTER,AMSTERDAM,ANXIETY,COPYRIGHT,DEPRESSION,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCALE,WILEY
169,ATTENTION,BACKGROUND,BLOOD,CONNERS,COPYRIGHT,INC,LABEL,METHODS,PEDIATR,PROCEDURE,RESULTS,REVISED,SURVIVORS,TEACHER,WILEY
169,233,COPYRIGHT,INC,MMR,OPG,OPTIC,TESTING,WILEY
169,183,FORTY,GEORG,STUTTGART,THESE,WHR
HISTOLOGY,UNIVERSITY
101,121,BACKGROUND,DIAGNOSTIC,FET,FRAME,LABEL,METHODS,OPERATION,PET,PRIOR,REACHABLE,RESULTS,VARIOGUIDE
600,647,800CW,ALEXA,CCD,COR,DESPITE,EGF,FLUOR,FMI,GRAND,HOWEVER,IRDYE,LINCOLN,PMT,SMALL
169,181,ABCB1,ABCC4,ABCG2,BBB,CONSORTIUM,COPYRIGHT,DARBY,FDA,HOWEVER,ITC,LTD,THESE,WILEY
183,CENTRAL,GEORG,PSA,STUTTGART
10001,333,HOWEVER,MEDICAL,PUBLISHERS,RCC,SEVENTH,USA
169,COPYRIGHT,FACULTY,HISTORIES,LEGAL,LTD
160,177,233,ENDOSCOPY,USING
107,945,AIM,BACKGROUND,CD133,EXPRESSION,GBM,HLA,ICT,IL13R,LABEL,MAGE1,METHODS,PCR,PFS,RESULTS,TAA,TRP
169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS
169,319,369,AMONG,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,COX,DESPITE,END,HOWEVER,ICD,LABEL,METHODS,PREDICTIVE,RECURSIVE,RESULTS
003,009,016,041,066,093,097,106,126,157,169,191,203,232,BESAG,CONTROL,COPYRIGHT,DIRECTIVE,INTEGRATED,LAPLACE,MOLLI,OTHER,POISSON,POLLUTANT,POLLUTION,POPULATION,PREVENTION,REGULATION,RELEASE,SPANISH,THESE
ENDOCRINE,HOWEVER,MANAGEMENT,RET,VHL
006,042,169,177,184,491,556,BACKGROUND,BECAUSE,CHINESE,CNS,COLLEGE,COPYRIGHT,CSF,EPIDERMAL,HOWEVER,INC,LABEL,MARCH,MEDICAL,METHODS,PUMCH,RESULTS,THERE,UNION
145,169,COPYRIGHT,INC,LNCAP,PCR,PWR,RYR,THREE,TOTAL
000,001,217,BACKGROUND,BETWEEN,BRAIN,COX,FIFTY,FURTHER,LABEL,LNR,MEIER,METHODS,NSCLC,PCI,RESULTS
007,039,174,571,CD117,GISTS,GLEEVEC,IHQ,III,STI
185,1ST,2ND,916,AIM,CONCLUSION,CRT,FCH,FDG,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,RESULTS,THERE
169,APPLIED,AUTHORS,BRITISH,CONCLUSION,DIFFUSE,FINALLY,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,WHOLE
169,801,956,AUTHORS,HOWEVER,JOURNAL,MDR1A,PCR,SOCIETY,SUBCHRONIC
BACKGROUND,ENDOSCOPIC,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVEN,USING

320,THESE,UNDER
167,AMONG,FCS,GENERAL,GMM,IL6,KARNOFSKY,SCALE,SLEEP,VARIATION
CONCLUSION,EIGHT,GRADE,III,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,THERE,WORLD
BIG,GOLGI,HEK,HLA,PCR
105,15B,184,203,34A,363,367,504,BECAUSE,GBM,HOWEVER,III,OLIG2,PRIMARY,YKL
160,BRAIN,HEARING,LAPATINIB,NF2
BACKGROUND,CONCLUSION,LABEL,METHODS,RCC,RESULTS
ACTIVATION,AKT,EDU,ERK,EXPRESSION,IGF,MIGRATION,P27,PHASE,S6K,SHH,THESE,TPA,U0126
946,AML,BACKGROUND,CONCLUSION,EIGHT,GBM,INHIBITION,LABEL,MATERIALS,METHODS,PI3KS,RESULTS,WHILE
FOLLICULAR,FSH,MRI
4TH,HOWEVER,MFH,MRI
CNS,MRI,PATIENT,PRIMARY,SINCE,SURGERY,TEN
HOWEVER,MRI
CNS,CRANIAL,TOTAL
EPIDERMOID,OCCURRENCE
AMERICA,CENTRAL,CHINA,EASTERN,JAPAN,NORTH
006,214,ELDERLY,END,GRADE,HOWEVER,III,MEIER,OVERALL,PATIENT,PXA,RESULTS,SURGERY
001,177,GTV,MIR,MRI,SRT
176,180,360,DVH,OAR,PLANS,SYNERGY
ALTERED,DU145,LNCAP,THESE
190,CONCLUSION,EAAT2,LABEL,METHODS,MOLECULAR,OBJECTIVE,RESULTS,TAS
001,967,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PRECISE,RESULTS,THREE
001,003,177,BACKGROUND,CONCLUSION,FINALLY,FRAMELESS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SEM
AVERAGE,BACKGROUND,CONCLUSION,EIGHT,LABEL,METHODS,OBJECTIVE,PRINCIPLE,RESULTS,SEVENTEEN,SIXTEEN,TEN,WHILE
954,ENDOGENOUS,MMP,PCR,U87,U87MG
CAPACITIVE,HEPG2,HOWEVER,MHZ,THESE
160,AMONG,CVS,FEWER,HOWEVER,SAH,THEIR,TSS
CURRENT,HRMAS
231BR,945,BRAIN,DUNNETT,KRUSKAL,MEIER,MRI
181,APOPTOTIC,BAX,BCL,BID,HOWEVER,MCL,QUERCETIN,SP1
160,181,200,ANNEXIN,ATTENTION,CURCUMA,DESPITE,MALIGNANT,MMP,PCR,TAKEN,TIMPS
169,COPYRIGHT,CRC,FINALLY,INC,K252A,THESE,TRK
CNS,DIAGNOSTIC,JXG,TREATMENT
ACUTE,AFTER,ATTENUATED,CHINESE,CNS,DIFFUSION,FLAIR,FLUID,INVERSION,MRI,MTX,T1W,T2W
103,ACTUARIAL,CNS,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIXTY,SRS,THERE
177,18F,CHANGES,CONCLUSION,DYNAMIC,LABEL,LNR,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,TAC
169,ADAMS,BRAIN,BTSCS,CELLS,COPYRIGHT,INHIBITION,IRELAND,LTD
169,COPYRIGHT,LVV,THESE
169,177,ALT,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,CROWN,FIFTEEN,HBS,HBSAG,HCV,INC,LABEL,METHODS,PUBLISHED,RESULTS,SEVEN
134,135,146,169,269,415,AFTER,AMONG,BNP,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,USING
169,COPYRIGHT,INC
169,AIS,BESIDES,COPYRIGHT,ENDOCRINE,FINALLY,LTD,MBC
001,005,007,008,031,045,047,169,177,COPYRIGHT,CROWN,IDEAL,LTD,PFS,PUBLISHED,WALES
BACKGROUND,EXPRESSION,LABEL,MET,METHODS,PCR,RESULTS,SATB1,SPECIAL
003,047,186,AMONG,BACKGROUND,CBR,CONCLUSION,LABEL,LAPATINIB,METHODS,OVERALL,PFS,RESULTS,TRIAL
100,200,300,CONCLUSION,DISEASE,GTN,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
GBM,HOWEVER,THESE,TMZ
FGFR1,FGFR3,GBM,INHIBITION,TACC1,TACC3
169,954,ADP,BAX,BCL,BIOLOGY,COPYRIGHT,DESPITE,GBM,GSH,INC,MOLECULAR,PEG,ROS,THEREFORE,THESE,UNION
003,114,BACKGROUND,CONCLUSION,EXPRESSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE
169,177,COPYRIGHT,INC,MRI,SINCE,SOLID,WILEY
LABEL,OPINION,PEMETREXED,STATEMENT,UNASSIGNED
THERE
169,COPYRIGHT,LTD
160,169,177,COPYRIGHT,LTD,MRS,PRESS,PUBLISHED,SINCE,SPECTRA
PITUITARY,POSTMORTEM
169,AGGRESSIVE,BRITISH,COPYRIGHT,DESPITE,LTD,MEDICAL,PUBLISHED
FIFTEEN,MRI,SEVEN,THEIR
002,005,018,AFTER,BACKGROUND,CONCLUSION,CSF,FURTHER,JANUARY,LABEL,METHODS,MRI,PITUITARY,RESULTS,SEPTEMBER,THERE,UNTIL
185,CDC42,FURTHER,HOWEVER,LEUCINE,LOW,LRR,LRRC4,VEGFA
155,169,GABRA,MICRORNAS,PML,WILEY
EEG,FUNCTIONAL
AUTHORITY,LOCAL,SIR,TURIN
169,AMP,COPYRIGHT,GBM,INC,MDR,USING,WILEY
HOWEVER,SURGERY,THERE,TOTAL
AWAKE,LGG,MRI,RESECTION,SEVERAL
960,ATP,ECS,GBM,GST,HGG,LGG,PGP,REFRACTORY,TCS
SIX,THERE,THESE
169,ANGELES,BASEL,CONCLUSION,COPYRIGHT,LABEL,LOS,METHODS,PFS,RESULTS,THERE,UNLABELLED
125,CHROMATIN,CONSORTIUM,CTDNEP1,DDX3X,DESPITE,GROUP,KDM6A,PROJECT,PTCH1,SEVERAL,SHH,SMARCA4,THESE,THOSE,WNT
087,945,946,954,GROUP,MYC,NDRG1,PARKINSON,RECURRENT,SCNAS,TGF
GADOLINIUM
309,343,442,628,686,BACKGROUND,DIETARY,FFQ,HODGKIN,LABEL,METHODS,NHL,ORS,RESULTS
169,181,BACKGROUND,BASEL,BMI,CONCLUSION,COPYRIGHT,EXENATIDE,LABEL,METHODS,OBJECTIVE,RESULTS
169,CD163,CNS,COPYRIGHT,LTD,THESE,VARIOUS
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,NEUROLOGY,SINCE,SMART

EULER,LABEL,METHODS,OBJECTIVE,PDE,PURPOSE,RESULTS,THESE
124,128,137,219,34A,805,92B,FIRST,GBM,HOWEVER,NOTCH,TFS
202,HUR
169,18F,COPYRIGHT,INC,MRI,WILEY
160,240,NF1,OPG,OVERALL,SIMILARLY
AFTER,BBB,KO143,MDR1A,PET
344,FISCHER,HOWEVER,SRC,THREE
177,956,ANESTHESIA,BACKGROUND,CONTROLLED,HENCE,HOWEVER,LABEL,METHODS,RESULTS,THERE
BACKGROUND,BMI,CSI,LABEL,METHODS,RESULTS,V10,V15,V20
013,018,030,038,041,043,046,055,136,177,ANAPLASTIC,COX,GROSS,HOWEVER,III,KPS,PFS,RPA
100,BASED,MALDI,MHC,SINCE,TOF
370,ALIVE,BACKGROUND,CONCLUSION,LABEL,MALIGNANT,METHODS,MRI,OUTLINE
100,33258,APOPTOSIS,HOECHST,MTT,PCR,TCP,THESE,TSA,WESTERN
BRAIN,THROUGH
SHH,WNT,WORLD
BIOLOGY,OTHER,PATHOGENIC,SYMPOSIUM
12Q14,160,19Q,22Q13,CGH,HOWEVER,NON,PIK3C2B,THEREFORE
CNS,EBV,EPSTEIN,MTX,PAX
160,20A,BRAINSTEM,BSG,HOWEVER,PCR
APOPTOSIS,BACKGROUND,HNSCC,LABEL,LDOC1,METHODS,PARKINSON,RESULTS,THESE
MENINGIOMA
160,956,BACKGROUND,CURRENTLY,LABEL,METHODS,MTT,RESULTS,SGH44,SHG44,TMZ
AMONG,CENTRAL,FURTHER,WHILE
160,HPC,MAS,MRI,MRS,THESE
40P53,916,ISOFORM,PCR,SDS
021,028,326,CPG,H3K79,MUTATIONS
GCT
100,153,169,BACKGROUND,COPYRIGHT,GROSS,III,INC,JANUARY,LABEL,METHODS,MEXICAN,OBJECTIVE,PARTIAL,PUBLISHED,RESULTS,SAMII,SEVENTY
122,ABUTALEBI,BILINGUALS,BRAIN,CHINESE,COGNITION,ENGLISH,GREEN,JOURNAL,PRICE,THERE
FGFR4,MMP,PITUITARY,WHILE
LABEL,SUMMARY
169,946,AKT,AZD6244,COPYRIGHT,CURRENT,ERBB2,IGF,INC,INCREASED,JUN,NF2,PDGFR,SCHWANNOMA,THEREFORE,USING,WILEY
19Q,218,ABI,GLIOMAS,HOWEVER,MET
132,165,III,R132H,SOMATIC
ACUTE,METASTASES,SRS
215,ACCORDING,BACKGROUND,CLINICIANS,CNS,CONCLUSION,DIFFUSE,DNH,ENGLISH,HBL,LABEL,METHODS,MRI,STEROID,TOTAL,VON
HGA,NPC,PRIMARY,TRPV1,WORLD
BRAIN,LABEL,LAPATINIB,NSCLC,OBJECTIVE,PURPOSE,REGARDING,RESULTS,SUMMARY,SUNITINIB,TARGETING,TKI,V600E
169,COPYRIGHT,INC,PNI,WHILE
946,COR,DDX3X,OVERALL,PTCH1,RECURRENT,SMARCA4,TCF,WNT
169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,QUERCETIN,RELEVANCE,RESULTS,THERE,THESE,WHEREAS
169,177,COPYRIGHT,FURTHER,IRELAND,LTD,WITHAFERIN
169,COPYRIGHT,INC,THESE
169,COPYRIGHT,DESPITE,HOWEVER,MIAMI,THESE,U87MG
169,COPYRIGHT,FDG,HOWEVER,KARNOFSKY,KPS,LGA,MET,PCV,PET,REGARDING,SCORE,SEVERAL,THROUGH,TMZ
169,CHANGES,COPYRIGHT,FLT,GBM,IMAGING,INC,MRI,PET,WHILE
169,231,233,COPYRIGHT,MRI,PUBLISHED,SAS,SMART,TRANSIENT
001,026,028,126,169,COPYRIGHT,COX,III,INC,JANUARY,LABEL,LOG,MATERIALS,METHODS,OBJECTIVE,PATHOLOGIC,PCI,PURPOSE,RESULTS,STAGE
169,COPYRIGHT,EWING,LATER,LTD,TMZ
100,169,COPYRIGHT,INC,LABEL,METASTATIC,METHODS,OBJECTIVE,PGS,PUBLISHED,RESULTS,SRS,TREATMENT
ENDOSCOPIC,LABEL,METHODS,NASAL,OBJECTIVE,OUTCOME,PATIENT,QOL,RESULTS,SHORT,SINONASAL,SIXTY,SKULL,THERE
ALZHEIMER,BBB,HOWEVER,MTS,NEURONS,TAU,THESE
BASED,BRAIN,HOWEVER,SUBSEQUENT
169,946,AURKB,CENTRAL,CNS,INSM1,MICROARRAY,NEUROD4,NHLH1,NTS,PBS,PCR,PCS,PTTG1,RGS16,SEVERAL,SOCIETY,THEIR,THESE,UBE2C,WNT
177,ADDITIONAL,CURRENTLY,FORTY,LABEL,METHODS,MRI,OBJECTIVE,RECORDS,RESULTS
CATHEPSIN,EXPRESSION,THERE
CONTROL,JNK
239,ALZHEIMER,BECAUSE,BLOOD
CLS,CTV,LABEL,METHODS,OAR,OBJECTIVE,RESULTS,THERE
CONVERSELY,GERMINOMA,HISTOLOGY,NGGCT,TREATMENT
CD133,CSC,DCX,LABEL,METHODS,OBJECTIVE,PSA,PURPOSE,RESULTS,TUC
HOWEVER,ROSETTE,V600E
001,003,010,169,422,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,RESULTS
107,177,AIP,ARRAY,DENSITY,EXPRESSION,HOWEVER,LOW,UTR
169,COPYRIGHT,EXTRACTION,NLO,NONLINEAR,RAMAN,VCH,WILEY

CNS,VII
001,176,27K,ATLAS,CPG,LOWER,PCR,STP27,USING
945,954,ECTOPIC,HOWEVER,KNOCKDOWN,USING
CNS,PEDIATRIC
TMZ,WHETHER
PHYSICIANS,THERE
CNS,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
CNS,CRANIAL,KNOWLEDGE,LABEL,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SUMMARY,THESE
CSF,LABEL,MRI,NEITHER,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SUMMARY,TREATMENT
BRAIN,CURRENTLY,LABEL,MANAGEMENT,OBJECTIVE,PURPOSE,RESULTS,SRS,SUMMARY
COGNITIVE,EFFECTIVE,INCREASING,LABEL,NON,OBJECTIVE,PURPOSE,RELATIVELY,RESULTS,STIMULANTS,SUMMARY,THERE
100,110,285,BRENNER,EFFECTIVE,PERNAMBUCO,VII
169,233,237,241,243,COPYRIGHT,DOLOR,PUBLISHED,REANIMACI,TERAP,THERE
169,CD8,COPYRIGHT,HOWEVER,IRELAND,LTD,WHILE
169,COPYRIGHT,DNT
HISTO,LABEL,MDT,MRI,MULTI,STAGING,UNASSIGNED,UNLABELLED,VIRTUAL
THESE,TOTAL,XERODERMA
PARTIAL
278,APPLIED,BACKGROUND,HOWEVER,LABEL,LYMPH,RESULTS,USING
AFTER,BECAUSE,IIIA4,MALIGNANT,METASTASES,THERE
ANAPLASTIC,EMA,GCE,GIANT,GROSS
ENGLISH,HOWEVER,NPS,SINCE
ERK,GBM,MDA,TRAIL,UTILIZING
001,CONCLUSION,DEFAULT,DMN,FDR,HOWEVER,LABEL,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESULTS
GNP,HOWEVER,MAD,MICROARRAY,POTENTIAL,SHH,STRUCTURE,SUSTAINED,THEREFORE
956,CY5,EGF,NIR,PEG
169,CNS,COPYRIGHT,FOCAL,INC,WILEY
169,274,BECAUSE,BRAIN,COPYRIGHT,INC,INVENTORY,MRI,NEO,REVISED,WILEY
129,CONCLUSION,FURTHER,HOWEVER,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SPITZER,SYMPTOM
001,003,017,946,HSP27,HSP70,III,LOH,LOW,MSP,PCR
CNS
180,265,KARNOFSKY,KPS,MEIER
169,FURTHER,TREATMENT
AFTER,BACKGROUND,CLOSE,CONCLUSION,FORTY,LABEL,MARCH,METHODS,OBJECTIVE,OVERALL,RESULTS,SIXTY
003,10Q,10Q26,404,ATLAS,DMBT1,III,PRIMARY,THESE,USING
HCV,HISTORY,HIV,MRI
169,AUTHORS,BRAIN,CD133,PATHOLOGY,SOCIETY,WNT
III,PERIPHERAL,PHANTOSMIA,WORLD
CONCLUSION,GIANT,LABEL,METHODS,OBJECTIVE,RESULTS
LABELED,MTT,UNDER
AKT,CDK,MALIGNANT,PIK
FACTORS,HGA,HISTOLOGY,KARNOFSKY,THESE,USING

114,864,AXIAL
100,BBI,CONSENSUS,OVERALL,ROUTINE,STUDIES,TRB,TREATMENT,TRILATERAL
DESPITE,THESE
AFTER
946,FSH,OCTREOTIDE,RECURRENCE
BACKGROUND,CASES,CONCLUSION,CONGENITAL,CONTEXT,FGFR1,IHH,KAL,LABEL,METHODS,MUTATIONS,NOR,OBJECTIVE,PIT,PROP1,ROUTINE,TSH
BLOOD,CHONNAM,CSF,DELAYED,JANUARY,LABEL,METHODS,NSF,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,TSA,UNIVERSITY
CONGENITAL
176,CHINESE,CURRENT,EFFICIENT,HAN,SOCIETY
945,CORRECT,DELAYED,LABEL,METHODS,OBJECTIVE,RESULTS
ANTIBODIES,EMA,LABEL,METHODS,MSA,OBJECTIVE,PRIMITIVE,RESULTS,SMA
CONCLUSION,IMAGING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RIM
MRI,PATIENT
ABCB1,ABCC1,ATP,BACKGROUND,CONCLUSION,LABEL,MATERIALS,MDR,METHODS,MRP,MULTIDRUG,RESULTS,SAMPLES,TAP
ACTIVATION,BACKGROUND,CONCLUSION,CYP4A,CYP4F,LABEL,MATERIALS,METHODS,PCR,RAS,RESULTS
AFTER,DECISIONS
BRN3A,CELLS,HOWEVER,INCREASED,NGF,ONS,UW228
DESPITE,EARLY,LABEL,OPINION,SEVERAL,STATEMENT,UNASSIGNED
012,014,169,BASEL,BETWEEN,COPYRIGHT,HPF,LABEL,METHODS,MIB,OBJECTIVE,OBJECTIVES,RESULTS
COLLEGE,MAS,MEDICAL,UNION
160,403,ACTIVATION,AKT,LOW,OVERALL,PI3,THESE
BRAIN,RHO,THESE,USING
125,BACKGROUND,LABEL,MAY,METHODS,PRIMARY,RESULTS,THERE
169,BRAIN,BTICS,COPYRIGHT,IRELAND,LTD
169,CLINICALLY,COPYRIGHT,DURAL,EBV,EPSTEIN,GLASGOW,HIV,LTD,MRI,SMT,THESE
169,945,946,CNS,COPYRIGHT,ERE,LTD,MCF,TAKEN,THESE
169,COPYRIGHT,COX,HOWEVER,ICR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SRS,WHILE
169,323,335,COPYRIGHT,INC
169,COPYRIGHT,HOWEVER,LTD
169,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,DIAGNOSTIC,DUE,EVALUATION,IRELAND,LABEL,LTD,MATERIALS,METASTASES,METHODS,RESULTS,SWI
169,COPYRIGHT,CSF,DESPITE,HOWEVER,MRI,PCD,PET,ROUTINE,SHORTLY,TESTICULAR
019,025,027,039,169,301,302,967,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,CURRENT,GSTP1,HAN,HARDY,HWE,LABEL,LTD,MASSEXTEND,METHODS,PLINK,RESULTS,SNP,THESE
169,CONCLUSION,COPYRIGHT,GBM,INCLUDING,LABEL,METHODS,OBJECTIVE,RESULTS,SGS
160,169,176,CONCLUSION,COPYRIGHT,DAILY,ISOTROPIC,LABEL,LTD,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SET,SIMILAR,SYSTEMATIC,THESE
BESIDES,DESPITE,ERBB2
169,445,AIM,APRIL,COLLEGE,COPYRIGHT,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SEVENTY,THERE
003,169,AIM,ASSESSMENT,COLLEGE,CONCLUSION,COPYRIGHT,GREATER,HOWEVER,KARNOFSKY,KPS,LABEL,LTD,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PUBLISHED,RAPID,RESULTS,ROYAL,SYMPTOM
CSF,ECTOPIC,PEDIATRIC
100,GRADE,HOWEVER,III,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
169,COPYRIGHT,HOWEVER,INC
169,CLINICIANS,COPYRIGHT,HODGKIN,INC,PCNSL,PRIMARY
169,COPYRIGHT,DISCUSSION,INC
169,COPYRIGHT,DISCUSSION,INC
169,ADP,COPYRIGHT,CURRENT,DESPITE,INC,ONGOING
169,COPYRIGHT,INC,OPTIONS,WHETHER
169,COPYRIGHT,CURRENT,INC,LOW,THERE
169,CNS,COPYRIGHT,INC
000,100,169,COPYRIGHT,HOWEVER,INC,THESE,TREATMENT
169,COPYRIGHT,INC,PUBLISHED
169,COPYRIGHT,INC,SEVERAL
131,200,BACKGROUND,DESPITE,DTC,EVALUATION,FTC,HOWEVER,LABEL,METHODS,PARTIAL,PATIENT,SOLID,SORAFENIB,SUMMARY
CNS,GRADE,ITO
100,169,AMONG,COPYRIGHT,ISUOG,JANUARY,LABEL,LTD,MEDICAL,METHODS,MOLECULAR,OBJECTIVE,PUBLISHED,RESULTS,SEVEN,THERE,THREE,TSC,WILEY
169,177,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,TESLA,WILEY
169,215,COPYRIGHT,ICE,INC,MRI,WILEY
CEREBELLAR
ACCORDING,CONCERNING,CSF,DESPITE,JANUARY
132,177,180,229,BACKGROUND,CONCLUSION,DOPPLER,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS
160,AAS,DAS,GBM,III,MALIGNANT,SEVEN,THERE
FINALLY,FRK,FYN,HOWEVER,JNK,JUN,SRC
177,CNS,CSF,LOCALIZED,PFS
954,AMONG,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,RESULTS
100,945,CCOTS,CPS,PMS,PODOPLANIN,POSITIVITY,THESE
160,646,ALTOGETHER,CBT,CONCLUSION,DENMARK,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
000,100,235,BACKGROUND,CONCLUSION,FEMALES,GENERAL,HHT,HITACHI,IBARAKI,JAPAN,LABEL,MEDICAL,METHODS,PAVMS,PREFECTURE,PULMONARY,RESULTS
169,COPYRIGHT,HPA,INC,SDR,SNS
QOL
6TH,AFTER,BECAUSE,CEF,CNB,PGR,SCC
169,COPYRIGHT,EARLIER,LTD,PXA
169,CONSISTENT,COPYRIGHT,FINALLY,INC,NF1,NSC
169,COPYRIGHT,GBM,HGF,INC,INHIBITION,MET,PTP1B
169,19Q,AKT,CHROMOSOME,COPYRIGHT,GERMLIN,III,NF1,NF2,RAF,RAS,SAS,TSC,V600E
169,ABCB1,ABCG2,AUTHORS,BACKGROUND,BBB,BRITISH,JOURNAL,KEY,LABEL,LDL,METHODS,OBJECTIVE,PGP,PURPOSE,RESULTS,SOCIETY,STATINS
000,122,146,169,355,400,500,550,616,625,682,750,880,975,ACADEMY,ALLERGY,BACKGROUND,CONCLUSION,COPYRIGHT,COSTS,LABEL,LLC,METHODS,MRI,RESULTS,RHINOLOGIC,SOCIETY
169,946,BRITAIN,COPYRIGHT,ELTD1,FILIP1L,GREAT,IRELAND,LTD,NOTABLY,PUBLISHED,SOCIETY,TENC1,TGF,THROUGH,WILEY
177,18F,HOWEVER,III,INTENSE,LABEL,MATERIALS,METHODS,MODERATELY,OBJECTIVE,PAROTID,PET,PURPOSE,RESULTS,SUV,SUVMEAN
001,312,423,505,CNS,PEARSON,REGRESSION,THESE
001,101,149,1VALUES,BETWEEN,CONCLUSION,GROUP,IGF,LABEL,METHODS,OBJECTIVE,RESULTS,SDS
169,500,COPYRIGHT,INC,TREATMENT
160,169,3CM,COPYRIGHT,PROGNOSIS,PUBLISHED,SAS,SURGERY,THESE,WHOLE
ASSESSMENT,BACKGROUND,BRAINSTEM,CONCLUSION,CYBERKNIFE,DESPITE,FIFTEEN,GPA,HOWEVER,LABEL,METHODS,MRI,PREDICTORS,PRIMARY,PROGNOSTIC,RESULTS,SIX,SIXTEEN,SRS,SRT,THREE,TREATMENT,TRILOGY
169,COPYRIGHT,DIFFUSE,EMA,ENGLISH,NUCLEAR,XIIIA
169,215,MRI,RESECTION,SOCIETY
FURTHER

14A,542,931,CDC,CDC14,HIPPO,KIBRA,SER
OESTROGEN
61G,857,BASED,EGF,EPIDERMAL,SNP,STUDIES,UTR
021,962,983,LABEL,METHODS,OBJECTIVE,OVERALL,PCI,RESULTS,SIXTEEN
945,AKT,CHINESE,MUTATIONS,PREVIOUSLY
DAL,GLC,H1299,NCI,NSCLC,THESE
MRI,PET
118,209,BACKGROUND,DESPITE,EEG,INFECTION,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SPIKE,UNIVERSITY
BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
DIFFERENT,EPIGENETIC,FINALLY
100,169,CD4,CD8,CURED,GITRL,LABEL,METHODS,OBJECTIVE,OX40L,PURPOSE,RESULTS,THESE,VACCINE
GAPDH,INHIBITION,LABEL,METHODS,OBJECTIVE,RESULTS,SDF,WESTERN
001,109,111,165,AGT,AOA,CAT,CGT,CONCLUSION,IDH,LABEL,METHODS,OBJECTIVE,RESULTS,TGT
CONCLUSION,COX,JANUARY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SIXTEEN,THERE
142,151,AUSTRIA,BACKGROUND,C15,EORTC,GERMANY,INITIAL,KARNOFSKY,LABEL,METHODS,PAL,QLQ,QOL,RESULTS,THREE
139,947,BASED,CAR,EPIDERMAL,GCS,GSC,III,PCR,THREE,USING
001,169,177,AMC,CNS,EPWORTH,FURTHER,HOWEVER,INCREASED,INVENTORY,PEDIATRIC,QOL,QUALITY,SCALE,SLEEP,SLEEPINESS,SOCIETY,STRENGTHS
177,CNS,DESPITE,EOC,PALLIATIVE
109,169,APMIS,APOPTOTIC,AUTHORS,DUE,FURTHER,MIB,MITOSES,ROSENTHAL,SCHERER
169,APMIS,AUTHORS,CONCERNING,MELATONIN,NIGHT,NONVISUAL,RETINAL,THEIR
TSH
DNETS
10001,333,ALA,ATTEMPTING,MEDICAL,MRI,PUBLISHERS,SEVENTH,USA
183,DUE,EXOPHYTIC,GBM,GEORG,STUTTGART
DTI,FET,KEY,LABEL,MET,METABOLIC,METHODS,MRI,OBJECTIVE,OBJECTIVES,PET,RESULTS

169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,THERE,TRAUMATIC,TREATMENT
169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DNT,HOWEVER,IIA,LABEL,METHODS,PALMINI,RESULTS,SINCE
169,BASEL,COPYRIGHT,HEMORRHAGE,MRI
001,003,033,169,198,BASEL,COPYRIGHT,FACTORS,FEVER,ICU,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,017,041,169,187,199,BACKGROUND,COPYRIGHT,EXPRESSION,HOWEVER,LABEL,LIS,METHODS,MIB,NUCLEAR,PITUITARY,PUBLISHED,RESULTS
169,AFTER,AVERAGE,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,TECHNIQUE,TOTAL
169,451,ACCORDING,BASEL,CAIRO,CENTRAL,CONCLUSION,COPYRIGHT,EGYPT,HOSPITALS,ICD,LABEL,METHODS,NERVOUS,OBJECTIVE,PEDIATRIC,PILOCYTIC,RESULTS,THERE,UNIVERSITY
169,189,289,BACKGROUND,BASEL,BECAUSE,COPYRIGHT,END,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
CLINICALLY,THESE
BACKGROUND,LABEL,METHODS,MTT,OBJECTIVE,PCR,PURPOSE,RESULTS,TAMOXIFEN,WESTERN
169,COPYRIGHT,FATIGUE,INC
4TH,5TH,AFTER,BRAIN,LOCALLY,PANCREATIC
BACKGROUND,CONCLUSION,LABEL,METASTASES,METHODS
100,CONCLUSION,INC,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SETTING,SIX,WILEY
169,AVAILABLE,BACKGROUND,CENTERS,COPYRIGHT,EXCELLENCE,FOUNDATION,HOEHN,INITIATIVE,LABEL,LTD,METHODS,NPF,PARKINSON,QII,QUALITY,RESULTS
000,106,134,CTV,EUD,HOWEVER,LGG,RBE
169,ALZHEIMER,AUTHORS,BPH,FURTHER,III,JPP,KEY,LABEL,MEGESTROL,OBJECTIVE,OBJECTIVES,PHASE,RESULTS,ROYAL,SOCIETY,STUDIES,SUMMARY
AQUAPORINS,THEREFORE
CSC,HOWEVER,NOTABLY
CNS,CURRENT,FORWARD,PRIMITIVE
AMYLOIDOMA,CAA,GENERAL,MRI,THESE
BACKGROUND,LABEL,METHODS,MMP,NUCLEAR,PROTEIN,RESULTS
CNS,CONTINUOUS,HOWEVER,PITUITARY,THERE
109,174,183,GEORG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,STUTTGART,THEIR,VARIOGUIDE
DESPITE,DICKMAN,END,LGG,NCI,OLDER,RESULTS
NUMERIC
253,945,H3K79,TET
BILATERAL,ENS,EPIDERMAL,MRI
001,004,014,032,041,045,III,INCREASED,KPNA2,RECURRENT
177,CNA,CNS,COX,DUE,INDIVIDUAL,LOW,MEDLINE,MEIER,OVERALL,SUMMARY
AMONG,HOWEVER,ISTHMIN,TAKEN,XENOPUS
169,GBM,HOWEVER,NPC,THESE
135,169,855,934,967,977,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,109,140,169,967,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,FIRST,H3F3A,LTD,THERE,THESE,THIRD,THREE
169,CHILDHOOD,COPYRIGHT,FINALLY,INC,THERE
169,ACUTE,COPYRIGHT,DUE,LTD,MRI,NEUROLOGY,PAEDIATRIC,PUBLISHED,SOCIETY,THERE
100,169,177,956,ABCG2,COPYRIGHT,CROWN,EXTRUSION,FTC,HOWEVER,MTT,PHOTOFRIN,PUBLISHED,ROS,SDT,TUNEL
001,002,005,037,169,417,936,AMONG,CAL,COPYRIGHT,COX,HEART,HOWEVER,III,INC,INCREASED
169,COPYRIGHT,IMAGING,INC,INSTITUTE,NETWORK,QIN
169,APOPTOSIS,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,LABEL,M059J,M059K,METHODS,MTT,PEDIATRIC,PUBLISHED,RESULTS,TREATMENT,WESTERN,YM155
169,AAO,ANY,CONCLUSION,COPYRIGHT,GARDNER,HNS,LABEL,METHODS,OBJECTIVE,RESULTS,ROBERTSON,SAS,THERE
148,163,169,177,185,196,236,AVERAGE,BETWEEN,CNS,COPYRIGHT,CSI,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,BUN,CONCLUSION,LABEL,METHODS,MYELOMA
001,177,478,755,DEVIATION,EUD,HGG,NON,PTV,TECHNIQUE,TEN,TREATMENT
218,GBM,MMP,PREVENTING,RESULTS,WNT
10B,GBM,MEANWHILE,MICRORNAS,MMP,PDCD4,TAKEN,TRANSWELL,TWIST,U87MG
BCL,CXS,GAP,GCV,HSV,TAKEN,THERE
020,055,BACKGROUND,CHO,CHOLINE,GBM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
102,19Q,AFTER,BACKGROUND,III,JANUARY,LABEL,LOH,MATERIALS,MEDICAL,MET,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,THESE,TOKYO,UNIVERSITY,WOMEN
169,ALONG,ALZHEIMER,COPYRIGHT,FURTHER,HB1,HOWEVER,INC,LOGICALLY,NGF,PARKINSON
006,015,148,169,241,825,BACKGROUND,COPYRIGHT,DESPITE,GGIII,IES,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
100,14YEARS,20010,CONCLUSION,EIGHT,JANUARY,LABEL,METHODS,OBJECTIVE,OBSTETRIC,PEDIATRIC,PRINGLE,RESULTS,THERE,TSC,YAOUNDE,YGOPH
169,BRAIN,CONCURRENT,COPYRIGHT,DESPITE,HGG,INC,LABEL,MACDONALD,MATERIALS,MEIER,METHODS,MRI,OBJECTIVE,PATTERN,PURPOSE,RECURRENT,RESULTS
169,CNS,FURTHER,INI,MRI,SOCIETY,THERE

169,COPYRIGHT,COX,HOWEVER,LTD,QUIGLEY,WILEY
D54,ERK,GBM,INDUCED,OVERALL,TMZ,U87
CDK,CYCLINS,EMBRYONAL,FURTHER,HRP,INCREASED,THERE
BECAUSE,CHOROID,HOWEVER,SILENCING
001,105,GBM,HOWEVER,ICM,III,S100B,SEVERAL,WORLD
142,148,169,780,AUSTRALIA,AUSTRALIAN,BACKGROUND,COLORECTAL,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RESULTS,SOUTH,UNIVARIATE
169,231,BT474,COPYRIGHT,DNMTS,MDA,RASSF1A,THESE

GLIOMAS,TALAIRACH
ARS,LDH,PEMFS,SATURATION,U87MG
001,024,946,BACKGROUND,BINDING,CASPASE,CATENIN,CLEAVED,CONCLUSION,EXPRESSION,KNOCKDOWN,LABEL,LOWERED,MTT,PRINCIPAL,RESULTS,SEVERAL,SNAIL,TRANSWELL,U87
177,BACKGROUND,COGNITIVE,CONCLUSION,CONTEXT,CUSHING,FATIGUE,FIFTY,LABEL,METHODS,NETWORK,OBJECTIVE,RESULTS,WORKING
ACCORDING,AFTER,DOCETAXEL,GRADE,HOWEVER,INDUCTION,LABEL,METHODS,OBJECTIVE,RESULTS,T4B,TREATMENT
MRI,POSTERIOR,SOL
CAUCASIAN,INITIAL,MRI
CUSHING
169,181,215,231,AFRICAN,CHCL3,COPYRIGHT,DRIED,KENYA,KOKWARO,LTD,MCF,MDA,MTT,WILEY
954,AGREEMENT,CHO,FDG,NAA,PEDIATRIC,PET,THESE,VOXEL

947,ASIAN,DCHDA,DIOC6,MANGOSTEEN,MANGOSTIN
AFTER,BACKGROUND,CTA,FUNDOSCOPY,KENNEDY,LABEL,METHODS,MRI,PRIMARY,PRIOR,RADIATION
385,449,557,589,879,957,BACKGROUND,COD,FIRST,LABEL,METHODS,MINOR,MORTALITY,NATIONS,OBJECTIVE,RESULTS
169,BECAUSE,HOWEVER,LABEL,METHODS,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,THROUGH,TREATMENT
169,215,3DCRT,DAO,DVH,INVERSE,LABEL,METHODS,MLC,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,SINCE
169,BRAIN,EVALUATION,INSTITUTE,LABEL,METHODS,MNI,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,THESE
169,DIFFERENT,LABEL,METHODS,MEV,OBJECTIVE,PHYSICISTS,PTV,PURPOSE,RESULTS,SINCE,TEN
DESPITE,PXA

000,100,BRAIN,CAESAREAN,DESPITE,HODGKIN,MRI,NHL
095,420,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SINCE
HISTONE,KAZAL,REVERSION,SINCE
CPG,FINALLY,GBM
BACKGROUND,CHRONIC,CONCLUSION,D54MG,GBM,LABEL,MATERIALS,METHODS,MIR,RESULTS,TMZ

AIM,BACKGROUND,CD133,CONCLUSION,HAIRY,LABEL,MATERIALS,METHODS,MTS,NOTCH,OBJECTIVE,PCR,REDUCTIONS,RESULTS,SHENG,SPLIT,ZSP
BACKGROUND,BORTEZOMIB,CONCLUSION,EFFECTS,FDA,LABEL,MATERIALS,METHODS,RESULTS,THESE
GIVEN,PRIMARY
III,NSCLC,PALLIATIVE
007,160,4EBP1,AKT,III,LOW,MIB,THERE,USING
FINALLY,GLIOMAS,PS2,TREATMENT
HGG,INHIBITING,LGG,PDGFB,STAT3,THESE
169,AKT,APOPTOSIS,INC,JAK,LC3,STAT3,WILEY
945,BTICS,CD133,CHITINASE,EGF,ELISA,GBM,H2A,MEDIA,PDGFR
HOWEVER,PROCESSING,THERE,VARIOUS
100,ANALYZING,GBM,TMZ
239,946,947,CD11B,FURTHER,HOWEVER,IFN,TGF,THESE
160,FOLLOWING
19Q,AFTER,HOWEVER,TMZ,WORLD
BRAIN,BSG,ENTRAPPED,FIFTEEN,III,MRI,OVERALL
CD8,GRANZYM,HLA,HOWEVER,MHC,NSCLC,RESULTS,TREATMENT
006,EGFRVIV,III,PFS
169,410,AKT,BESIDES,COPYRIGHT,CROWN,HGF,HOWEVER,LTD,MET,MICRORNAS,PUBLISHED,USING,UTR,WHILE

169,956,B16,COPYRIGHT,EEG,IRELAND,LTD,SLH
169,COPYRIGHT,LTD,NERVE,NTR
001,002,015,169,ADC,CHO,CONCLUSION,COPYRIGHT,DIAGNOSTIC,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRS,NAA,OBJECTIVE,RESULTS,ROC,THESE
169,COPYRIGHT,ECM,LTD,MMP,THESE
169,AFTER,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PFC,RESULTS
169,174,ACR,COLLEGE,COPYRIGHT,HOWEVER,INC,MRI,PET,PUBLISHED,RADIOLOGY,SCREENING,STAGE
169,BRAINSTEM,COPYRIGHT,HGG,INC,PUBLISHED,THESE
169,COPYRIGHT,INC
169,COPYRIGHT,FINALLY,INC,STUDIES
169,COPYRIGHT,INC
FURTHER,INC,PUBLISHED
169,COPYRIGHT,INC,PHASE,SEVERAL,STUDIES
169,CNS,COPYRIGHT,ENDOGENOUS,INC,MVP,SEVERAL
169,COPYRIGHT,INC,TARGETING
169,ATTEMPTED,COPYRIGHT,INC,ONGOING
169,CONFERRED,COPYRIGHT,DESPITE,INC
169,COPYRIGHT,INC
160,169,CD133,COPYRIGHT,GBM,INC,ORTHOTOPIC
169,COPYRIGHT,GBM,INC,SEVERAL,STAT3
169,ALA,COPYRIGHT,INC,THESE
169,COPYRIGHT,INC,NOVEL,PUBLISHED
BACKGROUND,HERCEPTIN,HOWEVER,LABEL,MONOCLONAL,RESULTS,SKOV3,WESTERN
001,025,ADC,AGA,ANALYTICAL,CONCLUSION,DEPARTMENT,DIFFUSION,DWI,KARACHI,LABEL,MARCH,METHODS,MRI,OBJECTIVE,PLACE,RADIOLOGY,RESULTS,THESE,UNIVERSITY
169,183,647,BACKGROUND,BLACKWELL,CONCLUSION,CUT,DESPITE,LABEL,LTD,METHODS,PUBLISHING,RESULTS,SEVENTY,VFD
CSF,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE,THREE
169,ASMES,ASTROCYTIC,ATLAS,CONSENSUS,DOC,GBM,HOWEVER,MIXED,NETWORK,OLIG2,OPC,PRECURSOR
000,007,FIFTY,GAMMA,KARNOFSKY,KNIFE,LEEDS,LOG,MARCH,SRS,STEROID,THERE
AFFYMETRIX,DIPGS,GATA3,LABEL,METHODS,MRI,OBJECTIVE,PNETS,RESULTS,SINCE,THERE
DIAGNOSTIC,GIVEN,LMS,PRIMARY
215,BRAIN,CNS,MRI,PRIMARY
916,AKT,EPIDERMAL,ERK,FINALLY,HOWEVER,NEURO2A,SCD,SFA,WNT,WNT5A,WNT7B
194,SOMATIC,TES
169,CONCLUSION,COPYRIGHT,INC,LABEL,LASER,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROI,SAN,WILEY
177,BACKGROUND,BECAUSE,CARDIAC,COMMITTEE,EVALUATION,LABEL,METHODS,RESULTS,REVIEWING,ST2
100,CHICAGO,CUSHING,ERDHEIM,FOLLOWING,FRIEDRICH,JAKOB,REGARDLESS
001,009,177,BACKGROUND,BLOOD,BROCA,FORTY,HOWEVER,LABEL,METHODS,RESULTS,SWG
GRADE,III,MRI,NON,PBV,PFS,SALVAGE,THERAPY
10172,246,668,844,945,946,ACADEMY,ACUTE,BACKGROUND,IL1RN,LABEL,METHODS,OBJECTIVE,ORG,PURPOSE,RESULTS,SAHLSIS,THREE,TREATMENT,TRIAL
177,215,ADC,CHO,DWI,FIFTY,LABEL,LIP,MATERIALS,METHODS,NAA,OBJECTIVE,PSR,PURPOSE,PWI,RESULTS,THERE
ADEXCAEGFP,MSC
004,005,041,045,BACKGROUND,CSF,FLAIR,LABEL,MENINGIOMA,METHODS,MRI,RESULTS,SIMPSON,THERE
001,014,017,079,725,741,869,967,ACCORDING,AUC,BACKGROUND,FORTY,GBM,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS
BRITISH,INSTITUTE,INTEGRATED,MARCH,RADIOLOGY,SPECT,THERE
LCA,PROGNOSTIC
MRI
001,169,220,266,BRITISH,CAUSE,COD,CONCLUSION,CONDITIONS,COPYRIGHT,LABEL,LTD,METHODS,NORWEGIAN,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STATISTICS,STAVANGER,UNIVERSITY
169,1ST,776,AFTER,AMONG,BACKGROUND,COPYRIGHT,DESPITE,DISEASE,III,LABEL,LTD,MAY,METHODS,OVERALL,RATES,RESULTS,TREATMENT
169,BACKGROUND,BLACKWELL,LABEL,LTD,METHODS,PUBLISHING,RESULTS,WESTERN
CLASSIFIED,DESPITE
004,008,BACKGROUND,CONCLUSION,HGF,HOWEVER,INCREASED,LABEL,METHODS,RESULTS,SEVENTY,U87MG
BRAIN,FDG,HOWEVER,LESIONS,MRI,PET
CURRENTLY,PML
INCREASED,RESULTS
160,THEIR,UNIVERSITY
142,150,172,200,AFTER,CONCLUSION,CRS,GBM,LABEL,METHODS,OBJECTIVE,ORR,PFS,PRS,PURPOSE,RESULTS,SERIOUS,THREE
258,BRAIN,CNS,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
CAT
946,954,956,CPG,FURTHER,MTT,THEREFORE,U87
160,BACKGROUND,CMS,DESPITE,ELOQUENCE,GLASGOW,LABEL,METHODS,RESULTS
412,ASSESSMENT,BACKGROUND,GPA,GROUP,HOWEVER,LABEL,METHODS,RADIATION,RESULTS,SRS,THERAPY
169,AUSTRIA,BASEL,CONCLUSION,COPYRIGHT,EAS,HEARING,INNSBRUCK,LABEL,LOW,MED,METHODS,OBJECTIVE,RESULTS,THERE,THESE
945,ATT20,CURCUMA,GH3,HIF1A,UNDER,VEGFA
AFTER,CTV,GTV,VX2,ZEALAND
DISCUSSION,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
453,474,IL2RG,MDA,MULTIORGAN,NVP
DESPITE,ENGLISH
945,AFP
169,ANNEXIN,COPYRIGHT,GENISTEIN,INC,WILEY
GIVEN,HOWEVER,MDR,MRP,THESE,TMZ,USING
001,004,169,308,AUSTRALIA,BACKGROUND,COPYRIGHT,COX,FACTORS,INSTITUTE,LABEL,MEIER,METHODS,OVERALL,PMS,RESULTS,SOCIETY
17P,19Q,GBM,LOH,OLIG2
100,177,239,CONCLUSION,III,LABEL,METHODS,OBJECTIVE,PCT,PERFUSION,PET,PURPOSE,RESULTS,THERE
000,200,AFTER,GERMANY,GNC,HELMHOLTZ
160,BACKGROUND,CONCLUSION,CSF,EARLY,EIGHT,FIFTEEN,JANUARY,LABEL,LARGE,LEQCS,MAY,METHODS,RESULTS,SIX,THERE
160,177,MEIER,SIRT2,WHITNEY
DIG
125
644,AGE,BLACK,COX
BACKGROUND,BECAUSE,HOPKINS,JOHNS,LABEL,METHODS,PCNSV,PRIMARY
AFTER,BACKGROUND,CLUSTER,HOWEVER,LABEL,METHODS
100,956,DROSOPHILA
014,111,131,AMONG,BACKGROUND,LABEL,MATERIALS,METHODS,MIB,RECURRENCE,RESULTS
169,183,BLACKWELL,CMT,CNS,LTD,PUBLISHING,QALYS,THERE
169,COPYRIGHT,ESTIMATING,LTD,SEVERAL,WILEY
000,026,101,CNS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TKI
DROSOPHILA,HOWEVER,KAPOSIFORM,PROX1
916,945,946,947,HOWEVER,TAP53,U87
CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PREVIOUSLY,RESULTS,THESE
008,019,025,119,130,967,BACKGROUND,CONCLUSION,CURRENT,LABEL,METHODS,RESULTS
BRAIN,JAKOB,SPECT,WHILE
169,510,822,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
000,169,350,ACTIVATION,COPYRIGHT,LTD
AREAS,BACKGROUND,COVERED,EPIDERMAL,FDA,GBM,HOWEVER,LABEL,METHODS,OPINION,PATHWAY,VEGFR
AWAKE,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,PROCEDURES,RESULTS,RTS,THREE
BACKGROUND,CONGRUENT,EMPOWERED,HEALTHY,HOWEVER,LABEL,OBESITY,RESULTS,STAGE,SUCCEED,SURVIVORS,THEREFORE,THREE,UTERINE
104,1ST,ACCORDING,ANTECEDENT,HOWEVER,JAN,TREATMENT,WORLD
110,666,BRITISH,COLORECTAL,OVERALL,THERE
160,BACKGROUND,BRAIN,CONCLUSION,LABEL,METHODS,PRE,RESULTS
BACKGROUND,CHO,HGG,III,LABEL,LGG,METHODS,MIB,MRI,NAA,RATIO,RESULTS,USING
000,250,453,ACCORDING,AMONG,BNP,CARDIAC,ERBB2,HOWEVER,LAPATINIB,MBC,THERE,THEREFORE,TKI
EMT,MET
174,AKT,THESE
004,100,177,ADC,CSF,DWI,EIGHT,GENERAL,LABEL,METHODS,MRI,OBJECTIVE,PAS,PMA,REGIONS,RESULTS,THERE
001,010,037,100,829,GPT,GROSS,LABEL,METHODS,MTS,OBJECTIVE,OCTOBER,RESULTS,SEVENTY,THERE,TREATMENT
169,BPA,COPYRIGHT,HOWEVER,LTD
945,EMA,MIB,NSE,PAX,PET,VERTEBRAL
HEMATOLOGY,JAPAN,LABEL,MEMBERS,METHODS,OBJECTIVE,OBJECTIVES,PEDIATRIC,PHYSICIANS,RESULTS,SOCIETY
100,CONCLUSION,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHORT,THERE
169,946,ALZHEIMER,CONVERSELY,COPYRIGHT,NFT,SINCE,STUDIES,YET
169,COPYRIGHT,INC,SNS
0MM,144,147,152,169,177,204,5MG,5MM,6MM,BACKGROUND,BNP,COPYRIGHT,IRELAND,LABEL,LTD,LVEDD,LVESD,METHODS,RESULTS
122,131,169,176,AMONG,COPYRIGHT,ENDOCRINE,INC,IQR,LABEL,METHODS,MOSBY,OBJECTIVE,PRECOCIOUS,RESULTS
002,106,138,169,177,215,ADC,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MENINGIOMA,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,WORLD
169,AVAILABLE,BBB,CNS,COPYRIGHT,LTD,MBC,NOVEL,SEVERAL,THESE
169,COPYRIGHT,DESPITE,IPILIMUMAB,LTD,METASTASIS
169,AVERAGE,COMPLEX,COPYRIGHT,ENGEL,FIFTEEN,III,LABEL,MEDICAL,METHODS,MRI,OBJECTIVE,RESULTS,THERE,UNIVERSITY
100,169,ANY,AXIAL,CAPECTH,COPYRIGHT,CSF,EXTRA,INSTEAD,LTD,POD,THESE,TREATED
131,169,1CM,ACCURAY,CHORDOMAS,COPYRIGHT,CYBERKNIFE,HOWEVER,LTD,MEYER,OVERALL,SRS,SUNNYVALE,THERE,USA
169,COPYRIGHT,DIFFUSION,HOD,INC,KNOWLEDGE,SUBSEQUENT
107,169,200,ASL,COPYRIGHT,INC,SIXTY
169,295,BACKGROUND,CLASS,CONCLUSION,COPYRIGHT,DESPITE,EEG,ENGEL,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,SAS,TOURS,VIDEO
169,954,COPYRIGHT,DROSOPHILA,EXPRESSION,PUBLISHED,THESE,WESTERN,WNT,WNTLESS
169,ADDITIONAL,BRITISH,COPYRIGHT,DISCUSSION,ENGEL,LABEL,LTD,MANAGEMENT,METHODS,OBJECTIVE,PATHOLOGY,PUBLISHED,PURPOSE,RESULTS,THERE,USING
169,AUTHORS,BLACKWELL,CENTRAL,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,THESE
029,177,GBM,JANUARY,LABEL,METHODS,NFP,OBJECTIVE,PFS,RESULTS,THREE
ACROMEGALY,CER,HEALTHCARE,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PROJECT,QOL,QUALITY,RESULTS,THESE,TREATMENT,UTILITY
CASES,END,INSTITUTE,LABEL,METHODS,OBJECTIVE,PROGRAM,RESULTS,THREE,VSS
169,AUTHORS,EPO,MEDLINE,NEUROLOGY,OVERALL,PSYCHIATRY,SCIENCE,SEVENTY,SEVERAL,SOCIETY,THREE,WEB
169,17Q24,AUTHORS,BRAIN,MIXED,PATHOLOGY,PCR,PGNTS,PRKCA,REVERSE,SEQUENCING,SLC44A1,SOCIETY,THESE
169,CONCLUSION,HAUKELAND,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OUTCOME,QOL,RESULTS,SURGERY,UNIVERSITY,WILEY
EVENTUALLY,INITIAL
001,100,106,132,967,CNS,LOG,MEIER,PEARSON,PFS,THEREFORE,VHL,VON
BASED,EPH,EPHA2,EPHB2,EPHB4,ERK,KNOCKDOWN
007,045,18F,AET,BACKGROUND,BECAUSE,CONTEXT,FDG,HOT,INSULAR,LABEL,METHODS,OBJECTIVE,OUTCOME,PET,PRIOR,RESULTS,TRAIT
BECAUSE,INITIAL,WHY
DDX3X,H3K27,KDM6A,MODELLING,RECURRENT,SMARCA4,THESE,WNT,ZMYM3
160,COMPARING,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRT
4T1,HOWEVER,SEMLIKI,SFV
BACKGROUND,CONCLUSION,DESPITE,LABEL,NEUROTOUCH,TECHNICAL,UNASSIGNED
169,ACQUIRING,ALA,BACKGROUND,CONCLUSION,GBM,HRMAS,LABEL,METHODS,NMR,RESULTS,SAMPLES
169,COPYRIGHT,EARLY,LTD
169,COPYRIGHT,LTD,SAH
169,BBB,CED,COPYRIGHT,HOWEVER,THESE
CAREFUL,SURGERY,TREATMENT
169,COPYRIGHT,NIDUS,PUBLISHED,SAS
GBM
GIVEN,MRI,MYC,SNP
19Q,ACCORDING,IDH,NETWORK,SYSTEMATIC
ALZHEIMER,EFFECTS,FIRST,FURTHER,PARKINSON,PROMINENT,RODENTS,SIX

ASSESSMENT,CASES,CENTRAL,EXPOSURES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERVICE,THESE
169,19Q,CIC,COPYRIGHT,IDH,NHE,SILENCING,WARBURG
945,AMONG,DN_IRE1,HENCE,HOWEVER,SPARC,U87,UPR
BACKGROUND,BLOOD,CONCLUSION,ICG,JANUARY,LABEL,METHODS,RESULTS,SURGERY
BACKGROUND,COMBINING,COX,FORTY,GBM,GLIADEL,LABEL,METHODS,RESULTS,TMZ
CNS,HOWEVER,PCA,PILOCYTIC
100,AFTER,BETWEEN,UNDER
177,200,ACTUARIAL,BETWEEN,IBT
GBM,NOTCH,SEVERAL
169,MRI,SOCIETY
169,CNS,HOWEVER,NFP,SEVERAL,SOCIETY,THESE

TREATMENT
CNS
078,156,169,780,973,AMONG,BACKGROUND,COPYRIGHT,EMPLOYMENT,EXPOSURES,INC,INDUSTRIAL,LABEL,LONGEST,MATERIALS,METHODS,MIDWEST,RESULTS,SAS,SIC,SOC,UPPER,WILEY
001,006,III,PCR,THEREFORE,WESTERN,WORLD
169,CARLO,COPYRIGHT,DCE,INC,MONTE,MRI,NOISE,USING,WILEY
001,ALTERED,AQP,AQUAPORIN,GBM
001,008,KARNOFSKY,MEANWHILE,PCR,SOX,SRY
100,120,321,329,ADVERSE,BETWEEN,BRAINSTEM,GIVEN,GRADE,HFSRT,KARNOFSKY,KYOTO,LOCAL,MEIER,OVERALL,SELECTION,UNIVERSITY
BESIDES,HDR,HOWEVER,LDR,SBT,THESE
001,008,AIM,COX,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PCR,REG,RESULTS,THEREFORE,THESE,UNASSIGNED,VIRTUAL,WESTERN
DTI,FUNCTIONAL,IPL,SLF,THESE,USING
169,33342,COPYRIGHT,CYCLING,GBM8401,HIF,HOECHST,HOWEVER,INC,NADPH,ROS
001,169,AFTER,COPYRIGHT,DISTANT,INC,JANUARY,LABEL,MAY,MEIER,METHODS,MOSBY,NSCLC,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SURGERY
ALGORITHMS,HSD
CNS,JXG,LANGERHAN
169,ABOUT,ACC,ADENOID,AIM,COX,ENDODONTIC,JOURNAL,LABEL,METASTATIC,OBJECTIVE,SUMMARY,THREE
169,955,AXIAL,BLACKWELL,CONCLUSION,DTISTUDIO,DTT,HGG,LABEL,LGG,LTD,METHODS,MRI,OBJECTIVE,PUBLISHING,RESULTS,THERE,TRACT
BLOKHIN,POGOSYANTS,RUSSIAN,XXI
169,CSC,ZORNIAK
169,COPYRIGHT,FURTHER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRINCIPAL,RESULTS,WILEY
FDOPA,FLT,MRI,PET,PFS,VOXEL
110,168,AFFYMETRIX,CONGENITAL,FURTHER
DSC,DWI,GBM,IMAGE,MRI,VARIABLES
110,18Q,22Q,287,AMONG,FIFTY,III,MRI,NF2,SEVENTY,SIXTY
CD133,FURTHER,MICRORNAS,MMP,THEREFORE,TIMP3
BASED,DZNEP,PRE,USING
106,AMONG,CEREBELLAR,R132G,THESE,V600E,WORLD
19Q,CODELETION,HOWEVER,III,WORLD
014,160,193,ADDITIONAL,BACKGROUND,HISTORY,HNSCC,HPV16,INVERSE,LABEL,METHODS,RESULTS,TH2,THESE
254,977,MINERPROT,TFDP2
169,946,COPYRIGHT,EMT,FEDERATION,SOCIETIES,TGF
169,CENTRAL,COPYRIGHT,GNC,HOWEVER,NERVOUS,PARTICULAR
CUSHING,DIAGNOSIS,FIRST,OTHER,SIGNS
157,169,268,AFFYMETRIX,COPYRIGHT,INC,THESE
169,BACKGROUND,BLACKWELL,CONCLUSION,FINALLY,FURTHER,GBM,HOWEVER,LABEL,LN229,LTD,METHODS,MTT,OBJECTIVE,PCR,PUBLISHING,PURPOSE,RESULTS,STAT3,U87
169,AGAINST,BLOCK,CONTROL,FDA,INC,KEY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAS,USING,WILEY
200,FDA,HAIFA,III,INC,NOVOTTF,PHASE,RESULTS
BACKGROUND,DISCUSSION,FIFTY,LABEL,MEDICAL,METHODS,PERIPHERAL,POSTCANCER,PRIMARY,RADBOUD,STUDIES,TRIAL,UNIVERSITY
169,BLACKWELL,BRAIN,COUNCIL,FEDERATION,HOWEVER,JOURNAL,LTD,POLITICAL,PUBLISHING,SOCIETIES,THEREFORE,WORLD
103,222,BESIDES,CORNELL,ECG,INDEX,LAYON,RESULTS,SOKOLOV
BRAIN,DUE
1980S,AMONG,ECT,HOWEVER,MINOR
MRI
169,CASES,COPYRIGHT,HOWEVER,INC,IOL,MEDICAL,TAKII,UNIVERSITY,WILEY
954,CENTRAL,COX,DECREASED,LAMININ,MMP
001,169,BACKGROUND,COPYRIGHT,FLAIR,LABEL,METHODS,RESULTS,SOCIETY,SRS,THESE
169,256,BACKGROUND,COPYRIGHT,FEW,GGS,IHC,INC,LABEL,METHODS,PROCEDURE,RESULTS,SEVEN,WESTERN,WILEY
100,CPT,CURRENTLY,ELSTS,EXPRESSION,THEREFORE,THESE
176,177,BACKGROUND,BECAUSE,INDEX,ISI,LABEL,METHODS,PITTSBURGH,QUALITY,RESULTS,SLEEP
LIVER
AFTER,FOLLOWING,III,LABEL,METHODS,OBJECTIVE,ONGOING,PFS,PURPOSE,RESULTS,SIXTY
945,946,947,954,CRH,LATENCY,SLEEP,THESE,TNF
009,566,603,RESULTS,SNP,VALIDATION,VARIANT
COMAMONAS
103,COX,FORTY,GAMMA,KARNOFSKY,KNIFE,KPS,LABEL,LIMITED,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVERALL,PURPOSE,RESULTS,SEPTEMBER,THERE,VARIABLES
BRAIN,HOWEVER
169,177,23120,23206,53097,BIM,CONCLUDING,COPYRIGHT,IRELAND,LTD,PCR,PRL,USING
002,BACKGROUND,EFS,FIFTY,GCT,LABEL,MARCH,METHODS,NGGCT,OBJECTIVE,OBJECTIVES,RESULTS,RFS,SETTING,SEVEN
169,945,946,CONVERSELY,COPYRIGHT,DESPITE,DEVELOPING,GENOMIC,HGG,HOWEVER,INC,PDGFR,USING
000,003,006,113,11647,169,249,260,373,465,BMS,CONCLUSION,COPYRIGHT,GERMANY,INSURANCE,LABEL,LIN,LYS,MEDIANS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PROPENSITY,RESULTS,SHI,SRS,STATUTORY
169,CLASS,COPYRIGHT,COX,FIFTY,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,SCORE
169,CNS,COPYRIGHT,HOWEVER,LTD
100,134,150,169,178,300,COPYRIGHT,CSF,EIGHT,EMA,ETO,GTN,INC,LABEL,METHODS,MTX,OBJECTIVE,RESULTS,SIX,THESE
169,COLLEGE,CONCLUSION,COPYRIGHT,FURTHER,GROUP,LABEL,LEUKAEMIA,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,898,973,AMONG,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RESULTS,SIMILARLY,SRS
169,COPYRIGHT,LTD,STILL
169,CLEARLY,COPYRIGHT,LTD,TREATMENTS
169,COPYRIGHT,CROWN,LTD,MCM,MRI,PUBLISHED
001,002,008,132,169,ASSESSMENT,CNS,COPYRIGHT,COX,GPA,INC,JANUARY,KARNOFSKY,KPS,LABEL,LUMINAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,PURPOSE,RESULTS,SRS
169,BACKGROUND,COPYRIGHT,DESPITE,HOWEVER,III,LABEL,METASTASES,METHODS,RESULTS
119,169,180,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNDERLYING,UROLOGICAL
169,231,233,COPYRIGHT,LOCAL,OPTIMAL,PITUITARY,PUBLISHED,SAS,THESE
AIM,BRAIN,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
177,DCS,HOWEVER,LABEL,MEG,METHODS,MOTOR,NAVIGATED,OBJECTIVE,RESULTS,SEM,THERE,THREE,TMS,WHILE
ASSESSMENT,DIAGNOSIS,DSGPA,GPA,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,USING
AMONG,INSTITUTE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,THREE
001,004,030,825,AMONG,BACKGROUND,INCIDENCE,JANUARY,LABEL,MARCH,METHODS,RESULTS
CSF,DMD,PATHOLOGY
106,AMONG,GHR,HOWEVER
AFTER,SINCE,SURGERY
124,ELEMENT,GBM,REPRESSOR,SILENCING,THESE
001,005,008,177,ANXIETY,ASSESSMENT,COGNITIVE,DEPRESSION,LABEL,MATERIALS,METHODS,NPC,OBJECTIVE,PURPOSE,QOL,RESULTS,SAS,SCALE,SCORE,SDS,SUBJECTIVE
HDACS,T98,THESE,TMZ,VPA
162,ASIAN,DESPITE
BMP,CPG,HOWEVER,REDUCED,THESE
001,002,014,018,945,BACKGROUND,HIF,HYPOXIC,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,USING
183,GEORG,INCOMPLETE,STUTTGART,THEIR,THESE
47D,BACKGROUND,BRAIN,CONCLUSION,DEFICIENT,EFFECTIVE,LABEL,MCT,METHODS,RESULTS,SELECTIVE,WHEREAS
001,002,003,007,120,ALZHEIMER,ASSESSMENT,BRAIN,CALIFORNIA,COMPLEX,DIGIT,FUNCTIONAL,HOWEVER,KPS,LABEL,OSTERRIETH,PARTS,PROFILE,RESULTS,REY,THERAPY,THERE,TMT,TRAIL,UNLABELLED
000,131,165,378,444,500,555,666,777,956,ADVERSE,AUTOLOGOUS,CONCLUSION,DLT,EIGHT,LABEL,MBQ,METHODS,NCA,RESULTS,THREE,UNLABELLED
001,169,BASEL,COPYRIGHT,LABEL,MARCH,METHODS,MRI,OBJECTIVE,PERFUSION,RESULTS

CONCLUSION,EARLY,INDUCTION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,TEN,THESE
MRI
MRI,THEIR
169,177,945,COPYRIGHT,INC,PUBLISHED,THESE,TNF
CD3,MITOSES,THERE
169,AUTHORS,BRAIN,PATHOLOGY,PITUITARY,SOCIETY,THEREFORE
169,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,CSF,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,MRI,PCNSL,RADIATION,RESULTS,ROYAL,THESE,ZEALAND
ACT,CTLA4,CYTOTOXIC,MALIGNANT,METASTASIS,STAT3,THEREFORE,THESE
LATER
001,BEP,BRAIN,CONCLUSION,DISEASE,EMA,FORTY,GTN,ICE,INITIAL,LABEL,METHODS,OBJECTIVE,OPERATIVE,RESULTS,SALVAGE,VIP
COMPOUNDS,POLYMERIC,WITHAFERIN
125,183,185,215,956,AMINO,DARBY,GDC,HOWEVER,MADIN,PARAMETERS,PHASE,PREDICTED,STUDIES,THESE
120,192,ACCORDING,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,GIVEN,GROUP,ICTRP,ISSUE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFS,PUBLISHED,RANDOMIZED,RCT,RESULTS,SELECTION,SMALL,THREE,TRIAL,WHILE
001,169,COPYRIGHT,HOWEVER,HUNDRED,INC,MELBOURNE,OCTOBER,PETROUS,ROYAL,THREE,WILEY
CONCLUSION,DESPITE,FINALLY,GAP,LABEL,METHODS,OBJECTIVE,PURPOSE,RAS,RESULTS,THESE
001,006,100,BLI,CED,DTATEGF,DTEGF,EGF,MEIER,MTT,NSCLC,PC9
BECAUSE
DTI,GENERALLY,MRI,NAVIGATION,USING
DEPARTMENT,EMERGENCY
169,946,CONSISTENT,CXCR4,GBM,GIC,GL261,NOTABLY,OTHER,TGF,THESE,U87MG
171,ASSESSMENT,COX,GPA,III,KARNOFSKY,MEIER,PROGNOSTIC
160,169,217,223,838,900,AMONG,BACKGROUND,BLOOD,CLOSE,CNS,CONCLUSION,COPYRIGHT,EARLY,GCT,INC,LABEL,MAKEI,METHODS,PEDIATR,PROCEDURE,RESULTS,THERE,THESE,WILEY
101,125,169,BACKGROUND,COPYRIGHT,HISTOLOGY,INC,LABEL,METHODS,PFS,RESULTS,SAMPLES,TAILORING,TREATMENT,WILEY
169,COPYRIGHT,IMAGING,INC,MRI,PRESS,RESONANCE,WILEY
100,121,224,ATLANTA,BETWEEN,CAUTION,EHC,EMORY,FINALLY,HEALTHCARE,HOWEVER,MRI
IDH,WORLD
ACC,FURTHER,MMR,OWING,THEREFORE
ACTINONIN,ALTOGETHER,AMONG,BNIP3,CANAVALIA,CONVERSELY,GIVEN,ILOMASTAT,MMP,MT1,PRE,U87
105,655,CONCLUSION,COX,FDG,LABEL,MATERIALS,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,SUV,THESE,TLG,UNIVARIATE,WHOLE
MOLECULAR,PITUITARY,SEVERAL
BACKGROUND,BLAND,BUFFY,GENOMIC,LABEL,METHODS,PCR,REGRESSION,RESULTS,TEN,THESE,UNASSIGNED,VIRTUAL
005,019,037,043,142,169,183,BACKGROUND,BRAIN,BRAINCHILD,CHILDHOOD,CNS,COPYRIGHT,DICKSON,FOUNDATION,FUNDING,INSTITUTE,LABEL,LIN28,LTD,METHODS,OLIG2,PNETS,RESULTS,TRUST
124,126,127,CNS,COMPARISON,DIGIT,SOS,WHILE
175,798,BACKGROUND,CIS,INSTITUTE,LABEL,METHODS,MIDWEST,MINNESOTA,NON,ORS,RESULTS,SIMILARLY,THERE,THESE,UPPER,WISCONSIN
169,AIM,AUTHORS,CONCLUSION,GYNECOLOGY,INITIALLY,JAPAN,JOURNAL,LABEL,METHODS,NON,OBJECTIVE,OBSTETRICS,RESULTS,SOCIETY,TEN
104,380,697,BARTHEL,BASED,BRAIN,HOWEVER,INDEX,KOREA
100,AMONG,ENGEL,MEG,SEOUL,TEN,UNIVERSITY
CONCLUSION,FDG,FLT,LABEL,MET,METHODS,MRI,PET,RESULTS,UNLABELLED
131,947,ADP,CONCLUSION,H2A,LABEL,METHODS,NAT,RESULTS,THREE,UNLABELLED,UVW
PRL
100,BESIDES,REPORTS,WORLD
169,COPYRIGHT,FAD,FMN,MAO,PARKINSON,VCH,WILEY
169,AMONG,COPYRIGHT,INC,WILEY
001,025,031,100,122,12P13,17Q12,17Q22,18Q23,215,903,FURTHER,PBT,PRMT8,STKY1
291,CONCURRENT,COX,GBM,GRADE,KETTERING,MEDICAL,SLOAN,TMZ
BAX,BCL,DESPITE,HOWEVER,PDCD5,PROGRAMMED,TAKEN,U87
ABCB6,ALA,ATP,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,WORLD
743,BLOOD,BRAIN,CD133,CPC,GBM,KARNOFSKY,KPS,TEN,VARIABLES
174,175,177,178,181,ACTIVATION,EPHA2,GBM,GPI,MMP,THESE
169,947,CD133,COPYRIGHT,GIC,HLA,HOWEVER,INCREASED,MHC
001,010,14A,177,178,337,594,824,995,AIM,BACKGROUND,BMI,EFFECTS,ISOKINETIC,JAMAR,LABEL,METHODS,REDUCED,RESULTS,THEREFORE
DIFFERENT,KEY,LABEL,METABOLIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
118,179,786,912,BRAIN,MENINGEAL,MRI,WBC
120,179,AFTER,BRAIN,CSF,HOWEVER,III,MRI,THOSE
169,177,2ND,APRIL,BACKGROUND,BASEL,COPYRIGHT,GBM,LABEL,METHODS,NON,PATUPILONE,PFS,PRIMARY,RESULTS,SECONDARY,THERE,TREATMENT
169,ATLAS,COPYRIGHT,CPG,INC,NETWORK,PATHOLOGY,PUBLISHED,SOCIETY,TET,THESE
169,371,600,ACCORDING,BASEL,CENTRAL,COPYRIGHT,ELECTRONIC,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,TGFSR
169,COPYRIGHT,INC,PATIENT

169,231,233,COPYRIGHT,PUBLISHED,SAS
169,200,400,COPYRIGHT,DESPITE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SORAFENIB,THERE
233,CONCLUSION,GRADE,HOWEVER,III,KARNOFSKY,LABEL,METHODS,PRIMARY,RESULTS,SCORE,UNLABELLED
167,1950S,1960S,1970S,CNS,GERMANY,PARTICULAR,PROPANE,SGB,THREE,VII
CARDIAC
HOWEVER
HENCE,SEMAPHORIN
160,MEM,TOTAL

OTHER,RENAL,WHILE
BACKGROUND,BECAUSE,DEPENDING,LABEL,UNLABELLED
BACKGROUND,EARLY,EIGHT,EVD,LABEL,METHODS,RESULTS
AFTER,BACKGROUND,LABEL,METHODS,N20,PATIENT,RESULTS,THEIR,USING
CORNO,USING
954,FURTHER,MEK,RAF,TAKEN
150,160,500,AMONGST,ARTEFACTS,CONCLUSION,JANUARY,KEY,LABEL,MEDLINE,METHODS,MRI,OBJECTIVE,OCTOBER,OTHER,RESULTS,STARD,THERE
945,946,EFFICIENT,FURTHER,GRO,MCP,SEVERAL,TGF,THESE
169,231,233,BRAIN,COPYRIGHT,HOWEVER,PUBLISHED,SAS
169,231,233,COPYRIGHT,PUBLISHED,SAS
169,COPYRIGHT,GLIOMAS,LTD
169,231,233,AFTER,COPYRIGHT,PUBLISHED,SAS,SERUM,SIADH,TREATMENT
169,231,233,CENTRAL,CNS,COPYRIGHT,DESPITE,GIVEN,PUBLISHED,SAS,SNFMI
001,143,147,169,290,ACROMEGALY,COPYRIGHT,IGF,LAS,LIEGE,SAS,SSA,THERE
169,COPYRIGHT,DESPITE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEMPORARY
169,BETWEEN,COPYRIGHT,INC,NSCLC
169,CCND1,CDK,COPYRIGHT,CYCLIND,EMBRYONAL,INC,RB1
169,236,462,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRONINGEN,IRELAND,LABEL,LTD,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,UNIVERSITY
169,COMPARING,COPYRIGHT,GBM,INC
169,COPYRIGHT,HOWEVER,LTD
221,222,BACKGROUND,DTI,FINALLY,FURTHER,HOWEVER,LABEL,METHODS,MIR,RESULTS,TIMP3,UTR
000,005,010,023,036,049,120,135,169,176,178,183,587,604,BACKGROUND,BECAUSE,BRITAIN,CENTRAL,COPYRIGHT,DEC,DEPARTMENT,ENGLAND,ERR,FUNDING,GREAT,INSTITUTE,JAN,LABEL,LTD,METHODS,NHS,POISSON,RESULTS,SERVICE,WALES
169,270,COPYRIGHT,FDG,HOWEVER,INC,PET,THERE,THEREFORE

001,002,037,089,100,169,266,902,BACKGROUND,GBM,JOURNAL,LABEL,LIBRARY,MEDLINE,METHODS,NEUROLOGY,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,TMZ
169,227,913,946,AIM,ALZHEIMER,CONCLUSION,GERIATRICS,JAPAN,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SOCIETY,THESE
MRI
BACKGROUND,GAB,LABEL,LGA,PCR,PRINCIPAL,RESULTS,SHORT,TSS
001,006,021,039,105,AFTER,AMONG,BACKGROUND,BCP,CK5,CMF,DFS,IHC,III,LABEL,MATERIALS,METHODS,PGR,RESULTS,SETTING
YET
DESPITE,GBM,MANAGEMENT,PROMISING
160,QUALITY,THERAPY,TYPICAL
112,149,169,177,946,BACKGROUND,COPYRIGHT,DOPPLER,INC,LABEL,METHODS,PROCEDURE,RESULTS,SCD,WILEY
169,COPYRIGHT,GST,H2A,INC,WILEY,ZNF24
169,BASEL,COPYRIGHT,IMAGE,IMAGING,RADIATION,SRS,WHOLE
MRI
PULMONARY,SMALL

001,169,ADENOID,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS
169,COPYRIGHT,IRELAND,LTD,NASAL
169,AFTER,COPYRIGHT,IRELAND,LTD,NON,NSCLC,PFS,THERE,TKI
100,114,118,169,BACKGROUND,COPYRIGHT,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,PCI,RESULTS
169,COPYRIGHT,DESPITE,FINALLY,GBM,THERE,THESE
169,COPYRIGHT,HODGKIN,NHL
CD8,CSC,GBM,NKG2D,TGF,TGFR2
19Q,946,GBM,GPC,HOWEVER,LABEL,MAP,METHODS,NOTCH,OBJECTIVE,PATIENT,PURPOSE,RESULTS,TGF,WNT
945,AP1,CK2,HDAC3,JUN,SER
100,131,169,177,209,721,884,COPYRIGHT,HOWEVER,LTD,MRI,WILEY

169,200,219,29C,AFTER,COPYRIGHT,COX,MEIER,NAT
001,122,123,150,15B,169,197,23A,497,COPYRIGHT,IDENTIFIED,III,PCR,SEVEN,THESE
146,ACUTE,AGE,CCI,CONFORMAL,GBM,INDEX,INFLUENCE,MAIER,PFS,PHASE,TMZ
284,AIM,CONCLUSION,HOWEVER,METHODS,MTX,RESULTS,THESE
150,169,200,595,AFTER,BACKGROUND,COPYRIGHT,EORTC,FET,GBM,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RECURRENCE,RESULTS,SEVENTY
169,177,289,BACKGROUND,COPYRIGHT,CSS,INC,LABEL,METHODS,PCI,RESULTS,THERE
AFTER,OCTREOTIDE
231,332,945,946,AFTER,AKT,ANOIKIS,BACKGROUND,BECAUSE,CONCLUSION,IDC,INTERFACE,LABEL,LAMININ,MDA,METHODS,RESULTS,THREE
ABCB1,ABCB1AB,BACKGROUND,CENTRAL,DISCUSSION,INSTITUTE,LABEL,MATERIALS,MAX,METHODS,PARKINSON,PRL,PSYCHIATRY,RESULTS,SNP,TREATMENT
BACKGROUND,CASP8,COX,DR4,EVALUATING,GATA6,LABEL,METHODS,PCR,RESULTS
169,19Q,945,AMONG,ARRAY,CGH,EVN,H09,ISOCITRATE,SOCIETY
169,AUTHORS,BRAIN,CNS,EMA,EPITHELIAL,PATHOLOGY,PEDIATRIC,PNETS,SEQUENCING,SOCIETY
004,112,169,264,ATLAS,AUTHORS,BRAIN,DESPITE,MET,PATHOLOGY,PCR,SOCIETY
169,CRD,GALECTINS,WILEY
169,ASL,AVERAGE,CBF,COPYRIGHT,DSC,GRASE,MRI,RESULTS,SOCIETY,THESE
HOWEVER,THESE
FINALLY,STUDIES
GBM,GBM26,MRI,SCS,TESLA,U87VIII
1AE,200,215,AFTER,CHLAMYDIA,HISTOLOGY,STAGE
ABSENCE,ASSOCIATED,CHILDHOOD,GOS,JANUARY,LABEL,METHODS,NF2,OBJECTIVE,RESULTS,SIMPSON,SIX,THREE
AMONG,BRAIN,BRIEF,FEMALES,FURTHER,INDEX,INVENTORY,LABEL,METHODS,OBJECTIVE,PITTSBURGH,PURPOSE,QUALITY,RESULTS,SLEEP,SYMPTOM,THESE
107,134,171,190,CONCLUSION,DOTATOC,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SINCE,THEREFORE,TUMOURS
9TH,MRI
160,177,APB,AVERAGE,BACKGROUND,COG,EUCLIDIAN,EXT,FDI,HEALTHY,ICC,III,LABEL,LARGELY,METHODS,OVERALL,RESTING,RESULTS,RMT
169
FLUENCY,HOWEVER,LESIONS,OVERALL
MAJOR
001,010,100,307,BACKGROUND,CONCLUSION,CRP,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SHORT,STR,THERE
1P19Q,P53,VDE,WORLD
169,COPYRIGHT,CSC,GBM,IRELAND,LTD,TEN
AREAS,BACKGROUND,BASED,COVERED,LABEL,METHODS,OPINION,VALPROATE,VPA
40S
AMONG,APRIL,CHINESE,LABEL,MACDONALD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,UNIVERSITY
CAUCASIAN,METASTASIS,MRI
001,CONCLUSION,CTX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
161,177,215,AFTER,ANAPLASIA,CONCLUSION,EARLY,EXCLUDING,LABEL,MBS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,VCR
007,137,177,274,CONCLUSION,EFS,HOWEVER,METHODS,PREVIOUSLY,PURPOSE,RESULTS,SURGERY
169,FIBULIN,MALIGNANT,NOTCH,TARGETING,THESE,USING
CDK,CONSISTENT,KNOCKDOWN,NIB,RE1,USP37
LOW,SAH,TUMOURS
GBM,HOWEVER,KARNOFSKY,KPS,MULTIFORME,SCORE,YOUNG
001,245,510,907,967,AIM,CONCLUSION,CSF,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
ACCORDING,AIM,BRAIN,CONCLUSION,CPT,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE,TOL
AFTER,AIM,CONCLUSION,GRADE,LABEL,METHODS,MIDAS,MRI,OBJECTIVE,RESULTS,REX
ACCORDING,CONCLUSION,CPA,DIAGNOSTIC,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,UNILATERAL
000,100,STUDIES
169,CIN,COPYRIGHT,INC,LEVEL,MIN,PCR,PIN
048,131,152,209,361,519,AFTER,AMONG,BACKGROUND,CHINESE,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS,SINGAPORE,THERE,THREE
AREAS,BACKGROUND,COVERED,FURTHER,GLIOMAS,HGG,LABEL,METHODS,OPINION,PHASE,WHILE
711,946,AGE,ALT,ALZHEIMER,EXOGENOUS
001,004,109,143,177,BRIEF,BSI,CHILDHOOD,GSTM1,GSTP1,GSTT1,HOMOZYGOUS,INVENTORY,NCQ,PCR,SYMPTOM
1P19Q,AFTER,ANAPLASTIC,III,LIMITED,PCV,PRIOR,TREATMENT
BASED,DIPGS,FORTY,GBM,IDH,MYC,NOTABLY,PEDIATRIC
001,006,124,137,160,171,322,BACKGROUND,INPATIENT,LABEL,LOS,METHODS,NATIONWIDE,NIS,OVERALL,RESULTS,SURGERIES
001,049,100,117,491,AIM,BETWEEN,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PEETS,REMISSION,RESULTS,SIXTY,TESTING
945,CHX,CROSS,HOMER,SINCE,THESE,TNF
721,751,ASIAN,INCIDENCE,KOREA,MEIER,PRIMARY,THESE,USING
176,177,ACCORDING,FIFTY,FUNCTIONAL,GRADE,III,INSTITUTE,KARNOFSKY,KPI,MRI,NIHSS,SCALE,SMA
177,229,282,327,400,409,AMONG,EORTC,JANUARY,OVERALL,PURPOSE,THERE,UNIVARIATE,WAITING
BBB,CSF,CURRENT,FDA

CONCLUSION,HSP27,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TOTAL,WESTERN
107,800,CONCLUSION,DVH,HEALTHY,LABEL,METHODS,MUS,OBJECTIVE,OVERALL,PTV,RESULTS,SIMILAR,THERE
110,169,COPYRIGHT,FIBER,INC,LABEL,MAPPING,MEP,METHODS,OBJECTIVE,PURPOSE,RESULTS,TMS
169,CHILDHOOD,COPYRIGHT,EVALUATION,FURTHER,INC,WOMEN
169,231,233,COPYRIGHT,PREVIOUSLY,PUBLISHED,SAS
169,AFTER,CONCLUSION,COPYRIGHT,III,IMAGING,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,RESULTS,TEN,THESE
001,169,18F,BACKGROUND,CIS,COPYRIGHT,FIRSTLY,FLT,HOWEVER,LABEL,LTD,METHODS,PET,RESULTS,STUDIES,SUFFICIENT
169,BASED,COMBINING,COPYRIGHT,HRR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,U87MG,XRCC2,XRCC4
169,300,COPYRIGHT,FDG,LTD,PET,PML
169,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,ESPECIALLY,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
AWAKE,BROCA,MRI,NAVIGATED,THEREFORE,TMS
150,200,215,750,GIVEN,PCNSL,SIXTEEN,TREATMENT
ADDITIONAL,CSF,FIFTY,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
105,946,BETWEEN,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,THERE,YKL
BENEFITING,GBM,THESE
006,012,100,945,AMT,CONCLUSION,KINETIC,LABEL,METHODS,MRI,PET,RESULTS,SEPARATION,UNLABELLED,WORLD
169,ABSENCE,ACT,CONCLUSION,COPYRIGHT,CPT,EELES,HOWEVER,INC,LABEL,LFS,METHODS,OBJECTIVE,PURPOSE,RELATIVES,RESULTS,RMS,SIR,WHETHER,WILEY
177,980,BACKGROUND,CONCLUSION,LABEL,LASER,METHODS,OBJECTIVE,RESULTS

GBM,MALIGNANT,THEIR

169,231,233,COPYRIGHT,GROSS,PUBLISHED,RADIATION,SAS
169,CONCLUSION,COPYRIGHT,FET,III,KPS,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,THERE,THEREFORE,THREE
001,169,177,CD133,COPYRIGHT,HOWEVER,IRELAND,LDL,LTD,NOTABLY,PATHOLOGIC
018,091,120TH,121,154,157,167,169,343,444,751,785,AFTER,AMONG,COPYRIGHT,GAMMA,HOWEVER,INC,KNIFE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
038,042,112,114,120,169,CONCLUSION,COPYRIGHT,COX,FACTORS,GIVEN,INC,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRS
PHASE,PRIOR,SATURATED,SUBJECT
BACKGROUND,CONCLUSION,CONVERSELY,LABEL,METHODS,PCR,RESULTS,SF763,SMAD1,U87
005,169,AMONGST,BACKGROUND,CONCLUSION,GBM,GIVEN,HBP,JOURNAL,LABEL,METHODS,NEUROLOGY,RESULTS,TREATMENT
ASSESSMENT,FDA,GBM,GROUP,HOWEVER,MECHANISMS,NEURO,OTHER,STRATEGIES,VEGFR,WORKING
23B,945,946,HIF,LUCIFERASE,RESTORING,TCF,THEREFORE,VHL,WESTERN
946,AKT,BECAUSE,BHP,CD133,COMPOUNDS,GSC,RAF,RAS,TAKEN,TREATMENT
945,947,DPP,FAP,GGT,III
AKT,ALZHEIMER
BACKGROUND,CENTRAL,CNS,DESPITE,HBD,LABEL,MATERIALS,MEIER,METHODS,RESULTS
005,EVALUATION,NUCLEAR,THERE
EMPLOYING,FINALLY,PROFILIN1,PROFILINS

GCT
001,025,035,041,115,169,254,442,865,BACKGROUND,COPYRIGHT,DISTANT,ELDERLY,LABEL,LOCAL,LTD,METHODS,RESULTS
130,169,BACKGROUND,COPYRIGHT,GAMMA,GKS,IRELAND,KNIFE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,SPA,SURGERY
201,PREVOTELLA,SUBSEQUENT,TEN
945,ALZHEIMER,HOWEVER,PARKINSON,TDP,THEREFORE
1ST,CHEST,PET,PULMONARY
169,AFTER,CONCLUSION,COPYRIGHT,FOLLOWING,LABEL,METHODS,OBJECTIVE,PRE,RESULTS,ROI,STIMULI,THESE
CONCLUSION,FOCUS,LABEL,METHODS,OBJECTIVE,PERCEIVED,RESULTS
NOWHERE,RAPID
HOWEVER,LOW
001,100,GRADE,III,JANUARY,THIRDLY,WORLD
FRACTAL,III
CONCLUSION,EARLY,FET,LABEL,MAXIMUM,METHODS,MRI,PET,PFS,RCX,RESULTS,SIX,TBR,UNLABELLED
947,99M,AFTER,CONCLUSION,FIRST,ICG,LABEL,LYMPHATIC,METHODS,RESULTS,SPECT,THESE,UNLABELLED
PROGNOSIS,THESE
214,CNP,MAXIMAL,MUTATIONS,PCR,SP1,SP3,THESE
135,169,AMONG,COPYRIGHT,EVALUATION,INCREASED,LABEL,LOWER,LTD,METHODS,OBJECTIVE,QOL,RESULTS,SCALE,WILEY
006,BACKGROUND,CONCLUSION,GBM,III,LABEL,METHODS,OVERALL,RESULTS,ROYAL
001,160,500,956,AMIDE,APT,CONCLUSION,GRE,LABEL,METHODS,MRI,MTR,OBJECTIVE,PHILIPS,PROCEDURES,PURPOSE,RESULTS,SENSE,TESLA,TSE,WASSR
001,002,335,ESPECIALLY,III,MIR,PCR,THESE
169,945,COPYRIGHT,DUE,INC,PPARS,WILEY
956,AUC,BEV,ECF,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,TMZ,U87
106,160,HOWEVER,PROGNOSTIC,SEVERAL,SRS,THEREFORE
ACTUARIAL,BETWEEN,MEDICAL,MRI,SRS,SRT,THREE
WHILE
160,THESE
BACKGROUND,BRAINSTEM,LABEL,METHODS
DESPITE,GBM,HSPGS,PDGFR
BLACK,GIVEN,WHITE
ANOTHER,BACKGROUND,CENTRAL,CURRENT,FURTHER,HOWEVER,LABEL,LEV,METHODS,NEURO,PHENYTOIN,PHY,RATIO,RCT,RESULTS,SIMILARLY,TRAUMATIC
000,100,GBM,IMAGING,PET,SPECT
DESPITE,GBM
CYBERKNIFE,GAMMA,GBM,KNIFE,LINAC,NOVALIS,PET,TREATMENT
CONCLUSION,GUIDELINES,INFANTS,JPA,LABEL,MANAGEMENT,METHODS,MRI,NEUROPATHY,OBJECTIVE,RESULTS,YOUNG
DEPENDING,THERE,THREE
947,CAJAL,HOWEVER,PML,SHH,SONIC,TELOMERES,TERFS,TERRA,THESE,USING
GLIOMAS,HOWEVER,MOLECULAR
CHRIS,NOW,THESE,THREE,WHY
169,COPYRIGHT,DESPITE,INC,PARTICULAR
169,COPYRIGHT,INC,NEWER,THERE
169,COPYRIGHT,INC,SLEEP,THESE
169,COPYRIGHT,INC,PATIENT,PREVIOUSLY,RADIATION
169,CAREFUL,COPYRIGHT,INC,THERE
ENGLISH,WHOLE
041,169,193,BLACKWELL,DEPARTMENT,EUROQOL,LABEL,LTD,METHODS,NFA,NHP,NON,NOTTINGHAM,OBJECTIVE,OVERALL,PATIENT,PROFILE,PUBLISHED,PUBLISHING,QOL,QUALITY,RESULTS,SCALE,SHORT,VAS
169,GBM,IDH,SOCIETY,THERE
001,169,370,372,AUTHORS,BJU,CONCLUSION,COX,CSS,LABEL,METHODS,OBJECTIVE,RCC,RESULTS,THERE,UNLABELLED
TYPICALLY
215,DESPITE,EXCEPTING,MRI
100,200,MRI,SOCIETY,TREATMENT
MALIGNANT,VARIOUS
BBB,OVERCOMING
AMONG,DENDRITIC,DESPITE,INCREASING,THEREFORE
916,G47,HSV,ONCOLYTIC
CURRENT,PEPTIDE
ANTIGENIC,BECAUSE,C3H,CD4,CD8,CLASS,FINALLY,FOX,LAK,MHC
THERE
CED,MONOCLONAL
1980S,ATV,CTL,LAK,SINCE
BACTERIAL,CPG,ODN,SEVERAL,TH1
CYTOKINES
BECAUSE
239,946,COX,TGF,THESE
FINALLY
GBM,TMZ
CLASS,GIVEN,HOWEVER,REFINEMENT,WHILE
DESPITE,GBM,HOWEVER
ADDITIONAL,CUTOFFS,MRI,NPV,PPV,RECORDS,SRS,THESE
001,114,AFRICAN,CAUCASIAN,MIXED,SOUTH,TAM,VARIATION
BACKGROUND,CERTAIN,CONCLUSION,LABEL,METHODS
155,301,AFTER,BRC,CAB,DAS,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS
100,150,300,CONCERNING,EIGHT,EMA,EVALUATION,FIFTEEN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
PALSY
BRAIN,TCD
169,COPYRIGHT,HOWEVER,INC,INCREASING
169,COPYRIGHT,EB1,EPOTHILONE,INC,MTS,TAKEN
169,192,COPYRIGHT,CXR,EORTC,GROUP,III,LTD,MRI,NSCLC,PET,PHYSICIANS,RESULTS,THESE
001,002,112,169,300,412,ADDITIONAL,AMONG,APRIL,BMS,COMPARING,CONCLUSION,COPYRIGHT,GERMANY,GPA,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PIS,PURPOSE,RESULTS,ROTTERDAM
169,COPYRIGHT,INC,RAS
003,035,169,177,946,COPYRIGHT,HOWEVER,PUBLISHED,TGF
5HT,ARC,CRH,GHRELIN,HENCE,NPY,PVN
AMONG,GHS,HOWEVER,R1A,R1B
169,174,231,233,COPYRIGHT,GAMMA,KNIFE,PUBLISHED,RADIOTH,SAS,SINCE,WHEREAS
DUE
001,002,012,032,039,129,135,169,177,759,AUTHORS,BEIJING,CHINESE,EYE,FOUNDATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,LABEL,METHODS,RESULTS,THESE
806,GAMMA,KARNOFSKY,KNIFE,LABEL,LEKSELL,LGK,METHODS,OBJECTIVE,PERFEXION,PFX,PITTSBURGH,PRIOR,RESULTS,RPA,SCALE,SEVEN,SIXTY,SRS,SUSTAINED,UNIVERSITY
120,121,144,BETWEEN,CHILD,CLASS,LABEL,LIVER,METHODS,OBJECTIVE,OTHERWISE,RESULTS,SURGERY,TBI
001,002,006,250,432,BACKGROUND,CONCLUSION,FORTY,GEFITINIB,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SEN,SEPTEMBER,SUN,TKI,UNIVERSITY,YAT
ANOTHER,TORRE
CBS,FINALLY,LABEL,MEASURE,METHODS,OBJECTIVE,PBT,PURPOSE,RESULTS,STRATEGIES,THESE,UNTREATED
CNS,SPECT,TBI
101,228,ACCORDING,APRIL,CONTROL,INSTITUTE,MAY,PILOCYTIC,SINCE,SRS,SRT,STR,THERE,THEREFORE
AGE,CYBERKNIFE,INDICES,SINCE,SRS
B1R,B2R,BTB,CONSISTENT,COX,F98,FISCHER,GADOMER,ICP,LYSDESARG,MAGNEVIST,MRI,TEN,THESE,TREATMENT
949,HOWEVER
CSC,NSC,THESE
367,DIAGNOSTIC,EEG,FAVORABLE
10001,333,BACKGROUND,CPA,CRANIAL,CSF,DESPITE,DISCUSSION,DUE,IAC,LABEL,MEDICAL,METHODS,MRI,PUBLISHERS,SEVENTH,USA
CNS,ELISA,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCNSL,PCR,PDCD4,PVRLS,RESULTS,SNP,VITREAL
169,186,COPYRIGHT,CURCUMA,FINALLY,GSH,JNK,LTD,MCI,PD98059,ROS,SCC,THEREFORE,TREATMENT,VAD,WILEY
4TH,BACKGROUND,CHOROID,CLINICALLY,LABEL,METASTASIS,METHODS,PREFERRED,THERE,TUMOURS
4EBP1,CONCLUSION,LABEL,METHODS,MIB,MUTATIONS,OBJECTIVE,OLIG2,RESULTS,WHILE
169,196,600,750,964,967,CONCLUSION,GRE,HIPAA,KENDALL,LABEL,MATERIALS,METHODS,MVD,MVS,OBJECTIVE,PEARSON,POTENTIAL,PURPOSE,RADIATION,RESULTS,ULTRAHIGH,WORLD
185,956,AFTER,III,PEG,PEGYLATED,THEREFORE
101,CLINICALLY,CTA,ICA
CARLO,DIRICHLET,GIVEN,MONTE,POTTS
169,BEHAVIORAL,CHANGES,COPYRIGHT,HOWEVER,INC
196,BACKGROUND,BESIDES,CAREFUL,EQUIVOCAL,FORTY,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,SURGERY
169,BIPAP,COPYRIGHT,INC,WHILE
169,231,233,COPYRIGHT,DOSES,MRI,PUBLISHED,RESULTS,SAS
169,COPYRIGHT,HOWEVER,INC,MMR,MSI,THESE
169,300,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,PRE,PUBLISHED,RESULTS,SEVEN,THESE
169,COPYRIGHT,EXPRESSION,INC,SHH,SONIC,THESE
100,169,DESPITE,HISTOLOGIC,MRI,SOCIETY
AFTER,BACKGROUND,CONCLUSION,LABEL,LITERATURE,METHODS
ACCORDING,III,IMAGING,MOLECULAR,MRI,NUCLEAR,PET,RESONANCE,SPECT,THEREFORE,TOMOGRAPHY,VARIOUS,WORLD
169,AMONG,CSF,LVV,PATIENT,POSTERIOR,PRE,THEIR,THESE,VCH,WILEY
ASTRA,BECAUSE,EFS,NTRK1,NTRK2
BACKGROUND,FINALLY,LABEL,METHODS,PATIENT,RESULTS,THESE
CAM,JUXTAPOSED,MITOSES,PAPILLARY,PATIENT
HOWEVER,LABEL,MALIGNANT,METHODS,OBJECTIVE,PEG,PHA,PURPOSE,RESULTS,THEIR,THEREFORE
008,028,169,231,287,BRAIN,MDA,THESE,TPI
169,231,233,COPYRIGHT,PUBLISHED,SAS,THERE
ALZHEIMER,BBB,CNS,DISORDERS,TECHNIQUES,THERE,ULTRASOUND
BACKGROUND,IMAGE,LABEL,METHODS,RESULTS,ROI,THREE,ULTRASOUND
SVM
BACKGROUND,CONCLUSION,LABEL,METHODS
MRI,PCR,TOTAL
169,2CL,AGAINST,ECS,INC,NKCC1,OPTICAL,THESE,TREATMENTS,WILEY
MEDLINE
HOWEVER
MEDLINE,PITUITARY
CUSHING,PITUITARY,THESE

003,057,107,134,AFTER,CNS,CSF,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OMU,RESULTS
DESPITE,MRI
CONVERSELY,FLAIR,GLIOMAS,HOWEVER,IMAGING,MRI,THESE
MRI,SOURCES,TECHNIQUES,THESE
IMAGING,RADIATION
MRI,NEURO
CURRENT,THESE
ESPECIALLY
HOWEVER,IMAGING,NEWER
170,99M,AFTER,DCE,DWI,EPPENDORF,FRP,HYPOXIA,MRI,OWING,PET,THESE
MRI
MRI
BRITISH,JOURNAL,MRI,RADIOLOGY
HOWEVER,MRI,WHILE
GBM
ATLAS,BRAIN,GBM,LABEL,METHODS,MOLECULAR,NEOPLASIA,OBJECTIVE,PURPOSE,REMBRANDT,REPOSITORY,RESULTS,THESE,U87
014,047,160,647,BACKGROUND,CONCLUSION,FIFTY,FRANK,LABEL,METHODS,RESULTS,THERE,THESE
160,RESECTION
001,009,207,ALU,BACKGROUND,CPG,CROHN,LABEL,METHODS,MSI,RESULTS,UNIVARIATE
170,BACKGROUND,BLACK,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,RESULTS,THESE,UNIVARIATE,USING
DETECTION,ISSUE,LABEL,METHODICAL,METHODS,MRI,OBJECTIVE,PET,POTENTIAL,PRACTICAL,RESULTS,STAGING,THESE,ULTRASOUND,WHOLE
100,160,169,183,AFTERWARDS,CONCLUSION,GEORG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUTTGART,SWI,THERE,THEREFORE,THREE,WITHOUT
160,169,183,CONCERNING,DWI,GEORG,HOWEVER,MRI,PET,STUTTGART,USING
160,185,ASTRO,BACKGROUND,CONCLUSION,DISCUSSION,ESTRO,LABEL,METHODS,OBJECTIVE,PURPOSE
169,904,COMPONENTS,CONVERSELY,DROSOPHILA,HIPPO,MOL,NF2,PHOSPHO,RES,TEAD1,USING,YES
LABEL,MICRORNAS,OBJECTIVE,PITUITARY,PURPOSE,RESULTS,SUMMARY,THERE
169,GBM,GSC,HOWEVER,INHIBITION,MET
11C,18F,945,BRAIN,CHO,DESPITE,EUR,FDG,FET,FLT,FMT,MET,PET,USD
INCREASED,MRI,PET,SPECT,THEREFORE
110,11C,18F,AMINO,FDG,FET,FLT,FMISO,HOWEVER,LATER,MET,METHIONINE,MRI,PET,SINCE,TOTAL
18F,CURRENTLY,FDG,FINALLY,PET
DTI,DWI,IMAGING,MRI,MRS,PWI
19Q,CENTRAL,DIFFERENT,MOLECULAR,NERVOUS,WORLD
AIM,AMONGST,CONCLUSION,DTI,IFO,LABEL,METHODS,OBJECTIVE,RESULTS
006,AFC,ART,BACKGROUND,FSH,HOWEVER,IVF,IVM,LABEL,METHODS,RESULTS,SINCE,THERE,WOMEN
FURTHER,HOWEVER,TARGETING
043,945,947,952,961,CNS,COX,MEIER,PCR
946,CHROMATIN,MAMMALIAN,NOTCH,PROMOTERS,WNT,WNT3A
169,ACTIVATION,COPYRIGHT,DESPITE,FINALLY,INC,PET,PK11195,WILEY
160,OCCASIONAL
102,132,165,291,CONCLUSION,LABEL,METHODS,MUTATIONS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
ALDOA,ALDOC,EXPRESSION,FIRST,FOLLOWING,GAPDH,HIF,HK2,IMAGING,MICROARRAY,PGI,RESONANCE
160,ASTROCYTIC,ERK,FINALLY,GAP,GTPASES,HOWEVER,IHC,III,MALIGNANT,REMBRANDT,RHO,STARD13
001,967,CHEMOKINE,HOWEVER,METASTATIC,NSCLC,SYNGENEIC
ACC,EARTHQUAKE,GMV,GREAT,JAPAN,OFC,THESE
CSC,GBM,THESE
169,945,947,COPYRIGHT,FINALLY,INC,PET,RAT
100,169,COPYRIGHT,LTD,MRI

956,ACCORDING,AFTER,IGF,LABEL,LANREOTIDE,METHODS,OBJECTIVE,RESULTS
BRAIN,SRS
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,NSCLC,OBJECTIVE,OCTOBER,ORR,PFS,RESULTS,SEPTEMBER,SMOKING
169,949,COGNITIVE,COPYRIGHT,FURTHER,INC,THESE,VBM,VOXEL
169,AIP,BLACKWELL,FURTHER,LTD,PITUITARY,PUBLISHING,YOUNG
CARCINOMA,CAUCASIAN,RCC,RENAL,THERE,VHL,VON
160,945,946,CAM,HOWEVER,MLD,NGF,THEREFORE
ESTIMATED,NEUROGENIC,PEDIATRIC,SVZ
169,916,923,COPYRIGHT,DYNAMIC,INC,PERFUSION,R2SE3,WILEY
047,111,125,217,218,243,244,252,273,286,298,302,322,351,377,482,483,567,640,796,811,926,BMS,CRANIAL,CRT,HOWEVER,MRI,PCI,PEARSON,TEN
045,177,ACTUARIAL,ADDITIONAL,CNS,EIGHT,JANUARY,LMS,MEIER,REGARDING,SIX,UNI
100,169,177,AGAIN,CENTRAL,CNS,COPYRIGHT,INDEX,LTD,PROGNOSTIC,RITUXIMAB,ROUTINE,WILEY
ALA,ARG,GLN,PEPTIDE
169,COPYRIGHT,CURRENT,INC
COLLEGE,LOCAL,RADIOLOGY,SUPPORTIVE,SURGERY,THERE
169,COPYRIGHT,INC,LTD,MATERIALIA,PUBLISHED,ROS
169,ALREADY,BBB,COPYRIGHT,ESPECIALLY,NPS,PERHAPS,THERE,WHILE
169,ATF,COPYRIGHT,DESPITE,FOS,HOWEVER,JUN,KNOCKDOWN,NER,PREVIOUSLY,XPF
169,603,COPYRIGHT,MTT,PTX
169,COPYRIGHT,LTD
169,BRAIN,COPYRIGHT,FEDERATION,IRELAND,LABEL,LTD,M1S,METHODS,MOTOR,OBJECTIVE,PARKINSON,PRINCIPAL,PUBLISHED,RESULTS,USING,WHILE
002,003,008,009,018,022,132,169,743,907,ACADEMY,ASTROCYTIC,AVERAGE,CCF,CLEVELAND,COPYRIGHT,FOUNDATION,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PROGRAM,PUBLISHED,RESULTS,SCLEROSIS,TSC
140,150,156,169,183,184,300,AUSTRALIA,BACKGROUND,COPYRIGHT,DABRAFENIB,DOSES,FUNDING,LABEL,LTD,MARCH,MAY,METHODS,RESPONSES,RESULTS,USA,VAL600GLU
022,100,117,120,169,24H,COPYRIGHT,III,KARNOFSKY,LABEL,LTD,METHODS,NOVOTTF,OBJECTIVE,PHASE,PRIMARY,PURPOSE,QUALITY,RESPONSES,RESULTS,TREATMENT,TTF
001,002,BACKGROUND,FPS,LABEL,METHODS,RESULTS,SINCE,THERE
246,THERE
BACKGROUND,BASED,BBB,BRAIN,COVERED,LABEL,METHODS,OPINION
169,298,323,BMS,ELECTRONIC,FOLLOWING,HOWEVER,INC,JANUARY,THERE,WILEY,WOMEN
194,BACKGROUND,C30,CFA,EORTC,IRANIAN,LABEL,METHODS,MULTITRAIT,PERSIAN,QLQ,RESULTS,THESE
CGH,THERE
946,RDB,TAKEN,WNT
GENERALLY,SMALL
AUTOIMMUNE,CONDITIONS,INFECTION
IRANIAN,PXA
EATON,FURTHER,LAMBERT,MRI

10001,333,FRAGILE,MEDICAL,PUBLISHERS,SEVENTH,USA
HISTOLOGY,MRI,PET,TREATMENT
HISTORY
19Q,CHROMOSOME,CLASSICAL,MRI,SIMILAR,THREE,WORLD
CLONE,CROSS,THESE
310,851,BACKGROUND,BRAIN,BROCA,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,1RA,946,BMI,CD4,COPYRIGHT,CRF,FATIGUE,HOWEVER,INC,TNF
169,COPYRIGHT,LTD,THESE
030,169,APRIL,COPYRIGHT,GTR,JANUARY,LTD,MAXIMAL,RECURRENCE,SIXTY,STR
148,169,BRAIN,COPYRIGHT,GBM,INSTITUTE,LTD,OCTOBER,PXA,SEPTEMBER,SINGAPORE
169,BETWEEN,BRAIN,COPYRIGHT,CPA,JANUARY,LTD,MRI,PRIMARY,T1W,T2W
150,169,180,664,AFTER,CONCLUSION,COPYRIGHT,HOWEVER,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PDT,PROTECTION,RESULTS,SCALE
NCF
GBM
GBM,SEVERAL
CNS,HODGKIN,IMPROVING,MTX,PCNSL,PRIMARY,SEVERAL,SG1,WHOLE
19Q,1ST,AFTERWARD
100,BASED,LDH
AFTER,HEALING,HOWEVER,NF1,SCC,THESE
100,200,945,BOUIN,CONCLUSION,FIFTEEN,FSP,GFR,INSTITUTE,LABEL,MATERIALS,METHODS,NF1,NTR,RESULTS,SCHWANN,SIX,THESE,UNLABELLED
954,K48,NOTCH,NUMBL,TRAF5
945,946,CLINICALLY,HOWEVER,INTEGRINS,TAKEN
116,169,945,A549T,COPYRIGHT,HCT,MTT,NMR,TAKEN,THESE,VCH,WILEY
ADENOVIRAL,CURRENTLY,GLIOMAS
AVP,BACKGROUND,CONCLUSION,DDAVP,ENDONASAL,LABEL,METHODS,PITUITARY
169,231,233,COPYRIGHT,FINALLY,MRI,PRINCIPLES,PUBLISHED,SAS
169,AMONG,BECAUSE,COPYRIGHT,HHV,LTD
INCREASED,PCR,SAMPLES,THEIR,TNF,UNDER
169,AFINITI,AUR,CONCLUSION,COPYRIGHT,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,VALIDATION
169,AUR,CBV,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PERFUSION,PUBLISHED,PURPOSE,RESULTS,THERE
228,TARGETING
125,133,169,175,180,185,19Q,AMONG,AUTHORS,BRAIN,ERK,IDH,PATHOLOGY,PCR,RAF,RAS,SIMILARLY,SOCIETY,THERE
239,BACKGROUND,BASED,DTI,EULER,LABEL,METHODS,RESULTS
AQUAPORIN,OAP,RG2,SMA
115,169,APC,CNP,GBM,GSC,III,IMMUNOBLOT,LABEL,METHODS,NPC,OBJECTIVE,OPC,ORTHOTOPIC,PURPOSE,RESULTS
169,ANCHORING,ECM,LARGE,NOTABLY,REDUCED,RESTORING
19Q,CIC,FUBP1,HOWEVER
169,ACTIVATION,ATP,GBM,INHIBITORS,LABEL,UNLABELLED,USING
169,LABEL,NCSLC,NSCLC,THESE,UNLABELLED
169,BARKOVICH,ERLOTINIB,OTHER,THESE,VIVANCO
116,AGE,BACKGROUND,COX,CURRENTLY,GBM,JANUARY,KARNOFSKY,KPS,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING
004,BACKGROUND,BRAIN,GAMMA,GKS,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,SCORE,SIXTEEN,THEIR,TOKYO
000,006,100,AGING,COX,GBM,HEART,HHP,ICD,JAPAN,PROGRAM,RECORDS
334,ECM,GENOMES,KYOTO,NOTCH,PATHWAY,PHPAS,SINCE
A71,IMMEDIATE,SVC
CLAUDIN,KIR,MAP,PTPRS,THESE
169,COPYRIGHT,INC,THESE
176,177,BACKGROUND,HOWEVER,KIRSTEN,LABEL,LOW,METHODS,PCR,RESULTS,VALIDATION
149,160,169,177,183,BACKGROUND,BLACKWELL,CONTEXT,CUSHING,FOLLOWING,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PREVALENCE,PRL,PRLOMAS,PUBLISHING,RESULTS,SETTING,SIMILARLY,THERE,THESE,TSH,UFC
169,954,AKT,UNCOVERING
418,ATT,CD44EXT,INCREASES,INVERSELY,MEK,PD98059,PMA,PP2,SHC,SRC
2OHOA,AKT,DESPITE,GIVEN,MAP,RAS,THESE,TMZ
169,A20,HOWEVER,LABEL,THESE,TNF,TRAIL,TREATMENT,UNLABELLED,ZNF
169,A20,AFTER,BELLAIL,DISCOVERY,TNF,TRAIL
120,150,169,175,946,COPYRIGHT,FINALLY,GENBANK,INC,MET,MSP,NSCLC,PCR,RON,RTK,SEVERAL,WILEY
002,004,005,012,024,119,127,177,185,CONCLUSION,COX,FIFTY,HRS,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THERE
169,AUTOPHAGY,COPYRIGHT,INC,WILEY
311,473,AKT,BACKGROUND,CONTEXT,EMA,LABEL,METHODS,OBJECTIVE,RESULTS,SCO,SER,SMI,SONIC,SPINDLE,THERE,THESE
BACKGROUND,COMPETING,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
026,108,120,162,196,206,718,BACKGROUND,ICH,LABEL,METHODS,OVERALL,RBC,RESULTS,SAH,THREE,UNIVERSITY
FIFTY,ICH,THERE,THESE,VTE
BECAUSE,FL1,HOWEVER,SEVENTY
FOLLOWING,MARCH,RECURRENCE,SINCE,WHILE
176,177,186,957,974,CALCULATED,GTC,ORTHOGONAL,SRT
431,AKT,BACKGROUND,ECS,FGF,INCREASED,INJECTION,LABEL,RESULTS,SEVERAL
169,862,BRAIN,CAT,COPYRIGHT,FABP7,INC,INCLUSION,SEQUENTIAL,THESE,USING,WHILE
BACKGROUND,EXPRESSION,GBM,LABEL,METHODS,PATIENT,RESULTS,SUB,TARGETING,U87MG
100,163,BACKGROUND,FTM,GBM,LABEL,METHODS,PFS,PRIMARY,RECURRENT,RESULTS,TMZ
169,177,18F,COPYRIGHT,FMISO,INC,LABEL,MATERIALS,METHODS,NEWPETGTVH,NPC,OBJECTIVE,PET,PURPOSE,RESULTS
005,169,BASED,COPYRIGHT,DSC,GROUP,INC,LABEL,MATERIALS,METHODS,METRICS,OBJECTIVE,PASSING,PURPOSE,RADIATION,RESULTS,SIMILARITY,THERAPY,THESE
AIM,CONCLUSION,LABEL,MATERIALS,METHODS,NANOSHELL,OBJECTIVE,PEG,RESULTS,SUBSEQUENT,VESSELS
169,APMIS,AUTHORS,BRAIN,CDC42,ELISA,HCC,HEPG2,INHIBITED
CONCLUSION,LABEL,METHODS,OBJECTIVE,PERSISTENT,REGULAR,THERE
GBM,MULTIFORME
464,946,BECAUSE,CHROMOSOME,ERK,EXOGENOUS,HCN,HOWEVER,PD98059,REGULATORY,RFX,SEVEN,TGF,THESE
CROSS,MRI,PET
386,891,956,AFTER,CD4,CHINESE,DIAGNOSIS,HAART,HIV
001,016,033,169,CONCLUSION,COPYRIGHT,DCE,III,INC,KRUSKAL,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,ROI,WHITNEY,WILEY
CRANIAL,DNT,MRI
300,DNT,FURTHER,THERE
177,APRIL,BACKGROUND,FIFTEEN,FRAMELESS,LABEL,LOS,METHODS,OBJECTIVE,PURPOSE,RESULTS
AGING,ANDROGENS,COUNTRIES,HOWEVER,OBESITY,SEX,THESE
001,177,202,EXTUBATION,GENERAL,ISO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDIES,TIMES,UNIVERSITY
BCL,BEADARRAY,COX,GH3,HOWEVER,MMP,PRL,THESE
AGGRESSIVE,HOWEVER,SEVERAL
100,118,125,177,ACTUARIAL,BECAUSE,BETWEEN,BSG,PFS,PROCEDURE,SBT,SPACE,WORLD
945,ATG,AUTOPHAGY,BIP,BP1,CSA,FORMATION,GFP,LC3,MALIGNANT,SALUBRINAL
34A,ADDITIONAL,CHROMOSOME,EXPRESSION,GBM,NOTABLY,YIN,YY1
160,169,804,952,956,BDI,BIOMASS,COOKING,COPYRIGHT,DEPRESSION,ELISA,IAP,INDIA,LTD
169,BAK,BAX,BCL,BH3,COPYRIGHT,INHIBITION,IRELAND,LTD
014,033,043,100,169,178,183,195,209,373,412,584,95E,BACKGROUND,BETWEEN,COPYRIGHT,DOHME,EFS,FUNDING,KARNOFSKY,LABEL,LTD,MAY,MERCK,METHODS,NOV,RESULTS,SHARP
169,BECAUSE,BRAIN,COPYRIGHT,IRELAND,LTD
001,008,BACKGROUND,CLIC1,GRADE,HOWEVER,III,KARNOFSKY,KPS,LABEL,METHODS,PCR,RESULTS,WORLD
420,882,912,DTH,HOWEVER,INPATIENT,LABEL,METHODS,NIS,OBJECTIVE,RESULTS,THESE
169,AUTHORS,HOWEVER,MAY,OBESITY
023,025,113,117,125,127,140,BETWEEN,DELAYED,GAMMA,GKS,KNIFE,LABEL,MARCH,MEIER,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
FDG,FLT,III,MET,MRI,PET
947,BAX,BCL,NSCLC,PREVENTIVE,THESE
AREAS,CONCLUSION,IMAGING,LABEL,LGFMS,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
000,286,CONCLUSION,EQUIVALENT,LABEL,MAXIMUM,METHODS,OBJECTIVE,PICTURE,PURPOSE,RESULTS,RIS,SAH
006,123,BACKGROUND,CONCURRENT,LABEL,MATERIALS,METHODS,MRS,NAA,OBJECTIVE,PRE,PURPOSE,RESULTS,SIACI
177,BASED,BETWEEN,CSF,INITIAL,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,TMZ
EARLY,MRI,PAROTID,PRIOR,WARTHIN,WTS
034,149,169,177,318,AUSTRALIA,BACKGROUND,BMI,CORONER,ENGLAND,LABEL,MALIGNANT,METHODS,MPM,POSTMORTEM,PULMONARY,RESULTS,WESTERN
BRAIN,MRI,PCNSL
CUSHING,CUSHINGOID
ATTENTION,BACKGROUND,CONCLUSION,CRANIAL,CSF,HOWEVER,IPH,LABEL,METHODS,OVERALL,PMC,RESULTS,SEVENTY
ALA,BACKGROUND,CONCLUSION,GBM,JANUARY,LABEL,METHODS,RESULTS,SINCE
14Q21,169,17Q21,17Q22,ANAPLASTIC,COPYRIGHT,GTG,III,LOH,THEREFORE,UPD
ACCORDING,CHINA,CONCLUSION,LABEL,METHODS,OBJECTIVE,PREDICTION,RESULTS,THIRD
189,BACKGROUND,EXTRACTION,LABEL,LAR,MEDLINE,METHODS,OBJECTIVE,OCTREOTIDE,PRIMARY,RESULTS,SOURCES
ARF,CRE,INK4A
103,169,AZD6244,BECAUSE,ERK,GBM,HOWEVER,MEK,NF1,PD0325901,RAF,RAS,TAKEN
006,ADC,CNS,FORTY,IDD,LABEL,LESIONS,METHODS,OBJECTIVE,OBJECTIVES,PERIPHERAL,RAPID,RESTRICTED,RESULTS,T2W
001,002,008,169,499,877,COPYRIGHT,FBS,FIRST,HYPOTHESIS,INC,INCIDENCE,ITF,LABEL,MEIER,METHODS,MINIMUM,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PARTIAL,PATIENT,PPS,RESULTS,SOCIETY,UNIVARIATE
183,GEORG,MODULATION,SOMATIC,STUTTGART
MICROGLIA,MICROGLIAL,WHILE
947,BRUTP,CD133,RADIATION,SOX,TAKEN,U87
17P11,17Q,DFS,OUTCOME,OVERALL,WHEREAS
160,ACHIEVA,FUNCTIONAL,PHILIPS
000,HMGA2,HOWEVER,INCREASES,P140K,RIS
100,169,BACKGROUND,BASEL,CHRONIC,CLONINGER,CONCLUSION,COPYRIGHT,CUSHING,EPQ,EYSENCK,LABEL,METHODS,OBJECTIVE,RESULTS,TPQ
BACKGROUND,CONCLUSION,CSF,IMPORTANCE,LABEL,METHODS
169,ACA,BASEL,COPYRIGHT,MRI
169,958,CDC42,COMPONENTS,DEPLETION,FINALLY,GEF,MALIGNANT,MOL,RES,RHO,TNF,TWEAK
169,ANZ,AUSTRALIA,AUTHORS,BACKGROUND,BETWEEN,COLLEGE,CONCLUSION,JANUARY,JOURNAL,LABEL,METHODS,RESULTS,ROYAL,SURGERY,WELLINGTON,ZEALAND
150,300,600,732,946,956,ALBUMIN,EM011,FE3O4,HOWEVER,NOSCAPINE,NPS,PAR,PHASE,SERUM,THEREFORE
609,DEASY,DSQ,LABEL,METHODS,OBJECTIVE,PRIMARY,PROCEDURES,RESULTS
169,APPLIED,AUTHORS,BRITISH,SOCIETY
DUE,EGF,EPIDERMAL,NKCC1,TAKEN,WNK
111,177,945,946,PBS,RGDYK,U87MG
424,ATLAS,FINALLY,KARNOFSKY,TMZ,UTR
ADDITIONAL,COMPARISON,STR,SUBSEQUENT
ALDER,DEFINITIVE,ENDOSCOPIC,FOUNDATION,GROUP,HEY,JANUARY,LABEL,LEUKAEMIA,MANAGEMENT,METHODS,NHS,OBJECTIVE,PARIS,PURPOSE,RESULTS,TEN,THERE,TRUST
945,BACKGROUND,CCND2,GBS,IDH,LABEL,METHODS,MICROARRAY,MOLECULAR,PEDIATRIC,RESULTS
001,008,046,072,098,100,119,169,177,336,534,BACKGROUND,COPYRIGHT,III,LABEL,METHODS,PTA,RESULTS,SOCIETY,SRS
947,IDEALLY,MRI

19Q,AMONG,EFFORTS,GBM,HOWEVER,III
212,233,313,390,CLINICALLY,CNFPA,KNOSP,MIB,MRI,NCA,OSA,SCA,SGA,THESE,THREE,TSH
022,169,BACKGROUND,COPYRIGHT,COX,END,LABEL,METHODS,RESULTS,SOCIETY,THESE

169,COPYRIGHT,ELK,ERG,ETS,ETV,HOWEVER,INC,SEVERAL,USING
169,CNS,COPYRIGHT,HOWEVER,LTD
169,945,AFTER,COPYRIGHT,IRELAND,LTD,PCR,U87
169,COPYRIGHT,FEDERATION,GBM,PUBLISHED,SOCIETIES
169,BACKGROUND,CONCLUSION,GBS,HOWEVER,LABEL,LDA,METHODS,RESULTS,SUBSEQUENT
ELISA,EPH,HOWEVER,KNOWING
9TH,BEIJING,CHINA,GENERAL,JANUARY,LABEL,MARCH,MONGOLIAN,MRI,OTHER,OUTER,PBL,PLA,UNASSIGNED,UNLABELLED,VIRTUAL
169,379,AUTHORS,BRAIN,CNS,CURRENTLY,III,PATHOLOGY,PFS,SOCIETY,THEREFORE,WORLD
10S,160,176,177,213,358,540,606,NPC,PTV,SIB,TEN,THERE
259,BACKGROUND,CONCLUSION,CSS,FIFTY,LABEL,METHODS,NEITHER,PFS,RESULTS
123,169,19Q,A598V,AUTHORS,BRAIN,PATHOLOGY,PCR,SEQUENCING,SOCIETY,THESE,V600E
BECAUSE,CURRENTLY,PARTICULAR
368,EEG,III
233,272,505,BAG,CASKI,FINALLY,HOWEVER,KNOCKDOWN,L9981,MCF,TAKEN

ATG16L1,AUTOPHAGY,HCQ,LYS01,LYS05
BRAIN,FDG,FEW,FIFTY,HCC,JANUARY,LIMITED,MEDLINE,PET
954,956,DAILY,ERK,GBM,GBM8401,MEK,MMP,MTT,SFN
GROUP,SHH,WNT
GBM
001,100,142,CONCLUSION,CSR,DISEASE,GENERAL,HRQOL,LABEL,METHODS,OBJECTIVE,OVERALL,PPR,PURPOSE,RESULTS,SCALE
326,34B,432,570,603,ALTERED,BACKGROUND,CONCLUSION,CONTEXT,FINALLY,HMGA1,HMGA2,LABEL,METHODS,OBJECTIVE,RESULTS,USING
169,ACE,COPYRIGHT,GIVEN,HIV,INC,PUBLISHED
169,BECAUSE,CUMULATIVE,INDEX,LABEL,LITERATURE,MEDLINE,METHODS,NURSING,OBJECTIVE,PURPOSE,RELEVANCE,RESULTS,SIGMA,SYMPTOM,TAU,THETA,WHILE
169,229,308,AUTHORS,HOWEVER,INSTEAD,JOURNAL,LNT,PCR,SOCIETY,TMZ
169,635,AFTER,BAX,BCL,HSP27,MTT,PDT,ROS,THEREFORE,WESTERN,WILEY
252,DEPARTMENT,MRI,THERE
BEHAVIORAL,DYNAMIC,MRI,PERSISTENT,REDUCTION,YET
ICH,VARIOUS
FAK,PC3,ROS,SRC
BCL,BGSCS,CURRENTLY,HOWEVER,PCR

946,CLONAGENIC,GH3,INHIBITION,PCR,REPRIMO
207,BRAIN,COMMITTEE,CUTANEOUS,JOINT,SEVENTY,STUDIES,THESE
AMONG,BACKGROUND,BECAUSE,CONCLUSION,FTB,GBM,LABEL,METHODS,MRI,PERFUSION,RESULTS,STUDIES,THERE
169,174,COPYRIGHT,CYBERKNIFE,GAMMA,KNIFE,LEKSELL,NOVALIS,PUBLISHED,SAS
169,ADDITIONAL,AFTER,AUC,BACKGROUND,BETWEEN,COPYRIGHT,GRADE,INHIBITION,IRELAND,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SUNITINIB
169,COPYRIGHT,LTD,MYELOID
169,22033,26033,BACKGROUND,CE5,CONSENSUS,COPYRIGHT,DIGITAL,EORTC,FIFTY,ICR,III,IRELAND,LABEL,LTD,METHODS,OAR,RELOCATION,RESULTS
169,947,ARTESUNATE,BACKGROUND,CONCLUSION,COPYRIGHT,EXPRESSION,GFP,INCUBATION,IRELAND,LABEL,LN229,LTD,MATERIALS,METHODS,MTT,NOVEL,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,U87MG,WESTERN
ACTIVATION,INC,PASD1,PUBLISHED
169,BRAIN,COPYRIGHT,FIRST,LTD,OVERALL,PUBLISHED
169,177,AIM,CHO,CHOLINE,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METABOLITE,METHODS,MRS,NAA,OBJECTIVE,RESULTS,THERE
169,CLASSICAL,COPYRIGHT,GWASS,INC,POOLING,PUBLISHED,SOCIETY
ENGLISH,FEWER
CSF,EVACUATION
100,HGS,MPNST
196,CONTINUOUS,III
CUTANEOUS,FURTHER,GABAPENTIN
169,COPYRIGHT,HOWEVER,INC,WILEY
INCREASING,KARNOFSKY,OAS,OLDER,PFS,RPA,SVZ
103,182,230,AVAILABLE,BACKGROUND,BASED,COMMISSION,LABEL,LAR,MATERIALS,METHODS,OBJECTIVE,PROTECTION,PURPOSE,RADIOLOGIC,RESULTS,VII
BACKGROUND,BROCA,IFG,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,STS,TPJ
DES,FUNCTIONAL,ULTRASOUND
CRADS,FDA,HB1,NSC,ONCOLYTIC
001,025,029,148,518,756,936,AFTER,DIAGNOSIS,FURTHER,LABEL,LOS,METHODS,OBJECTIVE,PROCEDURE,PURPOSE,RESULTS,USING
102,153,177,AIM,BNP,CONCLUSION,LABEL,METHODS,OBJECTIVE,PRESENT,RESULTS
100,677,FFPET,GSTM1,GSTP1,GSTT1,HOWEVER,ILE105VAL,MTHFR,PCR,WGA
169,ASSESSMENT,COPYRIGHT,LTD
100,169,72H,ACTIVATION,AKT,ANNEXIN,BACKGROUND,CONCLUSION,COPYRIGHT,FINALLY,HOWEVER,HYPEROXIA,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
954,EPHB2,FURTHER,GBM,MCP,PMEPA,U87
TEN
001,664,ASIAN,BACKGROUND,COX,END,GBM,HOWEVER,INSTITUTE,ISLANDERS,LABEL,MEIER,METHODS,MULTIFORME,NCI,OVERALL,PACIFIC,RESULTS,TRIAL,YOUNG
325,BMD,CONCLUSION,CONTINUOUS,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
CONCLUSION,LABEL,METHODS,OBJECTIVE,RBE,RESULTS,SEVERAL,THESE
945,946,ADDICTION,APLYSIA,SMOKING
EFFICIENT,NFPAS,NON
945,946,ALZHEIMER,DISTURBED,PARKINSON,TREATMENTS,WHILE
AFTERWARDS,HRMAS,METABOLITE
949,954,HOWEVER,IKK,SILENCING

169,BECAUSE,CHANGES,COPYRIGHT,INC,MEDICAL,PTV,PUBLISHED,SRS,TEN,UNIVERSITY
CLEAR,GRADE,III,MIB,MITOSES,THESE
19P13
169,COPYRIGHT,LTD
169,BRITISH,INTERVIEWS,IPA,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,SOCIETY,THESE,THREE
1990S,HOWEVER
100,THESE
169,AWARENESS,COPYRIGHT,CSF,INC,THESE,WILEY
241,AFFAIRS,BACKGROUND,CONCLUSION,DENMARK,FOUNDATION,FUNDING,FURTHER,HELEN,KEY,LABEL,METHODS,PRIMARY,PROTECTION,RESULTS,TIMES,TRIAL
AFFAIRS,BACKGROUND,BRAIN,CONCLUSION,DENMARK,FOUNDATION,FUNDING,HELEN,INTEGRATED,LABEL,METHODS,PATHWAY,PROTECTION,RESULTS,TRIAL
169,COPYRIGHT,DIFFUSION,DTI,INC,MRI,PWI
125,340,CONCLUSION,DISCUSSION,EVALUATION,GBM,III,LABEL,MACDONALD,METHODS,MRI,ORR,PFS,PRIMARY,PROLONGED,RESULTS,TREATMENT,UNLABELLED
CNS,LIU,SINCE
BAYVIEW,DYNAMIC,TORONTO
001,HOWEVER,IGFBP,THERE
AFTER,BRAIN,CONVERSELY,GBM,IDH,P53,THERE,UNTIL
WHILE
11195,181,BACKGROUND,CAM,CONCLUSION,LABEL,METHODS,RESULTS
BMP,METASTASIS,NOG,PIVOTAL,THESE,USING
001,AGGRESSIVE,EWING,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS
INTERICTAL,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
000,191,205,BIVARIATE,FURTHER,INPATIENT,LABEL,METHODS,OBJECTIVE,RESULTS,WHITNEY
GIVEN,III,REGIMEN,START,THREE
FIRST,LABEL,METHODS,MRI,NFPAS,OBJECTIVE,RESULTS
CAROTID,CBS
ALZHEIMER,COGNITIVE,CROSS,DISEASE,FURTHER,HOWEVER,LARGE,SIMILARLY,VITAMIN
215,945,BACKGROUND,FOLLOWING,LABEL,METHODS,PERHAPS,POTENTIAL,RESULTS
105,163,386,600,969,C22,DHA,HENCE,THERE,UNION,YET
126,136,144,ASSESSMENT,CONCLUSION,COX,DIAGNOSIS,GPA,GROUP,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RADIATION,RESULTS,RPA,THERAPY
BECAUSE,CAPILLARY,THESE
001,DELAYED,GAMMA,GKS,INCLUSION,KARNOFSKY,KNIFE,KPS,LOCAL,MEIER,SEVENTEEN,THESE
250,956,AFTER,CSC,GBM,HOWEVER,TMZ,USING
033,169,204,AFRICAN,AMERICANS,BACKGROUND,CAUCASIANS,COPYRIGHT,III,JANUARY,LABEL,METHODS,NETWORK,RESULTS,SOCIETY,SUBTYPE,WOMEN
ASTROCYTES,ASTROGLIAL,ATP,CNS,P2X,P2Y,P2YRS,SIGNALLING
ADRENAL,BASED,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VHL,VMA
AMONG,THERE
BACKGROUND,CAVUM,CONCLUSION,CSP,ENDOSCOPIC,LABEL,METHODS,THERE
CAREGIVER,CAREGIVERS,CLINICIANS,DYADS,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PAC,PITTSBURGH,PURPOSE,RESULTS,SETTING,VARIABLES,WHITNEY
136,169,CHANGES,COPYRIGHT,DESPITE,INC,PRO,THESE
169,179,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,XVI
CURRENTLY,DESPITE,DUE,LABEL,MRI,OBJECTIVE,PITUITARY
169,COPYRIGHT,EEG,INC,RESECTION,SUCCESSFUL
AMYLOID
169,946,COPYRIGHT,IFN,INTERFERON,IRELAND,LTD,PML,YES
169,CATHEPSIN,COPYRIGHT,D295N,GFP,HOWEVER,IRELAND,LC3,LTD,M059J,M059K,THESE
169,COPYRIGHT,IRELAND,LTD,SOX,SPARC,THESE,XRCC1
108,169,464,780,ASSESSMENT,BACKGROUND,COPYRIGHT,GPA,GROUP,HISTOLOGY,IRB,IRELAND,KPS,LABEL,LTD,MEIER,METHODS,MST,NSCLC,PROGNOSTIC,RADIATION,RESULTS,THERAPY,USING
169,COPYRIGHT,MOLECULAR,OCCURRENCE,PUBLISHED,SAS,THESE
169,AFTER,ASC,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,FMA,INC,INHIBITION,LABEL,METHODS,PET,POTENTIAL,RESULTS,THREE
169,ALTOGETHER,COPYRIGHT,EXTENSIVE,FINALLY,MEN,PUBLISHED,RET,SAS,THERE,THESE
169,CONCLUSION,COPYRIGHT,CURRENTLY,LABEL,MATERIALS,METHODS,MIB,OBJECTIVE,OBJECTIVES,RESULTS,SAS,SURGERY,SYSTEMATIC
169,500,COPYRIGHT,CUSHING,ERCUSYN,ESE,MEDICINES,REGISTRIES,SAS,THROUGH
015,123,169,579,CONFORMAL,COPYRIGHT,INC,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
002,107,169,201,201TL,263,372,775,826,926,COPYRIGHT,GKS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPECT
BACKGROUND,CONCLUSION,CPP,LABEL,METHODS,PATHOLOGY,THREE,USUALLY
MRI,PERIPHERAL

169,COPYRIGHT,RUBINSTEIN,TAYBI
PRIMARY,PSL
169,AUTHORS,GBM,JOURNAL,LN229,SULT1A1,SULT1C2,SULT4A1,SULTS,THEREFORE
200,233,500,ACCORDING,BACKGROUND,BERGONI,LABEL,LAW,RESULTS,TRIBONDEAU
ATG,BACKGROUND,BAX,BID,CAS,CASIOPEINA,FMK,GBM,III,JNK,LABEL,LC3,METHODS,RESULTS,ROS,THESE,VAD
ATLAS,CLASSICAL,GBM,LARGE,NF1,PRONEURAL,RESULTS,SUBTYPE
BACKGROUND,CXCR4,GBM,LABEL,MAPPING,MOLECULAR,PRINCIPAL,RESULTS,STROMAL,THESE
BLOOD,FIRST
384,AHR,FURTHER,PAH,THESE,USING
BACKGROUND,JANUARY,LABEL,LIBRARY,MAJOR,MANAGEMENT,SOCIETY,SUMMARY,SURGERY,THESE
177,198,295,AAS,CHANGES,CRT,CURRENTLY,III,RECURSIVE,RESULTS,SIXTY,TMZ
120,215,CSF,DEPOCYT,GRADE,LMD,THERE,TOXICITIES,TREATMENT
946,BMP7V,GBM,GSLCS,RECURRENCE,TGF
AMONG,BACKGROUND,BECAUSE,FIFTY,FSH,HOWEVER,IGF,LABEL,METHODS,RESULTS
DESPITE,PAPILLARY
008,010,013,177,ADC,BACKGROUND,COX,FDOPA,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PET,PURPOSE,RESTRICTED,RESULTS,THESE,TTP,TTS
BAHAWALPUR,CONCLUSION,FIFTY,GYS,INSTITUTE,JANUARY,KARNOFSKY,LABEL,METHODS,NUCLEAR,OBJECTIVE,PLACE,RESULTS,THERE,WHILE
131,169,AMONG,COPYRIGHT,DEPENDING,LABEL,MEIER,METHODS,MRI,NATURAL,OBJECTIVE,OBJECTIVES,PFS,RESULTS
169,CENTRAL,COPYRIGHT,FEW,LTD,MRI
006,043,178,BACKGROUND,EVALUATION,ITK,LABEL,METHODS,MRI,RESULTS,SEVENTY,SOLID,SRS,TUMOURS
100,169,AE1,AE3,BCL,CK7,CK8,CNS,HOWEVER,SOCIETY
120,169,III,INHIBITION,SIMILARLY,SIRT1,SIRTUIN,SOCIETY,UW228
ARF,CRE,GBM,GEM,INK4A,MRI,NTV,TMZ
102,AMONG,EFFORTS,ICAM1,PRE
949,A10,ALZHEIMER,FINALLY,PKC,PMA,THEREFORE,THESE,VHH
SEPARATING
LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOTAL
3T3,AFTER,APOPTOSIS,GREEK,HOWEVER,NIH,WHEREAS
MRI,NON,NSCLC,PET,SMALL
169,CONCLUSION,COPYRIGHT,GRADE,III,INC,LABEL,LACTATE,LCMODEL,MATERIALS,METHODS,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS,WILEY
CNS,MEDICAL,PHASE,UNIVERSITY
180,256,436,AFRICAN,BASIC,ELDORET,EVENTUALLY,EWING,HODGKIN,JANUARY,KENYA,LABEL,METHODS,MOI,NON,OBJECTIVE,RESULTS,SETTING,THERE,WESTERN
946,GROWING,SMAD4,TGF,TIAF1

100,AE1,AE3,AFP,BACKGROUND,CD133,CGA,CHOROID,CPC,EMA,LABEL,METHODS,R248Q
100,169,AMONG,COPYRIGHT,CTA,ESO,GBM,HOM,HOWEVER,LTD,MDA,MEL,MELAN,SCP,THESE,TRP
169,COPYRIGHT,EPIDERMOID,LTD,THESE
BACKGROUND,CONCLUSION,DESPITE,DIFFUSION,DTI,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS
169,COPYRIGHT,CROWN,DCA,HYBRIDARC,INC,MUS,PLANS,PUBLISHED
001,112,169,BACKGROUND,COPYRIGHT,CSF,DIAGNOSIS,FIFTY,KARNOFSKY,KPS,LABEL,METHODS,PROGNOSIS,PROGNOSTIC,PSS,RESULTS,SCALE,SCORING
946,AREAS,BACKGROUND,BRAIN,COVERED,CURRENT,GBM,IDO,LABEL,METHODS,OPINION,TGF,TREGS
947,HOWEVER,INSTEAD,IONPS,RESULTS,SINCE,WHILE
COX,FIRST,FRAMINGHAM,FUNCTIONAL,HEART,SNP
INHIBITION,TEN,THESE
CNS,DROSOPHILA,SLO,USHER,WHIRLIN
AFTER,MRI,WORLD
TTSME
4TH,BRAIN,CSF,FLAIR,MRI,REVERSIBLE,THESE,USUALLY
AFTER,BILATERAL,BRAIN,HOWEVER,MRI
916,947,BACKGROUND,BRAIN,BTSCS,CD133,CONCLUSION,LABEL,METHODS,NANOG,PCR,RESULTS,SRY,THEREFORE,THESE,U87MG,WST
169,2000S,528,696,ADMISSIONS,AMONG,BACKGROUND,CIS,CONCLUSION,COX,HRS,LABEL,METHODS,PATIENT,RESULTS,THESE,WHILE
CNS,CSF,MRI,OBESITY
3DCRT,BACKGROUND,COGNITIVE,CONCLUSION,CONFORMAL,CTCAE,FORTY,HGG,LABEL,MATERIALS,METHODS,MRI,RADIATION,RESULTS
126,252,ALZHEIMER,AVAILABLE,OCCURRENCE,STUDIES,THERE
169,COPYRIGHT,IRELAND,LTD
169,AFTER,COPYRIGHT,PUBLISHED
176,177,BACKGROUND,GTV,INTRA,LABEL,MATERIALS,METHODS,PATIENT,PRE,PTV,RESULTS,SIMULATION,THREE
FRESH,GBM,PCR
880,APOA1,HOWEVER,MEDIP,NDN,PEG,PWS,SNRPN,WILLI
091,100,CONCLUSION,ISM,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SURGERY
312,DESPITE,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,PRIOR,RESULTS,THERE,THREE
945,946,GBM,INCREASING
144,DYNAMIC,MET,PET,REGIONS,ROI,SUV,THERE,THESE
DCE,DSC,MRI,THESE
INHIBITION,KAZAL,MMP,VPA
103,125,AFTER,BETWEEN,IBT,NEITHER,SEPTEMBER
001,138,191,214,215,260,575,AFTER,BETWEEN,III,RPA,SRS
THEREFORE
160,EXPRESSION,GLIOMAS,GTPASES,LPA,RHO
FIFTY,MRI,SEVERAL,THERE,YET
100,132,172,236,267,274,HOWEVER,III,MUTATIONS,PFS,UNIVARIATE
11R,160,956,MTT,NLS,NSL,PTD,THESE
KNOWLEDGE
169,ACADEMY,ALLERGY,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,FIFTY,FURTHER,LABEL,LLC,METHODS,METICULOUS,RESULTS,RHINOLOGIC,SOCIETY,THESE
ICH,SHORT
GSC,HOWEVER,MICRORNAS,SEVERAL,TAKEN,TMZ,UTR
946,ALTOGETHER,THESE
BRAIN,DLBCL,EIGHT
19Q,THERE,THEREFORE
CPP
THESE
11Q13,ABOUT,AIP,ENDOCRINE,FURTHER,NEOPLASIA
160,BACKGROUND,DIAMETERS,FIFTEEN,LABEL,METHODS,MRI,PRL,RESULTS,THYROXINE,TSH
ACHIEVING,FURTHER
BACKGROUND,CONCLUSION,DTT,FINALLY,HOWEVER,LABEL,METHODS,RESULTS
6MO,AUTOLOGOUS,CONCLUSION,DENDRITIC,EORTC,EUDRACT,HGG,IIB,III,LABEL,METHODS,OBJECTIVE,OUTCOME,OVERALL,PFS,PURPOSE,RESULTS,RPA,THESE
215,ACUTE,GHENT,KARNOFSKY,KPS,MEIER,OVERALL,PATIENT,RATES,RPA,UNIVERSITY

AFTER,AUC,CAUCASIAN,HAN,LABEL,METHODS,OBJECTIVE,PATUPILONE,PHASE,PURPOSE,RESULTS
ASSESSMENT,BACKGROUND,BASED,CONCLUSION,GPA,HOWEVER,IDEALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPA,SRS
160,215,ACTUARIAL,BETWEEN,CONCLUSION,LABEL,MARCH,METHODS,MRI,OBJECTIVE,OCTOBER,PURPOSE,REPLACING,RESULTS,SALVAGE
001,160,DCA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRT
100,115,CONCLUSION,GIVEN,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
119,146,AMONG,INTERPHASE,LATS1,RT1
169,COPYRIGHT,COUPLED,PKA,PROTEIN,PUBLISHED,SAS
DNMTS,DRUGS,HDACS,STUDIES,SYNERGY,THESE
169,946,COPYRIGHT,EXPRESSION,GCV,HSV,INC,PCR,SUICIDE,TAKEN,TUNEL,U87,VPA
001,003,100,102,639,AUSTRALIA,CRC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SIX,THERE,USA,ZEALAND
ADAR2,GBM,GRADE,HOWEVER,THESE
ATP,DRAM1,GBM,HOWEVER,MET,TAKEN
000,100,1ST,698,BASED,CNS,DELHI,GLIOMAS,JANUARY,POPULATION
169,COPYRIGHT,EVALUATION,INC,WILEY
100,169,COPYRIGHT,IAP,LABEL,MEG,METHODS,OBJECTIVE,PARAMETERS,POWER,RESULTS
SINONASAL
CURRENT,THEREFORE,THESE,WORLD
HISTONE,THESE,VPA
021,024,075,083,169,186,477,CAD,CONCLUSION,COPYRIGHT,FPR,INC,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,PURPOSE,READING,RESULTS
169,COPYRIGHT,HOWEVER,LTD,LYMPHOMAS,MANAGEMENT,ORBITAL,PUBLISHED
001,169,231,233,956,AGE,BMI,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SEVENTY,SIXTY
169,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,SERAM
169,BACKGROUND,BASED,CONTEXT,COPYRIGHT,ENGLISH,INC,LABEL,METHODS,MPNST,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SETTING,SURGERY
169,ABC,ALS,ATP,CNS,COPYRIGHT,FINALLY,GIVEN,INC,TRANSPORT
947,ACTIVATION,BACKGROUND,CONCLUSION,ED1,ELISA,LABEL,METHODS,MICROGLIAL,RESULTS,RG2,TRAIL,TUNEL,WESTERN
000,001,006,023,169,194,568,AGE,BACKGROUND,COPYRIGHT,COX,FEW,INC,LABEL,MEIER,METHODS,OVERALL,PUBLISHED,RESULTS,SEX,THESE,USING,VPS
169,COPYRIGHT,SAS
169,177,COPYRIGHT,FORTY,GROSS,GTV,INC,LABEL,MATERIALS,MET,METHODS,MRI,OBJECTIVE,PET,PTV,PURPOSE,RESULTS,SRT
000,100,169,BELGIUM,COPYRIGHT,CROSS,FINLAND,PAS,SAS,STUDIES
169,COPYRIGHT,ENDOCRINE,INITIAL,METASTASIS,NEOPLASIA,PUBLISHED,SAS
BACKGROUND,BCL,BT325,ERK,LABEL,MCL,MEK,METHODS,MTT,RAF,RESULTS,SORAFENIB,VK1
001,119,126,169,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,MPS,OBJECTIVE,OBJECTIVES,RELEASE,RESULTS,SOCIETY,THROMBOSIS,VTE
169,ACCURATELY,BIOMETRIC,HOWEVER,RECURSIVE,REGRESSION,SOCIETY,THERE,TREES
CRITICALLY
AML,BAL,ESI,GMS,PCR,ULTIMATELY
VINCENT
016,061,068,095,150,178,200,AFTER,CONCLUSION,GBM,LABEL,MARCH,MAY,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
169,AFTER,BACKGROUND,COPYRIGHT,CRT,ESTIMATED,ESTIMATING,LABEL,LYL,METHODS,RADIATION,RESULTS,SOCIETY
008,112,169,26981,500,APPROACHES,BACKGROUND,BRAIN,CONSORTIUM,COPYRIGHT,EORTC,LABEL,METHODS,NABTT,RESULTS,SOCIETY,THERAPY,TREATMENT
008,009,056,169,337,828,AMONG,BACKGROUND,BASEL,CARDIAC,COPYRIGHT,GENERAL,HOWEVER,JANUARY,LABEL,MARCH,METHODS,RESULTS,THERE
BACKGROUND,CONCLUSION,FIBER,GLIOMAS,ICR,III,LABEL,METABOLITE,METHODS,OBJECTIVE,RESULTS,STRUCTURAL
100,169,265,437,BACKGROUND,COPYRIGHT,III,KARNOFSKY,LABEL,METHODS,RESULTS,RPA,SOCIETY
169,177,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIB,TREATMENT,WBI
001,169,269,ASSESSMENT,CIS,COPYRIGHT,DIAGNOSIS,GAMMA,GPA,GPS,HOWEVER,III,INC,KARNOFSKY,KNIFE,LABEL,MATERIALS,MEIER,METHODS,MST,NBC,OBJECTIVE,PROGNOSTIC,PURPOSE,RECURSIVE,RESULTS,RPA,THERE
169,CONCLUSION,COPYRIGHT,CRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
169,COPYRIGHT,HOWEVER,LTD,WHILE,WORLD
100,169,AMONG,COPYRIGHT,DIFFERENT,EFFORTS,HOWEVER,OVERALL
169,COPYRIGHT,FIFTY,FORTY,GROUP,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SIX,SIXTY,THERAPY
169,241,AEG,COPYRIGHT,JEGHERS,LYNCH,PEUTZ,STK11
MOTOR,PARESIS,SIXTEEN,THERE
CRANIAL,HOARSENESS,MECHANICAL,XTH
18F,GERSTMANN,KARNOFSKY
HOWEVER,ROC,THESE
029,3RD,429,AUTHORS,BACKGROUND,BASED,CENTRAL,COLLECTION,FISCHER,HOWEVER,ISSUE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCT,RADICAL,RANDOMISED,RCT,RESULTS,SELECTION,SINCE,THERE
00001,835,ADVERSE,AUTHORS,BACKGROUND,BASED,BRAIN,CENTRAL,COLLECTION,CONTROLLED,EIGHT,ISSUE,KARNOFSKY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PRESENTING,RANDOMIZED,RCT,RESULTS,SELECTION,THESE
BACKGROUND,BROCA,CAVERNOMAS,CONCLUSION,DIFFUSION,FIBER,FURTHER,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
143,379,437,ADDITIONAL,ADMISSION,CAESAREAN,CNS,INPATIENT,MALIGNANT,NATIONWIDE,NIS
PAT
231BR,945,946,FINALLY,GEF,HEPARANASE,THESE,THIRD,TREATMENT,VCAM1
169,ADC,AUR,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THERE,USING
AMONG,BACKGROUND,CONCLUSION,DUE,GRADE,GROSS,HOWEVER,KNOWLEDGE,LABEL,METHODS,MRI,RESULTS,ROSETTE
THROUGH
FINDING,RB1
004,014,016,102,103,239,334,BACKGROUND,CLINICALLY,DAS,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
AKT,CONVERSELY,NIBAN
169,231,947,BACKGROUND,BRAIN,COPYRIGHT,EGF,HOWEVER,IMMUNOBLOT,LABEL,MDA,METHODS,MTT,RESULTS,SOCIETY
LOCAL,NON,NSCLC
169,COPYRIGHT
169,CNS,COPYRIGHT,HODGKIN,IMPORTANT,LTD,PRIMARY
800,INSTITUTE,NOW,POPULATION
232,233,234,THOSE
169,ANZ,AUTHORS,COLLEGE,HOWEVER,INITIALLY,JOURNAL,ROYAL,SKULL,SURGERY
FURTHER,MAB,PEX14,PRESENTED,PROTEIN
945,946,PDGFR,PDGFS
BATTERY,COGNITIVE,COMPOSITE,CONTROLLED,COX,DIGIT,EXECUTIVE,GROUP,HOPKINS,IMPAIRMENT,KPS,MEIER,RADIATION,RATES,RECURSIVE,REVISED,RPA,THERAPY,TOTAL,TRAIL,TRIAL
EXTENSIVE,THESE
169,177,ADJUSTMENT,BASED,BIVARIATE,COPYRIGHT,HYPOTHESIS,INC,INSTRUMENT,LABEL,MEN,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PEARSON,RESULTS,SOCIETY
169,515,BACKGROUND,BASEL,BNI,CONCLUSION,COPYRIGHT,III,INSTITUTE,LABEL,LITERATURE,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,UNIVERSITY
150,169,177,252,AMONG,BACKGROUND,BASED,BASEL,CONCLUSION,COPYRIGHT,GIGANTISM,LABEL,METHODS,OBJECTIVE,REDUCTION,RESULTS,SOTOS
100,A138V,ASIAN,BACKGROUND,BRCA1,BRCA2,CLINICALLY,E285K,E346X,HOWEVER,LABEL,LFL,LFS,LOH,MEDICAL,METHODS,NOTABLY,RESULTS,UNIVERSITY
DECISIONS
169,COPYRIGHT,CRANIAL,FDA,FURTHER,HENCE,IRELAND,LTD,THESE
169,AMERICA,ANZ,COLLEGE,CUSHING,GALLIPOLI,JOURNAL,LEONARD,NORTH,ROYAL,SURGERY,USA
DIFFERENT,PAEDIATRIC,THESE
181,EXTENSIVE,GBM,HENCE,INHIBITORS,PTP,WHILE
164,214,947,956,960,AIR,CONCLUSION,DIXON,LABEL,METHODS,MRI,PET,PREDEFINED,RESULTS,ULTRASHORT,UNLABELLED,USING,UTE,UTILE
017,042,118,COX,PFS,SEVERAL,THESE,USING
169,291,AIC,BECAUSE,COPYRIGHT,INC,MRI,ROI,SEVERAL,STRUCTURAL,VBM,WILEY
252,BRAIN,DIFFUSE,FURTHER,MENINGEAL,NON,PERIPHERAL
CURRENT,MPR,RAMAN
160,492,956,HODGKIN,PRACTICAL,THYROID,WILMS
169,COPYRIGHT,INC,SURGERY,THESE
169,ALZHEIMER,AQP11,COPYRIGHT,HIV,LTD,WCP
169,ALZHEIMER,COPYRIGHT,CROWN,FHH,FOLLOWING,INC,PUBLISHED,SINCE
100,101,169,CBV,COPYRIGHT,ICA,PCA,PCC,PEARSON,PUBLISHED,SVM
169,ALANINE,AUR,BESIDES,CENTRAL,CNC,CONSISTENT,COPYRIGHT,INC,INTERFACE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESONANCE,RESULTS
169,BESIDES,COPYRIGHT,FINALLY,MEDICAL,PROLONGED,SAS
169,CLINICALLY,COPYRIGHT,MUTATIONS,PRKAR1A,SAS
001,002,004,006,007,016,041,124,169,179,COPYRIGHT,COX,FORTY,INC,JANUARY,KARNOFSKY,KPS,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
001,012,030,132,140,169,172,COPYRIGHT,HOWEVER,INC,ISOCITRATE,R132C,R132G,R132L,R132S,R172G,R172K,R172M,SOMATIC
128,135,152,164,177,182,BECAUSE,FURTHER,LABEL,METHODS,MRI,NF2,OBJECTIVE,OVERALL,RESULTS,SEVENTEEN,VSS
013,046,BASED,GBM,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
106,108,120,129,169,260,431,CONCLUSION,COPYRIGHT,GROUP,III,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
CONCLUSION,FIXED,GSTM1,GSTT1,LABEL,METHODS,MOLECULAR,OBJECTIVE,RESULTS,SIMILAR,THESE
008,061,129,246,611,653,724,901,963,967,BETWEEN,CIS,CRUDE,GST,GSTM1,GSTP1,GSTT1,ILE105VAL,LABEL,MEDLINE,METHODS,OBJECTIVE,ORS,OVERALL,RESULTS
169,CNS,COPYRIGHT,DAD,FDA,HCL,USING
003,169,967,BONFERRONI,COPYRIGHT,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS
DESPITE,PCI
001,151,COX,HOWEVER,KPS,PCR,WESTERN
567,BACKGROUND,ENE,FISCH,IVA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
954,AKT,CNS,HOWEVER,PIKES,SINCE
169,183,BECAUSE,C57BL,GEORG,OIL,STUTTGART,THESE
FETAL,LITERATURE,PALLISTER,PHS
002,041,169,AMMAN,AMONG,AUSTRALIAN,AUTHORS,COLLEGE,CONCLUSION,GBM,HUSSEIN,IMAGING,JOURNAL,LABEL,MANAGEMENT,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RADIATION,RECORDS,RESULTS,ROYAL,SEPTEMBER,SEVENTY,ZEALAND
BRAIN,CLINICALLY,GOVERNMENT,MRI,PUBLISHED,USA
169,CHANGES,COPYRIGHT,INC,INI,WORLD
169,4TH,COPYRIGHT,DIAGNOSIS,MANAGEMENT,PRIMARY,SAS
CARDIAC,THESE,TSC
CHESTER,CHRISTIAN,DURAL,ECD,ERDHEIM,LANGERHANS,WEBER
ACCORDING,THESE
CPP
169,AGAINST,AUTHORS,BRAIN,DESPITE,FCD,FINALLY,HOWEVER,LEATS,PATHOLOGY,PREDICTING,SOCIETY
115,134,169,239,493,945,AFTER,AIM,ANTIVIRAL,BACKGROUND,BLACKWELL,CHILD,CONTROL,ETV,FOUNDATION,HBV,HCC,HEPATOLOGY,III,JANUARY,JOURNAL,KOREA,LABEL,LAM,LTD,METASTASES,METHODS,NODES,OBJECTIVE,PTY,PUBLISHING,RESULTS,SEPTEMBER,SIXTY,TNM,TREATMENT,UNION
APOPTOSIS,BACKGROUND,BECLIN1,LABEL,PRINCIPAL,RESULTS,TMZ
946,AMP,ATP,EVIDENTLY,HK2,IRS,JCV,ROS,THESE
13R,CTL,MCP,THESE
001,128,AIM,LABEL,METHODS,MPG,OBJECTIVE,PCR,RESULTS,WESTERN
169,945,946,BRAIN,CATHEPSIN,CD151,FAK,INC,SRC,STUDIES,TAKEN,TREATMENT,WILEY
BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
APRIL,BACKGROUND,EIGHT,III,LABEL,LAPATINIB,METHODS,OBJECTIVE,PARTIAL,RESULTS,WOMEN
DEFINITIVE,STILL
169,CARLO,COPYRIGHT,FITTING,GBM,HOWEVER,LTD,MONTE,WILEY,YKL
100,177,181,CXC,THEIR
036,038,052,084,FORTY,GBM,GROUP,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCORE,THERE
11M1C,3512676,947,CD8,EIGHT,EVALUATION,INTERFERON,JOINT,SOLID,THERE,USING
LOCAL
AREAS,BACKGROUND,BLOOD,CBV,DIFFERENT,LABEL,METHODS,MRI,PCT,PERFUSION,RESULTS,SIXTEEN,THESE,TOMOGRAPHY
001,031,039,082,102,140,174,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE
169,COPYRIGHT,FINALLY,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SRS,THESE,THREE
AHS,THESE
215,ATLAS,EMT,GBM,SNAI2,THESE
BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS,U87,VZV
105,253,AML,BAALC,HOWEVER,RUNX1,SNP
10B,118,200,CSF,MACHINE,MEMBERS,PCR,SUPPORT
840,AGREEMENT,ASSESSMENT,EVALUATION,FLAIR,INTRA,MACDONALD,NEURO,SEVENTY,SOLID,THERE,WHETHER
000,001,102,132,961,III,PCR,PWI,TESLA,THESE
528,CSF,DDAH1,DETECTION,DIFFUSE,LTQ,PROTEIN,SEQUEST,SUITE,WESTERN
ACCORDING,CD105,III,IMAGING
198,HOWEVER,THESE,V600E
001,169,BACKGROUND,CHECKLIST,CHILD,COPYRIGHT,EFFECTIVE,INC,LABEL,METHODS,PROCEDURES,RESULTS,THESE,WILEY
169,APRIL,BACKGROUND,BAY,COPYRIGHT,FRANCISCO,HOUSTON,LABEL,MAY,METHODS,NORTH,REGARDLESS,RESULTS,SAN,SOCIETY,TEXAS
100,CONCLUSION,CSF,LABEL,METHODS,NASOSEPTAL,NORTH,OBJECTIVE,RESULTS,SETTING,SINCE,SIX,UNIVERSITY
100,239,ADDITIONAL,DETECTABLE,III,MRI,PRE,THERAPIES
FACTORS,SRS,TREATED
262,LABEL,METHODS,MMP,OBJECTIVE,RESULTS,SIXTY,THERE
23B,342,402,432,493,528,664,ACCORDING,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS
169,COPYRIGHT,FURTHER,INC,OVERALL
169,ASSOCIATED,COPYRIGHT,INC,MOLECULAR,PEDIATRIC,THESE
181,AFTER,GENERAL,LABEL,LVEDD,LVPWT,METHODS,OBJECTIVE,PLA,RESECTION,RESULTS
CONCLUSION,FSH,LABEL,METHODS,OBJECTIVE,PRL,RESULTS
AFTER,LABEL,MARCH,METHODS,OBJECTIVE,OPERATIVE,RESULTS
004,005,048,068,085,100,341,CHI,COX,CXC,CXCR4,DFS,INSTITUTE,JANUARY,LABEL,MEDICAL,MEIER,METHODS,MMP,OBJECTIVE,OCTOBER,RESULTS,TIANJIN,UNIVARIATE,UNIVERSITY
003,012,027,034,037,044,123,161,250,479,612,859,967,CONCLUSION,DCR,EASTERN,GROUP,III,JANUARY,LABEL,METHODS,NON,NSCLC,OBJECTIVE,ORR,REGARDING,RESULTS,XINQIAO
APY,EPH,EPHA4,ISOTHERMAL,KYL,NMR,VTM
BRAIN,EPIRUBICIN,GASTRIC,MRI,PET
GBM,NDRG4,PCR,SCHILLING,THESE,WESTERN
169,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FOCAL,INC,LABEL,LASER,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,UNDER,WILEY
160,ASA,HOWEVER,REGARDING,THESE,TNS
205,300,468,BETULINIC,CHINA,DSL,GSL,LEA,LEX,MCF,MDA,NAC,NEURAMINIC,ROSEMAN,TAMOXIFEN,THESE,UNDER
299,CNS,HOWEVER,LABEL,MEIER,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,STAGE,STAT3
001,002,005,169,328,ANXIETY,BACKGROUND,BARTHEL,BASEL,COPYRIGHT,DEPARTMENT,DEPRESSION,FATIGUE,FSS,HAUKELAND,INDEX,LABEL,METHODS,NEUROLOGY,PRIOR,RESULTS,SCALE,SYMPTOM,UNIVERSITY,VAS,WHEREAS
100,169,C57BL,COPYRIGHT,INC,NATURALLY,THESE,WILEY
CONCLUSION,IHC,LABEL,METHODS,MTT,OBJECTIVE,RAS,RESULTS,WESTERN
ADC,DWI,SOUNDNESS,SYSTEMATIC
956,CELLS,PAC,THESE
121,166,457,BACKGROUND,LABEL,METHODS,RESULTS,THESE
623,690,840,CD127,CD3,CD4,CD8,COX,DENDRITIC,FINALLY,LABEL,METHODS,OBJECTIVE,PBL,PHASE,PRE,PURPOSE,RESULTS
METASTASIS,SIX
003,004,006,013,038,160,409,LRIG1,LRIG2,LRIG3,NUCLEAR
BACKGROUND,BORRU,CONCLUSION,DR177,FANCONI,GSC,LABEL,METHODS,RESULTS
180,244,869,ADVERSE,CNS,DIAGNOSIS,DISCUSSION,LABEL,LIPOSOMAL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SPANISH,THERE
946,ATP,BACKGROUND,BLOOD,FIFTY,HOWEVER,LABEL,METHODS,NICORANDIL,NSE,RESULTS,SERUM,STATE,THEREFORE
169,BAX,COPYRIGHT,IRELAND,LTD,MFN,T109A,THESE
160,III,MIB,P53,THERE
MYC,NOTABLY
169,COPYRIGHT,MICRORNAS,THESE
169,945,COPYRIGHT,GMO,HOWEVER,INC,LTD,MATERIALIA,MDR,NPS,PUBLISHED
001,002,009,013,021,169,BACKGROUND,COPYRIGHT,FEW,GBM,GKS,INC,LABEL,METHODS,RESULTS,THESE
169,ADULT,CALIFORNIA,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,SCHEDULED,STATE
111,169,306,BACKGROUND,BETWEEN,COPYRIGHT,FACTORS,GKS,INC,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,RESULTS,RPA,SIXTY,UNIVERSITY
169,64257,COPYRIGHT,DGDPT,DOX,HAIYPRH,LTD,PEPTIDE,U87
169,ASTNP,BBB,COPYRIGHT,LTD,TGN
169,COPYRIGHT,ELISA,INC,THESE,TUSZYNSKI,USING
169,177,COPYRIGHT,FET,FLT,HGG,INC,LABEL,LGG,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TNR
100,150,160,169,200,ADVERSE,CONCLUSION,CONCURRENT,COPYRIGHT,GBM,INC,KARNOFSKY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,TMZ,TOXICITIES
106,169,191,883,COPYRIGHT,IGF,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WITHOUT
169,945,954,AKT,COPYRIGHT,COX,CROWN,CURCUMA,DDP,EASTERN,EXPRESSION,HIF,PCR,PUBLISHED,RESULTS,SEVERAL,STAT3,WESTERN
169,COPYRIGHT,INC,PRIMARY
169,CHILD,COPYRIGHT,MRI,NEUROLOGY,POSTMORTEM,PUBLISHED,SOCIETY
ARACHNOID,UNCAL
169,COPYRIGHT,LTD,MRI,SINCE
169,COPYRIGHT,INC
296,BACKGROUND,CENTRES,EXCELLENCE,INSTITUTE,KINGDOM,LABEL,MDT,METHODS,RESULTS,TA121,THEIR,THERE
215,AVERAGE,CONCLUSION,CSF,FOLEY,LABEL,MATERIALS,METHODS,MRI,NASAL,OBJECTIVE,RESULTS,SIX,THERE,TUBERCULUM
162,237,453,CIGARETTE,COX,CURRENT,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,USING
001,114,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
100,120,CAP,CARLO,COMMISSION,DLP,FIRST,LABEL,METHODS,MONTE,OBJECTIVE,ORGAN,PROTECTION,PURPOSE,RESULTS,SENSATION,SIEMENS,THIRD,USING
001,99M,AFTER,BACKGROUND,METHODS,OBJECTIVE,RESULTS,SPECT,THERE,TII,TSI
177,AFTER,BASED,CHK,CYTOMETRY,THESE
006,008,037,042,196,250,61A,BRAZILIAN,CONCLUSION,EGF,FUNCTIONAL,INCREASED,LABEL,MALIGNANT,METHODS,OBJECTIVE,PCR,PHASE,PURPOSE,RESULTS
001,063,102,110,116,136,177,183,216,329,381,387,528,BACKGROUND,EIGHT,HOWEVER,LABEL,METHODS,PCH,PULMONARY,RESULTS,THERE
177,956
169,COPYRIGHT,GAMMA,INC,INITIAL,KNIFE,LABEL,MALIGNANT,METHODS,MIB,OBJECTIVE,RESULTS
000,100,169,251,CNS,COPYRIGHT,CREOLES,INC,INSURANCE,LABEL,METHODS,OBJECTIVE,PARAMARIBO,RESULTS,STATE,THERE
169,AFTER,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
169,COLLEGE,COPYRIGHT,EXTRA,FOLLICULAR,LTD,PUBLISHED,ROYAL
34A,ATLAS,FINALLY,FURTHER,GBM,MICRORNAS,SIMILARLY,TAKEN,USING
HOWEVER
001,032,041,COX,DFS,KALLIKREIN,MEIER
104,129,157,556,558,593,604,ANGEL,BIOCHIM,BIOPHYS,BUSSOLINO,CICHOWSKI,CNS,FASEB,FOS,GIL,JACKS,KARIN,MOL,NPCIS,PNS,SILVESTRE,THESE,TREATMENT
946,ADP,ATP,EXCESSIVE,INCREASED,NAD,PARPS,THEREFORE
CNS,EBV,PCNSL,PRIMARY,THERE
FOURIER,FRESHLY,PAS
160,CNS,HISTOLOGY,THERE
ACUTE,CNS,MRI,THERAPY
ATOH1,CEREBELLAR,CNS,FABP4,NEUROG1,THESE
111,131,873,FDG,MRI,PET,SURGERY
169,174,308,511,ADT,BACKGROUND,COPYRIGHT,FATIGUE,IL6,INC,LABEL,METHODS,RESULTS,THESE
57RGD,IMPORTANT,RGD,TAT49,THEREFORE
LOW,MANAGEMENT,NOVEL,VTE
169,244,BURKITT,COPYRIGHT,EGYPT,HIV,HODGKIN,III,INC,NIGERIA,PEDIATRIC,PUBLISHED,SAHARAN,SHARPENING,SOUTH,SUDAN,THREE,THROUGHOUT
ANESTHESIA,AWAKE
DCS,DESPITE,GBM,GIVEN,PARTICULAR,TREATMENT
004,169,BETWEEN,COPYRIGHT,EVENT,FOLLOWING,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SCALE,WILEY
104,120,177,AFTER,BACKGROUND,EFS,HCT,LABEL,METHODS,MTX,PCNSL,RESULTS,SEQUENTIAL
169,183,BRAIN,FEW,GEORG,HOWEVER,SIMILARLY,STUTTGART,THESE
945,FGF,HOWEVER,IGF,LIF,OTHER,PGC,STUDIES
532,GBM,THESE,TMZ
000,ADP,AIF,FINALLY,GBM,HODGKIN,MICROARRAY,OVERALL,WORLD
SYLVIAN,TUMORAL
001,002,004,005,027,038,263,945,BACKGROUND,CONCLUSION,HIF,LABEL,METHODS,MIB,MVD,OBJECTIVE,PFS,RECURRENCE,RESULTS,SHORTER,USING
169,945,946,BRG,CONCLUSION,EBRGS,ENHANCING,FLAIR,LABEL,METHODS,MICROARRAY,MRI,NBRGS,OBJECTIVE,PDGFR,PRIMARY,PURPOSE,RESULTS,THESE,USING
115,215,232,314,315,619,635,749,ADULT,ATLAS,CAUCASIAN,CONCLUSION,COX,EXPRESSION,FRANCISCO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAN,SNP,SSBP2,USING
945,946,947,948,OTHER,PPARS,THESE,THREE,TZD,WHILE
240,BACKGROUND,DISCUSSION,HIT,LABEL,METHODS,PET,TOMOGRAPHY,TRIAL
169,AUS,AUSTRALIAN,BLACKWELL,CBT,CDS,COLLECTION,CONTROL,DISTRICTS,LTD,PUBLISHING,SES,STATISTICS,THESE
BASED,BRAIN,ENDOSCOPIC,HISTOLOGY,MRI,PERIMETRY,PREVIOUSLY
EEA
195,942,APPARENTLY,AVERAGE,CITATIONS,DIFFERENT
155,340,947,MALIGNANT
DEPLETION,FINALLY,GBM,MER,MERTK
945,954,BV6,IAP,INHIBITOR,KNOCKDOWN,TMZ,TNF,TNFR1,TRAIL
112,115,BACKGROUND,BETWEEN,CONCLUSION,CONTINUOUS,DESPITE,HOWEVER,IOM,LABEL,MEP,METHODS,OBJECTIVE,RESECTION,RESULTS
007,169,626,ADULT,COPYRIGHT,ENGEL,III,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,WORLD
169,COPYRIGHT,GERIATRIC,LTD,MANAGEMENT,SOCIETY
D90,D95,RECURRENT,THESE,TREATMENT
CNS,PCNST,PRIMARY,SINCE,SNP,THESE
169,BACKGROUND,CONCLUSION,CSF,EXTENSIVE,FIRST,INC,LABEL,MEDICAL,METHODS,MRI,OPENING,PUBLISHERS,RESULTS
034,169,174,192,BACKGROUND,CONCLUSION,COX,INC,LABEL,MEDICAL,METHODS,OVERALL,PATIENT,PUBLISHERS,RESULTS,TRONDHEIM
000,125,940,GBM,KARNOFSKY,MRI,PREVIOUSLY
CNS,HUNDRED,PRIMARY,THERE
209,COMPARABLE,GPA,HOWEVER,RPA,THEREFORE,WHILE
CNS,HOWEVER,TISSUES
ISOCITRATE,PAPILLARY,SEVERAL
MENINGEAL
169,485,547,603,606,623,783,808,848,BACKGROUND,CALCULATED,CNS,CONCLUSION,COPYRIGHT,FIRST,INC,LABEL,MATERIALS,METHODS,MVD,RESULTS,THESE,TVA,TVCSA,VARIOUS
169,BMM,COPYRIGHT,DIFFERENT,NILERED,PCR
169,AFTER,CHOROID,CNS,CONGENITAL,COPYRIGHT,GIVEN,LTD,OTHER,TERATOMAS
123,169,200,COPYRIGHT,MTT,SLN,THESE,U87
169,954,AKT,COPYRIGHT,CRT,FURTHER,HOWEVER,LTD,MANGIFERIN,MAP,MMP,PMA,U87MG
169,COPYRIGHT,PUBLISHED,SAS
169,337,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,PREVENTION,PUBLISHED,RESULTS,SAS,TEN,THREE
169,CNS,COPYRIGHT,HIV,INDIA,ITP,LABEL,METHODS,OBJECTIVE,RESULTS
10878,169,300,AGE,BACKGROUND,BRAIN,COPYRIGHT,EORTC,GBM,GROUP,LABEL,LTD,METHODS,PFS,PROGNOSTIC,RESULTS,TREATMENT,TUMOURS,WORLD
169,954,COPYRIGHT,INC
FURTHER,HODGKIN,PRIMARY
105,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SRS
169,ALZHEIMER,AMONG,AUTHORS,BLACKWELL,BRAIN,FRAGILE,FXTAS,LTD,PUBLISHING,SOCIETY
INHIBITING,NMT,TARGETING
BESIDES,HOWEVER,POLYSIA,POLYSIALIC,PST,SELECTIVE,STX
642,670,710,AFTER,BRAIN,MULTIMODAL
ANGPTL4
ARISING,MONRO,SEGAS,TSC
103,157,339,496,560,AFTER,COLLECTED,CTG,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SEGAS,SEVEN,TESLA,THEIR,TSC
DESPITE,HOWEVER
BLEOMYCIN,CRP,HOWEVER,ICB,LEAKAGE
THESE,YET
BECAUSE,CD117,CEA,CHEST,CK7,EMA,ESA,FIG,VIMENTINA
114,BACKGROUND,BNP,CHF,LABEL,METHODS,PRIMARY,RESULTS,THERE
100,184,CUSHING,EVALUATION,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS
GBM,OVERALL
DXR,GBM,IMIPRAMINE,NADPH,RT2
169,1P19Q,205,ATPASES,BECAUSE,C6BU1,COPYRIGHT,III,INC,WILEY

ARTICLE,INSTITUTE
KEY,SCHEDULED
176,ADULT,BACKGROUND,CLINICALLY,COX,DESPITE,END,FORTY,LABEL,MEIER,METHODS,PATIENT,PBL,RESULTS,SIXTY,UNIVARIATE,USING
177,BACKGROUND,COX,EXPRESSION,HIGHEST,IQR,LABEL,METHODS,RESULTS
106,388,BRAIN,CNS,CONCLUSION,DISABILITY,ELISA,HOWEVER,LABEL,METHODS,NMO,OBJECTIVE,OBJECTIVES,RESULTS,SCALE
169,600,BRAIN,COPYRIGHT,FURTHER,FVF,GVF,HOWEVER,INC,INTENSITY,LEVEL,MAC,REMARKABLE,THEREFORE
AML,MDS,TREATMENT
FDR,III,SHH,SUBSEQUENT,WNT
169,COLLEGE,COPYRIGHT,LTD,PRIMARY,PROMISING,PUBLISHED,QUALITY,ROYAL
169,BECAUSE,CNS,MIB,NUCLEAR,PPT,PPTID,SOCIETY,TMZ
106,215,AMD,ASIAN,CSF,CXCR4,HOWEVER,PERIPHERAL
388,DT388,HCDR3,LCDR1,RAJICELLS,SEVERAL,U87
001,177,GHD,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THEREFORE
ALZHEIMER,AMONG,PARKINSON,TYPES
160,545,771,904,COX,LABEL,METHODS,NIH,OBJECTIVE,PURPOSE,RESULTS
169,183,AFTER,BACKGROUND,BETWEEN,BRAIN,BRISTOL,COPYRIGHT,FUNDING,IPILIMUMAB,LABEL,LTD,METHODS,MYERS,RESULTS
BBB,FULLERENE,FULLERENES,HIV,WATER
169,BER,SOCIETY
BBB,CNS,HOWEVER
946,FINALLY
019,024,041,043,155,945,AKT,BACKGROUND,CONCLUSION,COX,IGF1R,LABEL,METHODS,PFS,RESULTS
BACKGROUND,C81,CONCLUSION,CPG,INHIBITION,LABEL,METHODS,NOVEL,PCR,PRIMARY,RELAPSE,RESULTS,SKMEL23
EXTENSIVE,FINALLY,WNT
THERE
001,230,CIN,HEPARANASE,HPSE2,IMAGE,LAB,LABEL,MATERIALS,METHODS,OBJECTIVE,THERE
AFTER,AGGRESSIVE,BECAUSE,HOWEVER,MRI
BRAIN

001,029,169,177,193,588,956,AFTER,CREATININE,IGF,JOURNAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEM,SOLUBLE
946,DEPLETION,DROSOPHILA,HOWEVER,MGR,MUTATIONS,PREFOLDIN,THESE,VHL
000,215,EARLIER,EARLY,METASTASES,METASTASIS,MRI
152,292,CONCLUSION,INSURANCE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,TAIWANESE
CERTAIN,SMALL,THESE
BRAIN,HENCE
AFTER,CONCLUSION,LABEL,MA2,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SEIZURE,SETTING
160,169,183,GEORG,PRIMARY,STUTTGART
CNS,DLBCL,FDG,MRI,PET,SEPTEMBER
BASED,MOTOR
CUSHING
169,956,COMPOUNDS,COPYRIGHT,MTT,NMR,SCHRENK,THEIR
ADC,DIFFUSION,DWI,EPI,HOWEVER,MRI,THEREFORE
183,ALA,CONCLUSION,FET,GBM,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,TEN,THESE
200,GAMMA,KNIFE,LEKSELL,SINCE,TODAY
GBM
22RV1,CADMIUM,CELLS,CWR,DU145,LNCAP
ABOUT
169,945,BNIP3,HIF,HOWEVER,HYPOXIA
ACCURATELY,CNS,GLIOMAS,MEG,MRI,THESE
103,169,233,418,COPYRIGHT,HGF,HISTIDINE,HOWEVER,INC,MET,WILEY
ALTERED,RINGO
ATM,GBM,HENCE,SER15,SUCCESS
169,BRAIN,COPYRIGHT
100,CASES,CCRCC,CNS,HBL,VON
104,64257,654,ASLNC2081,ASLNC20819,ASLNC22381,GBM,IGF,THESE
AVAILABLE,DAT,DEFORMABLE,LABEL,METHODS,OBJECTIVE,RESULTS
169,400,460,5MG,600,956,ADA,AFTER,APO,CD95L,COPYRIGHT,FAS,OVERALL,THESE
166,169,COPYRIGHT,INC,WORLD
169,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN
150,160,CHO,DIPGS,INC,LABEL,MATERIALS,MAXIMUM,METABOLITE,METHODS,MRS,NAA,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SVS,TECHNICAL,UTILITY
132,169,COPYRIGHT,DIANOVA,EXPRESSION,GERMANY,HAMBURG,III,INC,KNOWN,MUTATIONS,R132H,THREE,WORLD
169,946,ACTIVATION,COPYRIGHT,H60,MHC,NKG2D
013,022,029,169,ADVERSE,CONCLUSION,COPYRIGHT,INC,KAPLAIN,KARNOFSKY,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,SURGERY
169,CLASS,COPYRIGHT,GAMMA,GBM,GRADE,GROUP,INC,KNIFE,LABEL,MATERIALS,METHODS,MRS,OBJECTIVE,PHASE,PURPOSE,RADIATION,RESULTS,RPA,SRS,THERAPY,THESE,TREATMENT
169,ALS,BINDING,C9ORF72,COPYRIGHT,FUS,HENCE,ISSUE,SPECIAL,TDP,THESE,TLS
FLAIR,HOWEVER,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,TAKEN
006,016,121,BMI,CSF,HOWEVER,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS
EVALUATION,FATHERS
169,AUTHORS,BLACKWELL,FOUNDATION,ILLNESS,LTD,PUBLISHING,RESISTING,SOCIOLOGY
HOWEVER,RESULTS,SURVIVORS,THESE
COLLECTION,GAS,LABORATORY,LOUIS,MINUTES,POSTMORTEM,SAINT,SPECIMENS,THESE,TOXICOLOGY,UNIVERSITY
270,548,AFTER,BACKGROUND,CONTEXT,ECTOPIC,IGF,LABEL,METHODS,OUTCOME,RESULTS,SETTING
00062,011,015,031,033,069,088,100,110,150,966,BACKGROUND,DCE,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VIF,_SI
140,BASED,CENTRAL,CNS,EGGER,ENGLISH,FURTHER,HOWEVER,MAY,SRS,THERE
015,042,134,BACKGROUND,CLASS,IRRADIATED,LABEL,MATERIALS,METHODS,MST,OBJECTIVE,PURPOSE,RESULTS,RPA,THESE,UNIVARIATE,WHETHER
169,183,BARTH,GEORG,HOWEVER,STUTTGART
022,042,AMONG,GBM,MIB,RECURRENT
AMERICA,BRAIN,CNS,NORTH,PROTECTIVE,THEREFORE
CLEAR,LABEL,MARCH,METHODS,OBJECTIVE,RCC,RESULTS,SIX
945,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TSH
169,COPYRIGHT,EMT,HOWEVER,MET
169,194,COPYRIGHT,INC
169,194,AVASTIN,COPYRIGHT,DESPITE,HOWEVER,INC
169,194,BECAUSE,COPYRIGHT,INC,THERE
169,194,COPYRIGHT,INC,YET
INC,IRINOTECAN,NOW,PUBLISHED
169,194,COPYRIGHT,GLIADEL,HOWEVER,III,INC,PHASE
100,169,194,COPYRIGHT,INC,MRI,NOVEL,PUBLISHED,THERE
INC,PUBLISHED
DESPITE,HOWEVER,INC,PUBLISHED,STUDIES
169,194,COPYRIGHT,INC
169,194,COPYRIGHT,III,INC
169,194,COPYRIGHT,HGG,INC,SEIZURE
169,194,COPYRIGHT,INC,SURGERY
169,194,COPYRIGHT,INC,WHERE
169,194,COPYRIGHT,INC,SUCCESSFUL
039,169,250,265,300,492,AFTER,ANOVA,BACKGROUND,BNP,BUN,COLLEGE,COPYRIGHT,DESPITE,FLUID,INC,LABEL,METHODS,POD,PUBLISHED,RESULTS
122,169,177,AMONG,COPYRIGHT,EIGHT,IAC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
AREAS,BACKGROUND,COVERED,FINALLY,LABEL,LIPID,LNP,METHODS,OPINION
001,671,CONCLUSION,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PATIENT,PROVINCIAL,RESULTS,SCNEC,THERE
364,967,CONCLUSION,IMAGING,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RADIOLOGIC,RESULTS
109,169,BRAIN,COPYRIGHT,INC,MRI,THEREFORE,WILEY
169,381,BRAIN,COPYRIGHT,INC,MRI,THEREFORE,WILEY
169,COPYRIGHT,HPA,LABEL,LTD,MECHANISMS,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,THERE,THEREFORE,WILEY,WOMEN
169,246,COPYRIGHT,INC,MRI,ROI,VBM,WILEY
BASED,CXC,HOWEVER
AFTER,APART,DUE
EIGHT,LOCAL,SEVEN,SRS
ANOTHER
AIM,CONCLUSION,LABEL,METHODS,MRI,N20,OBJECTIVE,PATIENT,PEDIATRIC,RESULTS
002,103,169,CONCLUSION,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,SRS,UNIVARIATE
160,169,177,BECAUSE,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENTS
1PV,BACKGROUND,CNS,CONTINUAL,DISCUSSION,DUE,GBM,GERMANY,IDENTIFIER,IIA,LABEL,METHODS,MTD,PARVORYX01,PFS,POC,SECONDARY,THEREFORE,TREATMENT,TRIAL
025,BACKGROUND,CNS,DISCUSSION,HELICAL,ICC,III,ILC,LABEL,METHODS,SECONDARY,SIB,SRS,TRIAL,ULTIMATELY
176,400,BACKGROUND,CTCAE,GYE,HEIDELBERG,LABEL,MACDONALD,METHODS,MRI,PET,RESULTS,THERE,TREATMENT,UNIVERSITY
169,AUTHORS,COLLEGE,JOURNAL,LEGIONELLA,PHYSICIANS,ROYAL
945,CD133,DESPITE,GBM,SEVERAL
HOWEVER,ULTIMATELY
169,BACKGROUND,COPYRIGHT,EIGHT,INC,LABEL,METHODS,NF1,OBJECTIVE,RESULTS,SIX,WILEY
160,ADDITIONAL,AFTER,BECAUSE,CNS,EXPRESSION,PNETS
ECTOPIC,FINALLY,HOWEVER,JANUS,NOTCH,TAKEN
945,946,ALZHEIMER,DAT,DHA,SEVERAL
000,159,259,892,BASED,BAVARIA,CHANGES,GERMANY,POPULATION,SIR,SPC,UTILIZING
ANTIBODIES,MAB,SIMILAR
10825,132,140,169,BLACKWELL,FNA,LABEL,LTD,METHODS,MTC,OBJECTIVE,PUBLISHING,RESULTS
MUTATIONS
169,III,LBL,MRI,PPL,PTERIONAL,SOCIETY
ATP,BCL,BCL2L12,DESPITE,GBM,HALLMARKS,TMZ
53BP1,947,BRAIN,CD133,GBM,GIVEN,HOWEVER,THESE,TSC,UNDER,WHEREAS,XENOGRAFT
NF2,RESTORING,RHO
BACKGROUND,KINGDOM,LABEL,METHODS,RESULTS,THERE
169,473,AKT,CLINICALLY,MUTATIONS,NOTABLY,TAKEN
HOWEVER,MICRORNAS,MYC
169,177,AGE,BACKGROUND,BMD,CHART,CHILDHOOD,COPYRIGHT,DXA,GHD,INC,LABEL,METHODS,PROCEDURE,RESULTS,THERE,THOSE,WILEY
160,ECTOPIC,ESSPA,GOLGI,MITOTIC,NSE,REACTIVITY,SECRETIONS,SIXTEEN,SURGERY,THERE,THESE
177,215,CBV,DSC,HGG,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,THEREFORE
APRIL,DESPITE
BECAUSE,CSC,DESIGNING,FINALLY
BRAIN,BTICS,CSC,SHH,SONIC,WNT
169,956,CELLS,COMPARING,COPYRIGHT,CYP,GBM,IFO,LIVER,LTD,PLA,PTC,THESE,TMZ
BACKGROUND,CONCLUSION,LABEL,MARCH,METHODS,OCTOBER,RESULTS,WHOLE
TISSUES
168,169,BASED,COPYRIGHT,DIEGO,INC,LABORATORY,SAN,SIXTY,SNP,WILMS
THEREFORE
LABEL,METHODS,OBJECTIVE,RESULTS,SELDI,SERUM,TOF
CHO,CONCLUSION,DESPITE,DWI,LABEL,METHODS,NAA,OBJECTIVE,RESULTS,SVS,THRESHOLD
003,006,10Q,10Q22,ALLELIC,BACKGROUND,CGH,LABEL,METHODS,RESULTS,THEREFORE,THESE
169,22Q12,CHEK2,NF2,SUBSEQUENT,WILEY
BACKGROUND,CONTINUOUS,CSF,DIOXIDE,FORTY,GCS,GLASGOW,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATIVELY,RESULTS
SEVERAL
001,003,013,082,19Q,280,339,528,CHINESE,CONCLUSION,GLIOMAS,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
ALZHEIMER,ANTIBODIES,ARRAY,FUNCTIONAL,SINCE,U87MG

CRANIAL
AN1,AN2,AN3,ATOH1,PREVIOUSLY,RAB,RAB15,THESE
19Q,MALIGNANT,WORLD
946,LUMINAL,MCF,THESE
001,002,177,209,215,224,ADC,AVAILABLE,BRAIN,COX,GBM,LCP,LOW,MEIER,MRI,PFS
BETWEEN,GAMMA,GKS,MARCH,SALVAGE
AVERAGE,BACKGROUND,FUNCTIONAL,JANUARY,LABEL,MARCH,METHODS,PMC,RADICAL,RESULTS,SIMPSON
EMC,KNOWLEDGE
ALA,BACKGROUND,KARNOFSKY,KPS,LABEL,METHODS,MGS,MRI,OBJECTIVE,PURPOSE,RESULTS,SCALE,SIX
100,177,58102,750,BOARD,CR1,DIAGNOSES,FIFTY,III,NEUTROPHIL,SEVEN,THESE,WILMS
BBB,DII,GESTECS,HB1,TAKEN
2HG,IDH,SOMATIC
160,AFTER,ANAPLASTIC,HOWEVER,MRI,PCNSL,PRIMARY
BACKGROUND,CONCLUSION,IMPORTANCE,LABEL,METHODS,PAPILLARY,PEH,THESE
DIAGNOSIS,FINALLY,HENCE,HOWEVER,MAINSTAYS,MOLECULAR,MRI,PET
001,002,005,008,009,019,020,022,023,032,033,034,035,069,072,078,079,094,169,COPYRIGHT,DSC,DYNAMIC,EOR,FLAIR,KPS,LABEL,LGG,MATERIALS,METHODS,MFS,MRI,OBJECTIVE,OTHER,PFS,PRE,PROGNOSIS,RESULTS,SMALLER,THREE
169,ACCORDING,CMS,CONCLUSION,COPYRIGHT,DUE,LABEL,METHODS,OBJECTIVE,RESULTS
169,CNS,COPYRIGHT,LTD,MRI,PERINEURAL,PNI,VII
169,COPYRIGHT,GBM,INDIVIDUAL,MET,MICROGLIA,THESE
BRAIN,HOWEVER,REVERSIBLE
00070,100,135,174,19Q,392,HOWEVER,INTRARATER,LABEL,METHODS,MRI,OBJECTIVE,REDUCED,RESULTS,SIXTY,THERE,TTR
048,131,217,GAMMA,GKS,III,KNIFE,LABEL,MAXIMAL,METHODS,OBJECTIVE,RESULTS,THREE
250,956
ALZHEIMER,EARLIER,HOWEVER,INCREASED,MTS,THESE
100,CONFORMITY,DCA,IDS,LABEL,METHODS,NOVALIS,OBJECTIVE,PADDICK,RESULTS,THESE
00011,012,022,024,039,332,BACKGROUND,CBV,EXPRESSION,GBM,HIF1A,KDR,LABEL,MATERIALS,METHODS,OBJECTIVE,PCT,PURPOSE,RESULTS,TEK,VASH2
001,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PREVALENCE,PURPOSE,RESULTS,SWI
18F,CONCLUSION,FMISO,GRADING,HYPOXIA,III,LABEL,METHODS,OBJECTIVE,PET,RESULTS,THERE
FOLLOWING,VNR
ANA,CAF,DESPITE,VNR
FIRST,H2B,H3K79,HOWEVER
178,185,AIC,FLT,PET,REGIONS,TAC,THESE
012,100,121,160,169,215,COPYRIGHT,CSF,CSI,INC,LABEL,MATERIALS,METHODS,NGGCT,OBJECTIVE,PURPOSE,RESULTS,RFS,TEN,THREE,TREATMENT
002,009,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TESTS,THESE
018,100,169,203,COPYRIGHT,CRT,GCT,HPA,INC,LABEL,MATERIALS,METHODS,NGGCT,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN
030,169,178,250,683,EIS,HOWEVER,MMP,SOCIETY
100,200,600,CHIMERA,CISPLATIN,CYTARABINE,ETOPOSIDE,SPECIAL,USF
CONCLUSION,FIFTY,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
ANOTHER,MEDICAL,PARENTS,SURVIVORS
000,105,948,CARLO,CONCLUSION,GERMANY,LABEL,METHODS,MONTE,MRI,PET,RESULTS,UNLABELLED
001,BACKGROUND,CONTEXT,FGFR4,LABEL,MATERIALS,METHODS,OBJECTIVE,PITUITARY,RESULTS,SETTING,SEVENTY,SSTR2,SSTR3,SSTR5,THERE,USING
BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TURKISH
169,COPYRIGHT,GLUCOSE,LTD,MRS,NMR,THESE,WARBURG,WILEY
169,BECAUSE,BIOLOGY,COPYRIGHT,HOWEVER,INC,MOLECULAR,PREVENTING,UNION
120,169,400,517,CALIFORNIA,COA,COPYRIGHT,FRANCISCO,GTPASES,HMG,HYDROXY,INTAKES,JANUARY,RAS,RHO,SAN,UNIVERSITY
114,405,CONCLUSION,COSTS,FET,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL
169,956,GTPASES,INC,NSCLC,WILEY
CHONDROMA,MAFUCCI
CD8,HLA,OVERALL
160,ABOUT,BACKGROUND,BASED,CONCLUSION,FURTHER,HOWEVER,LABEL,MEDLINE,METHODS,RESULTS
BACKGROUND,CONCLUSION,EPSCC,LABEL,METHODS,NNT,OBJECTIVE,OVERALL,PCI,PURPOSE,RESULTS,THEREFORE

169,1ST,BACKGROUND,COPYRIGHT,EASTERN,GROUP,IRELAND,LABEL,LTD,METHODS,RESULTS,SINCE,THERE
MCF,MRI
BACKGROUND,CONCLUSION,LABEL,MCC,METHODS,OBJECTIVE,RESULTS,SEVEN
001,945,946,FURTHER,INHIBIN
169,1A1,ALDH1A1,AUTHORS,BRAIN,CNS,FINALLY,HOWEVER,OLIG2,PATHOLOGY,SOCIETY,THERE
147,AAT,ABOUT,AGITATION,DISCOMFORT,FATIGUE,INCREASED,METHODS,PCA,PESSIMISM
123,169,ABILITIES,AIM,AUTHORS,CDR,COGNITIVE,INSTRUMENT,LABEL,MAPPING,METHODS,OBJECTIVE,PARAMETRIC,RESULTS,SCREENING,SOCIETY,SPECT,TMT,TRAIL

100,103,120,AFTER,MRI,VDE
110,169,467,470,BTICS,CONSISTENT,COPYRIGHT,GBM,PRESS,SF188
115,169,BACKGROUND,BLAND,BRAIN,CAREGIVER,CAREGIVERS,COPYRIGHT,EVALUATING,INVENTORY,KARNOFSKY,KPS,LABEL,METHODS,PBT,RESULTS,SOCIETY,SYMPTOM,THESE
289,AIM,ASSOCIATED,CLEFT,CONCLUSION,FANCONI,GILBERT,LABEL,MEDICAL,METHODS,OBJECTIVE,PNETS,RESULTS
101,169,CONCLUSION,DESPITE,DIFFUSE,IDH,III,LABEL,METHODS,OBJECTIVE,PDGFR,PURPOSE,RESULTS,WORLD
13Q31,GLYPICANS,THESE,WESTERN
169,BACKGROUND,CASES,CONTINUOUS,COPYRIGHT,DISCUSSION,EEG,FDG,LABEL,LITERATURE,METHODS,MRI,PET,THESE,TREATMENT
GAD65,HOWEVER
169,888,892,ATLAS,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,CUTANEOUS,EEG,HPV,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIX,TORRELO,WHETHER
002,008,169,CONCLUSION,COPYRIGHT,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SIX,TMZ
011,169,6TH,7TH,APRIL,BACKGROUND,CENTRAL,CHI,KANDY,LABEL,LANKA,LTD,M1A,M1B,MARCH,METHODS,RESULTS,SIMILARLY,SRI,STAGING,TNM
184,AREAS,BACKGROUND,COVERED,FIRST,III,INHIBITION,LABEL,MAJOR,METHODS,OPINION,PHASE
ASSOCIATED,DUE,OPIOIDS
244,EST,IDS,LIBRARIES,THEREFORE,UNIGENE

169,CONGENITAL,IMAGING
169,VARIOUS
AKT,CD133,MICRO,MIR,NOTCH,SONIC
131,COMPARISON,EPWORTH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SEVERAL,SLEEPINESS,TEN
160,HIT,III,MENINGIOMA,PMN,SMN
132,172,EARLY,IDH,LGA,PCR,SAMPLES
169,COPYRIGHT,LTD,MONRO,MRI,THESE,UNDULATION
BACKGROUND,HPA,LABEL,METHODS,RESULTS,VARIATION
169,194,BBB,CNS,COPYRIGHT,DRUGS,LTD,PCNSL,PRIMARY,SINCE

GIVEN
150,169,241,COPYRIGHT,CORONARIAS,CRITICA,INTENSIVA,TOTAL
001,FINALLY,MOTOR,REDUCED,USING,WHILE
THESE,VARIOUS
CSF,PASSAGE
BLI,GAUSSIA,HOWEVER,NOTABLY,THESE,THREE,WHOLE

130,AGAINST,DESPITE,GIL,HGG,III,MEDICINES,THESE,USA
150,180,450,CYP3A,DASATINIB,DLT,EIAED,FORTY,III,MTD,SRC
100,GBM,LUXOL,MRI,TEN
196,BASED,BPS,RANGE,SEVEN,TEN
000,001,004,100,101,160,GBM,GRADE,RECURSIVE,SEVEN,THEREFORE,TMZ,VALPROATE
100,ALA,FIFTY,III,MRI,SAMPLES,THEREBY,VISIBLE
160,947,CGNPS,E2F,SHH,SONIC,THESE
GBM,PCR,SHH,SINCE
001,205,CONCLUSION,DUTCH,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,SIMPSON,WORLD
BECAUSE,CD4,HOWEVER
POSTERIOR,TREATMENT
00003,043,AGREEMENT,BACKGROUND,COMPARISON,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THERE
169,COPYRIGHT,EEG,LTD,SINCE
137,169,COPYRIGHT,COX,ECTOPIC,EXPRESSION,LTD,MICRORNAS,PCR,USING,UTR
169,1RA,COPYRIGHT,CRP,FATIGUE,FIFTY,III,INC,INDEX,INVENTORY,MIXED,PITTSBURGH,QUALITY,REPORTS,SHORT,SLEEP,SYMPTOM,THESE,THREE,WHILE
169,BBB,COMBINING,COPYRIGHT,CROWN,DOX,GBM,NOD,PRIOR,PUBLISHED,THERE
001,169,231,233,COPYRIGHT,PUBLISHED,SAS,USING
169,BACKGROUND,CEREBELLAR,CONCLUSION,COPYRIGHT,CSF,GAD,LABEL,METHODS,MRI,PATIENT,SAS
169,194,239,AFTER,ANOTHER,ASSESSMENT,BACKGROUND,COPYRIGHT,CPT,GBM,GROUP,INC,LABEL,MEIER,METHODS,NEURO,PFS,RESULTS,SIACI,USING,WORKING
169,BECAUSE,BLACKWELL,LTD,P53,PITUITARY,PREDICTING,PUBLISHING,UNTIL
BACKGROUND,CLINICALLY,CONCLUSION,HOWEVER,ICP,LABEL,LARGE,METHODS,RADIOLOGY,RESULTS,THOSE,THREE,UNLABELLED
MANAGEMENT
025,FORTY,FRAMELESS,LABEL,METHODS,OBJECTIVE,RESULTS,ROBOTIC,SURGISCOPE,THERE
MAXILLA
CROHN,THESE
169,BACKGROUND,BETWEEN,DEPENDING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIOCULAR,PUBLISHED,SOCIETY,SURGERY,WILEY
ACCORDING
CENTRAL
100,813,AGE,ANGELES,ATLANTA,BASED,COMPARISON,DETROIT,END,FRANCISCO,GEORGIA,HARDELL,HOWEVER,INTERPHONE,LABEL,LOS,METHODS,OBJECTIVE,RESULTS,SAN,SEATTLE,SETTING,SWEDISH
015,025,100,BONFERRONI,CONCLUSION,DIFFUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RESULTS,THERE,WHITNEY
BRAIN,YET
324,578,695,BACKGROUND,LABEL,LIGHT,METHODS,OBJECTIVE,PURPOSE,RESULTS,STROKES
001,COX,FAT10,MEIER,PCR,THEREFORE,WESTERN
182,183,AKT,CONVERSELY,INCREASED,KNOCKDOWN,MYC,SEVERAL
677,844,AMONG,BRAIN,CENTRAL,JAPAN,MENINGIOMA,MRI,NEUROLOGIA,OCTOBER,SOCIETY
160,956,CONCLUSION,INDOL,LABEL,METHODS,OBJECTIVE,PGP,PURPOSE,RESULTS,TAKEN
LMC,TREATMENT
001,BASED,DMEAN,MUS,ONCOR,PLANS,PROWESS,PTV,SEGMENT,SIEMENS,TREATMENT,XIO
CPT,HB1,IRINOTECAN,NSC
169,COPYRIGHT,HAUSDORFF,JACCARD,LTD,THESE
169,AGE,COPYRIGHT,ENGLISH,INC,LABEL,LMD,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
BACKGROUND,IDEALLY,LABEL,MRS,NMF,NON,RESULTS,SHORT
ABC,ATP,FTC,GBM,LN229,MDR,USING
947,FMK,STS
AE1,KIT,LCNEC,TTF
109,AMONG,HOWEVER,MIB,NEITHER,SCHERER,USING
109,DESPITE
001,002,006,160,LABEL,MAXIMAL,METHODS,OBJECTIVE,RESULTS
177,AMERICANS,BRAIN,CMV,CONCLUSION,HISPANICS,HOWEVER,INCIDENCE,LABEL,MATERIALS,METHODS,MEXICAN,NERVOUS,NUTRITION,OTHER,PCR,RATES,RESULTS,SURVEYS,UNLABELLED
200,ALKYLATING,ENROLMENT,FTM,FURTHER,GBM,RESULTS,SEVERAL,TMZ
CONCLUSION,FLUID,LABEL,LDL,LRP,METHODS,MTO,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,TREATMENT
GROWING,NOTCH,THESE
160,177,189,250,408,586,629,837,945,PCNSL,THERE
008,128,160,COX,KARNOFSKY,MYC,NDRG4,THESE,WESTERN
19Q,945,CPG,GLIOMAS,HIF,IDH,III,SEVERAL
169,AWAKE,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THESE
111,BRAIN,GAUSSIA
054,169,364,866,ADULT,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SAS,SEVENTY,SPAIN,SPANISH,TREATMENT
AED

945,946,ACTIVATION,ECS,FLICE,GBM,TNF
CURRENT,DESPITE,MEANINGFUL
108,110,191,BACKGROUND,BMI,CONCLUSION,FOLLOWING,IQR,LABEL,METHODS,PRE,RESULTS,STUDIES,THERE
177,1P19Q,945,AOS,HIF,HRM,HYPOXIA,IDH,KARNOFSKY,KPS,METHODS,PFS,SCALE,SCORING
132,164,HOWEVER,III,ISOCITRATE,KARNOFSKY,KPS,R132H,R132S
100,150,19Q,EIGHT,FIFTY,MRI,PFS,THREE
DIAGNOSTIC,EARLY,LOCAL,PALLIATIVE,PROGNOSIS
AIRCREW,HOWEVER,OVERALL,RADIATION,STUDIES,THESE
18F,AVAILABLE,MRI,PET
MICRORNAS,THESE
125,III,OUTCOME
AKT,SILENCING,TREATMENT
ANOTHER,FDA,GBM,PARTICULAR,SIXTEEN,TZM
169,CSF,DOUGLAS,FINALLY,HOWEVER,MRI,MVP,PRIMITIVE,RUSSELL,SOCIETY,THESE,WORLD
ANTIGEN,BACKGROUND,FINALLY,GBM,LABEL,OLIG2,PATHWAY,PRINCIPAL,RESULTS,TAA
001,BACKGROUND,COMBINING,CONCLUSION,EVANS,FIREFLY,GBM8401,LABEL,METHODS,NOD,RESULTS
CHEST,LITERATURE,MRI,NSCLC,PET,RUL
14Q32,MATERNALLY,THESE
177,CONCLUSION,FIFTY,LABEL,LGG,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,109,121,126,156,201,956,AGE,CHILDHOOD,CONCLUSION,EXPOSED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
GFP,HOWEVER,MODULATION,NEURO2A,THESE

AFTER,MRI,TOTAL
AMONG,CONCLUSION,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PARTIAL,RESULTS,SINCE,SURGERY
160,250,400,550,800,AES,CONTINUOUS,DLT,EIACD,GROUP,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SERIOUS,SIXTY,VEGFR
008,169,BACKGROUND,BURKITT,COPYRIGHT,CURRENTLY,EPSTEIN,LABEL,METHODS,MYC,OVERALL,RESULTS,SEVEN,SIX,SOCIETY,THERE
053,054,087,160,932,978,ANXIETY,BRAIN,CHILD,CONCLUSION,HRQOL,INVENTORY,K10,KESSLER,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,QUALITY,RATER,RESULTS,STAIC,STATE,SURVEYS,TRAIT
237,AFTER,ANIMALS,GLU,GLUTAMATE,RAT,THESE,TMZ,U87
169,BACKGROUND,COPYRIGHT,CYTOTOXIC,HOWEVER,LABEL,METHODS,MTT,RESULTS,SOCIETY,WESTERN
18F,AFTER,AUTOPSY,FDG,PET
131,IIDVS,SRS,V12,V15,V22
036,132,154,177,1P19Q,366,596,668,711,833,BECAUSE,MRI,MUTATIONS,WORLD

CHESTER,ECD,ERDHEIM,LANGERHANS,PREVIOUSLY
000,BACKGROUND,BRAIN,DCR,ERLOTINIB,LABEL,METHODS,NSCLC,PRS,RESULTS,SDS,THERE
169,194,954,ARSENIC,COPYRIGHT,CURRENT,CURRENTLY,EWING,FDA,GLI,INC,JNK,PML,POTENTIAL,RAR
169,946,HOWEVER,INSTITUTE,PHYSICS
169,INSTITUTE,PHYSICS,RBF
946,954,AHR,BASED,CLINICALLY,CSC,CXCR4,CYTOKINES,EMT,NANOG,NOTCH,OTHER,SEVERAL,TGF,WNT
945,946,ERS,HOWEVER,WHILE
COMPLETION,NEWER
ANTIGEN,HADES,INTRODUCED,PEG,USING
BACKGROUND,INHIBITION,LABEL,METHODS,RESULTS,SIMILARLY,SRY
ABOUT,CHINESE,CUSHING,FORTY,INDIANS,JANUARY,SEPTEMBER,SIXTEEN,THERE
041,045,CGHARRAYS,COX,DIFFUSE,DIPGS,WHILE
CADM1,FUNCTIONAL,VERTEBRATE
AFTER,EIGHT
169,ASPEN,ASSESSMENT,BACKGROUND,CASES,CIS,COPYRIGHT,EPA,HOWEVER,INC,KEY,LABEL,METHODS,NATIONWIDE,POPULATION,PROCEDURE,RESULTS,SNP,TEXAS,THERE,WILEY
169,193,COPYRIGHT,E2F,FINALLY,HMGA1,HOWEVER,INC,SP1,WILEY
000,BACKGROUND,CONCLUSION,CUSHING,HARDY,LABEL,METHODS
1980S,TOWARDS
100,20Q13,215,987,AMONG,CHINESE,FURTHER,GBM,HAN,OTHER,RTEL1,ZGPAT
100,169,174,BIERING,BILATERAL,COPYRIGHT,LTD,MVC,SEM,THERE,THESE
169,COPYRIGHT,FINALLY,THESE
100,169,AMONG,COPYRIGHT,IMAGE,LABEL,MATERIALS,METHODS,NMR,OBJECTIVE,RESULTS,THESE
169,COPYRIGHT,DIFFUSION,DTI,INC,MRI,OBJECTIVE,ROI,SEVEN
169,ACCORDING,AGRIN,ASTROGLIAL,BBB,CNS,COPYRIGHT,DDC,HOWEVER,LTD
169,C57BL,COPYRIGHT,HOWEVER,INC,ROS,SINCE
169,COPYRIGHT,DEHISCENCE,LTD,POTENTIAL,THESE
169,ACCORDING,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,HOWEVER,III,JANUARY,LABEL,METHODS,MOROCCO,OBJECTIVE,PATHOLOGY,PUBLISHED,PURPOSE,RABAT,RESULTS,SAS,SIX,THERE
169,232,929,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,DISCUSSION,FBTDB,LABEL,METHODS,OBJECTIVE,PCNST,PURPOSE,RESULTS,SAS,SCIENTIFIC,SOCIETIES
GRADE,PAPILLARY,SINCE
G395A,GRADE,IDH,III,ISOCITRATE,NIS,R132H
ACTIVATING,DEPENDING,RAF,THEREFORE,V600E
169,CMV,COPYRIGHT,HOWEVER,LTD,PCR
BACKGROUND,LABEL,METHODS,THERE
945,946,AFTER,BACKGROUND,HASHIMOTO,LABEL,METHODS,MRI,PATIENT,RESISTANCE,RTH,THYROID,TPO,TRH,TSH
131,BACKGROUND,HISTORY,LABEL,METHODS,RESULTS,THREE
188,362,441,942,BBB,LOG,THESE,VALUE
HOWEVER,III,MRI,THESE,USING,WHILE
AFTER,ANOSMIA,BECAUSE,HOWEVER
003,BETWEEN,COX,FREEDOM,GAMMA,GKS,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RCC,RESULTS
AWAKE,BACKGROUND,BASED,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL
BRAIN,PCNSL,SIMILAR
945,BACKGROUND,CD4,DACLIZUMAB,FOXP3,GBM,HOWEVER,III,LABEL,MAB,METHODS,OBJECTIVE,RESULTS,THESE,TMZ,TREGS,TRIAL
011,033,119,126,169,177,195,197,947,COPYRIGHT,GBM,KREBS,LTD,PPP,REMARKABLY,TAKEN,USING,WILEY
169,AIF,COPYRIGHT,INC,MRI,RESULTS,WILEY
019,123,414,629,954,ADULT,BACKGROUND,CNR,FINAL,GADOBENATE,GADOBUTROL,IMAGING,INTER,LABEL,LBR,MATERIALS,METHODS,OBJECTIVE,PURPOSE,READERS,RESULTS,THREE
039,14Q,14Q13,169,194,212,554,COPYRIGHT,FOXA1,INC,PRIMARY,SCC,THESE,WILEY
001,014,019,BACKGROUND,BRAIN,CEREBELLAR,FEW,LABEL,METHODS,RADIATION,RECORDS,RESULTS,THERE
DESPITE,EPIDERMAL,GBM,III,PCR,RADIATION,THESE
954,HEPG2,U87
025,215,AZD1152,INHIBITION,R273H,REDUCTION
NUCLEOLIN,REDUCTION,TAKEN,U87MG,USING,WHILE
031,ALBERTA,GBM,ORIGINALLY,PATIENT,THESE,TMZ
160,DEPARTMENT,THERE
BECAUSE,BRAINSTEM,DESPITE,HOWEVER,WHEREAS
DESPITE,HGG,SALVAGE
169,CONNECTING,COPYRIGHT,ENGLAND,HOWEVER,KEY,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
035,169,177,AFTER,CMS,COPYRIGHT,FORTY,INC,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS
169,BACKGROUND,COPYRIGHT,CSF,ETV,HOWEVER,ICP,INC,LABEL,LOW,METHODS,RESULTS
169,COPYRIGHT,ETV,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,ADDITIONAL,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MICROSCOPY,OBJECTIVE,OPERATING,PUBLISHED,QUALITY,RESULTS,TELESCOPIC,VIDEO
169,CONCLUSION,COPYRIGHT,CSF,DETAILS,INC,LABEL,METHODS,MONRO,OBJECTIVE,RESULTS,SMALL
169,COPYRIGHT,ETV,INC,PUBLISHED
100,169,AMONG,ANH,COPYRIGHT,FURTHER,GLASGOW,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PROCEDURES,PTT,RESULTS,SCALE
169,BACKGROUND,COPYRIGHT,CSF,ENDOSCOPIC,INC,LABEL,METHODS,RESULTS
169,COPYRIGHT,ENDOSCOPIC,INC,LABEL,MEMBRANOUS,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,CPC,ENDOSCOPIC,ETV,INC,LABEL,OPTIMAL,PRIMARY
CONCLUSION,III,LABEL,METHODS,OBJECTIVE,RESULTS,TMZ
035,20A,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS
035,130,169,COPYRIGHT,DCE,FORTY,HGG,LGG,LTD,MRI,ROC
001,169,459,ADVANCING,AMONG,BACKGROUND,BELONGING,COPYRIGHT,ELDERLY,INC,INCREASING,LABEL,METHODS,NORWEGIAN,PUBLISHED,RESULTS,THERE,TREATMENT
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,SCREENING
169,177,CO2,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OMNIGUIDE,RESULTS
111,131,200,3F8,CSF,ENDOSCOPIC,ETV,SUCCESSFUL,WHILE
103,243,350,APRIL,IMRIS,LABEL,LOUIS,MARCH,METHODS,OBJECTIVE,PATIENT,RESULTS,SINCE,THESE
FOUNDATION,THEIR,THESE
014,169,GBM,KPS,PCR,SOCIETY,STUPP
IVF
HOWEVER
CCT007093,CELLS,KNOCKDOWN
BRAIN,FDG,HGG,KARNOFSKY,MRI,NEURO,PET,PFS,PROGNOSIS
THESE
AMONG,ARF,HOWEVER,INK4A,MALIGNANT,P53,SP1,TIMP3
160,169,BASEL,COPYRIGHT,GSA,HOWEVER,SIMILARLY,SST,SV1,USING,WESTERN
110,134,169,288,492,CONCLUSION,COPYRIGHT,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SCORE,TOTAL
CHANGES,HOWEVER,SINCE,THESE,UNDER
005,006,008,011,026,027,049,176,BGS,EUD,HOWEVER,OAR,PTV,PTV50,PTV60,SELECTIVE,V95,VMAT1,VMAT2,VMATI
505,5MM,AFTER,CLEARLY,CTV,DOF,INITIAL,INTRA,PTV,ROBOTIC,TREATMENT
BLOOD,COMPARISON,CVR,DEPENDENT,DYNAMIC,HOWEVER,III,INVERSE,LEVEL,NCC,NVU,PERFUSION,SEVERAL,SINCE
RADIATION,STUDIES
LABEL,METHODS,OBJECTIVE,RESULTS,TSC,USING
BASED,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEGAS,TSC
178,185,99MTC,PHANTOM,SPECT,SUV
169,946,COPYRIGHT,HOWEVER,INC,MATH1,WILEY
3RD,7TH,BRAIN,SEPTEMBER,SINCE
001,002,003,CONCLUSION,COX,EPHB4,ESPECIALLY,HOWEVER,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,WORLD
800,CNS,ONGOING,TREATMENT,VHL
CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,NYSTAGMUS,OBJECTIVE,OTHERWISE,PURPOSE,RESULTS,SEVENTEEN,SLACK,THREE
FDG,GLUCOSE,GLUT1,HK2,PET,THERE
ASSESSMENT,BRIEF,CHILDHOOD,CONCLUSION,DEPRESSION,GIVEN,HOARE,KIDSCREEN,LABEL,MDI,METHODS,OBJECTIVE,OVERALL,PRIMARY,QOL,RESULTS
LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SERUM,SETTING,UNIVERSITY
169,400,500,BACKGROUND,COPYRIGHT,LABEL,LGG,METHODS,OUTCOME,PFS,RESULTS,SOCIETY
252,AHR,FINALLY,OTHER
001,133,148,157,182,201,460,731,BACKGROUND,INCREASED,LABEL,METHODS,RESULTS,THROMBOSIS
100,BRAINSUITE,DTI,MRI,SIX,TABLE
910,CASES,III,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROUTINE
169,194,COPYRIGHT,MELATONIN,PUBLISHED,PVL
169,261,COPYRIGHT,INC,MRI,STRUCTURAL,THESE
001,018,033,100,111,169,174,178,194,59YEARS,630,BACKGROUND,COPYRIGHT,COX,GBM,GYS,HOWEVER,LABEL,METHODS,PDT,RESULTS,THERE,USING
169,KARYOTYPIC,SOCIETY
BRAIN,VHL
156,160,ANOTHER,BACKGROUND,HOWEVER,LABEL,MATERIALS,MBC,METHODS,RESULTS
HANDPIECES,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STERANIOS,STORZ
OVERALL,PARENTS
233,272,ANTIASTHMA,BESIDES,BRAIN,CNS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
066,865,AGE,COX,END,FURTHER,GROSS,HAZARDS,INSTITUTE,MEIER,PILOCYTIC,PROGRAM,RELATIVELY,RESULTS
HOWEVER,HRQOL
CNS,STAGING,WITHOUT
AKT,BESIDES,FOLLOWING,GBM,JNK,MG132,PRE,PROTEASOME,U87
160,785,956,EIGHT,FINDR,III,RAMAN,THESE,VCA
961,BACKGROUND,LABEL,METHODS,MINOR,OUTCOME,RESULTS,THREE,WHITNEY
206,550,671,945,ARRAY,LNA,PCR,PDGFA,SIX
177,CONFORMITY,D95,DOSIMETRIC,ECLIPSE,INC,INDEX,MUS,OAR,PADDICK,PCI,PUBLISHED,SRS,THESE,TREATMENT,TRILOGY
169,COPYRIGHT,IGF,JAK,JANUS,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,V617F
100MG,169,199,239,500MG,5MG,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,MAY,METHODS,NEITHER,NSCLC,PFS,RESULTS,SECONDARY
169,EMA,SOCIETY,THERE
AED,BACKGROUND,CNS,CONCLUSION,DUE,EIGHT,FIFTEEN,JANUARY,LABEL,METHODS,OPTIMAL,OWNERSHIP,PHENYTOIN,PHYSICIANS,RESULTS,SEIZURE,SIX,THREE
124,159,192,477,936,ACROSTUDY,AFTER,BACKGROUND,CONTEXT,IGF,INJECTION,LABEL,MEASURE,METHODS,MRI,OBJECTIVE,OUTCOME,RESULTS,SERIOUS,SETTING,THERE
500,EVALUATION,EVENT,FURTHER,NSCLC,OVERALL,SOLID
108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,251,AKT,ALANINE,ARG,EPHA2,ERK,F120A,G117A,GLN,GLU,GLY,LEU,LYS,MUTANTS,PHE,PRO,R110A,T115A,THESE,THR,TREATMENT

APART
190,CCK,LABEL,METHODS,MMP,OBJECTIVE,PURPOSE,RESULTS,USING
ABSCESS,CRANIOTOMY

ARA,ARSENIC,CCND1,CD133,PML
125,ACUTE,ADH,AVP
160,BRAIN,HOMER,MIB,MRI,NFP,PPT,WORLD
BACKGROUND,BETWEEN,CONCLUSION,CURRENTLY,III,JANUARY,JUN,LABEL,LOW,METHODS,RESULTS,THEREFORE
001,169,194,215,956,AUC,COPYRIGHT,THERE
102,105,134,169,180,AFTER,BETWEEN,COPYRIGHT,CSI,GAMMA,HOWEVER,IGS,INC,JANUARY,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PROTRACTED,PURPOSE,RESULTS,THREE,UNIVARIATE
946,CD133,GSCPS,HOWEVER,III,PCR,SCRATCH,SU2,SU3,U251S
BEHAVIORAL,BRAIN,LABEL,METHODS,OBJECTIVE,RESULTS
100,169,174,AUTHORS,BRAIN,IDH,ISOCITRATE,PATHOLOGY,PCR,SOCIETY,USA
ADENOMA,AFTER,DURAL,ICG,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE
CONTINUAL,CSF,FOLLOWING,HOWEVER,MRI
CENTRAL,CNH,HODGKIN,NEUROGENIC,NON
AKT,BACKGROUND,HEPG2,LABEL,M14,MAP,MEK,METHODS,MKN,NIS,OVERALL,RDEA119,RESULTS
115,169,AMONG,BACKGROUND,COPYRIGHT,COX,III,LABEL,MEIER,METHODS,RESULTS,SOCIETY,THOSE
WHILE
169,CNR,CONCLUSION,COPYRIGHT,IEG,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,SLI,SWI,WILEY
021,025,111,169,BACKGROUND,COPYRIGHT,COX,GLIADEL,HOWEVER,LABEL,METHODS,RESULTS,SIMILARLY,SOCIETY,STUPP,TMZ
00001,169,BACKGROUND,COPYRIGHT,END,LABEL,METHODS,RESULTS,SOCIETY,TREATMENT
S100B
103,160,47E,FUNCTIONAL,GROUP,SHH,WNT
160,402,550,BASED,CGH,GROUP,HOWEVER,MOLECULAR,RESULTS,SHH,SNP,WNT
DIAGNOSIS,EARLY,PAPILLARY
163,169,600,CONCLUSION,HIPAA,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PURPOSE,RESULTS,SIMILAR
160,169,194,660,COPYRIGHT,H2ACPCLPH,H2ACPNO,H2BZPCLPH,H2BZPNO,HYDRAZONES,III,SAS,T98,U87
105,110,174,177,334,BACKGROUND,ELISA,FAK,GBM,HOWEVER,IMMUNOBLOT,INCREASED,LABEL,MATERIALS,METHODS,PCR,RESULTS,SRC,THERE,THESE,VEGFS
ONGOING,QOL,SMALL,TREATMENT
CONTROL,MICROARRAY,PCR,QUALITY,USING
946,947,ALZHEIMER,NOTCH,TIGHT
945,AMERICA,CCG,CNS,COG,CONCLUSION,EXECUTIVE,FIFTY,GROUP,LABEL,METHODS,NORTH,OBJECTIVE,PURPOSE,QOL,RESULTS,THESE
TREATMENT,WHETHER
GBM,HGG,HSV,LM113,NOD,ONCOLYTIC,THESE
AGAINST,BACKGROUND,CALIFORNIA,CONCLUSION,FRANCISCO,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SAN,UNIVERSITY

169,AMONG,COPYRIGHT,FDA
BACKGROUND,HCC,JANUARY,LABEL,METHODS,OBJECTIVE,PVE,RESULTS,THERE
028,032,107,169,ANGIOGENIC,AUTHORS,BRAIN,ENDOCAN,PATHOLOGY,PCR,SOCIETY
954,APART,CONUS,FURTHER,PVIIA
CROHN,CURRENT,HOWEVER,SINCE
083,100,ACCEURACY,AFTER,CPA,DURAL,FLAIR,GADOLINIUM,HIGHEST,IMAGING,MRI,NPV,OVERALL,PPV,RESONANCE,SCHWANNOMA
BH3,BIM,BTSCS,ERK,GBM,MAP,TMZ
125,227,724,BRAIN,CEA,CYFRA,MARCH,MAY,NSCLC,THESE,WHOLE
001,169,COPYRIGHT,INDEX,LABEL,LTD,METHODS,OBJECTIVE,OTHER,PARENTING,PARENTS,PSI,REGRESSION,RESULTS,SHORT,THERE,WILEY
001,286,COX,MEIER,MMP,RESULTS
160,945,CAB,DR2,HOWEVER,NFA,THESE
160,BACKGROUND,CONCLUSION,IMPORTANCE,LABEL,METHODS,PATIENT
257
372,500,CAGCT,CGGCT,CGTCG,MYC
HOWEVER,III,LABEL,MBC,OPINION,PFS,SINCE,STATEMENT,UNASSIGNED
AMONG,BACKGROUND,CSF,EEA,LABEL,MARCH,METHODS,RESULTS,ROUTINE,SKULL,THERE
PAPEZ,THESE
BESIDES
110,ACCORDING,ALTOGETHER,FIFTY,FINLAND,PREDICTORS,REGARDING,SIX,SURVIVORS,TAMPERE,UNIVERSITY
BRAIN,HOWEVER
177,CSI,EFFORTS,EFS,MRI,RESULTS

REGARDLESS
HOWEVER,THERE
001,014,050,066,121,122,144,544,735,CALIFORNIA,FIFTY,FRANCISCO,GTR,PFS,PRIMARY,SAN,SECONDARY,STR,THERE,UNIVERSITY,XRT

GBM,TORISEL,U87MG
177,401,BACKGROUND,LABEL,METHODS,MRI,RESULTS,THERE
CNS,MEDICAL,RADIATION
177,EMG,REGARDING,TUMOURS
MATH1,OTHER,SHH,SONIC,WNT
COX,FURTHER,LOX,PI3
946,ACP,ACTIVATING,BMP,FGF,FINALLY,SHH,WNT
AFTER,HOWEVER
160,ACUTE,BRAIN20,C30,CONCLUSION,DFS,EORTC,FET,JANUARY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PTV,PURPOSE,QLQ,QUALITY,RESULTS
147,160,BACKGROUND,CONCLUSION,DOSES,EQUIVALENT,EUD,GTV,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,RESULTS,USING
177,186,BACKGROUND,BETWEEN,CONCLUSION,LABEL,LINAC,LOCAL,MAXIMUM,METHODS,NSA,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THREE
169,COPYRIGHT,CSF,LTD,MRI,SUBSEQUENT
169,BACKGROUND,CONGENITAL,COPYRIGHT,FIFTY,INC,LABEL,METHODS,NIGERIA,OTHER,RESULTS,SURGERY
169,177,ADDITIONAL,BETWEEN,COPYRIGHT,GRADE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS
169,177,194,946,ANTAGONIST,BIM,CONCLUSION,COPYRIGHT,GUS,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PRL,RESULTS
001,005,11195,11C,231,MDA,NIR,NTBHS,OVERALL,TBH
BAX,CNS,SECONDARY
946,954,NUCLEAR,PREGNANCY,PREMATURE,SIMILARLY
ANOTHER,BASED
MYC
169,HOWEVER,KI16198,LPA,MMP,PANCREATIC
AKT,IHC,TFA,TFS
946,954,ILK,INSULIN
BLADDER,BRAIN,DROSOPHILA,E2F,NANOS,PUM,PUMILIO,SUBSEQUENT,THESE,UTR
68H,916,945,947,BBD,BECAUSE,HSV,ICP34,INFECTION
169,ATG,AUTOPHAGY,BECN1,COPYRIGHT,GFP,HOWEVER,INC,LC3,TAKEN,TMZ,WILEY
001,BGSCS,DESPITE,FAS,HOWEVER,PCR,THESE,TOTAL
946,SMAD7,TGF,USING,USP15
SHG
ADRENAL
169,COPYRIGHT,IRELAND,LTD
044,169,172,BACKGROUND,BASEL,BONFERRONI,CLONINGER,CONCLUSION,COPYRIGHT,EPQ,EYSENCK,HENCE,LABEL,METHODS,RESULTS,TPQ
BCSCS,DESPITE,PRIMARY,THESE
394,AKI,CKD,HOWEVER,KIDNEYS,PATHWAY
00002,006,169,BETWEEN,CONCURRENT,COPYRIGHT,COX,DISTANT,ECD,FEW,FIFTY,GAMMAKNIFE,GKSRS,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,WBI
169,COPYRIGHT,LTD,MRI,PUBLISHED,THESE
169,194,ALZHEIMER,BBB,CNS,COPYRIGHT,PARKINSON,THESE
169,ACUTE,AGE,COGNITIVE,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE
150,BECAUSE,GIVEN,MEIER,OVERALL,PUBLISHED,TMZ
169,AFTER,CBV,COPYRIGHT,DISCUSSION,LABEL,METHODS,MRI,MVL,OBJECTIVE,OBJECTIVES,PHILIPS,RESULTS,SAS,TESLA,USING
107,168,169,293,612,727,742,ASIAN,BACKGROUND,COPYRIGHT,HOWEVER,HRS,IRELAND,LABEL,LTD,METHODS,RESULTS,SERUM,WESTERN
169,194,COPYRIGHT,GTPASES,INC,PAK,RAS
169,194,COPYRIGHT,INC,MYC,SONIC,TRP53,WNT
PXA,THEREFORE
181,BACKGROUND,IGF,LABEL,METHODS,RESULTS,SIX
BACKGROUND,BPH,CKB,CONCLUSION,GST,LABEL,LNCAP,MALDI,METHODS,PCR,PSA,RESULTS,TOF,TOTALLY
027,ANOTHER,BACKGROUND,CHILDHOOD,CHINA,CUMULATIVE,EIGHT,LABEL,MAY,METHODS,RESULTS,SEVEN,TOTALLY,WALES
GISTS,LIVER,LYMPHATICS,MALIGNANT,METASTASIS
BACKGROUND,LABEL,METHODS,PCR,PTCH1,RESULTS,STUDIES,WHITNEY
150,200,CONCURRENT,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
BACKGROUND,EPIDERMAL,LABEL,MICROSCOPY,QDOTS,QUANTUM,RESULTS,THESE,USING
169,AUSTRALIA,AUSTRALIAN,AUTHORS,COLLEGE,CONCLUSION,FAILURE,HGG,HOWEVER,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RADIATION,RESULTS,ROYAL,TREATMENT,WESTERN,ZEALAND

001,040,076,112,276,394,512,517,522,572,AMONG,CONCLUSION,COSTS,DESPITE,ELENA,EUROS,INSTITUTE,LABEL,METHODS,OCTOBER,RESULTS,SINCE,UNLABELLED
EXECUTIVE
242,ASPIRATOR,CSF,LABEL,LMS,METHODS,OBJECTIVE,RESULTS,ULTRASONIC
ASTROCYTE,BRAIN,HIF,NADPH,THERE,THESE,WHEREAS
BBB,CED,CONVECTION
DESPITE,GBM,SMALL,TARGETING
CURRENT,MALIGNANT
ANOTHER,DEVELOPING,GLIOMAS,HOWEVER,III,SURGERY
GBM

19Q,1P19Q,BETWEEN,CONCLUSION,DEPARTMENT,III,LABEL,METHODS,OBJECTIVE,QUESTIONS,RESULTS,UNIVERSITY
169,BECAUSE,BINDING,COPYRIGHT,GRN,ISSUE,MUTATIONS,PUBLISHED,SEVERAL,SPECIAL,WHILE
135,136,GBM,INTERPRET,MRI,MRS,NMR,PATIENT,PERCHLORIC,PHANTOM,SPECTRA
CHO,LABEL,METHODS,MRS,OBJECTIVE,RESULTS,SINCE,TESLA,TOTALLY,USING
DTI,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SCT,TOTALLY
169,189,AFFYMETRIX,CNS9204,CNS9904,FREQUENCY,GROUP,LABEL,LEUKAEMIA,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,SOCIETY

HOD,MRI,THREE
AFTER,CONTRACTED,SEVERAL,THREE
152,BACKGROUND,INITIAL,INITIALLY,LABEL,METHODS,OBJECTIVE,POREX,PURPOSE,RESULTS
130,AFTER,BROCA,CRITICALLY,FUNCTIONAL,MRI
169,1970S,80S,90S,AMONG,COPYRIGHT,FURTHER,LTD,MOTHERS,SIR
001,002,19Q,DHPLC,III,LABEL,LOH,METHODS,NON,OBJECTIVE,PCR,RESULTS,THEIR,THERE
ACTIVATED,CD133,GSCPS,HLA,HOWEVER,LABEL,METHODS,MVS,OBJECTIVE,PAS,RESULTS,THREE,VMS
024,169,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,FIFTY,IRELAND,LABEL,LTD,MARCH,MAY,METHODS,MILIARY,MRI,NSCLC,RESULTS
169,AIM,ANTIBODIES,BLACKWELL,CD133,COS,CTR,ERK,GBM,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,REGIONS,RESULTS,USING
003,004,128,169,19Q,AOT,BLACKWELL,HOWEVER,III,INTRA,LABEL,LTD,METHODS,MIB,OBJECTIVE,PFS,PHASE,PUBLISHING,RESULTS
CNS,LAPATINIB
009,BALANCE,BRIEF,CTCAE,DIAGNOSES,FATIGUE,GAMMA,INVENTORY,IRB,KNIFE,PURPOSE,SEVENTY,SHORT,SRS,THERE,THREE
MAY,MRI,STRONTIUM
III,IMC,MBC
BACKGROUND,CONCLUSION,CONTEXT,EIGHT,LABEL,MRI,PITUITARY,PROGNOSIS,RELEVANCE,RESULTS,TEMODAR,THERE,THREE
628MG,AFTER
CHINESE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TOTAL,VARIOUS
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PSYCHOTIC,RESULTS,SINCE
AMONG,CSF,JANUARY,LABEL,LOG,MEIER,METHODS,MTX,OBJECTIVE,PCNSL,RESULTS
169,AMP,COPYRIGHT,INC,WILEY
GIVEN,PRE,SPATIAL
ANY,APART,BRAIN,FUNCTIONAL,MRI,SURGERY,THESE
145,170,171,205,357,527,ABOUT,MICRORNAS,MIRNA,NSCLC,RFS,TEN
004,160,AGE,FEW,KARNOFSKY,MIB,THEREFORE
160,ACCORDING,AE1,AE3,BCL,BER,CXCR4,EIGHT,EP4,HYAMS,MIB,NEITHER,OLFACTORY,ONB,REGARDING
SEVERAL,TECHNICAL
252,3T3,FATTY,GST,POZ,SP1,SRE,SREBP
174,267,ALP,BACKGROUND,BESIDES,BLOOD,CEA,CELLSEARCH,CTC,CYFRA,HOWEVER,LABEL,LDH,METHODS,PFS,RESULTS,SERUM
001,169,194,COPYRIGHT,INITIAL,KIT,KITLG,PCR,REPORTEDLY,RTK,USING
BRAIN,THESE,YET
AFTER,LABEL,METHODS,MRI,OBJECTIVE,RESULTS

946,ALZHEIMER,FURTHER,HOWEVER,THEREFORE
945,AIM,DISCUSSION,DOCETAXEL,LABEL,METHODS,OBJECTIVE,RESULTS
141,330,366,448,461,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PATIENT,RESULTS,THERE,VARIOUS
PSD,THESE
ABOVE,ACCORDING,COSIP,ILL,PARENTS,THEREFORE
006,036,306,395,946,MYC,WNT
ASSESSMENT,III,TBI,WORLD
ADVANTAGES,ASSESSMENT,FUNCTIONAL,GLASGOW,GOS,HOWEVER,KARNOFSKY,KPS,OUTCOME,SCALE
002,ACTIVATED,BASED,FORTY,INCREASED,LABEL,MATERIALS,METHODS,MMP,MT1,OBJECTIVE,RESULTS
001,015,016,022,027,19Q,219,64257,664,COX,GBM,GBMOS,HOWEVER
169,4CM,COPYRIGHT,GIANT,GROSS,GTR,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
169,COPYRIGHT,COX,CROWN,MEIER,PCR,PUBLISHED,WESTERN
169,194,COPYRIGHT,LTD
169,19Q13,371,373,AUTHORS,BRAIN,C19MC,HOWEVER,PATHOLOGY,PCR,SOCIETY
AUC,BCRP1,BECAUSE,CEDIRANIB,CONCURRENT,MDR1A,THESE
CHANGES,CONCLUSION,EARLY,FIFTY,LABEL,METHODS,PET,RESULTS,THESE,UNLABELLED
750,CONCURRENT,DOSES,EIASD,HYPOXIA,KARNOFSKY
722,7EGFR,916,CONSISTENT,DOCK180,EGF,FINALLY,FYN,LYN,SFK,SRC,THESE,Y722F
003,008,050,BASED,FIFTY,GRADE,HOWEVER,INITIAL,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,THREE,WHOLE
AML,CONVERSELY,IDH,MUTATIONS,R132C,R172S
EVALUATION,GROUP,SINCE,TAKEN
ALZHEIMER,BTC,DHEAS,EGF,SIGMA
CNS,THESE
202,507,586,654,795,BACKGROUND,COX,EDEMA,GBM,IMAGING,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PCR,PURPOSE,RESULTS,ROC
BACKGROUND,DTI,III,J48,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,THESE
005,160,169,183,BTO,CONCLUSION,GEORG,HMPAO,LABEL,MATERIALS,METHODS,OBJECTIVE,PERFUSION,PURPOSE,RESULTS,SACRIFICE,SPECT,STUTTGART,SURGERY
AGGRESSIVE,CELLS,CNS,E15,GFP,MBS,MECHANISMS,SMOM2
AKT,CURRENT,PKC,PROTEOMIC,PTMSCAN,SER,SIGNALING,SILAC,TECHNOLOGY,THR,VALIDATION
169,COPYRIGHT,IRELAND,LTD,THESE
ANT,BACKGROUND,BNP,CARDIAC,ELEVATIONS,LABEL,METHODS,PERSISTENT,RESULTS,SERUM,TBI,THESE
169,222,BACKGROUND,BASED,COPYRIGHT,CRC,INC,LABEL,METHODS,PUBLISHED,RESULTS,THESE
169,194,COPYRIGHT,FCD,HOWEVER,LTD,MRI,PATHOLOGY,TLE
169,COPYRIGHT,GERMINOMA,LTD,PRIMARY,SEX
169,COPYRIGHT,FDG,HGG,HOWEVER,LTD,MRI,OVERALL,PET,SPECT
180,FINALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUCCESSIVE
003,066,100,116,169,CEA,FURTHER,III,SEVERAL
220,BACKGROUND,DISCUSSION,EXCELLENCE,HOWEVER,INSTITUTE,LABEL,MDT,METHODS,MRI,PRE,RESULTS,SINCE,THERE
000,033,035,AFTER,BRAIN,COX,INSURANCE,STRATIFIED,TBI,TRAUMATIC
CARMUSTINE,HOWEVER,RESTRICTED,THESE
APRIL,FIRST,WASHINGTON
100,169,177,1E2,945,956,HEPATOCYTE,HGF,MET,NANOBODIES,PET,THESE,U87
113,132,148,222,234,443,AIP,BACKGROUND,BIC,CONCLUSION,CONTEXT,CUSHING,LABEL,METHODS,OBJECTIVE,PRL,RESULTS,SETTING,STUDIES,UNIVERSITY
945,954,ACTIVATION,APOPTOTIC,CK2,DRB,GBM,SIRT1,TNF
FIRST,NSCLC
200,BACKGROUND,BAGGING,COMPONENT,EMBEDDING,GRAPH,HOWEVER,LABEL,LOCALLY,MRI,PRINCIPAL,RESULTS
177,183,389,956,COLO205,ERK,GDC,PROTEIN,TAKEN
BACKGROUND,DISCUSSION,LABEL,SEVERAL
ADVERSE,BACKGROUND,BETWEEN,CONCLUSION,FOLLOWING,LABEL,LINAC,MARCH,METHODS,PRIOR,REBLEEDING,RESULTS,THERE
AFTER,BASED,MRI,VON
BACKGROUND,CHOLINE,CONCLUSION,FDG,LABEL,MALIGNANT,METHODS,PET,RESULTS
ECM,POTTS
CSF,SUSTAINING,TAKEN
312,945,AKT,BAD,BAK,BORTEZOMIB,CASPASE,ERK,FMK,THESE,VAD
LGG,MONITORING,P21,P27,P53
001,008,024,094,104,112,177,256,416,982,AGE,BACKGROUND,DTC,FIFTY,LABEL,METHODS,PFS,RAI,RATES,RESPONSES,RESULTS,THW,TSH
FURTHER,GBM,HOWEVER,LABEL,METHODS,MICROARRAY,OBJECTIVE,RESULTS,WILMS,WT1
CENTRAL,CNS
169,400,ACADEMY,ALLERGY,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,GROSS,JANUARY,LABEL,LLC,METHODS,MORBIDITY,OTHER,RESULTS,RHINOLOGIC,SOCIETY
169,COPYRIGHT,GBM,PRESS,RAI,SHC
001,150,CD105,CD133,CURRENT,ENPP5,GBM,III,MIPOL,PAEDIATRIC,SUPERVISED,WORLD
AHR,GNP,HOWEVER,PAS,PER,SIM,TAKEN,THEREFORE,THESE
169,NOTABLY,RTK
001,102,109,AED,CURRENT,HEMORRHAGE,KETTERING,MAY,OCTOBER,PPX,SEIZURE,SLOAN
ADDITIONAL,CSF,FEW
005,045NG,169,177,194,945,947,AXYSM,CAD,COPYRIGHT,DESPITE,FURTHER,GCPII,GENOTYPING,GLUTAMATE,H475Y,HOWEVER,NAALADASE,PCR,PYMOL
DICER,FINALLY,HODGKIN,HUR,MICRORNAS,THESE
EPHB2,FAK,GBM,TAKEN,THESE,XENOGRAFTS
169,194,COPYRIGHT,INC,MICROSOMAL,P450S,THESE
169,BACKGROUND,BASEL,BETWEEN,CONCLUSION,COPYRIGHT,CSF,JANUARY,LABEL,METHODS,RESULTS,SURGERY,THERE,TOTAL,VARIOUS
169,945,946,COPYRIGHT,HIF,IDH,LTD,R172G,THESE
169,947,ALZHEIMER,COPYRIGHT,LTD,MUTATIONS,NOTCH,SEVERAL
169,946,ADP,BID,DIAMIDINO,DR5,INHIBITORS,LABEL,MATERIALS,METHODS,MTS,OBJECTIVE,OBJECTIVES,PEITC,POLYMERASE,RESULTS,THESE,WESTERN,WILEY
110,CDX,CELLDEX,EGF,GBM,HOWEVER,PHASE
169,AUTHORS,COLLEGE,CURRENT,JOURNAL,TSC,YOUNGER
169,BLACKWELL,LTD,PILOT,PUBLISHING
104,169,ADULT,EDITION,INC,INDEX,INDEXES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PERCEPTUAL,PRI,REASONING,RESULTS,SCALE,THERE,VCI,WILEY
001,002,ABOUT,AFTER,AGE,AMONG,BLOOM,CONCLUSION,LABEL,METHODS,OBJECTIVE,OUTCOME,RADIOLOGY,RESULTS,TEN
141,EIGHT,MRI,THERE,THEREFORE
001,039,107,143,AVAILABLE,MRI,PATIENT
ACCORDING,BBB,MMP,WESTERN
001,100,177,400,CONCLUSION,FDG,FMISO,GBM,III,LABEL,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THESE
ASSIA,COGNITIVE,HOWEVER,PSYCHINFO,SCIENCE,STUDIES,WEB
SUBSEQUENT,THESE
001,002,005,118,DIGIT,FLUENCY,HOWEVER,INSPECTION,NEWLY,REY,THERE
FURTHER,LITERATURE
HOWEVER,READING
FURTHER,HOWEVER,OCULOMOTOR
001,947,CD4,CD8,CMV,GBM,HOWEVER,IE1,IFN
169,BBB,COPYRIGHT
ALZHEIMER,DESPITE,HOWEVER,PARKINSON,THEREFORE,THESE
003,006,007,024,057,169,221,572,697,AMONG,COPYRIGHT,EIGHT,INC,MEIER,THERE
160,169,COPYRIGHT,IGF,LTD,PIS,PITUITARY,THERE,WHILE
169,BASED,COPYRIGHT,LTD
105,169,248,ACTIVATED,ANAPLASTIC,COPYRIGHT,DIFFUSE,IDH,INC,NUMBERS,R132H
177,AGAINST,DCS,DESPITE,LABEL,METHODS,NAVIGATED,OBJECTIVE,RESULTS,TMS
001,014,039,6TH,800,HORMONE,HOWEVER,IHC,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS
169,INC,WILEY
177,392,426,591,726,DISEASE,INCIDENCE,JANUARY,LABEL,METHODS,OBJECTIVE,PREDICTORS,RESULTS
169,ASD,AUTHORS,BIOMARKERS,BLACKWELL,CNS,FOUNDATION,JOURNAL,LTD,MEASURING,MOLECULAR,PUBLISHING,SEVERAL,THERE
CIRCADIAN,DISTURBED,ENDOBIOTIC,HOWEVER,III,METABOLIC,PHASE,SCN,SEVERAL
169,AUTHORS,BRAIN,HOWEVER,INITIALLY,PATHOLOGY,SOCIETY
APRIL,BACKGROUND,ENGLISH,LABEL,MEDICAL,METHODS,RESULTS,SEVERAL
APRIL,BACKGROUND,ENGLISH,LABEL,MDD,MEDICAL,METHODS,RESULTS,STUDIES
462,CONCLUSION,FET,INCLUSION,LABEL,MEDLINE,METHODS,MRI,PBT,PET,RESULTS,TBR,UNLABELLED
185,ENDOCRINE,GAMMA,IMAGING,SIX,THREE
CEA,EMA,MRI,THESE
164,177,687,BACKGROUND,CONTEXT,DAS,FEW,LABEL,METHODS,OBJECTIVE,PRL,RECURRENCE,RESISTANCE,RESULTS
ATT20,CONSISTENT,CTBP1,ENPP2,GH4,SPROUTY,THESE
DISEASE,HPF,HPV,P63,SEVEN,SIX,THESE
169,ALZHEIMER,COPYRIGHT,DYNAMIC,FIRST,LTD,PSA
350,580,BACKGROUND,FACULTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIOR,PURPOSE,RESULTS,THERE
169,194,COPYRIGHT,LTD,PCDH9
169,194,BRITISH,COPYRIGHT,DESPITE,HYPOXIA,KNOWLEDGE,LTD,OTHER,PUBLISHED
169,194,COPYRIGHT,GLIOMAS,LTD,SEEDING
CNS,CONVERSELY,RIMONABANT,THERE,WHILE
945,ALZHEIMER,AUTHORS,CURRENT,PARKINSON
7NACHRS,945,NICOTINIC,STRATEGIES,THESE
945,ALZHEIMER,CNS,DESPITE,PARKINSON,PET
150,945,ALZHEIMER,GABAERGIC,HOWEVER,LOEWI,NOBEL,PARKINSON,PHYSIOLOGY,PRIZE
SSS
BACKGROUND,CRW,GTC,HNL,LABEL,LINAC,MATERIALS,METHODS,RADIONICS,RESULTS,SINCE
VESSELS,WHILE
100,227,CONCLUSION,GROSS,INTRA,KARNOFSKY,LABEL,LITERATURE,METHODS,MRI,PAULO,RESULTS,UNIVERSITY,UNLABELLED
001,041,177,ADDITIONAL,HSV,LESIONS,NEITHER
215,BACKGROUND,CONCLUSION,DIGITIZED,HAMAMATSU,INTRA,LABEL,METHODS,NANOZOOMER,NDP,RESULTS,ROSENTHAL,THESE
ALA,BACKGROUND,CONCLUSION,FRAMELESS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
169,1ST,491,820,BACKGROUND,COPYRIGHT,JANUARY,LABEL,LTD,METASTASIS,METHODS,OVERALL,RESULTS,SEVERAL
AMINO,BACKGROUND,EAATS,EXCITATORY,LABEL,METHODS,RESULTS,TAKEN
169,COPYRIGHT,PRIMARY
169,BLACKWELL,DELTA,HOWEVER,JAG,LABEL,LTD,METHODS,NOTCH,OBJECTIVE,PUBLISHING,RESULTS,THERE,THESE
215,IMAGING,RADIATION
AUTOPHAGIC,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,OXIDATIVE,RESULTS,WESTERN
CNS,HIV,MRI,MZBCL,PET,SUBSEQUENT
008,135,650,AUSTRALIA,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SETTING
003,200,219,FIFTEEN,LNA,METASTASES,PCR
169,185,945,CARLO,COPYRIGHT,DCE,ESTIMATION,INC,MONTE,MRI,SNR,THESE,TOFTS,WILEY
002,100,169,BACKGROUND,COMBINING,COPYRIGHT,FIFTY,LABEL,METHODS,METHYLIGHT,PCR,PFS,RESULTS,SOCIETY,STUPP,THERE
AKT,BRAIN,DERIVED,EPIDERMAL,MALIGNANT,PDGFR,THESE
C57BL,CSF,EGF,FINALLY,GL261,PLX3397,THESE
100,CASES,CNS,HODGKIN,HOWEVER,NF1

BRAIN,MRI
945,GBM,KNOCKDOWN,PDGFR,RTK,SULF2,THEREFORE
169,AQP,BASED,COPYRIGHT,LTD,USING
123,183,1A2,1B1,2A6,2B6,2C8,2C9,2D6,2E1,3A4,3A5,956,CYP2C19,HLM,IMP,ISOPROPYL,NADPH
169,16S,BASED,BAY,COPYRIGHT,DVR,INDIA,MCF,PYRIDINIUM,U87MG
BACKGROUND,BETWEEN,BRAIN,FORTY,HCC,HOWEVER,JANUARY,LABEL,METHODS,RESULTS,RPA,SRS,SUN,UNIVARIATE,UNIVERSITY,YAT
PAPILLARY
193,CAM,INHIBITORY,MALIGNANT,RAF,THEREFORE
DLPFC,FUNCTIONAL,HOWEVER,IDENTIFIED
026,029,118,CHINESE,HOWEVER,III,KPS,MEIER,P53,TMZ,YOUNGER
ATLAS,CCNE1,CNA,DESPITE,GBM,KDM5A,THESE,THIRD
124,36C,605,AIP,FUNCTIONAL,HOWEVER,I119T,MUTATIONS,SDS,T142T,THREE
200,250,500,BID,HOWEVER,THREE
APRIL,BACKGROUND,CONTINUOUS,CRP,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TRIAL,WBC
1980S,ACCORDING,CD4,CD8,CONVERSELY,CROHN,DESPITE,HIV,JCV,PML
THERAPY
GBM
BRAIN,DESPITE

MEMBERS,RESULTS
DESPITE
000,BECAUSE

945,946,957,DESPITE,DISCUSSION,HENCE,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SCREENING,TREATMENT,YET

ASSESSMENT,NEURO
SURGERY
000,STUPP,THERE,WITHOUT
177
169,COPYRIGHT,DESPITE,ELDERLY,FURTHER,HOWEVER,KARNOFSKY,KPS,LTD,THEREFORE

169,COPYRIGHT,PUTTING
169,AUTHORS,BRAIN,EMT,EXPRESSION,MMP,NUCLEAR,PATHOLOGY,SOCIETY,TWIST
001,008,015,019,026,032,169,177,AGGRESSIVE,AIM,AUTHORS,BETWEEN,BRAIN,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TREATMENT,UNIVARIATE
INTENSE
169,AFTER,BACKGROUND,CEA,COLORECTAL,COPYRIGHT,CRC,INC,LABEL,METHODS,RESULTS,WILEY
169,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INC,LABEL,METHODS,PROCEDURE,RESULTS,TOXICITIES,WHEREAS,WILEY
DRE,SEVERAL
169,COPYRIGHT,INHIBITION,LYS,THESE
169,COPYRIGHT,CXCR4,GBM,HOWEVER,NOD,REVERSELY,STEFA,STEFB,U87
19Q,275,350,GBM,IHC,III,PCR
BRAIN,HOWEVER,MTT,NSCLC,RESULTS,S100B,THESE,TRANSWELL
000,176,374,ANIMALS,CHOLINE,CONCLUSION,FMW,GBM,GL261,HOWEVER,HRMAS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
024,109,956,AFTER,BACKGROUND,BETWEEN,FIFTY,III,LABEL,LINAC,MAY,METHODS,MLC,RESULTS,THERE
177,BACKGROUND,CONCLUSION,HARDY,LABEL,METHODS,MRI,PREDICTORS,RESULTS,TOTAL
117,123,142,169,BACKGROUND,BASEL,COMPARING,COPYRIGHT,DESPITE,LABEL,METHODS,OBJECTIVE,REGARDING,RESULTS
000,169,218,250,406,750,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,FLORIDA,KARNOFSKY,LABEL,LINAC,METHODS,MRI,OBJECTIVE,OTHER,PRIMARY,RESULTS,SIXTY,SRS,UNIVERSITY
CONCLUSION,LABEL,METHODS,NON,OBJECTIVE,RESULTS,THERE,THESE
ACUTE,BACKGROUND,CAVERNOUS,CONCLUSION,IMAGE,IMPORTANCE,LABEL,METHODS
HIGHFIELD,HOWEVER,MRI
916,AMONG,ESPECIALLY,HOWEVER,THESE,VSV
DIPGS,H3F3A,PGS
140,BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,PILOCYTIC,RESULTS,THERE,THREE,WORLD
AFTER,HOWEVER
103,169,219,COPYRIGHT,WORLD
169,BASED,CA9,COPYRIGHT,HOWEVER,LTD,USING
169,176,365,CONVERSELY,COPYRIGHT,DAILY,FAVORABLE,GROUP,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,THERAPY,V10,V15,V45,WITHOUT
000,001,002,004,007,008,047,169,COPYRIGHT,GENERAL,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PRT,PURPOSE,RESULTS,TEN,TOTAL,XRT
177,600,AIM,BACKGROUND,CABYR,CONCLUSION,HEPG2,INCUBATION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS
169,COPYRIGHT,TOXOPLASMA,USING,WHILE
169,COPYRIGHT,FOLLOWING,IRELAND,LTD,TEN,THESE,USING
169,194,945,ABL,AKT,COPYRIGHT,ERLOTINIB,HCA,HGG,INC,INCREASED,INHIBITORS,KIT,PCA,PDGFR
100,110,169,CONCLUSION,HYPERICIN,JOHNS,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
EVALUATION,INC,NEUROLOGIC,PUBLISHED,THESE
169,CAREFUL,COPYRIGHT,HEADACHES,INC
033,101,956,AFTER,CUSHING,GIVEN,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SUBNORMAL
FURTHER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
945,946,ECM,JAK,ONCOLYTIC,PCR,STRIKINGLY
001,003,006,169,209,ALK,BACKGROUND,COPYRIGHT,KIRSTEN,LABEL,METHODS,NSCLC,RESULTS,SOCIETY
2HG,DETECTION,MRS,MUTATIONS,THESE,WORLD
169,CBV,CONCLUSION,COPYRIGHT,DSC,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,WILEY
BRAIN,MIB,PNETS,SMALL
CASES,ENDOSCOPIC,HOWEVER,MRI
GBM,THOSE
169,AWARENESS,COPYRIGHT,RETINAL,VHL
169,ANG,BBB,COPYRIGHT,DOX,LRP,LTD,MWNTS,PEG,PEGYLATED
INC,INSTITUTE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIX,THERE
MAP,NADPH,NOX,POTENTIAL,ROS,STATINS,THEREFORE,THESE,TNF
APC,ASIAN,BACKGROUND,BECAUSE,CDC27,CURCUMA,LABEL,METHODS,RESULTS,SAC
AIRES,ALK,ANAPLASTIC,ARGENTINA,CNS,EIGHT,IHC,IMT,THESE
111,DIAGNOSIS,MRI,PATIENT,SURGERY
208,GROUP,MAY,PRESS,RELEASE
100,169,967,BEHAVIORAL,COPYRIGHT,CRANIAL,LABEL,LOWER,LTD,METHODS,OBJECTIVE,OBJECTIVES,REFERRALS,RESULTS,WILEY
169,183,BACKGROUND,CONCLUSION,DONUT,GAMMA,GEORG,KNIFE,LABEL,LARGE,LEKSELL,RESULTS,STUTTGART,TREATMENT
169,183,AFTER,BACKGROUND,CONCLUSION,GEORG,LABEL,MATERIALS,METHODS,PROLENE,RESULTS,SKULL,STUTTGART,THESE
169,183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,STUTTGART
169,183,BACKGROUND,CHOROID,CONCLUSION,GEORG,LABEL,METHODS,MRI,PATIENT,STUTTGART,SYLVIUS
169,183,BACKGROUND,CONCLUSION,GEORG,GIVEN,IMAGING,LABEL,LESIONS,METHODS,STUTTGART,UNDER
169,183,ANTON,BACKGROUND,BRAMANN,CHESNEY,CONCLUSION,CSF,CUSHING,FOLLOWING,GEORG,HOPKINS,IRB,JOHNS,LABEL,MASON,MATERIALS,METHODS,NOTABLY,RESULTS,STUTTGART
169,183,BACKGROUND,BASED,GEORG,GROSS,LABEL,METHODS,RESULTS,SOUND,STUTTGART,SUPRA,VARIOUS
016,BACKGROUND,CONCLUSION,GBM,KARNOFSKY,LABEL,MATERIALS,METHODS,RESULTS

THESE
BECAUSE,HOWEVER,LTQ,TGF
100,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,POTENTIAL,RESULTS,VARIOUS
169,COPYRIGHT,DOPPLER,ICA,LTD,MAXILLO,PUBLISHED,SURGERY
100,118,169,COPYRIGHT,CRT,GAMMA,KNIFE,LINAC,LTD,NON,SRS,THESE,TREATMENT
102,169,193,AMONG,CLOSE,COPYRIGHT,GBM,INITIAL,LTD,PCNSL,WORLD
946,AOA,CNS,GBM,GLIOMAS,HOWEVER,IFN,III,INTERFERON,JAPAN,PREVIOUSLY,TMZ
176,252,GBM,LGG,NNB,SELECTIVE,U87,WESTERN,YET
13A,AKT,BASED,CNS,ERK,SAR,SINCE,WESTERN
19P,AKT,BIM,EXOGENOUS,HNSCC,INHIBITION,MECHANISMS,OSC,THESE,TRK,UTILIZING
18F,BLOOD,FDG,PET,THERE
001,038,177,228,355,465,536,ADC,BASED,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RESULTS
ACTIVATING,ALZHEIMER,AMP,FURTHER,JUN,MKFKLHV,NES,THESE
100,169,AGAINST,ALTOGETHER,AMONG,COPYRIGHT,CPG,FINALLY,GRADE,III,IMPAIRMENT,MASSARRAY,USING
4X3CM,BASED,MRI
ENDONASAL,ENDOSCOPIC,SINCE
AIM,CONCLUSION,LABEL,OBJECTIVE,RESULTS,THERE
AGT,BISULFITE,HOWEVER,PCR
005,006,012,CGT,CHINESE,HAN,THREE,VEGFR
AMONG,III,MEIER,MLN8237,PCR
001,009,200,956,BRAIN,CFU,DESPITE,MALIGNANT,RFP,SALMONELLA,U87

100,169,THESE,WILEY
169,COPYRIGHT,FIBRE,LTD,MEANWHILE,MRI,TESLA,THEREFORE
169,AIM,ALZHEIMER,BACKGROUND,BECAUSE,BETWEEN,BLACKWELL,COGNITIVE,CONCLUSION,IMPROVING,LABEL,LTD,MEDICATION,METHODS,OBJECTIVE,PUBLISHING,RESULTS,SCALE,TOTAL
150,169,BACKGROUND,BDR,CONCLUSION,DCR,DERMOSCOPY,DIAGNOSTIC,HOWEVER,LABEL,METHODS,RESULTS,THEREFORE,WILEY
10001,333,945,946,ESTROGENS,INITIATIVE,MEDICAL,MHT,PUBLISHERS,SEVENTH,THESE,USA,WOMEN
CHINESE,PROGNOSIS,RCC
CURRENT,FURTHER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
DESPITE,NOVEL
AMONG,GBM,GTR,HOWEVER,IDH
ASSESSING,AWAKE,COGNITIVE,SIX,THERE
100,GLUCEST,GLUTAMATE,THESE
250,500,956,BACKGROUND,CONCLUSION,FEW,INSTITUTES,LABEL,METHODS,MONOPOLAR,MOTOR,OBJECTIVE,RESULTS,SCALE,THESE,TOF
143,ADC,BONFERRONI,COX,DIFFUSION,FDM,FLAIR,FUNCTIONAL,MRI
169,COPYRIGHT,FEW,INC,INDIVIDUAL,PUBLISHED,SOCIETY
THERE
500,BECAUSE,NCI,SF295,SNB75
169,ACADEMY,CENTRAL,OTHER
BRAIN,HOWEVER,III,INTRINSIC
ADP,FINALLY,PARPS
CENTRAL,CNS,HOWEVER
100,300,ANOTHER,BBB,CNS,THESE
916,GBM,GRADE
015,048,773,BACKGROUND,LABEL,MATERIALS,METHODS,MRNOSWI,MRSWI,OBJECTIVE,ODS,PURPOSE,RESULTS,SWI,USING
001,925,ADC,BACKGROUND,GRADE,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
ADC,BACKGROUND,COX,ECM,GBM,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,USING
GBM,SHORT
2ND,3RD,LABEL,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESONANCE,RESULTS
HOWEVER,THREE
12A,CSF,INHIBITION,KO143,MDR1A,PGP,RESULTS
012,029,169,528,589,628,644,ADC,CONCLUSION,COPYRIGHT,DSC,DTI,LABEL,METHODS,MIB,MRI,OBJECTIVE,RESULTS,THERE
945,ABC,ABCG2,ATP,BBB,MK886,USING
160,ETHICAL,RELATIVES
169,BTICS,CD133,COPYRIGHT,FINALLY,GBM
169,194,BRITISH,COPYRIGHT,LTD,PUBLISHED
160,169,BASED,COPYRIGHT,EQD2S,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,169,AMONG,COPYRIGHT,GENOMIC,INC,MBS,SHH,SONIC,THESE
160,169,194,CNS,COPYRIGHT,MRI,PITUITARY,PRL,SAS,THESE,VHL,VON
100,169,194,CONCLUSION,COPYRIGHT,DETECTION,INC,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SMALL,WHOLE
BACKGROUND,CONCLUSION,CPG,DESPITE,DNMT1,EPIGENETIC,GLIOMAS,GLS,HOWEVER,LABEL,METHODS,PCR,RESULTS,UNASSIGNED,VIRTUAL
273,AMONG,CLEAR,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WHETHER
LABEL,MAY,METHODS,MTE,MTR,OBJECTIVE,PST,RESULTS,THERE,THREE
CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PEDIATRIC,REGARDING,RESULTS,UNIVERSITY
HOWEVER,SEVERAL
ADL,BRAIN,DEPENDENCE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,RPA,SHORT,SPMSQ
BACKGROUND,GENOMIC,LABEL,METHODS,NSCLC,RESULTS
153,191,BCL2L12,BH2,ECTOPIC,GBM,GFP,GSK3B,LARGE,S156A,STS,TAU,THESE,U87MG
AMONG,CONCLUSION,FORTY,GBM,LABEL,MEIER,METHODS,MMP,OBJECTIVE,PEARSON,RESULTS
1363C,CCM,CONCENTRIC,HISPANICS,KRIT1,SMA,TESTING
169,BNA,COPYRIGHT,CROSS,ERP,FEDERATION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THESE
169,COPYRIGHT,DYSARTHRIA,FACTORS,FOSSA,HOWEVER,LTD,MSD,NEUROLOGY,PAEDIATRIC,PFS,POSTERIOR,PUBLISHED,SOCIETY,SUBSEQUENT
11C,169,177,18F,ASL,COPYRIGHT,DOTATOC,DTI,FDG,FLAIR,FSE,IMAGE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,ROI,THESE
FURTHER,HOWEVER,JNK,JUN
BACKGROUND,CONTEXT,D2R,GH3,HOWEVER,LABEL,METHODS,MMQ,OBJECTIVE,RESULTS,THESE,WESTERN
BAX,BBB,CEC,FMK,ICR,PRIMARY,SEQUENTIAL,TAKEN,THEREFORE
FINALLY,HUR,RBP,UTR
ENDOSCOPIC,GBM,HOWEVER,TRANSIENT
001,002,004,018,111,945,BACKGROUND,EASTERN,ERCC1,EXPRESSION,GROUP,GYEONGSANG,HIF,HYPOXIA,JANUARY,LABEL,LOW,METHODS,RESULTS,UNIVERSITY
100,BACKGROUND,BLOOD,CELLSEARCH,COX,CTC,HRS,LABEL,LLC,METHODS,RESULTS,THRESHOLDS,VERIDEX
SIX
177,246,448,CNS,PUBLISHED,TRANSPLANT,USING
001,002,018,100,ADULT,BACKGROUND,CONCLUSION,CUSHING,DESPITE,GHD,LABEL,METABOLIC,METHODS,OBJECTIVE,RESULTS,SDS
947,COX,EPHA2,MMP,MVD
005,019,169,200,300,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,FIFTY,FRIDAYS,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,MONDAYS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,THESE,THURSDAYS,TMZ,WBI,WEDNESDAYS,WHOLE
DESPITE
002,009,160,945,ATP,CONVERSELY,EFFECTS,EXPRESSION,GBM,HIF,LABEL,METHODS,MODULATION,OBJECTIVE,P53,PURPOSE,RESULTS
178,CHANGES,GBM,LEAVE,MRI,PREDICTIVE
945,946,ARS,BTX,EFFECTS,GAD,H1299,MTT,NCI,NSCLC,SMOKING,USING,WESTERN
000002825,AGE,BACKGROUND,BRAIN,HOWEVER,LABEL,METHODS,RESULTS,TRIAL
124,BECAUSE,CD133,FINALLY,NANOG,SNAI2,THESE
CONCLUSION,DOSIMETRIC,GRADE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
252,HOWEVER,MEF,POK,POZ
169,335,565,COPYRIGHT,ENGLISH,HOWEVER,HYPOTHESIS,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SOCIETY,STUDIES,THERE
SAFER
183,215,CMC,SOD
009,025,033,CENTRAL,CNS,PARTIAL
169,194,BRITISH,COPYRIGHT,LTD,PUBLISHED,THEREFORE
121,500,BACKGROUND,BOARD,EXPRESSION,LABEL,METHODS,OVERALL,PCR,RESULTS,SAMPLES,SERUM
00097,103,169,1RA,COPYRIGHT,FATIGUE,INC,INVENTORY,MDASI,SERUM,SYMPTOM
001,003,006,008,009,010,019,035,045,141,144,169,AGE,AMONG,CONCLUSION,COPYRIGHT,GBM,GROSS,GTR,GUIDELINES,INC,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,REPORTING,RESULTS,THERE,WHILE
169,BACKGROUND,COPYRIGHT,INC,KARNOFSKY,KAROLINSKA,LABEL,METHODS,RADIOLOGY,RESULTS,SIMPSON,SWEDISH,TEN
009,169,1980S,COLLEGE,COPYRIGHT,DEPARTMENT,GLIAL,INC,LABEL,MENINGIOMA,METHODS,OBJECTIVE,RESULTS,SEOUL,UNIVERSITY
GBM,THESE
CLOSURE,CRANIAL
REMOVAL
ASB
RADICAL
LESIONS
BACKGROUND,CONCLUSION,DELAY,DELAYED,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS,SAH
916,CB1,CNS,HIV,THC,THESE
BASED,CNS,HODGKIN,LIMITED,NOVEL,THERAPY
130,177,AMONG,DWI,FORTY,INITIAL,KPS,MRI,OCTOBER,THERE,THEREFORE
ATLAS,CPE,GBM,PROGNOSIS,REDUCED
003,063,19Q,339,360,EXPRESSION,GBM,HOWEVER,PPN,TAKEN
FINALLY,HMGA1,REGARDING,UTR
BACKGROUND,CD133,CSC,HOWEVER,LABEL,MATERIALS,METHODS,NOTABLY,PROM1,RESULTS,STAT3,TARGETING,THESE,TREATMENT
250,BACKGROUND,CONCLUSION,INCIDENCE,IRS,LABEL,METHODS,RESULTS,SEVERAL
169,CLINICALLY,COPYRIGHT,EXPRESSION,LTD,SH3,THESE
169,COPYRIGHT,CRANIOTOMY,CROWN,LTD,PUBLISHED,WORLD
ABELSON,ABL,AHI,BCR,CML,DISCOVERY,HOWEVER,JOUBERT,SH3,THEREFORE,ULTIMATELY
33342,ABC,ABCG2,ALONG,ATP,HENCE,HOECHST,INC,MALIGNANT,PUBLISHED,SINCE
165,168,169,302,527,698,944,BLOOD,CHANGES,COPYRIGHT,FATTY,HOWEVER,INC,OBESITY,PUBLISHED,SCT,SOCIETY
169,194,956,COPYRIGHT,SEVERAL,THREE
916,E1B,HOWEVER,TAKEN
DISEASE,THERE
224,293,HEK,PCR
169,BLOOD,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,215,COPYRIGHT,EMA,INC,MIB,MRI,PATIENT,WILEY
169,326,CNS,COPYRIGHT,EOSIN,INC,SMEAR,WILEY
169,3H1,COPYRIGHT,FND,INC,MENDELIAN,MRI,WILEY
160,946,956,AKT,HAT,HOWEVER,JJ012,LAMININ,MAMMALIAN,MDR,MULTIDRUG,PHOSPHO,PKB,PROTEIN,PRP,RAS
100,142,339,473,BRAIN,CHT,CSI,DFS,GENERAL,HOWEVER,IDIGS,INITIALLY,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,SIX,SURVIVALS
16P11,16P12,19Q13,AMONG,CGH,FREQUENTLY,HOWEVER,LABEL,METHODS,MIB,OBJECTIVE,PAS,PTEN1,PURPOSE,RESULTS,SAMPLES
AFTERWARD,GIANT,HOWEVER
EXTENSIVE,SMALL,TNM,TREATMENT
169,633,COPYRIGHT,LTD,USING
169,COPYRIGHT,IRELAND,LTD,MRI,PET,TNM
169,COPYRIGHT,LTD,RECURRENT,WHILE,WORLD
169,COPYRIGHT,DOSIMETRIC,DVC,FORTY,GRADE,INC,LABEL,MATERIALS,METHODS,NPC,OAR,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE,V40
002,113,169,177,ADDITIONAL,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,177,194,300,BGO,CONCLUSION,COPYRIGHT,GTV,INC,LABEL,MATERIALS,METHODS,NPC,OBJECTIVE,PET,PTV,PURPOSE,RESULTS,THERE
169,500,ALKYLATING,COPYRIGHT,CPG,GBM,GLIOMAS,PARTICULAR,THESE
169,CENTRAL,CNS,COPYRIGHT,DLBCL,LTD
169,BRAIN,BRONCHIAL,CARCINOMA,COPYRIGHT,CUP,MRI,PUBLISHED,SAS,THROUGH
169,222,BIRTH,CALIFORNIA,CIS,CONCLUSION,COPYRIGHT,COX,DEFECTS,HRS,INC,LABEL,METHODS,MONITORING,MOSBY,OBJECTIVE,PROGRAM,RESULTS
169,CONCLUSION,COPYRIGHT,IDEAL,LABEL,METHODS,MONRO,OBJECTIVE,RESULTS,SUPPOSING
000,001,003,009,011,015,031,044,153,169,AFTER,BACKGROUND,BETWEEN,COPYRIGHT,LABEL,METHODS,OBJECTIVE,RESULTS
169,AMONG,COPYRIGHT,EPISTAXIS,ICA,SOCIETY,WHILE
041,169,183,BLACKWELL,CONCLUSION,CRH,CUSHING,FIFTY,INTERSINUS,IPS,LABEL,LTD,METHODS,MRI,OBJECTIVE,PROLACTIN,PUBLISHING,RESULTS,USING
ADVANTAGES,AFTER,LABEL,LESIONS,METHODS,OBJECTIVE,RESULTS
008,110,270,960,LABEL,MET,METHODS,OBJECTIVE,PET,PRM,RESULTS,WHILE,WILMS,WT1
143,177,240,AFTER,CADAVERIC,GLASGOW,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCALE,TEN,THEIR
GBM,INSTITUTE,RECEIPT,STUDIES,TMZ
295,CNS,HGA,INCREASING,LABEL,SUMMARY
006,011,786,842,964,BACKGROUND,DETECTION,ICH,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,ROC,TNC,USING,VNC
100,169,AJAP1,UNRAVELING,USING
AUTOLOGOUS,CNS,CULTURE,HOWEVER,PBSCT,TBC
AIP,HOWEVER,IGF,LAR,MEDICAL,PREGNANCY
750,BACKGROUND,CONCLUSION,DESPITE,DL1,DL3,DL4,DLT,GRADE,LABEL,LPT,MAD,METHODS,MTD,OTHER,RESULTS,VNR
124,HOWEVER,NEWLY
65310,945,APRIL,BECAUSE,METASTASIS,OCTOBER,SERUM,THREE,WHILE
169,215,CRIBRIFORM,EMA,MRI,SOCIETY
2HG,THESE
132,2HG,III,MRS,MUTATIONS
IDH
12B,COMPARISON,IFN,PCR,PET,SUCCESSFUL,THESE
001,007,018,169,2ND,ASSESSMENT,BACKGROUND,BASED,COPYRIGHT,DESPITE,DONEPEZIL,EDITION,EXECUTIVE,INC,KEF,LABEL,METHODS,PROCEDURE,RANGE,RESULTS,SEVENTY,TOWER,WILEY,WRAML
956,ABCB1,ABCC2,ABCG2,BECAUSE,HOWEVER
169,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,GUIDELINES,HOWEVER,INC,LABEL,METHODS,PROCEDURE,RESULTS,WILEY
178,ALZHEIMER,HIV,SMASE
181,BETWEEN,FIFTY,MRI,THEREFORE
BRAIN,CURRENT,MOLECULAR,PEDIATRIC
947,NKT,NOD,THESE
945,CURRENT,PML
001,169,307,AGE,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,INC,JANUARY,LABEL,MAY,MEDICAL,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROCHESTER,SIR,THERE
169,APHASIE,BACKGROUND,BROCA,COPYRIGHT,FRONTAL,GLIOMAS,IFG,LABEL,LESIONS,METHODS,RESULTS,SEVEN,SRL,VIRTUAL
169,CENTRAL,CHINESE,JIANG,LTD
169,1P19Q,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DIAGNOSTIC,HOWEVER,LABEL,METHODS,THEREFORE
169,BASEL,BRAIN,COPYRIGHT,SURGERY,WHOLE
169,BASEL,COPYRIGHT,POTENTIAL,SRS
022,057,113,128,169,180,198,654,676,AMONG,BASEL,COPYRIGHT,GAMMA,KNIFE,MEIER
169,BASEL,COPYRIGHT,HOWEVER,SRS
169,174,AMONG,BASEL,BECAUSE,COPYRIGHT,CYBERKNIFE,GAMMA,KNIFE,NOVALIS
169,BASEL,COPYRIGHT,HOWEVER,WHILE
169,BASEL,COPYRIGHT,CURRENTLY
169,BASEL,COPYRIGHT,DESPITE,EFFORTS,FINALLY,SRS
169,BASEL,BRAIN,CLASSIC,COPYRIGHT,CYBERKNIFE,GAMMA,KNIFE,SCIENTIFIC,UNTIL
000,169,BASEL,COPYRIGHT,GAMMA,KNIFE
169,BASEL,BRAIN,CAREFUL,COPYRIGHT,FURTHER,HOWEVER,LOCAL,REPORTS
169,BASEL,COPYRIGHT,HOWEVER,RCC,RENAL,SRS,THEREFORE,THESE
169,AGE,BASEL,COPYRIGHT,KARNOFSKY,METASTATIC,SCALE,SIMILARLY,SRS,THESE,WHOLE
169,ABOUT,BASEL,BRAIN,COPYRIGHT,HOWEVER,NSCLC,RECURSIVE,RPA,SMALL,SRS,SURGERY,WHOLE
169,BASEL,BRAIN,COPYRIGHT,GROUP,KNOWLEDGE,PHYSICIAN,RADIATION,THERAPY
169,BASEL,COPYRIGHT,MEMBERS
169,BASEL,CNS,COPYRIGHT,GUIDELINES,JOINT,RANDOMIZED,SECTION
169,BASEL,COPYRIGHT,CYTOTOXIC,HOWEVER
169,BASEL,COPYRIGHT,OWING
169,BASEL,COPYRIGHT,SRS
169,BASEL,BRAIN,COPYRIGHT,HOWEVER
169,BASEL,CNS,COPYRIGHT,DESPITE,SEVERAL
169,BASEL,CD3,COPYRIGHT
169,BASEL,BRAIN,COPYRIGHT,EARLY,THESE
169,BASEL,COPYRIGHT,SURGERY
169,COPYRIGHT,DOSIMETRIC,IRELAND,LABEL,LTD,MATERIALS,METHODS,MUS,NPC,OBJECTIVE,PHILIPS,PTV,PURPOSE,RESULTS,THERE,VOLUMETRIC
GBM
DMN,INCREASED,PCC,THESE
169,946,CONCLUSION,COPYRIGHT,EMT,HCC,HEPATOLOGY,HOWEVER,LABEL,LIVER,SCIRRHOUS,TGF,UNLABELLED
14Q32,ARLM1,B6X,CHR,LINKAGE,NF1,NPCIS,TRP53,USING,WHILE
078,169,COPYRIGHT,GRADE,IHC,TEN,TET
005,013,024,142,174,BACKGROUND,CEP17,FRANCISCO,H2T,HERMARK,INC,LABEL,METHODS,RESULTS,SAN,SOUTH,THESE,USING
002,006,012,014,015,028,041,105,160,BACKGROUND,CONCLUSION,KARNOFSKY,LABEL,METHODS,RESULTS,RPA,SCORE,WBI
001,160,215,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RATIONALE,RESULTS,SMOKERS,THERE
104,119,223,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS
120,177,365,380,450,485,884,AIM,BMI,CHI,IRANIAN,KOLMOGOROV,LABEL,LEGAL,MATERIALS,METHODS,OBJECTIVE,PITUITARY,RESULTS,SMIRNOV,THERE,THEREFORE,WHITNEY
001,014,033,124,213,BACKGROUND,BRAIN,CONCLUSION,LABEL,MEIER,METHODS,OESTROGEN,PGR,RESULTS
100,103,215,945,946,BACKGROUND,IDC,IHC,LABEL,METHODS,PRIMARY,RESULTS,VISIBLE
111,154,169,967,AIM,CONCLUSION,GERIATRICS,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
DIMER,EGFRS,ERBB1,FURTHER,GBM,NOTABLY,PLA,THESE,USING
169,COOMASSIE,COPYRIGHT,VCH,WILEY
001,100,DIPGS,GS2
CXCR2,ELISPOT,PERIPHERAL,TREATMENT,WESTERN
027,106,160,192,264,314,BACKGROUND,CONCLUSION,COX,GBM,KARNOFSKY,KPS,KPS70,KPS80,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,TMZ
001,160,BACKGROUND,CONCLUSION,HOWEVER,KARNOFSKY,KPS,LABEL,LMC,METHODS,MRI,OVERALL,PROGNOSTIC,RESULTS,SCORE,SEVEN
001,021,III,MEIER,PCR,WESTERN,WORLD
160,320,AMONG
100,HOWEVER,PATHOLOGIC
SUBSEQUENT,THESE
100,130,176,177,264,354,ALARA,BEV,MLC,OCTOBER,PLANS,PTV,TMI
173,177,PTV
PROGNOSIS
CED
BRAIN,TARGETING,TGF

ASIAN,BASED,BRAIN,CNS,CURRENT,NSCLC,THERE,UPFRONT
000,170,65533,BBB,BRAIN,BTB,CNS,ESTIMATED,METASTATIC,MRI,RESULTING,TYPICALLY,WHEREAS
DESPITE,MALIGNANT,OTHER
ABOUT,CNS,NSCLC,SEVERAL
AFTER,BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SCALP,THERE,TNM,UNDER
BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PKP,RESULTS,SEPTEMBER,T11,T12,THERE,VAS,WORLD
GCV,GLIOMAS,HOWEVER,ONCOLYTIC
000,240,CARLO,DESPITE,MONTE,ORGAN,PAEDIATRIC,THERE,THEREFORE
100,169,200,400,AKT,ARM,LABEL,MAY,METHODS,NEWER,OBJECTIVE,PFS,PURPOSE,RESULTS,SIGNALING,THREE
169,215,384,ADC,CNS,KARNOFSKY,LABEL,METHODS,MRI,MTR,OBJECTIVE,PCNSL,PURPOSE,RESULTS,RITUXIMAB
169,AMONG,CONCLUSION,GRADE,LABEL,METHODS,OBJECTIVE,ORR,PCR,PRS,PURPOSE,RESULTS,SIXTY
MRI,PET,PIB,PITTSBURGH
AFTER,FDG,MRI,PET,THESE
043,044,130,132,177,301,395,AFTERWARD,ALREADY,DUE,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEPARATION,SUV,SUVMEAN
AMINO,FDG,PET
177,615,785,819,942,943,954,995,FDG,GBM,IMAGING,LABEL,MET,METHODS,MRI,MRS,OBJECTIVE,PET,PURPOSE,RESULTS,SPATIALLY,THERE,USING
CURRENTLY,ENGLISH,GBM
EPENDYMOMA,RECURRENCE,REVIEWING,SIX,THESE
169,1920S,ATP,COPYRIGHT,HOWEVER,INC,LACTATE,THESE,USING,WARBURG,WHILE,WILEY
MICRORNAS
133,169,194,COPYRIGHT,CPT,CROWN,EPAC1,GDP,INC,KEY,LABEL,METHODS,MTT,NON,OBJECTIVE,PDE,PDE4A,PDE4B,PERCENTAGE,PKA,PUBLISHED,RAP,RESULTS,THESE,U87MG
169,COPYRIGHT,INC,NMR
000,100,154,169,700,947,CENTRAL,CNS,COPYRIGHT,EASTERN,EMBRYONAL,INCIDENCE,IRELAND,KINGDOM,LTD,NOS,OVERALL
169,COPYRIGHT,IMAGING,INC
169,313,BACKGROUND,BRAIN,CENTRAL,DISTANT,LABEL,LTD,METHODS,ORGAN,RESULTS
918,CNS,FACTORS,HEALTHCARE,INDICATOR,INPATIENT,LABEL,MEIER,METHODS,NORWEGIAN,OBJECTIVE,OVERALL,QUALITY,RESULTS,SEPTEMBER,STILL,THEREFORE,USING
INDUCTION,LABEL,LYMPHATIC,METASTASIS,METHODS,NSCLC,OBJECTIVES,PATHOLOGY,RESULTS,SIXTY,SURGERY,THERE,THESE,UNLABELLED
DELAYED,TRANS,UNDER
102,ACCORDING,AMONG,USING
FOCAL,LILLE,MANAGEMENT,MRI,ROGER
MCO,OBJECTIVES
169,1980S,COPYRIGHT,INC,NOW,PET
ACH,AKT,CANCERS,PRIMARY
169,COPYRIGHT,HOWEVER,LTD,MICRORNAS,PITUITARY,THEREFORE
169,COMPOSITE,COPYRIGHT,INC,MITOTIC,PALMINI,SEVEN,SIX,THREE,WORLD
001,002,021,169,684,AFTER,BACKGROUND,COX,INSURANCE,IRR,JOURNAL,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PURPOSE,RESULTS
100,ABSENCE,AWARENESS
EHE,ENGLISH,IVBAT,SINCE
184,435,436,AZA,BRAZILIAN,CDR,CHEMOKINES,CONVERSELY,CPG,CXCR4,MDA,MEIER,PCR,PMC,SEQUENCING,THESE
ANAPLASTIC,FIRST,HOWEVER
158,159,163,198,295,356,ATLAS,BMC,GBM,INTEGRATED,JIN,LUO,SIU,XIONG
127,143,198,378,BACKGROUND,COMPARING,ICH,LABEL,METHODS,RESULTS,THEREFORE
AFTER,BACKGROUND,BRAIN,EARLY,ENGEL,FORTY,GROSS,LABEL,METHODS,MRI,NEITHER,RESULTS,THERE

AMI,CAG,EMERGENCY,HOWEVER,LAD,PCI,THESE
DETECTION,HOD,MRI,SWI
ANTIBODIES
RADIATION
BECAUSE,NVP,USING
181,227,357,367,400,706,857,PAULO,SIMILARLY
006,ADOLESCENT,HOMA1,HOWEVER,LABEL,METHODS,OBJECTIVE,PEDIATRIC,RESULTS,SIXTEEN
ENDOCRINE,OPTIMAL,THEREFORE,USUALLY,WORLD,YET
WORLD
200,BTSCS,DESPITE,DUE,GBM,ISOLATION,MECHANISMS,MULTIFORME,THEREFORE,THESE
169,194,563,BACKGROUND,BRITISH,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,PUBLISHED,R132H,RESULTS,SEIZURE,SEQUENCING,SEVENTY,THESE
195,CCND3,THROUGH
130,956,CONTINUOUS,CRANIAL,INITIAL,MRI,POSTERIOR,RESOLUTION
001,008,009,128,COX,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
1PTER,890,CHROMOSOME,DELETIONS,RECOGNIZED

CYBERKNIFE,HOWEVER,THEREFORE
CD8,CNS,THESE,WHILE
000,006,100,103,146,174,273,AMERICA,CHICAGO,CONCLUSION,GBM,GROUP,III,KARNOFSKY,KPS,LABEL,METHODS,NORTH,OBJECTIVE,OVERALL,PHASE,RADIATION,RESULTS,THERAPY,TMZ
169,231,4T1,BRAIN,NOTABLY
956,GBM,HENCE,HOWEVER,U87MG
160,CANDIDATE,CONCLUSION,LABEL,LESIONS,METHODS,NPC,OBJECTIVE,PET,PURPOSE,RESULTS
ABL,AIM,BACKGROUND,BCR,JANUARY,LABEL,METHODS,OBJECTIVE,PDN,REMISSION,RESULTS,THERE
CNS,DESPITE
AQP,CD4,NMO
18F,99MTC,ANXA5,FDG,FLT,MOLECULAR,OTHER,PET,SINCE
65533,GBM,PFS
GCPII,GLUTAMATE,THROUGHOUT
021,023,030,AGE,BACKGROUND,GBM,LABEL,METHODS,MULTIPLEX,PCR,PFS,PROBE,RESULTS
945,ARSENICAL,HF2,MTT,NAA,TUNEL
11Q23,169,CNS,COPYRIGHT,INC,MLL,WILEY
169,COPYRIGHT,NOD,NPS,PRESS,THESE
100,AIM,AUSTRALIA,BACKGROUND,CHINA,CONCLUSION,HODGKIN,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SPAIN,UVB
008,AIM,AMONG,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
001,144,169,BACKGROUND,COPYRIGHT,COX,END,GROSS,INSTITUTE,LABEL,METHODS,RESULTS,SOCIETY
024,169,215,983,ADDITIONAL,CHINESE,CLPTM1L,COPYRIGHT,HAN,HAPMAP3,USING
169,ATM,INC,OVERALL,WILEY
252,EXONS,HOWEVER,KIT,THERE
BACKGROUND,CNS,DUE,EPI,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SPM
111,169,AED,LOW,PREDICTORS,PROLONGED
ASTROCYTES,BRAIN,HOWEVER,MOLECULAR,RAF,V600E
CURCUMA,FURTHER,PARKINSON,SEVERAL
002,004,016,169,177,183,AFTER,BLACKWELL,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS
169,BLACKWELL,DMBT1,EXPRESSION,HBV,HCC,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS
AFTER,BACKGROUND,CONCLUSION,FINALLY,INITIAL,LABEL,METHODS,SINGULTUS
1438A,244,309,DEPRESSION,DSM,HTR2A,HTT,INDIVIDUAL,INTERVIEW,LABEL,MET,METHODS,OBJECTIVE,RESULTS
947,CTL,DCS,IFN,THESE
CYBERKNIFE,HOWEVER,IMAGE
169,194,ADAMS,COPYRIGHT,ECM,PROTEASES
NSCLC
138,169,947,AKT,CNS,COPYRIGHT,ERK,GLIOMAS,MAP,SAS
169,ADC,COPYRIGHT,DMB,FLAIR,LOW,LTD,MRI,THERE
000,001,080,100,169,213,673,753,787,CHIBA,CLASS,COPYRIGHT,COX,GAMMA,INC,KARNOFSKY,KNIFE,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RPA
007,113,145,148,169,CIN,CLOSE,COPYRIGHT,GAMMA,GIN,HIN,INC,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,UNIVARIATE,V10,V12
049,100,157,164,169,191,423,936,COPYRIGHT,COX,GROUP,INC,KARNOFSKY,KPS,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RADIATION,RESULTS,SIXTY,SRS,THERAPY,WHOLE
043,068,100,169,945,946,ADULT,AFTER,CONCLUSION,COPYRIGHT,EQD,GIVEN,GROUP,III,INC,LABEL,MATERIALS,METHODS,NCF,OBJECTIVE,PURPOSE,RADIATION,REGRESSION,RESULTS,SCALE,THERAPY,WMS
169,194,4TH,BACKGROUND,CONCLUSION,COPYRIGHT,FUNCTIONS,LABEL,LUSCHKA,MAPPING,METHODS,MRI,PUBLISHED,THERE,TOTAL
001,160,169,ACCORDING,ACTUARIAL,ADVERSE,AVM,BRITISH,COPYRIGHT,COX,CROWN,EFFECTS,INC,LABEL,LOG,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QUANTEC,RESULTS,UNIVARIATE
BBB,BECAUSE,CNS,FUS,MALIGNANT,UNDER
169,CHEMICALS,COPYRIGHT,FIRST,JEM,LTD,SEG,SINCE
101,ANXIETY,BACKGROUND,BARTHEL,BETWEEN,C30,DEPRESSION,DISABILITY,EORTC,INDEX,KARNOVSKY,LABEL,METHODS,NHS,QLQ,QOL,RESULTS,SCALE,SCORE,SUMMARY,THERE,THESE,TREATMENT
EST,WHILE
BECAUSE,MICRORNAS

AFTER,DEPARTMENT,LABEL,MRI,THERE,UNLABELLED
PCR,USING
KARNOFSKY,RPA
177,945,BACKGROUND,BARTHEL,C30,EORTC,HRQOL,INDEX,LITHUANIAN,METHODS,MOTOR,OBJECTIVE,QLQ,QUALITY,RESULTS,STATE,TREATMENT
FIRST,SUFFICIENT,VALIDATION,VOI
AKT,APOPTOSIS,BCL,CONCLUSION,ECTOPIC,ERK,LABEL,METHODS,MIR,MTT,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
010,150,BACKGROUND,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
177,LAR,NFPAS,SHORT,SSTR3,SSTR5,SSTRS,TREATED
185,215,ADC,ANOVA,BACKGROUND,DSC,DWI,GRADE,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,STUDENT
LABEL,METHODS,OBJECTIVE,RESULTS,SCIENTIFIC,SINCE
169,COPYRIGHT,FIRST,INC,REACTIVITY,RESULTS
169,705,COPYRIGHT,DSRED,DYNAMIC,ECM,FURTHER,INC,MTT,SPARC,STAT3,TAKEN,THESE,TYR,UW228
CFS,HOWEVER,MLV,MOLONEY,PCR,POLYTROPIC,TAQ,THESE
EHV,MHC
136,BACKGROUND,HORMONE,IHC,LABEL,METHODS,MULTIPLEX,RESULTS,SEVERAL
CENTRAL,CNS,THESE
003,019,184,368,CNS,MRI,OUTCOME,RESULTS,STRUCTURAL,TBV,THESE
176,441,BRT,CONCLUSION,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RECURSIVE,RESULTS,RPA,SRS,THERAPY
DESPITE
DESPITE,HOWEVER,STUDIES
HOWEVER,QUINOLINIC
DIAGNOSIS
940,ASSESSMENT,CONCLUSION,GPA,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,UPDATES
650,700,FIFTY,GRN1005,MTD,SIXTEEN
RMS
CD133,GBM,III,THESE
BEV,GBM,INHIBITION,MEIER,PFS,PRIOR,THERE,TKI,VEGFR
A289V,CONSISTENT,LAPATINIB,SIX,SMALL,THESE
215,IMAGING,PXA,TOTAL
EMA,IDH,MAY,OLIG2,PILOCYTIC,ROSENTHAL,TOTAL
ALZHEIMER,MRI
HOWEVER,TEN,THESE
BRAIN,THREE
175,945,946,ALPHA
DESPITE,EXTENSIVE
BOUND,CNS,EMT,EPITHELIAL
ERT,IGF,INSULIN,THESE
FINALLY,GBM,HOWEVER
GBM,HOWEVER
GLIOMAS
ACCORDING,DROSOPHILA,STUDIES
257,278,CHINA,CHINESE,ERCC1,FURTHER,RESULTS,T19007C,WENZHOU
BOPTA,CHINESE,CONCLUSION,EVALUATION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SBM
169,COPYRIGHT,ENS,LTD,NEUROLOGY,PAEDIATRIC,PUBLISHED,SOCIETY
169,AFRICAN,BBB,COPYRIGHT,CTS,HAT,SAHARAN
A20,AREAS,BACKGROUND,CAM,CD133,COVERED,CURRENTLY,GBM,GSC,LABEL,METHODS,OPINION,THERE
169,CASES,COPYRIGHT,INC,PROGNOSTIC,RAPIDLY,SHH,THESE,WNT
BRAIN,THESE
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,MOFFITT,RESULTS,WBR
PCR,SOMATIC
BBB,COX,HBECS,MMP,TAKEN
945,FINALLY,FIRST,GH3,GHRHR,HMGA1,HMGA2,PRL,TAKEN,THEREFORE
CHINESE,INITIALLY,METASTATIC,THREE
223,946,ALZHEIMER,APP,CNS,GFP,PS1
COMPARISON,PRIMARY,PURPOSE,SIMPSON,SRS,SRT
CNS,PHASE,PNS
169,AMONG,BLOOD,CAREFUL,COPYRIGHT,INC,MRI,PUBLISHED,RADIATION,SOCIETY,TOTAL
057,BBB,THESE
169,194,COPYRIGHT,GROUP,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PRIOR,RESULTS,TAIWANESE
GBM,SIMULATING,TRAIL,USING
169,ACCORDING,AFTER,BACKGROUND,CONTEXT,COPYRIGHT,DESPITE,GBM,INC,LABEL,METHODS,NOVEL,OBJECTIVE,PBSCT,PURPOSE,RESULTS
169,290,COPYRIGHT,CSF,INC,SLEEP,THESE
169,COPYRIGHT,DIANOVA,DIFFUSE,GBM,GERMANY,HAMBURG,INC,ISOCITRATE,MUTATIONS,R132H
169,COPYRIGHT,MRI,MULTIMODAL,SAS,SWI
169,CLUSTERING,COMBINING,CONCLUSION,COPYRIGHT,FLAIR,GBM,LABEL,MET,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,PWI,RESULTS,SAS
103,131,169,COPYRIGHT,CRT,GENERALLY,INC,INVERSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
169,COPYRIGHT,CTV,DESPITE,END,HOUNSFIELD,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PAROTID,PLANNED,PURPOSE,RESULTS,TEN,THERE
140,169,177,194,267,288,COPYRIGHT,CPU,DSS,GPU,LTD,NETWORK,PROCESSING,SUPPORT
14Q,17Q,GRADE,III,NF2,OTHER,RADIATION,TELOMERASE
100,210,709,763,865,993,CONCLUSION,DELAYED,FLAIR,FSPGR,LABEL,METASTASES,METHODS,MRI,OBJECTIVE,RESULTS
CONCLUSION,LABEL,MRI,OBJECTIVE
DWI,HGG,PWI
MRI,OASIS,REM,RIEMANNIAN,THESE
005,037,160,174,177,CONCLUSION,EPI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROTATIONAL,THERE
BARRIER,BBB,BLOOD,BRAIN,M3G,M6G,SEVERAL,UDP,UGT
19Q,DNT,OLIG2
EPENDYMOMA,SELECTIVE,SIACI
169,215,COPYRIGHT,IRELAND,LTD,V95
169,GBM,GIC,HOWEVER
AIM,BACKGROUND,BETWEEN,CONCLUSION,CTC,KARNOFSKY,LABEL,LINAC,MANAGEMENT,METHODS,OBJECTIVE,PTV,RESULTS,SCORE,SRS
AVEOLAR,SMALL
189,362,BRAIN,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,177,CONCLUSION,FDG,LABEL,METHODS,NSCLC,PET,RESULTS,UNLABELLED
SYLVIAN,USING
1960S,CHRONIC,CUSHING
169,ATLAS,CONVERSELY,CPG,GBM,LABORATORY,MES,PDZ,PRESS,SILENCING,TAZ,TEAD2,USING
169,AIF,BECAUSE,COPYRIGHT,CORRECT,FIRST,HOWEVER,INC,MRI,OFTEN,THESE,WILEY
115,169,983,ATM,COPYRIGHT,DIFFUSE,INC,MPL,ONCOMAP,WILEY
100,10001,134,252,333,833,AIM,BACKGROUND,CNS,CONCLUSION,III,LABEL,MEDICAL,METHODS,MRS,OBJECTIVE,PCNSL,PUBLISHERS,RESULTS,ROC,SEVENTH,USA
169,BASEL,COPYRIGHT,HOWEVER,PHYSICIANS,THESE
169,COPYRIGHT,INC,SINCE,WILEY
HODGKIN,MRI,MYELOPATHY,NHL,SEVEN,SIX,SYMPTOM
001,014,025,125,156,160,177,195,BACKGROUND,BMS,CONCLUSION,CRT,INFLUENCE,LABEL,LIMITED,METHODS,OBJECTIVE,PCI,PURPOSE,RESULTS,SHORT,TRT
HOWEVER,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SONIC,SUMMARY,USING,WNT
100,AE1,AE3,AMM,HMB45,LCA,REGARDLESS,SMA,THEREFORE
169,177,BECAUSE,COPYRIGHT,FIFTY,INC,MEDICAL,NPC,PUBLISHED,V30
100,169,COPYRIGHT,DESPITE,FIFTY,INC,INVERSE,MEDICAL,OAR,PUBLISHED
169,ADDITIONAL,ATRTS,AUTHORS,BRAIN,CLDN6,IHC,INI,MSP,OVERALL,PATHOLOGY,PCR,SOCIETY,SRBCT
ATP,BACKGROUND,ENO,GAPDH,LABEL,RESULTS,SEQ,TCA,WARBURG,WHILE
169,BLAND,CONCLUSION,EXCITATION,LABEL,LASER,MATERIALS,METABOLITE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNR,SPECTRA
006,016,160,168,177,238,239,308,337,347,584,DETECTION,FREQUENCY,PRL
001,003,006,031,350,508,AFTER,AGE,CASES,ENGEL,III,MRI,SEIZURE,THESE,UNIVARIATE

001,156,195,269,365,418,550,633,642,738,947,BACKGROUND,CD3,CD4,CD8,CONTEXT,CONTROL,HLA,ICU,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RAPID,RESULTS,SETTING,THERE,WHETHER
SOD,THESE
583,ASSIGNMENT,BACKGROUND,CONCLUSION,HU133,LABEL,METHODS,RESULTS,SIMILAR
ALTERATION,BACKGROUND,BRAIN,CNS,COMPLEX,CONCLUSION,LABEL,METHODS,RESULTS
L858R
HOWEVER,MRI,THEREFORE,THESE
360,ALMUDEVAR,ANTHONY,BACKGROUND,GEORG,KRISTIN,LABEL,LOCAL,LUEBECK,METHODS,RESULTS,REVIEWERS,SWANSON,TOMAS,TRANSFORM
507,AGITATION,ANHEDONIA,AUSTRALIA,BACKGROUND,LABEL,METHODS,PCA,QUEENSLAND,REGRESSION,RESULTS
11CASES,13CASES,BACKGROUND,CHANGES,CONTENT,ESC,GRADE,HOWEVER,HSC,III,INHIBITION,LABEL,METHODS,PCR,RESULTS,SCREENING,U87,USING,ZFX,ZFY
946,BACKGROUND,EXPRESSION,FINALLY,FOLLOWING,GBM,HOWEVER,III,KNOCKDOWN,LABEL,METHODS,MTS,NFP,NOTABLY,NSE,RESULTS,WESTERN
004,123,131,99M,ENGINEERED,EXPRESSION,NIS
ATP,BNP,COA,FINALLY,LITERALLY
111,177,213,945,946,99M,ANOTHER,BECAUSE,BESIDES,FINALLY,LITERALLY,PET,SPECT,THERE,THESE
CONCLUSION,DTI,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN
000,215,22M1C,956,BIOMARKER,COMMITTEE,CONCLUSION,CRP,CRS,EVALUATION,HDI,JOINT,LABEL,METHODS,OBJECTIVE,PRS,PURPOSE,RESULTS,SOLID,THERE
946,BASED,CD133,EMT,MET
181,ADP,AIM,COMBINING,HGG,INCREASED,PARP1,PEDIATRIC,SYNTHETIC
15505,15516,284,ARG,FOLEY,H331K,POLYSIALIC,PST,REPLACING,SW2,TAKEN
169,APD,BACKGROUND,CNS,COPYRIGHT,HPT,INC,LABEL,LANGERHANS,LCH,METHODS,MRI,PROCEDURE,REGRESSION,RESULTS,WILEY
100,138,BETWEEN,CONCLUSION,CONTROL,GBM,GTR,GTV,JANUARY,KRUSKAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,SEPTEMBER,T2H
169,450,956,CONSISTENT,CONTROL,COPYRIGHT,INC,KNOCKDOWN,WILEY
001,107,290,AVERAGE,KAZAL,MVD
HOWEVER,IGE,POTENTIAL
100,215,435,GIVEN,MENINGITIS,PROMINENT
001,005,024,041,049,132,APRIL,BMS,COX,DBF,LABEL,MATERIALS,MAY,MDBFT,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,SRT
169,288,BACKGROUND,JOURNAL,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PURPOSE,RESULTS,SEX,THESE,UNDERLYING,UNIVARIATE
001,100,169,177,183,194,205,ADOLESCENT,BLACKWELL,CONCLUSION,DESPITE,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,QKD,RESULTS,SIXTEEN

004,FLAIR,FURTHER,GRADE,III,RESPONDERS,RRS,SIB,T50,VFL,VGD
FURTHER,SRS
AFTER,CAUCASIAN,DYSPHAGIA,ENDOSCOPIC,ESOPHAGUS,JAPAN,MALIGNANT,PRIMARY,THERE
169,22844,22845,BACKGROUND,COPYRIGHT,END,JANUARY,LABEL,METHODS,RECEIPT,RESULTS,SOCIETY,TREATMENT,WORLD
001,003,169,BACKGROUND,BETWEEN,COPYRIGHT,END,GBM,HOWEVER,INSTITUTE,LABEL,MEIER,METHODS,PROGNOSIS,PROGNOSTIC,RESULTS,SOCIETY,THERE,THEREFORE,TREATMENT
125,169,946,AGE,BACKGROUND,CNS,COPYRIGHT,FIFTY,INI,LABEL,METHODS,P53,PRIMARY,RESULTS,SMARCB1,SOCIETY
001,003,162,169,BACKGROUND,BETWEEN,COPYRIGHT,HCT,INC,INFANTS,JANUARY,LABEL,MEDICAL,METHODS,OTHER,PROCEDURE,RESULTS,TRANSPLANT,WILEY,YOUNGER
169,CHOROID,COPYRIGHT,ENGLISH,INC,WILEY
169,BACKGROUND,BIALLELIC,COPYRIGHT,INC,LABEL,LYNCH,METHODS,MMR,MRI,RESULTS,THESE,WILEY
169,261,BACKGROUND,BMS,BRAIN,COPYRIGHT,COX,LABEL,METHODS,RESULTS,SOCIETY
169,BACKGROUND,COPYRIGHT,JANUARY,LABEL,METHODS,RESULTS,SEVEN,SINCE,SOCIETY,SRS
946,BASED,DCC,EXPRESSION,GBM,PROGNOSIS,TGF,TMA
160,945,946,AKT,INCREASED,INDUCTION,LN229,N11,PCR,U87
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS
451,AKT,CAB39,EXPRESSION,LN229,PCR,U87,UTR,WESTERN
MICRORNAS
000,348,436,580,AUSTRIA,BMI,BRAIN,CONCLUSION,COX,DBP,INCREASED,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SBP
006,014,015,169,194,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PCR,RESULTS
169,ABSCESS,ANAEROBES,BRAIN,CONCLUSION,COPYRIGHT,FAVORABLE,FIFTY,LABEL,METHODS,NPC,OBJECTIVE,OBJECTIVES,RESULTS,THERE,WHITE
169,BRAIN,CD133,COPYRIGHT,LTD,THESE
169,COPYRIGHT,INC,THERE
169,241,COPYRIGHT,HCC,HOWEVER
AMONG,DORFMAN,LABEL,METHODS,OBJECTIVE,RESULTS,ROSAI,THERE
005,013,100,405,931,CHOROID,DOT,EMA,LABEL,METHODS,OBJECTIVE,RESULTS,TEN,THERE
100,AE1,AE3,CEA,CK5,CK8,DISTANT,EIGHT,EMA,FOCAL,HISTOLOGIC,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SEVEN,TTF
001,013,BACKGROUND,LABEL,METHODS,RESULTS
GBM,GPU,HOWEVER,MULTIFORME,MULTISCALE,THEREFORE
BIOMARKERS,GBM,INSTITUTES,MRI
169,AUTHORS,CB1,CB2,DGL,III,JOURNAL,MGL,PCR,PLD,SOCIETY
002,008,013,110,113,116,210,FORTY,HOWEVER,LABEL,METHODS,MIB,OBJECTIVE,RESULTS,SKULL,THERE
CD133,GBM,MAP
FGFR4,G388R,PITUITARY,PRL,SNP,SRC,STAT3,USING
IVL,LESIONS,PATHOLOGIC,PREMORTEM,SEVEN
016,177,215,317,532,883,ADC,BACKGROUND,GERMINOMAS,HOWEVER,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,OTHERWISE,PPV,PURPOSE,RESULTS,THESE
001,004,049,BACKGROUND,DTI,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
HOWEVER
003,228,916,ACTIVATED,ATM,BACKGROUND,G47,GSC,HSV,LABEL,MEIER,METHODS,RESULTS,TALALAY,TMZ
956,AKT,EPIDERMAL,ERK,MTT,U87,WESTERN
000,060,105,946,EARLY,HEX,THERE
BACKGROUND,CONCLUSION,HODGKIN,IVL,LABEL,METHODS,MRI,RESULTS,THERE
HOWEVER
108,169,AFTER,AMONG,BRAIN,C15,C30,CONCLUSION,COPYRIGHT,INC,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PAL,PALLIATIVE,PURPOSE,QLQ,QOL,QUALITY,RESULTS,TREATMENT
012,055,057,095,121,169,COPYRIGHT,COX,FREEDOM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS
001,123,134,161,169,CONCLUSION,COPYRIGHT,CRT,GROUP,ICT,INC,ITC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OVERALL,PCI,PURPOSE,REGIMEN,RESULTS,STAGE,THESE
10S,12S,335,HOWEVER,PKA,TAKEN,U87
016,169,194,BIOLOGICAL,BTV,CHO,CONCLUSION,COPYRIGHT,FDG,GRADE,III,INC,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,SIXTEEN,SUV
BACKGROUND,DISCUSSION,HOWEVER,INTERPHONE,LABEL,OBJECTIVE,OBJECTIVES
BRAIN,MEDICAL
133,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,MUTATIONS,OBJECTIVE,OLDER,OTHER,PGL,SDH,TTS
007,008,031,047,064,109,157,169,BACKGROUND,COPYRIGHT,ESCALATION,HOWEVER,LABEL,METHODS,RESULTS,SOCIETY
001,002,003,004,006,009,055,077,160,173,967,BACKGROUND,DISCUSSION,LABEL,METHODS,RESULTS,SURVIVORS,THESE,WHITE
945,946,CONSISTENT,GLU,HEK293T,TAKEN
003,018,027,040,052,059,077,18F,EFS,FDG,GROUP,HGG,KARNOFSKY,KPS,PET,RADIATION,RATIO,RECURSIVE,RPA,THERAPY
004,014,019,038,LABEL,METHODS,NUCLEAR,OBJECTIVE,RESULTS
CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,THREE,TMZ
169,COPYRIGHT,ERGONOMICS,LTD,RESULTS,SOCIETY
169,946,BECAUSE,COPYRIGHT,CPG,FURTHER,LTD,MMP,ODN,THERE
169,COPYRIGHT,MRI,SAS
GELATIN,MAJOR,THESE
102,BACKGROUND,CONCLUSION,EARLY,GBM,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,VPA
002,177,BASED,FIFTY,FORTY,GAMMA,LABEL,LOG,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,PFS,PPT,PRIOR,RESULTS,ROUTINE,SRS,THESE
MRI
138,AMONG,CSF,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
177,FINALLY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
177,AMONG,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
7TH,APHASIA,APRIL,AWAKE,CHINESE,FIRST,HOWEVER,LABEL,MEANWHILE,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESECTION,RESULTS
APRIL,BLOOD,BROCA,DTI,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS
122,AMONG,CHINA,DUE,LABEL,MARCH,METHODS,MRI,OBJECTIVE,RESULTS,SEPTEMBER,THERE
IGF,INCREASED
181,250,AFTER,MRI,SIADH,TESTS,THEREFORE,THESE
169,BRAIN,CSF,NSCLC,THESE
BACKGROUND,CNS,LABEL,METHODS,MRI,PCR,TOMOGRAPHY
MRI,SURGERY
SUBSEQUENT,WHILE
BRAIN,EVACUATION,TREATMENT
139,17097,1ST,210,COUNTRY,JANUARY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVERSITY
000,BACKGROUND,CONCLUSION,CONTEXT,DISCHARGE,LABEL,METHODS,MMD,OBJECTIVE,OUTCOME,PATIENT,RESULTS,RISKS,SETTING,SIR,SWEDISH
169,956,ADDITIONAL,INSTITUTE,STRUCTURE,TASPINS
166,ALCAM,AMONG,CD133,III,R132H,U87MG,WORLD
BT142,ENDOGENOUS,IDH,NOD,PRODUCTION,R132H,SOMATIC
OVERALL
CUSHING,VINCENT
EPIDERMAL,GBM,SRC,THESE,YIN,YY1
MHC,TECHNOLOGY

006,169,177,BACKGROUND,BCL,CONCLUSION,COPYRIGHT,ERK,EVENT,IIA,INC,LABEL,METHODS,PROCEDURE,RESULTS,STAT3,WHITMAN,WILEY
001,169,452,610,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,GHD,IGF,INC,LABEL,LUNAR,METHODS,PROCEDURE,PRODIGY,RESULTS,SDS,WHR,WILEY
169,945,946,COPYRIGHT,IMPORTANT,INC,MCT,MCT10,WILEY
570,624,CSF,DEPARTMENT,ENDOSCOPIC,HACETTEPE,JANUARY,THERE,THESE,UNIVERSITY
BBB,DESPITE
000,100,125,150,200,240,280,350,471,500,600,711,900,DEPARTMENT,GGT,THERE
169,183,GEORG,HOWEVER,MRI,PET,STRUCTURAL,STUTTGART,TAKEN
210,ABOUT,DESPITE,HOWEVER,PCR,SERUM,THESE,WESTERN
116,150,CONCLUSION,ENROLLMENT,EVEROLIMUS,GBM,LABEL,METHODS,NEIAEDS,OBJECTIVE,PURPOSE,RESULTS,TMZ
CPG,DETECTION,F10,HOWEVER,PCR,SF126,SF767
946,BCL,CURCUMA,ELEMENE,ERK,HOWEVER,HSP90,MEK,RAF,RAS,THESE
001,002,003,005,006,008,017,ACCORDING,ANXIETY,BRAIN,C30,CONCLUSION,DEPRESSION,EORTC,HRQOL,LABEL,MATERIALS,METHODS,MINIMENTAL,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SCALE,SIXTY,STATE,THERE,TREATMENT
BACKGROUND,DESPITE,DIAGNOSIS,DISCUSSION,DUE,LABEL,METHODS,RADICAL,THESE,YET
10Q,17Q,ACTIVATION,AMONG,CGH,FOCAL,HOWEVER,MBS,MYC,NON,SHH
BACKGROUND,CONCLUSION,FLAIR,HOWEVER,III,LABEL,METHODS,MIXTURE,MRI,RESULTS,SIMILARITY,T1W
ALTERED,BACKGROUND,CHANGES,GAMMA,LABEL,MATERIALS,METHODS,PCR,RESULTS,TALALAY,THESE,TMZ,TREATMENT,WESTERN,XTT
EXT,INT,PCR
205,ECTOPIC,MICRORNAS,TAKEN,UTR
CHANGES,EEG,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,SETTING,SIMILAR,UNIVERSITY
LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SETTING
100,AVM,THESE
CONCLUSION,DETECTION,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,SETTING,UNIVERSITY,WHOLE
001,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THEREFORE
BACKGROUND,BETWEEN,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,TEN
170,ATLAS,BECAUSE,CONSISTENT,GBM,IHC,RB1,THESE,USING
001,106,CNS,ERK,MAK,POLYMERASE,WORLD
946,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THERE
100,ANAPLASTIC,CLINICALLY,III,METASTATIC,WORLD
000,100,BACKGROUND,LABEL,METHODS,NUMBERS,RESULTS,STRINGENT,UNDERLYING
177,AMINO,CHO,FET,LABEL,LGG,METHODS,OBJECTIVE,PET,PURPOSE,REGIONS,RESULTS,SIX
HOWEVER,RECURRENCE
215,ERLOTINIB,MAY,THESE
038,100,528,985,AFTER,CSF,PCNSL,THESE
169,BASEL,COPYRIGHT,HODGKIN,NHL,RICHTER
169,BASEL,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,THIRD
30E,945,953,954,AMONG,HENCE,STIMULI,THESE,UTR
179,EVALUATION,GBM,HOWEVER,SILENCING,TMZ
BACKGROUND,CELLOMICS,CONCLUSION,GRADE,III,LABEL,METHODS,PCR,RESULTS,SHG44,U87,WHETHER
169,COPYRIGHT,DETECTION,GENBANK,MOUSE,PCR,THESE,WESTERN
169,COPYRIGHT,LTD,NCAM1,NCAM2,RNCAM,STRUCTURAL,THERE
169,2CM,COPYRIGHT,DIFFUSION,DWI,EUCLIDEAN,IMAGING,KNOWING,MRI,PARTIAL,PDE,RESONANCE,RESULTS,RIEMANNIAN,THESE,TOMOGRAPHY
169,946,COPYRIGHT,HOWEVER,LTD,TNKS1,WESTERN,WNT
BACKGROUND,CUSHING,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
169,COPYRIGHT,HOWEVER,INC,MBC,PBC,THESE
169,COPYRIGHT,HOWEVER,LTD,THESE,USING
169,COPYRIGHT,LTD,THESE,WESTERN
169,COPYRIGHT,LTD,TSH
003,007,011,120,169,COPYRIGHT,COX,CROWN,III,LOW,LTD,PUBLISHED,WESTERN,WORLD
025,027,056,094,169,224,AGE,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,HIT,LABEL,LTD,METHODS,PSI,RESULTS
101,155,169,BACKGROUND,BECAUSE,COPYRIGHT,ELD,END,FEW,HENCE,HGG,LABEL,LTD,METHODS,PALLIATIVE,PHYSICIANS,RESULTS
003,010,014,032,169,BECAUSE,CONCLUSION,COPYRIGHT,GPA,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,RPA,TREATMENT,WBI
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,TCR,TSS
169,177,BETWEEN,CENTRAL,LABEL,LTD,MARCH,MATERIALS,METHODS,OBJECTIVE,PMA,PURPOSE,RESULTS,THREE,WEBER
003,017,116,252,945,AP1,ATF,BACKGROUND,CFS,DEPRESSION,HCV,HOWEVER,IFN,INTERFERON,LABEL,METHODS,PBMCS,RESULTS
557,945,946,BACKGROUND,BCA,CELLS,EMT,HOWEVER,KNOCKDOWN,LABEL,MEIER,METHODS,RESULTS,RUNX2,SNAI2,TGF,UNKNOWN,WNT
100,169,177,AFTER,EMA,ENGEL,FLAIR,FOCAL,MRI,OCCASIONAL,SCHWANNOMA,SOCIETY,THESE
169,17Q,DESPITE,DUE,EGF,GROSS,IMAGING,MRI,SOCIETY
948,BACKGROUND,CATENIN,CONCLUSION,HOWEVER,III,LABEL,METHODS,MTT,RESULTS,TREATMENT,U87
DESPITE,FOLLOWING,JANUARY,MARCH,METASTATIC,PATHOLOGIC,SUBSEQUENT
169,AUTHORS,BRAIN,CURRENT,GLIOMAS,PATHOLOGY,RESISTANCE,SOCIETY
COPYRIGHT,NEOPLASTIC,OCT,RETINAL,SLACK,THOSE
946,AFP,BACKGROUND,CONCLUSION,DIAGNOSIS,ENDOCRINE,HISTOLOGIC,LABEL,METHODS,MRI,PATHOLOGY,TREATMENT
EXPRESSION,HENCE,HLA
101,CAS,CONCLUSION,GAMMA,GKS,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE

CURRENTLY,GBM,HOWEVER,III,MALIGNANT,PHASE,PROMISING
220,550,AFTER,CORKSCREW,LABEL,METHODS,OBJECTIVE,PHARYNGEAL,PHMEP,RESULTS
169,945,946,BBB,HOWEVER,INCREASED,LRP,OVERALL,PAMAM,RGDYK,SOCIETY,U87MG
ADDITIONAL,ADVERSE,FOCUSED,FURTHER,HIV,METHODS,NETWORK,PML,REACTIONS
169,COPYRIGHT,EVI,MALIGNANT,MOLECULAR,TAKEN,WHILE,WLS,WNT,WNTLESS
100,169,177,ANOTHER,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,EFS,INC,LABEL,LOW,METHODS,PROCEDURE,RESULTS,TOXICITIES,WILEY
945,III,SINCE,WHILE
169,17Q,CNS,COPYRIGHT,INC,MMB,MYC,WILEY
EORTC,III
174,251,BACKGROUND,DRS,GAMMA,GKS,KNIFE,LABEL,METHODS,RESULTS
CLINICALLY,SEVERAL
169,ALP,AUTOPHAGY,COPYRIGHT,DESPITE,DIFFERENT,EPOXOMICIN,NDS,PROTEASOME,PROTEOMICS,SHOTGUN,UBIQUITIN,UPS
001,144,777,967,ACCORDING,ASSESSMENT,BACKGROUND,CONCLUSION,DEFINITION,LABEL,METHODS,MRI,RESULTS
EMG,MONITORING,VARIOUS
000,160,235,246,500,700,989,OVERALL
MIB,PAPILLARY,ROSENTHAL
947,AKT,CLONOGENIC,COMET,FURTHER,SPARC,SPARCSIRNA
BRAIN,CHEST
BASAL,BCC,FINALLY,HOWEVER
169,954,AKT,GBM,LABEL,THESE,THROUGH,UNLABELLED
947,ACTIVATION,CLINICALLY,CRE,HOWEVER,LYS,MAC,NSCLC,THESE
MMR,N2A,STUDIES,USING,WHILE
ANALGESIC,HIV,INHIBITION,OTHER
169,CLINICALLY,FURTHER,MAE,ONCOGENES,TAKEN
169,177,181,215,946,COPYRIGHT,GOLGI,KCL,LTD,MANGANESE,MIN,MRI,THESE,WILEY,XFM
CNS,METASTASES,RATES,SRS
169,182,780,945,946,COPYRIGHT,D54,DPN,ESTRADIOL,ICI,III,PPT,SRC,WESTERN
169,BASEL,COPYRIGHT,MOLECULAR,THESE

AGE,BACKGROUND,CONCLUSION,EXCLUSION,FUNDING,HODGKIN,LABEL,METHODS,RESULTS,TRIAL
003,096,169,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,CONCLUSION,EARLY,GBM,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,RADIATION,RESULTS,ROYAL,STUPP,THESE,ZEALAND
ADR,ADVERSE,HOWEVER,MEDLINE,NARANJO,SCALE,TMZ
CSF,MENINGEAL,MRI,PRIOR
AUTHORS,DDS,SOCIETY,THERE
169,COPYRIGHT,DESPITE,GBM,HOWEVER,INC,INSIGHT,PUBLISHED
169,COPYRIGHT,GBM,GREATER,INC,PROGNOSIS
169,COPYRIGHT,INC,ONGOING,TREATMENT
000,282,BESIDES,FURTHER,PCR
031,134,144,166,169,207,233,COPYRIGHT,MSP,NETWORK,PCR,PFS,TAKEN
169,COPYRIGHT,ILF,INC,SCALE,SCN,SMC,WILEY
160,19Q,CONGENITAL,THERE
004,AVERAGE
100,946,BO6,CONVERSELY,METASTATIC,RCC,TGF,THESE
169,BRAIN
160,292,EXTENDING,LCA,MYC,SHH,WNT
100,BACKGROUND,CONCLUSION,DUE,G2G,KPS,LABEL,METHODS,RESECTION,RESULTS,THERE,THESE
CONVERSELY,FUNCTIONAL,GH3,HMGA1,HMGA2,PRL,THEREFORE,TRISOMY
SINCE,THEREFORE
169,194,COPYRIGHT,GCL,GLUTAMATE,GPX,GSH,GST,INC,WHILE
169,COPYRIGHT,CRMP5,CV2,ENGLISH,IGG,NMO
169,AMONG,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE
169,COPYRIGHT,LTD,PXA
169,COPYRIGHT,INC,MET
169,COMMITTEE,COPYRIGHT,ESPECIALLY,HOWEVER,INC,PHYSICIANS,PUBLISHED,YET
169,BRAINSTEM,COPYRIGHT,CURRENTLY,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SRS,SRT,WHERE
169,215,509,BREAKDOWN,COPYRIGHT,HOWEVER,LTD,SPECTRA,THERE
169,500,945,BACKGROUND,BNP,CONCLUSION,COPYRIGHT,DOPPLER,INC,LABEL,METHODS,MOSBY,NTPRO,RESULTS,SEVEN
169,183,AUTHORS,BACKGROUND,BCC,BETWEEN,BJD,BOWEN,BRITISH,CHINA,GYE,HEAVY,ION,LABEL,LANZHOU,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PAGET,PHASE,RESULTS,SCC,UNLABELLED
169,HOWEVER,PEG,PEGYLATED,PEGYLATION,SOCIETY
001,125,169,19Q,250,ARG132HIS,G395A,IDH,MUTATIONS,NOTABLY,THEREFORE
RADIATION,SRS
GBM,NOTCH
000,150,THERE
945,AC133,AMONG,COCL2,HIF,THESE,USING
CTX,DESPITE,MEDICAL,PFS,RTS,RTX,TEN,THESE,YOUNG
182,183,EXPRESSION,HENCE,MBS,METASTATIC,SHH,USING,XENOGRAFTS
CURRENT,GROUP,SHH,VARIATIONS,WHILE,WNT
300,ALK,BACKGROUND,IHC,LABEL,METHODS,PROGNOSTIC,RESULTS
169,ACTIVATED,ACTIVATORS,COPYRIGHT,HOWEVER,INC,JAK,JANUS,STAT3,U87
154,169,235,971,COPYRIGHT,LEV,LTD,PHENYTOIN,PHT

TREATMENT
100,LABEL,LIBRARY,METHODS,OBJECTIVE,PITUITARY,RESULTS,WHILE
LABEL,LGG,METHODS,OBJECTIVE,PET,RESULTS,TREATMENT,VARIOUS,WHILE
100,119,153,177,BRAIN,CHRONIC,CVA,FIFTEEN,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THEIR
VHL
150,177,212,CSF,ESTIMATED,GRADE,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,SEVEN,THERE
BGT,BRAIN,CHECKLIST,CHILD,GESTALT,LABEL,METHODS,OBJECTIVE,RESULTS,RETENTION,SCALE
177,BETWEEN,DIFFUSE,LABEL,LILLE,METHODS,OBJECTIVE,RESULTS,ROGER
ACTIVATION,AKT,AMONG,BACKGROUND,BCBMS,BCS,COX,EXPRESSION,INHIBITION,LABEL,MEIER,METHODS,RESULTS,SECONDARY,SIMILAR
AFTER,EIGHT,LESIONS,OTHER,UNDER
169,ANALYTICAL,BLOCH,COPYRIGHT,INC,WHILE,WILEY
169,COPYRIGHT,CURRENT,FOUNDATION,INC,PUBLISHED,TSC
RADIATION,THESE,VARIOUS
061,118,211,264,343,486,727,748,927,932,BACKGROUND,LABEL,METHODS,REDUCED,RESULTS
169,COPYRIGHT,FAS,FOREIGN,ITALIAN,LTD,STRUCTURAL
169,AURKB,BIOMARKER,CONCLUSION,COPYRIGHT,COX,CROWN,GLIOMAS,KIF2C,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PUBLISHED,RESULTS,USING,WESTERN
BMP,EXPRESSION,FINALLY,FRMD7,FURTHER,ICN,LABEL,METHODS,MYC,NT2,NTERA,OBJECTIVE,PCR,PURPOSE,RESULTS
CURRENT,HOWEVER,VII
169,COPYRIGHT,DYNAMIC,INC,MODEL,MRI,THESE,WILEY
HOWEVER,JUDICIOUS,MRI
AIM,BACKGROUND,CURRENT,LABEL,METHODS,OBJECTIVE,SURGERY,THERE,THESE
CONCLUSION,CPG,EXPRESSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PRL,RESISTANCE,RESULTS,SILENCING
250,BACKGROUND,CONCLUSION,EGF,EMERGENCY,HOWEVER,LABEL,RESULTS,WHILE
BACKGROUND,CONCLUSION,HEMOGLOBIN,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
002,012,279,AFTER,BACKGROUND,KARNOFSKY,KPS,LABEL,METHODS,REMAINDERS,RESULTS,SCORE
CRC,HNSCC,NSCLC
BACKGROUND,BRAIN,CONCLUSION,LABEL,METHODS,NAVIGATED,OBJECTIVE,RESULTS
231,CONCLUSION,IVIS200,LABEL,MDA,METHODS,MTT,OBJECTIVE,RESULTS,XENOGEN
233,DEPENDING,METHODS,OTT,PURPOSE,RESULTS,SRS,THEIR,WHILE
169,AUTHORS,BLACKWELL,LTD,PATHOLOGY,PTY,PUBLISHING,SEVEN,SINONASAL,SNTCS,SOCIETY
B16,HEPG2,MTT,VIABILITY
ACCORDING,CSC,GBM
160,229,956,BLOOD,CONCLUSION,DISPERSAL,GBM,GREEN,HISTOGRAMS,IMAGE,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS
100,CNS,MRI,PAPILLARY
000,AMBULATION,BALANCE,BTS,DESPITE,FUNCTIONAL,GENERAL,INDEX,MEASURE,SITTING
003,022,033,083,101,182,296,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,947,CD133,CNS,COPYRIGHT,DCS,DENDRITIC,HOWEVER,IFN,THERE,THEREFORE
PRIMITIVE
DESPITE
LABEL,OBJECTIVE,OTHER,PURPOSE,RESULTS,SRS,SUMMARY,THERE
169,945,AFTER,CHANGES,COPYRIGHT,HIF,MRI,PDT
169,CHUNG,COMMENTARY,COPYRIGHT,INC,JAHNG,KIM,RESUMPTION,SPINE
BACKGROUND,INTERVIEWS,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS
CONCLUSION,DIFFUSE,ENDOSCOPIC,EVN,EXTRA,HISTOLOGY,LABEL,METHODS,MRI,OBJECTIVE,PITUITARY
BACKGROUND,ENDOCRINE,LABEL,MAXIMUM,METHODS,OPERATIVE,PARTIAL,RESULTS,TEN
ASSAY,CSC,DISCOVERY,GENESIGDB,HOWEVER,ISA,TAB
177,BACKGROUND,CDI,CENTRAL,EARLY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,THEIR
016,018,031,036,282,DXY,MIB,PHOSPHO,SEVENTY,TEXAS,TPP,TTP,UNIVERSITY
169,AMONG,BORTEZOMIB,COPYRIGHT,DESPITE,DR5,ETOPOSIDE,GLIOMAS,INC,MG132,PROTEASOME,RESISTANCE,SIMILARLY,TRAIL,U87MG,VELCADE,WORTMANNIN
200,259,266,CONSISTENT,DIMSCAN,GBM,MYC,NOD,PCR,PGP,THESE,THREE
032,794,AMONG,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
169,COPYRIGHT,INC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
BACKGROUND,DUE,LABEL,METHODS,RESULTS
INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,194,BACKGROUND,COPYRIGHT,GIVEN,HISTOLOGY,INC,LABEL,METASTASIS,METHODS,RESULTS
169,BACKGROUND,CO2,COPYRIGHT,INC,LABEL,METHODS,PBF,RESULTS
169,BACKGROUND,COPYRIGHT,CROWN,INC,LABEL,LESIONS,METHODS,PUBLISHED,TECHNIQUE
001,111,169,346,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MEIER,METHODS,PROPENSITY,RESULTS,SRS,VIETNAM,VIETNAMESE,VND
001,015,027,034,169,AAIRS,AGE,ANGELES,APC,BACKGROUND,CALIFORNIA,CCR,COPYRIGHT,END,GBM,INC,INCIDENCE,INCREASED,INSTITUTE,LABEL,LAC,LOS,LOW,METHODS,PROGRAM,RESULTS,SAS
104,106,169,183,BETWEEN,COPYRIGHT,CUSHING,INC,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,OCTOBER,RESULTS,TORANOMON,TSS
169,BACKGROUND,CAREFUL,COPYRIGHT,DESPITE,GROSS,INC,LABEL,METHODS,RESULTS,SEVENTEEN
169,BACKGROUND,BECAUSE,COPYRIGHT,INC,LABEL,METHODS,RESULTS,TOTAL
169,ACP,BETWEEN,COPYRIGHT,FORTY,INC,INTRADURAL,JANUARY,LABEL,LSO,METHODS,OBJECTIVE,RESULTS,THERE
169,ACP,BETWEEN,CONCLUSION,COPYRIGHT,FORTY,INC,INTRADURAL,JANUARY,LABEL,LSO,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,ULTRASONIC
002,075,169,299,BACKGROUND,COPYRIGHT,GBM,INC,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OUTCOME,PFS,QOL,RESULTS,SCALE
105,169,22Q11,AMONG,BACKGROUND,BIRC2,BRAIN,COPYRIGHT,GAINS,III,INC,LABEL,LOW,MET,METHODS,RESULTS,WORLD
001,169,967,BASED,COPYRIGHT,CSF,GTR,INC,LABEL,MEDLINE,METHODS,OBJECTIVE,OTHER,RESULTS,THERE
169,945,946,COPYRIGHT,INC,J3T,LABEL,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGIC,RESULTS,THESE
169,AFTER,BECAUSE,COPYRIGHT,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SWI
169,ADULT,CHECKLIST,COPYRIGHT,CUSHING,DELIS,EXECUTIVE,FURTHER,INC,LABEL,METHODS,OBJECTIVE,OTHER,READING,RESULTS,REVISED,SCALE,SIMILARLY,SYMPTOM,THESE
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS
169,BRAIN,COPYRIGHT,DERMOID,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SIXTEEN,THESE
169,CAPILLARY,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SURGERY
001,002,017,026,032,055,100,121,140,169,AGE,COPYRIGHT,FIFTEEN,GKS,INC,LABEL,LOCAL,METHODS,MRI,OBJECTIVE,RADIATION,RESULTS,RPA,THERE
169,BACKGROUND,COPYRIGHT,CURRENTLY,DES,DESPITE,EMG,INC,LABEL,METHODS,RESULTS,THROUGH
169,198,249,ALU,COPYRIGHT,CPG,FOCAL,PCR,REGARDLESS
169,AAG,COPYRIGHT,DSRED,GABARAP,GABARAPL1,GABARAPL2,GST,HSP90,MCF,MG132,SAS
BRAIN,VTE
169,COPYRIGHT,FURTHER,HOWEVER,LTD,PFS,THEREFORE
160,169,194,955,ADC,AIM,ANOVA,CHO,COLLEGE,CONCLUSION,COPYRIGHT,DTI,EIGENVALUE,GROUP,LABEL,LTD,MATERIALS,METHODS,MRI,MRS,NAA,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,THERE
169,ALTERED,AMONG,COPYRIGHT,ERK,LTD,MEK,PITUITARY,RAF,STUDIES
169,CONCLUSION,COPYRIGHT,FSH,INC,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,PATIENT,PUBLISHED,RESULTS,SETTING,SOCIETY,UNIVERSITY
169,AIM,BACKGROUND,BESIDES,CASES,CONCLUSION,COPYRIGHT,JANEIRO,LABEL,METHODS,MOR,OBJECTIVE,RESULTS,RIO,STATE
169,ADDITIONAL,COPYRIGHT,GIVEN,HODGKIN,PCNSL,PRIMARY,WESTERN
169,COPYRIGHT,IDEALLY,PUBLISHED,SERAM
038,177,BACKGROUND,BRAIN,FEW,LABEL,METHODS,NON,NSCLC,OVERALL,PFS,RESULTS,THESE,THREE,WHOLE
169,230,COPYRIGHT,INC,PERLS,TODAY
AMBIENT
21Q,22Q,BRAIN,MEANWHILE,RIGHT,THERE
169,BASEL,COPYRIGHT,FINALLY,HOWEVER
215,256,954,BACKGROUND,DSA,FIFTEEN,FOURIER,LABEL,MATERIALS,METHODS,MRA,OBJECTIVE,PURPOSE,RESULTS,SENSE,SYSTEMATIC

954,BACKGROUND,FIFTY,LABEL,MATERIALS,METHODS,NRS,OBJECTIVE,PERFUSION,PHYSICIANS,PURPOSE,RESULTS
239,CURRENTLY,GENOMIC,PRINCIPAL,THERE
100,116,BACKGROUND,C30,EIGHT,KARNOFSKY,LABEL,METHODS,NOW,QLQ,RESULTS,STATE,TREATMENT
169,COPYRIGHT,DANTROLENE,DUE,LTD,PET,USING
169,COPYRIGHT,HGG,SAS
169,ACROMEGALY,COPYRIGHT,LTD,MEDICAL,OTHER,OVULATION,PREGNANCY,SHEEHAN
169,ACROMEGALY,COPYRIGHT,CUSHING,LTD,PRIMARY,THYROID
169,COPYRIGHT,INC,POSTERIOR
SAPHO,THESE
200,BACKGROUND,CELECOXIB,CONCLUSION,COX,LABEL,METHODS,RESULTS,U87MG,WESTERN
HENCE,MALIGNANT,REGARDLESS,THROUGH,WATER
916,EGF,GFP,HSP27,SPARC,U87MG,WOUND
ASL,BACKGROUND,CBF,CONCLUSION,DSC,HISTOGRAM,HOWEVER,LABEL,METHODS,MRI,NEITHER,OBJECTIVE,PERFUSION,PURPOSE,REGIONS,RESULTS

169,MANAGEMENT,MEDICAL,PUBLISHERS,SUCCESSFUL
001,NCN,RAS,RASSF,RASSF10
132,19Q,CNS,EXPRESSION,R132H

004,019,027,034,129,246,262,301,AFTER,ANP,BACKGROUND,BNP,CONCLUSION,CONTEXT,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SETTING
169,COPYRIGHT,THERE
160,BACKGROUND,CONCLUSION,IMAGING,LABEL,METHODS,PARASITIC,SUBSEQUENT
BIOMARKERS,GLIOMAS
169,METABOLITE,MMSAT,SOCIETY,SRM,WEB,WHILE,WITHOUT
CRANIAL
181,FINALLY,MICROSCOPY,MRM,OVERALL,RESONANCE,THEREFORE
ACCEPTING,THESE
CNS,JAPAN,THEREFORE,THESE,TREATMENT,WHILE
CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,PROLONGED,PURPOSE,RESULTS,THERE,TREATMENT,TTP
JAK,STAT3
169,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,LABEL,MEIER,METHODS,MRGLITT,MRI,OBJECTIVE,RESULTS,WILEY
000,100,257,322,461,568,ALBERTA,APRIL,CNS,FURTHER,III,MARCH,THERE
CNS,CPG,EPENDYMOMA,EPIGENETIC,HOWEVER,JNK,PPARG
100,CFR,GBM,ICB,RECORDS,TEN,WHILE
CTX
169,AROMATASE,COPYRIGHT,INC
169,COPYRIGHT,INC,MOSBY,PEDIATRIC,PUBLISHED,STRABISMUS
169,CLINICALLY,COPYRIGHT,INC,PROLACTIN
169,COPYRIGHT,INC,PITUITARY
169,BRAIN,COPYRIGHT,INC
001,185,693,BACKGROUND,CONCLUSION,FDG,LABEL,MET,METHODS,OBJECTIVE,PCT,PET,RESULTS,THREE
169,BLACKWELL,LTD,PUBLISHING
180,360,61G,CHINESE,EGF,EPIDERMAL,POLYMERASE,WORLD
BIOLOGICAL,BIOMARKERS,CDE,CONSENSUS,HOUSTON,INSTITUTE,ISBER,MARCH,NCI,PEDIATRIC,SOCIETY,TBI,TEXAS,THERE,THESE,WORKGROUP
169,CNS,COPYRIGHT,HLH,INC,WILEY
DEFINITIVE,ECTOPIC,EXTREME
012,045,100,112,351,AMONG,GBM,KPS,ROA,STUPP,SUB,TAKEN,TMZ
110,134,610,LABEL,METHODS,OBJECTIVE,PRESENTING,PRIMARY,PROGESTIN,RADICAL,RESULTS
001,111,150,153,242,826,954,AFTER,ANOTHER,CONCLUSION,EARLY,HOWEVER,INTRACLASS,LABEL,MATERIALS,MCNEMAR,METHODS,NUMERICAL,OBJECTIVE,RESULTS
169,194,CHANGES,COPYRIGHT,EIA,EXPRESSION,FINALLY,GH3,INHIBITORY,KEY,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,TAKEN,THEREFORE,WESTERN
101,169,194,201,BASED,CONCLUSION,COPYRIGHT,COX,LABEL,METHODS,MIB,OBJECTIVE,PFS,RESULTS,SPECT,THEREFORE
169,AMYLOID,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,MRI,RESULTS
169,BETWEEN,CONCLUSION,COPYRIGHT,GRADE,GYE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PFS,PURPOSE,RESULTS,TOXICITIES
AMINO,LIPID
001,ANY,CONCLUSION,LABEL,METHODS,OBJECTIVE,PRS,RESULTS,THERE
GAMMA
169,AMMAN,CNS,DISCUSSION,EMBRYONAL,EPITHELIAL,HUSSEIN,SIXTEEN,SOCIETY
524,CYT,DSC,LIPID,NLC,RESULTS,THEREFORE,THESE,XRD
CHANGES,INCREASED,QLQ,SERUM
100,DIEGO,GBM,MRI,SAN,SERUM,YKL
043,889,GBM,TOP2A,TOP2B,TOP3A
EVIDENCES,THERE
177,946,ALZHEIMER,COX,NEITHER,NITROSO,PGE,THESE

169,COPYRIGHT,CTX,HOWEVER,VTW
169,194,CMV,COPYRIGHT,COX,ERK,GIVEN,IE1,INC,MEC,POSTULATES,PUBLISHED
169,CED,COHORTS,CONVECTION,COPYRIGHT,GBM,INC,PUBLISHED
169,215,250,3MM,956,COPYRIGHT,CROWN,MRI,PUBLISHED,SNR

CENPJ,PCM,SCL,SEVEN,USING
001,004,169,938,BACKGROUND,CONCURRENT,COPYRIGHT,FDG,III,INDAR,IRELAND,JANUARY,LABEL,LIMBURG,LTD,METHODS,MRI,NSCLC,PET,RESULTS,SEQUENTIAL,THERE
001,125,148,169,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOVALIS,OBJECTIVE,PURPOSE,RES,RESULTS,SRT
000,150,169,215,24H,315,529,545,956,COPYRIGHT,GRACESMART,HOWEVER,HYDROXY,PALOMID,PUBLISHED
169,BACKGROUND,BECAUSE,BETWEEN,CONCLUSION,COPYRIGHT,DISCUSSION,DWI,FLAIR,IRELAND,LABEL,LTD,MACDONALD,MATERIALS,MAY,MEIER,METHODS,MRI,PROGNOSTIC,RESULTS,SEPTEMBER
169,BECAUSE,COPYRIGHT,INC,THERE,THESE
169,CONCLUSION,COPYRIGHT,GRADE,GYE,INC,IVA,IVB,LABEL,MATERIALS,METHODS,OBJECTIVE,PBT,PURPOSE,RESULTS,SEVENTEEN,STAGE,TSUKUBA,UNIVERSITY
945,ABC,ABCG2,AKT,ATP,BECAUSE,CURRENT,FINALLY,MDR,THEREFORE,THESE,UNTANGLING
160,169,CD133,COPYRIGHT,CSC,FINALLY,GBM,HOWEVER,LTD,MICRORNAS,PCR,PEI,THEREFORE,USING
169,CD163,GBM,SOCIETY,STUDIES
169,200,215,KAZAL,MVD,RGB,SOCIETY
CBV,CTP,FINALLY,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,PERFUSION,PURPOSE,RESULTS,TEN,USING
CPA
ADDITIONAL,ASSESSMENT,BACKGROUND,BRAIN,CONCLUSION,FUNCTIONAL,LABEL,MATERIALS,METHODS,QOL,RESULTS,STUDIES,THERAPY
BACKGROUND,BRAIN,C30,COMPLIANCE,CONCLUSION,EORTC,LABEL,MATERIALS,METHODS,QLQ,QOL,RESULTS,TREATMENT
215,RTS,THESE
946,AKT,GENISTEIN,GSK,HOWEVER,IGF,INHIBITION,LEF,SRC,TCF,THESE
AREAS,BACKGROUND,COVERED,DESPITE,GIVEN,III,LABEL,METHODS,OPINION,PHASE,WHILE
169,19Q,APPLIED,AUTHORS,BRITISH,FURTHER,HOWEVER,SOCIETY,THEREFORE
169,AUTHORS,BLACKWELL,CHRONIC,FEDERATION,JOURNAL,LTD,PUBLISHING,SOCIETIES,WHOLE
100,660,MEV,MTT,SINCE,THESE,U87
100,149,181,1C2,403,4A1,AG490,BACKGROUND,LABEL,MEANWHILE,NEITHER,PBC,PIAS3,PRINCIPAL,RESULTS,STAT3,SULT1A1,SULTS,TRANS,TREATMENT,UW228
015,026,CTV,DOSES,DOSIMETRIC,LABEL,METHODS,NPC,OBJECTIVE,REPLANNING,RESULTS,SIMULATED,THERE
177,FFM,LABEL,MAXIMUM,METHODS,OBJECTIVE,RESULTS,SEVENTEEN,WHETHER
956,AMONG,BACKGROUND,COX,DESPITE,DSC,HGG,LABEL,MATERIALS,METHODS,MVA,MVD,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,DIFFUSION,DTI,INC,MRI,MRS,THESE,USING,VOXEL,WILEY
169,ADENOSINE,AMONG,INC,WILEY
TAKEN,ULTRASOUND
CUP,SUNNYVALE
CNS,USING
169,COPYRIGHT,ERK,INC,ROS,TAKEN,TMZ
ABZ,ADP,BACKGROUND,BBB,BRAIN,EXPLOITING,FURTHER,LABEL,METHODS,RESULTS
177,181,AMONG,LABEL,METHODS,OBJECTIVE,PRL,RESULTS
169,250MG,3MONTHS,6MONTHS,9MONTHS,CNS,COGNITIVE,COPYRIGHT,FATAL,FATIGUE,GFT,HOWEVER,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TMZ
169,946,COPYRIGHT,E221V,EXPRESSION,IRELAND,LIPID,LTD,MMP,N238I,RII,TAKEN,TGF
169,APPLIED,AUTHORS,BRITISH,CONCLUSION,ECS,FABP4,FATTY,GBM,GRADE,III,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
169,945,946,954,AKT,IKK,INCREASED,INHIBITION,NOTCH,SNAIL,U87MG
169,ADENOSINE,ADK,AGAINST,III,INC,KEY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WESTERN,WILEY,WORLD
400,GBM,MACDONALD,VORINOSTAT
100,17P,DIMINISHED,HOWEVER,PEDIATRIC,WNT
FINALLY,GBM,THEREFORE,THESE,VIRUSES,WHILE
544,FDG,FUNCTIONAL,HOWEVER,MIB,PET,THESE,WORLD
001,945,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,STUDENT,THEREFORE
028,046,AGEWISE,GBM,HISTOLOGY,MOLECULAR,PEDIATRIC,PRIMARY,SEVENTY
ECTOPIC,EXPRESSION,FINALLY,HOWEVER,MICRORNAS,PCR
BACKGROUND,DISCUSSION,GALASSI,III,LABEL,RESULTS,SYLVIAN,THERE,THREE
001,123,125,BACKGROUND,JANUARY,LABEL,MEIER,METHODS,NSCLC,RESULTS
001,100,177,CBCTS,FORTY,THERE
169,CENTRAL,CNS,COPYRIGHT,GIVEN,LTD,MONRO,THESE
169,201,215,954,BACKGROUND,BIOLOGICAL,CHRONIC,COPYRIGHT,III,INC,LABEL,METHODS,PSYCHIATRY,PUBLISHED,REL,RESULTS,SEVENTY,SOCIETY,THESE
169,COPYRIGHT,DIAGNOSIS,ESR,LABORATORY,MRI
DICOM,DIGITAL,IMAGING,THESE
215,CNS,GBM,MICROGLIA,MMP,PPF,THESE
945,946,ATLAS,COCULTURE,CXCR4,EGF,GBM,GRK,NF1,PDGFR,PREVIOUSLY,TGF
447,644,988,DESPITE,HOWEVER
100,125,144,169,400,AGS,BACKGROUND,COPYRIGHT,KARNOFSKY,LABEL,METHODS,PFS,RESULTS,SOCIETY,TREATMENT
169,174,945,956,BACKGROUND,COPYRIGHT,HOWEVER,INTERFERON,LABEL,METHODS,PEG,QOL,QUALITY,RESULTS,SERUM,SOCIETY,STUDIES
160,PAPILLARY
AG490,CAM,CHICKEN,EPO,HOWEVER,MMQ,STAT3,THESE
130,EARLY,GBM,PREDICTIVE,TMZ
001,APRIL,DEVIATIONS,FRAMELESS,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OCTOBER,OVERALL,PURPOSE,RESULTS,SRS,UNIVERSITY
CHEST,INC,MOSBY,PERSISTENT,PUBLISHED,ULTRASOUND
014,038,101,169,APMIS,AUTHORS,AVASTIN,ELISA,FORTY
169,177,5274857,INHIBITION,SMO,SMOOTHENED,THESE
LABEL,METHODS,OBJECTIVE,OBJECTIVES,OLDER,REDUCED,RESULTS,SETTING,THESE,UNIVERSITY,WOMEN
CURRENT
19Q,CNS,MRI
583,JAPAN,MRI,OHASAMA
169,BACKGROUND,CONTEXT,COPYRIGHT,CSF,DESPITE,IGG,INC,LABEL,METHODS,MRI,NMO,OBJECTIVE,PURPOSE,RESULTS
22Q11,GGS,INI,MIB,RESULTS,V600E
SMARCB1,SUBSEQUENT
001,100,177,CONCLUSION,DEOXY,FDG,FINAL,FLT,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SUV
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
169,CCM,CLEAR,MIB,SOCIETY
ATTENTION,BACKGROUND,CONCLUSION,CYBERKNIFE,LABEL,METHODS,RESULTS,WEIGHTING
169,AUTHORS,BRAIN,CNS,HPC,MENINGEAL,PATHOLOGY,PFS,SFT,SOCIETY,WORLD
169,AUTHORS,BRAIN,CCRCC,CENTRAL,CNS,FINALLY,FURTHER,MET,MICRORNAS,PATHOLOGY,PCR,SOCIETY,TEN,VHL,WHILE
001,169,BACKGROUND,COPYRIGHT,DIFFUSION,DTI,FRACTIONAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROBIN,SOCIETY,VIRCHOW
109,135,144,169,BARCELONA,COPYRIGHT,INTERPRET,LTD,MRS,SPAIN,TES,WILEY
GBM,HOWEVER,MRI,NON,U87
APRIL,COGNITIVE,TOXICITIES
150,190,340,AGE,BASED,C15,C30,CONCLUSION,EORTC,LABEL,MATERIALS,METHODS,OBJECTIVE,PAL,PURPOSE,QLQ,QOL,RESULTS,SIMILAR,TREATMENT,USING
945,FURTHER,HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY
945,CAS,CRKII,DOCK180,FINALLY,PDGFR,SRC,TAKEN,THESE,Y1811
169,229,4IGB7H3,BECAUSE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THYROID,TSH,ULTRASOUND
ECT
007,008,017,PREDICTIVE
AIF,ALA,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
169,194,BETWEEN,BUGANDO,CONCLUSION,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,NORTHWEST,OBJECTIVE,OCTOBER,RESULTS,SEPTEMBER,THERE
100,169,ABOUT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OPTIC,REPORTS,RESULTS,THERE
169,AFTER,CONCLUSION,COPYRIGHT,INC,LABEL,LILIEQUIST,METHODS,MONRO,OBJECTIVE,RESULTS
150,160,169,200,COPYRIGHT,GBM,GRADE,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,SECONDARY,SEVENTY,TMZ
001,113,169,310,AMONG,COPYRIGHT,GAMMA,INC,KARNOFSKY,KNIFE,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,SRS,THERE
101,169,948,AKT,CAL,COPYRIGHT,GBM,HOWEVER,IC87114,ISOFORM,LTD
169,AFTER,BACKGROUND,BECAUSE,COPYRIGHT,CUSHING,INC,LABEL,METHODS,PITUITARY,RESULTS
169,COPYRIGHT,ELECTRICAL,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,ROBERTS,WELLS
169,174,COPYRIGHT,GERMANY,LTD,STORZ,TUTTLINGEN,VITOM
169,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,FIRST,LABEL,LTD,MALIGNANT,MAXILLO,METHODS,MRT,PUBLISHED,SURGERY,WILMS
169,COPYRIGHT,LTD,MAO
AKT,BACKGROUND,ERK,GBM,HOWEVER,HSP70,LABEL,MEK,METHODS,MO59J,OVERALL,RADIATION,RESULTS,SPHEROIDS,THESE,UGBM1
169,BLACKWELL,CNS,CSF,FOLLOWING,HOWEVER,LTD,LYMPHOMAS,PCNSL,PUBLISHING,SCNSL
10001,333,EPIDERMOID,MEDICAL,PUBLISHERS,SEVENTH,USA
178,200,CUSHING,HOWEVER,INITIAL,PITUITARY,TMZ
109,110,411,FURTHER,HOWEVER,KARNOFSKY,PFS
160,ANOTHER,HOWEVER,THESE
001,014,028,035,038,117,137,229,BSC,C30,CVD,DISEASE,III,INDEX,KARNOFSKY,OWING,PRIMARY,QLQ,TREATMENT
DWI,FURTHER,GBM,MRI,PNETS,R132H,RESTRICTED,SEVEN,TEN,THREE
066,201,252,542,647,977,AMONG,HOWEVER,MEANWHILE,MWCNT,THEREFORE,USING
221,222,BAX,HOWEVER,LN308,TAKEN,TMZ,U87
000,169,COLLEGE,COPYRIGHT,EXCELLENCE,INSTITUTE,LTD,PUBLISHED,ROYAL
169,COPYRIGHT,CYTOKINES,GBM,IRELAND,LTD,MULTIFORME
169,COPYRIGHT,DROSOPHILA,GIVEN,HIPPO,INC,SWH,TAO,USING,WARTS,YAP
174,450,BACKGROUND,BIOCHIP,LABEL,METHODS,RESULTS,TOTAL
ADP,ALKYLATING,BRCA2,DESPITE,FIRST,INHIBITION,RAD51
AEROBIC,AFTER,ATP,BECAUSE,NMR,PARTICULAR,ROS
169,945,946,BBB,BTB,COPYRIGHT,GBM,PEG,PEI,RGD,RGDYK,THESE,U87,VCH,WILEY
001,169,19Q,19Q13,BRITAIN,CIC,COPYRIGHT,GREAT,IDH,IRELAND,LTD,PUBLISHED,RECURRENT,SOCIETY,THESE,WILEY
AIM,SIMILAR,UTILIZING
AMONG,BECAUSE,BIOMARKERS,DCPIS,HOWEVER,MYC,PPI,PROTEIN,RB1,SDEGS
000,HOWEVER
000,170,AFTER,BRAIN
169,COPYRIGHT,LEV,LTD
CYBERKNIFE,EQUIPMENT,GAMMA,GIVEN,KNIFE,LABEL,LEKSELL,NOVEL,OBJECTIVE,PERFEXION,PURPOSE,RESULTS,SRS,SUMMARY
177,AGE,COGNITIVE,CONCLUSION,LABEL,METHODS,NFA,OBJECTIVE,PFC,RADIATION,RESULTS
CY5,GBM,MET,PEG,PEGYLATED,SLN
169,ALONG,APPLIED,AUTHORS,BRITISH,JUDICIOUS,SOCIETY,THESE
100,258,414,492,ALTOGETHER,ATLAS,BTSCS,CPG,GBM,SOX,THESE,TREATMENT
916,ACCORDING,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
100,125,134,160,177,274,437,559,ASL,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METASTASIS,METHODS,RCC,RESULTS,STUDENT
140,THESE,USING
AMONG,FINALLY,GAS41,MYC,TIP60,YEATS
BLOOD,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
AKT,GBM,GSC,HOWEVER,MRI,PI3,THESE
169,COPYRIGHT
001,108,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,VOLUMETRIC
112,115,BACKGROUND,BETWEEN,CONCLUSION,CONTINUOUS,DESPITE,HOWEVER,IOM,LABEL,MEP,METHODS,MONITORING,OBJECTIVE,RESECTION,RESULTS
ACCORDING,BACKGROUND,COMPOSITE,CONCLUSION,FIBER,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,SPATIAL,SYLVIAN,TALAIRACH
008,025,077,169,177,284,366,736,BACKGROUND,BASEL,COPYRIGHT,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SRS,USD
006,025,155,169,180,183,956,BACKGROUND,BLACKWELL,CONCLUSION,IGF,IQR,LABEL,LTD,METHODS,MRI,PRIMARY,PUBLISHING,RESULTS,ULN,VALID
001,002,004,005,BBO,CARLO,DBO,FURTHER,INTENSITY,MONTE,OAR,PLANS,TPS,TREATMENT,V95
HOWEVER,HYPOXIA,LDH
110,160,215,ARRAY,BIC,GIBBS,PCR,USING
BIOMARKERS,DOPPLER,EEG,S100B,TAU,UCH
001,169,200,215,CNS,GBM,III,INTENSITY,LABEL,MET,METHODS,MRI,MTD,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,TREATMENT
169,AKT,CELLTITER,CONCLUSION,FURTHER,GBM,KNOCKDOWN,LABEL,METHODS,MITOTIC,NVP,OBJECTIVE,PURPOSE,RESULTS,U87
BACKGROUND,BLOOD,LABEL,METHODS,RESULTS,THESE
946,APM,CD8,COMPARISON,DEFECTS,SINCE,TAKEN,TAP,THESE
ADDITIONAL,AFTER,CGH,CY5,DIAGNOSTIC,HISTOLOGIC,HISTOLOGY,NEXUS,REGIONS
FAK,GBM,KNOCKDOWN,THESE
150,200,956,AFTER,GBM,NSA
169,40YEARS,CNS,COPYRIGHT,DESPITE,EXPRESSION,HOWEVER,ISSUE,SPECIAL,SUPPORTED
BACKGROUND,DISCUSSION,ESO,FAS,HOWEVER,LABEL,METHODS,RESULTS,T98,TRA,TREATMENT
ABCA1,EPIDERMAL,GBM,LXR,SREBP,TARGETING,THESE
LNA,MET,PREVIOUSLY
005,035,037,FOLLOWING,FURTHER,III,PFS,SIX
169,AKT,BIM,GEFITINIB,INHIBITION,LC3,NOTABLY,YET
100,101,127,130,160,AFFYMETRIX,ASSIGNMENT,CODESET,COMPARISON,FINALLY,PEARSON,TECHNOLOGY
177,BACKGROUND,BMD,HOWEVER,LABEL,METHODS,RESULTS,SUMMARY,THERE,THEREFORE
169,194,945,956,ABCD1,ABCD3,ALD,C24,C26,COPYRIGHT,HOWEVER,INC,PMP70,THEREFORE,TNF,UNDER
169,194,CENTRAL,CMC,COPYRIGHT,LTD,PUBLISHED
EXCELLENT,EXTENSIVE,FINALLY,HOWEVER,PARKINSON,PSC,SHH,THERE,WHEREAS,WNT
946,CCND1,EGF,HDAC3,SRC,THESE,WARBURG,WNT
180,682
151,154,169,190,214,219,CONCLUSION,COPYRIGHT,CROWN,GROSS,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
169,ADJUSTMENT,BMP,COPYRIGHT,IRELAND,LTD,PRL
169,CHANGES,CHRONIC,CNS,COLLEGE,COPYRIGHT,CORPOREAL,FOLLOWING,HOWEVER,LTD,PUBLISHED,ROYAL
169,ADOLESCENT,AYA,BACKGROUND,COPYRIGHT,DEPARTMENT,END,GUSTAVE,INSTITUTE,LABEL,LTD,METHODS,PAEDIATRIC,RESULTS
169,ACT,AUR,BONES,CNS,CONCLUSION,COPYRIGHT,FORTY,INC,INSURANCE,LABEL,LANGERHANS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THERE,THREE
516,775,AIM,BACKGROUND,COMPLIANCE,CONCLUSION,GPS,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,THERE
001,AGE,EVN,GIVEN,GROSS,LABEL,MEIER,METHODS,MIB,OBJECTIVE,RESULTS,STR,THERE,TREATMENT,TYPICAL
14Q32,203,365,367,383,485,596,BACKGROUND,CHANGES,CONCLUSION,DENSITY,LABEL,LOW,MATERIALS,METHODS,RESULTS
053,142,215,BACKGROUND,COX,DISCHARGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHETHER,YEARS
000,101,107,241,421,640,AVM,COMPARABLE,CONCLUSION,LABEL,METHODS,NEP,OBJECTIVE,RESULTS,SIXTY
169,263,2DG,737,ABT,BAK,BCL,BECAUSE,HOWEVER,MCL
5HMDC
CNS,CSF,DWI,EPI,MRI
ADHERENCE,CED,CONVECTION,CSF,FORTY,INTRA,THERE
CONGENITAL,EVENTUALLY,PRIMITIVE
378,BRAIN,EFFORTS,MICRORNAS,MIR,NSCLC,PCR
169,946,ALZHEIMER,BECAUSE,COPYRIGHT,MYD88,TLR
115,CENTRAL,COMMITTEE
169,CNS,COPYRIGHT,INC
169,194,AFTER,COPYRIGHT,INC,SINCE
169,AGAINST,DNFFV,EEG,EMG,HFS,HOWEVER,INC,WILEY
946,ALTERED,EGF,GBS,GIVEN,MHC,PRESENTLY,TGF
THESE
BRAIN,JAPAN,SRS,THREE,USA,WHILE,WHOLE
184,DIFFERENT,III,PHASE
PHASE
BAETE,BOWSHER,CARLO,FDG,MAP,MONTE,MRI,NUYTS,PET
480,BIOMARKER,CIV,FOLLOWING,GBM,HOWEVER,PKS,RAF,RAS,SAMPLES,SERUM,TLN
CLINICIANS,HOWEVER,JANUARY,LOE,SIMON
948,954,FOLLOWING,PKC,TNF,TRAIL,TREATMENT
160,169,ANG,BBB,BCECS,CLP,COPYRIGHT,CROWN,LTD,PTX,PUBLISHED,THEREFORE,U87
169,BESIDES,BRAIN,COPYRIGHT,CURRENTLY,SURGERY
177,1NC,300,400,AAA,DCA,ECLIPSE,HD120,LABEL,METHODS,MLC,MUS,NOVALIS,OBJECTIVE,PURPOSE,RESULTS,THESE
ADDITIONAL,LABEL,METHODS,OBJECTIVE,PLANS,PRO,PURPOSE,RESULTS,THESE
ADC,BACKGROUND,BRAIN,CNS,DIFFUSION,DWI,GADOLINIUM,IVB,LABEL,METHODS,MRI,MTX,PHYSICIANS,THERE
ABI,ASSISTIVE,ATC,HEUGTEN,JOODE,PROMPTING,RESULTS,TAP,TELEVISION,TYP
BACKGROUND,BRAIN,CONCLUSION,LABEL,METHODS,OCD,THEREFORE
011,027,032,169,ACCORDING,CHO,CONCLUSION,COPYRIGHT,INC,LABEL,LAC,LGG,MATERIALS,METHODS,NAA,OBJECTIVE,PURPOSE,PWI,RESULTS,THESE,WILEY
160,DIFFUSE,THREE
169,194,BACKGROUND,COMMITTEE,COPYRIGHT,INC,LABEL,LEARNED,LESSONS,METHODS,PATIENT,PDNPP,PUBLISHED,RESULTS,STAFF
INTRA,LABEL,MRI,OBJECTIVE,PURPOSE,RESULTS,SUB,SUMMARY,UHF
259,673,AMONGST,COX,END,HOWEVER,MEIER,PROGRAM,RESULTS

ASN372HIS,BRCA1,BRCA2,EASTERN,FURTHER
176,960,CSF,FURTHER,INITIAL,PNETS,THERE,UNDER
SEVERAL
LGG,TAKEN
118,192,664,BETWEEN,CONCLUSION,CRT,GHD,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
ADC,BBB,DCE,DWI,MRI
APART,BRAIN,CONCLUSION,ENGLISH,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHERE
ACROMEGALY
THESE
000,200,ACHARYA,CNS,DETAILS,FOLLOWING,THESE
ENGRAFTED,GIVEN,LINAC,WHILE
169,ALZHEIMER,BASED,BASEL,COPYRIGHT,HUNTINGTON,III,NAD,PARKINSON,STUDIES
BACKGROUND,BRAIN,CONCLUSION,CONSISTENT,DESPITE,JANUARY,LABEL,METHODS,REGARDING,RESULTS
169,COPYRIGHT,DELAYED,DNT,THESE,TLE
CAG,GHRELIN,INC,MEN,PUBLISHED
ABC,ABCB1,ABCG2,ATP,CRUDE,PGP,THESE,TRANSIENT
169,COPYRIGHT,EPH,EPHA2,ERK,GPI,HOWEVER,LTD,MAP,UNTIL
131,CARLO,COMMISSION,FLORIDA,HENCE,LABORATORY,MEV,MONTE,OAK,PROTECTION,RIDGE,SAF,UNIVERSITY
112,356,AWAKE,BACKGROUND,FIFTY,HOWEVER,JANUARY,LABEL,METHODS,RESULTS,SIXTY,TOTALLY
000,012,036,ABILITY,BACKGROUND,CENTRAL,LABEL,METHODS,RESULTS,SURGERY,TELEPHONE,THEREFORE
000,100,272,304,374,945,954,967,AGE,BACKGROUND,CHINA,CHINESE,ESTIMATES,HOWEVER,JANUARY,LABEL,MCSBT,MEANWHILE,METHODS,OCTOBER,OPPOSED,PBT,POISSON,PREVALENCE,RESULTS,SEPTEMBER,WORLD
169,COPYRIGHT,PITUITARY,SAS
001,004,007,015,024,037,043,046,131,149,322,600,BACKGROUND,COMPARING,ERK,LABEL,MEK,METHODS,MUTATIONS,ONCOGENIC,RAF,RESULTS,THERAPY,TREATMENT,V600E,V600K,V600R
002,021,179,BACKGROUND,BETWEEN,BRAIN,CONCLUSION,ITALIAN,JANUARY,LABEL,METHODS,RESULTS
010,011,016,048,19Q,AGE,AOA,BEIJING,FURTHER,INTER,LOH,NONRANDOM,OTHER,P53,SEVENTY,TIANTAN
169,ACTIVATING,LABEL,MALIGNANT,MAS,METHODS,OBJECTIVE,PLX4720,PURPOSE,RESULTS,USING,V600E
143,160,BAF47,MRI,NF2,PREVIOUSLY,SMARCB1
129,141,322,ANNEXIN,DSRED,LRIG3,MONOMER,PCR,THESE,U87,WESTERN
135,160,177,ADC,CHO,CONCLUSION,DWI,FCD,FLAIR,FOCAL,GGS,GLX,LABEL,LDA,METHODS,MRI,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,UNIVARIATE
003,004,478,BONFERRONI,CHI,CSF,GIANT,MEDLINE,PATIENT,SIXTEEN,THERE
ALZHEIMER,KEY
BP1,CONCLUSION,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
138,154,403,557,BACKGROUND,BMI,CONCLUSION,COX,JANUARY,LABEL,METASTATIC,METHODS,RESULTS
FINALLY,SEQUENCING
00001,008,035,17Q12,ACCOUNTING,AFTER,CONSORTIUM,GLIOMAS,NPL
CNS,EPSTEIN,EXTRA,GIVEN
105,AFTER,GBM,HOWEVER
947,DMF,INDUCTION,T98,THEREFORE,TMZ,VPA
CNS,DUE,GTR,HEMATOLOGY,HIT,HOWEVER,PEDIATRIC,SOCIETY,TREATMENT
001,128,146,181,AFTER,ANOTHER,APRIL,BACKGROUND,BETWEEN,CONCLUSION,COX,KARNOFSKY,LABEL,METHODS,MRI,PFS,RESULTS,SEPTEMBER,TMZ
169,945,COPYRIGHT,HOWEVER,INC
PHACE,THEREFORE
DIFFUSION,HOWEVER,INITIAL,MRI
MRI
200,GROUP,MRI,OPERATION,TSS,USING
169,CONSISTENT,COPYRIGHT,EPH,EPHA7,FLS,FURTHER,INC,KNOCKDOWN
160,169,500,BACKGROUND,CONCLUSION,COPYRIGHT,EORTC,HEMATOLOGY,LABEL,METHODS,MSG,PRIMARY,PULMONARY,RESULTS,SAS,TUNISIA
169,194,COPYRIGHT,ENGLISH,ETIOLOGIES,POSTERIOR,PUBLISHED,PWD
169,COPYRIGHT,SAS
169,APPLIED,AUTHORS,BRITISH,HGG,MOUSE,SOCIETY,THERE
169,APPLIED,AUTHORS,BRITISH,SOCIETY
150,GBM,GRADE,III,LABEL,METHODS,OBJECTIVE,ONGOING,PFS,PHASE,RESULTS
AUSTRALIA,GRANT,KENNETH,MANUSCRIPT,MAY,SEPTEMBER
001,003,011,035,169,1P19Q,FURTHER,IDH,MRI
SHARING
177,ALZHEIMER
160,169,183,COLOR,DOPPLER,GEORG,IMAGING,PERFUSION,STUTTGART,TCS
198,202,230,BLOOD,IGF,THEIR,TSS
128,169,663,COPYRIGHT,DISEASE,FIFTY,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMON,USING
169,258,284,COPYRIGHT,CSF,FIFTEEN,ICP,LABEL,MANAGEMENT,METHODS,OUTCOME,RESULTS,SAS,UNLABELLED
169,AFTER,BACKGROUND,COPYRIGHT,IGF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PITUITARY,PUBLISHED,RESULTS,SPANISH,SURGERY,TREATMENT
100,AFTER,BACKGROUND,CONTEXT,GBM,KETTERING,LABEL,OBJECTIVE,RESULTS,SLOAN,WORLD

KTP,WHEREAS
946,ADULT,BACKGROUND,CONTEXT,CRF,GFRA2,GFRA3,GPS,HOWEVER,LABEL,METHODS,OBJECTIVE,PROP1,REDUNDANCY,RESULTS,RET,WESTERN
AROMATASE,CLOMIPHENE,FSH,LETROZOLE
CONCLUSION
BACKGROUND,CONCLUSION,GLASGOW,GLIOMAS,MRI,PILOCYTIC
180,CNS,CSF,RESULTS
BETWEEN,ENDOSCOPIC,FRAMELESS,MATERIALS,METHODS,OBJECTIVE,RESULTS
BRAIN,BTSCS,SIMILARLY
169,COPYRIGHT,PUBLISHED,SAS
106,169,181,COPYRIGHT,HISTOLOGIC,LOCAL,SAS
169,4TH,COPYRIGHT,PUBLISHED,SAS,THESE
169,COPYRIGHT,SAS
169,COPYRIGHT,HOWEVER,SAS,THALAMO
169,COPYRIGHT,SAS
169,ARACHNOID,CAVERNOMAS,COPYRIGHT,CSF,EPIDERMOID,METASTASES,MRI,PRIMARY,PUBLISHED,REBLEEDING,SAS,SIGNS,THEREFORE,THESE,TREATMENT
100,169,COPYRIGHT,INTRAMURAL,MONRO,OVERALL,SAS,THERE,THESE
670,946,AFTER,ALZHEIMER,ATP,BACKGROUND,BBB,DESPITE,LABEL,LASER,METHODS,NIR,OBJECTIVE,RESULTS
400,CPT,DLT,IGFBP,MTD,PFS,SERUM,VORINOSTAT
169,183,215,600,AFTER,ANAPLASTIC,APGAR,BACKGROUND,BECAUSE,CONCLUSION,DUE,FURTHER,GEORG,HIT,III,LABEL,METHODS,MRI,SKK,STUTTGART,TUMOURS
005,009,013,033,040,042,100,169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,RPA,SEVEN,SOCIETY
5ANGIOPEP,ANG1005,BACKGROUND,BBB,CONCLUSION,CONVERSELY,CY5,DECREASING,LABEL,METHODS,RESULTS,TRANSPORT,U87
AZD1480,GBM,JAK,JANUS
FDA,GBM,III,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
MRI,SNR,STIMULATED
169,ALZHEIMER,ASSOCIATES,CNS,COPYRIGHT,LTD,MULTIFORME,PUBLISHED
169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,009,029,044,101,117,121,130,160,169,ACTUARIAL,AVOIDANCE,BETWEEN,BRAIN,COPYRIGHT,GHENT,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,T4A,T4B,THERE,UNIVERSITY
BURKITT,FOCUS,HOWEVER
1634A,2976G,3014A,3024C,3056A,3130A,ARG992GLN,ASN1044ASP,GBM,GLU545ALA,HGG,III,ILE1019,IRANIAN,MET1005VAL,P53,SER1008CYS,THR170THR,THREE,VAL,WORLD
1950S,217,451,531,834,BASED,COX,POPULATION,THESE,WHILE
036,129,169,177,AFTER,DISEASE,END,IQR,JOURNAL,LABEL,METHODS,OBJECTIVE,OUTCOME,PREVEND,PREVENTION,RENAL,RESULTS
HEMIFACIAL,HFS,MRI

235,618,CONCLUSION,GBM,LABEL,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,R132MUT,RESULTS
169,COPYRIGHT,CSF,SEVERAL,SOCIETY
169,BRAIN,COPYRIGHT,EXPRESSION
MICROGLIA
002,032,11C,OCTOBER,PET
169,COPYRIGHT,SAS
169,COPYRIGHT,SAS,THEIR
III,LABEL,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS,THERE
AIP,BACKGROUND,CONTROL,FIRST,IGF,LABEL,METHODS,RESULTS,SEVEN,SIX,SMS
003,169,COPYRIGHT,EPIDERMOID,LTD,WHEREAS
169,COPYRIGHT,GAMMA,HAVEN,INC,JANUARY,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,WHILE
105,169,172,194,264,COPYRIGHT,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
036,10877,117,169,177,18YEARS,5MONTHS,7MONTHS,AGE,AMONG,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,FIFTEEN,GTR,HDC,HOWEVER,LABEL,LARGEST,LTD,METHODS,RESULTS,SIX,TEN,THERE,UPFRONT
125,CURRENTLY,HOWEVER,KARNOFSKY,KPS,PATIENT,PCNSL,TBC,TREATMENT,TRM
HOWEVER,THEREFORE
EDITING,SINCE
FDA
945,BRIEF,CONTROL,PROMOTION,USING
947,ATM,BACKGROUND,CONCLUSION,DSB,EFFICIENT,EXPRESSION,GBM,LABEL,MULTIFORME,NON,PRINCIPAL,PROTEASES,RESULTS,TREATMENT
953,PKC,RESULTS,SEVERAL,THESE
174,AFTER,CONCLUSION,DEPOCYT,HISTOLOGY,LABEL,METHODS,SECONDARY,UNLABELLED
169,ASSESSMENT,INC,THERE,WILEY
169,COPYRIGHT,DEFECTS,FIFTY,INC,LABEL,METHODS,OBJECTIVE,OTOLOGICAL,RADIATION,RESULTS,SETTING,SEVEN,SIXTY,SOCIETY,THERE,TREATMENT
169,COPYRIGHT,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,REASONS,RESULTS,SOCIETY
169,362,AMONG,COPYRIGHT,CPG,MSP,PCR
AMERICA,AUSTRALIA,EASTERN,NF1,PXA,SOUTH,THESE
000,382,BRESCIA,DEPARTMENT,HISTOLOGY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RECURSIVE,RESULTS,RPA,UNI,UNIVARIATE,UNIVERSITY
946,AKT,CD133,GBM,III,TUBULIN
ARF,EFFORTS,GBM,INHIBITION,INK4A,MET,THESE,USING
834,AFTER,III,LABEL,LEBANON,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
10Q,16Q,19P,19Q,22Q,CASES,HPF,IHC,PGNTS
ABDOMINAL,ASIAN,LABORATORY,POSTMORTEN

177,AGE,BACKGROUND,BLAND,FORTY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PGS,RESULTS,USING
ADC,BACKGROUND,BECAUSE,DWI,LABEL,MATERIALS,METHODS,MRI,RESULTS,SEVERAL,THERE
169,COPYRIGHT,ROS,THESE,VILLANO
004,006,018,160,169,171,177,180,261,274,307,343,350,479,718,880,CONCLUSION,CONTROL,COPYRIGHT,FUNCTIONAL,GRADE,GROUP,HOWEVER,INC,LABEL,METHODS,NEUROLOGIC,OBJECTIVE,PURPOSE,RADIATION,RESULTS
008,100,169,COPYRIGHT,GAMMA,INC,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PRIOR,PURPOSE,RESULTS,SRS
160,169,284,ASSOCIATED,CENTRAL,COPYRIGHT,GAMMA,LOCAL,MICROTUBUL,NSE,PROTEIN,PUBLISHED,SAS,THERE,UNEVENTFUL
169,COPYRIGHT,HOWEVER,LATERAL,MRI,PUBLISHED,SAS
169,AMERICA,BACKGROUND,COPYRIGHT,INCIDENCE,LABEL,LTD,METHODS,NORTH,RESULTS
169,AMONG,COPYRIGHT,GENERAL,IMAGING,LABEL,LESIONS,LIBERATION,METHODS,OBJECTIVE,RADICAL,RESULTS,SOLID,THESE
169,CASES,COLLEGE,CONGENITAL,COPYRIGHT,EAC,LTD,PUBLISHED,ROYAL
012,029,111IN,130,169,174,190,194,ADVERSE,AUC,BACKGROUND,BCL,BRESLOW,CHT,COPYRIGHT,CROWN,FORTY,GROUP,IRELAND,LABEL,LTD,METHODS,NSE,OCTREOTIDE,PUBLISHED,RESULTS,SSTRS,TTP,VEGFA,VEGFC
128,143,271,ABO,AFRICAN,AMERICANS,CAUCASIAN,CONCLUSION,FEW,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
CONCLUSION,CTC,FURTHER,HOWEVER,III,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RCT,RESULTS,THESE
231,CACO2,COMPARING,HOWEVER,LN229,MCF,MDA,TPP
169,945,SOCIETY
169,19Q,BECAUSE,CHROMOSOME,RGNTS,SOCIETY
121,136,138,DENMARK,PATIENT,RAD51L1
250,650,HOWEVER,MYC,TSS
358,403,729,AMONG,DANES,DENMARK,LABEL,METHODS,NATIONWIDE,OBJECTIVE,OUTCOME,POISSON,RESULTS,SETTING,SEX,THERE
CNS
003,026,AMONG,GAMMA,MODEL,MRS,MUTATIONS
CULTURE,HOWEVER,MICROGLIA,REMARKABLY
100,CST,DIFFUSION,DTI,IFO,INITIAL,SLF
AKT,ARF,DESPITE,INK4A,KIRSTEN,RAS,WHILE
GBM,HOWEVER,PI3,RAPAMYCIN,RAS,RTK,TORKINIBS
114,129,169,APRIL,BETWEEN,COPYRIGHT,FRT,LTD,THERE,UNIVARIATE
106,169,COPYRIGHT,HOWEVER,LIF,LTD,MRI,PRL
169,946,COPYRIGHT,FOXM1,INC,WNT,WNT3A
BLACKWELL,CD133,CSC,ESC,FORTY,LABEL,LIMITED,METHODS,NANOG,OBJECTIVE,PUBLISHING,RESULTS
100,BIS,BL2,CUANZHU,ELECTRO,FENGCHI,GROUP,HAN,HN4,LABEL,MAC,METHODS,OBJECTIVE,RESULTS,THERE,TIANZHU,YUYAO
CHANGES,CY5,EFFECTIVE,MRI
CNS,COGNITIVE,FIFTY,MRI,MTX,PCNSL,QUALITY
BQ788,EDN,EDNRB,GSC,MOLECULAR,NCC,SERUM,THESE,USING,YKL
100,143,169,181,215,678,BACKGROUND,COPYRIGHT,EFS,EWING,INC,LABEL,METHODS,MLN4924,NAE,NEDD8,PROCEDURES,RESULTS,TREATMENT,UPS,WILEY
169,AFTER,ALZHEIMER,AWARD,COPYRIGHT,EFFECTS,FORTY,INC,LECTURE,MEG,MRI,PARKINSON,SQUID,THESE,TMS,WILEY
BRAIN
AMONG,THEREFORE,THESE
1990S,ALREADY,BESTA,CARLO,INSTITUTE,ITALY,MILAN,NEURO
ACUTE,CHRONIC,EMERGENCY,ICP,INITIAL,SECONDARY,URI,WHILE
120,157,355,874,885,BRAIN,V600E,VE1
BASEDOW,MRI,ORTHOPTIC
DIAGNOSIS,NTG

12A,12B,170,222,AFTER,CHINESE
100,169,520,BACKGROUND,BORDERLINE,CIS,DESPITE,HOWEVER,IGE,INCREASED,LABEL,METHODS,NON,ORS,OVERALL,RESULTS,STRATIFIED,TOTAL
000,192,215,CARTESIAN,DCE,DSC,FOURIER,MRI
100,195,205,CLL,CONCLUSION,GENERIC,HODGKIN,HOWEVER,LABEL,LGG,MEDICAL,METHODS,NHL,OBJECTIVE,PURPOSE,RESULTS,SHORT,TREATMENT
177,215,400,541,CONCLUSION,III,KETTERING,LABEL,METHODS,MSKCC,MUCOSITIS,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,SLOAN,THESE
100,119,169,759,INC,MSI,MUTATIONS,OCCCS,THESE,WILEY
945,ANGIOGENIC,ENDOCRINE,RELATED,RWD
945,HIF,HYPOXIA,RSUME,RWD
500,CPG,HMGN1,MECP2,PCR,RECIPROCAL,WESTERN
ADP,AKT,ECM,ERK,GH3,HEPARANASE,MTT,NOTABLY,PCR,PITUITARY,SRC
006,045,147,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,KARNOFSKY,LABEL,LOG,MEIER,METHODS,RESULTS,SOCIETY,SRS
19Q,CENTRAL,DIFFERENT,MOLECULAR,NERVOUS,TUMOURS,WORLD
100,120,500,BACKGROUND,CONCLUSION,FEC,FLEMING,FOLLOWING,LABEL,MARCH,METHODS,RESULTS,SEQUENTIAL,USING
PAS,PILOCYTIC,PROMINENT,ROSENTHAL,THESE
160,AFTER,CD3,HRBCL,MRI,THESE
CURRENT
166,169,177,300,956,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,DSB,EOSIN,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTT,NEITHER,NIGERIA,OBJECTIVE,RELEVANCE,RESULTS,SOUTHWEST,SSB,THERE,U87MG
169,ADDITIONAL,EWING,EWSR1,SOCIETY
CONCLUSION,CRANIAL,LABEL,METHODS,OBJECTIVE,RESULTS
946,BECAUSE,GBM,HISTOLOGIC,LY2109761,MICROARRAY,TGF
FINALLY
COMPARISON,DCS,DIFFUSE,DOPPLER,FINALLY,MRI,VALIDATION
169,332,BRITAIN,COPYRIGHT,ECM,GENERIC,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
BASED,HOWEVER
BMS,BTR,SRS
BMS,EFFECTIVE
DIFFERENT,PET
131,PATHOLOGY,PRE
169,APRIL,BASEL,BETWEEN,CONCLUSION,COPYRIGHT,LABEL,MEDICAL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS

INTRA
BACKGROUND,CHANGES,CONCLUSION,DFI,LABEL,MARCH,METHODS,PGR,RESULTS,THESE
183,400,CNS,GROWING,MICROBEAM
183,LABEL,METHODS,OBJECTIVE,RESULTS,SEQ,SIB,THESE,V45

954,AKT,BACKGROUND,DELTA,ERK,EXOGENOUS,EXPRESSION,GBM,GLY,HES,LABEL,METHODS,NOTCH,OVERALL,RESULTS,SNB,VAL
001,002,035,169,726,913,917,ADC,AUC,CBV,CHO,CONCLUSION,COPYRIGHT,DIAGNOSTIC,DSC,DWI,FORTY,INC,LABEL,MATERIALS,MAXIMUM,METHODS,MRI,MRS,NAA,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,TESLA,WILEY
BACKGROUND,CONCLUSION,IOMRI,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,TESLA,THERE
169,ALA,CHO,CNC,CONCLUSION,COPYRIGHT,GBM,GLY,III,INC,LABEL,MATERIALS,MEN,METHODS,MRS,NAA,OBJECTIVE,OIV,PRESS,PRIOR,PURPOSE,RESULTS,WILEY
001,020,048,169,690,874,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RFY,THERE,WILEY
113,215,ACROMEGALY,AMONG,BECAUSE,SECONDARY
001,002,004,028,047,110,414,856,BACKGROUND,FINALLY,KPS,LABEL,METHODS,RESULTS,RPA,STUPP
ATTACHMENT,BRANCHING,C38,EPITHELIAL,H1650,THERE,THESE
19Q,945,INA,INTERNEXIN,NOTABLY,OMT,OTS
169,BRAIN,FUC,GD3,GGS,GM1,GM3,GM4,SOCIETY
INSTEAD
945,CRYSTAL,IDH,ISOCITRATE,LABEL,NADPH,OBJECTIVE,POINT,PURPOSE,RESULTS,SUMMARY
AFTER,DECREASED,INFECTIONS,THEREFORE
100MG,169,194,24H,760,AUC,COPYRIGHT,GBM,GIVEN,IRC,IRINOPHORE,IRN,TREATMENT
CETUXIMAB,CTD,GBM,GENOMIC,THEREFORE,TREATMENT
126,169,174,177,191NM,24H,956,COPYRIGHT,DOCETAXEL,FETEM,PEG,PEGYLATED
BRAIN,MRI
002,008,149,169,221,515,535,582,655,CERRAHPASA,COPYRIGHT,GKR,IGF,IQR,LTD,MEDICAL,METABOLISM,MRI,SIX
169,358,COPYRIGHT,GBM,INC,SVZ,USING
169,COPYRIGHT,EVEROLIMUS,LTD,NEUROLOGY,PAEDIATRIC,PUBLISHED,SOCIETY,THESE
169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SWI,TESLA,THESE
169,BILATERAL,CHILD,COPYRIGHT,CORONAL,EARLY,FSNF1,GIANT,MALIGNANT,MPNST,MRI,NEUROLOGY,NF1,PUBLISHED,SOCIETY,THEIR,VOLUMINOUS
110,169,CONCLUSION,COPYRIGHT,FOCSS,INC,LABEL,METHODS,OBJECTIVE,OVARIAN,PHASE,PSYFOCS,RESULTS,SCREENING,THESE
AMONG,CNS,RSV
GLIOMAS,HOWEVER,THEREFORE,THESE
169,EIGHT,INC,SRT,WILEY
028,100,DMBT1,DUE,PCR
108,248,ACSL5,BACKGROUND,CHEK1,FINALLY,LABEL,OSBPL1A,PCR,RESULTS,TCF12,TRAK1,TSS,WNT
001,039,COX,INCIDENTAL,LABEL,LGG,LOW,MEIER,METHODS,OBJECTIVE,PFS,PRIMARY,RESULTS,UNIVARIATE
BACKGROUND,BRAIN,ELISA,HCC,HEPG2,HOWEVER,K252A,LABEL,METHODS,RESULTS,THESE,TRK,TROPOMYSIN
CNS,III,MEETING,PHASE,PROGNOSTIC,SOCIETY,THERE
AKT,DECREASED,FDA,PAZOPANIB,RAF,RAS,V600E
001,219,ATLAS,BACKGROUND,BASED,CONCLUSION,DESPITE,FLAIR,GBM,LABEL,MEIER,METHODS,MRI,MULTIFORME,PERIOSTIN,POSTN,RESULTS,TOP
THESE,ULTIMATELY
169,EFFORTS,HOWEVER,KNOWLEDGE,THERE
AMONG,FORTY,III,OUTCOME,PFS,SALVAGE,THESE
CREB1,EWSR1,MITOTIC
023,044,059,ANGELES,BACKGROUND,CALIFORNIA,CONCLUSION,KARNOFSKY,LABEL,LINAC,LOS,METHODS,OBJECTIVE,RESULTS,SERIOUS,SRS,THERE,UNIVARIATE,UNIVERSITY
ACHIEVING,ADDITIONAL,AGE,BACKGROUND,CONCLUSION,GROSS,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
CLUSTER,COMPARING,ECM
473,AKT,FINALLY,LAK,ORIGINATED,PROTEIN,SER,USING
169,COPYRIGHT,EXCLUSIVE,IMPAIRMENT,IRELAND,LTD,RANDOMIZED,RCT,THERE
PATHOLOGY,PEM
PPV,SCHWANNOMA
ANOTHER,DCC,HOWEVER,SIMILAR,SNARE,SYTX1
169,COPYRIGHT,FNA,HASHIMOTO,HOWEVER,INC,MIXED,MTC,WHILE,WILEY
169,CELLS,COPYRIGHT,HISTOLOGIC,INC,SMALL,WHOLE,WILEY
169,183,AFTER,BACKGROUND,DTI,GEORG,LABEL,METHODS,MRI,RESULTS,STUTTGART,UNLABELLED
000,160,HOWEVER,IPC,OVERALL,SEVERAL,SOMETIMES
PET,QUALITY,SPECT,TECHNICAL
BRAIN,EVALUATION,ICP
FRT,GBM,NEWLY,PFS
HOPEFULLY

100,194,211,273,BACKGROUND,CONCLUSION,CSF,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,UNIVERSITY
001,169,CONTINUOUS,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY
947,FURTHER,GNS,MECHANISMS,THESE,WEE
AGING,BASED,LAN,LCA,MCIXC,WHILE
GLIOMAS
BECAUSE,CTA,HOWEVER,LABEL,METHODS,NLM,OBJECTIVE,PURPOSE,RESULTS,SINCE
139,544,690,DISCOVERY,FURTHER,IEC,LABEL,METHODS,OBJECTIVE,PET,PSF,PURPOSE,RESULTS,SIMILAR,THESE,TOF
CURRENTLY,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SEVERAL
AFTER,CISPLATIN,COMBINING,NSCLC,NSCLS,VINORELBIN
011,021,035,107,AIM,AUTONOMOUS,BRAIN,CONCLUSION,EXAMINING,FORTY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
197,ATP,SVM
179,ABC,ATP,BCECF,BTB,EXPRESSION,HIV,HOWEVER,HSECS,MDR1A,MRP,SERTOLI,TM4

BCA,HBS
108,155,177,954,CLINICIANS,CONCLUSION,CONSENTING,DIAGNOSTIC,DISORDERS,EDITION,INTER,INTERVIEW,INTERVIEWS,LABEL,MDD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STRUCTURED,THERE
169,DIFFUSIVE,DTI,FINALLY
946,FINALLY,INHIBITION,WNT,WNT5A
169,211,BACKGROUND,COPYRIGHT,CSE,EEG,INC,JANUARY,LABEL,LOOKING,METHODS,MRI,POSTERIOR,PROCEDURE,RESULTS,WILEY
169,814,BACKGROUND,COPYRIGHT,EXPRESSION,HOWEVER,IGFR1,INC,LABEL,METHODS,NBS,NGF,NTRK1,NTRK2,NTRK3,P75,PCR,RESULTS,WILEY
169,ANGELES,ANY,BACKGROUND,CHOROID,COPYRIGHT,CPC,CPT,INC,JANUARY,LABEL,LFS,LOS,METHODS,RESULTS,SIX,WILEY
169,COPYRIGHT,DTI,DWI,INC,MRI,WILEY
001,021,100,125,169,ADJUSTMENT,BACKGROUND,CHT,COPYRIGHT,COX,CSI,FOCAL,IGS,JANUARY,LABEL,MEIER,METHODS,RESULTS,RFS,SOCIETY,WBI,WVI
BLM,CENTRAL,NOW
ALTOGETHER,BACKGROUND,CD133,LABEL,METHODS,ORTHOTOPIC,RESULTS,THESE
101,116,ERK,HOWEVER,MEK,PAS,PILOCYTIC,RAF,SOX,THERE,TREATMENT
945,BLI,CELLS,HIF,HRE,MB231,MDA,ODD,THERE,THEREFORE,UNDER
169,ACC,COPYRIGHT,DESPITE,INC,THESE
CSC,EXTRINSIC,GBM,THESE,TMZ
158,169,194,BMI,CMV,COPYRIGHT,CRP,EBV,EPSTEIN,FATIGUE,INC,PRIOR
169,APPLIED,AUTHORS,BRITISH,DNT,LABEL,MATERIALS,METHODS,OBJECTIVE,OLC,RESULTS,SEVEN,SOCIETY,THEIR,THERE
DCS,FOLLOWING,MOTOR,PERMANENT,SSEPS,TCEMEPS
THESE
ARF,BIM,EFFORTS,GBM,GEFITINIB,INK4A,SUSTAINED,TKI
CELLSEARCH,CNS,CSF,HOWEVER,VERIDEX,WHILE
CNS,ENT,ICU,JAPAN,SCORE,SJOGREN,TETANUS,THEIR,THEREFORE,TSS
53BP1,947,956,GBM,SF763,SF767,TAC,THESE
10P,10P14,10P15,169,252,COPYRIGHT,INC,LOH,PCR,PFKFFB3,U87,WILEY
102,ANECDOTAL,BACKGROUND,CONCLUSION,LABEL,LGG,MATERIALS,METHODS,PAEDIATRIC,PARTIAL,SOCIETY
100,EEG,EPILEPTIC
100,ITALIAN,SEVERAL
MRI
100,150,CONTINUOUS,DESPITE,RECURRENT,TMZ

AVERAGE,CSF,ENDOSCOPY,EOR,GTR,HOWEVER,MRI
916,968,JUN,ROS
100,125,239,340,AUC,CYP3A,FORTY,GBM,GRADE,KPS,PFS,SIXTEEN,TREATMENT
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,MRI
001,010,029,084,169,766,BACKGROUND,CAREFUL,COPYRIGHT,INC,LABEL,MEDLINE,METHODS,RESULTS,THERE
BURKITT,UNILATERAL
169,COPYRIGHT,DOX,NMR,TEM
177,AFTER,AVAILABLE,BACKGROUND,BASAL,FIFTEEN,FSH,HOWEVER,HPT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM
169,946,BASEL,CHANGES,COPYRIGHT,DECREASED,EXPRESSION,LABEL,METHODS,NEITHER,OBJECTIVE,PFS,RESULTS,SMAD2,TGF
000,ALZHEIMER,CHEMBIONET,PAR,PROTEIN
177,BACKGROUND,BETWEEN,CYBERKNIFE,FURTHER,GBM,GRADE,LABEL,METHODS,PFS,RESULTS,SRS,TMZ,TTP
22981,26981,604,648,696,COX,END,EORTC,GBM,III,MEIER,RESULTS,THESE
DLT,DUE,GRADE,HGG,KPS,THERE
000,002,012,014,024,025,031,034,043,087,121,316,321,358,409,429,443,508,510,530,EXPRESSION,HMGA1,III,MMP,MVD,PCR,THESE
002,008,128,ADAM8,HOWEVER,KARNOFSKY,KPS,THEREFORE,THESE
GLIADEL,HOWEVER,STUPP
160,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,WHETHER
AUTOSOMAL,CEP63,USING
HOWEVER,PET,RESULTS,THERE

169,AMP,COPYRIGHT,IRELAND,LTD,PAP,PROSTATIC
001,169,177,195,231,361,956,BACKGROUND,CONSISTENT,COPYRIGHT,FDG,GBQ,INC,LABEL,MCF,MDA,METHODS,NOD,PET,RESULTS,STUDIES,WHILE
169,COPYRIGHT,INC,MALIGNANT,SWI
BACKGROUND,CHINA,LABEL,RESULTS
169,COPYRIGHT,INC,WHEREAS
AFTER,CBF,HOWEVER
945,946,DESPITE,GBM,KDA,PREVENTING,SPREADING,USING
FORESTS,NETWORK
001,002,004,007,ANXIETY,BRAIN,C30,CONCLUSION,DEPRESSION,EORTC,FORTY,HRQOL,LABEL,LGG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QUALITY,RELATED,RESULTS,SCALE,SEPTEMBER,STATE,TREATMENT
C10,D54,OBTAINING,P10,PROTEOMIC,SUCCESSFUL,TMZ,U87
119,139,17P,17Q,32K,AFFYMETRIX,BAC,CNS,PREVIOUSLY,SEVERAL,THESE,U133PLUS2
946,AGT,BRAIN,EPH,NET,NRP,TSP
HOWEVER,INCREASED,LAGRANGIAN,RESULTS

169,COPYRIGHT,DROSOPHILA,FRAGILE,HOWEVER,INC
169,COPYRIGHT,FOXM1
945,946,956,957,BACKGROUND,BBB,EIGHT,LABEL,LN229,METHODS,PERIPHERAL,RADIATION,RESULTS,STUDENT,SUBLETHAL,U87
107,124,138,149,III
160,200,228,300,375,AMONG,BURST,FEW,LABEL,METHODS,MLC,OAR,OBJECTIVE,PURPOSE,RESULTS,ROTATIONAL,TEN,USING
BACKGROUND,CONTEXT,INSTITUTES,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,PROLACTIN,RESULTS,SERUM,SETTING,WESTERN
169,916,COMBINING,CYTOTOXIC,G47,GBM,GSC,HSV,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TALALAY,THESE
ANNEXIN,GL261,GLIOMAS,KNOCKDOWN
ACTIVATION,AHR,BECAUSE,KYN,TDO,TRP
169,178,ACTIVATION,AKT,MMP,SHH,TAKEN,THESE
AVERAGE,EXAMINING,FLV,GCC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
005,037,177,201,CONVERSELY,FDG,GRADE,LABEL,METHODS,NH3,OBJECTIVE,PET,PURPOSE,RELATIVELY,RESULTS,SIMILAR,SPECT,TEN,THESE
11C,CHOLINE,CONCLUSION,FDG,FIFTY,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS
001,002,125,216,BACKGROUND,FIFTY,GBM,HOWEVER,JANUARY,KPS,METHODS,RESULTS,THESE,UNIVARIATE
10085,14117,281,888,IMAGING,MALDI,MBP,SINCE
169,ADENOVIRUS,AKT,COPYRIGHT,FTC,INJECTION,IRELAND,LTD
169,AUSTRALIA,AUSTRALIAN,AUTHORS,INCIDENCE,INDIGENOUS,LABEL,METHODS,OBJECTIVE,RESULTS,TOBACCO
CSF,FAILURE
APRIL,CNS,MAY,PFS
AFTER,BRAIN,CLINICALLY,CNS,PALLIATIVE
ACCORDING,BECAUSE,BER,HOWEVER,METASTATIC
CNS,PCNSL,PRIMARY,TCL
AFTER,DWI
946,BESIDES,GBM,PCR,PROTEIN,PTP1B,PTPIP51,RAF,SRC
015,026,10Q,115,19Q,BACKGROUND,DETECTION,HOWEVER,III,LABEL,METHODS,RESULTS
CNS,RESULTS,VSC
AREAS,THERE
CD133,GBM,THEREFORE,THESE
PREVENTING,THESE,VTE
DCLK1,DESPITE,THEREFORE
100,CHOROID,CONCLUSION,CSF,EVD,LABEL,METHODS,OBJECTIVE,RESULTS
ALLUSIONS,CNS,CSF,HOWEVER,MRI
BRAIN,CONCLUSION,DISTORTION,FOCAL,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THREE
REMARKABLY,STAT3
AUC,BACKGROUND,CONCLUSION,III,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
001,014,015,024,169,202,ADC,CONCLUSION,HISTOGRAM,LABEL,MATERIALS,METHODS,MINIMUM,OBJECTIVE,PURPOSE,REGIONS,RESULTS,ROC,STUDENT,TUKEY
GBM
019,11Q,656,717,AMONG,CONCLUSION,COX,EFS,EVENT,GROUP,LABEL,METHODS,MKI,OBJECTIVE,PURPOSE,RESULTS
125,126,147,160,177,CONCLUSION,HOWEVER,KARNOFSKY,LABEL,LGG,METHODS,NEUROLOGIC,OBJECTIVE,PROCEDURE,PROGNOSTIC,PURPOSE,RESECTION,RESULTS,SBT
001,498,CIS,CONCLUSION,COX,KARNOFSKY,KPS,LABEL,METHODS,MOTIVATED,OBJECTIVE,PURPOSE,RESULTS,WEIBULL
BRCA2
ALTOGETHER,ATO,CA9,GBM,MMP,U87MG
POSTMORTEM,POTENTIAL,SELECTIVE
CAREGIVERS,DESPITE,QUALITY
120,174,BSG,FORTY,HGG,STRATUM,TMZ
AQUAPORIN,GREATER,HOWEVER,WESTERN
100,BRAIN,THESE
TODAY,TRANS
THERE
GIVEN,HOWEVER,III,LABEL,OBJECTIVE,ONGOING,PFS,PHASE,PURPOSE,RESULTS,SUMMARY
AGE,CENTRAL,ELDERLY,GROUP,HOWEVER,LABEL,NERVOUS,OBJECTIVE,PRIMARY,PURPOSE,REGARDING,RESULTS,SUMMARY,THESE
HGF,LAL,NOTABLY,U87MG
HOWEVER,JCI,OVERALL
954,DESPITE,DHMEQ,INCREASED,THESE,U87,YKG
169,COPYRIGHT,INC,PARKINSON
169,180,ADDICTION,AUTHORS,BIOLOGY,CLUSTER,LPP,SMOKERS,SOCIETY,WHILE
170,ABCB1,ATP,DETAILS,PGP
366,BAGHDAD,IRAQI,SINCE,UNIVERSITY,WELFARE
BACKGROUND,BRAIN,CONCLUSION,CRC,HOWEVER,K252A,LABEL,METHODS,NGF,NTR,RESULTS,TAKEN,TRK
00001,AFTER,AIM,CONCLUSION,LABEL,METHODS,MRS,NORMALIZED,OBJECTIVE,PFS,RESULTS
100,CAM,EIGHT,GFP
103,CNS,COX,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PROGNOSTIC,RESULTS,THERE
169,COPYRIGHT,EXPRESSION,SILENCING,THESE
FOLLOWING,LIMITED,MOD,MPH,THERE
169,ANT,CEREBELLUM,COPYRIGHT,IRELAND,LTD,NETWORK,SEVERAL,THESE
169,COPYRIGHT,LOH,PCR
169,ALZHEIMER,COPYRIGHT,IRELAND,LTD,NURTURE,PARKINSON
001,169,346,AIM,ALA,COPYRIGHT,SEVERAL
169,177,3MM,521,5MM,925,945,947,BASED,CONCLUSION,COPYRIGHT,FINALLY,IRELAND,LABEL,LTD,METHODS,MIMIC,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,TTT,VOLUMETRIC
169,194,COPYRIGHT,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,YET
104,185,216,22Q11,524,AMONG,ANKDD1A,BACKGROUND,CONCLUSION,CPG,EIGHT,LABEL,LOH,MASSARRAY,MEDIP,METHODS,NIMBLEGEN,PCDHA13,PCR,RESULTS,SST,THESE
WILMS
HSV,PRIOR
AMONG,FOLLOWING,GIVEN,MCA,MPNST,NF1,WHILE
THERE
CHESNEY,CUSHING,FOLLOWING,HOPKINS,HOWEVER,JOHNS,LABEL,MASON,METHODS,OBJECTIVE,RESULTS
CSC,HOWEVER,III,THESE,WHILE,WORLD
168,196,BACKGROUND,COX,FALSE,LABEL,METHODS,ORS,RESULTS,THREE
GCC,LABEL,LAMBERT,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS,SAP
626,665,718,843,850,884,ASL,BACKGROUND,BLAND,DSC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PURPOSE,RESULTS,TBF
112,145,BACKGROUND,GCT,IMAGING,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCO,SEVENTY,WORLD
BACKGROUND,CNS,ECD,LABEL,LANGERHANS,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
POU
169,COPYRIGHT,EFFECTIVE,FUZZY,INC,WILEY
ECTOPIC,HOWEVER,MRI,PITUITARY
169,BSS,COMBINING,COPYRIGHT,ICA,LTD,MMLIP,WILEY
062,101,169,204,265,294,368,843,959,BACKGROUND,LABEL,METHODS,RESULTS,THERE
011,048,084,161,361,PREVALENCE,PRL
NASAL,THESE
BINOSTRIL,BRAIN,EARLY,THREE
283,288,3HS,MAXILLOFAC,ORN,SUCCESS
945,947,FDC,SYNUCLEINS,THERE,THESE
103,111,169,174,206,945,99M,AFL,ALBURES,ATN,COPYRIGHT,EXENDIN,HSA,LEVEMIR,TNF,VICTOZA
GSPCS,LC3,PCR,THESE,WESTERN
BRAIN,DESPITE,EPENDYMOMA,UNTIL
169,COPYRIGHT,LTD,MONITORING,SEVERAL,THERE
169,COPYRIGHT,INC,MOSBY,PEDIATRIC,PITUITARY,PUBLISHED,STRABISMUS
169,1960S,COPYRIGHT,PUBLISHED,TODAY
CONTROL,HIF1A,NOW,PCR,TRP,TRPC1,TRPC3,TRPC5,TRPC6,TRPM4,TRPM6,TRPM7
169,COPYRIGHT,ERK,HOWEVER,MEK,OVERCOMING,PRESS
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SCIATIC
000,120,138,210,ACCORDING,AGREEMENT,BACKGROUND,LABEL,METHODS,PROTECTION,RESULTS,SETTLEMENT
028,100,10Q25,160,BLADDER,DELETED,DISRUPTION,DMBT1,FIFTY,III,PCR,RUNX3,TOTAL
BACKGROUND,CONTEXT,DIAGNOSIS,LABEL,METHODS,RESULTS,SYNTHESIS
CONCLUSION,D95,DIFFERENT,HD120,IDS,LABEL,MATERIALS,METHODS,NOVALIS,OBJECTIVE,PURPOSE,RESULTS
BRAIN,IGA,MRI,POEMS
11C,BACKGROUND,DISCUSSION,FURTHER,HOWEVER,LABEL,MARCH,METHODS,MRI,PET,SURGERY
HISTOLOGIC,MRI,ROSENTHAL,THERE
MAP
19Q,IDH,ISOCITRATE,R132H,THEREFORE
AKT,COX,EEFEMP1,FOLLOWING,GBM,LABEL,METHODS,OBJECTIVE,OVERALL,PCR,PURPOSE,RESULTS,THERE,VEGFA
169,1YEAR,946,COPYRIGHT,DESPITE,GBM,IRELAND,LTD,U87MG
100,HOWEVER,THESE
174,945,CLEARLY,EARLY,EGF,IFN,LAR,SOM230C
CURRENT
FOLLOWING,IDH,MUTATIONS,WHILE
100,CNS,SOCIETY,USA
116,210,389,956,ACCORDING,DISCUSSION,LABEL,METHODS,NARANJO,OBJECTIVE,SUMMARY,SUNITINIB
ACHIEVING,GBM,THESE,TPT
177,600,800,BID,DLT,EIASD,FURTHER,MTD,SORAFENIB
GOVERNMENT,MDA,MRI,PUBLISHED,REMODELING,USA
169,956,ASP,AUTOMATIC,COPYRIGHT,ETHYL,F98,GL261,GLN,GLU,GUA,LAC,LTD,MMS,MRS,NAA,NMR,PRESS,RAT,RG2,TARQUIN,THESE,TOTALLY,U87,VAPOR,WILEY
169,AUC,COPYRIGHT,III,INTERPRET,LTD,MRI,MRS,NETWORK,PATTERN,RESONANCE,TUMOURS,USING,WILEY
APART,CHOROID,CPP
ACTIVATION,KNOCKDOWN,NFI,NUCLEAR,STAT3,YKL
160,231,BBB,FEW,GSK461364A,PREVIOUSLY,THESE,USING
030,125,160,280,BORTEZOMIB,CARDIAC,ELDERLY,INCREASED,INJ,PATIENT,SINCE,TAB,THREE
367,AGE,BECAUSE,COX,END,RESULTS,USING
100,169,AFTER,AUTHORS,BECAUSE,BLACKWELL,HERRING,LTD,NEITHER,PATHOLOGY,PTY,PUBLISHING,ROSENTHAL,SOCIETY
169,183,560,680,ASIAN,BLACKWELL,CONSORTIUM,DESPITE,EIGHT,JAPAN,LABEL,LTD,MEN,METHODS,OBJECTIVE,PRIMARY,PUBLISHING,RESULTS

AKT,ARF,CXCR4,FURTHER,GBM,GTV,HOWEVER,INK4A,MCS,NTV,SCF,SUPPORTING
200,NPS,THESE
174,AVASTIN,COMMITTEE,DESPITE,FRANCISCO,GBM,GENENTECH,HOWEVER,INC,INSTITUTE,SAN,SOUTH
BTSCS,DELTA,RGD
DESPITE,NSC,WHILE
DUE,OPTIMAL
950,CD11B,CD3,CRITICALLY,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
001,005,012,215,ADC,DTI,MRI,THERE,THESE
260,687,AFTER,AMONG,DYSPNEA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
ATLAS,MULTIMODAL,PROJECT
ACCORDING,ADDITIONAL,AVERAGE,CONCLUSION,DYNAMIC,FIFTY,KEY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIX
HEMORRHAGE,MRI,OCULOMOTOR
004,007,045,160,HOXA3,HOXA9,LABEL,MASSARRAY,METHODS,OBJECTIVE,PURPOSE,RESULTS
AKT,APOPTOSIS,BECLIN1,DBTRG,GBM,INDUCTION,LABEL,LC3,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,SINCE,U87MG
HODGKIN
DIA,DIG
ADAPTOR,AKT,CONTACTIN5,DISRUPTION,FYN,HOWEVER,NYAP1,NYAP2,NYAP3,NYAPS,PIP,WAVE1
BRAIN,COGNATE,NETRING,NGL,THESE
177,BACKGROUND,CONCLUSION,DTI,FIBER,FINAL,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,VOLUMETRIC
COX,REMARKABLY,STAT3,THESE
CNS,HAART,LABEL,OBJECTIVE,PCNSL,PURPOSE,RESULTS,SUMMARY
13R,945,G26,GBM,PEP,SNB19
169,BBB,COPYRIGHT,HOWEVER,INC,PREVIOUSLY,THESE
169,956,COPYRIGHT,ELF,LTD,ONGOING,OVERALL,THERE
169,7GY,COPYRIGHT,IRELAND,IRRADIATED,LTD
169,BCL,COPYRIGHT,ELONGATION,GLIOMAS,III,INC,NH125,TRAIL
169,194,CONCLUSION,COPYRIGHT,DEPARTMENT,HOWEVER,ILC,INVENTORY,JANUARY,KINDL,LABEL,LTD,METHODS,OBJECTIVE,PAEDIATRIC,PARENTS,PURPOSE,QOL,QUALITY,RESULTS,TRONDHEIM,UNIVERSITY
169,COPYRIGHT,HOWEVER,INC,LABEL,MEDICAL,METHODS,MEV,OAR,PTV,PUBLISHED,RESULTS,TREATMENT,UNLABELLED
169,176,COPYRIGHT,DOF,GERMANY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PADDICK,PATIENT,PURPOSE,RESULTS
169,COPYRIGHT,DICOM,LTD,RANDO,SCAN2MCNP
137,154,169,176,185,450,469,599,606,CONTINUED,COPYRIGHT,COX,DETECTING,EDUCATION,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RECURRENCE,RESULTS,UROLOGICAL,WHETHER
169,1N0,3M0,BECAUSE,COPYRIGHT,LTD,NSCLC,SMALL,TNM
169,COPYRIGHT,DCE,DSC,DYNAMIC,HOWEVER,SAS
001,BACKGROUND,EARLY,ERP,GBM,LABEL,MACDONALD,METHODS,MULTIFORME,RADIOLOGIC,RESPONSES,RESULTS,ROC
007,146,177,361,FOLLOWING,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE
GROSS,GTR,INITIAL,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS
271,AFTER,GH4C1,PIT,PRL,R271W
AFTER,GCC,HOWEVER,LABEL,LAMBERT,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS,SAP,SIX
DETECTING,LABEL,OBJECTIVE,PRL,PURPOSE,RESULTS,SUMMARY,THREE
BACKGROUND,BRAZILIAN,CARMUSTINE,CISPLATINE,LABEL,METHODS,PSI,RESULTS,SCALE,WISCIII
CNP,CXCR4,EAAT1,FURTHER,IGF
19Q13,945,946,III,OVERALL
AFTER,CNS,CONCLUSION,GREATER,LABEL,METHODS,MIXED,MRI,OBJECTIVE,RESULTS
169,194,COPYRIGHT,PAS,SHG44,U251AND,U251CELLS
026,169,186,963,COPYRIGHT,COX,III,MEIER,PENDING,PROGNOSTIC,SFN,STRATIFIN,WESTERN,WORLD
169,5MC,945,AUTHORS,BRAIN,CPG,EPIGENETIC,PATHOLOGY,SOCIETY,TET
169,COPYRIGHT,HOWEVER,INC,NUCLEOLIN,WILEY
169,COPYRIGHT,FAK,HOWEVER,INC,MMP,OCT,SRC,THEREFORE,THESE,WILEY
143,170,318,383,400,AFTER,CENTRAL,CNS,CTX,FURTHER,GKS,SEOUL,UNIVERSITY
GH4C1
BACKGROUND,BMI,COLLEGE,CONCLUSION,CORNELL,CSF,GROSS,GTR,LABEL,MEDICAL,METHODS,MINIMAL,OBJECTIVE,OUTCOME,RESULTS,SEVEN,WEILL
AVM,BACKGROUND,CONCLUSION,FORTY,LABEL,LESIONS,METHODS,OBJECTIVE,PERMANENT,RESULTS,SCALE,THERE
AMONG,BACKGROUND,CBM,CONCLUSION,CRANIAL,GROSS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PATIENT,QUESTIONS,RADIATION,RESULTS,SCALE,SEVEN
BRAINSCAN,CIS,CONCLUSION,D85,D90,D95,D99,DCA,DEFINITION,GERMANY,GROUP,IDS,LABEL,METHODS,NCI,OBJECTIVE,RADIATION,RESULTS,THERAPY,THREE
19Q,FURTHER,OGS,SEVERAL
100,15B,BECAUSE,CNS,CSF,MALIGNANT,MIR,PCR
131,215,AFTER,BACKGROUND,CONCLUSION,EARLY,FDG,LABEL,METHODS,PATHOLOGY,PATIENT
405,611,632,947,AMONG,CNS,CUMULATIVE,INCREASED,LLR,SMR,THESE,WLM
FINALLY,HUR,REGULATION,USING,UTR
160,ABOUT,BECAUSE
ADULT,BECAUSE,CNS,CPE,CSF,ECRG4,ESOPHAGEAL,PROTEIN,RELATED,TBI
BACKGROUND,CYCLING,GBM,GBM8401,HIF,HOECHST,HOWEVER,LABEL,METHODS,NADPH,PRINCIPAL,RESULTS,ROS,U87

100,191,946,ATLAS,BACKGROUND,BROAD,CONCLUSION,EPIDERMAL,GBM,INSTITUTE,LABEL,METHODS,PROFILING,PROPIDIUM,RESULTS,SELECTIVE,SRC,STAT3
BBB,CSF,MDR1A
001,069,119,212,242,936,BACKGROUND,III,LABEL,MDM,METHODS,P53,RESULTS,THERE
BACKGROUND,CONCLUSION,HOWEVER,IGG2B,LABEL,METHODS,MTT,RESULTS,ROBO1,ROUNDABOUT,SDS,SLIT2
BACKGROUND,CHINA,HOWEVER,ICA,LABEL,METHODS,MULTI,PARAMETERS,PITUITARY,RESULTS,THERE,WHILE
169,910,ACHIEVING,AGAINST,DNETS,ENGEL,GGS,INC,KEY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE,WILEY
CLEARLY,CSC,HOWEVER
10074,202,204,ERK,INCREASED,MAX,MEK,MYC,PREVIOUSLY,THR,TREATMENT,TYR,U0126
AFTER,CONCLUSION,GENBANK,GFP,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TCA8113
169,947,COPYRIGHT,GBM,GSI,MRM,NOTCH,OVERALL,SIGNALING,SUPPRESSED,VCH,WILEY
169,946,BACKGROUND,CNS,COPYRIGHT,DMM,LABEL,METHODS,OVERALL,RESULTS,SOCIETY
HODGKIN,MRI,PRIMARY
34A,AKT,BACKGROUND,CD133,DELTA,DESPITE,LABEL,MBS,MIR,NOTCH,PRINCIPAL,RESULTS,STAT3,THROUGH,USING
OTHERWISE,PRIMARY,THERE
14Q32,17Q,662,935,BASED,CD133,CLUSTERING,EXPRESSION,HENCE,PCR,SEVERAL,TRANSIENT
160,807,CPG,THESE,TRPC3
197,CAP,CRISP,CRYSTAL,ZN2
CONCLUSION,DIPGS,FOCAL,GENOMIC,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RAS,RESULTS
169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MAXIMAL,METHODS,OBJECTIVE,PCI,PURPOSE,RESULTS,THERE
AMONG,GPCRS,GSLCS,MALIGNANT,PUBLISHED
160,169,BASED,COPYRIGHT,GIVEN,INC
004,130,AMONG,APRIL,BACKGROUND,CNS,JANUARY,LABEL,METHODS,RESULTS
169,AUTHORS,BRAIN,FINALLY,GCS,HOWEVER,MUTATIONS,PATHOLOGY,PFS,PRIMARY,R132H,R132S,SOCIETY
140,ADDITIONAL,CARLO,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,USING
044,165,169,BACKGROUND,COPYRIGHT,DESPITE,FINALLY,KISS1,LABEL,METASTASES,METHODS,PCR,RESULTS,SOCIETY
945,946,GASCS,PDGFR,SMA
CPG,EPIGENETIC,GATA6,GBM,HOWEVER
160,BECAUSE,BRAIN,CASES,CONCLUSION,CSF,DEPARTMENT,ENFANTS,FIFTY,JANUARY,LABEL,MALADES,OBJECTIVE,PARIS,PEDIATRIC,PURPOSE,RESULTS
160,250,BACKGROUND,CASES,CONCLUSION,ETV,GENERAL,LABEL,METHODS,RESULTS,THERE
CUSHING,EXCELLENT,PITUITARY
MRI,T12
AWARENESS
160,BASED,BOTHELL,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PHILIPS,PURPOSE,RESULTS,THESE,USA
177,CAVERNOUS,CONCLUSION,DIFFERENT,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
ANXIETY,DEPRESSION,HOWEVER,MAJOR,SCALE,USING
ARF,DDR,EXPRESSION,RAD51
LIU,THEIR
169,COPYRIGHT,LTD,MAXILLO,PUBLISHED,SURGERY
100,169,194,CNS,COPYRIGHT,ELECTRONS,INC,INVERSE,MEDICAL,MLC,PUBLISHED,SSD,TPS
169,COPYRIGHT,GBM,IRELAND,LTD,NOSCAPINE,TMZ,TREATMENT,USING
169,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SERAM
169,945,956,BMS191011,COPYRIGHT,FAK,HEK,HEK293T,HOWEVER,INC,KEY,LABEL,METHODS,OBJECTIVE,RESULTS
169,229,461,945,COPYRIGHT,GBM,GNAS1,INCLUSION,LTD,T393C
169,COPYRIGHT,FUS,LTD,MRI
169,COPYRIGHT,EPHA2,IRELAND,LTD,THESE
169,COPYRIGHT,DESPITE,GCV,HSV,LTD,REDUCIBLE,SINCE,SUICIDE
169,194,COPYRIGHT,INC,THESE
241,APRIL,BACKGROUND,BRAIN,COX,KPS,LABEL,LOG,MEIER,METHODS,MRI,MST,NSCLC,OBJECTIVE,OCTOBER,RESULTS
169,BLACKWELL,BLU,BURKITT,DIFFUSE,FURTHER,LARGE,LTD,MYC,PUBLISHING,SUBSEQUENT
CURRENTLY,HLA,IGG,JAPAN,WELFARE
169,181,COPYRIGHT,EFS,INC,JNJ,OBJECTIVE,RESPONSES,WILEY
169,CHORDOMAS,COPYRIGHT,INC,WILEY
183,BACKGROUND,CONCERNED,CONCLUSION,EPENDYMOMA,GEORG,GLASCOW,HISTOLOGY,LABEL,METHODS,MONRO,STUTTGART
100,177,183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,RESULTS,STUTTGART,USING
183,BACKGROUND,BETWEEN,CONCLUSION,CSF,ENDOSCOPY,GEORG,LABEL,METHODS,RESULTS,STUTTGART
183,264,BACKGROUND,ENDOSCOPIC,GEORG,LABEL,METHODS,PUBLISHED,RESULTS,STUTTGART,THERE
MASAOKA
ICC
160,188,LABEL,METHODS,MMP,MTT,OBJECTIVE,PURPOSE,RESULTS,RUNX3
946,FURTHER,GBM,HENCE,MYC,PREVIOUSLY,TCF,WNT
27B,HOWEVER,PCR,STAT3,THESE,WESTERN
224,661,COX,FURTHER,HOWEVER
3BP,DAO,SPRAGUE,WARBURG
100,945,946,FINALLY,ID1,ID2,ID3,ID4,KIT,LOW,MALIGNANT,MARKERS,MRT,NANOG,NCMRT,PLACENTAL,RTS,SALL4,SIMILARLY,SMARCB1,THESE
169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PAS,RESULTS,TUKEY,USING
169,BASEL,CONCLUSION,COPYRIGHT,DESPITE,EEG,LABEL,METHODS,OBJECTIVE,RESULTS
945,946,MRI,RBE
009,357,822,RTEL1,THESE,THREE

001,002,009,120,215,500,516,BACKGROUND,CLINICALLY,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEX,SRS
003,012,169,COPYRIGHT,EARLY,ENDOSCOPIC,LTD,MRI,OCULOMOTOR
123,169,946,ABC,ABCB1,ABCC4,ABCG2,ALZHEIMER,ATP,BINDING,CNS,COPYRIGHT,DKK,THEIR,THESE,WNT,WNT3A
169,COPYRIGHT,GBM,LTD,THEREFORE
160,169,COPYRIGHT,INC
143TC,169,946,INC,WILEY,WNT
004,008,169,BACKGROUND,CNS,COPYRIGHT,COX,FIFTY,FORTY,IQR,KARNOFSKY,LABEL,MEIER,METHODS,OVERALL,PROGNOSTIC,RESULTS,SALVAGE,SOCIETY,SRS
100,ADC,ATRTS,IMAGING,JPA,KEY,LABEL,METHODS,OBJECTIVE,PNETS,RESULTS,WHOLE
160,DESPITE
122,232,494,571,AFTER,CPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
AFTER,MRI,PET
001,143,557,AGE,COCHRAN,CUSHING,LIBRARY,MEDLINE,MRI,NFA,PRL,RECURRENCE,REMISSION,SCIENCE,SURGERY,WEB
CSI,INSTITUTE,OAR,ORGAN,PATIENT,PTV,SINCE,SSD
037,169,193,FOXM1,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
AKT,BCL,BECAUSE,ERK,TAKEN,THEREFORE,TREATMENT,U87MG
128,177,183,BACKGROUND,CHRONIC,CONCLUSION,CUSHING,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
BACKGROUND,CONTEXT,H139D,LABEL,METHODS,MICROARRAY,OBJECTIVE,PCR,PRL,RESULTS,VALIDATION
945,CRH,EGF,ERBB2,SEVERAL,TGF
945,946,DESPITE,GLANZMANN,IIB,ITGB3,REPORTS
141,COEXISTENT,WORLD
169,COPYRIGHT,COX,CYBERKNIFE,EIGHT,GAMMA,GKS,HPC,KNIFE,LTD
169,COPYRIGHT,GALENIC,LTD,SUCCESSFUL
HOWEVER,MED,NUCLEUS,SEPTEMBER
CUSHING,GOVERNMENT,LABEL,METHODS,NIH,OBJECTIVE,PUBLISHED,RESULTS,THREE,USA
169,LDA,PCA,SOCIETY,VENTURI
160,BRAIN,THERE,THREE
AKT,AMONG,GBM,HOWEVER,OPN
001,BACKGROUND,LABEL,LAM,METHODS,RESULTS,SEGAS,SERUM,SIROLIMUS,THERE,TRIAL,TSC
000,100,AFTER,BACKGROUND,CNS,CONCLUSION,END,HIV,HODGKIN,LABEL,METHODS,PCNSL,PRIMARY,RESULTS,THERE
916,BEV,G47,GBM,HOWEVER,MRI,ONCOLYTIC,U87,USING
EAE,EXO,INTRANASAL,LPS,MOG,STAT3
945,GBM,MAP,NANTAIS,ORIGINE,RECEPTEUR,RON,TNF,TRAIL
ENGLISH
169,202,286,63C,A114V,BACKGROUND,CALIFORNIA,FETAL,GST,GSTM1,GSTM3,GSTP1,GSTT1,I105V,LABEL,METHODS,RESULTS,THESE,WASHINGTON
1P19Q,26951,AOA,AOD,ATLAS,CONCLUSION,CPG,EORTC,GBM,III,LABEL,LOH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUBSEQUENT
001,177,ACCORDING,EOR,GBM,GTR,HOWEVER,MEIER,MRI
945,946,DARMSTADT,EMD121974,GERMANY,MERCK,RGD
032,234,321,886,BACKGROUND,CK5,FINLAND,FINNISH,LABEL,LUMINAL,METHODS,PGR,PRIMARY,RESULTS,SEVERAL,SNAI1,SNAIL,TMA
124,CONCLUSION,HOWEVER,JSI,LABEL,LANGERHANS,METHODS,OBJECTIVE,RAF,RESULTS,STAT3
169,2HG,COPYRIGHT,III,MUTATED
APRIL,BETWEEN,BRAIN,CRC,FIFTY,RECURSIVE,RPA,SRS,SUN,TEN,UNIVERSITY,YAT

001,555,740,99M,MBQ,MRS,ROI,SPECT
888,ABT,ADP,DESPITE,DSB,PARPI
085,100,169,BASEL,CD133,COPYRIGHT,FURTHER,NEITHER,NEUROD1,PCR,PIT
HENCE,TCCUB
235,300,BECAUSE,CONCLUSION,FSTL5,INTEGRATED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHH,WNT
AKT,MYC,SAPK2,SEVERAL,THESE
169,COPYRIGHT,FIRST,FLAIR,MRI,PUBLISHED,RESULTS,SEVERAL
169,COMPLEX,COPYRIGHT,INC
160,IDH
000,100,AFTER,BACKGROUND,CONCLUSION,LABEL,LEV,METHODS,RESULTS,THERE,THEREFORE,THREE,TREATMENT
KDR,NOTABLY,PCR
127,BACKGROUND,HIPPO,HOWEVER,INHIBITION,LABEL,PP1,PRINCIPAL,RESULTS,YES
HODGKIN,THERE,THESE,THREE
BECAUSE,HOWEVER
ACUTE,CROHN,EPILEPTIC,SAS,SLC7A11
233,ABOUT,LISCH,MRI,NF1,URINARY
CRF,CUSHING,DDAVP,IGF,PRL,THESE,V1B
DIAGNOSIS,EAE,HOWEVER,IGG,MRI,NEGLIGIBLE,THERE,THESE
169,CD8,DCS,TLS
CD103,CD4,CD62L,FOXP3,GBM,GL261,HOWEVER,PREVIOUSLY,RASB8,TREGS
169,BCL,CHINESE,COPYRIGHT,SFT
160,169,ASYMMETRIC,COPYRIGHT,EGF,INC,NG2,OPC,POSTNATAL,REGULATORS
169,COPYRIGHT,HOWEVER,LIKELIHOOD,LTD
169,397,CHILDHOOD,COPYRIGHT,HODGKIN,NON,PUBLISHED,RISKS,THESE,THREE,WILMS,YOUNGER
169,COPYRIGHT,DIFFUSE,HOWEVER,SAS,SEVERAL
169,CNS,COPYRIGHT,ELDERLY,PCNSL,PRIMARY,SAS
169,COPYRIGHT,LTD,THESE,USING,VBM,WORKING
BCL,GBM,HOWEVER,PREVIOUSLY,SRC,STAT3,THEREFORE
004,945,956,BACKGROUND,BECAUSE,BETULINIC,CONCLUSION,FURTHER,HIF,INCUBATION,LABEL,METHODS,PREVIOUSLY,RESULTS,UNDER,WESTERN
169,INC,NF2,WILEY
169,FND,INC,THEREFORE,WHILE,WILEY
177,CSF,GBM,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,SEVEN,SIX,THERE
FEW,GRADE,HOWEVER,III,INSULAR,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,THERE

253,BACKGROUND,CNS,DLBCL,LABEL,MARCH,METHODS,MTX,PARTIAL,RESULTS,SCNSL,SECONDARY,THREE,WBRTX
EXPRESSION,GL261,KIF23,SF126,TAKEN,U87MG
001,102,144,550,ADDITIONAL,BECAUSE,CRH,CUSHING,HOWEVER,JANUARY,THERE
BACKGROUND,EXPRESSION,GBM,INHIBITION,LABEL,M059K,MDR,METHODS,MO59K,PROTEIN,RESULTS,TOPOIIA,TREATMENTS,WESTERN
FURTHER,METASTATIC
116,117,173,231,BACKGROUND,BETWEEN,CONCLUSION,CYBERKNIFE,GAMMA,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,SRS,WORLD
001,002,003,005,021,022,032,034,042,130,ACUTE,ALD,ANH,BACKGROUND,CEO,CONCLUSION,FORTY,HES,JUGULAR,LABEL,METHODS,RESULTS,THERE,VOLUVEN
169,AMONG,COPYRIGHT,MRI,PUBLISHED,SAS,YET
169,COPYRIGHT,HGG,LGG,PUBLISHED,SAS,TAKEN
169,COPYRIGHT,OPTIMIZING,SAS
000,001,100,169,229,316,III,LABEL,METHODS,OBJECTIVE,PATIENT,RECURSIVE,RESULTS,ULLEV,UNIVERSITY,WILEY
ATN,BRAIN,MALIGNANT
GREGORY
169,ABOVE,AC133,CD133,COPYRIGHT,GOLGI,INC,WILEY
169,7B2,COPYRIGHT,CPG,DMH,PCR,SGNE1,TREATMENT
169,945,946,COPYRIGHT,SCREENING,SMAD2,TGF
100,150,DIFFUSE,DIPGS,THINK,TORONTO
197,BACKGROUND,BRESLOW,CONCLUSION,COX,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
001,034,AIM,BACKGROUND,CONCLUSION,CURRENTLY,JANUARY,LABEL,MEIER,METHODS,NFA,NON,OBJECTIVE,RESULTS,THERE,THESE
961,GLIOMAS,MODEL,SIMULATED,WHEREAS,WORLD
169,CONSISTENT,CONVERSELY,GBM,NOS,NOTABLY,PCR,STAT3,TAKEN
169,559,AMONG,ARRAY,BRAIN,BTSCS,CELLS,COPYRIGHT,DENSITY,GBM,IRELAND,LOW,LTD,MULTIFORME,PROTEIN,U87
169,CNS,COPYRIGHT,SAS,TREATMENT,WHILE
169,239,COPYRIGHT,DERMO,MRI,PUBLISHED,SAS
T2AN0M0
169,COPYRIGHT,GLIOMAS,ISOCITRATE,MIT,VCH,WILEY
100,838,CONCLUSION,EIGHT,FINAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SEPTEMBER,SETTING,THEREFORE,THREE,UNIVERSITY
003,042,177,AIM,BACKGROUND,BCL,FCM,LABEL,MATERIALS,METHODS,MIB,MRI,OBJECTIVE,PITUITARY,PRE,RESULTS,SIMILARLY,SIX,SPF
954
TET
845,ACTIVATION,EGF,ERK,EXTENSIVE,GBM,III,SRC,THESE,TYR,XENOGRAFTS
200,250,ADJUSTING,GBM,KARNOFSKY,KPS,PFS,SIXTY,TREATMENT
001,004,011,014,016,024,134,169,183,19Q,BACKGROUND,DHPLC,GROSS,JOURNAL,LABEL,LOH,METHODS,MMP,MRI,NEUROLOGY,OBJECTIVE,P53,PURPOSE,RESULTS,UNIVARIATE
169,195,221,222,ABOVE,EVALUATION,GBM,MICRORNAS,MIR,THEREFORE
107,131,160,175,189,250,313,495,520,651,695,837,BACKGROUND,BMI,BRAIN,CARDIAC,COLLEGE,DIETARY,INDIA,LABEL,METHODS,MORADABAD,MUNICIPAL,NUTRITION,PREGNANCY,RENAL,RESULTS,THERE,TOBACCO
CANDIDA,FURTHER,SEVEN,USING
160,407,946,CD133,CNS,GENOMIC,HISTONE,III,NGC,NSC,TAKEN,WESTERN
65308,AFTER,AMS,FSH,HOWEVER,MRI
169,BASEL,BRAIN,COPYRIGHT,MRI
169,600,860,ANOTHER,BASEL,COPYRIGHT,LABEL,METHODS,UNLABELLED
169,BMI,MICHAUD
ANOTHER,FINALLY,HOWEVER,LOCAL
169,237,241,AFTER,COPYRIGHT,DISCUSSION,LABEL,METHODS,OCT,OFTALMOLOG,PUBLISHED
160,AGS,CENTRAL,NERVOUS,TUMOURS
BRAIN,CNS,DSC,MRI,MTT,PWI
MASSIVE
BECAUSE,INTENSITY,LABEL,OBJECTIVE,PURPOSE,RESULTS,SONIC,SUMMARY,TREMENDOUS,WNT
100,CONCLUSION,EARLY,FET,III,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,REGIONS,RESULTS,SEVENTEEN,SINCE,SOD,SUV,TPEAK
001,157,AGE,BACKGROUND,COCHRAN,FINALLY,INPATIENT,LABEL,METHODS,NATIONWIDE,RCC,RESULTS
ADC,CHANGES,GBM,TESLA
136,169,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,THREE
169,COPYRIGHT,SAS
169,COPYRIGHT,III,INITIAL,SAS
169,COPYRIGHT,FINALLY,IMAGING,MRI,RESONANCE,SAS
169,179,956,BBB,COPYRIGHT,IRELAND,LTD,NEITHER
100,169,BACKGROUND,COPYRIGHT,CSF,HOWEVER,LABEL,METHODS,MRI,PUBLISHED,RESULTS,SIGNA,THERE
169,ART,BACKGROUND,COPYRIGHT,CPG,FINALLY,GBM,GLIAL,III,LABEL,METHYLATOR,NF1,OMICS,PDGFR,RTEL1,SAS,STATE,SUPPORT,THESE,V600E
169,ART,BACKGROUND,COPYRIGHT,HOWEVER,IMPORTANT,LABEL,MECHANISMS,SAS,STATE
169,COPYRIGHT,HOWEVER,SAS,WHILE
169,1P19Q,ACCORDING,ADULT,BECAUSE,COPYRIGHT,DEPENDING,FINALLY,GBM,IDH,IDH1R132H,III,INA,LGG,MIXED,SAS,TAKEN,WORLD
169,194,COPYRIGHT,INC,MEDICAL,PHILIPS,PINNACLE3,PUBLISHED,RESULTS
002,004,022,041,043,169,177,CONCLUSION,COPYRIGHT,HOWEVER,KPS,LABEL,LOW,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS,YOUNGER
100,169,AUSTRALIA,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USA
169,COPYRIGHT,PUBLISHED,SAS
AUTOPSY,GIVEN,REVIEWING
PEG,PHMNP,SMN,TARGETING
169,BACKGROUND,COPYRIGHT,DBC,HOPKINS,LABEL,MEIER,METHODS,QOL,RESULTS,SECONDARY,SOCIETY,SRS,THERE,THREE,USING
BASED,HFS,RESOLUTION
946,ACTIVATION,AKT,BAX,BCL,GBM,HOWEVER,INHIBITION,STAT3,THESE,TMZ,U87
103,BAD,BAX,DR4,DR5,RECEPTORS,VMY
264,302,341,767,COX,HRS,INSTITUTES,NIH,NSAID,SEVERAL
001,009,BACKGROUND,INCREASING,LABEL,LAD,MATERIALS,METHODS,MOTOR,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RIGHT,THESE
EHE,WWTR1
169,COPYRIGHT,CROWN,DIFFERENT,DIFFUSION,MEYER,MRI,PUBLISHED,THESE
169,AKT,COPYRIGHT,HENCE,HIF,IGF,MALIGNANT,RKD
169,1P19Q,945,ATP,COPYRIGHT,HOWEVER,III,SAS
169,COPYRIGHT,HOWEVER,SAS
169,COPYRIGHT,INC,MOLECULAR,PATHOLOGY,PCR,PUBLISHED,RAF,SOCIETY,THESE,V600E
10Q,169,ALTOGETHER,COPYRIGHT,GAINS,INC,MOLECULAR,PATHOLOGY,PUBLISHED,SOCIETY
169,AIM,BLACKWELL,BNP,CONCLUSION,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PTY,PUBLISHING,RESULTS,SERUM,THERE,TRC,ULN
001,025,169,BLACKWELL,DNT,FORTY,HOWEVER,LABEL,LIMITED,METHODS,NON,OBJECTIVE,PUBLISHING,RESULTS,THREE
169,181,250,AIM,AUTHORS,BACKGROUND,COLLEGE,HPA,JOURNAL,LABEL,METHODS,OBJECTIVE,PHYSICIANS,RESPONSES,RESULTS,ROYAL,SEVENTEEN,THERE,USING
169,COPYRIGHT,CSF,SOCIETY
169,COPYRIGHT,GRAND,MRI,OUEST,PROJECT,SOCIETY,THEREFORE,THREE
169,946,BRITISH,CD7,CD8,CED,TCR,TEN,USING
169,945,ACUTE,BACKGROUND,BANKS,BLOOD,C5A,CONCLUSION,LABEL,METHODS,OTHER,PLT,RESULTS,USING
500,550,99M,BLOOD,CONCLUSION,DEMOTENSIN,FOCAL,FURTHER,LABEL,MBQ,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SPECT,URINARY
BRAIN,EMERGENCY,GTR,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,THREE
110,177,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SINCE,THEIR,THERE
169,674,AGE,BACKGROUND,COPYRIGHT,END,GBM,HRS,LABEL,MEIER,METHODS,PROGRAM,RESULTS,SOCIETY,WIDESPREAD
000,375,700,BACKGROUND,BID,CESSATION,CONCLUSION,LABEL,LEV,METHODS,MORTALITY,PGB,PHT,RESULTS,RSE,THERE,TID
DIAGNOSTIC,MEMBERS,NEURO
219,USA,VACCR
115,CSF
MUTATIONS,PSF,TAU,TAU3R,TAU4R
BACKGROUND,LABEL,RESULTS,SUMMARY
135,175,22981,252,26981,277,AED,EIAED,EORTC,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,TMZ,TREATMENT,VPA
ICG,MPA,PAM,PAT,POSSESSING,QDS,SWNTS
737,ABT,BAX,BCL,BH3,HOWEVER,RASSF1A,TREATMENT,UW228
001,002,005,013,116,170,177,247,426,600,CAF,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,RVFAC,SERUM,TAPSE,THERE,TRICUSPID
169,AIM,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEVEN,THESE
150,169,177,ABOUT,BETWEEN,CAUSE,COPYRIGHT,FUNCTIONAL,GROUP,INDEX,IRELAND,KARNOFSKY,KPS,LABEL,LTD,MATERIALS,METHODS,NEUROLOGIC,NFS,OBJECTIVE,OCTOBER,PURPOSE,RADIATION,RECURSIVE,RESULTS,RPA,SCORE,SEPTEMBER,SIR,SRS,THERAPY,VARIABLES
169,COPYRIGHT,CROWN,GSC,LTD,PUBLISHED
945,CNS,GBM,PDGFR
174,215,800,ACTUARIAL,CYBERKNIFE,DISTANT,HOWEVER,LOCAL,PRIMARY,SRS
946,AKT,GNA
AIM,BACKGROUND,CHILE,DEPARTMENT,INSTITUTE,LABEL,MATERIALS,METHODS,MORTALITY,OBJECTIVE,PCR,POPULATION,RESULTS
CONVERSELY,HENCE,JANUARY,MARCH,MLY,MRI,PML
948,ABELSON,ABL,BRAIN,CD133,HOWEVER,PKC,SIMILARLY,SMALL,THESE,TREATMENT
200,SFT,THREE
BACKGROUND,CARDIAC,CHANGES,CROSS,LABEL,METHODS,RESULTS,TVI
169,945,946,AAV,BACKGROUND,CONCLUSION,COPYRIGHT,INC,INF,LABEL,METHODS,MOSBY,MT330,OVERALL,RESULTS,SMA,XENOGRAFTS
169,394,ABR,AMONG,BACKGROUND,COPYRIGHT,DEPARTMENT,GPS,LABEL,METHODS,MRI,PARTNER,PUBLISHED,RESULTS,SOCIETY,TDT,URBAN
CASP8,CSC,TRAIL,WESTERN
CONCLUSION,JUDICIOUS,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR,THREE,TOTAL,UNSPECIFIC
CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE

ABSENCE,BASEL,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PROGNOSTIC,RESULTS
FAK,HOWEVER,PROTEIN,PTP,RAS,THESE
ADDITIONAL,CAREGIVERS,CAREGIVING,COMMITMENT,HEALTHCARE,INSTITUTE,LABEL,METHODS,MODEL,OBJECTIVE,OBJECTIVES,PARSE,PATIENT,PURPOSE,RESULTS,SETTING,STORY,VARIABLES
169,COPYRIGHT,INC,SMOKING
CURRENT,NOVEL,THERE,TREATMENT
AFTER
001,014,033,203,CHINESE,IDH,MUTATIONS,NORTH
00004,00007,020,242,HOWEVER,PCR,PEDIATRIC
946,MEANWHILE,MMP,PCR,SHG44,TGF
128,945,DECREASED,GLIOMAS,MICRORNAS,RTK,USING
19S,ACTIVATOR,DESPITE,ERK,FOS,FRA,PROTEIN,RAS,TBP,THESE
AKT,ATM,RADIATION,RADIO,SHH,SONIC,YAP,YES
CD3,EPSTEIN,GADOLINIUM,LYG,MRI,THESE
MRI,PILOCYTIC,ROSENTHAL
CPA,MENINGEAL,MRI
169,945,COPYRIGHT,MALIGNANT,PUBLISHED
169,2TK,956,AFTER,C17,CONNEXIN43,COPYRIGHT,GAP,GCV,HOWEVER,HSV,HSVTK,IRELAND,LTD,MBS,NSC,NSCTK
169,316,COPYRIGHT,COX,LTD,MEIER,MEMBERS,MYC,NDRG2
143,169,189,CENTRAL,CNS,CONCLUSION,COPYRIGHT,FLORIDA,GTR,LABEL,METHODS,OBJECTIVE,RESULTS,ROUGHLY,SFT,SIX,STR,UNIVERSITY
169,194,AFTER,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,946,AKT,AMP,COA,COPYRIGHT,HMG,INDUCTION,INHIBITION,LC3,LDH,LTD,MAMMALIAN,MEVALONATE,MTT,THESE
003,004,169,259,287,772,CENTRAL,CNS,COPYRIGHT,COX,LTD
169,COPYRIGHT,INC,NFA,PATHOLOGY,PCR,PRL,PUBLISHED,SOCIETY,USING
169,ACADEMY,COPYRIGHT,FUNCTIONAL,INC,PUBLISHED,STUDIES,THERE
169,177,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
AFTER,BACKGROUND,FCM,FINALLY,LABEL,LATER,METHODS,MRI,OVERALL,RESULTS,SIX,USING
ADULT,BACKGROUND,BASED,BIALLELIC,CPG,EFS,FYN,LABEL,MEIER,METASTATIC,METHODS,NOTABLY,PCR,RESULTS,THERE,UVEAL
GLIAL
CSF,GBM
100,200,215,250,400,800,GRADE,MRI,PFS,QUALITY,SECONDARY,SEVENTEEN
160,177,330,DELAYED,GREATER,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,THERE
001,118,142,ANIMALS,CPT,HB1,IRINOTECAN
AFTER,BACKGROUND,CO2,CONCLUSION,DESPITE,GAMMA,GIVEN,IMPORTANCE,KNIFE,LABEL,MEDICAL,MEDTRONIC,MEMPHIS,METHODS,MINIFRAME,MRI,STEALTH,TENNESSEE
181,947,AMP,GMP,SIMILAR,SNP,THESE
100,169,185,DIFFERENT,FLT,HOWEVER,LABEL,MBQ,METHODS,OBJECTIVE,PET,PFS,PURPOSE,RESULTS
125,156,177,245,277,JANUARY,LGG,MALIGNANT,PFS,SBT,WORLD
169,183,BASED,COPYRIGHT,LTD,MRI,SEVERAL,TESLA
023,169,183,BACKGROUND,COPYRIGHT,FRANKFURT,FUNDING,GERMANY,LABEL,LTD,METHODS,MRI,OCT,RESULTS,UNIVERSITY
169,BRAINSTEM,COPYRIGHT,LTD,MRI
169,COPYRIGHT,LTD
107,169,COPYRIGHT,CSF,INTENSIVE,LTD
169,COPYRIGHT,LTD
169,COPYRIGHT,DUE,LTD,METASTATIC
100,120,150,169,200,COPYRIGHT,LTD,MIS,NERVE,THERE
169,BECAUSE,COPYRIGHT,INC
169,435,COPYRIGHT,CPT,IRELAND,LTD,MDA
169,954,COPYRIGHT,INC,MMP,PLD,QUERCETIN,TAKEN,U87
BACKGROUND,GBM,GREATER,IACNS,LABEL,METHODS,MRI,SURGERY
169,945,COPYRIGHT,GBM,HYPOXIC,INC,THEIR,WILEY
160,AIM,DIAGNOSES,III,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
946,ALZHEIMER,INCREASING,SINCE
FUNCTIONAL,THERE,TOOUR,U87MG
HOWEVER,PROCESSING,THESE
19Q,ADC,ASS,DTI,FURTHER,OAS,ODS,SINCE,SMI,THERE,WORLD
EARLY,PET
CNS,ERLOTINIB,MUTATIONS,PULSATILE,T790M,TREATMENT
AIM,BACKGROUND,HEADACHES,JANUARY,LABEL,METHODS,OBJECTIVE,POSTERIOR,RESULTS
586,BACKGROUND,COHEN,CONCLUSION,IHC,KAPPA,LABEL,METHODS,MSP,RESULTS,SERUM
001,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,III,IRELAND,LABEL,LTD,METHODS,NSCLC,OTHER,POTENTIAL,RESULTS,SIMILARLY
169,1960S,COPYRIGHT,ENGLISH,HENCE,HOWEVER,ITALIAN,LABORATORY,LURIA,RUSSIAN,SRL
169,ALA,COPYRIGHT
169,183,BACKGROUND,CONCLUSION,ENDOSCOPIC,GEORG,HOWEVER,LABEL,METHODS,PATIENT,RESULTS,SHUNT,STUTTGART
001,004,023,029,033,039,047,ACTUARIAL,ANAPLASTIC,DESPITE,GROSS,PEDIATRIC,PFS
160
ESI,FURTHER,LIMITATION,PROTEIN,THERE
166,177,454,956,AUTOGEL,IGF,LAN,OCT,SIXTY
EP1NS,HDACI,NOVEL,VORINOSTAT
CD133,EXPRESSION,GBM,HOWEVER,NG2,ROS,SINCE
ALA,BACKGROUND,CONCLUSION,DCS,HSP,LABEL,METHODS,PDT,RESULTS,SPHEROIDS,U87
169,229,CNS,CURRENT
BECAUSE,CNS,OTHERWISE,THEREFORE,THESE
169,9TH,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,ORS,RESULTS,THERE
100,107,169,176,315,350,BRAIN,COPYRIGHT,DMEAN,DOSES,HOWEVER,INC,LOW,PTV,PUBLISHED
169,COPYRIGHT,COX,LTD,THERE
AKT,BRAIN,DUE,RAS,THESE
169,BRAIN,COPYRIGHT,HOWEVER,LTD,S100B,THEREFORE,WILEY
AFTER,BACKGROUND,BMS,CURRENT,LABEL,METHODS,RESULTS,SCHOLAR
134,HESRG,PCR,THESE
100,ADVERSE,CYBERKNIFE,DUE,FORTY,SRT,THESE,THREE,TOXICITIES
5256360,5560509,624,CHEMBRIDGE,GBM,THESE,TOP2A
946,GBM,HOWEVER,TAKEN,TGF
GBM,HUVEC,MMP,ORGANIZED
EVEROLIMUS,LOW,PITUITARY
HOWEVER,SEVERAL
HOWEVER,RECURRENT,SEVEN,THESE
200,BETWEEN,GRADE,III,METASTATIC,MRI,NEWLY,NOVEL,PFS,RESPONSES,SEPTEMBER,TMZ
AGE,BACKGROUND,CONCLUSION,GBM,KARNOFSKY,LABEL,METHODS,PATIENT,RESULTS,TMZ
BBB,BESIDES,CENTRAL,CNS,HOWEVER,MMP,TIGHT
DROSOPHILA,HIPPO,SWH,THEREFORE,WARTS
III,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
AUTHORS,BACKGROUND,CHILDHOOD,LABEL,METHODS,RESULTS
BACKGROUND,FOLLOWING,LABEL,METHODS,RADIATION,RESULTS
001,181,ADC,DIFFUSION,FLAIR,GBM,MRI,SEVENTY,THESE
001,002,19Q,FAVORABLE,III,PCR,THREE,UNIVERSITY
169,AIF,BAD,BAX,BCL,BNIP3,CELLS,COPYRIGHT,HIF,HOWEVER,HRE,THERE
169,200,COPYRIGHT,LTD,PFS,PLC,SCHMAHMANN,SHERMAN,SPECT,THESE
169,COPYRIGHT,INC,MPNST,NF1,PNS,RAS,SCHWANN,THESE
169,946,COMBINING,COPYRIGHT,WNT
10B,169,956,A2780,AZA,BE2,COPYRIGHT,CROWN,DU145,LTD,MCF,PUBLISHED,SUBSEQUENT,SW480
A37,EMH,EMHIN,FINAL,TREATMENT
169,ACADEMY,FAILURE,PITUITARY,POSTMORTEM
BRAIN,CUSHING,GENERAL,LEONARD,MENINGIOMA
100,162,163,805,849,886,AIM,CONCLUSION,LABEL,METHODS,MRI,NF1,OBJECTIVE,RESULTS,ROC
169,181,COPYRIGHT,FINALLY,INC,IPO,SOLID,THESE,WILEY
100,239,6PR,CNS,JAN,MST,OBJECTIVE,SUN,TREATMENT,UNIVERSITY
304,579,ENDOCRINE,FORTY,FSH,TORANOMON

GLIOMAS
169,MRI,TARGETING
AEG,AGGRESSIVE,ASTROCYTE,CBP,EAAT2,PEARSON,TAKEN,THESE,YY1
AUTOMATED,BACKGROUND,CLINICALLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
ANXIETY,BASED,INVENTORY,PHASE,STATE,TRAIT
BAX,BCL,C106A,DELETIONS,PARKINSON,THESE,UPS,UVB
111,169,BACKGROUND,BLACKWELL,LABEL,LTD,OBJECTIVE,PUBLISHING,PURPOSE,VAGAL
160,BBB,CAMELIDAE,FNIII,III,NPY,THESE
946,BECAUSE,FZD,FZD10,MBS,OVERALL,PCR,WESTERN,WNT
001,003,123,177,COX,FORTY,HDC,THERE
IMAGING,MINIMUM,MRI
160,200,ADDITIONAL,AUC,BORTEZOMIB,HEIAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY
177,227,233,243,947,IRMANDADE,JOS,MISERIC,OTHER,PCR,PORTO,PRL,SANTA,THERE
ARRAY
001,246,ADJUSTMENT,AIM,BACKGROUND,BNP,FRAMINGHAM,HEART,LABEL,METHODS,OBESITY,OBJECTIVE,RESULTS
019,150,ADP,AIF,III,PEDIATRIC,WORLD
101,169,180,COPYRIGHT,DVT,III,INC,THERE,THROMBI,WORLD
169,GSC,OVERALL
169,BACKGROUND,BIM,BLACKWELL,CLINICALLY,CONTEXT,FIRST,LABEL,LAR,LTD,OBJECTIVE,OCTREOTIDE,PATIENT,PUBLISHING,RESULTS,TSH,TSHOMAS
169,ALZHEIMER,AT8,AVM,SOCIETY,THERE
BASED,HOT,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,RESULTS,SUBJECTIVE,THESE,VASOMOTOR,WOMEN

677,C677T,EXPRESSION,MTHFR,THERE
945,954,CELECOXIB,COX,GBM,GLIOMAS,IKK,TNF,TUNEL
AVERAGE,DECOUPLING,FDG,PET
002,011,100,230,31P,600,658,EORTC,MCNEMAR,OXC,QOLIE,SIX,ZSDRS
196,200,341,353,BACKGROUND,INITIALLY,LABEL,METHODS,NAC,NSM,RESULTS,THERE,USING
532,BACKGROUND,LABEL,LMC,MARCH,METHODS,OCTOBER,RESULTS,WHILE
AFTER,BLI,DII,HOWEVER,MSC,NTV,THESE
FINALLY,MET,THERE,THESE,VAL
BCL,E26,ETS,GBM,MCL
THERE
BACKGROUND,DESPITE,DISCUSSION,LABEL,METHODS,PATIENT,RESULTS,THERE
100,160,BACKGROUND,LABEL,LATERAL,MAPPING,METHODS,RESULTS
CYBERKNIFE,GAMMAKNIFE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,SUMMARY
DESPITE,ENDOCRINE,LABEL,OBJECTIVE,PITUITARY,PRACTICAL,PURPOSE,RESULTS,SOCIETY,SUMMARY
215,ACCRUAL,ADV,ASSESSMENT,BRAIN,CD3,CONCLUSION,DESPITE,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RADIATION,RESULTS,THERAPY,THERE,THREE
CONTINUED
150,169,COPYRIGHT,LABEL,LTD,MBC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS
121,169,BETWEEN,COPYRIGHT,FORTY,INC,LABEL,M1A,MARCH,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,TNM,TYPES
BACKGROUND,LABEL,MALIGNANT,METHODS,RESULTS
169,AUSTRALIAN,AUTHORS,BACKGROUND,BED,COLLEGE,CONCLUSION,IMAGING,JOURNAL,LABEL,MATERIALS,MEDICAL,METHODS,NSC,PER,RADIATION,RESULTS,ROYAL,TREATMENT,ZEALAND
169,COPYRIGHT,FINALLY,VCH,WILEY
10001,333,MEDICAL,PAPILLARY,PUBLISHERS,SEVENTH,USA,WHILE
100,147,BACKGROUND,DIFFUSE,KPS,LABEL,LGG,METHODS,RESULTS,SIX
100,AGE,CNS,GTR,LOG,MEIER,MIXED,NEITHER,PEDIATRIC,PFS,STR,THERE,UNIVERSITY,WASHINGTON
AKT,DESPITE,GLIOMAS,MICRORNAS
ATG12,AUTOPHAGIC,AUTOPHAGY,BRAIN,LC3,MTS,ONS76,SILENCING,THESE,WESTERN
BCL,ERK,GBM,HOWEVER,JNK,JUN,NEUROPILIN,NRP,RESULTS,WESTERN
001,135,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,STUPP,THERE
220,RECURRENCE,SURGERY
110,223,362,542,639,834,967,COX,HODGKIN,NHL
STT
DIAGNOSTIC,MRI,PET,THEREFORE,THESE
169,COPYRIGHT,DESPITE,GROUP,IHC,INC
169,CBF,CONCLUSION,COPYRIGHT,DCE,DSC,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PARAMETRIC,RESULTS,SAS
169,COPYRIGHT,LIV,NEITHER,SAS
169,COPYRIGHT,SAS
000,131,169,181,AIM,AUC,AUTHORS,BRITISH,CNS,HDMTX,JOURNAL,LABEL,METHODS,MTX,OBJECTIVE,PCNSL,RESULTS,SOCIETY,THERE,THESE
123,177,191,252,263,316,339,462,517,641,691,ACTIVITIES,ADL,ASSOCIATED,CSF,JAPAN,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE,SEVEN,THIRD,WHITNEY
169,1970S,1980S,BACKGROUND,COPYRIGHT,CRS,END,LABEL,MEIER,METHODS,PNETS,RESULTS,SOCIETY,THERE,THESE
169,BACKGROUND,CAUCASIANS,CONVERSELY,COPYRIGHT,EARLY,END,INSTITUTE,LABEL,LFS,METHODS,OVERALL,PROGRAM,RESULTS,SARCOMA,SOCIETY,THOSE
100,169,BACKGROUND,BECAUSE,CALIFORNIA,COPYRIGHT,FRANCISCO,GREATER,HPC,LABEL,METHODS,RESULTS,SAN,SEVEN,SOCIETY,STRATEGIES,TREATMENT,UNIVARIATE,UNIVERSITY
169,177,322,367,ALA,BACKGROUND,COPYRIGHT,HOWEVER,III,LABEL,METHODS,PET,RESULTS,SOCIETY,THESE
MRI,THESE,THREE
MPE,MRI
GROSS,RADIOLOGIC
006,009,160,192,COX,JUN,MEIER,SER10
CENTRAL,EIGHT,NERVOUS,NOW
ABSCESS,ADC,BACKGROUND,DTI,DWI,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC
168,169,19Q,1P19Q,AMONG,COPYRIGHT,FINALLY,HOWEVER,INC
163,169,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LIBERAL,LTD,METHODS,OBJECTIVE,QALYS,QUALITY,RESULTS,SECONDARY
177LU
012,013,019,169,AIM,AUTHORS,BRAIN,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,DUKES,FIFTY,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,BLACKWELL,CONCLUSION,LABEL,LTD,MENINGIOMA,METHODS,NARRATIVE,OBJECTIVE,PUBLISHING,STUDIES
CNS,GBM,TAM,THESE
169,AGE,COPYRIGHT,INC,OVERGROWTH,SOTOS,SPANISH,WILEY
169,COPYRIGHT,LCMODEL,LTD,SIMULATION,WILEY
AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,EPILEPSIA,ISSUE,LABEL,LIBRARY,LIM,MAY,MEDLINE,METHODS,NEURO,NEUROLOGY,OBJECTIVE,OBJECTIVES,RESULTS,SELECTION,THERE,WHILE
001,003,106,143,165,166,171,177,195,312,470,BMI,COX,DIABETICS,FIFTEEN,FIFTY,HGG,INCREASING,KPS,PFS,PRE,RADIATION,VARIABLES
PITUITARY
006,007,009,032,048,055,160,177,380,ADC,BACKGROUND,CONCLUSION,III,LABEL,MAXIMUM,METHODS,REGARDING,RESULTS,WHILE,WHITNEY
071,1ST,CUSHING,FORTY,JANUARY,MAY,TEN
100,131,AE1,AE3,BCL,EMA,MU213,S10,SCO,SMA,SPINDLE,SPO
CAVERNOUS,DLBCL,GKS
19Q,CNS,MOLECULAR,MRI,WORLD
160,MRI,THERE
160,EXTENSIVE
160,BRAIN,DIRICHLET,HAUSDORFF,JACCARD,LABEL,METHODS,MRI,OBJECTIVE,PRECISION,PURPOSE,RESULTS,T1C,THEREFORE,USING,VALIDATION
BECAUSE,DIAGNOSTIC
AMONG,CNS,CSF,DESPITE,EXCLUSION,HIV,INCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PATHOLOGIC,PISCL,RESULTS
105,197,ELISA,INCREASES,MRI,SERUM,THREE,YKL
ABOUT,CTS,GERMANY
001,002,169,571,785,819,BACKGROUND,COPYRIGHT,III,INC,LABEL,METHODS,NSCLC,OVERALL,REGARDLESS,RESULTS,THEREFORE
169,COPYRIGHT,EEG,FCD
169,215,22Q,ALONGSIDE,CONFUSION,COPYRIGHT,EMA,MITOTIC
167,169,177,213,233,COPYRIGHT,CROWN,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,VIRTUAL
169,203,BACKGROUND,CONCLUSION,COPYRIGHT,CTC,FIFTEEN,FORTY,IRELAND,LABEL,LTD,METHODS,NCI,NSE,OVERALL,PROPORTION,RESULTS,SEPTEMBER,SEVENTY,SINCE
163,169,491,885,AMONG,COPYRIGHT,GBM,MICRORNAS,MMP,U87
19Q,CPG,GBM,GLIOMAS,LGG,TMZ
HOWEVER,MAY,METASTASES,SEPTEMBER
OWING
946,ALZHEIMER,AMYLOID,BACKGROUND,COGNITIVE,CONCLUSION,ELISA,HOWEVER,LABEL,METHODS,MICROGLIA,MICROGLIAL,PCR,RESULTS,TLR4M,TLR4W,WHILE
169,STAT3
169,AUTHORS,BRITISH,FINALLY,JOURNAL,SOCIETY
169,181,BBB,BBMEC,BOB,COPYRIGHT,DARBY,INC,LABEL,MANIN,METHODS,MRP,OBJECTIVE,PRIMARY,RESULTS,STUDIES,WILEY
045,156,EOR,FIFTEEN,GREATER,GTR,MANAGEMENT,PFS,STR
181,ASA,ASA20,ASA20CM,ASIATIC,BAD,CCM,CONSISTENT,EARLIER,FURTHER,HBMEC,HUVEC,MALIGNANT,OVERALL,SUSTAINED,THEREFORE,U87
11Q23,20Q13,LABEL,OBJECTIVE,PURPOSE,RESULTS,RTEL1,SEVEN,SEVERAL,SUMMARY
185,FIRST,LABEL,MET,OBJECTIVE,PET,PURPOSE,RESULTS,SUMMARY
200,260,358,444,ALT,AST,CNS,CONCLUSION,EXPRESSION,HES,LABEL,METHODS,MTD,NOTCH,OBJECTIVE,PBMCS,POPULATION,PURPOSE,RESULTS,SEVENTEEN,THERE
164,AQUAPORIN,BACKGROUND,CNS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTPATIENT,RESULTS,SETTING,THESE
100,CHINA,LABEL,METHODS,OBJECTIVE,ONB,RESULTS,SETTING,SUN,THERE,UNIVERSITY,YAT
CPG,NGS,SEQ,SIMILARLY
ALA,ANOTHER,COLLEGE,DEPARTMENT,MEDICAL,OSAKA,PCR,THESE
104,261,MEIER,PRIMARY,SALVAGE,TEN,THERE,THREE
100,169,COPYRIGHT,EMA,MRI,SCHWANN,SOX,THESE
169,194,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,DESPITE,HODGKIN,LABEL,LON,METHODS,MRI,NHL,NON,PRIMARY,SAS,WHILE
169,COPYRIGHT,INC,KLIPPEL,THEIR,THESE
169,403,COPYRIGHT,GIANT,INC,PREDICTIVE,THERE
LEUCINE,LRIG2,PCR
001,002,282,291,BACKGROUND,CONCLUSION,FURTHER,JANUARY,LABEL,METHODS,RESULTS,SIADH
AFTER,ANGELIS,DESPITE,HODGKIN,MULTISLICE,THERAPY
160,945,BNIP3,HIF,MMQ
945,946,954,FAS,IKK,INHIBITION,TNF,TRAIL
DESPITE
CURRENTLY,MALIGNANT,SIMILARLY,TNF,TRAIL
183,187,AFTER,DROSOPHILA,EXFGI,GC15914,GTDC1,III,INDUSTRIAL,JAPAN,LIBRARIES,PCR,PROJECT,TECHNOLOGY,TOKYO
169,AFTER,AGE,AREAS,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PHASE,PLPOP,PROGRAM,RESULTS
169,174,COMPRITOL,COPYRIGHT,EDELFOSINE,TWEEN
169,ARG,ASP,COPYRIGHT,ECM,GBM,GLY,INCREASING,LTD,RGD
169,AFTER,AUC,AUR,CHO,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRS,NAA,NON,NORMALIZED,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
169,ANNEXIN,COPYRIGHT,FCM,NIMUSTINE,PROPIDIUM,TFR,U87MG,USING
169,CONNEXIN43,COPYRIGHT,GAP,GIVEN,ISSUE,SPECIAL,THERE,THESE
169,COPYRIGHT,INC,RADICAL,THESE
169,COPYRIGHT,ENDOSCOPIC,INC,PUBLISHED
AFTER,BECAUSE,DBS,HEMICHOREA,UNTIL
153,FIM,FUNCTIONAL,GENERAL,LABEL,MARCH,MEASURE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERVICE,THERE,WHILE
149,CONCLUSION,CSF,LABEL,METHODS,OBJECTIVE,OUTCOME,RESORBABLE,RESULTS,SETTING,SEVENTY,THERE,UNIVERSITY,WOUND
AFTER,PCR,PILOCYTIC,THREE,WORLD
818,AGE,ALCOHOL,BACKGROUND,DENMARK,EARLY,LABEL,METHODS,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS,SCALE
BACKGROUND,CAROTID,CHRONIC,CONTROLLED,DISEASE,LABEL,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RESULTS
19Q,AMONG,CIC,DROSOPHILA,FUBP1,THESE
INSTEAD,THESE,WHILE
169,COPYRIGHT,LTD
169,WILEY
BACKGROUND,LABEL,RESULTS,THERE
FUNCTIONAL
238,247,262,BACKGROUND,DECISIONS,FIFTY,INCAPACITY,LABEL,METHODS,OCTOBER,RESULTS,SEVEN,STATE
129,160,376,AIM,CUT,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
619,ACP,COL,IHC,MMP
125,340,CHINESE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,SALVAGE,SETTING
AMONG,NAVIGATING,NKCC1,STE,TRANSWELL,WESTERN,WNK
103,105,247,511,BRAIN,CONSORTIUM,NORTH
946,EMT,GADD45A,MMP,RADIATION,TAKEN
169,IMAGE,LARGE
169,200MG,CONCURRENT,COPYRIGHT,CROWN,GRADE,LTD,PLD,PUBLISHED,TREATMENT
169,215,HOWEVER,SOCIETY
COMBINING,GLIOMAS,THEIR
BACKGROUND,CONCLUSION,DIFFUSION,FIBER,LABEL,METHODS,MINIMUM,OBJECTIVE,PTS,RESULTS
FLK,FURTHER,HBS,SCL,SSEA1,THERE
001,AKT,ANOVA,DECREASED,HIV,NELFINAVIR,PITUITARY,THERE,WESTERN
945,946,AXENFIELD,DVL,PITX2,SIMILAR,THEREFORE,WNT
945,946,947,FURTHER,P21,SURGERY
103,ATTENUATED,CONCLUSION,EIGHT,FIBER,LABEL,METHODS,PET,RESULTS,THREE,UNLABELLED
169,COPYRIGHT,THEREFORE
169,BRAIN,COPYRIGHT,CSC,GBM,INC,NANOG,THESE,USING
946,ABCG2,AKT,ATP,GBM,JNK,P38,REX
131,BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,PALMINI,RESULTS,THREE
001,AMONG,ANAPLASIA,BACKGROUND,BAF47,BRAIN,CONCLUSION,CONSORTIUM,CONTEXT,HOWEVER,INFANTS,LABEL,MBS,METHODS,OBJECTIVE,PEDIATRIC,PFS,RESULTS,RTS,THESE
169,COPYRIGHT,ERK,HOWEVER,INC,LRRC4,MALDI,STMN1,TOF,WILEY
160,169,183,ANOTHER,GEORG,PARKINSON,STUTTGART
ANTIVIRAL,HBV,HEPATITIS,TMZ
FAD,SMO,SPM
BACKGROUND,BILATERAL,BIPSS,BLOOD,CONCLUSION,CORRECT,CUSHING,LABEL,METHODS,MRI,RESULTS,UNTIL,USING
100,101,132,BACKGROUND,EIGHT,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TOTAL
001,006,CTS,MRI,THERAPY,THERE,THEREFORE
GD3,THREE,USING
13C,177,945,BECAUSE,EARLY,EVEROLIMUS,GBM,HIF,INC,INHIBITION,INNOVATIVE,MRI,PUBLISHED,SEVEN,USING
169,COPYRIGHT,IES,INC,MAB,PHA,RESULTS,SPOUSES,THESE
169,466,934,AFFYMETRIX,CCND1,CCNG2,CONCLUSION,COPYRIGHT,EP300,FGFR1,GBM,ID2,INC,LABEL,METHODS,OBJECTIVE,PDGFD,PRKCA,RESULTS,SEMUSTINE,SOCS2,SP1,STMN1,STUDIED,TNF
169,AUSTRALIAN,AUTHORS,COLLEGE,FETAL,JOURNAL,OBSTETRICS,REVERSIBLE,ROYAL,ZEALAND
AREAS,BACKGROUND,COVERED,EVEROLIMUS,FDA,FINALLY,LABEL,METHODS,OPINION,SEGAS,STUDIES,TSC
ADMISSION,AFTER,CSF,EMERGENCY,IMMEDIATE
CPP,HOWEVER,ICE
1970S,1980S,BRAIN,CURRENT,LABEL,METHODS,OBJECTIVE,RESULTS
PEDIATRIC,THESE
100,169,946,COPYRIGHT,GABAERGIC,PANCREATIC,STUDIES,THESE,VCH,WILEY
101,218,ACUTE,CSI,CTC,DFS,NCI,PRIMARY,TEN
956,CURRENTLY,DNMT1,DOCKING
116,150,400,600,605,657,666,CUSHING,INT,LITERATURE,MIB,MIN,MITOTIC,MRI,MUCIN,PITUITARY
946,GROUP,HOWEVER,IFN,JAPAN,TMZ
100,BTB,GFI,MIZ,MOUSE,MRE,MYC,POK,POZ
AKT,PDZ,PHLPP
ASTROCYTIC,BACKGROUND,III,LABEL,METHODS,RESULTS,THERE
USING
028,046,120,215,ANOTHER,FUNCTIONAL,MRI,MSIVP,RPT,THERE,TIN
145,155,20A,214,30B,365,CNS,DLBCL,GCB,HIV,HOWEVER,MICRO,MYC,PCNSL,PCR,THERE,USING
CONCLUSION,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS,TSH
AKT,ATTENTION,CURRENT,GBM,RAS,TMZ,WNT
169,COPYRIGHT,IRELAND,LTD,SHH,SONIC
169,CONCLUSION,COPYRIGHT,ECT,LABEL,OBJECTIVE,PFC,RESULTS,SRS
104,108,112,116,169,215,475,479,956,990,992,API,C18,COPYRIGHT,CSF,DETECTION,ESI,KINETEX
169,COPYRIGHT,IRELAND,LTD,THESE,TRAIL,TREATMENT
002,004,044,120,135,169,177,ARDMORE,COPYRIGHT,IMTEC,INC,LABEL,METHODS,MOSBY,OBJECTIVE,RESULTS,SCANS
129,169,ARRAY,COPYRIGHT,FIBER,GENOMES,KYOTO,LTD,PATHWAY,PITUITARY
169,COPYRIGHT,LTD,MRI
BARRIER,BLOOD,BRAIN
169,COPYRIGHT,FETAL,ISUOG,LTD,MRI,PUBLISHED,WILEY
492,769,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
CENTRAL
ACUTE,CNS,GROUP,ICSRT,INSTITUTES,RADIATION,SEVEN,THERAPY,TREATMENT,VHL

043,11P11,160,19P,AFFYMETRIX,CADPS,CENTRAL,CNS,COMPARISON,CURRENT,FAM129A,GENOMIC,NOVEL,OVERALL,PCDHGA3,PNETS,TARGETS
133,181,948,FGR,SAMPLES
CDC,CURRENT,CYCLING,E2F,GBM,HENCE,MCM,MITOSIS,NEUROGLIA,NG2
MANAGEMENT
100,110,125,131,956,AFTER,BACKGROUND,CELLS,CMV,LABEL,METHODS,NIS,RESULTS,WESTERN
000,169,177,205,277,281,ANGELES,BACKGROUND,COPYRIGHT,CUMULATIVE,FOLLOWING,INC,INTENSIVE,LABEL,LOS,METHODS,PATIENT,PRIMARY,PROCEDURE,RESULTS,START,WHILE,WILEY
169,CONCLUSION,COPYRIGHT,EFS,EIGHT,HIT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THREE,WILEY
169,947,COPYRIGHT,FURTHER,LTD,TESLA,THESE,USING,WILEY
169,COPYRIGHT,INTERPRET,KENNARD,LCMODEL,LTD,STONE,SUPPORT,WILEY
007,018,159,169,177,EFS,HIT2000,MBS,METASTATIC,PEDIATRIC,PFS,SOCIETY,THREE
POSTERIOR
10B,GBM
352,646,BACKGROUND,CIS,CONCLUSION,CONTROL,DENMARK,LABEL,METHODS,ORS,REGULAR,RESULTS
ANTIBODIES,C9NEO,CD138,CD3,CD4,CD8,CNS,COMPLEMENT,IGG,LABEL,METHODS,NMDAR,OBJECTIVE,OBJECTIVES,RESULTS,ROBIN,USING,VIRCHOW
EXPRESSION,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPTICAL,RESULTS
INFECTION,PREVALENCE,THESE,TOXOPLASMA
169,186,228,33B,512,ANTISENSE,AUTHORS,BRAIN,MICRORNAS,OVERALL,PATHOLOGY,PCR,SOCIETY,THESE
946,CODELIVERY,DEXAM
169,BACKGROUND,COPYRIGHT,GCT,INC,LABEL,LCMODEL,METABOLITE,METHODS,MRS,PPT,RESULTS,TAURINE,WILEY
169,AKT,COPYRIGHT,CSLCS,ERK,HOWEVER,MEK,PRESS,THESE
100,105,160,169,221,442,AMONG,APRIL,COPYRIGHT,ELF,MAY,THESE
169,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,METHODS,PFS,RESULTS,SOCIETY,THERE
HRM,MSP
CNS,EBV,EPSTEIN,LABEL,LYG,METHODS,OBJECTIVE,PURPOSE,RESULTS
177,THERE,THEREFORE,TMZ
HOWEVER
103,156,160,172,177,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS
296,ATM,BACKGROUND,BRITISH,CONCLUSION,ISLES,LABEL,METHODS,OVERALL,RESULTS,THERE
008,015,027,038,045,047,AIM,BETWEEN,CONCLUSION,FDG,GROUP,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PULMONARY,RESULTS,SEVEN,UNIVARIATE
AFTER,BACKGROUND,CONCLUSION,IMPORTANCE,LABEL,MCS,METHODS,MOTOR,SIX,TNP
003,201,215,BACKGROUND,CONCLUSION,FORTY,GAMMA,KNIFE,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,UNIVERSITY
024,025,123,213,264,320,AFFYMETRIX,BACKGROUND,CDCA1,CREST,CTAG2,DUTCH,EVALUATION,EXPRESSION,GENECHIPS,HD4,HOVON,LABEL,METHODS,NTR,RESULTS
169,COPYRIGHT
169,ALTOGETHER,AUTHORS,BRAIN,CETUXIMAB,GBM,GSC,HOWEVER,IL2,MHC,PATHOLOGY,SOCIETY
GBM,HOWEVER,LABEL,METHODS,MSP,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,THREE
160,HOWEVER,POE,SMALL,THERE,THEREFORE
BESIDES,C57BL,CONCLUSION,LETROZOLE,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CAREFUL,CONCLUSION,IMPORTANCE,LABEL,METHODS,SEBACEOUS
177,231,ANIMALS,BBB,ENHANCING,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
ECS,EGF,HOWEVER,HYPOXIC,INHIBITION,PAR
169,174,206,BACKGROUND,CIS,CONCLUSION,FACTORS,IGF,IGFBP,INSULIN,LABEL,METHODS,NUTRITION,ORS,RESULTS
169,HOWEVER,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,REGRESSION,REMAINING,RESULTS,THREE
CSLCS,GBM,HOWEVER,NOTABLY,NOTCH,SINCE
DESPITE,DR5,GBM,MALIGNANT,PEI,TRAIL,U87,WESTERN
947,INHIBITION
156,160,169,174,177,COPYRIGHT,EDC,LTD,NHS,PEG,PROLONGED,PTX,TAXOL,XPS
169,COPYRIGHT,INC
STRUCTURAL
169,174,AICHE,CONVECTION,COPYRIGHT,EFFECTIVE,ENGINEERS,GLIADEL,INSTITUTE,MALIGNANT,ONCOGEL
LESIONS,PCG
153,603,BACKGROUND,LABEL,METHODS,OBJECTIVE,PALLIATIVE,PURPOSE,RADIATION,RESULTS,THERAPY
130,152,177,TAG,THERE,THEREFORE,WESTERN,WHETHER
060,217,226,272,AMONG,CNS,HOWEVER,MEDICAL,SAMSUNG
070,519,860,COX,EVALUATION,MEIER,PFS,QVS,SOLID
BRAIN,THEREFORE
100,1P19Q,BECAUSE,C30,COGNITIVE,DIFFUSE,EORTC,FUNCTIONAL,HOWEVER,KPS,QLQ,SEVEN,TEN
000,322,335,339,425,954,FUNCTIONAL,MALIGNANT,RECURRENT
100,192,210,258,429,99A,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
CONCLUSION,KNOWLEDGE,LABEL,OBJECTIVE
945,946,ASTROCYTIC,ERK,HNK,HOWEVER,MEIER,OVERALL,SIMILARLY
945,AFTER,CNS,HGG,MOLECULAR,OTHER,P53,PDGFR,PEDIATRIC,POTENTIAL,SIMILARLY,STUDIES,THERE,WHILE
169,CAP43,CENTRAL,COPYRIGHT,DRG,LTD,NDRG1
169,AQP,COPYRIGHT,INC
169,ADJUNCTIVE,COPYRIGHT,GLASGOW,LTD,SCALE
169,COLLEGE,COPYRIGHT,FURTHER,GUIDELINES,LTD,PUBLISHED,ROYAL,SINCE
169,194,988,AMONG,CONCLUSION,COPYRIGHT,GIVEN,HNC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE
169,945,946,ACTIVATION,COPYRIGHT,CURRENT,IBA,INCREASING,INHIBITION,IRONICALLY,MAJOR,MANAGEMENT,MEDICAL,PUBLISHED,THESE
169,202,COPYRIGHT,GIRLS,INC,MRI,PVC,ROI
169,946,COPYRIGHT,EPO,INC,THESE
001,106,169,COPYRIGHT,DIGIT,LTD,PITUITARY,STRUCTURE,TRAIL
169,215,AGING,ALZHEIMER,ATG4C,COHORTS,CONSORTIUM,COPYRIGHT,GENOMIC,GRIA1,HEART,HECW2,INC,KCNQ4,NETO1,SNP,THESE
169,AFTER,AUC,BLACKWELL,CRH,CUSHING,DESIGNS,FURTHER,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHING,RESULTS,THEREFORE,V1R,V2R,V3R
BACKGROUND,BROCA,FUNCTIONAL,HOWEVER,LABEL,METHODS,REPETITION,RESULTS
AMONG,BAY,FRANCISCO,HOUSTON,LABEL,MAY,METHODS,NORTH,OBJECTIVE,RESULTS,SAN
160,GCDFP
169,194,COPYRIGHT,LTD,NCT
169,AMONGST,BACKGROUND,COPYRIGHT,FIRDA,FRONTAL,LABEL,LTD,METHODS,NEUROLOGY,OBJECTIVE,PAEDIATRIC,PUBLISHED,RESULTS,SIX,SOCIETY,THERE,THREE
169,3AB,ABI,COPYRIGHT,HOWEVER,LTD,METABOLIC,SAR,THESE
169,COPYRIGHT,FINALLY,INVERSE,JNK,LTD,PDCD4,TIMP2
169,AKT,BESIDES,CASPASE,CELLS,COPYRIGHT,GBM,HOWEVER,INC,U87
169,194,ADP,CONCLUSION,COPYRIGHT,FURTHER,GBM,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,33342,ABCG2,COPYRIGHT,CYTOMETRY,HO342,HOECHST,POPULATION,SOCIETY,SONIC,THEREFORE
166,800,CD8,ELISA,III,MACROPHAGE,MIF,NKG2D,PCR
120,CAR,EBV,EPSTEIN,PBMCS,PERIPHERAL
177,CITRATE,CURRENTLY,III,LGA,MEDICAL,MRS,TCA,THERE,WORLD
001,200,946,954,BACKGROUND,CONCLUSION,CONNECTIVE,ITGB1,LABEL,METHODS,RESULTS,TIC,TREATMENT,TSC,ZEB
001,COX,DFS,ETB,MEIER,SELECTIVE
945,APRIL,BIOACTIVE,DEPARTMENT,FSH,JANUARY,MRI
169,331,395,ACCORDING,AMONG,CENTRAL,CNS,COPYRIGHT,LIVER,NOTABLY,PONTINE
160,250,BRAIN,CSF,DOCETAXEL,DVS,FIFTY,GRADE,III,LABEL,M1C,METASTATIC,METHODS,OBJECTIVE,PFS,PREVIOUSLY,PURPOSE,RESULTS,SECONDARY,SIX
001,160,597,725,838,CD133,GSC,MSP,NOTABLY,PCR,PFS,SHG,THESE,WESTERN
149,150,AXIEM,BACKGROUND,CONCLUSION,LABEL,MAY,MEDTRONIC,METHODS,OBJECTIVE,OCTOBER,OUTCOME,RESULTS,STEALTH,THERE
009,CONCLUSION,III,INDEX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UTILITIES
945,HOWEVER,MONOCLONAL,REG,TMZ
169,COPYRIGHT,LTD,RCC,RENAL
143,169,ABC,ABCG2,CNS,COPYRIGHT,DARBY,DESPITE,LTD,MADIN
169,ANTIBODIES,BBB,CNS,COPYRIGHT,HOWEVER,PUBLISHED
169,AKT,AUTHORS,BAD,BRAIN,CTX,DNS,GCS,PATHOLOGY,SOCIETY,TAKEN,TSC,VEGFR
174,BACKGROUND,CRT,CSI,ESTIMATES,LABEL,METHODS,OED,PLANS,RESULTS,TREATMENT
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,ORS,RESULTS,THESE,TOTAL,TREATMENT
CONCLUSION,DIFFUSION,DOSES,DTI,FDG,FIFTEEN,III,IMAGING,INTENSITY,LABEL,METHODS,MLC,MODULATED,MRI,OBJECTIVE,PET,PLANS,PTV,PURPOSE,RADIATION,RESULTS,THERAPY,THREE
MEDICAL,PRL
169,BACKGROUND,COPYRIGHT,EGFRS,IMPROVING,LABEL,METHODS,RESULTS,SMALL,SOCIETY,SURFACE,THERE
181,GBM,SUBSEQUENT
140,215,300,400,500,FURTHER,SEVEN,SEVENTEEN,TEN
956,BREAKDOWN,CONCLUSION,DOSIMETRY,LABEL,MBQ,METHODS,MRI,MULTIORGAN,PET,RADIATION,RESULTS,SIX,THERE,THESE,UNLABELLED
169,CHINESE,COPYRIGHT,COX,GBM,LTD,SIP
169,5MM,ALFAROL,APRIL,BETWEEN,CONCLUSION,COPYRIGHT,FLAIR,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RESULTS,THERE
169,CLOSE,COPYRIGHT,LTD
169,COPYRIGHT,EARLY,HOWEVER,LTD,MRI,RADIATION,REPORTS
DESPITE,HOWEVER,LTD
169,COPYRIGHT,CRANIAL,INC,PUBLISHED
169,946,947,ATM,CELECOXIB,COPYRIGHT,COX,DDR,DESPITE,GBM,NPC,THEREFORE,U87MG
006,008,169,177,CONCLUSION,COPYRIGHT,CSF,CTS,ETS,GEMELLI,GTS,HEART,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,SUBJECT,UNIVERSITY
169,ACADEMY,BACKGROUND,COPYRIGHT,DISCLOSURE,FINANCIAL,HIV,INC,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,PURPOSE,RESULTS,SCC,SLE,THERE,THREE
215,ALA,BALANCE,EOR,FOLLOWING,GREATER,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,PHASE,RESULTS,TEN
354,CALIFORNIA,COX,FRANCISCO,GBM,LABEL,METHODS,OBJECTIVE,RESULTS,SAN,THERE,UNIVERSITY
945,EXPRESSION,HIF,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,THESE
169,306,CNS,COPYRIGHT,DIAGNOSTIC,INC,SMEAR,WILEY
169,COPYRIGHT,ELISA,HUVEC,IHC,INC,IRS,MTT,MVD,PCR,SHG44,WESTERN,WILEY
001,005,111,169,ACUTE,BACKGROUND,BECAUSE,COPYRIGHT,COX,GPA,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,RPA,SOCIETY,THESE,USING,WBI
101,104,177,215,252,ADC,CONCLUSION,DIFFERENT,DWI,LABEL,METHODS,MRI,MTR,NWM,OBJECTIVE,OBJECTIVES,RESULTS,T2W
BACKGROUND,BETWEEN,CONCLUSION,IFG,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STG,USING
DIA,FIFTY,H09,R132H
DIFFERENT,MOLECULAR,MRI,PET
ACTIVATION,ATP,CELLS,GBM,LANATOSIDE,TRAIL
003,015,022,042,160,468,CHO,COX,DIPGS,DSC,HOWEVER,IMAGING,INCREASED,MEIER,MRI,MRS,NAA,ROUTINE,SVS
011,160,169,231,233,BOOST,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RPA,SAS,SEX,THREE
007,133,177,AMONG,DISCUSSION,GBM,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,OLDER,RESULTS,THESE,VARIABLES
100,177,33342,635,956,ALA,CONCLUSION,HOECHST,LABEL,LIGHT,METHODS,MONOLAYER,OBJECTIVE,PDT,RESULTS,THESE
COMPARISON,CONCLUSION,DTI,ILF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,REVISED,SCALE,THESE,WMS
109,169,AUTHORS,BLACKWELL,EXCITATION,FOS,JOURNAL,LTD,MOTILIN,PUBLISHING,PVN,THESE
CRP,ORS,SERUM
169,COPYRIGHT,FOLLOWING,INC,MRI,WILEY
169,COPYRIGHT,HENCE,PRESS,THEREFORE
160,954,BACKGROUND,BCG,CONCLUSION,D311E,EBV,EPSTEIN,LABEL,METHODS,NUB,NUCLEAR,RESULTS
113,138,201,ALTOGETHER,BACKGROUND,COX,GBM,LABEL,METHODS,MRI,RESULTS,SPECT,TMZ
HOWEVER,RAS
BRISK,OCCASIONAL,PRIMARY,SCC
ABSENCE,DESPITE,FEW,GIANT,IHC,MIB,MICROARRAY,MKI67
163,AIP,BACKGROUND,CONCLUSION,HENCE,LABEL,LARGE,METHODS,OVERALL,RESULTS,TEN
111,123,BACKGROUND,CONCLUSION,FDA,FDG,FDOPA,LABEL,METHODS,OVERALL,PET,RATIONALE,RESULTS,TEN
GIVEN,IDH,THERE
169,187,AIM,BACKGROUND,BLACKWELL,DISCUSSION,FORTY,GUIDELINES,HODGKIN,LABEL,LTD,METHODS,NETWORK,OBJECTIVE,PUBLISHING,RELEVANCE,RESULTS,SYSTEMATIC,VIRUS,WITHOUT
001,169,177,183,3RD,AVERAGE,BLACKWELL,CPS,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PITUITARY,PUBLISHING,RESULTS
169,177,181,BBB,CHELATE,COPYRIGHT,DSC,LTD,MRI,THESE,USPIO,VSI,WILEY
136,956,BRAIN,CED,FLAIR,MAXIMUM,MEDTRONIC,SIMILARLY,SYNCHROMED
169,COPYRIGHT,EPO,ERK,HOWEVER,HYPOXIA,INC
100,169,BLOOD,CNS,COPYRIGHT,GENERAL,HODGKIN,INC,INSTITUTE,MRI,NHL,NOTABLY,PCNSL,PFS,PRIMARY,PUBLISHED,SCNSL,SECONDARY,SOCIETY,TBC
169,INFORMA,LTD,MANGANESE,MAPKS,MMP,MNSOD,NAC,PI3KS,SUBSEQUENT
STRIKINGLY,THESE,USING
001,176,299,560,CONCLUSION,DESPITE,ENGLISH,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,RESULTS,THERE
AIM,BACKGROUND,KNOWLEDGE,LABEL,METHODS,OBJECTIVE
200,736,LGG,LOW,PFS,REGIMEN,SECONDARY,TMZ,VARIOUS,WMAPS
001,002,007,013,017,022,027,033,042,048,CCA,DOPPLER,FDG,HGG,MCA,PET,PRE,SCS,SPECT
D2L,D2R,D2S,DAS,NFPAS,PCR,THESE,WHETHER
169,BETWEEN,COPYRIGHT,LTD
169,191,245,BECAUSE,CMF,CONCLUSION,COPYRIGHT,INCIDENTAL,LABEL,LTD,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,STRUCTURAL
169,CONVERSELY,COPYRIGHT,SINCE,THESE
DEVIC,NOTABLY,PCNSL,PFS
002,169,AGE,COPYRIGHT,INC,PERSISTENT,WILEY
169,200,300,600,AUTOLOGOUS,BACKGROUND,COPYRIGHT,CYCLE,EFS,EIGHT,HDC,INC,LABEL,METHODS,PHASE,PROCEDURES,PULMONARY,RESULTS,SCR,SEVEN,WILEY
DYNAMIC,HOWEVER,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS
106,255,811,ADPKD,AIP,HISTOLOGIC,IGF,PATHOLOGIC,SSTR2,SSTR5,THERE
CYP3A,DLT,FURTHER,GBM,IRINOTECAN,MTD,NON,PFS,VEGFR
112,AMP,BAD,BAX,BCL,GEFITINIB,H89,HOWEVER,PKA,U87
002,026,029,039,593,614,CAUCASIAN,CIS,COX,MICRORNAS,MORTALITY,SNP
003,AKT,BAX,BCL,HOWEVER,MRK,NOTCH,TAKEN
221,222,229,956,AMONG,DESPITE,PCR,PTP,U87MG
34A,GBM,KNOCKDOWN,SHG44
200,215,CONCURRENT,D341MED,D425MED,PATUPILONE,THESE
11Q23,160,20Q13,855,HOWEVER,RTEL1
CONCLUSION,CUSHING,HPA,LABEL,METHODS,OBJECTIVE,PARTICULAR,RESULTS
120,169,296,AVERAGE,COMPLEX,COPYRIGHT,ENGEL,GROSS,LABEL,MEDICAL,METHODS,OBJECTIVE,PXA,RESULTS,THERE,THREE,UNIVERSITY
CNS,GBM,GL261,U86
HSV,TTDRHSV
ADMISSION,CENTRAL,CNS,DUE,GNB,SIMILAR,THERE
AMONG,LABEL,METHODS,NFA,OBJECTIVE,RESULTS,SEVEN,SEVENTY,THESE,UNIVARIATE
BETWEEN,CAREFUL,CSF,HOWEVER,III,LABEL,METHODS,OBJECTIVE,OSAKA,RADICAL,RESULTS,SIMPSON,SIX,THERE,UNIVERSITY,VARIOUS,VIS
169,COPYRIGHT,EOC,EPITHELIAL,MOLECULAR
000,111,169,AMONG,COPYRIGHT,GREEN,INC,LARGE,LOW,NOTABLY,WILEY
169,CMV,COPYRIGHT,CSF,EBER1,EPSTEIN,INC,SEVERAL,SIX,VARICELLA,VZV,WILEY
REASONS
1990S,MICRORNAS,THEREAFTER
001,003,004,BACKGROUND,BASED,CONCLUSION,FDG,LABEL,METHODS,OTHER,PET,RECURRENT,RESULTS
500,945,946,AFTER,HOWEVER,THESE
DAS,ICD,IMPULSE,LABEL,METHODS,OBJECTIVE,PARKINSON,RESULTS
002,009,169,200,300,664,CD4,HGG,III,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
10Q,169,19Q,COPYRIGHT,INITIALLY,LOH,LTD,MRI,WORLD
169,194,COPYRIGHT,DENSITY,FORMATION,HOWEVER,ISSUE,METABOLISM,SPECIAL,TRIBUTE
FURTHER,ILLNESS,IPQ,LEVENTHAL,MODEL,OCS,REGULATORY,WOMEN
125,150,175,200,66336,COHORTS,DLT,SCH
001,003,020,033,049,917,945,946,EXPRESSION,PELP1,POTENTIAL,STILL,UNIVARIATE,WORLD
001,130,BLOOM,KPS,LDH,RICHARDSON,RPA,SEVEN
HOWEVER,MICRORNAS
169,COPYRIGHT,IRELAND,LTD,SOLID
169,CNS,COPYRIGHT,HOWEVER,PUBLISHED,SERAM
169,LPM,MRI,ROBIN,SOCIETY,VIRCHOW
EGL,FINALLY,FIRST,GIVEN,GLI,IMPORTANT,SHH,SONIC,THESE
169,CONTINUOUS,COPYRIGHT,PRODRUG,RESULTS
AFTER,MRI,RADICAL,RESECTION,THREE
AMONG,BACKGROUND,CSF,FIFTEEN,FINALLY,FIRST,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
AFTER,DIAGNOSIS,GAMMA,GKS,HOWEVER,MIB,SHRINKING
021,153,200,372,480,847,ACTUARIAL,DISTANT,FORTY
HOWEVER,PAX,RMS,WILMS
002,916,945,BACKGROUND,BIRC5,COX,EX3,LABEL,MEIER,METHODS,PCR,RESULTS,SURVIVIN3B
169,194,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,UNLABELLED
169,194,215,ADVERSE,COPYRIGHT,INC,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SITES,THREE,TRT,UNLABELLED
MRI
DICOM,FINALLY,LARGE,SVD
GBM,MICRORNAS
061,096,117,169,325,956,AFTER,COPYRIGHT,LOQ,SMALL,TMZ
169,176,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,ROTATIONAL
000,169,19Q,300,ADVANTAGES,ASSESSMENT,COPYRIGHT,CURRENT,FIFTEEN,INC,LOH,MOLECULAR,ODG,PATHOLOGY,PUBLISHED,SNP,SOCIETY,STR,TEN
169,ATLAS,CNS,COPYRIGHT,CPG,EXPRESSION,GBM,HK1,HK2,INC,OVERALL,PCR
169,175,275,963,BACKGROUND,CONCLUSION,HOWEVER,IGE,IMMUNOCAP,LABEL,METHODS,NUTRITION,RESULTS,WILEY
001,012,782,HOWEVER,IMD,MACROPHAGE,MIF
APART
ANXIETY,ASSESSMENT,BRAIN,CNS,DEPRESSION,DESPITE,FUNCTIONAL,INVENTORY,KARNOFSKY,KPS,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,THERAPY,THEREFORE,THESE
BETWEEN,CNS,DVH,MRI,ORS,PTV
GBM,HOWEVER,THESE
031,150,1P19Q,200,GBM,MOLECULAR,OVERALL,PFS,TMZ
153,CD133,EXPRESSION,LIN28,WHILE
160,19Q,FEW,LOH,MRI,NISSL
HOARSENESS,RADIOLOGIC
ENDOGENOUS,HOWEVER,INDUCTION
169,224,396,634,BACKGROUND,CONCLUSION,DESPITE,KINGDOM,LABEL,METHODS,ORS,POLYTOMOUS,POTENTIAL,RESULTS,SNP,USING
000,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE,USA
APOPTOSIS,ATHYMIC,IAP,INHIBITOR,PROTEIN,TAKEN,THESE
169,AZA,BRAIN,CHROMATIN,CPG,TAKEN,THESE
135,169,177,215,ADC,ANOVA,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,194,COPYRIGHT,HENCE,ORIGINALLY,PTV,PUBLISHED
100,160,169,241,AIM,BRAIN,CONCLUSION,COPYRIGHT,FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS
169,180,APPLIED,AUTHORS,BRITISH,CDH11,CONCLUSION,LABEL,METHODS,MICROARRAY,OBJECTIVE,PCSK6,PROMISING,RESULTS,SH3,SOCIETY,USING
001,005,009,043,169,183,945,ACUTE,BACKGROUND,BLACKWELL,CONTEXT,DENSELY,GSP,HOWEVER,IGF,LABEL,LTD,OBJECTIVE,OBJECTIVES,PROTEIN,PUBLISHING,RESULTS,SEVENTY,UNASSIGNED,WESTERN

176,CSF,DSC,FURTHER,GBM,SAMPLES,THERMAL,THESE
150,200,BBB,BECAUSE,MTX,PCNSL,PRS,THERE
001,946,ANALYZING,III,MBL,MED,MTT,NT3
HHV,WHILE
302,367,CXCR4,GBM,GLI,NANOG,SHH
174,946,ACCORDING,BACKGROUND,CSF,ELECSYS,HOWEVER,LABEL,METHODS,RESULTS,ROCHE,VALIDATION
169,COPYRIGHT,IMAGING,LTD,SELECTION,SEPTEMBER,SURGERY,TOTAL
169,COPYRIGHT,LTD,MDP,MEDICAL,PET
169,COPYRIGHT,LTD
117,169,194,BETWEEN,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOKYO,UNIVERSITY
001,002,003,007,028,169,AUR,CBF,CBV,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,OBJECTIVES,PCT,PUBLISHED,RATIONALE,RESULTS,VEGFR,WORLD
001,002,LOADING,MSC,TAKEN
00001,001,109,159,169,175,177,299,BACKGROUND,COPYRIGHT,COX,INDIVIDUAL,KENDALL,LABEL,METHODS,RESULTS,SOCIETY
001,004,006,127,169,BACKGROUND,CONVERSELY,COPYRIGHT,ENDPOINTS,JANUS,LABEL,METHODS,METHYLATED,OVERALL,PFS,RESULTS,SOCIETY,WORLD
4TH,ACUTE,ASD,CONCLUSION,DIAGNOSTIC,DISORDERS,DSM,FORTY,ICD,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATED,RESULTS
197,394,BECAUSE,CMV,DENMARK,EBNA1,EBV,EPSTEIN,FEW,IGG,INVERSE,LOW,THESE,VZV
257,ASIAN,BACKGROUND,ETHNICITY,LABEL,METHODS,OTHER,PACIFIC,RESULTS,TOBACCO,ZEALAND
160,CLUSTER,CONCLUSION,EIGHT,LABEL,MATERIALS,MDB,METHODS,OBJECTIVE,PROTEOMIC,RESULTS
CIC,GBM
111,158,531,BACKGROUND,CONCLUSION,FACTORS,FIFTY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTY,SRS,SUSTAINED
EWSR1,FUS,PRIMARY
007,CHO,LABEL,LNR,MET,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,1PV,CONCLUSION,INFECTION,LABEL,MEIER,METHODS,MRI,OBJECTIVE,PURPOSE,RAT,RESULTS,RNU,U87
001,017,030,042,BACKGROUND,CONTEXT,DESPITE,HOWEVER,IGF,KNOSP,LABEL,METHODS,OBJECTIVE,OUTCOME,REMISSION,RESULTS,SETTING,SIXTY
BACKGROUND,CLINICALLY,CONCLUSION,CONTEXT,FREQUENTLY,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS
110,239,BACKGROUND,CONTEXT,LABEL,MATCHED,MEASURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING
001,177,390,481,ADR,CUSHING,CUSHINGQOL,ECT,ERCUSYN,EUROQOL,LABEL,METHODS,OBJECTIVE,OVERALL,PIT,PREVALENCE,PROPORTION,REDUCED,RESULTS
150,ERLOTINIB,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THREE
169,215,380,381,525,966,ALT,AST,CD8,COPYRIGHT,GBM,III,LTD,WORLD
169,COPYRIGHT,DESPITE,INC

169,611,AMONG,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SARCOMA,STS,UNIVARIATE,WILEY
154,169,BACKGROUND,COPYRIGHT,GROSS,LABEL,METHODS,OPERATIVE,PCI,RESULTS,SOCIETY,SURGERY,TEXAS,UNIVERSITY
003,019,021,041,043,048,050,126,169,215,ATLAS,BACKGROUND,CONCLUSION,COPYRIGHT,GBM,LABEL,METHODS,RESULTS,SOCIETY
AICHI,BACKGROUND,EIGHT,III,LABEL,MARCH,METHODS,PCI,RESULTS,TEN,THERE
001,107,177,BACKGROUND,CONCLUSION,DISEASE,EPSCC,LABEL,METHODS,PCI,PROGNOSIS,RESULTS,SEVENTEEN
BACKGROUND,CASPASE,CONCLUSION,EPIGENETIC,GOLDENGATE,HOWEVER,LABEL,METHODS,RESULTS
BECAUSE,DANES,OVERALL,VESTIBULAR
110MG,169,COPYRIGHT,LABEL,METHODS,NOA,OBJECTIVE,RESULTS
169,COPYRIGHT,CR3,DELO3,E1A,HENCE,RGD,SINCE,TMZ
105,197,684,AMONG,CHANGES,ELISA,FORTY,MMP,MRI,SEPTEMBER,SERUM
126,137,160,163,391,656,BACKGROUND,CONCLUSION,JANUARY,LABEL,LIBRARY,METHODS,OBJECTIVE,OCTOBER,PRIOR,PURPOSE,RESULTS
IEAES,THEREAFTER
FAILURE,HEART,SUSPICION
150,200,CONCLUSION,GBM,GRADE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SEVENTY,TREATMENT
169,AUC,COPYRIGHT,GRP94,INC,PATHOLOGY,PUBLISHED,ROC,SOCIETY,THESE
GBM,NUCLEIC,THESE,VECTORS
DESPITE,GBM,HOWEVER,MECHANISMS
BLOOD,DUE,GBM
946,GBM,III
DIPTHERIA,EXTENSIVE,GBM,THEREFORE
AREAS,III,MAXIMUM,NEWCASTLE,NOVEL
DESPITE,HOWEVER,THEREFORE
BASED,SINCE,THESE
EXOPHYTIC,THESE
003,005,177,AGE,APRIL,BASED,CD3,CD4,CD8,FOXP3,GROUP,KARNOFSKY,RADIATION,RPA,SIXTY,THERAPY,THERE,UNIVARIATE
004,005,177,310,901,BACKGROUND,GBM,III,ION,KV1,LABEL,METHODS,RESULTS,SIXTY
AFTER
183,325,BPCAS,CAS,HSA,MRI
110,CNS,ORR
218,282,AMONG,BVZ,FORTY,ICH,VTE
CARDIAC,DIFFERENT,ENDOCRINE,LABEL,MEN,METHODS,NEOPLASIA,OBJECTIVE,PURPOSE,RESULTS,VARIANT
GBM,LOG,RESULTS
AFTER,ARG,BASAL,HORMONE,QOL,QUALITY,THEREFORE
252,MCNP5
104,169,194,COPYRIGHT,INC,MEDICAL,MUS,PUBLISHED,ROTATIONAL,TREATMENT
169,CONCLUSION,COPYRIGHT,HOWEVER,INCREASING,LABEL,METHODS,NDRG2,OBJECTIVE,PCR,RESULTS
169,COPYRIGHT,XANES
169,COPYRIGHT,INC,LABEL,MCF,MTO,NLDCS,NOVEL,SOL,UNASSIGNED,UNLABELLED
169,ADDITIONAL,APRIL,BACKGROUND,BASED,CONTEXT,COPYRIGHT,INCREASING,LABEL,MEDICAL,METHODS,OBJECTIVE,PAZOPANIB,PUBLISHED,RESULTS,SEQUENTIAL,SUNITINIB,SYNTHESIS,UNTIL,UROLOGY
169,194,350,BACKGROUND,COPYRIGHT,FINALLY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE,U87MG
169,COPYRIGHT,HOWEVER,INC,MPO,NOTABLY,PATHOLOGY,PUBLISHED,SOCIETY
169,COPYRIGHT,HOWEVER,MDR,TARIQUIDAR,THESE
946,ACCORDING,BID,DR4,DR5,ERK,HEP,JNK,JUN,MEK,PD98059,PEITC,THEREFORE
169,ADC,COPYRIGHT,CURRENTLY,DIFFUSION,FUNCTIONAL,INC,RESULTS,WILEY
169,AGE,COPYRIGHT,TAIWANESE,THESE
001,002,033,039,069,119,130,144,160,237,296,365,395,CUSHING,VIOLENT
442,628,686,DIETARY,HODGKIN,ORS,TFA,THERE
BACKGROUND,GTR,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,COPYRIGHT,SOCIETY
DESPITE,III,IPL,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS,SLF,SURGERY,THEREFORE
BRACHYURY,HOPKINS,HOWEVER,JOHNS,LABEL,METHODS,MOLECULAR,OBJECTIVE,RESULTS,SILENCING,USING,WESTERN
004,III,JANUARY,SINCE,THERE
ALTOGETHER,HOWEVER,TEA
GIVEN,MB231,MDA,SYSTEMATIC
946,GSK,INDIRUBINS,OVERALL
AGDEX,BACKGROUND,HOWEVER,LABEL,MOTIVATION,RESULTS
169,BACKGROUND,CNS,COPYRIGHT,ENROLLMENT,FIFTEEN,FURTHER,INC,LABEL,METHODS,MRA,ORR,PFS,RESPONSES,RESULTS,SAGOPILONE,SECONDARY,TREATMENTS,UNLABELLED,USING,WOMEN
001,003,130,169,277,AFTER,AIM,BAROREFLEX,CCS,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SINCE,TVI
169,945,CHRONIC,COPYRIGHT,CTR,FFA,INC,SERUM,ZAG
169,177,APPLIED,AUTHORS,BRITISH,FACTORS,GRADING,HOWEVER,III,LABEL,MEIER,METHODS,OBJECTIVE,PPT,PPTID,RESULTS,SOCIETY,WORLD
006,105,124,169,AIM,APPLIED,AUTHORS,BRITISH,EX15_BRAF,EX16_BRAF,EX9,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
120,169,800,900,CDMAONE,CLUSTER,COMPLIANCE,COPYRIGHT,DIGITAL,GSM,INC,INTERPHONE,MANHATTAN,MEDOIDS,MHZ,NMT,PDC,SAR,TELEPHONY,WILEY
BRAIN,DELHI,DIAGNOSTIC,IMAGING,INDIA,NOV,PEDIATRIC,RADIATION,THERE
169,HOWEVER,SOCIETY
169,COLLECTION,IMPORTANT,SIXTY,SOCIETY,TYPICALLY,WHEREAS
169,CPA,MRI,SOCIETY
200,BBB,NPS,PACLITAXEL,RG2,TUBULIN
005,FORTY,PARKINSON
000,115,119,CONCLUSION,ENGLISH,IRELAND,LABEL,MEDLINE,METHODS,MORBIDITY,OBJECTIVE,OBJECTIVES,RESULTS,SEGAS,TSC,WHILE
BRAIN,MORBIDITY,TODAY
EEG,ENGEL,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE
GRN
913,914,946,BMI,CD133,ERBB4,FGFR1,NOTCH,PCR,PDGFR,RTK
180,945,AMSTERDAM,ANXIETY,APAIS,BACKGROUND,DEPRESSION,DESPITE,HOWEVER,INSTEAD,LABEL,METHODS,OPTIMAL,RESULTS,SCALE
945,BACKGROUND,CONCLUSION,LABEL,METHODS,MISCODING,PCR,RESULTS
211,APA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,BASED,COPYRIGHT,INC,INCUBATION,MAST9,MMP,SC1,SEQUENCING,SLF,SPARC,WILEY
169,COPYRIGHT,INC,MRI,POSTNATAL,TSC,WILEY
MMD,THERE
160,CUSHING,MRI,SHI,VISIBLE
945,HIF,THESE
BTICS,CD133,CHROMATIN,KNOCKDOWN,SHH,SONIC,THESE
169,203,340,380,775,BMI,COX,RESULTS,USING
043,169,COPYRIGHT,III,LTD,MALIGNANT,TH2,UNIVARIATE
169,COPYRIGHT,EBC,IRELAND,LTD
169,COPYRIGHT,INC,WHILE
169,194,BPA,BSH,COPYRIGHT,GBM,LTD,MST
169,COPYRIGHT,GIANT,INC
EGF,EPIDERMAL,INC,LABEL,PUBLISHED,QDS,QUANTUM,UNASSIGNED,UNLABELLED
169,COPYRIGHT,EXPRESSION,IRELAND,LTD,OMNIBUS,THESE
CNS,GRADE,LABEL,METHODS,OBJECTIVE,PROTEOMES,RESULTS,THESE,TREATMENT,WESTERN,WHEREAS
169,COPYRIGHT,EHMT1,INC,MOLECULAR,POINT,TRAF2,WILEY
FURTHER
BASED,LIGHT,POLYMERASE
008,BECAUSE,HOWEVER,IAP,MDB,MEIER,TAKEN
160,HOWEVER,MIB,NEOPLASTIC,THEREFORE,WORLD
001,10Q,151,17P,17Q,ADULT,COMPARISON,SHH,SONIC
946,CD8,DESPITE,OVA,TCR,TGF,THESE,WHILE
PITUITARY
1RECEPTOR,224,ALTOGETHER,FINALLY,HEK,SIG1R,SIGMA,SILENCING,STUDIES,XENOPUS
169,CAVERNOMAS,COPYRIGHT
169,CENTRIOLES,COPYRIGHT,KNOWLEDGE,LTD
169,177,ABOUT,ACROMEGALY,BLACKWELL,DISEASE,FIFTY,FORTY,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,REMISSION,RESULTS,SSA,SURGERY
169,937,COPYRIGHT,HIV,HSP22,INC,RNR,RRE,SAM68,SRC,U87,WILEY
CD133,GSC,ORTHOTOPIC,SUBSETS,THROUGH
CRANIAL,JOHNSON,MULTIFORME,PHENYTOIN,SJS,STEVENS,THERAPY
AFTER,BACKGROUND,CONCLUSION,METHODS,RESULTS
169,BIALLELIC,COPYRIGHT,INC,WILEY
106,154,169,304,352,ADHERENCE,ALZHEIMER,CJD,COPYRIGHT,DISEASE,HEIGHTENED,JAKOB,JANUARY,LABEL,METHODS,OBJECTIVE,PATHOLOGY,PRION,RESERVE,RESULTS,RPD,SEVENTY,UNIVERSITY,WESTERN,WORLD
100,332,400,AED,HOWEVER,LACOSAMIDE,LCM,RESPONDER,THERE
ADDITIONAL,FSH,HORMONE,IGF,STH,TSH
177,430
169,945,946,DTC,FINALLY,SEVERAL
001,025,147,169,435,COPYRIGHT,HOWEVER,MDA,MMP,NOTABLY,SINCE,STAT3,TAKEN
169,COPYRIGHT,HDACI,STUDIES
169,CNS,COPYRIGHT,INC,WILEY
169,946,BACKGROUND,COPYRIGHT,FURTHER,HBS,HEMOGLOBIN,INC,LABEL,METHODS,MRI,RESULTS,SCD,TCD,THERE,WILEY
032,033,169,200,400,800,990,BACKGROUND,COPYRIGHT,CRT,FIFTY,INC,LABEL,METHODS,MRI,PROCEDURES,RESULTS,THESE,WILEY
000,298
001,002,003,005,015,018,026,027,032,040,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SCC
190,FOLLOWING,HEPARIN,IAC,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,THESE,TREATMENT
169,194,ATR,CHILD,COPYRIGHT,NEUROLOGY,PUBLISHED,SOCIETY
160,169,194,BFG,BIFOCAL,COPYRIGHT,CSF,CSI,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
169,CONCLUSION,COPYRIGHT,FEDERATION,GYNECOLOGY,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBSTETRICS,PUBLISHED,RESULTS
169,ADENOSINE,ALA,AUTHORS,JOURNAL,PHE39,PP1,PPP1R3F,R3F,SER14,SER18,SOCIETY
169,946,ALZHEIMER,AUTHORS,GIVEN,GSTP1,HOWEVER,INCREASED,JOURNAL,SOCIETY,THESE
169,AGAINST,IIA,INC,MRI,PALMINI,THESE,WILEY
GBM,MTT,NOTCH,PCR,PEI,THESE
126,155,160,CSF
100,118,ADVERSE,CYBERKNIFE,FORTY,MARCH,OCTOBER,SRT,TOXICITIES,TRANSIENT
169,ANXIETY,BDI,CONCURRENT,COPYRIGHT,DEPRESSION,INVENTORY
169,BRAINSTEM,CD105,COPYRIGHT,CPT,F98,LTD,MSC
169,955,CONCLUSION,COPYRIGHT,DIFFUSION,DXX,DXY,DXZ,DYY,DYZ,DZZ,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROI,SIXTEEN,THERE,THESE
109,169,194,ADC,COPYRIGHT,DTI,EARLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARAMETRIC,PURPOSE,RADIATION,RESULTS,SERVING,THOSE,THREE,VARIATIONS,VOLUMES
135,169,215,265,798,ADC,AIM,CHO,COLLEGE,CONCLUSION,COPYRIGHT,DTI,HOWEVER,KAPPA,LABEL,LTD,MATERIALS,METHODS,MRI,MRS,NAA,OBJECTIVE,PUBLISHED,RESULTS,ROC,ROYAL,THRESHOLDS,USING
33342,954,BIA,DHA,GBM,MTS,PRKDC,THESE,U87
HDMVP,HDVMP,HOWEVER,MTX,PCNSL,ULTIMATELY
004,215,237,956,CALIFORNIA,CD3,CD8,CONTROL,FRANCISCO,LABEL,METHODS,OBJECTIVE,RESULTS,SAN,UNIVERSITY,USING
010,141,330,558,750,871,GPA,HOWEVER,KARNOFSKY,THERE
104,ADJUSTMENT,BACKGROUND,BRAINSTEM,CST,LABEL,MEP,METHODS,MOTOR,RESULTS,WHILE
DISEASE,EVENT,FLORIDA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,ULTIMATELY,UNIVERSITY
008,135,153,156,BACKGROUND,CONCLUSION,CSF,LABEL,MENINGITIS,METHODS,OBJECTIVE,RESULTS,SETTING
135,553,676,AUSTRALIAN,INTERPHONE,ISRAELI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORS,RESULTS,THERE,ZEALAND
169,COPYRIGHT,CROWN,HISTOLOGY,LTD,PAPILLARY,PUBLISHED,WHILE,WORLD
169,COPYRIGHT,DUE,GBM,GIANT,LTD,WORLD
005,006,008,009,169,COPYRIGHT,DECREASED,FIFTEEN,FURTHER,INC,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PURPOSE,RESULTS,THERAPY,WORLD
FURTHER,HOWEVER,MICRORNAS,MIR
111,6POSITIVE,BIOLOGICAL,CK5,DFS,FACTORS,KARNOFSKY,KIT,KPS,PGR
SYMPTOM
150,160,200,AGE,LABEL,OLDER,OPINION,STATEMENT,UNASSIGNED
BACKGROUND,CONCLUSION,DIFFUSION,FORTY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
AKT,COMBINING,HGF,MET,MUTATIONS,THESE
10P,10Q,10Q24,19Q,1P19Q,BACKGROUND,CONCLUSION,HOWEVER,INA,LABEL,METHODS,OLIG2,RESULTS
24781,CASPASE,DESPITE,ENZYMES,GBM,HDACS,PCI,SEVERAL,TAKEN
001,104,169,COPYRIGHT,GBM,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,RESULTS
10Q26,169,17Q24,CHROMOSOME,COPYRIGHT,FORTY,IRELAND,LOH,LTD,MBS
169,AUTHORS,BECAUSE,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY
169,ACUTE,BACKGROUND,CNS,CONTINUOUS,COPYRIGHT,FIFTEEN,GRADE,LABEL,METHODS,RESULTS,SIX,SOCIETY,SUNITINIB,URINE
MICRORNAS
BACKGROUND,CONCLUSION,GRE,LABEL,MCNEMAR,METHODS,MRI,RESULTS

CRT,HOWEVER,YOUNGER
BASED,INHIBITION,KINASES,PACLITAXEL,SFK,SRC,TARGETING
ACTIVATION,GCP,MYC,SHH,SONIC,TAKEN
150,169,AKT,ARF,COPYRIGHT,ERK,INC,RAB,RAN,RAS,RGK,RHO,SMALL,THERE
144,169,183,278,336,629,BACKGROUND,BLACKWELL,CONTEXT,DEPARTMENT,ENDOCRINE,LABEL,LTD,METHODS,OBJECTIVE,PROLACTIN,PUBLISHING,RESULTS,THERE
946,HOWEVER,NMR,THESE,UDP,URIDINE
BECAUSE,CURIE,DIFFERENT,SRS,THERE
007,054,184,458,ATM,DENMARK,ERCC6,FINALLY,III,NEIL1,NEIL2
132,172,19Q,484,775,794,945,954,ANHYDRASE,CASP3,CASPASE,CNS,FDG,FINALLY,GLUCOSE,GLUT1,HIF,HYPOXIA,IDH,III,INDUCIBLE,MUTATIONS,PET,R132HIDH1
ALZHEIMER,HUNTINGTON,PARKINSON,THERE
167,19Q,287,343,III,MUTATIONS,R132H,R172M,THERE
003,019,100,116,180,239,ADJUSTMENT,CGB,COX,EOR,KARNOFSKY,KPS,LMD,MEIER,PFS,PRIMARY,TEXAS,THERE,UNIVERSITY
EDU,HOWEVER,HPS,TAS,THESE,THYMIDINE
160,177,DIVERSE,EMA,MIB,THEIR,THESE
160,19Q,859,III,MIB,THESE
160,BACKGROUND,BRAIN,BRAINSTEM,CONCURRENT,EEG,FLAIR,LABEL,METHODS,MRI,NAA,RESULTS,THERE
001,036,100,177,BRAIN,CCM,CLEAR,CPA,DEPARTMENT,EMA,LABEL,MAIER,METHODS,MIB,OBJECTIVE,RESULTS,THREE
174,267,AMONG,BACKGROUND,CELLSEARCH,CHANGES,CONCLUSION,CTC,LABEL,METHODS,PFS,RESULTS,THRESHOLD
KNOCKDOWN,MIA,NUCLEAR,TREATMENT
169,COPYRIGHT,HOWEVER,INC,MRI
169,COPYRIGHT,MRI,PUBLISHED,SAS
014,044,120,147,169,742,937,ANONYMIZED,COPYRIGHT,CUMULATIVE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PURPOSE,RESULTS,SIB,UNIVERSITY
169,COPYRIGHT,INC,SEIZURE,THESE
169,AML1A,COPYRIGHT,PUBLISHED,RUNX1,RUNX3,THESE
001,007,100,169,869,COPYRIGHT,CRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
025,037,169,177,194,209,447,953,AFTER,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RCC,RESULTS
001,002,008,125,169,172,333,BNP,CARDIAC,COPYRIGHT,DOSIMETRIC,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,TNI
177,ADDITIONAL,LABEL,METHODS,OBJECTIVE,PARTIAL,RESULTS,USING
698,AED,DESPITE,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,THERE
835,ADDITIONAL,GAMMA,GKS,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
000,001,005,169,268,828,APRIL,BACKGROUND,COPYRIGHT,FANCONI,HOWEVER,INC,LABEL,METHODS,PROCEDURE,RBC,RESULTS,VOD,WHILE,WILEY
956,CURRENT,DESPITE,IGF,IGFBP,SERUM,THREE
LITERATURE

997,CSF,HSE,HSV,MRI,PCR,THERE
001,005,804,AMONG,COX,MEIER
160,DEARING,PCR,RAS,REOVIRIDAE,THESE
169,947,AGAINST,GABAERGIC,INC,KEY,LABEL,MEMBRANES,METHODS,NKCC1,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,THESE,WESTERN,WILEY,XENOPUS
AREAS,BACKGROUND,COVERED,DESPITE,LABEL,METHODS,NOVEL,OPINION
GIVEN,MRI,REVERSIBLE
BACKGROUND,BRAIN,CONCLUSION,LABEL,METHODS,MRI,PCNSL,RESULTS
785,CONCLUSION,LABEL,METHODS,MRI,NMI,OBJECTIVE,PURPOSE,RESULTS,THERE
945,946,BACKGROUND,CONTEXT,HOWEVER,LABEL,METHODS,NUCLEAR,OBJECTIVE,PCR,RESULTS,THERE,WESTERN
131,DTC,HOWEVER,METASTASES,SPECT,WBS
169,180,AUTHORS,BRAIN,CPG,DECREASED,H3K9ME3,III,INSTITUTES,MOLECULAR,NEOPLASIA,NIH,PATHOLOGY,RAS,REMBRANDT,REPOSITORY,RRP22,SOCIETY,TAKEN,WORLD
169,2HG,AUTHORS,BRAIN,DETECTION,IDH,MUTATIONS,PATHOLOGY,SOCIETY,WHILE
ABC,ABCG2,ABL,ATP,BCR,CML,CONSISTENT,FURTHER,LLC,NILOTINIB,PGP,PK1,TAKEN,TASIGNA
169,COPYRIGHT,INC,SMEAR,WILEY
169,COPYRIGHT,EGF,NPS,VCH,WILEY
169,536,945,946,954,COPYRIGHT,GHRELIN,GHS,HOWEVER,IKK,INC,SER,THESE,TREATMENT,WILEY
000,169,210,500,956,COLLECTED,COPYRIGHT,FEU,INC,WILEY
169,183,BETWEEN,GEORG,III,LABEL,METHODS,OBJECTIVE,PERTINENT,PFS,PRIMARY,RESULTS,STUTTGART,SURGERY,WORLD
BRAIN,MRI,SUSPECTING
PAPILLARY,WORLD
179,ANAPLASTIC,BACKGROUND,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PRIMARY,RESULTS,TESTING
169,AGAINST,APHASIC,ASE,CONTINUOUS,EEG,HOWEVER,INC,KEY,LABEL,METHODS,MRI,OBJECTIVE,PLEDS,PURPOSE,RESULTS,WILEY
PXA,THERE,TMZ
100,CNS,GBM,GRADE,KARNOFSKY,MACDONALD,PFS,SIMON,SIXTEEN,TREATMENT
AGG,ANAPLASTIC,COX,END,FIFTY,MEIER,PATIENT,RESULTS,UNIVARIATE,USING
CALIFORNIA,HEMATOLOGY,HODGKIN,JOLLA,PRIMARY,SCRIPPS
ABC,ABCB1,ABCC4,ABCG2,ATP,BBB,CYP
WILMS
177,BACKGROUND,CONCLUSION,EOR,HOWEVER,III,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,VOLUMETRIC,WORLD
DESPITE,HODGKIN,MRI,PERHAPS,RESTRICTED
169,ACCORDING,COPYRIGHT,SRL,THEREFORE,THESE
169,COPYRIGHT,RADIATION
108,149,161,169,172,630,AMONG,BACKGROUND,BRITISH,CHUNG,CONCLUSION,CONFERENCE,CONSENSUS,COPYRIGHT,EPILEPTIC,INSTITUTES,LABEL,LTD,METHODS,MRI,NF1,OBJECTIVE,OTHER,PUBLISHED,RESULTS
169,ACUTE,CONCLUSION,COPYRIGHT,GENERAL,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
12009,946,CNS,DESPITE,IIB,III,TGF
169,177,223,801,BACKGROUND,BSLGT,BST,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MRI,PEDIATRIC,PFS,PROCEDURES,RESULTS,TORONTO,UPFRONT,WILEY
169,BECAUSE,CAS,COPYRIGHT,FIRST,GAL,INC,INM,MTF,POA,SDN,WILEY
CNS,PACLITAXEL
000,100,130,400,780,BACKGROUND,DISCUSSION,LABEL,THERE,UMBILICAL
001,463,BASED,MBC,SIMILARLY,STOCKHOLM,TREATMENT
019,020,947,ATM,DDR,GBM,GENOMIC,PFS,RAD17,REMARKABLY,SINCE
169,COPYRIGHT,LTD,MARKERS,XENOGRAFTS
169,947,BRAIN,COPYRIGHT,KARNOFSKY,KPS,LTD,MRI
169,COPYRIGHT,DUE,IRELAND,LTD,SMALL,THREE
001,160,169,COPYRIGHT,DTX,GAMMA,LTD,P80,PPI,U87MG
169,183,945,954,AEOL10150,ALLERGY,BRAIN,CNS,COPYRIGHT,COULTER,FEDERAL,GRANT,HENCE,HIF,III,IMP,INC,INFECTIOUS,INSTITUTE,METAL,MNTDE,MNTNHEX,OXIDATIVE,PHASE,PRESTON,PROGRAM,PYP,SOD,SUPEROXIDE,THEREFORE,TISCH,UNIVERSITY,USA,WALLACE,WHILE
169,1980S,1990S,COPYRIGHT,GDP,GTP,GTPASES,INC,ONCOGENIC,RAS,REGULATION,RNS,SINCE
169,946,AMONG,AUTHORS,BRAIN,BTICS,COMPLEX,GBM,HGF,MET,NOTCH,PATHOLOGY,SOCIETY,THEREFORE,THESE,WNT
169,CNS,CURRENT,DISEASE,IGM,MYCOPLASMA,SOCIETY
169,CNS,EWING,SOCIETY
169,ASIAN,EASTERN,GROUP,MRI,SOCIETY,SURGERY
AFTER,BURKITT,FEW,IGH,PRIMARY
MALIGNANT,MFH
BETWEEN,GROSS,HOWEVER,OCTOBER,SURGERY
205,608,813,BACKGROUND,BESIDES,CONCLUSION,CONTEXT,CRANIAL,EXTRACTION,FSH,LABEL,LIBRARY,METHODS,OBJECTIVE,RESULTS,SCIENCE,SELECTION,SOURCES,STUDIES,THERE,THEREFORE,THESE,TSH,WEB
177,226,268,384,775,CONCLUSION,LABEL,LARGE,METHODS,OBJECTIVE,PRIOR,RESULTS,VARIABLES
101,169,COPYRIGHT,EEG,MRI,NPC,SEIZURE
ESPECIALLY,GBM
169,183,BACKGROUND,BLACKWELL,CUSHING,IMAGING,LABEL,LTD,METHODS,MRI,OBJECTIVE,PUBLISHING,RESULTS,TESLA,WHERE
160,HITCHER,KRUSKAL,NDV,NEWCASTLE,THESE,U87
100,BACKGROUND,BRAIN,CONCLUSION,EEG,ICP,LABEL,LARGE,MATERIALS,METHODS,PET,RENAL,THESE,TSC
ASPIRATOR,CONCLUSION,ENDOSCOPE,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,PURPOSE,REGULAR,RESULTS,SURGEON
009,052,AFTER,AMONG,DEFINITIVE,FIFTY,GBM,JANUARY,LABEL,LARGE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RPA,WESTERN
AFTER,COCHRAN,CONCLUSION,CONVERSELY,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
127,169,194,233,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
EFFECTIVE,MALIGNANT
946,954,HDACS,IKK,ROS,SIMILARLY,TANACETUM,TCP
001,EIGHT,FDA,GBM,ICH,INSTITUTE,OVERALL,PHASE,TKI,VEGFR
001,957,EVALUATING,GROUP,MIXED,PATIENT,RADIATION,THERAPY,THERE,WHILE,ZPS
THERE
MATH1,SIMILARLY,SMOM2,SONIC,THESE
384,585,660,COX,HRS,KAROLINSKA,LABEL,METHODS,OBJECTIVE,PATIENT,POPULATION,RESULTS,SEVENTY,SWEDISH,THESE,UNIVERSITY
169,CONCLUSION,COPYRIGHT,DEPARTMENT,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,RESULTS,SINCE,THREE,UBN,VOR
169,194,2ND,COPYRIGHT,FORTY,ITALY,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RNS
169,COPYRIGHT,CYR61,INC,LABEL,METHODS,MOSBY,MVD,OBJECTIVE,RESULTS,WEIDNER
169,ACUTE,APRIL,BETWEEN,COPYRIGHT,CVD,GAMMA,GIVEN,GRADE,GROUP,INC,JANUARY,KNIFE,LABEL,MATERIALS,METHODS,MORBIDITY,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SCORING,THERAPY,TOXICITIES,TREATED
004,006,007,169,177,194,COPYRIGHT,CURRENT,DELAYED,DISEASE,GROSS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PEDIATRIC,PURPOSE,RESULTS,TEN
169,226,458,535,551,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,RESULTS
169,ACC,BRAIN,COPYRIGHT,CYBERKNIFE,MRI,PROFILE
ACTIVATION,DIFFERENT,INC,MRI,PUBLISHED,THESE
215,ADOLESCENT,BACKGROUND,CAUCASIAN,GIVEN,GYNECOLOGY,IMAGING,INC,LABEL,METHODS,NORTH,OVARIAN,PEDIATRIC,PUBLISHED,SOCIETY,SUBSEQUENT,VAN,WYK
169,COPYRIGHT,LTD,MRI
BECAUSE,NAD
CHROMATIN,D54,THESE,U87,VORINOSTAT
212,AFFYMETRIX,FAILURE,FUNCTIONAL,LABEL,MASSCLEAVE,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SNP,USING
CLINICALLY,D2R,PCR
HOWEVER
BOR,PENDRED,PREVIOUSLY,SYNDROMES
ASSET,BACKGROUND,DWI,EPI,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SNR
001,208,288,345,481,521,675,788,ADC,BACKGROUND,DWI,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESTRICTED,RESULTS,THESE
1980S,1990S,INITIALLY,TOBACCO
100,169,194,441,CLASS,CLASSES,COPYRIGHT,III,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA,THREE
146,169,ATLAS,BLACKWELL,FOUNDATION,GBM,HOWEVER,LTD,MOLECULAR,PUBLISHING,SUPERVISED,WHOLE
041,169,336,AMONG,APRIL,AUTHORS,COPYRIGHT,ESOPHAGUS,INC,JOURNAL,PET,PRIOR,SCC,SOCIETY,SUV,WILEY
131,AFTER,BACKGROUND,FTC,GBQ,LABEL,PITUITARY,PRESENTING,SEVEN,SINCE,SUMMARY,TSH

ASL,CBV,CONCLUSION,DSC,ESTIMATES,III,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PARAMETRIC,RESULTS,ROI,THESE
BRAIN,FINALLY,HOWEVER,MRI,SEQUENTIAL
AFTER,BACKGROUND,BASED,CONCLUSION,EFFECTIVE,GAMMA,HOWEVER,IMPORTANCE,LABEL,METHODS,MRI
ASSESSMENT,BACKGROUND,CONCLUSION,GROUP,LABEL,MACDONALD,METHODS,NEURO,OBJECTIVE,RESULTS,SURGERY,WORKING
160,169,APRIL,BETWEEN,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MAJOR,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,THERE
101,103,104,169,COPYRIGHT,FLAIR,GTV,INC,LABEL,MATERIALS,MAXIMUM,METHODS,NSC,OBJECTIVE,PURPOSE,RESULTS

100,AFTER,CONCURRENT,HOWEVER,KARNOFSKY,KPS,LABEL,MATERIALS,MEDICAL,MEIER,METHODS,OBJECTIVE,OVERALL,PRIMARY,RESULTS,SALVAGE,SEVENTEEN,TMZ
AWAKE,COLLEGE,FIFTY,HOWEVER,RCS,ROYAL,THESE
125,169,340,AUC,BACKGROUND,COPYRIGHT,CYP3A,GBM,LABEL,METHODS,PFS,RESULTS,SOCIETY,THERE,TREATMENT
169,ACTIVATION,AKT,BACKGROUND,COPYRIGHT,INHIBITION,LABEL,METHODS,PERIFOSINE,RESULTS,SOCIETY,TB3,WESTERN
AKT,ASSESSMENT,FAK,HOWEVER,JAK,SOCS3,STAT3
113,215,BCL,CONVERSELY,EMA,FSC,HISTOLOGY,SCO,SPINDLE,TTF
001,DESPITE,HOWEVER,JANUARY,KARNOFSKY,KPS,PFS,SCALE,THERE
GROUP,ICE,JAPAN,KCNA1,LABEL,METHODS,OBJECTIVE,OPERATIVE,PURPOSE,RESULTS,SEVENTEEN,SFRP1,SHH,THERE,THREE,TREATMENT,WNT
CHINESE,ENGLISH,HOWEVER,PARKINSON,RELATIVELY,SEVERAL,SRS
169,COPYRIGHT,ENDOSCOPIC,INC,PAPILLARY,SECONDARY,WILEY
169,177,COPYRIGHT,FETAL,ICP,ISUOG,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,WILEY
103,140,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
CPM,HOWEVER,PCI
FSH,HOWEVER,SINCE,TSH

ADJUNCTIVE,BACKGROUND,CONCLUSION,IMPORTANCE,LABEL,MALIGNANT,METHODS,THESE
HOWEVER,III,LABEL,MATERIALS,METHODS,MIB,NAR,NAT,OBJECTIVE,OBJECTIVES,RESULTS,THESE,TOTAL
013,HOWEVER,HYPOXIA,JTE,METABOLISM,MODULATION,S1P,TAKEN
169,183,BACKGROUND,CENTRES,CHI,CONCLUSION,GEORG,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,RESULTS,STUTTGART,THERE,TODAY
100,128,CBF,CBV,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VALIDATION,VOI
160,BRAIN,BTSCS,CD133,NANOG,U87
100,169,612,802,891,AUC,CHO,CONCLUSION,COPYRIGHT,DIFFERENT,INC,LABEL,METHODS,MRI,MRP,MRS,NAA,OBJECTIVE,PSR,RESULTS,ROC
169,COPYRIGHT,LTD,SRS,SRT
169,171,403,BACKGROUND,BASED,CNS,CONTINUOUS,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,RESULTS,THERE,TKI
169,ANY,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,RESULTS,THEREFORE
169,COPYRIGHT,CPA,EMPLOYING,GADOLINIUM,IMAGING,IRELAND,LTD,MRI,THESE
169,COPYRIGHT,GFP,LTD,NPS,PEG,PEI,TC2,TEM,THREE
100,169,COPYRIGHT,FEW,LTD,MENINGIOMA,NUCLEAR
169,BECAUSE,COPYRIGHT,FURTHER,INC,ROS
169,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
169,COPYRIGHT,DSP,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PTV,PURPOSE,RESULTS
001,100,120,169,177,COPYRIGHT,FET,GROSS,GTV,IMAGE,IMAGING,INC,LABEL,MATERIALS,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
001,004,100,132,169,19Q,653,CONCLUSION,COPYRIGHT,HENCE,IDH,III,INC,LABEL,METHODS,MUTATIONS,OBJECTIVE,OVERALL,PRIMARY,R132H,RESULTS,THERE,THESE
169,ABOUT,AGAINST,BECAUSE,DTI,HOWEVER,INC,KEY,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PURPOSE,RESULTS,WILEY
001,DTH,FURTHER,GRADE,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
142,CHO,CHOLINE,IRB,LAC,LIP,MRI,MRS,NAA,SCANS,SVS
130,200,400,AUC,DLT,FGF,LEVEL,MTD,OXO,SIX,SOX,THERE,TSU,VEGFR
HOWEVER,WHETHER
333,ATG,B16,HEPA1,SEA,TELOMERASE

BACKGROUND,ESHRE,GROUP,LABEL,LIFESTYLE,MEDLINE,METHODS,PARKINSON,RESULTS,SMOKING
169,194,BORON,CAPTURE,COPYRIGHT,EIGHT,LTD,NCT,RPA,THERAPY
169,COPYRIGHT,DESPITE,DIAGNOSIS,LTD,SIGNALLING,STAGING,TYPICAL
169,177,CD137,COPYRIGHT,FINALLY,GL261,HM1,INC
GROUP,THESE
169,BACKGROUND,CENTRAL,CNS,COPYRIGHT,GCT,KNOWLEDGE,LABEL,MANAGEMENT,METHODS,RESULTS,SOCIETY,WORKING
946,ALZHEIMER,BAX,HOWEVER,TAKEN,YAP,YES
001,945,CRC,ECTOPIC,HOWEVER,MTT,PCR,RKO,THESE,WESTERN
BACKGROUND,CONCLUSION,CONVECTION,III,LABEL,METHODS,OBJECTIVE,RESULTS,TOPOTECAN
BACKGROUND,CONCLUSION,FIFTEEN,LABEL,METHODS,N20,OBJECTIVE,P25,P30,RESULTS,UNIVERSITY
059,196,228,502,BACKGROUND,CNV,DANES,FINALLY,GST,GSTM1,GSTT1,IHD,IVD,LABEL,METHODS,RESULTS,THESE
18F,FMISO,GBM,MRI,PET
025,128,169,342,AUTHORS,BENJAMINI,BIOMARKERS,JOURNAL,PCR,SOCIETY,STUDENT
14Q,22Q,BACKGROUND,CK7,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
AFTER,CUSHING
945,946,GBM,HEPG2,HIF,IL1,MANUMYCIN,RAS,SINCE,TREATMENT
AVASTIN,BACKGROUND,CONCLUSION,CONCURRENT,LABEL,METHODS,REVERSIBLE

169,COPYRIGHT,LNC,MIAMI,THESE,U87MG
ABILITY,FIRST,INC,PUBLISHED,STUDIES
169,756,AUTHORS,BRAIN,PATHOLOGY,PCNST,SOCIETY,THEREFORE
100,956,DBTRG,DTT,GLIOMAS
CONCLUSION,DPD,EVALUATION,FU2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TPF,UH2
BRAIN,THESE
APOPTOSIS,CKO,FURTHER,HOWEVER,PNAS4,XENOPUS
BACKGROUND,BECAUSE,LABEL,METHODS,MYC,RESULTS,SP1,TELOMERASE,THESE,USING
114,125,BACKGROUND,CONCLUSION,FACTORS,GAMMA,KNIFE,LABEL,METHODS,NFPAS,OBJECTIVE,PRIOR,RESULTS
169,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,RESECTION,WHILE
169,COPYRIGHT
169,1P19Q,ANALYZING,CENTRAL,COPYRIGHT,EORTC,GROUP,INC,INTERGROUP,LABEL,LGG,MATERIALS,METHODS,NORTH,OBJECTIVE,PFS,PURPOSE,RESULTS,TREATMENT
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,MAR,METHODS,OPINION
ALA
009,037,043,135,AWAKE,DESPITE,FIFTEEN,FLAIR,GRADE,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,RESULTS,SEIZURE,THEIR,THESE,YET

001,002,196,CLASS,CLASSES,FORTY,GBM,GROUP,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,RPA,SCALE,SEVENTY,THERAPY
160,BACKGROUND,DESPITE,FUNCTIONAL,JANUARY,LABEL,METHODS,RESULTS,ROCHESTER,SEPTEMBER,SEVEN,SIX,TEN,THESE,USING
151,945,GBM,HOWEVER,HUVEC,NG2,TFA,THESE,WILLEBRAND
100,CNS,COL,DLT,EIADS,MTD,THREE
000,169,ART,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,SAS,STATE,SURGERY
ATP,G44,GBM,HOWEVER
FDA,KCL,MIGRATING,NKCC1
442,628,686,BACKGROUND,DIETARY,HODGKIN,LABEL,METHODS,NHL,ORS,RESULTS
BACKGROUND,GBM,ICH,JANUARY,LABEL,METHODS,NSCLC,PRIMARY,RESULTS,THERE
257,BACKGROUND,CONCLUSION,KOREA,LABEL,MAY,METHODS,NMO,NMOSD,RESULTS
100,169,177,867,ASTROCYTIC,CONCLUSION,COPYRIGHT,DSC,HIROSHIMA,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PWI,RESULTS,SNR,THESE,UNIVERSITY
033,100,215,501,508,550,591,608,642,784,945,BACKGROUND,CONCLUSION,DCE,HIF,LABEL,METHODS,MMP,MRI,PEARSON,PERFUSION,PRL,RESULTS
169,233,CARLO,COPYRIGHT,FINALLY,LTD,MONTE,MRS,RAO,USING,WILEY
169,COPYRIGHT,DESPITE,DROSOPHILA,GBM,INC,RAS,SIGNATURE,USING,WILEY
008,026,169,294,687,BACKGROUND,BRAIN,COPYRIGHT,DESPITE,FIFTY,LABEL,METHODS,RESULTS,SOCIETY,TREATMENT
160,CONCLUSION,DESPITE,KINDL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
369,C15,C30,CONCLUSION,FEW,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OTHER,PAL,PURPOSE,QLQ,QOL,RESULTS,SYMPTOM,TREATMENT
946,BHB,CEREBELLAR,HOWEVER,USING
160,DWI,HOWEVER,III,MRS,PWI,WORLD
DTI,FIRST,HOWEVER,SLF,SMG,THEREFORE,THIRD,USING
001,166,PRIMARY
ACCORDING,GRADE,GROSS,III,LABEL,OPINION,SRS,STATEMENT,THESE,UNASSIGNED,WORLD
169,AUR,COPYRIGHT,DIFFUSION,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THESE
CHR,STUDIES,TYPICALLY
160,177,BARTHEL,BFI,BRIEF,C30,DEPRESSION,EORTC,FATIGUE,INDEX,INVENTORY,KARNOFSKY,KPS,LABEL,MBI,METHODS,MOTRICITY,OBJECTIVE,OBJECTIVES,PFS,PIPER,QLQ,QUALITY,RESULTS,SCALE,THESE,TREATMENT
17P,17Q,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS,SIX
BACKGROUND,CONCLUSION,CONTINUED,DIFFUSE,DUE,EXHAUSTIVE,LABEL,METHODS
MAGNEVIST,MRI
006,027,039,101,COX,HOWEVER,MEIER,MMP,PAS,WHILE
CONVERSELY,DESPITE,DSC,HOWEVER,U87
110,120,TEN
144,158,169,177,BBB,COPYRIGHT,CTX,HOWEVER,LTD,MRI
169,194,CD4,CHILD,COPYRIGHT,DEX,MINOR,NBOMA,NEUROLOGY,OMS,PUBLISHED,SOCIETY,THESE
169,CNS,COPYRIGHT,III,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,SERAM
001,169,244,520,646,968,BIA,BNP,CONCLUSION,COPYRIGHT,FLUID,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,TOTAL
169,194,CARLO,COPYRIGHT,LTD,MCNP5,MONTE,TOP
100,130,169,174,194,COPYRIGHT,ONCOR,PUBLISHED,SIEMENS
100,169,AFTER,COPYRIGHT,GROSS,GTV,INC,LABEL,MATERIALS,METHODS,MRI,NFPAS,OBJECTIVE,PURPOSE,RESULTS,SHRINKAGE,THERE
104,169,176,298,307,373,BETWEEN,CLASS,COPYRIGHT,GAMMA,IDENTIFIED,III,INC,KNIFE,KPS,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RPA,UNIVARIATE
169,CONCLUSION,COPYRIGHT,KARNOFSKY,KPS,LABEL,METHODS,NAVIGATION,OBJECTIVE,RESULTS
773,ACHIEVING,GROSS,LABEL,METHODS,OBJECTIVE,OTHER,RATES,RESULTS,SEIZURE
160,ADVERSE,AFTER,BACKGROUND,CHF,ELDERLY,LABEL,METHODS,RESULTS,THREE
002,230,246,BACKGROUND,LABEL,METHODS,RESULTS,SIR,WALDENSTR
169,ADP,BRCA1,COLLEGE,COPYRIGHT,DESPITE,LTD,PUBLISHED,ROYAL
160,AFTER,ECS,HOWEVER,MRI,PLL,THESE
GRADE,III,MGD,MRI,SIXTY,SRS
001,018,047,070,190,282,333,403,436,571,576,579,585,722,743,770,954,CRT,EPIGENETIC,HGG,MEDLINE,STUDIES
DESPITE,HOWEVER
150,169,183,248,BLACKWELL,LABEL,LTD,METHODS,MRI,OBJECTIVE,OBJECTIVES,PUBLISHING,RESULTS,THERE
020,034,044,169,177,183,295,432,454,490,553,740,BECAUSE,BLACKWELL,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS,SCN,SLEEP,SUBJECTIVE,VALIDATED
068,169,496,946,ACTIVATED,COPYRIGHT,INC,NAG,TGF,TIRFM,USING,WILEY
DEFICIENCY,MHC,OVERALL,PDT,THESE
005,017,091,092,108,359,444,606,615,961,ASSESSMENT,BRAIN,CIQ,COGNITIVE,COMMUNITY,FIFTY,FUNCTIONAL,NEITHER,QUALITY,ROC,STATE,THERAPY,USING
000,250,320,357,3A4,750,BSV,LABEL,LAPATINIB,METHODS,MONOLIX,OBJECTIVE,PURPOSE,RESULTS,WOMEN
946,CONVERSELY,CURCUMA,FINALLY,GMF,HOWEVER,TAKEN,U87
169,HOWEVER,MOLONEY,PIM,SIMILAR
169,CNS,FURTHER,HOWEVER,ROSETTE,SOCIETY
001,003,100,1P19Q,ALPHA,INA,MANAGEMENT,R132H,SIMILARLY,THESE
160,584,CONVERSELY,UNDERLYING,WHEREAS
CEDIRANIB,GBM,TMZ,U87
101,ATTRIBUTES,DIAGNOSIS,DIFFERENT,FIRST,KNN,LABEL,LOO,METHODS,MRI,OBJECTIVE,PURPOSE,RESONANCE,RESULTS,SCATTER
169,CONCLUSION,COPYRIGHT,FATIGUE,INVENTORY,LABEL,METHODS,MFI,OBJECTIVE,RESULTS,SAS,SCALE,THERE,VAS
160,169,201,COLLEGE,COPYRIGHT,FDG,IMAGING,LTD,MRS,PCNSL,PET,PRIMARY,PUBLISHED,ROYAL,SPECT,ULTIMATELY
AFTER,ALA,BESIDES,LABEL,METHODS,MMP,OBJECTIVE,PDT,RESULTS,THEREFORE
ASSESSMENT,BARTHEL,BRAIN,CONCLUSION,FUNCTIONAL,INDEX,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,THERAPY
CASES
638,669,H2A,H2AFX,HOWEVER,ORS,SNP,THESE
BAI,FINALLY,GPCRS,WHILE
001,002,003,007,008,BACKGROUND,BASIC,BRAIN,CONCLUSION,COX,INDEX,LABEL,MEIER,METASTASES,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SCORE,SHORTER,SRS,TREATMENT
001,002,008,303,967,BACKGROUND,CONCLUSION,GLASGOW,LABEL,METHODS,OBJECTIVE,OUTCOME,PEARSON,RESULTS,SCALE
169,177,323,453,538,754,ALA,AREAS,COPYRIGHT,DIFFUSE,FET,GRADE,III,LABEL,METHODS,MRI,OBJECTIVE,PET,PRIOR,RESULTS
006,213,945,AED,APRIL,CAREFUL,CARMUSTINE,DEPARTMENT,III,SEPTEMBER
101,CBV,MTT,RESULTS,USING
CBV,MRI,VNI
ADS,DCS,FLT3L,GBM,RECURRENT,SIMPLEX,THESE,VIRUS
100,169,181,AG490,CD133,COPYRIGHT,FINALLY,FIRSTLY,GBM,INC,MICROARRAY,STAT3,TIC,WILEY
169,COPYRIGHT,GBM,IL4,INC,NBI,TGF,WILEY
100,177,DIAGNOSIS,DNT,FDG,PET,SEVEN
ATLAS,BASED,EGF,EPIDERMAL,G55,GBM,HOWEVER,MEIER,PCR,SF767,TM7,USING
169,3CM,7CM,ACTUARIAL,AVM,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,MEIER,METHODS,NON,OBJECTIVE,PRIOR,PUBLISHED,RECORDS,RESULTS,ROYAL

IMAGING,WHILE
002,011,016,219,251,502,INVENTORY,RESULTS,THEIR,THEREFORE
THESE
PHYSICIANS
177,GOLGI,III,NON,REVERSE,THERE,WESTERN,WHETHER
ANTISENSE,CHANGES,DUSP6,ERK,FUNCTIONAL,MAPK1,PCR,PROTEIN,PYST1
214,385,945,HIF,HOWEVER,THERE
373,AFTER,BACKGROUND,CONCLUSION,ENGLISH,FORTY,GTR,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
104,110,133,140,169,194,400,AMONG,ASSESSMENT,COPYRIGHT,COX,FACTORS,GPA,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,MST,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA,THESE
005,006,169,954,COPYRIGHT,III,INC,NUCLEAR
169,236,302,946,CHRONIC,COPYRIGHT,CRP,III,IL1,IL6,INC,SNP,STILL,THREE
169,AGGRESSIVE,AUTHORS,BACKGROUND,FOUNDATION,HOWEVER,JOURNAL,LABEL,LOW,MATERIALS,METHODS,OVERALL,RESULTS,SOCIETY,STICHTING,TREATMENT
169,BACKGROUND,CNS,COPYRIGHT,EVALUATION,INC,LABEL,METHODS,RESULTS,WILEY
100,123,131,169,AFTER,BACKGROUND,BLOOD,COPYRIGHT,CRS,EARLY,INC,LABEL,METHODS,PEDIATR,PROCEDURES,RESULTS,SEVENTY,SUBSEQUENT,WILEY
103,169,BACKGROUND,COPYRIGHT,FURTHER,IMPORTANT,LABEL,MEIER,METHODS,PREVIOUSLY,RESULTS,SOCIETY
169,197,220,CAH,COPYRIGHT,COX,LTD,MEIER,PUBLISHED,SCC,THREE,USING
005,014,169,194,BVZ,COPYRIGHT,GRADE,INC,KARNOFSKY,KPS,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SALVAGE,SEPTEMBER,SRS,TREATMENT,WORLD
169,COPYRIGHT,IMAGING,SAS,THEREAFTER
AWAKE,EDINBURGH,HANDEDNESS,HOWEVER,INVENTORY,KARNOFSKY,KPS,LGG,LOW,SCORE
001,003,154,169,184,338,BACKGROUND,COPYRIGHT,COX,FORTY,FUHRMAN,KETTERING,LABEL,MEIER,METHODS,RESULTS,SLOAN,SOCIETY,THERE,TKI,TREATMENT

13CRA,701,956,CEP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRB,TALALAY,TRK
946,ADDITIONAL,ALZHEIMER,ANS,GOLGI,HSP70
239,ASIAN,BID,CAUCASIAN,LABEL,METHODS,OBJECTIVE,ORR,PFS,PRIMARY,PURPOSE,RESULTS,SECONDARY,SIMON,THREE
169,194,BPA,COPYRIGHT,GBM,III,LTD,TMZ
131,169,ADVERSE,CONCLUSION,COPYRIGHT,CSI,GRADE,INC,INSTITUTE,LABEL,MEIER,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SIX,THERE
169,19Q,ADDITIONAL,OTHER,R132H,SOCIETY,THERE,THESE
169,19Q13,946,ASIAN,CATENIN,CNS,EBL,HOMER,SOCIETY
169,CNS,EMA,MIB,MRI,SOCIETY,THERE,ZEE
169,945,A17,AKT,COPYRIGHT,ECM,INC,MTT,TGF,U87,WESTERN,WILEY
125,AFTER,CNS,MRI,SBT,THERE
ANOTHER,CD133,EGF,SAA,SFM,SHG62,SHG66,U87
002,007,012,037,BACKGROUND,CD133,GBM,LABEL,MATERIALS,METHODS,PATIENT,PCR,QRT,RESULTS,THESE
160,BRAIN,FIFTEEN,JANUARY,LABEL,METASTASES,METHODS,OBJECTIVE,PALLIATIVE,PROGRAM,PURPOSE,RAPID,RAPRP,RESULTS
BOARD,LABEL,METHODS,OBJECTIVE,PATIENT
169,194,BASED,BORON,CAPTURE,COPYRIGHT,LTD,NEUTRON,QUADRUPOLE,THERAPY
169,251,255,261,289,APRIL,CONCLUSION,COPYRIGHT,DWIBS,HOWEVER,IRELAND,LABEL,LESIONS,LTD,METHODS,OBJECTIVE,OCTOBER,RESULTS,THERE,TOMOGRAPHY
001,012,020,029,162,169,215,293,455,COPYRIGHT,EIGHT,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGARDING,RESULTS,RPA,SHORTER,USING
100,125,169,170,194,460,CARLO,COPYRIGHT,DEPENDING,GENERALLY,INC,INCREASING,LABEL,MATERIALS,METHODS,MONTE,OAR,OBJECTIVE,PURPOSE,RESULTS,TESTICULAR
130,169,COPYRIGHT,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
121,169,AVERAGE,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,MARCH,MAY,METHODS,OPERATIVE,PROCEDURES,RESULTS,SOCIETY,UNIVERSITY
160,BESIDES,CMS,GROUP,HOWEVER,PLI,POSTERIOR
160,956,CUSHING,ENDOCRINE,SIMILARLY,SMR,THERE,TSH,USING
169,COPYRIGHT,OBESITY
001,946,BACKGROUND,CCAAT,CONCLUSION,EBP,HOMOLOGOUS,LABEL,METHODS,OBJECTIVE,PROTEIN,REGARDLESS,RESULTS,TFS
233,BACKGROUND,CALVARIAL,CONCLUSION,IMPORTANCE,INITIAL,LABEL,METHODS
BACKGROUND,CONCLUSION,CST,DEDICATED,DTI,LABEL,METHODS,OBJECTIVE,RESULTS
169,174,194,AFTER,COPYRIGHT,DOSIMETRY,IBA,ICA,INC,LABEL,MATERIALS,MATRIXX,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
003,100,147,169,177,181,AGE,COPYRIGHT,COX,FFP,FIFTY,GRADE,GTR,INC,LABEL,LOG,LOW,MATERIALS,METHODS,NF1,OBJECTIVE,PURPOSE,RESULTS,ROUTINE,THERE
169,AUTHORS,BECAUSE,BRAIN,CGH,NERVOUS,PAPILLARY,PATHOLOGY,PRIMARY,PTPRS,SOCIETY,WORLD
024,13Q14,13Q32,160,169,19Q,279,631,ARF,AUTHORS,BRAIN,CGH,FURTHER,INK4A,INK4B,PATHOLOGY,RB1,SOCIETY,THESE
108,127,169,366,BACKGROUND,COMMITTEE,CONCLUSION,COPYRIGHT,DSS,HISTOLOGIC,INC,INT,JOINT,LABEL,METHODS,NAZIONALE,RESULTS,THERE,WILEY
APART,GBM,QOL
DIFFUSION,PERFUSION,PWI
CNS
128,135,169,COPYRIGHT,LTD,MRS,WILEY
169,947,C53,COPYRIGHT,DENDRA2,INC,TUBULIN,USING,WILEY
169,194,AMONG,COPYRIGHT,GBM,GTV,LTD
169,185,607,684,CODES,CONCLUSION,COPYRIGHT,DENMARK,ICD,INC,JUTLAND,LABEL,MEDICAL,METHODS,NORTH,NPR,OBJECTIVE,PATIENT,RECORDS,RESULTS,SETTING,TENTH
169,194,COPYRIGHT,JAPAN,LTD,OSAKA,THESE
169,BLOOD,CBV,CONCLUSION,COPYRIGHT,DIFFERENT,FRACTIONAL,IRELAND,LABEL,LTD,METHODS,NORMALIZED,OBJECTIVE,OPERATING,PCT,PERFUSION,PREDICTIVE,RESONANCE,RESULTS,ROI,SRT,WHITNEY
169,BIOMETRIC,HOWEVER,SOCIETY
070,098,169,177,BACKGROUND,COPYRIGHT,HYPERICIN,LABEL,MEIER,METHODS,RESULTS,SEVENTEEN,SOCIETY,SYNTHETIC
107,169,225,263,315,601,COPYRIGHT,DRAWING,HOWEVER,INSURANCE,SIR,THOSE
169,960,COPYRIGHT,CPT,FURTHER,GST,TMZ,U87
OTHER
945,AIP,TPR
169,99M,COPYRIGHT,INC,IVL,PUBLISHED
BACKGROUND,DIRECTIONS,LABEL,RESULTS
169,328,330,BRAIN,COPYRIGHT,EFFORTS,NSCLC,PCR,PRKCA,USING
001,005,160,CNS,EMMPRIN,HOWEVER,THEREFORE
CHADC,FLAIR,HOUNSFIELD
000,169,177,956,CONCLUSION,CSF,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QSI,RESULTS,SOCIETY,WHITNEY
169,COPYRIGHT,MFH,PRIMARY,SOCIETY
169,19Q,ANOTHER,COPYRIGHT,CPG,DIFFUSE,IDH,INC,NF1,PRONEURAL,WHILE,WILEY
169,COPYRIGHT,HOWEVER,INC,WILEY
TREATMENT
157,233,324,693,ANZ0001,ANZ8101,ANZ8614,ANZ9311,FACTORS,WOMEN
AIM,BACKGROUND,ENGLAND,ENGLISH,EPISODE,LABEL,LINKAGE,METHODS,RESULTS,STATISTICS,STUDIES,SUBSEQUENT,USING
MRI,NEURO,PFS,SIMILARLY,VOXEL
AFTER,DIAGNOSIS,ENDOSCOPIC,MRI
CAREFUL,CNS,CONCLUSION,LABEL,MATERIALS,MEDICAL,METHODS,MPNST,NF1,OBJECTIVE,OBJECTS,RESULTS,SEVEN,THERE,THREE
116,125,169,2ML,9ML,AFTER,BETWEEN,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SEPTEMBER,TEN
169,ANATOMICAL,COPYRIGHT,GALEN,INC,SEVERAL,THERE,WILEY
169,946,COPYRIGHT,CPG,EGR,INCUBATION,NAG,TREATMENT
108,169,171,342,945,BACKGROUND,CHILD,COPYRIGHT,DESPITE,HCC,LABEL,METHODS,RESULTS,SOCIETY,THESE
HOWEVER,SINCE,SMALL
169,CLOSE,COPYRIGHT,THESE
ABC,ABCB1,ABCG2,ADENOSINE,ALZHEIMER,CHANGES,PARKINSON,PET,PGP,SPECT
100,160,229,CNS,INITIAL,KPS,LOCAL,NSCLC,SRS,SURGERY,THESE
110,177,AFTER,APB,BACKGROUND,CONCLUSION,DCS,LABEL,METHODS,OBJECTIVE,RESULTS,SEM,TMS
BACKGROUND,CED,CONCLUSION,CONVECTION,FLAIR,HSA,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIMILAR
DIFFERENT,OPTIMAL
871,AGE,COX,CRT,GBM,GYE,HDT,RANDOMISED,TREATMENT
133,209,BACKGROUND,CK5,EXPRESSION,LABEL,METHODS,RESULTS
001,169,398,567,763,AML,BACKGROUND,COPYRIGHT,FATIGUE,HOWEVER,HRQOL,INC,LABEL,METHODS,NORWEGIAN,PROCEDURE,REGARDLESS,RESULTS,SEVENTY,SHORT,THERE,WILEY,WILMS
169,AMONG,COPYRIGHT,EPIGENETIC,HOWEVER,MMR,PRS,TMZ
169,COPYRIGHT,VCH,WILEY
954,GIC,THEREFORE,THESE
945,946,AIM,BACKGROUND,EXPRESSION,LABEL,METHODS,OBJECTIVE,PATIENT,PCR,PRL,RESULTS,RII,TGF,THERE
ADHERENCE,BACKGROUND,DISCUSSION,EVALUATION,FURTHER,HOWEVER,LABEL,PROGRAMME,RESULTS,SPLITTING,THERE,UNLABELLED
001,113,119,169,COPYRIGHT,GRADE,HBO,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS
169,COPYRIGHT,INC,LABEL,MALIGNANT,UNASSIGNED,UNLABELLED
169,ACHENBACH,AIM,ASSESSMENT,AUTHORS,BASED,COLLEGE,CONCLUSION,DEPARTMENT,EMOTIONAL,JANUARY,JOURNAL,LABEL,METHODS,OBJECTIVE,PAEDIATRIC,RESULTS,SCIENCE,STRENGTHS,TRONDHEIM,UNIVERSITY
LIN28,MALIGNANT,NANOG,SALL4,SINCE,SMARCB1,SNF,SWI
160,BACKGROUND,CPP,HOWEVER,ICP,LABEL,MAP,METHODS,RESULTS,SAH,SAO,TBI,THERE
215,BACKGROUND,CALCIFYING,CONCLUSION,IMPORTANCE,LABEL,METHODS,MRI
156,202,235,BACKGROUND,BLOOD,CONCLUSION,EARLY,EFFECTIVE,FINAL,HEMOSTASIS,LABEL,METHODS,MPH,OBJECTIVE,RESULTS,SUBJECTIVE,THERE
169,COPYRIGHT,CPP
169,BRAIN,COPYRIGHT,INC,MRI,PUBLISHED
169,244,28061,CNS,DIA,DIG,GERMANY,HOWEVER,INSTITUTE,JAPAN,KOREA,REPORTS,SOCIETY,ZULCH
169,AMONG,APRIL,AUTHORS,BACKGROUND,CNS,DEPARTMENT,JAPAN,LABEL,MARCH,METHODS,PEDIATRIC,PEDIATRICS,RESULTS,SOCIETY,THERE
169,916,AEA,AUTHORS,BRITISH,CNS,FURTHER,JOURNAL,SOCIETY,THC
169,AMP,AUTHORS,BRITISH,JOURNAL,METFORMIN,SOCIETY
001,005,371,549,685,COX,FURTHER,GBM,LOG,RATIO,SERUM
BACKGROUND,LABEL,METHODS,RESULTS,RUGBY,TOP
113,196,ACCORDING,DISORDERS
169,BIOMETRIC,SOCIETY
169,945,954,COPYRIGHT,FINALLY,K252A,THESE,TRK
054,116,118,BBB,MRI,STUDIES,THESE
200,BACKGROUND,CURRENT,GBM,GROSS,LABEL,MATERIALS,METHODS,RESULTS,SALVAGE,SIXTY,TMZ
169,177,956,AMIDE,APT,COPYRIGHT,INC,MRI,MTR,WILEY
169,177,COPYRIGHT,INC,MAPPING,MRI,WILEY
100,169,177,233,COPYRIGHT,GLYCINE,INC,METABOLITE,MODEL,RAO,WILEY
004,109,172,548,565,605,906,CHINESE,FURTHER,GBM,MEANWHILE,THESE
779,CCI,ERK,GFP,HOWEVER,MB231,MDA,MEK,PD98059,SL327
001,074,160,BRAIN,DIFFERENT,HODGKIN,HOWEVER,USING
WIG
MACDONALD
DESPITE,FURTHER,HOWEVER,PRIMARY,SUGGESTED,THERE,THEREFORE
001,169,177,519,572,COPYRIGHT,FORTY,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PARENTS,RECOVERED,RESULTS,SLEEP,THEIR,THESE
ALZHEIMER,PARKINSON
169,350,COMBINING,COPYRIGHT,INC,RESULTS,STRUCTURAL,WILEY
005,169,420,BACKGROUND,HOWEVER,INITIAL,LABEL,MEIER,METHODS,PFS,RESULTS,SOCIETY,TEN
001,025,041,ASSAY,BTS,HOWEVER,PCR,THESE
169,CDA,COPYRIGHT,HLA,HOWEVER,INC,JXG,LANGERHANS,WILEY
169,225,COPYRIGHT,ERBB2,JUN,MCF,NOTABLY
169,ACTIVATING,COPYRIGHT,GBM,HOWEVER,TRANSIENT
001,160,COMPARISON,ECC,EDINBURGH,GRADE,III,IMMEDIATE,USING
CHORDOMAS,CURRENT,DESPITE,HOWEVER,WHILE
GBM
350,CD133,EXPRESSION,GBM,HES,HEY,MSI,NOTCH,SCS,SOX
119,370,CNS,FLORIDA,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVERSITY,VARIABLES
169,177,390,KDR,KIT,PCR,SCREENING,SOCIETY
169,BRAIN,CNS,CSF,IVL,MRI,PERIPHERAL,SOCIETY,THESE

001,054,056,160,ACCORDING,BCL,CNS,DLBCL,EASTERN,FORTY,GROUP,HOWEVER,LDH,PCNSL,PFS,RESULTS
147,169,194,COPYRIGHT,OVERALL,SRL
169,COPYRIGHT,FINALLY,HOWEVER,INC,THEREFORE
160,19Q,GRADE,III,NOA,PFS,SECONDARY,TMZ
001,160,204,LMD,TREATMENT
118,CD171,EXOSOME,FAK,GBM,HOWEVER,III,INJECTION,L1CAM,SCRATCH,SUPER,THESE,WESTERN
GLIOMAS,HMGN5,NSBP1,U87
001,100,169,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,CSF,DIAGNOSTIC,IRELAND,LABEL,LTD,METHODS,MRI,PPV,RESULTS,THEREFORE
00001,001,169,177,ADS,BACKGROUND,BRAIN,COPYRIGHT,FORTY,IRELAND,JANUARY,LABEL,LTD,METHODS,MTS,RESULTS,SCC,STAGE,THREE
169,177,ANGELES,BACKGROUND,COPYRIGHT,GROSS,INC,JANUARY,LABEL,LOS,METHODS,PROCEDURE,RADIATION,RESULTS,TEN,WILEY
169,CLUSTER,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY
AUTOPSY,DESPITE,FURTHER,HOWEVER,IGG,LABORATORY
EWING,PRIMARY
169,BLACKWELL,FINALLY,FOUNDATION,GBM,JOURNAL,LTD,MOLECULAR,PRE,PUBLISHING,THEREFORE
ALZHEIMER,ASIAN,EXTENSIVE,PARKINSON,WHY
AKT,AMONG,APART,DUE,ECM,EGF,GBM,INHIBITION,MMP,PI3,REPRESSION,THESE
BRAIN,THEREFORE
160,AFP,EIGHT,HCG,JANUARY,SERUM,SIX
10Q,140,19Q,BACKGROUND,CONCLUSION,GLIOMAS,HOWEVER,III,LABEL,METHODS,OBJECTIVE,RESULTS,WORLD
100,169,MRI,SOCIETY,THERE,THESE,USING
III,REMISSION,SIMPSON
169,AFTER,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,PATHOLOGY,RESULTS,SEVEN
169,945,COPYRIGHT,HOWEVER,INC,NONGENOMIC,NUCLEAR,THESE
169,COPYRIGHT,INC,THESE,WHILE,XENOPUS
100,125,169,COPYRIGHT,DLT,GRADE,INC,KARNOFSKY,LABEL,MATERIALS,METHODS,MTD,OBJECTIVE,PHASE,PURPOSE,RESULTS,TAMOXIFEN,WORLD
169,ASL,CBF,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAS,USING
016,100,169,300,600,COPYRIGHT,EEG,FEDERATION,HFO,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS
100,169,BASED,CONCLUSION,COPYRIGHT,FDG,FGD,GRADE,IRELAND,LABEL,LTD,METHODS,MRI,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS
169,BBB,CENTRAL,CNS,COPYRIGHT,DROSOPHILA,INC,WILEY
169,COPYRIGHT,FURTHER,INC,MALIGNANT,SINCE,WILEY
169,COPYRIGHT,INC,WHILE,WILEY
169,ABCB1,ABCG2,ATP,BBB,BRAIN,COPYRIGHT,SUNITINIB
150,AGE,BETWEEN,COMPARISON,CONCLUSION,EFS,LABEL,LOW,MEIER,METHODS,OBJECTIVE,OPTIC,PURPOSE,RESULTS,SURGERY
AFTER,DETACHMENT,TEN,TOXIC
ASNCMTRNAS,BACKGROUND,CONCLUSION,ISH,LABEL,METHODS,RESULTS,RNASE
160,5TA,RSV,SUICIDE,THEREFORE
033,040,169,ACTUARIAL,BACKGROUND,COPYRIGHT,DESPITE,INC,KARNOFSKY,KPS,LABEL,METHODS,PCI,RESULTS,SEVENTY,SRS
169,CONFORMITY,COPYRIGHT,CROWN,HOWEVER,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS
169,COPYRIGHT,CSI,DELAYED,FORTY,HEIDELBERG,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIXTY,UNIVERSITY
100,169,CAREFUL,COPYRIGHT,INC,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS

000,163,640,BASED,DEPENDING,ENGLAND,GBM,GLIADEL,III,SINCE,STUPP,TA121
THERE
WHILE
160,INDIA,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SOUTH
100,CONCLUSION,D95,D99,HOWEVER,IDS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PTV,RESULTS
BASED,CUSHING,GHRELIN,PRL,TSH
169,GAE,PROLONGED,SUCCESSFUL,WILEY
GBM,PATIENT,RBC,THESE,WESTERN
AFTER,CD8,CTL,DCS,HSP70,MHC,THESE
001,118,160,BETWEEN,BRAIN,CRC,FORTY,KOREA,SOUTH
BACKGROUND,CONCLUSION,DORELLO,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
169,COPYRIGHT,DPTOOLS,IRELAND,LTD,REGIONS
001,002,003,016,027,143,169,177,321,336,AUTHORS,BEIJING,EYE,FIELD,FOUNDATION,LABEL,LARGE,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
946,INCREASED,IPF,NT4,NTS,PRIMARY,TAKEN
169,COPYRIGHT,ECNCI,EXCELLENT,HEG,HEV,INC,WILEY
169,COPYRIGHT,MALIGNANT,PKA,TMZ
102,160,473,559,785,KINGDOM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMR,THERE
417,517,900,AGE,APC,BRAIN,MALIGNANT,PRATO
160,AMONG,APRIL,BETWEEN,HOWEVER,JANUARY
160,946,INTEGRA,INTEGRATED,INTERFERON,OVERALL,PHASE,TRIAL
005,008,160,C57BL,NPC,RADIATION,SVZ
MINST,MPNST,THESE
HOWEVER,LAPATINIB
120,155,8G7G3,AMONG,BASED,BENCHMARK,CNS,FEW,III,SPT24,TTF,ULTRA
100,ANCHORING,BACKGROUND,BASED,BRAIN,C30,CONCLUSION,ESTIMATES,HRQOL,LABEL,MATERIALS,MCIDS,METHODS,QLQ,QUALITY,RESULTS,THESE,TREATMENT,WORLD
160,167,169,ADDITIONAL,ANXIETY,COPYRIGHT,FCS,GMM,INVENTORY,LABEL,LOW,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,STATE,SUBGROUPS,USING,YOUNGER
001,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PURPOSE,RECORDS,RESULTS,SLACK
BACKGROUND,LABEL,MAXIMUM,METHODS,OVERALL,PFS,PRIMARY,RESULTS,SAGOPILONE,TREATMENT
500,BACKGROUND,BRAIN,CHEMONAIVE,CONCLUSION,FORTY,FUNCTIONAL,GRADE,III,INITIAL,LABEL,METHODS,NON,NSCLC,PEMETREXED,PRIMARY,RESULTS,SECONDARY,WHOLE
169,262,BRAIN,COPYRIGHT,METASTATIC,PROLONGED,SOCIETY
ETFAL,SISLI,THEREFORE
BRAIN,CHANGES,THESE
169,AID,APHAB,BENEFIT,CONCLUSION,COPYRIGHT,HEARING,IRELAND,LABEL,LTD,METHODS,NOISE,OBJECTIVE,PROFILE,QUALITY,RESULTS,SOUND,TESTS
169,AUTHORS,BRAIN,EIGHT,III,PATHOLOGY,R132H,SOCIETY,WORLD,YET
LOW,OVERALL,SS3,THERE,TMZ,WHEREAS
001,006,160,AREAS,QUESTIONS
AVASTIN,HOWEVER,THERE,THEREFORE,TREATMENT
169,COPYRIGHT,INC,NF1,PDGFR,THESE,USING,WILEY
CTA,INITIAL,MRI,NON,SUBSEQUENT
BACKGROUND,BASED,DISCUSSION,FURTHER,HOWEVER,LABEL,TSC
000,154,177,954,COX,NUCLEAR,TAKEN,THESE
001,004,156,BMD,FRACTURED,FRACTURES,IGF,PRL,VERTEBRAL
300,ADI,ADIPSIC,AVP,DDAVP,FLUID,HSI,THEIR,THESE,THREE,VAS
160,CIR,CYBERKNIFE,IIR,LINAC,RAD51,THREE,U87
169,177,BACKGROUND,COLLEGE,CONCLUSION,COPYRIGHT,DEPARTMENT,FLAIR,HOWEVER,IMAGING,IRELAND,JANUARY,LABEL,LTD,METHODS,MRI,NIGERIA,OBJECTIVE,PITUITARY,RADIOLOGY,RESULTS,SINCE,T1W,T2W,TOF,UCH,UNIVERSITY
107,169,3DCRT,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,V75
001,017,169,229,362,ACCORDING,BETWEEN,CONCLUSION,COPYRIGHT,GLIADEL,GRADE,HOWEVER,III,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RFS,STUPP
118,169,BETWEEN,COPYRIGHT,GROUP,HEIDELBERG,INC,ION,LABEL,METHODS,RADIATION,RESULTS,THERAPY,UNLABELLED
135,169,COPYRIGHT,GENERAL,INC,LABEL,MATERIALS,MCO,METHODS,MGH,OBJECTIVE,PLANS,PURPOSE,RESULTS,TEN
120,169,180,300,740,BACKGROUND,BNP,COPYRIGHT,ECG,FURTHER,HOWEVER,INC,LABEL,METHODS,RESULTS,THP,WILEY
169,945,946,BACKGROUND,COPYRIGHT,CORRECTION,ERBB2,EXP,INC,LABEL,MBS,METHODS,PCR,PDGFR,PROCEDURE,RESULTS,SAMPLES,SEVERAL,SPARC,WILEY
ACUTE,DIFFUSE,DIPGS,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THREE
132,169,172,945,COPYRIGHT,IDH,III,INC,ISOCITRATE,MUTATIONS,NADPH,WILEY
000,064,100,119,231,280,783,BACKGROUND,COSTS,LABEL,LYS,METHODS,QALYS,RESULTS,SRS
160,CSF,CVS,KLEBSIELLA,MENINGITIS,THESE
023,169,BACKGROUND,BLOOD,BOSWELLIA,BOSWELLIC,COPYRIGHT,FORTY,KBA,LABEL,METHODS,MRI,RESULTS,SECONDARY,SOCIETY,THERE,THESE
006,169,AFTER,BACKGROUND,COGNITIVE,COPYRIGHT,DECLINE,EEG,ELDERLY,HOWEVER,HYPERBARIC,INFORMANT,LABEL,LERCS,METHODS,NCT,NEITHER,P3A,P3B,RESULTS,SOCIETY,TEN
CHILD,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SYSTEMATIC,USING,WHILE
11Q23,13Q,14Q,169,20Q,22Q,9PTER,SOCIETY
169,CNS,EVALUATION,FURTHER,HLA,PRIMARY,STAGING,TRANSPLANT,WILEY
161,169,BACKGROUND,COPYRIGHT,CRT,HOWEVER,INC,LABEL,METHODS,PREVALENCE,PROCEDURE,RESULTS,SURVIVORS,SYMPTOM,THESE,WILEY
GRADE,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,THERE
160,17R,HOWEVER,IHC,MEANWHILE,MMP,THESE
100,109,190,945,BONFERRONI,CRANIAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRT,PTV,PUBLISHED,PURPOSE,RESULTS
169,HOWEVER,RTS,SMARCB1,SOCIETY
169,HOWEVER,SEVERAL,SOCIETY,TAU,THERE,THESE
160,CNS,KARNOFSKY,KPS,LMS,SYMPTOM,VPS
100,BACKGROUND,CNIII,CNS,FIFTEEN,LABEL,METHODS,MRA,PITUITARY,RESULTS,TESLA
ADDITIONAL,AIM,AMONG,BACKGROUND,GRP,LABEL,METHODS,OBJECTIVE,PCR,PITUITARY,PRL,RAS,RESULTS,USING
169,BCL,COPYRIGHT,IRELAND,LTD
020,169,177,AUTOPHAGY,INDUCTION,LAMP1,SOCIETY,THESE,TMZ,WESTERN
169,CD133,CHONNAM,COX,HOWEVER,SOCIETY,UNIVERSITY
12Q,HOWEVER,III,PCR,RAS,RRP22,THEREFORE,WORLD
041,169,177,328,567,AUTHORS,BRAIN,CHI,CLAUDIN,CNS,PATHOLOGY,RTS,SMARCB1,SOCIETY
CHILDHOOD,MMR,THESE,WILEY
169,202,ASL,COPYRIGHT,GMD,INC,MRI,PERFUSION,STRUCTURAL,WILEY
DELAY,DIFFERENT,POSTERIOR,THEREFORE,TREATMENT
169,174,BASED,COGNITIVE,CONCLUSION,COPYRIGHT,FEW,JANUARY,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SCREENING,WILEY
11P,11Q,169,ALLELIC,BRAIN,COMPARISON,HTATIP2,PATHOLOGY,PRL,SOCIETY,WHILE
LONAFARNIB,MALIGNANT,RAS,THESE,U87
ALZHEIMER,DESPITE,FIRSTLY,THERE
000,100,448,BACKGROUND,CONCLUSION,HOWEVER,JAPAN,LABEL,METHODS,RESULTS,THESE,WESTERN
AFTER,HENCE,HOWEVER,MRI,U87
169,ACUTELY,APRIL,CONCURRENT,COPYRIGHT,GBM,GIVEN,GRADE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHASE,RESULTS,SEVEN,USING
169,ACUTE,CONCLUSION,COPYRIGHT,GRADE,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,OVERALL,PHASE,PURPOSE,RESULTS,THERE,WORLD
105,110,AFTER,ART,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RIVERVIEW,UMM,UNIVERSITY,UWR,WISCONSIN
169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
MRI
CNS,MRI,THERE,THESE,WHETHER
231,231BR,361,946,ACTIVATION,CONSISTENT,PKA,THESE
CPG,DNMT1,DNMTS,H3K4ME2,H3K9ME2,HOWEVER,INHIBITING
AOA,CENTRAL,GBM,NERVOUS,OLIGO,TUMOURS
BACKGROUND,BRAIN,CONCLUSION,DIC,LABEL,LMWHS,LOW,METHODS,MTS,RAYNAUD,RESULTS,THERE,THESE,TREATMENT,VTE
160,AMONG,HOWEVER,III,MINIMAL,PEABODY,PICTURE,SCALE,VOCABULARY,WHILE
120,150,180,200,230,260,290,320,AKT,BACKGROUND,BETWEEN,CONCLUSION,CONTINUOUS,CRM,DISEASE,DLT,DOSES,ESCALATION,EXCLUSIONS,LABEL,METHODS,MKC,MTD,OTHER,RCC,RESULTS,SECONDARY
042,169,BACKGROUND,COPYRIGHT,FDG,INCREASED,KINETIC,LABEL,LEU,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SOCIETY,SUV,SWS,WEBER
160,SUBSEQUENT
945,APOA1,FIFTEEN,III,NETWORK,SHOTGUN,SYSTEMATIC,VDAC2,WESTERN
100,120,150,160,AFTER,HOWEVER,IGF,PEG,SSA
112,136,244,260,711,753,780,796,COLLEGE,GBM,GROUP,OVERALL,RADIATION,RPA,THERAPY
BBB,NANOSHELLS,NIR,PEGYLATED
AVASTIN,FDA,KNOWN,MALIGNANT
169,ANOVA,CONCLUSION,COPYRIGHT,DIFFUSION,DTI,LABEL,METHODS,OBJECTIVE,RESULTS,ROI,SAS,THERE
169,COPYRIGHT,DIFFERENT,DUE,IRELAND,LTD,PARENTERAL,ROO
160,215,ACTUARIAL,COX,LINAC,LOCAL,MEIER,NON,NSCLC,OVERALL,PRIMARY,PROGNOSTIC,SRS
568,ALBERTA,EXCEL,GROUP,KPS,LABEL,METHODS,OBJECTIVE,OVERALL,RADIATION,RECURSIVE,RESULTS,STATA,THERAPY,TREATMENT
ANEURYSMS,DISCUSSION,HOWEVER,SUGGESTED,UNCOMMONLY
003,169,COPYRIGHT,COX,REF

169,BIALLELIC,DIAGNOSTIC,HOWEVER,IHC,LYNCH,MMR,MSI,NF1,THESE,WILEY
CNS,HOWEVER,THERE
191,639,649,AMONG,CASES,CAUCASIAN,GBM,MALIGNANT,RESULTS,RTEL1,THESE

432,JANUARY
ACC,ADENOID,BARTHOLIN,CAUCASIAN,INSTITUTE

HIRSUTISM,SEVERAL,WHILE
914,FOLLOWING,HOWEVER,MRI,THERE,ULTRASOUND

LDD,LHERMITTE,MRI
CUSHING,HENCE,KNOWLEDGE,MRI
DUE
100
DUKES,HICKMAN,HOWEVER,MRI
METASTATIC,PRIMARY
215,AFTER,IMAGING,PITUITARY

169,945,AKT,AMINO,COPYRIGHT,GLUR2,GLUTAMATE,INC,SEVERAL,WILEY
154,DENMARK,HOWEVER,OVERALL,SEVENTEEN,VEGFR
169,ANAPLASTIC,CALIFORNIA,COPYRIGHT,FRANCISCO,HOWEVER,SAN,SEVERAL,UNIVERSITY
19Q,AFTER,EIGHT,HISTOLOGY,MAXIMUM,MRI,PRIMARY,T10
150,ROC
160,CAUCASIAN,HISTOLOGY,III,LOUIS,MRI,T10,TEO,WORLD
001,005,102,378,724,849,NGALR,PCR,THEREFORE,THESE,USING
BMI,CD133,VWF
169,194,ALA,COPYRIGHT,MRI
160,946,AGAIN,CRH,CUSHING,SIMILARLY,THESE
174,248,AFTER,AGE,CNS,FORTY,HENCE,HIT,PNETS,PRIMARY,SKK,START,T10
100,CONVERSELY,DIFFUSELY,EPIGENETIC,THESE
154,159,967,GBM,GROUP,III,KARNOFSKY,KPS,OVERALL,RADIATION,RECURSIVE,RPA,SINCE,THERAPY,THEREFORE,THREE,TMZ,USING,WHILE
169,215,DEFINITIVE,EHE,MRI,SOCIETY
169,2H3,916,945,ACU,AUTHORS,BACKGROUND,BDS,BRITISH,CANNABINOL,CBC,CBD,CBG,CBN,COS,JOURNAL,KEY,LABEL,METHODS,OBJECTIVE,PURPOSE,RBL,RESULTS,SOCIETY,THC,THCVA,THESE,TRP,TRPA1,TRPM8,TRPV1,TRPV2
001,144,169,179,AGE,AUSTRALIA,COLON,COPYRIGHT,COX,CRC,MUTYH,THERE,USING
108,DEFERRING,HDC,HOWEVER,KPS,OBJECTIVE,ONGOING,PCNSL,PFS,SIXTY,TREATMENT,WHOLE
097,169,BRIGHAM,COPYRIGHT,DISTANT,FRAMELESS,GRADE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,WHOLE,WOMEN
169,956,BECAUSE,CARLO,CONCLUSION,COPYRIGHT,DET,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,THESE
104,105,162,169,253,296,957,ALONG,CONCLUSION,COPYRIGHT,DIFFUSE,DIR,HGG,HOWEVER,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BECAUSE,GD2,GD3
GIVEN,INTERVIEWS
CD133,PAS
MEANWHILE,NOTABLY,NPTX2,WHILE
160,DESPITE,ENGLISH,PRIMARY,WHOLE
AFTER,BRA,CLINICALLY,GCDFP,HISTOLOGY,OSS,TNM
CSF,DIAGNOSIS
038,106,169,AUTHORS,BJU,EASTERN,FORTY,FURTHER,GROUP,LABEL,LOCAL,METHODS,OBJECTIVE,OVERALL,RESULTS,SECONDARY,SRS,THERE
100,169,272,612,961,CHO,CONCLUSION,COPYRIGHT,FDG,III,INTENSITY,LABEL,METHODS,MRI,MRS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SOCIETY
035,085,212,279,913,COX,GAMMA,GKS,HOWEVER,KNIFE,PFS,THERE,UNIVARIATE,VFD
INTERVIEWS,PURPOSIVE
100,137,946,ABL,ADULT,BCR,DASATINIB,EPHA2,GBM,KIT,KPS,PDGFR,PFS,SIX,SRC,THERE,TREATMENT
001,012,024,028,029,034,036,037,076,740,AGE,BACKGROUND,BR2,BRESLOW,CLARK,CNS,CONCLUSION,COX,III,LABEL,LDH,M1A,M1B,M1C,METHODS,OLDER,RESULTS,THREE
169,BLACKWELL,CNS,LTD,MODULATING,PUBLISHING,THEREFORE,USING
101,DC101,INHIBITION,USING
000,007,100,383,411,439,ABOUT,BETWEEN,DEPARTMENT,ICT,MENINGIOMA,PATHOLOGY,SABAH
019,034,10Q23,169,COX,MEIER,SOCIETY
945,AKT,AMP,ATP,MYC,NAD,PEROXISOME,PGC,SIRT1,THEREFORE
COX,GBM,MRI,SVZ,THESE,UNIVARIATE,WHILE
169,215,500,ACCORDING,ADC,BACKGROUND,BOARD,COPYRIGHT,DWI,FLAIR,IRELAND,LABEL,LTD,MATERIALS,MAX,METHODS,MIN,MRI,OBJECTIVE,PURPOSE,RESULTS,ROI,TESLA
169,275,4EBP1,COPYRIGHT,DFSPS,EVALUATION,FIFTEEN,HOWEVER,PARTIAL,PDGFB,SECONDARY,SOLID,THREE
001,CPG,MEIER,MSP
169,289,ANATOMY,COPYRIGHT,DICOM,HOWEVER,INACCURACY,INC,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS,THERE,USING
169,FCD,IIA,MAP,MIB,MRI,SOCIETY,THEREFORE,THESE
945,946,GBM,GBM8401,HIF,INHIBITION,NODAL,TAKEN,U87MG,USING
CD133,EMA,HOWEVER,IHC,MGACS,MGSCS,THESE
EARLY,REASONS,TSH
BACKGROUND,CASKI,CONCLUSION,DENMARK,GERMANY,HOWEVER,HPV,KIT,LABEL,MATERIALS,MCF,METHODS,PCR,PROBE,RESULTS,SAMPLES,SCREENING,THEREFORE,THREE,ZYTOMED
175,BETWEEN,CALVARIAL,HOWEVER,MARCH,METASTATIC,PRIMARY,QOL,RADIATION,SEPTEMBER,SKULL,TREATMENT
FIREFLY,ICP,ICR,LUCIFERASE,NANOSHELL,PRKDC,SUCCESS,THERE,TREATMENT
001,100,999,AMONG,LEV,QOL,RESPONDER
THERE
OVERALL,SURGERY,THERE,THREE,TREATMENT,TVR
001,052,271,802,ADDITIONAL,ASSESSMENT,BRAIN,DEPRESSION,FEW,FUNCTIONAL,GOALS,INVENTORY,LABEL,MEASURE,METHODS,OBJECTIVE,RESULTS,SCALE,SYMPTOM,THERAPY
001,160,177,215,ADC,BACKGROUND,CONCLUSION,DWI,FLAIR,HGG,LABEL,MAXIMUM,METHODS,MRI,PWI,RESULTS,STUDENT
233,GBS,THERE
FOCAL,IGF,IHC,MAS,MEDICAL,PRL,TREATMENT
169,945,COPYRIGHT,INC,NKT,PUBLISHED,SEVERAL
169,COPYRIGHT,CTV,GBM,HOWEVER,INC,LABEL,MATERIALS,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
169,CNS,FOCALLY,MRI,ROSENTHAL,ROSETTE,SOCIETY
169,AFTER,CHINESE,CNS,INI,SOCIETY,WORLD
160,AKT,BREFELDIN,COX,FINALLY,GIVEN,GRP78,MMP,MT1,U87
136,169,AUTHORS,BJU,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
160,ADDITIONAL,BACKGROUND,BECAUSE,CONCLUSION,ELECTRONIC,III,IMAGING,LABEL,METHODS,PPTID,RESULTS,T1WIS,T2WIS,WHILE,WORLD
001,159,169,COPYRIGHT,DUTCH,EXCLUSION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,YET
116,160,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
DIRECTIONS,NOW
001,160,BACKGROUND,GBM,LABEL,METHODS,MRI,RESULTS,THERE
PCT,PERFUSION
049,560,669,861,BMI,DELAYED,FIFTEEN,GHRELIN,INSULIN
002,100,177,CNS,CONCLUSION,FDG,LABEL,MET,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,SUV,THERE
100,169,BLACKWELL,III,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHING,RESULTS,SMEAR
169,LYNCH,MAP,MUTYH,NF1,WILEY
100,169,194,BACKGROUND,BRAIN,CHEST,COMBINING,COPYRIGHT,EMBOLIC,EVALUATION,FURTHER,HYPERDENSE,INC,LABEL,MEDLINE,METHODS,PUBLISHED,PULMONARY,RESULTS,TCD
113,120,125,169,AFTER,COPYRIGHT,GBM,GRADE,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS
169,250,BECAUSE,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,ROYAL,SRS,THERE
103,117,169,COPYRIGHT,IRELAND,LTD,MBC,PFS,THESE
100,123,169,200,300,ADVERSE,CONCLUSION,COPYRIGHT,CTCAE,DLT,FURTHER,GBM,GRADE,INC,LABEL,MATERIALS,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIX,SRS,TEN,TREATMENT,VANDETANIB
001,005,016,100,169,ATRTS,BETWEEN,CONCLUSION,COPYRIGHT,CPM,END,INC,INFANTS,LABEL,LEADING,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PURPOSE,RESULTS
169,600,ADL,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,FEW,FLEMING,FORTY,FUNCTIONAL,IRELAND,LABEL,LTD,METHODS,QUALITY,RATIONALE,RESULTS,SECONDARY,SPECIAL,TREATMENT
169,AFTER,CONCLUSION,COPYRIGHT,COX,INC,KARNOVSKY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERAPIES,WORLD
INDIVIDUAL,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WORLD
169,AMONG,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESECTION,RESULTS
169,CNS,COPYRIGHT,GIS,INSTITUTE,JENIN,KULLDORFF,NCI,SATSCAN,TULKARM,UNDER
001,007,ASSESSMENT,COGNITIVE,CST,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,STATE
DSM,IES,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,STRUCTURED
169,BECAUSE,CD138,CNS,COPYRIGHT,CSF,EPSTEIN,EXTRAORAL,HIV,INC,MOLECULAR,PBL,PCNSPBL,WILEY
CRANIAL,CUSHING,HENCE
169,300,AFTER,CONCLUSION,COPYRIGHT,DLT,EIAED,FIFTY,GROUP,INC,LABEL,METHODS,MTD,OBJECTIVE,PHASE,PURPOSE,RESULTS,TIPIFARNIB,TMZ
169,COPYRIGHT,CRT,CSI,DOSIMETRIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OED,PBT,PURPOSE,RESULTS
169,AFTER,APRIL,BETWEEN,CONCLUSION,COPYRIGHT,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,169,180,CONCLUSION,COPYRIGHT,FINALLY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
150,169,200,ADVERSE,CONCURRENT,COPYRIGHT,GRADE,INC,KARNOFSKY,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,TMZ
321,324,767,771,ANTICANCER,CENTRAL,CNS,DPD,DRUGS,HILDEBRAND,MCGEE,NEUROLOGIC,ONCOL,PERIPHERAL,PNS,THERE,TOXIC
FORTY,INCREASED,LABEL,METHODS,OBJECTIVE,PARENTS,PURPOSE,RESULTS
002,004,018,232,309,808,AUC,BACKGROUND,BIOMARKER,INCREASED,JANUARY,LABEL,MDR,METHODS,RESULTS,THERE
169,AFTER,AQUAPLAST,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
169,174,BBB,CED,COPYRIGHT,FDA,GBM,GLIADEL,III,IRELAND,LTD
169,488,672,CLASSES,COPYRIGHT,FITNESS,GBM,GROUP,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RPA,THERAPY
169,COPYRIGHT,FINALLY,THERE
KIT,METASTATIC
169,COPYRIGHT,FURTHER,INC,MTL,THESE,WILEY
169,AKT,BACKGROUND,CHANGES,COPYRIGHT,FDG,GRADE,INC,LABEL,MATERIALS,METHODS,PHASE,RESULTS,THROUGHOUT,TMZ
4T1,DOX,FGF,HDACI,MYC,ROS
160,AFTER,GBM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THOSE
169,COPYRIGHT,INC,ULTIMATELY
001,124,160,CPG,GLIOMAS,III,INDIA,INDIANS,PCR,TOTAL,WESTERN
BRAIN,FFDBF,III,PFS,RCC,RPA,SRS
169,223,AFTER,COPYRIGHT,FURTHER,GRO,INC,INHIBITION,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TREATMENT,UNIVERSITY
160,CONCLUSION,FIRST,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
ERK,MMP,RESULTS,U0126,U87
CONCLUSION,CONFORMITY,GAMMA,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS
169,ADRIAMYCIN,COPYRIGHT,EASTERN,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCNSL,PURPOSE,RESULTS,TEN
169,BECAUSE,BETWEEN,COPYRIGHT,DESPITE,FIFTY,FURTHER,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS
005,112,131,169,265,ARM,BECAUSE,CNT,COPYRIGHT,HOPKINS,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,RESULTS,THERE,THOSE
169,COPYRIGHT,EMOTIONAL,HOWEVER,INC,MANAGEMENT,SCALE,SITUATION,THESE,VBM,WILEY
047,169,AMONG,COPYRIGHT,COX,ESTIMATION,FIFTY,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGIC,PATHOLOGY,PREDICTORS,PURPOSE,RESULTS,WORLD
IHC,MSP,P14,P53,THEREFORE
169,CHEMOKINES,COPYRIGHT,FINALLY,IRELAND,LTD,THEREFORE
100,169,ADC,AUC,CHO,COMBINING,CONCLUSION,COPYRIGHT,DWI,GBM,IRELAND,LABEL,LTD,MATERIALS,METHODS,NAA,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS,ROC,THRESHOLD,WHILE
169,CONCLUSION,CONSISTENT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
CUSHING,FSH,MRI,SEVERAL,TSH
HOWEVER,MRI
EBV,EPSTEIN,FURTHER,HK1,K252A,NPC,SOUTHEAST,TRK
169,384,COPYRIGHT,GREATER,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PROVISION,REDUCTIONS,RESULTS,THERE,TRACE,WILEY
001,169,836,AMONG,COPYRIGHT,COX,ELDERLY,END,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,THOSE,UNIVARIATE
169,COPYRIGHT,INC,THESE,TOWER,WHOLE,WILEY
OVERALL
100,169,183,CONCLUSION,ENQUIRIES,GEORG,LABEL,METHODS,MICROSCOPY,MINOR,OBJECTIVE,RESULTS,STUTTGART,THEREFORE,WORKING
169,CONCLUSION,COPYRIGHT,IMAGING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OTHER,PAS,PILOMYXOID,PMA,PURPOSE,RESULTS,SIX,SOLID
FINALLY,GBM
169,292,ACTUARIAL,CONFORMAL,COPYRIGHT,DESPITE,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERSISTENT,PURPOSE,RESULTS,STAGE
169,ADC,ADCMEAN,CONCLUSION,COPYRIGHT,DWI,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIB,MINIMUM,MRI,OBJECTIVE,PROPELLER,RESULTS,USING
169,COPYRIGHT,MULTIMODAL,SOCIETY,THROMBOSED
169,COPYRIGHT,IRELAND,LTD
BACKGROUND,DESPITE,DISCUSSION,FURTHER,LABEL,METHODS,UTERINE
160,AFTER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PANCREATIC,SIXTEEN
160,BTR,HENCE,HOWEVER,III,JAPAN,KPS,NSCLC,RCT,RPA,SRS,TREATMENT
169,COPYRIGHT,INC,LABEL,METASTATIC,METHODS,OBJECTIVE,ORR,OTHER,PFS,RCC,RESULTS,SEVENTY,THERE
BACKGROUND,BCA,CBT,COMPONENTS,CONCLUSION,DEPRESSION,DSM,HYPOTHESES,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
HOWEVER,IRS,MVD,ODG,PCR,WESTERN
001,004,005,104,129,144,248,579,ATM,IRANIAN,PCR
ACCORDING,DIAGNOSIS,USUALLY
100,160,ACCORDING,PRECISE,TELOMERES
169,AREAS,COMPONENTS,CONCLUSION,COPYRIGHT,DSA,DWI,EROSION,IRELAND,ISFTS,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,RESTRICTED,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,HOMOGENOUS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,THERE
122,CNS,ELISA,HIV,MRI,PRIMARY,STAGING

NMC,NUT
ACROMEGALY,BACKGROUND,LABEL,UNASSIGNED
IMAGING
6TH,PITUITARY
169,200,AIM,BACKGROUND,CONCERNING,DUE,LABEL,LITERATURE,METHODS,OBJECTIVE,OUTCOME,RESULTS,SOCIETY,ZNS
246,BECAUSE,GERMINOMAS,INITIAL
DIFFERENT,OPTIC,THERE
LANGERHANS,SEVEN,THERE
BACKGROUND,CONCLUSION,LABEL,MANAGEMENT,METHODS,PITUITARY,RECURRENCE,RESULTS
SCO,SPINDLE
AFTER,NON,PRIMARY,WHILE
000,111IN,AFTER,HENCE,HOWEVER,MEDICAL,MRI,OCTREOSCAN,PITUITARY
946,GCT,PATIENT,SEVERAL
GIANT,THESE,TREATMENT
